<DOC>
<DOCNO>WT22-B27-1</DOCNO>
<DOCOLDNO>IA089-000952-B037-23</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AS1996.html 192.102.250.248 19970208032758 text/html 4627
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:15:18 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:49 GMT
Content-type: text/html
Content-length: 4444
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Applied Physics</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Applied Physics</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Butler, D.J.</b>, *Kohler, R. and *Forbes, G.W. (1996)
Diffraction effects in the radiometry of coherent beams.
<i>
Applied Optics</i>
35(13): 2162-6  11 refs, illus.
<P><B>Ciddor, P.E.</b> (1996)
Refractive index of air: new equations for the visible and near infrared.
<i>
Applied Optics</i>
35(9): 1566-73  36 refs
<P><B>Cox, P.</b>, Shiel, R.J. and *Green, J.D. (1996)
Rotifera recorded from New Zealand, 1859-1995, with comments on zoogeograph.
<i>
New Zealand Journal of Zoology</i>
23: 193-209  85 refs
<P><B>Fletcher, N.H.</b>, *Hilton, A.D. and <B>Ricketts, B.W.</b> (1996)
Optimization of energy storage density in ceramic capacitors.
<i>
Journal of Physics. D. Applied Physics</i>
29: 253-258 11 refs, illus.
<P>*Fletcher, N.H. and <B>Thwaites, S.</b> (1996)
Propagant phase in reverberant environments.
<i>
Journal of the Acoustical Society of America</i>
99(1): 314-323 11 refs, illus.
<P><B>Gardner, J.L.</b> (1996)
A four-element transmission trap detector.
<i>
Metrologia</i>
32: 469-72  6 refs, illus.
<P><B>Glass, M.</b> (1996)
Fresnel diffraction from curved fiber snippets with application to fiber diameter measurements.
<i>
Applied Optics</i>
35(10): 1605-16  9 refs, illus.
<P><B>Hariharan, P.</b> (1996)
Optical flat surfaces: direct measurements of the spatial frequency spectrum of surface errors.
<i>
Optical Engineering</i>
35(2): 484-5  4 refs, illus.
<P>*Hilton, A.D. and <B>Ricketts, B.W.</b> (1996)
Dielectric properties of Ba<sub> 1</sub>-<sub> x</sub>Sr<sub> x</sub>TiO<sub> 3</sub> ceramics.
<i>
Journal of Physics. D. Applied Physics</i>
29: 1321-5  27 refs, illus.
<P><B>Lowke, J.J.</b> (1996)
A theory of ball lightning as an electric discharge.
<i>
Journal of Physics. D. Applied Physics</i>
29: 1237-44  49 refs, illus.
<P><B>Muller, K-H.</b>, <B>Savvides, N.</b>, <B>Katsaros, A.</b>, *Guo, Y.C. and *Dou, S.X. (1996)
AC loss from susceptibility measurements in Bi-2223 / Ag superconducting tapes.
<i>
Czechoslovak Journal of Physics</i>
46 (supp. S3): 1297-8  2 refs, illus.
[Also published in the Proceedings of the 21st International Conference on Low Temperature Physics. Part S3 - Superconductivity 2: HTS - Granular superconductors (Prague, Czechoslovakia: August 8-14, 1996)]
<P><B>Murphy, A.B.</b> (1996)
Demixing in a free-burning arc in a mixture of argon and nitrogen.
<i>
In: Fauchais, P (ed.). Proceedings of the International Symposium on Heat and Mass Transfer under Plasma Conditions</i>
pp. 151-7  4 refs, illus.
(NY, USA: Begell House)
<P><B>Murphy, A.B.</b> (1996)
A comparison of treatments of diffusion in thermal plasmas.
<i>
Journal of Physics. D. Applied Physics</i>
29: 1922-32  46 refs, illus.
<P><B>Murphy, A.B.</b> (1996)
Modelling and diagniostics of plasma chemical processes in mixed-gas arcs.
<i>
Pure and Applied Chemistry</i>
68(5): 1137-42  15 refs, illus.
<P><B>Osman, P.D.</b> and Cornell, B.A. (1996)
The phosphorus-31 spectra of dielectrophoretically reoriented tubules in the H<sub>II</sub> phase of DOPE.
<i>
Biochimica et Biophsica Acta</i>
1278: 160-168 26 refs, illus.
<P>*Somlo, P.I. and <B>Hunter, J.D.</b> (1996)
On the TE<sub>10</sub>-mode cutoff frequency in lossy-walled rectangular waveguides.
<i>
IEEE Transactions on Instrumentation and Measurement</i>
45(1): 301-304 11 refs, illus.
<P><B>White, G.K.</b> and <B>Andrikidis, C.</b> (1996)
Thermal expansion of chromium at high temperature.
<i>
Physical Review. B. Condensed Matter</i>
53(13): 8145-7  17 refs, illus.
<P><B>Wylie, R.G.</b> and <B>Fisher, R.S.</b> (1996)
Molecular interaction of water vapor and oxygen.
<i>
Journal of Chemical and Engineering Data</i>
41: 175-80  9 refs, illus.
<P><B>Wylie, R.G.</b> and <B>Fisher, R.S.</b> (1996)
Molecular interaction of water vapor and air.
<i>
Journal of Chemical Engineering Data</i>
41: 133-142 32 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-2</DOCNO>
<DOCOLDNO>IA057-000941-B003-65</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/PX1995.html 192.102.250.248 19970208042712 text/html 10434
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:14:32 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:39 GMT
Content-type: text/html
Content-length: 10250
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Petroleum Resources</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Petroleum Resources</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Amalfitano, C., <B>Quezada, R.A.</b>, <B>Wilson, M.A.</b> and Hanna, J.V. (1995)
Chemical composition of humic acids: a comparison with precursor "light fraction" litter from different vegetations using spectroscopic techniques.
<i>
Soil Science</i>
159(6): 391-401 31 refs, illus.
<P>*Casareo, F., *Batts, B., *Conaghan, P., <B>George, S..</b> and *Jardine, D. (1995)
Petrography & aliphatic hydro-carbon composition of the Barrett Coal Member, Upper Permian Wittingham Coal Measures, Northern Sydney Basin, NSW.
<i>
In: Boyd, R L and MacKenzie, G A (eds.). Proceedings of the 29th Newcastle Symposium on "Advances in the Study of the Sydney Basin" (Newcastle, NSW: April 6-9, 1995)</i>
pp.102-110 28 refs, illus.
<P>*Casareo, F.E., *Batts, B.D., *Conaghan, P.J., <B>George, S.C.</b> and *Jardine, D.R. (1995)
Implications of variations in petrography on the aliphatic hydrocarbon composition within the Barrett Coal Member. Upper Permian Wittingham Coal Measures, northern Sydney Basin, New South Wales (NSW), Australia.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
1: 279-282 10 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P>*Diessel, C.F.K. and <B>Smyth, M.</b> (1995)
Petrographic constituents of Australian coals.
<i>
In: Ward, C R, Harrington, H J, Mallett, C W, and Beeston, JW (eds.) Geology of Australian Coal Basins</i>
Special publication (1): 63-81  71 refs, illus ISBN 0909869960
(Geological Society of Australia Coal Geology Group)
<P>*Ferguson, J., *Radke, B.M., *Jacobson, G., *Evans, W.R., Chambers, L.A., White, I., Wooding, R.A., <B>Whitford, D.J.</b> and *Allan, G.L. (1995)
The Scotia groundwater discharge complex, Murray Basin, SE Australia.
<i>
AGSO Record</i>
(1995/43): 67p., 67 refs, illus. ISBN 0642249644
<P><B>George, S.C.</b>, <B>Sherwood, N.R..</b>, *Yonada Gu, <B>Greenwood, P.F.</b>, *Keming Cheng and *Changyi Zhao (1995)
Molecular geochemistry of oil-generating coals from Turpan Basin, China.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic geochemistry: developments and applications to energy, climate, environment and human history. Selected papers from the 17th International Meeting on Organic Geochemistry (The Basque Country, Spain: September 4-8, 1995)</i>
pp.563-565 5 refs, illus. ISBN 8460532976
(The Basque Country, Spain: AIGOA)
<P><B>George, S.C.</b>, <B>Eadington, P.J.</b> and <B>Hamilton, P.J.</b> (1995)
Organic geochemistry of petroleum-bearing fluid inclusions in quartz grains from a Cretaceous sandstone.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic geochemistry: developments and applications to energy, climate, environment and human history. Selected papers from the 17th International Meeting on Organic Geochemistry (The Basque Country, Spain: September 4-8, 1995)</i>
pp.282-283 2 refs ISBN 8460532976
(The Basque Country, Spain: AIGOA)
<P><B>George, S.C.</b> and *Smith, J.W. (1995)
The influence of depositional environment on the methylphenanthrene index.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
1: 287-290 7 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P><B>Greenwood, P.F.</b> and <B>Sherwood, N.R..</b> (1995)
A review: organic geochemical studies by laser pyrolysis mass-spectrometry and how they compare with flash pyrolysis mass-spectrometry studies.
<i>
APEA Journal</i>
pp.633-644 29 refs, illus.
<P><B>Greenwood, P.F.</b>, <B>Sherwood, N.R..</b> and *Willett, G.D. (1995)
Chemical examination of some petroleum source rocks by laser pyrolysis-mass spectrometry and flash pyrolysis-gas chromatography/mass spectrometry.
<i>
Journal of Analytical and Applied Pyrolysis</i>
31: 177-202 39 refs, illus.
<P>*Gu, Y., <B>Wilson, M.A.</b>, *Fisher, K.J., *Dance, I.G., *Willett, G.D., *Ren, D. and *Volkova, I.B. (1995)
Fullerences and shungite [letter].
<i>
Carbon</i>
33: 862-863 16 refs, illus.
<P>*Heinrich, C.A., *Bain, J.H.C., *Mernagh, T.P., *Wyborn, L.A.I., <B>Andrew, A.S.</b> and *Waring, C.L. (1995)
Fluid and mass transfer during metabasalt alteration and copper mineralization at Mount Isa, Australia.
<i>
Economic Geology</i>
90(4): 705-730 75 refs, illus.
<P>*He, S.J.X., *Long, M.A., <B>Wilson, M.A.</b>, *Gorbaty, M.L. and *Maa, P.S. (1995)
Methylation of benzene by methane-<sup>13</sup>C over zeolitic catalysts at 400&#176;C.
<i>
Energy & Fuels</i>
9: 616-619 6 refs, illus.
<P>Hill, R.E.T., Barnes, S.J., <B>Gole, M.J.</b> and <B>Dowling, S.E.</b> (1995)
The volcanology of komatiites as deduced from field relationships in the Norseman-Wiluna greenstone belt, Western Australia.
<i>
Lithos</i>
34: 159-188 80 refs, illus.
<P>*Inukai, Y., Attalla, M.I., <B>Pang, L.S.K.</b> and <B>Wilson, M.A.</b> (1995)
Separation of fullerenes by chromatography on coal.
<i>
Fuel</i>
74(1): 83-87 29 refs, illus.
<P>*Landenberger, B., *Farrell, T.R., *Offler, R., *Collins, W.J. and <B>Whitford, D.J.</b> (1995)
Tectonic implications of Rb-Sr biotite ages for the Hillgrove plutonic suite, New England Fold Belt, N.S.W., Australia.
<i>
Precambrian Research</i>
71: 251-263 26 refs, illus.
<P><B>Pang, L.S.K.</b>, <B>Prochazka, J.L.</b>, <B>Quezada, R.A.</b>, <B>Wilson, M.A.</b>, <B>Pallasser, R.J.</b>, *Fisher, K.J., *Fitzgerald, J.D., *Taylor, G.H., *Willett, G.D. and *Dance, I.G. (1995)
Competitive reactions during plasma arcing of carbonaceous materials.
<i>
Energy and Fuels</i>
9: 38-44 66 refs, illus.
<P><B>Pang, L.S.K.</b>, <B>Wilson, M.A.</b>, *Batts, B.D., *Smith, J.W., *Yang, K., *Voigtmann, M.F. and *He, S.J.X. (1995)
Incorporation of methane into petroleum: evidence from thermodynamic model compounds, coal and kerogen studies.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic geochemistry: developments and applications to energy, climate, environment and human history.  Selected papers from the 17th Interntional Meeting on Organic Geochemistry (The Basque Country, Spain: September 4-8, 1995)</i>
pp.1017-1020 5 refs ISBN 8460532976
(The Basque Country, Spain: AIGOA)
<P><B>Pang, L.S.K.</b>, <B>Wilson, M.A.</b>, <B>Quezada, R.A.</b> and <B>Pallasser, R.J.</b> (1995)
Mechanism of plasma-arc formation of fullerenes from coal and related materials.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
1: 1181-1184 7 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P><B>Pang, L.S.K.</b>, <B>Wilson, M.A.</b>, <B>Pallasser, R.J.</b> and <B>Prochazka, J.L.</b> (1995)
Isotope effects in plasma arcing experiments with various carbon anodes.
<i>
Energy & Fuels</i>
9: 704-706 31 refs
<P><B>Quezada, R.A.</b>, <B>Wilson, M.A.</b> and <B>Pang, L.S.K.</b> (1995)
Polycyclic aromatic hydrocarbons from plasma arcing of coal.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic geochemistry: developments and applications to energy, climate, environment and human history.  Selected papers from the 17th Interntional Meeting on Organic Geochemistry (The Basque Country, Spain: September 4-8, 1995)</i>
pp.965-968 9 refs ISBN 8460532976
(The Basque Country, Spain: AIGOA)
<P><B>Smith, J.W.</b>, <B>George, S.C.</b> and *Batts, B.D. (1995)
The geosynthesis of alkylaromatics.
<i>
Organic Geochemistry</i>
23(1): 71-80 37 refs, illus.
<P>*Song, Z., *Batts, B.D. and <B>Smith, J.W.</b> (1995)
The sulfur geochemistry of some Australian brown coals.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
2: 1661-1664 7 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P><B>Wilkins, R.W.T.</b>, <B>Wilmshurst, J.R.</b>, <B>Hladky, G.</b>, <B>Ellacott, M.V.</b> and <B>Buckingham, C.P.</b> (1995)
Should fluorescence alteration replace vitrinite reflectance as a major tool for thermal maturity determination in oil exploration?.
<i>
Organic Geochemistry</i>
22(1): 191-209 80 refs, illus.
<P><B>Wilmshurst, J.R.</b>, *Diessel, C., <B>Wilkins, R.W.</b>, <B>Buckingham, C.P.</b> and *Gammidge, L. (1995)
Fusibility assessment of coking coals by scanning laser fluorescence microprobe: a progress report.
<i>
In: Boyd, R L and MacKenzie, G A (eds.). Proceedings of the 29th Newcastle Symposium on Advances in the Study of the Sydney Basin (Newcastle, NSW: April 6-9, 1995)</i>
pp.188-194 8 refs, illus.
<P><B>Wilmshurst, J.R.</b>, *Diessel, C.F.K., <B>Wilkins, R.W.T.</b>, <B>Buckingham, C.P.</b> and *Gammidge, L. (1995)
Coking coal assessment by scanning laser fluorescence microprobe.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
1: 323-326 10 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P><B>Wilson, M.A.</b>, <B>Pang, L.S.K.</b> and *Inukai, Y. (1995)
Industrial process for preparing fullerenes from coal.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Conference on Coal Science. Coal Science and Technology 24</i>
1: 1177-1180 15 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)
<P>*Zhu, Z., *Gu, Y., <B>Wilson, M.A.</b>, *Huggins, F.E. and *Huffman, G.P. (1995)
A study of sulphur and nitrogen in two high sulphur coals.
<i>
In: Pajares, J A and Tascon, J M D (eds.). Proceedings of the 8th International Confernece on Coal Science. Coal Science and Technology 24</i>
2: 1681-1684 8 refs, illus. ISBN 0444822275
(Amsterdam: Elsevier Science B.V.)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-3</DOCNO>
<DOCOLDNO>IA089-000952-B042-333</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/EN1997.html 192.102.250.248 19970208034909 text/html 997
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:36:30 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:09 GMT
Content-type: text/html
Content-length: 815
</DOCHDR>
<html>
<head>
<title>1997 Publications - CSIRO Division of Entomology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Entomology</h2></td>
</tr>
<tr><td></td>
<td><H2>1997 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Zimmerman, E.C.</b> (1997)
Australian weevils: (Coleoptera: Curculionoidea). Volume 7. Phanerognatha I.
approx. 700p., illus. ISBN 0643052240
(East Melbourne, VIC: CSIRO Information Services)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-4</DOCNO>
<DOCOLDNO>IA089-000952-B048-92</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/HN1995.html 192.102.250.248 19970208040525 text/html 17628
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:52:47 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:21 GMT
Content-type: text/html
Content-length: 17444
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Human Nutrition</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Human Nutrition</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abbey, M.</b>, <B>Noakes, M.</b> and <B>Nestel, P.J.</b> (1995)
Dietary supplementation with orange and carrot juice in cigarette smokers lowers oxidation products in copper-oxidized low-density lipoproteins.
<i>
Journal of the American Dietetic Association</i>
95: 671-675 48 refs
<P><B>Abbey, M.</b>, *Hirata, F., <B>Chen, G.Z.</b>, <B>Ross, R.</b>, <B>Noakes, M.</b>, <B>Belling, G.B.</b>, <B>Clifton, P.M.</b> and <B>Nestel, P.J.</b> (1995)
Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol.
<i>
Canadian Journal of Cardiology</i>
11(Supp.G): 79G-85G 52 refs
<P><B>Abbey, M.</b> (1995)
The importance of vitamin E in reducing cardiovascular risk.
<i>
Nutrition Reviews</i>
53(9): S28-S32 44 refs, illus.
<P><B>Abeywardena, M.Y.</b>, <B>Turner, J.</b>, <B>McLennan, P.L.</b> and <B>Charnock, J.S.</b> (1995)
Cardiovascular effects of edible oils: a histological and biochemical asessment of cardiac damage following long term dietary lipid supplementation in the rat.
<i>
Malaysian Oil Science and Technology</i>
4(1): 81-6  33 refs, illus.
[Based on a paper presented at  the Oils and Fats International Congress (Kuala Lumpur, Malaysia: September 5-8, 1994)]
<P><B>Abeywardena, M.Y.</b>, <B>Turner, J.</b>, <B>McLennan, P.L.</b> and <B>Charnock, J.S.</b> (1995)
Cardiovascular effects of edible oils: a histological and biochemical assessment of cardiac damage following long term dietary lipid supplementation in the rat.
<i>
Malaysian Oil Science and Technology</i>
4(1): 81-6  33 refs, illus.
<P><B>Abeywardena, M.Y.</b> and <B>Charnock, J.S.</b> (1995)
Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat.
<i>
Lipids</i>
30(12): 1151-6  26 refs, illus.
[Based on a paper presented at the PORIM International Palm Oil Congress (Kuala Lumpur, Malaysia: Septemer 1993)]
<P><B>Annison, G.</b>, <B>Trimble, R.P.</b> and <B>Topping, D.L.</b> (1995)
Feeding Australian <i>Acacia</i> gums and gum arabic leads to non-starch polysaccharide accumulation in the cecum of rats.
<i>
Journal of Nutrition</i>
125: 283-292 36 refs, illus.
<P><B>Baghurst, K.I.</b> (1995)
Consumer attitudes to cereal foods results from a random population survey.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.46-49 3 refs, illus. ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P><B>Baghurst, K.I.</b> (1995)
Vitamin E: borderline intake and dropping.
<i>
Persectives in food and nutrition</i>
(2): 1-2  2 refs, illus.
(North Sydney, NSW: Burson-Marsteller)
<P><B>Baghurst, P.A.</b>, <B>McMichael, A.J.</b>, *Tong, S., *Wigg, N.R., *Vimpani, G.V. and *Robertson, E.F. (1995)
Exposure to environmental lead and visual-motor integration at age 7 years: the Port Pirie Cohort Study.
<i>
Epidemiology</i>
6: 104-109 46 refs, illus.
<P><B>Baghurst, P.A.</b> and *Rohan, T.E. (1995)
Dietary fiber and risk of benign proliferative epithelial disorders of the breast.
<i>
International Journal of Cancer</i>
63: 481-485 25 refs
<P>*Beanland, C., *Browne, C., *Young, R., *Owens, J., <B>Walton, P.E.</b> and *Thorburn, G. (1995)
Fetal plasma insulin-like growth factor-binding protein-3 concentrations are elevated following bilateral nephrectomy in fetal sheep.
<i>
Reproduction, Fertility and Development</i>
7(3): 345-349 24 refs, illus.
[Paper presented at the Thorburn Symposium on Reproductive and Perinatal Physiology (Hamilton Island, QLD: August 5-9, 1994). Also published in: Harding, R, Jenkin, G and Grant, A (eds.). Progress in Perinatal Physiology.]
<P><B>Choct, M..</b>, *Hughes, R.J., <B>Trimble, R.P.</b>, *Angkanaporn, K. and <B>Annison, G.</b> (1995)
Non-starch polysaccharide-degrading enzymes increase the performance of broiler chickens fed wheat of low apparent metabolizable energy.
<i>
Journal of Nutrition</i>
125: 485-492 31 refs, illus.
<P><B>Clark, D.G.</b>, <B>Tomas, F.M.</b>, *Withers, R.T., <B>Brinkman, M.</b>, *Berry, M.N., *Oliver, J.R., <B>Owens, P.C.</b>, *Butler, R.N., <B>Ballard, F.J.</b> and <B>Nestel, P.J.</b> (1995)
Differences in substrate metabolism between self-perceived "large-eating" and "small-eating" women.
<i>
International Journal of Obsesity</i>
19: 245-252 41 refs, illus.
<P><B>Clifton, P.M.</b>, <B>Abbey, M.</b>, <B>Noakes, M.</b>, <B>Beltrame, S.</b>, <B>Rumbelow, N.</b> and <B>Nestel, P.J.</b> (1995)
Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women.
<i>
Arteriosclerosis, Thrombosis, and Vascular Biology</i>
15(8): 1070-1078 67 refs, illus.
<P><B>Clifton, P.M.</b> (1995)
Antioxidant vitamins and coronary heart disease risk.
<i>
Current Opinion in Lipidology</i>
6: 20-4  37 refs
<P>*Clifton, V.L., <B>Owens, P.C.</b>, *Robinson, P.J. and *Smith, R. (1995)
Identification and characterization of a corticotrophin-releasing hormone receptor in human placenta.
<i>
European Journal of Endocrinology</i>
133: 591-7  35 refs, illus.
<P><B>Cobiac, L.</b> and <B>Syrette, J.A.</b> (1995)
What is the nutritional status of older Australians?.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: 139-145 18 refs, illus.
<P><B>Cobiac, L.</b> and <B>Syrette, J.A.</b> (1995)
What is the nutritional status of older Australians?.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: 139-45  18 refs, illus.
<P>*Cooper, K.V., <B>Choct, M..</b> and <B>Barbarowska, A.</b> (1995)
Triticale: a high-fibre cereal awaiting development for food use.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.44-45 1 ref ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P><B>Dreosti, I.E.</b> (1995)
Magnesium status and health.
<i>
Nutrition Reviews</i>
53(9): S23-S27 37 refs
<P>*Dyerber, J., *Leaf, A., *Galli, C., *Simopoulos, A.P., *Ackman, R.G., *Grawford, M., *De Caterina, R., *Hornstra, G., *Innis, S.M., *Karyadi, D., *Koletzko, B., *Lagarde, M., *Leighton, F., *Martin, R., *Martinez, M., <B>Nestel, P.J.</b>, *Norday, A., *Renaud, S., *Spector, A., *Tamura, Y. and *Uauy, R. (1995)
ISSFAL Board statement: recommendations for the essential fatty acid requiremt for infant formula [Letter].
<i>
Journal of the American College of Nutrition</i>
14(2): 213-14  
<P><B>Fenech, M.F.</b> and <B>Rinaldi, J.</b> (1995)
A comparison of genetic damage and plasma micronutrients in vegetarians and non-vegetarians.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p.134 2 refs
<P><B>Fenech, M.F.</b> and <B>Rinaldi, J.</b> (1995)
A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians.
<i>
Carcinogenesis</i>
16(2): 223-230 63 refs, illus.
<P><B>Fenech, M.F.</b> and <B>Rinaldi, J.</b> (1995)
A comparison of genetic damage and plasma micronutrients in vegetarians and non-vegetarians.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 134  2 refs
<P>*Han, P., *Stacy, D., *Story, C. and <B>Owens, P.C.</b> (1995)
The role of haemopoietic growth factors in the pathogenesis of the early anaemia of premature infants.
<i>
British Journal of Haematology</i>
91: 327-9  13 refs, illus.
<P>*Hayashi, S., *Kusano, T., *Mitsunaga, T. and <B>McIntosh, G.H.</b> (1995)
New thinking!! Barley as a food source and exciting news from Japan.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
p.424 ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P><B>Howe, P.R.C.</b> (1995)
Can we recommend fish oil for hypertension?.
<i>
Clinical and Experimental Pharmacology and Physiology</i>
22: 199-203 32 refs, illus.
<P><B>Jablonskis, L.T.</b> and <B>Howe, P.R.C.</b> (1995)
Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats.
<i>
Journal of Hypertension</i>
13: 319-325 24 refs, illus.
<P>*Jeffreson, S., *Rush, R., *Zettler, C., *Frewin, D.B. and <B>Head, R.J.</b> (1995)
The influence of the renin angiotensin system on abnormal expression of nerve growth factor in the spontaneously hypertensive rat.
<i>
Clinical and Experimental Pharamacology and Physiology</i>
22: 478-480 15 refs, illus.
[Paper presented at a meeting of the High Blood Pressure Research Council of Australia (8-9 December, 1994)]
<P>*Kind, K.L., *Owens, J.A., *Robinson, J.S., <B>Quinn, K.J.</b>, *Grant, P.A., <B>Walton, P.E.</b>, *Gilmour, R.S. and <B>Owens, P.C.</b> (1995)
Effect of restriction of placental growth onexpression of IGFs in fetal sheep: relationship to fetal growth, circulating IGFs and binding proteins.
<i>
Journal of Endocrinology</i>
146: 23-34  56 refs, illus.
<P><B>Kotlarski, N.</b> (1995)
Studies into the scale-up of a process to produce a biosynthetic insulin-like growth factor.
<i>
Transactions of the Institution of Chemical Engineers. Series C</i>
73(C): 27-32  17 refs, illus.
<P>*Kusano, T., *Imaoka, S., *Ryushima, M., *Hayashi, S. and <B>McIntosh, G.H.</b> (1995)
Morphological studies with scanning electron microscopy of the influence of draft barley flours in noodle and bread making.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.370-371 7 refs ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P>*Lee, R.M.K.W., *Owens, G.K., *Scott-Burden, T., <B>Head, R.J.</b>, *Mulvany, M.J. and *Schiffrin, E.L. (1995)
Pathophysiology of smooth muscle in hypertension.
<i>
Canadian Journal of Physiology and Pharmacology</i>
73: 574-584 103 refs, illus.
[Review paper presented at the 8th International Symposium on Vascular Neuroeffector Mechanisms (Alberta, Canada: August 1-4, 1994)]
<P><B>Mano, M.T.</b>, <B>Bexis, S.</b>, <B>Abeywardena, M.Y.</b>, <B>McMurchie, E.J.</b>, <B>King, R.A.</b>, <B>Smith, R.M.</b> and <B>Head, R.J.</b> (1995)
Fish oils modulate blood pressure and vascular contractility in the rat and vascular contractility in the primate.
<i>
Blood Pressure</i>
4: 177-186 36 refs, illus.
<P><B>McIntosh, G.H.</b>, *Newman, R.K. and *Newman, C.W. (1995)
Barley foods and their influence on cholesterol metabolism.
<i>
World Review of Nutrition and Dietetics</i>
77: 89-108 73 refs, illus.
<P><B>McLennan, P.L.</b> and <B>Dallimore, J.A.</b> (1995)
Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats.
<i>
Journal of Nutrition</i>
125: 1003-1009 22 refs, illus.
<P><B>McMurchie, E.J.</b> and <B>Head, R.J.</b> (1995)
Human buccal epithelial cells as a potential biochemical predictor of essential hypertension: identification of key cellular processes.
<i>
Clinical and Experimental Pharmacology and Physiology</i>
22: 772-774 8 refs, illus.
<P>*Milner, S.J., <B>Francis, G.L.</b>, *Wallace, J.C., *Magee, B.A. and <B>Ballard, F.J.</b> (1995)
Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties.
<i>
Biochemistry Journal</i>
308: 865-71  30 refs, illus.
<P><B>Nestel, P.J.</b> (1995)
The role of antioxidants in preventing coronary heart disease.
<i>
Food Australia</i>
47(3): S28-S29 12 refs
<P><B>Nestel, P.J.</b>, <B>Noakes, M.</b>, <B>Belling, G.</b>, <B>McArthur, R.</b> and <B>Clifton, P.M.</b> (1995)
Effect on plasma lipids of interesterifying a mix of edible oils.
<i>
American Journal of Clinical Nutrition</i>
62: 950-955 29 refs
<P><B>Noakes, M.</b>, <B>Nestel, P.J.</b>, <B>Belling, G.B.</b>, <B>McArthur, R.</b> and <B>Clifton, P.M.</b> (1995)
Effect of interesterifying a mix of edible oils on plasma lipids [abstract].
<i>
Circulation</i>
92(8): p.350
<P><B>Noakes, M.</b>, *Nestel, P.J. and <B>Clifton, P.M.</b> (1995)
Novel dairy fats lower plasma cholesterol.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 107  2 refs
<P><B>Noakes, M.</b>, <B>Nestel, P.J.</b> and <B>Clifton, P.M.</b> (1995)
Novel dairy fats lower plasma cholesterol.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p.107 2 refs
<P><B>Noakes, M.</b>, <B>Nestel, P.J.</b> and <B>Clifton, P.M.</b> (1995)
Frying fats and plasma lipids.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p.191 2 refs
<P><B>Noakes, M.</b>, <B>Clifton, P.M.</b>, <B>McIntosh, G.H.</b>, <B>Le Leu, R.K.</b> and *Nestel, P.J. (1995)
Effect of high amylose starch on metabolic variables and bowel function in subjects with insulin resistance.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
p.34 4 refs ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P><B>Noakes, M.</b>, *Nestel, P.J. and <B>Clifton, P.M.</b> (1995)
Frying fats and plasma lipids.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 191  1 ref
<P>*Opatpatanakit, Y., *Kellaway, R.C., *Lean, I.J., <B>Annison, G.</b> and *Kirby, A. (1995)
Effects of cereal grains on fibre digestion <i>in vitro</i>.
<i>
Australian Journal of Agricultural Research</i>
46(2): 403-413 21 refs, illus.
<P><B>Owens, P.C.</b> (1995)
Designer genes: genetic manipulation in food production.
<i>
Food Australia</i>
47(5): 201-202 1 ref
[Paper presented at the Food Alert '95 Conference (Sydney, NSW: February 1-2, 1995)]
<P>*Pepe, S. and <B>McLennan, P.L.</b> (1995)
Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats.
<i>
Journal of Nutrition</i>
126: 34-42 42 refs, illus.
<P><B>Record, I.R.</b>, <B>Jannes, M.</b>, <B>Dreosti, I.E.</b> and <B>King, R.A.</b> (1995)
Induction of micronucleus formation in mouse splenocytes by the soy isoflavone genistein <i>in vitro</i> but not <i>in vivo</i>.
<i>
Food and Chemical Toxicology</i>
33(11): 919-922 26 refs
<P><B>Record, I.R.</b>, <B>Dreosti, I.E.</b> and <B>McInerney, J.K.</b> (1995)
The antioxidant activity of genistein <i>in vitro</i>.
<i>
Nutritional Biochemistry</i>
6: 481-485 24 refs, illus.
<P>*Smid, S.D., *Frewin, D.B., <B>Wyartt, C.L.</b> and <B>Head, R.J.</b> (1995)
Functional tolerance to {alpha}-adrenergic receptor blockade in the spontaneously hypertensive rat highlights the multifunctional role of vascular angiotensin II in the development of hypertension.
<i>
Journal of Vascular Research</i>
32: 247-253 29 refs, illus.
<P>*Smith, A.M., <B>Baghurst, K.I.</b> and *Owen, N. (1995)
Dietary behaviours of volunteers for a nutrition eduction program, compared with a population sample.
<i>
Australian Journal of Public Health</i>
19(1): 64-9  23 refs
<P><B>Smith, A.M.</b>, <B>Baghurst, K.I.</b> and *Owen, N. (1995)
Socioeconomic status and personal characteristics as predictors of dietary change.
<i>
Journal of Nutrition Education</i>
27: 173-181 26 refs
<P>*Sunic, D., <B>Belford, D.A.</b>, *McNeil, J.D. and *Wiebkin, O.W. (1995)
Insulin-like growth factor binding proteins (IGF-BPs) in bovine articular and ovine growth-plate chondrocyte cultures: their regulation by IGFs and modulation of proteoglycan synthesis.
<i>
Biochimica et Biophysica Acta. G</i>
1245: 43-8  28 refs, illus.
<P><B>Suzukawa, M.</b>, <B>Abbey, M.</b>, <B>Howe, P.R.C.</b> and <B>Nestel, P.J.</b> (1995)
Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.
<i>
Journal of Lipid Research</i>
36: 473-484 70 refs, illus.
<P><B>Tomas, F.M.</b> and *Pym, R.A. (1995)
Muscle protein turnover and growth.
<i>
Archiv fur Geflugelkunde</i>
pp. 23-26  21 refs, illus.
<P><B>Topping, D.L.</b>, *Gooden, J., <B>Marsono, Y.</b>, <B>Illman, R.J.</b> and <B>Biebrick, D.A.</b> (1995)
Caecal starch concentrations are higher in pigs fed coarse rice than in those fed fine rice.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 40  2 refs
<P><B>Topping, D.L.</b>, *Gooden, J., <B>Marsono, Y.</b>, <B>Illman, R.J.</b> and <B>Biebrick, D.A.</b> (1995)
Caecal starch concentrations are higher in pigs fed coarse rice than in those fed fine rice.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p.40 2 refs
<P><B>Wang, Y.H.A.</b> and <B>McIntosh, G.H.</b> (1995)
The nutritional value of chickpeas, peas, lentils and faba beans, and their influences on blood cholesterol concentrations and pancreatic weights of rats.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.200-201 2 refs ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-5</DOCNO>
<DOCOLDNO>IA057-000941-B005-220</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/RP1994.html 192.102.250.248 19970208043224 text/html 5877
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:19:45 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:40 GMT
Content-type: text/html
Content-length: 5694
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Radiophysics</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Radiophysics</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Ables, J.G.</b> (1994)
Parkes in the eighties.
<i>
In: Goddard, D E and Milne, D K (eds.). Parkes: thirty years of radio astronomy</i>
pp.130-133, illus. ISBN 0643055479
(East Melbourne, Vic: CSIRO Australia)
<P><B>Ables, J.G.</b> (1994)
The <i>Giotto</i> and <i>Voyager</i> missions.
<i>
In: Goddard, D E and Milne, D K (eds.). Parkes: thirty years of radio astronomy</i>
pp.138-140 ISBN 0643055479
(East Melbourne, Vic: CSIRO Australia)
<P><B>Barnett, S.B.</b>, <B>Kossoff, G.</b> and *Edwards, M.J. (1994)
Is diagnostic ultrasound safe? Current international consensus on the thermal mechanism.
<i>
Medical Journal of Australia</i>
160: 33-37 18 refs
<P><B>Barnett, S.B.</b>, *ter Haar, G.R., *Ziskin, M.C., *Nyborg, W.L., *Maeda, K. and *Bang, J. (1994)
Current status of research on biophysical effects of ultrasound.
<i>
Ultrasound in Medicine and Biology</i>
20(3): 205-218 87 refs
<P><B>Bateman, D.G.</b>, <B>Bird, T.S.</b>, <B>Kot, J.S.</b> and <B>James, G.C.</b> (1994)
Mode-matching analysis of arrays of non-contacting circular stepped horns.
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.30 3 refs, illus.
<P>*Bedding, T.R., *Robertson, J.G. and <B>Marson, R.G.</b> (1994)
An optical interferometer with wavelength dispersion.
<i>
Astronomy and Astrophysics</i>
290: 340-348 37 refs, illus.
<P><B>Bird, T.S.</b> and <B>Bateman, D.G.</b> (1994)
Mutual coupling between rotated horns in a ground plane.
<i>
IEEE Transactions of Antennas and Propagation</i>
42(7): 1000-1006 17 refs, illus.
<P><B>Clark, P.R.</b> and <B>James, G.L.</b> (1994)
A new dual-band feed system [abstract].
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.11
<P><B>Cooper, B.F.C.</b> (1994)
Our first radio receivers.
<i>
In: Goddard, D E and Milne, D K (eds.). Parkes: thirty years of radio astronomy</i>
pp.44-46 ISBN 0643055479
(East Melbourne, Vic: CSIRO Australia)
<P><b>CSIRO Division of Radiophysics</b> (1994)
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994).
47p., refs, illus.
<P>*Granet, C. and <B>James, G.L.</b> (1994)
A new focal system for the Nan{cedil}cay radio telescope [abstract].
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.12
<P><B>Hayman, D.B.</b> and <B>Bateman, D.G.</b> (1994)
Design and measurement of a flat-plate antenna.
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.42 2 refs, illus.
<P><B>Hay, S.G.</b> and <B>Poulton, G.T.</b> (1994)
Shaping reflectors for directivity patterns within prescribed bounds [abstract].
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.8
<P><B>James, G.C.</b> and <B>Bird, T.S.</b> (1994)
Design of a shaped reflector antenna with a dual-band feed [abstract].
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.28 2 refs
<P><B>Kossoff, G.</b>, <B>Griffiths, K.A.</b> and *Warren, P.S. (1994)
Real-time quasi-three-dimensional viewing in sonography, with conventional, gray-scal volume imaging.
<i>
Ultrasound Obstetrics and Gynecology</i>
4: 211-16  8 refs, illus.
<P><B>Kukushkin, A.V.</b> (1994)
Propagation modelling in mobile communications.
<i>
Australian Telecommunications Research</i>
28(1): 1-14 79 refs, illus.
<P><B>Kukushkin, A.V.</b> (1994)
Performance of a circularly polarized base-station antenna in a microcellular environment.
<i>
Proceedings of the Asia-Pacific Microwave Conference (Tokyo, Japan: Deember 6-9, 1994)</i>
1: 109-112 1 ref, illus.
<P><B>Nikolic, N..</b> and <B>Kot, J.S.</b> (1994)
Analysis and measurement of an integrated ring-slot antenna with cavity-loading.
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.39, illus.
<P>Roy, A.L., <B>Norris, R.P.</b>, Kesteven, M.J., Troup, E.R. and Reynolds, J.E. (1994)
Compact radio cores in Seyfert galaxies.
<i>
Astrophysical Journal</i>
432: 496-507 52 refs, illus.
<P><B>Sprey, M.A.</b>, <B>Bird, T.S.</b> and <B>Barker, S.J.</b> (1994)
Measured performance of a multibeam earth-station antenna [abstract].
<i>
Abstracts of Papers and Information of the Fourth Australian Symposium on Antennas (Sydney, NSW: February 16-17, 1994)</i>
p.14
<P><B>Talhami, H.E..</b>, <B>Wilson, L.S.</b> and *Neale, M.L. (1994)
Spectral tissue strain: a new technique for imaging tissue strain using intravascular ultrasound.
<i>
Ultrasound in Medicine and Biology</i>
20(8): 759-772 34 refs, illus.
<P><B>Young, J.A.</b>, <B>Rogers, P.G.</b>, *Thomson, S. and *Neil, M. (1994)
Australian development of tomographic radio imaging as a new tool in mining geophysics.
<i>
Butsuri-Tansa</i>
47(4): 249-255 11 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-6</DOCNO>
<DOCOLDNO>IA057-000941-B006-193</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/SA1995.html 192.102.250.248 19970208043400 text/html 26793
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:21:15 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:42 GMT
Content-type: text/html
Content-length: 26609
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Soils</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Soils</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Backes, C.A., *McLaren, R.G., *Rate, A.W. and <B>Swift, R.S.</b> (1995)
Kinetics of cadmium and cobalt desorption from iron and manganese oxides.
<i>
Soil Science Society of America Journal</i>

59: 778-85  38 refs, illus.
<P>Baker, G.H., Barrett, V.J., Carter, P.J., <B>Buckerfield, J.C.</b>, <B>Williams, P.M.L.</b> and <B>Kilpin, G.P.</b> (1995)
Abundance of earthworms in soils used for cereal production in south-eastern Australia and their role in reducing soil acidity.
<i>
In: Date, R A #et al# (eds.). Plant soil interactions at low pH</i>
pp.213-218 22 refs, illus.
(The Netherlands: Kluwer Academic Publ.)
<P>*Bell, M.J., *Harch, G.R. and <B>Bridge, B.J.</b> (1995)
Effects of continuous cultivation on ferrosols in subtropical southeast Queensland. 1. Site characterization, crop yields and soil chemical status.
<i>
Australian Journal of Agricultural Research</i>
46(1): 237-253 36 refs, illus.
<P>*Bernas, S.M., *Oades, J.M. and <B>Churchman, G.J.</b> (1995)
Effects of latex and poly-DADMAC on erosion, hydrophobicity and water retention on two different soils.
<i>
Australian Journal of Soil Research</i>
33(5): 805-816 21 refs, illus.
<P>*Bernas, S.M., *Oades, J.M., <B>Churchman, G.J.</b> and *Grant, C.D. (1995)
Comparison of the effects of latex and poly (DADMAC) on structural stability and strength of soil aggregates.
<i>
Australian Journal of Soil Research</i>
33(2): 369-380 22 refs, illus.
<P>*Biddle, D.L., *Chittleborough, D.J. and <B>Fitzpatrick, R.W.</b> (1995)
Field-based comparison of platinum and wax impregnated graphite redox electrodes.
<i>
Australian Journal of Soil Research</i>
33(3): 415-424 12 refs, illus.
<P><B>Bird, A.F.</b> and <B>Self, P.G.</b> (1995)
Chitin in <i>Meloidogyne javanica</i>.
<i>
Fundamental and Applied Nematology</i>
18(3): 235-239 10 refs, illus.
<P><B>Bird, A.F.</b> (1995)
Studies on <i>Eutobrilus heptapapillatus</i> (Nematoda: Tobrilidae) the predominant nematode inhabiting the bottoms of Lakes Albert and Alexandrina, South Australia.
<i>
Transactions of the Royal Society of South Australia</i>
119(3): 133-141 9 refs, illus.
<P><B>Bond, W.J.</b> (1995)
On the Rothmund-Kornfeld description of cation exchange.
<i>
Soil Science Society of America Journal</i>
59(2): 436-443 20 refs, illus.
<P><B>Bond, W.J.</b>, <B>Smith, C.J.</b>, <B>Gibson, J.A.E.</b> and <B>Willett, I.R.</b> (1995)
The effect of sulfate and fluoride on the mobility of aluminium in soil.
<i>
Australian Journal of Soil Research</i>
33(6): 883-897 31 refs, illus.
<P><B>Bramley, R.G.V.</b>, *Wood, A.W. and *Cristaudo, R. (1995)
Improving the precision of phosphorus fertiliser recommendations for sugar cane.
<i>
Proceedings of Australian Society of Sugar Cane Technologists</i>
pp.179-186 18 refs, illus.
<P><B>Bramley, R.G.V.</b> and Johnson, A.K.L. (1995)
Nutrient loss from sugar cane land in the Herbert River catchment - what role for riparian vegetation?.
<i>
Proceedings of Conference on Wetlands for Water Quality Control (Townsville, Qld: 25-29 September, 1995)</i>
(1995): 315-20, 16 refs
<P>*Bresson, L.M. and <B>Moran, C.J.</b> (1995)
Structural change induced by wetting and drying in seedbeds of a hardsetting soil with contrasting aggregate size distribution.
<i>
European Journal of Soil Science</i>
46: 205-214 27 refs, illus.
<P><B>Brisbane, P.G.</b>, <B>Neate, S.M.</b>, <B>Pankhurst, C.E.</b>, Scott, N.S. and Thomas, M.R. (1995)
Sequence-tagged site markers to identify <i>Rhizoctonia solani</i> Ag 4 or 8 infecting wheat in South Australia.
<i>
Phytopathology</i>
85(11): 1423-1427 24 refs, illus.
<P><B>Bui, E.N..</b>, <B>Cannon, M.G.</b> and <B>Hicks, W.S.</b> (1995)
A preliminary study on the geographic distribution of sodic soils in north Queensland.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.2.4): 53-55 4 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P>*Campbell, G.S., *Jungbauer, J.D., <B>Bristow, K.L.</b> and *Hungerford, R.D. (1995)
Soil temperature and water content beneath a surface fire.
<i>
Soil Science</i>
159(6): 363-373 11 refs, illus.
<P>Chen, D.L., *Chalk, P.M., Freney, J.R., <B>Smith, C.J.</b> and *Luo, Q.X. (1995)
Estimation of nitrification rates in flooded soils.
<i>
Microbial Ecology</i>
30: 269-84  37 refs, illus.
<P><B>Churchman, G.J.</b> and <B>Weissmann, D.A.</b> (1995)
Particle mobility as a parameter in soil dispersibility.
<i>
In: Naidu, R, Rengasamy, P and Sumner, M E (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.6.4): 191-194 17 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Churchman, G.J.</b>, <B>Fitzpatrick, R.W.</b> and *Eggleton, T. (Editors) (1995)
Clays: controlling the environment.
700p. ISBN 0643055363
(East Melbourne, VIC: CSIRO Information Services)
<P><B>Churchman, G.J.</b>, <B>Skjemstad, J.O.</b> and *Oades, J.M. (1995)
Effects of clay minerals and organic matter on sodicity.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.4.1): 107-119 118 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Churchman, G.J.</b> and *Weissmann, D.A. (1995)
Separation of sub-micron particles from soils and sediments without mechanical disturbance.
<i>
Clays and Clay Minerals</i>
43(1): 85-91 12 refs, illus.
<P><B>Churchman, G.J.</b>, *Davy, T.J., *Aylmore, L.A.G. and *Gilkes, R.J. (1995)
Characteristics of fine pores in some halloysites.
<i>
Clay Minerals</i>
30: 89-98 35 refs, illus.
<P><B>Cresswell, H.P.</b> and <B>Paydar, Z.</b> (1995)
Parameterisation and application of a model simulating water flow through unsaturated soil.
<i>
In: Alonso, E E and Delage, P (eds.). Unsaturated soils. Proceedings of the 1st International Conference on Unsaturated Soils (Paris, France: September 6-8, 1995)</i>
pp.355-360 6 refs, illus. ISBN 9054105836
(Rotterdam: A.A. Balkema)
<P><B>Cresswell, H.P.</b> and Kirkegaard, J.A. (1995)
Subsoil amelioration by plant roots: the process and the evidence.
<i>
Australian Journal of Soil Research</i>
32(2): 221-239 70 refs, illus.
<P><b>CSIRO Division of Soils</b> (1995)
Research Report 1995.
<i>
Research Report. Division of Soils. CSIRO Australia</i>
25p., illus.
<P>*Di, H.J., <B>Kookana, R.S.</b> and *Aylmore, L.A.G. (1995)
Application of a simple model to assess the ground water contamination potential of pesticides.
<i>
Australian Journal of Soil Research</i>
33(6): 1031-1040 18 refs, illus.
<P><B>Doube, B.M.</b>, <B>Buckerfield, J.C.</b>, Barrett, V.J., Carter, P.J., *Baldock, C.J. and *Oades, M. (1995)
The effects of lime, gypsum and wheat straw on four species of earthworms in a red-brown earth in South Australia.
<i>
Acta Zoologica Fennica</i>
196: 150-155 11 refs, illus.
<P><B>Doube, B.M.</b>, <B>Ryder, M.H.</b>, *Dovoren, C.W. and *Meyer, T. (1995)
Earthworms: a down-under delivery service for biocontrol agents of root disease.
<i>
Acta Zoologica Fennica</i>
196: 219-223 13 refs, illus.
<P><B>Doube, B.M.</b>, <B>Naidu, R.</b>, <B>McClure, S.G.</b> and *Davoren, C.W. (1995)
Distribution of particles of calcium carbonate in the soil matrix and in casts of <i>Aporrectodea trapezoides</i> (Duges) and its response to gradients in soil pH.
<i>
Acta Zoologica Fennica</i>
196: 65-66 6 refs, illus
<P><B>Emerson, W.W.</b> (1995)
Water retention, organic C and soil texture.
<i>
Australian Journal of Soil Research</i>
33(2): 241-251 21 refs, illus.
<P><B>Emerson, W.W.</b> (1995)
The plastic limit of silty, surface soils in relation to their content of polysaccharide gel.
<i>
Australian Journal of Soil Research</i>
33(1): 1-9 24 refs, illus.
<P><B>Fitzpatrick, R.W.</b> and <B>Naidu, R.</b> (1995)
Properties, genesis and classification of a "sodic" red-brown earth (<i>Calcic Natrixeralf</i>) near Kapunda, South Australia.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.2.6): 65-69 10 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Gessler, P.E.</b>, *Moore, I.D., <B>McKenzie, N.J.</b> and Ryan, P.J. (1995)
Soil-landscape modelling and spatial prediction of soil attributes.
<i>
International Journal of Geographical Information Systems</i>
9(4): 421-432 37 refs, illus.
<P>*Golchin, A., *Clarke, P., *Oades, J.M. and <B>Skjemstad, J.O.</b> (1995)
The effects of cultivation on the composition of organic matter and structural stability of soils.
<i>
Australian Journal of Soil Research</i>
33(6): 975-993 42 refs, illus.
<P>*Golchin, A., *Oades, J.M., <B>Skjemstad, J.O.</b> and *Clarke, P. (1995)
Structural and dynamic properties of soil organic matter as reflected by <sup>13</sup>C Natural abundance, pyrolysis mass spectrometry and solid-state <sup>13</sup>C NMR spectroscopy in density fractions of an oxisol under forest and pasture.
<i>
Australian Journal of Soil Research</i>
33(1): 59-76 36 refs, illus.
<P><B>Hamblin, A.P.</b> and <B>Williams, J.</b> (1995)
Soils: key issues in sustaining the land resource base.
<i>
Sustaining the Agricultural Resource Base. Paper for the 12th meeting of the Prime Minister's Science and Engineering Council (Canberra, ACT: June 23, 1995)</i>
(Ch.3): 31-39 11 refs ISBN 0644453095
(Canberra, ACT: AGPS)
<P>*Ham, G.J., *McMahon, G.G., *Elliot, P.J. and <B>Smettem, K.R.J.</b> (1995)
Cropping sodic soils in the Burdekin River Irrigation Area.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.5.2): 139-146 22 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Handreck, K.A.</b> (1995)
Tips on saving water in the garden.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(85): p.7, illus.
<P><B>Handreck, K.A.</b> (1995)
Growing Australian plants: do you wonder about this? Series 2.
<i>
Australian Plants</i>
18(144): 173-6  
<P><B>Harris, A.R.</b> (1995)
Damping-off survey supports research.
<i>
Australian Nursery</i>
(May): 12-13, illus.
<P><B>Hignett, C.T.</b> (1995)
Wheat crop root development and soil water availability in a sodic subsoil.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.5.3): 147-154 18 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Hollingsworth, I.D.</b>, *Boardman, R. and <B>Fitzpatrick, R.W.</b> (1995)
Quantitative land resource assessment for <i>Pinus radiata</i> (D.Don) in South Australia.
<i>
ACLEP Newsletter. Australian Collaborative Land Evaluation Program. Division of Soils. CSIRO Australia</i>
4(2): 6-10 12 refs, illus.
<P><B>Hollingsworth, I.D.</b>, <B>Naidu, R.</b> and <B>Fitzpatrick, R.W.</b> (1995)
Warren Reservoir Catchment studies: soil distribution and stream water salinity.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.6.2): 177-183 25 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P>Humphreys, E., Muirhead, W.A., <B>Ringrose-Voase, A.J.</b> and <B>Kirby, J.M.</b> (1995)
Minimising deep percolation from rice. Final report to Rural Industries Research and Development Corporation.
<i>
Consultancy Report. Division of Water Resources. CSIRO Australia</i>
(95/15): 46p. 38 refs, illus. ISBN 0642227421
<P><B>Isbell, R.F.</b> (1995)
The use of sodicity in Australian soil classification systems.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.2.2): 41-45 24 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Janik, L.J.</b> and <B>Skjemstad, J.O.</b> (1995)
Characterization and analysis of soils using mid-infrared partial least-squares. 2. Correlations with some laboratory data.
<i>
Australian Journal of Soil Research</i>
33(4): 637-650 15 refs, illus.
<P><B>Janik, L.J.</b>, <B>Skjemstad, J.O.</b> and <B>Raven, M.D.</b> (1995)
Characterization and analysis of soils using mid-infrared partial least squares. 1. Correlations with XRF-determined major element composition.
<i>
Australian Journal of Soil Research</i>
33(4): 621-636 12 refs, illus.
<P>Jones, D.R., <B>Ragusa, S.R.</b>, *Unger, C. and *McAllister, R. (1995)
Performance of constructed wetlands at the Ranger Uranium mine.
<i>
Proceedings of the National Conference on Wetlands for Water Quality Control (Townsville, QLD: September 25-29, 1995)</i>
pp. 295-303  11 refs  illus.
<P><B>Kirby, J.M.</b>, <B>Mockler, S.P.</b> and *Zoz, F. (1995)
Influence of varying axle load and tyre pressure on soil stresses and resulting compaction.
<i>
SAE Technical Papers</i>
(952096): 9p. 16 refs, illus.
[Proceedings of the International Off-Highway & Powerplant Congress & Exposition (Milwaukee, WI, USA: September 11-13, 1995)]
<P><B>Kirby, J.M.</b> (1995)
The influence of soil variability on predictions of compaction by agricultural tyres.
<i>
In: Alonso, E E and Delage, P (eds.). Proceedings of the 1st International Conference on Unsaturated Soils (Paris, France: September 6-8, 1995)</i>
2: 1079-1084 9 refs, illus. ISBN 9054105852
(Rotterdam, The Netherlands: A A Balkema)
<P><B>Kirby, J.M.</b> and <B>Smiles, D.E.</b> (1995)
The use of material coordinates in fluid flow and contaminant transport in soils.
<i>
In: Alonso, E E and Delage, P (eds.). Proceedings of the 1st International Conference on Unsaturated Soils (Paris, France: September 6-8, 1995)</i>
1: 381-386 5 refs, illus. ISBN 9054105844
(Rotterdam, The Netherlands: A A Balkema)
<P>*Kluitenberg, G.J., <B>Bristow, K.L.</b> and *Das, B.S. (1995)
Error analysis of heat pulse method for measuring soil heat capacity, diffusivity, and conductivity.
<i>
Soil Science Society of America Journal</i>
59: 719-726 9 refs, illus.
<P>Koltunow, A.M.G., Soltys, K.A., *Nito, N. and <B>McClure, S.G.</b> (1995)
Anther, ovule, seed, and nucellar embryo development in <i>Citrus sinensis</i> cv. Valencia.
<i>
Canadian Journal of Botany</i>
73: 1567-1582 30 refs, illus.
<P><B>Kookana, R.S.</b>, *Di, H.J. and *Alymore, L.A.G. (1995)
A field study of leaching and degradation of nine pesticides in a sandy soil.
<i>
Australian Journal of Soil Research</i>
33(6): 1019-1030 20 refs, illus.
<P><B>Little, I.P.</b> (1995)
Effect of leaching on the dispersibility of acid sodic subsoils from south-eastern Queensland.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.3.4): 95-99 11 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Matthew, J.S.</b>, <B>Hawke, B.G.</b> and <B>Pankhurst, C.E.</b> (1995)
A DNA probe for identification of <i>Pythium irregulare</i> in soil.
<i>
Mycological Research</i>
99(5): 579-584 20 refs, illus.
<P><B>Mayocchi, C.L.</b> and <B>Bristow, K.L.</b> (1995)
Soil surface heat flux: some general questions and comments on measurements.
<i>
Agricultural and Forest Meteorology</i>
75: 43-50 11 refs, illus.
<P>McIvor, J.G., <B>Williams, J.</b> and Gardener, C.J. (1995)
Pasture management influences runoff and soil movement in the semi-arid tropics.
<i>
Australian Journal of Experimental Agriculture</i>
35: 55-65 49 refs, illus.
<P><B>Merry, R.H.</b>, *Hodge, T.J.V., *Lewis, D.C. and *Jacka, J. (1995)
Evaluation of liming materials used in South Australia.
<i>
In: Date, R A (ed.). Plant soil interactions at low pH</i>
pp.497-503 8 refs, illus.
(Amsterdam, The Netherlands: Kluwer Academic Publ.)
<P><B>Moran, C.J.</b> and <B>Kirby, J.M.</b> (1995)
Numerical simulation of deformation of soil pore structure.
<i>
In: Alonso, E E and Delage, P (eds.). Proceedings of the 1st International Conference on Unsaturated Soils (Paris, France: September 6-8, 1995)</i>
2: 1123-1128 6 refs, illus. ISBN 9054105852
(Rotterdam, The Netherlands: A A Balkema)
<P><B>Naidu, R.</b>, <B>de Lacy, N.J.</b>, <B>Hollingsworth, I.D.</b> and <B>Fitzpatrick, R.W.</b> (1995)
Seasonal changes of iron and dissolved organic carbon concentrations in streams in the Warren Catchment, South Australia.
<i>
In: Naidu, R, Rengasamy, P and Sumner, M E (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.6.3): 185-189 20 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Naidu, R.</b>, *Rengasamy, P., <B>de Lacy, N.J.</b> and <B>Zarcinas, B.A.</b> (1995)
Soil solution composition of some sodic soils.
<i>
In: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management</i>
(Ch.5.4): 155-161 42 refs, illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
<P><B>Naidu, R.</b>, *Rengasamy, P. and *Sumner, M.E. (Editors) (1995)
Australian sodic soils: distribution, properties and management.
352p., illus. ISBN 0643055371
(East Melbourne, VIC: CSIRO Australia)
[Proceedings of the First National Conference and Workshop on Sodic Soils (Adelaide, SA: November 9-13, 1992)]
<P><B>Neate, S.M.</b> and <B>Benger, A.M.</b> (1995)
Nylon netting technique for the study of the three dimensional growth of <i>Rhizoctonia solani</i> in soil.
<i>
Soil Biology and Biochemistry</i>
27(12): 16171-1621 21 refs, illus.
<P><B>Oliver, D.P.</b>, *Gartrell, J.W., <B>Tiller, K.G.</b>, Correll, R.L., <B>Cozens, G.D.</b> and *Youngberg, B.L. (1995)
Differential responses of Australian wheat cultivars to cadmium concentration in wheat grain.
<i>
Australian Journal of Agricultural Research</i>
46(5): 873-886 16 refs, illus.
<P><B>Pankhurst, C.E.</b>, <B>McDonald, H.J.</b> and <B>Hawke, B.G.</b> (1995)
Influence of soil-water matric potential on the control of <i>Pythium</i> root infection of wheat with metalaxyl in two contrasting soils of South Australia.
<i>
Australian Journal of Experimental Agriculture</i>
35(5): 603-610 26 refs
<P><B>Pankhurst, C.E.</b>, <B>Hawke, B.G.</b>, <B>McDonald, H.J.</b>, <B>Kirkby, C.A.</b>, <B>Buckerfield, J.C.</b>, *Michelsen, P., *O'Brien, K.A., *Gupta, V.V.S.R. and <B>Doube, B.M.</b> (1995)
Evaluation of soil biological properties as potential bioindicators of soil health.
<i>
Australian Journal of Experimental Agriculture</i>
35(7): 1015-1028 63 refs, illus.
<P><B>Pankhurst, C.E.</b> and *Lynch, J.M. (1995)
The role of soil microbiology in sustainable intensive agriculture.
<i>
Advances in Plant Pathology</i>
11(Ch.12): 229-247 63 refs, illus. ISBN 0120337118
<P><B>Pankhurst, C.E.</b>, <B>McDonald, H.J.</b> and <B>Hawke, B.G.</b> (1995)
Influence of tillage and crop rotation on the epidemiology of <i>Pythium</i> infections of wheat in a red-brown earth of South Australia.
<i>
Soil Biology and Biochemistry</i>
27(8): 1065-1073 40 refs, illus.
<P>*Poss, R., <B>Noble, A.D.</b>, Dunin, F.X. and Reyenga, W. (1995)
Evaluation of ceramic cup samplers to measure nitrate leaching in the field.
<i>
European Journal of Soil Science</i>
46(4): 667-674 17 refs, illus.
<P>*Poss, R., <B>Smith, C.J.</b>, Dunin, F.X. and Angus, J.F. (1995)
Rate of soil acidification under wheat in a semi-arid environment.
<i>
Plant and Soil</i>
177(1): 85-100 30 refs, illus.
<P>Prosser, I.P. and <B>Hairsine, P.B.</b> (1995)
The role of perennial grasses in reducing erosion and nutrient loss.
<i>
In: Curtis, A and Millar, J (eds.). Community Grasses Project Workshop Proceedings (Albury, NSW: 1995). Johnstone Centre of Parks, Recreation and Heritage. Report</i>
(39): 8-15 23 refs, illus. ISBN 187575816X
<P><B>Reuter, D.J.</b>, *Dyson, C.B., *Elliott, D.E., *Lewis, D.C. and *Rudd, C.L. (1995)
An appraisal of soil phosphorus testing data for crops and pastures in South Australia.
<i>
Australian Journal of Experimental Agriculture</i>
35(7): 979-995 80 refs, illus.
<P><B>Roget, D.K.</b> (1995)
Decline in root rot (<i>Rhizoctonia solani</i> AG-8) in wheat in a tillage and rotation experiment at Avon, South Australia.
<i>
Australian Journal of Experimental Agriculture</i>
35(7): 1009-1013 27 refs, illus.
<P><B>Rosbrook, P.A.</b> and <B>Reddell, P.</b> (1995)
Isolation of <i>Frankia</i> from root nodules of three species of <i>Casuarina</i>.
<i>
Soil Biology and Biochemistry</i>
27(4/5): 427-429 12 refs
<P><B>Ross, P.J.</b>, *Parlange, J-Y. and *Haverkamp, R. (1995)
Two-dimensional interaction of a wetting front with an impervious layer: analytical and numerical solutions.
<i>
Transport in Porous Media</i>
20: 251-263 14 refs, illus.
<P>*Schweiger, P.F., *Robson, A.D. and <B>Barrow, N.J.</b> (1995)
Root hair length determines beneficial effect of a <i>Glomus</i> species on shoot growth of some pasture species.
<i>
New Phytologist</i>
131: 247-254 33 refs, illus.
<P>*Siwek, K., <B>Harris, A.R.</b> and *Scott, E.S. (1995)
Hyphal interactions between binucleate <i>Rhizoctonia</i> and the plant pathogen, <i>Pythium ultimum</i> [abstract].
<i>
Program and Abstracts of the International Symposium on Rhizoctonia (Noordwijkerhout, The Netherlands: June 27-30, 1995)</i>
p.70
<P><B>Smiles, D.E.</b>, *Gardner, W.R. and *Schulz, R.K. (1995)
Diffusion of tritium in arid disposal sites.
<i>
Water Resources Research</i>
31(6): 1483-1488 25 refs, illus.
<P><B>Smiles, D.E.</b> (1995)
Liquid flow in swelling soils.
<i>
Soil Science Society of America Journal</i>
59(2): 313-318 45 refs, illus.
<P><B>Smith, C.J.</b>, *Goh, K.M., <B>Bond, W.J.</b> and Freney, J.R. (1995)
Effects of organic and inorganic calcium compounds on soil-solution pH and aluminium concentration.
<i>
European Journal of Soil Science</i>
46: 53-63 39 refs, illus.
<P><B>Smith, C.J.</b>, *Goh, K.M., <B>Bond, W.J.</b>, Freney, J.R. and <B>Tuomi, S.S.</b> (1995)
Amelioration of acidity in subsurface soil using organic and inorganic calcium compounds.
<i>
In: Date, R A, Grundon, N J, Rayment, G E and Probert, M E (eds.). Proceedings of the 3rd International Symposium on Plant-Soil Interactions at Low pH (Brisbane, QLD: September 12-16, 1993)</i>
pp.573-577 17 refs, illus. ISBN 0792331982
(Dordrecht: Kluwer Academic Publ.)
[Reprinted from Plant and Soil, v.171(1), 1995]
<P><B>Swift, R.S.</b>, *Rate, A.W. and <B>McLaren, R.G.</b> (1995)
Interactions of copper with soil humic substances.
<i>
In: Huang, P M  et al (ed.). Environmental impact of soil component interactions: metals, other inorganics, and microbial activities. Vol. 2</i>
ch. 2: 19-27  14 refs, illus. ISBN 0873719158
<P>Tan, Y. and <B>Bond, W.J.</b> (1995)
Modeling subsurface transport of microorganisms.
<i>
In: Singh, V P (ed.). Environmental Hydrology</i>
(Ch.9): 321-355 99 refs, illus.
(Amsterdam, The Netherlands: Kluwer Academic Publ.)
<P><B>Tiller, K.G.</b> (1995)
Predicting and minimizing cadmium in cereal grain.
<i>
Division of Soils [miscellaneous publication]. CSIRO Australia</i>
8p.
<P><B>Verburg, K.</b>, <B>Bristow, K.L.</b>, <B>Ross, P.J.</b> and Keating, B.A. (1995)
Modelling solute movement in sugarcane soils.
<i>
In: Robertson, M J (ed.). Research and modelling approaches to assess sugarcane production opportunities and constraints: Workshop Proceedings (St Lucia, QLD: November 10-11, 1994)</i>
pp.59-64 4 refs, illus. ISBN 0643057684
(St Lucia, QLD: CSIRO Division of Tropical Crops and Pastures)
<P><B>Waldon, C.L.</b> and <B>Slater, B.D.</b> (1995)
A soil information strategy for the Murray-Darling basin.
<i>
ACLEP Newsletter. Australian Collaborative Land Evaluation Program. Division of Soils. CSIRO Australia</i>
4(4): 7-8
<P>Walker, G.R. and <B>Fitzpatrick, R.W.</b> (Editors) (1995)
Project database and list of publications relating to dryland salinity in South Australia: 1991-1994.
<i>
Division of Soils [miscellaneous publication]. CSIRO Australia</i>
54p. 28 refs ISBN 0730806561
<P>Wang, Y.P., Meyer, C.P., <B>Smith, C.J.</b> and Galbally, I.E. (1995)
Prediction of carbon dioxide and nitrous oxide fluxes from a legume-pasture soil at Wagga Wagga.
<i>
In: Binning, P, Bridgman, H and Williams, B (eds.). Proceedings of the International Congress on Modelling and Simulation. Vol.1. Agriculture, catchment hydrology and industry (Newcastle, NSW: November 27-30, 1995)</i>
pp.83-88 13 refs, illus.
(Canberra, ACT: Modelling and Simulation Society of Australia)
<P><B>Webb, M.J.</b>, <B>Mazza, G.M.</b>, <B>Reddell, P.</b>, *Poa, D. and *Hambleton, A. (1995)
Nutrition of high value timber trees.
<i>
Pacific Islands Forests & Trees</i>
(Sept): 3-4  illus.
<P><B>Webb, M.J.</b>, *Poa, D., *Hambleton, A. and <B>Reddell, P.W.</b> (1995)
Identifying and solving nutritional problems in establishing plantation of high-value tropical cabinet timbers: a case study from Kolombangara in the Solomon Islands.
<i>
In: Schulte, A and Ruhiyat, D (eds.). Proceedings of the International Congress on Soils of Tropical Forest Ecosystems/3rd Conference on Forest Soils. Vol.4: Soils and Plantation Forestry (Balipapan, Indonesia: October 29-November 3, 1995)</i>
pp.148-165 4 refs, illus.
<P><B>Willett, I.R.</b> and <B>Bond, W.J.</b> (1995)
Sorption of manganese, uranium, and radium by highly weathered soils.
<i>
Journal of Environmental Quality</i>
24(5): 834-845 43 refs, illus.
<P>*Wong, M.T.F. and <B>Swift, R.S.</b> (1995)
Amelioration of aluminium phytotoxicity with organic matter.
<i>
In: Date, R A #et al# (eds.). Plant soil interactions at low pH</i>
pp.41-45 24 refs, illus.
(Amsterdam, The Netherlands: Kluwer Academic Publ.)
<P>*Wong, M.T.F., *Akyeampong, E., *Nortcliff, S. and <B>Swift, R.S.</b> (1995)
Initial responses of maize and beans to decreased concentrations of monomeric inorganic aluminium with application of manure or tree prunings to an Oxisol in Burundi.
<i>
Plant and Soil</i>
171: 275-282 25 refs, illus.
<P><B>Zarcinas, B.A.</b> (1995)
Suppression of iron interference in the determination of boron using the azomethine-H procedure.
<i>
Communications in Soil Science and Plant Analysis</i>
26(5&6): 713-729 20 refs, illus.
<P>Zierholz, C. and <B>Hairsine, P.B.</b> (1995)
Runoff and soil erosion in bushland following the Sydney bushfires.
<i>
Australian Journal of Soil and Water Conservation</i>
8(4): 28-37 53 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-7</DOCNO>
<DOCOLDNO>IA089-000952-B045-71</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FS1995.html 192.102.250.248 19970208035614 text/html 19590
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:43:33 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:16 GMT
Content-type: text/html
Content-length: 19406
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Fisheries</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Fisheries</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abbott, D.J.</b> (1995)
Translations in Australia.
<i>
In: Markham, J W and Duda, A L (eds.). Building Global Connections. Proceedings of the 20th Annual Conference of the International Association of Aquatic and Marine Sceicne Libraries and Information Centers (Honolulu, Hawaii, USA: October 9-13, 1994)</i>
p.163-165
<P>Bakes, M.J., <B>Elliott, N.G.</b>, *Green, G.J. and Nichols, P.D. (1995)
Variation in lipid composition of some deep-sea fish (Teleostei: Oreosomatidae and Trachichthyidae).
<i>
Comparative Biochemistry and Physiology. B</i>
111(4): 633-642 28 refs, illus.
<P>Barrett, S.M., Volkman, J.K., Dunstan, G.A. and <B>Leroi, J-M.</b> (1995)
Sterols of 14 species of marine diatoms (Bacillariophyta).
<i>
Journal of Phycology</i>
31: 360-369 53 refs, illus.
<P><B>Berry, D.G.</b> (1995)
Speaking for the silent majority.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(85): 34-35, illus.
<P><B>Blaber, S.J.M.</b>, <B>Milton, D.A.</b>, *Smith, G.C. and <B>Farmer, M.J.</b> (1995)
Trawl discards in the diets of tropical seabirds of the northern Great Barrier Reef, Australia.
<i>
Marine Ecology. Progress Series</i>
127: 1-13 39 refs, illus.
<P><B>Blaber, S.J.M.</b>, <B>Brewer, D.T.</b> and <B>Salini, J.P.</b> (1995)
Fish communities and the nursery role of the shallow inshore waters of a tropical bay in the Gulf of Carpentaria, Australia.
<i>
Estuarine, Coastal and Shelf Science</i>
40: 177-193 30 refs, illus.
<P><B>Blaber, S.J.M.</b> (1995)
"On the sex of fish and the gender of scientists" by Daniel Pauly, Fish and Fisheries Series 14. Chapman & Hall: London, 1994 250p. [book review].
<i>
Australian Marine Science Bulletin</i>
(130): 18-19
<P><B>Brewer, D.T.</b>, <B>Rawlinson, N.J.F.</b> and *Eayrs, S. (1995)
Bycatch reduction devices show promise in the NPF.
<i>
Australian Fisheries</i>
54(5): 24-26, illus.
<P><B>Brewer, D.T.</b>, <B>Blaber, S.J.M.</b>, <B>Salini, J.P.</b> and <B>Farmer, M.J.</b> (1995)
Feeding ecology of predatory fishes from Groote Eylandt in the Gulf of Carpentaria, Australia, with special reference to predation on penaeid prawns.
<i>
Estuarine, Coastal and Shelf Science</i>
40: 577-600 39 refs, illus.
<P><B>Brown, M.R.</b> (1995)
Effects of storage and processing on the ascorbic acid content of concentrates prepared from <i>Chaetoceros calcitrans</i>.
<i>
Journal of Applied Phycology</i>
7: 495-500 15 refs, illus.
<P><B>Brown, M.R.</b> and <B>Jeffrey, S.W.</b> (1995)
The amino acid and gross composition of marine diatoms potentially useful for mariculture.
<i>
Journal of Applied Phycology</i>
7: 521-527 34 refs
<P><B>Bruce, B.D.</b> (1995)
Larval development of King George whiting, <i>Sillaginodes punctata</i>, school whiting, <i>Sillago bassensis</i>, and yellow fin whiting, <i>Sillago schomburgkii</i> (Percoidei: Sillaginidae), from South Australian waters.
<i>
Fishery Bulletin</i>
93: 27-43 31 refs, illus.
<P><B>Bulman, C.M.</b> and <B>Koslow, J.A.</b> (1995)
Development and depth distribution of the eggs of orange roughy, <i>Hoplostethus atlanticus</i> (Pisces: Trachichthyidae).
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(4): 697-705 34 refs, illus.
<P><B>Burford, M.A.</b>, <B>Rothlisberg, P.C.</b> and Wang, Y-G. (1995)
Spatial and temporal distribution of tropical phytoplankton species and biomass in the Gulf of Carpentaria, Australia.
<i>
Marine Ecology Progress Series</i>
118: 255-266 34 refs, illus.
<P>*Butterworth, D.S., <B>Punt, A.E.</b>, *Oosthuizen, W.H. and *Wickens, P.A. (1995)
The effects of future consumption by the Cape fur seal on catches and catch rates of the Cape hakes. 3. Modelling the dynamics of the Cape fur seal <i>Arctocephalus pusillus pusillus</i>.
<i>
South African Journal of Marine Science</i>
16: 161-183  47 refs, illus.
<P><B>Cowling, A.M.</b> and <B>Polacheck, T.W.</b> (1995)
Development of a fishery independent index of SBT abundance.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
57p. 10 refs, illus.
<P><B>Crocos, P.J.</b> and <B>Van Der Velde, T.D.</b> (1995)
Seasonal, spatial and interannual variability in the reproductive dynamics of the grooved tiger prawn <i>Penaeus semisulcatus</i> in Albatross Bay, Gulf of Carpentaria, Australia: the concept of effective spawning.
<i>
Marine Biology</i>
122: 557-570 41 refs, illus.
<P><b>CSIRO Division of Fisheries</b> (1995)
Getting a grip on phytoplankton.
<i>
Western Fisheries</i>
(Sept): 42-43, illus.
<P><B>Dall, W.</b> (1995)
Carotenoids versus retinoids (Vitamin A) as essential growth factors in penaeid prawns (<i>Penaeus semisulcatus</i>).
<i>
Marine Biology</i>
124: 209-213 21 refs, illus.
<P><B>Dall, W.</b>, <B>Smith, D.M.</b> and <B>Moore, L.E.</b> (1995)
Carotenoids in the tiger prawn <i>Penaeus esculentus</i> during ovarian maturation.
<i>
Marine Biology</i>
123: 435-441 28 refs, illus.
<P><B>Davenport, S.R.</b> (1995)
Mercury in blue sharks and deepwater dogfish from around Tasmania.
<i>
Australian Fisheries</i>
54(3): 20-22 6 refs, illus.
<P><B>Elliott, N.G.</b> and <B>Ward, R.D.</b> (1995)
Genetic relationships of eight species of Pacific tunas (Teleostei: Scombridae) inferred from allozyme analysis.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(7): 1021-1032 32 refs, illus.
<P><B>Elliott, N.G.</b> and <B>Ward, R.D.</b> (1995)
Genetic relationships of eight species of pacific tunas (Teleostei : Scombridae) inferred from allozyme analysis.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(7): 1021-32, 32 refs
<P><B>Elliott, N.G.</b>, Haskard, K.A. and <B>Koslow, J.A.</b> (1995)
Morphometric analysis of orange roughy (<i>Hoplostethus atlanticus</i>) off the continental slope of southern Australia.
<i>
Journal of Fish Biology</i>
46: 202-220 34 refs, illus, appendix
<P><B>Fitzpatrick, J.J.</b> and <B>Kirkman, H.</b> (1995)
Effects of prolonged shading stress on growth and survival of seagrass <i>Posidonia australis</i> in Jervis Bay, New South Wales, Australia.
<i>
Marine Ecology Progress Series</i>
127: 279-289 36 refs, illus.
<P><B>Giles, J.W.B.</b> (1995)
Urgent need to conserve Asian fishery.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(84): 6-7, illus.
<P>*Hastings, K., *Hesp, P. and <B>Kendrick, G.A.</b> (1995)
Assessing seagrass change off Western Australia.
<i>
GIS Asia Pacific</i>
1(2): 32-35, illus.
<P>*Hastings, K., *Hesp, P. and <B>Kendrick, G.A.</b> (1995)
Seagrass loss associated with boat moorings at Rottnest Island, Western Australia.
<i>
Ocean & Coastal Management</i>
26(3): 225-246 24 refs, illus.
<P><B>Haywood, M.D.E.</b>, <B>Vance, D.J.</b> and <B>Loneragan, N.R.</b> (1995)
Seagrass and algal beds as nursery habitats for tiger prawns (<i>Penaeus semisulcatus</i> and <i>P. esculentus</i>) in a tropical Australian estuary.
<i>
Marine Biology</i>
122: 213-223 29 refs, illus.
<P>*Hurn, A.S. and <B>McDonald, A.D.</b> (1995)
The empirical size and power of some tests for detecting autoregressive conditional heteroskedasticity in the presence of seria correlation.
<i>
University of Melbourne Research Paper</i>
(471): 16p. 8 refs ISBN 0732512263
<P>*Hurn, A.S. and <B>McDonald, A.D.</b> (1995)
Isolating cyclical patterns in irregular time series data.
<i>
University of Melbourne Research Paper</i>
(473): 10p. 10 refs, illus. ISBN 073251228X
<P><B>Kendrick, G.A.</b>, <B>Kirkman, H.</b> and <B>Burton, C.L.K.</b> (1995)
An investigation into beach cast macro algae and marine angiosperms.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
63p. 119 refs, illus.
<P><B>Kendrick, G.A.</b> and *Walker, D.I. (1995)
Dispersal of propagules of <i>Sargassum</i> spp. (Sargassaceae: Phaeophyta): observations of local patterns of dispersal and consequences for recruitment and population structure.
<i>
Journal of Experimental Marine Biology and Ecology</i>
192: 273-288 50 refs, illus.
<P><B>Klaer, N.</b> and <B>Polacheck, T.W.</b> (1995)
Japanese longline seabird bycatch in the Australian fishing zone April 1991 - March 1994: Catch and catch rates by area and season and an evaluation of the effectiveness of mitigation measures.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
95p. 30 refs, illus.
<P><B>Koslow, J.A.</b>, *Bell, J., Virtue, P. and *Smith, D.C. (1995)
Fecundity and its variability in orange roughy: effects of population density, condition, egg size, and senescence.
<i>
Journal of Fish Biology</i>
47: 1063-1080 50 refs, illus.
<P><B>Koslow, J.A.</b>, <B>Bulman, C.M.</b>, *Lyle, J.M. and <B>Haskard, K.A.</b> (1995)
Biomass assessment of a deep-water fish, the orange roughy (<i>Hoplostethus atlanticus</i>), based on an egg survey.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(5): 819-830 20 refs, illus.
<P><B>Koslow, J.A.</b>, <B>Kloser, R.J.</b> and <B>Stanley, C.A.</b> (1995)
Avoidance of a camera system by a deepwater fish, the orange roughy (<i>Hoplostethus atlanticus</i>).
<i>
Deep-Sea Research I</i>
42(2): 233-244 30 refs, illus.
<P><B>Koslow, J.A.</b> and *Exon, N. (1995)
Seamount discoveries prompt calls for exploration and conservation.
<i>
Australian Fisheries</i>
54(2): 10-13, illus.
<P><B>Koslow, J.A.</b> (1995)
Quiet revolution in the deep.
<i>
Australian Fisheries</i>
54(6): 17-18, illus.
<P><B>Koslow, J.A.</b>, *Higginbottom, I. and Haskard, K.A. (1995)
The relationship of echo-integration estimates of orange roughy biomass with indices based on echogram recordings of school size. Final Report to Fisheries Research Reserve Fund [consultancy report].
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
19p. 1 ref, illus.
<P><B>Lemmens, J.W.T.J.</b>, *Arnold, P.W. and *Birtles, R.A. (1995)
Distribution patterns and selective feeding in two <i>Astropecten</i> species (Asteroidea: Echinodermata) from Cleveland Bay, Northern Queensland.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(2): 447-455 28 refs, illus.
<P><B>Lemmens, J.W.T.J.</b> (1995)
Nucleic acid levels, cellular activity and growth during the puerulus stage of the western rock lobster (<i>Panulirus cygnus</i> (George); Decapoda: Palinuridae).
<i>
Journal of Experimental Marine Biology and Ecology</i>
194: 143-156 40 refs, illus.
<P><B>Loneragan, N.R.</b>, Wang, Y-G., <B>Kenyon, R.A.</b>, *Staples, D.J. and <B>Vance, D.J.</b> (1995)
Estimating the efficiency of a small beam trawl for sampling tiger prawns <i>Penaeus esculentus</i> and <i>P. semisulcatus</i> in seagrass by removal experiments.
<i>
Marine Ecology Progress Series</i>
118: 139-148 31 refs, illus.
<P><B>Long, B.G.</b>, <B>Poiner, I.R.</b> and <B>Wassenberg, T.J.</b> (1995)
Distribution, biomass and community structure of megabenthos of the Gulf of Carpentaria, Australia.
<i>
Marine Ecology Progress Series</i>
129: 127-139 49 refs, illus.
<P><B>Long, B.G.</b>, <B>Skewes, T.D.</b> and <B>Poiner, I.R.</b> (1995)
Torres Strait Marine Geographic Information System.
<i>
In: Bellwood, O, Choat, H and Saxena, N (eds.). Recent advances in marine science and technology '94</i>
pp.231-239 19 refs, illus. ISBN 0864435401
(Townsville, QLD: James Cook Univ. of North Queensland)
<P>Mackey, D.J., <B>Parslow, J..</b>, Higgins, H.W., <B>Griffiths, F.B.</b> and O'Sullivan, J.E. (1995)
Plankton productivity and biomass in the western equatorial Pacific: biological and physical controls.
<i>
Deep-Sea Research II</i>
42(2-3): 499-533 93 refs, illus.
<P>*Martin, T.J., <B>Brewer, D.T.</b> and <B>Blaber, S.J.</b> (1995)
Factors affecting distribution and abundance of small demersal fishes in the Gulf of Carpentaria, Australia.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(6): 909-20, 13 refs, illus.
<P>*McWilliam, P.S., <B>Phillips, B.F.</b> and *Kelly, S. (1995)
Phyllosoma larvae of <i>Scyllarus</i> species (Decapoda, Scyllaridae) from the shelf waters of Australia.
<i>
Crustaceana</i>
68(5): 537-566 42 refs, illus.
<P><B>Milton, D.A.</b>, <B>Blaber, S.J.M.</b> and <B>Rawlinson, N.J.F.</b> (1995)
Fecundity and egg production of four species of short-lived clupeoid from Solomon Islands, tropical South Pacific.
<i>
ICES Journal of Marine Science</i>
52: 111-125 57 refs, illus.
<P><B>Milton, D.A.</b>, *Short, S.A., <B>O'Neill, M.F.</b> and <B>Blaber, S.J.M.</b> (1995)
Ageing of three species of tropical snapper (Lutjanidae) from the Gulf of Carpentaria, Australia, using radiometry and otolith ring counts.
<i>
Fishery Bulletin</i>
93: 103-115 36 refs, illus.
<P>*Moverley, J.H., <B>Ritz, D.A..</b> and Garland, C.P. (1995)
Development and testing of a meiobenthic mesocosm system for ecotoxicological experiments.
<i>
Technical Report. National Pulp Mills Research Program. Institute of Natural Resources and Environment. CSIRO Australia</i>
(14): 111p. 42 refs, illus. ISBN 0643057412
<P><B>Murray, A.G.</b> (1995)
Phytoplankton exudation: exploitation of the microbial loop as a defence against algal viruses.
<i>
Journal of Plankton Research</i>
17(5): 1079-1094 59 refs, illus.
<P><B>Pitcher, C.R.</b>, <B>Skewes, T.D.</b> and <B>Dennis, D.M.</b> (1995)
Biology and fisheries ecology of the ornate rock lobster in Torres Strait.
<i>
In: Bellwood, O, Choat, H and Saxena, N (eds.). Recent advances in marine science and technology '94</i>
pp.311-321 22 refs, illus. ISBN 0864435401
(Townsville, QLD: James Cook Univ. of North Queensland)
<P><B>Polacheck, T.W.</b>, *Wenzel, F.W. and *Early, G. (1995)
What do stranding data say about Harbor Porpoises (<i>Phocoena phocoena</i>)?.
<i>
Report. International Whaling Commission</i>
Special issue(16): 169-79  20 refs, illus.
<P>*Pollock, K.H., *Conroy, M.J. and <B>Hearn, W.S.</b> (1995)
Separation of hunting and natural mortality using ring-return models: an overview.
<i>
Journal of Applied Statistics</i>
22(5/6): 557-566 29 refs
<P><B>Proctor, C.H.</b>, <B>Thresher, R.E.</b>, <B>Gunn, J.S.</b>, Mills, D.J., Harrowfield, I.R. and Sie, S.H. (1995)
Stock structure of the southern bluefin tuna <i>Thunnus maccoyii</i>: an investigation based on probe microanalysis of otolith composition.
<i>
Marine Biology</i>
122: 511-526 42 refs, illus.
<P><B>Punt, A.E.</b> and *Butterworth, D.S. (1995)
The effects of future consumption by the Cape fur seal on catches and catch rates of the Cape hakes. 4. Modelling the biological interaction between Cape fur seals <i>Arctocephalus pusillus pusillus</i> and the Cape hakes <i>Merluccius capensis</i> and <i>M. Paradoxus</i>.
<i>
South African Journal of Marine Science</i>
16: 255-285  39 refs, illus.
<P><B>Punt, A.E.</b> and *Leslie, R.W. (1995)
The effects of future consumption by the Cape fur seal on catches and catch rates of the Cape hakes. 1. Feeding and diet of the Cape hakes <i>Merluccius capensis</i> and <i>M. paradoxus</i>.
<i>
South African Journal of Marine Science</i>
16: 37-55  45 refs, illus.
<P><B>Punt, A.E.</b>, *Butterworth, D.S. and *Penney, A.J. (1995)
Stock assessment and  risk analysis for the South Atlantic population of albacore <i>Thunnus alalunga</i> using an age-structured production model.
<i>
South African Journal of Marine Science</i>
16: 287-310  58 refs, illus.
<P><B>Rawlinson, N.J.F.</b>, <B>Milton, D.A.</b>, <B>Blaber, S.J.M.</b>, *Sesewa, A. and *Sharma, S.P. (1995)
A survey of the subsistence and artisanal fisheries in rural areas of Viti Levu, Fiji.
<i>
ACIAR Monograph</i>
(35): 126p. 19 refs, illus. ISBN 1863201424
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Rothlisberg, P.C.</b>, Church, J.A. and Fandry, C.B. (1995)
A mechanism for near-shore concentration and estuarine recruitment of post-larval <i>Penaeus plebejus</i> Hess (Decapoda, Penaeidae).
<i>
Estuarine, Coastal and Shelf Science</i>
40: 115-138 49 refs, illus.
<P><B>Smith, D.M.</b> and <B>Barclay, M.C.</b> (Editors) (1995)
Lipid analysis comparison trial. Report for Fisheries Research & Development Corporation: Replacement of Fishmeal in Aquaculture Diets Sub Program 93/120.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
31p. 4 refs, illus.
<P><B>Thresher, R.E.</b> and <B>Proctor, C.H.</b> (1995)
Otoliths: unlock mysteries of the deep.
<i>
Australian Fisheries</i>
54(6): 19-21 2 refs, illus.
<P><B>Thresher, R.E.</b> and <B>Martin, R.B.</b> (1995)
Controlling marine introductions: crimp.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
22(3): 24-26 4 refs
<P>Virtue, P., <B>Johannes, R.E.</b>, Nichols, P.D. and <B>Young, J.W.</b> (1995)
Biochemical composition of <i>Nyctiphanes australis</i> and its possible use as an aquaculture feed source: lipids, pigments and fluoride content.
<i>
Marine Biology</i>
122: 121-128 65 refs, illus.
<P>Volkman, J.K., Barrett, S.M., <B>Blackburn, S.I.</b> and *Sikes, E.L. (1995)
Alkenones in <i>Gephyrocapsa oceanica</i>: implications for studies of paleoclimate.
<i>
Geochimica et Cosmochimica Acta</i>
59(3): 513-520 48 refs, illus.
<P><B>Wallner, B.G.</b> and <B>Phillips, B.F.</b> (1995)
Development of a trawl fishery for deepwater metanephropid lobsters off the northwest continental slope of Australia: designing a management strategy compatible with species life history.
<i>
ICES Marine Science Symposia</i>
199: 379-390 48 refs, illus.
<P>Wang, Y-G., Thomas, M.R. and <B>Somers, I.F.</b> (1995)
A maximum likelihood approach for estimating growth from tag-recapture data.
<i>
Canadian Journal of Fisheries and Aquatic Sciences</i>
52(2): 252-259 15 refs, illus.
<P><B>Ward, R.D.</b> and <B>Andrew, B.J.</b> (1995)
Population genetics of the northern Pacific seastar <i>Asterias amurensis</i> (Echinodermata: Asteriidae): allozyme differentiation among Japanese, Russian, and recently introduced Tasmanian populations.
<i>
Marine Biology</i>
124: 99-109 25 refs, illus.
<P><B>Ward, R.D.</b>, <B>Elliott, N.G.</b> and <B>Grewe, P.</b> (1995)
Allozyme and mitochondrial DNA separation of pacific northern bluefin tuna, <i>thunnus thynnus orientalis</i> (Temminck and Schlegel), from southern bluefin tuna, <i>thunnus maccoyii</i> (Castelnau).
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(6): 921-30, 19 refs
<P><B>Ward, R.D.</b> (1995)
Population genetics of tunas.
<i>
Journal of Fish Biology</i>
47(Supp.A): 259-280 69 refs, illus.
<P><B>Ward, T.J.</b> and <B>Jacoby, C.A.</b> (1995)
Deciphering spatiotemporal dynamics: what can mesocosm experiments do to improve predictions of environmental impacts?.
<i>
Australasian Journal of Ecotoxicology</i>
1: 51-54 4 refs, illus.
<P><B>Young, P.C.</b>, <B>McLoughlin, R.J.</b> and <B>Martin, R.B.</b> (1995)
Vertical distribution of larvae and spat of the commercial scallop, <i>Pecten fumatus</i>.
<i>
Actes de Colloques</i>
(17): 199-205 15 refs, illus. ISBN 2905434600
[Proceedings of the 8th International Pectinid Workshop: Fisheries, Biology and Aquaculture of Pectinids (Cherbourg, France: May 22-29, 1991)]<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-8</DOCNO>
<DOCOLDNO>IA057-000941-B009-184</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/WB1994.html 192.102.250.248 19970208044206 text/html 45003
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:29:10 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:47 GMT
Content-type: text/html
Content-length: 44819
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Water Resources</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Water Resources</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>Abel, D.J., Kilby, P.J. and <B>Davis, J.R.</b> (1994)
The systems integration problem.
<i>
Int. J. Geographical Information Systems</i>
8(1): 1-12, 20 refs, illus.
<P>*Ahmad, A.R., *Zulkefli, M., *Ahmed, M., *Aminuddin, B.Y., <B>Sharma, M.L.</b> and *Zain, M.M. (1994)
Environmental impact of agricultural inorganic pollution on groundwater resources of the Kelantan Plain, Malaysia.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 8-21 7 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P>*Ahmed, M., <B>Sharma, M.L.</b> and <B>Richards, Q.D.</b> (1994)
Evaluation of field sampling methods for soil water quality.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 64-70 14 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P>*Ahmed, M., <B>Sharma, M.L.</b>, <B>Richards, Q.D.</b> and *Ahmad, A.R. (1994)
Field-scale nitrogen leaching: application of model "LEACHN"
.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 45-52 11 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P>*Akilan, K., *Considine, J.A., Joyce, D.C. and <B>Marshall, J.K.</b> (1994)
Morphological responses of Geraldton wax to transient soil-water deficit.
<i>
Australian Journal of Botany</i>
42(2): 205-217 21 refs, illus.
<P>*Akilan, K., *Considine, J.A. and <B>Marshall, J.K.</b> (1994)
Water use by Geraldton wax (<i>Chamelaucium uncinatum</i> Schauer) as measured by heat balance stem flow gauges.
<i>
New Zealand Journal of Crop and Horticultural Science</i>
22: 285-294 26 refs, illus.
<P><B>Allison, G.B.</b> (1994)
Where now with cities and our environment?.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(6): 3-4, illus.
<P><B>Anderson-Carnahan, L.J.</b> (1994)
Development of methods for culturing and conducting aquatic toxicity tests with the Australian cladoceran <i>Moina australiensis</i>.
<i>
Water Resources Series. Division of Water Resources. CSIRO Australia</i>
(13): 56p., illus.
<P>Atwell, B.J. and <B>Heritage, A.D.</b> (1994)
Reduced susceptibility of roots of safflower to <i>Phytophthora cryptogea</i> after prior adaptation of roots to hypoxic conditions.
<i>
Australian Journal of Botany</i>
42(1): 29-36 12 refs, illus.
<P>*Ayob, A.H., *Zulkefli, M., *Mohammud, C.H., <B>Sharma, M.L.</b>, *Zain, M.M., *Aminuddin, B.Y. and *Ahmad, A.R. (1994)
Water and nutrient balance study in the KADA paddy irrigation scheme.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 33-44 8 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P><B>Barber, C.</b>, <B>Bates, L.E.</b> and <B>Allison, H.J.</b> (1994)
Evaluation of DRASTIC: a regional aquifer vulnerability assessment procedure.
<i>
Proceedings of an International Symposium on Groundwater, Drought, Pollution and Management (Wallingford, UK: February 1-3, 1994)</i>
9p. 9 refs, illus.
(Wallingford, UK: International Association for Hydraulic Res.)
<P><B>Barber, C.</b>, <B>Bates, L.E.</b>, <B>Barron, R.J.W.</b> and <B>Allison, H.J.</b> (1994)
Comparison of standardised and region-specific methods for assessment of the vulnerability of groundwater to pollution: a case study in an agricultural catchment.
<i>
Proceedings of Water Down Under '94 (Adelaide, SA: November 21-25, 1994)</i>
8p. 7 refs, illus.
<P><B>Barber, C.</b> and <B>Davis, G.B.</b> (1994)
Representative sampling of groundwater from boreholes.
<i>
In: Adriano, D C, Iskandar, A K, Murarka, I P (eds.). Contamination of groundwaters</i>
(Ch.5): 141-160 31 refs, illus. ISBN 0905927443
(Northwood, UK: Science Reviews)
<P><B>Barrs, H.D.</b> and <B>Prathapar, S.A.</b> (1994)
An inexpensive and effective basis for monitoring rice areas using GIS and remote sensing.
<i>
Australian Journal of Experimental Agriculture</i>
34(7): 1079-1083 9 refs, illus.
[Reprinted as a specia lissue of the journal; Temperate rice: achievements and potential.]
<P><B>Bates, B.C.</b>, <B>Charles, S.P.</b>, <B>Sumner, N.R.</b> and <B>Fleming, P.M.</b> (1994)
Climate change and its hydrological implications for South Australia.
<i>
Transactions of the Royal Society of South Australia</i>
118(1&2): 35-43 22 refs, illus.
<P><B>Bates, B.C.</b>, <B>Jakeman, A.J.</b>, <B>Charles, S.P.</b>, <B>Sumner, N.R.</b> and <B>Fleming, P.M.</b> (1994)
Impact of climate change on Australia's surface water resources.
<i>
Paper presented at Greenhouse 94: An Australian-New Zealand Conference on Climate Change (Wellington, NZ: October 10-14, 1994)</i>
19p. 21 refs, illus.
<P>*Benker, E., <B>Davis, G.B.</b>, *Appleyard, S., *Barry, D.A. and <B>Power, T.R.</b> (1994)
Groundwater contamination by trichloroethene (TCE) in a residential area of Perth: distribution, mobility, and implications for management.
<i>
Proceedings of the 25th Congress of IAH (Adelaide, SA: November 21-25, 1994)</i>
2A: 261-266 15 refs, illus.
<P>*Bourgault du Coudray, P.L., <B>Williamson, D.R.</b> and *Scott, W.D. (1994)
Chloride movement in a de-watered saline soil profile.
<i>
In: Harper, R J (compiler). Soils '94. Proceedings of the 3rd Triennial Western Australian Soil Science Conference (Busselton, WA: September 7-9, 1994)</i>
pp.135-142 15 refs, illus.
<P><B>Bowmer, K.H.</b>, <B>Bales, M.T..</b> and <B>Roberts, J.</b> (1994)
Potential use of irrigation drains as wetlands.
<i>
Water Science and Technology</i>
29(4): 151-158 8 refs, illus.
<P><B>Bowmer, K.H.</b>, <B>Korth, W.</b>, <B>Thomas, H.M.</b> and <B>McCorkelle, G.</b> (1994)
River pollution with agricultural chemicals.
<i>
In: Roberts, J and Oliver, R L (eds.). The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April 1992)</i>
(Ch.2): 7-19 12 refs, illus. ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P>*Brooker, A.M.H. and <B>Townley, L.R.</b> (1994)
Flow and solute transport through a levee separating fluids with different densities.
<i>
Water Resources Research</i>
30(6): 1847-1856 19 refs, illus.
<P><B>Bryant, M.M.</b> (1994)
Perth's mysterious red Swan.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(79): p.4, illus.
<P><B>Buia, M.</b>, <B>Simmons, C.T.</b> and <B>Narayan, K.A.</b> (1994)
Interfacing the FEMCAD-generated finite-element mesh with the groundwater-flow and solute-transport model SUTRA.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/4): 61p. 6 refs, illus. ISBN 0643056599
<P>Buselli, G. and <B>Williamson, D.R.</b> (1994)
The use of broadband electromagnetic methods to differentiate layered models of soil salinity profiles.
<i>
Exploration Geophysics</i>
25: 89-102 20 refs, illus.
<P><B>Cai, L.</b>, <B>Prathapar, S.A.</b> and *Beecher, H.G. (1994)
Modelling leaching and recharge in a bare transitional red-brown earth ponded with low salinity water in summer.
<i>
Australian Journal of Experimental Agriculture</i>
34(7): 1085-1092 17 refs, illus.
[Reprinted as a spcial issue of the journal; Temperate rice: achievements and potential.]
<P><B>Caitcheon, G.G.</b>, <B>Donnelly, T.H.</b>, <B>Wallbrink, P.J.</b> and <B>Murray, A.S.</b> (1994)
Sources of phosphorus and sediment in the catchment of Chaffey Reservoir, New South Wales.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/16): 29p. 12 refs, illus.
<P><B>Charlesworth, A.T.</b> and <B>Narayan, K.A.</b> (1994)
Sensitivity analysis of solute transport modelling at Lake Ranfurly, Victoria.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/4): 28p. 6 refs, illus.
<P><B>Charlesworth, A.T.</b>, <B>Narayan, K.A.</b> and <B>Simmons, C.T.</b> (1994)
Modelling salt accession within the Chowilla Anabranch and possible mitigation schemes.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/7): 23p. 19 refs, illus.
[Modified version also published in: Water Resources Series (15): 47-61.  CSIRO Division of Water Resources; 1996]
<P>*Cheah, U.B., <B>Sharma, M.L.</b>, *Aminuddin, B.Y., *Mohammud, C.H. and *Zain, M.M. (1994)
Pesticide residues in water resources of the agricultural plains of Kelantan.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 22-8 22 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P><B>Cook, P.G.</b>, <B>Jolly, I.D.</b>, <B>Leaney, F.W.</b>, <B>Walker, G.R.</b>, *Allan, G.L., *Fifield, L.K. and <B>Allison, G.B.</b> (1994)
Unsaturated zone tritium and chlorine 36 profiles from southern Australia: their use as tracers of soil water movement.
<i>
Water Resources Research</i>
30(6): 1709-1719 39 refs, illus.
<P><b>CSIRO Division of Soils</b> and <b>CSIRO Division of Water Resources</b> (1994)
Dryland farming systems for catchment care.
<i>
Challenge</i>
(Dec): 12-13, illus.
<P><b>CSIRO Division of Water Resources</b> (1994)
Nutrients in rivers: is irrigation drainage to blame?.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(18): 4-5 1 ref, illus.
<P><b>CSIRO Division of Water Resources</b> (1994)
Sharing water with the environment.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(18): 1-3,8, illus.
<P><b>CSIRO Division of Water Resources</b> (1994)
Australian Research Centre for Water in Society: about the Centre.
<i>
Division of Water Resources [miscellaneous publication]. CSIRO Australia</i>
16p.
<P><b>CSIRO Division of Water Resources</b> (1994)
CSIRO Land and Water Care Program: outcomes '93.
<i>
Division of Water Resources [miscellaneous publication]. CSIRO Australia</i>
16p., illus.
<P><b>CSIRO Division of Water Resources</b> (1994)
Whodunit?.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(17): 1-2
<P><b>CSIRO Division of Water Resources</b> (1994)
Plugging the leaks.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(17): p.6, illus.
<P><b>CSIRO Division of Water Resources</b> (1994)
Alligator weed.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(17): 4-5, illus.
<P><B>Daniel, P.J.</b>, <B>Alksnis, H.</b> and <B>Kalma, J.D.</b> (1994)
The regional evapotranspiration project: climate data.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/14): 18p. 4 refs, illus, appendixes ISBN 0643056319
<P><B>Davis, G.B.</b> and <B>Salama, R.B.</b> (1994)
Modeling point sources of groundwater contamination: a review and case study.
<i>
In: Adriano, D C, Iskandar, A K, Murarka, I P (eds.). Contamination of groundwaters</i>
(Ch.4): 111-140 76 refs, illus. ISBN 0905927443
(Northwood, UK: Science Reviews)
<P><B>Davis, J.R.</b> (1994)
An expert system for estimating nutrient generation rates.
<i>
AI Applications</i>
8(3): p.67
<P><B>Davis, J.R.</b>, <B>Young, W.J.</b> and <B>Marston, F.M.</b> (1994)
Expert parameter estimation: capturing expertise about nutrient generation rates.
<i>
Proceedings of Conference on Resource Technology '94 (Melbourne, Vic: September 1994)</i>
(1994): 222-31, 21 refs
<P><B>Davis, J.R.</b> and *Guariso, G. (1994)
Chapter 10: Expert system support for environmental decisions.
<i>
In: 'Environemntal Modelling, Vol. II' ed. Paolo Zannetti (Computational Mechanics Publications, Boston, 1994)</i>
(1994): 325-50, 52 refs, illus.
<P><B>Dawes, W.R.J.</b> and <B>Short, D.L.</b> (1994)
The significance of topology for modeling the surface hydrology of fluvial landscapes.
<i>
Water Resources Research</i>
30(4): 1045-1055 37 refs, illus.
<P><B>Dawes, W.R.J.</b> and <B>Short, D.L.</b> (1994)
Comment on "An efficient numerical solution of the transient storage equations for solute transport in small streams" by R.L. Runkel and S.C. Chapra.
<i>
Water Resources Research</i>
30(10): 2859-2862 9 refs
<P><B>Draper, G.A.</b> (1994)
Residential demand for water: a time-series model.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/5): 37p. 36 refs, illus.
<P><B>Fairweather, P.G.</b> (1994)
Improving the use of science in environmental assessments.
<i>
Australian Zoologist</i>
29(3-4): 217-223 20 refs
<P><B>Farrington, P.</b>, <B>Bartle, G.A.</b>, <B>Watson, G.D.</b> and <B>Salama, R.B.</b> (1994)
Long-term transpiration in two eucalypt species in a native woodland estimated by the heat-pulse technique.
<i>
Australian Journal of Ecology</i>
19(1): 17-25 39 refs, illus.
<P><B>Fleming, P.M.</b> (1994)
Surface water.
<i>
In: Bambrick, S (ed.). The Cambridge Encyclopedia of Australia</i>
pp.15-17, illus. ISBN 0521365112
(UK: Cambridge Univ. Press)
<P>*Frecker, T. and <B>Cuddy, S.M.</b> (1994)
Review of common management practices for controlling nutrient loads in urban runoff within the Hawkesbury-Nepean Basin for use in <i>CMSS</i>.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/8): 55p. 55 refs, illus.
<P><B>Gerritse, R.G.</b> (1994)
The effects of flow rate and distance travelled on the mobility of phosphate in soils.
<i>
Transport in Porous Media</i>
16: 237-251 16 refs, illus.
<P><B>Godwin, D.C.</b>, <B>Meyer, W.S.</b> and *Singh, U. (1994)
Simulation of the effect of chilling injury and nitrogen supply on floret fertility and yield in rice.
<i>
Australian Journal of Experimental Agriculture</i>
34: 921-926 21 refs, illus.
[Reprinted as a special issue of the journal; Temperate rice: achievements and potential.]
<P>*Harrison, J.E. and <b>CSIRO Division of Water Resources</b> (1994)
Review of nutrients in irrigation drainage in the Murray-Darling Basin.
<i>
Water Resources Series. Division of Water Resources. CSIRO Australia</i>
(11): 149p. 65 refs, illus, appendix
<P><B>Heritage, A.D.</b>, <B>Pistillo, P.</b>, <B>Sharma, K.P..</b> and *Lantzke, I.R. (1994)
Treatment of primary-settled urban sewage in pilot-scale vertical flow wetland filters: comparison of four emergent macrophyte species over a 12 month period.
<i>
Paper presented at the 4th International Conference on Wetland Systems for Water Pollution Control (Guangzhou, China: November 6-10, 1994)</i>
12p. 9 refs, illus.
<P>Hill, A.S., Skerritt, J.H., *Bushway, R.J., *Pask, W., *Larkin, K.A., <B>Thomas, H.M.</b>, <B>Korth, W.</b> and <B>Bowmer, K.H.</b> (1994)
Development and application of laboratory and field immunoassays for chlorpyrifos in water and soil matrices.
<i>
Journal of Agricultural and Food Chemistry</i>
42: 2051-2058 34 refs, illus.
<P>Hocking, P.J. and <B>Steer, B.T.</b> (1994)
The distribution and identity of assimilates in tomato with special reference to stem reserves.
<i>
Annals of Botany</i>
73: 315-325 40 refs, illus.
<P><B>Humphreys, E.</b> (1994)
Sustainability.
<i>
Farmers Newsletter</i>
(143): 14-6, illus.
<P><B>Humphreys, E.</b>, <B>Meyer, W.S.</b>, <B>Prathapar, S.A.</b> and <B>Smith, D.J.</b> (1994)
Estimation of evapotranspiration from rice in southern New South Wales: a review.
<i>
Australian Journal of Experimental Agriculture</i>
34(7): 1069-1078 19 refs, illus.
[Reprinted as a special of the journal; Temperate rice: achievements and potential.]
<P><B>Humphreys, E.</b>, *Van der Lely, A., <B>Muirhead, W.A.</b> and *Hoey, D. (1994)
The development of on-farm restrictions to minimise recharge from rice in New South Wales.
<i>
Australian Journal of Soil and Water Conservation</i>
7(2): 11-20 22 refs, illus.
<P><B>Humphreys, E.</b>, *Lewin, L.G., *Clampett, W.S., Anderson, C.A. and Fegent, J.C. (Editors) (1994)
Temperate rice: achievements and potential.
215p., refs, illus. ISBN 0643056874
(East Melbourne, VIC: CSIRO Australia)
[Reprinted from: Australian Journal of Experimental Agriculture, 1994, Vol.34 (7). Proceedings of the First International Temperate Rice Conference (Yanco, NSW: February 21-24, 1994)]
<P><B>Humphreys, E.</b> (1994)
Water and rice.
<i>
Waterlink. CSIRO Division of Water Resources Industry News. CSIRO Australia</i>
(18): 6-7, illus.
<P><B>Humphreys, E.</b>, <B>Muirhead, W.A.</b>, <B>Fawcett, B.J.</b>, <B>Townsend, J.T.</b>, <B>Murray, E.A.</b>, Kirby, J.M., Ringrose-Voase, A.J. and Blunden, B.G. (1994)
Puddling to reduce deep percolation from rice in New South Wales: a review.
<i>
In: Humphreys, E, Murray, E A, Clampett, W A and Lewin, L G (eds.). Temperate rice: achievements and potentials. Proceedings of a Conference (Leeton, NSW: February 21-24, 1994)</i>
2: 345-354 14 refs, illus. ISBN 0646204114
(Griffith: NSW Agriculture)
<P>*Jacobs, S.W.L., *Perrett, F., <B>Sainty, G.R.</b>, <B>Bowmer, K.H.</b> and *Jacobs, B.J. (1994)
<i>Ludwigia peruviana</i> (Onagraceae) in the botany wetlands, near Sydney, Australia.
<i>
Australian Journal of Marine and Freshwater Research</i>
45(8): 1481-1490 19 refs, illus.
[Reprinted in: Boon, P I and Brock, M (eds.). Plants and wetland processes (1995)]
<P><B>Jakeman, A.J.</b> and Pittock, A.B. (Editors) (1994)
Climate Impact Assessment Methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993).
210p., refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Jayawardane, N.S.</b> and *Chan, K.Y. (1994)
The management of soil physical properties limiting crop production in Australian sodic soils: a review.
<i>
Australian Journal of Soil Research</i>
32(1): 13-44 120 refs, illus.
[Reprinted in: Naidu, R, Sumner, M E and Rengasamy, P (eds.). Australian sodic soils: distribution, properties and management papers presented at the First National Conference and Workshop on Sodic Soils (Adelaide, SA: November 9-13, 1992)]
<P><B>Jayawardane, N.S.</b>, Cook, F.J., <B>Blackwell, J.</b> and <B>Nicoll, G.D.</b> (1994)
Modelling of some hydrological aspects of the filter technique.
<i>
Poster Paper to be presented at BNR2 - Second Australian Conference on Biological Nutrient Removal from Wastewater (Albury, NSW: October 5, 1994)</i>
8p. 6 refs, illus.
<P><B>Jayawardane, N.S.</b>, Cook, F.J., <B>Blackwell, J.</b> and <B>Nicoll, G.D.</b> (1994)
Modelling of some hydrological aspects of the FILTER technique [poster paper].
<i>
Poster paper presented at-the  2nd Australian Conference on Biological Nutrient Removal from Wastewater (Albury, NSW: October 5, 1994)</i>
8p.  6 refs, illus.
<P><B>Jayawardane, N.S.</b>, <B>Blackwell, J.</b>, <B>Muirhead, W.A.</b>, *Kirchhof, G. and *Smart, R. (1994)
Slotting: a new deep-tillage technique for improving crop productivity on sodic, acid, and other degraded soils; and for land treatment of urban and rural waste.
<i>
Water Resources Series. Division of Water Resources. CSIRO Australia</i>
(14): 23p. 12 refs, illus.
<P>Johannes, R.E., Pearce, A.F., Wiebe, W.J., Crossland, C.J., Rimmer, D.W., Smith, D.F. and <B>Manning, C.</b> (1994)
Nutrient characteristics of well-mixed coastal waters off Perth, Western Australia.
<i>
Estuarine, Coastal and Shelf Science</i>
39: 273-285 36 refs, illus.
<P><B>Johnston, C.D.</b> and <B>Patterson, B.M.</b> (1994)
Distribution of nonaqueous phase liquid in a layered sandy aquifer.
<i>
In: Hinchee, R E, Alleman, B C, Hoeppel, R E and Miller, R N (eds.). Hydrocarbon bioremediation</i>
pp.431-437 3 refs, illus.
(Boca Raton: Lewis Publ.)
<P><B>Jolly, I.D.</b>, <B>Walker, G.R.</b> and *Thorburn, P.J. (1994)
Salt balances in semi-arid floodplain soils and consequences for riparian vegetation health.
<i>
Proceedings of a conference on Water Down Under (Adelaide, SA: November 21-25, 1994). Institution of Engineers, Australia. National Conference Publication</i>
94/14: 687-690 14 refs, illus.
<P><B>Jolly, I.D.</b>, <B>Walker, G.R.</b> and <B>Narayan, K.A.</b> (1994)
Floodwater recharge processes in the Chowilla anabranch system, South Australia.
<i>
Australian Journal of Soil Research</i>
32(3): 417-435 25 refs, illus.
<P><B>Jones, G.J.</b>, <B>Bourne, D.G..</b>, *Blakeley, R.L. and *Doelle, H. (1994)
Degradation of the cyanobacterial hepatotoxin microcystin by aquatic bacteria.
<i>
Natural Toxins</i>
2: 228-235 30 refs, illus.
<P><B>Jones, G.J.</b> and <B>Orr, P.T.</b> (1994)
Release and degradation of microcystin following algicide treatment of a <i>Microcystis aeruginosa</i> bloom in a recreational lake, as determined by HPLC and protein phosphatase inhibition assay.
<i>
Water Research</i>
28(4): 871-876 13 refs, illus.
<P><B>Jones, G.J.</b>, Blackburn, S.I. and Parker, N.S. (1994)
A toxic bloom of <i>Nodularia spumigena</i> Mertens in Orielton Lagoon, Tasmania.
<i>
Australian Journal of Marine and Freshwater Research</i>
45(5): 787-800 42 refs, illus.
[Reprinted in: Jones, G J (ed.). Cyanobacterial research in Australia.]
<P><B>Jones, G.J.</b> (1994)
Cyanobacterial blooms: a "natural" feature of impounded Australian waters?.
<i>
In: Steffensen, D A and Nicholson, B C (eds.). Proceedings of an International Workshop. Toxic Cyanobacteria: Current Status of Research and Management (Adelaide, SA: March 22-26, 1994)</i>
pp. 51-2  3 refs
<P><B>Jones, G.J.</b> (Editor) (1994)
Cyanobacterial research in Australia.
193p., refs, illus. ISBN 0643056432
(East Melbourne, VIC: CSIRO Australia)
[Reprinted from: #Australian Journal of Marine and Freshwater Research#, Vol.45(5), 1994.]
<P><B>Jones, G.J.</b>, <B>Orr, P.T.</b>, <B>Negri, A.P.</b>, Riddles, P.W., *Blakeley, R., *Jones, A. and *Bourne, D. (1994)
Persistence and biodegradation of cyanobacterial toxins in the aquatic environment.
<i>
In: Steffensen, D A and Nicholson, B C (eds.). Proceedings of an International Workshop on Toxic Cyanobacteria: Current Status of Research and Management (Adelaide, SA: March 22-26, 1994)</i>
pp. 119-21  12 refs
(Salisbury, SA: Australian Centre for Water Quality Research)
<P><B>Jones, G.J.</b> (1994)
Weir pool conditions stimulating cyanobacterial blooms in the Murrumbidgee River.
<i>
In: Roberts, J and Oliver, R L (eds.). The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April 1992)</i>
(Ch.9): 70-82 6 refs, illus. ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P><B>Jones, G.J.</b>, Nichols, P.D. and *Shaw, P.M. (1994)
Analysis of microbial sterols and hopanoids.
<i>
In: Goodfellow, M and O'Donnell, A G (eds.). Chemical methods in prokaryotic systematics</i>
(Ch.6): 163-195 65 refs, illus. ISBN 0471941913
(Chichester, UK: Wiley)
<P><B>Jones, G.J.</b> (1994)
Bloom-forming blue-green algae (Cyanobacteria).
<i>
In: Sainty, G R and Jacobs, S W L (eds.). Waterplants in Australia: a field guide</i>
3rd ed. pp.267-284 14 refs, illus. ISBN 0646159399
(Darlinghurst, NSW: Sainty and Associates)
<P><B>Jupp, D.L.B.</b>, Kirk, J.T.O. and Harris, G.P. (1994)
Detection, identification and mapping of cyanobacteria: using remote sensing to measure the optical quality of turbid inland waters.
<i>
Australian Journal of Marine and Freshwater Research</i>
45(5): 801-828 34 refs, illus.
[Reprinted as a special issue of the journal; Jones, G J (ed). Cyanobacterial Research in Australia.]
<P><B>Jupp, D.L.B.</b> (1994)
Trends in the application of remote sensing for coastal resource studies.
<i>
Paper presented at the Living Coastal Resources Symposium (Bangkok, Thailand: May 16-20, 1994)</i>
6p. 18 refs
<P><B>Kealey, L.M.</b>, <B>Humphreys, E.</b>, *Black, A.S. and <B>Muirhead, W.A.</b> (1994)
Presowing nitrogen fertiliser management for aerial-sown rice on puddled soil.
<i>
Australian Journal of Experimental Agriculture</i>
34(7): 1013-1020 34 refs
[Reprinted as a special issue of the journal; Temperate rice: achievements and potential.]
<P><B>Kennett-Smith, A.K.</b>, <B>Cook, P.G.</b> and <B>Walker, G.R.</b> (1994)
Factors affecting groundwater recharge following clearing in the south western Murray Basin.
<i>
Journal of Hydrology</i>
154: 85-105 46 refs, illus.
<P><B>Kennett-Smith, A.K.</b>, <B>Narayan, K.A.</b> and <B>Walker, G.R.</b> (1994)
The impact of change in agricultural land management on the groundwater and salt balances in a regional groundwater discharge zone.
<i>
Proceedings of Water Down Under 94 Conference, Vol 2. Part B Groundwater Papers. Preprints of Papers (Adelaide, SA: November 21-25, 1994)</i>
pp. 485-9  7 refs, illus.
<P><B>Laslett, R.D.</b> and <B>Davis, G.B.</b> (1994)
Using HST3D to model flow and tracer transport in an unconfined sandy aquifer with large drawdowns.
<i>
Water Down Under '94</i>
99-104, 12 refs, illus.
[Based on a paper presented at the Water Down Under '94 Conference (Adelaide, Australia: 21-25 November, 1994)]
<P><B>Laslett, R.D.</b> (1994)
FX: a three-dimensional graphical visualisation tool and macro language. Users manual. Version 1.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/1): 99p. 17 refs, illus, appendixes
<P><B>Laut, P.</b>, <B>Marston, F.M.</b> and <B>Cuddy, S.M.</b> (1994)
Land cover and infrastructure mapping of the Hawkesbury-Nepean Basin.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/2): 65p., illus.
<P>Leeming, R.L., *Ball, A., *Ashbolt, N., <B>Jones, G.J.</b> and Nichols, P.D. (1994)
Distinguishing between human and animal sources of faecal pollution.
<i>
Chemistry in Australia</i>
61(8): 434-435 8 refs, illus.
[Also published in: Water Journal, 1994, 21(4), supp., pp.6-7.]
<P><B>Marshall, J.K.</b> and *Chester, G.W. (1994)
Water use by rehabilitation vegetation at Del Park. Final Report to Alcoa of Australia: Executive summary.
<i>
Report. Division of Water Resources. CSIRO Australia</i>
(94/28): 12p., illus.
<P><B>Martin, P.G.</b> (1994)
The European Space Agency: an overview.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(60): p.9, illus.
<P>Matveev, V., Matveeva, L. and <B>Jones, G.J.</b> (1994)
Study of the ability of <i>Daphnia carinata</i> King to control phytoplankton and resist cyanobacterial toxicity: implications for biomanipulation in Australia.
<i>
Australian Journal of Marine and Freshwater Research</i>
45(5): 889-904 77 refs, illus.
[Reprinted as a special issue of the journal; Jones, G J (ed). Cyanobacterial Research in Australia.]
<P>Matveev, V., Matveeva, L. and <B>Jones, G.J.</b> (1994)
Phytoplankton stimulation by mosquitofish in the presence of large <i>Daphnia</i>.
<i>
Verhandlungen der Internationalen Vereinigung fuer Theoretische und Angewandte Limnologie</i>
25: 2193-2197 16 refs, illus.
<P><B>McEwan, K.L.</b>, <B>Jolly, I.D.</b> and <B>Holub, A.N.</b> (1994)
Effects of flooding on the water use of <i>Eucalyptus largiflorens</i>: compilation of results from the 1992/93 flood.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/5): 31p. 8 refs, illus.
<P><B>McEwan, K.L.</b>, <B>Kennett-Smith, A.K.</b>, <B>Holub, A.N.</b>, <B>Streeter, T.C.</b> and <B>Taylor, P.J.</b> (1994)
Results from hydrological studies in the Upper South East, South Australia. 1. Plant water use.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/1): 57p. 5 refs, illus.
<P><B>Meyer, W.S.</b> (1994)
Environmental impact of irrigation: assessment, directions and questions.
<i>
In: Roberts, J and Oliver, R L (eds.). The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April 1992)</i>
(Ch.10): 83-88 7 refs ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P><B>Murray, A.S.</b>, *Olive, L., <B>Olley, J.M.</b>, *Stanton, R., *Dias, A., <B>Caitcheon, G.G.</b>, <B>Wallbrink, P.J.</b> and <B>Wasson, R.J.</b> (1994)
Sourcing turbidity in the Murrumbidgee River.
<i>
In: Roberts, J and Oliver, R L (eds.). The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April 1992)</i>
(Ch.11): 89-107, illus. ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P><B>Nancarrow, B.E.</b> (Editor) (1994)
International & national trends in public involvement: where to next for the Australian Water Industry? Proceedings of a review (Sydney, NSW: April 11, 1994).
92p., illus. ISBN 0643056505
(Floreat Park, WA: CSIRO Division of Water Resources)
<P><B>Narayan, K.A.</b>, <B>Walker, G.R.</b>, <B>Charlesworth, A.T.</b> and *Newman, B.J. (1994)
Numerical simulation of groundwater flow and solute transport on a saline floodplain in South Australia using a density dependent model SUTRA.
<i>
In: Blain, W R and Katsifarakis, K L (eds.). Proceedings of the 5th International Conference on Hydraulic Engineering Software Hydrosoft 94. Water Resources and Distribution, Vol. 1</i>
pp. 213-22  6 refs, illus. ISBN 185312365X
(Southampton, UK: Computational Mechanics Publications)
<P><B>Narayan, K.A.</b> and <B>Simmons, C.T.</b> (1994)
Density dependent groundwater flow and solute transport below a saline lake bed.
<i>
Water Down Under '94</i>
119-24, 15 refs, illus.
[Based on a paper presented at the Water Down Under '94 Conference (Adelaide, Australia: 21-25 November, 1994)]
<P><B>Nicoll, C.L.</b> (1994)
A directory and bibliography of tree water use research.
<i>
Division of Water Resources [miscellaneous publication]. CSIRO Australia</i>
[loose-leaf binder] 100p.
<P>*Nield, S.P., <B>Townley, L.R.</b> and <B>Barr, A.D.</b> (1994)
A framework for quantitative analysis of surface water-groundwater interaction: flow geometry in a vertical section.
<i>
Water Resources Research</i>
30(8): 2461-2475 20 refs, illus.
<P><B>O'Loughlin, E.M.</b>, <B>Aryal, S.K.</b> and <B>Vertessy, R.A.</b> (1994)
Design of trench absorption systems for effluent disposal.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(2): 21-23 6 refs, illus.
<P><B>Oliver, J.E.</b> and *Frylinck, J. (1994)
Libtrekking across the Library: an interactive multimedia guide to library and information resources.
<i>
Proceedings of a Conference of College and Universities System Exchange (CAUSE) in Australasia: Information Resources Management in Australia (Melbourne, Vic: July 10-13, 1994)</i>
pp.111-125 5 refs
(Bundoora, Vic: LaTrobe University Library)
<P><B>Oliver, J.E.</b> (1994)
CSIRO's urban water research in 1994.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/7): 29p. 3 refs, illus. ISBN 0643055886
<P><B>Otto, C.J.</b> (1994)
Performance of an evaporation basin in a linked enhanced-discharge/evaporative-disposal system near Quairading, Western Australia.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/12): 24p. 19 refs, illus, appendixes ISBN 0643055932
<P><B>Otto, C.J.</b> and <B>Salama, R.</b> (1994)
Linked enhanced discharge - evaporation disposal systems for the control of dryland salinity.
<i>
Water Down Under '94</i>
391-5, 5 refs, illus.
[Based on a paper presented at the Water Down Under '94 Conference (Adelaide, Australia: 21-25 November, 1994)]
<P><B>Overton, I.C.</b>, *Taylor, P.J., <B>Hodgson, G.</b>, Correll, R.L., <B>Hatton, T.J.</b> and <B>Walker, G.R.</b> (1994)
The evaluation of a geographical information system for assessing the health of vegetation on a River Murray Floodplain.
<i>
Paper presented at Water Down Under '94 Conference (Adelaide, SA: November 21-25, 1994)</i>
4p. 11 refs, illus.
<P><B>Pavelic, P.</b>, <B>Dillon, P.J.</b>, <B>Narayan, K.A.</b>, *Herrmann, T.N. and *Barnett, R. (1994)
Integrated groundwater flow and agronomic modelling for improved dryland salinity management.
<i>
Water Down Under '94</i>
397-402, 15 refs, illus.
[Based on a paper presented at the Water Down Under '94 Conference (Adelaide, Australia: 21-25 November, 1994)]
<P><B>Pickup, G.</b>, Griffin, G.F. and Morton, S.R. (1994)
Desertification and biodiversity in the drylands: regional considerations, Australia.
<i>
Biological diveristy in the drylands of the world</i>
pp. 57-76  61 refs, illus.
(International Panel of Experts Subgroup on Biodiversity (IPED))
[Preliminary and incomplete version, June 1994]
<P><B>Prathapar, S.A.</b>, *Williams, R.M. and *Funthakey, J.F. (1994)
Optimising the short- to medium-term salinisation consequences of land clearing in the N.S.W. mallee, Australia.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/2): 35p. 10 refs, illus. ISBN 0643056483
<P><B>Prathapar, S.A.</b>, <B>Meyer, W.S.</b>, <B>Jain, S.</b> and *van der Lelij, A. (1994)
SWAGSIM: a soil water and groundwater simulation model.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/3): 38p. 31 refs, illus. ISBN 0643056580
<P>*Punthakey, J.F., <B>Prathapar, S.A.</b> and *Hoey, D. (1994)
Optimising pumping rates to control piezometric levels: a case study.
<i>
Agricultural Water Management</i>
26: 93-106 13 refs, illus.
<P><B>Richardson, D.P.</b> and <B>Williams, B.G.</b> (1994)
Assessing discharge characteristics of upland landscapes using electromagnetic induction techniques.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/3): 10p. 10 refs, illus.
<P><B>Rizzoli, A.E.</b> (1994)
A software architecture for model management and integration: theoretical background.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/10): 19p. 24 refs, illus.
<P><B>Rizzoli, A.E.</b> (1994)
A software architecture for model management and integration: an application to catchment runoff modelling.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/9): 68p. 22 refs, illus.
<P><B>Roberts, J.</b> and Oliver, R.L. (Editors) (1994)
The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April, 1992).
125p., refs, illus. ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P><B>Roberts, J.</b> (1994)
Riverbanks, plants and water management.
<i>
In: Roberts, J and Oliver, R L (eds.). The Murrumbidgee, past and present: a forum on past and present research on the lower Murrumbidgee River (Griffith, NSW: April 1992)</i>
(Ch.13): 119-125 9 refs ISBN 0643056602
(Griffith, NSW: CSIRO Division of Water Resources)
<P><B>Roberts, J.</b>, <B>Meredith, S.N.</b> and <B>Sainty, G.</b> (1994)
Seeing through a muddy issue: carp in irrigation systems.
<i>
Murrumbidgee Catchment Management Committee Carp Forum</i>
39-42, 10 refs
[Proceedings of the forum on European Carp (Wagga Wagga, NSW: 20 June, 1994)]
<P><B>Salama, R.B.</b>, <B>Farrington, P.</b>, <B>Bartle, G.A.</b>, <B>Watson, G.D.</b> and <B>Hawkes, G.E.</b> (1994)
Salinity investigations in selected wheatbelt catchments of Western Australia. 3. Base data for Wallatin Creek Catchment.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/6): 145p. 12 refs, illus.
<P>*Seligman, C., <B>Syme, G.J.</b> and *Gilchrist, R. (1994)
The role of values and ethical principles in judgements of environmental dilemmas.
<i>
Journal of Social Issues</i>
50(3): 105-19, 9 refs
<P>Shao, Y., Raupach, M.R. and <B>Short, D.L.</b> (1994)
Preliminary assessment of wind erosion patterns in the Murray-Darling Basin.
<i>
Australian Jurnal of Soil and Water Conservation</i>
7(3): 46-51 14 refs, illus.
<P><B>Sharma, M.L.</b>, <B>Byrne, J.D.</b>, <B>Herne, D.E.</b> and <B>Kin, P.G.</b> (1994)
Nutrient leaching beneath horticultural land use: West Australian examples.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 82-9 15 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P><B>Sharma, M.L.</b>, *Mohammud, C.H., *Zain, M.M., *Ahmed, M. and <B>Richards, Q.D.</b> (1994)
Piezometer grid studies to assess pollution sources at tobacco and paddy farms, Kelantan, Malaysia.
<i>
In: Aminuddin, B Y, Sharma, M L and Willett, I R (eds.).  Agricultural impacts on groundwater quality.  Proceedings of an International Workshop (Kota Bharu, Malaysia: October 24-27, 1994).  ACIAR Proceedings</i>
(61): 53-63 5 refs, illus. ISBN 1863201688
(Canberra, ACT: Australian Centre for International Agricultural Research)
<P>Sherman, B.S., <B>Jones, G.J.</b> and Webster, I.T. (1994)
Low, stratification and the growth of algae and cyanobacteria in Maude Weir pool on the Murrumbidgee River.
<i>
Proceedings of the Environmental Flows Seminar (Canberra, ACT: August 25-26, 1994)</i>
pp.170-177 3 refs, illus.
<P><B>Sides, R.D.</b> (1994)
The use of porous ceramic tubes for meteorological wet bulbs.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/18): 11p. 2 refs, illus. ISBN 0643056351
<P>Sie, S.H., <B>Leaney, F.W.</b>, *Gillespie, R., Suter, G.F. and Ryan, C.G. (1994)
Radiocarbon measurements at the CSIRO AMS facility.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
92: 35-38 5 refs, illus.
<P>*Smith, A., *Bye, J., <B>Dillon, P.J.</b> and <B>Pavelic, P.</b> (1994)
Tidal simulation in an unconfined aquifer impinging on a sloping beach [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.76
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Stanhill, G.</b> and <B>Kalma, J.D.</b> (1994)
Secular variation of global irradiance in Australia.
<i>
Australian Meteorological Magazine</i>
43(2): 81-86 25 refs, illus.
<P>*Steffy, D.A., <B>Johnston, C.D.</b> and *Barry, D.A. (1994)
Response of LNAPL pore pressure to a dynamic water table [poster abstract].
<i>
Abstract presented at the American Geophysical Union Fall Meeting (San Francisco, USA: December, 1994)</i>
1p.
<P><B>Syme, G.J.</b> (1994)
Community acceptance of risk: applying social justice research to the concepts of trust, liability and consent.
<i>
Proceedings of a joint ANCOLD/MUNRO Centre Seminar: "Acceptable Risks for Extreme Events in the Planning and Design of Major Infrastructure" (Sydney, NSW: April 26-27, 1994)</i>
10p. 50 refs
<P><B>Syme, G.J.</b> (1994)
What should we do with an unguided missile? Future directions for public involvement in Australia.
<i>
In: Nancarrow, B E (ed.). International & national trends in public involvement: where to next for the Australian Water Industry? Proceedings of a review (Sydney, NSW: April 11, 1994)</i>
pp.77-84 ISBN 0643056505
(Floreat Park, WA: CSIRO Division of Water Resources)
<P><B>Syme, G.J.</b> (1994)
Community acceptance of risk: Trust, liability and consent.
<i>
Proceedings of the Seminar on Acceptable Risks for Extreme Events in the Planning and Design of Major Infrstructure (Sydney, NSW: 26-27 April, 1994)</i>
(1994): 31-9, 51 refs
<P><B>Syme, G.J.</b> (1994)
Dam break: creating a vigilant community.
<i>
Resource and Environmental Studies</i>
(10): 43-6, 9 refs, illus.
<P><B>Thomas, J.F.</b> and <B>Oliver, J.E.</b> (1994)
CSIRO's multi-divisional research program on urban water systems: a prospectus.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/19): 19p., illus. ISBN 064305636X
<P>*Thorburn, P.J., <B>Mensforth, L.J..</b> and <B>Walker, G.R.</b> (1994)
Reliance of creek-side river red gums on creek water.
<i>
Australian Journal of Marine and Freshwater Research</i>
45(8): 1439-1443 12 refs, illus.
[Reprinted in: Boon, P I and Brock, M (eds.). Plants and wetland processes (1995)]
<P><B>Townley, L.R.</b> (1994)
Hydrogeological modelling of the Koongarra Site.
<i>
In: von Maravic, H and Smellie, J (eds.). Proceedings of an International Workshop on Nuclear Science and Technology (Toledo, Spain: October 5-9, 1992)</i>
pp.57-62 2 refs, illus.
<P><B>Tregaskis, K.L.</b> and <B>Prathapar, S.A.</b> (1994)
Selected papers researching the effects of salinity and waterlogging on crops within the Murray Basin.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/11): 61p. 39 refs, illus, appendixes
<P><B>Tunstall, B.R.</b> (1994)
Environmental impact assessment of the Cowley Beach Training Area.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/17): 75p. 30 refs, illus. ISBN 0643056343
<P><B>Tunstall, B.R.</b> (1994)
Environmental impact assessment of the Tully Training Area.
<i>
Technical Memorandum. Division of Water Resources. CSIRO Australia</i>
(94/15): 72p. 23 refs, illus. ISBN 0643056327
<P><B>Turner, J.V.</b>, <B>Townley, L.R.</b>, <B>Rosen, M.R.</b> and *Milligan, N. (1994)
Groundwater recharge to paleochannel aquifers in the eastern goldfields of Western Australia.
<i>
Water Down Under '94</i>
511-6, 5 refs, illus.
[Based on a paper presented at the Water Down Under '94 Conference (Adelaide, Australia: 21-25 November, 1994)]
<P>*Vader, L., <B>Jolly, I.D.</b> and <B>Walker, G.R.</b> (1994)
Hydrochemistry and stable isotopes as indicators of groundwater mixing and discharge to streams in the Chowilla Region, south-eastern Australia.
<i>
Divisional Report. Division of Water Resources. CSIRO Australia</i>
(94/6): 32p. 13 refs, illus.
<P><B>Vertessy, R.A.</b>, *Benyon, R. and *Haydon, S. (1994)
Melbourne's forest catchments: effect of age on water yield.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(2): 17-20 18 refs, illus.
<P><B>Vertessy, R.A.</b>, *Benyon, R. and *Haydon, S. (1994)
Melbourne's forest catchments: effect of age on water yield.
<i>
Water</i>
17-20, 18 refs, illus.
<P><B>Vertessy, R.A.</b>, <B>O'Loughlin, E.M.</b>, <B>Beverly, C.R..</b> and <B>Butt, A.J..</b> (1994)
Australian experiences with the CSIRO Topog model in land and water resources management.
<i>
Proceedings of the International UNESCO Symposium on Water Resources Planning in a Changing World (Karlsruhe, Germany: June 28-30, 1994)</i>
3: 135-144 18 refs, illus.
<P><B>Wallbrink, P.J.</b>, <B>Olley, J.M.</b> and <B>Murray, A.S.</b> (1994)
Measuring soil movement using <sup>137</sup>Cs: implications of reference site variability.
<i>
In: Olive, L J, Loughran, R J and Kesby, J A (eds.). Variability in stream erosion and sediment transport. Proceedings of a Canberra Symposium (Canberra, ACT: December, 1994). IAHS Publication</i>
(224): 95-102 15 refs, illus.
<P><B>Wallbrink, P.J.</b> and <B>Murray, A.S.</b> (1994)
Fallout of <sup>7</sup>Be in south eastern Australia.
<i>
Journal of Environmental Radioactivity</i>
25: 213-228 29 refs, illus.
<P><B>Wasson, R.J.</b> (1994)
Annual and decadal variation of sediment yield in Australia, and some global comparisons.
<i>
Proceedings of a Conference on Variability in Stream Erosion and Sediment Transport (Canberra, ACT: December 1994)</i>
(224): 269-79, 14 refs, illus
<P><B>Wasson, R.J.</b> (1994)
Living with the past: uses of history for understanding landscape change and degradation.
<i>
Land Degradation & Rehabilitation</i>
5, 79-87, 32 refs
<P>Webster, I.T., <B>Hancock, G.J.</b> and <B>Murray, A.S.</b> (1994)
Use of radium isotopes to examine pore-water exchange in an estuary.
<i>
Limnology and Oceanography</i>
39(8): 1917-1927 19 refs, illus.
<P>*Wu, H., *Rykiel, E.J., <B>Hatton, T.J.</b> and <B>Walker, J.</b> (1994)
An integrated rate methodology (IRM) for multi-factor growth rate modelling.
<i>
Ecological Modelling</i>
73: 97-116 36 refs, illus.
<P><B>Young, W.J.</b>, *Verhoeven, T.J. and <B>Cuddy, S.</b> (1994)
Nutrient management at a catchment scale.
<i>
Proceedings of a Conference 'Water Down Under '94' (Adelaide, SA: 21-25 November, 1994)</i>
(1994): 79-83, 6 refs<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-9</DOCNO>
<DOCOLDNO>IA089-000952-B037-237</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AV1995.html 192.102.250.248 19970208032954 text/html 60128
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:17:04 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:51 GMT
Content-type: text/html
Content-length: 59944
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Atmospheric Research</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Atmospheric Research</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abbs, D.J.</b> (1995)
Numerical modelling of extreme precipitation events from a PMP perspective [abstract].
<i>
Abstracts of the 5th International Conference on Precipitation: Space-Time Variability and Dynamics of Rainfall (Elounda, Crete, Greece: June 14-16, 1995)</i>
p.1.6
<P><B>Abbs, D.J.</b> (1995)
"Sea breeze and local wind", by J.E. Simpson, Cambridge University Press 1994, 234p. [book review].
<i>
WMO Bulletin</i>
4(3): 307-308 2 refs ISBN 0521452112
<P><B>Abbs, D.J.</b> and Trinidad, G.S. (1995)
Extreme weather events and the built environment.
<i>
Paper presented at a Workshop on Atmospheric Hazards (Brisbane, QLD: September 20-22, 1995)</i>
13p. 14 refs, illus.
<P><B>Allan, R.J.</b>, *Lindesay, J.A. and *Reason, C.J.C. (1995)
Multidecadal variability in the climate system over the Indian Ocean Region during the austral summer.
<i>
Journal of Climate</i>
8(7): 1853-1873 16 refs, illus.
<P><B>Allan, R.J.</b> and *Reason, C.J. (1995)
Modelling Indian Ocean responses to low frequency fluctuations in observed wind patterns.
<i>
Mathematical and Computer Modelling</i>
21(9): 143-149 9 refs, illus.
<P>*Artaxo, P., *Parry, D., <B>Gillett, R.W.</b>, <B>Selleck, P.W.</b> and <B>Ayers, G.P.</b> (1995)
Black carbon, elemental and ionic composition of atmospheric aerosols in northern Australia.
<i>
Extended Abstracts of Papers presented at the WMO-IGAC Conference on the Measurement and Assessment of Atmospheric Composition Change (Beijing, China: October 9-14, 1995). WMO Report</i>
(107): 186-189, illus.
<P><B>Austin, R.T.</b> (1995)
Remote sensing at the CSIRO Division of Atmospheric Research.
<i>
IEEE Geoscience and Remote Sensing Society Newsletter</i>
(Sep): 19-23 10 refs, illus.
<P><B>Ayers, G.P.</b>, <B>Bentley, S.T.</b>, *Ivey, J.P. and *Forgan, B.W. (1995)
Dimethylsulfide in marine air at Cape Grim, 41&#176;S.
<i>
Journal of Geophysical Research</i>
100(D10): 21,013-21,021 51 refs, illus.
<P><B>Ayers, G.P.</b> and <B>Galbally, I.E.</b> (1995)
A preliminary estimation of a boundary layer-free troposphere entrainment velocity at Cape Grim.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
pp.10-15 18 refs, illus.
<P><B>Ayers, G.P.</b>, *Ivey, J.P., <B>Gillett, R.W.</b>, *Kittler, P. and <B>Cainey, J.M.</b> (1995)
Sulfur.
<i>
In: Dick, A L and Fraser, P J (eds.). Baseline Atmospheric Program Australia, 1992.  CSIRO Australia</i>
pp.41-43
<P><B>Ayers, G.P.</b>, <B>Gillett, R.W.</b>, *Ivey, J.P., *Schafer, B. and *Gabric, A. (1995)
Short-term variability in marine atmospheric dimethylsulfide concentration.
<i>
Geophysical Research Letters</i>
22(18): 2513-2516 20 refs, illus.
<P><B>Ayers, G.P.</b> (1995)
Deposition of Biogeochemically Important Trace Species (DEBITS): an activity of the International Global Atmospheric Chemistry Project (IGAC).
<i>
Global Change Newsletter</i>
(21): 4-5, illus.
<P><B>Ayers, G.P.</b>, *Malfroy, H., <B>Gillett, R.W.</b>, *Higgins, D., <B>Selleck, P.W.</b> and <B>Marshall, J.C.</b> (1995)
Deposition of acidic species at a rural location in New South Wales, Australia.
<i>
Water, Air and Soil Pollution</i>
85: 2089-94  11 refs, illus.
[Also published in: Grennfelt, P, Rodhe, H, Thornelof, E, and Wisniewski, J (eds.).  Acid Reign '95?: proceedings from the 5th International Conference on Acidic Deposition: Science & Policy (Goteborg, Sweden: June 26-30, 1995). Volume 4: Emissions, atmospheric and deposition processes, acidification outside Europe and North America, critical loads, regional air pollution control strategies, effects on materials]
<P><B>Ayers, G.P.</b>, <B>Gillett, R.W.</b>, *Ginting, N., *Hooper, M., <B>Selleck, P.W.</b> and *Tapper, N. (1995)
Atmospheric sulfur and nitrogen in West Java.
<i>
Water, Air and Soil Pollution</i>
85: 2083-8  20 refs
[Also published in: Grennfelt, P, Rodhe, H, Thornelof, E, and Wisniewski, J (eds.).  Acid Reign '95?: proceedings from the 5th International Conference on Acidic Deposition: Science & Policy (Goteborg, Sweden: June 26-30, 1995). Volume 4: Emissions, atmospheric and deposition processes, acidification outside Europe and North America, critical loads, regional air pollution control strategies, effects on materials]
<P><B>Ayers, G.P.</b>, <B>Gillett, R.W.</b>, <B>Selleck, P.W.</b> and <B>Bentley, S.T.</b> (1995)
Rainwater composition and acid deposition in he vicinity of fossil fuel-fired power plants in souther Australia.
<i>
Water, Air and Soil Pollution</i>
85: 2313-8  19 refs, illus.
[Also published in: Grennfelt, P, Rodhe, H, Thornelof, E, and Wisniewski, J (eds.).  Acid Reign '95?: proceedings from the 5th International Conference on Acidic Deposition: Science & Policy (Goteborg, Sweden: June 26-30, 1995). Volume 4: Emissions, atmospheric and deposition processes, acidification outside Europe and North America, critical loads, regional air pollution control strategies, effects on materials]
<P><B>Ayers, G.P.</b> and <B>Granek, H.</b> (1995)
Sulfur in the Australian atmosphere.
<i>
Proceedings, of a National Conference on Managing SO{sub 2} in Australia: issues and strategies (Melbourne, VIC: November 27-28, 1995)</i>
18p.  42 refs, illus.
(Clean Air Society of Australia and New Zealand)
<P><B>Baines, P.G.</b> (1995)
The impact of baroclinic Rossby waves on western boundary currents, with application to ENSO [abstract].
<i>
In: Jasper, D and Smith, N (eds.). TOGA 95. International Scientific Conference: abstracts (Melbourne, VIC: April 2-7, 1995)</i>
p.139
<P><B>Baines, P.G.</b> and <B>Cai, W.</b> (1995)
Forcing of the Antarctic Circumpolar Current by deep convection and bottom topography [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.4
<P><B>Baines, P.G.</b> and <B>Murray, D.L.</b> (1995)
Topographic influence on the pattern of flow through Bass Strait.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(4): 763-767 3 refs, illus.
<P><B>Baines, P.G.</b> (1995)
Topographic effects in stratified flows.
482p, refs, illus. ISBN 0521435013
(UK: Cambridge Univ. Press)
<P>*Barbetti, M., *Bird, T., *Dolezal, G., *Taylor, G., <B>Francey, R.J.</b>, *Cook, E. and *Peterson, M. (1995)
Radiocarbon variations from Tasmanian conifers: results from three early Holocene logs.
<i>
Radiocarbon</i>
37(2): 361-9  15 refs, illus.
[Also published in: Cook, G T and Harkness, D D (eds.). Proceedings of the 15th International {sup 14}C Conference]
<P><B>Barton, I.J.</b> (1995)
Satellite-derived sea surface temperatures: current status.
<i>
Journal of Geophysical Research</i>
100(C5): 8777-8790 42 refs, illus.
<P><B>Barton, I.J.</b> and <B>Prata, A.J.</b> (1995)
Satellite derived sea surface temperature data sets for climate applications.
<i>
Advances in Space Research</i>
16(10): 127-136 21 refs, illus.
<P><B>Barton, I.J.</b>, <B>Prata, A.J.</b> and <B>Cechet, R.P.</b> (1995)
Validation of the ATSR in Australian waters.
<i>
Journal of Atmospheric and Oceanic Technology</i>
12(2): 290-300 23 refs, illus.
<P><B>Beardsmore, D.J.</b> and <B>Pearman, G.I.</b> (1995)
Baseline carbon dioxide monitoring.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
pp.31-33 3 refs, illus.
<P><B>Beer, T.</b> (1995)
The predicted impact of revised Australian car design rules on Melbourne air quality trends.
<i>
Mathematical and Computer Modelling</i>
21(9): 99-103 6 refs, illus.
<P><B>Beer, T.</b>, *Bridgman, H. and <B>Manins, P.C.</b> (1995)
Predicting dust concentrations in Newcastle, NSW.
<i>
Mathematical and Computer Modelling</i>
21(9): 131-135 7 refs, illus.
<P><B>Beer, T.</b> (1995)
Risk assessment for environmental management.
<i>
In: Norton, T W, Beer, T and Dovers, S R (eds.). Proceedings of the 1995 Australian Academy of Science Fenner Conference on the Environment.  Risk and Uncertainty  in Environmental Management (Canberra, ACT: November 13-16, 1995)</i>
pp. 74-83  illus.
(Australian Academy of Science)
<P><B>Beer, T.</b>, *Zabawi, M. and *Ghani, A. (1995)
The relation between actual and potential evaporation [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.5
<P><B>Beer, T.</b> and *Williams, A. (1995)
Estimating Australian forest fire danger under conditions of doubled carbon dioxide concentrations.
<i>
Climatic Change</i>
29: 169-188 31 refs, illus.
<P><B>Beer, T.</b> (1995)
Fire propagation in vertical stick arrays: the effects of wind.
<i>
International Journal of Wildland Fire</i>
5(1): 43-49 13 refs, illus.
<P>*Bigg, E.K., <B>Gras, J.L.</b> and *Mossop, D.J.C. (1995)
Wind-produced submicron particles in the marine atmosphere.
<i>
Atmospheric Research</i>
36: 55-68 24 refs, illus.
<P><B>Bigg, E.K.</b> (1995)
Implications of persistence effects for cloud seeding analysis.
<i>
Summaries of papers presented to the Precipitation Enhancement Workshop (Terrigal, NSW: April 24-28, 1995)</i>
pp.29-34 5 refs, illus.
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Boers, R.</b>, *Melfi, S.H. and *Palm, S.P. (1995)
Fractal nature of the planetary boundary layer depth in the trade-wind cumulus regime.
<i>
Geophysical Research Letters</i>
22(13): 1705-1708 15 refs, illus.
<P><B>Boers, R.</b> (1995)
Influence of seasonal variation in cloud condensation nuclei, drizzle, and solar radiation, on marine stratocumulus optical depth.
<i>
Tellus. Series B</i>
47: 578-586 34 refs, illus.
<P><B>Borgas, M.S.</b> (1995)
Turbulent dispersion with broken reflexional symmetry.
<i>
Proceedings of the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
2(Sessions 6-9): 613-616 16 refs, illus.
<P><B>Cai, W.</b>, *Tomczak, M. and <B>Allan, R.J.</b> (1995)
Effect of hemispheric conjugate atmospheric variations and global warming on north atlantic deep water formation in a global ocean general circulation model.
<i>
Global Atmosphere and Ocean Systems</i>
2: 325-350 46 refs, illus.
<P><B>Cai, W.</b> (1995)
Stability of deep ocean circulations [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.41-42, 8 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Cai, W.</b> and Godfrey, J.S. (1995)
Surface heat flux parameterizations and the variability of thermohaline circulation.
<i>
Journal of Geophysical Research</i>
100(C6): 10,679-10,692 51 refs, illus.
<P><B>Cai, W.</b> (1995)
The different behaviour of modeled ocean circulation under an atmosphere with different heat capacity.
<i>
Journal of Oceanography</i>
51(5): 499-517 23 refs, illus.
<P><B>Cai, W.</b>, *Greatbatch, R.J. and *Zhang, S. (1995)
Interdecadal variability in an ocean model driven by a small, zonal redistribution of the surface buoyancy flux.
<i>
Journal of Physical Oceanography</i>
25(9): 1998-2010 27 refs, illus.
<P><B>Cai, W.</b> (1995)
Interdecadal variability driven by mismatch between surface flux forcing and oceanic freshwater/heat transport.
<i>
Journal of Physical Oceanography</i>
25(11): 2643-2666 34 refs, illus.
<P><B>Cai, W.</b> (1995)
Global present-day ocean climate and its stability under various surface thermohaline forcing conditions derived from Levitus climatology.
<i>
Progress in Oceanography</i>
36: 219-247 52 refs, illus.
<P><B>Cai, W.</b> and *Greatbatch, R.J. (1995)
Compensation for the NADW outflow in a global ocean general circulation model.
<i>
Journal of Physical Oceanography</i>
25(2): 226-241 25 refs, illus.
<P><B>Cai, W.</b> (1995)
Effect of different residence time due to basin width on the asymmetry between the Pacific and the Atlantic thermohaline circulation and their variabilities [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.18
<P>*Carter, E.J. and <B>Long, A.B.</b> (1995)
Australian winter storms experiment II. Water budget, precipitation efficiency and modeling.
<i>
Proceedings of a Conference on Cloud Physics (Dallas, TX, USA: January 15-20, 1995)</i>
pp.292-297 17 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P>*Ciais, P., <B>Francey, R.J.</b>, *Tans, P.P., *White, J.W.C. and *Trolier, M. (1995)
An analytical error estimate for the ocean and land uptake of CO<sub>2</sub> using {delta}<sup>13</sup>C observations in the atmosphere.
<i>
NOAA Technical Memorandum ERL CMDL-8</i>
13p. 21 refs
<P>*Ciais, P., *Tans, P.P., *Trolier, M., *White, J.W.C. and <B>Francey, R.J.</b> (1995)
A large Northern Hemisphere terrestrial CO<sub>2</sub> sink indicated by the <sup>13</sup>C/<sup>12</sup>C ratio of atmospheric CO<sub>2</sub>.
<i>
Science</i>
269: 1098-1102 25 refs, illus.
<P>*Ciais, P., *Tans, P.P., *White, J.W.C., *Trolier, M., <B>Francey, R.J.</b>, *Berry, J.A., *Randall, D.R., *Sellers, P.J., *Collatz, J.G. and *Schimel, D.S. (1995)
Partitioning of ocean and land uptake of CO<sub>2</sub> as inferred by {delta}<sup>13</sup>C measurements from the NOAA Climate Monitoring and Diagnostics Laboratory Global Air Sampling Network.
<i>
Journal of Geophysical Research</i>
100(D3): 5051-5070 97 refs, illus.
<P><B>Collier, M.A.</b> (1995)
Wilkes land wanderings: WLEX95: an international study of Antarctic bottom water formation.
<i>
AMOS Bulletin</i>
8(4): 68-77, illus.
<P><b>CSIRO Division of Atmospheric Research</b> (1995)
Research report 1992-94.
<i>
Research Report. Division of Atmospheric Research. CSIRO Australia</i>
41p., illus.
<P><b>CSIRO Division of Atmospheric Research</b> (1995)
Summaries of papers presented to the Precipitation Enhancement Workshop (Terrigal, NSW: April 24-28, 1995).
67p., refs, illus.
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Davies, H.L.</b> (1995)
Infinity arithmetic, comparisons and J.
<i>
In: Griffiths, M and Whitehouse, D (eds.). Proceedings of the International Conference on APL (San Antonio, TX, USA: June 4-8, 1995) APL Quote Quad</i>
25(4): 28-34 13 refs
<P>*Dick, A.L. and <B>Fraser, P.J.</b> (Editors) (1995)
Baseline Atmospheric Program, Australia: 1992.
<i>
Baseline Atmospheric Program. Australia. CSIRO Australia</i>
73p., refs, illus.
<P><B>Dix, M.R.</b> and <B>Hunt, B.G.</b> (1995)
Climatic modelling: doubling of CO<sub>2</sub> levels and beyond. Final report to the Federal Department of the Environment Sport and Territories.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
28p., illus. <a href= "http://kaos.erin.gov.au/portfolio/esd/climate/publications/intro.html"> http://kaos.erin.gov.au/portfolio/esd/climate/publications/intro.html</a> (Visited 1996, Dec 17)
<P><B>Dix, M.R.</b> and <B>Hunt, B.G.</b> (1995)
Chaotic influences and the problem of deterministic seasonal predictions.
<i>
International Journal of Climatology</i>
15: 729-752 44 refs, illus.
<P><B>Dix, M.R.</b> and <B>Hunt, B.G.</b> (1995)
Chaotic influences and the problem of deterministic seasonal predictions.
<i>
International Journal of Climatology</i>
15: 729-52  44 refs, illus.
<P>*Dlugokencky, E.J., <B>Steele, L.P.</b>, *Lang, P.M. and *Masarie, K.A. (1995)
Atmospheric methane at Mauna Loa and Barrow observatories: presentation and analysis of <i>in situ</i> measurements.
<i>
Journal of Geophysical Research</i>
100(D11): 23,103-23,113 32 refs, illus.
<P>*Du, S., <B>Sawford, B.L.</b>, *Wilson, J.D. and *Wilson, D.J. (1995)
Estimation of the Kolmogorov constant (C<sub>0</sub>) for the Lagrangian structure function, using a second-order Lagrangian model of grid turbulence.
<i>
Physics of Fluids</i>
7(12): 3083-3090 27 refs, illus.
<P><B>Enting, I.G.</b> (1995)
Analysing the conflicting requirements of the framework convention of climate change.
<i>
Climatic Change</i>
31(1): 5-18 11 refs, illus.
<P><B>Enting, I.G.</b>, <B>Trudinger, C.M.</b> and <B>Francey, R.J.</b> (1995)
A synthesis inversion of the concentration and {delta}<sup>13</sup>C of atmospheric CO<sub>2</sub>.
<i>
Tellus. Series B</i>
47: 35-52 45 refs, illus.
<P><B>Finn, M.L.</b> and <B>Manins, P.C.</b> (1995)
AIRWATCH: the CSIRO kit. Version 1.0K.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
51p., illus.
<P>*Fowler, A.M. and <B>Hennessy, K.J.</b> (1995)
Potential impacts of global warming on the frequency and magnitude of heavy precipitation.
<i>
Natural Hazards</i>
11(3): 283-303 36 refs, illus.
<P><B>Francey, R.J.</b>, <B>Allison, C.E.</b> and <B>Welch, E.D.</b> (1995)
The 11-year high precision <i>in situ</i> CO<sub>2</sub> stable isotope record from Cape Grim, 1982-1992.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
pp.16-25 18 refs, illus.
<P><B>Francey, R.J.</b> (1995)
The carbon cycle: the imprint of the ocean on the atmosphere [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.35
<P><B>Francey, R.J.</b>, *Tans, P.P., <B>Allison, C.E.</b>, <B>Enting, I.G.</b>, *White, J.W.C. and *Troller, M. (1995)
Changes in oceanic and terrestrial carbon uptake since 1982 [letter].
<i>
Nature</i>
373(6512): 326-330 20 refs, illus.
<P><B>Fraser, P.J.</b> and <B>Derek, N.</b> (1995)
Halocarbons, nitrous oxide, methane and carbon monoxide: the GAGE Program.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
pp.45-53 8 refs, illus.
<P><B>Fraser, P.J.</b>, <B>Derek, N.</b>, <B>Langenfelds, R.L.</b>, *Porter, L., *Weiss, R., *Miller, B., *Simmonds, P., *Alyea, F., *Cunnold, D. and *Prinn, R. (1995)
ALE-GAGE global halocarbon measurements and the Montreal Protocol.
<i>
Extended Abstracts of Papers presented at the WMO-IGAC Conference on the Measurement and Assessment of Atmospheric Composition Change (Beijing, China: October 9-14, 1995). WMO Report</i>
(107): 225-229 18 refs, illus.
<P>*Frederiksen, C.S. and <B>Frederiksen, J.S.</b> (1995)
The influence of Indian Ocean/Indonesian SST anomalies on Southern Hemisphere Storm Tracks and Circulation anomalies associated with the Australian Northwest cloudband [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.36
<P>*Frederiksen, C.S. and <B>Frederiksen, J.S.</b> (1995)
Indian Ocean - Indonesian SST anomalies and the development of atmospheric circulation anomalies associated with the Australian Northwest Cloudband.
<i>
Proceedings of the International Scientific Conference on Tropical Global Atmosphere (TOGA) Programme (Melbourne, VIC: April 2-7, 1995). WCRP-91-WMO/TD No.717</i>
1: 317-321 4 refs, illus.
<P><B>Frederiksen, J.S.</b> and *Frederiksen, C.S. (1995)
The roles of SST anomalies and latent heat release in the formation of atmospheric teleconnection pattern and intraseasonal oscillation modes.
<i>
Proceedings of the International Scientific Conference on Tropical Global Atmosphere (TOGA) Programme (Melbourne, VIC: April 2-7, 1995). WCRP-91-WMO/TD No.717</i>
1: 317-321 4 refs, illus.
<P><B>Frederiksen, J.S.</b> and *Frederiksen, C.S. (1995)
Development of storm tracks, blocks, monsoon disturbances and low frequency anomalies in the Southern Hemisphere [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.37
<P>*Gabric, A.J., <B>Ayers, G.P.</b> and *Sander, G.C. (1995)
Independent marine and atmospheric model estimates of the sea-air flux of dimethylsulfide in the Southern Ocean.
<i>
Geophysical Research Letters</i>
22(24): 3521-3524 35 refs, illus.
<P><B>Galbally, I.E.</b>, <B>Bentley, S.T.</b>, <B>Weeks, I.A.</b>, <B>Ye, R.Y.</b> and <B>Elsworth, C.M.</b> (1995)
A report on volatile organic compound sampling during the Perth photochemical smog study: Final report to Western Power of Western Australia [consultancy report].
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
66p. 63 refs, illus, appendix
<P><B>Garratt, J.R.</b> (1995)
Observed screen (air) and GCM surface/screen temperatures: implications for outgoing longwave fluxes at the surface.
<i>
Journal of Climate</i>
8(5,Pt.2): 1360-1368 13 refs, illus.
<P><B>Garratt, J.R.</b> (1995)
Climatic change and human evolution.
<i>
Australian Science Teachers Journal</i>
41(4): 16-23  illus.
<P>*Gleckler, P.J., *Randall, D.A., *Boer, G., *Colman, R., <B>Dix, M.R.</b>, *Galin, V., *Helfand, M., *Kiehl, J., *Kitoh, A., *Lau, W., *Liang, X-Y., *Lykossov, V., *McAvaney, B., *Miyakoda, K., *Planton, S. and *Stern, W. (1995)
Cloud-radiative effects on implied oceanic energy transports as simulated by atmospheric general circulation models.
<i>
Geophysical Research Letters</i>
22(7): 791-794 16 refs, illus.
<P><B>Gordon, H.B.</b> and <B>O'Farrell, S.P.</b> (1995)
The CSIRO coupled model [abstract].
<i>
Proceedings of the Workshop on Global Coupled General Circulation Models (La Jolla, CA, USA: October 10-12, 1994)</i>
p.30
<P>*Grace, W.J., *Sha, W. and <B>Physick, W.L.</b> (1995)
Some observations and simulaitons of the gully winds of the Mount Lofty ranges of South Australia [abstract].
<i>
Proceedings of the 6th Fire Weather Workshop (Hahndorf, South Australia: June 18-22, 1995)</i>
pp. 24-5
(Adelaide, SA: Bureau of Meteorology)
<P><B>Granek, H.</b> (1995)
Generalized smoothing splines in CO<sub>2</sub> analysis.
<i>
Journal of Geophysical Research</i>
100(D8): 16,857-16,865 24 refs, illus.
<P><B>Grant, I.F.</b>, *MacDougal, J.W., *Ruohoniemi, J.M., *Bristow, W.A., *Sofko, g..j., *Koehler, J.A., *Danskin, D. and *Andre, D. (1995)
Comparison of plasma flow velocities determined by the ionosonde Doppler drift technique, SuperDARN radars, and patch motion.
<i>
Radio Science</i>
30(5): 1537-49
<P><B>Grant, I.F.</b> and *Burns, G.B. (1995)
Observation and modeling of correlated Pi B magnetic and auroral luminosity pulsations.
<i>
Journal of Geophysical Research</i>
100(A10): 19,387-404  49 refs, illus.
<P><B>Gras, J.L.</b> (1995)
CN, CCN and particle size in Southern Ocean air at Cape Grim.
<i>
Atmospheric Research</i>
35: 233-251 29 refs, illus.
<P><B>Gras, J.L.</b> (1995)
Particles.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
pp.35-39, illus.
<P><B>Gras, J.L.</b> and *Bates, T.S. (1995)
IGAC and GAW aerosol programs: a complementary approach.
<i>
Extended Abstracts of Papers presented at the WMO-IGAC Conference on the Measurement and Assessment of Atmospheric Composition Change (Beijing, China: October 9-14, 1995). WMO Report</i>
(107): 179-181
<P>*Harries, J.E., *Llewellyn-Jones, D.T., *Mutlow, C.T., *Murray, M.J., <B>Barton, I.J.</b> and <B>Prata, A.J.</b> (1995)
The ATSR programme: instruments, data and science.
<i>
In: Mather, P M (ed.). TERRA 2: understanding the terrestrial environment: remote sensing data systems and networks</i>
(Ch.1): 19-28 6 refs, illus.
(Chichester, UK: John Wiley & Sons)
[Proceedings of an international conference of the Remote Sensing Society (Chester, UK: September 14-15, 1993)]
<P><B>Hennessy, K.J.</b> and <B>Holper, P.N.</b> (1995)
Collaboration in scenario development and impact projects 1990-95 [book review].
<i>
Climate Change Newsletter</i>
7(4): p. 11
<P><B>Hennessy, K.J.</b> and <B>Pittock, A.B.</b> (Editors) (1995)
Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995).
118p. ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Hennessy, K.J.</b> and *Clayton-Greene, K. (1995)
Greenhouse warming and vernalisation of high-chill fruit in southern Australia.
<i>
Climatic Change</i>
30: 327-348 30 refs, illus.
<P><B>Hennessy, K.J.</b> and <B>Pittock, A.B.</b> (1995)
Greenhouse warming and threshold temperature events in Victoria, Australia.
<i>
International Journal of Climatology</i>
15: 591-612 27 refs, illus.
<P><B>Hennessy, K.J.</b>, <B>Whetton, P.H.</b> and <B>Pittock, A.B.</b> (Editors) (1995)
Climate Change Research Program: Collaboration in scenario development and impact projects 1990-1995.
57p. ISBN 064305796X
<P><B>Hennessy, K.J.</b>, <B>Holper, P.N.</b> and <B>Pittock, A.B.</b> (Editors) (1995)
Regional impact of the Greenhouse Effect on New South Wales: final report.
97p., refs, illus. ISBN 0643056025
(Aspendale: CSIRO Division of Atmospheric Research)
<P><B>Hennessy, K.J.</b> and <B>Suppiah, R.</b> (1995)
Extreme rainfall events [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.52, 4 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Hennessy, K.J.</b>, <B>Whetton, P.H.</b> and <B>Pittock, A.B.</b> (Editors) (1995)
Collaboration in scenario development and impact projects 1990-1995.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
57p. ISBN 064305796X
<P><B>Hennessy, K.J.</b>, <B>Holper, P.N.</b> and <B>Pittock, A.B.</b> (Editors) (1995)
Climate change in New South Wales major findings of a five-year research program.
<i>
Progress Report. Climate Change Research Program. Division of Atmospheric Research. CSIRO Australia</i>
13p. 11 refs, illus.
<P><B>Hibberd, M.F.</b> and <B>Manins, P.C.</b> (1995)
Towing tank study of the plume from a model potroom: summary report.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
25p., illus.
<P><B>Hill, R.H.</b> and <B>Long, A.B.</b> (1995)
The CSIRO dual-frequency microwave radiometer.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(35): 16p. 22 refs, illus. ISBN 0643056041
<P><B>Hill, R.H.</b> (1995)
A report on unmanned aerial vehicle technology and a proposed plan for the introduction of this technology into CSIRO.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
26p. 5 refs, illus.
<P><B>Hirst, A.C.</b> (1995)
Application of an eddy transport parameterisation to a global ocean GCM [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.56
<P><B>Holper, P.N.</b> (1995)
Discovery shines LITE on clouds.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(83): p.5, illus.
<P><B>Holper, P.N.</b> (1995)
Space probe into world's cloudy issues.
<i>
Geo</i>
17(2): 20-21, illus.
<P><B>Holper, P.N.</b> (1995)
Carbon cycle research.
<i>
Information Sheet. Division of Atmospheric Research. CSIRO Australia</i>
(95/1): 2p.
<P><B>Holper, P.N.</b> (1995)
The dangers overhead.
<i>
The Courier-Mail</i>
(Sept.14): p.21, illus.
<P><B>Holper, P.N.</b> (1995)
Acid air? Tracking acidification in Australia and Asia.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(86): 30-34, illus.
<P><B>Hunt, B.G.</b>, <B>Gordon, H.B.</b> and <B>Davies, H.L.</b> (1995)
Impact of the greenhouse effect on sea-ice characteristics and snow accumulation in the polar regions.
<i>
International Journal of Climatology</i>
15: 3-23 56 refs, illus.
<P><B>Hunt, B.G.</b> (1995)
The CSIRO9 Global Climatic Model [abstract].
<i>
Abstracts of the 1st International AMIP Scientific Conference (Monterey, CA, USA: May 15-19, 1995)</i>
p.102
<P><B>Hunt, B.G.</b> (1995)
CSIRO GISST simulation [abstract].
<i>
Abstracts of the 1st International AMIP Scientific Conference (Monterey, CA, USA: May 15-19, 1995)</i>
p.125
<P><B>Hunt, B.G.</b> (1995)
Multi-seasonal prediction experiments at the CSIRO Division of Atmospheric Research.
<i>
Proceedings of the International Scientific Conference on Tropical Global Atmosphere (TOGA) Programme (Melbourne, VIC: April 2-7, 1995). WCRP-91-WMO/TD No.717</i>
2: 680-684 4 refs, illus.
<P><B>Hunt, B.G.</b> (1995)
The CSIRO Global Climatic Model.
<i>
In: Gates, W L (ed.). Proceedings of the 1st International AMIP Scientific Conference (Monterey, CA, USA: May 15-19, 1995)</i>
pp.337-342 12 refs, illus.
<P><B>Hurley, P.J.</b> (1995)
PARTPUFF - a Lagrangian particle - puff approach for plume dispersion modelling applications.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(5): 11p., 16 refs, illus.
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Hurley, P.J.</b> and <B>Manins, P.C.</b> (1995)
Plume rise and enhanced dispersion in LADM.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(4): 4p. 4 refs
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Hurley, P.J.</b> and <B>Boers, R.</b> (1995)
The effect of cloud cover on surface net radiation: simple formulae for use in mesoscale models.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(2): 8p., 14 refs, illus.
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Hurley, P.J.</b> and <B>Manins, P.C.</b> (1995)
Meteorological modelling on high-ozone days in Perth, Western Australia.
<i>
Journal of Applied Meteorology</i>
34(7): 1643-1652 15 refs, illus.
<P><B>Hurley, P.J.</b>, <B>Manins, P.C.</b>, Johnson, G.M. and Azzi, M. (1995)
Modelling the winds on days of high ozone in Perth.
<i>
Mathematical and Computer Modelling</i>
21(9): 105-110 9 refs, illus.
<P><B>Hurley, P.J.</b>, <B>Manins, P.C.</b> and <B>Noonan, J.A.</b> (1995)
Modelling wind fields in MAQS.
<i>
In: Binning, P, Bridgman, H and Williams, B (eds.). Proceedings of the International Congress on Modelling and Simulation. Vol.2. Air pollution and climate (Newcastle, NSW: November 27-30, 1995)</i>
pp.151-158 10 refs, illus.
(Canberra, ACT: Modelling and Simulation Society of Australia)
<P>*Jaffe, D.A., *Honrath, R.E., *Furness, D., *Conway, T.J., *Dlugokencky, E. and <B>Steele, L.P.</b> (1995)
A determination of the CH<sub>4</sub>, NO<sub>x</sub> and CO<sub>2</sub> emissions from the Prudhoe Bay, Alaska oil development.
<i>
Journal of Atmospheric Chemistry</i>
20: 213-227 14 refs, illus.
<P><B>Jensen, J.B.</b> (1995)
Cloud physics and cloud seeding.
<i>
Summaries of papers presented to the Precipitation Enhancement Workshop (Terrigal, NSW: April 24-28, 1995)</i>
pp.20-21
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Jensen, J.B.</b> (1995)
The interaction of a front with topography: a comparison of pre-frontal and post-frontal organization and microphysical conditions [abstract].
<i>
Programme & Abstracts of the New Zealand Meteorological and Hydrological Symposium (Christchurch, NZ: November 12-16, 1995)</i>
1p.
<P><B>Katzfey, J.J.</b> and *Leslie, L. (1995)
Downscaling through nested models [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.51, 1 ref ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Katzfey, J.J.</b> (1995)
Simulations of an extreme precipitation event over New Zealand [abstract].
<i>
Programme & Abstracts of the New Zealand Meteorological and Hydrological Symposium (Christchurch, NZ: November 12-16, 1995)</i>
2p. 4 refs, illus.
<P><B>Katzfey, J.J.</b> (1995)
CSIRO-DAR Limited Area Model : 15 km prognoses for Victoria [abstract].
<i>
Proceedings of the 6th Fire Weather Workshop (Hahndorf, South Australia: June 18-22, 1995)</i>
p. 17
(Adelaide, SA: Bureau of Meteorology)
<P><B>Katzfey, J.J.</b> (1995)
Simulation of extreme New Zealand precipitation events. Part 1. Sensitivity to orography and resolution.
<i>
Monthly Weather Review</i>
123(3): 737-754 32 refs, illus.
<P><B>Katzfey, J.J.</b> (1995)
Simulation of extreme New Zealand precipitation events. Part 2. Mechanisms of precipitation development.
<i>
Monthly Weather Review</i>
123(3): 755-775 16 refs, illus.
<P>*Kidson, J.W. and <B>Watterson, I.G.</b> (1995)
A synoptic climatological evaluation of the changes in the CSIRO nine-level model with doubled CO<sub>2</sub> in the New Zealand region.
<i>
International Journal of Climatology</i>
15: 1179-1194 32 refs, illus.
<P>*Latham, D.J. and <B>Beer, T.</b> (1995)
Australian-American match tests.
<i>
United States Department of Agriculture. Forest Service. Intermountain Research Station. Research Note</i>
(INT-RN-426): 5p. 8 refs, illus.
<P>*Levin, I., *Kromer, B. and <B>Francey, R.J.</b> (1995)
Continuous measurements of <sup>14</sup>C in atmospheric CO<sub>2</sub> at Cape Grim.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
p.63 4 refs
<P>*Li Chongyin and <B>Smith, I.N.</b> (1995)
Numerical simulation of the tropical intraseasonal oscillation and the effect of warm SST.
<i>
Acta Meteorologica Sinica</i>
9(1): 1-12 30 refs, illus.
<P><B>Luhar, A.K.</b> and <B>Sawford, B.L.</b> (1995)
Lagrangian particle modelling of plume fumigation in coastal environments.
<i>
Proceedings of the 11th Symposium on Boundary Layers and Turbulence (Charlotte, NC, USA: March 27-31, 1995)</i>
pp.90-93 10 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>Luhar, A.K.</b> (1995)
Studies of fumigation processes in atmospheric thermal internal boundary layers.
<i>
Proceedings of the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
2: 609-612 11 refs, illus.
<P><B>Luhar, A.K.</b> and <B>Sawford, B.L.</b> (1995)
Lagrangian stochastic modeling of the coastal fumigation phenomenon.
<i>
Journal of Applied Meteorology</i>
34(10): 2259-2277 43 refs, illus.
<P>*Makino, Y., *Ikegami, M., *Tsutsumi, Y., *Zaizen, Y., *Okada, K., *Inoue, Y.H., *Matsueda, H., *Nikaidou, Y., <B>Gras, J.L.</b>, <B>Jensen, J.B.</b> and *Kirstament, I. (1995)
Aircraft measurements of atmospheric chemistry over the western Pacific Ocean (PACE).
<i>
Extended Abstracts of Papers presented at the WMO-IGAC Conference on the Measurement and Assessment of Atmospheric Composition Change (Beijing, China: October 9-14, 1995). WMO Report</i>
(107): 157-159 3 refs
<P><B>Manins, P.C.</b>, <B>Hurley, P.J.</b> and <B>Noonan, J.A.</b> (1995)
Modelling regional wind fields on high pollution days.
<i>
Proceedings of the 1st International Joint Seminar on the Regional Deposition Processes in the Atmosphere (Seoul, Korea: November 20-24, 1995)</i>
pp.114-121 10 refs, illus.
(Seoul National Univ./Korea Meteorological Administration)
<P><B>Manins, P.C.</b> and <B>Holper, P.N.</b> (1995)
Air pollution.
<i>
In: Kelly, R and O'Neill, M (eds.). Australia: a leader in environmental solutions</i>
(Ch.6): 103-111, illus. ISBN 1875359265
(Double Bay, NSW: Focus Publ.)
<P><B>Manins, P.C.</b> (1995)
Regional air pollution modelling for planners.
<i>
Terrestrial, Atmospheric and Oceanic Sciences</i>
6(3): 393-401 16 refs, illus.
<P><B>Manins, P.C.</b> (1995)
Atmospheric pollution measurements using advanced techniques.
<i>
Testing Technology</i>
(3): 9-13 10 refs, illus.
<P><B>McGregor, J.L.</b> and <B>Katzfey, J.J.</b> (1995)
DARLAM simulations of cyclogenesis: sensitivity to cumulus parameterization.
<i>
Proceedings of an International Workshop on Limited-Area and Variable Resolution Models (Beijing, China: October 23-27, 1995). Programme Weather Prediction Research (PWPR) No.7</i>
(WMO/TD699): 329-332 5 refs, illus.
(World Meteorological Organization)
<P><B>McInnes, K.L.</b> and *Hubbert, G.D. (1995)
Extreme weather events and coastal inundation.
<i>
Paper resented at a Workshop on Atmospheric Hazards (Brisbane, QLD: September 20-22, 1995)</i>
14p. 3 refs, illus.
<P><B>McInnes, K.L.</b> (1995)
Extreme weather events and coastal inundation in Port Phillip Bay [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.113-114, 6 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>McInnes, K.L.</b> and *Curry, J.A. (1995)
Life cycles of summertime Arctic stratus clouds.
<i>
Proceedings of the 4th Conference on Polar Meteorology and Oceanography (Dallas, TX, USA: January 15-20, 1995)</i>
3p. 9 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>McInnes, K.L.</b> and *Hubbert, G.D. (1995)
Implications of climate change for storm surges in Port Phillip Bay [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.81
<P><B>McInnes, K.L.</b> and *Curry, J.A. (1995)
Modelling the mean and turbulent structure of the summertime Arctic cloudy boundary layer.
<i>
Boundary-Layer Meteorology</i>
73(1-2): 125-143 27 refs, illus.
<P>*McKeon, G.M., *Carter, J.O., Stafford Smith, D.M., Ash, A.J., <B>Pittock, A.B.</b> and *Howden, S.M. (1995)
Evaluating impact of climate change on Queensland's grazing lands [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.59-60, 2 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Mitchell, C.D.</b> (Editor) (1995)
Climate Change Projects 1994-95: research program.
<i>
Climate Change Research Program: Projects. Division of Atmospheric Research.  CSIRO Australia</i>
140p., refs, illus. ISBN 0643057544
<P><B>Mitchell, C.D.</b> (1995)
Greenhouse: the underlying science [abstract].
<i>
Paper presented at the Proceedings of the 1995 Energy & Air Quality Conference (Sydney, NSW: November 2-3, 1995)</i>
1p.
<P><B>O'Brien, D.M.</b> and *Stephens, G.L. (1995)
Entropy and climate. 2. Simple models.
<i>
Quarterly Journal of the Royal Meteorological Society</i>
121: 1773-1796 16 refs, illus.
<P><B>O'Farrell, S.P.</b> and <B>Gordon, H.B.</b> (1995)
The variability in the high latitude oceans and sea ice cover in a coupled GCM [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.95
<P><B>O'Farrell, S.P.</b> (1995)
ENSO in a warmer world [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.54 ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P>*Oram, D.E., *Reeves, C.E., *Penkett, S.A. and <B>Fraser, P.J.</b> (1995)
Measurements of HCFC-142b and HCFC-141b in the Cape Grim air archive: 1978-1993.
<i>
Geophysical Research Letters</i>
22(20): 2741-2744 19 refs, illus.
<P><B>Pearman, G.I.</b> (1995)
Advances in Australian science of climate change [abstract].
<i>
Proceedings of the ANZAAS '95 Congress (Newcastle, NSW: September 24-27, 1995)</i>
p.60
<P><B>Pearman, G.I.</b> (1995)
The science of climate change: state of the art.
<i>
Climate Change Newsletter</i>
7(2): 7-9, illus.
<P><B>Pearman, G.I.</b> (1995)
The science of climate change: state of the art.
<i>
Proceedings of the 25th National Agricultural and Resources Outlook Conference (Canberra, ACT: February 7-9, 1995)</i>
pp.133-139, illus.
(Canberra, ACT: ABARE)
<P><B>Physick, W.L.</b> and <B>Garratt, J.R.</b> (1995)
Incorporation of a high-roughness lower boundary into a mesoscale model for studies of dry deposition over complex terrain.
<i>
Boundary-Layer Meteorology</i>
74(1-2): 55-71 23 refs, illus.
<P><B>Physick, W.L.</b>, <B>Kowalczyk, E.</b>, <B>Garratt, J.R.</b> and <B>Krummel, P.B.</b> (1995)
The vegetative canopy scheme in LADM.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(9): 9p.,11 refs
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Physick, W.L.</b> (1995)
Surface fluxes and PBL height in LADM.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(6): 4p., 6 refs
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Physick, W.L.</b>, <B>Hurley, P.J.</b> and <B>Manins, P.C.</b> (1995)
Environmental impact assessment of industrial development at Gladstone, Australia.
<i>
International Journal of Environment and Pollution</i>
5(4-6): 548-556 2 refs, illus.
[Proceedings of the Workshop on Operational Short-range Atmospheric Dispersion Models for Environmental Impact Assessment in Europe (Mol, Belgium: November 21-24, 1994)]
<P><B>Physick, W.L.</b> (1995)
Smoke dispersion in the Adelaide region using a mesoscale model [abstract].
<i>
Proceedings of the 6th Fire Weather Workshop (Hahndorf, South Australia: June 18-22, 1995)</i>
p. 22
(Adelaide, SA: Bureau of Meteorology)
<P>*Pinto, J.O., *Curry, J.A. and <B>McInnes, K.L.</b> (1995)
Atmospheric convective plumes emanating from leads. 1. Thermodynamic structure.
<i>
Journal of Geophysical Research</i>
100(C3): 4621-4631 21 refs, illus.
<P><B>Pittock, A.B.</b> (1995)
Climate change and world food supply.
<i>
Environment</i>
37(9): 25-30 42 refs, illus.
<P><B>Pittock, A.B.</b> (1995)
What do we mean by scenarios? [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.30, 3 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Pittock, A.B.</b> (1995)
Comments on climate change scenario development.
<i>
Mathematical and Computer Modelling</i>
21(9): 1-4 10 refs, illus.
<P><B>Pittock, A.B.</b> and <B>Dix, M.R.</b> (1995)
Going beyond 2{mult}CO<sub>2</sub>: why and what? [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.56, 5 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Pittock, A.B.</b> (1995)
Foreword.
<i>
In: Crowley, B M (ed.). Hotting up: how the greenhouse effect and ozone depletion will change Australia during the next 40 years</i>
pp.vii-xi ISBN 1863210075
(South Melbourne, VIC: Magistra Publ.)
<P><B>Pittock, A.B.</b> (1995)
Impact of climate change and variability on tourism.
<i>
Proceedings of the Tourism MDP Workshop: The arguments for various areas of research opportunity (Leura, NSW: September 4-7, 1995)</i>
pp.32-34
<P><B>Platt, C.M.R.</b>, <B>Young, S.A.</b> and <B>Robbins, F.J.</b> (1995)
Active radiation.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
p.44
<P><B>Platt, C.M.R.</b> and *Winker, D.M. (1995)
Multiple scattering effects in clouds observed from LITE.
<i>
SPIE Proceedings</i>
2580: 60-71 14 refs, illus. ISBN 0819419443
[In: Kohnle, A (ed.). Optics in atmospheric propagation and adaptive systems]
<P><B>Platt, C.M.R.</b> (1995)
LITE: a revolutionary view of the global atmosphere.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(62): 5-6, illus.
<P><B>Platt, C.M.R.</b>, <B>Young, S.A.</b>, <B>Manson, P.J.</b>, <B>Patterson, G.R.</b> and Marsden, S. (1995)
The optical properties of equatorial cirrus in the pilot radiation observation experiment.
<i>
Proceedings of the 5th Atmospheric Radiation Measurement (ARM) Science Team Meeting (CA, USA: March 19-23, 1995)</i>
pp. 245-51  6 refs, illus.
(United States Dept. of Energy)
<P><B>Post, D.A.</b>, <B>Beer, T.</b> and *Moghissi, A.A. (1995)
Water modelling [editorial].
<i>
Environment International</i>
21(5): p.475
<P>*Power, S.B., *Tseitkin, F., <B>Dix, M.R.</b>, *Kleeman, R., *Colman, R. and *Holland, D. (1995)
Stochastic variability at the air-sea interface on decadal timescales.
<i>
Geophysical Research Letters</i>
22(19): 2593-6  25 refs, illus.
<P><B>Prata, A.J.</b>, *Caselles, V., *Coll, C., *Sobrino, J.A. and *Ottle, C. (1995)
Thermal remote sensing of land surface temperature from satellites: current status and future prospects.
<i>
Remote Sensing Reviews</i>
12: 175-224 117 refs, illus.
<P>*Prather, M., *Derwent, R., *Ehhalt, D., <B>Fraser, P.J.</b>, *Sanhueza, E. and *Zhou, X. (1995)
Radioactive forcing of climate change. 2.2. Other trace gases and atmospheric chemistry.
<i>
In: Houghton, J T et al (eds.). Climate Change 1995 : the science of climate change. Contribution of WGI to the 2nd Assessment Report of the Intergovernmental Panel on Climate Change</i>
pp. 86-103, refs, illus.
(Cambridge Univ. Press)
<P>*Prinn, R.G., *Weiss, R.F., *Miller, B.R., *Huang, J., *Alyea, F.N., *Cunnold, D.M., <B>Fraser, P.J.</b>, *Hartley, D.E. and *Simmonds, P.G. (1995)
Atmospheric trends and lifetime of CH<sub>3</sub>CCl<sub>3</sub> and global OH concentrations.
<i>
Science</i>
269(5221): 187-192 26 refs, illus.
<P><B>Rayner, P.J.</b> and <B>Law, R.M.</b> (1995)
A comparison of modelled responses to prescribed CO<sub>2</sub> sources.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(36): 84p. 35 refs, illus. ISBN 064305605X
<P><B>Rayner, P.J.</b> and *Law, R. (1995)
Uncertainties in regional carbon budgets: a model comparison [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.101, illus.
<P><B>Rotstayn, L.D.</b> (1995)
Inclusion of prognostic cloud water in the CSIRO atmospheric GCM.
<i>
Proceedings of a Workshop on Cloud Microphysics Parameterizations in Global Atmospheric Circulation Models (Kananaskis, Alberta, Canada: May 23-25, 1995)</i>
pp.327-345 51 refs, illus.
(World Meteorological Organization)
<P><B>Ryan, B.F.</b> (1995)
A critical review of the Australian experience in cloud seeding.
<i>
Summaries of papers presented to the Precipitation Enhancement Workshop (Terrigal, NSW: April 24-28, 1995)</i>
pp.13-16, illus.
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Ryan, B.F.</b> (1995)
Cloud resolving models as planning and analysis tools for field experiments [abstract].
<i>
Programme & Abstracts of the New Zealand Meteorological and Hydrological Symposium (Christchurch, NZ: November 12-16, 1995)</i>
1p.
<P><B>Ryan, B.F.</b> (1995)
The nature of precipitating layer clouds around the world.
<i>
Proceedings of a Workshop on Modelling, Validation and Assimilation of Clouds (Reading, UK: October 31-November 4, 1994)</i>
p.393-421 84 refs, illus.
(Reading, UK: European Centre for Medium-Range Weather Forecasts)
<P><B>Ryan, B.F.</b> and *Sadler, B.S. (1995)
Guidelines for the utilisation of cloud seeding as a tool for water management in Australia: an outline of the Australian experience and principles for water managers.
28p. 28 refs, illus. ISBN 0731023501
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Sawford, B.L.</b> and <B>Tivendale, C.M.</b> (1995)
Intermittency of scalar concentration in turbulent plumes.
<i>
Proceedings of the 11th Symposium on Boundary Layers and Turbulence (Charlotte, NC, USA: March 27-31, 1995)</i>
pp.160-163 3 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>Sawford, B.L.</b> and *Sullivan, P.J. (1995)
A simple representation of a developing contaminant concentration field.
<i>
Journal of Fluid Mechanics</i>
289: 141-157 16 refs, illus.
<P>*Schlunzen, K.H., <B>McGregor, J.L.</b> and <B>Walsh, K.J.E.</b> (1995)
Regional climate model results for the Weddell Sea area.
<i>
Annalen der Meteorologie</i>
(31): 141-142 5 refs, illus.
<P>*Schreider, S.Y., *Jakeman, T.J., <B>Whetton, P.H.</b> and <B>Pittock, A.B.</b> (1995)
Comparative analysis  of climate impacts on streamflow for snow-free and snow-affected catchments.
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.88-91, 6 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P>*Sha, W., <B>Physick, W.L.</b> and *Grace, W. (1995)
A numerical experiment on the Adelaide Gully Wind of South Australia.
<i>
Mathematical and Computer Modelling</i>
21(9): 119-123 26 refs, illus.
<P>*Simpson, J.J., <B>Barton, I.J.</b>, Kingwell, J., *Neal, A.B. and Wallace, J. (1995)
Review of CSIRO Multi-Divisional Program on satellite data acquisition and utilisation (MDP-19): analysis of CSIRO earth observation needs.
<i>
COSSA Publication. CSIRO Australia</i>
(34): 44p., 51 refs, illus. ISBN 0643047697
<P>*Slingo, J.M., *Sperber, K.R., *Boyle, J.S., *Ceron, J-P., <B>Dix, M.R.</b>, *Dugas, B., *Ebisuzaki, W., *Fyfe, J., *Gregory, D., *Gueremy, J-F., *Hack, J., *Harzallah, A., *Inness, P., *Kitoh, A., *Lau, W.K-M., *McAvaney, B., *Madden, R., *Matthews, A., *Palmer, T.N., *Park, C-K., *Randall, D. and *Renno, N. (1995)
Intraseasonal oscillations in 15 atmospheric general circulation models: results from AMIP Diagnostic Subproject 1.
<i>
In: Gates, W L (ed.). Proceedings of the 1st International AMIP Scientific Conference (Monterey, CA, USA: May 15-19, 1995)</i>
pp.119-124 1 ref, illus.
<P>*Slingo, J.M., *Sperber, K.R., *Boyle, J.S., *Ceron, J-P., <B>Dix, M.R.</b>, *Dugas, B., *Ebisuzaki, W., *Fyfe, J., *Gregory, D., *Gueremy, J-F., *Hack, J., *Harzallah, A., *Inness, P., *Kitoh, A., *Lau, WK-M., *McAvaney, B., *Madden, R., *Matthews, A., *Palmer, T.N., *Park, C-K., *Randall, D. and *Renno, N. (1995)
Intraseasonal oscillations in 15 atmospheric general circulation models (results from an AMIP diagnostic subproject).
<i>
World Meteorological Organisation. Technical Document</i>
(661): 32p. 47 refs, illus.
<P><B>Smith, I.N.</b> (1995)
A GCM simulation of global climate internannual variability: 1950-1988.
<i>
Journal of Climate</i>
8(4): 709-718 36 refs, illus.
<P><B>Smith, I.N.</b> (1995)
Atmospheric and oceanic anomalies during the 1991-94 SOI event [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.116, illus.
<P><B>Steele, L.P.</b>, <B>Langenfelds, R.L.</b>, <B>Lucarelli, M.P.</b> and <B>Welch, E.D.</b> (1995)
Atmospheric methane, carbon dioxide, carbon monoxide, and hydrogen by gas chromatography.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
p.35
<P><B>Suppiah, R.</b> (1995)
The Australian summer monsoon: CSIRO9 GCM simulations for 1 x CO<sub>2</sub> and 2 x CO<sub>2</sub> conditions.
<i>
Global and Planetary Change</i>
11(3): 95-109 32 refs, illus.
<P><B>Suppiah, R.</b> and <B>Hennessy, K.J.</b> (1995)
Trends in the intensity and frequency of heavy rainfall in tropical Australia and links with the Southern Oscillation.
<i>
Proceedings of the International Scientific Conference on Tropical Global Atmosphere (TOGA) Programme (Melbourne, VIC: April 2-7, 1995). WCRP-91-WMO/TD No.717</i>
2: 897-901 8 refs, illus.
<P><B>Syktus, J.I..</b> and *Chappell, J. (1995)
Modeling of the sensitivity of monsoonal circulation to the orbital, solar and CO<sub>2</sub> forcing [abstract].
<i>
Proceedings of the International Himalayan/Tibetan Plateau Paleoclimate Workshop (Kathmandu, Nepal: April 2-7, 1995)</i>
p.32
<P><B>Syktus, J.I..</b> and *Chappell, J. (1995)
Modelling of the sensitivity of monsoonal circulation to the orbital, solar and CO<sub>2</sub> forcing [abstract].
<i>
Abstracts of the 2nd Genesis User's Workshop (Boulder, CO, USA: August 8-10, 1995)</i>
1p.
<P><B>Tucker, G.B.</b> (1995)
Troubled waters at CSIRO.
<i>
IPA Review</i>
47(3): 12-14 4 refs
<P>*Vogel, C.A., *Baldocchi, D.D., <B>Luhar, A.K.</b> and *Rao, K.S. (1995)
A comparison of a hierarchy of models for determining energy balance components over vegetation canopies.
<i>
Journal of Applied Meteorology</i>
34(10): 2182-2196 44 refs, illus.
<P><B>Walsh, K.J.E.</b> (1995)
Automatic detection on tropical cyclones in high-resolution analyses and an assessment of the tropical vortex climatology of a limited area model.
<i>
Paper presented at a Workshop on Atmospheric Hazards (Brisbane, QLD: September 20-22, 1995)</i>
6p. 6 refs, illus.
<P><B>Walsh, K.J.E.</b> and <B>McGregor, J.L.</b> (1995)
January and July climate simulations over the Australian region using a limited-area model.
<i>
Journal of Climate</i>
8(10): 2387-2403 44 refs, illus.
<P><B>Walsh, K.J.E.</b> (1995)
Reply [to comments by Lenters, J D, Cook, K H and Ringler, T D (1995) on "On the influence of the Andes on the general circulation of the Southern Hemisphere"].
<i>
Journal of Climate</i>
8(8): 2116-2118 3 refs, illus.
<P><B>Walsh, K.J.E.</b> (1995)
Developing climate change scenarios for tropical cyclones [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.53, 7 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Wang, Y.P.</b>, <B>Meyer, C.P.</b>, Smith, C.J. and <B>Galbally, I.E.</b> (1995)
Prediction of carbon dioxide and nitrous oxide fluxes from a legume-pasture soil at Wagga Wagga.
<i>
In: Binning, P, Bridgman, H and Williams, B (eds.). Proceedings of the International Congress on Modelling and Simulation. Vol.1. Agriculture, catchment hydrology and industry (Newcastle, NSW: November 27-30, 1995)</i>
pp.83-88 13 refs, illus.
(Canberra, ACT: Modelling and Simulation Society of Australia)
<P><B>Wang, Y.P.</b> and Polglase, P.J. (1995)
Carbon balance in the tundra, boreal forest and humid tropical forest during climate change: scaling up from leaf physiology and soil carbon dynamics.
<i>
Plant, Cell and Environment</i>
18: 1226-1244 70 refs, illus.
<P><B>Wang, Y.P.</b> and Gifford, R.M. (1995)
A model of wheat grain growth and its applications to different temperature and carbon dioxide levels.
<i>
Australian Journal of Plant Physiology</i>
22(5): 843-855 45 refs, illus.
<P><B>Warner, J.H.</b> (1995)
The World Meteorological Organization's Precipitation Enhancement Project (PEP).
<i>
Summaries of papers presented to the Precipitation Enhancement Workshop (Terrigal, NSW: April 24-28, 1995)</i>
pp.53-56
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Waterman, L.J.</b> (1995)
Seasonal climatology of an Indian Ocean general circulation model [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.135
<P><B>Watterson, I.G.</b>, <B>Dix, M.R.</b>, <B>Gordon, H.B.</b> and <B>McGregor, J.L.</b> (1995)
The CSIRO nine-level atmospheric general circulation model and its equilibrium present and doubled CO<sub>2</sub> climates.
<i>
Australian Meteorological Magazine</i>
44(2): 111-125 46 refs, illus.
<P><B>Watterson, I.G.</b>, *Evans, J.L. and <B>Ryan, B.F.</b> (1995)
Seasonal and interannual variability of tropical cyclogenesis: diagnostics from large-scale fields.
<i>
Journal of Climate</i>
8: 3052-3066 29 refs, illus.
<P>*Watts, P.D., *Zovody, A.M., *Mutlow, C.T., <B>Barton, I.J.</b>, *Minnett, P.J. and *Llewellyn-Jones, D.T. (1995)
Comment on "Effect of surface wind speed and sensor view zenith angle dependence of emissivity on SST retrieval from thermal infrared data: ATSR".
<i>
International Journal of Remote Sensing</i>
16(11): 2099 2103 16 refs
<P>*Weiss, W., *Sartorius, H., *Levin, I. and <B>Francey, R.J.</b> (1995)
Atmospheric <sup>85</sup>Kr at Cape Grim.
<i>
Baseline Atmospheric Program. Australia, 1992. CSIRO Australia</i>
p.64 2 refs
<P><B>Whetton, P.H.</b> (Editor) (1995)
Climate change under enhanced greenhouse conditions in northern Australia. First Annual Report 1994-95.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
(1st): 33p., illus.
<P><B>Whetton, P.H.</b> (1995)
Incorporating uncertainties into impact assessments [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.69, 1 ref ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Whetton, P.H.</b> (1995)
Comparison of slab-ocean and coupled ocean model results [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.40, 1 ref ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P>*Wright, W.J., <B>Smith, I.N.</b> and <B>Allan, R.J.</b> (1995)
The 1991-95 extended warm Pacific event: Southern Hemisphere effects and predictability.
<i>
Proceedings of the International Scientific Conference on Tropical Ocean Global Atmosphere (TOGA) Programme (Melbourne, VIC: April 2-7, 1995)</i>
2: 875-881 4 refs, illus.
<P>*Wright, W.J., <B>Smith, I.N.</b> and <B>Allan, R.J.</b> (1995)
The 1991-94 SOI event: Southern hemisphere effects and predictability [abstract].
<i>
In: Jasper, D and Smith, N (eds.). TOGA 95. International Scientific Conference: abstracts (Melbourne, VIC: April 2-7, 1995)</i>
p.430
<P><B>Ye, R.</b>, <B>Weeks, I.A.</b> and <B>Galbally, I.E.</b> (1995)
Analyses of exhaust samples. Third progress report to Environment Protection Agency, Department of Environment, Sports and Territories.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
16p. 2 refs
<P><B>Ye, Y.</b>, *Duke, C.C. and *Holder, G.M. (1995)
Identification of hepatic metabolites of two highly carcinogenic polycyclic aza-aromatic compounds, 7,9-dimenthylbenz[<i>c</i>]acridine and 7,10-dimethylbenz[<i>c</i>]acridine.
<i>
Chemical Research in Toxicology</i>
8: 188-202 49 refs, illus.
<P><B>Ye, Y.</b>, *Scharping, E. and *Holder, G.M. (1995)
The hepatic metabolism of two carcinogenic dimethylbenz[<i>c</i>]acridines in control and induced rats: the distribution and the mutagenicity of metabolites.
<i>
Carcinogenesis</i>
16(4): 787-793 39 refs, illus.
<P><B>Ye, Y.</b>, *Duke, C.C. and *Holder, G.M. (1995)
The stereochemistry of the major rat hepatic microsomal metabolites of 7,9-dimethylbenz[<i>c</i>]acridine and 7,10-dimethylbenz[<i>c</i>]acridine.
<i>
Chemical Research in Toxicology</i>
8: 203-208 38 refs, illus.
<P><B>Ye, Y.</b>, <B>Weeks, I.A.</b>, <B>Galbally, I.E.</b>, Duffy, B.L., Nelson, P.F. and Nelson, P.F. (1995)
Benzene, toluene, xylenes and 1,3-butadiene concentrations in emissions from a representative portion of the Australian car fleet. Final report. Division of Atmospheric Research, CSIRO.
<i>
Miscellaneous Publication. Division of Atmospheric Research. CSIRO Australia</i>
(1995):43p. 23 refs, illus.
<P><B>Young, S.A.</b> (1995)
Analysis of lidar backscatter profiles in optically thin clouds.
<i>
Applied Optics</i>
34(30): 7019-7031 33 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-10</DOCNO>
<DOCOLDNO>IA089-000952-B048-112</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/HN1996.html 192.102.250.248 19970208040538 text/html 7842
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:52:59 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:21 GMT
Content-type: text/html
Content-length: 7659
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Human Nutrition</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Human Nutrition</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abbey, M.</b> (1996)
Functional foods: designer foods, pharmafoods, nutraceuticals [book review].
<i>
Food Australia</i>
p. 140
<P><B>Abeywardena, M.Y.</b> and <B>Head, R.J.</b> (1996)
Dietary fatty acid modulation of vascular function [abstract].
<i>
Journal of Molecular Cell Cardiology</i>
27(8): p. A487
<P><B>Baghurst, K.I.</b>, <B>Record, S.J.</b>, <B>Syrette, J.A.</b> and <B>Powis, G.A.</b> (1996)
Food & nutrition in Australia - does five years make a difference? Results from the CSIRO Australian Food and Nutrition Surveys 1988 and 1993.
<i>
Publication. Division of Human Nutrition. CSIRO Australia</i>
58p., illus. ISBN 0643058230
<P><B>Baghurst, K.I.</b> (1996)
Food guides: is there an answer?.
<i>
Perspectives in Food and Nutrition</i>
(4): 2-3
(North Sydney, NSW: Unifoods/Burson-Marsteller)
<P><B>Baghurst, P.A.</b>, <B>Baghurst, K.I.</b> and <B>Record, S.J.</b> (1996)
Dietary fibre, non-starch polysaccharides and resistant starch: a review.
<i>
Food Australia</i>
48(3 ; Supp.): S1-S36  170 refs, illus.
<P><B>Baghurst, P.A.</b>, <B>Baghurst, K.I.</b> and <B>Record, S.J.</b> (1996)
Dietary fibre, non-starch polysaccharides and resistant starch: a review.
<i>
Food Australia</i>
48(3; Supp.): S3-S35  171 refs, illus.
<P><B>Baghurst, P.A.</b> (1996)
Phytoestrogens: probably beneficial: but not aphrodisiacs!.
<i>
Australian Journal of Nutrition and Dietetics</i>
53(1): 3-4  5 refs
<P><B>Baghurst, P.A.</b>, <B>Baghurst, K.I.</b> and <B>Record, S.J.</b> (1996)
Dietary fibre, non-starch polysaccharides and resistant starch: a review.
<i>
Food Australia</i>
48(3): S3-S35, refs, illus.
<P><B>Ballard, F.J.</b> (1996)
Intellectual property licensing: a case study of dairy wastes.
<i>
Food Australia</i>
48(3): 128-9  
<P>*Braun, B., *Zimmermann, M.B., *Kretchmer, N., *Spargo, R.M., <B>Smith, R.M.</b> and *Gracey, M. (1996)
Risk factors for diabetes and cardiovascular disease in young Australian aborigines.
<i>
Diabetes Care</i>
19(5): 472-9  34 refs, illus.
<P>*Fong Lok, *Owens, J.A., *Mundy, L., *Robinson, J.S. and <B>Owens, P.C.</b> (1996)
Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation.
<i>
American Journal of Physiology</i>
270: R1148-R1155  33 refs, illus.
<P>*Gracey, M., *Spargo, R.M., *Smith, P., <B>Smith, R.M.</b>, *Burke, V., *Beilin, L.J. and *Beilby, J. (1996)
Risk factors for ill-health in a remote desert-dwelling Aboriginal community in Western Australia.
<i>
Australian and New Zealand Journal of Medicine</i>
26: 171-9  42 refs, illus.
<P><B>King, R.A.</b>, *Broadbent, J.L. and *Head, R.J. (1996)
Absorption of excretion of the soy isoflavone genistein in rats.
<i>
Journal of Nutrition</i>
126: 176-82  28 refs, illus.
<P>*Li, J., *Owens, J.A., <B>Owens, P.C.</b>, *Saunders, J.C., *Fowden, A.L. and *Gilmour, R.S. (1996)
The ontogeny of hepatic growth hormone receptor and insulin-like growth factor I gene expression in the sheep fetus during late gestation: developmental regulation by cortisol.
<i>
Endocrinology</i>
137(5): 1650-7  36 refs, illus.
<P><B>McIntosh, G.H.</b>, <B>Leleu, R.K.</b>, <B>Royle, P.J.</b> and *Young, G.P. (1996)
A comparative study of the influence of differing barley brans on DMH-induced intestinal tumours in male Sprague-Dawley rats.
<i>
Journal of Gastroenterology and Hepatology</i>
11: 113-9  44 refs, illus.
<P><B>McLennan, P.L.</b>, <B>Howe, P.R.</b>, <B>Abeywardena, M.Y.</b>, *Muggli, R., *Raederstorff, D., <B>Mano, M.T.</b>, <B>Rayner, T.E.</b> and <B>Head, R.J.</b> (1996)
The cardiovascular protective role of docosahexaenoic acid.
<i>
European Journal of Pharmacology</i>
300: 83-9  36 refs, illus.
<P><B>Noakes, M.</b>, <B>Nestel, P.J.</b> and <B>Clifton, P.M.</b> (1996)
Commercial frying fats and plasma lipid-lowering potential
.
<i>
Australian Journal of Nutrition and Dietetics</i>
53(1): 25-30  33 refs
<P><B>Noakes, M.</b>, <B>Nestel, P.J.</b> and <B>Clifton, P.M.</b> (1996)
Modifying the fatty acid profile of dairy products through feedlot technology lowers plasma cholesterol of humans consuming the products.
<i>
American Journal of Nutrition</i>
63: 42-6  46 refs
<P><B>Noakes, M.</b> (1996)
Fats & cholesterol: the latest CSIRO studies.
<i>
Perspectives in Food and Nutrition</i>
(3): 4-5  3 refs, illus.
<P><B>Patten, G.S.</b>, <B>Leifert, W.R.</b>, <B>Burnard, S.L.</b>, <B>Head, R.J.</b> and <B>McMurchie, E.J.</b> (1996)
Stimulation of human cheek cell Na<sup> +</sup>/H<sup> +</sup> antiporter activity by saliva and salivary electrolytes: amplification by nigericin.
<i>
Molecular and Cell Biochemistry</i>
154: 133-41  19 refs, illus.
<P>*Regester, G.O., <B>McIntosh, G.H.</b>, *Lee, V.W.K. and Smithers, G.W. (1996)
Whey proteins as nutritional and functional food ingredients.
<i>
Food Australia</i>
48(3): 123-7  19 refs, illus.
<P>*Regester, G.O., <B>McIntosh, G.H.</b>, *Lee, V.W.K. and Smithers, G.W. (1996)
Whey proteins as nutritional and functional food ingredients.
<i>
Food Australia</i>
48(3): 123-7  18 refs, illus.
<P>Regester, G.O., <B>McIntosh, G.H.</b>, *Lee, V.W.K. and Smithers, G.W. (1996)
Whey proteins as nutritional and functional food ingredients.
<i>
Food Australia</i>
48(3): 123-127 18 refs, illus.
<P><B>Siebert, B.D.</b>, *Deland, M.P. and *Pitchford, W.S. (1996)
Breed differences in the fatty acid composition of subcutaneous and intramuscular lipid of early and late maturing, grain-finished cattle.
<i>
Australian Journal of Agricultural Research</i>
47(6): 943-52 18 refs
<P>*Stern, L.M., <B>Tomas, F.M.</b> and <B>Burgoyne, J.</b> (1996)
Monitoring the effect of prednisone in Duchenne dystrophy [letter].
<i>
Journal of Paediatric Child Health</i>
32: p. 196  6 refs
<P><B>Tomas, F.M.</b>, *Lemmey, A.B., *Read, L.C. and <B>Ballard, F.</b> (1996)
Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins in maintained when administered by injection.
<i>
Journal of Endocrinology</i>
150: 77-84  23 refs, illus.
<P><B>Tomas, F.M.</b>, <B>Knowles, S.E.</b>, <B>Owens, P.C.</b>, <B>Burgoyne, J.L.</b>, <B>Chandler, C.S.</b> and <B>Ballard, F.J.</b> (1996)
Conjoint IGF-I and insulin infusion shows diverse interactive effects in diabetic rats.
<i>
Diabetes</i>
45: 170-7  50 refs, illus.
<P><B>Wang, Y.H.A.</b>, <B>Leibholz, J.</b>, *Bryden, W.L. and *Fraser, D.R. (1996)
Lipid peroxidation status as an index to evaluate the influence of dietrary fats on vitamin E requirements of young pigs.
<i>
British Journal of Nutrition</i>
75: 81-95  39 refs, illus.
<P>Wong, C.W.W., Regester, G.O., <B>Francis, G.L.</b> and Watson, D.L. (1996)
Immunomodulatory activities of whey fractions in efferent prefemoral lymph of sheep.
<i>
Journal of Dairy Research</i>
63: 257-67  27 refs, illus.
<P>*Xian, C.J., <B>Upton, Z.</b>, *Shoubridge, C.A., <B>McNeil, K.A.</b>, *Wallace, J.C., *Read, L.C. and <B>Francis, G.L.</b> (1996)
Production of human epidermal growth factor fusion protein and its degradation in rat gastrointestinal flushings.
<i>
Journal of Molecular Endocrinology</i>
16: 89-97  35 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-11</DOCNO>
<DOCOLDNO>IA089-000952-B037-194</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AV1994.html 192.102.250.248 19970208032931 text/html 67466
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:16:45 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:50 GMT
Content-type: text/html
Content-length: 67282
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Atmospheric Research</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Atmospheric Research</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Allan, R.J.</b> (1994)
Modelling climatic change and variability.
<i>
Transactions of the Royal Society of South Australia</i>
118(1): 9-15 23 refs, illus.
<P><B>Allan, R.J.</b> and <B>Smith, I.N.</b> (1994)
The El Nino - southern oscillation (ENSO).
<i>
In: Mitchell, C D, Hennessy, K J and Pittock, A B (eds.). The Greenhouse Effect Regional Implications for Western Australia</i>
(1994): 52-5, illus. ISBN 0643055819
<P><B>Allan, R.J.</b> and *Lindesay, J.A. (1994)
A reassessment of historical ENSO and anti-ENSO events [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.1
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Allan, R.J.</b> and *Lindesay, J. (1994)
Global ENSO and climate variability atlas [abstract].
<i>
Australia-New Zealand Climate Forum. 8th Australasian Forum on Climatology (Toowoomba, Qld: February 7-9, 1994)</i>
p.10
(Qld Dept. of Primary Industries)
<P><B>Allan, R.J.</b> (1994)
Climate change and ENSO.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.5): 29-36 8 refs, illus.
(Canberra, ACT: CSIRO Division of Water and Land Resources)
<P><B>Allan, R.J.</b> (1994)
Historical climatology of pressure anomalies, ENSO and Australian rainfall.
<i>
Agricultural Systems and Information Technology</i>
6(2): 15-18 4 refs, illus.
<P><B>Allison, C.E.</b>, *Verkouteren, M. and *Currie, L.A. (1994)
Quality assurance of high-precision isotope analysis of atmospheric trace gases.
<i>
In: Rozanski, K (ed.). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
pp.6-7
<P><B>Allison, C.E.</b>, <B>Francey, R.J.</b>, <B>Steele, L.P.</b> and <B>de Silva, F.R.</b> (1994)
The IAEA interlaboratory calibration program: air standards for the IAEA round-robin exercise.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
4p. 1 ref, illus.
<P><B>Allison, C.E.</b>, <B>Francey, R.J.</b>, <B>Langenfelds, R.L.</b> and <B>Welch, E.D.</b> (1994)
Comparison of high precision Cape Grim CO<sub>2</sub> stable isotope measurements using two mass spectrometers.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.10-19 22 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P>*Ankilov, A., *Baklanov, A., *Colhoun, M., *Enderle, K-H., *Filipovicova, D., <B>Gras, J.L.</b>, *Julanov, Y., *Lindner, A., *Lushnikov, A.A., *Majerowicz, A.E., *Mavliev, R., *McGovern, F., *Mirme, A., *O'Connor, T.C., *Podzimek, J., *Preining, O., *Reischl, G.P., *Rudolf, R., *Sem, G., *Szymanski, W.W., *Tamm, E., *Wagner, P.E., *Winklmayr, W. and *Zagaynov, V. (1994)
Workshop on intercomparison of condensation nuclei and aerosol particle counters, Vienna, 1993: an overview [workshop summary].
<i>
Journal of Aerosol Science</i>
25(1): S533-S534 2 refs, illus.
<P><B>Ayers, G.P.</b> and <B>Boers, R.</b> (1994)
Climate clouds and the sulfur cycle [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
p.7
<P><B>Ayers, G.P.</b> (1994)
Deposition of biogeochemically important trace species (DEBITS).
<i>
In: Pszenny, A A P and Prinn, R G (eds.). International Global Atmospheric Chemistry (IGAC) Project. The Operational Plan. Report</i>
(32): 30-32
<P><B>Ayers, G.P.</b>, *Penkett, S.A., <B>Gillett, R.W.</b> and *Bandy, B. (1994)
Peroxide and air at Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
p.51 1 ref
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Baines, P.G.</b> and <B>Mitsudera, H.</b> (1994)
On the mechanism of shear flow instabilities.
<i>
Journal of Fluid Mechanics</i>
276: 327-342 26 refs, illus.
<P><B>Baines, P.G.</b> (1994)
Mechanisms for upstream effects in two-dimensional stratified flow.
<i>
In: Castro, I P and Rockliff, N J (eds.). Stably stratified flows: flow and dispersion over topography. Based on the proceedings of the 4th Conference on Stably Stratified Flows (Surrey, UK: September, 1992)</i>
14p. 16 refs, illus.
(Oxford, UK: Clarendon Press)
<P><B>Baines, P.G.</b> and <B>Murray, D.L.</b> (1994)
Modelling of the airflow over Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.20-24, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Baines, P.G.</b> (1994)
Topographic effects in stratified flows [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.4
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Barton, I.J.</b> (1994)
Satellite-derived sea surface temperatures: current status.
<i>
In: Prata, A J (ed.). AVHRR Workshop Papers (Melbourne, Vic: February 28, 1994)</i>
(Ch.6): 57-65
(Aspendale, Vic: CSIRO Division of Atmospheric Research)
<P><B>Barton, I.J.</b>, <B>Prata, A.J.</b> and <B>Cechet, R.P.</b> (1994)
Validation of the ATSR in the Coral and Tasman Seas.
<i>
In: Le Marshall, J  and Jasper, J D (eds.). Technical Proceedings of the 2nd Pacific Ocean Remote Sensing Conference: PORSEC '94 (Melbourne, Vic: March 1-4, 1994)</i>
pp.95-102 13 refs, illus.
(Melbourne, Vic: Bureau of Meteorology Res. Centre)
<P><B>Barton, I.J.</b>, *Zavody, A.M., *Mutlow, C.T. and *Llewellyn-Jones, D.T. (1994)
Water vapour retrievals using combined ATSR infrared and microwave data.
<i>
Proceedings of the 2nd ERS-1 Symposium on Space at the Service of our Environment (Hamburg, Germany: October 11-14, 1993)</i>
pp.819-824 5 refs, illus.
<P><B>Barton, I.J.</b>, *Mutlow, C.T., *Zavody, A.M. and *Llewellyn-Jones, D.T. (1994)
Intercomparison of AVHRR and ATSR data and data products.
<i>
Proceedings of the 2nd ERS-1 Symposium on Space at the Service of our Environment (Hamburg, Germany: October 11-14, 1993)</i>
pp.1099-1102 4 refs, illus.
<P>*Bates, T.S. and <B>Gras, J.L.</b> (1994)
Multiphase atmospheric chemistry (MAC).
<i>
In: Pszenny, A A P and Prinn, R G (eds.). International Global Atmospheric Chemistry (IGAC) Project. The Operational Plan. Report</i>
(32): 92-96
<P><B>Beardsmore, D.J.</b> and <B>Pearman, G.I.</b> (1994)
Baseline carbon dioxide concentrations.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.36-38 3 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Beer, T.</b> (1994)
Prediction of Australian fire danger using general circulation models [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.6
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Beer, T.</b>, <B>Galbally, I.E.</b> and *Howden, M. (1994)
Greenhouse gas inventory Victoria [consultancy report].
<i>
Report to the Environment Protection Authority. EPA Publication 408</i>
62p. 22 refs, illus.
<P>*Bhattacharya, S.K., *Jani, R.A., *Borole, D.V. and <B>Francey, R.J.</b> (1994)
Monsoonal effect on isotopic composition of CO<sub>2</sub> and trace gas concentration in a tropical coastal site in India.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
8p. 2 refs, illus.
<P><B>Boers, R.</b> (1994)
Modeling the seasonal cycle in marine stratocumulus cloud depth [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P><B>Boers, R.</b>, <B>Jensen, J.B.</b>, <B>Gras, J.L.</b>, <B>Platt, C.M.</b> and <B>Ryan, B.F.</b> (1994)
The Southern Ocean Cloud Experiment I (SOCEX I): first results [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P><B>Boers, R.</b>, <B>Ayers, G.P.</b> and <B>Gras, J.L.</b> (1994)
Coherence between seasonal variation in satellite-derived cloud optical depth and bounary layer CCN concentrations at a mid-latitude Southern Hemisphere station.
<i>
Tellus. Series B</i>
46: 123-131 38 refs, illus.
<P><B>Boers, R.</b> and <B>Mitchell, R.M.</b> (1994)
Absorption feedback in stratocumulus clouds influence on cloud top albedo.
<i>
Tellus. Series A</i>
46: 229-241 29 refs, illus.
<P><B>Borgas, M.S.</b> and <B>Sawford, B.L.</b> (1994)
Stochastic equations with multifractal random increments for modeling turbulent dispersion.
<i>
Physics of Fluids</i>
6(2): 618-633 34 refs, illus.
<P><B>Borgas, M.S.</b> and <B>Sawford, B.L.</b> (1994)
A family of stochastic models for two-particle dispersion in isotropic homogeneous stationary turbulence.
<i>
Journal of Fluid Mechanics</i>
279: 69-99 33 refs, illus.
<P><B>Bouma, W.J.</b> (1994)
International Symposium on Non-CO<sub>2</sub> Greenhouse Gases, Why and How to Control? Conference Report (Maastricht, The Netherlands: December 13-15, 1993).
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
11p., illus, attachments
<P>*Bower, K.N., *Choularton, T.W., *Latham, J., *Nelson, J., *Baker, M.B. and <B>Jensen, J.B.</b> (1994)
A parameterization of warm clouds for use in atmospheric general circulation models.
<i>
Journal of the Atmospheric Sciences</i>
51(19): 2722-2732 30 refs, illus.
<P>*Briggs, K.M., <B>Enting, I.G.</b> and *Guttmann, A.J. (1994)
Series studies of the Potts model. 2. Bulk series for the square lattice.
<i>
Journal of Physics. A. Mathematical and General</i>
27: 1503-1523 29 refs, illus.
<P>*Butler, J.H., *Elkins, J.W., *Hall, B.D., *Montzka, S.A., *Cummings, S.O., <B>Fraser, P.J.</b> and *Porter, L.W. (1994)
Recent trends in the global atmospheric mixing ratios of Halon-13001 and Halon-1211.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.29-32 9 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Cai, W.</b> (1994)
Circulation driven by observed surface thermohaline fields in a coarse resolution ocean general circulation model.
<i>
Journal of Geophysical Research</i>
99(C5): 10,163-10,181 52 refs, illus.
<P><B>Cechet, R.P.</b> (1994)
Diurnal SST cycle in the western equatorial Pacific: measurements made aboard the R.V. Franklin during TOGA-COARE [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.14
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Cechet, R.P.</b>, <B>Bennett, J.W.</b>, Helmond, I.D., Coppin, P.A., Bradley, E.F., <B>Barton, I.J.</b> and Godfrey, J.S. (1994)
TASITA: towed air-sea interface temperature analyzer.
<i>
Journal of Atmospheric and Oceanic Technology</i>
11(3): 801-813 34 refs, illus.
<P>*Ciais, P., *Tans, P.P., *Trolier, M. and <B>Francey, R.J.</b> (1994)
Deconvolution of ocean and land uptake of CO<sub>2</sub> for the 1990's using <sup>13</sup>C observations in the atmosphere.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
2p. 4 refs
<P>Coppin, P.A. and <B>Cechet, R.P.</b> (1994)
AMOS National Conference Incorporating 5th Air-Sea Interaction Conference. Measurements of the ocean surface diurnal warm layer in the western equatorial Pacific, and its effect on the overlying atmosphere.
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.17 3 refs
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><b>CSIRO Division of Atmospheric Research</b> (1994)
Blue Poles. Division of Atmospheric Research Library News. CSIRO Australia.
no.1-  [weekly]
<P><b>CSIRO Division of Atmospheric Research</b> (1994)
Airwaves. Staff Newsletter of the Division of Atmospheric Research. CSIRO Australia.
Vol.11-   [monthly]
<P><b>CSIRO Division of Atmospheric Research</b> (1994)
Slowdown in growth rate of atmospheric methane.
<i>
DAR Bulletin. Division of Atmospheric Research. CSIRO Australia</i>
(18): p.1, illus.
<P><b>CSIRO Division of Atmospheric Research</b> (1994)
Report on Regional Tutorial Course on Climate Change and General Circulation Models (Aspendale, Vic: May 2-13, 1994).
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
19p., illus, appendixes
<P>*Cunold, D.M., <B>Fraser, P.J.</b>, *Weiss, R.F., *Prinn, R.G., *Simmonds, P.G., *Miller, B.R., *Alyea, F.N. and *Crawford, A.J. (1994)
Global trends and annual releases of CCl<sub>3</sub>F and CCl<sub>2</sub>F<sub>2</sub> estimated from ALE/GAGE and other measurements from July 1978 to June 1991.
<i>
Journal of Geophysical Research</i>
99(D1): 1107-1126 34 refs, illus.
<P><B>Davies, H.L.</b> (1994)
Closing the feedback loop: correcting the correction [letter].
<i>
UNIX World's Open Computing</i>
11(1): p.107
<P><B>Davies, H.L.</b> (1994)
Introduction to J.
<i>
In: Delmotte, A (ed.). Proceedings of an International Conference on APL (Antwerp, Belgium: September 11-15, 1994)</i>
30p. 5 refs, illus.
<P><B>Davies, H.L.</b> (1994)
Use of APL in climate modelling.
<i>
In: Delmotte, A (ed.). Proceedings of an International Conference on APL (Antwerp, Belgium: September 11-15, 1994)</i>
2p. 4 refs
<P><B>Davies, H.L.</b> (1994)
APL and efficient portable array files using netCDF.
<i>
In: Delmotte, A (ed.). Proceedings of an International Conference on APL (Antwerp, Belgium: September 11-15, 1994)</i>
2p. 3 refs
<P><B>Davies, H.L.</b> and <B>Hunt, B.G.</b> (1994)
The problem of detecting climatic change in the presence of climatic variability.
<i>
Journal of the Meteorological Society of Japan</i>
72(5): 765-771 19 refs, illus.
<P>*Dick, A.L. and <B>Gras, J.L.</b> (1994)
Baseline Atmospheric Program (Australia) 1991.
92p., refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Dilley, A.C.</b> and <B>Elsum, C.C.</b> (1994)
Improved AVHRR data navigation using automated land feature recognition to correct a satellite orbital model.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(34): 22p. 20 refs, illus.
<P>*Dlugokencky, E.J., *Lang, P.M., *Masarie, K.A. and <B>Steele, L.P.</b> (1994)
Global CH<sub>4</sub> record from the NOAA/CMDL air sampling network.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.262-266 13 refs, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P>*Dlugokencky, E.J., *Lang, P.M., *Masarie, K.A. and <B>Steele, L.P.</b> (1994)
Atmospheric CH<sub>4</sub> records from sites in the NOAA/CMDL air sampling network.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.274-350 13 refs, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P>*Dlugokencky, E.J., *Masarie, K.A., *Lang, P.M., *Tans, P.P., <B>Steele, L.P.</b> and *Nisbet, E.G. (1994)
Reply to "Comments on 'A Dramatic Decrease in the Growth Rate of Atmospheric Methane in the Northern Hemisphere During 1992'" [letter].
<i>
Geophysical Research Letters</i>
21(22): 2447-2448 11 refs
<P>*Dlugokencky, E.J., <B>Steele, L.P.</b>, *Lang, P.M. and *Masarie, K.A. (1994)
The growth rate and distribution of atmospheric methane.
<i>
Journal of Geophysical Research</i>
99(D8): 17,021-17,043 66 refs, illus.
<P>*Dlugokencky, E.J., *Masaire, K.A., *Lang, P.M., *Tans, P.P., <B>Steele, L.P.</b> and *Nisbet, E.G. (1994)
A dramatic decrease in  the growth rate of atmospheric methane in the northern hemisphere during 1992.
<i>
Geophysical Research Letters</i>
21(1): 45-48 18 refs, illus.
[Also presented at: International Symposium on Global Cycles of Atmospheric Greenhouse Gases (Sendai, Japan: March 7-10, 1994)]
<P>*Elkins, J.W., *Thompson, T.M., *Butler, J.H., *Montzka, S.A., *Myers, R.C., *Clarke, A.D., *Swanson, T.H., *Endres, D.J., *Yoshinaga, A.M., *Schnell, R.C., *Winey, M., *Mendonca, B.G., *Losleben, M.V., *Trivett, N.B.A., *Worthy, D.E.J., *Hudec, V., *Chorney, V., <B>Fraser, P.J.</b> and *Porter, L.W. (1994)
Atmospheric halocarbon records from the NOAA/CMDL flask sampling program.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.432-471 15 refs, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P>*Elkins, J.W., *Thompson, T.M., *Butler, J.H., *Myers, R.C., *Clarke, A.D., *Swanson, T.H., *Endres, D.J., *Yoshinaga, A.M., *Schnell, R.C., *Winey, M., *Mendonca, B.G., *Losleben, M.V., *Trivett, N.B.A., *Worthy, D.E.J., *Hudec, V., *Chorney, V., <B>Fraser, P.J.</b> and *Porter, L.W. (1994)
Global and hemispheric means of CFC-11 and CFF-12 from the NOAA/CMDL flask sampling program.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.422-430 1 ref, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P><B>Enting, I.G.</b>, *Wigley, T.M.L. and *Heimann, M. (1994)
Future emissions and concentrations of carbon dioxide: key ocean/atmosphere/land analyses.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(31): 120p. 126 refs, illus, appendixes ISBN 0643052569
[Includes model calculations and descriptions contributed by other authors]
<P><B>Enting, I.G.</b>, *Guttmann, A.J. and *Jensen, I. (1994)
Low-temperature series expansions for the spin-1 Ising model.
<i>
Journal of Physics A: Mathematics and General</i>
27: 6987-7005 29 refs, illus.
<P><B>Enting, I.G.</b> (1994)
Report on workshop on inverse modelling problems in atmospheric constituent transport.
<i>
Bulletin of the Australian Meteorological and Oceanographic Society</i>
7(1): 13-14 2 refs
<P><B>Enting, I.G.</b> (1994)
Final report for SECV contract on 3-dimensional atmospheric transport modelling.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
37p., illus.
<P><B>Etheridge, D.M.</b>, <B>Steele, L.P.</b>, <B>Langenfelds, R.L.</b>, *Barnola, J-M. and *Morgan, V.I. (1994)
Major changes in the growth rate of atmospheric methane since 1750 AD derived from new measurements of air in ice and firn from Law Dome, Antarctica.
<i>
International Symposium on Global Cycles of Atmospheric Greenhouse Gases (Sendai, Japan: March 7-10, 1994)</i>
2p.
(Japan: Tohuku Univ.)
<P><B>Etheridge, D.M.</b>, <B>Pearman, G.I.</b> and <B>Fraser, P.J.</b> (1994)
Historical CH<sub>4</sub> record from the "DE08" ice core at Law Dome.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.256-257, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P><B>Etheridge, D.M.</b>, <B>Pearman, G.I.</b> and <B>De Silva, F.R.</b> (1994)
Historical N<sub>2</sub>O record from the "BHD" ice core at Law Dome.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.391-394 3 refs, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P>*Evans, J.L., <B>Ryan, B.F.</b> and <B>McGregor, J.L.</b> (1994)
A numerical exploration of the sensitivity of tropical cyclone rainfall intensity to sea surface temperature.
<i>
Journal of Climate</i>
7(4): 616-623 33 refs, illus.
<P><B>Francey, R.J.</b>, <B>Allison, C.E.</b>, <B>Welch, E.D.</b> and <B>Langenfelds, R.L.</b> (1994)
<sup>13</sup>C/<sup>12</sup>C and <sup>18</sup>O/<sup>16</sup>O in carbon dioxide.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.39-40 5 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Francey, R.J.</b>, <B>Allison, C.E.</b>, <B>Steele, L.P.</b>, <B>Langenfelds, R.L.</b>, <B>Welch, E.D.</b>, *White, J.W.C., *Trolier, M., *Tans, P.P. and *Masarie, K.A. (1994)
Intercomparison of stable isotope measurements of CO<sub>2</sub>.
<i>
In: Peterson, J T (ed.). Climate monitoring and diagnostics laboratory. Summary report 1993</i>
(22): 106-110 24 refs, illus.
<P><B>Francey, R.J.</b>, *Bhattacharya, S.K., *Gaudry, A., *Trolier, M. and *Zimnoch, M. (1994)
Monitoring of stable isotope composition of atmospheric CO<sub>2</sub>.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
p.3-4
<P><B>Francey, R.J.</b> and <B>Allison, C.E.</b> (1994)
The trend in atmospheric {gamma}<sub>13</sub>CO<sub>2</sub> over the last decade.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
7p. 18 refs, illus.
<P>Francis, R.S., Mathieson, I.D., Whiting, P.G., <B>Dix, M.R.</b>, <B>Davies, H.L.</b> and <B>Rotstayn, L.D.</b> (1994)
A data parallel scientific modelling language.
<i>
Journal of Parallel and Distributed Computing</i>
21: 46-60 23 refs, illus.
<P><B>Fraser, P.J.</b> (1994)
CFCs, HCFCs, the Antarctic hole and the Montreal Protocol.
<i>
Paper presented at an RACI Symposium on CFCs: environmental impacts and industrial alternatives (North Ryde, NSW: August 31, 1994)</i>
3p.
<P><B>Fraser, P.J.</b>, <B>Coram, S.A.</b> and <B>Derek, N.</b> (1994)
Atmospheric methane, carbon monoxide and carbon dioxide by gas chromatography.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.60-64 7 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Fraser, P.J.</b> (1994)
Nitrous oxide and halocarbon intercalibration experiment (NOHALICE).
<i>
In: Pszenny, A A P and Prinn, R G (eds.). International Global Atmospheric Chemistry (IGAC) Project. The Operational Plan. Report</i>
(32): 105-108
<P><B>Fraser, P.J.</b>, *Rasmussen, R. and *Khalil, M. (1994)
Observations of CFC-11, -12, -113 and HCFC-22 from the Oregon Graduate Institute (OGI) flask sampling program, 1984-1990.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.65-69 5 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Fraser, P.J.</b> and <B>Derek, N.</b> (1994)
Halocarbons, nitrous oxide, methane and carbon monoxide: the GAGE program.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.70-82 8 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Fraser, P.J.</b> (1994)
Ozone science update.
<i>
Paper prepared for the ANZECC Ozone Protection Consultative Committee Meeting (Darwin, NT: August 19, 1994)</i>
8p. 29 refs, illus.
<P><B>Frederiksen, J.S.</b> and *Frederiksen, C.S. (1994)
Mechanisms of the formation of Australian monsoon disturbances and intraseasonal oscillations.
<i>
Proceedings of the International Conference on Monsoon Variablility and Prediction (Trieste, Italy: May 9-13, 1994)</i>
1: 372-379 5 refs, illus.
<P><B>Frederiksen, J.S.</b>, <B>Davies, A.G.</b> and <B>Bell, R.C.</b> (1994)
Closure theories with non-Gaussian restarts for truncated two-dimensional turbulence.
<i>
Physics of Fluids</i>
6(9): 3153-3163 34 refs, illus.
<P><B>Galbally, I.E.</b> (1994)
Greenhouse gas emissions.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.2): 9-13 3 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Galbally, I.E.</b> (1994)
Australian participation in IGAC.
<i>
Transcript of a Symposium on International and Australian Activities in Global Change and ENSO: a major factor in the environment of the Australasian Region (Canberra, ACT: December 12, 1994)</i>
pp.17-22, illus.
(Canberra, ACT: Australian Academy of Science)
<P><B>Galbally, I.E.</b> (1994)
RIRDC Project CSD-47A. The role of legume pasture in greenhouse gas emissions from Australia: final report.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
32p. 44 refs, illus. ISBN 0643056033
<P><B>Garratt, J.R.</b> (1994)
Net radiation over land: validation of GCM simulations [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P><B>Garratt, J.R.</b>, Raupach, M.R. and *McNaughton, K.G. (1994)
Climate and the terrestrial biosphere [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
p.9
<P><B>Garratt, J.R.</b> (1994)
Review: the atmospheric boundary layer.
<i>
Earth-Science Reviews</i>
37: 89-134 200 refs, illus.
<P><B>Garratt, J.R.</b> (1994)
Representation of boundary-layer processes in large-scale numerical models of the atmosphere.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 19-31 29 refs, illus.
<P><B>Garratt, J.R.</b> (1994)
Incoming shortwave fluxes at the surface: a comparison of GCM results with observations.
<i>
Journal of Climate</i>
7(1): 72-80 19 refs, illus.
<P><B>Garratt, J.R.</b> (1994)
The Bureau of Meteorology: a guide for CSIRO personnel.
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
30p., illus.
<P><B>Garratt, J.R.</b> (Editor) (1994)
BMRC-DAR joint research activities and collaboration. Report on the BMRC-DAR Planning Workshop (Melbourne Vic: June 28, 1993).
<i>
Division of Atmospheric Research [miscellaneous publication]. CSIRO Australia</i>
48p.
<P><B>Gillett, R.W.</b>, <B>Ayers, G.P.</b> and *Noller, B.N. (1994)
The concentration and distribution of acidic gases at Jabiru, northern Australia.
<i>
Clean Air</i>
28(3): 35-43 41 refs, illus.
<P><B>Gillett, R.W.</b>, <B>Ayers, G.P.</b>, *Tworek, D. and <B>Selleck, P.W.</b> (1994)
Measurement of gases and aerosols inside and outside the Museum of Victoria.
<i>
Clean Air</i>
28(4): 33-38 15 refs
<P><B>Gordon, H.B.</b>, *McAvaney, B.J. and <B>McGregor, J.L.</b> (1994)
Modelling of climate change [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
p.4
<P><B>Gordon, H.B.</b> and <B>Hunt, B.G.</b> (1994)
Climatic variability within an equilibrium greenhouse simulation.
<i>
Climate Dynamics</i>
9: 195-212 35 refs, illus.
<P><B>Granek, H.</b> (1994)
Stochastic models of CO<sub>2</sub> data [abstract].
<i>
12th Australian Statistical Society Conference.  Program and Abstracts (Clayton, Vic: July 4-8, 1994)</i>
1p.
<P><B>Gras, J.L.</b> (1994)
Particles.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.41-46, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Gras, J.L.</b> (1994)
"Air filtration: an integrated approach to the theory and applications of fibrous filters" by R C Brown. Pergamon Press, Oxford, UK, 1993, 272p. [book review].
<i>
Clean Air</i>
28(4): p.42
<P>*Guttmann, A.J. and <B>Enting, I.G.</b> (1994)
The high-temperature specific heat exponent of the 3D Ising model.
<i>
Journal of Physics. A. Mathematical and General</i>
27: 8007-8010 8 refs
<P><B>Haylock, M.R.</b>, <B>Whetton, P.H.</b> and *Desborough, C. (1994)
Climate change and snow cover duration in the Victorian Alps.
<i>
Environment Protection Authority. Publication</i>
(403): 45p. 26 refs, illus.
<P><B>Hennessy, K.J.</b> (1994)
Extreme temperature and rainfall.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.11): 67-71 4 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Hennessy, K.J.</b> (1994)
Climate change scenarios for Australia in the year 2030.
<i>
In: Panozzo, J F and Downie, P G (eds.). Proceedings of the 44th Australian Cereal Chemistry Conference (Ballarat, VIC: September 12-15, 1994)</i>
pp.10-13 4 refs, illus.
(North Melbourne, VIC: Royal Australian Chemical Inst.)
[Abstract published in #Chemistry in Australia#, 1994, 61(9), pp.497-512.]
<P><B>Hennessy, K.J.</b> (1994)
Climate change scenarios for Australia in 2030 [abstract].
<i>
Chemistry in Australia</i>
61(9): p.498
[Abstract to be presented at the 44th Royal Australian Chemical Institute Cereal Chemistry Conference (Ballarat, Vic: September 12-16, 1994)]
<P><B>Hennessy, K.J.</b> (1994)
Climate change impact on wheat.
<i>
In: Coombs, B (ed.). Australian grains</i>
pp.213-219 6 refs, illus.
(Camberwell, VIC: Morescope Publ.)
<P><B>Hennessy, K.J.</b> (1994)
Climate change scenarios for Australia in the year 2030 [abstract].
<i>
Australia-New Zealand Climate Forum. 8th Australasian Forum on Climatology (Toowoomba, Qld: February 7-9, 1994)</i>
p.8
(Qld Dept. of Primary Industries)
<P><B>Hennessy, K.J.</b> (1994)
Climate change scenarios for Australia in the year 2030.
<i>
Proceedings of the 8th Australasian Forum on Climatology. Australian-New Zeland Climate Forum (Toowoomba, QLD: February 7-9, 1994)</i>
p. 8
(Brisbane, QLD: Queensland Dept. of Primary Industries)
<P><B>Hibberd, M.F.</b> and <B>Sawford, B.L.</b> (1994)
Design criteria for water tank models of dispersion on the planetary convective boundary layer.
<i>
Boundary-Layer Meteorology</i>
67: 97-11 46 refs, illus.
<P><B>Hibberd, M.F.</b> and <B>Sawford, B.L.</b> (1994)
A saline laboratory model of the planetary convective boundary layer.
<i>
Boundary-Layer Meteorology</i>
67: 229-250 46 refs, illus.
<P><B>Hibberd, M.F.</b> (1994)
"Time to change" by D Suzuki. Allen & Unwin, 1993, 230p. [book review].
<i>
Clean Air</i>
28(4): p.44
<P><B>Hirst, A.C.</b> and <B>Cai, W.</b> (1994)
Sensitivity of a world ocean GCM to changes in subsurface mixing parameterization.
<i>
Journal of Physical Oceanography</i>
24(6): 1256-1279 50 refs, illus.
<P><B>Hirst, A.C.</b> (1994)
On the fate of north Atlantic deep water as simulated global ocean GCM [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.36
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Hirst, A.C.</b> and Godfrey, J.S. (1994)
The response to a sudden change in Indonesian throughflow in a global ocean GCM.
<i>
Journal of Physical Oceanography</i>
24(9): 1895-1910 23 refs, illus.
<P><B>Holper, P.N.</b> (1994)
Atmosphere: weather, climate and pollution.
81p., illus. ISBN 0521436397
(UK: Cambridge Univ. Press)
<P><B>Holper, P.N.</b> (1994)
Ozone depletion: the hole story.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(80): p.4, illus.
<P><B>Hunt, B.G.</b>, *Zebiak, S.E. and *Cane, M.A. (1994)
Experimental predictions of climatic variability for lead times of twelve months.
<i>
International Journal of Climatology</i>
14: 507-526 28 refs, illus.
<P><B>Hunt, B.G.</b> (1994)
Rain, runoff and recharge: a simulation study [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P><B>Hunt, B.G.</b> (1994)
The use of global climatic models in deriving seasonal outlooks.
<i>
Agricultural Systems and Information Technology</i>
6(2): 11-15 5 refs, illus.
<P><B>Hurley, P.J.</b> and <B>Manins, P.C.</b> (1994)
The meteorology of MAOS: numerical studies.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
2: 275-282 7 refs, illus.
<P><B>Hurley, P.J.</b> and <B>Manins, P.C.</b> (1994)
Air quality modelling in complex terrain: Gladstone.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
2: 141-149 10 refs, illus.
<P><B>Hurley, P.J.</b> (1994)
PARTPUFF: a Lagrangian particle-puff approach for plume dispersion modeling applications.
<i>
Journal of Applied Meteorology</i>
33(2): 285-294 16 refs, illus.
<P>*Hurst, D.F., *Griffith, D.W.T., Carras, J.N., Williams, D.J. and <B>Fraser, P.J.</b> (1994)
Measurements of trace gases emitted by Australian savanna fires during the 1990 dry season.
<i>
Journal of Atmospheric Chemistry</i>
18: 33-56 53 refs, illus.
<P>Jakeman, A.J. and <B>Pittock, A.B.</b> (Editors) (1994)
Climate Impact Assessment Methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993).
210p., refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P>*Joos, F., *Bruno, M., *Leuenberger, M. and <B>Francey, R.J.</b> (1994)
Carbon isotopes as constraints for global carbon cycle models.
<i>
In: Rozanski, K (ed). Final Report. Final Research Coordination Meeting Coordinated Research Programme on Isotope Variations of Carbon Dioxide and other Trace Gases in the Atmosphere (Vienna, Austria: November 7-10, 1994)</i>
5p. 12 refs
<P><B>Katzfey, J.J.</b> (1994)
Simulations of an extreme precipitation event over New Zealand [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.46
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Katzfey, J.J.</b> (1994)
Simulations of an extreme precipitation events over New Zealand.
<i>
Proceedings of the 6th Conference on Mesoscale Processes (Portland, Oregon, Canada: July 18-22, 1994)</i>
pp.483-484 3 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>Katzfey, J.J.</b> (1994)
Investigations of cumulus parameterizations for an Australian coastal low.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 129-134 10 refs, illus.
<P><B>Katzfey, J.J.</b> and <B>McGregor, J.L.</b> (1994)
Impact of vertical and horizontal resolution on a coastal storm simulation.
<i>
Proceedings of the 10th Conference on Numerical Weather Prediction (Portland, OR, USA: July 18-22, 1994)</i>
pp.475-476 4 refs, illus.
<P><B>Kowalczyk, E.A.</b>, <B>Garratt, J.R.</b> and <B>Krummel, P.B.</b> (1994)
Implementation of a soil-canopy scheme into the CSIRO GCM: regional aspects of the model response.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(32): 59p. 36 refs, illus.
<P>*Lemus, L., <B>Platt, C.M.R.</b> and *Simmonds, I. (1994)
Impact of a new cloud optical parameterization on the Earth's radiation balance and zonal temperature and winds.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 199-205 9 refs, illus.
<P>*Lemus, L., <B>Platt, C.M.R.</b> and *Simmonds, I. (1994)
Impact of a new cloud optical parameterization on the earth's radiation balance and zonal temperature and winds [abstract].
<i>
Report of International Workshop on Cloud-Radiation Interactions and their Parameterization in Climate Models (Camp Springs, MD, USA: October 18-20, 1993)</i>
p.109
<P>*Levin, I., *Kromer, B. and <B>Francey, R.J.</b> (1994)
Continuous measurements of <sup>14</sup>C in atmospheric CO<sub>2</sub> at Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
p.84 5 refs
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Luhar, A.K.</b> and *Rao, K.S. (1994)
Source footprint analysis for scalar fluxes measured in flows over an inhomogeneous surface.
<i>
In: Gryning, S-E and Millan, M M (eds.). Air pollution modeling and its application: 10</i>
pp.315-323 13 refs, illus.
(New York: Plenum Press)
<P>*Lunney, K., *Best, P., *Anh, V., Johnson, G.M. and <B>Physick, W.L.</b> (1994)
A case study of photochemical pollution in a sub-tropical city.
<i>
In: Baldasano, J M, Brebbia, C A, Power, H and Zannetti, P (eds.). Air Pollution II. Volume 1: Computer simulation</i>
1: 259-267 5 refs, illus.
(Southampton, Boston, USA: Computational Mechanics Publications)
<P><B>Manins, P.C.</b> (1994)
Cleaning up the atmosphere takes action.
<i>
Clean Air</i>
28(3): 2-3 1 ref, illus.
<P><B>Manins, P.C.</b> (1994)
New measurement and modelling work on dry acid deposition.
<i>
Proceedings of an International Workshop on the Regional Air Quality Problems (Seoul, Korea: August 29, 1994)</i>
pp.27-34 13 refs, illus.
<P><B>Manins, P.C.</b>, <B>Physick, W.L.</b>, <B>Hurley, P.J.</b> and <B>Noonan, J.A.</b> (1994)
The role of coastal terrain in the dispersion of pollutants from Australia's major cities.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
2: 179-188 21 refs, illus.
<P><B>Manins, P.C.</b> (1994)
Quality air: our shared resource.
<i>
Environment Management Industry Association of Australia Yearbook</i>
pp.178-179, illus.
<P><B>Manins, P.C.</b> (1994)
Advanced air pollution modelling for environmental approvals.
<i>
Proceedings of the 2nd National Hazardous & Solid Waste Convention and Trade Exhibition. Achievements and Challenges (Melbourne, Vic: May 8-12, 1994)</i>
pp.308-313 5 refs, illus.
(Artarmon, NSW: Aust. Water & Wastewater Assoc./Waste Management Assoc. of Australia)
<P><B>Manins, P.C.</b> (1994)
The network of air pollution modellers in project CREN.
<i>
Proceedings of the International Symposium on Environmental Technology Research Network in the Asia-Pacific Region (Tsukuba, Japan: January 24-25, 1994)</i>
p.5-15, illus.
<P>*Manning, M.R., <B>Pearman, G.I.</b>, <B>Etheridge, D.M.</b>, <B>Fraser, P.J.</b>, <B>Steele, L.P.</b> and *Lowe, D.C. (1994)
The changing composition of the atmosphere [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
p.3
<P>*Marsden, A.J., *Lynch, M.J., *Forgan, B.W. and <B>Mitchell, R.M.</b> (1994)
The estimation and validation of aerosol optical depths from NOAA/AVHRR.
<i>
In: Le Marshall, J  and Jasper, J D (eds.). Technical Proceedings of the 2nd Pacific Ocean Remote Sensing Conference: PORSEC '94 (Melbourne, Vic: March 1-4, 1994)</i>
pp.119-126 21 refs
(Melbourne, Vic: Bureau of Meteorology Res. Centre)
<P><B>McGregor, J.L.</b> and <B>Walsh, K.J.E.</b> (1994)
Climate change simulations of Tasmanian precipitation using multiple nesting.
<i>
Journal of Geophysical Research</i>
99(D10): 20,889-20,905 17 refs, illus.
<P><B>McGregor, J.L.</b> (1994)
Nested climate models for regional studies.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.6): 37-42, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>McInnes, K.L.</b>, *McBride, J.L. and *Leslie, L.M. (1994)
Cold fronts over southeastern Australia: their representation in an operational numerical weather prediction model.
<i>
Weather and Forecasting</i>
9(3): 384-409 63 refs, illus.
<P><B>McInnes, K.L.</b> and *Hubbert, G.D. (1994)
The impact of east coast lows on storm surges: implications for climate change.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.16): 97-103 12 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>McInnes, K.L.</b> and *Curry, J.A. (1994)
Modelling the mean and turbulent structure of the Arctic cloudy boundary layer.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 179-184 11 refs, illus.
<P><B>McInnes, K.L.</b> and *Hubbert, G.D. (1994)
The impact of east coast lows on storm surges: implications for climate change [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.57
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Meyer, M.</b> (1994)
"Assessment and control of VOC emissions from waste treatment and disposal facilities" by T T Shen, C E Schmidt and T R Card. Van Nostrand Reinhold, New York, 1993 [book review].
<i>
Clean Air</i>
28(4): p.42
<P><B>Mitchell, C.D.</b>, <B>Hennessy, K.J.</b> and <B>Pittock, A.B.</b> (Editors) (1994)
Annual Report: 1992-93.
<i>
Annual Report. Regional Impact of the Enhanced Greenhouse Effect on New South Wales. Division of Atmospheric Research. CSIRO Australia</i>
71p., refs, illus.
<P><B>Mitchell, C.D.</b> (1994)
Climate change: a 1994 science summary.
<i>
APEA Journal</i>
(2): 104-117 22 refs, illus.
<P><B>Mitchell, C.D.</b> (1994)
An overview of CSIRO's climate change research [abstract].
<i>
Proceedings of the 8th Australasian Forum on Climatology. Australian-New Zeland Climate Forum (Toowoomba, QLD: February 7-9, 1994)</i>
p. 7
(Brisbane, QLD: Queensland Dept. of Primary Industries)
<P><B>Mitchell, C.D.</b> (1994)
An overview of CSIRO's climate change research [abstract].
<i>
Australia-New Zealand Climate Forum. 8th Australasian Forum on Climatology (Toowoomba, Qld: February 7-9, 1994)</i>
p.7
(Qld Dept. of Primary Industries)
<P><B>Mitchell, C.D.</b>, <B>Hennessy, K.J.</b> and <B>Pittock, A.B.</b> (Editors) (1994)
The greenhouse effect regional implications for Western Australia: Final Report 1992-93.
99p.refs, illus. ISBN 0643055819
(Aspendale, VIC : Division of Atmospheric Research)
<P><B>Mitchell, R.M.</b> (1994)
In-flight calibration of the NOAA AVHRR shortwave channels: review and recent developments.
<i>
In: Prata, A J (ed.). AVHRR Workshop Papers (Melbourne, Vic: February 28, 1994)</i>
(Ch.4): 31-39, illus.
(Aspendale, Vic: CSIRO Division of Atmospheric Research)
<P><B>Mitsudera, H.</b> and *Grimshaw, R. (1994)
Capture and resonant forcing of solitary waves by the interaction of a baroclinic current with topography.
<i>
Journal of Physical Oceanography</i>
24: 2217-2244 28 refs, illus.
<P><B>Mitsudera, H.</b> (1994)
Eady solitary waves: a theory of type B cyclogenesis.
<i>
Journal of the Atmospheric Sciences</i>
51(21): 3137-3154 34 refs, illus.
<P>*Montzka, S.A., *Nowick, M.R., *Myers, R.C., *Elkins, J.W., *Butler, J.H., *Cummings, S.O., <B>Fraser, P.J.</b> and *Porter, L.W. (1994)
NOAA-CMDL chlorodifluoromethane (HCFC-22) observations at Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
pp.25-28 1 ref, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Moore, A.M.</b> and <B>Gordon, H.B.</b> (1994)
An investigation of climate drift in a coupled atmosphere-ocean-sea ice model.
<i>
Climate Dynamics</i>
10: 81-95 33 refs, illus.
<P>*Mutlow, C.T., <B>Barton, I.J.</b> and *Llewellyn-Jones, D.T. (1994)
Sea surface temperature measurements by the along-track scanning radiometer on the ERS 1 satellite: early results.
<i>
Journal of Geophysical Research</i>
99(C11): 22,575-22,588 24 refs, illus.
<P><B>Nguyen, K.C.</b>, <B>Noonan, J.A.</b> and <B>Physick, W.L.</b> (1994)
Comparison of Eulerian and Lagrangian model predictions of power station plume dispersion.
<i>
In: Baldasano, J M, Brebbia, C A, Power, H and Zannetti, P (eds.). Air Pollution II. Volume 1: Computer simulation</i>
1: 183-190 3 refs, illus.
(Southampton, Boston, USA: Computational Mechanics Publications)
<P><B>Nguyen, K.C.</b>, <B>Noonan, J.A.</b>, <B>Galbally, I.E.</b> and <B>Physick, W.L.</b> (1994)
Comparison of Eulerian and Lagrangian model predictions of plume dispersion form elevated sources in complex terrain.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
2: 297-308 7 refs, illus.
<P><B>Noonan, J.A.</b> and *Smith, R.K. (1994)
On the generation and maintenance of 'morning glory' bore waves.
<i>
Proceedings of the 6th Conference on Mesoscale Processes (Portland, Oregon, Canada: July 18-22, 1994)</i>
pp.190-193 5 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>Noonan, J.A.</b>, <B>Physick, W.L.</b>, Carras, J.N. and Williams, D.J. (1994)
Dispersion modelling and observations from elevated sources in coastal terrain.
<i>
In: Gryning, S-E and Millan, M M (eds.). Air pollution modeling and its application: 10</i>
pp.533-540 8 refs, illus.
(New York: Plenum Press)
<P><B>O'Farrell, S.P.</b> (1994)
Inclusion of sea ice processes in atmospheric models.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 59-63, illus.
<P><B>O'Farrell, S.P.</b> (1994)
Performance of a dynamic sea ice model in a coupled ocean atmosphere climate model [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.61
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Pearman, G.I.</b> (1994)
The science of global warming.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
1: 79-94 15 refs, illus.
<P><B>Physick, W.L.</b> and <B>Manins, P.C.</b> (1994)
Application of the air quality model LADM for regional planning purposes.
<i>
In: Baldasano, J M, Brebbia, C A, Power, H and Zannetti, P (eds.). Air Pollution II. Volume 1: Computer simulation</i>
2: 27-34 6 refs, illus.
(Southampton, Boston, USA: Computational Mechanics Publications)
<P><B>Physick, W.L.</b>, <B>Noonan, J.A.</b>, <B>McGregor, J.L.</b>, <B>Hurley, P.J.</b>, <B>Abbs, D.J.</b> and <B>Manins, P.C.</b> (1994)
LADM: a Lagrangian atmospheric dispersion model.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(24): 137p. 44 refs, illus.
<P><B>Physick, W.L.</b> and <B>Hurley, P.J.</b> (1994)
A fast Lagrangian particle model for use with three-dimensional mesoscale models.
<i>
In: Gryning, S-V and Millan, M M (eds.). Air pollution modeling and its application: 10</i>
pp.235-241 13 refs, illus.
(New York: Plenum Press)
<P><B>Physick, W.L.</b> (1994)
Calculation of dry deposition velocities in LADM.
<i>
ECRU Technical Note. Division of Atmospheric Research. CSIRO Australia</i>
(1): 3p., 3 refs
(Environmental Consulting and Research Unit (ECRU). CSIRO Division of Atmospheric Research)
<P><B>Physick, W.L.</b>, *Best, P., *Lunney, K. and Johnson, G.M. (1994)
Designing an air quality network for Brisbane using a mesoscale model.
<i>
In: Gryning, S-E and Millan, M M (eds.). Air pollution modeling and its application: 10</i>
pp.583-585 2 refs
(New York: Plenum Press)
<P><B>Pittock, A.B.</b> (Editor) (1994)
Towards an integrated approach to climate change impact assessment. Abstracts presented at a workshop (Melbourne: April 26, 1994).
24p.
(Mordialloc: CSIRO Division of Atmospheric Research)
<P><B>Pittock, A.B.</b> (1994)
"Human impacts on weather and climate, geophysical science series Vol.2" by W R Cotton and R A Pielke. Aster Press, 1992, 288p. [book review].
<i>
Australian Meteorological Magazine</i>
43(4): 299-300 5 refs
<P><B>Pittock, A.B.</b> (1994)
National and international developments.
<i>
In: Mitchell, C D, Hennessy, K J and Pittock, A B (eds.). The Greenhouse Effect Regional Implications for Western Australia</i>
(1994): 56-75 ISBN 0643055819
<P><B>Pittock, A.B.</b> (1994)
Modeling of present and future climate: interpolation to regional scales.
<i>
Intergovernmental Panel on Climate Change Special Workshop: Article 2 of the United Nations Framework Convention on Climate Change (Fortaleza, State of Ceara, Brazil: October 17-21, 1994)</i>
pp.63-67
<P><B>Pittock, A.B.</b>, <B>Whetton, P.H.</b> and <B>Wang, Y.</b> (1994)
Climate and food supply [letter].
<i>
Nature</i>
371(6492): p.25 10 refs
<P><B>Pittock, A.B.</b> (1994)
Constructing climate scenarios: the philosophy.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.3): 15-20 5 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Pittock, A.B.</b> (1994)
Climate change modelling: advances in global and regional modelling and scenario development.
<i>
In: Bhattacharya, S C, Pittock, A B and Lucas, N J D (eds.). Proceedings of the Workshop on Global Warming Issues in Asia (Bangkok, Thailand: September 8-10, 1993)</i>
pp.11-30 49 refs, illus.
<P><B>Platt, C.M.R.</b> (1994)
Current activities in cloud-radiation research in Australia.
<i>
Report of International Workshop on Cloud-Radiation Interactions and their Parameterization in Climate Models (Camp Springs, MD, USA: October 18-20, 1993)</i>
pp.120-122
<P><B>Platt, C.M.R.</b> (1994)
Parameterization of cloud-radiation interactions from observations.
<i>
In: Jasper, J D and Meighen, P J (eds.). Parameterisation of Physical Processes. Papers presented at the 5th BMRC Modelling Workshop (Melbourne, Vic: November 15-18, 1993). Bureau of Meteorology Research Centre.  Research Report</i>
(46): 153-158 12 refs, illus.
<P><B>Platt, C.M.R.</b>, <B>Young, S.A.</b>, *Carswell, A.I., *Pal, S.R., *McCormick, M.P., *Winker, D.M., *DelGuasta, M., *Stefanutti, L., *Eberhard, W.L., *Hardesty, M., *Flamant, P.H., *Valentin, R., *Forgan, B., *Gimmestad, G.G., *Jager, H., *Khmelevtsov, S.S., *Kolev, I., *Kaprieolev, B., *Lu, D-R., *Sassen, K., *Shamanaev, V.S., *Uchino, O., *Mizuno, Y., *Wandinger, U., *Weitkamp, C., *Ansmann, A. and *Wooldridge, C. (1994)
The Experimental Cloud Lidar Pilot Study (ECLIPS) for cloud-radiation research.
<i>
Bulletin of the American Meteorological Society</i>
75(9): 1635-1654 43 refs, illus.
<P><B>Platt, C.M.R.</b>, <B>Young, S.A.</b>, <B>Manson, P.J.</b>, <B>Patterson, G.R.</b> and *Forgan, B. (1994)
Optical remote sounding of clouds from the ground.
<i>
Proceedings of the 8th Conference on Atmospheric Radiation (Nashville, TN, USA: January 23-28, 1994)</i>
pp.279-281 12 refs, illus.
(Boston, MA, USA: American Meteorological Society)
<P><B>Platt, C.M.R.</b> (1994)
Active radiation.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
p.58
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Platt, C.M.R.</b>, <B>Bennett, J.W.</b>, <B>Young, S.A.</b>, <B>Fenwick, M.D.</b>, <B>Manson, P.J.</b>, <B>Patterson, G.R.</b> and <B>Petraitis, B.S.</b> (1994)
Narrow-beam fast filter radiometry and the use of the lidar/radiometer method in the atmospheric radiation measurement program.
<i>
Proceedings of the 3rd Atmospheric Radiation Measurement (ARM) Science Team Meeting (Norman, Oklahoma, USA: March 1-4, 1993)</i>
pp.293-297 7 refs, illus.
<P>*Power, S.B., <B>Moore, A.M.</b>, <B>Post, D.A.</b>, *Smith, N.R. and *Kleeman, R. (1994)
Stability of North Atlantic deep water formation in a global ocean general circulation model.
<i>
Journal of Physical Oceanography</i>
24(5): 904-916 40 refs, illus.
<P><B>Prata, A.J.</b> (1994)
Land surface temperatures derived from the advanced very high resolution radiometer and the along-track scanning radiometer. 2. Experimental results and validation of AVHRR algorithms.
<i>
Journal of Geophysical Research</i>
99(D6): 13,025-13,058 41 refs, illus.
<P><B>Prata, A.J.</b> (1994)
Land surface temperature derivation from the AVHRR: status.
<i>
In: Prata, A J (ed.). AVHRR Workshop Papers (Melbourne, Vic: February 28, 1994)</i>
(Ch.7): 67-79
(Aspendale, Vic: CSIRO Division of Atmospheric Research)
<P><B>Prata, A.J.</b> (1994)
Land surface termperature determination from satellites.
<i>
Advances in Space Research</i>
14(3): 15-26 11 refs, illus.
<P><B>Prata, A.J.</b> (Editor) (1994)
AVHRR Workshop Papers (Melbourne, Vic: February 28, 1994).
99p., bibliography
(Aspendale, Vic: CSIRO Division of Atmospheric Research)
<P><B>Prata, A.J.</b> (1994)
Infrared measurements of land surface temperature from space and the effects of viewing geometry.
<i>
Proceedings of the 6th International Symposium on Physical Measurements and Signatures in Remote Sensing (Val D'Isere, France: January 17-21, 1994)</i>
p.759-771 17 refs, illus.
<P><B>Prata, A.J.</b> (1994)
Validation data for land surface temperature determination from satellites.
<i>
Technical Paper. Division of Atmospheric Research. CSIRO Australia</i>
(33): 36p. 14 refs, illus.
<P><B>Prata, A.J.</b> and Kingwell, J. (1994)
Australia's continental integrated ground-truth site network.
<i>
COSSA [miscellaneous publication]. CSIRO Australia</i>
pamphlet
<P>*Prinn, R.G., *Weiss, R.F., *Alyea, F.N., *Cunnold, D.M., <B>Fraser, P.J.</b>, *Simmonds, P.G., *Crawford, A.J., *Rasmussen, R.A. and *Rosen, R.D. (1994)
Atmospheric CFC-11 (CCl<sub>3</sub>F), CFC-12 (CCl<sub>2</sub>F<sub>2</sub>), and N<sub>2</sub>O from the ALE/GAGE network.
<i>
In: Boden, T A, Kaiser, D P and Sepanski, R J and Stoss, F W (eds.). Trends '93: A compendium of data on global change</i>
pp.396-420 10 refs, illus.
(Oak Ridge, TN, USA: Oak Ridge National Laboratory)
<P>*Prinn, R.G., *Weiss, R.F., *Alyea, F.N., *Cunnold, D.M., <B>Fraser, P.J.</b>, <B>Steele, L.P.</b> and *Simmonds, P.G. (1994)
Advanced Global Atmospheric Gases Experiment (AGAGE).
<i>
In: Peterson, J T (ed.). Climate monitoring and diagnostics laboratory. Summary report 1993</i>
(22): 135-136 4 refs
<P>*Quay, P., *Stutsman, J. and <B>Fraser, P.J.</b> (1994)
<sup>13</sup>C/<sup>12</sup>C ratio of atmospheric methane at Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
p.59 3 refs, illus.
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Rotstayn, L.D.</b> (1994)
Modelling climate with a spectral GCM on a silicon graphics symmetric multiprocessor.
<i>
In: Hoffmann, G R and Kreitz, N (ed.). Proceedings of the 6th ECMWF Workshop on the Use of Parallel Processors in Meteorology (Reading, UK: November 21-25, 1994)</i>
pp.472-493 22 refs, illus.
(Singapore: World Scientific)
<P>*Rustana, C.E., *Lynch, M.J., *Foster, I. and <B>Prata, A.J.</b> (1994)
The performance of satellite estimates of LST in the WA agricultural region.
<i>
In: Le Marshall, J  and Jasper, J D (eds.). Technical Proceedings of the 2nd Pacific Ocean Remote Sensing Conference: PORSEC '94 (Melbourne, Vic: March 1-4, 1994)</i>
pp.153-160 16 refs, illus.
(Melbourne, Vic: Bureau of Meteorology Res. Centre)
<P>*Rustana, C.E., *Lynch, M.J. and <B>Prata, A.J.</b> (1994)
Development and validation of algorithms for land surface temperature measurement from NOAA-11/AVHRR satellite data.
<i>
In: Le Marshall, J  and Jasper, J D (eds.). Technical Proceedings of the 2nd Pacific Ocean Remote Sensing Conference: PORSEC '94 (Melbourne, Vic: March 1-4, 1994)</i>
pp.161-168 13 refs, illus.
(Melbourne, Vic: Bureau of Meteorology Res. Centre.)
<P><B>Ryan, B.F.</b> (1994)
Climate change and tropical cyclone activity.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.13): 79-83 3 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Ryan, B.F.</b> (1994)
Studies of precipitating layer clouds in Australia.
<i>
Report of International Workshop on Cloud-Radiation Interactions and their Parameterization in Climate Models (Camp Springs, MD, USA: October 18-20, 1993)</i>
pp.118-119 7 refs
<P><B>Ryan, B.F.</b> (1994)
The nature of precipitating layer clouds around the world [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P><B>Ryan, B.F.</b>, <B>Katzfey, J.J.</b> and <B>Turner, P.J.</b> (1994)
The validation of a mesoscale model cloud climatology using an observed AVHRR cloud climatology [abstract].
<i>
Abstracts of oral and poster sessions of the European Conference on the Global Energy and Water Cycle (London, UK: July 18-22, 1994)</i>
1p.
(London, UK: Royal Society)
<P>*Salinger, M.J., <B>Allan, R.J.</b>, *Bindoff, N., *Hannah, J., *Lavery, B., *Lin, Z., *Lindesay, J., *Nicholls, N., *Plummer, N. and *Torok, S. (1994)
Observed variability and change in climate and sea-level in Oceania [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
p.5
<P>*Sanhueza, E., <B>Fraser, P.J.</b> and *Zander, R.J. (1994)
Source gases: trends and budgets.
<i>
Scientific Assessment of Ozone Depletion: 1994. World Meteorological Organization, Global Ozone Research and Monitoring Project: Report</i>
(37): 2.1-2.38 221 refs, illus.
<P><B>Sawford, B.L.</b> and <B>Borgas, M.S.</b> (1994)
On the continuity of stochastic models for the Lagrangian velocity in turbulence.
<i>
Physica D</i>
76: 297-311 33 refs, illus.
<P><B>Smith, I.N.</b> (1994)
Drought.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.15): 91-95 2 refs, illus
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Smith, I.N.</b> (1994)
Assessments of categorical rainfall predictions.
<i>
Australian Meteorological Magazine</i>
43: 143-151 14 refs, illus.
<P><B>Smith, I.N.</b> (1994)
Significance of skill scores, EOFs and regression relationships [abstract].
<i>
In: 12th Australian Statistical Society Conference.  Program and Abstracts (Clayton, Vic: July 4-8, 1994)</i>
1p.
<P><B>Smith, I.N.</b> (1994)
Indian Ocean sea-surface temperature patterns and Australian winter rainfall.
<i>
International Journal of Climatology</i>
14: 287-305 23 refs, illus.
<P><B>Smith, I.N.</b> (1994)
A GCM simulation of global climate trends: 1950-1988.
<i>
Journal of Climate</i>
7(5): 732-744 35 refs, illus.
<P>*Stephens, A.J. and <B>Abbs, D.J.</b> (1994)
A high resolution simulation of the convective structure in a tropical cyclone [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.80
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Suppiah, R.</b> (1994)
The Asian monsoons: simulations from four GCMs and likely changes under enhanced greenhouse conditions.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.12): 73-78 6 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Suppiah, R.</b> (1994)
Synoptic aspects of wet and dry conditions in central Australia: observations and GCM simulations for 1{mult}CO<sub>2</sub> and 2{mult}CO<sub>2</sub> conditions.
<i>
Climate Dynamics</i>
10(8): 395-405 16 refs, illus.
<P><B>Syktus, J.I..</b>, <B>Gordon, H.B.</b> and *Chappell, J. (1994)
Sensitivity of a coupled atmosphere-dynamic upper ocean GCM to variations of CO<sub>2</sub>, solar constant, and orbital forcing.
<i>
Geophysical Research Letters</i>
21(15): 1599-1602 23 refs, illus.
<P>*Tomczak, M. and <B>Baines, P.G.</b> (Editors) (1994)
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). Abstracts. AMOS Publication.
(9): 100p.
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Trudinger, C.M.</b>, <B>Enting, I.G.</b> and <B>Francey, R.J.</b> (1994)
Estimation of CO<sub>2</sub> fluxes using a synthesis inversion technique [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.85
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Tucker, G.B.</b> (1994)
The sustainable development fallacy.
<i>
Proceedings of the Clean Air Society of Australia and New Zealand 12th International Conference and 6th Regional Conference of the International Union of Air Pollution Prevention and Environmental Protection Association (Perth, WA: October 23-28, 1994)</i>
pp.95-110 24 refs, illus.
<P>*Volz-Thomas, A., *Ridley, B.A., *Andreae, M.O., *Chameides, W.L., *Derwent, R.G., <B>Galbally, I.E.</b>, *Lelieveld, J., *Penkett, S.A., *Rodgers, M.O., *Trainer, M., *Vaughan, G. and *Zhou, X.J. (1994)
Tropospheric ozone.
<i>
Scientific Assessment of Ozone Depletion: 1994. World Meteorological Organization, Global Ozone Research and Monitoring Project: Report</i>
(37): 5.1-5.30 189 refs, illus.
<P><B>Walsh, K.J.E.</b> and <B>McGregor, J.L.</b> (1994)
The variability of a limited area climate model over Australia and the surrounding regions [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.89 3 refs, illus.
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P><B>Walsh, K.J.E.</b> (1994)
On the influence of the Andes on the general circulation of the Southern Hemisphere.
<i>
Journal of Climate</i>
7(6): 1019-1025 26 refs, illus.
<P><B>Wang, Y.</b> (1994)
Models for assessing the impact of climate change on forests.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.22): 133-136 7 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Waterman, L.J.</b> and McIntosh, P.C. (1994)
Vertical mixing in an Indian Ocean general circulation model [abstract].
<i>
Proceedings of the 1st National AMOS Conference: Incorporating 5th Air-Sea Interaction Conference (Adelaide, SA: February 14-16, 1994). AMOS Publication</i>
(9): p.91
(Melbourne, Vic: Australian Meteorological and Oceanographic Society)
<P>*Weiss, W., *Sartorius, H., *Levin, I. and <B>Francey, R.J.</b> (1994)
Atmospheric <sup>85</sup>Kr at Cape Grim.
<i>
In: Dick, A L and Gras, J L (eds.). Baseline Atmospheric Program (Australia) 1991</i>
p.85 3 refs
(Bureau of Meteorology/CSIRO Division of Atmospheric Research)
<P><B>Whetton, P.H.</b>, *Mullan, B. and <B>Pittock, A.B.</b> (1994)
Climate change scenarios for Australia and New Zealand [abstract].
<i>
Abstracts of the Australian-New Zealand Conference on Climate Change: "Greenhouse 94" (Wellington, NZ: October 10-14, 1994)</i>
pp.10-11
<P><B>Whetton, P.H.</b> (1994)
"El Ni{tilde}no: historical and paleoclimatic aspects of the Southern Oscillation" edited by H.F. Diaz and V. Markgraf, Cambridge University Press, 1992, 476p. [book review].
<i>
Australian Meteorological Magazine</i>
pp.214-215
<P><B>Whetton, P.H.</b> and *Rutherfurd, I. (1994)
Historical ENSO teleconnections in the eastern hemisphere.
<i>
Climatic Change</i>
28: 221-253 95 refs, illus.
<P><B>Whetton, P.H.</b> (1994)
Constructing climate scenarios: the practice.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.4): 21-27 3 refs, illus.
(Canberra, ACT: CSIRO Division of Water and Land Resources)
<P><B>Whetton, P.H.</b>, *Rayner, P.J., <B>Pittock, A.B.</b> and <B>Haylock, M.R.</b> (1994)
An assessment of possible climate change in the Australian region based on an intercomparison of general circulation modeling results.
<i>
Journal of Climate</i>
7(3): 441-463 42 refs, illus.
<P><B>Wilson, S.G.</b> and Desmarchelier, J.M. (1994)
Aeration according to seed wet-bulb temperature.
<i>
Journal of Stored Product Research</i>
30(1): 45-60 16 refs, illus.
<P>*Yu, Y. and <B>Barton, I.J.</b> (1994)
A non-regression-coefficients method of sea surface temperature retrieval from space.
<i>
International Journal of Remote Sensing</i>
15(6): 1189-1206 13 refs, illus.
<P>*Zavody, A.M., *Mutlow, C.T., *Llewellyn-Jones, D.T. and <B>Barton, I.J.</b> (1994)
Quantitative remote sensing in the 11{micr}m wavelength region using ATSR.
<i>
Proceedings of the 2nd ERS-1 Symposium on Space at the Service of our Environment (Hamburg, Germany: October 11-14, 1993)</i>
pp.829-833 8 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-12</DOCNO>
<DOCOLDNO>IA089-000952-B046-276</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FA1994.html 192.102.250.248 19970208040104 text/html 29523
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:48:25 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:13 GMT
Content-type: text/html
Content-length: 29339
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Forestry and Forest Products</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Forestry and Forest Products</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Balodis, V.</b> (1994)
Quality assurance in pulpwood testing: the sample.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 191-195 13 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>*Bauhus, J. and <B>Khanna, P.K.</b> (1994)
Carbon and nitrogen turnover in two acid forest soils of southeast Australia as affected by phosphorus addition and drying and rewetting cycles.
<i>
Biology and Fertility of Soils</i>
17: 212-218 33 refs, illus.
<P><B>Booth, T.H.</b>, <B>Jovanovic, T.</b> and *Yan Hong (1994)
Climatic analysis methods to assist choice of Australian species and provenances for frost-affected areas in China.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 26-31 12 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>Booth, T.H.</b> (1994)
Determining the climatic requirements of trees suitable for agroforestry.
<i>
Climatic Change</i>
27: 93-102 30 refs, illus.
<P><B>Booth, T.H.</b> (1994)
Forestry impacts.
<i>
In: Jakeman, A J and Pittock, A B (eds.). Climate impact assessment methods for Asia and the Pacific. Proceedings of a Regional Symposium (Canberra, ACT: March 10-12, 1993)</i>
(Ch.21): 129-131 4 refs, illus.
(Canberra, ACT: Australian Int. Dev. Assistance Bureau)
<P><B>Bougher, N.L.</b>, *Fuhrer, B.A. and *Horak, E. (1994)
Taxonomy and biogeography of Australian <i>Rozites</i> species mycorrhizal with <i>Nothofagus</i> and Myrtaceae.
<i>
Australian Systematic Botany</i>
7(4): 353-375 33 refs, illus.
<P><B>Bougher, N.L.</b> (1994)
Collection, isolation and identification of ectomycorrhizal fungi.
<i>
In: Brundrett, M, Melville, L and Peterson, L (eds.). Practical methods in mycorrhiza research</i>
(Ch.10): 81-87, illus.
(Ontario, Canada: Mycologue Publications)
[Based on a paper presented at a workshop of the 9th North American Conference on Mycorrhizae, University of Guelph, Ontario, Canada]
<P>Brooker, M.I.H. and <B>Kleinig, D.A.</b> (1994)
Field guide to eucalypts. Volume 3. Northern Australia.
3: 383p., refs, illus. ISBN 090960567X
(Sydney, NSW: Inkata Press)
<P><B>Brown, A.G.</b> (Editor) (1994)
Australian tree species research in China: proceedings of an International Workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings.
(48): 226p., refs, illus. ISBN 1863200959
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>*Burgess, T., *Dell, B. and <B>Malajczuk, N.</b> (1994)
Variation in mycorrhizal development and growth stimulation by 20 <i>Pisolithus</i> isolates inoculated on to <i>Eucalyptus grandis</i> W. Hill ex Maiden.
<i>
New Phytologist</i>
127: 731-739 27 refs, illus.
<P>*Butcher, P.A., <B>Doran, J.C.</b> and *Slee, M.U. (1994)
Intraspecific variation in leaf oils of <i>Melaleuca alternifolia</i> (Myrtaceae).
<i>
Biochemical Systematics and Ecology</i>
22(4): 419-430 49 refs, illus.
<P><B>Byrne, M.</b>, <B>Moran, G.F.</b> and <B>Murrell, J.C.</b> (1994)
Detection and inheritance of RFLPs in <i>Eucalyptus nitens</i>.
<i>
Theoretical and Applied Genetics</i>
89: 397-402 24 refs, illus.
<P>*Castellano, M.A. and <B>Bougher, N.L.</b> (1994)
Consideration of the taxonomy and biodiversity of Australian ectomycorrhizal fungi.
<i>
In: Robson, A D, Abbott, L K and Malajczuk, N (eds.). Proceedings of an International Symposium on Management of Mycorrhizas in Agriculture, Horticulture and Forestry (Perth, WA: September 28-October 2, 1992)</i>
pp.37-46 30 refs
(Dordrecht, The Netherlands: Kluwer Academic Publ.)
[Also published in: Plant and Soil, v.159, no.1, 1994.]
<P><B>Chafe, S.C.</b> (1994)
Relationships between shrinkage and specific gravity in the wood of <i>Eucalyptus</i>.
<i>
Australian Forestry</i>
57(2): 59-61 13 refs, illus.
<P><B>Clark, N.B.</b>, <B>Balodis, V.</b>, *Fang Guigan and *Wang Jingxia (1994)
Pulpwood potential of acacias.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, Fujian: November 2-5, 1992). ACIAR Proceedings</i>
(48): 196-202 14 refs
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>*Cole, S.P., *Woo, K.C., *Eamus, D., <B>Harwood, C.E.</b> and *Haines, M.W. (1994)
Field measurements of net photosynthesis and related parameters in four provenances of <i>Acacia auriculiformis</i>.
<i>
Australian Journal of Botany</i>
42(4): 457-470 25 refs, illus.
<P>*Comerford, N.B., <B>Smethurst, P.J.</b> and *Escamilla, J.A. (1994)
Nutrient uptake by woody root systems.
<i>
New Zealand Journal of Forestry Science</i>
24(2/3): 195-212 82 refs, illus.
<P><B>Cromer, R.N.</b> (1994)
Physiological attributes of eucalyptus strategies to increase productivity.
<i>
In: Santiago, B A, Jose, A P D, Carlos, A S (eds.). Actas Simposio Los Eucaliptos en el Desarrollo Forestal de Chile (Pucon, Chile: November, 24-26, 1993)</i>
pp.129-142 33 refs, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Waxed box technology still a winner.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.5, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Furniture to withstand extremes.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.3, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Plans for rayon pilot plant.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.6, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
New instrument will aid adhesives development.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.5
<P><b>CSIRO Division of Forest Products</b> (1994)
Program aids wood identification.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.2, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Vacuum drying of eucalypt wood.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.2, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Towards a Murray-Darling Basin forest products industry.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.1, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Wood-fibre tracks that last.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.5
<P><b>CSIRO Division of Forest Products</b> (1994)
Monitor helps tune veneer driers.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.3, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Wood preservatives: new Standard and protocols.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.3, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
A way to reduce wood damage during drying.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.5, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
CSIRO Division of Forest Products Report 1994-95.
<i>
Report. Division of Forest Products. CSIRO Australia</i>
(1994/95): 40p., illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Phone books for cats.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.1, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
New instrument helps wood protection studies.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.2
<P><b>CSIRO Division of Forest Products</b> (1994)
A termite test for the tropics.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.3
<P><b>CSIRO Division of Forest Products</b> (1994)
New life for Scrimber.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.2, illus.
<P><b>CSIRO Division of Forest Products</b> (1994)
Reducing pulp bleaching requirements.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.3, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Restoring and managing a degraded forest.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.4, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Judging log by looking inside.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.5, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Increasing pine productivity in the 'Green Triangle'.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.2, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Award for Australian Tree Seed Centre.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.1, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Increasing production in regrowth forests.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.3, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
A guide to trial design and analysis.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Summer): p.3, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Selecting trees for salt-affected land.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(79): p.7, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Breakthrough in genetic mapping.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.1, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Australian fungi on Chinese menus?.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.3, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Boosting tea tree oil production.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Winter): p.5, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Growing better trees in China - and Australia.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.4
<P><b>CSIRO Division of Forestry</b> (1994)
Understorey can restrict thinning benefits.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Spring): p.6, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
After the fires.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.2, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Endangered eucalypt with commercial prospects.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.6, illus.
<P><b>CSIRO Division of Forestry</b> (1994)
Colour clue to nitrogen loss.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.2
<P><b>CSIRO Division of Forestry</b> (1994)
Advanced breeding plan for <i>Pinus radiata</i>.
<i>
Onwood: Research Updates from the CSIRO Divisions of Forestry and Forest Products. CSIRO Australia</i>
(Autumn): p.4, illus.
<P>*Davis, J.S., *McKenny, D.W., *Turnbull, J.W. and <B>Searle, S.D.</b> (1994)
Impact of Australian tree species research in China: an update.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 9-18 16 refs
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>*Dell, B., <B>Malajczuk, N.</b>, <B>Bougher, N.L.</b> and *Thomson, G. (1994)
Development and function of <i>Pisolithus</i> and <i>Scleroderma</i> ectomycorrhizas formed in vivo with <i>Allocasuarina</i>, <i>Casuarina</i> and <i>Eucalyptus</i>.
<i>
Mycorrhiza</i>
5: 129-138 18 refs, illus.
<P>*Dell, B. and <B>Malajczuk, N.</b> (1994)
Boron deficiency in eucalypt plantations in China.
<i>
Canadian Journal of Forest Research</i>
24: 2409-2416 34 refs, illus.
<P><B>Devey, M.E.</b>, *Fiddler, T.A., *Liu, B-H., *Knapp, S.J. and *Neale, D.B. (1994)
An RFLP linkage map for loblolly pine based on a three-generation outbred pedigree.
<i>
Theoretical and Applied Genetics</i>
88: 273-278 18 refs, illus.
<P><B>Doran, J.C.</b> and *Bell, R.E. (1994)
Influence of non-genetic factors on yield of monoterpenes in leaf oils of <i>Eucalyptus camaldulensis</i>.
<i>
New Forests</i>
8: 363-379 14 refs, illus.
<P><B>Doran, J.C.</b> and <B>Williams, E.R.</b> (1994)
Fast-growing <i>Eucalyptus camaldulensis</i> clones for foliar-oil production in the tropics.
<i>
Commonwealth Forestry Review</i>
73(4): 261-266 18 refs, illus.
<P><B>Doran, J.C.</b> and <B>Gunn, B.V.W.</b> (1994)
Exploring the genetic resources or tropical melaleucas.
<i>
Forest Genetic Resources</i>
(22): 12-24 17 refs, illus.
<P><B>Doran, J.C.</b> and <B>Matheson, A.C.</b> (1994)
Genetic parameters and expected gains from selection for monoterpene yields in Petford <i>Eucalyptus camaldulensis</i>.
<i>
New Forests</i>
8: 155-167 14 refs, illus.
<P><B>Ellis, R.C.</b> (1994)
Long term effects of vegetation and soil of burning or not burning.
<i>
Australian Forest Grower</i>
17(2): 5p. 10 refs, illus.
<P>Gifford, R.M., <B>Cheney, N.P.</b>, Noble, J.C., Russell, J.S., *Wellington, A.B. and *Zammit, C. (1994)
Australian land use, primary production of vegetation and carbon pools in relation to atmospheric carbon dioxide concentration.
<i>
In: Gifford, R M and Barson, M M (eds.). Australia's renewable resources: sustainability and global change. Proceedings of the Australian-IGBP Planning Workshop (Canberra, ACT: October 3-4, 1990). Bureau of Rural Resources Proceedings</i>
(14): 151-187 107 refs, illus.
(Canberra, ACT: AGPS)
<P>*Goncalves, J.L.M. and <B>Carlyle, J.C.</b> (1994)
Modelling the influence of moisture and temperature on net nitrogen mineralization in a forested sandy soil.
<i>
Soil Biology and Biochemistry</i>
26(11): 1557-1564 31 refs, illus.
<P><B>Gould, J.S.</b> (1994)
Evaluation of McArthur's control burning guide in regrowth <i>Eucalyptus sieberi</i> forest.
<i>
Australian Forestry</i>
57(2): 86-93 20 refs, illus.
<P>*Grant, J.E., <B>Moran, G.F.</b> and <B>Moncur, M.W.</b> (1994)
Pollination studies and breeding system in <i>Acacia mearnsii</i>.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, Fujian: November 2-5, 1992). ACIAR Proceedings</i>
(48): 165-170 16 refs
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>Grove, T.S.</b> and <B>Malajczuk, N.</b> (1994)
The potential for management of ectomycorrhiza in forestry.
<i>
In: Robson, A D, Abbot, L K and Malazjczuk (eds.). Proceedings of an International Symposium on Management of Mycorrhizas in Agriculture, Horticulture and Forestry (Perth, WA: September 28-October 2, 1992)</i>
pp.201-210 55 refs, illus.
[Also published in:  Plant and Soil, v.159, no.1, 1994.]
<P>*Gu Renxia and <B>Yazaki, Y.</b> (1994)
Quality analyses of black wattle bark samples [appendix].
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 212-213, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>Harcourt, R.L., Southerton, S.G.., Xiaomei Zhu, <B>Hartney, V.J.</b>, Llewellyn, D.J., Olive, M.R., Peacock, W.J. and Dennis, E.S. (1994)
Genetic engineering for insect resistance in eucalypts.
<i>
In: Akhurst, R J (ed.). Proceedings of the 2nd Canberra #Bacillus thuringiensis# Meeting (Canberra, ACT: September, 1993)</i>
pp.85-93 17 refs ISBN 0643056157
(Canberra, ACT: CSIRO Division of Entomology)
<P><B>Harwood, C.E.</b> (1994)
Human food potential of the seeds of some Australian dry-zone <i>Acacia</i> species.
<i>
Journal of Arid Environments</i>
27: 27-35 30 refs, illus.
<P><B>Harwood, C.E.</b> (1994)
Appendix 6. Summary of progress made up to April 1994, subsequent to first printing.
<i>
In: House, A P N and Harwood, C E (eds.). Australian Dry-Zone Acacias for Human Food. Proceedings of a workshop (Glen Helen, NT: August 7-10, 1991)</i>
pp.146-151 9 refs
(Canberra, ACT: CSIRO Australia)
<P><B>House, A.P.N.</b> and <B>Bell, J.C.</b> (1994)
Isozyme variation and mating system in <i>Eucalyptus urophylla</i> S.T. Blake.
<i>
Silvae Genetica</i>
43(2/3): 167-176 45 refs, illus.
<P><B>Khanna, P.K.</b>, <B>Raison, R.J.</b> and <B>Falkiner, R.A.</b> (1994)
Chemical properties of ash derived from <i>Eucalyptus</i> litter and its effects on forest soils.
<i>
Forest Ecology and Management</i>
66: 107-125 18 refs, illus.
<P><B>Khanna, P.K.</b> (1994)
Evaluating various indices for measuring N and P status of forest stands with examples from pine and eucalypt sites.
<i>
Interciencia</i>
19(6): 366-373 39 refs, illus.
<P><B>Kile, G.A.</b> (1994)
A more serious debate needed on our forests.
<i>
The Age</i>
(Dec 29): 1p.
<P><B>Kile, G.A.</b> (1994)
Pathogen and pest threats to Chilean eucalypt plantations.
<i>
In: Santiago, B A, Jose, A P D and Carlos A S (eds.). Actas Simposio Los Eucaliptos en el Desarrollo Forestal de Chile (Pucon, Chile: November 24-26, 1993)</i>
pp.305-320 42 refs
(Santiago, Chile: Instituto Forestal Filial Corfo)
<P><B>Kirschbaum, M.U.F.</b>, *King, D.A., *Comins, H.N., *McMurtrie, R.E., *Medlyn, B.E., *Pongracic, S., *Murty, D., <B>Keith, H.</b>, <B>Raison, R.J.</b>, <B>Khanna, P.K.</b> and <B>Sheriff, D.W.</b> (1994)
Modelling forest response to increasing CO<sub>2</sub> concentration under nutrient-limited conditions.
<i>
Plant, Cell and Environment</i>
17: 1081-1099 105 refs, illus.
<P><B>Kirschbaum, M.U.F.</b> (1994)
The sensitivity of C<sub>3</sub> photosynthesis to increasing CO<sub>2</sub> concentration: a theoretical analysis of its dependence on temperature and background CO<sub>2</sub> concentration.
<i>
Plant, Cell and Environment</i>
17: 747-754 39 refs, illus.
<P><B>Malajczuk, N.</b>, <B>Grove, T.S.</b>, <B>Bougher, N.L.</b>, *Dell, B. and *Gong Mingqin (1994)
Ectomycorrhizas and nutrients: their importance to eucalypts in China.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 132-139 30 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>Malajczuk, N.</b>, Reddell, P. and *Brundrett, M. (1994)
Role of ectomycorrhizal fungi in minesite reclamation.
<i>
In: Pfleger, F L and Linderman, R G (eds.). Mycorrhizae and plant health</i>
pp.83-100 22 refs, illus.
(St Paul, MN, USA: APS Press)
<P><B>Marcar, N.E.</b>, <B>Crawford, D.F.</b>, <B>Leppert, P.M.</b> and *Nicholson, A. (1994)
Tree growth on saline land in southern Australia.
<i>
Proceedings of the 3rd National Workshop on Productive Use of Saline Lands (Echuca, Vic: March 15-17, 1994)</i>
pp.60-65 13 refs, illus.
<P>*Martin, F., <B>Tommerup, I.C.</b> and *Tagu, D. (1994)
Genetics of ectomycorrhizal fungi: progress and prospects.
<i>
Plant and Soil</i>
159: 159-170 52 refs, illus.
<P><B>Matheson, A.C.</b>, <B>Spencer, D.J.</b> and Magnussen, D. (1994)
Optimum age for selection in <i>Pinus radiata</i> using basal area under bark for age:age correlations.
<i>
Silvae Genetica</i>
43(5/6): 352-358 16 refs, illus.
<P><B>Moncur, M.W.</b>, *Rasmussen, G.F. and *Hasan, O. (1994)
Effect of paclobutrazol on flower-bud production in <i>Eucalyptus nitens</i> espalier seed orchards.
<i>
Canadian Journal of Forest Research</i>
24: 46-49 16 refs
<P><B>Moncur, M.W.</b> and *Hasan, O. (1994)
Floral induction in <i>Eucalyptus nitens</i>.
<i>
Tree Physiology</i>
14: 1303-1312 14 refs, illus.
<P><B>Nelson, P.J.</b> (1994)
Dioxin measurements in relation to the Australian pulp and paper industry.
<i>
Technical Report. National Pulp Mills Research Program. Institute of Natural Resources and Environment. CSIRO Australia</i>
(6): 30p. 21 refs, illus.
<P><B>O'Connell, A.M.</b> (1994)
Decomposition and nutrient content of litter in a fertilized eucalypt forest.
<i>
Biology and Fertility of Soils</i>
17: 159-166 29 refs, illus.
<P><B>Old, K.M.</b> (1994)
Session 1: Biology [conference summary].
<i>
Journal of the Royal Society of Western Australia</i>
77(4): p.101
[Summary from a Symposium on Plant Diseases in Ecosystems: Threats and impacts in south-western Australia (Murdoch, WA: April 16, 1994)]
<P><B>Pinyopusarerk, K.</b> (1994)
<i>Styrax tonkinensis</i>: taxonomy, ecology, silviculture and uses. ACIAR Technical Report.
(31): 14p. 23 refs, illus. ISBN 1863201300
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Raymond, C.A.</b>, <B>Balodis, V.</b> and *Dean, G.H. (1994)
Hot water extract and pulp yield in provenances of <i>Eucalyptus regnans</i>.
<i>
Appita Journal</i>
47(2): 159-162 13 refs
<P>*Romanya, J., <B>Khanna, P.K.</b> and <B>Raison, R.J.</b> (1994)
Effects of slash burning on soil phosphorus fractions and sorption and desorption of phosphorus.
<i>
Forest Ecology and Management</i>
65: 89-103 36 refs, illus.
<P><B>Searle, S.D.</b>, <B>Owen, J.V.</b> and <B>Snowdon, P.</b> (1994)
Frost tolerance variation amongst 25 provenances of <i>Acacia mearnsii</i>.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 140-148 21 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>Smith, D.N.</b> and <B>Devey, M.E.</b> (1994)
Occurrence and inheritance of microsatellites in <i>Pinus radiata</i>.
<i>
Genome</i>
37: 977-983 38 refs, illus.
<P><B>Thomson, B.D.</b>, <B>Malajczuk, N.</b>, <B>Grove, T.S.</b> and <B>Hardy, G.E.St.J.</b> (1994)
The spread and persistence of inoculant ectomycorrhizal fungi on <i>Eucalyptus globulus</i> outplanted on farm sites.
<i>
In: Pankhurst, C E (ed.). Soil biota: management in sustainable farming systems: poster papers</i>
p.45 ISBN 0643055983
(East Melbourne, Vic: CSIRO Information Services)
[Poster paper presented at a Workshop on Management of the Soil Biota in Sustainable Farming Systems (Adelaide, SA: March 15-16, 1994)]
<P><B>Thomson, B.D.</b>, <B>Grove, T.S.</b>, <B>Malajczuk, N.</b> and *Hardy, G.E.StJ. (1994)
The effectiveness of ectomycorrhizal fungi in increasing the growth of <i>Eucalyptus globulus</i> Labill. in relation to root colonization and hyphal development in soil.
<i>
New Phytologist</i>
126: 517-524 18 refs, illus.
<P><B>Thomson, L.A.J.</b> (1994)
<i>Acacia aulacocarpa</i>, <i>A. cincinnata</i>, <i>A. crassicarpa</i> and <i>A. wetarensis</i>: an annotated bibliography.
131p., illus. ISBN 0643057005
(East Melbourne, VIC: CSIRO Australia)
<P><B>Tommerup, I.C.</b>, <B>Bougher, N.L.</b>, <B>Malajczuk, N.</b>, <B>Grove, T.S.</b> and <B>Old, K.M.</b> (1994)
Australian ectomycorrhizal fungi: biodiversity, remnant vegetation and hardwood plantations on rural land.
<i>
In: Pankhurst, C E (ed.). Soil biota: management in sustainable farming systems: poster papers</i>
pp.145-146 8 refs ISBN 0643055983
(East Melbourne, Vic: CSIRO Information Services)
[Poster paper presented at a Workshop on Management of the Soil Biota in Sustainable Farming Systems (Adelaide, SA: March 15-16, 1994)]
<P><B>Turnbull, C.R.A.</b>, <B>Beadle, C.L.</b>, <B>West, P.W.</b> and <B>Ottenschlaeger, M.L.</b> (1994)
Effect of post-planting applications of granulated atrazine and fertiliser on the early growth of <i>Eucalyptus nitens</i>.
<i>
New Forests</i>
8: 323-333 29 refs, illus.
<P><B>Turnbull, C.R.A.</b>, <B>Beadle, C.L.</b>, <B>West, P.W.</b> and <B>Cromer, R.N.</b> (1994)
Copper deficiency a probable cause of stem deformity in fertilised <i>Eucalyptus nitens</i>.
<i>
Canadian Journal of Forest Research</i>
24: 1434-439 29 refs, illus.
<P>*Turvey, N.D. and <B>Smethurst, P.J.</b> (1994)
Soil types as classes for managing the nutrient status of planted <i>Pinus radiata</i> in Victoria, Australia.
<i>
Australian Forestry</i>
57(4): 148-156 27 refs, illus.
<P>*Turvey, N.D. and <B>Smethurst, P.J.</b> (1994)
Nutrient concentrations in foliage, litter and soil in relation to wood production of 7- to 15-year-old <i>Pinus radiata</i> in Victoria, Australia.
<i>
Australian Forestry</i>
57(4): 157-164 31 refs, illus.
<P>*Volker, P.W., <B>Owen, J.V.</b> and *Borralho, N.M.G. (1994)
Genetic variances and covariances for frost tolerance in <i>Eucalyptus globulus</i> and <i>E. nitens</i>.
<i>
Silvae Genetica</i>
43(5/6): 366-372 33 refs, illus.
<P><B>Wallis, A.F.A.</b> and <B>Wearne, R.H.</b> (1994)
Characterization of the high molar mass organic material in filtrates from bleaching eucalypt kraft pulps.
<i>
Appita Journal</i>
47(4): 309-314 34 refs, illus.
[Paper presented at 48th Annual General Conference of Appita, Melbourne, 1994.]
<P><B>Wallis, A.F.A.</b> (1994)
Characterisation of high molecular weight material in filtrates from bleaching eucalypt kraft pulps.
<i>
Technical Report. National Pulp Mills Research Program. Institute of Natural Resources and Environment. CSIRO Australia</i>
(4): 23p. 39 refs
<P><B>Wallis, A.F.A.</b>, <B>Smith, T.J..</b> and <B>Wearne, R.H.</b> (1994)
Characterisation of the major components (by mass) of selected effluent from bleaching eucalypt kraft pulp.
<i>
Technical Report. National Pulp Mills Research Program. Institute of Natural Resources and Environment. CSIRO Australia</i>
(9): 47p. 86 refs, illus. ISBN 0643056823
<P><B>White, D.A.</b>, <B>Beadle, C.L.</b>, <B>Honeysett, J.L.</b> and <B>Worledge, D.</b> (1994)
Stomatal conductance of <i>Eucalyptus globulus</i> and <i>E. nitens</i> in irrigated and rainfall plantations.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 56-63 16 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>White, D.A.</b> and <B>Kile, G.A.</b> (1994)
Breakdown of barrier zones and prediction of the spread of discolouration and decay resulting from stem wounds in <i>Eucalyptus regnans</i> and <i>E. obliqua</i>.
<i>
European Journal of Forest Pathology</i>
24: 71-78 14 refs, illus.
<P><B>White, D.A.</b>, <B>Beadle, C.L.</b>, <B>Honeysett, J.L.</b> and <B>Worledge, D.</b> (1994)
The effect of drought stress on height, diameter and leaf area index of <i>Eucalyptus globulus</i> and <i>E. nitens</i>.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 71-76 9 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P>Williams, E.R. and <B>Matheson, A.C.</b> (1994)
Experimental design and analysis for use in tree improvement.
174p., refs, illus. ISBN 064305555X
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Wimmer, S..</b> (1994)
Reef science.
<i>
Helix. Magazine of CSIRO's Double Helix Science Club</i>
(36): 16-18, illus.
<P>*Yang, H.A., *Zhou, J., *Sivasithamparam, K., <B>Tommerup, I.C.</b>, *Barton, J.E. and *O'Brien, P.A. (1994)
Genetic variability in pectic enzymes of <i>Rhizoctonia solani</i> isolates causing bare-patch disease of cereals.
<i>
Journal of Phytopathology</i>
141: 259-266 13 refs, illus.
<P><B>Yazaki, Y.</b>, *Gu Renxia, *Lin, Y. and *Chen, W. (1994)
A rapid analysis method for tannin content of black wattle (<i>Acacia mearnsii</i>) bark.
<i>
In: Brown, A G (ed.). Australian tree species research in China. Proceedings of an international workshop (Zhangzhou, China: November 2-5, 1992). ACIAR Proceedings</i>
(48): 218-224 13 refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-13</DOCNO>
<DOCOLDNO>IA089-000952-B048-305</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/IF1995.html 192.102.250.248 19970208040728 text/html 4105
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:54:51 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:25 GMT
Content-type: text/html
Content-length: 3922
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Information Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Information Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Adcock, W., *Brunger, M.J., *Clark, C.I., *McCarthy, I.E., *Weigold, E., <B>Michalewicz, M.T.</b>, Winkler, D.A. and *von Niessen, W. (1995)
Electron momentum spectroscopy of [1.1.1]propellane.
<i>
Chemical Physics Letters</i>
244: 433-439 18 refs, illus.
<P><B>Balbo, S.</b> (1995)
Task models and automation of the evaluation of user interface usability.
<i>
Proceedings of the OZCHI'95 Conference (Wollongong, NSW: November 27-30, 1995)</i>
2p. 13 refs, illus. ISBN 0864183860
(Downer, ACT: Ergonomics Society of Australia)
<P><B>Barrass, S.</b> and <B>Robertson, P.K.</b> (1995)
Navigating with sound using a perceptually linearized sound space.
<i>
Paper presented at IS&T/SPIE Symposium on Electronic Imaging: Science and Technology (San Jose, CA, USA: February, 1995)</i>
10p. 21 refs, illus.
<P><B>Barrass, S.</b> (1995)
Personify: a toolkit for perceptually meaningful sonification.
<i>
Paper presented at the Australian Computer Music Conference 95 (Parkville, VIC: June 9-11, 1995)</i>
12p. 12 refs, illus.
<P><B>Horn, M.E.T.</b> (1995)
Solution techniques for large regional partitioning problems.
<i>
Geographical Analysis</i>
27(3): 228-248 23 refs, illus.
<P><B>Jaktman, C.B.</b> (1995)
Software reuse: fact or fiction?.
<i>
Australian Computer Society Monthly Newsletter</i>
(Sept): 8p. 9 refs
<P><B>Kumar, V.R.</b> and <B>Lindley, C.A.</b> (1995)
Improving decision support through hypermedia.
<i>
In: Yfantis, E A (ed.). Intelligent Systems</i>
pp. 351-61  10 refs, illus.
(The Netherlands: Kluwer Academic Publishers)
<P><B>Lamb, P.R..</b> (1995)
Partitioned all-pairs shortest path matrices.
<i>
Technical Report. Division of Information Technology. CSIRO Australia</i>
(95/25): 14p. 7 refs, illus.
<P><B>Michalewicz, M.T.</b> (1995)
Rational nanoelectronic device design: a definition of another grand challenge problem.
<i>
Proceedings of the High Performance Computing: ASIA '95 Conference (Taiwan, 1995)</i>
7p.  22 refs, illus.
<P><B>Michalewicz, M.T.</b>, *McCarthy, I.E., *Brunger, M. and <B>Norling, V.M.</b> (1995)
Combining UniChem and electron momentum spectroscopy to study valence electronic structure of molecules.
<i>
Proceedings of the Fall 1995 Cray Users Group (AK, USA: 1995)</i>
pp. 37-41  22 refs, illus.
<P><B>Michalewicz, M.T.</b> and *Brown, R.W. (1995)
Computation of the local electronic density of states for all surface atoms in different microfacet models of <i>TiO<sub>2</sub></i>(100)1 {mult} 3.
<i>
High performance computing 1995. Grand challenges in computer simulation</i>
p. 101-624 refs, illus. ISBN 1565550781
<P>Power, W.L., <B>Lamb, P.R..</b> and Horowitz, F.G.. (1995)
From databases to visualisation: data transfer standards and data structures of 3D geological modelling.
<i>
Proceedings of the APCOM 25th 1995. Application of Computers and Operations Research in the Mineral Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 65-70 6 refs, illus. ISBN 1875776265
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Yap, K..</b> and <B>Simpson-Young, W.</b> (1995)
The BIOS trials on the Telstra experimental broadband network.
<i>
Paper presented at the Australian Telecommunications and Networking Applications Conference (Sydney, NSW: December, 1995)</i>
6p. 6 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-14</DOCNO>
<DOCOLDNO>IA089-000953-B002-1</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MF1994.html 192.102.250.248 19970208041109 text/html 6606
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:58:27 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:26 GMT
Content-type: text/html
Content-length: 6423
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Materials Science and Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Materials Science and Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Allen, L.J., *Josefsson, T.W. and <B>Rossouw, C.J.</b> (1994)
Interaction delocalization in characteristic x-ray emission from light elements.
<i>
Ultramicroscopy</i>
55: 258-267 34 refs, illus.
<P><B>Badwal, S.P.S.</b> (1994)
Ceramic superionic conductors.
<i>
In: Cahn, R W, Haasen, P and Kramer, E J (eds.). Materials Science and Technology: a comprehensive treatment</i>
(Ch.11): 567-633, refs, illus.
(Weinheim, Germany: VCH)
<P><B>Bastow, T.J.</b> (1994)
<sup>139</sup>La nuclear magnetic resonance characterisation of La<sub>2</sub>O<sub>3</sub> and La<sub>1-X</sub>Sr<sub>x</sub>MO<sub>3</sub> where M = Cr, Mn or Co.
<i>
Solid State Nucelar Magnetic Resonance</i>
3: 17-22 17 refs, illus.
<P><B>Bastow, T.J.</b>, Hall, J.S., *Smith, M.E. and *Steuernagel, S. (1994)
Characterisation of hydrated aluminas by MAS and DOR <sup>27</sup>A1 NMR.
<i>
Materials Letters</i>
18: 197-200 7 refs, illus.
<P><B>Bastow, T.J.</b> (1994)
Materials characterisation by nuclear quadrupole interaction.
<i>
Zeitschrift fuer Naturforschung. Series C</i>
49: 320-328 15 refs, illus.
<P><B>Bastow, T.J.</b>, *Hobday, M.E., <B>Smith, M.E.</b> and *Whitfield, H.J. (1994)
Structural characterisation of Na<sub>2</sub>ZrO<sub>3</sub>.
<i>
Solid State Nuclear Magnetic Resonance</i>
3: 49-57 23 refs, illus.
<P><B>Davis, T.J.</b> (1994)
A unified treatment of small-angle x-ray scattering, x-ray refraction and absorption using the Rytov approximation.
<i>
Acta Crystallographica. Series A</i>
50: 686-690 21 refs, illus.
<P><B>Davis, T.J.</b> (1994)
Dynamical X-ray diffraction from imperfect crystals: a solution based on the Fokker-Planck equation.
<i>
Acta Crystallographica. Series A</i>
50: 224-231 23 refs, illus.
<P><B>Doblin, C.</b>, *Mathews, J.F. and <B>Turney, T.W.</b> (1994)
Shape selective cracking of <i>n</i>-octane and 2,2,4-trimethylpentane over an alumina-pillared clay.
<i>
Catalysis Letters</i>
23: 151-160 22 refs, illus.
<P><B>Drennan, J.</b>, *Clarke, D.R., <B>Hannink, R.H.J.</b> and *Shaw, T.M. (1994)
Effect of oxygen partial pressure during sintering on the microstructure of Mg-PSZ with strontia and silica additions.
<i>
Journal of the American Ceramic Society</i>
77(8): 2001-2008 14 refs, illus.
<P><B>Hannink, R.H.J.</b> and Swain, M.V. (1994)
Progress in transformation toughening of ceramics.
<i>
Annual Review of Material Science</i>
24: 359-408 141 refs, illus.
<P><B>Hannink, R.H.J.</b>, *Howard, C.J., *Kisi, E.H. and Swain, M.V. (1994)
Relationship between fracture toughness and phase assemblage in Mg-PSZ.
<i>
Journal of the American Ceramic Society</i>
77(2): 571-579 38 refs, illus.
<P>*Hansen, S. and <B>Wilkins, S.W.</b> (1994)
On uncertainty in maximum-entropy maps and the generalization of 'classic MaxEnt'.
<i>
Acta Crystallographica. Series A</i>
50: 547-550 8 refs, illus.
<P><B>Hughes, A.E.</b>, <B>Ciacchi, F.T.</b> and <B>Badwal, S.P.S.</b> (1994)
Role of O<sup>2-</sup>, OH<sup>-</sup> and anion vacancies in the degradation of Y-TZP in moist environments.
<i>
Journal of Material Chemistry</i>
4(2): 257-263 43 refs, illus.
<P><B>Jaeger, H.K.</b> and <B>Behrsing, T.</b> (1994)
The dual nature of vapour-grown carbon fibres.
<i>
Composites Science and Technology</i>
51: 231-242 13 refs, illus.
<P><B>Kershaw, J.R.</b> and <B>Smart, P.J.</b> (1994)
Extraction of coal-tar pitch and the effect on carbonization.
<i>
Carbon</i>
32(1): 85-92 29 refs, illus.
<P>Kershaw, J.R. and <B>Smart, P.J.</b> (1994)
Supercritical fluid extraction of coal-tar pitch. Part 2. Extraction of the lower molecular weight species with aliphatic solvents.
<i>
Fuel Processing Technology</i>
38: 1-15 24 refs, illus.
<P>Maitra, A.M. and <B>Foger, K.</b> (1994)
Identification of solid solutions and other phases in strontium and barium catalysts containing oxides of magnesium, aluminum or silicon as additive. 2. Catalyst characterisation.
<i>
Applied Catalysis. Series A</i>
114: 83-107 23 refs, illus.
<P><B>Neal, G.S.</b>, *Smith, M.E., <B>Trigg, M.B.</b> and <B>Drennan, J.</b> (1994)
Solid-state NMR examination of the formation of {beta}-sialon by carbothermal reduction and nitridation of halloysite clay.
<i>
Journal of Materials Chemistry</i>
4(20): 245-251 28 refs, illus.
<P><B>O'Halloran, R.J.</b>, Pilkington, N.H. and <B>Sexton, B.A.</b> (1994)
Continuous monitoring of sewage and industrial effluents.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(1): 17-21 23 refs, illus.
<P><B>Rossouw, C.J.</b>, <B>Miller, P.R.</b>, *Josefsson, T.W. and *Allen, L.J. (1994)
Zone-axis back-scattered electron contrast for fast electrons.
<i>
Philosophical Magazine. Series A</i>
70(6): 985-998 24 refs, illus.
<P><B>Smith, M.E.</b>, <B>Trigg, M.B.</b>, <B>Drennan, J.</b> and <B>Neal, G.S.</b> (1994)
Characterisation by solid state NMR of the carbothermal reduction reaction to produce {beta}-sialon.
<i>
Transactions of the Materials Research Society of Japan</i>
14A: 547-552 28 refs, illus.
<P><B>Stevenson, A.W.</b> (1994)
Thermal vibrations and bonding in GaAs: an extended-face crystal study.
<i>
Acta Crystallographica. Series A</i>
50: 621-632 68 refs, illus.
<P><B>Stuart, S.N.</b> (1994)
Residual interactions of a quadrupolar nucleus subject to high magnetic field and magic-angle spinning.
<i>
Solid State Nuclear Magnetic Resonance</i>
3: 199-207 41 refs, illus.
<P>*Wannstrom, A., <B>Gough, D.S.</b> and <B>Hannaford, P.</b> (1994)
High resolution laser spectroscopy on yttrium ions in a sputtered vapour.
<i>
Zeitschrift fuer Physik. D</i>
29: 39-44 25 refs, illus.
<P>*Zipper, M.D. and <B>Hill, A.J.</b> (1994)
The application of positron annihilation lifetime spectroscopy to the study of glassy and partially crystalline materials.
<i>
Materials Forum</i>
18: 215-233 140 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-15</DOCNO>
<DOCOLDNO>IA089-000953-B001-18</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MT1995.html 192.102.250.248 19970208040937 text/html 15679
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:56:56 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:31 GMT
Content-type: text/html
Content-length: 15495
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Manufacturing Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Manufacturing Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Ahmed, N.U.</b>, <B>Jarvis, B.L.</b> and <B>Viano, D.M.</b> (1995)
High-current GTA welding: the benefits.
<i>
Australasian Welding Journal</i>
pp.14-16 7 refs, illus.
<P><B>Ahmed, N.U.</b>, <B>Viano, D.M.</b>, *Zhu, J. and *Bee, J.V. (1995)
Structure and properties of GTA weldments in AA5083 aluminium alloys.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA362): 3p., illus.
<P><B>Ahmed, N.U.</b>, <B>Jarvis, B.L.</b> and <B>Syrek, G.J.</b> (1995)
Development of equipment and technology for high current GTA welding.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA363): 12p. 8 refs, illus.
<P><B>Auty, G.W.</b>, <B>Corke, P.I.</b>, <B>Dunn, P.A.</b>, <B>Jensen, M.J.</b>, <B>MacIntyre, I.B.</b>, <B>Mills, D.C.</b>, <B>Nguyen, T.H.H.</b> and <B>Simons, B.F.</b> (1995)
An image acquisition system for traffic monitoring applications.
<i>
Proceedings of the International Society for Optical Engineering</i>
2416: 119-133 14 refs, illus.
[Paper presented at a Conference on Cameras and Systems for Electronic Photography and Scientific Imaging (San Jose, CA, USA: February 8-9, 1995)]
<P><B>Bemelman, R.</b> and <B>Jarvis, D.H.M.</b> (1995)
Manufacturing strategy assessment for enterprise integration.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA353): 18p. 10 refs, illus.
<P>*Bernus, P. and <B>Nemes, L.</b> (1995)
Enterprise integration: engineering tools for designing the business processes of enterprises.
<i>
Proceedings of the Australia-Taiwan Joint Workshop on Materials Processing Technology (Wollongong, NSW: June 26-27, 1995)</i>
pp.151-157 6 refs ISBN 1875618139
<P>Bernus, P. and <B>Nemes, L.</b> (1995)
A framework to define a generic enterprise reference architecture and methodology (GERAM).
<i>
Divisional Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTM366): 22p. 11 refs, illus.
<P><B>Calcraft, R.C.</b> (1995)
Review of "Aircraft" aluminium alloys for ship hull manufacture.
<i>
Divisional Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA347): 35p. 26 refs
<P>*Calder, P., <B>Jarvis, D.H.M.</b>, *Jarvis, J.H. and *Thomas, B.H. (1995)
A collaborative Gantt Chart Editor System.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA337): 21p. 20 refs, illus.
<P>*Campbell, G., <B>Rogers, K.J.</b> and Gibert, J. (1995)
PIRAT: a system for quantitative sewer assessment.
<i>
Paper for the 12th International Conference on Trenchless Technology for Pipeline & Cable Construction (Dresden, Germany: September 19-22, 1995)</i>
8p., illus.
<P><B>Cirocco, L.R.</b>, <B>Jarvis, D.H.M.</b>, *Jarvis, J.H. and *Ryan, A. (1995)
Simulation of a PLC-controlled vehicle assembly station.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA333): 25p. 6 refs, illus.
<P><b>CSIRO Division of Manufacturing Technology</b> (1995)
Light metals build bridges to the future.
<i>
Research Results. CSIRO Australia</i>
(3): 8-11, illus.
<P><b>CSIRO Division of Manufacturing Technology</b> (1995)
RPD builds your product: while you watch.
<i>
Research Results. CSIRO Australia</i>
(3): 49-52, illus.
<P><b>CSIRO Division of Manufacturing Technology</b> (1995)
CSIRO's eyes help ROBOSORTER make the grade.
<i>
Research Results. CSIRO Australia</i>
(3): 20-23, illus.
<P><B>Deam, R.T.</b>, <B>Dayal, A.R.</b>, <B>McAllister, T.</b>, <B>Mundy, A.E.</b>, <B>Western, R.J.</b>, Besley, L.M., Farmer, A.J.D., Horrigan, E.C. and Murphy, A.B. (1995)
Interconversion of chlorofluorocarbons in plasmas.
<i>
Journal of the Chemical Society. Chemical Communications</i>
(3): 347-348 15 refs, illus.
<P><B>Dunn, P.A.</b> (1995)
A configurable logic processor for machine vision.
<i>
In: Moore, W and Luk, W (eds.). Field-Programmable Logic and Applications. Proceedings of the 5th International Workshop (Oxford, UK: August 29-September 1, 1995). Lecture Notes in Computer Science 975</i>
pp.68-77 4 refs, illus. ISBN 3540602941
(Berlin, Germany: Springer-Verlag)
<P><B>French, I.E.</b>, <B>Tyagi, V.K.</b> and *Brooks, G. (1995)
The influence of power source characteristics on particulate fume generation and composition.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA360): 9p. 12 refs, illus.
<P><B>Gunasegaram, D.R.</b>, van der Touw, J.W. and <B>Nguyen, T.T.</b> (1995)
Heat transfer at metal-mould interfaces.
<i>
Proceedings of an International Conference on Casting & Solidification of Light Alloys (Gold Coast, QLD: August 30-31, 1995)</i>
pp.91-96 11 refs, illus. ISBN 0958812829
(Parkville, VIC: Institute of Metals and Materials Australasia)
<P><B>Gupta, S.K.</b> and *Grieveson, P. (1995)
Reduction behavior of ilmenite with carbon at 1240 &#176;C.
<i>
Metallurgical and Materials Transactions B</i>
26B: 401-403 17 refs, illus.
<P><B>Gupta, S.K.</b> (1995)
Viscosity of PbO-SiO<sub>2</sub> melts.
<i>
Metallurgical and Materials Transactions B</i>
26B: 281-287 22 refs, illus.
<P><B>Houghton, M.E.</b> (1995)
The effectiveness of non-destructive techniques for assessment of quality of plasma-sprayed coatings.
<i>
In: Strafford, K N, Smart, R St C, Sare, I and Subramanian C (eds.). Surface engineering: processes and applications</i>
(Ch.17): 313-330 40 refs, illus. ISBN 1566761549
(Basel, Switzerland Lancaster, PA: Technomic)
<P><B>Jarvis, B.L.</b>, <B>Viano, D.M.</b>, *Zhu, J.H., *Dunne, D. and <B>Ahmed, N.U.</b> (1995)
Final report for project no. 93.06. Division of Manufacturing Technology.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(365/1995): 94p., refs, illus.
<P><B>Jarvis, J.H.</b> and <B>Jarvis, D.H.M.</b> (1995)
Simulation of a PLC-controlled assembly line.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA369): 27p. 6 refs, illus.
<P><B>Johnson, R.C.</b> (1995)
A technical note on the bonding of ceramic insulators to copper contact tips used in narrow gap welding.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA360): 3p., illus.
<P><B>Lapovok, R.Y.</b> (1995)
A damage mechanics approach to fatigue fracture of tools in metal working processes.
<i>
In: Owen, D R J and Onate, E (eds.). Proceedings of the 4th International Conference on Computational Plasticity: Fundamentals and Applications (Barcelona, Spain: April 3-6, 1995)</i>
pp.1119-1130 20 refs, illus.
(Swansea, UK: Pineridge Press)
<P>*Li, Y., <B>Winstanley, G.J.</b>, <B>Corke, P.I.</b>, Hainsworth, D.W. and <B>Gurgenci, H.</b> (1995)
Dragline bucket location using machine vision.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 53-56 3 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>McAllister, T.</b> (1995)
Thermochemistry and kinetics of plasma waste destruction.
<i>
Proceedings of the 12th International Symposium on Plasma Chemistry (Minneapolis, MN, USA: August 21-25, 1995)</i>
pp.1027-1032 5 refs, illus. ISBN 1887976027
<P><B>McPherson, R.</b> (1995)
Plasma sprayed ceramic coatings.
<i>
In: Strafford, K N, Smart, R St C, Sare, I and Subramanian C (eds.). Surface engineering: processes and applications</i>
(Ch.1): 3-20 49 refs, illus. ISBN 1566761549
(Basel, Switzerland Lancaster, PA: Technomic)
<P><B>Murray, M.T.</b>, <B>Sequeira, W.P.</b> and *D'Allesandro, R. (1995)
Design of magnesium castings.
<i>
Proceedings of an International Conference on Casting & Solidification of Light Alloys (Gold Coast, QLD: August 30-31, 1995)</i>
pp.37-42 6 refs, illus. ISBN 0958812829
(Parkville, VIC: Institute of Metals and Materials Australasia)
<P><B>Murray, M.T.</b> (1995)
Simulation and modelling techniques in the production of high pressure diecastings.
<i>
Proceedings of the 1995 Workshop of the Joint Australia-Korea Workshop on Manufacturing Technology (Wollongong, NSW: November 20-21, 1995)</i>
pp.107-113 6 refs, illus. ISBN 1875618201
(Canberra, ACT: Australian Academy of Science)
<P><B>Murray, M.T.</b>, <B>D'Alessandro, R.P.</b> and *Sequeira, W.P. (1995)
Properties and design of castings in magnesium alloy AZ91D.
<i>
Transactions of the 18th International Die Casting Congress and Exposition (Indianapolis, Indiana: October 2-5, 1995)</i>
pp.191-196 6 refs, illus.
(Rosemont, IL, USA: North American Die Casting Association)
<P><B>Nguyen, T.T.</b> and <B>Ito, F.</b> (1995)
Simulation of mould filling in a cylinder head casting.
<i>
Proceedings of an International Conference on Casting & Solidification of Light Alloys (Gold Coast, QLD: August 30-31, 1995)</i>
pp.101-106 4 refs, illus. ISBN 0958812829
(Parkville, VIC: Institute of Metals and Materials Australasia)
<P><B>Painter, M.J.</b>, *Davies, M.H., *Smailes, A. and *Wahab, M.A. (1995)
The modelling of heat transfer, and weld pool phenomena in gas metal arc welding.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA373): 10p. 30 refs, illus.
[Paper presented at Manufacturing Technology Workshop (Adelaide, SA: November 20-21, 1995)]
<P><B>Powell, G.L.F.</b> and <B>Lloyd, P.G.</b> (1995)
Characterisation of an elongated gas pore in a weld in terms of solidification mechanics.
<i>
Praktische Metallographie</i>
32(1): 25-31 11 refs, illus.
<P><B>Ramakrishnan, S.</b>, <B>Rogozinski, M.W.</b>, <B>Sanders, N.A.</b> and <B>Couch, R.W.</b> (1995)
Nozzle clogging phenomenon in a plasma arc cutting torch.
<i>
Divisional Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTM390): 13p. 12 refs, illus.
<P><B>Ramakrishnan, S.</b> (1995)
Technological challenges in thermal plasma production.
<i>
Australian Journal of Physics</i>
48(3): 377-401 36 refs, illus.
<P><B>Ramakrishnan, S.</b> (1995)
Examples of advanced automation using non-intrusive sensing.
<i>
Proceedings of the 1995 Workshop on Australia-Taiwan Joint Workshop on Materials Processing Technology (Wollongong, NSW: June 26-27, 1995)</i>
pp.17-28 9 refs, illus. ISBN 1875618139
<P><B>Ramakrishnan, S.</b>, <B>Rogozinski, M.W.</b>, *Sanders, N.A. and *Couch, R.W. (1995)
Nozzle clogging phenomenon in a plasma arc cutting torch.
<i>
Proceedings of the 11th International Conference on Gas Discharges and their Applications (Tokyo, Japan: September 11-15, 1995)</i>
2: 268-271 12 refs, illus. ISBN 4886864996
(Tokyo: Institute of Electrical Engineers of Japan)
<P><B>Redden, G.R.</b> (1995)
Report on overseas visits: Germany, United Kingdom, Canada and The United States.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA383): 38p., illus, appendixes
<P><B>Rogozinski, M.W.</b> and <B>Ramakrishnan, S.</b> (1995)
Process monitoring and control in plasma arc cutting.
<i>
Proceedings of the 1995 Workshop of the Joint Australia-Korea Workshop on Manufacturing Technology (Wollongong, NSW: November 20-21, 1995)</i>
pp.75-81, illus. ISBN 1875618201
(Canberra, ACT: Australian Academy of Science)
<P><B>Sare, I.R.</b> and <B>Ramakrishnan, S.</b> (1995)
Manufacturing research and development in CSIRO.
<i>
Proceedings of the 1995 Workshop of the Joint Australia-Korea Workshop on Manufacturing Technology (Wollongong, NSW: November 20-21, 1995)</i>
13p., illus. ISBN 1875618201
(Canberra, ACT: Australian Academy of Science)
<P><B>Sare, I.R.</b> and <B>Arnold, B.K.</b> (1995)
The influence of heat treatment on the high-stress abrasion resistance and fracture toughness of alloy white cast irons.
<i>
Metallurgical and Materials Transactions A</i>
26A: 1785-1793 25 refs, illus.
<P><B>Sare, I.R.</b> and <B>Arnold, B.K.</b> (1995)
The effect of heat treatment on the gouging abrasion resistance of alloy white cast irons.
<i>
Metallurgical and Materials Transactions A</i>
26A: 357-370 40 refs, illus.
<P><B>Schaefer, H.</b> (1995)
Distributed control systems for existing PLC controlled discrete manufacturing systems: a preliminary study.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA363): 51p. 7 refs, illus.
<P><B>Syrek, G.J.</b> (1995)
Determination of resistance spot welding joint characteristics by on-line analysis of resistance of the joint.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA356): 6p. 8 refs, illus.
<P><B>Syrek, G.J.</b> (1995)
Determination of resistance spot welding joint characteristics by on-line analysis of resistance of the joint.
<i>
Proceedings of an International Conference on Materials in Welding and Joining (Adelaide, SA: August 23-24, 1995)</i>
pp.121-126 8 refs, illus.
(Melbourne, VIC: Inst. of Metals and Materials Australasia/Welding Technology Inst. of Australia)
<P><B>Syrek, G.J.</b> and <B>Dick, I.R.</b> (1995)
A literature review of electromagnetic compatibility in welding systems and power converters.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA345): 24p. 53 refs
<P><B>Tharumarajah, A.</b>, <B>Wells, A.J.</b> and *Wirth, A. (1995)
Scheduling in distributed production systems.
<i>
Proceedings of the 6th International Conference on Manufacturing Engineering (Melbourne, VIC: November 29-December 1, 1995)</i>
1: 87-93 15 refs, illus. ISBN 0858256339
(Barton, ACT: Institution of Engineers, Australia)
<P><B>Tharumarajah, A.</b>, <B>Wells, A.J.</b> and *Couchman, P. (1995)
Designing team-based cellular assembly systems.
<i>
Proceedings of the 6th International Conference on Manufacturing Engineering (Melbourne, VIC: November 29-December 1, 1995)</i>
2: 769-774 1 ref, illus. ISBN 0858256339
(Barton, ACT: Institution of Engineers, Australia)
<P><B>Thorpe, W.R.</b> (1995)
Comparison of die casting processes.
<i>
Proceedings of an International Conference on Casting & Solidification of Light Alloys (Gold Coast, QLD: August 30-31, 1995)</i>
pp.133-137 10 refs ISBN 0958812829
(Parkville, VIC: Institute of Metals and Materials Australasia)
<P>*Venkatesan, K., *Subramanian, C. and <B>Summerville, E.</b> (1995)
Hot forging dies: failure mechanisms and surface engineering.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA395): 4p. 17 refs, illus.
[IMMA Conference '96, Materials Research, Qld - July 1996]
<P><B>Western, R.J.</b>, Vit, I.A. and <B>McAllister, T.</b> (1995)
Plasma destruction of PCB waste.
<i>
In: Dundas, D and Salter-Duke, B (eds.). Proceedings of the 4th Environmental Chemistry Conference (Darwin, NT: July 9-14, 1995)</i>
pp.13.1-13.3 3 refs ISBN 0909589836
<P>*Wong, Y.C., *Doyle, E.D., <B>Gane, N.</b> and *Dearnley, P.A. (1995)
<i>In-situ</i> duplex plasma treatments for hardened and tempered alloy steels.
<i>
Proceedings of the IPENZ Annual Conference "Innovative Technology" (Palmerston North, NZ: February 10-14, 1995)</i>
pp.255-260  21 refs, illus.
(Wellington, NZ: Institution of Professional Engineers New Zealand)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-16</DOCNO>
<DOCOLDNO>IA089-000952-B046-4</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FX1994.html 192.102.250.248 19970208035846 text/html 17673
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:45:58 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:19 GMT
Content-type: text/html
Content-length: 17489
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Food Science and Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Food Science and Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>Best, D.J., <B>Graham, D.</b> and *Rayner, J.C.W. (1994)
Estimating correlation from categorized bivariate normal data.
<i>
Journal of Statistical Computation and Simulation</i>
49: 141-149 15 refs
<P><B>Buhot, J.W.</b> (1994)
Advances in the automation of beef cattle slaughter.
<i>
Proceedings of the Conference on Food Processing Automation III (Orlando, FL, USA: February 9-12, 1994)</i>
5p.
(St Joseph, MI, USA: ASAE)
<P><B>Chandry, P.S.</b>, <B>Moore, S.C.</b>, *Davidson, B.E. and <B>Hillier, A.J.</b> (1994)
Analysis of the <i>cos</i> region of the <i>Lactococcus lactis</i> bacteriophage sk1.
<i>
Gene</i>
138: 123-126 18 refs, illus.
<P><B>Christian, J.H.B.</b> (1994)
Problems with HACCP.
<i>
Food Australia</i>
46(2): 81-83 4 refs
[Paper presented at the Food Industry Conference: FOODPRO (Sydney, NSW: July, 1993)]
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Active packaging.
<i>
Division of Food Science and Technology [miscellaneous publication]. CSIRO Australia</i>
4p.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Migration from packaging materials.
<i>
Division of Food Science and Technology [miscellaneous publication]. CSIRO Australia</i>
3p.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
The use of food additives in Australia.
<i>
Division of Food Science and Technology [miscellaneous publication]. CSIRO Australia</i>
3p.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Where has all the lead gone?.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(25): p.2
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
The unknowns of irritation.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(25): p.3, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Yoghurt: a treat for ulcer patients.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(80): p.5, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
A juicy story about adulteration.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(26): 1,3, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Processing power.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(25): p.1, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Whey proteins to enter lucrative new market.
<i>
DRL News. Newsletter of the CSIRO Dairy Research Laboratory. CSIRO Australia. Published in: Australian Dairy Foods</i>
(April): p.61, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Fungal spoilage of high-fat foods.
<i>
DRL News. Newsletter of the CSIRO Dairy Research Laboratory. CSIRO Australia. Published in: Australian Dairy Foods</i>
(April): 60-61
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
From WPC to WPF at UMT.
<i>
DRL News. Newsletter of the CSIRO Dairy Research Laboratory. CSIRO Australia. Published in: Australian Dairy Foods</i>
(Feb): p.52, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Preservation of vegetables in oil and vinegar.
<i>
Division of Food Science and Technology [miscellaneous publication]. CSIRO Australia</i>
2p., illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Fututech automated meat processing systems: set to save Australian beef industry millions.
<i>
Meat Researcher. CSIRO Meat Research Laboratory (Division of Food Science and Technology) and Meat Research Corporation</i>
1(4): 3-4, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Camembert quality is under control at SC&W.
<i>
DRL News. Newsletter of the CSIRO Dairy Research Laboratory. CSIRO Australia. Published in: Australian Dairy Foods</i>
(Feb): p.53, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Definition of protein an important issue.
<i>
DRL News. Newsletter of the CSIRO Dairy Research Laboratory. CSIRO Australia. Published in: Australian Dairy Foods</i>
(Feb): p.53
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Snow shoot to the target market.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(27): p.2 7 refs
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Musty freight containers: a long term problem.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(27): 1-2, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Rib deboner goes on show.
<i>
Meat Researcher. CSIRO Meat Research Laboratory (Division of Food Science and Technology) and Meat Research Corporation</i>
2(1): p.1, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Packaging that debitters.
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(27): p.3, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
In future you could see "freshness".
<i>
Food Research News. Division of Food Science & Technology. CSIRO Australia</i>
(27): p.4
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Fututech update.
<i>
Meat Researcher. CSIRO Meat Research Laboratory (Division of Food Science and Technology) and Meat Research Corporation</i>
2(1): p.4, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
The safety of microwave ovens.
<i>
Division of Food Science and Technology [miscellaneous publication]. CSIRO Australia</i>
3p.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
Retail-ready packaging technology now available.
<i>
Meat Researcher. CSIRO Meat Research Laboratory (Division of Food Science and Technology) and Meat Research Corporation</i>
2(1): p.7, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1994)
New project aims to improve appeal & shelf life.
<i>
Meat Researcher. CSIRO Meat Research Laboratory (Division of Food Science and Technology) and Meat Research Corporation</i>
2(1): p.16
<P>*Curtain, C.C., <B>Separovic, F.</b>, Rivett, D.E., Kirkpatrick, A., *Waring, A.J., *Gordon, L.M. and *Azad, A.A. (1994)
Fusogenic activity of amino-terminal region of HIV Type 1 Nef protein.
<i>
AIDS Research and Human Retroviruses</i>
10(10): 1231-1240 53 refs, illus.
<P><B>Dyer, S.K.</b> and <B>McCammon, S.A.</b> (1994)
Detection of toxigenic isolates of <i>Aspergillus flavus</i> and related species on coconut cream agar.
<i>
Journal of Applied Bacteriology</i>
76: 75-78 26 refs
<P><B>Eyles, M.J.</b> (1994)
Recent evolution of quality systems.
<i>
Australian Dairy Industry Yearbook</i>
pp.107-110, illus.
<P><B>Eyles, M.J.</b> (1994)
Australian perspective on <i>Listeria monocytogenes</i>.
<i>
Dairy, Food and Environmental Sanitation</i>
14(4): 205-206,208-209 10 refs, illus.
[Paper presented at: IAMFES 80th Annual Meeting (Atlanta, GA, USA: August 2, 1993)]
<P><B>Eyles, M.J.</b> (1994)
Microbial concerns of the Pacific Rim countries and implications for harmonizing free trade.
<i>
Dairy, Food and Environmental Sanitation</i>
14(8): 467-470 9 refs
[Paper presented at the 80th IAMFES Annual Meeting in the Microbial Concerns of the International Community Symposium (Atlanta, GA, USA: August 3, 1993)]
<P>*Fayle, D. and <B>Playne, M.J.</b> (1994)
Biotechnology in Australia in 1993.
<i>
Australasian Biotechnology</i>
4(6): 325-332 5 refs, illus.
<P>Greve, J.V.S., <B>Hocking, A.D.</b> and <B>Sharp, A.K.</b> (1994)
Traditional storage of pandanus nuts in the Papua New Guinea highlands.
<i>
In: Highley, E, Wright, E J, Banks, H J and Champ, B R (eds.). Proceedings of the 6th International Working Conference on Stored-product protection (Canberra, ACT: April 17-23, 1994)</i>
pp.1068-1074 24 refs, illus.
(Wallingford, Oxon, UK: CAB International)
<P><B>Gutzke, D.A.</b>, <B>Trout, G.R.</b>, *D'Arcy, B.R. and <B>Powell, V.H.</b> (1994)
The colour stability of common retail cuts from beef, lamb, pork and venison [abstract].
<i>
Program and Abstract Book of the 27th Annual Convention of the Australian Institute of Food Science & Technology (Canberra, ACT: May 9-13, 1994)</i>
p.A25
<P><B>Hillier, A.J.</b> and *Davidson, B.E. (1994)
The use of pulsed field gel electrophoresis for microbial strain identification.
<i>
Australasian Biotechnology</i>
4(3): 167-168
<P><B>Hocking, A.D.</b>, <B>Charley, N.J.</b> and <B>Pitt, J.I.</b> (Editors) (1994)
FRR Culture Collection catalogue.
1st ed.: 73p.
<P><B>Hocking, A.D.</b> (1994)
Fungal spoilage of high-fat foods.
<i>
Food Australia</i>
46(1): 30-33 21 refs
[Paper presented at the AIFST Convention, 1993]
<P><B>Hocking, A.D.</b>, <B>Miscamble, B.F.</b> and <B>Pitt, J.I.</b> (1994)
Water relations of <i>Alternaria alternata</i>, <i>Cladosporium cladosporioides</i>, <i>Cladosporium sphaerospermum</i>, <i>Curvularia lunata</i> and <i>Curvularia pallescens</i>.
<i>
Mycological Research</i>
98(1): 91-94 22 refs, illus.
<P><B>Holland, R.V.</b> (1994)
"Physical chemistry of food processes" by Baianu, I C with H Pessen and T F Kumosinski (vol.2) AVI/Van Nostrand Reinhold, 1992. 622p. [book review].
<i>
Food Australia</i>
46(3): p.140
<P>*Holmes, G.J., *Eckert, J.W. and <B>Pitt, J.I.</b> (1994)
Revised description of <i>Penicillium ulaiense</i> and its role as a pathogen of citrus fruits.
<i>
Phytopathology</i>
84(7): 719-727 31 refs, illus.
<P><B>Horwood, J.F.</b>, <B>Shanley, R.M.</b> and <B>Sutherland, B.J.</b> (1994)
Chemistry of cheese curd slurries: effect of oxygen on flavour and fatty acid production.
<i>
Australian Journal of Dairy Technology</i>
49(2): 63-69 46 refs, illus.
<P><B>Jameson, G.W.</b> (1994)
Environmental aspects of dairy manufacturing [abstract].
<i>
Paper presented to a panel discussion at CSIRO-UNIDO Conference on Economic Growth with Clean Production (Melbourne, Vic: February 7-10, 1994)</i>
1p.
<P><B>Jameson, G.W.</b> (1994)
CSIRO Dairy Research Laboratory.
<i>
Australasian Biotechnology</i>
4(1): 34-36, illus.
<P><B>Kneale, C.R.</b>, <B>Hood, R.L.</b> and <B>Oakenfull, D.G.</b> (1994)
Potential of grain amaranth as a nutrient for the Australian food industry.
<i>
Proceedings of the Nutrition Society of Australia</i>
18: p.170
<P><B>Kuypers, R.</b>, *Tyler, M., <B>Kurth, L.B.</b> and <B>Horgan, D.J.</b> (1994)
The molecular location of ehrlich chromogen and pyridinoline cross-links in bovine perimysial collagen.
<i>
Meat Science</i>
37: 67-89 28 refs, illus.
<P>*Laing, D.G., <B>Eddy, A.I.</b> and Best, D.J. (1994)
Perceptual characteristics of binary, trinary, and quaternary odor mixtures consisting of unpleasant constituents.
<i>
Physiology and Behavior</i>
56(1): 81-93 10 refs, illus.
<P>*Laing, D.G., <B>Prescott, J.</b>, <B>Bell, G.A.</b>, <B>Gillmore, R.P.</b>, <B>Allen, S.A.</b>, Best, D.J., *Yoshida, M., *Yamazaki, K. and *Ishii, R. (1994)
Responses of Japanese and Australians to sweetness in the context of different foods.
<i>
Journal of Sensory Studies</i>
9: 131-155 8 refs, illus.
<P>*Matsuo, T., <B>Graham, D.</b>, <B>Patterson, B.D.</b> and Hockley, D.G. (1994)
An electrophoretic method to detect cold-induced dissociation of proteins in crude extracts of higher plants.
<i>
Analytical Biochemistry</i>
123: 181-184 13 refs, illus.
<P><B>Mayes, J.J.</b>, <B>Urbach, G.E.</b> and <B>Sutherland, B.J.</b> (1994)
Does addition of buttermilk affect the organoleptic properties of low-fat Cheddar cheese?.
<i>
Australian Journal of Dairy Technology</i>
49: 39-41 8 refs
<P>*Mottram, D.S. and <B>Whitfield, F.B.</b> (1994)
Aroma volatiles from meatlike Maillard systems.
<i>
In: Parliment, T H, Morello, M J and McGorrin, R J (eds.). Thermally generated flavors: Maillard, microwave, and extrusion processes. Proceedings of a Symposium at the 204th National Meeting of the American Chemical Society (Washington, DC, USA: August 23-28, 1992). ACS Symposium Series 543</i>
(Ch.14): 180-191 29 refs, illus.
<P><B>Muller, L.L.</b> (1994)
Growth in dairy product exports.
<i>
Food Australia</i>
46(9): 399-404, illus.
<P>Osman, P.D. and <B>Cornell, B.A.</b> (1994)
The effect of pulsed electric fields on the phosphorus-31 spectra of lipid bilayers.
<i>
Biochimica et Biophysica Acta</i>
1195: 197-204 36 refs, illus.
<P><B>Pitt, J.I.</b>, <B>Hocking, A.D.</b>, *Bhudhasamai, K., <B>Miscamble, B.F.</b>, <B>Wheeler, K.A.</b> and *Tanboon-Ek, P. (1994)
The normal mycoflora of commodities from Thailand. 2. Beans, rice, small grains and other commodities.
<i>
International Journal of Food Microbiology</i>
23: 35-53 10 refs
<P><B>Pitt, J.I.</b> (1994)
Fungi from Indonesian dried fish.
<i>
In: Champ, B R and Highley, E (eds.). Proceedings of an International Workshop on Fish drying in Indonesia (Jakarta, Indonesia: February 9-10, 1994). ACIAR Proceedings</i>
(59): 89-96 12 refs, illus. ISBN 1863201440
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Pitt, J.I.</b> (1994)
The current role of <i>Aspergillus</i> and <i>Penicillium</i> in human and animal health.
<i>
Journal of Medical and Veterinary Mycology</i>
32(Supp.1): 17-32 75 refs
<P><B>Playne, M.J.</b> (1994)
Prospects and problems of the new biotechnologies in the dairy industry.
<i>
Australasian Biotechnology</i>
4(1): 10-14, illus.
[Paper presented at the DIAA Annual Meeting (Melbourne, Vic: April, 2, 1993)]
<P>*Powell, I.B., *Romano, G.M., <B>Hillier, A.J.</b> and *Davidson, B.E. (1994)
Genetic enhancement of phage resistance in a commercial cheese starter.
<i>
Australian Journal of Dairy Technology</i>
49: 30-33 25 refs
<P><B>Prescott, J.</b> (1994)
The hot topic in food flavours.
<i>
Food Australia</i>
46(2): 74-77 21 refs, illus.
[Paper presented at the AIFST Convention, 1993]
<P><B>Richardson, K.C.</b> (1994)
Microbiological safety of chilled foods.
<i>
Food Australia</i>
46(6): 277-278
<P><B>Separovic, F.</b>, *Gehrmann, J., *Milne, T., <B>Cornell, B.A.</b>, *Lin, S.Y. and *Smith, R. (1994)
Sodium ion binding in the gramicidin A channel, solid-state NMR studies of the tryptophan residues.
<i>
Biophysical Journal</i>
67: 1495-1500 30 refs, illus.
<P><B>Shorthose, W.R.</b> (1994)
Mechanical methods to determine the tenderness of cooked meat.
<i>
Paper presented at the OECD Workshop on Mechanical Evaluation of Tenderness (Kulmbach, Germany: February 21-22, 1994)</i>
11p. 7 refs, illus.
<P>*Smith, R., <B>Separovic, F.</b>, *Milne, T.J., *Whittaker, A., *Bennett, F.M., <B>Cornell, B.A.</b> and *Makriyannis, A. (1994)
Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers.
<i>
Journal of Molecular Biology</i>
241: 456-466 55 refs, illus.
<P><B>Stevenson, R.J.</b> and <B>Prescott, J.</b> (1994)
The effects of prior experience with capsaicin on ratings of its burn.
<i>
Chemical Senses</i>
19(6): 651-656 23 refs, illus.
<P><B>Torley, P.J.</b>, <B>Trout, G.R.</b> and *D'Arcy, B. (1994)
The use of processing conditions to improve the functional properties of PSE pork [abstract].
<i>
Program and Abstract Book of the 27th Annual Convention of the Australian Institute of Food Science and Technology (Canberra, ACT: May 9-13, 1994)</i>
p.A26
<P><B>Trout, G.R.</b> and *Chen, C.M. (1994)
Improving the colour stability of frozen restructured beef steaks prepared with a calcium alginate binder [abstract].
<i>
Program and Abstract Book of the 27th Annual Convention of the Australian Institute of Food Science & Technology (Canberra, ACT: May 9-13, 1994)</i>
p.A26
<P><B>Urbach, G.E.</b> and *Gordon, M.H. (1994)
Flavours derived from fats.
<i>
In: Moran, D P J and Rajah, K K (eds.). Fats in food products</i>
(Ch.10): 347-405 208 refs, illus.
(London, UK: Blackie Academic & Professional)
<P><B>Whitfield, F.B.</b>, <B>Shaw, K.J.</b>, <B>Lambert, D.E.</b>, <B>Ford, G.L.</b>, <B>Svoronos, D.</b> and <B>Hill, J.L.</b> (1994)
Freight containers: major sources of chloroanisoles and chlorophenols in foodstuffs.
<i>
In: Maarse, H and van der Heij, D G (eds.). Trends in flavour research</i>
pp.401-407 5 refs
<P><B>Whitfield, F.B.</b>, <B>Shaw, K.J.</b> and <B>Svoronos, D.</b> (1994)
Effect of the natural environment on the flavour of seafoods: the flavour of <i>Girella tricuspidata</i>.
<i>
In: Maaarse, H and van der Heij, D G (eds.). Trends in flavour research</i>
pp.417-419
(The Netherlands: Elsevier Science)
<P><B>Whitfield, F.B.</b> (1994)
Pitfalls of export in freight containers.
<i>
Food Australia</i>
46(9): 419-423 30 refs
<P>*Xu, Y., *Hourigan, J., <B>Sleigh, R.W.</b> and <B>Johnson, R.L.</b> (1994)
Chinese dairy industry takes a higher profile.
<i>
Australian Dairy Foods</i>
(Feb): 19-23 14 refs, illus.
<P><B>Yang, A.</b>, <B>Trout, G.R.</b>, *Keeton, J.T. and <B>Shay, B.W.J.</b> (1994)
Evaluation of fat substitutes in low-fat frankfurters [abstract].
<i>
Program and Abstract Book of the 27th Annual Convention of the Australian Institute of Food Science and Technology (Canberra, ACT: May 9-13, 1994)</i>
p.A26<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-17</DOCNO>
<DOCOLDNO>IA057-000941-B011-96</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/WY1995.html 192.102.250.248 19970208044625 text/html 67761
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:33:36 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:52 GMT
Content-type: text/html
Content-length: 67577
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Wildlife and Ecology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Wildlife and Ecology</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abensperg-Traun, M.</b> and <B>Steven, D.E.</b> (1995)
The effects of pitfall trap diameter on ant species richness (Hymenoptera: Formicidae) and species composition of the catch in a semi-arid eucalypt woodland.
<i>
Australian Journal of Ecology</i>
20(2): 282-287 33 refs, illus.
<P><B>Andersen, A.N.</b> (1995)
Palaeontology, adaptation and community ecology: a response to Walter and Paterson (1994).
<i>
Australian Journal of Ecology</i>
20: 458-462 51 refs
<P><B>Andersen, A.N.</b> (1995)
Measuring more of biodiversity: genus richness as a surrogate for species richness in Australian ant faunas.
<i>
Biological Conservation</i>
73: 39-43 22 refs, illus.
<P><B>Andersen, A.N.</b> (1995)
A classification of Australian ant communities, based on functional groups which parallel plant life-forms in relation to stress and disturbance.
<i>
Journal of Biogeography</i>
22: 15-29 76 refs, illus.
<P><B>Arnold, G.W.</b> (1995)
Incorporating landscape pattern into conservation programs.
<i>
In: Hansson, L, Fahrig, L and Merriam, G (eds.). Mosaic landscapes and ecological processes</i>
(Ch.13): 309-337 53 refs, illus. ISBN 0412454602
(London: Chapman & Hall)
<P><B>Arnold, G.W.</b>, <B>Weeldenburg, J.R.</b> and *Ng, V.M. (1995)
Factors affecting the distribution and abundance of Western grey kangaroos (<i>Macropus fuliginosus</i>) and euros (<i>M. robustus</i>) in a fragmented landscape.
<i>
Landscape Ecology</i>
10(2): 65-74 23 refs, illus.
<P>*Artois, M. and <B>Bradley, M.P.</b> (1995)
Un vaccin contre les renards.
<i>
La Recherche</i>
(281): 40-41 6 refs, illus.
<P><B>Atkins, L.J.</b> and <B>Hobbs, R.J.</b> (1995)
Measurement and effects of fire heterogeneity in south-west Australian wheatbelt vegetation.
<i>
CALMScience. Supplement</i>
4: 67-76 14 refs, illus.
<P><B>Atkins, L.J.</b> and <B>Hobbs, R.J.</b> (1995)
Communicating research: how well are we actually doing?.
<i>
In: Saunders, D A, Craig, J L, and Mattiske, E M (eds.). Nature Conservation 4: the role of networks</i>
Ch. 79: pp. 649-52  8 refs, illus.
(Sydney, NSW: Surrey Beatty & Sons)
<P><B>Bastin, G.N.</b>, <B>Pickup, G.</b> and <B>Pearce, G.</b> (1995)
Utility of AVHRR data for land degradation assessment: a case study.
<i>
International Journal of Remote Sensing</i>
16(4): 651-672 51 refs, illus.
<P><B>Beaton, S.</b>, <B>Ten Have, J.F.</b>, <B>Cleary, A.J.</b> and <B>Bradley, M.P.</b> (1995)
Cloning and partial characterization of the cDNA encoding the fox sperm protein FSA-Acr.1 with similarities to the SP-10 antigen.
<i>
Molecular Reproduction and Development</i>
40: 242-252 17 refs, illus.
<P><B>Belbin, D.L.</b> (1995)
A multivariate approach to the selection of biological reserves.
<i>
Biodiversity and Conservation</i>
4: 951-963 39 refs, illus.
<P>*Bomford, M., <B>Newsome, A.E.</b> and *O'Brien, P. (1995)
Solutions to feral animal problems: ecological and economic principles.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Sivertsen, D P (eds.). Conserving biodiversity: threats and solutions</i>
pp.202-209 29 refs, illus.
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P><B>Braithwaite, L.W.</b>, <B>Austin, M.P.</b> and <B>Catling, P.C.</b> (1995)
Forest and woodland communities.
<i>
In: Cho, G, Georges, A, Stoutjesdijk, R and Longmore, R (eds.). Kowari 5. Jervis Bay: a place of cultural, scientific and educational value</i>
(Ch.12): 91-98, illus.
(Canberra, ACT: Australian Nature Conservation Agency)
<P><B>Braithwaite, R.W.</b>, <B>Morton, S.R.</b>, *Burbidge, A.A. and <B>Calaby, J.H.</b> (1995)
Australian names for Australian rodents.
34p. ISBN 0642213739
(Canberra, ACT: Australian Nature Conservation Agency)
<P><B>Braithwaite, R.W.</b> (Editor), <B>McKaige, B.J.</b> and <B>Waggitt, W.M.</b> (1995)
Kapalga Research Station: two decades of research for the monsoonal tropics.
<i>
Division of Wildlife and Ecology [miscellaneous publication]. CSIRO Australia</i>
91p., illus.
<P><B>Braithwaite, R.W.</b> (1995)
Fire intensity and the maintenance of habitat heterogeneity in a tropical savanna.
<i>
CALM Science Supplement</i>
supp. 4: 189-96  30 refs, illus.
<P><B>Braithwaite, R.W.</b> and *Roberts, S. (1995)
Between bining and balanda.
<i>
Wildfire</i>
pp. 29-37  11 refs, illus.
<P><B>Braithwaite, R.W.</b> and *Begg, R.J. (1995)
Northern quoll: <i>Dasyurus hallucatus</i> Gould, 1842.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
Rev.ed.: 65-66 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Braithwaite, R.W.</b> (1995)
Southern brown bandicoot: <i>Isoodon obesulus</i> (Shaw, 1797).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.176-177 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Braithwaite, R.W.</b> (1995)
Brown antechinus: <i>Antechinus stuartii</i> (Macleay, 1841).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.94-97 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Braithwaite, R.W.</b> and *Baverstock, P.R. (1995)
Pale field-rat: <i>Rattus tunneyi</i> (Thomas, 1904).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.662-664 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Braithwaite, R.W.</b> and *Covacevich, J. (1995)
Delicate mouse: <i>Pseudomys delicatulus</i> (Gould, 1842).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.592-593, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Brooker, M.G.</b>, <B>Smith, G.T.</b>, <B>Saunders, D.A.</b>, <B>Ingram, J.A.</b>, <B>Leone, J.</b> and <B>de Rebeira, C.P.S.</b> (1995)
A biological survey of Garden Island, Western Australia. 1. Birds and reptiles.
<i>
Western Australian Naturalist</i>
20(4): 169-184 26 refs, illus.
<P><B>Brooker, M.G.</b>, <B>Smith, G.T.</b>, <B>Leone, J.</b> and <B>Ingram, J.A.</b> (1995)
A biological survey of Garden Island, Western Australia. 2. Terrestrial mammals.
<i>
Western Australian Naturalist</i>
20(4): 211-220 9 refs, illus.
<P><B>Brooker, M.G.</b> and <B>Rowley, I.C.R.</b> (1995)
The significance of territory size and quality in the mating strategy of the splendid fairy-wren.
<i>
Journal of Animal Ecology</i>
64: 614-627 29 refs, illus.
<P><B>Brown, P.R.</b>, <B>Singleton, G.R.</b> and *Griffiths, J. (1995)
Best farm management practices to control mouse population in Victoria.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 24-8  8 refs
<P><B>Calaby, J.H.</b> (1995)
Fawn antechinus: <i>Antechinus bellus</i> (Thomas, 1904).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.85-86 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Calaby, J.H.</b> (1995)
Red-necked wallaby: <i>Macropus rufogriseus</i> (Desmarest, 1817).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.350-352 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Calaby, J.H.</b> (1995)
Antilopine wallaroo: <i>Macropus antilopinus</i> (Gould, 1842).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.324-325 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Calaby, J.H.</b> (1995)
Black wallaroo: <i>Macropus bernardus</i> Rothschild, 1904.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.326-327 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Calver, M.C., <B>Hobbs, R.J.</b>, *Horwitz, P. and *Main, A.R. (1995)
Science, principles and fores management: a response to Abbott and Christensen .
<i>
Australian Forestry</i>
59(1): 1-6  43 refs
<P><B>Catling, P.C.</b> and <B>Burt, R.J.</b> (1995)
Studies of the ground-dwelling mammals of eucalypt forests in south-eastern New South Wales: the effect of environmental variables on distribution and abundance.
<i>
Wildlife Research</i>
22(6): 669-685 33 refs, illus.
<P><B>Catling, P.C.</b> and <B>Burt, R.J.</b> (1995)
Why are red foxes absent from some eucalypt forests in eastern New South Wales?.
<i>
Wildlife Research</i>
22(5): 535-546 42 refs, illus.
<P><B>Catling, P.C.</b> and <B>Burt, R.J.</b> (1995)
Studies of the ground-dwelling mammals of eucalypt forests in south-eastern New South Wales: the effect of habitat variables on distribution and abundance.
<i>
Wildlife Research</i>
22(3): 271-288 45 refs, illus.
<P><B>Caughley, G.J.</b> and *Gunn, A. (1995)
Conservation biology in theory and practice.
459p., refs, illus. ISBN 0865424314
(Cambridge, MA, USA: Blackwell Science)
<P><B>Chewings, V.H.</b> (1995)
Remote sensing and GIS in the Northern Territory.
<i>
Range Management Newsletter</i>
(95/1): p.16
<P><B>Cocks, K.D.</b>, <B>Ive, J.R.</b> and <B>Clark, J.L.</b> (Editors) (1995)
Forest issues: processes and tools for inventory, evaluation, mediation and allocation.
128p., illus. ISBN 0643057773
(Lyneham, ACT: CSIRO Australia)
<P><B>Cooke, B.D.</b> (1995)
Spanish rabbit fleas, <i>Xenopsylla cunicularis</i>, in arid Australia: a progress report.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 399-401  3 refs
<P><B>Cook, G.D.</b> and <B>Setterfield, S.A.</b> (1995)
Ecosystem dynamics and the management of environmental weeds in wetlands.
<i>
In: Finlayson, C M (ed.). Proceedings of a Workshop on Wetland research in the wet-dry tropics of Australia (Jabiru, NT: March 22-24, 1995). Supervising Scientist Report</i>
(101): 200-205 23 refs, illus. ISBN 064224300X
(Barton, ACT: Supervising Scientist)
<P><B>Cook, G.D.</b>, *Hurst, D. and *Griffith, D. (1995)
Atmospheric trace gas emissions from tropical Australian savanna fires.
<i>
CALMScience. Supplement</i>
4: 123-128 13 refs, illus.
<P><B>Coops, N.</b>, <B>Austin, M.</b> and Ryan, P. (1995)
Global vegetation datasets utilising remotely sensed data: applications to eucalypt forestsq.
<i>
In: Bren, L and Greenwood, C (eds.). Proceedings of the Institute of Foresters of Australia 16th Biennial Conference. Applications of New Technologies in Forestery (Ballarat, VIC: April 18-21, 1995)</i>
pp. 127-36  34 refs, illus. ISBN 0646232274
<P><B>Coops, N.C.</b> (1995)
Spectral and textural remotely sensed responses to predict forest standing volume at Batemans Bay.
<i>
In: Bishop, A W and Coops, N C (eds.). Remote sensing of forest vegetation: Batemans Bay, NSW, Australia</i>
CD-ROM
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
<P><B>Coops, N.C.</b>, <B>Austin, M.P.</b> and Ryan, P.R. (1995)
Global vegetation datasets utilising remotely sensed data: applications to eucalypt forests.
<i>
In: Bishop, A W and Coops, N C (eds.). Remote sensing of forest vegetation: Batemans Bay, NSW, Australia</i>
CD-ROM
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
<P><B>Coops, N.C.</b> (1995)
Temporal response of Landsat MSS NDVI over the south coast of NSW.
<i>
In: Bishop, A W and Coops, N C (eds.). Remote sensing of forest vegetation: Batemans Bay, NSW, Australia</i>
CD-ROM
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
<P><B>Corbett, L.K.</b> (1995)
Swamp buffalo: <i>Bubalus bubalis</i> (Linnaeus, 1758).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
Rev.ed: 723-725 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Corbett, L.K.</b> (1995)
Bali Banteng: <i>Bos javanicus</i> D'Alton, 1823.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
Rev.ed: 726-728, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Corbett, L.K.</b> (1995)
Dingo: <i>Canis lupus dingo</i> Linnaeus, 1758.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.696-698 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Corbett, L.K.</b> (1995)
The dingo in Australia and Asia.
200p., refs, illus. ISBN 0868402303
(Sydney, NSW: Univ. of New South Wales Press)
<P><B>Corbett, L.K.</b> (1995)
Does dingo predation or buffalo competition regulate feral pig populations in the Australian wet-dry tropics? an experimental study.
<i>
Wildlife Research</i>
22(1): 65-74 23 refs, illus.
<P><B>Corbett, L.K.</b> (1995)
Subspecies in Australian and Thai dingoes: implications for the keepers of zoos and wildlife parks.
<i>
Proceeding of the ARAZPA/ASZK Conference (Darwin, NT: April 17-22, 1994)</i>
pp. 105-17  12 refs, illus.
<P><B>Corbett, L.K.</b> (1995)
Dingoes: expatriate wolves or native dogs?.
<i>
Nature Australia</i>
pp. 46-55  illus.
<P><B>Cork, S.J.</b> (1995)
Life in a salad bowl?.
<i>
Nature Australia</i>
pp. 30-7  
<P><B>Cork, S.J.</b> (1995)
Koala conservation in the south-east forests: consultancy for the NSW National Parks and Wildlife Service and State Forests of New South Wales.
1-78, 11 refs ISBN 0959903542
(National Parks & Wildlife Service)
<P><B>Cork, S.J.</b> (1995)
Life in a salad bowl?.
<i>
Nature Australia</i>
25(2): 30-37 4 refs, illus.
<P>*Craig, J.L., <B>Saunders, D.A.</b> and *Mattiske, E.M. (1995)
Effective conservation requires people networked for action.
<i>
In: Saunders, D A, Craig, J L and Mattiske, E M (eds.). Nature Conservation 4: the role of the networks</i>
ch. 80: 653-60  10 refs ISBN 0949324655
<P><b>CSIRO Division of Wildlife and Ecology</b> (1995)
The futures gazette.
<i>
The futures gazette. Division of Wildlife and Ecology. CSIRO Australia</i>
1-       [irregular]
<P><b>CSIRO Division of Wildlife and Ecology</b> (1995)
Publication List: September 1995.
<i>
Publication List. Tropical Ecosystems Research Centre. Division of Wildlife and Ecology. CSIRO Australia</i>
113p.
<P>Cullen, J.M., Lonsdale, W.M., *Auld, B.A., <B>Hodgkinson, K.C.</b> and *Hynes, R.J. (1995)
Vegetation management and the impact of weeds.
<i>
Sustaining the Agricultural Resource Base. Paper for the 12th meeting of the Prime Minister's Science and Engineering Council (Canberra, ACT: June 23, 1995)</i>
(Ch.4): 40-47 6 refs, illus. ISBN 0644453095
(Canberra, ACT: AGPS)
<P><B>Doherty, M.D.</b> and <B>Coops, N.C.</b> (1995)
Vegetation of the Batemans Bay Study Area.
<i>
In: Bishop, A W and Coops, N C (eds.). Remote sensing of forest vegetation: Batemans Bay, NSW, Australia</i>
CD-ROM
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
<P>*Elis, W.A.H., *Melzer, A., <B>Green, B.F.</b>, <B>Newgrain, K.W.</b>, *Hindell, M.A. and *Carrick, F.N. (1995)
Seasonal variation in water flux, field metabolic rate and food consumption of free-ranging koalas (<i>Phascolarctos cinereus</i>).
<i>
Australian Journal of Zoology</i>
43(1): 59-68 21 refs, illus.
<P>*Erb, E., <B>Shaughnessy, P.D.</b> and *de B. Norman, R.J. (1995)
Dental and mandibular injury in an Antarctic fur seal, <i>Arctocephalus gazella</i>, at Heard Island, Southern Ocean.
<i>
Journal of Wildlife Disease</i>
32(2): 376-80 14 refs, illus.
<P><B>Faith, D.P.</b>, *Dostine, P.L. and *Humphrey, C.L. (1995)
Detection of mining impacts on aquatic macroinvertebrate communities: results of a disturbance experiment and the design of a multivariate BACIP monitoring programme at Coronation Hill, Northern Territory.
<i>
Australian Journal of Ecology</i>
20(1): 167-180 27 refs, illus.
<P><B>Faith, D.P.</b> (1995)
Biodiversity and regional sustainability analysis.
<i>
Division of Wildlife and Ecology [miscellaneous publication]. CSIRO Australia</i>
30p. 37 refs, illus. ISBN 0643057641
<P><B>Faith, D.P.</b> and <B>Walker, P.A.</b> (1995)
Diversity: a software package for sampling phylogenetic and environmental diversity. User's guide. Part of volume 3: BioRap tools for assessing priority areas.
<i>
Division of Wildlife and Ecology [miscellaneous publication]. CSIRO Australia</i>
68p., ilus.
<P><B>Foran, B.D.</b> (1995)
Ecological footprints.
<i>
Nature & Society</i>
1(4): 28-31 13 refs, illus.
<P><B>Foran, B.D.</b> and *Wardle, K. (1995)
Transitions in land use and the problems of planning: a case study from the mountainlands of New Zealand.
<i>
Journal of Environmental Management</i>
43: 97-127 54 refs, illus.
<P><B>Foran, B.D.</b> (1995)
Environmental futures and future faculties.
<i>
Proceedings of Gatton International Workshop on Land and Food Systems: Visions for the Future (Gatton, QLD: September 29-30, 1995)</i>
pp.4-9 ISBN 0867766328
(Gatton, QLD: Univ. of Queensland)
<P><B>Freudenberger, D.O.</b> and <B>Palmer, R.</b> (1995)
A case for harvesting kangaroos: is their impact different than sheep?.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 161-2  15 refs, illus.
(Denver, CO, USA: Society for Range Management)
<P><B>Freudenberger, D.O.</b>, *Hacker, R. and *Brill, T. (1995)
Tactical management of kangaroo and goat grazing pressure by manipulating access to water supplies.
<i>
In: Page, M J and Beutel, T S (eds.). Ecological Research and Management in the Mulgalands Conference Proceedings (Lawes, QLD: July 5-6, 1994)</i>
pp.133-137 8 refs, illus. ISBN 0909816263
(Lawes, QLD: University of Queensland)
<P><B>Freudenberger, D.O.</b> (1995)
Separating the sheep from the roos: do we know the difference?.
<i>
In: Grigg, G C, Hale, P T and Lunney, D (eds.). Conservation through sustainable use of wildlife</i>
ch. 33: 208-14  29 refs, illus.
<P><B>Freudenberger, D.O.</b> and *Hacker, R. (1995)
The short-term effect of selectively excluding kangaroos from stock watering points.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 309-12  6 refs, illus.
<P><B>Friedel, M.H.</b> and <B>James, C.D.</b> (1995)
How does grazing of native pastures affect their biodiversity?.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Sivertsen, D P (eds.). Conserving biodiversity: threats and solutions</i>
pp.249-259 61 refs, illus.
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P><B>Friend, G.R.</b> and <B>Calaby, J.H.</b> (1995)
Black-footed tree-rat: <i>Mesembriomys gouldii</i> (Gray, 1843).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.564-566 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Gaston, K.J. and <B>Nicholls, A.O.</b> (1995)
Probable times to extinction of some rare breeding bird species in the United Kingdom.
<i>
Proceedings of the Royal Society of London. B</i>
259: 119-123 18 refs, illus.
<P>*Gibbons, L.M. and <B>Spratt, D.M.</b> (1995)
Two new species of <i>Odilia</i> (Nematoda: Heligmonellidae) from Australian rodents, with comments on <i>O. bainae</i> Beveridge & Durette-Desset, 1992.
<i>
Systematic Parasitology</i>
31: 67-79 8 refs, illus.
<P>*Gilmour, J. and <B>Saunders, D.A.</b> (1995)
EARTHWATCH: an international network in support of research on nature conservation.
<i>
In: Saunders, D A, Craig, J L and Mattiske, E M (eds.). Nature Conservation 4: the role of the networks</i>
ch. 75: 627-35  4 refs, illus. ISBN 0949324655
<P><B>Goldsworthy, S.D.</b> and <B>Shaughnessy, P.D.</b> (1995)
Antarctic fur-seal: <i>Arctocephalus gazella</i> (Peters, 1875).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.678-680 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Goldsworthy, S.D.</b> and <B>Shaughnessy, P.D.</b> (1995)
Subantarctic fur-seal: <i>Arctocephalus tropicalis</i> (Gray, 1872).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.683-684 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Goss, K., *Chisholm, T., <B>Graetz, R.D.</b>, *Noble, I. and *Barson, M. (1995)
State of the agricultural resource base: a framework for government response.
<i>
Sustaining the Agricultural Resource Base. Paper for the 12th meeting of the Prime Minister's Science and Engineering Council (Canberra, ACT: June 23, 1995)</i>
(Ch.1): 7-17 8 refs ISBN 0644453095
(Canberra, ACT: AGPS)
<P><B>Graetz, R.D.</b>, <B>Wilson, M.A.</b> and <B>Campbell, S.K.</b> (1995)
Landcover disturbance over the Australian continent: a contemporary assessment.
<i>
Department of the Environment, Sport and Territories. Biodiversity Series</i>
(7): 86p. 56 refs, illus. ISBN 0642229058
<P>*Hacker, R.B. and <B>Hodgkinson, K.C.</b> (1995)
Implementation of tactical grazing in whole property management.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 197-8  4 refs
(Denver, CO, USA: Society for Range Management)
<P><B>Hall, L.S..</b> and <B>Richards, G.C.</b> (1995)
Diadem leafnosed-bat: <i>Hipposideros diadema</i> (Geoffroy, 1813).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.459-461 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Hall, L.S..</b>, <B>Richards, G.C.</b> and *Spencer, H.J. (1995)
Eastern tube-nosed bat: <i>Nyctimene robinsoni</i> Thomas, 1904.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.426-428 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Hamilton, N.</b> (1995)
Controls on the global distribution of coastal titanium-zirconium placers.
<i>
International Geology Review</i>
37: 755-79  100 refs, illus.
<P><B>Hamilton, N.T.M.</b> and <B>Cocks, K.D.</b> (1995)
A small-scale spatial analysis system for maritime Australia.
<i>
Ocean and Coastal Management</i>
27(3): 163-95  44 refs
<P><B>Hamilton, N.T.M.</b> (1995)
Impacts of Australia's coastal population growth.
<i>
People and Place</i>
3(2): 24-29 18 refs, illus.
<P><B>Hamilton, N.T.M.</b> and <B>Cocks, K.D.</b> (1995)
The application of marine biogeographic techniques to the oceanic environment.
<i>
In: Muldoon, J (ed.). Towards a marine regionalisation for Australia. Proceedings of a workshop (Sydney, NSW: March 4-6, 1994). Ocean Rescue 2000 Workshop Series Publication</i>
(1): 81-90 34 refs ISBN 0642174393
(Great Barrier Reef Marine Park Authority)
<P><B>Hamilton, N.T.M.</b>, <B>Cocks, K.D.</b>, *Busby, J. and *Burne, R.V. (1995)
CAMRIS, NATMIS, and AGSO coastal and marine information systems.
<i>
In: Muldoon, J (ed.). Towards a marine regionalisation for Australia. Proceedings of a workshop (Sydney, NSW: March 4-6, 1994). Ocean Rescue 2000 Workshop Series Publication</i>
(1): 195-208 12 refs ISBN 0642174393
(Great Barrier Reef Marine Park Authority)
<P><B>Harrington, G.N.</b> and <B>Driver, M.A.</b> (1995)
The effect of fire and ants on the seed-bank of a shrub in a semi-arid grassland.
<i>
Australian Journal of Ecology</i>
20: 538-547 25 refs, illus.
<P><B>Heyligers, P.C.</b> (1995)
Waterbuttons, <i>Cotula coronopifolia</i>: some comments on Nick Romanowski's article in <i>Indigenotes</i> 7(11), November 1994.
<i>
Indigenotes</i>
8(5): 2-4 12 refs
<P><B>Hobbs, R.J.</b> and <B>Saunders, D.A.</b> (1995)
Conversing with aliens: do scientists communicate with each other well enough to solve complex environmental problems?.
<i>
In: Saunders, DA, Craig, J L, and Mattiske, E M (eds.) Nature conservation 4: the role of networks</i>
Ch. 20: pp. 195-8  14 refs
(Surry Beatty & Sons)
<P><B>Hobbs, R.J.</b> (1995)
Invasive weeds: prevention is the key.
<i>
In: Burke, G (ed.). Invasive weeds & regenerating ecosystems in Western Australia</i>
pp.13-17, illus.
(Perth, WA: Murdoch Univ.)
<P><B>Hobbs, R.J.</b>, *Richardson, D.M. and *Davis, G.W. (1995)
Mediterranean-type ecosystems: opportunities and constraints for studying the function of biodiversity.
<i>
In: Davis, G W and Richardson, D M (eds.). Mediterranean-type ecosystems: the function of biodiversity</i>
(Ch.1): 1-42 187 refs, illus. ISBN 3540578099
(Berlin, Germany: Springer-Verlag)
[Ecological Studies, Vol.109]
<P><B>Hobbs, R.J.</b> and <B>Humphries, S.E.</b> (1995)
An integrated approach to the ecology and management of plant invasions.
<i>
Conservation Biology</i>
9(4): 761-770 75 refs, illus.
<P><B>Hobbs, R.J.</b>, Groves, R.H., *Hopper, S.D., *Lambeck, R.J., *Lamont, B.B., *Lavorel, S., *Main, A.R., *Majer, J.D. and <B>Saunders, D.A.</b> (1995)
Function of biodiversity in the mediterranean-type ecosystems of southwestern Australia.
<i>
In: Davis, G W and Richardson, D M (eds.). Mediterranean-type ecosystems: the function of biodiversity</i>
(Ch.5): 233-284 176 refs, illus. ISBN 3540578099
(Berlin, Germany: Springer-Verlag)
[Ecological Studies, Vol.109]
<P><B>Hobbs, R.J.</b> (1995)
Research into remnant management issues: nuts and bolts and the big picture.
<i>
Proceedings of the Dryandra Workshop on Remnant Native Vegetation: a decade of research and management (Perth, WA: September, 1993)</i>
pp.21-23 20 refs
<P><B>Hobbs, R.J.</b> and *Mooney, H.A. (1995)
Spatial and temporal variability in California annual grassland: results from a long-term study.
<i>
Journal of Vegetation Science</i>
6: 43-56 63 refs, illus.
<P><B>Hobbs, R.J.</b> and *Mooney, H.A. (1995)
Effects of episodic rain events on Mediterranean-climate ecosystems.
<i>
In: Roy, J, Aronson, J and de Castri, F (eds.). Time scales of biological responnses to water constraints</i>
pp.71-85 73 refs, illus.
(Amsterdam, The Netherlands: Academic Publ.)
<P><B>Hobbs, R.J.</b> (1995)
Landscape ecology.
<i>
In: Nierenberg, W A (ed.). Encyclopedia of Environmental Biology</i>
2: 417-428 12 refs, illus. ISBN 012226732X
(San Diego: Academic Press)
<P><B>Hobbs, T.J.</b> (1995)
The use of NOAA-AVHRR NDVI data to assess herbage production in the arid rangelands of central Australia.
<i>
International Journal of Remote Sensing</i>
16(7): 1289-1302 31 refs, illus.
<P><B>Hodgkinson, K.C.</b> (1995)
CSIRO research in mulgalands.
<i>
In: Page, M J and Beutel, T S (eds.). Ecological Research and Management in the Mulgalands Conference Proceedings (Lawes, QLD: July 5-6, 1994)</i>
pp.25-29 12 refs ISBN 0909816263
(Lawes, QLD: University of Queensland)
<P><B>Hodgkinson, K.C.</b> and *Beeston, G.R. (1995)
<i>Eremophila mitchellii</i> Benth.
<i>
In: Groves, R H, Shepherd, R C H and Richardson, R G (eds.). The biology of Australian weeds</i>
1: 123-135 86 refs, illus. ISBN 0646259563
(Frankston, VIC: R.G. and F.J. Richardson)
<P><B>Hodgkinson, K.C.</b> and <B>Cook, J.D.</b> (1995)
The ecology of perennial grass collapse under grazing.
<i>
In: Page, M J and Beutel, T S (eds.). Ecological Research and Management in the Mulgalands Conference Proceedings (Lawes, QLD: July 5-6, 1994)</i>
pp.203-207 8 refs, illus. ISBN 0909816263
(Lawes, QLD: University of Queensland)
<P><B>Hodgkinson, K.C.</b> (1995)
A model for perennial grass mortality under grazing.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 240-1  5 refs, illus.
(Denver, CO, USA: Society for Range Management)
<P><B>Hodgkinson, K.C.</b>, *Terpstra, J.W. and Muller, W.J. (1995)
Spatial and temporal pattern in the grazing of grasses by sheep within a semi-arid wooded landscape.
<i>
Rangeland Journal</i>
17(2): 154-165 20 refs, illus.
<P>*Holling, C.S., *Schindler, D.W., <B>Walker, B.H.</b> and *Roughgarden, J. (1995)
Biodiversity in the functioning of ecosystems: an ecological synthesis.
<i>
In: Perrings, C, Maler, K G, Folke, C, Holling, C S and Jansson, B O (eds.). Biodiversity loss: economic and ecological issues</i>
(Ch.2): 44-83, illus.
(Cambridge, UK: Cambridge Univ. Press)
<P>*Hoye, G.A. and <B>Richards, G.C.</b> (1995)
Greater broad-nosed bat: <i>Scoteanax rueppellii</i> (Peters, 1866).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.527-528 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Humphrey, C.L., <B>Faith, D.P.</b> and *Dostine, P.L. (1995)
Baseline requirements for assessment of mining impact using biological monitoring.
<i>
Australian Journal of Ecology</i>
20(1): 150-166 44 refs, illus.
[Paper presented at an International Conference on Use of Biota to Assess Water Quality]
<P><B>James, C.</b>, <B>Landsberg, J.J.</b> and <B>Morton, S.R.</b> (1995)
Integrating grazing and biodiversity conservation in Australia's arid rangelands.
<i>
Range Management Newsletter</i>
(95/2): 7-8
<P><B>James, C.d.</b>, <B>Landsberg, J.J.</b> and <B>Morton, S.R.</b> (1995)
Ecological functioning in arid Australia and research to assist conservation of biodiversity.
<i>
Pacific Conservation Biology</i>
2: 126-142, 144 refs
<P><B>Kerr, P.J.</b>, <B>Saint, K.M.</b>, <B>Silvers, L.E.</b>, <B>French, N.</b> and *Williams, K. (1995)
Epidemilogy of myxoma virus: how can we understand the dynamics of field strains.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 408-13  1 ref, illus.
<P><B>Kerr, P.J.</b> (1995)
Persistence of antibodies to myxoma virus in European rabbits: characterization of an ELISA for studying the epidemiology of myxomatosis.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 433-4  4 refs
<P><B>Kerr, P.J.</b> and <B>Jackson, R.J.</b> (1995)
Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus.
<i>
Vaccine</i>
13(17): 1722-6  30 refs, illus.
<P>*Klemperer, N., *Lyttle, D.J., *Tauzin, D., *Traktman, P. and <B>Robinson, A.J.</b> (1995)
Identification and characterization of the orf virus type 1 topoisomerase.
<i>
Virology</i>
206: 203-215 46 refs, illus.
<P><B>Knight, A.W.</b> (1995)
REMA: a neutral model to reveal patterns and processes of cover change in wooded rangelands.
<i>
Remote Sensing of Environment</i>
52: 1-14 50 refs, illus.
<P><B>Knight, A.W.</b>, *McTainsh, G.H. and *Simpson, R.W. (1995)
Sediment loads in an Australian dust storm: implications for present and past dust processes.
<i>
Catena</i>
24: 195-213 59 refs, illus.
<P>*Koch, G.W., *Vitousek, P.M., <B>Steffen, W.L.</b> and <B>Walker, B.H.</b> (1995)
Terrestrial transects for global change research.
<i>
Vegetatio</i>
121: 53-65  45 refs, illus.
<P>*Krebs, C.J., *Chitty, D., <B>Singleton, G.R.</b> and *Boonstra, R. (1995)
Can changes in social behaviour help to explain house mouse plagues in Australia?.
<i>
Oikos</i>
73(3): 429-434 35 refs
<P><B>Krebs, C.J.</b> (1995)
Two paradigms of population regulation.
<i>
Wildlife Research</i>
22(1): 1-10 41 refs, illus.
<P>*Krebs, C.J., *Kenney, A.J. and <B>Singleton, G.R.</b> (1995)
Movements of feral house mice in agricultural landscapes.
<i>
Australian Journal of Zoology</i>
43(3): 293-302 38 refs, illus.
<P><B>Lambeck, R.J.</b> (1995)
The use of remnant vegetation by nectarivorous birds: biodiversity as a model for management in the wheatbelt of Western Australia.
<i>
Proceedings of the Dryandra Workshop on Remnant Native Vegetation: a decade of research and management (Perth, WA: September, 1993)</i>
pp.33-36 2 refs
<P><B>Landsberg, J.J.</b>, <B>James, C.</b> and <B>Morton, S.</b> (1995)
Integrating grazing and biodiversity conservation in Australia's arid rangelands.
<i>
Trees and Natural Resources</i>
37(3): 6-10  illus.

<P><B>Landsberg, J.J.</b> and *Gillieson, D.S. (1995)
Regional and local variation in insect herbivory, vegetation and soils of eucalypt associations in contrasted landscape positions along a climatic gradient.
<i>
Australian Journal of Ecology</i>
20: 299-315 57 refs, illus.
<P><B>Landsberg, J.J.</b> and *Gilleison, D. (1995)
Looking beyond the piospheres to locate biodiversity reference areas in Australia's rangelands.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 304-5  11 refs, illus.
(Denver, CO, USA: Society for Range Management)
<P><B>Laurance, W.F.</b> (1995)
Extinction and survival of rainforest mammals in fragmented tropical landscapes.
<i>
In: Lidicker Jr, W Z (ed.). Landscape approaches in mammalian ecology and conservation</i>
Ch. 3: 46-63  59 refs, illus ISBN 0816625875
[Based on a paper presented at the 6th International Theriological Congress (Sydney, NSW: July, 1993)]
<P><B>Laurance, W.F.</b> (1995)
Exotic pathogens and aquatic wildlife: a conservation dilemma.
<i>
Search</i>
26(10): 200-303 9 refs, illus.
<P><B>Lebel, L.</b> (1995)
Impacts of global change on agriculture, forestry and biodiversity conservation in southeast Asia [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p.87 ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Lebel, L.</b> (1995)
GCTE Global Change Impacts Centres for developing regions [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
p. 87 ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P>*Lombard, A.T., <B>Nicholls, A.O.</b> and *August, P.V. (1995)
Where should nature reserves be located in South Africa? A snake's perspective.
<i>
Conservation Biology</i>
9(2): 363-372 34 refs, illus.
<P>*Lott, R.H., <B>Harrington, G.N.</b>, <B>Irvine, A.K.</b> and *McIntyre, S. (1995)
Density-dependent seed predation and plant dispersion of the tropical palm <i>Normanbya normanbyi</i>.
<i>
Biotropica</i>
27(1): 87-95 19 refs, illus.
<P><B>Lowe, L.M.</b> (1995)
Preliminary investigations of the biology and management of Leichhardt's grasshopper, <i>Petasida ephippigera</i> White.
<i>
Journal of Orthoptera Research</i>
(4): 219-221 8 refs, illus.
<P><B>Ludwig, J.A.</b> and <B>Tongway, D.J.</b> (1995)
Desertification in Australia: an eye to grass roots and landscapes.
<i>
Environmental Monitoring and Assessment</i>
37: 231-237 33 refs, illus.
<P><B>Ludwig, J.A.</b>, <B>Marsden, S.</b> and <B>Tongway, D.J.</b> (1995)
Impacts of climate change and degradation on sustainability of Australian rangelands: a simulation.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 326-7  9 refs, illus.
(Denver, CO, USA: Society for Range Management)
<P><B>Ludwig, J.A.</b> and <B>Tongway, D.J.</b> (1995)
Recent rangelands ramblings.
<i>
Range Management Newsletter</i>
(95/1): 18-19
<P><B>Ludwig, J.A.</b> and <B>Marsden, S.G.</b> (1995)
A simulation of resource dynamics within degraded semi-arid landscapes.
<i>
Mathematics and Computers in Simulation</i>
39: 219-224 9 refs, illus.
<P><B>Ludwig, J.A.</b> and <B>Marsden, S.G.</b> (1995)
Modelling the impacts of climate change and degradation on semi-arid landscape systems.
<i>
In: Binning, P, Bridgman, H and William, B (eds.) Paper  presented at  the International Congress on Modelling and Simulation (Canberra, ACT: 1995).   Vol. 2: Air Pollution and Climate</i>
4p.  24 refs, illus.
<P><B>Ludwig, J.A.</b> and <B>Tongway, D.J.</b> (1995)
Spatial organisation of landscapes and its function in semi-arid woodlands, Australia.
<i>
Landscape Ecology</i>
10(1): 51-63 37 refs, illus.
<P>*Lynch, J.F., *Carmen, W.J., <B>Saunders, D.A.</b> and <B>Cale, P.G.</b> (1995)
Use of vegetated road verges and habitat patches by four bird species in the central wheatbelt of Western Australia.
<i>
In: Saunders, D A, Craig, J L and Mattiske, E M (eds.). Nature Conservation 4: the role of the networks</i>
ch. 4: 34-42  28 refs, illus. ISBN 0949324655
<P><B>Margules, C.R.</b> and Redhead, T.D. (1995)
Guidelines for using the BioRap methodology and tools.
70p. 63 refs, illus. ISBN 0643058311
(Canberra, ACT: CSIRO Institute of Natural Resources and Environment)
<P><B>Margules, C.R.</b> and <B>Austin, M.P.</b> (1995)
Biological models for monitoring species decline: the construction and use of data bases.
<i>
In: Lawton, J H and May, R M (eds.). Extinction rates</i>
(Ch.12): 183-196 37 refs, illus. ISBN 019854829X
(UK: Oxford Univ. Press)
<P><B>Margules, C.R.</b>, *Davies, K.F., <B>Meyers, J.A.</b> and <B>Milkovits, G.A.</b> (1995)
The responses of some selected arthropods and the frog <i>Crinia signifera</i> to habitat fragmentation.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Sivertsen, D P (eds.). Conserving biodiversity: threats and solutions</i>
pp.94-103 28 refs, illus.
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P>*Marsh, H., *Corkeron, P.J., *Limpus, C.J., <B>Shaughnessy, P.D.</b> and *Ward, T.M. (1995)
The reptiles and mammals in Australian seas: their status and management.
<i>
In: Zann, L P and Kailola, P (eds.). The State of the Marine Environment Report for Australia: Technical Annex 1. The marine environment</i>
pp.151-166 100 refs, illus.
(Townsville, QLD: Great Barrier Reef Marine Park Authority)
<P><B>McIlroy, J.C.</b> (1995)
New techniques for an old problem: recent advances in feral pig control in Australia.
<i>
IBEX Journal of Mountain Ecology</i>
(3): 241-4  17 refs
<P><B>McIlroy, J.C.</b> (1995)
Common wombat: <i>Vombatus ursinus</i> (Shaw, 1800).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.204-205 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>McIvor, J.G., Ash, A.J. and <B>Cook, G.D.</b> (1995)
Land condition in the tropical tallgrass pasture lands. 1. Effects on herbage production.
<i>
Rangeland Journal</i>
17(1): 69-85 36 refs, illus.
<P><B>McKaige, B.J.</b> (1995)
Cease-fire at Kapalga.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(84): 8-10, illus.
<P>*McKenzie, L.M., <B>Poole, W.E.</b>, <B>Collet, C.C.</b> and *Cooper, D.W. (1995)
Higher female than male recombination rates in a marsupial mammal, the tammar wallaby (<i>Macropus eugenii</i>).
<i>
Cytogenetics and Cell Genetics</i>
68: 64-66 21 refs
<P>*McKeon, G.M., *Carter, J.O., <B>Stafford Smith, D.M.</b>, Ash, A.J., Pittock, A.B. and *Howden, S.M. (1995)
Evaluating impact of climate change on Queensland's grazing lands [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.59-60, 2 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Morton, S.R.</b>, <B>Stafford Smith, D.M.</b>, <B>Friedel, M.H.</b>, <B>Griffin, G.F.</b> and <B>Pickup, G.</b> (1995)
The stewardship of arid Australia: ecology and landscape management.
<i>
Journal of Environmental Management</i>
43: 195-217 75 refs, illus.
<P><B>Morton, S.R.</b>, <B>Short, J.C.</b> and <B>Barker, R.D.</b> (1995)
Refugia for biological diversity in arid and semi-arid Australia.
<i>
Department of the Environment, Sport and Territories. Biodiversity Series Paper No. 4</i>
171p., refs, illus. ISBN 0642227314
(Canberra, ACT: Department of Environment, Sport and Territories)
[Includes an appendix (pp.138-145) by Griffin, G F and Pearce, G.]
<P><B>Morton, S.R.</b> (1995)
Striped-faced Dunnart.
<i>
In: Grahan, R (ed.). The Mammals of Australia: National Photographic Index of Australian Wildlife</i>
pp. 148-9  1 ref, illus.
<P>*Munks, S.A. and <B>Green, B.F.</b> (1995)
Energy allocation for reproduction in a marsupial arboreal folivore, the common ringtail possum (<i>Pseudocheirus peregrinus</i>).
<i>
Oecologia</i>
101: 94-104 61 refs, illus.
<P><B>Newsome, A.E.</b> (1995)
Socio-ecological models for red fox populations subject to fertility control in Australia.
<i>
Annales Zoologici Fennici</i>
32: 99-110 72 refs, illus.
<P><B>Newsome, A.E.</b>, <B>Hinds, L.A.</b> and <B>Bubela, T.M.</b> (1995)
Social systems, compensatory breeding and prospects for immuno-sterility in foxes.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
p. 377
<P><B>Newsome, A.E.</b> (1995)
Cat: <i>Felis catus</i> Linnaeus, 1758.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.700-702 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Newsome, A.E.</b> (1995)
Red kangaroo: <i>Macropus rufus</i> (Desmarest, 1842).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.353-355 3 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Nicholas, K.R.</b>, *Wilde, C.J., <B>Bird, P.H.</b>, *Hendry, K.A.K., <B>Tregenza, K.J.</b> and *Warner, B. (1995)
Asynchronous concurrent secretion of milk proteins in the tammar wallaby (<i>Macropus eugenii</i>).
<i>
In: Wilde, C J, Peaker, M and Knight, C H (eds.). Intercellular Signalling in the Mammary Gland</i>
pp. 153-70  47 refs, illus.
(NY, USA: Plenum Press)
<P><B>Nicholls, A.O.</b> and *Cunningham, R.B. (1995)
Strategies for evaluating wildlife management.
<i>
In: Cork S J, Feary S and Mackowski C (eds.). Koala Conservation</i>
9-15, 8 refs, illus. ISBN 0959903534
(National Parks & Wildlife Services)
<P><B>Noble, J.C.</b> (1995)
Response to letter by Dr Kate Short.
<i>
Rural Research</i>
(167): p.4
<P><B>Noble, J.C.</b> (1995)
Bettong (<i>Bettongia</i> spp.) biocontrol of shrubs in semi-arid mulga (<i>Acacia aneura</i>) rangelands: an hypothesis.
<i>
In: Page, M J and Beutel, T S (eds.). Ecological Research and Management in the Mulgalands Conference Proceedings (Lawes, QLD: July 5-6, 1994)</i>
pp.139-145 28 refs, illus. ISBN 0909816263
(Lawes, QLD: University of Queensland)
<P><B>Noble, J.C.</b> (1995)
Mesomarsupial ecology in Australian rangelands: burrow, bettongs (<i>Bettongia</i> Spp.) and biocontrol of shrubs.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 395-6  9 refs, illus.
(Denver, CO, USA: Society for Range Management)
<P>*Norton, D.A., <B>Hobbs, R.J.</b> and <B>Atkins, L.J.</b> (1995)
Fragmentation, disturbance, and plant distribution: mistletoes in woodland remnants in the Western Australian wheatbelt.
<i>
Conservation Biology</i>
9(2): 426-438 56 refs, illus.
<P>*Obendorf, D. and <B>Spratt, D.M.</b> (1995)
Wildlife disease and its relevance to conservation biology and biodiversity.
<i>
Australasian Biotechnology</i>
5(4): 217-219
<P><B>Olsen, P.D.</b> (1995)
Australian birds of prey: the biology and ecology of raptors.
256p., refs, illus. ISBN 0868400394
(Sydney, NSW: Univ. of New South Wales)
<P><B>Parer, I.P.</b> (1995)
Relationship between survival rate and survival time of rabbits, <i>Oryctolagus cuniculus</i> (L.), challenged with  myxoma virus.
<i>
Australian Journal of Zoology</i>
43(3): 303-311 20 refs, illus.
<P><B>Parer, I.P.</b>, <B>Sobey, W.R.</b>, <B>Conolly, D.I.</b> and Morton, R. (1995)
Sire transmission of acquired resistance to myxomatosis.
<i>
Australian Journal of Zoology</i>
43(5): 459-465 26 refs, illus.
<P>*Parkinson, A.L., *Whittington, A.T., *Spencer, P.B.S., *Grigg, G., <B>Hinds, L.A.</b>, *Gallagher, C., *Kuchel, P. and *Agar, N.S. (1995)
Comparative erythrocyte metabolism in marsupials and monotremes.
<i>
Comparative Biochemistry and Physiology</i>
110C(3): 261-265 18 refs
<P><B>Pausas, J.G.</b>, <B>Braithwaite, L.W.</b> and <B>Austin, M.P.</b> (1995)
Modelling habitat quality for arboreal marsupials in the South Coastal forests of New South Wales, Australia.
<i>
Forest Ecology and Management</i>
78: 39-49  43 refs, illus.
<P><B>Pech, R.P.</b>, <B>Bradley, M.P.</b> and <B>Robinson, A.J.</b> (1995)
Fertility control of foxes in Australia.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 361-5  13 refs
<P><B>Pech, R.P.</b>, <B>McIlroy, J.C.</b> and <B>Clough, M.F.</b> (1995)
Models for predicting the dynamics and control of contact-spread diseases in feral pigs (<i>Sus scrofa</i>) in Australia.
<i>
IBEX Journal of Mountain Ecology</i>
(3): 95-7  11 refs
<P><B>Pech, R.P.</b>, <B>Bradley, M.P.</b> and <B>Robinson, A.J.</b> (1995)
Fertility control of foxes in Australia.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference (Hobart, TAS: May, 1995)</i>
pp.361-365 13 refs ISBN 0724263659
(Kings Meadows, TAS: Dept. of Primary Industries and Fisheries)
<P><B>Pech, R.P.</b>, *Sinclair, A.R.E. and <B>Newsome, A.E.</b> (1995)
Predation models for primary and secondary prey species.
<i>
Wildlife Research</i>
22(1): 55-64 34 refs, illus.
<P>*Perrings, C.A. and <B>Walker, B.H.</b> (1995)
Biodiversity loss and the economics of discontinuous change in semiarid rangelands.
<i>
In: Perrings, C, Maler, K G, Folke, C, Holling, C S and Jansson, B O (eds.). Biodiversity loss: economic and ecological issues</i>
(Ch.6): 190-210, illus.
(Cambridge, UK: Cambridge Univ. Press)
<P><B>Pickup, G.</b> (1995)
A simple model for predicting herbage production from rainfall in rangelands and its calibration using remotely-sensed data.
<i>
Journal of Arid Environment</i>
30: 227-245 36 refs, illus.
<P><B>Pickup, G.</b>, <B>Bastin, G.N.</b>, <B>Chewings, V.H.</b> and <B>Pearce, G.</b> (1995)
Correction and classification procedures for assessing rangeland vegetation cover with airborne video data.
<i>
Proceedings of the 15th Biennial Workshop on Videography & Color Photography in Resource Assessment (Terre Haute, Indiana: May 1-3, 1995)</i>
pp.305-314 12 refs, illus.
<P><B>Pickup, G.</b>, <B>Chewings, V.H.</b> and <B>Pearce, G.</b> (1995)
Procedures for correcting high resolution airborne video imagery.
<i>
International Journal of Remote Sensing</i>
16(9): 1647-1662 23 refs, illus.
<P>Pickup, G. and <B>Morton, S.R.</b> (1995)
Restoration of arid lands.
<i>
In: Munasinghe, M and Shearer, W (eds.). Defining and measuring sustainability: the biogeophsical foundations</i>
ch. 13: 177-92  52 refs, illus. ISBN 0821331345
<P><B>Poole, W.E.</b> (1995)
Common wallaroo <i>Macropus robustus</i> Gould, 1841.
<i>
In: Strahan, R (ed.). The mammals of Australia</i>
2nd ed.: 347-349, illus. ISBN 0730104842
(Chatswood, NSW: Reed Books)
<P><B>Poole, W.E.</b> (1995)
Eastern grey kangaroo <i>Macropus giganteus</i> Shaw, 1790.
<i>
In: Strahan, R (ed.). The Mammals of Australia</i>
2nd ed.: pp.335-338, illus. ISBN 0730104842
(Chatswood, NSW: Reed Books)
<P><B>Poole, W.E.</b> (1995)
Western grey kangaroo <i>Macropus fuliginosus</i> (Desmarest, 1817).
<i>
In: Strahan, R (ed.). The mammals of Australia</i>
2nd ed.: pp.332-334, illus. ISBN 0730104842
(Chatswood, NSW: Reed Books)
<P>*Priddel, D., *Carlile, N., <B>Davey, C.C.</b> and <B>Fullagar, P.J.</b> (1995)
The status of Gould's petrel, <i>Pterodroma leucoptera leucoptera</i>, on Cabbage Tree Island, New South Wales.
<i>
Wildlife Research</i>
22(5): 601-610 26 refs
<P>*Reid, J.W.R. and <B>Morton, S.R.</b> (1995)
Forrest's mouse: <i>Leggadina forresti</i>.
<i>
In: Strahan, R (ed.). The Mammals of Australia: National Photographic Index of Australian Wildlife. Rev. ed.</i>
pp. 555-6  2 refs, illus. ISBN 0730104824
<P><B>Richards, G.C.</b> (1995)
A review of ecological interactions of fruit bats in Australian ecosystems.
<i>
In: Racey, P A and Swift, S M (eds.). Proceedings of a Symposium on Ecology, Evolution and Behaviour of Bats (London, UK: November 26-27, 1993). Symposia of the Zoological Society of London</i>
(67): 79-96 74 refs ISBN 0198549458
(Oxford, UK: Clarendon Press)
<P><B>Richards, G.C.</b> (1995)
Torresian tube-nosed bat: <i>Nyctimene vizcaccia</i> Thomas, 1914.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
p.429, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> and *Spencer, H.J. (1995)
Spectacled flying-fox: <i>Pteropus conspicillatus</i> (Gould, 1850).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.435-437 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Torresian flying-fox: <i>Pteropus</i> sp.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.443-444 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> and *Thomson, B. (1995)
Papuan sheathtail-bat: <i>Saccolaimus mixtus</i> Troughton, 1925.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.468-469 ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
White-striped freetail-bat: <i>Nyctinomus australis</i> (Gray, 1838).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.487-488 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> and *Hand, S. (1995)
Ghost bat: <i>Macroderma gigas</i> (Dobson, 1880).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.446-447, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Lord Howe Island bat: <i>Nyctophilus howensis</i> McKean, 1973.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.506-507 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Northern freetail-bat: <i>Chaerephon jobensis</i> (Miller, 1902).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.479-480 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Little pied bat: <i>Chalinolobus picatus</i> (Gould, 1852).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.517-518 1 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Yellow-bellied sheathtail-bat: <i>Saccolaimus flaviventris</i> (Peters, 1867).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.467-468, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Coastal sheathtail-bat: <i>Taphozous australis</i> Gould, 1854.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.471-472 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Southern freetail-bat: <i>Mormopterus planiceps</i> (Peters, 1866).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.485-486 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Inland forest bat: <i>Vespadelus baverstocki</i> Kitchener, Jones and Caputi, 1987.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.534-535 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Little broad-nosed bat: <i>Scotorepens greyii</i> (Gray, 1843).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.530-531 1 ref, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b>, Coles, R.B.. and *Spencer, H.J. (1995)
Tube-nosed insect bat: <i>Murina florium</i> Thomas, 1908.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.496-497 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Richards, G.C.</b> (1995)
Large-footed myotis: <i>Myotis adversus</i> (Morsfield, 1824).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.521-523 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Rishworth, C., <B>McIlroy, J.C.</b> and *Tanton, M.T. (1995)
Factors affecting population densities of the common wombat, <i>Vombatus ursinus</i>, in plantations of <i>Pinus radiata</i>.
<i>
Forest Ecology and Management</i>
76: 11-19 17 refs, illus.
<P><B>Robinson, A.J.</b>, <B>Kerr, P.J.</b> and <B>Pech, R.P.</b> (1995)
Release of novel myxoma virus strains: can they compete with field strains?.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 414-18  8 refs, illus.
<P><B>Robinson, A.J.</b> and <B>Holland, M.K.</b> (1995)
Testing the concept of virally vectored immunosterilisation for the control of wild rabbit and fox populations in Australia.
<i>
Australian Veterinary Journal</i>
72(2): 65-68 29 refs
<P>*Ross, G.J.B., *Burbidge, A.A., *Brothers, N., *Canty, P., *Dann, P., *Fuller, P.J., *Kerry, K.R., *Norman, F.I., *Menkhorst, P.W., *Pemberton, D., *Shaughnessy, G., <B>Shaughnessy, P.D.</b>, *Smith, G.C., *Stokes, T. and *Tranter, J. (1995)
The status of Australia's seabirds.
<i>
In: Zann, L P and Kailola, P (eds.). The State of the Marine Environment Report for Australia: Technical Annex 1. The marine environment</i>
pp.167-182 83 refs, illus.
(Townsville, QLD: Great Barrier Reef Marine Park Authority)
<P><B>Rowley, I.C.R.</b> and <B>Russell, E.M.</b> (1995)
The breeding biology of the white-winged fairy-wren <i>Malurus leucopterus leuconotus</i> in a Western Australian coastal heathland.
<i>
Emu</i>
95: 175-184 25 refs, illus.
<P>Ryan, P., <B>Coops, N.</b>, <B>Austin, M.P.</b> and *Binns, D. (1995)
Incorporating soil chemical data into environmental models for predicting forest species distribution in south-east NSW.
<i>
In: Bren, L and Greenwood, C (eds.). Proceedings of the Institute of Foresters of Australia 16th Biennial Conference. Applications of New Technologies in Forestery (Ballarat, VIC: April 18-21, 1995)</i>
pp. 145-55  25 refs, illus. ISBN 0646232274
<P>Ryan, P.., <B>Coops, N.C.</b>, <B>Austin, M.P.</b> and *Binns, D. (1995)
Incorporating soil chemical data into environmental models for predicting forest species distribution in south-east NSW.
<i>
In: Bren, L and Greenwood, C (eds.). Proceedings of the Institute of Foresters of Australia 16th Biennial Conference on Applications of New Technologies in Forestry (Ballarat, VIC: April 18-21, 1995)</i>
pp.145-155 26 refs, illus.
<P><B>Saunders, D.A.</b> and <B>Ingram, J.A.</b> (1995)
Birds of southwestern Australia: an atlas of changes in the distribution and abundance of wheatbelt avifauna.
296p.  ISBN 0949324574
<P><B>Saunders, D.A.</b> and <B>Hobbs, R.J.</b> (1995)
Habitat reconstruction: the revegetation imperative.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Sivertsen, D P (eds.). Conserving, Biodiversity: Threats and Solutions</i>
pp.104-112 45 refs, illus.
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P><B>Saunders, D.A.</b> (1995)
Setting the scene: research on remnants during the past decade.
<i>
Proceedings of the Dryandra Workshop on Remnant Native Vegetation: a decade of research and management (Perth, WA: September, 1993)</i>
pp.5-9 23 refs
<P><B>Shaughnessy, P.D.</b>, *Testa, J.W. and *Warneke, R.M. (1995)
Abundance of Australian fur seal pups, <i>Arctocephalus pusillus doriferus</i>, at Seal Rocks, Victoria, in 1991-92 from Petersen and Bayesian estimators.
<i>
Wildlife Research</i>
22(6): 625-632 9 refs, illus.
<P><B>Shaughnessy, P.D.</b>, *Goldsworthy, S.D. and <B>Libke, J.A.</b> (1995)
Changes in the abundance of New Zealand fur seals, <i>Arctocephalus forsteri</i>, on Kangaroo Island, South Australia.
<i>
Wildlife Research</i>
22(2): 201-215 16 refs, illus.
<P><B>Short, J.C.</b>, <B>Turner, B.G.</b>, *Parker, S. and *Twiss, J. (1995)
Reintroduction of endangered mammals to mainland Shark Bay: a progress report.
<i>
In: Serena, M (ed.). Reintroduction biology of Australian and New Zealand fauna</i>
(Ch.30): 183-188 19 refs, illus. ISBN 0949324566
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P><B>Singleton, G.R.</b>, <B>Chambers, L.K..</b> and <B>Spratt, D.M.</b> (1995)
An experimental field study to examine whether <i>Capillaria hepatica</i> (Nematoda) can limit house mouse populations in eastern Australia.
<i>
Wildlife Research</i>
22(1): 31-53 50 refs, illus.
<P><B>Singleton, G.R.</b> (1995)
Control of rodents: the integration of population ecology, bio-control and the assessment of management and cultural practices.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 19-23  31 refs, illus.
<P><B>Singleton, G.R.</b> (1995)
House mouse: <i>Mus musculus</i> Linnaeus, 1758.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.646-647 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Smith, G.T.</b> and <B>Rowley, I.C.R.</b> (1995)
Survival of adult and nestling western long-billed corellas, <i>Cacatua pastinator</i>, and Major Mitchell cockatoos, <i>C. leadbeateri</i>, in the wheatbelt of Western Australia.
<i>
Wildlife Research</i>
22(2): 155-162 23 refs, illus.
<P><B>Smyth, R.E.</b>, <B>Coops, N.</b>, <B>Austin, M.</b> and <B>Walker, P.</b> (1995)
GIS in the real world: practical problems and difficulties.
<i>
Proceedings of the 9th Annual Symposium on Geographic Information Systems (Vancouver, Canada: 1995)</i>
pp. 80-6  20 refs, illus.
(GIS World, Inc.)
<P><B>Stafford Smith, D.M.</b>, *Campbell, B., <B>Steffen, W.L.</b>, *Archer, S. and *Ojima, D. (Editors) (1995)
Global change impacts on pastures and rangelands implementation plan.
<i>
Global Change and Terrestrial Ecosystems Report No.3</i>
59p. 2 refs, illus.
(Canberra, ACT: GCTE Core Project Office)
[Based on discussions at a workshop (Canberra, ACT: July 12-15, 1994)]
<P><B>Stafford Smith, D.M.</b> (1995)
Changeable climates in rangelands grazing systems [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.93-94, 1 ref ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Stafford Smith, D.M.</b> (1995)
Deserts, Australian.
<i>
Encyclopedia of Environmental Biology</i>
1: 493-505 10 refs, illus.
(Academic Press)
<P><B>Steffen, W.L.</b> and *Ingram, J.S.I. (1995)
Global change and terrestrial ecosystems: an initial integration.
<i>
Journal of Biogeography</i>
22: 165-174 46 refs, illus.
<P><B>Stocker, G.C.</b>, Thompson, W.A., <B>Irvine, A.K.</b>, <B>Fitzsimon, J.D.</b> and Thomas, P.R. (1995)
Annual patterns of litterfall in a lowland and tableland rainforest in tropical Australia.
<i>
Biotropica</i>
27(4): 412-420 35 refs, illus.
<P><B>Ten Have, J.F.M.</b>, *Green, M.M. and *Howells, A.J. (1995)
Molecular charagterization of spontaneous mutations at the <i>scarlet</i> locus of <i>Drosophila melanogaster</i>.
<i>
Molecular and General Genetics</i>
249: 673-81  40 refs, illus.
<P><B>Tongway, D.J.</b> and <B>Hindley, N.L.</b> (1995)
Manual for soil condition assessment of tropical grasslands.
60p., illus. ISBN 064305779X
(Gungahlin, ACT: CSIRO Division of Wildlife and Ecology)
<P><B>Tongway, D.J.</b> and <B>Ludwig, J.A.</b> (1995)
Restoration of landscape patchiness in semi-arid rangeland, Australia.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress  (UT, USA: July 23-28, 1995). Rangelands in a Sustainable Biosphere. Vol. 1. Contributed presentations </i>
pp. 563-4  8 refs
(Denver, CO, USA: Society for Range Management)
<P><B>Tongway, D.J.</b> (1995)
Monitoring soil productive potential.
<i>
Environmental Monitoring and Assessment</i>
37: 303-18  17 refs
<P><B>Tongway, D.J.</b> and <B>Ludwig, J.A.</b> (1995)
Function and dysfunction in mulga woodlands.
<i>
In: Page, M J and Beutel, T S (eds.). Ecological Research and Management in the Mulgalands Conference Proceedings (Lawes, QLD: July 5-6, 1994)</i>
pp.85-89 15 refs, illus. ISBN 0909816263
(Lawes, QLD: University of Queensland)
<P><B>Tyndale-Biscoe, C.H.</b>, *Calaby, J.H. and *Davies, S.J.J.F. (1995)
Harold James Frith: 1921-1982.
<i>
Historical Records of Australian Science</i>
10(3): 247-263 126 refs, illus.
<P><B>Tyndale-Biscoe, C.H.</b> (1995)
Vermin and viruses: risks and benefits of viral-vectored immunosterilisation.
<i>
Search</i>
26(8): 239-244 15 refs, illus.
<P><B>Tyndale-Biscoe, C.H.</b> (1995)
Teaching biology at university: the importance of knowing what we don't know.
<i>
Australian Biologist</i>
8(3): 145-150
<P>*Viggers, K.L. and <B>Spratt, D.M.</b> (1995)
The parasites recorded from <i>Trichosurus</i> species (Marsupialia: Phalangeridae).
<i>
Wildlife Research</i>
22(3): 311-332 113 refs
<P><B>Walker, B.H.</b> (1995)
Conserving biological diversity through ecosystem resilience.
<i>
Conservation Biology</i>
9(4): 747-752 15 refs, illus.
<P><B>Walker, B.H.</b> (1995)
National, regional and local scale priorities in the economic growth versus environment trade-off.
<i>
Ecological Economics</i>
15: 145-147 6 refs, illus.
<P><B>Walker, B.H.</b> (1995)
Rangeland ecology: managing change in biodiversity.
<i>
In: Perrings, C A, Maler, K-G, Folke, C, Holling, C S and Jansson, B-O (eds.). Biodiversity conservation: problems and policies</i>
(Ch.5): 69-85, illus. ISBN 079233616X
(Dordrecht, The Netherlands: Kluwer Academic Publ.)
<P>*Whittington, A.T., *Parkinson, A.L., *Spencer, P.B.S., *Grigg, G., <B>Hinds, L.A.</b>, *Gallagher, C.H., *Kuchel, P.W. and *Agar, N.S. (1995)
Comparative study of the antioxidant defence systems in the erythrocytes of Australian marsupials and monotremes.
<i>
Comparative Biochemistry and Physiology</i>
110C(3): 267-272 32 refs, illus.
<P><B>Williams, C.K.</b> and <B>Moore, R.J.</b> (1995)
Effectiveness and cost-efficiency of control of the wild rabbit, <i>Oryctolagus cuniculus</i> (L.), by combinations of poisoning, ripping, fumigation and maintenance fumigation.
<i>
Wildlife Research</i>
22(3): 253-269 28 refs, illus, appendix
<P><B>Williams, C.K.</b> (1995)
Dusky rat: <i>Rattus colletti</i> (Thomas, 1904).
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.648-649 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P><B>Williams, C.K.</b>, <B>Parer, I.P.</b>, *Coman, B.J., *Burley, J. and *Braysher, M.L. (1995)
Managing vertebrates pests: rabbits.
284p., refs, illus. ISBN 0644296232
(Canberra, ACT: AGPS)
<P><B>Williams, J.E.</b> and Gill, A.M. (1995)
The impact of fire regimes on native forests in eastern New South Wales.
<i>
In: Ray, A (ed.). Environmental Heritage Monograph Series No.2 Forest Issues 1</i>
68p. 292 refs, illus. ISBN 0731008219
(Hurstville, NSW: NSW National Parks and Wildlife Service)
<P><B>Williams, K.</b>, <B>Davey, C.C.</b>, <B>Moore, R.J.</b>, <B>Bray, J.A.</b>, <B>Silvers, L.E.</b>, <B>Hinds, L.A.</b>, <B>Pech, R.P.</b> and <B>Kerr, P.J.</b> (1995)
Responses of wild rabbit populations to imposed sterility.
<i>
Proceedings of the 10th Australian Vertebrate Pest Control Conference</i>
pp. 392-8  7 refs
<P><B>Williams, R.J.</b>, <B>Cook, G.D.</b>, <B>Braithwaite, R.W.</b>, <B>Andersen, A.N.</b> and <B>Corbett, L.K.</b> (1995)
Australia's wet-dry tropics: identifying the sensitive zones.
<i>
In: Pernatta, J, Leemans, R, Elder, D and Humphrey, S (eds.). Impacts of climate change on ecosystems and species: terrestrial ecosystems</i>
pp.39-65 83 refs, illus.
(Gland, Switzerland: IUCN)
<P><B>Williams, R.J.</b> (1995)
Tree mortality in relation to fire intensity in a tropical savanna of the Kakadu region, Northern Territory, Australia.
<i>
CALMScience. Supplement</i>
4: 77-82 17 refs, illus.
<P><B>Williams, R.J.</b> and *Douglas, M. (1995)
Windthrow in a tropical savanna in Kakadu National Park, northern Australia.
<i>
Journal of Tropical Ecology</i>
11: 547-558 33 refs, illus.
<P><B>Woinarski, J.C.Z.</b>, <B>Braithwaite, R.W.</b> and *Maguire, M. (1995)
Kakadu pebble-mound mouse: <i>Pseudomys calabyi</i> Kitchener and Humphreys, 1987.
<i>
In: Strahan, R (ed.). The mammals of Australia: national photographic index of Australian wildlife</i>
pp.589-590 2 refs, illus. ISBN 0730104842
(Sydney, NSW: Reed Books)
<P>*Wondzell, S. and <B>Ludwig, J.A.</b> (1995)
Community dynamics of desert grasslands: influences of climate, landforms, and soils.
<i>
Journal of Vegetation Science</i>
6: 377-90  51 refs, illus.
<P>Woolaston, R.R., Ward, J.L., <B>Arnold, G.W.</b>, Charlick, A.J. and Clune, G. (1995)
Fitness and production in Merinos: is there an antagonism?.
<i>
Proceedings of the 11th Conference of the Australian Association of Animal Breeding and Genetics (Adelaide, SA: July 3-5, 1995)</i>
11: 134-137 13 refs ISBN 095951256X
<P>*Yates, C.J., *Taplin, R., <B>Hobbs, R.J.</b> and *Bell, R.W. (1995)
Factors limiting the recruitment of <i>Eucalyptus salmonophloia</i> in remnant woodlands. 2. Post-dispersal seed predation and soil seed reserves.
<i>
Australian Journal of Botany</i>
43(2): 145-155 49 refs, illus.
<P><B>Young, M.D.</b>, <B>Walker, P.A.</b>, <B>Mallawaarachchi, T.</b> and <B>Smyth, R.E.</b> (1995)
National and GIS-based regional resource accounting in Australia.
<i>
In: Milon, J W and Shogren, J F (eds.). Integrating economic and ecological indicators</i>
(Ch.11): 169-179
(Westport: Praeger)
<P><B>Young, M.D.</b> and <B>Ryan, S.A.</b> (1995)
Using environmental indicators to promote environmentally, ecologically, and socially-sustainable resource use: a policy-orientated methodology.
<i>
EPAT/MUCIA Manual</i>
(3): 37p. 7 refs, illus.
<P><B>Young, M.D.</b> (1995)
Inter-generational equity, the precautionary principle and ecologically sustainable development.
<i>
Nature & Resources</i>
31(1): 16-27 48 refs, illus.
<P><B>Young, M.D.</b> and *McCay, B.J. (1995)
Building equity, stewardship, and resilience into market-based property rights systems.
<i>
In: Hanna, S and Munasinghe, M (eds.). Property Rights and the Environment: social and ecological issues</i>
ch. 7: 88-102  29 refs, illus. ISBN 0821334158
<P><B>Young, M.D.</b> and *Wilson, A.D. (1995)
When will it pay to farm kangaroos?.
<i>
In: Grigg, G C, Hale, P T and Lunney, D (eds.). Conservation through sustainable use of wildlife</i>
ch. 18: 106-9  13 refs
<P><B>Young, M.D.</b> (1995)
Some socio-economic and ecological implications of alternative biological diversity conservation strategy options.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Sivertsen, D P (eds.). Conserving biodiversity: threats and solutions</i>
pp.360-364 10 refs, illus.
(Chipping Norton, NSW: Surrey Beatty & Sons)
<P>*Zann, R.A., <B>Morton, S.R.</b>, <B>Jones, K.R.</b> and *Burley, N.T. (1995)
The timing of breeding by zebra finches in relation to rainfall in central Australia.
<i>
Emu</i>
95: 208-222 47 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-18</DOCNO>
<DOCOLDNO>IA089-000952-B040-239</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/BC1994.html 192.102.250.248 19970208034025 text/html 46739
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:27:41 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:56 GMT
Content-type: text/html
Content-length: 46555
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Building, Construction and Engineering</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Building, Construction and Engineering</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Banks, P.J.</b> and <B>Bowman, R.G.</b> (1994)
Prediction of failure in tiling systems.
<i>
Paper presented at Austceram 94: International Ceramic Conference (Sydney, NSW: July 25-27, 1994)</i>
pp.1259-1264 15 refs
<P><B>Banks, R.W.</b> (1994)
Designing for wind loading.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.4, illus.
<P><B>Baweja, D.</b>, <B>Sirivivatnanon, V.</b>, *Gross, W. and *Laurie, G. (1994)
High performance Australian concretes for marine applications.
<i>
Paper presented at the ACI International Conference on High Performance Concrete (Singapore: November 15-18, 1994)</i>
15p. 10 refs, illus.
<P><B>Baweja, D.</b> (1994)
Blended cements work well in marine environs.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.4, illus.
<P><B>Baweja, D.</b>, *Roper, H. and <B>Sirivivatnanon, V.</b> (1994)
Concretes for aggressive marine environments: performance and specification.
<i>
Proceedings of the 2nd International Symposium on Blended Cements (Malaysia: November 10-11, 1994)</i>
pp.13-18 12 refs, illus.
(Singapore: CI-Premiere Conference Organisation)
<P><B>Beretka, J.</b>, *Cioffi, R., *Santoro, L. and *Valenti, G. (1994)
Cementitious mixtures containing industrial process wastes suitable for the manufacture of preformed building elements.
<i>
Journal of Chemical Technology and Biotechnology</i>
59: 243-247 11 refs
<P><B>Beretka, J.</b> and *Nelson, P. (1994)
The current state of utilisation of fly ash in Australia.
<i>
Proceedings of the 2nd International Symposium on 'Ash: A valuable resource' (Johannesburg, South Africa: February 21-23, 1994)</i>
pp.51-63 43 refs, illus.
<P><B>Beretka, J.</b>, *Cioffi, R., *Santoro, L. and *Valenti, G.L. (1994)
Fly ash: raw material for special low energy cements.
<i>
Proceedings of the 2nd International Symposium on 'Ash: A valuable resource' (Johannesburg, South Africa: February 21-23, 1994)</i>
1: 39-49 22 refs, illus.
<P><B>Blackmore, J.</b>, <B>Leong, F.P.Y.</b> and <B>Sharpe, R.</b> (1994)
Intentions and credences: an Australian approach to computerised building regulation.
<i>
Paper presented at First ASCE Congress on Computing in Civil Engineering (Washington, DC, USA: June 20-22, 1994)</i>
1: 131-136 3 refs
(New York, USA: American Society of Civil Engineers)
<P><B>Bowman, R.G.</b> (1994)
Footnote on slippery floors.
<i>
Building Dispute Practitioners' Society. Newsletter</i>
(Aug): 15-17
<P><B>Bowman, R.G.</b> (1994)
Development of ceramic tile quality systems: keeping up with consumer expectations.
<i>
Qualicer 94. 3rd World Congress on Ceramic Tile Quality (Castellon, Spain: March 6-9, 1994)</i>
12p. 24 refs, illus.
<P><B>Bowman, R.G.</b> (1994)
The new Australian slip resistance standard.
<i>
Ceramic Tiles Today</i>
1(4): 54-58
<P><B>Bowman, R.G.</b> (1994)
Seeking competitive advantage in the traditional ceramic industries.
<i>
Paper presented at National Science & Industry Forum. Ceramics in Australia: Science, Applications and Opportunities (Thredbo, NSW: February 4-6, 1994)</i>
12p. 5 refs
<P><B>Bowman, R.G.</b>, <B>Westgate, P.L.</b> and <B>Maliwat, M.E.</b> (1994)
Coefficient of restitution as an indication of impact resistance.
<i>
Paper presented at AUSTCERAM 94. International Ceramic Conference (Sydney, NSW: July 25-27, 1994)</i>
pp.1271-1276 7 refs
<P><B>Bowman, R.G.</b> (1994)
Improving the accuracy of moisture expansion determinations.
<i>
Paper for the 8th CIMTEC: World Ceramic Congress and Forum on New Materials (Florence, Italy: June 29-July 4, 1994)</i>
8p. 18 refs, illus.
<P><B>Bowman, R.G.</b> and <B>Westgate, P.L.</b> (1994)
Moisture expansion kinetics as a function of conditioning.
<i>
Paper presented at AUSTCERAM 94. International Ceramic Conference (Sydney, NSW: July 25-27, 1994)</i>
pp.1265-1270 10 refs
<P><B>Bowman, R.G.</b> (1994)
Will the proposed ISO ceramic tile standards meet consumer expectations?.
<i>
Ceramic Engineering and Science Proceedings</i>
15(1): 359-364 2 refs
<P><B>Bowman, R.G.</b> (1994)
The classical ceramics industry: an Australian survey.
<i>
In: Vincenzini, P (ed.). Proceedings of the 8th CIMTEC-World Ceramics Congress and Forum on New Materials (Florence, Italy: June 29-July 4, 1994)</i>
14p. 5 refs, illus.
<P><B>Bowman, R.G.</b> (1994)
Legal and practical aspects of problems arising from slippery floors.
<i>
Building Dispute Practitioners'Society Newsletter</i>
(May): 6p. 8 refs
<P><B>Bowman, R.G.</b> and <B>Banks, P.J.</b> (1994)
Theoretical modelling of external wall tiling systems.
<i>
Paper for International Conference on Building Envelope Systems and Technology (Singapore: December 7-8, 1994)</i>
6p. 13 refs
<P><B>Bowman, R.G.</b> (1994)
Tiling 2000: Whither or wither?.
<i>
Paper presented at the Australian Association of Ceramic Tile Merchants Annual Conference (Sydney, NSW: March, 1994)</i>
12p., illus.
<P><B>Bowman, R.G.</b> (1994)
Australian ceramic tiling standards: current activities.
<i>
Ceramic Tiles Today</i>
(Spring): 56,58,60
<P><B>Brown, S.K.</b> (1994)
Tracing the invisible.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.6, illus.
<P><B>Brown, S.K.</b> (1994)
Volatile organic compounds in indoor air: sources and control.
<i>
Paper presented at a Symposium on Healthy Buildings in the Urban Environment (Kowloon, Hong Kong: September 8, 1994)</i>
8p. 16 refs, illus.
<P><B>Brown, S.K.</b>, *Garrett, M.H. and <B>Martin, A.K.</b> (1994)
Application of an optimised procedure for measuring house dust mite numbers in carpet and furniture.
<i>
Paper for International Workshop on Indoor Air (Gold Coast, Qld: November 27-December 1, 1994)</i>
4p. 6 refs
<P><B>Brown, S.K.</b> (1994)
Specification of coating systems for improvement of building environments.
<i>
Paper for First Trans-Tasman Surface Coatings Conference (Gold Coast, Qld: August 24-28, 1994)</i>
10p. 23 refs, illus.
<P><B>Brown, S.K.</b> (1994)
Source emission control of indoor air pollution.
<i>
Paper for International Workshop on Indoor Air (Gold Coast, Qld: November 27-December 1, 1994)</i>
4p. 8 refs, illus.
<P><B>Brown, S.K.</b>, <B>Cole, I.S..</b> and <B>Martin, A.K.</b> (1994)
The effect of building factors and indoor climate on house dust mite numbers in three houses.
<i>
Paper presented at a Conference on Mites, Asthma and Domestic Design (Sydney, NSW: November 26, 1994)</i>
5p. 4 refs, illus.
<P><B>Brown, S.K.</b>, *Sim, M.R., *Abramson, M.J. and *Gray, C.N. (1994)
Concentrations of volatile organic compounds in indoor air: a review.
<i>
Indoor Air</i>
4: 1213-134 67 refs
<P><B>Brown, S.K.</b> (1994)
Optimisation of a screening procedure for house dust mite numbers in carpets and preliminary application to buildings.
<i>
Experimental and Applied Acarology</i>
18(7): 423-434 21 refs, illus.
<P><B>Brown, S.K.</b> (1994)
World markets want pollutant-free interior paints.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 6-7, illus.
<P><B>Brumale, S.A.</b>, Ha, J., <B>Kao, P.</b>, <B>Proctor, D.</b> and <B>Pearson, I.G.</b> (1994)
Pulse combustion: a low NO<sub>x</sub> heating source.
<i>
Paper for the 22nd Australian Chemical Engineering Conference: CHEMECA '94 (Perth, WA: September 25-28, 1994)</i>
9p. 12 refs, illus.
<P><B>Bucea, L.</b>, <B>Sirivivatnanon, V.</b>, <B>Yozghatlian, S.P.</b>, <B>Cao, H.T.</b> and *Nelson, P. (1994)
Influence of fly ash, ground granulated blast furnace slag and silica fume on sulphate resistance of blended cements.
<i>
Proceedings of the 2nd International Symposium on Blended Cements (Malaysia: November 10-11, 1994)</i>
pp.32-39 9 refs, illus.
(Singapore: CI-Premiere Conference Organisation)
<P><B>Bullock, G.</b> and *Barnhart, A. (1994)
How the internet can improve the flow of information among inFIRE members.
<i>
Paper presented at inFIRE Annual Conference (Virginia, USA: May 11-14, 1994)</i>
15p. 7 refs
<P><B>Burn, L.S.</b> (1994)
The durability of plastics in buildings.
<i>
Proceedings of a Conference on Service Durability of Organic Materials (Melbourne, Vic: October 27, 1994)</i>
13p. 23 refs, illus.
<P><B>Burn, L.S.</b> (1994)
Lifetime prediction of uPVC pipes: experimental and theoretical comparisons.
<i>
Plastics, Rubber and Composites Processing and Applications</i>
21: 99-108 30 refs, illus.
[Also published in: Proceedings of the 8th Conference on Plastic Pipes (Eindhoven, The Netherlands: September 21-24, 1992). Plastics and Rubber Institute.]
<P><B>Cao, H.T.</b>, <B>Bucea, L.</b> and <B>Sirivivatnanon, V.</b> (1994)
Influence of binder type on anodic dissolution of steel embedded in cement pastes.
<i>
Cement and Concrete Research</i>
24(2): 203-213 5 refs, illus.
<P><B>Cao, H.T.</b>, <B>Bucea, L.</b>, <B>Wortley, B.A.</b> and <B>Sirivivatnanon, V.</b> (1994)
Corrosion behaviours of steel embedded in fly ash blended cements.
<i>
Paper presented at 3rd CANMET/ACI International Conference on Durability of Concrete (Nice, France: May 22-28, 1994)</i>
13p. 15 refs, illus.
<P><B>Cao, H.T.</b>, <B>Sirivivatnanon, V.</b> and <B>Khatri, R.</b> (1994)
Properties and applications of high volume fly ash concretes.
<i>
Proceedings of the 2nd International Symposium on Blended Cements (Malaysia: November 10-11, 1994)</i>
pp.40-49 16 refs, illus.
(Singapore: CI-Premiere Conference Organisation)
<P><B>Cerra, A.P.</b> (1994)
Whether sealants weather.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.11, illus.
<P><B>Chandrasekaran, V.</b>, <B>Suresh, R.</b> and <B>Grubits, S.J.</b> (1994)
Performance mechanisms of fire walls at high temperatures.
<i>
Proceedings of 3rd International Conference and Exhibition on Fire and Materials (Washington, USA: October 27-28, 1994)</i>
pp.51-62 8 refs, illus.
<P><B>Chandrasekaran, V.</b>, <B>Duong, D.Q.</b> and <B>Suresh, R.</b> (1994)
Mathematical modelling for the analysis of fire and structures.
<i>
Proceedings of the 3rd National Conference on Structural Engineering (Hanoi, Vietnan: November 3-4, 1994)</i>
pp.345-371 23 refs
<P><B>Chandrasekaran, V.</b>, <B>Suresh, R.</b> and <B>Grubits, S.J.</b> (1994)
Design solutions for steel beams exposed to fire.
<i>
Proceedings of the '94 Asian Fire Science Seminar (Sanur, Bali, Indonesia: December 5-6, 1994)</i>
8p. 10 refs, illus.
<P><B>Chandrasekaran, V.</b> and <B>Suresh, R.</b> (1994)
Analysis of steel columns exposed to fire.
<i>
Proceedings of 3rd International Conference and Exhibition on Fire and Materials (Washington, USA: October 27-28, 1994)</i>
pp.41-50 14 refs, illus.
<P><B>Chandrasekaran, V.</b>, <B>Suresh, R.</b>, <B>Grubits, S.J.</b> and *Gunaratnan, D.G. (1994)
Performance of steel columns exposed to fire.
<i>
Proceedings of the 5th International Conference on Steel Structures (Jakarta, Indonesia: December 12-14, 1994)</i>
pp.47-56 20 refs
<P><B>Cole, I.S..</b> and *Andenna, C. (1994)
An assessment of a micro-mechanic model of hydrogen-induced stress corrosion cracking, based on a study of an X65 line pipe steel.
<i>
Fatigue Fracture of Engineering Materials and Structures</i>
17(3): 265-275 11 refs, illus.
<P><B>Cole, I.S..</b> (1994)
An analysis of the microclimate of Australian wall cavities.
<i>
Construction and Building Materials</i>
8(4): 267-275 6 refs, illus.
<P><B>Cole, I.S.</b> and *Brook, R. (1994)
Fractography of crack growth in stress-corrosion cracking and corrosion fatigue of a number of offshore steels.
<i>
International Journal of Offshore and Polar Engineering</i>
4(3): 234-240 8 refs, illus.
[Also published in: ISOPE-93: 3rd International Offshore and Polar Engineering Conference (Singapore: June 6-11, 1993)]
<P><B>Collins, G.E.</b> (1994)
Preserving our heritage.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.5, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1994)
Building Innovation and Construction Technology. Division of Building, Construction and Engineering. CSIRO Australia.
no.1-  [bi-monthly]
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1994)
Watching the trends.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 12-13, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1994)
The White way.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 8-10, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1994)
Concrete: the durability factor.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 14-15, illus.
<P><B>Delsante, A.E.</b> and <B>Spencer, J.W.</b> (1994)
Calculation of the proportion of sky seen by windows with finite horizontal and vertical projections.
<i>
Solar Energy</i>
52(6): 547-551 8 refs, illus.
<P>*Dhanasekar, M., <B>Chandrasekaran, V.</b> and <B>Grubits, S.J.</b> (1994)
A numerical model for thermal bowing of masonry walls.
<i>
Proceedings of the 10th International Brick/Block Masonry Conference: "IB{sup2}MAC" (Calgary, Canada: July 5-7, 1994)</i>
pp.1093-1101 1 ref, illus.
<P><B>Dowling, V.P.</b> (1994)
Ignition of timber bridges in bushfires.
<i>
Fire Safety Journal</i>
22: 145-168 5 refs, illus.
<P><B>Duong, D.Q.</b> and <B>Chandrasekaran, V.</b> (1994)
Application of computer zone fire models for the prediction of structural failure due to thermal effects.
<i>
Proceedings of the 3rd National Conference on Structural Engineering (Hanoi, Vietnam: November 3-4, 1994)</i>
pp.463-472 9 refs, illus.
<P><B>Ferguson, J.A.</b> and <B>Banks, P.J.</b> (1994)
Assessing the plastic properties of Australian paver clays by triaxial compression testing.
<i>
Austceram 94. International Ceramic Conference (Sydney, NSW: July 25-27, 1994)</i>
7p. 6 refs, illus.
<P><B>Gipps, P.G.</b> (1994)
Align3D: a package for planning rail alignments.
<i>
Paper presented at COMPRAIL 94 Conference (Madrid, Spain: September 7-9, 1994)</i>
8p. 6 refs
<P><B>Graham, L.J.W.</b> and *Soria, J. (1994)
Near wake of an inclined cylinder.
<i>
Paper presented at an International Colloquium on Jets, Wakes and Shear Layers (Melbourne, Vic: April 18-20, 1994)</i>
8p. 11 refs, illus.
<P><B>Graham, L.J.W.</b> and *Soria, J. (1994)
A study of an inclined cylinder wake using digital particle image velocimetry.
<i>
Proceedings of the 7th International Symposium on Applications of Laser Techniques to Fluid Mechanics (Lisbon, Portugal: July 11-14, 1994)</i>
8p. 23 refs, illus.
<P><B>Grubits, S.J.</b>, <B>Quaglia, C.M.</b> and <B>Chandrasekaran, V.</b> (1994)
Cost-effective fire regulations for developing countries.
<i>
Paper presented at the 7th International Research and Training Seminar on Regional Divelopment Planning for Disaster Prevention. Improved Firesafety Systems in Developing Countries (Tokyo, Japan: October 17, 1994)</i>
11p.
<P><B>Grubits, S.J.</b> and <B>Chandrasekaran, V.</b> (1994)
Fire testing and smoke control for lift doors: present and future trends.
<i>
Paper presented at the International Research and Training Seminar on Regional Development Planning for Disaster Prevention: Improved Firesafety Systems in Developing Countries (Tokyo, Japan: October 17, 1994)</i>
11p.
(Nagoya, Japan: UN Centre for Regional Development)
<P>*Guirguis, S., <B>Cao, H.T.</b> and <B>Baweja, D.</b> (1994)
Minimising corrosion of steel reinforcement: implementation of research into practice.
<i>
Paper for the 3rd CANMET/ACI International Conference on Durability of Concrete (Nice, France: May 22-28, 1994)</i>
19p 18 refs, illus.
<P><B>Gutowski, W.S.</b>, *Lalas, P. and <B>Cerra, A.P.</b> (1994)
Structural silicone in curtain walls: pure and applied.
<i>
Proceedings of the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994). National Conference Publication</i>
94/8(Vol.2): 891-898 11 refs, illus.
(Canberra, ACT: Institution of Engineers, Australia)
<P><B>Haselden, P.C.</b> (1994)
BCAider: Building Code of Australia expert assistant.
<i>
Building Science Forum of Australia Seminar on the Building Code of Australia (Canberra, ACT: August 17, 1994)</i>
8p., illus.
<P><B>Haselden, P.C.</b> and <B>Sharpe, R.</b> (1994)
Interface between BCAider and AutoCAD.
<i>
CADEX 1994 Conference (Melbourne, Vic: May 25-28, 1994)</i>
13p. 13 refs, illus.
<P><B>Ho, D.W.S.</b> and <B>Cao, H.T.</b> (1994)
Water sorptivity of steam-cured concrete.
<i>
Paper for CIA Seminar (NSW) on the Structural Use of Precast Concrete (Sydney, NSW: March 7, 1994)</i>
10p. 5 refs, illus.
<P><B>Ho, D.W.S.</b> (1994)
Utilisation of industrial by-products in the production of concrete.
<i>
UNIDO Conference "Economic Growth with Clean Production" (Melbourne, Vic: February 7-10, 1994)</i>
2p.
<P><B>Ho, D.W.S.</b> (1994)
The 4C's for durable concrete.
<i>
Paper presented at CIA Seminar 'How to Specify & Produce Concrete for Durable Structures' (Melbourne, Vic: August 16, 1994)</i>
4p. 12 refs
<P><B>Holmes, J.D.</b> and <B>Paevere, P.J.</b> (1994)
Along-wind response of lattice towers.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
3p. 5 refs, illus.
<P><B>Holmes, J.D.</b> (1994)
Along-wind response of lattice towers. Part 1. Derivation of expressions for gust response factors.
<i>
Engineering Structures</i>
16(4): 287-292 13 refs, illus.
<P><B>Holmes, J.D.</b> (1994)
Wind pressures on tropical housing.
<i>
Journal of Wind Engineering and Industrial Aerodynamics</i>
53: 105-123 21 refs, illus.
<P>*Horoschun, G., <B>Pham, L.</b> and *Wilson, J. (1994)
Proposed revisions to the earthquake section of the Australian Steel Structures Standards AS 4100.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
4p. 5 refs
<P>*Hutchinson, G., *Wilson, J., <B>Pham, L.</b>, *Billings, I., *Jury, R. and *King, A. (1994)
Developing a common Australasian Earthquake Loading Standard.
<i>
Proceedings of the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
pp.853-858 13 refs, illus.
<P>*Hutchinson, G.L., <B>Pham, L.</b> and *Wilson, J.L. (1994)
Earthquake resistant design of steel structures: an introduction for the practising engineer.
<i>
Steel Construction</i>
28(2): 6-22 30 refs, illus.
<P>*King, A. and <B>Pham, L.</b> (1994)
The harmonisation of Australian/New Zealand structural standards.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
3p. 2 refs
<P><B>King, G.A.</b>, *Kapetas, J. and *Bates-Brownsword, D. (1994)
Corrosivity mapping as a fundamental tool in assessing the integrity of the distribution/transmission system for the Electricity Trust of South Australia.
<i>
Corrosion 9'94. NACA Annual Conference & Corrosion Show (Baltimore, USA: February 28-March 4, 1994)</i>
(106): 1-18 13 refs, illus.
<P><B>King, G.A.</b> (1994)
The influence of marine environments on the relative corrosion performance of zinc and the zinc-based alloys used for steel sheet applications.
<i>
Proceedings of the 4th International Zinc Coated Sheet Conference: Interglava 94 (Paris, France: June 9-10, 1994)</i>
12p. 13 refs, illus.
<P><B>King, G.A.</b>, *Kapetas, J. and *Bates-Brownsword, D. (1994)
Corrosivity mapping used for transmission line maintenance by the Electricity Trust of South Australia.
<i>
Proceedings of the Australasian Corrosion Association Conference: Corrosion & Prevention 94 (Adelaide, SA: November 27-30, 1994)</i>
10p. 8 refs, illus.
<P><B>Koskela, L.</b> (1994)
Lean construction.
<i>
Paper presented at I.E.Aust./UNSW National Construction & Management Conference (Sydney, NSW: February 17-18, 1994)</i>
14p. 18 refs, illus.
<P>*Koskela, L. and <B>Sharpe, R.</b> (1994)
Flow process analysis in construction.
<i>
Paper presented at 11th International Symposium on Automation and Robotics in Construction (Brighton, UK: May 24-25, 1994)</i>
8p. 5 refs, illus.
<P><B>Lawrence, S.J.</b> and <B>So, L.</b> (1994)
The influence of some factors on the tensile bond strength of masonry.
<i>
Proceedings of the 10th International Brick/Block Masonry Conference: "IB{sup2}MAC" (Calgary, Canada: July 5-7, 1994)</i>
pp.929-938 5 refs, illus.
<P><B>Lawrence, S.J.</b> and *Page, A.W. (1994)
The Australian Masonry Code.
<i>
Proceedings of the 10th International Brick/Block Masonry Conference (Calgary, Canada: July 5-7, 1994)</i>
pp.1509-1518 7 refs
<P><B>Lawrence, S.J.</b> (1994)
Lateral loading of masonry: an overview.
<i>
Proceedings of the 3rd National Masonry Conference (Brisbane, Qld: July 14-15, 1994)</i>
pp.20.1-20.9 19 refs, illus.
<P><B>Lawrence, S.J.</b> and *Page, A.W. (1994)
Bond studies in masonry.
<i>
Prceedings of the 10th International Brick/Block Masonry Conference (Calgary, Canada: July 5-7, 1994)</i>
pp.909-917 13 refs, illus.
<P><B>Lawrence, S.J.</b> (1994)
Out-of-plane lateral load resistance of clay brick panels.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
pp.657-663 6 refs, illus.
<P><B>Lawrence, S.J.</b> and <B>So, L.</b> (1994)
The influence of some factors on the tensile bond strengths of masonry.
<i>
Paper for the 10th International Brick/Block Masonry Conference (Calgary, Canada: July 5-7, 1994)</i>
10p. 5 refs, illus.
<P><B>Lawrence, S.J.</b> (1994)
Legislation: BCA: the Masonry Code AS 3700.
<i>
Proceedings of the 3rd National Masonry Conference on Earth, Wind & Fire (Brisbane, QLD: July 14-15, 1994)</i>
pp.2.1-2.8 12 refs, illus.
<P><B>Leicester, R.H.</b> and *Carson, J. (1994)
Australian standards for structural timber.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
5p. 17 refs, illus.
<P><B>Leicester, R.H.</b> (1994)
Human impact on glass.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.3, illus.
<P><B>Leicester, R.H.</b> (1994)
Quantification of serviceability criteria.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
5p. 25 refs, illus.
<P><B>Leong, F.P.Y..</b> (1994)
Give credit where credit is due.
<i>
Building Products News</i>
29(9): 16-17, illus.
<P><B>Li, C.Q.</b> (1994)
An alternative approach for time-dependent structural system reliability.
<i>
Paper for the 2nd International Conference on Computational Structural Technology (Athens, Greece: August 30-September 1, 1994)</i>
7p. 13 refs, illus.
<P><B>Li, C.Q.</b> and *Melchers, R.E. (1994)
Computation of time-dependent structural system reliability.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
6p. 6 refs, illus.
<P><B>Liffman, K.</b>, *Chan, D.Y.C. and *Hughes, B.D. (1994)
On the stress depression under a sandpile.
<i>
Powder Technology</i>
78: 263-271 10 refs, illus.
<P><B>Li, Y.</b> (1994)
The role of computational fluid dynamics in air flow design within buildings.
<i>
Proceedings of the Australia and New Zealand 3rd Regional Conference of CIBSE: Engineering for Better Building Performance (Melbourne, VIC: February 16-18, 1994)</i>
15p. 26 refs, illus.
<P><B>Li, Y.</b> (1994)
A simple assembly approach for representing complex geometry on non-body-fitted Cartesian grids.
<i>
Paper for the 4th International Conference on Air Distribution in Rooms (Krakow, Poland: June 15-17, 1994)</i>
15p. 12 refs, illus.
<P><B>Li, Y.</b>, *Holmberg, S., *Paprocki, A. and *Tang, Y-Q. (1994)
Simulation of room flows with small ventilation openings by a local grid-refinement technique.
<i>
Building Services Engineering Research and Technology</i>
15(1): 10p. 17 refs, illus.
<P><B>Li, Y.</b> (1994)
The role of computational fluid dynamics in air flow design within buildings.
<i>
CIBSE Australian & New Zealand 3rd Regional Conference (Melbourne, Vic: February 16-18, 1994)</i>
15p. 25 refs, illus.
<P><B>Li, Y.</b> (1994)
A note on general thermal boundary conditions in mathematical modeling of indoor air flows.
<i>
Paper presented to IBPSA Workshop (Australasian Chapter): Issues in Building Simulation (Melbourne, VIC: November 29, 1994)</i>
7p. 6 refs, illus.
<P><B>Lu, J.P.</b> and <B>Leicester, R.H.</b> (1994)
Deformation and strength loss due to mechano-sorptive effects.
<i>
Proceedings of the Pacific Timber Engineering Conference (Gold Coast, QLD: July 11-15, 1994)</i>
5p. 8 refs, illus.
<P><B>MacIndoe, L.C.</b> and *Hanks, P. (1994)
Standard tests for cold-formed steel single fastener connections.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
5p. 12 refs, illus.
<P><B>Mak, S.L.</b> and *Anai Lu (1994)
Engineering properties of high performance concretes containing blast furnace slag under 'in situ' moisture and temperature conditions.
<i>
Paper presented at the ACI International Conference on High Performance Concrete (Singapore: November 15-18, 1994)</i>
26p. 17 refs, illus.
<P><B>Mak, S.L.</b>, *Attard, M.M., <B>Ho, D.W.S.</b> and *Darvall, P.LeP. (1994)
Cross-sectional strength gradients in high strength concrete columns.
<i>
Cement and Concrete Research</i>
24: 139-149 18 refs, illus.
<P><B>Mak, S.L.</b> and *Lu, A. (1994)
Temperature effects on the early-age properties of high strength binder systems containing blast furnace slag.
<i>
Paper presented at the 2nd International Symposium on Blended Cements (Kuala Lumpur, Malaysia: November 10-11, 1994)</i>
pp.72-76 10 refs, illus.
<P><B>Mak, S.L.</b> (1994)
High performance concrete: defining performance and basic considerations for materials and mix design.
<i>
Seminar on High Performance Concrete (Parkville, VIC: February, 1994)</i>
15p. 21 refs, illus.
<P><B>Mann, B.A..</b> and <B>White, R.F.</b> (1994)
Comparison of the LIF and DFWM techniques for detection and imaging of nitrogen dioxide.
<i>
Proceedings of the 7th International Symposium on Applications of Laser Techniques to Fluid Mechanics (Lisbon, Portugal: July 11-14, 1994)</i>
6p. 10 refs, illus.
<P>*Mansell, D.S. and <B>Pham, L.</b> (1994)
Economical design using a lower-tier design approach.
<i>
Paper for the 5th International Conference on Steel Structures (Jakarta, Indonesia: December 12-14, 1994)</i>
4p. 6 refs, illus.
<P>*Mansell, D.S. and <B>Pham, L.</b> (1994)
A case for regional consistency in structural engineering standards.
<i>
Paper for the 5th International Conference on Steel Structures (Jakarta, Indonesia: December 12-14, 1994)</i>
4p. 7 refs
<P><B>Moller, S.K.</b> and <B>Delsante, A.E.</b> (1994)
Windows: win/win? or When are windows net energy sources?.
<i>
Paper presented at the ANZSES Solar Energy Conference (Sydney, NSW: November 30-December 2, 1994)</i>
10p. 6 refs, illus.
<P>*Monaghan, J.J., <B>Thompson, M.C.</b> and <B>Hourigan, K.</b> (1994)
Simulation of free surface flows with SPH.
<i>
Paper for the 5th International Symposium on Solid-Liquid Flows (Nevada, USA: June 19-23, 1994)</i>
6p. 6 refs, illus.
<P><B>Narang, P.P.</b> (1994)
Acoustic privacy and urban consolidation policies in Australia.
<i>
Acoustics Australia</i>
22(2): 51-55 13 refs, illus.
<P><B>Narang, P.P.</b> (1994)
Inter-laboratory comparison of sound transmission loss: reference specimen study.
<i>
Paper for Australian Acoustical Society Conference 'Noise and Sound: Nuisance and Amenity' (Sydney, NSW: November 9-11, 1994)</i>
8p. 11 refs, illus.
<P><B>Narang, P.P.</b> (1994)
Transforming wall studs to slit resonator studs for improving sound insulation in walls.
<i>
Applied Acoustics</i>
43: 81-90 11 refs, illus.
<P><B>Narang, P.P.</b> (1994)
Sound bridging by wall ties in cavity brick walls: theory and experiment.
<i>
Journal of Sound and Vibration</i>
174(2): 169-180 13 refs, illus.
<P><B>Neil, C.C.</b> and <B>Salomonsson, G.D.</b> (1994)
Prior-use evaluation of the impact on company work precedures of using robots on construction sites.
<i>
Paper for the 11th International Symposium on Automation and Robotics in Construction (Brighton, UK: May 24-26, 1994)</i>
8p. 7 refs
<P><B>Newton, P.W.</b> and <B>Sharpe, R.</b> (1994)
Teleconstruction: an emerging opportunity.
<i>
Paper presented at I.E.Aust./UNSW National Construction & Management Conference (Sydney, NSW: February 17-18, 1994)</i>
10p. 13 refs, illus.
<P><B>Newton, P.W.</b>, <B>Wilson, B.G.</b>, <B>Crawford, J.R.</b>, <B>Tucker, S.N.</b> and *Clarke, S. (1994)
Networking CAD.
<i>
Environment and Planning B: Planning and Design</i>
21: 737-758 24 refs, illus.
<P><B>Paterson, D.A.</b> (1994)
Help our hail engineers.
<i>
Helix. Magazine of CSIRO's Double Helix Science Club</i>
(38): 16-18, illus.
<P><B>Paterson, D.A.</b> (1994)
Smart scales.
<i>
Helix. Magazine of CSIRO's Double Helix Science Club</i>
(38): p.23, illus.
<P><B>Paterson, D.A.</b> and <B>Sankaran, R.</b> (1994)
On hail damage to building facades.
<i>
Proceedings of the 4th National Workshop of the Australian Wind Engineering Society (Sydney, NSW: October 6-7, 1994)</i>
pp.67-70 4 refs, illus.
<P><B>Paterson, D.A.</b> and <B>Sankaran, R.</b> (1994)
Wind driven rain: a computational study.
<i>
Proceedings of the 4th National Workshop of the Australian Wind Engineering Society (Sydney, NSW: October 6-7, 1994)</i>
pp.172-177 5 refs, illus.
<P><B>Paterson, D.A.</b> and <B>Sankaran, R.</b> (1994)
Hail impact on building envelopes.
<i>
Journal of Wind Engineering</i>
53: 229-246 13 refs, illus.
<P><B>Paterson, D.A.</b> and <B>Sankaran, R.</b> (1994)
Hailstorms and building envelopes.
<i>
Proceedings of the 2nd International Conference on Building Envelope Systems and Technology (Singapore: December 7-8, 1994)</i>
pp.555-560 5 refs, illus.
<P><B>Paterson, D.A.</b>, <B>Sankaran, R.</b> and <B>Farrance, G.S.</b> (1994)
Dynamic weather testing facility at CSIRO, Australia.
<i>
Proceedings of the 2nd International Conference on Building Envelope Systems and Technology (Singapore: December 7-8, 1994)</i>
pp.150-155 1 ref, illus.
<P><B>Paterson, D.A.</b> and <B>Sankaran, R.</b> (1994)
Hail: occurrence and impact.
<i>
Proceedings of the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
pp.1191-1196 9 refs, illus.
<P><B>Pham, L.</b> and <B>Li, C.Q.</b> (1994)
Domestic construction and serviceability.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
pp.847-851 9 refs, illus, appendix
<P><B>Pham, L.</b> and *Stark, G.K. (1994)
Australian developments in steel framed domestic construction.
<i>
Paper for the 5th International Conference on Steel Structures (Jakarta, Indonesia: December 12-14, 1994)</i>
4p. 7 refs, illus.
<P>*Pullum, L., <B>Welsh, M.C.</b>, *Baillie, K. and *Dam, P. (1994)
A flow visualisation study of mixing solid/liquid slurries by mechanical agitation.
<i>
5th International Symposium on Solid-Liquid Flows (Nevada, USA: June 19-23, 1994)</i>
11p. 7 refs, illus.
<P><B>Quaglia, C.M.</b> (1994)
Engineered systems versus prescriptive systems.
<i>
Paper presented at the Institution of Engineers, Australia (Queensland Division) Southern Engineering Conference (Brisbane, QLD: 1994)</i>
19p. 22 refs, illus.
<P><B>Quaglia, C.M.</b> (1994)
Hazard analysis using "FIRECALC".
<i>
Paper presented at the '94 Asian Fire Seminar (Sanur, Bali, Indonesia: December 6-7, 1994)</i>
12p. 11 refs, illus.
<P><B>Ramsay, G.C.</b> (1994)
Rebuilding after the NSW bushfires.
<i>
Architectural and Interior Specifier</i>
3(2): 40-41, illus.
<P><B>Ramsay, G.C.</b>, <B>McArthur, N.A.</b> and <B>Dowling, V.P.</b> (1994)
Effective planning in fire-prone areas.
<i>
Proceedings Nature Conservation Council of NSW Seminar "Fire: Looking to the Future" (Sydney, NSW: June 24-25, 1994)</i>
8p. 5 refs
<P><B>Ramsay, G.C.</b>, <B>McArthur, N.A.</b> and <B>Dowling, V.P.</b> (1994)
The January 1994 bushfires in Australia: preliminary observations on building performance.
<i>
Paper presented at the Asian Fire Science Seminar (Sanur, Indonesia: December 5-6, 1994)</i>
8p. 5 refs
<P><B>Ramsay, G.C.</b>, <B>McArthur, N.A.</b> and <B>Dowling, V.P.</b> (1994)
Bushfires: lessons for planners.
<i>
Proceedings of the Queensland Planners Conference (Yeppoon, QLD: September 14-16, 1994)</i>
8p. 5 refs
<P><B>Ramsay, G.C.</b>, <B>McArthur, N.A.</b> and <B>Dowling, V.P.</b> (1994)
Planning in fire-prone areas: building survival.
<i>
In: Brown, C and Tohver, L (eds.). Bushfire: looking to the future. Papers from the Nature Conservation Council of NSW Seminar (Sydney, NSW: June, 1994)</i>
(Ch.5): 142-150 5 refs ISBN 0858811405
(Sydney, NSW: Envirobook Publ.)
<P>*Roper, H., <B>Sirivivatnanon, V.</b> and <B>Baweja, D.</b> (1994)
Long-term performance of Portland and blended cement concretes under marine conditions.
<i>
Paper presented at 3rd CANMET/ACI International Conference on Durability of Concrete (Nice, France: May 22-28, 1994)</i>
22p. 19 refs, illus.
<P><B>Roy, J.R.</b> (1994)
Trade with and without intermediaries: some alternative model formulations.
<i>
Annals of Regional Science</i>
28: 329-43  14 refs
[This paper was presented in draft form at an International Worshop on Trade, Knowledge and the Network Economy (Mallacoota, QLD: December 1992)]
<P><B>Rudman, M.</b> and <B>Hourigan, K.</b> (1994)
The importance of shear-rate history in aggregation processes.
<i>
Presented at the 8th International Conference on Surface and Colloid Science (Adelaide, SA: February 13-18, 1994)</i>
8p. 14 refs, illus.
<P><B>Rudman, M.</b>, <B>Thompson, M.C.</b> and <B>Hourigan, K.</b> (1994)
Particle shear-rate history in a Taylor-Couette colume.
<i>
Paper for the 5th International Symposium on Solid-Liquid Flows (Nevada, USA: June 19-23, 1994)</i>
14p. 6 refs, illus.
<P><B>Rudman, M.</b> (1994)
Numerical simulation of a jet in a cross-flow.
<i>
Paper presented at an International Colloquium on Jets, Wakes and Shear Layers (Melbourne, Vic: April 18-20, 1994)</i>
8p. 17 refs, illus.
<P><B>Ryan, M.A.</b>, <B>Hildebrandt, M.</b>, <B>Chandrasekaran, V.</b>, <B>McArthur, N.A.</b> and <B>Ramsay, G.C.</b> (1994)
Investigation of smoke and temperature distribution in multi compartments.
<i>
Paper presented at Asian Fire Science Seminar (Sanur, Bali, Indonesia: December 5-6, 1994)</i>
5p., illus.
<P><B>Sagoe-Crentsil, K.K.</b> and <B>Mak, S.L.</b> (1994)
Blended cements cured at elevated temperatures.
<i>
Proceedings of the 2nd International Symposium on Blended Cements (Kuala Lumpur, Malaysia: November 10-11, 1994)</i>
pp.95-99 6 refs, illus.
<P><B>Salomonsson, G.D.</b> and <B>MacSporran, C.</b> (1994)
Recycling of materials in building construction.
<i>
Paper presented at 1st International Conference on Building and the Environment, CIB Task Group 8 (Watford, UK: May 16-20, 1994)</i>
8p. 4 refs
<P><B>Samarasinghe, W.</b> and <B>Lawrence, S.J.</b> (1994)
Behaviour of masonry under combined torsion and compression.
<i>
Proceedings of the 10th International Brick/Block Masonry Conference (Calgary, Canada: July 5-7, 1994)</i>
pp.1057-1066 7 refs, illus.
<P><B>Sankaran, R.</b> and <B>Paterson, D.A.</b> (1994)
Building envelope research in Australia.
<i>
Paper presented at the International Forum on Building Envelope Research (Singapore: December 9, 1994)</i>
8p.
<P><B>Sankaran, R.</b> and <B>Paterson, D.A.</b> (1994)
Wind driven rain: a data collection facility.
<i>
Proceedings of the 4th National Workshop of the Australian Wind Engineering Society (Sydney, NSW: October 6-7, 1994)</i>
pp.37-39 3 refs, illus.
<P><B>Sankaran, R.</b> and <B>Paterson, D.A.</b> (1994)
An open jet wind tunnel at CSIRO, Australia.
<i>
Proceedings of the 4th National Workshop of the Australian Wind Engineering Society (Sydney, NSW: October 6-7, 1994)</i>
pp.25-27 1 ref, illus.
<P><B>Schafer, B.L.</b> (1994)
Consumer versus producer.
<i>
Paper presented at the International Meeting of Technical Agreement Organizations (Sao Paulo, Brazil: June 20-23, 1994)</i>
7p. 1 ref
<P><B>Schafer, B.L.</b> (1994)
ABSAC: the building product appraisal body that operates in Australia.
<i>
Paper presented at an International Meeting of Technical Agreement Organizations (Sao Paulo, Brazil: June 20-23, 1994)</i>
9p., illus.
<P><B>Sharpe, R.</b> (1994)
Accelerating innovation: teleconstruction and decision support systems.
<i>
Paper presented to Achieving World Class Construction Conference (Sydney, NSW: August 30-31, 1994)</i>
12p. 15 refs, illus.
<P><B>Sharpe, R.</b>, <B>Oakes, S.</b>, <B>Haselden, P.C.</b> and <B>Davidson, I.N.P.</b> (1994)
Building Code of Australia expert assistant: putting research into practice.
<i>
Paper presented at First ASCE Congress on Computing in Civil Engineering (Washington, DC, USA: June 20-22, 1994)</i>
2: 1679-1686 9 refs, illus.
(New York, USA: American Society of Civil Engineers)
<P><B>Shayan, A.</b> and <B>Quick, G.W.</b> (1994)
Alkali-aggregate reaction in concrete railway sleepers from Finland.
<i>
Proceedings of the 16th International Conference on Cement Microscopy (Richmond, USA: April 11-14, 1994)</i>
11p. 6 refs, illus.
<P><B>Shayan, A.</b> (1994)
Deterioration of bridge structures due to alkali-aggregate reaction (AAR) in concrete.
<i>
Austroads 1994 Bridge Conference (Melbourne, Vic: February 20, 1994)</i>
8p. 16 refs, illus.
<P><B>Shayan, A.</b> (1994)
Alkali-aggregate reaction: a bridge management problem for road authorities.
<i>
Proceedings of the  17th Australian Road Research Board Conference (Gold Coast, Qld: August 15-19, 1994)</i>
pp.71-85 25 refs, illus.
<P><B>Shayan, A.</b>, <B>Ivanusec, I.</b> and <B>Diggins, R.G.</b> (1994)
Suitability of two rapid test methods for determining the alkali reactivity of sands.
<i>
Cement and Concrete Composites</i>
16: 177-188 16 refs, illus.
<P><B>Shayan, A.</b> (1994)
An illustrated guide to the identification of alkali-aggregate reaction in concrete structures.
<i>
Technical Report. Division of Building, Construction and Engineering. CSIRO Australia</i>
(TR94/2): 24p., illus. ISBN 0643056440
<P><B>Shepherd, I.C.</b>, <B>La Fontaine, R.F.</b>, <B>Welch, L.W.</b> and <B>Downie, R.J.</b> (1994)
Velocity measurement in fan and pump rotors using particle image velocimetry.
<i>
ASME Fluids Engineering Division Summer Meeting (Nevada, USA: June 16-23, 1994)</i>
5p. 14 refs, illus.
<P><B>Shepherd, I.C.</b>, <B>La Fontaine, R.F.</b>, <B>Welch, L.W.</b> and <B>Downie, R.J.</b> (1994)
Velocity measurement in fan rotors using particle image velocimetry.
<i>
Paper presented at 5th International Symposium on Solid-Liquid Flows. ASME Summer Meeting (Nevada, USA: June 19-23, 1994)</i>
5p. 14 refs, illus.
<P>*Sheridan, J., <B>Wu, J.</b>, <B>Pullum, L.</b> and <B>Welsh, M.C.</b> (1994)
Non-Newtonian flow over the trailing edge of an aerofoil.
<i>
Paper presented at an International Colloquium on Jets, Wakes and Shear Layers (Melbourne, Vic: April 18-20, 1994)</i>
8p. 6 refs, illus.
<P><B>Shestopal, V.O.</b> and <B>Grubits, S.J.</b> (1994)
Evacuation model for merging traffic flows in multi-room and multi-storey buildings.
<i>
Paper presented at 4th International Symposium on Fire Safety Science (Ottawa, Canada: June 13-17, 1994)</i>
8p. 7 refs, illus.
<P><B>Sirivivatnanon, V.</b>, <B>Cao, H.T.</b> and <B>Nelson, P.</b> (1994)
Mechanical and durability properties of high volume fly ash concrete.
<i>
In: Malhotra, V M (ed.). Proceedings of the 3rd CANMET-ACI International Conference. Durbility and Concrete (Nice, France: May 22-28, 1994)</i>
pp. 967-84  15 refs, illus.
<P><B>Sirivivatnanon, V.</b>, <B>Cao, H.T.</b> and *Nelson, P. (1994)
Mechanical and durability properties of high volume fly ash concrete.
<i>
Paper presented at 3rd CANMET/ACI International Conference on Durability of Concrete (Nice, France: May 22-28, 1994)</i>
20p. 15 refs, illus.
<P><B>Syme, M.J.</b> and <B>Holmes, J.D.</b> (1994)
Optimised wind loads for steel framed industrial buildings.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
4p. 6 refs, illus.
<P><B>Syme, M.J.</b>, <B>Pham, L.</b> and <B>Leicester, R.H.</b> (1994)
The design of rafter overhangs.
<i>
Proceedings of the Pacific-Timber Engineering Conference (Gold Coast, Qld: July 11-15, 1994)</i>
pp.149-152 3 refs, illus, appendix
<P><B>Symons, J.G.</b>, <B>Li, Y.</b>, <B>Delsante, A.E.</b> and <B>Vidakovic, S.S.</b> (1994)
Computational and experimental modelling of building ventilation.
<i>
Paper for AIRAH Conference on International Air Conditioning and Refrigeration (Melbourne, Vic: April 30-May 3, 1994)</i>
10p. 11 refs, illus.
<P><B>Trinidad, G.S.</b> and <B>Marquez, L.O.</b> (1994)
Interfacing GIS with models for urban planning and analysis.
<i>
Proceedings of the International Seminar on Transportation Planning and Policy in a Network and Price Equilibrium Framework (Highett, VIC: August 10-11, 1994)</i>
10p. 10 refs, illus.
<P><B>Tucker, S.N.</b>, <B>Salomonsson, G.D.</b> and <B>MacSporran, C.</b> (1994)
Energy implications of building materials recycling.
<i>
Paper for CIB W70 Symposium on Strategies and Technologies for Maintenance of Modernisation of Buildings (Tokyo, Japan: October 26-28, 1994)</i>
8p. 6 refs, illus.
<P><B>Tucker, S.N.</b> and <B>Treloar, G.J.</b> (1994)
Energy embodied in construction and refurbishment of buildings.
<i>
Paper presented at the 1st International Conference on Building and the Environment, CIB Task Group 8 (Watford, UK: May 16-20, 1994)</i>
8p. 8 refs, illus.
<P><B>Vorobieff, G.</b>, <B>Paterson, D.A.</b> and <B>Knightley, R.</b> (1994)
Hailstone evaluation of cladding materials.
<i>
Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
pp.737-743 12 refs, illus, appendix
<P><B>Walker, G.R.</b> (1994)
Structural codes and standards: the next generation.
<i>
Paper for the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
6p.
<P><B>Way, S.J.</b> and <B>Shayan, A.</b> (1994)
A discussion of the paper "Solubility of Ca(OH)<sub>2</sub> and CaSO<sub>4</sub>.2H<sub>2</sub>O in the liquid phase from hardened cement paste" by W. Ma, P.W. Brown and D. Shi.
<i>
Cement and Concrete Research</i>
24(2): 387-388 8 refs
<P><B>Welsh, M.C.</b>, *Pullum, L., *Baillie, K. and *Kam, P. (1994)
Physical modelling of a bauxite de-silication tank.
<i>
Mech '94. International Mechanical Engineering Congress (Perth, WA: May 15-19, 1994)</i>
7p. 7 refs, illus.
<P><B>Whitlock, J.A.</b> (1994)
Fire technology: on the move.
<i>
Village Views. Riverside Corporate Park. CSIRO Australia</i>
(Nov): 5-6, illus.
<P><B>Williams, P.B..</b> (1994)
Technical approval and quality assurance overcoming market barriers.
<i>
Proceedings of the International Seminar on Importance of Technical Approval in the Civil Construction Quality Development (Sao Paolo, Brazil: June 22-23, 1994)</i>
pp.165-171 9 refs
<P><B>Williams, P.B..</b> (1994)
A decision support system for the economic evaluation of building regulations.
<i>
In: Wakefield, R R, Carmichael, D G (eds.). Proceedings of the National Construction and Management Conference (Sydney, NSW: February 17-18, 1994)</i>
pp.95-111 12 refs, illus.
<P><B>Woodhead, W.D.</b> (1994)
Cost of high density housing.
<i>
Focus. Newsletter. Division of Building, Construction and Engineering. CSIRO Australia</i>
(Winter): p.2, illus.
<P><B>Woodhead, W.D.</b> (1994)
The economics of higher density housing.
<i>
Urban Futures</i>
3(4)/4(1): 43-48 7 refs, illus.
<P><B>Wu, J.</b>, *Sheridan, J., <B>Welsh, M.C.</b>, <B>Hourigan, K.</b> and <B>Thompson, M.C.</b> (1994)
Longitudinal vortex structures in a cylinder wake.
<i>
Physics of Fluids</i>
6(9): 2882-2885 10 refs, illus.
<P>*Wu, J., *Sheridan, J., <B>Soria, J.</b> and <B>Welsh, M.C.</b> (1994)
An experimental investigation of streamwise vortices in the wake of a bluff body.
<i>
Journal of Fluids and Structures</i>
8: 621-635 24 refs, illus.
<P><B>Wu, J.</b>, *Sheridan, J., <B>Welsh, M.C.</b> and <B>Hourigan, K.</b> (1994)
Longitudinal vortices developing in a plane strain field.
<i>
Paper presented at an International Colloquium on Jets, Wakes and Shear Layers (Melbourne, Vic: April 18-20, 1994)</i>
8p. 9 refs, illus.
<P><B>Wu, J.</b>, *Sheridan, J., <B>Welsh, M.C.</b>, <B>Hourigan, K.</b>, *Soria, J. and <B>Thompson, M.C.</b> (1994)
Shear layer vortices and longitudinal vortices in the wake of a circular cylinder.
<i>
Paper presented at an International Colloquium on Jets, Wakes and Shear Layers (Melbourne, Vic: April 18-20, 1994)</i>
7p. 10 refs, illus.
<P>*Wu, J., <B>Welch, L.W.</b>, <B>Welsh, M.C.</b>, *Sheridan, J. and *Walker, G.J. (1994)
Spanwise wake structures of a circular cylinder and two circular cylinders in tandem.
<i>
Experimental Thermal and Fluid Science</i>
9: 299-308 18 refs, illus.
<P><B>Yang, J.H.</b>, <B>Pham, L.</b> and <B>Leicester, R.H.</b> (1994)
Strength and stiffness of floor systems.
<i>
Proceedings of the Pacific-Timber Engineering Conference (Gold Coast, Qld: July 11-15, 1994)</i>
pp.140-143 10 refs, illus, appendix
<P><B>Yeoh, G.H.</b> and <B>Chandrasekaran, V.</b> (1994)
Comparison of effects of central and corner fires using computational fluid dynamics (CFD) techniques.
<i>
Paper presented at '94 Asian Fire Science Seminar (Sanur, Bali, Indonesia: December 5-6, 1994)</i>
5p. 6 refs, illus.
<P>*Young, S.A., *Clancy, P., *Beck, V.R. and <B>Leicester, R.H.</b> (1994)
Model for the performance of timber-framed assemblies in real fires.
<i>
Proceedings of the Australasian Structural Engineering Conference (Sydney, NSW: September 21-23, 1994)</i>
2: 705-711 20 refs, illus.
<P>*Yu, J., *Brook, R., <B>Cole, I.S.</b>, *Morabito, D. and *Demofonti, G. (1994)
Corrosion fatigue of TCMP offshore structural steel in marine environment.
<i>
Paper presented at Royal Society Conference on Structural Materials in Marine Environments (London, UK: May 11-12, 1994)</i>
10p. 30 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-19</DOCNO>
<DOCOLDNO>IA089-000952-B042-45</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/CX1995.html 192.102.250.248 19970208034638 text/html 4014
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:33:59 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:07 GMT
Content-type: text/html
Content-length: 3831
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Office of Space Science and Applications (COSSA)</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>CSIRO Office of Space Science and Applications (COSSA)</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><b>CSIRO Office of Space Science and Applications</b> (1995)
Can SETI connect with ET phoning home?.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(62): p.9, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1995)
CSIRO's Space Science and Technology programs.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(66): 3-8, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1995)
1995 Australia Prize: a new look at the Earth.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(62): 1,4-5, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1995)
New European remote sensing spacecraft launched.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(64): p.7, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1995)
CSIRO's space science and technology programs.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(66): 3-8, illus.
<P><B>de Vries, D.F.</b> (1995)
Pre-dawn thermal infra-red imagery: an airborne acquired user-friendly data set.
<i>
Paper presented at NARGIS 95 (Darwin, NT: July 18-20, 1995)</i>
4p.  10 refs
<P><B>de Vries, D.F.</b> (1995)
Real time bush fire detection using airborne thermal infra-red imagery.
<i>
Paper presented at the Australain Emergency Management Institute Workshop (August 2-4, 1995)</i>
4p. 4 refs
<P><B>de Vries, D.F.</b> (1995)
Successful launch of AUSROC II.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(64): p.6, illus.
<P><B>deVries, D.F.</b> (1995)
Airborne multispectral data including thermal IR from a Learjet platform (Daedalus 1268).
<i>
Paper presented at the 16th Asian Conference on Remote sensing (Thailand: November 20-24,  1995)</i>
6p.  10 refs
<P>*Goss, K., *Chisholm, T., <B>Graetz, R.D.</b>, *Noble, I. and *Barson, M. (1995)
State of the agricultural resource base: a framework for Government response.
<i>
Sustaining the agriculture resource base: a paper prepared by an independent working group for consideration by the Prime Minister's Science and Engineering Council at it 12th meeting (Canberra, ACT: June 23, 1995)</i>
pp. 7-17  8 refs
<P><B>Kingwell, J.</b> (Editor) (1995)
Annual report: 1993-94.
<i>
Annual Report. Satellite Data Acquisition and Utilisation Program. CSIRO Australia</i>
11p. 11 refs, illus, appendix ISBN 0643047670
<P>*Simpson, J.J., Barton, I.J., <B>Kingwell, J.</b>, *Neal, A.B. and Wallace, J. (1995)
Review of CSIRO Multi-Divisional Program on satellite data acquisition and utilisation (MDP-19): analysis of CSIRO earth observation needs.
<i>
COSSA Publication. CSIRO Australia</i>
(34): 44p., 51 refs, illus. ISBN 0643047697
<P>*Williams, G.E., Schmidt, P.W. and <B>Embleton, B.J.J.</b> (1995)
Comment on "The Neoproterozoic (1000-540 Ma) glacial intervals: no more snowball earth?" by Joseph G. Meert and Rob van der Voo.
<i>
Earth and Planetary Science Letters</i>
131: 115-122 12 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-20</DOCNO>
<DOCOLDNO>IA057-000941-B007-368</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/TC1996.html 192.102.250.248 19970208043819 text/html 35951
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:25:37 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:44 GMT
Content-type: text/html
Content-length: 35767
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Tropical Crops and Pastures</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Tropical Crops and Pastures</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Antony, G. and <B>Cox, P.G.</b> (1996)
Sustainable resource use and the evaluation of agronomy R & D.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 76-87  4 refs, illus.
<P>*Armstrong, R.D., <B>Probert, M.E.</b> and *McCosker, K. (1996)
Utilisation of nitrogen from plant residues and fertilisers by wheat in Central Queensland farming systems.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 84-7  4 refs, illus.
<P><B>Ash, A.J.</b>, <B>Howden, S.M.</b> and <B>McIvor, J.G.</b> (1996)
Improved rangeland management and its implications for carbon sequestration.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress: Rangelands in a Sustainable Biosphere  (UT, USA: July 23-28, 1995). Vol. 1. Contributed presentations </i>
pp. 19-20  9 refs ISBN 1884930034
(Denver, CO, USA: Society for Range Management)
<P><B>Aylward, J.H.</b>, <B>Xue, G-P.</b> and <B>Gobius, K.S.</b> (1996)
Rumen biotechnology, probiolics and trace elements in extra production and good animal health.
<i>
Proceedings of the Seminar '96 Goats: for all seasons, for all reasons (Brisbane, QLD: May 4-5, 1996)</i>
pp. 65-8
(Dairy Goat Society of Australia)
<P><B>Besse, P.</b> and <B>McIntyre, C.L.</b> (1996)
Molecular markers: useful tools for sugarcane breeders.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
59-60, 11 refs, illus. ISBN 0643059415
<P><B>Besse, P.</b> and <B>McIntyre, C.L.</b> (1996)
Isolation of an <i>erianthus</i> sect. <i>ripidium</i> specific ribosomal DNA spacer fragment and its usefulness for studying <i>saccarum</i> X <i>erianthus</i> introgression populations.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
61-63, 20 refs, illus. ISBN 0643059415
<P><B>Biggs, J.S.</b>, <B>Vallis, I.</b>, *Kokot, S. and <B>Keating, B.A.</b> (1996)
Effect of depth of urea application on loss of nitrogen by volatilisation from acid soils.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
198-9, 12 refs, illus. ISBN 0643059415
<P><B>Brandon, N.J.</b> and *Dalzell, S.A. (1996)
<i>Macroptilium bracteatum</i>: a promising legume for leys.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference (Toowoomba, QLD: January-February, 1996)</i>
p. 625  3 refs
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Brown, J.R.</b>, <B>Grice, A.C.</b>, <B>McIvor, J.G.</b> and <B>Ash, A.J.</b> (1996)
Herbaceous change in Australia's tropical woodlands. 4. Management implications.
<i>
In: West, N E (ed.). Proceedings of the 5th International Rangeland Congress: Rangelands in a Sustainable Biosphere  (UT, USA: July 23-28, 1995). Vol. 1. Contributed presentations </i>
pp. 70-1  10 refs, illus. ISBN 1884930034
(Denver, CO, USA: Society for Range Management)
<P><B>Brown, J.R.</b> and <B>Ash, A.J.</b> (1996)
Pastures for prosperity. 4. Managing resources: moving from sustainable yield to sustainability in tropical rangelands.
<i>
Tropical Grasslands</i>
30: 47-57  42 refs, illus.
<P><B>Cameron, D.F.</b>, <B>Chakraborty, S.</b>, <B>Manners, J.M.</b> and <B>Edye, L.A.</b> (1996)
Protecting stylo from anthracnose.
<i>
Tropical Grasslands</i>
30: p. 130
<P><B>Cameron, D.F.</b>, <B>Boland, R.M.</b> and <B>Chakraborty, S.</b> (1996)
Breeding shrubby stylo with durable anthracnose resistance.
<i>
Tropical Grasslands</i>
30: p. 132
<P><B>Cameron, D.F.</b>, <B>Edye, L.A.</b>, *Chakraborty, S., *Manners, J.M., <B>Liu, C.J.</b>, <B>Date, R.A.</b> and <B>Boland, R.M.</b> (1996)
An integrated program to improve anthracnose resistance in <i>Stylosanthes</i>: a review.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 112-5  15 refs
<P><B>Campbell, J.A.</b>, <B>Kerslake, R.G.</b> and <B>Tuckett, P.G.</b> (1996)
Sugarcane growth in a controlled environment. I.  Technical specifications and cultural requirements.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
75-76, 9 refs, illus. ISBN 0643059415
<P><B>Campbell, J.A.</b>, <B>Naidu, B.P.</b>, <B>Weaich, K.</b> and <B>Wilson, J.R.</b> (1996)
Preliminary investigation of the effects of foliar application of glycine betaine on the sucrose content of sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
181-2, 14 refs ISBN 0643059415
<P><B>Campbell, J.A.</b> and <B>Bonnett, G.D.</b> (1996)
Sugarcane growth in a controlled environment. 2. Comparison with growth in field environments.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
77-79, 9 refs, illus. ISBN 0643059415
<P><B>Campbell, J.A.</b> and *Strother, S. (1996)
Seasonal variation in pH, carbohydrate and nitrogen of xylem exudate of <i>Vitis vinifera</i>.
<i>
Australian Journal of Plant Physiology</i>
23(1): 115-118 19 refs, illus.
<P><B>Chakraborty, S.</b>, <B>Cameron, D.F.</b>, *Kelemu, S., *Fernandes, C.D. and *d' A. Charchar, M.J. (1996)
risk of serious anthracnose damage to stylo cultivars.
<i>
Tropical Grasslands</i>
30: p. 129
<P><B>Chakraborty, S.</b>, Thomas, M.R. and Ellis, N. (1996)
A multivariate analysis of pathogenic variation  in <i>Colletotrichum gloeosporioides</i> infecting the tropical pasture legume, <i>Stylosanthes scabra</i>.
<i>
Ecology and Epidemilogy</i>
86(3):  283-9  24 refs, illus.
<P><B>Chakraborty, S.</b>, <B>Cameron, D.F.</b> and <B>Lupton, J.A.</b> (1996)
Management through improved understanding: a case history of <i>Stylosanthes</i> anthracnose in Australia.
<i>
In: Chakraborty, S  et al (ed.). Proceedings of a Trilateral Workshop. Pasture and Forage Crop Pathology (MS, USA: April 10-13, 1995)</i>
pp. 603-19  60 refs
(MS, USA: American Society of Agronomy, Inc.)
<P><B>Chakraborty, S.</b> and <B>Cameron, D.F.</b> (1996)
Risks to stylosanthes cultivars from anthracnose disease.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 632
<P>*Chapman, L.S. and <B>Wilson, J.R.</b> (1996)
Economics of ratoon cycle length in sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
169-71, 4 refs, illus. ISBN 0643059415
<P><B>Clements, R.J.</b> (1996)
Pastures for prosperity. 3. The future for new tropical pasture plants.
<i>
Tropical Grasslands</i>
30: 31-46  46 refs, illus.
<P>*Clem, R.L., <B>Brandon, N.J.</b>, *Conway, M.J., <B>Jones, R.M.</b>, *Esdale, C.R., *Hilder, T.B., *Robertson, B., *Willcocks, J., *Chamberlain, J., <B>Date, R.A.</b>, *Cawley, S., *Taylor, K., *Douglas, N. and *Darrow, B. (1996)
Legumes for clay soil: an integrated research project.
<i>
Tropical Grasslands</i>
30: p. 136
<P><B>Coates, D.B.</b> (1996)
Verano and Seca stylos: comparative digestibility, crude protein and mineral levels of plucked shoots.
<i>
Tropical Grasslands</i>
30: p. 134
<P>*Conway, M.J., *Esdale, C.R., *Clem, R.L. and <B>Brandon, N.J.</b> (1996)
Legumes for clay soils: demonstrating establishment, production and persistence.
<i>
Tropical Grasslands</i>
30: p. 137
<P><B>Cox, P.G.</b> and <B>Chapman, S.C.</b> (1996)
Caught in the web: use of the Internet in agricultural R,D&E.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 164-7  17 refs
<P><B>Cox, P.G.</b>, <B>MacLeod, N.D.</b>, *Ridge, P.E. and *Shulman, A.D. (1996)
Reengineering agricultural R,D&E to support management decision-making: problems and prospects.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 168-75  5 refs, illus.
<P><b>CSIRO Division of Tropical Crops and Pastures</b> (1996)
Shadegro on the move!.
<i>
Capricornucopia. Newsletter of Division of Tropical Crops and Pastures. CSIRO Australia</i>
(161): p.1, illus.
<P><B>Dalgliesh, N.P.</b> (1996)
Soil sampling techniques for monitoring water and nitrogen.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 639  2 refs
<P><B>Dalgliesh, N.P.</b> (1996)
Measuring plant-available soil water storage capacity in northern Australia.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 638
<P><B>Date, R.A.</b>, <B>Edye, L.A.</b> and <B>Liu, C.J.</b> (1996)
<i>Stylosanthes</i> sp.aff. <i>scabra</i>: a potential new forage plant for northern Australia.
<i>
Tropical Grasslands</i>
30: p. 133
<P><B>Date, R.A.</b> (1996)
Collecting <i>Rhizobium, Frankia</i> and mycorrhizal fungi.
<i>
Collecting Plant Genetic Diversity: Technical Guidelines</i>
p.551-60, 31 refs
<P><B>Davis, R.</b> and *Gardner, E. (1996)
MEDLI - bringing effluent irrication design into the 21st century.
<i>
Water</i>
May/June: 12-4  18 refs
<P><B>Denman, S.E.</b>, <B>Xue, G-P.</b> and *Patel, B. (1996)
Characterization of a <i>Neocallimastix patriciarum</i> cellulase cDNA (<i>celA</i>) homologous to <i>Trichoderma reesei</i> cellobiohydrolase II.
<i>
Applied and Environmental Microbiology</i>
62(6): 1889-96  51 refs  illus.
<P><B>Diatloff, E.</b>, *Asher, C.J. and <B>Smith, F.W.N.</b> (1996)
Rare earth elements and plant growth.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 203-6  5 refs, illus.
<P><B>Diatloff, E.</b>, *Asher, C.J. and <B>Smith, F.W.N.</b> (1996)
Concentrations of rare earth elements in some Australian soils.
<i>
Australian Journal of Soil Research</i>
34(5): 735-47 33 refs, illus.
<P><B>Eagles, D.A.</b> and <B>Pengelly, B.C.</b> (1996)
Morphological and agronomic attributes of a collection of the genus <i>Teramnus</i>.
<i>
Genetic Resources Communication. Division of Tropical Crops and Pastures. CSIRO Australia</i>
(1996/24): 15p., 9 refs ISBN 0643059075
<P><B>Foale, M.A.</b>, *Carberry, P.S., *McCown, R.L., *Probert, M.E., *Dimes, J.P., *Dalgliesh, N.P. and *Lack, D. (1996)
Farmers, advisers and researchers learning together better management of crops and croplands.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 258-61  3 refs
<P><B>Foale, M.A.</b>, *Cahill, M.A., *Cox, H.W., *Douglas, N. and *Dowling, C. (1996)
Prime hard wheat and malting barley: how does profile nitrogen influence the farmer's choice?.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 254-7   4 refs
<P><B>Gobius, K.S.</b>, <B>Xue, G-P.</b> and <B>Aylward, J.H.</b> (1996)
Towards genetic modification of rumen bacteria for improved pasture fibre digestion.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 655  5 refs
<P><B>Grof, C.P.L.</b>, <B>Glassop, D.</b>, *Quick, W.P., *Sonnewald, U. and <B>Campbell, J.A.</b> (1996)
Molecular manipulation of sucrose phosphate synthase in sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
124-6, 11 refs, illus. ISBN 0643059415
<P><B>Grof, C.P.L.</b>, *Elliott, A., <B>Glassop, D.</b>, *Bertram, J.R., <B>Campbell, J.A.</b> and *Birch, R.G. (1996)
Differential expression of {beta}-glucuronidase in sugarcane under the control of the rice rubisco small subunit promoter.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
120-3, 10 refs, illus. ISBN 0643059415
<P><B>Hacker, J.B.</b>, *Simon, B.K. and *Phengvichith, V. (1996)
The pek savannas of the Lao People's Democratic Republic - ecology and floristics.
<i>
Genetic Resources Communication. Division of Tropical Crops and Pastures. CSIRO Australia</i>
(1996/23): 38p., 1 ref, illus. ISBN 0643053379
<P><B>Hacker, J.B.</b>, *Glatzle, A. and *Vanni, R. (1996)
Paraguay - a potential source of new pasture legumes for the subtropics.
<i>
Tropical Grasslands</i>
30: 273-81, 14 refs, illus.
<P><B>Hacker, J.B.</b> and <B>Pengelly, B.C.</b> (1996)
New plant collections bring opportunities for central Queensland graziers.
<i>
Tropical Grasslands</i>
30: p. 139
<P><B>Hacker, J.B.</b>, <B>Williams, R.J.</b> and <B>Pengelly, B.C.</b> (1996)
A characterisation study of the genus <i>Vigna</i> with regard to potential as forage.
<i>
Genetic Resources Communication. Division of Tropical Crops and Pastures. CSIRO Australia</i>
(1996/22): 20p., 6 refs ISBN 0643053395
<P><B>Hansen, R.W.</b>, <B>Campbell, J.A.</b> and <B>Wilson, J.R.</b> (1996)
Rapid enzymatic assay technique for determination of sucrose in extracts of sugarcane tissues.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
87-88, 3 refs, illus. ISBN 0643059415
<P><B>Harwood, M.R.</b>, <B>Hacker, J.B.</b> and *Mott, J.J. (1996)
<i>Urochloa mosambicensis</i>: a grass with potential for coal mine revegetation in central Queensland.
<i>
Tropical Grasslands</i>
30: p. 152
<P>*Herridge, D.F., <B>Palmer, B.</b>, *Nurhayati, D.P. and Peoples, M.B. (1996)
Evaluation of the xylem ureide method for measuring N<sub> 2</sub> fixation in six tree legume species.
<i>
Soil Biology and Biochemistry</i>
28(3): 218-9  30 refs, illus.
<P>*Herridge, D.F., <B>Palmer, B.</b>, *Nurahyati, D.P. and Peoples, M.B. (1996)
Evaluation of the xylem ureide method for measuring N<sub>2</sub> fixation in six tree legume species.
<i>
Soil Biology and Biochemistry</i>
28(3): 281-289 30 refs, illus.
<P>Higgins, T.J.V., *Randles, J.W. and <B>Manners, J.M.</b> (1996)
Molecular approaches to the management of pasture diseases.
<i>
In: Chakraborty, S  et al (ed.). Proceedings of a Trilateral Workshop. Pasture and Forage Crop Pathology (MS, USA: April 10-13, 1995)</i>
pp. 533-61  15 refs, illus.
(MS, USA: American Society of Agronomy, Inc.)
<P>Holt, J.A., Bristow, K.L. and <B>McIvor, J.G.</b> (1996)
The effects of grazing pressure on soil animals and hydraulic properties of two soils in semi-arid tropical Queensland.
<i>
Australian Journal of Soil Research</i>
34(1): 69-79 22 refs, illus.
<P><B>Horne, P.M.</b> and *Stur, W.W. (1996)
Forages for smallholder livestock production in South-east Asia.
<i>
Tropical Grasslands</i>
30: p. 159
<P><B>Horne, P.M.</b> (1996)
Partnership in research and technology transfer for livestock production through famers' involvment.
<i>
In: Haron, S  et al (eds.). Proceedings of the Silver Jubilee Malaysian Society of Animal Production (MSAP) Conference. New Perspective in Animal Production ( Sarawak, Malaysia: May 28-31, 1996)</i>
pp. 156-62  13 refs, illus.
(Selanger, Malaysia: Malaysian Society of Animal  Production (MSAP))
<P>*Hughes, R.M. and <B>Muchow, R.C.</b> (1996)
Rainfall variability and the New South Wales sugar industry.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
28-30, 6 refs, illus. ISBN 0643059415
<P><B>Huth, N.I.</b>, <B>Keating, B.A.</b>, Bristow, K.L., Verburg, K. and Ross, P.J. (1996)
SWIMV2 in APSIM: an integrated plant, soil water and solute modelling framework.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 667  3 refs
<P>*Jackson, F.S., *Barry, T.N., *Lascano, C. and <B>Palmer, B.</b> (1996)
The extractable and bound condensed tannin content of leaves from tropical tree, shrub and forage legumes.
<i>
Journal of the Science of Food and Agriculture</i>
71: 103-10  20 refs
<P><B>Jackson, P.A.</b> and *Galvez, G. (1996)
Role of variable soil nutrient levels in causing genotype X site interactions in sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
52-54, 5 refs, illus. ISBN 0643059415
<P><B>James, A.T.</b>, *Lawn, R.J. and <B>Imrie, B.C.</b> (1996)
Raising soybean yield through application of crop physiology to agronomy and breeding.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 333-6  10 refs, illus.
<P><B>Jansen, P.I.</b> and <B>Edye, L.A.</b> (1996)
<i>Stylosanthes</i> SP. aff. <i>Scabra</i>, a new stylo for heavy soils.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 670  2 refs
<P><B>Jansen, P.I.</b> and <B>Edye, L.A.</b> (1996)
Variation within <i>Stylosanthes</i> sp. aff. <i>scabra</i> and comparison with its closest allies, <i>S. scabra</i> and <i>S. hamata</i>.
<i>
Australian Journal of Agricultural Research</i>
47(6):  985-96 11 refs, illus.
<P><B>Johnson, A.K.L.</b>, *Shrubsole, D. and *Merrin, M. (1996)
Integrated catchment management in northern Australia: From concept to implementation.
<i>
Land Use Policy</i>
13(4):303-16, illus.
<P><B>Johnson, A.K.L.</b> and *Cramb, R.A. (1996)
Integrated land evaluation to generate risk-efficient land-use options in a coastal catchment.
<i>
Agricultural Systems</i>
50: 287-305 28 refs, illus.
<P><B>Jones, R.M.</b>, <B>Brandon, N.J.</b> and *Conway, M.J. (1996)
<i>Indigofera schimperi</i>: a promising legume for permanent pastures on clay soils.
<i>
Tropical Grasslands</i>
30: p. 138
<P><B>Keating, B.A.</b>, <B>Robertson, M.J.</b>, <B>Muchow, R.C.</b> and <B>Huth, N.I.</b> (1996)
APSIM - Sugar: a modelling framework for sugarcane production systems.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 675  1 ref
<P><B>Keating, B.A.</b>, <B>Dimes, J.P.</b> and <B>McCown, R.L.</b> (1996)
How bad is the drought? Using a cropping system model to assess severity of drought.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 674  3 refs
<P><B>Liu, C.J.</b> and <B>Imrie, B.C.</b> (1996)
Breeding vigorous growth perennial <i>Lablab</i> cultivars.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 679
<P><B>Liu, C.J.</b> and *Musial, J.M. (1996)
Development and application of RFLP and STS in <i>Stylosanthes</i>.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 381-4  12 refs, illus.
<P><B>Liu, C.J.</b> and <B>Imrie, B.C.</b> (1996)
<i>Lablab purpureus</i>: breeding and genetic diversity study.
<i>
Tropical Grasslands</i>
30: p. 147
<P><B>Liu, C.J.</b>, *Musial, J.M. and <B>Cameron, D.F.</b> (1996)
Progress on tagging genes confering anthracnose resistance in <i>Stylosanthes</i> spp.
<i>
Tropical Grasslands</i>
30: p. 131
<P>Lowry, J.B., McSweeney, C.S. and <B>Palmer, B.</b> (1996)
Changing perceptions of the effect of plant phenolics on nutrient supply in the ruminant.
<i>
Australian Journal of Agricultural Research</i>
47(6): 829-42 74 refs, illus.
<P><B>MacLeod, N.D.</b> and Norton, G.A. (1996)
Economic considerations for the assessment of losses due to pasture diseases.
<i>
In: Chakraborty, S  et al (ed.). Proceedings of a Trilateral Workshop. Pasture and Forage Crop Pathology (MS, USA: April 10-13, 1995)</i>
pp. 119-59  78 refs, illus.
(MS, USA: American Society of Agronomy, Inc.)
<P><B>McCown, R.L.</b>, *Hammer, G.L., <B>Hargreaves, J.N.G.</b>, *Holzworth, D.P. and *Freebairn, D.M. (1996)
APSIM: a novel software system for model development, model testing and simulation in agricultural systems research.
<i>
Agricultural Systems</i>
50: 255-271 42 refs, illus.
<P><B>McDonald, C.K.</b> and <B>Clements, R.J.</b> (1996)
Perceived threats and limitations to the future use of sown tropical pasture plants.
<i>
Tropical Grasslands</i>
30: p. 160
<P><B>McDonald, C.K.</b> and <B>Hodgkinson, J.J.</b> (1996)
Measuring spatial variation within pastures.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 686  1 ref
<P><B>McDonald, C.K.</b>, <B>Corfield, J.P.</b>, <B>Hargreaves, J.N.</b> and <B>O'Toole, J.G.</b> (1996)
BOTANAL - a comprehensive sampling and computing procedure for estimating pasture yield and composition. 3. Field recording direct to computer (2nd ed.).
<i>
Technical Memorandum. Division of Tropical Crops and Pastures. CSIRO Australia</i>
(88): 37p. 3 refs ISBN 0643054871
<P><B>McIntyre, C.L.</b> and <B>Jackson, P.A.</b> (1996)
How much selfing occurs in sugarcane breeding programs?.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
47-48, 3 refs ISBN 0643059415
<P><B>McIntyre, C.L.</b> and <B>Manners, J.M.</b> (1996)
Strategies for the suppression of peroxidase gene expression in tobacco. 1. Designing efficient ribozymes.
<i>
Trangenic Research</i>
5: 257-62  19 refs, illus.
<P><B>McIntyre, C.L.</b>, <B>Bettenay, H.M.</b> and <B>Manners, J.M.</b> (1996)
Strategies for the suppression of peroxidase gene expression in tobacco. 2. <i>In vivo</i> suppression of peroxidase activity in transgenic tobacco using ribozyme and antisense constructs.
<i>
Trangenic Research</i>
5: 263-70  33 refs, illus.
<P><B>McIntyre, S.</b> (1996)
Grasses that come and go.
<i>
Growing Idea</i>
(Autumn): 4-5, illus.
<P><B>McIvor, J.G.</b>, *Singh, V., <B>Corfield, J.P.</b> and <B>Jones, R.J.</b> (1996)
Seed production by native and naturalised grasses in north-east Queensland: effects of stocking rate and season.
<i>
Tropical Grasslands</i>
30(2): 262-9, 24 refs, illus.
<P><B>McIvor, J.G.</b>, *Singh, V., <B>Corfield, J.P.</b> and <B>Jones, R.J.</b> (1996)
Seed production by native and naturalised grasses in north-east Queensland: effects of stocking rate season.
<i>
Tropical Grasslands</i>
30: 262-9  24 refs, illus.
<P><B>McNeil, S.D.</b> and <B>Wilson, J.R.</b> (1996)
Measurements of sugarcane (<i>Saccharum</i> sp.) respiration rates using detached stem and leaf tissue and <i>in situ</i> stem tissue.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
80-81, 8 refs, illus. ISBN 0643059415
<P>*Merrin, M., <B>Johnson, A.K.L.</b> and *Prove, B. (1996)
Integrated catchment management.
<i>
Symposium Proceedings. Australian Institute of Agricultural Science</i>
(91):19-35, 4 refs, illus. ISBN 0858561247
<P><B>Muchow, R.C.</b>, *Wood, A.W., <B>Spillman, M.F.</b>, <B>Robertson, M.J.</b> and Thomas, M.R. (1996)
Field techniques to quantify the yield-determining processes in sugarcane. 1. Methodology.
<i>
Proceedings of the Australian Society of Sugar Cane Technologists</i>
pp. 336-43  9 refs, illus.
<P><B>Muchow, R.C.</b>, <B>Robertson, M.J.</b>, *Wood, A.W. and <B>Keating, B.A.</b> (1996)
Effect of nitrogen on the time-course of sucrose accumulation in sugarcane.
<i>
Field Crops Research</i>
47:143-53, 21 refs, illus.
(Elsevier)
<P><B>Muchow, R.C.</b> and *Wood, A.W. (1996)
Rainfall risk and scheduling the harvest of sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
26-27, 5 refs, illus. ISBN 0643059415
<P><B>Naidu, B.P.</b>, <B>Thumma, B.R.</b>, <B>Cameron, D.F.</b> and <B>Hacker, J.B.</b> (1996)
A biochemical approach to improving survival of salt- or drought-stressed plants.
<i>
Tropical Grasslands</i>
30: p. 141
<P>*Parton, W.J., *Mosier, A.R., *Ojima, D.S., *Valentine, D.W., *Schimel, D.S., <B>Weier, K.L.</b> and *Kulmala, A.E. (1996)
Generalized model for N<sub>2</sub> and N<sub>2</sub>O production from nitrification and denitrification.
<i>
Global Biogeochemical Cycles</i>
10(3): 401-12, 36 refs, illus.
<P><B>Pengelly, B.C.</b> and <B>Eagles, D.A.</b> (1996)
Diversity in the tropical legume genus <i>Teramnus</i>.
<i>
Tropical Grasslands</i>
30:298-307, 13 refs, illus.
<P>Peoples, M.B., <B>Palmer, B.</b>, Lilley, D.M., *Minh Duc, L. and *Herridge, D.F. (1996)
Application of <sup>15</sup>N and xylem ureide methods for assessing N<sub>2</sub> fixation of three shrub legumes periodically pruned for forage.
<i>
Plant and Soil</i>
182: 125-37, 33 refs, illus.
<P>*Peters, K.F., <B>Grof, C.P.L.</b>, *Botella, J. and *Albert, H. (1996)
Isolation and genetic manipulation of invertase genes in sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
127-9, 13 refs, illus. ISBN 0643059415
<P>*Pittaway, P. and <B>Weier, K.L.</b> (1996)
Microbial contributions to the fertility and sustainability of ponded pasture systems.
<i>
In: Pittaway, P A, Wildin, J H and McDonald, C K (eds.). Beef production from ponded pastures. Proceedings of a workshop (Yeppoon, QLD: April, 1993). Tropical Grassland Society of Australia, Occasional Publication</i>
(7): 105-107 4 refs ISBN 0959094873
<P>*Prentis, D., *Holmes, P. and <B>Cox, P.G.</b> (1996)
The simultaneous management of price and production risk.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 454-7  8 refs
<P><B>Probert, M.E.</b>, <B>Dimes, J.P.</b>, *Dalal, R.C. and *Strong, W.M. (1996)
APSIM soilwat and soiln: validaiton against observed data for a cracking clay soil.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 458-61  2 refs, illus.
<P><B>Probert, M.E.</b> and <B>Keating, B.A.</b> (1996)
Modelling changes in soil microbial biomass in response to added crop residues.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 462-5  6 refs, illus.
<P><B>Rae, A.L.</b>, <B>Bettenay, H.M.</b>, <B>He, C.</b>, *Masel, A., *Curtis, M.D. and <B>Manners, J.M.</b> (1996)
Genetic engineering to improve <i>Stylosanthes</i>.
<i>
Tropical Grasslands</i>
30: p. 128
<P>*Ramirez, L. and <B>Hacker, J.B.</b> (1996)
Effect of time of tiller emergence and nitrogen fertiliser on seed yield components of <i>Digitaria eriantha</i> cv. Premier.
<i>
Australian Journal of Experimental Agriculture</i>
36(2): 189-195 15 refs, illus.
<P>*Ridge, P.E. and <B>Cox, P.G.</b> (1996)
Models and decision support: bridging the model gap.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 474-7  7 refs
<P>*Ridge, P.E., <B>Foale, M.A.</b>, <B>Cox, P.G.</b> and <B>Carberry, P.S.</b> (1996)
interpretation and value of soil nitrate nitrogen at depth.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 478-81  8 refs
<P>*Roberts, E.H., *Qi, A., *Ellis, R.H., *Summerfield, R.J., <B>Lawn, R.J.</b> and *Shanmugasundaram, S. (1996)
Use of field observations to characterise genotypic flowering responses to photoperiod and temperature: a soyabean exemplar.
<i>
Theoretical and Applied Genetics</i>
93: 519-33, 58 refs, illus.
<P><B>Robertson, M.J.</b>, <B>Muchow, R.C.</b>, *Inman-Bamber, N.G. and *Wood, A.W. (1996)
Relationship between biomass and sucrose accumulation by sugarcane.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
84-86, 9 refs, illus. ISBN 0643059415
<P><B>Robertson, M.J.</b>, <B>Muchow, R.C.</b> and <B>Prestwidge, D.B.</b> (1996)
The sugarbag database system: enhancing the ability of field experimentation to overcome constraints to sugarcane production.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
19-21, 6 refs ISBN 0643059415
<P><B>Roberts, S.E.</b>, <B>Grof, C.P.L.</b>, Bucheli, C.S., Robinson, S.P. and <B>Wilson, J.R.</b> (1996)
Genetic engineering of sugarcane for low colour raw sugar.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
130-2, 16 refs, illus. ISBN 0643059415
<P><B>Russell, J.S.</b> (1996)
Lime the best conditioner for solodic soil.
<i>
Farming Ahead</i>
(49): 33-34, illus.
<P><B>Taylor, J.A.</b> and Braithwaite, R.W. (1996)
Interactions between land uses in Australia's savannas - it's largely in the mind!.
<i>
The futures gazette. Division of Wildlife and Ecology. CSIRO Australia</i>
Ch 10: 107-18, 66 refs ISBN 0643057846
(Collingwood, Vic : CSIRO Publishing)
<P>*Ternouth, J.H., *Bortolussi, G., <B>Coates, D.B.</b>, *Hendricksen, R.E. and <B>McLean, R.W.</b> (1996)
The phosphorus requirements of growing cattle consuming forage diets.
<i>
Journal of Agricultural Science (Cambridge)</i>
126: 503-10  25 refs, illus.
<P>*Turpin, J.E., <B>Huth, N.I.</b>, <B>Keating, B.A.</b> and *Thompson, J.P. (1996)
Computer simulation of the effects of cropping rotations and falow management on solute movement.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 558-61  7 refs, illus.
<P>*Turpin, J.E., <B>Probert, M.E.</b>, *Holford, I.C.R. and <B>Poulton, P.L.</b> (1996)
Simulation of cereal-legume rotations using APSIM.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 562-5  8 refs, illus.
<P>*Uwins, P.J.R., <B>Caglar, A.K.</b>, <B>Imrie, B.C.</b> and *Yago, A.J.E. (1996)
Monitoring water pathways through mungbean pods using backscattered electron microscopy.
<i>
Microscopy Research and Technique</i>
34: 177-89  13 refs, illus.
<P><B>Vallis, I.</b>, <B>Catchpoole, V.R.</b>, *Hughes, R.M., *Myers, R.J.K., *Ridge, D.R. and <B>Weier, K.L.</b> (1996)
Recovery in plants and soils of <sup>15</sup>N applied as subsurface bands of urea to sugarcane.
<i>
Australian Journal of Agricultural Research</i>
47(3): 355-370 29 refs, illus.
<P>*Vanderlip, R.L., *Hammer, G.L. and <B>Muchow, R.C.</b> (1996)
Assessing planting opportunities in semiarid subtropical environments.
<i>
Agricultural Systems</i>
51: 97-112 13 refs, illus.
<P>Verburg, K., <B>Keating, B.A.</b>, Bristow, K.L., <B>Huth, N.I.</b>, Ross, P.J. and <B>Catchpoole, V.R.</b> (1996)
Evaluation of nitrogen fertiliser management strategies in sugarcane using APSIM-SWIM.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
200-2, 5 refs, illus. ISBN 0643059415
<P>Verburg, K., <B>Keating, B.A.</b>, Bristow, K.L., <B>Huth, N.I.</b> and Ross, P.J. (1996)
Modelling nitrate leaching under sugarcane using APSIM-SWIM.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 724  5 refs
<P><B>Walker, D.H.</b> and <B>Johnson, A.K.L.</b> (1996)
Development of a flexible decision support environment for use in evaluating off-site impacts of cane production.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
261-3, 8 refs, illus. ISBN 0643059415
<P><B>Weier, K.L.</b> (1996)
Trace gas emissions from a trash blanketed sugarcane field in tropical Australia.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
271-2, 14 refs ISBN 0643059415
<P><B>Weier, K.L.</b>, <B>McEwan, C.W.</b>, <B>Vallis, I.</b>, <B>Catchpoole, V.R.</b> and *Myers, R.J. (1996)
Potential for biological denitrification of fertilizer nitrogen in sugarcane soils.
<i>
Australian Journal of Agricultural Research</i>
47(1): 67-79 28 refs, illus.
<P><B>Weier, K.L.</b> and *Pittaway, P. (1996)
Nitrogen economy of ponded pasture systems.
<i>
In: Pittaway, P A, Wildin, J H and McDonald, C K (eds.). Beef production from ponded pastures. Proceedings of a workshop (Yeppoon, QLD: April, 1993). Tropical Grassland Society of Australia. Occasional Publication</i>
(7): 88-91 9 refs, illus. ISBN 0959094873
<P><B>Weier, K.L.</b>, <B>Keating, B.A.</b> and *Sunners, F. (1996)
Nitrogen isotope ratios as indicator of the source of nitrate contamination in groundwater.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
269-70, 11 refs, illus. ISBN 0643059415
<P><B>Wilson, J.R.</b> and Kennedy, P.M. (1996)
Plant and animal constraints to voluntary feed intake associated with fibre characteristics and particle breakdown and passage in ruminants.
<i>
Australian Journal of Agricultural Research</i>
47(2): 199-225 66 refs, illus.
<P><B>Wilson, J.R.</b> (1996)
Shade-stimulated growth and nitrogen uptake by pasture grasses in a subtropical environment.
<i>
Australian Journal of Agricultural Research</i>
47(7): 1075-93, 47 refs, illus.
<P><B>Wilson, J.R.</b>, <B>Hogarth, D.M.</b>, <B>Campbell, J.A.</b> and <B>Garside, A.L.</b> (Editors) (1996)
Sugarcane: research towards efficient and sustainable production. Sugar 2000 symposium.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
272 p., refs, illus. ISBN 0643059415
<P><B>Xue, G-P.</b>, <B>Johnson, J.S.</b>, <B>Smyth, D.J.</b>, <B>Dierens, L.M.</b>, <B>Wang, X.</b>, <B>Simpson, G.D.</b>, <B>Gobius, K.S.</b> and <B>Aylward, J.H.</b> (1996)
Temperature-regulated expression of the <i>tac/lacl</i> system for overproduction of a fungal xylanase in <i>Escherichia coli</i>.
<i>
Applied Microbiology and Biotechnology</i>
45: 120-6  12 refs, illus.
<P><B>Xue, G-P.</b>, <B>Gobius, K.S.</b>, <B>Ealing, P.M.</b> and <B>Aylward, J.H.</b> (1996)
Rumen fungal {beta}-glucanased and xylanase genes: potential for genetically engineered cereal crops.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp. 602-5  21 refs<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-21</DOCNO>
<DOCOLDNO>IA089-000952-B044-166</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/EX1996.html 192.102.250.248 19970208035400 text/html 4133
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:41:21 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:12 GMT
Content-type: text/html
Content-length: 3950
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Exploration and Mining</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Exploration and Mining</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Binns, R.A.</b> and *Scott, S.D. (1996)
Massive sulfide mineralisation in felsic volcanic rocks of the eastern Manus Back-Arc Basin, Western Pacific: ODP proposal 479 [extended abstract].
<i>
AGSO Record </i>
 1996(4): 5-8  2 refs, illus. ISBN 0642223955
(Australian Geological Survey Organisation)
[In: Stagg, H M J & Symonds, P A (comp.) Australian and the ocean drilling program: extended abstracts from the 13th Australian Geological Convention (Canberra, 1996).  Based on abstracts originally published in the Geological Society of Australia Abstracts Number 41, Canberra, 1996]
<P><B>Dai, C.</b>, <B>Muhlhaus, H.B.</b>, *Meek, J. and *Fama, M.D. (1996)
Modelling of blocky rock massess using the Cosserat method.
<i>
International Journal of Rock Mechanics and Mining Sciences and Geomechanics Abstracts</i>
33(4): 425-32  10 refs, illus.
<P>*Force, E.R., *Richards, R.P., <B>Scott, K.M.</b>, *Valentine, P.C. and *Fishman, N.S. (1996)
Mineral intergrowths replaced by "elbow-twinned" rutile in altered rocks.
<i>
Canadian Mineralogist</i>
34: 605-14  21 refs, illus.
<P><B>Gulson, B.L.</b> (1996)
Tooth analyses of sources and intensity of lead exposure in children.
<i>
Environmental Health Perspectives</i>
104(3): 306-12  27 refs, illus.
<P><B>Gulson, B.L.</b>, <B>Mizon, K.J.</b>, <B>Korsch, M.J.</b>, *Howarth, D., *Phillips, A. and *Hall, J. (1996)
Impact of blood lead in children and adults following relocation from their source of exposure and contribution of skeletal tissue to blood level.
<i>
Bulletin of Environmental Contamination and Toxicology</i>
56: 543-50  24 refs
<P><B>Gulson, B.L.</b> (1996)
Nails: condern over their use in lead exposure assessment.
<i>
Science of the Total Environment</i>
177: 323-7  6 refs. illus.
<P><B>Gulson, B.L.</b>, <B>Mizon, K.J.</b>, <B>Korsch, M.J.</b> and *Howarth, D. (1996)
Non-orebody sources are significant contributors to blood lead of some children with low to moderate lead exposure in a major lead mining community.
<i>
Science of the Total Environment</i>
36: 309-21  23 refs, illus.
<P><B>O'Brien, G.D.</b>, <B>Esterle, J.S..</b>, Firth, B. and *Kojovic, T. (1996)
Tracking selective in-plant coal breakage by petrographic and probability analysis.
<i>
Proceedings of the Annual Meeting of the Society for Mining, Metallurgay and Exploration (Phoenix, AR, USA: March 11-14, 1996)</i>
(96/48): 4p. 7 refs, illus.
<P><B>Perring, C.S.</b>, <B>Barnes, S.J.</b> and <B>Hill, R.E.T.</b> (1996)
Geochemistry of komatiites from Forrestania, Southern Cross Province, Western Australia: evidence for crustal contamination.
<i>
Lithos</i>
37: 181-97  46 refs, illus.
<P><B>Ramanaidou, E.</b>, *Nahon, D., *Decarreau, A. and *Melfi, A.J. (1996)
Hematite and goethite from duricrusts developed by lateritic chemical weathering of Precambrian banded iron formations, Minas Gerais, Brazil.
<i>
Clays and Clay Minerals</i>
44(1): 22-31  39 refs, illus.
<P><B>Robertson, I.D.M.</b> (1996)
Interpretation of fabrics in  ferruginous lag.
<i>
AGSO Journal of Australian Geology and Geophysics</i>
16(3): 263-70  15 refs, illus.
<P><B>Ryan, C.G.</b> and <B>Griffin, W.L.</b> (1996)
Garnet geotherms: pressure-temperature data from Cr-pyrope garnet xenocrysts in volcanic rocks.
<i>
Journal of Geophysical Research</i>
101(B3): 5611-25  40 refs. illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-22</DOCNO>
<DOCOLDNO>IA057-000940-B048-236</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/OC1996.html 192.102.250.248 19970208041826 text/html 16474
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:05:45 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:33 GMT
Content-type: text/html
Content-length: 16290
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Oceanography</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Oceanography</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Boon, P.I., <B>Virtue, P.</b> and <B>Nichols, P.D.</b> (1996)
Microbial consortia in wetland sediments: a biomarker analysis of the effects of hydrological regime, vegetation and season on benthic microbes.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(1): 27-41 59 refs,  illus.
<P>Brown, M.R., <B>Dunstan, G.A.</b>, Norwood, S.J.. and Miller, K.A. (1996)
Effects of harvest stage and light on the biochemical composition of the diatom <i>Thalassiosira pseudonana</i>.
<i>
Journal of Phycology</i>
32: 64-73 43 refs, illus.
<P><B>Butler, E.C.</b>, <B>Green, G.J.</b>, <B>Higgins, H.W.</b>, <B>Holdsworth, D.G.</b>, <B>Leeming, R.L.</b>, <B>Mackey, D.J.</b>, <B>Morgan, P.P.</b>, <B>Nichols, P.D.</b>, <B>O'Sullivan, J.E.</b>, <B>Plaschke, R.B.</b>, <B>Revill, A.T.</b>, <B>Volkman, J.K.</b> and <B>Watson, R.J.</b> (1996)
Contaminants in the Derwent Estuary: 20 years on.
<i>
Proceedings of the 23rd Hydrology and Water Resources Symposium (Hobart, TAS: May 21-24, 1996)</i>
pp. 679-80  8 refs
<P><B>Butler, E.C.V.</b> (1996)
The analytical chemist at sea: measurements of iodine and arsenic in marine waters.
<i>
Trends in Analytical Chemistry</i>
15(1): 45-52 45 refs, illus.
<P>*Caputi, N., *Fletcher, W.J., <B>Pearce, A.F.</b> and *Chubb, C.F. (1996)
Effect of the Leeuwin current on the recruitment of fish and invertebrates along the Western Australian coast.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(2): 147-55 37 refs, illus.
<P><B>Clift, S.H.</b> (1996)
The Tasmanian Earth Resources Satellite Station, TERSS.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.129
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P>*Coleman, R., <B>White, N.J.</b> and <B>Church, J.A.</b> (1996)
Progress in estimating ocean circulation from satellite altimetry.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.31
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Craig, P.D.</b> (1996)
Undercurrents in Australian coastal oceanography.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.34
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Craig, P.D.</b> (1996)
Velocity profiles and surface roughness under breaking waves.
<i>
Journal of Geophysical Research</i>
101(C1): 1265-1277 34 refs, illus.
<P><B>Cresswell, G.R.</b>, *Changbao, Z., <B>Tildesley, P.C.</b> and <B>Nilsson, C.S.</b> (1996)
SAR observations of internal lee and wake waves from sea mounts.
<i>
COSSA Publication. CSIRO Australia</i>
(37): 36-44 13 refs, illus. ISBN 064305457X
[Kingwell, J (ed.). Proceedings of the First Australian ERS Symposium (Hobart, TAS: February 6, 1996)]
<P><B>Cresswell, G.R.</b>, <B>Tildesley, P.C.</b>, <B>Nilsson, C.S.</b> and *Changbao, Z. (1996)
SAR observations of internal lee and wake waves from sea mounts [abstract].
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.35
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><b>CSIRO Division of Oceanography</b> (1996)
Oceanographers apply heat to the Indonesian throughflow.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(3): 3 illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Captain Neil Cheshire.
<i>
Oceanography Update. Newsletter of the Division of Oceanography. CSIRO Australia</i>
(4): p.5, illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Ocean probe technique.
<i>
Oceanography Update. Newsletter of the Division of Oceanography. CSIRO Australia</i>
(4): p.6, illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Indian Ocean studies generate baseline data.
<i>
Oceanography Update. Newsletter of the Division of Oceanography. CSIRO Australia</i>
(4): p.3, illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Scientists elated at acoustic success.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(3): 4-5 illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Antarctic circumpolar current.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(3): 1, 8 illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Tailoring the diet.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(2): p.5, illus.
<P><b>CSIRO Division of Oceanography</b> (1996)
Changes in the ocean lower WA rainfall?.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(2): 1-2
<P><b>CSIRO Division of Oceanography</b> (1996)
George Cresswell.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(2): p.6, illus.
<P><B>Dunstan, G.A.</b>, <B>Baillie, H.J.</b>, <B>Barrett, S.M.</b> and <B>Volkman, J.K.</b> (1996)
Effect of diet on the lipid composition of wild and cultured abalone.
<i>
Aquaculture</i>
140: 115-27  41 refs
<P>*Fairall, C.W., Bradley, E.F., <B>Godfrey, J.S.</b>, *Wick, G.A., *Edson, J.B. and *Young, G.S. (1996)
Cool-skin and warm-layer effects on sea surface temperature.
<i>
Journal of Geophysical Research</i>
101(C1): 1295-1308 22 refs, illus.
<P><B>Fandry, C.B.</b> (1996)
Checking Australia's rain gauge.
<i>
Oceanography Update. Newsletter of the Division of Oceanography. CSIRO Australia</i>
(4): 1-2, illus.
<P><B>Fandry, C.B.</b>, <B>Walker, S.</b> and <B>Andrewartha, J.R.</b> (1996)
Modelling effluent dispersion in Australian coastal waters.
<i>
Technical Report. National Pulp Mills Research Program. Institute of Natural Resources and Environment. CSIRO Australia</i>
(16): 96p. 14 refs, illus. ISBN 0643059059
<P>Franzmann, P.D., Patterson, B.M., Power, T.R., <B>Nichols, P.D.</b> and Davis, G.B. (1996)
Microbial biomass in a shallow, urban aquifer contaminated with aromatic hydrocarbons: analysis by phospholipid fatty acid content and composition.
<i>
Journal of Applied Bacteriology</i>
(80): 617-25, 30 refs, illus.
<P>Franzmann, P.D., Patterson, B.M., Power, T.R., <B>Nichols, P.D.</b> and Davis, G.B. (1996)
Microbial biomass in a shallow, urban aquifer contaminated with aromatic hydrocarbons: analysis by phospholipid fatty acid content and composition.
<i>
Journal of Applied Bacteriology</i>
80: 617-25  30 refs, illus.
<P>*Gersbach, G., *Pattiaratchi, C., <B>Pearce, A.F.</b> and *Ivey, G. (1996)
The summer dynamics of the oceanography of the south-west coast of Australia: the Capes Current.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.132
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Griffin, D.A.</b> and *Thompson, K.R. (1996)
The adjoint method of data assimilation used operationally for shelf circulation.
<i>
Journal of Geophysical Research</i>
101(C2): 3457-3477 38 refs, illus.
<P>*Guthriel, J.N., *Blackall, L.L., *Moriarty, D.J.W. and <B>Nichols, P.D.</b> (1996)
Decomposers of shipwreck HMS Pandora.
<i>
Microbiology Australia</i>
(March): p.17 6 refs, illus.
<P>Hirst, A.C. and <B>McDougall, T.J.</b> (1996)
Deep-water properties and surface buoyancy flux as simulated by a z-coordinate model including eddy-induced advection.
<i>
Journal of Physical Oceanography</i>
26(7): 1320-43  56 refs, illus.
<P>Hirst, A.C., <B>Jackett, D.R.</b> and <B>McDougall, T.J.</b> (1996)
The meridional overturning cells of a World Ocean model in neutral density coordinates.
<i>
Journal of Physical Oceanography</i>
26(5): 775-91  29 refs, illus.
<P>*Karoly, D.J., <B>McIntosh, P.C.</b>, <B>McDougall, T.J.</b>, Hirst, A.C. and *Berrisford, P. (1996)
Similarities of the Deacon cell in the Southern Ocean and the ferrel cells in the atmosphere.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.48
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Latham, V.</b>, <B>Rayner, M.S.</b>, <B>Leeming, R.L.</b>, <B>Nichols, P.D.</b> and <B>Cresswell, G.R.</b> (1996)
Nutrient concentrations in Sydney's continental shelf waters, 1989-1993.
<i>
Proceedings of the 23rd Hydrology and Water Resources Symposium (Hobart, TAS: May 21-24, 1996)</i>
pp. 735-6  2 refs, illus.
<P>*Lenanton, R.C., *Ayvazian, S.G., <B>Pearce, A.F.</b>, *Steckis, R.A. and *Young, G.C. (1996)
Tailor (<i>Pomatomus saltatrix</i>) off Western Australia: where does it spawn and how are the larvae distributed?.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(2): 337-46 27 refs, illus.
<P><B>McDougall, T.J.</b>, Hirst, A.C., *England, M.H. and <B>McIntosh, P.C.</b> (1996)
Implications of a new eddy parameterization for ocean models.
<i>
Geophysical Research Letters</i>
23(16): 2085-8  21 refs, illus.
<P><B>McDougall, T.J.</b>, Hirst, A.C., *England, M.H. and <B>McIntosh, P.C.</b> (1996)
Implications of a new eddy parameterization for ocean models.
<i>
Geophysical Research Letter</i>
23(16): 2085-8  21 refs, illus.
<P><B>McIntosh, P.C.</b> (1996)
Eddies don't always diffuse: the temporal-residual-mean circulation [abstract].
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.65
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Meyers, G.A.</b>, Barton, I.J. and *Coleman, R. (1996)
Ocean structure observed by satellite and Australian droughts in 1993 and 1994 [abstract].
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.71
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Meyers, G.A.</b> (1996)
Variation of Indonesian throughflow and ENSO 1983-1994 [abstract].
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.70
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P><B>Meyers, G.A.</b>, Barton, I.J. and *Coleman, R. (1996)
Ocean structure observed by satellite, and Australian droughts in 1993 and 1994.
<i>
COSSA Publication. CSIRO Australia</i>
(37): 85-93 8 refs, illus. ISBN 064305457X
[Kingwell, J (ed.). Proceedings of the First Australian ERS Symposium (Hobart, TAS: February 6, 1996)]
<P>*Mills, D., *D'Adamo, N., *Wyllie, A. and <B>Pearce, A.F.</b> (1996)
The response of stratified shelf waters to the Leeuwin Current and wind forcing: winter observation off Perth, Western Australia.
<i>
Coastal and estuarine studies. Vol. 50. Mixing in estuaries and coastal seas</i>
(Ch. 2): 5-28  25 refs, illus.
(American Geophysical Union)
<P><B>Nichols, P.D.</b>, <B>Leeming, R.L.</b>, <B>Rayner, M.S.</b> and <B>Latham, V.</b> (1996)
Use of capillary gas chromatography for measuring fecal-derived sterols: application to stormwater, the sea-surface microlayer, beach greases, regional studies, and distinguishing algal blooms and human and non-human sources of sewage pollution.
<i>
Journal of Chromatography</i>
733: 497-509  23 refs, illus.
<P><B>Nilsson, C.S.</b>, <B>Cresswell, G.R.</b> and <B>Tildesley, P.C.</b> (1996)
Imaging of oceanic features by synthetic aperture radar [abstract].
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.78
(Hobart, TAS: Australian Meteorological and Oceanographic Society)
<P>Pittock, A.B., Dix, M.R., Hennessy, K.J., <B>Jackett, D.R.</b>, Katzfey, J.J., <B>McDougall, T.J.</b>, McInnes, K.L., O'Farrell, S.P., Smith, I.N., Suppiah, R., Walsh, K.J.E., Whetton, P.H. (-) and Wilson, S.G. (1996)
Progress towards climate change scenario and impact studies for the Southwest Pacific.
<i>
Paper presented at a conference on Science and Impacts of Climate Change in the Pacific Islands (Apia, Western Samoa: April 29 - May 3, 1996)</i>
22p.  72 refs
<P>*Quadfasel, D., *Frische, A. and <B>Cresswell, G.R.</b> (1996)
The circulation in the source area of the South Equatorial Current in the eastern Indian Ocean.
<i>
Journal of Geophysical Research</i>
101(C5): 12,483-8  16 refs, illus.
<P><B>Ridgway, K.R.</b> and <B>Godfrey, J.S.</b> (1996)
Long-term temperature and circulation changes off eastern Australia.
<i>
Journal of Geophysical Research</i>
101(C2): 3615-27  38 refs, illus.
<P>Rothlisberg, P.C., <B>Craig, P.D.</b> and <B>Andrewartha, J.R.</b> (1996)
Modelling penaeid prawn larval advection in Albatross Bay, Australia: defining the effective spawning population.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(2): 157-68 31 refs, illus.
<P>*Taggart, C.T., *Thompson, K.R., *Maillet, G.L., *Lochman, S.E. and <B>Griffin, D.A.</b> (1996)
Abundance distribution of larval cod (<i>Gadus morhua</i>) and zooplankton in gyre-like water mass on the Scotian Shelf.
<i>
Proceedings of an International Workshop on Survival Strategies in Early Life Stages of Marine Resources (Yokohama, Japan: October 11-14, 1994)</i>
pp. 155-73  43 refs, illus.
(Rotterdam, The Netherlands: A. A. Balkema)
<P>Turner, P.J., *Burzins, B.A., *Jones, R.T. and <B>Tildesley, P.C.</b> (1996)
A standard archiving format for NOAA HRPT full pass data.
<i>
Proceedings of a Workshop of the 8th Australasian Remote Sensing Conference: Land AVHRR Data Users Group (Canberra, ACT: March 25, 1996)</i>
pp.3-10 4 refs, illus.
(Canberra, ACT: CSIRO Division of Water Resources)
<P>Waterman, L.J., Hirst, A.C. and <B>Godfrey, J.S.</b> (1996)
Seasonal variability and near-surface mixing in a numerical simulation of the Indian Ocean  [abstract].
<i>
Eos</i>
77(22; Supp.): p. W58
[Paper presented at the SEDI International Symposim : Western Pacific Geophysics Meeting (Brisbane, QLD: July 23-27, 1996)]
<P><B>Wijffels, S.E.A.</b> (1996)
Towards the mean circulation of the equatorial Pacific Ocean.
<i>
In: Paltridge, G and Platt, C M R (eds.). Proceedings of the 3rd National AMOS Conference: incorporating the 4th Australasian Conference on the Physics of Remote Sensing of Atmosphere and Ocean and the 1st Australian ERS-1 Symposium (Hobart, TAS: February 5-7, 1996)</i>
p.115
(Hobart, TAS: Australian Meteorological and Oceanographic Society)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-23</DOCNO>
<DOCOLDNO>IA057-000941-B004-100</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/PL1996.html 192.102.250.248 19970208042922 text/html 33812
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:16:41 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:36 GMT
Content-type: text/html
Content-length: 33628
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Plant Industry</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Plant Industry</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Adams, L.G.</b> (1996)
Two new endemic species of <i>Sagina L.</i> (Caryophyllaceae) from Australia.
<i>
Muelleria</i>
9: 63-6  illus.
<P><B>Agostino, A.</b>, *Heldt, H.W. and <B>Hatch, M.D.</b> (1996)
Mitochondrial respiration in relation to photosynthetic C<sub>4</sub> acid decarboxylation in C<sub>4</sub> species.
<i>
Australian Journal of Plant Physiology</i>
23(1): 1-7 24 refs, illus.
<P>*Akiew, S., *Trevorrow, P.R. and <B>Kirkegaard, J.A.</b> (1996)
Mustard green manure reduces bacterial wilt.
<i>
Bacterial Wilt Newsletter</i>
(13): 5-6  7 refs
<P><B>Andersson, C.R.</b>, *Jensen, E.O., <B>Llewellyn, D.J.</b>, <B>Dennis, E.S.</b> and <B>Peacock, W.J.</b> (1996)
A new hemoglobin gene from soybean: a role for hemoglobin in all plants.
<i>
Proceedings of the National Academy of Sciences, USA</i>
93: 5682-7  31 refs, illus.
<P><B>Andrews, J.L.</b>, <B>Blundell, M.J.</b> and <B>Skerritt, J.H.</b> (1996)
Differentiation of wheat-rye translocation lines using antibody probes for <i>GLi-B1</i> and <i>Sec-1</i>.
<i>
Journal of Cereal Science</i>
23: 61-72  40 refs, illus.
<P><B>Angus, J.F.</b>, <B>Peoples, M.B.</b>, <B>Gault, R.R.</b>, <B>Gardner, P.A.</b> and <B>Howe, G.N.</b> (1996)
Improved pastures and their effects on subsequent crops.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.68-71 12 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Angus, J.F.</b>, *Williams, R.L. and <B>Durkin, C.O..</b> (1996)
MAMAGE RICE: decision support for tactical crop management.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.72-75 11 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Angus, J.F.</b>, *Gupta, V.S.S.R., *Good, A.J., <B>Howe, G.N.</b> and *Pitson, G.D. (1996)
Anhydrous ammonia applied as Coldflo<sup>TM</sup> to wheat.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.617
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Barlow, B.A.</b> (1996)
Advances in systematic knowledge of Australian Loranthaceae and Viscaceae: a review.
<i>
Telopea</i>
6(4): 851-62  54 refs
<P><B>Barrett, D.J.</b>, Hatton, T.J., *Ash, J.E. and *Ball, M.C. (1996)
Transpiration by trees from contrasting forest types.
<i>
Australian Journal of Botany</i>
44: 249-63 45 refs, illus.
<P>*Bellotti, W.D., <B>Moore, A.D.</b>, *Grace, P.R. and *Trigg, I.R. (1996)
Predicting growth of wheat following pasture.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.621 1 ref
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Bergersen, F.J.</b> (1996)
Delivery of O<sub> 2</sub> to bacteroids in soybean nodule cells: consideration of gradients of concentration of free, dissolved O<sub> 2</sub> in and near symbiosomes and beneath intercellular spaces.
<i>
Protoplasma</i>
191: 9-20  23 refs, illus.
<P>Berman, M., <B>Bason, M.L.</b>, *Ellison, F. and <B>Wrigley, C.W.</b> (1996)
Image analysis of whole grains to screen for flour-milling yield in wheat breeding.
<i>
Cereal Chemistry</i>
73(3): 323-7  19 refs, illus.
<P>Berman, M., <B>Bason, M.L.</b>, *Ellison, F., Peden, G.M. and <B>Wrigley, C.W.</b> (1996)
Image analysis of whole grains to screen for flour-milling yield in wheat breeding.
<i>
Cereal Chemistry</i>
73(3): 323-327  19 refs, illus.
<P>*Bishop, H.G., *Cook, B.G., *Hopkinson, J.M., *Hilder, T.B. and <B>Oram, R.N.</b> (Registrar) (1996)
New herbage plant cultivar. B. Legumes.
<i>
Tropical Grasslands</i>
30(2): 271-2, 7 refs
<P>*Blum, A., <B>Munns, R.E.</b>, <B>Passioura, J.B.</b> and <B>Turner, N.C.</b> (1996)
Genetically engineered plants resistant to soil drying and salt stress: how the interpret osmotic relations? [letter].
<i>
Plant Physiology</i>
110: 1051-3  
<P>*Carslon, I.T., <B>Oram, R.N.</b> and *Surprenant, J. (1996)
Reed canarygrass and other <i>Phalaris</i> species.
<i>
In: Bartels, J M (Managing ed.) Cool-season forage grasse. Agronomy Monograph no. 34</i>
Ch. 18: 569-604  241 refs, illus.
(Madison, WI, USA: American Society of Agronomy, Inc.)
<P><B>Chapple, R.M.</b>, <B>Chaudhury, A.M.</b>, <B>Blomer, K.C.</b>, <B>Farrell, L.B.</b> and <B>Dennis, E.S.</b> (1996)
Construction of a YAC contig of 2 megabases around the <i>MS1</i> gene in <i>Arabidopsis thaliana</i>.
<i>
Australian Journal of Plant Physiology</i>
23(4): 453-65 32 refs, illus.
<P>*Chin-Atkins, A.N., <B>Craig, S.</b>, *Hocart, C.H., <B>Dennis, E.S.</b> and <B>Chaudhury, A.M.</b> (1996)
Increased endogenous cytokinin in the <i>Arabidopsis amp1</i> mutant corresponds with de-etiolation response.
<i>
Planta</i>
198: 549-56  39 refs, illus.
<P><B>Craig, S.</b> and Beaton, C.D. (1996)
A simple cryo-SEM method for delicate plant tissues.
<i>
Journal of Microscopy</i>
182(pt 2): 102-5  8 refs, illus.
<P><B>Craven, L.A.</b> and *Withers, R.M. (1996)
A second species of <i>Rhododendron</i> (Ericaceae) from Australia.
<i>
Ediburgh Journal of Botany</i>
53(1): 27-37  8 refs, illus.
<P><B>Craven, L.A.</b> (1996)
Proposal to conserve the name <i>Rhododendron lochiae</i> F. Muell. (<i>Ericaceae</i>) with a conserved type.
<i>
Taxon</i>
(45): 135-136
<P><b>CSIRO Division of Plant Industry</b>, <b>CSIRO Division of Soils</b>, <b>NSW Agriculture</b>, <b>NSW Department of Land and Water Conservation</b> and <b>CSIRO Centre for Environmental Mechanics</b> (1996)
Research for profitable and sustainable cropping.
<i>
Miscellaneous Bulletin. Institute of Plant Production & Processing. CSIRO Australia</i>
16p., illus.
<P><B>Culvenor, R.A.</b> and <B>Oram, R.N.</b> (1996)
Comparison of winter-active phalaris with the Australian cultivar under rotational grazing 1. Basal area and plant density.
<i>
Australian Journal of Experimental Agriculture</i>
36(3):  277-86 31 refs, illus.
<P><B>Culvenor, R.A.</b>, Wood, J.T. and <B>Oram, R.N.</b> (1996)
Comparison of winter-active phalaris with the Australian cultivar under rotational grazing 2. Dry matter on offer, pasture composition and animal production.
<i>
Australian Journal of Experimental Agriculture</i>
36(3): 287-97 15 refs, illus.
<P><B>Dann, P.R.</b>, *Derrick, J.W., *Dumaresq, D.C. and *Ryan, M.H. (1996)
The response of organic and conventionally grown wheat to superphosphate and reactive phosphate rock.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 71-8 35 refs, illus.
<P><B>de Bruxelles, G.L.</b>, <B>Peacock, W.J.</b>, <B>Dennis, E.S.</b> and <B>Dolferus, R.</b> (1996)
Abscisic acid induces the alcohol dehydrogenase gene in Arabidopsis.
<i>
Plant Physiology</i>
111: 381-91  55 refs, illus.
<P><B>de Feyter, R.C.</b>, *Young, M., <B>Schroeder, K.A.</b>, <B>Dennis, E.S.</b> and *Gerlach, W. (1996)
A ribozyme gene and an antisense gene are equally effective in conferring resistance to tobacco mosaic virus on transgenic tobacco.
<i>
Molecular and General Genetics</i>
250: 329-38  52 refs, illus.
<P><B>Delhaize, E.</b> (1996)
A metal-accumulator mutant of <i>Arabidopsis thaliana</i>.
<i>
Plant Physiology</i>
111: 849-55  27 refs, illus.
<P>Denmead, O.T., Raupach, M.R., <B>Dunin, F.X.</b>, Cleugh, H.A. and Leuning, R. (1996)
Boundary layer budgets for regional estimates of scalar fluxes.
<i>
Global Change Biology</i>
2: 255-64  15 refs, illus.
<P><B>Dennis, E.S.</b>, <B>Finnegan, E.J.</b>, <B>Bilodeau, P.</b>, <B>Chaudhury, A.M.</b>, *Genger, R., <B>Helliwell, C.A.</b>, <B>Sheldon, C.C.</b>, <B>Bagnall, D.J.</b> and <B>Peacock, W.J.</b> (1996)
Vernalization and the initiation of flowering.
<i>
Cell & Development Biology</i>
7: 441-8  42 refs, illus.
<P>*Denton, M.D., *Hill, C.R., *Bellotti, W.D., *Ballard, R.A. and <B>Gibson, A.H.</b> (1996)
Host specificity of the annual medic-hyphen <i>Rhizobium</i> symbiosis.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.640
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Donnelly, J.R.</b> and <B>Freer, M.</b> (1996)
Using the GrassGro decision support system to establish objective criteria for the definition of exceptional drought.  Report to Bureau of Resource Sciences, Agricultural Production and Natural Resources Branch.
<i>
Division of Plant Industry [miscellaneous publication]. CSIRO Australia</i>
82p. illus.
<P><B>Dove, H.</b> (1996)
Constraints to the modelling of diet selection and intake in the grazing ruminant.
<i>
Australian Journal of Agricultural Research</i>
47(2): 257-275 94 refs, illus.
<P><B>Dove, H.</b> and *Mayes, R.W. (1996)
Plant wax components: a new approach to estimating intake and diet composition in herbivores.
<i>
Journal of Nutrition</i>
126: 13-26 62 refs, illus.
<P><B>Dove, H.</b>, *Mayes, R.W. and <B>Freer, M.</b> (1996)
Effects of species, plant part, and plant age on the n-alkane concentrations in the cuticular wax of pasture plants.
<i>
Australian Journal of Agricultural Research</i>
47(8): 1333-47, 21 refs, illus.
<P><B>Evans, L.T.</b> and <B>Wardlaw, I.F.</b> (1996)
Wheat.
<i>
In: Zamski, E and Schaffer, A A (eds.). Photoassimilate Distribution in Plants and Crops: source-sink relationshipsb</i>
ch. 22: 501-18  138 refs, illus. ISBN 0824794400
<P><B>Freer, M.</b> (1996)
Simulation of animal production and emission of methane and nitrous oxide at four sites, using the GrassGro decision support system.  Report to Hassall and Associates Pty Ltd [consultancy report].
<i>
Division of Plant Industry [miscellaneous publication]. CSIRO Australia</i>
51p. 8 refs, illus.
[Report prepared for the Department of Primary Industries and Energy in support of a project on greenhouse gas implications of sustainable land management practices]
<P><B>Gallardo, M.</b>, <B>Eastham, J.</b>, <B>Gregory, P.J.</b> and <B>Turner, N.C.</b> (1996)
A comparison of plan hydraulic conductances in wheat and lupins.
<i>
Journal of Experimental Botany</i>
47(295): 233-9  42 refs, illus.
<P>*Garcia-Guzman, G., <B>Burdon, J.J.</b>, *Ash, J.E. and *Cunningham, R.B. (1996)
Regional and local patterns in the spatial distribution of the flower-infecting smut fungus <i>Sporisorium amphilophis</i> in natural populations of its host <i>Bothriochloa macra</i>.
<i>
New Phytologist</i>
132: 459-69  28 refs, illus.
<P><B>Gardner, P.A.</b>, *Pitson, G.D. and <B>Angus, J.F.</b> (1996)
Control of take-all of wheat with chloride, break crops, fungicide, fumigation and micro-organisms.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.652
(Carlton, VIC: Australian Society of Agronomy)
<P>*Garnock-Jones, P.J. and <B>Craven, L.A.</b> (1996)
The correct scientific name in <i>Lophomyrtus</i> (Myrtaceae) for ramarama is <i>L. bullata</i> Burret.
<i>
New Zealand Journal of Botany</i>
34: 279-80  5 refs
<P>*Garrill, A., *Tyerman, S.D., *Findlay, G.P. and <B>Ryan, P.R.</b> (1996)
Effects of NPPB and niflumic acid on outward K<sup>+</sup> and CI<sup>-</sup> currents across the plasma membrane of wheat root protoplasts.
<i>
Australian Journal of Plant Physiology</i>
23(4): 527-34 23 refs, illus.
<P><B>Gill, A.M.</b> and <B>Moore, P.H.R.</b> (1996)
Regional and historical fire weather patterns pertinent to the January 1994 Sydney bushfires.
<i>
Proceedings of the Linnean Society of New South Wales</i>
116: 27-36  8 refs, illus. ISBN q
<P><B>Gill, A.M.</b>, <B>Moore, P.H.R.</b> and Williams, R.J. (1996)
Fire weather in the wet-dry tropics of the World Heritage Kakadu National Park, Australia.
<i>
Australian Journal of Ecology</i>
21: 302-308, 28 refs
<P><B>Gill, A.M.</b> and <B>Moore, P.H.R.</b> (1996)
Regional and historical fire weather patterns pertinent to the January 1994 Sydney bushfire.
<i>
Proceedings of the Linnean Society of New South Wales</i>
116: 27-36 8 refs, illus.
<P><B>Gill, A.M.</b> and <B>Moore, P.H.</b> (1996)
Ignitibility of leaves of Australian plants: A contract report to the Australian Flora Foundation.
<i>
Division of Plant Industry [miscellaneous publication]. CSIRO Australia</i>
34 p., illus.
<P><B>Grace, P.R.</b> and <B>Moore, A.D.</b> (1996)
Pasture strategies and fertilizer tactics in cereal-pasture farming: rewards and risks.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.657
(Carlton, VIC: Australian Society of Agronomy)
<P>*Grayling, P.M. and <B>Brooker, M.I.H.</b> (1996)
Evidence for the identity of the hybrid <i>Eucalyptus</i> `brachyphylla' (Myrtaceae) from morphology and essential-oil composition.
<i>
Australian Journal of Botany</i>
44(1): 1-13 20 refs, illus.
<P><B>Gregory, P.J.</b> and <B>Eastham, J.</b> (1996)
Growth of shoots and roots, and interception of radiation by wheat and lupin crops on a shallow, duplex soil in response to time of sowing.
<i>
Australian Journal of Agricultural Research</i>
47(3): 427-447 37 refs, illus.
<P><B>Hearn, A.B.</b> (1996)
An agronomist's odyssey.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.2-16 43 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P>Henry, D.A., *Macmillan, R.H. and <B>Simpson, R.J.</b> (1996)
Measurement of the shear and tensile fracture properties of leaves of pasture grasses.
<i>
Australian Journal of Agricultural Research</i>
47(4): 587-603 32 refs, illus.
<P>*Herridge, D.F., Palmer, B., *Nurhayati, D.P. and <B>Peoples, M.B.</b> (1996)
Evaluation of the xylem ureide method for measuring N<sub> 2</sub> fixation in six tree legume species.
<i>
Soil Biology and Biochemistry</i>
28(3): 218-9  30 refs, illus.
<P>*Herridge, D.F., Palmer, B., *Nurahyati, D.P. and <B>Peoples, M.B.</b> (1996)
Evaluation of the xylem ureide method for measuring N<sub>2</sub> fixation in six tree legume species.
<i>
Soil Biology and Biochemistry</i>
28(3): 281-289 30 refs, illus.
<P><B>Higgins, T.J.V.</b>, *Randles, J.W. and Manners, J.M. (1996)
Molecular approaches to the management of pasture diseases.
<i>
In: Chakraborty, S  et al (ed.). Proceedings of a Trilateral Workshop. Pasture and Forage Crop Pathology (MS, USA: April 10-13, 1995)</i>
pp. 533-61  15 refs, illus.
(MS, USA: American Society of Agronomy, Inc.)
<P><B>Hocking, P.J.</b>, <B>Pinkerton, A.</b> and *Good, A. (1996)
Recovery of field-grown canola from sulfur deficiency.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 79-85 23 refs, illus.
<P><B>Hocking, P.J.</b>, <B>Pinkerton, A.</b> and *Good, A. (1996)
Recovery of field-grown canola from sulfur deficiency.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 79-85 23 refs, illus.
<P>*Horvath, Z.S., *Gooley, A.A., <B>Wrigley, C.W.</b>, *Margolis, J. and *Williams, K.L. (1996)
Preparative affinity membrane electrophoresis.
<i>
Electrophoresis</i>
17: 224-226 8 refs, illus.
<P><B>Jarosz, A.M.</b> and <B>Burdon, J.J.</b> (1996)
Resistance to barley scald (<i>Rhynchosporium secalis</i>) in wild barley grass (<i>Hordeum glaucum</i> and <i>Hordeum leporinum</i>) populations in south-eastern Australia.
<i>
Australian Journal of Agricultural Research</i>
47(3): 413-425 24 refs, illus
<P><B>Jolly, C.J.</b>, *Glenn, G.M. and <B>Rahman, S.</b> (1996)
<i>GSP-1</i> genes are linked to the grain hardness locus (<i>Ha</i>) on wheat chromosome 5D.
<i>
Proceedings of the National Academy of Sciences, USA</i>
93: 2408-2413 39 refs, illus.
<P><B>Kelman, W.M.</b> (1996)
Evaluation of <i>Astragalus</i> L. and <i>Lotus</i> L. on two acid soil sites on the Southern Tablelands of New South Wales.
<i>
Australian Plant Introduction Review. Division of Plant Industry. CSIRO Australia</i>
26(129): 17-38, 35 refs, illus.
<P><B>Kelman, W.M.</b> and *Bowman, A.M. (1996)
Monitoring improvements in seed production and seedling vigour of greater lotus (<i>Lotus pedunculatus</i> Cav.).
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.341-344 5 refs
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Khan, M.R.I.</b>, <B>Ceriotti, a.</b>, <B>Tabe, L.M.</b>, <B>Aryan, A.P.</b>, <B>McNabb, W.</b>, <B>Moore, A.D.</b>, <B>Craig, S.</b>, <B>Spencer, D.</b> and <B>Higgins, T.J.V.</b> (1996)
Accumulation of a sulphur-rich seed albumin from sunflower in the leaves of transgenic subterranean clover (<i>Trifolium subterraneum</i> L.).
<i>
Transgenic Research</i>
5: 179-85  27 refs, illus.
<P><B>King, R.W.</b> and <B>Bagnall, D.J.</b> (1996)
Photoreceptors and the photoperiodic response controlling flowering of <i>Arabidopsis</i>.
<i>
Cell & Development Biology</i>
7: 449-54  34 refs, illus.
<P><B>King, R.W.</b>, *Pate, J.S. and <B>Johnston, J.</b> (1996)
Ecotypic differences in the flowering of <i>Pimelea ferruginea</i> (Thymelaeaceae) in response to cool temperatures.
<i>
Australian Journal of Botany</i>
44(1): 47-55 10 refs, illus.
<P><B>Kirkegaard, J.A.</b>, *Wong, P.T.W. and Desmarchelier, J.M. (1996)
<i>In vitro</i> suppression of fungal root pathogens of cereals by <i>Brassica</i> tissue.
<i>
Plant Pathology</i>
45: 593-603  26 refs, illus.
<P><B>Kirkegaard, J.A.</b>, *Wong, P.T.W. and Desmarchelier, J.M. (1996)
<i>In vitro</i> suppression of fungal root pathogens of cereals by <i>Brassica</i> tissues.
<i>
Plant Pathology</i>
45: 593-603  26 refs, illus.
<P><B>Kirkegaard, J.A.</b>, <B>Angus, J.F.</b>, <B>Howe, G.N.</b>, <B>Gardner, P.A.</b> and Cresswell, H.P. (1996)
Grain oats: a poor break crop for wheat.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.349-352 7 refs
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Kirkegaard, J.A.</b> and *Wong, P.T.W. (1996)
Suppression of soil-borne cereal pathogens and inhibition of wheat germination by mustard seed meal.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.353-356 9 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P>*Ladha, J.K., *Kundu, D.K., *Angelo-Van Coppenolle, M.G., <B>Peoples, M.B.</b>, *Carangal, V.R. and *Dart, P.J. (1996)
Legume productivity and soil nitrogen dynamics in lowland rice-based cropping systems.
<i>
Soil Science Society of America Journal</i>
60(1): 183-92  32 refs, illus.
<P><B>Li, Y.</b>, <B>Tanner, G.</b> and <B>Larkin, P.J.</b> (1996)
The DMACA-HCI protocol and the threshold proanthocyanidin content for bloat safety in forage legumes.
<i>
Journal of Science Food and Agriculture</i>
70: 89-101 46 refs, illus.
<P><B>Llewellyn, D.J.</b> and <B>Last, D.I.</b> (1996)
Genetic engineering of crops for tolerance to 2,4-D.
<i>
In: Duke, S O (ed.). Herbicide-resistant crops: agricultural, environmental, economic, regulatory, and technical aspects</i>
(Ch.10): 159-174 59 refs, illus. ISBN 1566700450
(Boca Raton: CRC Press, Lewis Publ.)
<P><B>Mackie, A.M.</b>, Sharp, P.J. and <B>Lagudah, E.S.</b> (1996)
The nucleotide and derived amino acid sequence of a HMW glutenin gene from <i>Triticum tauschii</i> and comparison with those from the D genome of bread wheat.
<i>
Journal of Cereal Science</i>
24: 73-8  21 refs, illus.
<P>*Mathews, A., <B>Llewellyn, D.J.</b>, <B>Wu, Y.</b> and <B>Dennis, E.S.</b> (1996)
Isolation and characterisation of full-length cDNA clones of the giant taro (<i>Alocasia macrorrhiza</i>) trypsin / chymotrypsin inhibitor.
<i>
Plant Molecular Biology</i>
30: 1035-9  13 refs, illus.
<P><B>Meister, M.</b>, <B>Agostino, A.</b> and <B>Hatch, M.D.</b> (`) (1996)
The roles of malate and aspartate in C<sub> 4</sub> photosynthetic metabolism of <i>Flaveria bidentis</i> (L.)
.
<i>
Planta</i>
199: 262-9  24 refs, illus.
<P><B>Millar, A.A.</b> and <B>Dennis, E.S.</b> (1996)
Protein synthesis during oxygen deprivation in cotton.
<i>
Australian Journal of Plant Physiology</i>
23(3): 341-348 28 refs, illus.
<P>*Namkoong, G., *Boyle, T., *Gregorius, H-R., *Joly, H., *Savolainen, O., *Ratnam, W. and <B>Young, A.G.</b> (1996)
Testing criteria and indicators for assessing the sustainability of fores management: genetic criteria and indicators.
<i>
CIFOR Working Paper No. 10</i>
12p.  4 refs, illus.
<P><B>Oram, R.N.</b> and <B>Edlington, J.P.</b> (1996)
Breeding non-toxic phalaris (<i>Phalaris aquatica</i> L.).
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.450-453 10 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Palta, J.A.</b> and <B>Ludwig, C.</b> (1996)
Why lupin cannot fill all the pods?.
<i>
Agriculture Western Australia. Miscellaneous Publication</i>
(2/96): 106-107 2 refs, illus.
[Nelson, P (ed.). Proceedings of the 4th Western Australian Lupin Update Meeting for Advisers and Consultants (Perth, WA: February 20, 1996)]
<P><B>Palta, J.A.</b> and <B>Ludwig, C.</b> (1996)
Do more pods mean higher seed yields for lupin?.
<i>
Agriculture Western Australia. Miscellaneous Publication</i>
(2/96): 104-105 5 refs, illus.
<P><B>Park, Y-I.</b>, <B>Anderson, J.M.</b> and <B>Chow, W.S.</b> (1996)
Photoinactivation of functional photosystem II and D1-protein synthesis <i>in vivo</i> are independent of the modulation of the photosynthetic apparatus by growth irradiance.
<i>
Planta</i>
198: 300-309 48 refs, illus.
<P><B>Park, Y-I.</b>, <B>Chow, W.S.</b>, <B>Anderson, J.M.</b> and *Hurry, V.M. (1996)
Differential susceptibility of photosystem II to light stress in light-acclimated pea leaves depends on the capacity for photochemical and non-radiative dissipation of light.
<i>
Plant Science</i>
115: 137-49  37 refs, illus.
<P><B>Peoples, M.B.</b>, Palmer, B., <B>Lilley, D.M.</b>, *Minh Duc, L. and *Herridge, D.F. (1996)
Application of <sup>15</sup>N and xylem ureide methods for assessing N<sub>2</sub> fixation of three shrub legumes periodically pruned for forage.
<i>
Plant and Soil</i>
182: 125-37, 33 refs, illus.
<P><B>Pollard, N.J.</b>, <B>Wrigley, C.W.</b>, <B>Bekes, F.</b>, *Aumatell, A. and <B>MacRitchie, F.</b> (1996)
Distinction between genotypes of <i>Lupinus</i> species by sodium dodecyl sulphate-gel electrophoresis and by capillary electrophoresis.
<i>
Electrophoresis</i>
17: 221-223 7 refs, illus.
<P><B>Prober, S.M.</b> (1996)
Conservation of the grassy white box woodlands: rangewide floristic variation and implications for reserve design.
<i>
Australian Journal of Botany</i>
44(1): 57-77 48 refs, illus.
<P>*Quigley, P., *Riffkin, P. and <B>Peoples, M.B.</b> (1996)
Limitations to nitrogen fixation in white clover dairy pastures.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.702
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Rebetzke, G.J.</b> and <B>Richards, R.A.</b> (1996)
Improving the establishment and early vigour of wheat.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.466-469 7 refs
(Carlton, VIC: Australian Society of Agronomy)
<P>*Reeves, M., *Fulkerson, W.J., *Kellaway, R.C. and <B>Dove, H.</b> (1996)
A comparison of three techniques to determine the herbage intake of dairy cows grazing kikuyu (<i>Pennisetum clandestinum</i>) pasture.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 23-30 32 refs
<P>*Reeves, M., *Fulkerson, W.J., *Kellaway, R.C. and <B>Dove, H.</b> (1996)
A comparison of three techniques to determine the herbage intake of dairy cows grazing kikuyu (<i>Pennisetum clandestinum</i>) pasture.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 23-30 32 refs, illus.
<P><B>Russell, C.A.</b> and <B>Fillery, I.R.P.</b> (1996)
Estimates of lupin below-ground biomass nitrogen, dry matter, and nitrogen turnover to wheat.
<i>
Australian Journal of Agricultural Research</i>
47(7): 1047-59, 32 refs
<P><B>Russell, C.A.</b> and <B>Fillery, I.R.P.</b> (1996)
<i>In situ</i> <sup>15</sup>N labelling of lupin below-ground biomass.
<i>
Australian Journal of Agricultural Research</i>
47(7): 1035-46, 33 refs, illus.
<P><B>Sadras, V.O.</b> and <B>Wilson, L.J.</b> (1996)
Effects of timing and intensity of spider mite infestation on the oil yield of cotton crops.
<i>
Australian Journal of Experimental Agriculture</i>
36(5): 577-80 16 refs
<P><B>Samarakoon, A.B.</b> and <B>Gifford, R.M.</b> (1996)
Water use and growth of cotton in response to elevated CO<sub>2</sub> in wet and drying soil.
<i>
Australian Journal of Plant Physiology</i>
23(1): 63-74 34 refs, illus.
<P><B>Samarakoon, A.B.</b> and <B>Gifford, R.M.</b> (1996)
Elevated CO<sub>2</sub> effects on water use and growth of maize in wet and drying soil.
<i>
Australian Journal of Plant Physiology</i>
23(1): 53-62 30 refs, illus.
<P><B>Sharma, I.K.</b> and *Donaldson, S. (1996)
The known rust fungus, <i>Puccinia plagianthi</i>, on a new host, <i>Gynatrix pulchella</i>.
<i>
Australasian Plant Pathology</i>
25(2): p 144  2 refs, illus.
<P><B>Skerritt, J.H.</b> and *Tatham, A.S. (1996)
Cereal seed storage proteins.
<i>
In: van Regenmortel, M H V. Structure of antigens. Vol. 3</i>
(Ch. 12): 349-86  207 refs, illus ISBN 084939225X
(Boca Raton, FL, USA: CRC Press)
<P><B>Skerritt, J.H.</b> and *Rani, B.E.A. (1996)
Detection and removal of sample matrix effects in agrochemical immnoassays.
<i>
In: Beier, R S and Stanker, L H (eds.). Immunoassays for residue analysis: food safety. ACS Symposium Series 621</i>
ch. 3: 29-43  48 refs, illus. ISBN 0841233799
[Developed fro a symposium sponsored by the Division of Agriculture and Food Chemistry at the 209th National Meeting of the American Chemical Society, (Anaheim, CA, USA: April 2-7, 1995)]
<P>*Slafer, G.A. and <B>Rawson, H.M.</b> (1996)
Thermal amplitude does not change rate of development in wheat.
<i>
Cereal Research Communications</i>
24(1): 69-75  23 refs, illus.
<P>*Smettem, K.R.J. and <B>Gregory, P.J.</b> (1996)
The relation between soil water retention and particle size distribution parameters for some predominantly sandy Western Australian soils.
<i>
Australian Journal of Soil Research</i>
34(5): 695-708 37 refs, illus.
<P>Smith, C.J., <B>Freney, J.R.</b> and Bond, W.J. (1996)
Ammonia volatilisation from soil irrigated with urban sewage effluent.
<i>
Australian Journal of Soil Research</i>
34(5): 789-802 33 refs, illus.
<P>*Sorensen, M.B., *Muller, M., <B>Skerritt, J.H.</b> and *Simpson, D. (1996)
Hordein promoter methylation and transcriptional activity in wild-type and mutant barley endosperm.
<i>
Molecular and General Genetics</i>
250: 750-60  54 refs, illus.
<P><B>Stirzaker, R.J.</b> and <B>Passioura, J.B.</b> (1996)
The water relations of the root-soil interface.
<i>
Plant, Cell and Environment</i>
19: 201-8  31 refs, illus.
<P>Stirzaker, R.J. and <B>Passioura, J.B.</b> (1996)
The water relations of the root-soil interface.
<i>
Plant, Cell and Environment</i>
19: 201-8  31 refs, illus.
<P><B>Stirzaker, R.J.</b> and <B>Passioura, J.B.</b> (1996)
The water relations of the root-soil interface.
<i>
Plant, Cell and Environment</i>
19: 201-208 31 refs, illus.
<P>*Strid, A., <B>Chow, W.S.</b> and <B>Anderson, J.M.</b> (1996)
Changes in the relaxation of electrochromic shifts of photosynthetic pigments and in the levels of mRNA transcripts in leaves of <i>Pisum sativum</i> as a result of exposure to supplementary UV-B radiation. The dependency on the intensity of the photosynthetically active radiation.
<i>
Plant and Cell Physiology</i>
37(1): 61-67 23 refs, illus.
<P>*Strid, A., <B>Chow, W.S.</b> and <B>Anderson, J.M.</b> (1996)
Temperature-dependency of changes in the relaxation of electrochromic shifts, of chlorophyll fluorescence, and in the levels of mRNA transcripts in detached leaves from <i>Pisum sativum</i> exposed to supplementary UV-B radiation.
<i>
Plant Science</i>
115: 199-206 15 refs, illus.
<P>*Sutton, K.H. and <B>Wrigley, C.W.</b> (1996)
Megamolecules of protein in our daily bread.
<i>
Chemistry in Australia</i>
August: 346-7  14 refs, illus.
<P><B>Szabo, C.E.</b>, <B>Bekes, F.</b> and <B>Murray, D.</b> (1996)
<i>In vitro</i> polymerisation studies on glutenin subunits.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.63-68 2 refs, illus. ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P>*Toner, M.S., *King, R.H., *Dunshea, F.R., <B>Dove, H.</b> and *Atwood, C.S. (1996)
The effect of exogenous somatotropin on lactation performance of first-litter sows.
<i>
Journal of Animal Science</i>
74: 167-72  21 refs, illus.
<P><B>Turner, N.C.</b>, *Leport, L., *French, R.J., *Thomson, B.D. and *Siddique, K.H.M. (1996)
Adaptation of cool-season pulses to water-limited environments.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.554-557 6 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Van Herwaarden, A.F.</b>, *Farquhar, G.D., <B>Angus, J.F.</b> and <B>Richards, R.A.</b> (1996)
Physiological responses of six spring wheat varieties to nitrogen fertiliser.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.570-573 8 refs, illus.
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Van Herwaarden, A.F.</b> (1996)
Haying-off in wheat: enduring myth or current problem?.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.566-569 19 refs
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Van Herwaarden, A.F.</b> (1996)
Are nitrogen responses of spaced wheat plants representative of a field crop?.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.721
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Wardlaw, I.F.</b> (1996)
Controlling mechanisms of photosynthate translocation in relation to crop yield.
<i>
In: Ishii, R and Horie, T (eds.). Crop Research in Asia: Achievements and Perspective. Proceedings of the 2nd Asian Crop Science Conerence (Fukui, Japan: August 21-3, 1996)</i>
pp. 160-6  30 refs. illus.
<P><B>Ward, P.R.</b>, <B>Dunin, F.X.</b> and <B>Micin, S.F.</b> (1996)
Water balance and drainage in duplex soils.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p.726
(Carlton, VIC: Australian Society of Agronomy)
<P><B>Wilson, L.J.</b>, <B>Bauer, L.R.</b> and *Walter, G.H. (1996)
"Phytophagous" thrips are facultative predators of twospotted spider mites (Acari: Tetranychidae) on cotton in Australia.
<i>
Bulletin of Entomological Research</i>
86: 297-305  46 refs, illus
<P>*Wittenberg, J.B., *Wittenberg, B.A., *Day, D.A., *Udvardi, M.K. and <B>Appleby, C.A.</b> (1996)
Siderophore-bound iron in the peribacteroid space of soybean root nodules.
<i>
Plant and Soil</i>
178: 161-169 39 refs, illus.
<P><B>Wrigley, C.W.</b> (1996)
Second annual meeting of the Australian Electrophoresis Society, Sydney, Australia, April 1995.
<i>
Electrophoresis</i>
17: 203-204
<P><B>Wrigley, C.W.</b>, *Booth, R.I., *Bason, M.L. and *Walker, C.E. (1996)
Rapid Visco Analyser: progress from concept to adoption.
<i>
Cereal Foods World</i>
41(1): 6-11 12 refs, illus.
<P><B>Wrigley, C.W.</b> (1996)
Giant proteins with flour power
.
<i>
Nature</i>
381: 738-9  8 refs, illus.
<P><B>Wrigley, C.W.</b> (1996)
Second annual meeting of the Australian Electrophoresis Society, Sydney, Australia, April 1995.
<i>
Electrophoresis</i>
17: 203-4  
<P><B>Wrigley, C.W.</b>, *Margolis, J. and *Manusu, H.P. (1996)
Large-scale preparative electrophoresis of proteins.
<i>
American Biotechnology Laboratory</i>
14(6): 8, 12  7 refs, illus.
[This paper was presented originally In: Rutherford, E (ed.).  PrepTech '95 Conference (NJ, USA: February 13-15, 1995)]<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-24</DOCNO>
<DOCOLDNO>IA089-000952-B049-149</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MT1994.html 192.102.250.248 19970208040924 text/html 9301
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:56:45 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:31 GMT
Content-type: text/html
Content-length: 9118
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Manufacturing Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Manufacturing Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Bee, J.V., <B>Powell, G.L.F.</b> and <B>Bednarz, B.</b> (1994)
A substructure within the austenitic matrix of high chromium white irons.
<i>
Scripta Metallurgica et Materialia</i>
31(12): 1735-1736 9 refs, illus.
<P><B>Bemelman, R.</b> and <B>Jarvis, D.H.M.</b> (1994)
The facility design toolkit: an overview.
<i>
Divisional Report MTA. Division of Manufacturing Technology. CSIRO Australia</i>
(322): 16p. 16 refs, illus.
<P>*Bergmann, N.W., *Harris, D., <B>Jarvis, D.H.M.</b> and *Mudge, J.C. (1994)
Collaboration technology support for the distributed design process.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA310): 22p. 11 refs, illus.
<P>*Bernus, P. and <B>Nemes, L.</b> (1994)
A framework to define a generic enterprise reference architecture and methodology.
<i>
ICARCV '94. Proceedings of the 3rd International Conference on Automation, Robotics and Computer Vision (Shangri-La, Singapore: November 9-11, 1994)</i>
1: 88-92 12 refs, illus.
(Singapore: Institution of Engineers)
<P>*Calder, P., <B>Jarvis, D.H.M.</b> and *Thomas, B.H. (1994)
A flexible Gantt Chart Editor system.
<i>
Divisional Report MTA. Division of Manufacturing Technology. CSIRO Australia</i>
(309): 18p. 7 refs, illus.
<P><B>Castles, J.</b> and <B>French, I.E.</b> (1994)
Influence of consumable type, power source characteristics, and welding parameters on arc welding fume.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA288): 23p. 28 refs, illus.
<P><B>Corke, P.I.</b>, <B>Dunn, P.A.</b> and <B>Mills, D.C.</b> (1994)
Real time industrial machine vision.
<i>
EEC 94. Electrical Engineering Congress on Enabling Technologies - Developing Industry Congress and Exhibition. Preprints (Sydney, NSW: November 24-30, 1994)</i>
1: 371-375 11 refs, illus. ISBN 0858256088
(Barton, ACT: Institution of Engineers, Australia)
<P><B>Corke, P.I.</b> and Hainsworth, D.W. (1994)
Automated control of a dragline using machine vision.
<i>
EEC 94. Electrical Engineering Congress on Enabling Technologies - Developing Industry Congress and Exhibition. Preprints (Sydney, NSW: November 24-30, 1994)</i>
2: 597-600 6 refs, illus. ISBN 0858256088
(Barton, ACT: Institution of Engineers)
<P><b>CSIRO Division of Coal and Energy Technology</b>, <b>CSIRO Division of Exploration and Mining</b>, <b>CSIRO Division of Manufacturing Technology</b> and <b>CSIRO Division of Mineral and Processing Engineering</b> (1994)
Inside Info. Library. Queensland Centre for Advanced Technologies. CSIRO Australia.
no.1-   [12 p.a.]
<P><b>CSIRO Division of Manufacturing Technology</b> (1994)
Lasers drill through to new export markets.
<i>
Research Results. CSIRO Australia</i>
(2): 51-53, illus.
<P><b>CSIRO Division of Manufacturing Technology</b> (1994)
Mantech matters.
<i>
Mantech Matters. Division of Manufacturing Technology. CSIRO Australia</i>
no.1-    1994 [6 p.a.]
<P><b>CSIRO Division of Manufacturing Technology</b> (1994)
Melbourne Lab News. Newsletter of the CSIRO Division of Manufacturing Technology.
94/1-     [fortnightly]
<P><b>CSIRO Division of Manufacturing Technology</b> (1994)
Fast track Safe-T-Cam helps make roads secure.
<i>
Research Results. CSIRO Australia</i>
(2): 10-13, illus.
<P><b>CSIRO Division of Manufacturing Technology</b> (1994)
Plasma arc technology harnessed for waste destruction.
<i>
Research Results. CSIRO Australia</i>
(2): 20-21, illus.
<P>*Davies, M.H., <B>Painter, M.J.</b> and *Wahab, M. (1994)
A comparison of weld pool shapes prediced from models incorporating conduction and convection: a report on work being done under CRC Project: 93.04.
<i>
Divisional Report MTA. Division of Manufacturing Technology. CSIRO Australia</i>
(316): 9p. 19 refs, illus.
<P>*Davies, M.H., *Wahab, M. and <B>Painter, M.J.</b> (1994)
An investigation of the interaction of a molten droplet with a liquid weld pool surface: a computational & experimental approach.
<i>
Divisional Report MTA. Division of Manufacturing Technology. CSIRO Australia</i>
(294): 10p. 30 refs, illus.
<P><B>Esdaile, R.J.</b> (1994)
Tooling research in the CRC for Alloy & Solidification Technology (CAST).
<i>
Tools '94 Conference Proceedings (Sydney, NSW: September 13-14, 1994)</i>
4p.
<P><B>French, I.E.</b>, <B>Schumann, G-O.</b> and <B>Gordon, T.W.</b> (1994)
Variation of weld mechanical properties with welding practice for gas-shielded flux-cored arc welding.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA276): 12p. 9 refs, illus.
<P><B>Gane, N.</b>, <B>Rogozinski, M.W.</b>, <B>Polivka, F.B.</b>, <B>Doolette, A.G.</b> and <B>Ramakrishnan, S.</b> (1994)
Quality of cut in air plasma arc cutting.
<i>
Proceedings of the 42nd National Welding Conference 1994 (Melbourne, VIC: October 24-27, 1994)</i>
2: 16p. 15 refs, illus.
(Silverwater, NSW: Welding Technology Institute of Australia)
<P><B>Guo, L.</b>, <B>Rogers, K.J.</b> and <B>Kirkham, R.</b> (1994)
A climbing robot with continuous motion.
<i>
Proceedings of the IEEE International Conference on Robotics and Automation (San Diego, CA, USA: May 8-13, 1994)</i>
pp.2495-2500 3 refs, illus.
(Los Alamitos, CA, USA: IEEE Computer Society Press)
<P><B>Jarvis, B.L.</b>, <B>Viano, D.M.</b> and <B>Ahmed, N.U.</b> (1994)
Annual technical report for Project No.93-06: CRC for Materials Welding & Joining.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA306): 23p. 26 refs, illus.
<P><B>Lamacraft, R.R.</b> and <B>Tharumarajah, A.</b> (1994)
Visit to intelligent manufacturing systems test case participants: USA, Canada and Spain, 6-21 October 1994.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA323): 23p.
<P><B>Mills, D.C.</b> (1994)
An extensible architecture for automated surface inspection.
<i>
EEC 94. Electrical Engineering Congress on Enabling Technologies - Developing Industry Congress and Exhibition. Preprints (Sydney, NSW: November 24-30, 1994)</i>
1: 377-381 7 refs, illus. ISBN 0858256088
(Barton, ACT: Institution of Engineers, Australia)
<P><B>Powell, G.L.F.</b> and <B>Lloyd, P.G.</b> (1994)
Comment on "Effect of M<sub>7</sub>C<sub>3</sub>{rarr}M<sub>23</sub>C<sub>6</sub> transformation on fracture behaviour of cast ferritic stainless steels".
<i>
Scripta Metallurgica et Materialia</i>
31(9): 1283-1284 9 refs, illus.
<P><B>Powell, G.L.F.</b> and <B>Carlson, R.A.</b> (1994)
The morphology and microtexture of M<sub>7</sub>C<sub>3</sub> carbides in Fe-Cr-C and Fe-Cr-C-Si alloys of near eutectic composition.
<i>
Journal of Materials Science</i>
29: 1-8 18 refs, illus.
<P><B>Powell, G.L.F.</b> and *Bee, J.V. (1994)
Secondary carbide precipitation in a 18 wt% Cr 1 wt% Mo white iron.
<i>
Technical Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA307): 20p. 8 refs, illus.
<P><B>Redden, G.R.</b> (1994)
Cast tools: a review of technology and techniques using rapid prototyping.
<i>
Divisional Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA325): 32p. 68 refs, illus.
<P><B>Robinson, P.M.</b> (1994)
Manufacturing in the 21st century: towards an holistic future.
<i>
Mantech Matters. Division of Manufacturing Technology. CSIRO Australia</i>
(4): 1-3
<P><B>Robinson, P.M.</b> (1994)
Spreading the manufacturing technology word.
<i>
Australian R&D Review</i>
(April): 21-22, illus.
<P><B>Robinson, P.M.</b> (1994)
On the nature of organisations.
<i>
Mantech Matters. Division of Manufacturing Technology. CSIRO Australia</i>
(3): 1-3
<P><B>Rogozinski, M.W.</b>, <B>Doolette, A.G.</b>, <B>Ramakrishnan, S.</b>, *Farley, P.A., *Sanders, N.A. and *Couch, R.W. (1994)
Development of a "smart" plasma ARC cutting system.
<i>
EEC 94. Electrical Engineering Congress on Enabling Technologies - Developing Industry Congress and Exhibition (Sydney, NSW: November 24-30, 1994). National Conference Publication</i>
94/11(Vol.1): 365-370 24 refs, illus. ISBN 0858256088
(Barton, ACT: Institution of Engineers, Australia)
<P><B>Schumann, G-O.</b> and <B>French, I.E.</b> (1994)
Influence of welding variables on weld metal from microalloyed, rutile-flux cored wires.
<i>
Report. Division of Manufacturing Technology. CSIRO Australia</i>
(MTA290): 8p. 12 refs, illus.
<P><B>Wells, A.J.</b> and <B>Jarvis, D.H.M.</b> (1994)
Visit to Holonic Manufacturing Systems test case participants: Japan 19-30 September, 1994.
<i>
Divisional Report MTA. Division of Manufacturing Technology. CSIRO Australia</i>
(321): 12p., illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-25</DOCNO>
<DOCOLDNO>IA089-000952-B039-123</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/BO1994.html 192.102.250.248 19970208033550 text/html 5587
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:23:11 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:01 GMT
Content-type: text/html
Content-length: 5404
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Biometrics Unit, INRE</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Biometrics Unit, INRE</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Brophy, J.J., *Clarkson, J.R., Craven, L.A. and <B>Forrester, R.I.</b> (1994)
The essential oils of Australian members of the genus <i>Asteromyrtus</i> (Myrtaceae).
<i>
Biochemical Systematics and Ecology</i>
22(4): 409-417 11 refs, illus.
<P>Burdon, J.J., *Wennstrom, A., <B>Muller, W.J.</b> and *Ericson, L. (1994)
Spatial patterning in young stands of <i>Pinus sylvestris</i> in relation to mortality caused by the snow blight pathogen <i>Phacidium infestans</i>.
<i>
Oikos</i>
71: 130-136 18 refs, illus.
<P><B>Correll, R.L.</b>, Butler, J.H., Spouncer, L.R. and Wrigley, C.W. (1994)
The relationship between grain-protein content of wheat and barley and temperatures during grain filling.
<i>
Australian Journal of Plant Physiology</i>
21(6): 869-873 7 refs, illus.
[Paper presented at a workshop on Heat Tolerance in Temperate Cereals (Hawaii: February 5-10, 1994)]
<P>Field, J.B. and <B>Correll, R.L.</b> (1994)
Using bushfire risk assessment to upgrade the electricity distribution system [abstract].
<i>
12th Australian Statistical Society Conference.  Program and Abstracts (Clayton, Vic: July 4-8, 1994)</i>
1p.
<P>Greene, R.S.B., Kinnell, P.I.A. and <B>Wood, J.T.</b> (1994)
Role of plant cover and stock trampling on runoff and soil erosion from semi-arid wooded rangelands.
<i>
Australian Journal of Soil Research</i>
32(5): 953-973 54 refs, illus.
<P>Harris, A.N.M., Dews, G.J., Poiner, I.R. and <B>Kerr, J.D.</b> (1994)
The traditional and island based catch of the Torres Strait Protected Zone: Final report on CSIRO research, 1990-1993.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
47p. 26 refs, illus.
<P>Harris, A.R., Schisler, D.A., <B>Correll, R.L.</b> and Ryder, M.H. (1994)
Soil bacteria selected for suppression of <i>Rhizoctonia solani</i>, and growth promotion, in bedding plants.
<i>
Soil Biology and Biochemistry</i>
26(9): 1249-1255 24 refs
<P>Jernakoff, P., Fitzpatrick, J.J., *Phillips, B.F. and <B>de Boer, E.S.</b> (1994)
Density and growth in populations of juvenile western rock lobsters, <i>Panulirus cygnus</i> (George).
<i>
Australian Journal of Marine and Freshwater Research</i>
45(1): 69-81 26 refs, illus.
<P>Kirkegaard, J.A., Angus, J.F., Gardner, P.A. and <B>Muller, W.J.</b> (1994)
Reduced growth and yield of wheat with conservation cropping. 1. Field studies in the first year of the cropping phase.
<i>
Australian Journal of Agricultural Research</i>
45(3): 511-528 36 refs, illus.
<P>Landsberg, J.J., Stol, J.M. and <B>Muller, W.J.</b> (1994)
Telling the sheep (dung) from the goats.
<i>
Rangeland Journal</i>
16(1): 122-134 15 refs, illus.
<P>Lodder, M.S., Groves, R.H. and <B>Muller, W.J.</b> (1994)
Early seedling growth of three species of <i>Danthonia</i> as affected by depth of sowing and nutrient supply.
<i>
Australian Journal of Botany</i>
42(5): 543-554 27 refs, illus.
<P><B>Morton, R.</b> (1994)
Quasilikelihoods, constrained parameters and E-M algorithm [abstract].
<i>
In: Proceedings of the 12th Australian Statistical Society Conference. Program and Abstracts (Clayton, Vic: July 4-8, 1994)</i>
1p.
<P>Overton, I.C., *Taylor, P.J., Hodgson, G., <B>Correll, R.L.</b>, Hatton, T.J. and Walker, G.R. (1994)
The evaluation of a geographical information system for assessing the health of vegetation on a River Murray Floodplain.
<i>
Paper presented at Water Down Under '94 Conference (Adelaide, SA: November 21-25, 1994)</i>
4p. 11 refs, illus.
<P>Parer, I.P., Sobey, W.R., Conolly, D.I. and <B>Morton, R.</b> (1994)
Virulence of strains of myxoma virus and the resistance of wild rabbits, <i>Oryctolagus cuniculus</i> (L.), from different locations in Australasia.
<i>
Australian Journal of Zoology</i>
42(3): 347-362 51 refs, illus.
<P>Ryder, M.H., Pankhurst, C.E., Rovira, A.D., <B>Correll, R.L.</b> and Ophel Keller, K.M. (1994)
Detection of introduced bacteria in the rhizosphere using marker genes and DNA probes.
<i>
In: O'Gara, F, Dowling, D N and Boesten, B (eds.). Molecular ecology of rhizosphere microorganisms: biotechnology and the release of GMOs</i>
(Ch.3): 29-47 70 refs, illus. ISBN 352730052X
(Weinheim, Germany: VCH)
<P>Smith, C.J., *Chalk, P.M., *Crawford, D.M. and <B>Wood, J.T.</b> (1994)
Estimating gross nitrogen mineralization and immobilization rates in anaerobic and aerobic soil suspensions.
<i>
Soil Science Society of America Journal</i>
58(6): 1652-1660 45 refs, illus.
<P><B>Williams, E.R.</b> and Matheson, A.C. (1994)
Experimental design and analysis for use in tree improvement.
174p., refs, illus. ISBN 064305555X
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Wood, J.T.</b>, *O'Neill, T.J. and *Donnelly, C.F. (1994)
Analysis of medical data from fatal road crashes.
<i>
Federal Office of Road Safety. Report</i>
(CR123): 51p. 10 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-26</DOCNO>
<DOCOLDNO>IA057-000941-B006-232</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/SA1996.html 192.102.250.248 19970208043417 text/html 14908
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:21:39 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:42 GMT
Content-type: text/html
Content-length: 14724
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Soils</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Soils</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>Andersen, A.N. and <B>Spain, A.V.</b> (1996)
The ant fauna of the Bowen Basin, in the semi-arid tropics of central Queensland (Hymenoptera: Formicidae).
<i>
Australian Journal of Entomology</i>
35:213-222, 23 refs, illus.
<P><B>Barrow, N.J.</b> (1996)
The reaction of anions and cations with metal oxides as models for their reation with soil.
<i>
In: Dabrowski, A and Tertykh, V A (eds.). Adsorption on New and Modified Inorganic Sorbents. Studies in Surbace Science and Catalysis, Vol. 99</i>
ch. 3.7: 829-56  81 refs, illus. ISBN 0444821791
<P><B>Bramley, R.G.V.</b>, <B>Roe, S.P.</b>, <B>Barrow, N.J.</b> and <B>Whelan, B.R.</b> (1996)
An evaluation of the P<sub> i</sub> test for soil phosphorus.
<i>
In: Baigent, D R (ed.). Proceedings of the 1st National Workshop on Soil and Plant Analysis (Ballarat, VIC: March 2-4, 1993)</i>
pp. 18-19  3 refs
(Australian Soil and Plant Analysis Council)
<P><B>Bramley, R.G.V.</b>, Ellis, N., <B>Nable, R.O.</b> and *Garside, A.L. (1996)
Changes in soil chemical properties under long-term sugar cane monoculture and their possible role in sugar yield decline.
<i>
Australian Journal of Agricultural Research</i>
34(6): 967-84, 26 refs, illus.
<P><B>Bridge, B.J.</b>, *Sabburg, J., *Habash, K.O., *Ball, J.A.R. and *Hancock, N.H. (1996)
The dielectric behaviour of clay soils and its application to time domain reflectometry.
<i>
Australian Journal of Agricultural Research</i>
34(6): 825-35, 24 refs, illus.
<P><B>Cass, A.</b>, Walker, R.R. and <B>Fitzpatrick, R.W.</b> (1996)
Vineyard soil degradation by salt accumulation and the effect on the performance of the vine.
<i>
Proceedings of the 9th Australian Wine Industry Technical Conference</i>
pp. 153-60  24 refs, illus
<P><B>Cook, S.E.</b>, <B>Corner, R.J.</b>, *Groves, P.R. and *Grealish, G.J. (1996)
Use of airborne gamma radiometric data for soil mapping.
<i>
Australian Journal of Soil Research</i>
34(1): 183-194 23 refs, illus.
<P>*Cox, J.W., *Fritsch, E. and <B>Fitzpatrick, R.W.</b> (1996)
Interpretation of soil features produced by ancient and modern processes in degraded landscapes. 7. Water duration.
<i>
Australian Journal of Agricultural Research</i>
34(6): 803-24, 30 refs, illus.
<P><B>Cresswell, H.P.</b> and <B>Paydar, Z.</b> (1996)
Water retention in Australian soils. 1. Description and prediction using parametric functions.
<i>
Australian Journal of Soil Research</i>
34(2): 195-212 23 refs, illus.
<P><b>CSIRO Division of Plant Industry</b>, <b>CSIRO Division of Soils</b>, <b>NSW Agriculture</b>, <b>NSW Department of Land and Water Conservation</b> and <b>CSIRO Centre for Environmental Mechanics</b> (1996)
Research for profitable and sustainable cropping.
<i>
Miscellaneous Bulletin. Institute of Plant Production & Processing. CSIRO Australia</i>
16p., illus.
<P><b>CSIRO Division of Soils</b> (1996)
Scientific programs and projects.
<i>
Scientific Programs and Projects. Division of Soils.  CSIRO Australia</i>
22p.
<P><b>CSIRO Division of Soils</b> (1996)
Strategic plan: 1996-2000.
<i>
Strategic Plan. Division of Soils.  CSIRO Australia</i>
22p.
<P>*Dang, Y.P., <B>Tiller, K.G.</b>, *Dalal, R.C. and *Edwards, D.G. (1996)
Zinc speciation in soil solutions of vertisols.
<i>
Australian Journal of Soil Research</i>
34(3): 369-383 45 refs, illus.
<P>*Geeves, G.W., <B>Cresswell, H.P.</b>, *Murphy, B.W. and <B>Chartres, C.J.</b> (1996)
Productivity and sustainability from managing soil structure in cropping soils of southern NSW and northern Victoria with lighter-textured surfaces.
<i>
Division of Soils [miscellaneous publication]. CSIRO Australia</i>
16p., illus.
<P>Greene, R.S.B. and <B>Nettleton, W.D.</b> (1996)
Soil genesis in a logitudinal dune-swale landscape, New South Wales, Australia.
<i>
AGSO Journal of Australian Geology & Geophysics</i>
16(3): 277-87  31 refs, illus.
<P><B>Hairsine, P.B.</b> (1996)
Comparing grass filter strips and near-natural riparian forests for buffering intense hillslope sediment sources.
<i>
In: Rutherford, I and Walker, M (eds.). Proceedings of the 1st National Conference on Stream Management in Australia (Merrijig, VIC: February 19-23, 1996)</i>
pp.203-206 7 refs, illus. ISBN 1876006072
<P>*Hamblin, A. and <B>Williams, J.</b> (1996)
Alarming erosion of Australia's soil and land base.
<i>
ATSE Focus</i>
(90): 10-12  4 refs
<P><B>Hollingsworth, I.D.</b>, <B>Fitzpatrick, R.W.</b> and <B>Hudnall, W.</b> (1996)
Distribution and properties of soils in an experimental sub-catchment with altered soil water regimes near Cooke Plains, South Australia.
<i>
Divisional Report. Division of Soils. CSIRO Australia</i>
(126): 42p. 30 refs, illus. ISBN 064305863X
<P><B>Hollingsworth, I.D.</b>, *Boardman, R. and *Fitzpatrick, R.W. (1996)
A soil-site evaluation index of productivity in intensively managed <i>Pinus radiata</i> (D.Don) plantations in South Australia.
<i>
Environmental Monitoring and Assessment</i>
39: 531-41  21 refs, illus.
<P><B>Holt, J.A.</b>, <B>Bristow, K.L.</b> and McIvor, J.G. (1996)
The effects of grazing pressure on soil animals and hydraulic properties of two soils in semi-arid tropical Queensland.
<i>
Australian Journal of Soil Research</i>
34(1): 69-79 22 refs, illus.
<P><B>Huang, J.</b>, *Lacey, S.T. and Ryan, P.J. (1996)
Impact of forest harvesting on the hydraulic properties of surface soil.
<i>
Soil Science</i>
161(2): 79-86 20 refs, illus.
<P>Huth, N.I., Keating, B.A., <B>Bristow, K.L.</b>, <B>Verburg, K.</b> and <B>Ross, P.J.</b> (1996)
SWIMV2 in APSIM: an integrated plant, soil water and solute modelling framework.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 667  3 refs
<P><B>Janik, L.J.</b> and *Keeling, J.L. (1996)
Quantitative determination of halloysite using FT-IR PLS analysis and its application to the characterisation of kaolins from north-western Eyre Peninsula, South Australia.
<i>
Divisional Report. Division of Soils. CSIRO Australia</i>
(129): 1-59, 19 refs, illus.
<P><B>Kinnell, P.I.</b> (1996)
Runoff and sheet erosion from tillage trials under artificial rainfall at Harden, New South Wales.
<i>
Australian Journal of Agricultural Research</i>
34(6): 863-77, 20 refs, illus.
<P><B>Kinnell, P.I.</b>, *Ramos, M.C. and *Uson, A. (1996)
Method-induced variations in soil erodibility in erosion experiments with rain-impacted flow.
<i>
Australian Journal of Soil Research</i>
34(5): 715-20 8 refs, illus.
<P>Kirkegaard, J.A., Angus, J.F., Howe, G.N., Gardner, P.A. and <B>Cresswell, H.P.</b> (1996)
Grain oats: a poor break crop for wheat.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference on Agronomy: Science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
pp.349-352 7 refs
(Carlton, VIC: Australian Society of Agronomy)
<P>Mackenzie, D.H. and <B>Hairsine, P.B.</b> (1996)
The hydraulics of shallow overland flow: a comparison between a grass filter strip and a near-natural riparian forest.
<i>
In: Rutherford, I and Walker, M (eds.). Proceedings of the 1st National Conference on Stream Management in Australia (Merrijig, VIC: February 19-23, 1996)</i>
pp.207-211 13 refs, illus. ISBN 1876006072
<P>*Macks, S.P., *Murphy, B.W., <B>Cresswell, H.P.</b> and *Koen, T.B. (1996)
Soil friability in relation to management history and suitability for direct drilling.
<i>
Australian Journal of Soil Research</i>
34(3): 343-360 42 refs, illus.
<P><B>McKenzie, N.J.</b>, Ryan, P., <B>Gessler, P.E.</b> and <B>O'Connell, D.</b> (1996)
Terrain analysis for land resource assessment.
<i>
ACLEP Newsletter. Australian Collaborative Land Evaluation Program. Division of Soils. CSIRO Australia</i>
5(2): 4-7, 12 refs, illus.
<P><B>McKenzie, N.J.</b> and <B>Jacquier, D.W.</b> (1996)
Procedures for field sampling and laboratory measurement of saturated and unsaturated hydraulic conductivity on large soil cores.
<i>
Divisional Report. Division of Soils. CSIRO Australia</i>
(125): 1-20, 27 refs, illus.
<P><B>McLaughlin, M.J.</b>, <B>Tiller, K.G.</b>, <B>Naidu, R.</b> and *Stevens, D.P. (1996)
Review: the behaviour and environmental impact of contaminants in fertilizers.
<i>
Australian Journal of Soil Research</i>
34(1): 1-54 294 refs, illus.
<P>*McNeill, A.M., *Pilbeam, C.J., *Harris, H.C. and <B>Swift, R.S.</b> (1996)
Seasonal variation in the suitability of different methods for estimating biological nitrogen fixation by grain legumes under rainfed conditions.
<i>
Australian Journal of Agricultural Research</i>
47(7): 1061-73, 35 refs, illus.
<P>*Murray-Wallace, C.V., *Leary, S.P. and <B>Kimber, R.W.</b> (1996)
Amino acid racemisation dating of a last interglacial estuarine deposit at Largs, New South Wales.
<i>
Proceedings of the Linnean Society of New South Wales</i>
116: 213-22  29 refs, illus.
<P>Myers, B.J., Theiveyanathan, S., O'Brien, N.D. and <B>Bond, W.J.</b> (1996)
Growth and water use of <i>Eucalyptus grandis</i> and <i>Pinus radiata</i> plantations irrigated with effluent.
<i>
Tree Physiology</i>
16: 211-219 35 refs, illus.
<P><B>Naidu, R.</b>, <B>McClure, S.G.</b>, <B>McKenzie, N.J.</b> and <B>Fitzpatrick, R.W.</b> (1996)
Soil solution composition and aggregate stability changes caused by long-term farming at four contrasting sites in South Australia.
<i>
Australian Journal of Soil Research</i>
34(4): 511-27 44 refs, illus.
<P><B>Oliver, D.P.</b>, <B>Tiller, K.G.</b>, *Conyers, M.K., *Slattery, W.J., *Alston, A.M. and <B>Merry, R.H.</b> (1996)
Effectiveness of liming to minimise uptake of cadmium by wheat and barley grain grown in the field.
<i>
Australian Journal of Agricultural Research</i>
47(7): 1181-93, 28 refs, illus.
<P><B>Paydar, Z.</b> and <B>Cresswell, H.P.</b> (1996)
Water retention in Australian soils. 2. Prediction using particle size, bulk density, and other properties.
<i>
Australian Journal of Soil Research</i>
34(5): 679-93 27 refs, illus.
<P>*Robinson, B., *Malfroy, H., <B>Chartres, C.J.</b>, *Helyar, K. and Ayers, G.P. (1996)
The sensitivity of ecosystems to acid inputs in the Hunter Valley, Australia.
<i>
Water, Air and Soil Pollution</i>
85: 1721-6  12 refs, illus.
[Reprinted in: Grennfelt, P, Rodhe, H, Thornelof, E, and Wisniewski, J (eds.).  Acid Reign '95? Proceedings from the 5th International Conference on Acidic Deposition: Science & Policy (Goteborg, Sweden: June 26-30, 1995). Volume 3]
<P><B>Roget, D.K.</b>, <B>Neate, S.M.</b> and *Rovira, A.D. (1996)
Effect of sowing point design and tillage practice on the incidence of rhizoctonia root rot, take-all and cereal cyst nematode in wheat and barley.
<i>
Australian Journal of Experimental Agriculture</i>
36(6): 683-93, 31 refs, illus.
<P>*Rolfe, B.G., *Carlson, R.W., *Ridge, R.W., *Dazzo, F.B., *Mateos, P.F. and <B>Pankhurst, C.E.</b> (1996)
Defective infection and nodulation of clovers by exopolysaccharide mutants of <i>Rhizobium leguminosarum</i> bv. <i>trifolii</i>.
<i>
Australian Journal of Plant Physiology</i>
23(3): 285-303 84 refs, illus.
<P>*Skene, T.M., <B>Skjemstad, J.O.</b>, *Oades, J.M. and *Clarke, P.J. (1996)
The influence of inorganic matrices on the decomposition of straw.
<i>
Australian Journal of Soil Research</i>
34(3): 413-426 23 refs, illus.
<P><B>Skjemstad, J.O.</b>, *Clarke, P., *Taylor, J.A., *Oades, J.M. and <B>McClure, S.G.</b> (1996)
The chemistry and nature of protected carbon in soil.
<i>
Australian Journal of Soil Research</i>
34(2): 251-271 34 refs, illus.
<P><B>Smith, C.J.</b>, Freney, J.R. and <B>Bond, W.J.</b> (1996)
Ammonia volatilisation from soil irrigated with urban sewage effluent.
<i>
Australian Journal of Soil Research</i>
34(5): 789-802 33 refs, illus.
<P><B>Smolders, E.</b> and <B>McLaughlin, M.J.</b> (1996)
Effect of Cl on Cd uptake by Swiss chard in nutrient solutions.
<i>
Plant and Soil</i>
179: 57-64 28 refs, illus.
<P><B>Thompson, C.H.</b>, *Bridges, E.M. and *Jenkins, D.A. (1996)
Pans in humus podzols (Humods and Aquods) in coastal southern Queensland.
<i>
Australian Journal of Soil Research</i>
34(1): 161-182 27 refs, illus.
<P><B>Verburg, K.</b>, Keating, B.A., <B>Bristow, K.L.</b>, Huth, N.I. and <B>Ross, P.J.</b> (1996)
Modelling nitrate leaching under sugarcane using APSIM-SWIM.
<i>
In: Asghar, M (ed.). Proceedings of the 8th Australian Agronomy Conference. Agronomy: science with its sleeves rolled up (Toowoomba, QLD: January 30-February 2, 1996)</i>
p. 724  5 refs
<P><B>Verburg, K.</b>, Keating, B.A., <B>Bristow, K.L.</b>, Huth, N.I., <B>Ross, P.J.</b> and Catchpoole, V.R. (1996)
Evaluation of nitrogen fertiliser management strategies in sugarcane using APSIM-SWIM.
<i>
Division of Tropical Crops and Pastures [miscellaneous publication]. CSIRO Australia</i>
200-2, 5 refs, illus. ISBN 0643059415
<P>Wilson, C.J., *Argent, R., *Bunn, S., *Davies, P., *Grayson, R., <B>Hairsine, P.B.</b> and *Rutherfurd, I. (1996)
A simple model to illustrate the effects of riparian revegetation on stream values in large catchments.
<i>
In: Rutherford, I and Walker, M (eds.). Proceedings of the 1st National Conference on Stream Management in Australia (Merrijig, VIC: February 19-23, 1996)</i>
pp.189-195 10 refs, illus. ISBN 1876006072
<P>*Xu, Z.H., <B>Ladd, J.N.</b> and *Elliott, D.E. (1996)
Soil nitrogen availaability in the cereal zone of South Australia. I. Soil organix carbon, total nitrogen, and nitrogen mineralisation rates.
<i>
Australian Journal of Agricultural Research</i>
34(6): 937-48, 23 refs, illus.
<P>*Xu, Z.H., <B>Amato, M.</b>, <B>Ladd, J.N.</b> and *Elliott, D.E. (1996)
Soil nitrogen availability in the cereal zone of South Australia. II. Buffer-extractable nitrogen, mineralisable nitrogen, and mineral nitrogen in soil profile under different land uses.
<i>
Australian Journal of Agricultural Research</i>
34(6): 949-65, 41 refs, illus.
<P><B>Zarcinas, B.A.</b>, <B>McLaughlin, M.J.</b> and <B>Smart, M.K.</b> (1996)
The effect of acid digestion technique on the performace of nebulization systems used in inductively coupled plasma spectrometry.
<i>
Communications in Soil Science and Plant Analysis</i>
27(5-8): 1331-54  19 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-27</DOCNO>
<DOCOLDNO>IA089-000952-B042-287</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/EN1995.html 192.102.250.248 19970208034839 text/html 30956
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:35:55 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:09 GMT
Content-type: text/html
Content-length: 30772
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Entomology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Entomology</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Aeschlimann, J-P.</b>, *Horn, D., *Mackauer, M. and <B>Wellings, P.W.</b> (1995)
Augmentation and enhancement of aphidophaga.
<i>
Agriculture, Ecosystems and Environment</i>
52: 1-2 5 refs
<P><B>Aeschlimann, J-P.</b> (1995)
Lessons from post-release investigations in classical biological control: the case of <i>Microctonus aethiopoides</i> loan (Hym., Braconidae) introduced into Australia and New Zealand for the biological control of <i>Sitona discoideus</i> Gyllenhal (Col., Curculionidae).
<i>
In: Hokkanen, H M T and Lynch, J M (eds.). Biological control: benefits and risks</i>
(Ch.7): 75-83 31 refs, illus. ISBN 0521473535
(UK: Cambridge Univ. Press)
<P>*Allen, M.S., <B>Lacey, M.J.</b> and *Boyd, S.J. (1995)
Methoxypyrazines in red wines: occurrence of 2-methoxy-3-(1-methylethyl)pyrazine.
<i>
Journal of Agricultural and Food Chemistry</i>
43: 769-772 14 refs, illus.
<P><B>Annis, P.C.</b> (1995)
Protected stored grain without methyl bromide in the African environment.
<i>
Paper presented at the Regional Workshop on Methyl Bromide for English-speaking Africa (Harare, Zimbabwe: September 25-26, 1995)</i>
5p. 
<P><B>Annis, P.C.</b>, <B>Banks, H.J.</b> and <B>Graver, J.E.van.S.</b> (1995)
Disinfestation of bagged commodities in-storage, and in-transit with carbon dioxide.
<i>
Proceedings of an Annual International Conference on Methyl Bromide Alternatives and Emissions Reduction (San Diego, USA: November 6-8, 1995)</i>
2p. 5 refs
<P><B>Baker, G.H.</b>, <B>Carter, P.J.</b> and <B>Woods, J.P.</b> (1995)
The potential for earthworms to ameliorate soil acidity.
<i>
Proceedings of the National Soil Acidity Workshop (El Caballo, WA: September 18-21, 1995)</i>
(Ch.12): 145-149 14 refs, illus.
<P><B>Baker, G.H.</b>, <B>Barrett, V.J.</b>, <B>Carter, P.J.</b>, Buckerfield, J.C., Williams, P.M.L. and Kilpin, G.P. (1995)
Abundance of earthworms in soils used for cereal production in south-eastern Australia and their role in reducing soil acidity.
<i>
In: Date, R A #et al# (eds.). Plant soil interactions at low pH</i>
pp.213-218 22 refs, illus.
(The Netherlands: Kluwer Academic Publ.)
<P><B>Baker, G.H.</b> (1995)
Worming your way out of acid problems.
<i>
Pasture Plus</i>
p.380, illus.
<P><B>Baker, G.H.</b>, *Dyer, A.R. and *Fowler, J.C.S. (1995)
Earthworms: what have the French got that we haven't?.
<i>
Working Papers of a Tillage Workshop (Adelaide, SA: March 30-31, 1995)</i>
pp.72-73
<P><B>Banks, H.J.</b> (1995)
Reducing quantity of methyl bromide emitted to the atmosphere through altered practice: contaimnment/reclamation/recycling.
<i>
Paper presented at the Regional Workshop on Methyl Bromide for English-Speaking Africa (Harare, Zimbabwe: September 25-26, 1995)</i>
9p.
<P><B>Banks, H.J.</b> (1995)
Preshipment and quarantine uses of methyl bromide.
<i>
Paper presented at the Regional Workshop on Methyl Bromide for English-Speaking Africa (Harare, Zimbabwe: September 25-26, 1995)</i>
3p.
<P><B>Banks, H.J.</b> (1995)
Practical advantages and disadvatages of methyl bromide in agriculture.
<i>
Paper presented at the Regional Workshop on Methyl Bromide for English-speaking Africa (Harare, Zimbabwe: September 25-26, 1995)</i>
4p. 
<P><B>Banks, H.J.</b> and *Fields, P. (1995)
Physical methods for insect control in stored-grain ecosystems.
<i>
In: Jayas, D, White, N D G and Muir, W E (eds.). Stored-grain ecosystems</i>
(Ch.11): 353-407, refs, illus.
(New York, USA: Marcel Dekker)
<P>*Boothroyal, I.K.G. and <B>Cranston, P.S.</b> (1995)
Two Orthocladinae (Chironomidae) genera common to New Zealand and Australia: <i>Pirara</i> n. gen. and <i>Eukiefferiella</i> Thienemann.
<i>
In: Cranston, P S (ed.). Chironomids: from genes to ecosystems</i>
pp.389-408, illus. ISBN 0643056564
(East Melbourne, VIC: CSIRO Australia)
<P><B>Braby, M.F.</b> (1995)
Seasonal changes in relative abundance and spatial distribution of Australian lowland tropical satyrine butterflies.
<i>
Australian Journal of Zoology</i>
43(3): 209-229 55 refs, illus.
<P><B>Britton, E.B..</b> (1995)
A synopsis of the genera of Diphucephalini (Coleoptera: Scarabaeidae: Melolonthinae) including <i>Watkinsia</i>, gen. nov. et spp. nov.
<i>
Invertebrate Taxonomy</i>
9(1): 115-128 5 refs, illus.
<P><B>Brun, L.A.</b>, <B>Sheppard, A.W..</b>, <B>Delmotte, E.</b>, <B>Hasan, S.</b> and <B>Jourdan, M.</b> (1995)
Development of cercospora blight epidemics and effect on the summer annual <i>Heliotropium europaeum</i> in the field.
<i>
Annals of Applied Biology</i>
127: 137-150 22 refs, illus.
<P><B>Caddick, L.P.</b> (1995)
Can higher moisture wheat be handled safely?.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
(June): p.5, illus.
<P><B>Calder, A.A.</b> (1995)
Genera of Australian click beetles (Coleoptera; Elateridae).
approx. 596p., illus. ISBN 0643056718
(East Melbourne, VIC: CSIRO Australia)
<P><B>Carver, M.</b> (1995)
<i>Euryischomyia</i> Girault (Hymenoptera; Chalcidoidea: Aphelinidae: Eriaporinae: Euryischiini).
<i>
Journal of Hymenoptera Research</i>
4: 64-76 32 refs, illus.
<P><B>Carver, M.</b> (1995)
"A catalogue of the aphids (Homoptera: Aphidoidea) of sub-Saharan Africa" by I M Millar, 1994 [book review].
<i>
Journal of the Australian Entomological Society</i>
34: p.264 3 refs
<P><B>Cassells, J.A.</b>, *Collins, P.J. and <B>Banks, H.J.</b> (1995)
Devitalisation of maize and sorghum by methyl bromide and chloropicrin.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(61): 10p. 7 refs, illus. ISBN 0643052054
<P><B>Cassells, J.A.</b>, *Collins, P.J. and <B>Banks, H.J.</b> (1995)
Devitalisation of maize and sorghum by methyl bromide and chloropicrin.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(61): 10p., illus. ISBN 0643052054
<P><B>Champ, B.R.</b> and *Highley, E. (Editors) (1995)
Fish drying in Indonesia: Proceedings of an international workshop (Jakarta, Indonesia: February 9-10, 1994). ACIAR Proceedings.
(59): 106p., refs, illus. ISBN 1863201440
(Canberra, ACT: Australian Centre for International Agricultural Res.)
<P><B>Clarke, G.M.</b>, *Arthington, A.H. and *Pusey, B.J. (1995)
Fluctuating asymmetry of chironomid larvae as an indicator of pesticide contamination in freshwater environments.
<i>
In: Cranston, P S (ed.). Chironomids: from genes to ecosystems</i>
pp.101-109, illus. ISBN 0643056564
(East Melbourne, VIC: CSIRO Australia)
<P><B>Clarke, G.M.</b> (1995)
ANIC curation evaluation.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(6): 3-4, illus.
<P><B>Clarke, G.M.</b> (1995)
Relationships between developmental stability and fitness: application for conservation biology.
<i>
Conservation Biology</i>
9(1): 18-24 74 refs, illus.
<P><B>Colloff, M.J.</b> (1995)
Dust mites: ancient associates or a 20th century blight?.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): 6-8, illus.
<P><B>Coupland, J.B.</b> (1995)
Susceptibility of helicid snails to isolates of the nematode <i>Phasmarhabditis hermaphrodita</i> from southern France.
<i>
Journal of Invertebrate Pathology</i>
66: 207-208 7 refs, illus.
<P><B>Cranston, P.S.</b> and *Kitching, R. (1995)
The Chironomidae of Austrao-oriental phytotelmata (plant-held waters): <i>Richea pandonifolia</i> Hook.f.
<i>
In: Cranston, P S (ed.). Chironomids: from genes to ecosystems</i>
pp.225-231, illus. ISBN 0643056564
(East Melbourne, VIC: CSIRO Australia)
<P><B>Cranston, P.S.</b> (Editor) (1995)
Chironomids: from genes to ecosystems.
482p., illus. ISBN 0643056564
(East Melbourne, VIC: CSIRO Australia)
<P><b>CSIRO Division of Entomology</b> (1995)
Protecting farm-stored grain.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
(June): 1-2, illus.
<P><b>CSIRO Division of Entomology</b> (1995)
Importation of grain: assessing and minimising the risks.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
(June): p.4
<P><b>CSIRO Division of Entomology</b> (1995)
Brassicas: natural soil fumigants.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
(June): p.3, illus.
<P><b>CSIRO Division of Entomology</b> (1995)
Research profile: Dr John Lawrence.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): 15-17, illus.
<P><b>CSIRO Division of Entomology</b> (1995)
Report of Research: July 1993-July 1995.
<i>
Report of Research. Division of Entomology. CSIRO Australia</i>
157p., illus. ISBN 0643057277
<P><b>CSIRO Information Services</b> and <b>CSIRO Division of Entomology</b> (1995)
Insects: a world of diversity: Version 2 [multimedia CD-ROM].
100p. paperback book plus CD-ROM ISBN 0643057072
<P><B>Cullen, J.M.</b>, <B>Lonsdale, W.M.</b>, *Auld, B.A., Hodgkinson, K.C. and *Hynes, R.J. (1995)
Vegetation management and the impact of weeds.
<i>
Sustaining the Agricultural Resource Base. Paper for the 12th meeting of the Prime Minister's Science and Engineering Council (Canberra, ACT: June 23, 1995)</i>
(Ch.4): 40-47 6 refs, illus. ISBN 0644453095
(Canberra, ACT: AGPS)
<P><B>Curran, J.</b> (1995)
The Molecular Systematics Unit.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): p.15, illus.
<P>*Dalby, P.R., <B>Baker, G.H.</b> and *Smith, S.E. (1995)
Glyphosate, 2,4-DB and dimethoate: effects on earthworm survival and growth.
<i>
Soil Biology and Biochemistry</i>
27(12): 1661-1662 14 refs
<P>*Davis, D.R., *Karsholt, O., *Kristensen, N.P. and <B>Nielsen, E.S.</b> (1995)
Revision of the genus <i>Ogygioses</i> (Palaeosetidae).
<i>
Invertebrate Taxonomy</i>
9(6): 1231-1263 29 refs, illus.
<P><B>De Barro, P.J.</b> (1995)
<i>Bemisia tabaci</i> biotype B: a review of its biology, distribution and control: second edition.
<i>
Technical Paper. Division of Entomology. CSIRO Australia</i>
(36): 58p., refs, illus.
<P><B>De Barro, P.J.</b> (1995)
<i>Bemisia tabaci</i> biotype B: a review of its biology, distribution and control.
<i>
Technical Paper. Division of Entomology. CSIRO Australia</i>
(36): 58p. 460 refs, illus. ISBN 064305719
<P><B>Dillon, G.E.</b> and <B>Fitt, G.P.</b> (1995)
Reassessment of sampling relationships for <i>Helicoverpa</i> spp. (Lepidoptera: Noctuidae) in Australian cotton.
<i>
Bulletin of Entomological Research</i>
85: 321-329 27 refs, illus.
<P>Doube, B.M., Buckerfield, J.C., <B>Barrett, V.J.</b>, <B>Carter, P.J.</b>, *Baldock, C.J. and *Oades, M. (1995)
The effects of lime, gypsum and wheat straw on four species of earthworms in a red-brown earth in South Australia.
<i>
Acta Zoologica Fennica</i>
196: 150-155 11 refs, illus.
<P><B>Drury, G.P.</b> (1995)
Consider temperature and moisture when aerating stored grain.
<i>
Australian Grain</i>
5(3): 16,18, illus.
<P><B>Edwards, E.D.</b> (1995)
The Richmond birdwing butterfly: what's in a name?.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): 12-14, illus.
<P><B>Fitt, G.P.</b>, <B>Dillon, M.L.</b> and *Hamilton, J.G. (1995)
Spatial dynamics of <i>Helicoverpa</i> populations in Australia: simulation modelling and empirical studies of adult movement.
<i>
Computers and Electronics in Agriculture</i>
13: 177-192 31 refs, illus.
<P><B>Floyd, R.B.</b>, <B>Sutherst, R.W.</b> and *Hungerford, J. (1995)
Modelling the field efficacy of a genetically engineered vaccine against the cattle tick, <i>Boophilus microplus</i>.
<i>
International Journal for Parasitology</i>
25(3): 285-291 19 refs, illus.
<P>Fox, D.R. and <B>Ridsdill-Smith, T.J.</b> (1995)
Tests for density dependence revisited.
<i>
Oecologia</i>
103: 435-443 34 refs, illus.
<P><B>Graver, J.E.van.S.</b> (1995)
An introduction to sealed bag-stack technology for grain storage.
<i>
Paper presented at the Regional Workshop on Methyl Bromide for English-speaking Africa (Harare, Zimbabwe: September 25-26, 1995)</i>
7p.  
<P><B>Greenslade, P.J.M.</b> (1995)
Report on invertebrates of the Marble Range Region, Eyre Peninsula.
<i>
The South Australian Naturalist</i>
69(3/4): 4-17 7 refs
<P><B>Greenslade, P.J.M.</b> (1995)
A review of research on the invertebrates of western New South Wales.
<i>
In: Lunney, D, Hand, S, Reed, P & Butcher, D (eds). Future of the fauna of western New South Wales</i>
Ch 7: 78-91  95 refs, illus. ISBN 0959995196
(Mosman, NSW: Royal Zoological Society of New South Wales)
<P><B>Greenslade, P.J.M.</b> (1995)
Report on invertebrates of the Marble Range region, Eyre Peninsula.
<i>
South Australian Naturalist</i>
69(3/4): 4-16  3 refs, illus.
<P><B>Greenslade, P.J.M.</b> (1995)
Management of Australia's rangelands for the conservation of invertebrates.
<i>
Acta Zoologica Fennica</i>
196: p.226 1 ref
[Proceedings of the 11th International Colloquium on Soil Zoology (Jyvaskyla, Finland: August 10-14, 1992)]
<P><B>Hawkins, Y.F.</b> (Compiler) (1995)
Stored Grain Research Laboratory: Staff Publication List.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(65): 24p. ISBN 0643057285
<P><B>Heard, T.A.</b> (1995)
Oviposition preferences and larval performance of a flower-feeding weevil, <i>Coelocephalapion aculeatum</i>, in relation to host development.
<i>
Entomologia Experimentalis et Applicata</i>
76: 195-201 23 refs, illus.
<P><B>Heard, T.A.</b> (1995)
Oviposition and feeding preferences of a flower-feeding weevil, <i>Coelocephalapion aculeatum</i>, in relation to conspecific damage to its host-plant.
<i>
Entomologia Experimentalis et Applicata</i>
76: 203-209 15 refs, illus.
<P>Hobbs, R.J., <B>Groves, R.H.</b>, *Hopper, S.D., *Lambeck, R.J., *Lamont, B.B., *Lavorel, S., *Main, A.R., *Majer, J.D. and Saunders, D.A. (1995)
Function of biodiversity in the mediterranean-type ecosystems of southwestern Australia.
<i>
In: Davis, G W and Richardson, D M (eds.). Mediterranean-type ecosystems: the function of biodiversity</i>
(Ch.5): 233-284 176 refs, illus. ISBN 3540578099
(Berlin, Germany: Springer-Verlag)
[Ecological Studies, Vol.109]
<P><B>Hodda, M.E.</b> (1995)
Nematodes in the Soil Biodiversity Unit and ANIC.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(6): 8-10, illus.
<P>*Ho, S.H. and <B>Winks, R.G.</b> (1995)
The response of <i>Liposcelis bostrychophila</i> Badonnel and <i>L. entomophila</i> (Enderlein) (Psocoptera) to phosphine.
<i>
Journal of Stored Products Research</i>
31(3): 191-197 17 refs, illus.
<P><B>Jackson, J.E.</b> (1995)
Notes on the biology of <i>Eudonia mawsoni</i> (Lepidoptera: Pyralidae) on subantarctic Macquarie Island.
<i>
Polar Biology</i>
15: 289-294 24 refs, illus.
<P><B>Julien, M.H.</b>, *Skarratt, B. and *Maywald, G.F. (1995)
Potential geographical distribution of alligator weed and its biological control by <i>Agasicles hygrophila</i>.
<i>
Journal of Aquatic and Plant Management</i>
33: 55-60 24 refs, illus.
<P>Kirkegaard, J.A., <B>Matthiessen, J.N.</b> and <B>Desmarchelier, J.M.</b> (1995)
Biofumigation: using <i>Brassica</i> species to control pests and diseases in Australian agriculture and horticulture [abstract].
<i>
European Journal of Plant Pathology. Abstracts of the 13th International Plant Protection Congress (The Hague, The Netherlands: July 2-7, 1995)</i>
1p.
(The Netherlands: Kluwer Academic Publ.)
<P>Kirkegaard, J.A., <B>Matthiessen, J.N.</b>, <B>Desmarchelier, J.M.</b>, Sarwar, M. and *Wong, P.T.W. (1995)
Biofumigation of pests and pathogens using <i>Brassica</i> species: progress and potential.
<i>
In: Potter, T D (ed.). Proceedings of the 10th Australian Research Assembly on #Brassicas# (Straun, SA: September 26-28, 1995)</i>
pp.100-105 13 refs ISBN 0730842444
<P>Kirkegaard, J.A., <B>Matthiessen, J.N.</b> and <B>Desmarchelier, J.M.</b> (1995)
Biofumigation: using <i>Brassica</i> species to control pests and diseases in Australian agriculture and horticulture.
<i>
Proceedings of 9th International Rapeseed Congress (Cambridge, UK: July 4-7, 1995)</i>
4: 1225-1227 9 refs
<P>Marcar, N.E., Crawford, D.F., Leppert, P.M., Jovanovic, T., <B>Floyd, R.B.</b> and <B>Farrow, R.A.</b> (1995)
Trees for saltland: a guide to selecting native species for Australia.
72p., refs, illus. ISBN 0643058192
(Canberra, ACT: CSIRO Division of Forestry)
<P><B>Matthiessen, J.N.</b> (1995)
Challenges in implementing IPM for low economic threshold soil insect pests [abstract].
<i>
European Journal of Plant Pathology. Abstracts of the 13th International Plant Protection Congress (The Hague, The Netherlands: July 2-7, 1995)</i>
1p.
(The Netherlands: Kluwer Academic Publ.)
<P><B>Matthiessen, J.N.</b> and *Learmonth, S.E. (1995)
Impact of the soil insects African black beetle, <i>Heteronychus arator</i> (Coleoptera: Scarabaeidae) and whitefringed weevil, <i>Graphognathus leucoloma</i> (Coleoptera: Curculionidae), on potatoes and effects of soil insecticide treatments in south-western Australia.
<i>
Bulletin of Entomological Research</i>
85: 101-111 18 refs, illus.
<P>*McDonald, G., *New, T.R. and <B>Farrow, R.A.</b> (1995)
Geographical and temporal distribution of the common armyworm, <i>Mythimna convecta</i> (Lepidoptera: Noctuidae), in eastern Australia: larval habitats and outbreaks.
<i>
Australian Journal of Zoology</i>
43(6): 601-629 54 refs, illus.
<P><B>Milne, W.M.</b> (1995)
Use of trap plants as a means of measuring the activity of cereal aphid parasitoids in the field.
<i>
Agriculture, Ecosystems & Environment</i>
52(1-2): 31-34 3 refs, illus.
<P><B>Moore, B.P.</b> (1995)
Two remarkable new genera and species of troglobitic Carabidae (Coleoptera) from Nullarbor caves.
<i>
Journal of the Australian Entomological Society</i>
34: 159-161 7 refs, illus.
<P><B>Morrison, S.M..</b> and <B>Scott, J.K.</b> (1995)
Chromosome numbers of Cape tulips (<i>Homeria</i> species) in South Australia and Western Australia.
<i>
Plant Protection Quarterly</i>
10(3): 96-98 16 refs
<P><B>Mound, L.A.</b> (1995)
The McMaster thrips project.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): 9-10, illus.
<P>Nagorcka, B.N., Dollin, A.E., Hollis, D.E. and <B>Beaton, C.D.</b> (1995)
A technique to quantify and characterize the density of fibres and follicles in the skin of sheep.
<i>
Australian Journal of Agricultural Research</i>
46(8): 1525-1534 14 refs, illus.
<P><B>Naumann, I.D.</b> (1995)
Australian spider wasps.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(6): 7-8, illus.
<P><B>Nielsen, E.S.</b>, *Edwards, E.D. and <B>Rangsi, T.V.</b> (Editors) (1995)
Checklist of the Lepidoptera of Australia.
<i>
Monographs on Australian Lepidoptera</i>
4: 400p., illus. ISBN 0643050280
(East Melbourne, VIC: CSIRO Information Services)
<P>*Norris, R.H.. and <B>Norris, K.R.</b> (1995)
The need for biological assessment of water quality: Australian perspective.
<i>
Australian Journal of Ecology</i>
20(1): 1-6 53 refs
[Paper presented at an International Conference on Use of Biota to Assess Water Quality]
<P>Old, K.M., <B>Floyd, R.B.</b>, Harcourt, R.L. and Byrne, M. (1995)
Potential of pests and diseases to limit the productivity of industrial forest plantations.
<i>
In: Prana, Ms, Lamoureux, C H, Sukara, E et al (eds.) Proceedings of an International Workshop bon Biotechnology and  Development of Species for Industrial Timber Estates (Bogor, Indonesia: 1995)</i>
pp. 93-136  172 refs
93-136  172 refs
<P>*Panetta, F.D. and <B>Scott, J.K.</b> (1995)
Weeds and feral animals: management of future threats.
<i>
In: Bradstock, R A, Auld, T D, Keith, D A, Kingsford, R T, Lunney, D and Siverstsen, D P (eds.). Conserving biodiversity: threats and solutions</i>
pp.220-228 46 refs, illus.
(NSW: Surrey Beatty & Sons)
<P><B>Pullen, K.R.</b> (1995)
Invertebrate survey at Calperum and the Bookmark Biosphere Reserve.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(7): 10-12 1 ref, illus.
<P><B>Rees, D.P.</b> and <B>Wright, E.J.</b> (1995)
<i>Lachesilla quercus</i> (Kolbe) (Psocoptera: Lachesillidae): first record in Australia and a new pest of grain stores.
<i>
Journal of the Australian Entomological Society</i>
34: 355-357 10 refs, illus.
<P><B>Rentz, D.C.F.</b> (1995)
Nature sounds.
<i>
Australasian Sound Archive</i>
(18/19): 11-21 7 refs, illus.
<P><B>Rentz, D.C.F.</b> (1995)
Do the spines on the legs of katydids have a role in predation? (Orthoptera: Tettigoniidae: Listroscelidinae).
<i>
Journal of Orthoptera Research</i>
(4): 199-200 9 refs, illus.
<P><B>Rentz, D.C.F.</b> (1995)
The Changa mole cricket, <i>Scapteriscus didactylus</i> (Latreille), a new world pest established in Australia (Orthoptera: Gryllotalpidae).
<i>
Journal of the Australian Entomological Society</i>
34: 303-306 14 refs, illus.
<P>*Richardson, A.M.M. and <B>Jackson, J.E.</b> (1995)
The first record of a terrestrial landhopper (Crustacea: Amphipoda: Talitradae) from Macquarie Island.
<i>
Polar Biology</i>
15: 419-422 23 refs, illus.
<P><B>Ridsdill-Smith, T.J.</b> (1995)
Responses and feeding damage of redlegged earth mite (Acarina: Penthaleidae) to seedlings of resistant and susceptible subterranean clover varieties.
<i>
Australian Journal of Agricultural Research</i>
46(5): 1091-1099 21 refs
<P><B>Ridsdill-Smith, T.J.</b> and *Gaull, K.R. (1995)
An improved method for rearing <i>Halotydeus destructor</i> (Acari: Penthaleidae) in the laboratory.
<i>
Experimental and Applied Acarology</i>
19: 337-345 15 refs, illus.
<P><B>Ridsdill-Smith, T.J.</b>, Jiang, Y. and *Ghisalberti, E.L. (1995)
Antixenosis resistance in subterranean clover to redlegged earth mite [abstract].
<i>
Abstracts of the International Plant Protection Congress (The Hague, The Netherlands: July 2-7, 1995)</i>
1p.
(The Netherlands: Kluwer Academic Publ.)
<P><B>Ridsdill-Smith, T.J.</b>, *Jiang, Y;. and *Ghisalberti, E.L. (1995)
A method to test compounds for feeding deterrence towards redlegged earth mite (<i>Acarina: Penthaleidae</i>)

.
<i>
Annals of Applied Biology</i>
127: 593-600  19 refs, illus.
<P><B>Room, P.M.</b> (1995)
<i>Salvinia molesta</i> D.S. Mitchell.
<i>
In: Groves, R H, Shepherd, R C H and Richardson, R G (eds.). The biology of Australian weeds</i>
1: 217-230 89 refs, illus. ISBN 0646259563
(Frankston, VIC: R.G. and F.J. Richardson)
<P><B>Room, P.M.</b> (1995)
Basic concepts fundamental to weed biocontrol: population ecology and types of biological control.
<i>
In: Brown, S (ed.). Biocontrol of tropical weeds</i>
pp.85-97 3 refs, illus.
(Brisbane, QLD: CTPM)
<P><B>Sagliocco, J-L.</b> and <B>Coupland, J.B.</b> (1995)
Biology and host specificity of <i>Chamaesphecia mysiniformis</i> (Lepidoptera: Sesiidae), a potential biological control agent of <i>Marrubium vulgare</i> (Lamiaceae) in Australia.
<i>
Biocontrol Science and Technology</i>
5: 509-515 18 refs, illus.
<P><B>Schmedding, R.A.</b> (1995)
Monumental work with weevils.
<i>
Ecos. CSIRO's Science and the Environment Magazine</i>
(84): p.35, illus.
<P><B>Scott, J.K.</b> and <B>Yeoh, P.B.</b> (1995)
The rediscovery and distribution of <i>Rumex drummondii</i> (Polygonaceae) in south-western Australia.
<i>
Australian Journal of Botany</i>
43(4): 397-405 14 refs, illus.
<P><B>Scott, J.K.</b> (1995)
Classical biological control of plant pathogens.
<i>
Advances in Plant Pathology</i>
11(Ch.7): 131-146 84 refs ISBN 0120337118
<P><B>Scott, J.K.</b> (1995)
Bridal creeper, <i>Myrsiphyllum asparagoides</i>: the past, future and relations.
<i>
In: Cooke, D and Choate, J (eds.). Weeds of conservation concern. Seminar and Workshop Papers (Adelaide, SA: April 5-6, 1995)</i>
pp.11-16 26 refs, illus.
(SA: Dept of Environment and Natural Resources)
<P><B>Scott, J.K.</b> and *Adair, R.J. (1995)
Selection of biological control agents for <i>Chrysanthemoides monilifera</i>, a weed of protected natural areas in Australia.
<i>
In: Delfosse, E S and Scott, R R (eds.). Proceedings of the 8th International Symposium on Biological Control of Weeds (Lincoln, NZ: February 2-7, 1992)</i>
pp.61-67 25 refs, illus.
<P><B>Scott, J.K.</b>, *Shivas, R.G. and <B>Yeoh, P.B.</b> (1995)
Integration of biological and other weed control in annual pasture-crop rotations [abstract].
<i>
European Journal of Plant Pathology</i>
1p.
(The Hague, The Netherlands: Kluwer Academic Publ.)
[Abstract of a paper presented at the 13th International Plant Protection Congress (The Hague, The Netherlands: July 2-7, 1995)]
<P>*Shaaya, E. and <B>Desmarchelier, J.M.</b> (1995)
Analysis, sorption and residues of a homologous series of isothiocyanates on wheat.
<i>
Pesticide Science</i>
44: 249-253 5 refs, illus.
<P><B>Sheppard, A.W..</b> (1995)
Ophthalmomyiasis: a shot in the eye [letter].
<i>
Medical Journal of Australia</i>
162(10): p.560 4 refs
<P><B>Sheppard, A.W..</b>, <B>Aeschlimann, J-P.</b>, <B>Sagliocco, J-L.</b> and <B>Vitou, J.</b> (1995)
Below-ground herbivory in <i>Carduus nutans</i> (Asteraceae) and the potential for biological control.
<i>
Biocontrol Science and Technology</i>
5: 261-270 35 refs, illus.
<P>*Smith, M. and <B>Cranston, P.S.</b> (1995)
"Recovery" of an acid mine-waste impacted tropical stream - the chironomid story.
<i>
In: Cranston, P S (ed.). Chironomids: from genes to ecosystems</i>
pp.161-173, illus. ISBN 0643056564
(East Melbourne, VIC: CSIRO Australia)
<P><B>Spradbery, J.P.</b>, <B>Mahon, R.J.</b>, Morton, R. and <B>Tozer, R.S.</b> (1995)
Dispersal of the old world screw-worm fly <i>Chrysomya bezziana</i>.
<i>
Medical and Veterinary Entomology</i>
9: 161-168 36 refs, illus.
<P><B>Strong, K.L.</b> (1995)
Burrowing cockroaches and their mites.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(6): 10-11, illus.
<P>*Suhardjono, Y.R. and <B>Greenslade, P.J.M.</b> (1995)
<i>Folsomides arnoldi</i> n. sp. (Isotomidae): a new Collembolan abundant in arid Australia, with a redescription of <i>Folsomides denisi</i> (Womersley).
<i>
Proceedings of the Linnean Society of New South Wales</i>
114(1): 21-7  9 refs, illus.
<P><B>Sutherst, R.W.</b>, <B>Floyd, R.B.</b> and <B>Maywald, G.F.</b> (1995)
The potential geographical distribution of the cane toad, <i>Bufo marinus</i> L. in Australia.
<i>
Conservation Biology</i>
9(6): 294-9  21 refs, illus.
<P><B>Sutherst, R.W.</b> and <B>Tozer, R.S.</b> (1995)
Control of buffalo fly (<i>Haematobia irritans exigua</i> de Meijere) on dairy and beef cattle using traps.
<i>
Australian Journal of Agricultural Research</i>
46(2): 269-284 16 refs, illus.
<P><B>Sutherst, R.W.</b> (1995)
The potential advance of pests in natural ecosystems under climate change: implications for planning and management.
<i>
In: Pernetta, J C, Leemans, R, Elder, D and Humphrey, S (eds.). Impacts of climate change on ecosystems and species: terrestrial ecosystems</i>
pp.83-98 37 refs, illus.
(Gland, Switzerland: IUCN)
<P><B>Sutherst, R.W.</b>, <B>Maywald, G.F.</b> and *Skarratt, D.B. (1995)
Predicting insect distributions in a changed climate.
<i>
In: Harrington, R and Stork, N E (eds.). Insects in a changing environment</i>
(Ch.4): 59-91 67 refs, illus.
(London, UK: Academic Press)
<P><B>Traynier, R.M.M.</b> and <B>Schumacher, R.K.</b> (1995)
Yeast odours localize oviposition by <i>Tinea translucens</i> and <i>T. pellionella</i> (Lepidoptera: Tineidae).
<i>
Journal of Stored Products Research</i>
31(4): 301-305 15 refs, illus.
<P><B>Watson, J.A.L.</b> (1995)
The conservation status of the enigmatic Australian dragonfly <i>Hemiphlebia mirabilis</i> Selys.
<i>
In: Corbet, P S, Dunkle, S W and Ubukata, H (eds.). Proceedings of the International Symposium on the Conservation of Dragonflies and their Habitats (Kushiro, Japan: January, 1995)</i>
pp.16-18 9 refs, illus.
<P><B>Whitten, M.J.</b> (1995)
Global food security: held to ransom by biotechnology.
<i>
Search</i>
26(6): 183-185, illus.
<P><B>Whitten, M.J.</b> (1995)
R&D reports share basic sense.
<i>
Canberra Times</i>
(Jan 31): p.11, illus.
<P><B>Whittle, C.P.</b>, <B>Vickers, R.A.</b>, *Kuniata, L.S., <B>Bellas, T.E.</b> and <B>Rumbo, E.R.</b> (1995)
Identification of an attractant for the caneborer <i>Sesamia grisescens</i> Walker (Lepidoptera: Noctuidae).
<i>
Journal of Chemical Ecology</i>
21(10): 1409-1420 21 refs, illus.
<P>*Willis, A.J., *Ash, J.E. and <B>Groves, R.H.</b> (1995)
The effects of herbivory by a mite, <i>Aculus hyperici</i>, and nutrient deficiency on growth in <i>Hypericum</i> species.
<i>
Australian Journal of Botany</i>
43(3): 305-316 38 refs, illus.
<P>*Wilson, P.A., <B>Room, P.M.</b> and <B>Hanan, J.S.</b> (1995)
Modelling multi-trophic level interactions with virtual plants [poster paper].
<i>
In: Granger, A C and Brown, J K (eds.). Paper presented at a Symposium on Multitrophic Interactions in Terrestrial Systems (London, UK: September 19-21, 1995)</i>
2p.  5 refs, illus.
(British Ecological Society)
<P><B>Winks, R.G.</b>, <B>Whittle, C.P.</b> and *Ryan, R.F. (1995)
Improved methods of application for fumigating grain with phosphine and the associated benefits.
<i>
In: Williams, Y A and Wrigley, C W (eds.). Cereals `95. Proceedings of the 45th Australian Cereal Chemistry Conference (Adelaide, SA: September 10-14, 1995)</i>
pp.526-529 5 refs, illus. ISBN 0909589860
(North Melbourne, VIC: Royal Australian Chemical Institute)
<P><B>Winks, R.G.</b>, <B>Waterford, C.J.</b> and <B>Russell, G.F.</b> (1995)
Environmental and workspace levels of phosphine produced by Siroflo&reg;.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(63): 8p. 2 refs, illus.
<P><B>Winks, R.G.</b>, <B>Waterford, C.J.</b> and <B>Russell, G.F.</b> (1995)
Environmental and workspace levels of phosphine produced by SIROFLO.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(1995/63): 8p., 2 refs, illus. ISBN 0643057269
<P><B>Wright, E.J.</b> and Morton, R. (1995)
Daily flight activity of <i>Trogoderma variabile</i> (Coleoptera: Dermestidae) and <i>Rhyzoptertha dominica</i> (Coleoptera: Bostrichidae).
<i>
Journal of Stored Products Research</i>
31(3): 177-184 22 refs, illus.
<P><B>Wright, E.J.</b> and *Cogan, P.M. (1995)
Trapping and sampling: a proposal for standards in reporting.
<i>
Journal of Stored Products Research</i>
31(3): 175-176
<P><B>Zimmerman, E.C.</b> (1995)
Australian weevils: (Coleoptera: Curculionoidea). Volume 4. Adelognatha.
 ISBN 0643051481
(East Melbourne, VIC: CSIRO Information Services)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-28</DOCNO>
<DOCOLDNO>IA089-000952-B036-331</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AS1994.html 192.102.250.248 19970208032727 text/html 10505
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:14:48 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:48 GMT
Content-type: text/html
Content-length: 10321
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Applied Physics</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Applied Physics</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Aubrecht, V. and <B>Lowke, J.J.</b> (1994)
Calculations of radiation transfer in SF<sub>6</sub> plasmas using the method of partial characteristics.
<i>
Journal of Physics. D. Applied Physics</i>
27: 2066-2073 32 refs, illus.
<P><B>Bendavid, A.</b>, <B>Martin, P.J.</b>, <B>Netterfield, R.P.</b> and <B>Kinder, T.J.</b> (1994)
The properties of TiN films deposited by filtered arc evaporation.
<i>
Surface and Coatings Technology</i>
70: 97-106 50 refs, illus.
<P><B>Bendeli, A.</b> (1994)
You miss, I miss, we all miss but UMIS?.
<i>
CoResearch. CSIRO's Staff Newspaper</i>
(359): p.4, illus.
<P><B>Betts, P.J.</b> (1994)
Self-calibratable voltage transformer with part-per-million accuracy.
<i>
IEE Proceedings on Science, Measurement and Technology</i>
141(5): 379-382 4 refs, illus.
<P><B>Chan, H.L-W.</b>, <B>Whitnall, D.F.</b> and <B>Dencher, P.R.</b> (1994)
PVDF hydrophone and hydrophone array with side-looking elements.
<i>
Review of Scientific Instruments</i>
65(7): 2376-2381 9 refs, illus.
<P><B>Cook, R.R.</b> (1994)
Traceable measurements for quality systems.
<i>
Proceedings of the 3rd Australasian Instrumentation and Measurement Conference (Adelaide, SA: April 26-29, 1994)</i>
7p. 7 refs, illus.
<P><B>Cook, R.R.</b> (1994)
Measurement uncertainty.
<i>
Proceedings of the Electrical Engineering Congress on Enabling Technologies - Developing Industry (Sydney, NSW: November 24-30, 1994)</i>
5p. 3 refs
<P><B>Cook, R.R.</b> (1994)
Uncertainty of measurement.
<i>
ADI ICAMS Seminar (Melbourne, VIC: August 23, 1994)</i>
6p. 3 refs
<P>*Creath, K., *Gilliand, Y.A. and <B>Hariharan, P.</b> (1994)
Interferometric testing of high-numerical-aperture convex surfaces.
<i>
Applied Optics</i>
33(13): 2585-2588 2 refs, illus.
<P><b>CSIRO Division of Applied Physics</b> (1994)
Tough European EMC stance boosts new Australian testing industry.
<i>
Research Results. CSIRO Australia</i>
(2): 14-15, illus.
<P><b>CSIRO Division of Applied Physics</b> (1994)
DAP rap. Division of Applied Physics. CSIRO Australia.
[203+; approx. monthly]
[Previous title: Monthly Newsletter. Applied Physics. National Measurement Laboratory.]
<P><b>CSIRO Division of Applied Physics</b> (1994)
The mint makes hard cash for Australia...While market potential grow for die-coating process.
<i>
Research Results. CSIRO Australia</i>
(2): 28-31, illus.
<P><B>Fisk, D.J.</b> and <B>Henderson, M.</b> (1994)
Midwife at the birth of an alemba.
<i>
DAP rap.  Division of Applied Physics. CSIRO Australia</i>
(206): 5-6, illus.
[Previous title: Monthly Newletter. Applied Physics. National Measurement Labortory.]
<P><B>Gardner, J.L.</b> (1994)
Transmission trap detectors.
<i>
Applied Optics</i>
33(25): 5914-5918 8 refs, illus.
<P><B>Giardini, W.J.</b> and Ha, J. (1994)
Measurement, characterization and volume determination of approximately spherical objects.
<i>
Measurement and Science Technology</i>
5: 1048-1052 9 refs, illus.
<P><B>Haidar, J.</b> and <B>Farmer, A.J.D.</b> (1994)
Large effect of cathode shape on plasma temperature in high-current free-burning arcs.
<i>
Journal of Physics. D. Applied Physics</i>
27: 555-560 15 refs, illus.
<P>Hannink, R.H.J. and <B>Swain, M.V.</b> (1994)
Progress in transformation toughening of ceramics.
<i>
Annual Review of Material Science</i>
24: 359-408 141 refs, illus.
<P>Hannink, R.H.J., *Howard, C.J., *Kisi, E.H. and <B>Swain, M.V.</b> (1994)
Relationship between fracture toughness and phase assemblage in Mg-PSZ.
<i>
Journal of the American Ceramic Society</i>
77(2): 571-579 38 refs, illus.
<P><B>Hariharan, P.</b> and <B>Ciddor, P.E.</b> (1994)
An achromatic phase-shifter operating on the geometric phase.
<i>
Optics Communications</i>
110: 13-17 16 refs, illus.
<P><B>Jones, T.P.</b> (1994)
Management of calibration facilities using temperature measurement as a case study.
<i>
Proceedings of Workshop on Establishing International Recognition of National Measurements Standards of Developing Countries (Hsinchu, Taiwan: October 25-November 4, 1994)</i>
pp.234-248
<P><B>Jurczyk, M.</b> and <B>Gwan, P.B.</b> (1994)
Processing of Nd(Fe,Mo)<sub>12</sub>N<sub>x</sub> magnets by mechanical milling, nitriding and hot pressing.
<i>
In: Manwaring, C A F, Jones, D G R, Williams, A J and Harris, I R (eds.). Proceedings of the 8th International Symposium on Magnetic Anisotropy and Coercivity in Rare Earth Transition Metal Alloys (Birmingham, UK: September 15, 1994)</i>
pp.371-376 9 refs, illus.
<P><B>Margarian, A.</b>, <B>Dunlop, J.B.</b>, <B>Day, R.K.</b> and *Kalceff, W. (1994)
Phase equilibria in the Fe-rich corner of the Nd-Fe-Ti ternary alloy system at 110O &#176;C.
<i>
Journal of Applied Physics</i>
76(10): 6153-6155 13 refs, illus.
<P><B>Morgan, V.T.</b> (1994)
The effects of temperature, mechanical pressure and air pressure on the dielectric properties of multilayers of dry Kraft paper.
<i>
Proceedings of the 4th International Conference on Properties and Applications of Dielectric Materials (Brisbane, QLD: July 3-8, 1994)</i>
pp.884-886 8 refs, illus.
<P><B>Morgan, V.T.</b> and *Slaninka, P. (1994)
The external thermal resistance of power cables in a group buried in non-uniform soil.
<i>
Electric Power Systems Research</i>
29: 35-42 33 refs, illus.
<P><B>Morgan, V.T.</b> (1994)
Effect of surface-temperature rise on external thermal resistance of single-core and multi-core bundled cables in still air.
<i>
IEE Proceedings-General Transmission and Distribution</i>
141(3): 215-218 4 refs, illus.
<P><B>Muller, K-H.</b> and <B>Andrikidis, C.</b> (1994)
Flux jumps in melt-textured Y-Ba-Cu-O.
<i>
Physical Review B</i>
49(2): 1294-1307 29 refs, illus.
<P><B>Muller, K-H.</b>, <B>Andrikidis, C.</b>, *Liu, H.K. and *Dou, S.X. (1994)
Weak-link behaviour of PbBi-2223 silver-sheathed tapes.
<i>
Physica C</i>
235-240: 3037-3038 7 refs, illus.
<P><B>Muller, K-H.</b>, <B>Andrikidis, C.</b>, *Liu, H.K. and *Dou, S.X. (1994)
Intergranular and intragranular critical currents in silver-sheathed Pb-Bi-Sr-Ca-Cu-O tapes.
<i>
Physical Review B</i>
59(14): 10,218-10,224 27 refs, illus.
<P><B>Murphy, A.B.</b> (1994)
Laser-scattering temperature measurements of a free-burning arc in nitrogen.
<i>
Journal of Physics. D. Applied Physics</i>
27: 1492-1498 19 refs, illus.
<P><B>Murphy, A.B.</b> and *Ma Bing (1994)
Equilibrium calculations of the reduction of titanium tetrachloride by aluminium and hydrogen.
<i>
High Temperatures-Chemical Processes</i>
3: 365-374 16 refs, illus.
<P><B>Murphy, A.B.</b> and <B>Arundell, C.J..</b> (1994)
Transport coefficients of argon, nitrogen, oxygen, argon-nitrogen, and argon-oxygen plasmas.
<i>
Plasma Chemistry and Plasma Processing</i>
14(4): 451-490 95 refs, illus.
<P><B>Murphy, A.B.</b> (1994)
Demixing due to frictional forces in an electric arc.
<i>
Physical Review Letters</i>
73(13): 1797-1800 13 refs, illus.
<P><B>Murphy, A.B.</b> (1994)
Modified Fowler-Milne method for the spectroscopic measurement of temperature and composition of multielement thermal plasmas.
<i>
Review of Scientific Instruments</i>
65(11): 3423-3427 19 refs, illus.
<P><B>Osman, P.D.</b> and Cornell, B.A. (1994)
The effect of pulsed electric fields on the phosphorus-31 spectra of lipid bilayers.
<i>
Biochimica et Biophysica Acta</i>
1195: 197-204 36 refs, illus.
<P><B>Savvides, N.</b> and <B>Katsaros, A.</b> (1994)
Growth and evolution of microstructure of epitaxial YBa<sub>2</sub>Cu<sub>3</sub>O<sub>7-x</sub> ultrathin and thin films on MgO.
<i>
Physica C</i>
226: 23-36 52 refs, illus.
<P><B>Savvides, N.</b>, <B>Katsaros, A.</b>, <B>Foley, C.P.</b> and <B>Sloggett, G.J.</b> (1994)
Growth and microstructure of YBa<sub>2</sub>Cu<sub>3</sub>O<sub>7-x</sub> thin films for superconductor devices.
<i>
In: Reed, R P #et al# (eds.). Advances in Cryogenic Engineering</i>
40: 409-416 16 refs, illus.
(New York: Plenum Press)
<P><B>Savvides, N.</b> and <B>Yau, J.</b> (1994)
Strain dependence of the critical current density of Bi-2223 multifilament tape conductors.
<i>
Physica C</i>
235-240: 3457-3458 6 refs, illus.
<P><B>Sierota, A.</b> and <B>Rungis, J.</b> (1994)
Electrostatic charging in transformer oils: testing and assessment.
<i>
IEEE Transactions on Dielectrics and Electrical Insulation</i>
1(5): 840-870 136 refs, illus.
<P><B>Sloggett, G.J.</b>, *Cook, C.D., *Dou, S.X., <B>Savvides, N.</b> and *Secrett, A.C.D. (1994)
Opportunities in power applications of superconductors.
<i>
Proceedings of the Electrical Engineering Congress (Sydney, NSW: November 24-30, 1994)</i>
pp.163-169 28 refs, illus.
<P><B>Small, G.W.</b>, <B>Dencher, P.R.</b>, <B>Leslie, K.E.</b> and <B>Sloggett, G.J.</b> (1994)
A high-performance digital synchronous noise filter.
<i>
Measuring Science Technology</i>
5: 503-508 9 refs, illus.
<P><B>White, G.K.</b> (1994)
Thermal behavior.
<i>
In: Westbrook, J H and Fleischer, R L (eds.). Intermetallic Compounds. Volume 1. Principles</i>
(Ch.44): 1017-1030 58 refs, illus.
(John Wiley & Sons)
<P><B>White, G.K.</b> and *Minges, M.L. (1994)
Thermophysical properties of some key solids.
<i>
International Journal of Thermophysics</i>
15(6): 1333-1343 29 refs, illus.
[Paper presented at the 12th Symposium on Thermophysical Properties (Boulder, CO, USA: June 19-24, 1994)]
<P>Yau, J. and <B>Savvides, N.</b> (1994)
Strain tolerance of multifilament Bi-Pb-Sr-Ca-Cu-O/silver composite superconducting tapes.
<i>
Applied Physics Letters</i>
65(11): 1454-1456 12 refs, illus.
<P>Young, R., Garrett, R.J. and <B>Walsh, C.J.</b> (1994)
Pricing of research: what will the market bear?.
<i>
Prometheus</i>
12(2): 173-188 37 refs, illus.
[Based on a paper presented at the 36th Annual Conference of the Australian Agricultural Economics Society (Canberra, ACT: February 11, 1992)]<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-29</DOCNO>
<DOCOLDNO>IA089-000952-B048-282</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/IF1994.html 192.102.250.248 19970208040717 text/html 2376
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:54:36 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:24 GMT
Content-type: text/html
Content-length: 2193
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Information Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Information Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abel, D.J.</b>, <B>Kilby, P.J.</b> and Davis, J.R. (1994)
The systems integration problem.
<i>
Int. J. Geographical Information Systems</i>
8(1): 1-12, 20 refs, illus.
<P><B>Barrass, S.</b> (1994)
A naturally ordered geometric model of sound inspired by colour theory.
<i>
Paper presented at Synaesthetica 94 Conference (Canberra, ACT: 1994)</i>
10p. 11 refs, illus.
<P><B>Barrass, S.</b> (1994)
A perceptual framework for the auditory display of scientific data.
<i>
Paper presented at ICAD 94 Conference (Santa Fe, NM, USA: November, 1994)</i>
14p. 24 refs, illus.
<P><b>CSIRO Division of Information Technology</b> (1994)
CSIRO/3M respirator system helps clients choose safety equipment.
<i>
Research Results. CSIRO Australia</i>
(2): 42-43, illus.
<P><b>CSIRO Division of Information Technology</b> (1994)
The SWAMP project: making the most of a 'legacy model'.
<i>
Research Results. CSIRO Australia</i>
(2): 22-24, illus.
<P><B>Francis, R.S.</b>, <B>Mathieson, I.D.</b>, <B>Whiting, P.G.</b>, Dix, M.R., Davies, H.L. and Rotstayn, L.D. (1994)
A data parallel scientific modelling language.
<i>
Journal of Parallel and Distributed Computing</i>
21: 46-60 23 refs, illus.
<P>Harrowfield, I.R., Cranswick, L.M.D. and <B>Youl, S.F.</b> (1994)
Comparison of computed and measured bremsstrahlung spectra to test electron energy-loss models.
<i>
Microbeam Analysis</i>
3: 161-175 40 refs, illus.
<P><B>Moore, A.J.</b> (1994)
Sather Tcl/Tk interface.
<i>
Technical Report. Division of Information Technology. CSIRO Australia</i>
(TR-GA-94-01): 15p.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-30</DOCNO>
<DOCOLDNO>IA057-000940-B048-65</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FW1996.html 192.102.250.248 19970208041705 text/html 1654
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:04:22 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:18 GMT
Content-type: text/html
Content-length: 1471
</DOCHDR>
<html>
<head>
<title>1996 Publications - Murray-Darling Freshwater Research Centre</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Murray-Darling Freshwater Research Centre</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Baldwin, D.S.</b>, *Beattie, J.K. and Jones, D.R. (1996)
Hydrolysis of an organic phosphorus compound by iron-oxide impregnated filter papers.
<i>
Water Research</i>
30(5): 1123-6  19 refs, illus.
<P>Cox, P., <B>Shiel, R.J.</b> and *Green, J.D. (1996)
Rotifera recorded from New Zealand, 1859-1995, with comments on zoogeograph.
<i>
New Zealand Journal of Zoology</i>
23: 193-209  85 refs
<P><B>Hawking, J.H.</b> and *New, T.R. (1996)
The development of dragonfly larvae (Odonata: Anisoptera) from two streams in north-eastern Victoria, Australia.
<i>
Hydrobiologia</i>
317: 13-30 21 refs, illus.
<P><B>Raisin, G.W.</b> (1996)
The role of small wetlands in catchment management: their effects on diffuse agricultural pollutants.
<i>
Internationale Revue der Gesamten Hydrobiologie</i>
81(2): 213-22  33 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-31</DOCNO>
<DOCOLDNO>IA089-000952-B044-145</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/EX1995.html 192.102.250.248 19970208035345 text/html 25217
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:40:59 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:11 GMT
Content-type: text/html
Content-length: 25033
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Exploration and Mining</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Exploration and Mining</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Alehossein, H..</b> and <B>Boland, J.N.</b> (1995)
Modelling rock behaviour in rock cutting.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): pp.521-528 31 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Alehossein, H..</b> (1995)
Continuum modelling of granular rocks in high pressure rolls crushers.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 319-324 14 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Anand, R.R.</b> (1995)
Lateritic weathering and regolith evolution.
<i>
17th International Geochemical Exploration Symposium (Townsville, QLD: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.3-18, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Anand, R.R.</b> and <B>Smith, R.E.</b> (1995)
Mt. Gibson District.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.25-36, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Anand, R.R.</b> (1995)
Lawlers District.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.39-52, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Anand, R.R.</b> (1995)
Bronzewing gold deposit.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.67-80 20 refs, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Anand, R.R.</b> (1995)
Genesis and classification of ferruginous regolith materials in the Yilgarn craton: implications for mineral exploration.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(3): 3-5 3 refs, ilus.
<P><B>Andrew, A.S.</b>, *Hensen, B.J., *Dunlop, A.C. and *Agnew, P.D. (1995)
Oxygen and hydrogen isotope evidence for the origin of platinum-group element mineralization in Alaskan-type intrusions at Fifield, Australia.
<i>
Economic Geology</i>
90: 1831-40  38 refs, illus
<P>*Ballhaus, C. and <B>Ryan, C.G.</b> (1995)
Platinum-group elements in the Merensky reef. I. PGE in solid solution in base metal sulfides and the down-temperature equilibration history of Merensky ores.
<i>
Contributions to Mineralogy and Petrology</i>
122: 241-251 55 refs, illus.
<P>*Ballhaus, C. and <B>Ryan, C.G.</b> (1995)
Platinum-group elements in the Merensky reef. 1. PGE in solid solution in base metal sulfides and the down-temperature equilibration history of Merensky ores.
<i>
Contributions to Mineralogy and Petrology</i>
122: 241-251 55 refs, illus.
<P><B>Barnes, S.J.</b>, *Lesher, C.M. and *Keays, R.R. (1995)
Geochemistry of mineralised and barren komatiites from the Perseverance nickel deposit, Western Australia.
<i>
Lithos</i>
34: 209-234  44 refs, illus.
<P>*Barron, B.J. and <B>Binns, R.A.</b> (1995)
Fractionated alkaline rocks in the Willyama Complex, New South Wales: where is the Broken Hill carbonatite?.
<i>
In: Facer, R A and Branagan, D F (eds.). Proceedings of the 8th Edgeworth David Day Symposium: Mineral Search in the south-west Pacific Region (Sydney, NSW: September, 1995)</i>
pp.51-64 12 refs, illus.
<P><B>Binns, R.A.</b>, <B>Parr, J.M.</b>, *Scott, S.D., *Gemmell, J.B. and *Herzig, P.M. (1995)
PACMANUS: an active seafloor hydrothermal field on siliceous volcanic rocks in the eastern Manus Basin, Papua New Guinea.
<i>
In: Mauk, J L and St George, J D (eds.). Proceedings of the PACRIM Congress 1995 (Auckland, NZ: November 19-22, 1995)</i>
pp.49-54 18 refs, illus.
<P><B>Borsaru, M.</b>, <B>Ceravolo, C.</b> and <B>Tchen, T.</b> (1995)
The application of the low activity borehole logging tool to the iron ore mining industry.
<i>
Nuclear Geophysics</i>
9(1): 55-62 6 refs, illus.
<P><B>Borsaru, M.</b> and *Pinault, J.L. (1995)
Simulation of the neutron-gamma and gamma-gamma Sirolog tools response for coal logging using the MOCA Monte Carlo code.
<i>
Nuclear Geophysics</i>
9(5): 387-399 6 refs, illus.
<P>*Brand, N.W. and <B>Butt, C.R.M.</b> (1995)
The Mt. Keith MDS5 nickel sulphide deposit.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3.  Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.53-66, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Buselli, G.</b> and Cameron, M.A. (1995)
A robust method for reducing spike-like noise.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 3-4, illus.
<P><B>Butt, C.R.M.</b> (1995)
Regolith geochemistry, mystery zone, Mt. Percy Gold Mine.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.81-94, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Butt, C.R.M.</b>, <B>Gray, D.J.</b>, Douglas, G.B.. and *Fulwood, K. (1995)
Geochemistry and mineralogy of lignites in the Ambassador Deposit, Mulga Rock, Western Australia.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 10-12, illus.
<P><B>Butt, C.R.M.</b>, <B>Anand, R.R.</b> and <B>Smith, R.E.</b> (1995)
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia.
134p. 55 refs, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Butt, C.R.M.</b> (1995)
Supergene gold deposits in the Yilgarn Craton: genesis and geochemistry.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.19-24, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Carr, G.R.</b>, <B>Dean, J.A.</b>, *Suppel, D.W. and *Heithersay, P.S. (1995)
Precise lead isotope fingerprinting of hydrothermal activity associated with Ordovician to Carboniferous metallogenic events in the Lachlan Fold Belt of New South Wales.
<i>
Economic Geology</i>
90: 1467-505  207 refs, illus
<P><B>Clark, D.A.</b>, <B>Schmidt, P.W.</b> and *Logan, K. (1995)
Palaeomagnetism, magnetic petrophysics and magnetic signature of the Porgera Intrusive Complex, PNG.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 6-7,10, illus.
<P><b>CSIRO Division of Exploration and Mining</b> (1995)
"Acoustic vision" makes a splash with underwater imaging system.
<i>
Research Results. CSIRO Australia</i>
(3): 28-30, illus.
<P><b>CSIRO Division of Exploration and Mining</b> (1995)
CSIRO Division of Exploration and Mining [leaflet].
<i>
Division of Exploration and Mining [miscellaneous publication]. CSIRO Australia</i>
12p., illus.
<P>*Dell, M. and <B>Anand, R.R.</b> (1995)
Kanowna District.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.99-110, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P><B>Dickson, B.L.</b> (1995)
Uranium-series disequilibrium in Australian soils and its effect on aerial gamma-ray surveys.
<i>
Journal of Geochemical Exploration</i>
54: 177-186 25 refs, illus.
<P><B>Dickson, B.L.</b>, <B>Parr, J.M.</b> and <B>Binns, R.A.</b> (1995)
Rapid growth of sea-floor sulfides.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(3): 12-13 3 refs, illus.
<P><B>Duncan Fama, M.E.</b>, <B>Trueman, R..</b> and <B>Craig, M.S.</b> (1995)
Two- and three-dimensional elasto-plastic analysis for coal pillar design and its application to highwall mining.
<i>
International Journal of Rock Mechanics and Mining Sciences and Geomechanics Abstracts</i>
32(3): 215-225 15 refs, illus.
<P><B>Eisler, P.L.</b> (1995)
CSIRO borehole logging technologies for iron-ore mining in Australia.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(3): 6-7 5 refs,illus.
<P><B>Evans, N.J.</b>, *Ahrens, T.J. and *Gregoire, D.C. (1995)
Fractionation of ruthenium from iridium at the Cretaceous-Tertiary boundary.
<i>
Earth and Planetary Science Letters</i>
134: 141-153 56 refs, illus.
<P>*Fitton, N. and <B>Cox, S.J.D.</b> (1995)
Linear feature extraction in geoscientific data.
<i>
In: Maeder, A and Lovell, B (eds.). Digital Image Computing: techniques and applications. Proceedings of the 3rd Biennial Conference of the Australian Pattern Recognition Society (Brisbane, QLD: December 6-8, 1995)</i>
pp.104-109 6 refs, illus.
(Brisbane, QLD: Australian Pattern Recognition Society) <a href= "http://www.ned.dem.csiro.au/AGRC/publications/9596/csiro.html"> http://www.ned.dem.csiro.au/AGRC/publications/9596/csiro.html</a> (Visited 1996, Dec 18)
<P><B>Griffin, W.L.</b> and <B>Ryan, C.G.</b> (1995)
Trace elements in indicator minerals: area selection and target evaluation in diamond exploration.
<i>
Journal of Geochemical Exploration</i>
53: 311-337 30 refs, illus.
<P><B>Griffin, W.L.</b>, <B>Ryan, C.G.</b> and <B>Win, T.T.</b> (1995)
Mapping the Earth's mantle in 4D using the proton microprobe.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
104: 456-63  28 refs, illus.
<P><B>Gulson, B.L.</b>, *Mahaffey, K.R., <B>Mizon, K.J.</b>, <B>Korsch, M.J.</b>, Cameron, M.A. and *Vimpani, G. (1995)
Contribution of tissue lead to blood lead in adult female subjects based on stable lead isotope methods.
<i>
Journal of Laboratory and Clinical Medicine</i>
125(6): 703-712 35 refs, illus.
<P><B>Gulson, B.L.</b>, <B>Davis, J.J.</b> and *Bawden-Smith, J. (1995)
Paint as a source of recontamination of houses in urban environments and its role in maintaining elevated blood leads in children.
<i>
Science of the Total Environment</i>
164: 221-235 31 refs, illus.
<P><B>Gulson, B.L.</b> and *Calder, I.C. (1995)
Lead mobilisation during pregnancy.
<i>
Medical Journal of Australia</i>
163: p.44 5 refs, illus.
<P><B>Gulson, B.L.</b>, <B>Davis, J.J.</b>, <B>Mizon, K.J.</b>, <B>Korsch, M.J.</b> and *Bawden-Smith, J. (1995)
Sources of lead in soil and dust and the use of dust fallout as a sampling medium.
<i>
Science of the Total Environment</i>
166: 245-262 33 refs, illus.
<P><B>Gwyther, R.L.</b> and <B>Gladwin, M.T.</b> (1995)
Long-term monitoring of mining-induced strain variations.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 12-14 5 refs, illus.
<P><B>Henley, S.</b> (1995)
Project databases: standards and security.
<i>
In: Giles, J R A (ed.). Geological data management. Geological Society Special Publication</i>
(97): 97-101 3 refs
<P><B>Hill, R.E.T.</b>, <B>Barnes, S.J.</b>, Gole, M.J. and Dowling, S.E. (1995)
The volcanology of komatiites as deduced from field relationships in the Norseman-Wiluna greenstone belt, Western Australia.
<i>
Lithos</i>
34: 159-188 80 refs, illus.
<P><B>Hobbs, B.E.</b> and <B>Henley, S.</b> (1995)
Computing for the exploration and mining industries to the year 2000.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 437-441 ISBN 1875776265
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy) <a href= "http://www.ned.dem.csiro.au/DEM/hh.html"> http://www.ned.dem.csiro.au/DEM/hh.html</a> (Visited 1996, Dec 18)
<P><B>Huntington, J.F.</b> (1995)
Airborne mineralogy: a new exploration method.
<i>
ACRES Update</i>
(May): 8-9
<P>*Huston, D.L., <B>Sie, S.H.</b>, <B>Suter, G.F.</b>, *Cooke, D.R. and *Both, R.A. (1995)
Trace elements in sulfide minerals from eastern Australian volcanic-hosted massive sulfide deposits: Part 1. Proton microprobe analyses of pyrite, chalcopyrite, and sphalerite, and Part 2. Selenium levels in pyrite: comparision with {delta}<sup>34</sup>S values and implications for the source of sulfur in volcanogenic hydrothermal systems.
<i>
Economic Geology</i>
90: 1167-1196 95 refs, illus.
<P>*Jessell, M.W., <B>Cox, S.J.D.</b>, *Schwarze, P. and <B>Power, W.L.</b> (1995)
The anisotropy of surface roughness measured using a digital photogrammetric technique.
<i>
In: Ameen, M S (ed.). Fractography: fracture topography as a tool in fracture mechanics and stress analysis. Geological Society Special Publication</i>
(92): 27-37 7 refs, illus.
<P>*Jung, G., *Cull, J.P. and <B>Cox, S.J.D.</b> (1995)
Spectral acoustic techniques for joint and fracture characterization.
<i>
Exploration Geophysics</i>
26(2/3): 374-378 17 refs, illus.
[Paper presented at the Australian Society of Exploration Geophysicists 11th Geophysical Conference and Exhibition Conference (Adelaide, SA: September 3-6, 1995)]
<P><B>Lilly, P.A.</b> (1995)
Production scheduling in an automated mine.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 1-2, illus.
<P><B>Lintern, M.J.</b>, <B>Gray, D.J.</b>, <B>Scott, K.M.</b> and <B>Butt, C.R.M.</b> (1995)
The Panglo gold deposit.
<i>
17th International Geochemical Exploration Symposium (Townsville, Qld: May 5-12, 1995). Excursion 3. Regolith Geology and Exploration Geochemistry in the Yilgarn Craton, Western Australia</i>
pp.119-130, illus. ISBN 0643057706
(Floreat Park, WA: CSIRO Division of Exploration and Mining)
<P>*Li, Y., Winstanley, G.J., Corke, P.I., <B>Hainsworth, D.W.</b> and Gurgenci, H. (1995)
Dragline bucket location using machine vision.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 53-56 3 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P>*Matthal, S.K., *Henley, R.W., *Bacigalupo-Rose, S., <B>Binns, R.A.</b>, <B>Andrew, A.S.</b>, <B>Carr, G.R.</b>, <B>French, D.H.</b> and <B>McAndrew, J.</b> (1995)
Intrusion-related, high-temperature gold quartz veining in the cosmopolitan Howley metasedimentary rock-hosted gold deposit, Northern Territory, Australia.
<i>
Economic Geology</i>
90: 1012-1045 72 refs, illus.
<P><B>Nickel, E.H.</b> (1995)
The definition of a mineral.
<i>
Canadian Mineralogist</i>
33: 689-690
<P>*O'Reilly, S.Y. and <B>Griffin, W.L.</b> (1995)
Trace-element partitioning between garnet and clinopyroxene in mantle-derived pyroxenites and eclogites: P-T-X controls.
<i>
Chemical Geology</i>
121: 105-130 39 refs, illus.
<P>*Onederra, I.A. and <B>Trueman, R..</b> (1995)
Predicting machine cutting and cutter wear rates for mining applications.
<i>
EXPLO 95. Proceedings of a Conference on Exploring the Role of Rock Breakage in Mining and Quarrying (Brisbane, QLD: September 4-7, 1995). AIMM Publication</i>
(6/95): 157-165 48 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Ord, A.</b> and *Oliver, N. (1995)
Modelling of structural controls on fluid flow.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(4): 4-6 3 refs, illus.
<P><B>Parr, J.M.</b>, *Murao, S. and <B>Binns, R.A.</b> (1995)
A comparison of massive sulfide deposits forming at the PACMANUS (Manus Basin, PNG) and Jade (Okinawa Trough, South China Sea) seafloor hydrothermal fields.
<i>
In: Mauk, J L and St George, J D (eds.). Proceedings of the PACRIM Congress 1995 (Auckland, NZ: November 19-22, 1995)</i>
pp.453-458 13 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P>Patterson, J.H., Corcoran, J.F. and <B>Kinealy, K.M.</b> (1995)
Carbonate mineralogy of the Hoskissons seam & equivalents in the Sydney & Gunnedah basins.
<i>
In: Boyd, R L and MacKenzie, G A (eds.). Proceedings of the 29th Newcastle Symposium on Advances in the Study of the Sydney Basin (Newcastle, NSW: April 6-9, 1995)</i>
pp.94-101 10 refs, illus.
<P>Patterson, J.H., Corcoran, J.F. and <B>Kinealy, K.M.</b> (1995)
Regional studies of carbonate minerals in the Baralaba and Rangal coal measures.
<i>
Australian Coal Geology</i>
10: 4-13 14 refs, illus.
<P><B>Perring, C.S.</b>, <B>Barnes, S.J.</b> and <B>Hill, R.E.T.</b> (1995)
The physical volcanology of Archaean komatiite sequences from Forrestania, Southern Cross Province, Western Australia.
<i>
Lithos</i>
34: 189-207 25 refs, illus.
<P>*Pirajno, F., <B>Butt, C.R.M.</b> and *Winter, E. (1995)
Gold enrichment in weathered carbonatite pyroclastics of the Kruidfontein Volcanic Complex, South Africa
.
<i>
South African Journal of Geology</i>
98(3): 319-25  25 refs, illus.
<P>*Poniewierski, J., <B>Cheung, L.C.C.</b> and <B>Maconochie, A.P.</b> (1995)
SIROFRAG: a new technique for post-blast rock fragmentation size distribution measurement.
<i>
EXPLO 95. Proceedings of a Conference on Exploring the Role of Rock Breakage in Mining and Quarrying (Brisbane, QLD: September 4-7, 1995). AIMM Publication</i>
(6/95): 263-267 14 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Poulsen, B.A.</b> and *Williams, D.J. (1995)
Application of the boundary element method to large-scale analyses in geomechanics.
<i>
Proceedings of the APCOM 25th Conference on Application of Computers and Operations Research in the Minerals Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 491-499 7 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Power, W.L.</b>, Lamb, P.R.. and <B>Horowitz, F.G..</b> (1995)
From databases to visualisation: data transfer standards and data structures of 3D geological modelling.
<i>
Proceedings of the APCOM 25th 1995. Application of Computers and Operations Research in the Mineral Industries (Brisbane, QLD: July 9-14, 1995). AIMM Publication</i>
(4/95): 65-70 6 refs, illus. ISBN 1875776265
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P><B>Power, W.L.</b> and <B>Bellgard, M.I.</b> (1995)
UPREP:  preprocessing for UDEC.  User's manual version 1.0.
<i>
Confidential Report. Division of Exploration and Mining. CSIRO Australia</i>
(165C): 19p.
<P>Proctor, C.H., Thresher, R.E., Gunn, J.S., Mills, D.J., Harrowfield, I.R. and <B>Sie, S.H.</b> (1995)
Stock structure of the southern bluefin tuna <i>Thunnus maccoyii</i>: an investigation based on probe microanalysis of otolith composition.
<i>
Marine Biology</i>
122: 511-526 42 refs, illus.
<P>*Prozesky, V.M., *Przybylowicz, W.J., *van Achterbergh, E., *Churms, C.L., *Pineda, C.A., *Springhorn, K.A., *Pilcher, J.V., <B>Ryan, C.G.</b>, *Kritzinger, J., *Schmitt, h. and *Swart, T. (1995)
The NAC nuclear microprobe facility.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
104: 36-42  20 refs, illus.
<P>*Rajagopalan, S. and <B>Clark, D.A.</b> (1995)
Magnetic mineralogy of the Black Hill Norite and its aeromagnetic and palaeomagnetic implications.
<i>
Exploration Geophysics</i>
26(2/3): 215-220 6 refs, illus.
[Paper presented at the Australian Society Exploration Geophysicists 11th Geophysical Conference and Exhibition Conference (Adelaide, SA: September 3-6, 1995)]
<P><B>Ryan, C.G.</b>, *Jamieson, D.N., *Churms, C.L. and *Pilchner, J.V. (1995)
A new method for on-line true-elemental  imaging using PIXE and the proton microprobe.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
104: 157-65  22 refs, illus.
<P><B>Ryan, C.G.</b>, *Heinrich, C.A., *van Achterbergh, E., *Ballhaus, C. and *Mernagh, T.P. (1995)
Microanalysis of ore-forming fluids using the scanning proton microprobe.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
104: 182-90  16 refs, illus.
<P><B>Ryan, C.G.</b> (1995)
The nuclear microprobe as a probe of earth sructure and geological process.
<i>
Nuclear Instruments and Methods in Physics Research. Series B</i>
104: 377-94  148 refs, illus.
<P><B>Schmidt, P.W.</b> and *Williams, G.E. (1995)
The Neoproterozoic climatic paradox: equatorial palaeolatitude for Marinoan glaciation near sea level in South Australia.
<i>
Earth and Planetary Science Letters</i>
134: 107-124 48 refs, illus.
<P><B>Schmidt, P.W.</b>, *Lackie, M.A. and *Anderson, J.C. (1995)
Palaeomagnetic evidence for the age of the Lapstone Monocline, NSW.
<i>
Australian Coal Geology</i>
10: 14-19 15 refs, illus.
<P><B>Smith, R.C.G.</b>, *Adams, J., *Stephens, D.J. and <B>Hick, P.T.</b> (1995)
Forecasting wheat yield in a Mediterranean-type environment from the NOAA satellite.
<i>
Australian Journal of Agricultural Research</i>
46(1): 113-125 39 refs, illus.
<P><B>Spain, A.V.</b>, <B>Esterle, J.S..</b> and <B>McLennan, T.P.T.</b> (1995)
Information from geology: implications for soil formation and rehabilitation in the post coalmining environment, Bowen Basin, Australia.
<i>
In: Follington, I L, Beeston, J W and Hamilton, L H (eds.). Proceedings of the Bowen Basin Symposium (MacKay, QLD: October 1-3, 1995)</i>
pp.147-155 30 refs, illus. ISBN 0909869987
(Geological Society of Australia)
<P>*Stolz, N., <B>Raiche, A.P.</b>, <B>Sugeng, F.</b> and *Macnae, J. (1995)
Is full 3-D inversion necessary for interpreting EM data?.
<i>
Exploration Geophysics</i>
26(2/3): 167-171 14 refs, illus.
[Paper presented at the ASEG 11th Geophysical Conference and Exhibition Conference (Adelaide, SA: September 3-6, 1995)]
<P><B>Tchen, T.</b>, <B>Eisler, P.L.</b> and <B>Ceravolo, C.</b> (1995)
Characterisation of the Bulli seam using a radiometric tool: prospects for in-seam drilling.
<i>
Advances in the Study of the Sydney Basin </i>
pp. 221-8  4 refs, illus.
[Proceedings of the 29th Newcastle Symposium (Newcastle, NSW: April 6-9, 1995)]
<P><B>Thomson, J.</b> (1995)
Remote sensing for mineral exploration: a winner.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(3): 15-16, illus.
<P>*Walsh, L. and <B>Esterle, J.S..</b> (1995)
A geological model for the distribution of coal type and quality in the Katoomba Seam, Illawarra Coal Measures, Sydney Basin.
<i>
Exploration & Mining Research News. Division of Exploration and Mining. CSIRO Australia</i>
(3): 13-15 3 refs, illus.
<P>*Warren, R.G., *Thorpe, R.I., <B>Dean, J.A.</b> and *Mortensen, J.K. (1995)
Pb-isotope data from base-metal deposits in central Australia: implications for Proterozoic stratigraphic correlations.
<i>
AGSO Journal of Australian Geology and Geophysics</i>
15(4): 501-509 32 refs, illus.
<P>*Williams, G.E., <B>Schmidt, P.W.</b> and Embleton, B.J.J. (1995)
Comment on "The Neoproterozoic (1000-540 Ma) glacial intervals: no more snowball earth?" by Joseph G. Meert and Rob van der Voo.
<i>
Earth and Planetary Science Letters</i>
131: 115-122 12 refs, illus.
<P>*Zaw, K., *Gemmel, J.B., *Hunns, S.R., *Mernagh, T.P., <B>Ryan, C.G.</b>, *Large, R.R. and *Both, R.A. (1995)
Composition of fluid inclusions from the Hellyer and Mt. Chalmers VHMS deposits, Australia: implications for source of ore-forming fluids.
<i>
In: Mauk, J L and St George, J D (eds.). Proceedings of the PACRIM Congress (Auckland, New Zealand: November 19-22, 1995)</i>
pp. 663-8  15 refs, illus.
(Carlton, VIC: Australasian Inst. of Mining and Metallurgy)
<P>*Zhao, P., <B>Hatherly, P.J.</b> and *Uren, N. (1995)
Two step inversion (tomography and pre-stack migration) for high resolution seismic imaging in Crosshole or VSP surveys.
<i>
Exploration Geophysics</i>
26(2/3): 336-339 12 refs, illus.
[Paper presented at the Australian Society of Exploration Geophysicists 11th Geophysical Conference and Exhibition Conference (Adelaide, SA: September 3-6, 1995)]<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-32</DOCNO>
<DOCOLDNO>IA058-000946-B026-332</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AH1994.html 192.102.250.248 19970208032221 text/html 48562
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:09:34 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:44 GMT
Content-type: text/html
Content-length: 48378
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Animal Health</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Animal Health</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Ali, D.N.</b> and <B>Hennessy, D.R.</b> (1994)
The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.27
(Australian Society for Parasitology)
<P><B>Anderton, N.A.</b>, <B>Gosper, J.J.</b> and <B>May, C.</b> (1994)
The inclusion of pyrrolizidine alkaloids by {alpha}- and {beta}-cyclodextrins.
<i>
Australian Journal of Chemistry</i>
47(5): 853-857 5 refs, illus.
<P><B>Andrew, M.E.</b>, <B>Janardhana, V.</b> and <B>Coupar, B.E.H.</b> (1994)
Specificity of cytotoxic T lymphocytes in bluetongue virus-immune sheep [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A99
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Andrew, M.E.</b>, <B>Janardhana, V.</b> and <B>Coupar, B.E.</b> (1994)
Expression of ovine cytokines from recombinant vaccinia viruses [poster abstract].
<i>
Paper presented at the CRC-VT Conference (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P>Atwell, J.L., <B>Tennent, J.M.</b>, <B>Lepper, A.W.D.</b> and Elleman, T.C. (1994)
Characterization of pilin genes from seven serologically defined prototype strains of <i>Moraxella bovis</i>.
<i>
Journal of Bacteriology</i>
176(16): 4875-4882 26 refs, illus.
<P><B>Bagust, T.J.</b> (1994)
Improving health for poultry production in Asia: a developmental perspective.
<i>
Avian Pathology</i>
23: 395-404 18 refs, illus.
<P>*Bao, S., <B>McClure, S.J.</b>, <B>Emery, D.L.</b> and *Husband, A.J. (1994)
The detection of interleukin-5 (IL-5) in eosinophils and its role in parasite immunity in sheep [abstract].
<i>
Programme and Abstracts of the Australasian Society for Immunology, 24th Annual Scientific Meeting (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P>*Bao, S., <B>McClure, S.J.</b>, <B>Emery, D.L.</b> and *Husband, A.J. (1994)
Role of interleukin-5 in eosinophilia and parasite immunity in sheep [abstract].
<i>
Paper presented at the 33rd National Scientific Conference of the Australian Society for Medical Research (Melbourne, VIC: November 27-30, 1994)</i>
1p.
<P><B>Barger, I.A.</b>, <B>Barnes, E.H.</b> and <B>Dobson, R.J.</b> (1994)
Modelling anthelmintic resistance.
<i>
In: Perry, B D and Hansen, J W (eds.). Modelling vector-borne and other parasitic diseases. Proceedings of a workshop (Nairobi, Kenya: November 23-27, 1992)</i>
pp.177-190 29 refs, illus.
(Nairobi, Kenya: International Lab. for Res. on Animal Diseases)
<P><B>Bashiruddin, J.B.</b>, <B>Taylor, T.K.</b> and <B>Gould, A.R.</b> (1994)
A PCR-based test for the specific identification of <i>Mycoplasma mycoides</i> subspecies <i>mycoides</i> SC.
<i>
Journal of Veterinary Diagnostic Investigation</i>
6: 428-434 14 refs, illus.
<P><B>Beh, K.J.</b> and <B>Blattman, A.N.</b> (1994)
The major histocompatibility complex system of vertebrates.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.5): 37-48 117 refs, illus. ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Billman-Jacobe, H.</b>, <B>Wang, L-F.</b>, Kortt, A.A., <B>Stewart, D.J.</b> and *Radford, A. (1994)
Expression and secretion of heterologous proteases by <i>Corynebacterium glutamicum</i> [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A74
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Billman-Jacobe, H.</b>, <B>Hodgson, A.L.M.</b>, *Lightowlers, M., <B>Wood, P.R.</b> and <B>Radford, A.J.</b> (1994)
Expression of ovine gamma interferon in <i>Escherichia coli</i> and <i>Corynebacterium glutamicum</i>.
<i>
Applied and Environmental Microbiology</i>
60(5): 1641-1645 23 refs, illus.
<P><B>Blacksell, S.D.</b>, <B>Lunt, R.A.</b> and <B>Newberry, K.M.</b> (1994)
Identification of epizootic haemorrhagic disease of deer virus serotypes using a fluorescence inhibition test.
<i>
Journal of Virological Methods</i>
46: 251-254 12 refs
<P><B>Blacksell, S.D.</b>, <B>Lunt, R.A.</b> and <B>White, J.R.</b> (1994)
A rapid indirect ELISA for the serogrouping of Australian orbiviruses.
<i>
Journal of Virological Methods</i>
49: 67-78 39 refs
<P><B>Blacksell, S.D.</b>, <B>Lunt, R.A.</b>, *Chamnanpood, C., *Linchongsubongkoch, W., *Nakarungkul, N., <B>Gleeson, L.J.</b> and *Megkamol, C. (1994)
Establishment of a typing enzyme-linked immunosorbent assay for foot and mouth disease antigen, using reagents against viruses endemic in Thailand.
<i>
Revue Scientifique et Technique (Office International des Epizooties)</i>
13(3): 701-709 21 refs, illus.
<P><B>Blacksell, S.D.</b>, <B>Gleeson, L.J.</b>, <B>Lunt, R.A.</b> and *Chamnanpood, C. (1994)
Use of combined Shewhart-CUSUM control charts in internal quality control of enzyme-linked immunosorbent assays for the typing of foot and mouth disease virus antigen.
<i>
Revue Scientifique et Technique OIE (Office International des Epizooties)</i>
13(3): 687-699 17 refs, illus.
<P>*Blitvich, B.J., *MacKenzie, J.S., *Coelen, R.J., <B>Scanlon, D.B.</b> and *Hall, R.A. (1994)
Heterogeneity of the flavivirus nonstructural protein NSI [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A117
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Boyle, D.B.</b>, <B>Pye, A.D.</b>, <B>Kocherhans, R.</b>, *Adair, B.M., Vrati, S. and Both, G.W. (1994)
Characterisation of Australian ovine adenovirus isolates.
<i>
Veterinary Microbiology</i>
41: 281-291 27 refs, illus.
<P><B>Boyle, D.B.</b> (1994)
Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors.
<i>
Reproduction, Fertility and Development</i>
6(3): 393-400 39 refs
[Paper presented at a Boden Research Conference on Immunological Control of Fertility: from Gametes to Gonads (Thredbo, NSW: February 9-11, 1994)]
<P><B>Boyle, D.B.</b> (1994)
Viral vaccines for animal disease control.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.24): 187-192 26 refs ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Boyle, D.B.</b> and <B>Heine, H.G.</b> (1994)
Influence of dose and route of inoculation on responses of chickens to recombinant fowlpox virus vaccines.
<i>
Veterinary Microbiology</i>
41: 173-181 18 refs, illus.
<P>*Brookes, S.M., <B>Hyatt, A.D.</b> and <B>Eaton, B.T.</b> (1994)
The use of immuno-gold silver staining in bluetongue virus adsorption and neutralisation studies.
<i>
Journal of Virological Methods</i>
46: 117-132 33 refs, illus.
<P>*Buddle, B.M., *Aldwell, F.E., *Pfeffer, A., *de Lisle, G.W. and <B>Corner, L.A.</b> (1994)
Experimental <i>Mycobacterium bovis</i> infection of cattle: effect of dose of <i>M. bovis</i> and pregnancy on immune responses and distribution of lesions.
<i>
New Zealand Veterinary Journal</i>
42: 167-172 24 refs, illus.
<P><B>Byrne, N.A.</b> (1994)
Recognising screw worm fly.
<i>
Rural Research</i>
(162): 18-19, illus.
<P><B>Callaghan, M.J.</b> and <B>Beh, K.J.</b> (1994)
A middle-repetitive DNA sequence element in the sheep parasitic nematode, <i>Trichostrongylus colubriformis</i>.
<i>
Parasitology</i>
109: 345-350 23 refs, illus.
<P><B>Callaghan, M.J.</b> and <B>Beh, K.J.</b> (1994)
Characterization of a tandemly repetitive DNA sequence from <i>Haemonchus contortus</i>.
<i>
International Journal for Parasitology</i>
24(1): 137-141 13 refs, illus.
<P><B>Cao, Y.</b>, *Christopherson, R.I., *Elix, J.A. and <B>Gaul, K.L..</b> (1994)
Synthesis of a phosphinic acid transition state analogue inhibitor of dihydroorotase.
<i>
Australian Journal of Chemistry</i>
47(5): 903-911 15 refs, illus.
<P>*Carn, V.M., *Kitching, R.P., <B>Hammond, J.M.</b> and *Chand, P. (1994)
Use of a recombinant antigen in an indirect ELISA for detecting bovine antibody to capripoxvirus.
<i>
Journal of Virological Methods</i>
49: 285-294 8 refs, illus.
<P>*Cartwright, G.A., <B>Rothel, J.S.</b> and *Lightowlers, M.W. (1994)
Conventional immunoassays underestimate anti-GST antibody titre [abstract].
<i>
Programme and Abstracts of the 24th Annual Scientific Meeting of the Australasian Society for Immunology (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P>*Cartwright, G.A., *Chen, D., *Hanna, P.J., <B>Gudkovs, N.</b> and *Tajima, K. (1994)
Immunodiagnosis of virulent strains of <i>Aeromonas hydrophila</i> associated with epizootic ulcerative syndrome (EUS) using a monoclonal antibody.
<i>
Journal of Fish Diseases</i>
17: 123-133 32 refs, illus.
<P>*Chandrasekaran, S., <B>Kennett, L.T..</b>, *Yeap, P.C., <B>Muniandy, N.</b>, *Rani, B. and <B>Mukkur, T.K.S.</b> (1994)
Characterization of immune response and duration of protection in buffaloes immunized with haemorrhagic septicaemia vaccines.
<i>
Veterinary Microbiology</i>
41: 213-219 9 refs
<P><B>Clarke, R.A.</b> and <B>Beh, K.J.</b> (1994)
Expression of a recombinant sheep IgE gene.
<i>
Immunological Investigations</i>
23(1): 25-37 27 refs, illus.
<P><B>Colditz, I.G.</b> and Eisemann, C.H. (1994)
The effect of immune and inflammatory mediators on growth of <i>Lucilia cuprina</i> larvae <i>in vitro</i>.
<i>
International Journal for Parasitology</i>
24(3): 401-403 13 refs, illus.
<P><B>Colditz, I.G.</b>, Lax, J., *Mortimer, S.I., <B>Clarke, R.A.</b> and <B>Beh, K.J.</b> (1994)
Cellular inflammatory responses in skin of sheep selected for resistance or susceptibility to fleece rot and fly strike.
<i>
Parasite Immunology</i>
16: 289-296 23 refs, illus.
<P>*Collins, D.M., <B>Radford, A.J.</b>, *de Lisle, G.W. and <B>Billman-Jacobe, H.</b> (1994)
Diagnosis and epidemiology of bovine tuberculosis using molecular biological approaches.
<i>
Veterinary Microbiology</i>
40: 83-94 51 refs, illus.
<P><B>Corino, G.L.</b>, <B>Scanlon, D.B.</b>, <B>Shiell, B.J.</b>, <B>Hansson, E.</b> and <B>Della-Porta, A.J.</b> (1994)
The use of electrospray mass spectrometry to analyse the structure of the F2 portion of the fusion (F) glycoprotein of Newcastle disease virus [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A59
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Corner, L.A.</b> (1994)
Post mortem diagnosis of <i>Mycobacterium bovis</i> infection in cattle.
<i>
Veterinary Microbiology</i>
40: 53-63 17 refs, illus.
<P><B>Coupar, B.E.</b>, <B>Hammond, J.M.</b> and <B>Andrew, M.E.</b> (1994)
Vaccinia virus expression systems [poster abstract].
<i>
Paper presented at the CRC-VT Conference (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><b>CSIRo Division of Animal Health</b> (1994)
Quality.
<i>
Quality. Division of Animal Health. CSIRO Australia</i>
1st ed.-   [irregular]
<P><b>CSIRO Division of Animal Health</b> (1994)
TB test has huge potential market.
<i>
Research Results. CSIRO Australia</i>
(2): 32-35, illus.
<P><B>Daniels, P.W.</b> (1994)
Ethics and efficacy in scientific technology transfer [abstract].
<i>
Paper presented at 1st Australian Conference on Ethics and Development (Geelong, VIC: November 28-29, 1994)</i>
1p.
<P><B>Darwish, A.</b> (1994)
Determination of deltamethrin levels in wool by reversed-phase high performance liquid chromatography.
<i>
Journal of Liquid Chromatography</i>
17(19): 4215-4228 10 refs, illus.
<P><B>Dobson, R.J.</b> and <B>Waller, P.J.</b> (1994)
Alternative control strategies to minimize the evolution of anthelmintic resistance.
<i>
In: Ozcel, M A and Alkan, M Z (eds.). Abstracts of the 8th International Congress of Parasitology (Izmir, Turkey: October 10-14, 1994)</i>
p.28
<P><B>Dobson, R.J.</b>, <B>Barnes, E.H.</b> and <B>Barger, I.A.</b> (1994)
Genetics of anthelmintic resistance & drug management [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.19
(Australian Society for Parasitology)
<P>*Du Plessis, D.H., <B>Wang, L-F.</b>, *Jordaan, F. and <B>Eaton, B.T.</b> (1994)
Fine mapping of a continuous epitope on VP7 of bluetongue virus using overlapping synthetic peptides and a random epitope library [abstract].
<i>
Paper presented at the South African Biochemical Society 12th Congress (Stellenbosch, South Africa: January 24-26, 1994)</i>
1p.
<P>*Du Plessis, D.H., <B>Wang, L-F.</b>, *Jordaan, F.A. and <B>Eaton, B.T.</b> (1994)
Fine mapping of a continuous epitope on VP7 of bluetongue virus using overlapping synthetic peptides and a random epitope library.
<i>
Virology</i>
198: 346-349 29 refs, illus.
<P><B>Edgar, J.A.</b> (1994)
Vaccination against low molecular weight natural toxicants.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.19): 149-153 17 refs ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Edgar, J.A.</b> (1994)
Toxins in temperate grasses: implications and solutions.
<i>
New Zealand Journal of Agricultural Research</i>
37(3): 341-347 51 refs ISBN 0643056734
[Reprinted as a special issue: "Improvements of Australian temperate perennial grasses". Also published in: Archer, K, Oram, R A and Michalk, D L (eds.). Proceedings of the 1st National Perennial Grass Workshop (Hamilton, Vic: October 27-29, 1993)]
<P>*Egan, P.J., <B>Rothel, J.S.</b>, *Andrews, A.E., <B>Seow, H.F.</b>, <B>Wood, P.R.</b> and *Nash, A.D. (1994)
Characterization of monoclonal antibodies to ovine tumor necrosis factor-{alpha} and development of a sensitive immunoassay.
<i>
Veterinary Immunology and Immunopathology</i>
41: 259-274 39 refs, illus.
<P><B>Fifis, T.</b>, <B>Rothel, J.S.</b> and <B>Wood, P.R.</b> (1994)
Soluble <i>Mycobacterium bovis</i> protein antigens: studies on their purification and immunological evaluation.
<i>
Veterinary Microbiology</i>
40: 65-81 78 refs, illus.
<P><B>Fifis, T.</b>, <B>Corner, L.A.</b>, <B>Rothel, J.S.</b> and <B>Wood, P.R.</b> (1994)
Cellular and humoral immune responses of cattle to purified <i>Mycobacterium bovis</i> antigens.
<i>
Scandinavian Journal of Immunology</i>
39: 267-274 47 refs, illus.
<P><B>Gaul, K.L..</b>, <B>Gallagher, P.F.</b>, <B>Reyes, D.</b>, <B>Stasi, S.</b> and <B>Edgar, J.A.</b> (1994)
Poisoning of pigs and poultry by stock feed contaminated with heliotrope seed.
<i>
In: Colegate, S M and Dorling, P R (eds.). Plant-associated toxins: agricultural, phytochemical and ecological aspects</i>
(Ch.26): 137-142 9 refs, illus.
(Wallingford, Oxon, UK: CAB International)
<P>Geddes, N.J., Paschinger, E.M., Furlong, D.N., *Ebara, Y., *Okahata, Y., <B>Than, K.A.</b> and <B>Edgar, J.A.</b> (1994)
Piezoelectric crystal for the detection of immunoreactions in buffer solutions.
<i>
Sensors and Actuators B</i>
17: 125-131 16 refs, illus.
<P>Geddes, N.J., *Martin, A.S., Caruso, F., Urquhart, R.S., Furlong, D.N., *Sambles, J.R., <B>Than, K.A.</b> and <B>Edgar, J.A.</b> (1994)
Immobilisation of IgG onto gold surfaces and its interaction with anti-IgG studied by surface plasmon resonance.
<i>
Journal of Immunological Methods</i>
175: 149-160 31 refs, illus.
<P><B>Gill, J.H.</b>, <B>Le Jambre, L.F.</b>, <B>Kerr, C.A.</b> and <B>Lenane, I.J.</b> (1994)
Inheritance of avermectin resistance in <i>Haemonchus contortus</i> [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.24 2 refs
(Australian Society for Parasitology)
<P><B>Gould, A.R.</b>, <B>Martyn, J.C.</b> and <B>Stevenson, L.A..</b> (1994)
Expression of the non-structural protein NSI of bluetongue virus in bacteria and yeast: identification of two antigenic sites at the amino terminus.
<i>
Virus Research</i>
31: 291-303 37 refs, illus.
<P><B>Gudkovs, N.</b> and *Carson, J. (1994)
Electrophoretic and immunoblot characterisation of <i>Aeromonas salmonicida</i> [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A92
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P>*Haig, D.M., *McInnes, C.J., <B>Wood, P.R.</b> and <B>Seow, H.F.</b> (1994)
The cytokines: origin, structure and function.
<i>
In: Goddeeris, B M L and Morrison, W I (eds.). Cell-mediated immunity in ruminants</i>
(Ch.5): 75-92 21 refs, illus.
(Boca Raton, FL, USA: CRC Press)
<P><B>Hammond, J.M.</b>, <B>Sproat, K.W.</b>, <B>Andrew, M.E.</b> and <B>Coupar, B.E.</b> (1994)
Vaccinia virus expression of chimeric hepatitis B core antigen particles containing an influenza HA epitope [poster abstract].
<i>
Paper presented at the CRC-VT Conference (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>Hansson, E.</b>, <B>Selleck, K.N.</b> and <B>Della-Porta, A.J.</b> (1994)
Molecular epidemiology of Australian Newcastle disease virus: use of polymerase chain reaction (PCR) [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A62
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Heine, H.G.</b>, <B>Foord, A.J.</b> and <B>Boyle, D.B.</b> (1994)
Firefly luciferase as reporter for membrane targeting sequences [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A131
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Heine, H.G.</b>, <B>Hyatt, A.D.</b> and <B>Boyle, D.B.</b> (1994)
Modification of infectious bursal disease virus antigen VP2 for cell surface location fails to enhance immunogenicity.
<i>
Virus Research</i>
32: 313-328 31 refs, illus.
<P><B>Hennessy, D.R.</b> (1994)
The disposition of antiparasitic drugs in relation to the development of resistance by parasites of livestock.
<i>
Acta Tropica</i>
56: 125-141 97 refs, illus.
<P><B>Hennessy, D.R.</b> (1994)
Therapy: disposition of anthelmintics in relation to effective parasite chemotherapy.
<i>
Proceedings of Meetings. Third International Sheep Veterinary Conference on "Science Serving Sheep", 1993</i>
17: 99-110 71 refs, illus.
(Sheep Veterinary Society)
<P><B>Hennessy, D.R.</b>, <B>Ali, D.N.</b> and <B>Tremain, S.A.</b> (1994)
The partition and fate of soluble and digesta particulate associated oxfendazole and its metabolites in the gastrointestinal tract of sheep.
<i>
International Journal for Parasitology</i>
24(3): 327-333 28 refs, illus.
<P><B>Hertig, C.</b>, <B>Pye, A.D.</b>, <B>Hyatt, A.D.</b> and <B>Boyle, D.B.</b> (1994)
Retrovirus-like particles produced by vaccinia viruses expressing <i>gag-pro-pol</i> region genes of bovine leukaemia virus.
<i>
Journal of General Virology</i>
75: 2213-2221 28 refs, illus.
<P><B>Hodgson, A.L.M.</b> (1994)
Bacterial vaccine vectors.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.23): 177-186 78 refs, illus. ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Hulme, D.J.</b>, Smith, A.J. and <B>Beh, K.J.</b> (1994)
Microsatellite markers and resource families for mapping parasite resistance genes in sheep [abstract].
<i>
Paper presented at the 5th Australasian Gene Mapping Workshop (Armidale, NSW: July 6-8, 1994)</i>
1p.
<P><B>Hulme, D.J.</b>, Silk, J.P., <B>Redwin, J.M.</b>, Barendse, W.J. and <B>Beh, K.J.</b> (1994)
Ten polymorphic ovine microsatellites.
<i>
Animal Genetics</i>
25: 434-435, illus.
<P><B>Hunt, J.D.</b>, *Jackson, D.C., *Brown, L.E., <B>Wood, P.R.</b> and <B>Stewart, D.J.</b> (1994)
Antigenic competition in a multivalent foot rot vaccine.
<i>
Vaccine</i>
12(5): 457-464 24 refs, illus.
<P><B>Ignjatovic, J.</b> and <B>Galli, L.</b> (1994)
The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens.
<i>
Archives of Virology</i>
138: 117-134 37 refs, illus.
<P>*Jallow, O.A., *McGregor, B.A., <B>Anderson, N.</b> and *Holmes, J.H.G. (1994)
Intake of trichostrongylid larvae by goats and sheep grazing together.
<i>
Australian Veterinary Journal</i>
71(11): 361-364 16 refs, illus.
<P><B>Janardhana, V.</b>, <B>Andrew, M.E.</b>, *Thomas, S. and <B>Coupar, B.E.</b> (1994)
Recombinant vaccinia viruses expressing interleukin-5 stimulate an earlier appearance of antibody-secreting cells in the lung.
<i>
European Journal of Immunology</i>
24: 2266-2269 20 refs
<P>*Jones, G.P., *Birkett, A., *Sanigorski, A., *Sinclair, A.J., <B>Hooper, P.T.</b>, *Watson, T. and *Rieger, V. (1994)
Effect of feeding quandong (<i>Santalum acuminatum</i>) oil to rats on tissue lipids, hepatic cytochrome <i>P</i>-450 and tissue histology.
<i>
Food and Chemical Toxicology</i>
32(6): 521-525 24 refs
<P><B>Jones, W.O.</b>, <B>Emery, D.L.</b>, <B>McClure, S.J.</b> and <B>Wagland, B.M.</b> (1994)
Changes in inflammatory mediators and larval inhibitory activity in intestinal contents and mucus during primary and challenge infections of sheep with <i>Trichostrongylus colubriformis</i>.
<i>
International Journal for Parasitology</i>
24(4): 519-525 19 refs, illus.
<P><B>Knox, M.R.</b>, Kennedy, P.M., <B>Hennessy, D.R.</b>, <B>Steel, J.W.</b> and <B>Le Jambre, L.F.</b> (1994)
Comparative pharmacokinetics of fenbendazole in buffalo and cattle.
<i>
Veterinary Research Communications</i>
18: 209-216 20 refs, illus.
<P><B>Knox, M.R.</b>, <B>Steel, J.W.</b> and *Leng, R.A. (1994)
The effects of urea supplementation on gastrointestinal parasitism in sheep being fed low quality roughage diets [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.28
(Australian Society for Parasitology)
<P><B>Knox, M.R.</b>, *Singh, R., *Manueli, R., <B>Steel, J.W.</b> and <B>Le Jambre, L.F.</b> (1994)
Formulation and use of anthelmintic blocks for sheep and goats in Fiji.
<i>
Proceedings of the 6th EAVPT International Congress (Edinburgh, Scotland: August 7-11, 1994)</i>
p.248 3 refs
<P>Kortt, A.A. and <B>Stewart, D.J.</b> (1994)
Properties of the extracellular acidic proteases of <i>Dichelobacter nodosus</i> stability and specificity of peptide bond cleavage.
<i>
Biochemistry and Molecular Biology International</i>
34(6): 1167-1176 28 refs, illus.
<P>Kortt, A.A., Burns, J.E., <B>Vaughan, J.A.</b> and <B>Stewart, D.J.</b> (1994)
Purification of the extracellular acidic proteases of <i>Dichelobacter nodosus</i>.
<i>
Biochemistry and Molecular Biology International</i>
34(6): 1157-1166 25 refs, illus.
<P>Kortt, A.A., Caldwell, J.B., Lilley, G.G., <B>Edwards, R.D.</b>, <B>Vaughan, J.A.</b> and <B>Stewart, D.J.</b> (1994)
Characterization of a basic serine proteinase (pI {simil} 9.5) secreted by virulent strains of <i>Dichelobacter nodosus</i> and identification of a distinct, but closely related, proteinase secreted by benign strains.
<i>
Biochemical Journal</i>
299: 521-525 27 refs, illus.
<P><B>Labato, Z.I.P.</b>, <B>Andrew, M.E.</b> and <B>Coupar, B.E.H.</b> (1994)
Vaccinia virus recombinants expressing core and capsid proteins of bluetongue virus [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A-130
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Lacey, E.</b> and <B>Gill, J.H.</b> (1994)
Biochemistry of benzimidazole resistance.
<i>
Acta Tropica</i>
56: 245-262 51 refs, illus.
<P><B>Lacey, E.</b>, <B>Craven, J.H.</b>, <B>Gill, J.H.</b>, <B>Barnes, E.H.</b>, <B>Waller, P.J.</b> and Baker, P.J. (1994)
The larval development assay as an alternative to faecal egg reduction tests for field diagnosis of broad spectrum anthelmintic resistance [abstract].
<i>
Conference Program and Proceedings of the 7th International Symposium on World Association of Veterinary Laboratory Diagnosticians (Buenos Aires, Argentina: November 8-11, 1994)</i>
p.87
<P>*Larsen, J.W., <B>Anderson, N.</b> and *Vizard, A.L. (1994)
Diarrhoea in Merino ewes during winter.
<i>
Proceedings of Conference of Australian Veterinary Association: Into the Future (Canberra, ACT: March 6-11, 1994)</i>
pp.20-23 8 refs
(Australian Sheep Veterinary Society)
<P>*Larsen, J.W.A., <B>Anderson, N.</b>, *Vizard, A.L., *Anderson, G.A. and *Hoste, H. (1994)
Diarrhoea in Merino ewes during winter: association with trichostrongylid larvae.
<i>
Australian Veterinary Journal</i>
71(11): 365-372 29 refs, illus.
<P><B>Le Blanc Smith, P.M.</b>, <B>Abraham, G.</b> and <B>Nguyen, S.V.</b> (1994)
Formaldehyde decontamination in laboratory practice [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A93
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Lenghaus, C..</b> (1994)
Experimental rabbit haemorrhagic disease in wild Australian rabbits [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A29
[Symposium paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P>*Lindsay, D., <B>Wood, P.R.</b>, Willadsen, P., Hoskinson, R.M. and Vercoe, J.E. (1994)
Summary of final discussion.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.26): 203-206 ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Lowenthal, J.W.</b>, <B>Digby, M.R.</b> and <B>York, J.J.</b> (1994)
Production of type I and II interferon by avian T cell clones [abstract].
<i>
Paper presented at Conference of Avian Immunology Research Group (Reading, UK: March 20-24, 1994)</i>
1p.
<P><B>Lowenthal, J.W.</b>, <B>Connick, T.E.</b>, <B>McWaters, P.G.</b> and <B>York, J.J.</b> (1994)
Development of T cell immune responsiveness in the chicken.
<i>
Immunology and Cell Biology</i>
72: 115-122 20 refs, illus.
<P><B>Lund, K.M.</b>, <B>Rothel, L.J..</b> and <B>Hodgson, A.L.M.</b> (1994)
Regulation of foreign gene expression in <i>C. pseudotuberculosis</i> [abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>Lunt, R.A.</b>, *Stanislawek, W.L., <B>Blacksell, S.D.</b>, <B>Newberry, K.M.</b> and <B>White, J.R.</b> (1994)
An antigen-capture ELISA (Ag-ELISA) for the detection of bluetongue virus (BTV) antigen directly from blood samples [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A99
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Lunt, R.A.</b>, *Linchongsubongkoch, W. and <B>Gleeson, L.J.</b> (1994)
A modified liquid phase (LP) blocking ELISA used to assess type O foot-and-mouth disease virus antigenic variation in Thailand.
<i>
Veterinary Microbiology</i>
42: 79-90 19 refs, illus.
<P><B>Lunt, R.A.</b>, <B>Blacksell, S.D.</b> and <B>Newberry, K.M.</b> (1994)
The use of an indirect ELISA with protein G-peroxidase conjugate and a blocking ELISA to demonstrate recent bluetongue infection in sheep.
<i>
Journal of Virological Methods</i>
48: 53-64 34 refs, illus.
<P><B>Martyn, J.C.</b>, <B>Gould, A.R.</b> and <B>Yu, M.</b> (1994)
Expression of the outer capsid proteins VP2 and VP5 of bluetongue virus in <i>Saccharomyces cerevisiae</i>.
<i>
Virus Research</i>
33: 11-25 48 refs, illus.
<P><B>McClure, S.J.</b> (1994)
The WCI antigen expressed by Tcr{alpha}{beta}<sup>+</sup> T-cells is also expressed on smooth muscle cells [abstract].
<i>
Programme and Abstracts of the Australasian Society for Immunology, 24th Annual Scientific Meeting (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P><B>McClure, S.J.</b>, <B>Emery, D.L.</b>, <B>Stewart, M.J.</b>, <B>Davey, R.J.</b>, <B>Bendixsen, T.</b> and <B>Tremain, S.A.</b> (1994)
Local immune responses to <i>Trichostrongylus colubriformis</i> [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.90
(Australian Society for Parasitology)
<P><B>McClure, S.J.</b> and <B>Emery, D.L.</b> (1994)
Effects of monoclonal antibodies <i>in vivo</i> on immune responses to parasites and adjuvants in sheep [abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>McColl, K.A.</b> and <B>Gould, A.R.</b> (1994)
Bluetongue virus infection in sheep: haematological changes and detection by polymerase chain reaction.
<i>
Australian Veterinary Journal</i>
71(4): 97-101 22 refs, illus.
<P><B>McColl, K.A.</b>, <B>Gould, A.R.</b>, <B>Pritchard, L.I.</b>, *Melville, L. and *Bellis, G. (1994)
Phylogenetic characterisation of bluetongue viruses from naturally-infected insects, cattle and sheep in Australia.
<i>
Australian Veterinary Journal</i>
71(4): 102-105 22 refs, illus.
<P><B>Michalski, W.P.</b>, <B>Crooks, J.K.</b> and <B>Prowse, S.J.</b> (1994)
Purification and characterisation of a serine-type protease from <i>Eimeria tenella</i> oocysts.
<i>
International Journal for Parasitology</i>
24(2): 189-195 24 refs, illus.
<P><B>Michalski, W.P.</b> and <B>Billman-Jacobe, H.</b> (1994)
Purification and characterisation of manganese-containing superoxide dismutase from gram-positive bacterium <i>Corynebacterium glutamicum</i>.
<i>
International Journal of Bio-Chromatography</i>
1: 127-136 39 refs, illus.
<P><B>Morrissy, C.J.</b> and <B>Collins, B.J.</b> (1994)
Development of diagnostic tests for a non-cultivable rabbit calicivirus [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A29
[Symposium paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>O'Brien, P.M.</b>, <B>Seow, H.F.</b>, <B>Rothel, J.S.</b> and <B>Wood, P.R.</b> (1994)
Cloning and sequencing of an ovine granulocyte colony-stimulating factor cDNA.
<i>
DNA Sequence: Journal of Sequencing and Mapping</i>
4: 339-342 26 refs
<P>*Obranovich, T., <B>Strom, A.D.G.</b>, <B>McWaters, P.G.</b>, <B>Lowenthal, J.W.</b> and *Boyd, R. (1994)
BSL.2: a novel avian cytokine [abstract].
<i>
Paper presented at meeting of Avian Immunology Research Group (Reading, UK: March 20-24, 1994)</i>
1p.
<P><B>Pallister, J.A.</b>, <B>Fahey, K.J.</b> and <B>Sheppard, M.</b> (1994)
Cloning and sequencing of the chicken anaemia virus (CAV) ORF-3 gene, and the development of an ELISA for the detection of serum antibody to CAV.
<i>
Veterinary Microbiology</i>
39: 167-178 27 refs, illus.
<P><B>Parsonson, I.M.</b> (1994)
Biotechnology and the food supply: control of development from laboratory to release.
<i>
Food Australia</i>
46(1): 25-27 6 refs
[Paper presented at the joint CAFTA/CSIRO 7th National Food Industry Conference, Glenelg, SA, August 20, 1993]
<P>*Pepin, M., <B>Seow, H.F.</b>, <B>Rothel, J.S.</b>, <B>Corner, L.A.</b>, <B>Hodgson, A.L.M.</b> and <B>Wood, P.R.</b> (1994)
Analysis of cytokines involved in pyogranuloma formation by a semi-quantitative PCR technique [abstract].
<i>
Abstracts of the 12th European Immunology Meeting (Barcelona, Spain: June 14-17, 1994)</i>
p.436
(European Federation of Immunological Societies)
<P>*Piedrafita, D., *Spithill, T.W., *Sandeman, M., <B>Rothel, J.S.</b>, <B>Wood, P.R.</b> and *Parsons, J.M. (1994)
<i>Fasciola hepatica</i>: free radical killing of newly excysted juvenile liver fluke and potential parasite defences against oxidant damage [abstract].
<i>
Paper presented athe 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26030, 1994)</i>
p.91 1 ref
<P>*Piedrafita, D., *Spithill, T.W., *Sandeman, M., <B>Rothel, J.S.</b>, <B>Wood, P.R.</b> and *Parsons, J.C. (1994)
Free radical killing of newly excysted juvenile liver fluke of <i>Fasciola hepatica</i> [abstract].
<i>
Program and Abstracts of the 3rd Conference of the Immunology Group of Victoria (Melbourne, Vic: October 13-14, 1994)</i>
p.16 1 ref
<P><B>Pritchard, L.I.</b> and <B>Gould, A.R.</b> (1994)
Evolutionary relationships among VP3 genes of bluetongue viruses [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A130
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P>*Ramsay, A.J., *Leong, K-H., <B>Boyle, D.B.</b>, *Ruby, J. and *Ramshaw, I.A. (1994)
Enhancement of mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors.
<i>
Reproduction, Fertility and Development</i>
6(3): 389-392 9 refs, illus.
[Paper presented at a Boden Research Conference on Immunological Control of Fertility: from Gametes to Gonads (Thredbo, NSW: February 9-11, 1994)]
<P><B>Ratnamohan, N..</b>, <B>Lenghaus, C..</b>, <B>Else, P.</b>, <B>Westbury, H.A.</b> and <B>Collins, B.J.</b> (1994)
Studies on rabbit haemorrhagic disease virus in blood monocyte alveolar macrophage and hepatocyte cell cultures [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A99
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Riffkin, M.C.</b>, *Jackson, D., *Brown, L., <B>Wood, P.R.</b> and <B>Seow, H.F.</b> (1994)
Detection of immunosuppressive factors from <i>Trichostrongylus colubriformis</i> [abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>Scanlon, D.B.</b> and *Craik, D. (1994)
Synthesis of kalata B1 peptide, a cyclic 29 amino acid peptide containing three disulfide bonds [abstract].
<i>
Paper presented at 1st Australian Peptide Conference (Daydream Island, QLD: October 16-21, 1994)</i>
1p. 2 refs
<P><B>Scanlon, D.B.</b>, <B>Corino, G.L.</b>, <B>Daglas, S.</b>, <B>Hansson, E.</b>, <B>Young, J.G.</b> and <B>Della-Porta, A.J.</b> (1994)
Typing of Australian and exotic isolates of Newcastle disease virus isolates using anti-peptide sera reactive with putative pathoneumonic regions of the glycoproteins [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A129
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Selleck, P.W.</b>, <B>Hooper, P.T.</b>, *Grix, D.C. and *Morrow, C.J. (1994)
The characterisation of an influenza A virus isolated from Victorian ducks.
<i>
Australian Veterinary Journal</i>
71(7): 222-223 15 refs
<P><B>Seow, H.F.</b>, *Pepin, M., <B>Rothel, J.S.</b>, <B>Corner, L.A.</b>, <B>Hodgson, A.L.M.</b> and <B>Wood, P.R.</b> (1994)
Development of ovine cytokine reagents and their use for analysis of cytokine profiles in <i>Corynebacterium pseudotuberculosis</i> infection [abstract].
<i>
Program and Abstracts of the Australasian Society for Immunology 24th Annual Scientific Meeting (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P><B>Seow, H.F.</b>, <B>David, M-J.</b>, <B>Hurst, L.A.</b> and <B>Wood, P.R.</b> (1994)
Progress in ovine cytokine research [abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P>*Siatskas, C., <B>Lowenthal, J.W.</b> and *Boyd, R.C. (1994)
<i>In vitro</i> characterisation of a novel avian haemopoietic growth factor derived from stromal cells [abstract].
<i>
Paper presented at Conference of Avian Immunology Research Group (Reading, UK: March 20-24, 1994)</i>
1p.
<P>*Simmons, C., <B>Hodgson, A.L.M.</b> and *Strugnell, R. (1994)
Construction of a defined aromatic mutant of <i>Corynebacterium pseudotuberculosis</i> [poster abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>Stewart, M.J.</b>, <B>McClure, S.J.</b>, *Rothwell, T.L.W. and <B>Emery, D.L.</b> (1994)
Changes in the enteric innervation of the sheep during primary or secondary immune responses to the nematode <i>Trichostrongylus colubriformis</i>.
<i>
Regional Immunology</i>
6: 460-470 28 refs, illus.
<P><B>Strom, A.D.G.</b>, <B>Turney, K.L.</b>, *Martin, S., <B>Rothel, J.S.</b> and <B>Wood, P.R.</b> (1994)
Progress in porcine cytokine research [abstract].
<i>
Program and Abstracts of the Australasian Society for Immunology 24th Annual Scientific Meeting (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P><B>Tremain, S.A.</b>, <B>Emery, D.L.</b> and *Heywood, L.H. (1994)
Myoelectric activity of the small intestine during parasite rejection [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitiology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.43
(Australian Society for Parasitology)
<P>*Upcroft, J.A., <B>Lacey, E.</b> and *Upcroft, P. (1994)
Albendazole resistance in <i>Giardia</i> [abstract].
<i>
Programme and abstracts of papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.20 4 refs
<P>Vaughan, P.R., <B>Wang, L-F.</b>, <B>Stewart, D.J.</b>, Lilley, G.G. and Kortt, A.A. (1994)
Expression in <i>Escherichia coli</i> of the extracellular basic protease from <i>Dichelobacter nodosus</i>.
<i>
Microbiology</i>
140: 2093-2100 20 refs, illus.
<P><B>Waller, P.J.</b> (1994)
Workshop summary: sustainable production systems.
<i>
Veterinary Parasitology</i>
54: 305-307
<P><B>Waller, P.J.</b>, <B>Larsen, M.</b>, <B>Faedo, M.</b> and <B>Hennessy, D.R.</b> (1994)
The potential of nematophagous fungi to control the free-living stages of nematode parasites of sheep: in vitro and in vivo studies.
<i>
Veterinary Parasitology</i>
51: 289-299 6 refs, illus.
<P><B>Waller, P.J.</b> and *Hansen, J.W. (1994)
Anthelmintic resistance in east and west Africa (Kenya, Tanzania, Ghana, Senegal and the Gambia).
<i>
Third Annual Meeting of the Danida Funded Ruminant Helminth Research Project Programme (Zambia, South Africa: January 24-27, 1994)</i>
1p.
<P><B>Waller, P.J.</b> and *Hansen, J.W. (1994)
War against the worm.
<i>
African Farming</i>
(July/August): 19-20
<P><B>Waller, P.J.</b> (1994)
Anthelmintic resistance in Australia: attempts to turn the tide.
<i>
Proceedings of Meetings. Third International Sheep Veterinary Conference on "Science Serving Sheep", 1993</i>
17: 194-195, illus.
(Sheep Veterinary Society)
<P><B>Waller, P.J.</b> (1994)
The development of anthelmintic resistance in ruminant livestock.
<i>
Acta Tropica</i>
56: 233-243 45 refs, illus.
<P><B>Waller, P.J.</b> and *Taira, N. (1994)
The prospects for controlling <i>Strongyloides papillosus</i> infections of calves by the use of nematode destroying fungi [abstract].
<i>
Proceedings of the Japanese Society of Veterinary Science Annual Conference (Tokyo, Japan: April 1-4, 1994)</i>
p.136
<P><B>Wang, L.</b>, <B>Scanlon, D.B.</b>, <B>Kattenbelt, J.A.</b>, *Mecham, J.O. and <B>Eaton, B.T.</b> (1994)
Fine mapping of a surface-accessible, immunodominant site on the bluetongue virus major core protein VP7.
<i>
Virology</i>
204: 811-814 30 refs, illus.
<P><B>Wang, L-F.</b>, <B>Voysey, R.D.</b> and <B>Yu, M.</b> (1994)
Simplified large-scale alkaline lysis preparation of plasmid DNA with minimal use of phenol.
<i>
BioTechniques</i>
17(1): 26,28 6 refs, illus.
<P><B>Wang, L-F.</b>, <B>Kattenbelt, J.A.</b>, <B>Gould, A.R.</b>, <B>Pritchard, L.I.</b>, <B>Crameri, G.S.</b> and <B>Eaton, B.T.</b> (1994)
Major core protein VP7 of Australian bluetongue virus serotype 15: sequence and antigenicity divergence from other BTV serotypes.
<i>
Journal of General Virology</i>
75: 2421-2425 29 refs, illus.
<P><B>Wang, L-F.</b>, *Hertzog, P.J., *Galanis, M., *Overall, M.L., *Waine, G.J. and *Linnane, A.W. (1994)
Structure-function analysis of human IFN-{alpha}: mapping of a conformational epitope by homologue scanning.
<i>
Journal of Immunology</i>
152: 705-715 36 refs, illus.
<P>Watson, D.L., <B>Colditz, I.G.</b> and *Gill, H.S. (1994)
Immunological effector mechanisms in ruminants.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.4): 21-36 208 refs, illus. ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P>Watson, D.L., <B>Colditz, I.G.</b>, <B>Andrew, M.E.</b>, *Gill, H.S. and Altmann, K.G. (1994)
Age-dependent immune response in Merino sheep.
<i>
Research in Veterinary Science</i>
57: 152-158 27 refs, illus.
<P>*Weir, R.P., *Harmsen, M.B., *Hunt, N.T., *Melville, L.F., <B>Blacksell, S.D.</b>, <B>Lunt, R.A.</b>, <B>Newberry, K.M.</b>, <B>Pritchard, L.I.</b>, <B>Hyatt, A.D.</b> and <B>Gould, A.R.</b> (1994)
EHDV-1, a new Autralian serotype belonging to the EHDV serogroup, recently isolated from sentinel cattle in the Northern Territory: serological, morphological and genotypic studies [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A62
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Werner, W.J.</b>, <B>Johnson, M.A.</b>, <B>Sheppard, M.</b> and <B>Prowse, S.J.</b> (1994)
A viral vector based vaccine protects against IBDV [abstract].
<i>
Programme and Abstracts of the 24th Annual Scientific Meeting of the Australasian Society for Immunology (Canberra, ACT: December 5-7, 1994)</i>
1p.
<P><B>White, J.R.</b>, <B>Millard, J.M..</b>, <B>Boyd, V.</b>, <B>Blacksell, S.D.</b> and <B>Lunt, R.A.</b> (1994)
Variation in the antigenic expression of conserved epitopes on the surface of bluetongue viruses [abstract].
<i>
Australian Microbiologist</i>
15(4): p.A59
[Paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>White, J.R.</b> (1994)
Validation of a quantitative ELISA for comparison of monoclonal antibody affinities for isolates of bluetongue virus.
<i>
Journal of Immunological Methods</i>
177: 79-88 41 refs, illus.
<P><B>Williams, L.M.</b>, <B>McRae, C.L.</b>, <B>Crane, M.St.J.</b> and <B>Gudkovs, N.</b> (1994)
Identification of fish viruses by western blot technique [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A129
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]
<P><B>Windon, R.G.</b>, *Haig, D.M., <B>Seow, H.F.</b>, <B>Rothel, J.S.</b> and <B>Wood, P.R.</b> (1994)
Colony stimulating activity in sheep bred for resistance and susceptibility to the intestinal nematodes <i>Trichostrongylus colubriformis</i> [abstract].
<i>
Program and Abstracts of the Conference of the CRC for Vaccine Technology (Noosa, QLD: August 24-26, 1994)</i>
1p.
<P><B>Windon, R.G.</b>, *Haig, D.M., <B>Seow, H.F.</b> and <B>Rothel, J.S.</b> (1994)
Colony stimulating activity in sheep genetically resistant and susceptible to the intestinal nematode <i>Trichostrongylus colubriformis</i> [abstract].
<i>
Programme and Abstracts of Papers presented at the 30th Annual Scientific Meeting of the Australian Society for Parasitology (Nelson Bay, NSW: September 26-30, 1994)</i>
p.96
<P>*Wiyono, A., *Baxter, S.I.F., *Saepulloh, M., *Damayanti, R., <B>Daniels, P.W.</b> and *Reid, H.W. (1994)
PCR detection of ovine herpesvirus-2 DNA in Indonesian ruminants: normal sheep and clinical cases of malignant catarrhal fever.
<i>
Veterinary Microbiology</i>
42: 45-52 29 refs, illus.
<P><B>Wood, P.R.</b>, Willadsen, P., Vercoe, J.E., Hoskinson, R.M. and *Demeyer, D. (1994)
Vaccines in agriculture: immunological applications to animal health and production.
219p., refs, illus. ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Wood, P.R.</b>, <B>Hodgson, A.L.M.</b>, <B>Rothel, J.S.</b> and <B>Seow, H.F.</b> (1994)
New developments in vaccines for ruminants [abstract].
<i>
Handbook of the Australian Veterinary Association Annual Conference (Canberra, ACT: March 6-11, 1994)</i>
p.59
<P><B>Wood, P.R.</b> (1994)
Gamma interferon assay and ELISA for the diagnosis of mycobacterial infections [abstract].
<i>
Abstracts of a workshop on diagnosis and control of tuberculosis and paratuberculosis in wildlife and domestic animals (Onderstepoort, South Africa: March 18, 1994)</i>
1p.
<P><B>Wood, P.R.</b> and <B>Corner, L.A.</b> (1994)
The future of the tuberculin test in national eradication programs [abstract].
<i>
Abstracts of a scientific conference and workshops on the short term future of tuberculosis in the developing world with particular emphasis on Africa (Pretoria, South Africa: March 13-17, 1994)</i>
1p.
<P><B>Wood, P.R.</b>, <B>Hodgson, A.L.M.</b>, <B>Rothel, J.S.</b> and <B>Seow, H.F.</b> (1994)
New development in vaccines for ruminants.
<i>
Proceedings of Conference of Australian Veterinary Association: Into the Future (Canberra, ACT: March 6-11, 1994)</i>
pp.45-47 14 refs
(Australian Sheep Veterinary Society)
<P><B>Wood, P.R.</b> and <B>Rothel, J.S.</b> (1994)
<i>In vitro</i> immunodiagnostic assays for bovine tuberculosis.
<i>
Veterinary Microbiology</i>
40: 125-135 51 refs, illus.
<P><B>Wood, P.R.</b>, <B>Seow, H.F.</b> and <B>Rothel, J.S.</b> (1994)
Cytokines and regulation of the immune response.
<i>
In: Wood, P R, Willadsen, P, Vercoe, J E, Hoskinson, R M and Demeyer, D (eds.). Vaccines in agriculture: immunological applications to animal health and production</i>
(Ch.6): 49-55 61 refs, illus. ISBN 0643055355
(East Melbourne, Vic: CSIRO Information Services)
<P><B>Wood, P.R.</b>, <B>Corner, L.A.</b> and *Cousins, D.V. (1994)
Eradication of bovine tuberculosis in Australia.
<i>
WHO/FAO/OIE Consultation on Animal Tuberculosis Vaccines (Geneva: August 3-5, 1994)</i>
4p. 10 refs
<P><B>Wood, P.R.</b>, *Davidson, P. and *Forsyth, J. (1994)
The interferon gamma assay: an alternative screening test for mycobacterial infections [abstract].
<i>
Program and Abstracts of the National Tuberculosis Conference on TB: a global emergency (Sydney, NSW: November 28-30, 1994)</i>
p.48
<P><B>Wood, P.R.</b> and <B>Fifis, T.</b> (1994)
<i>Mycobacterium bovis</i> antigens.
<i>
WHO/FAO/OIE Consultation on Animal Tuberculosis Vaccines (Geneva: August 3-5, 1994)</i>
5p. 35 refs
<P><B>York, J.J.</b>, <B>Connick, T.E.</b>, <B>McWaters, P.G.</b>, <B>Strom, A.D.G.</b>, <B>Prowse, S.J.</b> and <B>Lowenthal, J.W.</b> (1994)
Administration of cMGF to newly hatched chickens elevates blood monocyte number and function [abstract].
<i>
Paper presented at meeting of Avian Immunology Research Group (Reading, UK: March 20-24, 1994)</i>
1p.
<P><B>York, J.J.</b>, <B>Strom, A.D.G.</b>, <B>Connick, T.E.</b>, <B>McWaters, P.G.</b> and <B>Lowenthal, J.W.</b> (1994)
A chicken haemopoietic factor with <i>in vivo</i> activity similar to M-CSF [abstract].
<i>
Cytokine</i>
6(4): 1p.
<P><B>Yu, M.</b>, <B>Gould, A.R.</b>, <B>Morrissy, C.J.</b> and <B>Westbury, H.A.</b> (1994)
High level expression of the envelope glycoprotein (gp53) of bovine viral diarrhoea virus (Singer) and its potential use as diagnostic reagent.
<i>
Virus Research</i>
34: 178-186 26 refs, illus.
<P><B>Yu, M.</b>, <B>Wang, L-F.</b>, <B>Morrissy, C.J.</b>, <B>Gould, A.R.</b> and <B>Westbury, H.A.</b> (1994)
Phage surface display of immunodominant epitopes of hog cholera virus envelope protein gp55 [poster abstract].
<i>
Australian Microbiologist</i>
15(4): p.A129
[Poster paper presented at Australian Society for Microbiology, Annual Scientific Meeting (Melbourne, VIC: September 25-30, 1994)]<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-33</DOCNO>
<DOCOLDNO>IA089-000953-B002-286</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MS1996.html 192.102.250.248 19970208041332 text/html 4413
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:00:55 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:30 GMT
Content-type: text/html
Content-length: 4230
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Mathematics and Statistics</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Mathematics and Statistics</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Berman, M.</b>, Bason, M.L., *Ellison, F. and Wrigley, C.W. (1996)
Image analysis of whole grains to screen for flour-milling yield in wheat breeding.
<i>
Cereal Chemistry</i>
73(3): 323-7  19 refs, illus.
<P><B>Berman, M.</b>, Bason, M.L., *Ellison, F., <B>Peden, G.M.</b> and Wrigley, C.W. (1996)
Image analysis of whole grains to screen for flour-milling yield in wheat breeding.
<i>
Cereal Chemistry</i>
73(3): 323-327  19 refs, illus.
<P><B>Buckley, M.J.</b> and <B>Jones, R.</b> (1996)
Characterisation of extruded products using image analysis.
<i>
Proceedings of the Smart Extrusion Workshop (Sydney : August 1996)</i>
4, 1 ref, illus.
(North Ryde, NSW : CSIRO Division of Food Science and Technology)
<P><B>Constantine, A.G.</b>, *Darroch, J. and <B>Miller, R.B.</b> (1996)
Predicting underground pipeline failure.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
23(2): 9-10  illus.
<P><b>CSIRO Division of Mathematics and Statistics</b> (1996)
Hot spots, cold spots and landmines.
<i>
Competitive Edge. Division of Mathematics and Statistics. CSIRO Australia</i>
(20): p.1  illus.
<P><b>CSIRO Division of Mathematics and Statistics</b> (1996)
When too much is not enough.
<i>
Competitive Edge. Division of Mathematics and Statistics. CSIRO Australia</i>
(20): p.2  illus.
<P><b>CSIRO Division of Mathematics and Statistics</b> (1996)
From Tasmania to the top ends: monitoring petrol temperatures.
<i>
Competitive Edge. Division of Mathematics and Statistics. CSIRO Australia</i>
(19): 1p., illus.
<P><B>Davies, S.J.</b> and *Hall, P. (1996)
Fractal analysis of surface roughness using spatial data.
29p.  44 refs
(Canberra, ACT: Australian National University)
[Statistics Research Report No. SRR 008-96]
<P><B>Gates, D.J.</b> and <B>Westcott, M.</b> (1996)
Solar cars and variational problems equivalent to shortest paths.
<i>
SIAM Journal of Control and Optimization</i>
34(2): 428-36  6 refs, illus.
<P><B>Gates, D.J.</b> and <B>Westcott, M.</b> (1996)
A stochastic line model for paper stiffness.
<i>
Appita Journal</i>
49(3): 189-92  10 refs
<P><B>Li, C.</b> and <B>Jenkins, D.R.</b> (1996)
Modelling extrusion cooking.
<i>
Proceedings of the Smart Extrusion Workshop (Sydney : August 1996)</i>
11, illus.
(North Ryde, NSW : CSIRO Division of Food Science and Technology)
<P>Moore, G.P., <B>Jackson, N.</b>, Isaacs, K. and Brown, G.H. (1996)
Development and density of wool follicles in Merino sheep selected for single fibre characteristics.
<i>
Australian Journal of Agricultural Research</i>
47(8): 1195-201, 18 refs, illus.
<P><B>Neilson, Maurice.</b> (1996)
Facilities design for manufacturers.
<i>
Competitive Edge. Division of Mathematics and Statistics. CSIRO Australia</i>
(21): 1p., illus.
<P>*Outteridge, P. and <B>Charrett, D.M.</b> (1996)
SEweb.
<i>
Proceedings of the 9th Australian Software Engineering Conference. ASWEC '96 (July 14-18, 1996)</i>
pp. 93-101  illus
<P><B>Robinson, N.I.</b> (1996)
Some alternate series solutions for bending of rectangular plates.
<i>
Proceedings of the 18th Southern Conference on Applied and Theoretical Mechanics (Alabama, USA: April 14-16, 1996)</i>
9p. 6 refs
<P><B>Shaw, D.E.</b> and Sellahewa, J.N. (1996)
Data - its quality and relationships.
<i>
Proceedings of the Smart Extrusion Workshop (Sydney : August 1996)</i>
5, illus.
(North Ryde, NSW : CSIRO Division of Food Science and Technology)
<P><B>Sparks, R.S.</b> and *Eagle, A. (1996)
Graphical process monitoring in the service industry: a case study.
<i>
Journal of Quality Technology</i>
28(1): 99-115 11 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-34</DOCNO>
<DOCOLDNO>IA089-000952-B040-291</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/BC1995.html 192.102.250.248 19970208034046 text/html 40387
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:27:58 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:56 GMT
Content-type: text/html
Content-length: 40203
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Building, Construction and Engineering</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Building, Construction and Engineering</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>Abbs, D.J. and <B>Trinidad, G.S.</b> (1995)
Extreme weather events and the built environment.
<i>
Paper presented at a Workshop on Atmospheric Hazards (Brisbane, QLD: September 20-22, 1995)</i>
13p. 14 refs, illus.
<P><B>Allan, H.A.</b> and <B>Hooke, J.G.</b> (1995)
Hot-smoke test used to advance smoke control methodology.
<i>
Proceedings of Asiaflame Conference (Kowloon, Hong Kong: March 15-16, 1995)</i>
pp.345-350 3 refs, illus.
<P><B>Allan, H.A.</b>, <B>Quaglia, C.M.</b> and <B>Grubits, S.J.</b> (1995)
Fire safety engineering and the approving authorities: a case study.
<i>
Proceedings of a Conference on Fire Safety by Design (Sunderland, UK: July 10-12, 1995)</i>
pp.47-58 3 refs ISBN 0952739836
(Newcastle upon Tyne, UK: Tyne and Wear Metropolitan Fire Brigade)
<P><B>Bandopadhayay, P.C.</b>, <B>Mahoney, K.J.</b> and <B>Salt, H.</b> (1995)
The effect of non-condensable gas on the performance of planar heat pipes used for space heating.
<i>
Paper for 9th International Heat Pipe Conference (Albuquerque, New Mexico, USA: May 1-5, 1995)</i>
5p. 2 refs, illus.
<P><B>Banks, R.W.</b>, <B>Holmes, J.D.</b> and <B>Paevere, P.J.</b> (1995)
Full-scale measurements of topographic multipliers for a steep escarpment.
<i>
Paper for Ninth International Conference on Wind Engineering (New Delhi, India: January 9-13, 1995)</i>
9p. 8 refs, illus.
<P>*Baweja, D., *Roper, H. and <B>Sirivivatnanon, V.</b> (1995)
Durability of plain and blended cement concretes as predicted by corrosion potentials.
<i>
Australian Civil Engineering Transactions</i>
CE37(3): 247-254 14 refs, illus.
<P><B>Blackburn, H.M.</b> and *Henderson, R.D. (1995)
Near-wake vorticity dynamics in bluff body flows.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 7 refs, illus.
<P><B>Bock, G.C.</b> (1995)
The end was to build well: a half-century of Australian  government building research.
359p., illus, appendix ISBN 0643057064
(Clayton, VIC: CSIRO Australia)
<P><B>Bowman, R.G.</b> (1995)
Due care in selecting tiles for slip resistance.
<i>
Ceramic Tiles Today</i>
(Nov): 18,55
<P><B>Bowman, R.G.</b> and *Cass, C. (1995)
How to improve the management of tiling industry information to increase sales and ensure installation quality.
<i>
Paper presented at the 6th Annual `Profit by Design' Conference (Miami Beach, FL, USA: April 26-29, 1995)</i>
12p. 13 refs, illus.
<P><B>Bowman, R.G.</b> (1995)
2001: a tile odyssey [conference summary].
<i>
Ceramic Tiles Today</i>
pp.10-17, illus.
<P><B>Bowman, R.G.</b> (1995)
The Australian standard for slip resistance of pedestrian surfaces.
<i>
In: Palmonari, C (ed.). Fourth Euro Ceramics: floor and wall tiles</i>
pp.247-258 32 refs
(Italy: Gruppo Editoriale Faenza Editrice)
<P><B>Bowman, R.G.</b> (1995)
Competitive advantages in traditional ceramics.
<i>
American Ceramic Society Bulletin</i>
74(11): 65-67 2 refs, illus.
<P><B>Bowman, R.G.</b> and *Cass, C. (1995)
How to use computer based systems to increase sales and ensure installation quality.
<i>
Ceramic Tiles Today</i>
(Nov): 38-48 5 refs
<P><B>Bowman, R.G.</b> (1995)
The impact of new standards on the specification of tiling systems and products.
<i>
Paper presented at Tilex 95 on Raising the Profile (Sydney, NSW: June 5-7, 1995)</i>
12p. 22 refs
<P><B>Brotchie, J.F.</b>, <B>Newton, P.W.</b> and <B>Gipps, P.G.</b> (1995)
Land use-transport interactions and telecommunications impacts.
<i>
Proceedings of the 7th World Conference on Transport Research (Sydney, NSW: July 17-21, 1995)</i>
17p. 13 refs
<P><B>Bucea, L.</b>, <B>Sirivivatnanon, V.</b>, <B>Yozghatlian, S.P.</b>, <B>Cao, H.T.</b> and *Nelson, P.F. (1995)
Influence of fly ash, ground granulated blast furnace slag and silica fume on sulphate resistance of blended cements.
<i>
In: Loo, Y-C (ed.). Building for the 21st Century. Proceedings of the 5th East Asia-Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
2: 987-992 9 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P><B>Burn, L.S.</b> and *Richards, T.J. (1995)
Factors affecting the fracture toughness measurement of uPVC pipe samples.
<i>
Paper presented at the 9th Conference on Plastic Pipes (Edinburgh, UK: September 18-21, 1995)</i>
10p. 16 refs, illus.
<P>*Campbell, G., Rogers, K.J. and <B>Gibert, J.</b> (1995)
PIRAT: a system for quantitative sewer assessment.
<i>
Paper for the 12th International Conference on Trenchless Technology for Pipeline & Cable Construction (Dresden, Germany: September 19-22, 1995)</i>
8p., illus.
<P><B>Cerra, A.P.</b> and <B>Gutowski, W.S.</b> (1995)
Performance-based testing of structural sealants.
<i>
Proceedings of the 5th ASTM Symposium on Science and Technology of Building Seals and Sealants (Phoenix, USA: January 25-26, 1995)</i>
16p. 6 refs, illus.
<P><B>Chandrasekaran, V.</b>, <B>Yeoh, G.H.</b>, <B>Yuen, K.K.</b> and <B>Grubits, S.J.</b> (1995)
The analysis of smoke and fire spread using special purpose computational fluid dynamics code.
<i>
Paper presented at Workshop on Fire Growth Modelling for Engineering Applications (Espoo, Finland: January 10-13, 1995)</i>
17p. 16 refs, illus.
<P>*Chirgwin, G.J. and <B>Ho, D.W.S.</b> (1995)
The RTA approach and the use of water sorptivity for comparing the durability quality of concrete.
<i>
Paper for the A.M. Neville Symposium (Las Vegas, USA: June 14, 1995)</i>
22p. 24 refs, illus.
<P><B>Clarke, R.E.</b> (1995)
Do "insulating" paints work?.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 23-24, illus.
<P><B>Cole, I.S..</b>, *Holgate, R., <B>Kao, P.</b> and <B>Ganther, W.D.</b> (1995)
The rate of drying of moisture from a metal surface and its implication for time of wetness.
<i>
Corrosion Science</i>
37(3): 455-465 10 refs, illus.
<P><B>Cole, I.S..</b>, <B>Balatbat, J.B.</b> and <B>Young, R.S.</b> (1995)
Changes in the wettability and surface energy of galvanised and 55% aluminium-zinc-coated steel subjected to high humidity and salt exposures.
<i>
Paper presented at the 9th Asian-Pacific Corrosion Control Conference (Taiwan, China: November 5-10, 1995)</i>
6p. 7 refs, illus.
<P><B>Collins, G.E.</b> (1995)
Lift landing doors under fire.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.25, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
When plastics won't stick.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.17, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
PIRAT underground.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.14, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
When floors have flaws.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.19, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
CAD link with the building code.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.30
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Follow the bouncing ball.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.29, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Trap seal loss a puzzling plumbing problem.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.30
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
The Berg vision.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 8-10, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Saving steel in industrial buildings.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.21, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Using timber wisely.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 4-6, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Bushfires and buildings.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 27-29 5 refs, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Galloping vapours.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.15
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Noise and buildings.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 4p., illus.
[Building Technology File (1)]
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Flashing materials.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 4p., illus.
[Building Technology File (2)]
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Fire safety for Olympic swimmers.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.18, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Creep in high strength concrete.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): p.19, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Industrial problems solved with fluid dynamics.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 8-9, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Maps reveal atmospheric corrosion hazards.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 29-30, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
New products register opens doors - and lays new floors.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 26-27, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Plastic wall ties.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 28-29, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Strategic layout planning.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 28-29, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Telecommunications: the big picture.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 11-12, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Inside the greenhouse.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 24-26, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Reducing energy costs.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.21, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Stormwater run-off from building facades.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 4p., illus.
[Building Technology File (3)]
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Encapsulants for weathered asbestos-cement.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): p.15, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> and *Thwaites, T. (1995)
Fixing a mixing problem.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 10-11
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Wynhoven's engineering world.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 20-22, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> and *Thwaites, T. (1995)
Clean combustion can be cost-effective.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 11-12, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Building out energy.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.16, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
New stone age dawns.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 16-17, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Australia building links with Asia.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): p.28, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
High tech low-down.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.20, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
T40 to reduce construction time.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): 17-19, illus.
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Measuring performance-based standards.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): p.19
<P><b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Housing and urban developments in Vietnan.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 25-27, illus.
<P><B>Dai, W.</b> (1995)
A software engineering approach to building reusable expert systems.
<i>
SEKE '95. Proceedings of the 7th International Conference on Software Engineering and Knowledge Engineering (Maryland, USA: June 22-24, 1995)</i>
pp.212-219 16 refs, illus.
<P><B>Dai, W.</b> (1995)
Development of reusable expert system components: preliminary experience.
<i>
Proceedings of the ACM-SIGSOFT Symposium on Software Reusability (New York, USA: April, 1995)</i>
pp.238-246 13 refs, illus.
(ACM Press)
<P><B>Davy, J.L.</b> (1995)
Insulating buildings against aircraft noise.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(2): 5-7, illus.
<P>*de Vitis, N., *Page, A.W. and <B>Lawrence, S.J.</b> (1995)
Influence of age on the development of bond strength.
<i>
Paper presented at the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
9p. 4 refs, illus.
<P><B>Delsante, A.E.</b> (1995)
A comparison of Chenath, the nationwide house energy rating scheme simulation engine, with measured test cell data.
<i>
Paper for the ANZSES Solar Energy Conference (Hobart, TAS: November 29-December 1, 1995)</i>
6p. 4 refs, illus.
<P><B>Delsante, A.E.</b> (1995)
Using the building energy simulation test (BESTEST) to evaluate Chenath, the nationwide house energy rating scheme simulation engine.
<i>
Paper for the ANZSES Solar Energy Conference (Hobart, TAS: November 29-December 1, 1995)</i>
9p. 4 refs, illus.
<P><B>Foliente, G.C.</b> (1995)
Earthquake performance of light-frame wood and wood-based buildings: state-of-the-art and research needs.
<i>
Proceedings of the Pacific Conference on Earthquake Engineering (Melbourne, VIC: November 20-22, 1995)</i>
pp.333-342 22 refs, illus.
<P><B>Foliente, G.C.</b> (1995)
Hysteresis modeling of wood joints and structural systems.
<i>
Journal of Structural Engineering</i>
121(6): 1013-1022 36 refs, illus.
<P><B>Foliente, G.C.</b> (1995)
Evolution of structural timber use.
<i>
In: Giuliani, G C (ed.). Spatial structures: heritage, present and future. Proceedings of the IASS International Symposium (Milano, Italy: June 5-9, 1995)</i>
2: 1381-1388 16 refs, illus. ISBN 8886281102
(Padova, Italy: SGEditoriali)
<P><B>Gibert, J.</b> and <B>Maheepala, S.</b> (1995)
Decision support system (DSS) for integrated planning and management of urban water system.
<i>
Preprints of Papers of the 2nd International Symposium on Urban Stormwater Management: integrated management of Urban Environments (Melbourne, VIC: July 11-13, 1995)</i>
1: 119-124 9 refs, illus.
<P><B>Graham, L.J.W.</b>, *Thompson, M.C. and *Hourigan, K. (1995)
The torsionally driven cavity: a test case for comparison between experiment and prediction.
<i>
Paper presented at the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 6 refs, illus.
<P><B>Graham, L.J.W.</b>, *Soria, J. and *Bremhurst, K. (1995)
Examination of the flow around a hot-wire probe using particle image velocimetry.
<i>
Experiments in Fluids</i>
19: 379-82  9 refs, illus.
<P><B>Holmes, J.D.</b>, <B>Syme, M.J.</b> and *Kasperski, M. (1995)
Optimised design of a low-rise industrial building for wind loads.
<i>
Journal of Wind Engineering and Industrial Aerodynamics</i>
57: 391-401 13 refs, illus.
<P><B>Holmes, J.D.</b> and *Kasperski, M. (1995)
Equivalent static wind loading distributions.
<i>
Paper for the 14th Australasian Conference on the Mechanics of Structures and Materials (Hobart, TAS: December 11-13, 1995)</i>
5p. 11 refs, illus.
<P><B>Holmes, J.D.</b> (1995)
Equivalent time averaging in wind engineering.
<i>
Paper for the 9th International Conference on Wind Engineering (New Delhi, India: January 9-13, 1995)</i>
10p. 14 refs, illus.
<P><B>Khatri, R.P.</b>, *Gross, W., *Baweja, D. and <B>Sirivivatnanon, V.</b> (1995)
High performance concretes for coastal and offshore structures.
<i>
Paper for the Concrete Institute of Australia Conference: Towards Better Concrete Structures (Brisbane, QLD: September 4-7, 1995)</i>
7p. 2 refs, illus.
<P><B>Khatri, R.P.</b>, <B>Sirivivatnanon, V.</b> and *Gross, W. (1995)
Effect of different supplementary cementitious materials on mechanical properties of high performance concrete.
<i>
Cement and Concrete Research</i>
25(1): 209-220 16 refs, illus.
<P><B>King, M..</b> and <B>Ramsay, G.C.</b> (1995)
Australian fire statistics.
<i>
Proceedings of the Building and Industrial Fire Safety Seminar (Bogor, Indonesia: July 12-13, 1995)</i>
12p. 6 refs, illus.
<P><B>Lawrence, S.J.</b> (1995)
The behaviour of masonry in horizontal flexure.
<i>
Paper for the 7th Canadian Masonry Symposium (Hamilton, Ontario, Canada: June 4-7, 1995)</i>
12p. 8 refs, illus.
<P><B>Lawrence, S.J.</b> and *Page, A. (1995)
Mortar bond: a major research program.
<i>
Proceedings of the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp.31-37 11 refs
<P><B>Lawrence, S.J.</b> (1995)
The Masonry Code AS 3700.
<i>
Proceedings of the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp.91-96 9 refs
<P><B>Lawrence, S.J.</b> (1995)
Plastic wall ties: an innovation in the Australian market.
<i>
Proceedings of the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp.48-54 4 refs, illus.
<P><B>Leicester, R.H.</b> (1995)
Fire codes and timber structures in Australia.
<i>
Paper presented at a National Workshop on Fire and Timber in Modern Building Design (Kuala Lumpur, Malaysia: July 18-19, 1995)</i>
13p. 28 refs, illus.
<P><B>Li, C.Q.</b> and <B>Pham, L.</b> (1995)
A closed-form solution for reliability-based optimised design.
<i>
Proceedings of the 7th International Conference on Applications of Statistics and Probability (paris, France: July 10-13, 1995)</i>
6p. 6 refs, illus.
<P>*Li, C.Q. and <B>Holmes, J.D.</b> (1995)
Failure prediction of transmission line structural systems under severe thunderstorms.
<i>
Australian Civil Engineering Transactions</i>
CE37(4): 309-314 9 refs, illus.
<P><B>Li, C.Q.</b> and <B>Holmes, J.D.</b> (1995)
Failure prediction of transmission line structural systems under severe thunderstorms.
<i>
Paper for the 7th International Conference on Applications of Statistics and Probability (Paris, France: July 10-13, 1995)</i>
6p. 8 refs, illus.
<P><B>Li, C.Q.</b>, <B>Pham, L.</b> and *Georgiadis, A. (1995)
Uncertainty of structural modelling in structural design.
<i>
In: Loo, Y-C (ed.). Building for the 21st century. Proceedings of the 5th East Asia-Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
3: 2215-2220 7 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P><B>Li, C.Q.</b> (1995)
Modelling system effects in structural design.
<i>
Paper for the 4th Australasian Conference on the Mechanics of Structures and Materials (Hobart, TAS: December 11-13, 1995)</i>
5p. 7 refs, illus.
<P><B>Li, C.Q.</b> (1995)
Progressive failure of redundant structures.
<i>
In: Loo, Y-C (ed.). Building for the 21st century. Proceedings of the 5th East Asia-Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
1: 3-8 5 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P><B>Li, C.Q.</b> and <B>Holmes, J.D.</b> (1995)
Design of transmission line structures in Australia: present and future.
<i>
In: Loo, Y-C (ed.). Building for the 21st century. Proceedings of the 5th East Asia-Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
3: 2317-2322 6 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P><B>Li, C.Q.</b> and *Melchers, R.E. (1995)
Failure probability of reinforced concrete columns under stochastic loads.
<i>
Engineering Structure</i>
17(6): 419-24  13 refs, illus.
<P><B>Liffman, K.</b> (1995)
A collocation spectral method for high Reynolds number flow.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 8 refs, illus.
<P><B>Li, Y.</b> and *Baldacchino, L. (1995)
Accuracy and efficiency of some higher-order schemes on non-uniform grids for fluid flow problems.
<i>
Paper presented at the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 5 refs, illus.
<P><B>Li, Y.</b>, <B>Symons, J.G.</b> and *Thorpe, G. (1995)
Second-order numerical simulation of porous natural convection using non-uniform grids.
<i>
Paper presented at the 7th Biennial Computational Techniques and Applications Conference (Melbourne,  VIC: July 3-5, 1995)</i>
8p. 7 refs, illus.
<P><B>Li, Y.</b> and <B>Rudman, M.J.</b> (1995)
Assessment of higher-order upwind schemes incorporating FCT for convection-dominated problems.
<i>
Numerical Heat Transfer. Part B</i>
27: 1-21 32 refs, illus.
<P><B>MacIndoe, L.C.</b> and <B>Pham, L.</b> (1995)
Performance of screwed connections in shear using G550 grade steel.
<i>
Proceedings of the 14th Australasian Conference on the Mechanics of Structures and Materials (Hobart, TAS: December 11-13, 1995)</i>
2: 393-397 7 refs, illus. ISBN 0859016269
<P><B>Mak, S.L.</b>, <B>Sagoe-Crentsil, K.K.</b>, <B>Taylor, A.H.</b> and <B>Ritchie, D.J.B.</b> (1995)
Application of microwave-accelerated processing in cement and concrete technology.
<i>
Paper presented at a Conference on Our World in Concrete and Structures (Singapore: August 23-25, 1995)</i>
3p. 9 refs, illus.
<P><B>Mak, S.L.</b> and <B>Sagoe-Crentsil, K.K.</b> (1995)
Application of non-destructive diagnosis and condition monitoring for improved concrete infrastructure.
<i>
Paper for Concrete 95 Conference: Towards Better Concrete Structures (Brisbane, QLD: September 4-7, 1995)</i>
5p. 22 refs, illus.
<P><B>Mak, S.L.</b> (1995)
An overview of the use of fibres in concrete.
<i>
Paper presented at the Concrete Institute of Australia Seminar on Fibres in Concrete (Melbourne, VIC: March 15, 1995)</i>
9p. 9 refs, illus.
<P><B>Manasseh, R.</b> and *Ching, C-Y. (1995)
The isolated propagating flow: a hybrid between a solitary wave and a density-driven flow.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 15 refs, illus.
<P><B>Marquez, L.O.</b> and <B>Maheepala, S.</b> (1995)
A decision support system for the appraisal of urban development and utility services.
<i>
Paper presented at the 4th International Conference on Computers in Urban Planning and Urban Management (Melbourne, VIC: July 11-14, 1995)</i>
13p. 18 refs, illus.
<P><B>Mashford, J.S.</b> (1995)
A neural network image classifiction system for automatic pipe inspection.
<i>
Proceedings of the IEEE International Conference on Neural Networks (Perth, WA:  November 27-December 1, 1995)</i>
6p. 11 refs
<P><B>Mashford, J.S.</b> (1995)
A neural network image classification system for automatic inspection.
<i>
Proceedings of the IEEE International Conference on Neural Networks (Perth, WA: November 27-December 1, 1995)</i>
2: 713-717 11 refs ISBN 0780327683
<P><B>Metcalfe, G.</b> and *Behringer, R.P. (1995)
Novel convective instabilities of low- to moderate-Prandtl number fluids.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 7 refs, illus.
<P><B>Metcalfe, G.</b> and *Shattuck, M. (1995)
Radial and axial transport of solids in a slowly rotating tube.
<i>
Paper presented at the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 4 refs, illus.
<P><B>Mohamed, S.</b> and <B>Tucker, S.N.</b> (1995)
Current trends in Australian construction management research.
<i>
Paper presented at the 11th Annual ARCOM Conference and Annual General Meeting on Advances in Construction Management Research (York, UK: September 18-20, 1995)</i>
10p. 27 refs, illus.
<P><B>Mohamed, S.</b> (1995)
Benchmarking, best practice - and all that.
<i>
Paper for the 3rd Annual Conference of the International Group for Lean Construction (New Mexico, USA: October 16-18, 1995)</i>
9p. 15 refs
<P><B>Mohamed, S.</b> (1995)
Improving construction through QFD application.
<i>
In: Hunt, R A (ed.). Proceedings of the 1st Pacific Rim Symposium on Quality Deployment (Sydney, NSW: February 15-17, 1995)</i>
pp.237-243 7 refs
<P><B>Mohamed, S.</b> and *Yates, G. (1995)
Re-engineering approach to construction: a case study.
<i>
In: Loo, Y-C (ed.). Building for the 21st Century. Proceedings of the 5th East Asian Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
1: 775-780 5 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P><B>Mohamed, S.A.M.</b> (1995)
Analysis and design of sleeve-bolted connections in precast concrete frames.
<i>
Australian Civil Engineering Transactions</i>
CE37(4): 293-301 16 refs, illus.
<P>*Morton, D.E., <B>Rudman, M.J.</b> and *Liow, J-L. (1995)
Numerical simulation of flow due to impacting drops.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
6p. 12 refs, illus.
<P>*Morton, D.E., <B>Rudman, M.J.</b> and *Liow, J-L. (1995)
Numerical simulation of splashing phenomena.
<i>
Paper for the 9th International Conference on Numerical Methods in Laminar and Turbulent Flow (Atlanta, GA, USA: July 10-14, 1995)</i>
12p. 11 refs, illus.
<P><B>Narang, P.P.</b> (1995)
Noise control stategies for occupational safety and better working environments.
<i>
International Journal of Occupational Safety and Ergonomics</i>
1(4): 311-29  29 refs, illus.
<P><B>Narang, P.P.</b> (1995)
Material parameter selection in polyester fibre insulation for sound transmission and absorption.
<i>
Applied Acoustics</i>
45: 335-358 8 refs, illus.
<P><B>Narang, P.P.</b> (1995)
Insulating houses against aircraft noise: a pilot study.
<i>
Paper presented at the Australian Acoustical Society Conference 'Acoustics Applied-Putting the Science and Technology to Work' (Perth, WA: November 15-17, 1995)</i>
7p. 2 refs, illus.
<P><B>Narang, P.P.</b> and <B>Lawson, A.W.</b> (1995)
Noise emission measurements and rating of plumbing appliances.
<i>
Australian Plumbing Industry</i>
10(3): 22-29 3 refs, illus.
<P><B>Narang, P.P.</b> (1995)
The pitter patter of the rain on the roof.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(1): p.25
<P>*Niclasen, D.A. and <B>Blackburn, H.M.</b> (1995)
A comparison of mass lumping techniques for the two-dimensional Navier-Stokes equations.
<i>
Paper presented at the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 7 refs, illus.
<P><B>Norberg, S.P.</b>, <B>King, G.A.</b> and <B>O'Brien, D.J.</b> (1995)
Corrosivity studies and microclimate measurements in marine environments.
<i>
Paper presented at the Australasian Corrosion Association Conference (Perth, WA: November 12-16, 1995)</i>
12p. 14 refs, illus.
<P><B>Pham, L.</b> and <B>MacIndoe, L.C.</b> (1995)
Efficiency of prototype testing provisions.
<i>
Proceedings of the 14th Australasian Conference on the Mechanics of Structures and Materials (Hobart, TAS: December 11-13, 1995)</i>
2: 389-392 6 refs ISBN 0859016269
<P><B>Pham, L.</b> and *Griffith, M. (1995)
Review of building performance in recent earthquakes.
<i>
Proceedings of the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp.14-20 9 refs, illus.
<P><B>Quaglia, C.M.</b> (1995)
Industrial fire safety through fire engineering.
<i>
Paper presented at the Joint Seminar CSIRO/LIPI on Building and Industrial Fire Safety (Bandung, Indonesia: July 12-13, 1995)</i>
15p. 17 refs
<P><B>Quaglia, C.M.</b> and <B>Grubits, S.J.</b> (1995)
Fire-safety engineering.
<i>
Paper presented at Fire Technology Update Seminar (Perth, WA: June 19, 1995)</i>
11p. 11 refs, illus.
(AIRAH)
<P><B>Quaglia, C.M.</b> (1995)
Fire safety of warehouse storage.
<i>
Paper presented at HAZMAT Group Breakfast Meeting (Parramatta, NSW: July 26, 1995)</i>
17p., illus.
<P><B>Quaglia, C.M.</b> (1995)
Smoke control in buildings.
<i>
Australian Refrigeration, Air Conditioning and Heating</i>
49(11): 35-36
<P><B>Quaglia, C.M.</b> and <B>Grubits, S.J.</b> (1995)
Fire-safety engineering design of airport terminals.
<i>
Proceedings of Asiaflame Conference (Kowloon, Hong Kong: March 15-16, 1995)</i>
pp.561-567 5 refs
<P><B>Ramsay, G.C.</b> (1995)
Fire research in Australia.
<i>
Proceedings of the Building and Industrial Fire Safety Seminar (Bogor, Indonesia: July 12-13, 1995)</i>
18p.
<P><B>Ramsay, G.C.</b>, <B>McArthur, N.A.</b> and *Rudolph, L. (1995)
Towards an integrated model for designing for building survival in bushfires.
<i>
CALMScience Supplement</i>
4: 101-108 14 refs
<P><B>Ramsay, G.C.</b> and <B>McArthur, N.A.</b> (1995)
Building in the urban interface; lessons from the January 1994 Sydney bushfires.
<i>
Paper presented at Bushfire '95 (Hobart, TAS: September, 1995)</i>
13p. 6 refs, illus.
<P><B>Ramsay, G.C.</b>, <B>Dowling, V.P.</b>, <B>McKechnie, B.R.</b> and <B>Leonard, J.</b> (1995)
Methods for assessing the fire performance of phenolic resins and composites.
<i>
In: Bulgakov, V K and Karpov, A I (eds.). Proceedings of the 2nd Asia - Oceania Symposium Fire Science and Technology (Khabarovsk, Russia: September 13-17, 1995)</i>
pp. 355-66  21 refs, illus.
(Khabarovsk, Russia: Khabarovsk State Univ. of Technology)
<P><B>Rudman, M.J.</b> (1995)
Mixing in the wavy vortex regime of Taylor-Couette flow.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 10 refs, illus.
<P><B>Rudman, M.J.</b> (1995)
The wake vortex system of a jet in a cross-flow.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 10 refs, illus.
<P><B>Sagoe-Crentsil, K.K.</b> and <B>Mak, S.L.</b> (1995)
Performance of precast concrete containing blended cements.
<i>
Paper for Concrete 95 Conference: Towards Better Concrete Structures (Brisbane, QLD: September 4-7, 1995)</i>
5p. 8 refs, illus.
<P><B>Sagoe-Crentsil, K.K.</b> and <B>Taylor, A.H.</b> (1995)
Cement-fly ash stabilised heavy-metal waste: a potential raw material resource in mass construction.
<i>
Proceedings of the 11th National Conference on Waste Management (Sydney, NSW: March 8-10, 1995)</i>
8p., illus.
<P><B>Samarasinghe, W.</b>, <B>Lawrence, S.J.</b> and <B>Wilms, J.W.</b> (1995)
Myths of Briktor.
<i>
Proceedings of the 4th Australasian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp.199-207 2 refs, illus.
<P><B>Sankaran, R.</b> and <B>Paterson, D.A.</b> (1995)
Wind driven rain: data collection facility at CSIRO, Sydney, Australia.
<i>
Proceedings of the 9th International Conference on Wind Engineering (New Delhi, India: January 9-13, 1995)</i>
pp.2023-2033 8 refs, illus.
<P><B>Sankaran, R.</b> and <B>Paterson, D.A.</b> (1995)
Computation of rain falling on a tall rectangular building.
<i>
Proceedings of the 9th International Conference on Wind Engineering (New Delhi, India: January 9-13, 1995)</i>
pp.2127-2137 9 refs, illus.
<P><B>Schafer, B.L.</b> (1995)
Discussion paper on the fire performance of external insulation and finishing systems using different thicknesses of expanded polystyrene.
<i>
Paper presented at the ASTM Symposium on External Insulation & Finishing Systems: materials, properties and performance (Denver, USA: March 11-12, 1995)</i>
8p. 10 refs, illus.
<P><B>Schafer, B.L.</b> (1995)
Appraisal, accreditation, product certification, standards: what do they achieve?.
<i>
Paper presented at the Pacific Rim Conference of Building Officials (Darwin, NT: May 14-20, 1995)</i>
8p. 2 refs
<P><B>Schafer, B.L.</b> (1995)
Waterproofing requirements for bathrooms.
<i>
Paper presented at a Meeting of Architects and Builders (Canberra, ACT: June 23-24, 1995)</i>
7p., illus.
<P><B>Sharpe, R.</b>, <B>Gibert, J.</b> and <B>Oakes, S.</b> (1995)
Expert systems and artificial intelligence applications in engineering design and inspection.
<i>
Proceedings of the 8th International Conference on Industrial and Engineering Applications of AI and Expert Systems (Melbourne, VIC: June 6-8, 1995)</i>
pp.99-109 11 refs, illus.
<P><B>Sharpe, R.</b>, <B>Newton, P.W.</b>, <B>Brotchie, J.F.</b> and *Moeljono, J.H. (1995)
Australia-Indonesia infrastructure research collaboration.
<i>
Paper presented at the Infrastructure '95 Conference (Bali: July 2-6, 1995)</i>
14p.
<P><B>Shayan, A.</b> and <B>Ferguson, J.A.</b> (1995)
Reactive quartz gravel from eastern Victoria.
<i>
Paper presented at the 10th International Conference on Alkali-Aggregate Reaction in Concrete (Melbourne, VIC: August 18-23, 1995)</i>
8p. 13 refs, illus.
<P><B>Shayan, A.</b>, <B>Diggins, R.G.</b> and <B>Ivanusec, I.</b> (1995)
Long-term effectiveness of fly ash in preventing deleterious expansion due to alkali-aggregate reaction in concrete.
<i>
Paper presented at the 10th International Conference on Alkali-Aggregate Reaction in Concrete (Melbourne, VIC: August 18-23, 1995)</i>
8p. 39 refs, illus.
<P><B>Shayan, A.</b> (1995)
Developments in testing for AAR in Australia.
<i>
Paper presented at the 3rd CANMET/ACI International Workshop on Alkali-Aggregate Reactions in Concrete (Dartmouth, Canada: October 1-5, 1995)</i>
14p. 25 refs, illus.
<P><B>Shayan, A.</b> (1995)
Behaviour of precast prestressed concrete railway sleepers affected by AAR.
<i>
Proceedings of the 5th CANMET/ACI International Conference on Fly Ash, Slag, Silica Fume and Natural Possolans in Concrete (Milwaukee, USA: June 4-9, 1995)</i>
pp.1-24 16 refs, illus.
<P><B>Sirivivatnanon, V.</b> and <B>Cao, H.T.</b> (1995)
Build to last with the right materials.
<i>
Paper presented at the CPAC Annual Seminar (Bangkok, Thailand: September 27, 1995)</i>
15p. 34 refs, illus.
<P><B>Sirivivatnanon, V.</b> (1995)
Applications of high volume fly ash concretes.
<i>
In: Loo, Y-C (ed.). Building for the 21st century. Proceedings of the 5th East Asia-Pacific Conference on Structural Engineering and Construction (Gold Coast, QLD: July 25-27, 1995)</i>
2: 981-986 15 refs, illus. ISBN 0868576719
(Gold Coast, QLD: Griffith Univ.)
<P>*Stokes, J.R., <B>Graham, L.J.W.</b> and *Boger, D.V. (1995)
Observation of elastic effects in confined swirling flow of viscoelastic fluids.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
5p. 12 refs, illus.
<P>*Sugo, H.O., *Page, A.W. and <B>Lawrence, S.J.</b> (1995)
A closer look at the structure of mortars and the effects of air entraining agent on bond strength.
<i>
Proceedings of the 4th Australian Masonry Conference (Sydney, NSW: November 23-24, 1995)</i>
pp. 285-94  12 refs, illus.
<P><B>Suresh, R.</b>, <B>Chandrasekaran, V.</b> and <B>Grubits, S.J.</b> (1995)
Numerical studies on bond strength of reinforced concrete specimens exposed to fire.
<i>
Proceedings of a Conference at the Asiaflam Hong Kong Conference Programme on Fire Science and Engineering (Kong Kong: March 15-16, 1995)</i>
pp.617-627 10 refs, illus.
<P>*Thwaites, T. and <b>CSIRO Division of Building, Construction and Engineering</b> (1995)
Keeping comfort a high priority.
<i>
Innovation. Division of Building, Construction and Engineering. CSIRO Australia</i>
(3): 9-10, illus.
<P><B>Vidakovic, S.S.</b> and *Luxton, R.E. (1995)
Secondary jet injection at the throat of an axisymmetric nozzle: deduction of a vortex skeleton.
<i>
Paper presented at the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 12 refs, illus.
<P><B>Weinert, D.W.</b> and <B>Salt, H.</b> (1995)
Vacuum methods to examine the desorption of gases in heat pipe preparation.
<i>
Paper for 9th International Heat Pipe Conference (Albuquerque, New Mexico, USA: May 1-5, 1995)</i>
5p. 13 refs, illus.
<P><B>Welsh, M.C.</b> and <B>Rudman, M.</b> (1995)
What CSIRO can do for you: some successful case studies.
<i>
Paper presented at the Institution of Engineers, Aust. (Qld Div.) Central Region Conference & Engineering Expo (Gladstone, QLD: September 7-10, 1995)</i>
12p., illus.
<P><B>Whitlock, J.A.</b> (1995)
Research is the key to fire safety engineering.
<i>
SPECnews</i>
(Jan): p.10
<P><B>Williams, P.B..</b> (1995)
A regulation evaluation system: a decision support system for the Building Code of Australia.
<i>
Construction Management and Economics</i>
13: 197-208 16 refs, illus.
<P><B>Wu, J.</b>, *Sheridan, J., <B>Welsh, M.C.</b> and *Hourigan, K. (1995)
Three-dimensional vortex structures in bluff-body wakes.
<i>
Paper for the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
4p. 18 refs, illus.
<P><B>Yeoh, G.H.</b>, <B>Chandrasekaran, V.</b>, <B>Hildebrandt, M.</b> and <B>Grubits, S.J.</b> (1995)
A numerical investigation of fire in a large arbitrary shape compartment.
<i>
Proceedings of Asiaflame Conference (Kowloon, Hong Kong: March 15-16, 1995)</i>
pp.593-604 15 refs, illus.
<P><B>Yeoh, G.H.</b> and <B>Chandrasekaran, V.</b> (1995)
Three-dimensional numerical study of fire in a large compartment incorporating soot and radiation.
<i>
Paper for the 8th Symposium on Transport Phenomena in Combustion (San Francisco, CA, USA: July 16-20, 1995)</i>
18p. 21 refs, illus.
<P><B>Yeoh, G.H.</b>, <B>Chandrasekaran, V.</b> and *Leonardi, E. (1995)
Numerical prediction of fire and smoke spread.
<i>
Australian Refrigeration, Air Conditioning and Heating</i>
49(1): 13-18 10 refs, illus.
<P>*Yuen, R., <B>Yeoh, G.H.</b>, *Casey, R., <B>Chandrasekaran, V.</b>, *de Vahl Davis, G. and *Leonardi, E. (1995)
Three-dimensional numerical prediction of burning of wood in a cone calorimeter.
<i>
Paper presented at the International Conference on Fire Research & Engineering (Orlando, FL, USA: September 10-15, 1995)</i>
6p. 16 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-35</DOCNO>
<DOCOLDNO>IA057-000941-B011-138</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/WY1996.html 192.102.250.248 19970208044641 text/html 20256
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:33:59 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:52 GMT
Content-type: text/html
Content-length: 20072
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Wildlife and Ecology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Wildlife and Ecology</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abensperg-Traun, M.</b> (1996)
Abandon the paddock : a valid method of rehabilitation?.
<i>
Journal of Agriculture. Department of Agriculture. Western Australia</i>
37(2): 39-43  illus.
<P><B>Andersen, A.N.</b> and Spain, A.V. (1996)
The ant fauna of the Bowen Basin, in the semi-arid tropics of central Queensland (Hymenoptera: Formicidae).
<i>
Australian Journal of Entomology</i>
35:213-222, 23 refs, illus.
<P>*Anderson, J.E., *Williams, J., Kriedemann, P.E., <B>Austin, M.P.</b> and *Farquhar, G.D. (1996)
Correlations betwwn carbon isotope discrimination and climate of native habitats for diverse eucalypt taxa growing in  a common garden.
<i>
Australian Journal of Plant Physiology</i>
23: 311-20  47 refs, illus.
<P>*Anderson, J.E., *Williams, J., Kriedemann, P.E., <B>Austin, M.P.</b> and *Farquhar, G.D. (1996)
Correlations between carbon isotope discrimination and climate of native habitats for diverse eucalypt taxa growing in a common garden.
<i>
Australian Journal of Plant Physiology</i>
23(3): 311-320 47 refs, illus.
<P>*Anderson, V.J., <B>Hodgkinson, K.C.</b> and *Grice, A.C. (1996)
The influence of recent grazing pressure and landscape position on grass recruitment in a semi-arid woodland of eastern Australia.
<i>
Rangeland Journal</i>
18(1): 3-9  22 refs, illus.
<P><B>Austin, M.P.</b>, <B>Pausas, J.G.</b> and <B>Nicholls, A.O.</b> (1996)
Patterns of tree species richness in relation to environment in southeastern New South Wales, Australia.
<i>
Australian Journal of Ecology</i>
21: 154-64  43 refs, illus.
<P><B>Bastin, G.N.</b>, Pickup, G., *Stanes, J. and *Stanes, A. (1996)
Estimating landscape resilience from satellite data and its application to pastoral land management.
<i>
Rangeland Journal</i>
18(1): 118-35  41 refs, illus.
<P>*Beveridge, I. and <B>Spratt, D.M.</b> (1996)
The helminth fauna of Australasian marsupials: origins and evolutionary biology.
<i>
Advances in Parasitology. Vol. 37</i>
37: 136-254  271 refs, illus. ISBN 0120317370
<P><B>Bishop, A.W.</b> and <B>Coops, N.C.</b> (Editors) (1996)
Remote sensing of forest vegetation: Batemans Bay, NSW, Australia.
CD-ROM and leaflet
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
[For optimum use, the presentation should be viewed within "Netscape Navigator" v 2.0, or higher]
<P><B>Braithwaite, L.W.</b> (1996)
Conservation of arboreal herbivores: the Australian scene.
<i>
Australian Journal of Ecology</i>
21: 21-30  9 refs, illus.
[Paper presented at the 6th International Theriological Congress]
<P><B>Braithwaite, R.W.</b> and <B>Griffiths, A.D.</b> (1996)
The paradox of <i>Rattus tunneyi</i>: endangerment of a native pest.
<i>
Wildlife Research</i>
23(1): 1-21 45 refs, illus.
<P><B>Braithwaite, R.W.</b> (1996)
Biodiversity and fire in the savanna landscape.
<i>
In: Solbrig, O T, Median, E, and Silva, J F (eds.). Biodiversity and savanna ecosystem processes: a global perspective</i>
Ch. 7: 121-40  55 refs, illus.
(Berlin/Heidelberg: Springer-Verlag)
[Ecological Studies, Vol. 121]
<P>*Calver, M.C., <B>Hobbs, R.J.</b>, *Horwitz, P. and *Main, A.R. (1996)
Science, priciples and forest management: a response to Abbott and Christensen.
<i>
Australian Forestry</i>
59(1): 1-6  43 refs
<P><B>Chambers, L.K..</b>, <B>Singleton, G.R.</b> and <B>Van Wensveen, M.</b> (1996)
Spatial heterogeneity in wild populations of house mice (<i>Mus domesticus</i>) on the Darling Downs, south-eastern Queensland.
<i>
Wildlife Research</i>
23(1): 23-38 44 refs, illus.
<P>*Christian, K.A., <B>Corbett, L.K.</b>, <B>Green, B.F.</b> and *Weavers, B.W. (1996)
Seasonal activity and energetics of two species of varanid lizards in tropical Australia.
<i>
Oecologia</i>
103: 349-57  48 refs, illus.
<P>*Clay, R.E. and <B>Andersen, A.N.</b> (1996)
Ant fauna of a mangrove community in the Australian seasonal tropics, with particular reference to zonation.
<i>
Australian Journal of Zoology</i>
44(5): 521-33, 34 refs, illus.
<P><B>Cocks, K.D.</b> and <B>Ive, J.R.</b> (1996)
Mediation support for forest land allocation: the SIRO-MED system.
<i>
Environmental Management</i>
20(1): 41-52  23 refs, illus.
<P><B>Cocks, K.D.</b> (1996)
People policy.
347p., refs, illus. ISBN 0868402478
(Sydney, NSW: Univ. of New South Wales Press)
<P><B>Coops, N.</b> (1996)
Characterisation of temporal patterns in the spectral response of eucalyptus in a GIS environment.
<i>
In: Masters, E G (ed.). AURISA 94 Proceedings of the 22nd Annual Conference of the Australasian Urban and Regional Information Systems Association Inc. "Information Systems...The Bottom Line" (Sydney, Australia: November 21-25, 1994)</i>
pp. 473-84  32 refs, illus.
(Sydney, NSW: Australasian Urban and Regional Information Systems Association Inc.)
<P><B>Corbett, L.K.</b>, <B>Hertog, A.L.</b> and Muller, W.J. (1996)
An experimental study of the impact of feral swam buffalo <i>Bubalus bubvalis</i> on the breeding habitat and nesting success of magpie geese <i>Anseranas semipalmata</i> in Kakadu Naitonal Park.
<i>
Biological Conservation</i>
76: 277-87  31 refs, illus.
<P><B>Cork, S.J.</b> (1996)
Digestive constraints on dietary scope in small and moderately-small mammals: how much do we really understand?.
<i>
In: Chivers, D J and Langer, P (eds.). The digestive system in mammals: food, form and function</i>
ch. 21: 337-69  120 refs, illus. ISBN 0521440165
<P><B>Cork, S.J.</b> (1996)
Optimal digestive strategies for arboreal herbivorous mammals in contrasting forest types: why koalas and colobines are differenct.
<i>
Australian Journal of Ecology</i>
21: 10-20  41 refs, illus.
<P>*Daly, R.L. and <B>Hodgkinson, K.C.</b> (1996)
Relationships between grass, shrub and tree cover on four landforms of semi-arid eastern Australia, and prospects for changing by burning.
<i>
Rangeland Journal</i>
18(1): 104-17  48 refs, illus.
<P><B>Dennis, T.E.</b> and <B>Shaughnessy, P.D.</b> (1996)
Status of the Australian sea lion, <i>Neophoca cinerea</i>, in the Great Australian Bight.
<i>
Australian Journal of Zoology</i>
23(6): 741-54, 17 refs, illus.
<P><B>Egan, J.L.</b> and <B>Williams, R.J.</b> (1996)
Lifeform distributions of woodland plant species along a moisture availability gradient in Australia's monsoonal tropics.
<i>
Australian Systematic Botany</i>
9(2): 205-17 33 refs, illus.
<P><B>Faith, D.P.</b> and <B>Walker, P.A.</b> (1996)
Environmental diversity: on the best-possible use of surrogate data for assessing the relative biodiversity of sets of areas.
<i>
Biodiversity and Conservation</i>
5: 399-415  38 refs, illus.
<P><B>Faith, D.P.</b> and <B>Walker, P.A.</b> (1996)
Integrating conservation and development: incorporating vulnerability into biodiversity-assessment of areas.
<i>
Biodiversity and Conservation</i>
5: 417-29  24 refs, illus.
<P><B>Faith, D.P.</b> and <B>Walker, P.A.</b> (1996)
Integrating conservation and development: effective trade-offs between biodiversity and cost in the selection of protected areas.
<i>
Biodiversity and Conservation</i>
5: 431-46  20 refs, illus.
<P>*Foley, W.J., *Mclean, S. and <B>Cork, S.J.</b> (1996)
Consequences of biotransformation of plant secondary metabolities on acid-base metabolism in mammals: a final common pathway?.
<i>
Journal of Chemical Engineering</i>
21(6): 721-43  70 refs, illus.
<P><B>Foran, B.D.</b> and <B>Poldy, F.</b> (1996)
National and regional sustainability issues: agriculture and some views of the future?.
<i>
Proceedings of a National Conference on Professional Responsibility for the Environment. Sustaining Agri-Industry: Valuing the Environment. (Rydges, ACT: August 6-7, 1996)</i>
pp. B1-B12  28 refs, illus.
(Carlton, VIC: The Australian Institute of Agricultural Science)
[AIAS Occasional Publication No. 96]
<P><B>Foran, B.D.</b> (1996)
Ecological footprints and challenging the assumption of growth forever.
<i>
Consumption and the environment</i>
pp. 19-26  46 refs ISBN 064224880X
[Environmental Economics Seminar series]
<P>*Freitag, S., <B>Nicholls, A.O.</b> and *van Jaarsveld, A.S. (1996)
Nature reserve selection in the Transvaal, South Africa: what data should we be using?.
<i>
Biodiversity and Conservation</i>
5: 685-98  41 refs, illus.
<P><B>Freudenberger, D.O.</b> (1996)
Rangeland management.
<i>
Australasian Science</i>
17(2): 14-17  illus.
<P><B>Friedel, M.H.</b>, Muller, W.J. and <B>Kinloch, J.E.</b> (1996)
The potential of some mechanical treatments for rehabilitating arid rangelands. 2. Identifying indicators from between-site comparisons.
<i>
Rangeland Journal</i>
18(1): 165-78  16 refs, illus.
<P><B>Friedel, M.H.</b>, <B>Kinloch, J.E.</b> and Muller, W.J. (1996)
The potential of some mechanical treatments for rehabilitating arid rangelands. 1. Withing -sete effects and economic returns.
<i>
Rangeland Journal</i>
18(1): 150-64  18 refs
<P>Gill, A.M., Moore, P.H.R. and <B>Williams, R.J.</b> (1996)
Fire weather in the wet-dry tropics of the World Heritage Kakadu National Park, Australia.
<i>
Australian Journal of Ecology</i>
21: 302-308, 28 refs
<P><B>Green, B.F.</b>, *Krause, W.J. and <B>Newgrain, K.W.</b> (1996)
Milk composition in the North American opossum (<i>Didelphis virginiana</i>).
<i>
Comparative Biochemistry and Physiology</i>
113B(3): 619-23  21 refs, illus
<P><B>Greene, R.S.B.</b> and Nettleton, W.D. (1996)
Soil genesis in a logitudinal dune-swale landscape, New South Wales, Australia.
<i>
AGSO Journal of Australian Geology & Geophysics</i>
16(3): 277-87  31 refs, illus.
<P><B>Hamilton, N.</b> and *Cocks, D. (1996)
Coastal growth and the environment.
<i>
In: Newton, P W and Bell, M (eds.). Population Shift: mobility and change in Australia</i>
ch. 11: 182-91  13 refs, illus. ISBN 0644361182
<P><B>Hinds, L.A.</b>, *Fletcher, T.P. and *Rodger, J.C. (1996)
Hormones of oestrus and ovulation and their manipulation in marsupials.
<i>
Reproduction, Fertility and Development</i>
8(4): 661-72 56 refs, illus.
<P><B>Hobbs, R.J.</b> (1996)
Integrating biodiversity conservation and forestry production: a challenge for professional forestry.
<i>
In: Norton, D A & Allen, J C (eds.).  Issues in forest management.  School of Forestry  Paper</i>
(23): 27-34, 54 refs, illus.
(Christchurch, NZ: University of Canterbury)
<P><B>Hobbs, R.J.</b> and *Norton, D.A. (1996)
Towards a conceptual framework for restoration ecology [commentary].
<i>
Restoration Ecology</i>
4(2): 93-110  98 refs, illus.
<P><B>James, C.D.</b> (1996)
Ecology of the pygmy goanna (<i>Varanus brevicauda</i>) in spinifex grasslands of central Australia.
<i>
Australian Journal of Zoology</i>
44(2): 177-192 57 refs, illus.
<P>*Karasov, W.H. and <B>Cork, S.J.</b> (1996)
Test of a reactor-based digestion optimization model for nectar-eating rainbow lorikeets.
<i>
Physiological Zoology</i>
69(1): 117-38  40 refs, illus.
<P><B>Kearns, A.</b> (1996)
Yesterday, today and tomorrow: the changing role of engineers in planning and implementing sustainable development.
<i>
Proceedings of the Darwin Summit on Engineering (Darwin, NT: April 21-24, 1996)</i>
pp. 295-302  42 refs
(Institution of Engineers, Australia)
<P>*Kelt, D.A., *Brown, J.H., *Heske, E.J., *Marquet, P.A., <B>Morton, S.R.</b>, <B>Reid, J.R.W.</b>, *Rogovin, K.A. and *Shenbrot, G. (1996)
Community structure of desert small mammals: comparisons across four continents.
<i>
Ecology</i>
77(3): 746-61  101 refs, illus.
<P><B>Mallawaarachchi, T.</b>, <B>Walker, P.A.</b>, <B>Young, M.D.</b>, <B>Smyth, R.E.</b>, <B>Lynch, H.S.</b> and *Dudgeon, G. (1996)
GIS-based integrated modelling systems for natural resource management.
<i>
Agricultural Systems</i>
50: 169-189 50 refs, illus.
<P><B>Masters, P.</b> (1996)
The effects of fire-driven succession on reptiles in spinifex grasslands at Uluru National Park, Northern Territory.
<i>
Wildlife Research</i>
23(1): 39-48 28 refs, illus.
<P><B>Merchant, J.C.</b>, <B>Libke, J.A.</b> and <B>Newgrain, K.W.</b> (1996)
Milk consumption and estimates of growth energetics in pouch young of the northern brown bandicoot, <i>Isoodon macrourus</i> (Peramelidae, Marsupialia), in captivity.
<i>
Journal of Zoology. [London]</i>
238: 483-94  25 refs, illus.
<P><B>Milham, N.P.</b>, Pickup, G. and <B>Bastin, G.N.</b> (1996)
Remote sensing and range monitoring and assessment: a cost-benefit analysis of the grazing gradient approach.
<i>
Australian Journal of Environmental Management</i>
3(1): 58-73  42 refs
[This article is a summary of an unpublished report: Milman, N, Cost Benefit Analysis of the Land Degradation Assessment and Forecasting Project (CSIRO Division of Wildlife and Ecology. Alice Spings, 1993) which can be obtained through the authors]
<P><B>Missingham, R.</b> (1996)
A World-Wide Web of information: the solution to our problems or a new reason for information specialists?.
<i>
Australian Library Review</i>
13(1): 39-43
<P><B>Missingham, R.</b> (1996)
Access: the information superhighway to your doorstep.
<i>
Australian Library Review</i>
13(1): 65-69
<P><B>Morton, S.R.</b>, <B>Andersen, A.N.</b>, <B>Cork, S.J.</b>, <B>Hobbs, R.J.</b>, <B>Noble, J.C.</b>, <B>Saunders, D.A.</b>, <B>Stafford Smith, D.M.</b> and <B>Young, M.D.</b> (1996)
Looking after our land: a future for Australia's biological diversity.
20p., illus. ISBN 0643058397
(Canberra, ACT: CSIRO Division of Wildlife and Ecology)
<P>*Muths, E. and <B>Hinds, L.A.</b> (1996)
Circulating levels of prolactin and progesterone in a wild population of red kangaroos (<i>Macropus rufus</i>) Marsupialia: Macropodidae.
<i>
General and Comparative Endocrinology</i>
101: 317-322  29 refs, illus.
<P><B>Nicholas, K.R.</b>, *Wilde, C.J., *Bird, P.H. and *Hendry, K.A.K. (1996)
Asynchronous expression of milk protein genes during lactation in the tammar wallaby (<i>Macropus eugenii</i>).
<i>
Trends in Comparative Biochemistry and Physiology. 1</i>
pp. 959-72  43 refs, illus.
<P><B>Nicholls, A.O.</b>, *Viljoen, P.C., *Knight, M.H. and *van Jaarsveld, A.S. (1996)
Evaluating population persistence of censused and unmanaged herbivore populations from the Kruger National Park, South Africa.
<i>
Biological Conservation</i>
76: 57-67  31 refs, illus.
<P><B>Noble, J.C.</b>, *Whitford, W.G. and *Kaliszweski, M. (1996)
Soil and litter microarthropod population from two contrasting ecosystems in semi-arid eastern Australia.
<i>
Journal of Arid Environments</i>
32: 329-46  54 refs, illus.
<P>*Park, H.C., *Orsini, J.P.G., *Majer, J.D. and <B>Hobbs, R.J.</b> (1996)
A model of litter harvesting by the Western Australian wheatbelt termite, <i>Drepanotermes tamminensis</i> (Hill), with particular reference to nutrient dynamics.
<i>
Ecological Research</i>
11: 69-78  12 refs, illus.
<P>*Pearce, D., *Jackson, A. and <B>Braithwaite, R.W.</b> (1996)
Aboriginal people of the tropical savannas: resource utilization and conflict resolution.
<i>
The futures gazette. Division of Wildlife and Ecology. CSIRO Australia</i>
Ch 9: 88-103, 27 refs, illus. ISBN 0643057846
(Collingwood, Vic : CSIRO Publishing)
<P>*Reichel, H. and <B>Andersen, A.N.</b> (1996)
The rainforest ant fauna of Australia's Northern Territory.
<i>
Australian Journal of Zoology</i>
44(1): 81-95 32 refs, illus.
<P>*Robertson, .G. and <B>Newgrain, K.W.</b> (1996)
The food and energy intake rates of adult emperor penguins (<i>Aptenodytes forsteri</i>) rearing chicks.
<i>
Antarctic Science</i>
8(1): 37-44  38 refs
<P><B>Russell, E.M.</b> and <B>Rowley, I.C.R.</b> (1996)
Partnerships in promiscuous Splendid Fairy-wrens.
<i>
In: Black, J M (ed.).  Partnerships in birds</i>
Ch. 8: 162-73  23 refs, illus.
(Oxford, UK: Oxford University Press)
<P><B>Saunders, D.A.</b> and *Hussey, B.M.J.(Penny). (1996)
Creating a Hans Heysen: painting saline lands into a nature conservation picture.
<i>
Proceedings of the 4th National Conference and Workshop on the Productive Use and Rehabilitation of Saline Lands (Albany, WA: March 25-30, 1996)</i>
pp. 59-66  15 refs
(Applecross, WA: Promaco Conventions Pty Ltd)
<P><B>Saunders, D.A.</b>, *Craig, J.L. and *Mattiske, E.M. (Editors) (1996)
Nature Conservation 3: The role of networks.
684p. ISBN 0949324655
<P><B>Saunders, D.A.</b> (1996)
Sustaining agricultural productivity and conserving nature in Western Australia.
<i>
In: Donaghey, R and McKay, K (eds.). Proceedings of the TCT-TFGA Nature Conservation Conference on the Benefits of Sustaining Biological Diversity on the Farm (Hobart, TAS: August, 1993)</i>
pp.9-19 39 refs, illus.
<P>*Setterfield, S.A. and <B>Williams, R.J.</b> (1996)
Patterns of flowering and seed production in <i>Eucalyptus miniata</i> and <i>E. tetrodonta</i> in a tropical savanna woodland, northern Australia.
<i>
Australian Journal of Botany</i>
44(2): 107-22 41 refs, illus.
<P><B>Shaughnessy, P.D.</b>, *Stirling, I. and *Dennis, T.E. (1996)
Changes in the abundance of New Zealand fur seals, <i>arctocephalus forsteri</i>, on the Neptune Islands, South Australia.
<i>
Australian Journal of Zoology</i>
23(6): 697-709, 16 refs, illus.
<P><B>Sinclair, A.R.E.</b> and <B>Pech, R.P.</b> (1996)
Density dependence, stochasticity, compensation and predator regulation.
<i>
Oikos</i>
75: 164-73  71 refs, illus.
<P><B>Singleton, G.R.</b> and <B>Chambers, L.K.</b> (1996)
A manipulative field experiment to examine the effect of <i>Capillaria hepatica</i> (Nematoda) on wild mouse populations in southern Australia.
<i>
International Journal for Parasitology</i>
26(4): 383-98  31 refs, illus.
<P><B>Sraml, M.</b>, *Christidis, L., *Easteal, S., *Horn, P. and <B>Collet, C.C.</b> (1996)
Molecular relationships within Australasian waterfowl (Anseriformes).
<i>
Australian Journal of Zoology</i>
44(1): 47-58 43 refs, illus.
<P>Taylor, J.A. and <B>Braithwaite, R.W.</b> (1996)
Interactions between land uses in Australia's savannas - it's largely in the mind!.
<i>
The futures gazette. Division of Wildlife and Ecology. CSIRO Australia</i>
Ch 10: 107-18, 66 refs ISBN 0643057846
(Collingwood, Vic : CSIRO Publishing)
<P><B>Tyndale-Biscoe, C.H.</b> (1996)
Boden conference on marsupial gametes and embryos; summing up.
<i>
Reproduction, Fertility and Development</i>
8(4): 831-4 10 refs
<P>*Valsecchi, P. (`), <B>Singleton, G.R.</b> and <B>Price, W.J.</b> (1996)
Can social behaviour influence food preference of wild mice, <i>Mus domesticus</i>, in confined field populations?.
<i>
Australian Journal of Zoology</i>
44(5): 493-501 28 refs, illus.
<P><B>Young, M.D.</b> and <B>Walker, P.A.</b> (1996)
Delivering policy relevant information to government for environmental and resource management.
<i>
In: Masters, E G (ed.). AURISA 94 Proceedings of the 22nd Annual Conference of the Australasian Urban and Regional Information Systems Association Inc. "Information Systems...The Bottom Line" (Sydney, Australia: November 21-25, 1994)</i>
pp. 25-31  3 refs
(Sydney, NSW: Australasian Urban and Regional Information Systems Association Inc.)
<P><B>Young, M.D.</b>, <B>Howard, B.</b>, *Gunningham, N., *Grabosky, P., *McCrone, E., *Elix, J. and *Lambert, J. (1996)
Reimbursing the future: an evaluation of motivational, voluntary, price-based, property-right, and regulatory incentives for the conservation of biodiversity. A report to the Biodiversity Unit of the Dept. of the Environment, Sport and Territories.
<i>
Department of  the Environment, Sport and Territories. Biodiversity Series. Paper</i>
(9): part 1: 209p.;  part 2: 199p. ISBN 0642244294
<P><B>Young, M.D.</b> and <B>Howard, B.</b> (1996)
Can Australia afford a representative reserve network by 2000?.
<i>
Search</i>
27(1): 22-26 16 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-36</DOCNO>
<DOCOLDNO>IA089-000953-B003-124</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MO1996.html 192.102.250.248 19970208041515 text/html 4552
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:02:37 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:28 GMT
Content-type: text/html
Content-length: 4369
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Minerals</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Minerals</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Farrow, J.B.</b> and <B>Swift, J.D.</b> (1996)
A new procedure for assessing the performance of flocculants.
<i>
International Journal of Mineral Processing</i>
46: 263-75  16 refs, illus.
<P>*Galbreath, K., *Zygarlicke, C., *Casuccio, G., *Moore, T., <B>Gottlieb, P.</b>, <B>Agron-Olshina, N.A.</b>, *Huffman, G., *Shah, A., *Yang, N., *Vleeskens, J. and *Hamburg, G. (1996)
Collaborative study of quantitative coal mineral analysis using computer-controlled scaning electron microscopy.
<i>
Fuel</i>
75(4): 424-30  22 refs, illus.
<P><B>Lim, I.L.</b>, *Voigt, W. and <B>Weller, K.R.</b> (1996)
Product size distribution and energy expenditure in grinding minerals and ores in high pressure rolls.
<i>
International Journal of Mineral Processing</i>
44-45: 539-59  12 refs, illus.
<P><B>Liu, Y.</b> (1996)
Calibrating an industrial microwave six-port instrument using the artificial neural network technique.
<i>
IEEE Transactions on Instrumentation and Measurement</i>
45(2): 651-6  23 refs, illus.
<P><B>Mumme, W.G.</b>, <B>Tsambourakis, G.</b>, <B>Madsen, I.C.</b> and <B>Hill, R.J.</b> (1996)
Improved pegrological modal analyses from X-ray powder diffraction data by use of the Rietveld method. Part 2. Selected seimentary rocks.
<i>
Journal of Sedimentary Research</i>
66(1): 132-8  41 refs, illus.
<P><B>Mumme, W.G.</b>, <B>Cranswick, L.M.</b> and *Chakoumakos, B. (1996)
Rietveld crystal structure refinements from high temperature neutron powder diffraction data for the polymorphs of dicalcium silicate.
<i>
N. Jb. Miner. Abh.</i>
170(2): 171-88, 11 refs, illus.
<P><B>Mumme, W.G.</b>, <B>Tsambourakis, G.</b>, <B>Madsen, I.C.</b> and <B>Hill, R.J.</b> (1996)
Improved petrological modal analyses from x-ray powder diffraction data by use of the Rietveld method. 2. Selected sedimentary rocks.
<i>
Journal of Sedimentary Research</i>
66(1): 132-138 41 refs, illus.
<P><B>Nguyen, T.H.</b> and <B>Death, D.L.</b> (1996)
Slag analysis by laser Raman scattering.
<i>
Paper presented at the 3rd Australian Melt Chemistry Symposium (Clayton, VIC: January, 1996)</i>
4p. 14 refs, illus.
<P><B>Rand, D.A.J.</b> (1996)
Energy storage in lead-acid batteries: the Faraday way to sustainability.
<i>
Philosophical Transactions. Royal Society of London. A</i>
354: 1529-44  6 refs
<P><B>Schwarz, M.P.</b> (1996)
Simulation of gas injection into liquid melts.
<i>
Applied Mathematical Modelling</i>
20: 41-51 39 refs, illus.
<P>Shepherd, I.C., Lafontaine, R.F., <B>Hooper, J.D.</b>, Davy, J.L., Burton, D.R., <B>Beeby, C.J..</b> and <B>White, R.B.</b> (1996)
A robust probe to measure the movement of particles and gas in a high temperature abrasive environment.
<i>
Paper for the 4th International Alumina Quality Workshop (Darwin, NT: June 2-7, 1996)</i>
10p. 2 refs, illus.
<P><B>Stojanovic, R.S.</b>, <B>Dorin, R.</b> and <B>Frazer, E.J.</b> (1996)
Investigation of the aluminium electrodeposition process in cryolite-based melts using a rotating ring-disc electrode: evidence for the existence of a subvalent intermediate species.
<i>
Journal of Applied Electrochemistry</i>
26: 249-254 23 refs, illus.
<P><B>Vecchio-Sadus, A.M.</b>, <B>Constable, D.C.</b>, <B>Dorin, R.</b>, <B>Frazer, E.J.</b>, Fernandez, I., Neal, G.S., Lathabai, S. and Trigg, M.B. (1996)
The dioxide-based ceramics as inert anodes for aluminium smelting: a laboratory study.
<i>
In: Hale, W (ed.). Light metals</i>
pp.259-265 29 refs, illus.
(The Minerals, Metals & Materials Society)
<P><B>Weller, K.R.</b>, *Morell, S. and <B>Gottlieb, P.</b> (1996)
Use of grinding and liberation models to simulate tower mill circuit performance in lead / zinc concentrator to increase flotation recovery.
<i>
International Journal of Mineral Processing</i>
44-45: 683-702  6 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-37</DOCNO>
<DOCOLDNO>IA089-000952-B046-38</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FX1995.html 192.102.250.248 19970208035858 text/html 11928
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:46:20 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:19 GMT
Content-type: text/html
Content-length: 11744
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Food Science and Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Food Science and Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Beilken, S.L.</b>, <B>Dettloff, U.R.</b> and <B>Shay, B.W.J.</b> (1995)
Sodium lactate effects on the sensory and physical properties of ham.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8B.13-8B.18 5 refs, illus.
<P><B>Ben, A.</b> and <B>Kurth, L.B.</b> (1995)
Edible film coatings for meat cuts and primals.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.10.13-10.15 5 refs, illus.
<P><B>Buhot, J.W.</b> (1995)
Trends in abattoir automation: research and development aspects.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.4B.1-4B.2, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1995)
Thought for food at CSIRO.
<i>
Research Results. CSIRO Australia</i>
(3): 39-41, illus.
<P><b>CSIRO Division of Food Science and Technology</b> (1995)
Food Safety and Hygiene. Division of Food Science and Technology. CSIRO Australia.
no.1-   [quarterly]
<P><b>CSIRO Information Services</b>, <b>CSIRO Division of Plant Industry</b> and <b>CSIRO Division of Food Science and Technology</b> (1995)
Eatsmart [multimedia CD-ROM].
CD-ROM plus leaflet ISBN 0643057080
<P>*Davidson, B.E. and <B>Hillier, A.J.</b> (1995)
Developing new starters for fermented milk products.
<i>
Australian Journal of Dairy Technology</i>
50(1): 6-9 49 refs
<P><B>Eyles, M.J.</b> and <B>Shay, B.W.J.</b> (1995)
The quality/safety issues affecting the marketing of meat.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.5.19-5.23 20 refs, illus.
<P><B>Grau, F.H.</b> (1995)
Smallgoods and listeria.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8B.5-8B.8, illus.
<P><B>Grau, F.H.</b> (1995)
<i>Escherichia coli</i> in Australia.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.5.7-5.9 3 refs, illus.
<P><B>Heidke, D.J.</b> (1995)
Boning technology.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.4B.13-4B.16, illus.
<P><B>James, E.A.</b>, <B>Gutzke, D.A.</b> and <B>Ferguson, A.W.</b> (1995)
Properties of carnosine and its extraction from isolated muscle protein (IMP) waste material.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.6B.13-6B.16 33 refs, illus.
<P><B>Johnson, R.L.</b>, <B>Htoon, A.K.</b> and <B>Shaw, K.J.</b> (1995)
Detection of orange peel extract in orange juice.
<i>
Food Australia</i>
47(9): 426-32  28 refs, illus.
<P><B>Johnson, R.L.</b>, <B>Htoon, A.K..</b> and <B>Shaw, K.J.</b> (1995)
Detection of orange peel extract in orange juice.
<i>
Food Australia</i>
47(9): 426-432 27 refs, illus.
<P><B>Kuypers, R.</b> and <B>Kurth, L.B.</b> (1995)
Collagen's contribution to meat texture.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.11B.1-11B.8 27 refs, illus.
<P>*Milgate, J.M., <B>Oakenfull, D.G.</b> and *Roberts, D.C.K. (1995)
Alfalfa sprouts and cholesterol metabolism.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 49  illus.
<P><B>Pearce, R.J.</b> (1995)
Food functionality: success or failure for dairy based ingredients.
<i>
Australian Journal of Dairy Technology</i>
50(1): 15-23 105 refs, illus.
<P><B>Pitt, J.I.</b> (1995)
Phylogeny in the genus <i>Penicillium</i>: a morphologist's perspective.
<i>
Canadian Journal of  Botany</i>
73(Supp.1): S768-S777 44 refs, illus.
<P><B>Pitt, J.I.</b> and <B>Hocking, A.D.</b> (1995)
Current knowledge of fungi and mycotoxins associated with food commodities in southeast Asia.
<i>
In: Highley, E and Johnson, G I (eds.). Mycotoxin contamination in grains: papers presented at the 17th ASEAN Technical Seminar on Grain Postharvest Technology (Lumut, Malaysia: July 25-27, 1995). ACIAR Technical Report No. 37</i>
pp. 5-10  11 refs ISBN 1863201718
<P><B>Powell, V.H.</b> and *Ozutsumi, K. (1995)
Beef meat quality in Japan.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 62-63 3 refs, illus.
<P><B>Prescott, J.</b> and <B>Stevenson, R.J.</b> (1995)
Pungency in food perception and preference.
<i>
Food Review International</i>
11(4): 665-698 139 refs, illus.
<P>*Ravindran, V., <B>Hood, R.L.</b>, *Gill, R.J., <B>Kneale, C.R.</b> and *Bryden, W.L. (1995)
Effect of processing on the feeding value of grain amaranth for broilers.
<i>
Proceedings of the Nutrition Society of Australia</i>
19: p. 202  3 refs
<P><B>Richardson, K.C.</b> (1995)
Food science and food law: partners in progress?.
<i>
Food Australia</i>
47(6): 260-262 8 refs
<P><B>Roberts, M.</b>, <B>Wijesundera, R.C.</b>, *Bruinenberg, P.G. and *Limsowtin, G.K.Y. (1995)
Development of an aseptic cheese curd slurry system for cheese ripening studies.
<i>
Australian Journal of Dairy Technology</i>
50(2): 66-69 11 refs, illus.
[Based on a paper presented at the International Lactic Acid Bacteria Conference (Palmerston North, NZ: February 19-23, 1995)]
<P><B>Shaw, F.D.</b> and <B>Powell, V.H.</b> (1995)
Meat quality aspects of hot boning.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.12B.1-12B.3 5 refs, illus.
<P><B>Shay, B.W.J.</b> and *Souness, R. (1995)
Recent regulations impacting on the smallgoods industry.
<i>
Food Australia</i>
47(11): 491-494, illus.
[Paper presented at Meat '95, the CSIRO Meat Industry Research Conference (Brisbane, QLD: September 10-12, 1995)]
<P><B>Shay, B.W.J.</b> and *Souness, R. (1995)
Recent regulations impacting on the smallgoods industry.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8B.1-8B.4 3 refs, illus.
<P><B>Shay, B.W.J.</b> and <B>Bill, B.A.</b> (1995)
Retail-ready packaging for domestic and export markets.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.10.5-10.8 7 refs, illus.
<P><B>Shorthose, W.R.</b> (1995)
Beef carcases: grade or describe?.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 204-205 5 refs
<P><B>Shorthose, W.R.</b> (1995)
The relative importance of production factors on meat.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.4A.11-4A.16 8 refs, illus.
<P><B>Smith, M.G.</b> (1995)
Survival of <i>E. coli</i> and <i>Salmonella</i> after chilling and freezing in liquid media.
<i>
Journal of Food Science</i>
60(3): 509-512 22 refs, illus.
<P>*Sookhareea, R., *Taylor, D.G., *Dryden, G.McL., <B>Tume, R.K.</b>, <B>Shorthose, W.R.</b> and <B>Larsen, T.W.</b> (1995)
The effect of sex type and age on fatty acid composition of intramuscular lipid of loin muscle of Javan rusa (<i>Cervus timoriensis</i>) deer and its relation to palatability.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 46-47 17 refs
<P><B>Steele, R.J.</b> and <B>Johnson, R.L.</b> (1995)
New strategies for kiwifruit processing.
<i>
International Journal of Food Science and Technology</i>
30: 13-21  8 refs
<P><B>Steven Shann-Tzong Jiang</b> and <B>Kurth, L.B.</b> (1995)
Red meat IMP processing and its potential as a surimi replacer.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.6B.1-6B.6 60 refs, illus.
<P><B>Steven Shann-Tzong Jiang</b> (1995)
The contribution of muscle proteinases to meat texture.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.11B.9-11B.14 92 refs, illus.
<P><B>Torley, P.J.</b>, <B>Trout, G.R.</b> and *D'Arcy, B.R. (1995)
The effect of polyphosphates on the functional properties of pale, soft, exudative (PSE) pork.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8B.19-8B.21 3 refs, illus.
<P><B>Trout, G.R.</b> and <B>Gutzke, D.A.</b> (1995)
The relationship between discolouration rate during refrigerated display and the autoxidation rate of purified myoglobin: the effects of muscle type and species.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 404-405 12 refs
<P><B>Tume, R.K.</b>, <B>Larsen, T.W.</b> and <B>Yang, A.</b> (1995)
Comparison of some fat quality attributes of <i>long-term grainfed</i> Australian and Japanese beef [poster abstract].
<i>
Schriftenreihe des Forschungsinstitutes fuer die Biologie Landwirtschaftlicher Nutztiere (FBN)</i>
(6): p.173
[Ender, K (ed.). Proceedings of the 2nd Dummerstorf Muscle-Workshop Muscle Growth and Meat Quality (Rostock, Germany: May 17-19, 1995)]
<P><B>Tume, R.K.</b> and <B>Yang, A.</b> (1995)
Factors affecting fat hardness of beef carcases.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8A.11-8A.15 24 refs, illus.
<P><B>Vanderlinde, P.B.</b> (1995)
Microbiological implications of hot boning.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.5.11-5.17, illus.
<P><B>Vanderlinde, P.B.</b>, <B>Shay, B.W.J.</b> and *Brett, D. (1995)
Evaluation of a commercial hot water decontamination cabinet.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 282-283 2 refs
<P><B>Yang, A.</b>, <B>Trout, G.R.</b> and <B>Shay, B.W.J.</b> (1995)
Evaluation of carrageenan, isolated soy protein and a modified starch in low-fat frankfurters.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 435-436
<P><B>Yang, A.</b>, <B>Larsen, T.W.</b> and <B>Tume, R.K.</b> (1995)
Comparison of some fat quality attributes of Japanese and Australian beef.
<i>
Proceedings of the 41st Annual International Congress of Meat Science and Technology (San Antonio, TX, USA: August 20-25, 1995)</i>
2: 60-61, illus.
<P><B>Yang, A.</b>, <B>Beilken, S.L.</b> and <B>Shay, B.W.J.</b> (1995)
Low fat pork products.
<i>
In: Fearon, P H (ed.). Queensland Pig Research and Development Seminar.  Proceedings of the 1st Research and Development Seminar of the Queensland Pig Consultancy Group (Gatton, QLD: September 8, 1995)</i>
pp.48-49
<P><B>Yang, A.</b>, <B>Trout, G.R.</b> and <B>Shay, B.W.J.</b> (1995)
Low-fat meat products.
<i>
Proceedings of the Australian Meat Industry Research Conference (Gold Coast, QLD: September 10-12, 1995)</i>
pp.8B.9-8B.12 11 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-38</DOCNO>
<DOCOLDNO>IA057-000940-B048-204</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/OC1995.html 192.102.250.248 19970208041808 text/html 16325
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:05:30 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:33 GMT
Content-type: text/html
Content-length: 16141
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Oceanography</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Oceanography</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Argote, M.L., *Amador, A., *Lavin, M.F. and <B>Hunter, J.R.</b> (1995)
Tidal dissipation and stratification in the Gulf of California.
<i>
Journal of Geophysical Research</i>
100(C8): 16,103-16,118 48 refs, illus.
<P><B>Bakes, M.J.</b> and <B>Nichols, P.D.</b> (1995)
Lipid, fatty acid and squalene composition of liver oil from six species of deep-sea sharks collected in southern Australian waters.
<i>
Comparative Biochemistry and Physiology</i>
110B(1): 267-275 22 refs, illus.
<P><B>Bakes, M.J.</b>, Elliott, N.G., *Green, G.J. and <B>Nichols, P.D.</b> (1995)
Variation in lipid composition of some deep-sea fish (Teleostei: Oreosomatidae and Trachichthyidae).
<i>
Comparative Biochemistry and Physiology. B</i>
111(4): 633-642 28 refs, illus.
<P><B>Barrett, S.M.</b>, <B>Volkman, J.K.</b>, <B>Dunstan, G.A.</b> and Leroi, J-M. (1995)
Sterols of 14 species of marine diatoms (Bacillariophyta).
<i>
Journal of Phycology</i>
31: 360-369 53 refs, illus.
<P><B>Butler, E.C.V.</b> (1995)
Estuarine chemistry: towards tools for environmental managers.
<i>
Chemistry in Australia</i>
62(8): 9-10, illus.
<P>Cai, W. and <B>Godfrey, J.S.</b> (1995)
Surface heat flux parameterizations and the variability of thermohaline circulation.
<i>
Journal of Geophysical Research</i>
100(C6): 10,679-10,692 51 refs, illus.
<P><B>Cavanagh, J-A.E..</b>, *Juhasz, A.L., <B>Nichols, P.D.</b>, *Franzmann, P.D. and *McMeekin, T.A. (1995)
Analysis of microbial hydrocarbon degradation using TLC-FID.
<i>
Journal of Microbiological Methods</i>
22: 119-130 31 refs, illus.
<P><B>Craig, P.D.</b> (1995)
`Oceans-EEZ' will describe Australia's oceans.
<i>
Australian Fisheries</i>
54(4): 10-11, illus.
<P><B>Craig, P.D.</b> (1995)
Scientists develop a national ocean weather map for mariners.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(Nov): p.3, illus.
<P><B>Craig, P.D.</b> and <B>Wilkin, J.L.</b> (1995)
An ocean model for Australia's Exclusive Economic Zone.
<i>
Proceedings of the 12th Australasian Coastal & Ocean Engineering Conference combined with the 5th Australasian Port & Harbour Conference (Melbourne, Australia: May 28 - June 2, 1995)</i>
pp. 279-85  30 refs
<P><B>Cresswell, G.R.</b> (1995)
The ASEAN-Australia Regional Ocean Dynamics Expeditions 1993-1995.
<i>
Maritime Studies</i>
(85): 13-20  4 refs, illus.
<P><b>CSIRO Division of Oceanography</b> (1995)
Research update.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
no.1-    [quarterly]
<P><b>CSIRO Division of Oceanography</b> (1995)
Annual Report: 1993-94.
<i>
Annual Report. National Facility Steering Committee Oceanographic Research Vessel. Division of Oceanography. CSIRO Australia</i>
40p., illus.
<P><b>CSIRO Division of Oceanography</b> (1995)
Strategic research directions 1995-2000.
<i>
Division of Oceanography [miscellaneous publication]. CSIRO Australia</i>
14p., illus.
<P><B>England, M.H.</b> (1995)
The age of water and ventilation timescales in a global ocean model.
<i>
Journal of Physical Oceanography</i>
25(11, pt 1): 2757-77  33 refs, illus.
<P><B>England, M.H.</b> (1995)
Using chlorofluorocarbons to assess ocean climate models.
<i>
Geophysical Research Letters</i>
22(22): 3051-3054 12 refs, illus.
<P><B>England, M.H.</b> (1995)
CFC uptake and ventilation time-scales in a world ocean model [abstract].
<i>
Abstracts of the Australian Physical Oceanography and Australian Meteorological and Oceanographic Society Joint Conference (Lorne, VIC: February 20-22, 1995)</i>
p.31, illus.
<P><B>England, M.H.</b> (1995)
The age of water and ventilation timescales in a Global Ocean model.
<i>
Journal of Physical Oceanography</i>
25: 2756-77  34 refs, illus.
<P><B>England, M.H.</b> (1995)
Using chlorofluorocabons to assess ocean climate.
<i>
Geophysical Research Letters</i>
22(22): 2051-4  12 refs, illus.
<P><B>England, M.H.</b> (1995)
Using chlorofluorocarbons to assess ocean climate.
<i>
Geophysical Research Letters</i>
22(22): 3051-4  12 refs, illus
<P><B>Fandry, C.B.</b> (1995)
A model ocean.
<i>
Helix. Magazine of CSIRO's Double Helix Science Club</i>
(44): p.21, illus.
[Earlier version published in: Helix, 1992, (26): p.33]
<P>*Gent, P.R., *Willebrand, J., <B>McDougall, T.J.</b> and *McWilliams, J.C. (1995)
Parameterizing eddy-induced tracer transports in ocean circulation models.
<i>
Journal of Physical Oceanography</i>
25(4): 463-474 30 refs, illus.
<P><B>Godfrey, J.S.</b> (1995)
Australian involvement in TOGA-COARE: a journalistic view.
<i>
Australian Meteorological Magazine</i>
44(2): 147-153 16 refs, illus.
<P><B>Godfrey, J.S.</b> and <B>Wilkin, J.L.</b> (1995)
Reply [to comment by A L Gordon: "When is appearance reality? A comment on why does the Indonesian throughflow appear to originate from the North Pacific"].
<i>
Journal of Physical Oceanography</i>
25(6,Part II): 1568-1570 5 refs, illus.
<P>*Green, G. and <B>Nichols, P.D.</b> (1995)
Hydrocarbons and sterols in marine sediments and soils at Davis Station, Antarctica: a survey for human-derived contaminants.
<i>
Antarctic Science</i>
7(2): 137-144 31 refs, illus.
<P>*Hanawa, K., *Rual, P., <B>Bailey, R.J.</b>, *Sy, A. and *Szabados, M. (1995)
A new depth-time equation for Sippican or TSK <i>T</i>-7, <i>T</i>-6 and <i>T</i>-4 expendable bathythermographs (XBT).
<i>
Deep-Sea Research </i>
42(8): 1423-51  26 refs, illus.
<P><B>Jackett, D.R.</b> and <B>McDougall, T.J.</b> (1995)
Neutral density.
<i>
Interntional WOCE Newsletter</i>
(19): 30-33 4 refs, illus.
<P><B>Jackett, D.R.</b>, <B>McDougall, T.J.</b> and *England, M.H. (1995)
Sea level rise in the Australia/New Zealand region [abstract].
<i>
In: Hennessy, K J and Pittock, A B (eds.).  Development and application of climate change scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC: December 4-5, 1995)</i>
pp.43-45, 5 refs ISBN 0643056084
(Aspendale, VIC: CSIRO Division of Atmospheric Research)
<P><B>Jackett, D.R.</b> and <B>McDougall, T.J.</b> (1995)
Minimal adjustment of hydrographic profiles to achieve static stability.
<i>
Journal of Atmospheric and Oceanic Technology</i>
12(2): 381-389 9 refs, illus.
<P>Koslow, J.A., *Bell, J., <B>Virtue, P.</b> and *Smith, D.C. (1995)
Fecundity and its variability in orange roughy: effects of population density, condition, egg size, and senescence.
<i>
Journal of Fish Biology</i>
47: 1063-1080 50 refs, illus.
<P><B>Leeming, R.L.</b> (1995)
New technique to trace faecal pollution.
<i>
Research Update. Division of Oceanography. CSIRO Australia</i>
(Nov): p.4, illus.
<P><B>Leeming, R.L.</b> and <B>Nichols, P.D.</b> (1995)
Use of faecal sterols and bacterial indicators to discriminate sources of faecal pollution in urban creeks and lakes of Wyong, NSW [Consultancy report].
<i>
Division of Oceanography [miscellaneous publication]. CSIRO Australia</i>
11p. 4 refs, illus.
<P><B>Mackey, D.J.</b> (1995)
Marine chemistry and the Greenhouse effect.
<i>
Chemistry in Australia</i>
62(8): 39-40, illus.
<P><B>Mackey, D.J.</b>, Parslow, J.., <B>Higgins, H.W.</b>, Griffiths, F.B. and <B>O'Sullivan, J.E.</b> (1995)
Plankton productivity and biomass in the western equatorial Pacific: biological and physical controls.
<i>
Deep-Sea Research II</i>
42(2-3): 499-533 93 refs, illus.
<P>*Mancuso, C.A., *McMeekin, T.A., *Nichols, D.S. and <B>Nichols, P.D.</b> (1995)
The Australian Collection of Antarctic Microorganisms (ACAM): an increasing demand for a new resource.
<i>
Chemistry in Australia</i>
62(8): 11-12 3 refs, illus.
<P><B>McDougall, T.J.</b> (1995)
The influence of ocean mixing on the absolute velocity vector.
<i>
Journal of Physical Oceanography</i>
25(5): 705-725 22 refs, illus.
<P><B>McDougall, T.J.</b> (1995)
The three-dimensional mean velocity for stratified turbulent flows: the temporal-residual-mean velocity.
<i>
Proceedings of the 12th Australasian Fluid Mechanics Conference (Sydney, NSW: December 10-15, 1995)</i>
pp.351-354 16 refs
<P><B>Meyers, G.A.</b>, <B>Bailey, R.J.</b> and *Worby, A.P. (1995)
Geostrophic transport of Indonesian throughflow.
<i>
Deep-Sea Research</i>
42(7): 1163-1174 30 refs, illus.
<P><B>Morgan, P.P..</b> (1995)
Box inverse modelling with DOBOX 4.2.
<i>
Report. Marine Laboratories. CSIRO Australia</i>
(225): 26p. 8 refs, illus. ISBN 0643057870
<P>*Nichols, D.S., <B>Nichols, P.D.</b> and *McMeekin, T.A. (1995)
A new n-C<sub>31:9</sub> polyene hydrocarbon from Antarctic bacteria.
<i>
FEMS Microbiology Letters</i>
125: 281-286 21 refs, illus.
<P>*Nichols, D.S., <B>Nichols, P.D.</b> and *McMeekin, T.A. (1995)
Ecology and physiology of psychrophilic bacteria from Antarctic saline lakes and sea-ice.
<i>
Science Progress</i>
78(4): 311-47  139 refs, illus.
<P><B>Nilsson, C.S.</b> and <B>Tildesley, P.C.</b> (1995)
Imaging of oceanic features by ERS 1 synthetic aperture radar.
<i>
Journal of Geophysical Research</i>
100(C1): 953-967 41 refs, illus.
<P><B>O'Leary, T.</b>, <B>Leeming, R.L.</b>, <B>Nichols, D.S.</b> and <B>Volkman, J.K.</b> (1995)
Biomarker assessment of natural and pollutant sources of organic matter in Port Phillip Bay, Australia.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic Geochemistry: developments and applicaitons to energy, climate, environment and human history (San Sebastian, Spain: September 4-8, 1995)</i>
pp. 680-1  5 refs, illus.
[Selected papers from the 17th International Meeting on Organic Geochemistry]
<P><B>O'Sullivan, J.E.</b>, <B>Watson, R.J.</b> and <B>Mackey, D.J.</b> (1995)
A guide to trace metal sampling in estuarine waters.
<i>
Paper presented at a conference on "Ocean Rescue 2000: Data Collection Management Guidelines: Oceanography and Meteorology"</i>
15p.  5 refs <a href= "http://Kaos.erin.gov.au/marine/natmis/standards/oceanography/osullivan"> http://Kaos.erin.gov.au/marine/natmis/standards/oceanography/osullivan</a> (Visited 1996, Dec 18)
<P>*Provost, C., *Gana, S., *Garcon, V., *Maamaatuaiahutapu, K. and <B>England, M.H.</b> (1995)
Hydrographic conditions in the Brazilian-Malvinas Confluence during austral summer 1990.
<i>
Journal of Geophysical Research</i>
100(C6): 10,655-78  27 refs, illus.
<P><B>Reid, J.S.</b> (1995)
Observational evidence of the interaction of ocean wind-sea with swell.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
46(2): 419-425 18 refs, illus.
<P><B>Revill, A.T..</b>, <B>Volkman, J.K.</b>, <B>O'Leary, T.</b>, *Summons, R.E., *Boreham, C.J., *Banks, M.R. and *Denwer, K. (1995)
Reply to the Comment by E. W. Domack on "Hydrocarbon biomarkers, thermal maturity, and depositional setting of tasmanite oil shales from Tasmania, Australia".
<i>
Geochimica et Cosmochimica Acta</i>
59(11): 2397-2399 15 refs
<P><B>Revill, A.T.</b> (1995)
Petroleum industry [encyclopedia entry].
<i>
Encyclopedia of Analytical Science</i>
pp. 3012-22  5 refs, illus. ISBN 0122267001
(Academic Press)
<P>*Robertson, L., <B>Revill, A.T.</b>, <B>Volkman, J.K.</b> and *Sikes, E.L. (1995)
Organic geochemistry of Antarctic saline lakes and fjords.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic Geochemistry: developments and applications to energy, climate, environment and human history (San Sebastian, Spain: September 4-8, 1995)</i>
pp. 253-4  2 refs, illus
(European Association of Organic Geochemists)
[Selected papers from the 17th International Meeting on Organic Geochemistry]
<P>*Rosenberg, M., *Eriksen, R., *Bell, S., *Bindoff, N. and <B>Rintoul, S.R.</b> (1995)
Aurora Australis Marine Science Cruise AU9407: oceanographic field measurements and analysis.
<i>
Research Report. Antarctic CRC</i>
(6): 97p. 6 refs, illus. ISBN 1875796010
<P>*Rosenberg, M., *Eriksen, R. and <B>Rintoul, S.R.</b> (1995)
Aurora Australis Marine Science Cruise AU9309/AU9391: oceanographic field measurements and analysis.
<i>
Research Report. Antarctic CRC</i>
(2): 103p. 5 refs, illus. ISBN 0642225338
<P>Rothlisberg, P.C., <B>Church, J.A.</b> and <B>Fandry, C.B.</b> (1995)
A mechanism for near-shore concentration and estuarine recruitment of post-larval <i>Penaeus plebejus</i> Hess (Decapoda, Penaeidae).
<i>
Estuarine, Coastal and Shelf Science</i>
40: 115-138 49 refs, illus.
<P>*Rowland, S.J., <B>Revill, A.T.</b>, *Thomas, K.V., *Baas, M., *Largeau, C., *de Leeuw, J.W., *Hodges, M., *Lyne, P. and *Smith, C. (1995)
Unresolved complex mixtures of hydrocarbons in oils: origins and characterization.
<i>
In: Grimalt, J O and Dorronsoro, C (eds.). Organic Geochemistry: developments and applications to energy, climate, environment and human history (San Sebastian, Spain: September 4-8, 1995)</i>
pp. 933-6  6 refs, illus
(European Association of Organic Geochemists)
[Selected papers from the 17th International Meeting on Organic Geochemistry]
<P>*Rowland, S.J. and <B>Revill, A.T.</b> (1995)
Chromatography in petroleum geochemistry.
<i>
In: Adlard, E R, (ed.). Chromatography in the Petroleum Industry. Journal of Chromatography Library Series, v. 56</i>
56 ch. 5: 127-141  103 refs, illus
<P><B>Shannon, G.</b> (1995)
Underwater probe monitors dumping at sea.
<i>
Geo</i>
17(4): 20-21, illus.
<P>*Skerratt, J.H., <B>Nichols, P.D.</b>, *McMeekin, T.A. and *Burton, H. (1995)
Seasonal and inter-annual changes in planktonic biomass and community structure in eastern Antarctica using signature lipids.
<i>
Marine Chemistry</i>
51: 93-113 54 refs, illus.
<P>*Sprintall, J., *Roemmich, D., *Stanton, B. and <B>Bailey, R.J.</b> (1995)
Regional climate variability and ocean heat transport in the southwest Pacific Ocean.
<i>
Journal of Geophysical Research</i>
100(C8): 15,865-71  18 refs, illus.
<P><B>Tilbrook, B.D.</b> and *Karl, D.M. (1995)
Methane sources, distributions and sinks from California coastal waters to the oligotrophic North Pacific gyre.
<i>
Marine Chemistry</i>
49: 51-64 44 refs, illus.
<P><B>Virtue, P.</b>, Johannes, R.E., <B>Nichols, P.D.</b> and Young, J.W. (1995)
Biochemical composition of <i>Nyctiphanes australis</i> and its possible use as an aquaculture feed source: lipids, pigments and fluoride content.
<i>
Marine Biology</i>
122: 121-128 65 refs, illus.
<P><B>Volkman, J.K.</b>, <B>Barrett, S.M.</b>, Blackburn, S.I. and *Sikes, E.L. (1995)
Alkenones in <i>Gephyrocapsa oceanica</i>: implications for studies of paleoclimate.
<i>
Geochimica et Cosmochimica Acta</i>
59(3): 513-520 48 refs, illus.
<P><B>Watson, R.J..</b> and <B>Mackey, D.J.</b> (1995)
Clean rooms are not just for the manufacture of CDs.
<i>
Chemistry in Australia</i>
62(8): p.13, illus.
<P><B>Wilkin, J.L.</b>, <B>Mansbridge, J.V.</b> and *Hedstrom, K. (1995)
An application of the capacitance matrix method to accommodate masked land areas and island circulations in a primitive equation ocean model.
<i>
International Journal for Numerical Methods in Fluids</i>
20: 649-662 18 refs, illus.
<P><B>Wilkin, J.L.</b>, <B>Mansbridge, J.V.</b> and <B>Godfrey, J.S.</b> (1995)
Pacific Ocean heat transport at 24&#176;N in a high resolution global model.
<i>
Journal of Physical Oceanography</i>
25(10): 2204-2214 24 refs, illus.
<P>*Woodward, D.R., *Riley, M.D., *Buick, D.R., <B>Nichols, D.S.</b> and <B>Nichols, P.D.</b> (1995)
Nutritional analysis of the flesh and oil of yolla, the Tasmanian mutton bird <i>Puffinus tenuirostris</i>: a useful source of omega-3 polyunsaturated fatty acids.
<i>
Australian Journal of Nutrition and Dietetics</i>
52(2): 87-90 30 refs
<P>*You, Y., <B>McDougall, T.J.</b> and *Schmitt, R.W. (1995)
Dianeutral motion, water mass conversion, and nonlinear effects on the density ratio in the Pacific thermocline.
<i>
Journal of Physical Oceanography</i>
25(8): 1891-1904 18 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-39</DOCNO>
<DOCOLDNO>IA089-000953-B003-103</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/MO1995.html 192.102.250.248 19970208041458 text/html 12461
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:02:11 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:28 GMT
Content-type: text/html
Content-length: 12277
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Minerals</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Minerals</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Apateanu, L. and <B>Rand, D.A.J.</b> (1995)
Recent publications on lead/acid batteries and related phenomena: 1993, No. 2, B19-B36.
<i>
Journal of Power Sources</i>
56: B19-B36
<P>*Apateanu, L. and <B>Rand, D.A.J.</b> (1995)
Recent publications on lead/acid batteries and related phenomena: 1994, Nos. 1 and 2, B1-B22.
<i>
Journal of Power Sources</i>
56: B1-B22
<P><B>Bear, I.J.</b>, <B>Flann, R.C.</b> and <B>McDonald, K.J.</b> (1995)
Activated basket anodes from nickel powder: the production of composite nickel-iron anodes.
<i>
International Journal of Powder Metallurgy</i>
31(2): 121-131 9 refs, illus.
<P>*Bockri, J.O'M., <B>Fletcher, S.</b>, *Gale, R.J., *Khan, S.U.M., *Kolb, D.M., *Mazur, D.J., *Uosaki, K. and *Weinberg, N.L. (1995)
Electrochemistry (1992-1995).
<i>
Annual Reports of The Royal Society of Chemistry</i>
92 (Section C): 23-73  621 refs, illus.
<P>Buckley, A.N. and <B>Woods, R.</b> (1995)
Identifying chemisorption in the interaction of thiol collectors with sulfide minerals by XPS: adsorption of xanthate on silver and silver sulfide.
<i>
Colloids and Surfaces. A. Physicochemical and Engineering Aspects</i>
104: 295-305 44 refs, illus.
<P>Buckley, A.N., *Laajalehto, K., *Suoninen, E. and <B>Woods, R.</b> (1995)
Flotation-related surface reactivity of molybdenite.
<i>
In: Laskowski, J S and Poling, G W (eds.). Processing of hydrophobic minerals and fine coal. Proceedings of the 1st UBC-McGill Bi-Annual International Symposium on Fundamentals of Mineral Processing (Vancouver, BC, Canada: August 20-24, 1995)</i>
pp.29-42 46 refs, illus. ISBN 0919086594
(Montreal, Canada: Canadian Inst. of Mining, Metallurgy and Petroleum)
<P>Buckley, A.N. and <B>Woods, R.</b> (1995)
Comment on "Scanning tunnelling microscopy studies of galena: the mechanism of oxidation in air" by B.S. Kim, R.A. Hayes, C.A. Prestidge, J. Ralston and R.St.C. Smart.
<i>
Applied Surface Science</i>
84: 223-224 6 refs
<P><B>Coghill, P.J.</b>, *Bassett, I., *Barrow, R., *Rohatgi, S. and *Vance, R. (1995)
Field trial of an elecrically passive optical-fiber manetometer.
<i>
Applied Optics</i>
34(31): 7258-62  5 refs, illus.
<P><B>Constanti-Carey, K.K.</b>, <B>Hollenkamp, A.F.</b>, <B>Koop, M.J..</b> and <B>McGregor, K.</b> (1995)
Physical change in positive-plate material: an underrated contributor to premature capacity loss.
<i>
Journal of Power Sources</i>
55: 269-275 17 refs, illus.
<P><B>Cranswick, L.M.</b>, *Silverton, J. and *Buckner, T. (1995)
Global communication.
<i>
IUCr Newsletter</i>
3(1): 6-10, illus.
<P><b>CSIRO Division of Minerals</b> (1995)
Process.
<i>
Process. Division of Minerals. CSIRO Australia</i>
Issue 3-
[Initially published by CSIRO Division of Mineral Processing/CSIRO Division of Mineral and Process Engineering]
<P><B>Davidson, M.R.</b> (1995)
An adaptive method of predicting the air core diameter for numerical models of hydrocyclone flow.
<i>
International Journal of Mineral Processing</i>
43: 167-77  15 refs, illus.
<P><B>Deutscher, R.L.</b>, Florence, T.M. and <B>Woods, R.</b> (1995)
Investigations on an aqueous lithium secondary cell.
<i>
Journal of Power Sources</i>
55: 41-46 16 refs, illus.
<P>*Fernandez, P.G., <B>Linge, H.G.</b>, *Hughes, H.H. and *Dunn, J.G. (1995)
The Chemtronics PDV 2000 voltammeter: analysis of As(III) above 10PPB.
<i>
Proceedings of the Randol Gold Forum: Gold Metallurgy & Environmental Management (Perth, WA: March 14-17, 1995)</i>
pp. 159-61  5 refs, illus.
(Golden,CO, USA: Randol International Ltd.)
<P><B>Gao, M-W.</b> and *Forssberg, E. (1995)
Prediction of product size distributions for a stirred ball mill.
<i>
Powder Technology</i>
84: 101-6  10 refs, illus.
<P><B>Hawkins, K.D.</b> and <B>Aral, H.</b> (1995)
Metamict zircon: is its importance understood?.
<i>
Zircon 95. Proceedings of the Intertech Conference (Munich, Germany: May 10-12, 1995)</i>
15p. 36 refs, illus.
<P><B>Hawkins, K.D.</b> and <B>Aral, H.</b> (1995)
Metamict zircon: is its importance understood?.
<i>
Zircon 95 (Munich, Germany: May 10-12, 1995)</i>
15p. 36 refs, illus.
[Paper presented by G J Sparrow]
<P><B>Houchin, M.R.</b>, *Dallison, A.M., *Kaka, K.M., <B>Strode, P.R.</b> and <B>Van Merkestein, R.W.</b> (1995)
Metal finishing effluent treatment with magnesium oxide.
<i>
Surface Finishing News</i>
3(2): 6-8,10, illus.
[Also published: Proceedings of the Asia Pacific Interfinish 1994 Conference (Melbourne, VIC: October 2-6, 1994): pp.79.1-79.8]
<P><B>Ilievski, D.</b>, <B>Parker, A.J.</b> and *White, E.T. (1995)
Modelling Bayer precipitation with agglomeration.
<i>
In: Ewans, J (ed.). Light Metals. Proceedings of the 124th TMS Annual Meeting (Las Vegas, USA: February 12-16, 1995)</i>
pp.55-61 30 refs, illus. ISBN 0873392760
(Warrendale, PA, USA: The Minerals, Metals & Materials Society)
<P><B>Ilievski, D.</b> and *White, E.T. (1995)
Agglomeration during precipitation: 1. Tracer crystals for Al(OH)<sub>3</sub> precipitation.
<i>
AIChE Journal</i>
41(3): 518-524 26 refs, illus.
<P><B>Ilievski, D.</b> and *Hounslow, M.J. (1995)
Agglomeration during precipitation: 2. Mechanism deduction from tracer data.
<i>
AIChE Journal</i>
41(3): 525-535 13 refs, illus.
<P>*Kunath-Fandrei, G., Bastow, T.J., <B>Hall, J.S.</b>, *Jager, C. and Smith, M.E. (1995)
Quantification of aluminum coordinations in amorphous aluminas by combined central and satellite transition magic angle spinning NMR spectroscopy.
<i>
Journal of Physical Chemistry</i>
99: 15138-41  15 refs, illus.
<P><B>Lam, T.L.</b>, <B>Hynh, T.D.</b>, <B>Haigh, N.P.</b>, <B>Douglas, J.D.</b>, <B>Rand, D.A.J.</b>, *Lakshmi, C.S., *Hollingsworth, P.A., *See, J.B., *Manders, J. and *Rice, D.M. (1995)
Influence of bismuth on the age-hardening and corrosion behaviour of low-antimony lead alloys in lead/acid battery systems.
<i>
Journal of Power Sources</i>
53: 63-74 11 refs, illus.
<P><B>Lam, T.L.</b>, <B>Ozgun, H.</b>, <B>Lim, O.V.</b>, <B>Hamilton, J.A.</b>, <B>Vu, L.H.</b>, <B>Vella, D.G.</b> and <B>Rand, D.A.J.</b> (1995)
Pulsed-current charging of lead/acid batteries: a possible means for overcoming premature capacity loss?.
<i>
Journal of Power Sources</i>
53: 215-228 24 refs, illus.
<P><B>Linge, H.G.</b> (1995)
Is pyrrhotite (FeS<sub>1+ x</sub>) really a cyanicide in carbon-in-pulp/leach circuits?.
<i>
Proceedings of the Randol Gold Forum: Gold Metallurgy & Environmental Management (Perth, WA: March 14-17, 1995)</i>
pp. 153-6  7 refs, illus.
(Golden,CO, USA: Randol International Ltd.)
<P><B>Linge, H.G.</b> (1995)
Prodcessing of arsenopyritic (FeAsS) gold concentrates with chlor-alkali technology.
<i>
Proceedings of the Randol Gold Forum: Gold Metallurgy & Environmental Management (Perth, WA: March 14-17, 1995)</i>
pp. 157-8  10 refs
(Golden,CO, USA: Randol International Ltd.)
<P><B>Linge, H.G.</b> (1995)
Anodic oxidation of pyrrhotite in simulated CIP liquors.
<i>
Minerals Engineering</i>
8(7): 795-806 23 refs, illus.
<P><B>Liu, Y.</b> (1995)
Industrial microwave six-port calibration: a comparison of two nonlinear techniques.
<i>
Proceedings of the International Conference and Exhibition on Electronic Measurement and Instrumentation (Shanghai, China: October 17-20, 1995)</i>
4p. 18 refs, illus.
<P><B>Mumme, W.G.</b> (1995)
Crystal structure of tricalcium silicate from a Portland cement clinker and its application to quantitative XRD analysis.
<i>
Neues Jahrbuch fuer Mineralogie. Monatshefte</i>
4: 145-160 19 refs, illus.
<P><B>Mumme, W.G.</b>, <B>Hill, R.J.</b>, *Bushnell-Wye, G. and <B>Segnit, E.R.</b> (1995)
Rietveld crystal structure refinements, crystal chemistry and calculated powder diffraction data for the polymorphs of dicalcium silicate and related phases.
<i>
Neues Jahrbuch fuer Mineralogie, Abhandlungen</i>
169(1): 35-68 34 refs, illus.
<P><B>Newnham, R.H.</b>, <B>Hollenkamp, A.F.</b> and <B>Rand, D.A.J.</b> (1995)
Effect of chlorine-containing species on lead/acid battery posts.
<i>
Journal of Power Sources</i>
53: 93-98 17 refs, illus.
<P><B>Parks, T.C.</b> (1995)
"Leapfrog thermodynamics" among binary magnetic phases competing for stability.
<i>
Journal of Solid State Chemistry</i>
116: 92-94 16 refs, illus.
<P><B>Pownceby, M.I.</b> and *O'Neill, H.St.C. (1995)
Thermodynamic data from redox reactions at high temperatures. 5. Thermodynamic properties of NiO-MnO solid solutions from emf measurements.
<i>
Contributions to Mineralogy and Petrology</i>
119: 409-421 20 refs, illus.
<P>Proctor, C.H., Thresher, R.E., Gunn, J.S., Mills, D.J., <B>Harrowfield, I.R.</b> and Sie, S.H. (1995)
Stock structure of the southern bluefin tuna <i>Thunnus maccoyii</i>: an investigation based on probe microanalysis of otolith composition.
<i>
Marine Biology</i>
122: 511-526 42 refs, illus.
<P>*Sahajwalla, V., <B>Taylor, I.F.</b>, <B>Washington, B.</b> and Wright, J.K. (1995)
Wettability of carbonaceous substrates by slags.
<i>
Proceedings of the 2nd Australian Melt Chemistry Symposium (Clayton, VIC: February 16-17, 1995)</i>
pp.113-125 19 refs, illus.
<P><B>Senior, G.D.</b>, <B>Trahar, W.J.</b> and <B>Guy, P.J.</b> (1995)
The selective flotation of pentlandite from a nickel ore.
<i>
International Journal of Mineral Processing</i>
43: 209-34  29 refs, illus.
<P>*Shapiro, J.S., *Smith, W.T. and <B>MacRae, C.M.</b> (1995)
Wrinkle morphology of polypyrrole films grown in thin-layer cells.
<i>
Synthetic Metals</i>
69: 506-506 12 refs
<P>*Shapiro, J.S., *Smith, W.T. and <B>MacRae, C.M.</b> (1995)
Morphology of polypyrrole films grown in thin-layer cells and on indium-tin oxide conductive glass.
<i>
Polymer</i>
36(6): 1133-1140 17 refs, illus.
<P><B>Smith, P.G.</b>, *Austin, P. and <B>Ilievski, D.</b> (1995)
Modelling the induction period in gibbsite precipitation.
<i>
In: Ewans, J (ed.). Light Metals. Proceedings of the 124th TMS Annual Meeting (Las Vegas, USA: February 12-16, 1995)</i>
pp.45-49 2 refs, illus. ISBN 0873392760
(Warrendale, PA, USA: The Minerals, Metals and Materials Society)
<P><B>Sparrow, G.J.</b> and <B>Woodcock, J.T.</b> (1995)
Cyanide and other lixiviant leaching systems for gold with some practical applications.
<i>
Mineral Processing and Extractive Metallurgy Review</i>
14: 193-247 240 refs, illus.
<P><B>Stojanovic, R.S.</b>, <B>Kubacki, J.F.</b>, <B>Dorin, R.</b> and <B>Frazer, E.J.</b> (1995)
Development of a rotating ring-disc electrode for high temperature studies in cryolite-based melts.
<i>
Journal of Applied Electrochemistry</i>
25: 456-461 26 refs, illus.
<P><B>Sutherland, D.N.</b> (1995)
Comminution research at the Centre for Mining Technology and Equipment.
<i>
Paper presented at the International Mineral Processing Conference (Kanpur, India: December 11-15, 1995)</i>
6p. 9 refs
<P><B>Tsambourakis, G.</b> (1995)
Phase analysis program for magnesia refractories.
<i>
American Ceramic Society Bulletin</i>
74(2): 74-79 5 refs, illus.
<P><B>Vecchio-Sadus, A.M.</b>, <B>Dorin, R.</b> and <B>Frazer, E.J.</b> (1995)
Evaluation of low-temperature cryolite-based electrolytes for aluminium smelting.
<i>
Journal of Applied Electrochemistry</i>
25: 1098-1104 26 refs, illus.
<P>*Weissenborn, P.K., <B>Warren, L.J.</b> and *Dunn, J.G. (1995)
Selective flocculation of ultrafine iron ore. 1. Mechanism of adsorption of starch onto hematite.
<i>
Colloids and Surfaces</i>
99: 11-27 42 refs, illus.
<P>*Weissenborn, P.K., <B>Warren, L.J.</b> and *Dunn, J.G. (1995)
Selective flocculation of ultrafine iron ore. 2. Mechanism of selective flocculation.
<i>
Colloids and Surfaces</i>
99: 29-43 42 refs, illus.
<P><B>Woods, R.</b>, *Kim, D.S., *Basilio, C.I. and *Yoon, R-H. (1995)
A spectroelectrochemical study of chemisorption of ethyl xanthate on gold.
<i>
Colloids and Surfaces</i>
94: 67-74 25 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-40</DOCNO>
<DOCOLDNO>IA089-000952-B042-19</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/CX1994.html 192.102.250.248 19970208034623 text/html 2418
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:33:46 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:07 GMT
Content-type: text/html
Content-length: 2235
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Office of Space Science and Applications (COSSA)</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>CSIRO Office of Space Science and Applications (COSSA)</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><b>CSIRO Office of Space Science and Application</b> (1994)
Legislation enacted for Australian Space Council.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(57): 1,3, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1994)
CSIRO in new study of ozone hole.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(57): p.5, illus.
<P><b>CSIRO Office of Space Science and Applications</b> (1994)
Highlights from COSSA's first ten years, 1984-1994.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(61): 8-9
<P><B>Embleton, B.J.J.</b> (1994)
Space: the changing external environment.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(61): 2,4, illus.
<P><B>Kingwell, J.</b> (1994)
The rise of the Asian space dragon.
<i>
Space Policy</i>
10(3): 185-6
<P><B>Kingwell, J.F.</b> (1994)
Asian space dragons stretch their wings.
<i>
CSIRO Space Industry News. CSIRO Office of Space Science and Applications. CSIRO Australia</i>
(56): 7-8, illus.
<P><B>Kingwell, J.F.</b> (1994)
The NOAA 1 km Land Data Project: status.
<i>
In: Prata, A J (ed.). AVHRR Workshop Papers (Melbourne, Vic: February 28, 1994)</i>
(Ch.1): 9-15
(Aspendale, Vic: CSIRO Division of Atmospheric Research)
<P>Prata, A.J. and <B>Kingwell, J.</b> (1994)
Australia's continental integrated ground-truth site network.
<i>
COSSA [miscellaneous publication]. CSIRO Australia</i>
pamphlet<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-41</DOCNO>
<DOCOLDNO>IA089-000952-B036-362</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/AS1995.html 192.102.250.248 19970208032742 text/html 8133
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:15:01 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:47:49 GMT
Content-type: text/html
Content-length: 7950
</DOCHDR>
<html>
<head>
<title>1995 Publications - CSIRO Division of Applied Physics</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Applied Physics</h2></td>
</tr>
<tr><td></td>
<td><H2>1995 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Bendavid, A.</b>, <B>Martin, P.J.</b>, *Wang, X., <B>Wittling, M.</b> and <B>Kinder, T.J.</b> (1995)
Deposition and modification of titanium nitride by ion assisted arc deposition.
<i>
Journal of Vacuum Science and Technology A</i>
13(3): 1658-1664 29 refs, illus.
<P><B>Brown, N.</b>, <B>Winter, J.G.</b> and <B>Fujima, I.</b> (1995)
An interferometer for measuring surveyor's pillars in the open air.
<i>
Measurement</i>
15: 245-249 6 refs, illus.
<P><B>Budovsky, I.F..</b> (1995)
Very low frequency AC-DC transfer standard.
<i>
IEEE Transactions on Instrumentation and Measurement</i>
44(2): 367-369 4 refs, illus.
<P><B>Clark, N.H.</b> and <B>Thwaites, S.</b> (1995)
Local phase velocity measurements in plates.
<i>
Journal of Sound and Vibration</i>
187(2): 241-252 8 refs, illus.
<P><B>Clark, N.H.</b> (1995)
Low-frequency absolute calibration of accelerometers.
<i>
Acoustics Australia</i>
23(2): 39-43 9 refs, illus.
<P><b>CSIRO Division of Applied Physics</b> (1995)
CSIRO measures up for Asia-Pacific trade.
<i>
Research Results. CSIRO Australia</i>
(3): 31-35, illus.
<P><b>CSIRO Division of Applied Physics</b> (1995)
Checking for sound components: with sound.
<i>
Research Results. CSIRO Australia</i>
(3): 59-61, illus.
<P>Deam, R.T., Dayal, A.R., McAllister, T., Mundy, A.E., Western, R.J., <B>Besley, L.M.</b>, <B>Farmer, A.J.D.</b>, <B>Horrigan, E.C.</b> and <B>Murphy, A.B.</b> (1995)
Interconversion of chlorofluorocarbons in plasmas.
<i>
Journal of the Chemical Society. Chemical Communications</i>
(3): 347-348 15 refs, illus.
<P><B>Ediriweera, R.N.</b> (Editor) (1995)
Tests and measurements 1995.
76p., illus. ISBN 0643057676
(Lindfield, NSW: CSIRO Division of Applied Physics)
<P><B>Haidar, J.</b> and <B>Farmer, A.J.D.</b> (1995)
Surface temperature measurements for tungsten-based cathodes of high-current free-burning arcs.
<i>
Journal of Physics. D. Applied Physics</i>
28: 2089-2094 10 refs, illus.
<P><B>Haidar, J.</b> (1995)
Local thermodynamic equilibrium in the cathode region of a free burning arc in argon.
<i>
Journal of Physics. D. Applied Physics</i>
28: 2494-2504 32 refs, illus.
<P><B>Hariharan, P.</b> and <B>Ciddor, P.E.</b> (1995)
Achromatic phase-shifters. 2. A quantized ferroelectric liquid-crystal system.
<i>
Optics Communications</i>
117: 13-15 10 refs, illus.
<P><B>Hariharan, P.</b> (1995)
Achromatic retrders using quartz and mica.
<i>
Measurement Science and Technology</i>
6: 1078-1079 5 refs, illus.
<P><B>Hariharan, P.</b>, <B>Brown, N.</b>, <B>Fujima, I.</b> and *Sanders, B.C. (1995)
Heterodyne interferometry at the single-photon level.
<i>
Proceedings of the International Society for Optical Engineering on Interferometry VII: Techniques and Analysis (San Diego, CA, USA: July 11-12,. 1995)</i>
2544: 140-147 14 refs, illus.
<P><B>Hibino, K.</b>, <B>Oreb, B.F.</b>, <B>Farrant, D.I.</b> and *Larkin, K.G. (1995)
Phase shifting for nonsinusoidal waveforms with phase-shift errors.
<i>
Journal of the Optical Society of America. Part A</i>
12(4): 761-768 12 refs, illus.
<P><B>Jaatinen, E.A.</b> and <B>Brown, N.</b> (1995)
A simple external iodine stabilizer applied to 633 nm, 612 nm and 543 nm He-Ne lasers.
<i>
Metrologia</i>
32: 95-101 23 refs, illus.
<P><B>Jurczyk, M.</b>, <B>Gwan, P.B.</b> and <B>Collocott, S.J.</b> (1995)
Magnetic properties of high-energy ball-milled and HDDR processed Nd<sub>12</sub>Fe<sub>75</sub>-{gamma}Co{gamma}Mo<sub>13</sub> (O{le}{gamma}{le}75) powders and their nitrides.
<i>
Journal of Alloys and Compounds</i>
221: 114-119 12 refs, illus.
<P><B>Jurczyk, M.</b>, <B>Cook, J.S.</b> and <B>Collocott, S.J.</b> (1995)
Application of high energy ball milling to the production of magnetic powders from NdFeB-type alloys.
<i>
Journal of Alloys and Compounds</i>
217: 65-68 8 refs, illus.
<P><B>Leslie, K.E.</b>, <B>Small, G.W.</b> and <B>Sloggett, G.J.</b> (1995)
Cancellation of periodic noise in low-level magnetic signals.
<i>
Measurement Science and Technology</i>
6: 1093-1098 6 refs, illus.
<P><B>Lowke, J.J.</b> and <B>Morrow, R.</b> (1995)
Theory of chemical processing using pulsed precipitators.
<i>
Australian Journal of Physics</i>
48(3): 403-409 14 refs, illus.
<P><B>Lowke, J.J.</b> (1995)
Theoretical analysis of removal of oxides of sulphur and nitrogen in pulsed operation of electrostatic precipitators.
<i>
IEEE Transactions on Plasma Science</i>
23(4): 661-671 35 refs, illus.
<P><B>Morgan, V.T.</b> (1995)
Statistical distributions of wind parameters at Sydney, Australia.
<i>
Renewable Energy</i>
6(1): 39-47 47 refs, illus.
<P><B>Morrow, R.</b> and <B>Lowke, J.J.</b> (1995)
Electrical breakdown in air and in SF<sub>6</sub>.
<i>
Australian Journal of Physics</i>
48(3): 453-460 16 refs, illus.
<P><B>Muller, K-H.</b>, <B>Andrikidis, C.</b>, *Liu, H.K. and *Dou, S.X. (1995)
Critical current and hysteretic AC loss in monofilamentary Bi-2223 / Ag tapes.
<i>
Institute of Physics. Conference Series No. 148</i>
pp. 439-42  3 refs, illus.
(IOP Publishing Ltd)
<P><B>Muller, K-H.</b>, <B>Andrikidis, C.</b>, *Liu, H.K. and *Dou, S.X. (1995)
AC hysteresis losses in monofilamentary Pb-Bi-Sr-Ca-Cu-O/Ag tapes.
<i>
Physica C</i>
247: 74-82 27 refs, illus.
<P><B>Muller, K-H.</b> and <B>Andrikidis, C.</b> (1995)
Intergranular and intragranular critical states in high-temperature superconductors.
<i>
In: Tachikawa, K, Kitazawa, K, Maeda, H, Matsushita, T (eds.). Proceedings of the 1994 Topical International Cryogenic Materials Conference on Critical State in Superconductors (Honolulu, Hawaii, USA: October 24-26, 1994)</i>
pp.36-43 15 refs, illus.
(Singapore: World Science Publ.)
<P><B>Murphy, A.B.</b> (1995)
Demixing in a free-burning arc in a mixture of argon and nitrogen.
<i>
In: Fauchais, P (ed.). Heat and mass transfer under plasma conditions: proceedings of the International Sympsium on Heat and Mass Transfer Uunder Plasma Conditions</i>
pp. 151-8  19 refs, illus. ISBN 15667000355
<P><B>Murphy, A.B.</b> (1995)
Transport coefficients of air, argon-air, nitrogen-air, and oxygen-air plasmas.
<i>
Plasma Chemistry and Plasma Processing</i>
15(2): 279-307 43 refs, illus.
<P>Raner, K.D., Strauss, C.R., Trainor, R.W.. and <B>Thorn, J.S.</b> (1995)
A new microwave reactor for batchwise organic synthesis.
<i>
Journal of Organic Chemistry</i>
60: 2456-2460 32 refs, illus.
<P>*Shapiro, E. and <B>Budovsky, I.F..</b> (1995)
Thermal watt-transfer standard.
<i>
IEEE Transactions on Instrumentation and Measurement</i>
44(2): 399-402 4 refs, illus.
<P><B>Sierota, A.</b> and <B>Rungis, J.</b> (1995)
Electrical insulating oils. Part 1. Characterization and pre-treatment of new transformer oils.
<i>
IEEE Electrical Insulation Magazine</i>
11(1): 8-20 83 refs
<P>*Snyder, S.C., <B>Murphy, A.B.</b>, *Hofeldt, D.L. and *Reynolds, L.D. (1995)
Diffusion of atomic hydrogen in an atmospheric-pressure free-burning arc discharge.
<i>
Physical Review E</i>
52(3): 2999-3009 44 refs, illus.
<P><B>Thwaites, S.</b> and <B>Clark, N.H.</b> (1995)
Non-destructive testing of honeycomb sandwich structures using elastic waves.
<i>
Journal of Sound and Vibration</i>
187(2): 253-269 4 refs, illus.
<P>*Zhu, P., <B>Lowke, J.J.</b>, <B>Morrow, R.</b> and <B>Haidar, J.</b> (1995)
Prediction of anode temperatures of free burning arcs.
<i>
Journal of Physics. D. Applied Physics</i>
28: 1369-1376 21 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-42</DOCNO>
<DOCOLDNO>IA089-000952-B042-310</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/EN1996.html 192.102.250.248 19970208034852 text/html 18178
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:36:12 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:09 GMT
Content-type: text/html
Content-length: 17994
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Entomology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Entomology</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Allen, S.E.</b> and <B>Desmarchelier, J.M.</b> (1996)
Evolution of gases from paddy rice at various moisture contents.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(1996/69): 15p., 4 refs, illus.
<P><B>Annis, P.C.</b> (1996)
The use of oil and water to reduce air-borne dust in grain handling facilities.
<i>
Proceedings of the 1996 Dust Explosion Summit (Sydney, NSW: February 12-13, 1996)</i>
12p. 9 refs, illus.
(Sydney, NSW: IBC Conferences Pty Ltd)
<P><B>Annis, P.C.</b> and <B>Waterford, C.J.</b> (1996)
Alternatives: chemicals.
<i>
In: Bell, C H, Price, N, and Chakrabarti, B (eds.). The methyl bromide issue: agrochemicals and plant protection, v. 1</i>
Ch. 7:  pp. 275-321  136 refs ISBN 0471955213
(New York: John Wiley)
<P><B>Baker, G.H.</b>, <B>Barrett, V.J.</b>, <B>Carter, P.J.</b> and <B>Woods, J.P.</b> (1996)
Method for caging earthworms for use in field experiments.
<i>
Soil Biology and Biochemistry</i>
28(3): 331-9  42 refs, illus.
<P><B>Baker, G.H.</b> (1996)
Worms can help restore soil health.
<i>
Farming Ahead</i>
(49): 24,26, illus.
<P><B>Banks, H.J.</b> (1996)
Update on aeration - a versatile management tool.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
1-2, illus.
<P><B>Braby, M.F.</b> (1996)
A new handbook on Australian butterflies [book review].
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 6-9
<P><B>Braby, M.F.</b> (1996)
A new species of <i>Nesolycaena</i> Waterhouse and Turner (Lepidoptera: Lycaenidae) from northeastern Australia.
<i>
Australian Journal of Entomology</i>
35-9-17  13 refs, illus.
<P><B>Brown, W.V.</b>, <B>Watson, J.A.L(Deceased).</b>, <B>Lacey, M.J.</b>, Morton, R. and <B>Miller, L.R.</b> (1996)
Composition of cuticular hydrocarbons in the Australian harvester termite <i>Drepanotermes perniger</i> (Isoptera: Termitidae): variation among individuals, castes, colonies and locations.
<i>
Sociobiology</i>
27(2): 181-97  22 refs, illus.
<P><B>Brown, W.V.</b>, <B>Watson, J.A.L(Deceased).</b> and <B>Lacey, M.J.</b> (1996)
A chemotaxonomic survey using cuticular hydrocarbons of some species of the Australian harvester termite genus <i>Drepanotermes</i> (Isoptera: Termitida).
<i>
Sociobiology</i>
27(2): 199-221  26 refs, illus.
<P><B>Cassells, J.A.</b> (1996)
New guidelines for harvesting and safe storage of legumes.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
illus.
<P><B>Clark, S.D.</b> and <B>Greenslade, P.J.M.</b> (1996)
Review of Tasmanian <i>Hanseniella</i> Bagnall (Symphyla: Scutigerellidae).
<i>
Invertebrate Taxonomy</i>
10(1): 189-212 15 refs, illus.
<P>*Convey, P., <B>Greenslade, P.J.M.</b>, *Richard, K.J. and *Block, W. (1996)
The terrestrial arthropod fauna of the Byers Peninsula, Livingston Island, South Shetland Island : Collembola.
<i>
Polar Biology</i>
16: 257-9  8 refs
<P><B>Coupland, J.B.</b> (1996)
Influence of snail feces and mucus on oviposition and larval behavior of <i>Pherbellia cinerella</i> (Diptera: Sciomyzidae).
<i>
Journal of Chemical Ecology</i>
22(2): 183-9  19 refs, illus.
<P>Craig, S. and <B>Beaton, C.D.</b> (1996)
A simple cryo-SEM method for delicate plant tissues.
<i>
Journal of Microscopy</i>
182(pt 2): 102-5  8 refs, illus.
<P><B>Cranston, P.S.</b> (1996)
Research activities - Natural history collections - a modern role.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 4-6, illus.
<P><B>Cranston, P.S.</b> (1996)
Research profile: Dr Peter Cranston.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 13-16, illus.
<P><B>Dallwitz, M.J.</b>, <B>Paine, T.A.</b> and <B>Zurcher, E.J.</b> (1996)
INTKEY for Windows.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 11-12, illus.
<P><B>Desmarchelier, J.M.</b>, *Allanson, R., <B>Allen, S.E.</b> and *Moss, R. (1996)
Dryacide<sup>REGD</sup> removal during wheat cleaning.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(68): 21p. 8 refs, illus. ISBN 0643057315
<P><B>Desmarchelier, J.M.</b>, *Allanson, R., <B>Allen, S.E.</b> and *Moss, R. (1996)
Dryacide&reg; removal during wheat cleaning.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(68): 21p. 1 ref, illus. ISBN 0643057315
<P><B>Edwards, P.B.</b> (1996)
Biological control of bridal creeper (<i>Asparagus asparagoides</i>): a review of potential agents from South Africa.
<i>
Plant Protection Quarterly</i>
11(2): p. 48
[Paper based on a paper in: Cooke, D and Choate, J (eds.). Weeds of Conservation Concern, 5-6 April 1995.]
<P><B>Gaull, K.R.</b> and <B>Ridsdill-Smith, T.J.</b> (1996)
The foraging behaviour of redlegged earth mite, <i>Halotydeus destructor</i> (Acarina: Penthaleidae), in an annual subterranean clover pasture.
<i>
Bulletin of Entomological Research</i>
86: 247-252  22 refs, illus.
<P><B>Greenslade, P.J.M.</b> and *Rusek, J. (1996)
<i>Tasphorura</i>, a new genus of Tullbergiinae (Collembola: Onychiuridae) abundant in Tasmanian <i>Nothofagus</i> forest.
<i>
Systematic Entomology</i>
21: 27-38  23 refs, illus.
<P><B>Greenslade, P.J.M.</b> (1996)
A contribution to fire risk management on Beecroft Peninsula: responses of insects to accidental burns.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 12-13, illus.
<P><B>Heard, T.A.</b> (1996)
Stingless bees.
<i>
Nature Australia</i>
(Spring): 51-5, 5 refs, illus.
<P><B>Hilton, S.J.</b> (1996)
Carbon disulphide - a fumigant born again?.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
illus.
<P>*Hosking, J.R., *Smith, J.M.B. and <B>Sheppard, A.W.</b> (1996)
The biology of Australian weeds. 28. <i>Cytisus scoparius</i> (L.) Link subsp. <i>scoparius</i>.
<i>
Plant Protection Quarterly</i>
11(3): 102-6  59 refs, illus.
<P><B>Hughes, R.D.</b> (1996)
A synopsis of information on the Russian wheat aphid, <i>Diuraphis noxia</i> (Mordwilko) (Revised Edition).
<i>
Technical Paper. Division of Entomology. CSIRO Australia</i>
(34): 97p. ISBN 0643048723
<P><B>Hughes, R.D.</b> (1996)
A synopsis of information on the Russian wheat aphid, <i>Diuraphis noxia</i> (Mordwilko).
<i>
Technical Paper. Division of Entomology. CSIRO Australia</i>
(34): 97p. illus. ISBN 0643048723
<P>*Jiang, Y. and <B>Ridsdill-Smith, T.J.</b> (1996)
Antixenotic resistance of subterranean clover cotyledons to redlegged earth mite, <i>Halotydeus destructor</i>.
<i>
Entomologia Experimentalis et Applicata</i>
79: 161-9  20 refs, illus.
<P>*Jiang, Y., <B>Ridsdill-Smith, T.J.</b> and *Ghisalberti, E.L. (1996)
Assays for the effects of volatile compounds from artificially damaged cotyledons of subterranean clover on the redlegged earth mite, <i>Halotydeus destructor</i>.
<i>
Experimental & Applied Acarology</i>
20: 61-72 9 refs, illus.
<P>*Jiang, Y. and <B>Ridsdill-Smith, T.J.</b> (1996)
Examination of the involvement of mechanical strength in antixenotic resistance of subterranean clover cotyledons to the redlegged earth mite (<i>Halotydeus destructor</i>) (Acarina: Penthaleidae).
<i>
Bulletin of Entomological Research</i>
86: 263-70  19 refs, illus.
<P>*Jiang, Y., *Ghisalberti, E.L. and <B>Ridsdill-Smith, T.J.</b> (1996)
Correlation of 1-octen-3-one with antixenotic resistance in subterranean clover cotyledons to red-legged earth mite, <i>Halotydeus destructor</i> (Acarina: Penthaleidae).
<i>
Journal of Chemical Ecology</i>
22(2): 369-382 11 refs, illus.
<P><B>Johnston, F.M.</b> (1996)
Toxicity to insects of volatile organic compounds in relation to boiling point.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(1996/70): 29p., 11 refs, illus.
<P>Kirkegaard, J.A., *Wong, P.T.W. and <B>Desmarchelier, J.M.</b> (1996)
<i>In vitro</i> suppression of fungal root pathogens of cereals by <i>Brassica</i> tissues.
<i>
Plant Pathology</i>
45: 593-603  26 refs, illus.
<P>Kirkegaard, J.A., *Wong, P.T.W. and <B>Desmarchelier, J.M.</b> (1996)
<i>In vitro</i> suppression of fungal root pathogens of cereals by <i>Brassica</i> tissue.
<i>
Plant Pathology</i>
45: 593-603  26 refs, illus.
<P>*Lockwood, J.A. and <B>Rentz, D.C.F.</b> (1996)
Nest construction and recognition in a gryllacridid: the discovery of pheromonally mediated autorecognition in an insect.
<i>
Australian Journal of Zoology</i>
44(2): 129-141 47 refs, illus.
<P>MacLeod, N.D. and <B>Norton, G.A.</b> (1996)
Economic considerations for the assessment of losses due to pasture diseases.
<i>
In: Chakraborty, S  et al (ed.). Proceedings of a Trilateral Workshop. Pasture and Forage Crop Pathology (MS, USA: April 10-13, 1995)</i>
pp. 119-59  78 refs, illus.
(MS, USA: American Society of Agronomy, Inc.)
<P><B>Mazanec, Z.</b> (1996)
Key factor analysis of population data for <i>Perthida glyphopa</i> Common (Lepidoptera: invurvariidae).
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(67): 32p. 23 refs, illus. ISBN 0643057307
<P><B>Morrison, S.M.</b> and <B>Scott, J.K.</b> (1996)
Variation in populations of <i>Tribulus terrestris</i> (zygophyllaceae). 3. Isozyme analysis.
<i>
Australian Journal of Botany</i>
44(2): 201-12 31 refs, illus.
44(2): 201-12 31 refs, illus.
<P><B>Morrison, S.M.</b> and <B>Scott, J.K.</b> (1996)
Variation in populations of <i>Tribulus terrestris</i> (zygophyllaceae). 2. Chromosome numbers.
<i>
Australian Journal of Botany</i>
44(2): 191-99 37 refs, illus.
<P><B>Osborne, R.J.</b>, <B>Osborne, R.J.</b>, <B>Symonds, T.M.</b>, <B>Sriskantha, A.</b>, <B>Lai-Fook, J.</b>, <B>Fernon, C.A.</b> and <B>Dall, D.J.</b> (1996)
An entomopoxvirus homologue of the vaccinia virus DI3L encoded "rifampicin resistance" protein.
<i>
Journal of General Virology</i>
77: 839-46  31 refs, illus.
<P>*Pheloung, P.C., <B>Scott, J.K.</b> and *Randall, R.P. (1996)
Predicting the distribution of <i>Emex</i> in Australia.
<i>
Plant Protection Quarterly</i>
11(4): 138-40, 18 refs, illus.
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P>*Pheloung, P.C. and <B>Scott, J.K.</b> (1996)
Climate-based prediction of <i>Asparagus asparagoides</i> and <i>A. declinatus</i> distribution in Western Australia.
<i>
Plant Protection Quarterly</i>
11(2): 51-3  8 refs, illus.
<P><B>Rees, D.P.</b> (1996)
Prospects for biological control of grain and cereal pests.
<i>
Proceedings of the Combined Conference of the Stock Feed Manufacturer's Association of Australia and the Australian Technical Millers' Association: Technical advances towards 2000 (Sydney, NSW: March 27-29, 1996)</i>
pp.18-22
<P><B>Rees, D.P.</b> (1996)
Coleoptera.
<i>
In: Subramanyam, B and Hagstrum, D W (eds.). Integrated management of insects in stored products</i>
(Ch.1): 1-39 58 refs, illus. ISBN 0824795229
(New York, USA: Marcel Dekker)
<P><B>Rees, D.P.</b> (1996)
"Stored-Grain Ecosystems" edited by D S Jayas, N D G White and W E Muir, 1995, New York, USA, Marcel Dekker 757p. [book review].
<i>
Postharvest Biology and Technology</i>
7: 285-287
<P><B>Rentz, D.C.</b> (1996)
The sounds of insects.
<i>
ANIC News. Division of Entomology. CSIRO Australia</i>
(8): 9-11, illus.
<P><B>Room, P.M.</b> (1996)
Use virtual plants as new tools to help feed, clothe and house the world.
<i>
Spirit of enterprise: the 1996 Rolex Awards</i>
pp. 158-9
(Geneva, Switzerland: The Secretariat of the Rolex Awards for Enterprise)
<P><B>Room, P.M.</b>, <B>Hanan, J.S.</b> and *Prusinkiewicz, P. (1996)
Virtual plants: new perspectives for ecologists, pathologists and agricultural scientists.
<i>
Trends in Plant Science: Update</i>
1(1): 33-38 25 refs, illus.
<P>*Ryan, R. and <B>Winks, R.G.</b> (1996)
New, tailor-made fumigation techniques.
<i>
Stored Grain Australia. Newsletter of the Stored Grain Research Laboratory. Division of Entomology. CSIRO Australia</i>
illus.
<P><B>Scott, J.K.</b> and *Bowran, D.G. (1996)
Workshop to identify research priorities for <i>Emex</i> species.
<i>
Plant Protection Quarterly</i>
11(4): 75-6
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P><B>Scott, J.K.</b>, *Bowran, D.G. and <B>Corey, S.</b> (1996)
<i>Emex australis</i> - biology, management and research.
<i>
Plant Protection Quarterly</i>
11(4): p.137, 3 refs
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P><B>Scott, J.K.</b> and Beasley, P.J. (1996)
Annotated bibliography of the weed <i>Asparagus asparagoides</i> (L.) W. Wight (bridal creeper).
<i>
CRC for Weed Management Systems Technical Series</i>
(1): 30p., illus.
<P><B>Scott, J.K.</b> and Beasley, P.J. (1996)
Bibliography of the weeds, <i>Emex australis</i> and <i>Emex spinosa</i>.
<i>
Plant Protection Quarterly</i>
11(4): 168-74
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P><B>Scott, J.K.</b> and <B>Yeoh, P.B.</b> (1996)
Assessment of potential biological control insects associated with <i>Emex spinosa</i>.
<i>
Plant Protection Quarterly</i>
11(4): 165-7, 28 refs
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P><B>Scott, J.K.</b> and <B>Morrison, S.M.</b> (1996)
Variation in populations of <i>Tribulus terrestris</i> (zygophyllaceae). 1. Burr morphology.
<i>
Australian Journal of Botany</i>
44(2): 175-90 36 refs, illus.
<P><B>Scott, J.K.</b>, *Bowran, D.G. and <B>Corey, S.</b> (Editors) (1996)
<i>Emex australis</i>: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995).
<i>
Plant Protection Quarterly</i>
11(4): 52p.
[Reprinted from Plant Protection Quarterly 11(4): 137-78]
<P><B>Stegeman, D.A.</b>, <B>Tozer, R.S.</b> and <B>Sutherst, R.W.</b> (1996)
Procedures for mass rearing the buffalo fly, <i>Haematobia irritans exigua</i> de Meijere (Diptera: Muscidae).
<i>
Australian Journal of Entomology</i>
35: 77-79 8 refs, illus.
<P><B>Storrs, M.J.</b> and <B>Julien, M.H.</b> (1996)
Salvinia: a handbook for the integrated control of <i>Salvinia molesta</i> in Kakadu National Park.
<i>
Nothern Landscapes Occasional Papers, Paper No. 1</i>
58p.  94 refs, illus.
<P><B>Sutherst, R.W.</b>, *Yonow, T., *White, N. and *Skilton, S. (1996)
Current status of Australian cast study on integrating impacts of pests, diseases and weeds.
<i>
In: Hennessy, K J and Pittock, A B (eds.). Development and Application of Climate Change Scenarios. Abstracts of the Climate Impacts Assessment Workshop (St Kilda, VIC : December 4-5, 1995)</i>
p.104 ISBN 0643056084
<P><B>Tyndale-Biscoe, M.</b> and <B>Vogt, W.G.</b> (1996)
Population status of the bush fly, <i>Musca vetustissima</i> (Deptera: Muscidae), and native dung beetles (Coleoptera: Scarabaeinae) in south-eastern Australia in relation to establishment of exotic dung beetles.
<i>
Bulletin of Entomological Research</i>
84: 183-92  21 refs, illus.
<P><B>Tyndale-Biscoe, M.</b> (1996)
Australia's introduced dung beetles: original releases and redistributions.
<i>
Technical Report. Division of Entomology. CSIRO Australia</i>
(62): 149p. ISBN 0643057250
<P><B>Van Someren Graver, J.E.</b> and <B>Winks, R.G.</b> (1996)
A brief history of grain protection in Australia. Part 3.  The dawn of a new era: nil tolerance.
<i>
Australian Grain</i>
pp. 34, 37  illus
<P><B>Van Someren Graver, J.E.</b> and <B>Winks, R.G.</b> (1996)
A brief history of grain protection in Australia. Part 2.
<i>
Australian Grain</i>
6(2): 34-5  illus.
<P><B>Van Someren Graver, J.E.</b> and <B>Winks, R.G.</b> (1996)
A short history of grain protection in Australia: part 1.
<i>
Australian Grain</i>
6(1): 33-4  illus.
<P><B>Winks, R.G.</b> (1996)
New technique delivers improved stored grain protection.
<i>
Australian Grain</i>
6(2): 25-6  illus.
<P><B>Winterton, S.L.</b> and <B>Brancatini, V.A.L.</b> (1996)
New information on Australian <i>Ankylopteryx</i> Brauer and <i>Brinckochrysa</i> Tjeder (Neuroptera: Chrysopidae).
<i>
Australian Entomologist</i>
23(1): 21-6  6 refs, illus.
<P><B>Woodburn, T.L.</b> (1996)
Reduction of seed set in nodding thistle (<i>Carduus nutans</i>) by the seed-fly, <i>Urophora solstitialis</i>, in Australia.
<i>
In: McPherson, B A and Steck, G J (eds.). Fruit Fly Pests: a world assessment of their biology and management</i>
pp. 165-9  9 refs, illus. ISBN 1574440140
<P><B>Yeoh, P.B.</b> and <B>Scott, J.K.</b> (1996)
Utilizing existing natural enemies to enhance the control of <i>Emex australis</i> in south-west Australia.
<i>
Plant Protection Quarterly</i>
11(4): 162-4, 27 refs
[Reprinted in: Scott, J K, Bowran, D G and Corey, S A (eds.). #Emex australis#: biology, management and research.  Proceedings of a workshop (Floreat Park, WA : December 11, 1995)]
<P><B>Yong-Lin Ren</b>, *O'Brien, I.G. and <B>Desmarchelier, J.M.</b> (1996)
Effect of hydrogen cyanide and carbonyl sulphide on the germination of plumule vigour of wheat.
<i>
Pesticide Science</i>
47: 1-5  14 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-43</DOCNO>
<DOCOLDNO>IA089-000952-B047-188</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/HO1994.html 192.102.250.248 19970208040316 text/html 19984
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:50:29 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:23 GMT
Content-type: text/html
Content-length: 19800
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Horticulture</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Horticulture</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>*Akilan, K., *Considine, J.A., <B>Joyce, D.C.</b> and Marshall, J.K. (1994)
Morphological responses of Geraldton wax to transient soil-water deficit.
<i>
Australian Journal of Botany</i>
42(2): 205-217 21 refs, illus.
<P>*Akkaravessapong, P., <B>Joyce, D.C.</b>, *Simons, D.H. and <B>Shorter, A.J.</b> (1994)
Can the pressure chamber be used to reduce the initial postharvest water potential of Hass avocado fruit?.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.359-361 6 refs
<P>*Batten, D.J., <B>McConchie, C.A.</b> and *Lloyd, J. (1994)
Effects of soil water deficit on gas exchange characteristics and water relations of orchard lychee (<i>Litchi chinensis</i> Sonn.) trees.
<i>
Tree Physiology</i>
14: 1177-1189 30 refs, illus.
<P>*Bonruengsri, U., *Simons, D.H. and <B>Joyce, D.C.</b> (1994)
Does retention of the stalk influence the postharvest greenlife of "Fuerte" avocado (<i>Persea americana</i> Mill.) fruit?.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.433-435 2 refs, illus.
<P><B>Brennan, A.M.</b> (Editor) (1994)
Research projects 1994.
<i>
Research Projects. Division of Horticulture. CSIRO Australia</i>
34p.
<P><B>Brennan, A.M.</b> (Editor) (1994)
Division of Horticulture. Research Projects 1994.
36p.
<P><B>Bucheli, C.S.</b> and <B>Robinson, S.P.</b> (1994)
Contribution of enzymic browning to color in sugarcane juice.
<i>
Journal of Agricultural and Food Chemistry</i>
42: 257-261 26 refs, illus.
<P><B>Clingeleffer, P.R.</b> (1994)
Wine grape research and industry competitiveness.
<i>
Paper presented to the Royal Society of Victoria (Melbourne, VIC: November, 1994)</i>
2p.
<P><B>Clingeleffer, P.R.</b> and <B>Scott, N.S.</b> (1994)
Integration of molecular techniques and conventional breeding.
<i>
Paper presented to 6th International Symposium on Grape Breeding (Yalta, Crimea, Ukraine: September 4-10, 1994)</i>
pp.85-88 18 refs
<P><B>Clingeleffer, P.R.</b> (1994)
Minimal pruning of wine varieties in warm, irrigated regions.
<i>
Murray Valley Winegrapegrowers</i>
1(2): 9-10
<P><B>Clingeleffer, P.R.</b> (1994)
Changing technology of dried fruit production for yield, quality and profitability increases.
<i>
In: McMichael, P A and Scholefield, P B (eds.). Proceedings of the 2nd Horticultural Industry Technical Conference: Gaining the competitive edge (Wentworth, NSW: July 27-30, 1994)</i>
pp.44-47 28 refs, illus. ISBN 1875130187
(Marleston, SA: Winetitles)
<P>*Coates, L.M., <B>Johnson, G.I..</b>, *Sardsud, U. and *Cooke, A.W. (1994)
Postharvest diseases of lychee in Australia, and their control.
<i>
In: Johnson, G I and Highley, E (eds.). Development of postharvest handling technology for tropical tree fruits: Proceedings of a workshop (Bangkok, Thailand: July 16-18, 1992). ACIAR Proceedings</i>
(58): 68-69 4 refs
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Davies, C.</b> (1994)
Cloning and characterization of a tomato GTPase-like gene related to yeast and <i>Arabidopsis</i> genes involved in vesicular transport.
<i>
Plant Molecular Biology</i>
24: 525-531 40 refs, illus.
<P>*Day, J.S., <B>Loveys, B.R.</b> and *Aspinall, D. (1994)
Manipulation of flowering and vegetative growth of brown boronia (<i>Boronia megastigma</i> Nees.) and white myrtle (<i>Hypocalymma angustifolium</i> Endl.) using plant growth regulators.
<i>
Scientia Horticulturae</i>
56: 309-320 21 refs, illus.
<P>*Day, J.S., <B>Loveys, B.R.</b> and *Aspinall, D. (1994)
Environmental control of flowering of <i>Boronia megastigma</i> (Rutaceae) and <i>Hypocalymma angustifolium</i> (Myrtaceae).
<i>
Australian Journal of Botany</i>
42(2): 219-229 29 refs, illus.
<P><B>Downton, W.J.S.</b> and <B>Grant, W.J.R.</b> (1994)
Photosynthetic and growth responses of variegated ornamental species to elevated CO<sub>2</sub>.
<i>
Australian Journal of Plant Physiology</i>
21(3): 273-279 14 refs
<P><B>Dry, I.B.</b> and <B>Robinson, S.P.</b> (1994)
Molecular cloning and characterisation of grape berry polyphenol oxidase.
<i>
Plant Molecular Biology</i>
26: 495-502 27 refs, illus.
<P>*Emmett, R.W., <B>Clingeleffer, P.R.</b>, *Wicks, T.J., *Hall B, *Hart, K.M. and *Clarke, K. (1994)
Canopy management and disease control: Victorian and South Australian experiences.
<i>
Paper presented at: Autumn vineyard seminar: "Canopy management for disease control" (Hunter Valley, NSW: 1994)</i>
5p. 9 refs, illus.
<P>*Emmett, R.W., <B>Clingeleffer, P.R.</b>, *Wicks, T.J., *Hall, B., *Hart, K.M. and *Clarke, K. (1994)
Canopy management and disease control.
<i>
Australian Grapegrower and Winemaker</i>
(369): 22-24, illus.
<P>*Fowler, J.C.S., *Kijas, J.M.K. and <B>Thomas, M.R.</b> (1994)
Current molecular methods for plant genome identification.
<i>
Australasian Biotechnology</i>
4: 153-7  39 refs
<P><B>Glover, H.</b> and <B>Brady, C.J.</b> (1994)
Purification of three pectin esterases from ripe peach fruit.
<i>
Phytochemistry</i>
37(4): 949-955 43 refs, illus.
<P><B>Habili, N.</b> and <B>Scott, N.S.</b> (1994)
Towards grapevine virus control by genetic engineering.
<i>
Australian Grapegrower and Winemaker</i>
pp.72-74 10 refs
<P><B>Jobling, J.J.</b>, *McGlasson, B.W., *Hourigan, J. and *Miller, P. (1994)
Gala, Fuji and Lady Williams apples: each cultivar has a unique physiology that affects its maturity and storage life.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.153-156 11 refs, illus.
<P><B>Johnson, G.I..</b> (1994)
Control of postharvest diseases of fruit: challenges for the future.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.65-71 47 refs
<P><B>Johnson, G.I..</b> and *Heather, N.W. (1994)
Postharvest disease and pest control in tropical fruit.
<i>
In: Champ, B R and Highley, E (eds.). Proceedings of an International Workshop on Postharvest Technology for Agricultural Products in Vietnam (Hanoi, Vietnam: December 8-9, 1994). ACIAR Proceedings</i>
(60): 100-126 30 refs, illus. ISBN 1863201483
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Johnson, G.I..</b> and Highley, E. (Editors) (1994)
Development of postharvest handling technology for tropical tree fruits: Proceedings of a Workshop  (Bangkok, Thailand: July 16-18, 1992). ACIAR Proceedings.
(58): 86p., refs, illus. ISBN 1863201327
(Canberra, ACT:  Australian Centre for International Agric. Res.)
[Includes an introduction by G J Johns, pp.5-8.]
<P><B>Johnson, G.I..</b> and *Highley, E. (1994)
Proceedings of a Workshop on Development of postharvest handling technology for tropical tree fruits (Bangkok, Thailand: July 16-18, 1992).
(58): 86p., refs, illus.
(Canberra, ACT: Australian Centre for International Agricultural Res.)
[Includes an introduction by GI Johnson: pp.5-8]
<P><B>Johnson, G.I..</b>, *Coates, L.M., *Cooke, A.W. and *Wells, I.A. (1994)
Postharvest control of mango diseases.
<i>
In: Johnson, G I and Highley, E (eds.). Development of postharvest handling technology for tropical tree fruits: Proceedings of a workshop (Bangkok, Thailand: July 16-18, 1992). ACIAR Proceedings</i>
(58): 70-71
(Canberra, ACT: Australian Centre for International Agric. Res.)
<P><B>Johnson, G.I..</b>, *Ledger, S.N. and *Baker, J.A. (1994)
Post-harvest disease control.
<i>
In: Broodley, R H (ed.). Protect your cucurbits</i>
(Ch.11): 53-55
(Brisbane, QLD: Dept. of Primary Industries)
<P><B>Joyce, D.C.</b> and <B>Shorter, A.J.</b> (1994)
High-temperature conditioning reduces hot water treatment injury of 'Kensington Pride' mango fruit.
<i>
HortScience</i>
29(9): 1047-1051 17 refs, illus.
<P><B>Joyce, D.C.</b>, *Joyce, P.A., *Miranda, J., *Hetherington, S. and <B>Shorter, A.J.</b> (1994)
Is kangaroo paw cv. "Bush Dawn" chilling sensitive?.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.149-152 10 refs, illus.
<P>*Kijas, J.M.H., *Fowler, J.C.S., *Garett, C.A. and <B>Thomas, M.R.</b> (1994)
Enrichment of microsatellites from the citrus genome using biotinylated oligonucleotide sequences bound to streptavidin-coated manetic particles.
<i>
BioTechniques</i>
16(4): 658-62  10 refs, illus.
<P>*King, G.A. and <B>Morris, S.C.</b> (1994)
Physiological changes of broccoli during early postharvest senescence and through the preharvest-postharvest continuum.
<i>
Journal. American Society for Horticultural Science</i>
119(2): 270-275 21 refs, illus.
<P>*King, G.A. and <B>Morris, S.C.</b> (1994)
Early compositional changes during postharvest senescence of broccoli.
<i>
Journal. American Society for Horticultural Science</i>
119(5): 1000-1005 26 refs, illus.
<P><B>Koltunow, A.M.G.</b> (1994)
Apomixis: other pathways for reproductive development in angiosperms.
<i>
In: Williams, E G #et al# (eds.). Genetic control of self-incompatibility and reproductive development in flowering plants</i>
(Ch.23): 486-512 58 refs, illus.
(The Netherlands: Kluwer Academic Publ.)
<P>*Landrigan, M., *Sarafis, V., <B>Morris, S.C.</b> and *McGlasson, W.B. (1994)
Structural aspects of rambutan (<i>Nephelium lappaceum</i>) fruits and their relations to postharvest browning.
<i>
Journal of Horticultural Science</i>
69(3): 571-579 25 refs, illus.
<P><B>Lester, D.R.</b>, <B>Speirs, J.</b>, <B>Orr, G.R.</b> and <B>Brady, C.J.</b> (1994)
Peach (<i>Prunus persica</i>) endopolygalacturonase cDNA isolation and mRNA analysis in melting and nonmelting peach cultivars.
<i>
Plant Physiology</i>
105: 225-231 32 refs, illus.
<P>*Longhurst, T., <B>Lee, E.</b>, *Hinde, R., <B>Brady, C.J.</b> and <B>Speirs, J.</b> (1994)
Structure of the tomato <i>Adh2</i> gene and <i>adh2</i> pseudogenes, and a study of <i>adh2</i> gene expression in fruit.
<i>
Plant Molecular Biology</i>
26: 1073-1084 36 refs, illus.
<P><B>Loveys, B.R.</b> and *Jusaitis, M. (1994)
Stimulation of germination of quandong (<i>Santalum acuminatum</i>) and other Australian native plant seeds.
<i>
Australian Journal of Botany</i>
42(5): 565-574 20 refs, illus.
<P>*Maclachlan, G. and <B>Brady, C.J.</b> (1994)
Endo-1,4-{beta}-glucanase, xyloglucanase, and xyloglucan endo-transglycosylase activities versus potential substrates in ripening tomatoes.
<i>
Plant Physiology</i>
105: 965-974 33 refs, illus.
<P>*Matsuo, T., Graham, D., Patterson, B.D. and <B>Hockley, D.G.</b> (1994)
An electrophoretic method to detect cold-induced dissociation of proteins in crude extracts of higher plants.
<i>
Analytical Biochemistry</i>
123: 181-184 13 refs, illus.
<P>*Mazucco, R.A., <B>Joyce, D.C.</b> and *Hockings, P.D. (1994)
Magnetic resonance imaging applied to harvested mango fruit.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.355-358 8 refs, illus.
<P><B>McConchie, C.A.</b>, <B>Vithanage, H.I.M.V.</b> and *Batten, D.J. (1994)
Intergeneric hybridisation between litchi (<i>Litchi chinensis</i> Sonn.) and longan (<i>Dimocarpus longan</i> Lour.).
<i>
Annals of Botany</i>
74: 111-118 12 refs, illus.
<P><B>McConchie, C.A.</b> (1994)
Tree pruning and thinning in macadamia.
<i>
Australian Macadamia Society News Bulletin</i>
(July): 14-17 14 refs
<P><B>Morris, S.C.</b> and *Jessup, A.J. (1994)
Irradiation.
<i>
In: Paull, R E and Armstrong, J W (eds.). Insect Pests and Fresh Horticultural Products: Treatments and Responses</i>
(Ch.9): 163-190 32 refs, illus.
(Wallingford, UK: CAB International)
<P><B>O'Brien, S.P.</b> (1994)
Andromonoecy and fruit set in <i>Leptospermum myrsinoides</i> and <i>L. continentale</i> (Myrtaceae).
<i>
Australian Journal of Botany</i>
42(6): 751-762 31 refs, illus.
<P>*Ollat, N., <B>Sommer, K.J.</b>, *Pool, R.M. and <B>Clingeleffer, P.R.</b> (1994)
La taille minimale, pratique viticole Australienne.
<i>
Progres Agricole et Viticole</i>
111(13-14): 329-334 15 refs, illus.
<P><B>Patterson, B.D.</b>, <B>Jobling, J.J.</b> and <B>Moradi, S.</b> (1994)
Water relations after harvest: new technology helps translate theory into practice.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.99-102 21 refs, illus.
<P><B>Patterson, B.D.</b> and <B>Jobling, J.J.</b> (1994)
Progress in active packaging for fruits, vegetables and flowers.
<i>
Agricultural Science</i>
7(2): 42-45 3 refs, illus.
<P><B>Possingham, J.V.</b> (1994)
New concepts in pruning grapevines.
<i>
In: Janick, J (ed.). Horticultural Reviews</i>
16(Ch.7): 235-254 47 refs, illus.
<P><B>Possingham, J.V.</b> (1994)
Production of table grapes in South India.
<i>
In: Rantz, J M (ed.). Proceedings of the International Symposium Table Grape Production (CA, USA: June 28-29, 1994)</i>
pp. 38-42  10 refs, illus. ISBN 0963071114
<P>*Rathjen, J.P., *Karageorgos, L.E., <B>Habili, N.</b>, Waterhouse, P.M. and *Symons, R.H. (1994)
Soybean dwarf luteovirus contains the third variant genome type in the luteovirus group.
<i>
Virology</i>
198: 671-679 30 refs, illus.
<P><B>Rigden, J.E.</b>, <B>Krake, L.R.</b>, <B>Rezaian, M.A.</b> and <B>Dry, I.B.</b> (1994)
ORF C<sub>4</sub> of tomato leaf curl geminivirus is a determinant of symptom severity.
<i>
Virology</i>
204: 847-850 15 refs, illus.
<P>*Sage, T.L., *Bertin, R.I. and <B>Williams, E.G.</b> (1994)
Ovarian and other late-acting self-incompatibility systems.
<i>
In: Williams, E G #et al# (eds.). Genetic control of self-incompatibility and reproductive development in flowering plants</i>
(Ch.7): 116-140, refs, illus.
(The Netherlands: Kluwer Academic Publ.)
<P><B>Shorter, A.J.</b> and <B>Joyce, D.C.</b> (1994)
Effect of surface coatings on sap burn of Kensington Pride mango fruit.
<i>
Tropical Agriculture (Trinidad)</i>
71(3): 243-246 12 refs, illus.
<P><B>Shorter, A.J.</b>, <B>Joyce, D.C.</b> and *Akkaravessapong, P. (1994)
The use of perforated film wraps to extend the shelf life of avocados.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.121-123 17 refs
<P>*Somers, T., *Nair, T. and <B>Clingeleffer, P.R.</b> (1994)
Comparison of two methods of mechanical leaf removal on the control of Botrytis bunch rot.
<i>
Paper presented at: Autumn vineyard seminar: "Canopy management for disease control" (Hunter Valley, NSW: 1994)</i>
7p. 8 refs, illus.
<P><B>Sommer, K.J.</b> and Lang, A.R.G. (1994)
Comparative analysis of two indirect methods of measuring leaf area index as applied to minimal and spur pruned grape vines.
<i>
Australian Journal of Plant Physiology</i>
21(2): 197-206 18 refs, illus, appendix
<P>*Sriskandarajah, S., *Goodwin, P.B. and <B>Speirs, J.</b> (1994)
Genetic transformation of the apple scion cultivar 'Delicious' via <i>Agrobacterium tumefaciens</i>.
<i>
Plant Cell, Tissue and Organ Culture</i>
36: 317-329 37 refs, illus.
<P><B>Storey, R.</b> and <B>Treeby, M.T.</b> (1994)
The morphology of epicuticular wax and albedo cells of orange fruit in relation to albedo breakdown.
<i>
Journal of Horticultural Science</i>
69(2): 329-338 27 refs, illus.
<P><B>Storey, R.</b> and *Thomson, W.W. (1994)
An x-ray microanalysis study of the salt glands and intracellular calcium crystals of <i>Tamarix</i>.
<i>
Annals of Botany</i>
73: 307-313 17 refs, illus.
<P><B>Sykes, S.R.</b>, <B>Koltunow, A.M.G.</b> and *Lee, S. (1994)
The genetic improvement of mandarins in Australia.
<i>
Australian Citrus News</i>
70: 8-12, illus.
<P><B>Tarr, C.R.</b>, Hilton, S.J., Graver, J.E.van.S. and <B>Clingeleffer, P.R.</b> (1994)
Carbon dioxide fumigation of processed dried vine fruit (sultanas) in sealed stacks.
<i>
In: Highley, E, Wright, E J, Banks, H J and Champ, B R (eds.). Proceedings of the 6th International Working Conference on Stored-product protection (Canberra, ACT: April 17-23, 1994)</i>
pp.204-209 7 refs, illus.
(Wallingford, Oxon, UK: CAB International)
<P><B>Thomas, M.R.</b> (1994)
Simple, effective cleanup of DNA ligation reactions prior to electro-transformation of <i>E. coli</i>.
<i>
BioTechniques</i>
16(6): 988,990 5 refs
<P><B>Thomas, M.R.</b>, <B>Cain, P.A.</b> and <B>Scott, N.S.</b> (1994)
DNA typing of grapevines: a universal methodology and database for describing cultivars and evaluating genetic relatedness.
<i>
Plant Molecular Biology</i>
25: 939-949 20 refs, illus.
<P><B>Thomas, M.R.</b> and <B>Scott, N.S.</b> (1994)
Sequence-tagged sited markers for microsatellites: simplified technique for rapidly obtaining flanking sequences.
<i>
Plant Molecular Biology Reporter</i>
12(1): 58-64 11 refs, illus.
<P><B>Thygesen, P.W.</b>, <B>Dry, I.B.</b> and <B>Robinson, S.P.</b> (1994)
Polyphenol oxidase in potato tubers.
<i>
In: Belknap, W R, Vayda, M E and Park, W D (eds.). The molecular and cellular biology of the potato</i>
2nd ed.(Ch.11): 151-159 19 refs, illus.
(Wallingford, UK: CAB International)
<P><B>Treeby, M.T.</b> (1994)
Update on albedo breakdown research.
<i>
Australian Citrus News</i>
(Nov): 6-7
<P>*Trueman, S.J. and <B>Turnbull, C.G.N.</b> (1994)
Effects of cross-pollination and flower removal on fruit set in macadamia.
<i>
Annals of Botany</i>
73: 23-32 26 refs, illus.
<P>*Trueman, S.J. and <B>Turnbull, C.G.N.</b> (1994)
Fruit set, abscission and dry matter accumulation on girdled branches of macadamia.
<i>
Annals of Botany</i>
74: 667-674 17 refs, illus.
<P><B>Vithanage, H.I.M.V.</b> (1994)
The role of pollination in improving yield and quality of fruits and nuts.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.369-371 7 refs
<P><B>Walker, R.R.</b> (1994)
Grapevine responses to salinity.
<i>
Bulletin de l'Office International de la Vigne et du Vin</i>
67: 761-762 48 refs, illus.
<P><B>Wiebel, J.</b>, <B>Chacko, E.K.</b>, <B>Downton, W.J.S.</b> and *Ludders, P. (1994)
Influence of irradiance on photosynthesis, morphology and growth of mangosteen (<i>Garcinia mangostana</i> L.) seedlings.
<i>
Tree Physiology</i>
14: 263-274 34 refs, illus.
<P><B>Williams, E.G.</b> (1994)
Postharvest horticulture and industry: better dialog for better progress.
<i>
Proceedings of the Australasian Postharvest Conference (Gatton, QLD: September 20-24, 1993)</i>
pp.201-202
<P><B>Williams, M.H.</b>, <B>Brown, M.A.</b>, *Vesk, M. and <B>Brady, C.J.</b> (1994)
Effect of postharvest heat treatments on fruit quality, surface structure, and fungal disease in Valencia oranges.
<i>
Australian Journal of Experimental Agriculture</i>
34(8): 1183-1190 30 refs, illus.
<P>*Yadegari, R., *de Paiva, G.R., *Laux, T., <B>Koltunow, A.M.G.</b>, *Apuya, N., *Zimmerman, J.L., *Fischer, R.L., *Harada, J.J. and *Godberg, R.B. (1994)
Cell differentiation and morphogenesis are uncoupled in Arabidopsis <i>raspberry</i> embryos.
<i>
Plant Cell</i>
6: 1713-29  40 refs, illus.
<P><B>Yunusa, I.A.M.</b>, *Sedgley, R.H. and *Siddique, K.M.H. (1994)
Influence of mulching on the pattern of growth and water use by spring wheat and moisture storage on a fine textured soil.
<i>
Plant and Soil</i>
160: 119-130 26 refs, illus.
<P><B>Yunusa, I.A.M.</b>, *Sedgley, R.H. and *Tennant, D. (1994)
Evaporation from bare soil in south-western Australia: a test of two models using lysimetry.
<i>
Australian Journal of Soil Research</i>
32(3):  437-446 16 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-44</DOCNO>
<DOCOLDNO>IA057-000941-B012-181</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/WO1996.html 192.102.250.248 19970208044915 text/html 4327
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 04:36:36 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:50 GMT
Content-type: text/html
Content-length: 4144
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Wool Technology</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Wool Technology</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Blanchonette, I.</b> (1996)
Tension measurements in weaving of singles worsted wool yarns.
<i>
Textile Research Journal</i>
66(5): 323-8  11 refs, illus.
<P><B>Church, J.</b> and <B>Millington, K.R.</b> (1996)
Photodegradation of wool keratin: Part 1. Vibrational spectroscopic studies.
<i>
Biospectroscopy</i>
2:249-58, 21 refs, illus.
<P><B>Church, J.S.</b> (1996)
The characterisation of modified wool fibres by FT-Raman spectroscopy.
<i>
In: Asher, S A and Stein, P (eds.). Proceedings of the 15th International Confernce on Raman Spectroscopy (PA, USA: August 11-16, 1996)</i>
pp. 1090-1  3 refs, illus.
(Chichester, UK: Wiley)
<P><B>Crowe, D.W.</b>, Davis, G.P., <B>Whiteley, K.J.</b>, *Ma, H-Z. and *Zheng, B-D. (1996)
Performance of wool from rugged and unrugged sheep in north-west China.
<i>
Wool Technology and Sheep Breeding</i>
44(1): 17-28  25 refs 
<P><b>CSIRO Division of Wool Technology</b> (1996)
Very high speed carding.
<i>
Division of Wool Technology [miscellaneous publication]. CSIRO Australia</i>
(26): 4, illus.
(CSIRO Division of Wool Technology)
<P><B>De Boos, A.G.</b>, <B>Fincher, K.W.</b> and <B>Wemyss, A.M.</b> (1996)
'Wrinkle-free' wool-rich trousers.
<i>
Proceedings of the AATCC International Conference (Nashville, USA: 1996)</i>
(1996): 137-46, 17 refs, illus.
<P>Gray, S.R., Le, N.P., Dixon, D.R., <B>Jones, F.W.</b> and <B>Bateup, B.O.</b> (1996)
Supercritical carbon dioxide extraction of wool wax from wool scour sludges.
<i>
Environmental Technology</i>
17:1131-8, 9 refs, illus.
<P><B>Huson, M.G.</b>, <B>Titcombe, L.A.</b> and *Lawrence, F.A. (1996)
Microstructure and water ujptake studies of wool using atomic force microscopy and confocal laser scanning microscopy.
<i>
International Wool Textile Organisation, Technology and Standards Committee Report No. 4 (Cape Town, South Africa: April 1996)</i>
11p.  23 refs, illus.
(International Wool Textile Organisation, Technology and Standards Committee)
<P><B>Jones, L.N.</b> (1996)
Locations of synthesis of hair structural proteins in human anagen follicles.
<i>
British Journal of Dermatology</i>
134: 649-56  30 refs, illus.
<P><B>King, D.G.</b> (1996)
Chrome dyeing of wool.
<i>
Textile Research Journal [letter]</i>
66(9): 604-5, illus.
<P><B>Le, C.V.</b>, <B>Ly, N.G.</b> and *Stevens, M.G. (1996)
Measuring the contact angles of liquid droplets on wool fibres and determining surface energy components.
<i>
Textile Research Journal</i>
66(6): 389-97  34 refs, illus.
<P><B>Money, C.A.</b> (1996)
Land irrigation with tannery effluents.
<i>
World Leather</i>
(Nov): 60-64, illus.
<P><B>Roczniok, A.F.</b>, <B>Sarlej, L.M.</b> and <B>Ly, N.G.</b> (1996)
An interlaboratory trial of the Sirolan Press Test.
<i>
International Wool Textile Organisation Technology and Standards Committee Report No. 8, April/May 1996</i>
13p.  4 refs, illus.
(Cape Town, South Africa: International Wool Textile Organisation Technology and Standards Committee)
<P><B>Salter, C.J.</b>, Stephens, L.G., <B>Higgerson, G.J.</b> and <B>Samuelsdorff, M.J.</b> (1996)
The perception of wrinkling: the effects of fabric pattern.
<i>
Journal of the Textile Institute</i>
87(pt 1, 1): 166-71  7 refs, illus.
<P><B>van Schie, H.F.</b> and Orszulok, E.O. (1996)
1995 measurement of laserscan reference tops.
<i>
International Wool Textile Organisation Technology and Standards Committee Report No. 8, April/May 1996</i>
20p.  9 refs, illus.
(Cape Town, South Africa: International Wool Textile Organisation Technology and Standards Committee)<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-45</DOCNO>
<DOCOLDNO>IA089-000952-B045-103</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/FS1996.html 192.102.250.248 19970208035627 text/html 9136
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:43:47 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:16 GMT
Content-type: text/html
Content-length: 8953
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Division of Fisheries</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Fisheries</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Abbott, D.J.</b> (1996)
Australian fisheries research publications database: an Australian input centre for the <i>Aquatic Sciences and Fisheries Abstracts</i> database.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
8p. 5 refs ISBN 0643057919
[Report on Project FRDC 92/1047]
<P><B>Brown, M.R.</b>, Dunstan, G.A., <B>Norwood, S.J..</b> and <B>Miller, K.A.</b> (1996)
Effects of harvest stage and light on the biochemical composition of the diatom <i>Thalassiosira pseudonana</i>.
<i>
Journal of Phycology</i>
32: 64-73 43 refs, illus.
<P><B>Bruce, B.D.</b>, <B>Sutton, C.A.</b> and <B>Thresher, R.E.</b> (1996)
An ichthyoplankton based analysis of the spawning distribution and stock structure of temperate Australian finfish. Final report to Fisheries Research and Development Corporation. Grant 92/19.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
65p. 63 refs, illus.
<P><B>Conacher, C.A.</b>, *O'Brien, C., *Horrocks, J.L. and <B>Kenyon, R.A.</b> (1996)
Litter production and accumulation in stressed mangrove communities in the Embley River estuary, north-eastern Gulf of Carpentaria, Australia.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(5): 737-43, 20 refs, illus.
<P>*Courtney, A.J., <B>Die, D.J.</b> and *McGilvray, J.G. (1996)
Lunar periodicity in catch rate and reproductive condition of adult eastern king prawns, <i>Penaeus plebejus</i>, in coastal waters of south-eastern Queensland, Australia.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(1): 67-76 31 refs, illus.
<P><B>Elliott, N.G.</b> (1996)
Allozyme and mitochondrial DNA analysis of the ropical saddle-tail sea perch, <i>lutjanus malabaricus</i> (schneider), from Australian waters.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(7): 869-76, 44 refs, illus.
<P><B>Furlani, D.M.</b> (1996)
A guide to the introduced marine species in Australian waters.
<i>
Technical Report. Division of Fisheries. CSIRO Australia</i>
(5): 120p. refs, illus. ISBN 0643057935
<P><B>Grewe, P.</b> (1996)
Review and evaluation of the potential of molecular approaches for the environmentally benign management of the common carp (<i>cyprinus carpio</i>) in Australian waters.
<i>
Technical Report. Centre for Research on Introduced Marine Pests. CSIRO Australia</i>
(1996/10): 22p., 23 refs, illus.
<P>*Hanamura, Y. and <B>Evans, D.R.</b> (1996)
Deepwater caridean shrimps of the families Nematocarcinidae, Stylodactylidae, Pandalidae and Crangonidae (Crustacea: Decapoda) from Australia.
<i>
Bulletin of Nansei National Fisheries Research Institute</i>
(29): 1-18  33 refs, illus.
<P><B>Hewitt, C.</b> and <B>Martin, R.B.</b> (1996)
Port surveys for introduced marine species - background considerations and sampling protocols.
<i>
Technical Report. Centre for Research on Introduced Marine Pests. CSIRO Australia</i>
(1996/4): 40p., 10 refs, illus.
<P><B>Lemmens, J.W.T.J.</b>, *Kirkpatrick, D. and <B>Thompson, P.A.</b> (1996)
The clearance rates of four ascidians from Marmion Lagoon, Western Australia.
<i>
In: Kuo, J, Phillips, R C, Walker. D I and Kirkman, H (eds.). Proceedings of an International Workshop on Seagrass Biology (Rottnest Island, WA: January 25-29, 1996)</i>
pp.277-282 27 refs, illus.
<P><B>Long, B.G.</b> and <B>Skewes, T.D.</b> (1996)
On the trail of seagrass dieback in Torres Strait.
<i>
Professional Fisherman</i>
18(4): 15-16,18 2 refs, illus.
<P><B>Long, B.G.</b>, <B>Dennis, D.M.</b>, <B>Skewes, T.D.</b> and <B>Poiner, I.R.</b> (1996)
Detecting an environmental impact of dredging on seagrass beds with a BACIR sampling design.
<i>
Aquatic Botany</i>
53: 235-43  15 refs, illus.
<P>*Mapstone, B.D., <B>Campbell, R.A.</b> and <B>Smith, A.D.M.</b> (1996)
Design of experimental investigations of the effects of line and spear fishing on the Great Barrier Reef.
<i>
CRC Reef Research Centre Technical Report</i>
(7): 86p. 42 refs ISBN 1876054050
<P><B>Milton, D.A.</b>, <B>Rawlinson, N.J.F.</b> and <B>Blaber, S.J.M.</b> (1996)
Recruitment patterns and factors affecting recruitment of fove species of short-lived clupeoids in the tropical South Pacific.
<i>
Fisheries Research</i>
26: 239-55  55 refs, illus.
<P><B>Milton, D.A.</b>, *Smith, C. and <B>Blaber, S.J.M.</b> (1996)
Variable success in breeding of the Roseate Tern <i>Sterna dougallii</i> on the northern Great Barrier Reef.
<i>
Emu</i>
96: 123-31  37 refs, illus.
<P>*Miskiewicz, A.G., <B>Bruce, B.D.</b> and *Dixon, P. (1996)
Distribution of Tailor (<i>Pomatomus saltatrix</i>) larvae along the coast of New South Wales, Australia.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(2): 331-6 29 refs, illus.
<P><B>Parslow, J.</b>, <B>Koslow, J.A.</b>, <B>Griffiths, F.B.</b>, <B>Clementson, L.A.</b>, <B>Rathbone, C.E.</b>, <B>Bonham, P.I.</b> and <B>McKenzie, D.C.</b> (1996)
Tasmanian slope trophodynamics: Final report.
<i>
Report. FRDC Project 91/17, Sept. 1996, Hobart: CSIRO Division of Fisheries</i>
(91/17): 160p., 48 refs, illus. ISBN 0643057951
<P><B>Rothlisberg, P.C.</b>, Craig, P.D. and Andrewartha, J.R. (1996)
Modelling penaeid prawn larval advection in Albatross Bay, Australia: defining the effective spawning population.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(2): 157-68 31 refs, illus.
<P><B>Smith, A.D.M.</b> (1996)
Evaluation of harvesting strategies for Australian fisheries at different levels of risk from economic collapse. Final report to Fisheries Research and Development Corporation. Project number T93/238.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
163p. 13 refs, illus. ISBN 0643057889
<P><B>Sutton, C.</b> and <B>Bruce, B.D.</b> (1996)
Temperature and salinity tolerances of the larvae of the northern Pacific seastar <i>asterias amurensis</i>.
<i>
Technical Report. Centre for Research on Introduced Marine Pests. CSIRO Australia</i>
(1996/6): 32p., 36 refs, illus.
<P><B>Thresher, R.E.</b> (1996)
Environmental tolerances of larvae of the european parasitic barnacle, <i>sacculina carcini</i> (rhizocephala: sacculinidae): implications for use as a biological control agent against the introduced european crab, <i>carcinus maenas</i>.
<i>
Technical Report. Centre for Research on Introduced Marine Pests. CSIRO Australia</i>
(1996/7): 24p., 11 refs, illus.
<P><B>Vance, D.J.</b>, <B>Haywood, M.D.E.</b>, <B>Heales, D.S.</b> and *Staples, D.J. (1996)
Seasonal and annual variation in abundance of postlaval and juvenile grooved tiger prawns <i>Penaeus semisulcatus</i> and environmental variation in the Embley River, Australia: a six year study.
<i>
Marine Ecology. Progress Series</i>
135: 43-55  36 refs, illus
<P><B>Vance, D.J.</b>, <B>Haywood, M.D.</b>, <B>Heales, D.S.</b>, <B>Kenyon, R.A.</b>, <B>Loneragan, N.R.</b> and <B>Pendrey, R.C.</b> (1996)
How far do prawns and fish move into mangroves? Distribution of juvenile banana prawns <i>Penaeus merguiensis</i> and fish in a tropical mangrove forest in northern Australia.
<i>
Marine Ecology. Progress Series</i>
131: 115-24  20 refs, illus.
<P><B>Vance, D.J.</b>, <B>Haywood, M.D.E.</b>, <B>Heales, D.S.</b>, <B>Kenyon, R.A.</b>, <B>Loneragan, N.R.</b> and <B>Pendrey, R.C.</b> (1996)
How far do juvenile banana prawns and fish move into mangroves?.
<i>
Professional Fisherman</i>
18(6): 28-32, illus.
<P><B>Wang, Y-G.</b> and <B>Die, D.J.</b> (1996)
Stock-recruitment relationships of the tiger prawns (<i>Penaeus esculentus</i> and <i>Penaeus semisulcatus</i>) in the Australian Northern Prawn Fishery.
<i>
Marine and Freshwater Research. CSIRO Australia</i>
47(1): 87-95 32 refs, illus.
<P><B>Ward, R.D.</b> and *Ward, J. (1996)
Biochemical genetics of the introduced marine fanworm <i>sabella spallanzanii</i>.
<i>
Technical Report. Centre for Research on Introduced Marine Pests. CSIRO Australia</i>
(1996/8): 36p., 33 refs, illus.
<P><B>Ward, R.D.</b>, <B>Elliott, N.G.</b>, <B>Yearsley, G.K.</b> and <B>Last, P.R.</b> (1996)
Species and stock delineation in Australasian oreos (Oreosomatidae). Final report to Fisheries Research and Development Corporation. Grant Number 92/24.
<i>
Division of Fisheries. [miscellaneous publication]. CSIRO Australia</i>
144p. 98 refs, illus. ISBN 0643057897
<P><B>Yearsley, G.K.</b> (1996)
Know your catch: oreo resources of Australia.
<i>
Professional Fisherman</i>
18(3): 26,28, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-46</DOCNO>
<DOCOLDNO>IA089-000952-B039-380</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/BI1996.html 192.102.250.248 19970208033755 text/html 1292
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:25:17 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:00 GMT
Content-type: text/html
Content-length: 1109
</DOCHDR>
<html>
<head>
<title>1996 Publications - CSIRO Biometrics Unit, IPPP</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Biometrics Unit, IPPP</h2></td>
</tr>
<tr><td></td>
<td><H2>1996 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P>Bramley, R.G.V., <B>Ellis, N.</b>, Nable, R.O. and *Garside, A.L. (1996)
Changes in soil chemical properties under long-term sugar cane monoculture and their possible role in sugar yield decline.
<i>
Australian Journal of Agricultural Research</i>
34(6): 967-84, 26 refs, illus.
<P>Joyce, D.C., Shorter, A.J. and <B>Jones, P.N.</b> (1996)
A triazole compound extends the vase life of Geraldton waxflower.
<i>
Australian Journal of Experimental Agriculture</i>
36(1): 117-119 15 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-47</DOCNO>
<DOCOLDNO>IA089-000952-B041-86</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/its/csxpubs/CQ1994.html 192.102.250.248 19970208034240 text/html 7494
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 03:29:55 GMT
Server: NCSA/1.5.2
Last-modified: Tue, 21 Jan 1997 03:48:05 GMT
Content-type: text/html
Content-length: 7311
</DOCHDR>
<html>
<head>
<title>1994 Publications - CSIRO Division of Chemicals and Polymers</title>
</head>
<body bgcolor="#ffffff">
<hr>
<TABLE cellspacing = 10 border=0>
<tr><td><IMG src="csiro.gif"></td><td VALIGN = BOTTOM><h2>Division of Chemicals and Polymers</h2></td>
</tr>
<tr><td></td>
<td><H2>1994 Publications</H2></td>
</tr>
</TABLE>
<hr>
Authors from this CSIRO Division are shown in <b>bold</b> type.<BR>
Authors from other CSIRO Divisions are shown in normal type.<BR>
*Non-CSIRO authors are prefixed with an asterisk.<HR>
<P><B>Ali, A.S.</b>, <B>Liepa, A.J.</b>, Thomas, M.D., <B>Wilkie, J.S.</b> and <B>Winzenberg, K.N.</b> (1994)
Preparation of cyclohexane-1,3-dione herbicide precursors by Birch reduction of 3,5-dimethoxyphenyl-substituted silane derivatives.
<i>
Australian Journal of Chemistry</i>
47(6): 1205-1210 12 refs, illus.
<P><B>Appleby, T.</b>, *Cser, F., <B>Moad, G.</b>, <B>Rizzardo, E.</b> and <B>Stavropoulos, C.</b> (1994)
Compatibilisation of polystyrene-polyolefin blends: impact properties.
<i>
Polymer Bulletin</i>
32: 479-485 13 refs, illus.
<P>Bakes, M.J., Nichols, P.D. and <B>Strauss, C.R.</b> (1994)
Value-added products from Australian shark liver oils.
<i>
In: Bellwood, O, Choat, H and Saxena, N (eds.). Proceedings of Pacon International and James Cook University of North Queensland on Recent Advances in Marine Science and Technology '94 (Townsville, QLD: July, 1994)</i>
pp.47-53 12 refs, illus.
<P><B>Bolto, B.A.</b> (1994)
Polymeric flocculants in water purification.
<i>
Chemistry in Australia</i>
61(8): 431-433 7 refs, illus.
[Also published in: Water Journal, 1994, 21(4), supp., pp.3-5.]
<P><B>Cablewski, T.</b>, <B>Faux, A.F.</b> and <B>Strauss, C.R.</b> (1994)
Development and application of a continuous microwave reactor for organic synthesis.
<i>
Journal of Organic Chemistry</i>
59(12): 3408-3412 24 refs, illus.
<P><B>Dai, L.</b>, <B>Mau, A.W.</b>, <B>Griesser, H.J.</b> and <B>Winkler, D.A.</b> (1994)
Conducting polymers from polybutadiene: molecular configuration effects on the iodine-induced conjugation reactions.
<i>
Macromolecules</i>
27: 6728-6735 33 refs, illus.
<P><B>Dixon, D.R.</b> (1994)
IAWQ Flotation Conference.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(5): 36-37
<P><B>Evans, R.A..</b>, <B>Moad, G.</b>, <B>Rizzardo, E.</b> and <B>Thang, S.H.</b> (1994)
New free-radical ring-opening acrylate monomers.
<i>
Macromolecules</i>
27: 7935-7937 21 refs, illus.
<P><B>Geddes, N.J.</b>, *Martin, A.S., <B>Caruso, F.</b>, <B>Urquhart, R.S.</b>, <B>Furlong, D.N.</b>, *Sambles, J.R., Than, K.A. and Edgar, J.A. (1994)
Immobilisation of IgG onto gold surfaces and its interaction with anti-IgG studied by surface plasmon resonance.
<i>
Journal of Immunological Methods</i>
175: 149-160 31 refs, illus.
<P><B>Geddes, N.J.</b>, <B>Paschinger, E.M.</b>, <B>Furlong, D.N.</b>, *Ebara, Y., *Okahata, Y., Than, K.A. and Edgar, J.A. (1994)
Piezoelectric crystal for the detection of immunoreactions in buffer solutions.
<i>
Sensors and Actuators B</i>
17: 125-131 16 refs, illus.
<P><B>Gengenbach, T.R.</b>, <B>Xie, X.</b>, <B>Chatelier, R.C.</b> and <B>Griesser, H.J.</b> (1994)
Evolution of the surface composition and topography of perfluorinated polymers following ammonia-plasma treatment.
<i>
Journal of Adhesion Science and Technology</i>
8(4): 302-328 42 refs, illus.
<P><B>Griesser, H.J.</b>, <B>Chatelier, R.C.</b>, <B>Gengenbach, T.R.</b>, Johnson, G. and Steele, J.G. (1994)
Growth of human cells on plasma polymers: putative role of amine and amide groups.
<i>
Journal of Biomaterials Science. Polymer Edition</i>
5(6): 531-554 63 refs, illus.
<P><B>Hawthorne, D.G.</b>, <B>Hodgkin, J.H.</b>, <B>Jackson, M.B.</b>, <B>Loder, J.W.</b> and <B>Morton, T.C.</b> (1994)
Preparation and characterization of some new diaminobisimides.
<i>
High Performance Polymers</i>
6: 287-301 17 refs, illus.
<P><B>Hodgkin, J.H.</b>, <B>Jackson, M.B.</b> and <B>Morton, T.C.</b> (1994)
Thermal stability predictions of polymeric composites: comparison of medium-term weight loss at 250&#176;C with a kinetic mapping procedure.
<i>
High Performance Polymers</i>
6: 437-446 20 refs, illus.
<P><B>Johansen, O.</b>, <B>Marcuccio, S.M.</b> and <B>Mau, A.W-H.</b> (1994)
Nucleosides. 3. Investigation of the electrochemical synthesis of <i>N</i><sup>4</sup>,<i>O</i><sup>5</sup>-diacetyl-2',3'-dideoxy-2',3'-didehydrocytidine.
<i>
Australian Journal of Chemistry</i>
47(10): 1843-1850 13 refs, illus.
<P><B>Johnson, W.M.</b>, <B>Littler, S.W.</b> and <B>Strauss, C.R.</b> (1994)
Structural revision and synthesis of sinharine and methylsinharine.
<i>
Australian Journal of Chemistry</i>
47(4): 751-756 7 refs, illus.
<P><B>Kelly-Basetti, B.M.</b>, *Mackay, M.F., <B>Pereira, S.M-L.</b>, <B>Savage, G.P.</b> and <B>Simpson, G.W.</b> (1994)
Asymmetric synthesis of a homochiral {delta}<sup>2</sup>-isoxazoline amino acid derivative.
<i>
Heterocycles</i>
37(1): 529-539 24 refs, illus.
<P><B>Kershaw, J.R.</b> and Smart, P.J. (1994)
Supercritical fluid extraction of coal-tar pitch. Part 2. Extraction of the lower molecular weight species with aliphatic solvents.
<i>
Fuel Processing Technology</i>
38: 1-15 24 refs, illus.
<P><B>Mokbel, L.</b>, <B>Savage, G.P.</b> and <B>Simpson, G.W.</b> (1994)
Alkylation reactions of 2-methylpropyl 3-(2-methylpropoxy)-5-oxocyclohex-3-ene-1-carboxylate.
<i>
Australian Journal of Chemistry</i>
47(9): 1727-1734 10 refs, illus.
<P>O'Halloran, R.J., <B>Pilkington, N.H.</b> and Sexton, B.A. (1994)
Continuous monitoring of sewage and industrial effluents.
<i>
Water. Journal of the Australian Water and Waste Water Association.</i>
21(1): 17-21 23 refs, illus.
<P><B>Pilkington, N.H.</b> and <B>Bridger, J.S.</b> (1994)
Flow-proportional sampling of sewage.
<i>
Chemistry in Australia</i>
61(8): 438-439, illus.
[Also published in: Water Journal, 1994, 21(4), supp., pp.10-11.]
<P><B>Pilkington, N.H.</b> and *Bayly, R.C. (Editors) (1994)
Proceedings of the Second Australian Conference on Biological Nutrient Removal from Wastewater: BNR2 (Albury, NSW: October 4-6, 1994).
452p., refs, illus. ISBN 064305670X
(Artarmon, NSW: Australian Water and Wastewater Association)
<P><B>Raper, W.G.C.</b>, *Crockett, J. and *Glover, P. (1994)
Purpose built prefermenter for West Wodonga.
<i>
In: Pilkington, N H and Bayly, R C (eds.). Proceedings of the Second Australian Conference on Biological Nutrient Removal from Wastewater: BNR2 (Albury, NSW: October 4-6, 1994)</i>
pp.209-216 24 refs, illus. ISBN 064305670X
(Artarmon, NSW: Australian Water and Wastewater Association)
<P>*Seen, A.J., *Cavell, K.J., <B>Mau, A.W-H.</b> and <B>Hodges, A.M.</b> (1994)
Nafion supported cationic palladium complexes as catalysts.
<i>
Journal of Membrane Science</i>
87: 149-157 14 refs, illus.
[Paper presented at the International Membrane Science and Technology Conference (Sydney, NSW: November 10-12, 1992)]
<P><B>Urquhart, R.S.</b>, <B>Furlong, D.N.</b>, *Mansur, H., *Grieser, F., *Tanaka, K. and *Okahata, Y. (1994)
Quartz crystal microbalance and UV-vis absorption study of Q-state CdS particle formation in cadmium arachidate Langmuir-Blodgett films.
<i>
Langmuir</i>
10: 899-904 30 refs, illus.<P><HR><i>Source: CSIRO Index Database (CSIX), Corporate Information Management, Clayton, VIC</i>
</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-48</DOCNO>
<DOCOLDNO>IA057-000935-B039-241</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/maq9604.htm 192.102.250.248 19970208000431 text/html 11714
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:51:52 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 03 Oct 1996 03:55:34 GMT
Content-type: text/html
Content-length: 11530
</DOCHDR>
<HTML>
<head>
<title>Monthly Asked Questions (MAQs)</title>
</head>

<BODY BACKGROUND="../strip.gif" bgcolor="#ffffff">

<BLOCKQUOTE>
<DL><DL><DD>
<IMG src="usersupp.gif"><IMG src="http://www.cis.csiro.au:8001/cim/cimsm.gif" 
alt="CIM banner"></DL></DL>
</BLOCKQUOTE>

<P><P><HR ALIGN=LEFT SIZE=4 WIDTH =100%><P>
<BLOCKQUOTE>



<CENTER><B><H2>Monthly Asked Questions (MAQs)</H2></CENTER>
<CENTER><H3>April 1996</H3>

[<a href="#cat"><B>CAT</B></a>]
[<a href="#circ"><B>CIRC</B></a>]
[<a href="#opac"><B>OPAC</B></a>]

</CENTER>
<P>


<H3><A NAME="cat">CATALOGUING</A></H3>
<P>
<I>Q:</I></B> 	<B><I>Just editing a couple of holdings records (ones which came over from Geac) 
and when saving to the database, get a message that the first indicator in 014 is invalid. On 
checking what this should be, it says 0 for holdings record number, and 1 for bib record number. 
Well, the number used doesn't match either in the two records I've done! So, any preferences 
which we should use? 1 or 0?</I>
<P>
A:</B>	It is not necessary to insert an 014 field when creating Holdings records. You will notices that the 
templates Robert Ho has created do not include the 014 field. For simplicity, it is recommended you 
leave it out.
<P>.
<P>

<B><I>Q:</I></B> 	<B><I>When I open the search dialog box in the Cataloguing module, and 
retrieve a list of search types, Staff Name Headings Search is about the fifth item in the list.  If I 
run a title search first, and complete the search, when I then retrieve the search type list, for 
example to check if a name is in the database, Staff Name Headings is no longer  included in the 
list.  I don't know if it disappears after carrying out any type of search, as I've only noticed it after 
a title search as I do these most often.</I>
<P>

A:</B>	This is no longer a problem in Voyager 3.1.1. However, if you run an unsuccessful search then 
display the list of Search By options you will notice the Staff Name Headings option is missing from 
the list. You must hit the <B>Clear</B> button after running an unsuccessful search and before 
entering the criteria for your next search. By doing this you will ensure you receive a complete list of 
Search By options.
<P>.
<P>

<B><I>Q:	When deleting a template, the Delete option is greyed out but still works</B>.<B></I></B> 
<P>

<B>A:	</B>This has been fixed with Version 3.1.1 If the template is displayed and you select the 
<B>File</B> pulldown menu, then select the <B>Template</B> pull down menu, you will notice the 
<B>Delete</B> option is still greyed out. However, now it is greyed out because the option does not 
work. It seems that to delete the Template currently, you must delete from your Windows File 
Manager. You do not seem able to delete a template from within Voyager. 
<P>.
<P>

<B><I>Q:	The 856 in Cataloguing appears on the Description page in OPAC.  Should it be a 
hyperlink on the Attachment page in OPAC?</I>
<P>

A:	</B>This problem will occur if the 856 field has been incorrectly entered in the Bibliographic record. 
Most of the records have been amended so this problem should now be a rarity. If it does occur, 
please correct the Bibliographic record. (Please contact Robert Ho if you need assistance amending 
the record).
<P>.
<P>

<B><I>Q:	How do I insert a field in a Holdings record?</I>
<P>

A:	</B>The process is the same for Holdings, Authorities or Bibliographic Records. Click to highlight the 
field below or above which you wish to add the new line in the record. Select <B>Insert Field 
Before</B> or <B>Insert Field After</B> from the <B>Edit</B> pulldown menu. There are also 
shortcut keys available rather than selecting from the <B>Edit </B>pulldown menu. Insert Field Before 
= <B>&lt;F3&gt;</B>, Insert Field After = <B>&lt;F4&gt;</B>. Please ensure that you insert the 
Tag in its correct place in the list. That is, in ascending numeric order.
<P>.
<P>

<B><I>Q:	How do I save a record before I'm finished editing it?</I>
<P>

A:	</B>You can save a record to your hard disk rather than to the database. This can be a very useful 
tool, especially if you cannot save to the database at the time or if you are interrupted. Just click on 
the <B>Save</B> icon (it looks like a floppy disk), you are then presented with the Save As window. 
Type in the file name and select the directory you wish it to be saved to (preferable a WORK 
directory) and click on the <B>OK</B> button. Alternatively, you can select <B>Save</B> or <B>Save 
As</B> from the <B>File</B> pull down menu and do the same.
<P>
	You can then recall the file in Voyager Cataloguing, finish editing and then save it to the Database. 
Please note: you must be aware that you should not forget to finalise these records and save them to 
the database.
<P>.
<P>

<B><I>Q:	How do we add our library codes to the 852 field</I>
<P>
A:	</B>The 852 field is constructed as follows, a example would be
<Center> <B>852 8 - bSOILS#aSS:SO#b T 631.4(943) </B></CENTER>
Do where the # represents the Voyager subfield delimiter which you can obtain by hitting the &lt;F9&gt; key.
<P>.
<P>

<B><I>Q:	Inconsistencies with the way long fields are entered. When I create an authority record in 
CAT which contains a long field, Voyager automatically opens the extended box and allows me to 
keep  typing, which is really convenient.  When I create a bib. 
record which contains a long field, after a certain no. of characters (at least 6 characters short of 
a full line), Voyager stops me from typing any further until I click on the ellipsis to open the 
extended box, which is really frustrating (it became more frustrating when I discovered that the 
same procedure in authority records was the ideal situation)</I>
<P>

A:	</B>This has been fixed in Version 3.2
<P>.
<P>

<B><I>Q:	I can't use the double dagger symbol, can I use $ instead for subfields?</I>
<P>

A:</B>	<B>No</B>. Voyager will only recognise the double dagger symbol as a subfield delimiter. To 
insert the double dagger symbol, place your cursor in the field you wish the double dagger to appear. 
Select <B>Insert a Subfield</B> from the <B>Edit </B>pulldown menu. Alternatively, simply hit the 
&lt;F9&gt; key to insert the subfield delimiter.
<P>
	You can also position the cursor where the subfield is to be added and hit &lt;F2&gt; and select the 
relevant subfield from the list. This will insert both the subfield delimiter and the subfield code.
<P>.
<P>

<B><H3><A NAME="circ">CIRCULATION</A></H3>
<P>

<I>Q:</I></B><B><I>Where can we get more Patron and Item Barcodes from?</I>
<P>
A:	</B>By contacting us at User Support. <A HREF="mailto: helpdesk@cis.csiro.au">Email: helpdesk@cis.csiro.au</A>   or Phone: (03) 9518 5990
<P>.
<P>

<B><H3><A NAME="opac">OPAC</A></H3></B> 
<P>

<B><I>Q:</I></B> 	<B><I>Response times are woeful!</I>
<P>

A:</B>	User Support are currently doing response times testings with the aid of the Library Network.
<P>.
<P>

<B><I>Q:</I></B> 	<B><I>OPAC  - Gets a variety of search results when truncating and limiting 
searches.</I>
<P>

A:</B>	The reason for varying results is tied in with the time it takes to search in Other Searches that 
require limiting. Limiting your search will result in a greater amount of processing time. This means, in 
cases where there are a large number of search results, these results will be truncated. That is, the 
entire result set will not be shown. You will receive a dialogue box informing you that the search has 
been truncated. The number of results returned will depend on the timeout set in your OPAC.ini file. If 
you wish to extend the search time please refer to OPAC FAQ2 on the WWW:
<CENTER>	<I><A HREF="http://www.cis.csiro.au/usersupp/opac2.htm">http://www.cis.csiro.au/usersupp/opac2.htm</A></CENTER>
	</I><P>
	Because returning results are also tied into network issues, the time it takes to retrieve results will vary 
depending on the network usage. Because of this variability, the number of results that are retrieved in 
a truncated search may also vary depending on the network usage when you run the search. This is 
also being looked into as part of the response times testings coordinated by User Support.<P>
	Please remember, in a truncated search it's not the actual number of hits that vary. It is the number of 
results retrieved that vary.
<P>.
<P>

<B><I>Q:</I></B> <B>	<I>Can we set the default search type in a basic search in OPAC?</I>
<P>

A:	</B>To the best of our knowledge, there is no way to change the default search type in the Basic 
Search window. Users can choose the default of certain things. For example, you will be able to 
decide if you prefer to have your search results display default to the Description Page rather than the 
Holdings display. For instructions on making these changes, please refer to OPAC FAQ on the WWW 
at: 
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/faqopa03.htm">http://www.cis.csiro.au/usersupp/faqopa03.htm</A></I></CENTER>
<P>.
<P>

<B><I>Q:</I></B> 	<B><I>How do you view the results of a search when a "see also" reference 
given in the results of a search?</I>
<P>

A:	</B>Some of you may have noticed that a search in OPAC can sometimes result in a "See Also" link 
or a "Note" link being displayed next to a reference in red. It seems the "Note" link is not working at 
the moment, however, the "See Also" link is working. <P>
	If you move your cursor to the red link, you will notice at the bottom of the OPAC screen some help 
text appears. It instructs you to click on the link with your right mouse button. If you have a standard 
mouse (ie one which you move around on a mouse pad and with only two buttons), you will see the 
information displayed in a dialogue box by clicking on the right button when your cursor is over the 
link. <P>
	Alternatively, you can chose not to use any mouse button and just press the F8 key. This will work as 
long as your cursor is on the relevant red link.<P>
	If you have a non-standard mouse, please refer to OPAC FAQ2 at:
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/opac2.htm">http://www.cis.csiro.au/usersupp/opac2.htm</A></I></CENTER>
<P>.
<P>

<H3>OPAC Suggested Bugs and Enhancements Outstanding</H3>
<P>
<UL>
<LI>Can we limit locality to more than one site. EG. Div Hort has four sites and wish to be able to limit search to all of these sites, not just Merbein?
<LI>Is it possible to download records from Voyager Opac into Procite?
<LI>OPAC time out. Even after setting OPAC to the highest time out value, when it times out, it pops up on top of the current working window and interrupts my thought processes. Could we ask for this to be stopped?
<LI>Can we please have an option in the Catalogue module <B>File</B> menu to change the printer setup as OPAC has?
<LI>OPAC - with Keyword searching we should be given an option not to proceed with the search if there are more than a certain number of headings.
</UL>
<P>.
<P>

<B><H3>OPAC ASCII</H3></B> 
<P>
<B><I>Q:</I></B> 	<B><I>What is the more command for?</I>
<P>
A:</B> 	The more command merely indicates that there is more of a record available for viewing.  You 
access the rest of the record by pressing the page down key.
<B>Miscellaneous</B> 
<P>.
<P>

<B><I>Q:</I></B>	<B><I>Can we give partial access only to users for some modules</B>?<B></I>
<P>
A:	</B>Partial access cannot be granted. Users must have either full access or no access.
<P>.
<P>


  _________________________________________________________________________________ April 96 MAQ
 	

30/09/96

</HTML>

</DOC>
<DOC>
<DOCNO>WT22-B27-49</DOCNO>
<DOCOLDNO>IA057-000935-B039-269</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/maq9605.htm 192.102.250.248 19970208000446 text/html 8828
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:52:05 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 03 Oct 1996 03:55:35 GMT
Content-type: text/html
Content-length: 8645
</DOCHDR>
<HTML>

<head>
<title>Monthly Asked Questions (MAQs)</title>
</head>

<BODY BACKGROUND="../strip.gif" bgcolor="#ffffff">

<BLOCKQUOTE>
<DL><DL><DD>
<IMG src="usersupp.gif"><IMG src="http://www.cis.csiro.au:8001/cim/cimsm.gif" 
alt="CIM banner"></DL></DL>
</BLOCKQUOTE>

<P><P><HR ALIGN=LEFT SIZE=4 WIDTH =100%><P>
<BLOCKQUOTE>


<CENTER><B><H2>Monthly Asked Questions (MAQs)</H2></CENTER>
<CENTER><H3>May 1996</H3>

[<a href="#acq"><B>ACQ</B></a>]
[<a href="#cat"><B>CAT</B></a>]
[<a href="#circ"><B>CIRC</B></a>]
[<a href="#opac"><B>OPAC</B></a>]

</CENTER>
<P>

<H3><A NAME="acq">ACQUISTIONS</A></H3>
Q:	<I>The size of the vendor note field in orders is far too small  (seems to be 60 characters), can this be extended?</I>
<P>
A:	</B>This is no longer a problem in Version 3.1.1
<P>.
<P>


<B><H3><A NAME="cat">CATALOGUING</A></H3>
<P>
Q:	<I>I can't save a record to the Database. I receive the following error message reads "Unable to Add Record" </I>
<P>

A:</B>	This problem has been fixed in Voyager Version 3.0
<P>.
<P>

<B>Q:	<I>Can't use the Search facility in the Authority Validation window when entering a new bib record</I></B>        
<P>
      
<B>A:	</B>This is no longer a problem with Voyager Version 3.1.1
<P>.
<P>

<B>Q:	<I>Do we just create name authorities in voyager cat or should we also create subject &amp; series 
authorities.</I>
<P>

A:	</B>Robert Ho advises just to create name authorities in voyager.
<P>.
<P>

<B>Q:	<I>Can't save an ODC Holdings record that was created using the DDC template.</I>
<P>

A:	</B>When adding ODC holdings you must use the UDC template - not the DDC template.
<P>.
<P>

<B>Q:	<I>When adding an authority record I get the error message 'invalid modifying agency' in #d field.  What is 
the modifying agency?</I>
<P>

A:	</B>This should be added in the #d field.  In the #a field should be added CSIRO. The record should read: #aCSIRO  #dSS:SO.<BR>(The # represents the double-dagger subfield delimiter)
<P>.
<P>

<B>
<H3><A NAME="circ">CIRCULATION</A></H3>
Q:	<I>How do you remove item holdings records incorrectly created in CIRC?</I>
<P>

A:	</B>To delete a holdings record, you need to call up the record in Cataloguing and then select <B>Delete</B> from 
the <B>Record</B> pulldown menu.
<P>.
<P>

<B>Q:	<I>How do I merge Patron records. Eg. copy &amp; paste Barcode from G records to HR record OR change 
Institute Id from HR to G?</I>
<P>

A:	</B>After the loading of Patron records into Voyager from the Human Resources system, some libraries will notice that 
some patrons may have two records. You must keep the Patron Record where the Institute Id begins with "HR" and 
delete the other. <P>
	If you have never used CIRC before, that is, there have been no transactions against the Patron, deleting the Old Record 
(ie the record where the Institute Id does not begin with "HR") is easy; <P>

<OL>
<LI>Pull up the Patron Record 
<LI>From the Patron pulldown menu, select Edit Patron 
<LI>Click on Delete 
<LI>Click on OK in the Confirmation window
</OL>
	If you have previously recorded transactions against the Old Patron Record, you will want to keep that history. 
Therefore, you must copy the details from the old Patron Record to the new Patron Record. You must also ensure you 
copy across the Institution Id, so that the one record remaining for the Patron can be easily updated with the details from 
the Human Resources System periodically. 

<OL>
<LI> Pull up the New Patron Record (ie. where the Institution Id begins with "HR") 
<LI> Alt-Tab to reactivate the Program Manager window. (While holding the Alt key down on your keyboard, hit the Tab key until you find the Program Manager icon and release both of the keys. This will put the Program Manager 
window to the front of your screen.) 
<LI>Start another CIRC session. You will now have two CIRC sessions running concurrently. 
<LI>Pull up the Old Patron Record (ie. where the Institution Id does not begin with "HR") 
<LI>From the Patron pulldown menu, select Edit Patron 
<LI>Copy and Paste all the details from the New Record to the Old Record by highlighting the fields and using Cntrl+C to Copy fields and Cntrl+V to Paste. 
<BR><B> NOTE:</B> the Copy and Paste options in the Edit pulldown menu will not work. 
<LI>Use Alt-Tab to move between the two records. 
<LI>Click on Save to save the Old record with the details of the New Record and with the Institution Id beginning with "HR". You can now end this CIRC session. 
<LI>Delete the record no longer required by clicking on Delete in the Edit Patron Window. 
<LI>Click on OK in the Confirmation window
</OL>
	Please refer to the Circulation FAQ on WWW at: 
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/faqcir01.htm">http://www.cis.csiro.au/usersupp/faqcir01.htm</A></I></CENTER>
<P>.
<P>

<B>Q:	<I>How do I add a barcode to a record in CIRC? </I>
<P>

A:	</B>Find the item. Select <B>Barcodes</B> from the <B>Item</B> pulldown menu. Click on the <B>Add 
</B>button and key in the appropriate code.
<P>.
<P>

<B>Q:	<I>How do I stop my Barcode reader from placing an 'A' at the end of each wanded item barcode</I></B>.
<P>

<B>A: </B>Thanks to Norma Penny QS:TL for providing the following instructions to reconfigure your barcode reader: 
<OL>
<LI>Wand top left barcode (Enter the configuration mode). Should get four high pitched beeps. 
<LI>Go to Page 2.6 and wand the barcode 2nd from top 1 field setting (one beep). 
<LI>Go to Appendix Page 5 and wand CODABAR (4th from bottom) (one beep). 
<LI>Back to Page 2.6 and wand "with left deletion" (one beep). 
<LI>Go to Appendix-1 and wand 1 (2nd from top) (one beep). 
<LI>Back to Page 2.6 and wand field setting (same as 2. above) (one beep) 
<LI>Go to Appendix Page 5 and want CODABAR (4th from bottom) (one beep). 
<LI>Back to Page 2.6 and wand "with right deletion" (one beep) 
<LI>Go to Appendix-1 and wand 1 (one beep). 
<LI>Go to Appendix-2. Wand "exit and save" (one beep, followed by four beeps). 
</OL>
	If it doesn't work, restore defaults, and try again. If you get three beeps anywhere along the way, something has gone 
wrong, so restore defaults and start again. 
<BR>
	To restore defaults: 
<OL>
<LI>Appendix-2 and wand "enter configuration". 
<LI>Wand "default" (last one) 
<LI>Wand "exit and save"
</OL>
	Please refer to Circulation FAQ on WWW at:
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/faqcir01.htm">http://www.cis.csiro.au/usersupp/faqcir01.htm</A></I></CENTER>
<P>.
<P>

<H3>Circulation Suggested Bugs and Enhancements Outstanding</H3>

<UL>
<LI>Once an item record is displayed in CIRC,  clicking on the <B>Edit</B> pulldown menu causes a General Protection Fault error which then throws you out of CIRC. This does not happen on all machines.
</UL>
<P>.
<P>

<H3><A NAME="opac">OPAC</A></H3>
<B>Q:	<I>Search by Title in Voyager seems to be restricted to entering under 50 Characters</I></B>
<P>

A: </B>No longer a problem with Version 3.1.1
<P>.
<P>

<B>Q:	<I>When and how can the divisional general staff load OPAC on to the PCs on their desktops?</I>
<P>

A:	</B>Divisional staff can download OPAC onto their desktop PCs through CSI on WWW at:
<CENTER><I><A HREF="http://www.csiro.au/csi/index.html">http://www.csiro.au/csi/index.html</A></I></CENTER>
	Select <B>Voyager OPAC</B> under the <B>Library Utilities</B> heading 
<P>.
<P>

<H3>OPAC Suggested Bugs and Enhancements Outstanding</H3>
<P>
<UL>
<LI>We can experience some very slow response times in Voyager OPAC<P>
<LI>Can we limit locality to more than one site. EG. Div Hort has four sites and wish to be able to limit search to all of these sites, not just Merbein?<P>
<LI>Is it possible to download records from Voyager Opac into Procite?<P>
<LI>OPAC time out. Even after setting OPAC to the highest time out value, when it times out, it pops up on top of the current working window and interrupts my thought processes. Could we ask for this to be stopped?<P>
<LI>Can we please have an option in the Catalogue module <B>File</B> menu to change the printer setup as OPAC has?<P>
<LI>OPAC - with Keyword searching we should be given an option not to proceed with the search if there are more than a certain number of headings.<P>
<LI>Can we have a facility to append saved displays to existing files over different sessions.<P>
<LI>I would like to be able to limit keyword searches to our own collection.<P>
<LI>The help text that appears in the basic search box says that truncation on the left is implied - when it should be truncation on the right is implied
<P>.
<P>


</UL>

  ___________________________________________________________________________ May 96 MAQ

30/09/96
</HTML>



</DOC>
<DOC>
<DOCNO>WT22-B27-50</DOCNO>
<DOCOLDNO>IA057-000935-B039-308</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/maq9606.htm 192.102.250.248 19970208000458 text/html 10515
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:52:19 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 03 Oct 1996 03:55:35 GMT
Content-type: text/html
Content-length: 10331
</DOCHDR>
<HTML>

<head>
<title>Monthly Asked Questions (MAQs)</title>
</head>

<BODY BACKGROUND="../strip.gif" bgcolor="#ffffff">

<BLOCKQUOTE>
<DL><DL><DD>
<IMG src="usersupp.gif"><IMG src="http://www.cis.csiro.au:8001/cim/cimsm.gif" 
alt="CIM banner"></DL></DL>
</BLOCKQUOTE>

<P><P><HR ALIGN=LEFT SIZE=4 WIDTH =100%><P>
<BLOCKQUOTE>


<CENTER><B><H2>MONTHLY ASKED QUESTIONS  (MAQ'S)</H2></CENTER>
<CENTER><H3>June 1996</H3>
<P>

[<a href="#acq"><B>ACQ</B></a>]
[<a href="#cat"><B>CAT</B></a>]
[<a href="#circ"><B>CIRC</B></a>]
[<a href="#opac"><B>OPAC</B></a>]
[<a href="#misc"><B>MISC</B></a>]


</CENTER>
<P>

<B><H3><A NAME="acq">ACQUISITIONS</A></H3>
<P>

Q.	<I>I am experiencing extremely slow response times in Acquisitions today (Thursday 6/6 approx 
3.00 pm)</I>
<P>

A.	</B>Please see the answer to the response time speed question under <B>OPAC.</B>
<P>.
<P>

<H3>Acquisitions Bugs and Enhancements Outstanding</H3>
<UL>
<LI>Automatic duplicate checking by order number and title when entering a new order in Acq.
<LI>The 'unlink' button in Acq does not appear to work after the order has been approved.
<LI>Cannot update the Currency on a pending PO once the header information has been saved (Even though no line items have been added and PO is unnaproved)
<LI>It is possible to delete a holdings record in Cat by deleting an order linked to that location in Acq, even if the holdings was already in Cat.
</UL>
<P>.
<P>


<B><H3><A NAME="cat">CATALOGUING</A></H3>

Q.	<I>Is there any way of altering the date that the item is catalogued?</I>
<P>

A.	</B>You can go into the 008 field in the Bibliographic record and change the date there.
<P>.
<P>

<B>Q.	<I>When creating authorities for conferences: Do we just put in </B>#<B>n ... 
</B>#<B>d...:</I></B> <B><I></B>#<B>c?</I>
<br> (Where <B>#</B> represents the double-dagger subfield delimiter)
<P>

A.	</B>For authority heading creation, the data are to be input exactly as the bibliographic data.  The 
sequence and spelling, etc. should all be the same. The Voyager system cannot do any close/near 
check. It has to be bull's eye matching.
<P>.
<P>

<B>Q.</B>	<B><I>We are unable to remove holdings for a journal title despite following Robert 
instructions.</I></B> 
<P>

<B>A.</B>	The holdings record was created through Acqusitions during the serials data entry project.  
Each serial that gets entered in Acq is linked to an existing record in Cat. If there is no existing Cat  
record, a brief holdings record is created when the order is entered in Acq.To delete this record, call 
up the Purchase Order in Acq. Click on the Copies/Funds field in the Item Line of the Order. Click on 
the Holdings field and click on Unlink to remove the link to the holdings record. Note: this function 
only works if the order has not been approved. Then delete the Holdings record in Cat.
<P>.
<P>

<B>Q.	<I>When I maximise the authority or bib record window the extended text box does not 
automatically open.</I>
<P>

A.	</B>Fixed in new version 3.1.1
<P>.
<P>

<B>Q.	<I>How do I delete a holding?</I>
<P>

A.	</B>To delete a holdings record, you need to call up the record in Cataloguing and then select 
<B>Delete</B> from the <B>Record</B> pulldown menu.
<P>.
<P>

<B><H3><A NAME="circ">CIRCULATION</A></H3>
<P>

Q.	<I>Is there a way of increasing the number of items available for loan before the limit is reached? 
Is there any way of modifying the default loan period from 1 week to 4 weeks? Or even a function 
for Permanent loan?</I>
<P>

A.	</B>Those libraries that have not as yet joined CIRC officially will have only access to the generic 
CIRC parameters. The CIRC pack which will be sent our soon will give every library (or site if 
requested) a chance to specify their own CIRC parameters, eg number of items available for loan, 
length of loan periods, types of loans.
<P>.
<P>

<B>Q.	<I>When using the Barcode readers A's appear at the beginning &amp; end of our 
barcodes.</I>
<P>

A.	</B>Please refer to Circulation FAQ on WWW at:
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/faqcir01.htm">http://www.cis.csiro.au/usersupp/faqcir01.htm</A></I></CENTER>
<P>.
<P>

<B>Q.	<I>Could I request that if for some reason notices are not run we can be notified?</I>
<P>

A.	</B>Hans is now running daily CIRC print jobs.
<P>.
<P>

<B>Q.	<I>Why is it that some times when I'm using CIRC to delete patrons (for example) I get the 
message "Out of memory" and then I am being thrown out of Voyager?</I>
<P>

A.	</B>This is a common problem in CIRC whenever you save a few records. It seems that Voyager does 
not handle the PCs resources (eg memory) very well and so when a user modifies and saves a number 
of records, Voyager eventually runs out of memory. This has been logged as a system bug and I'm 
afraid we cannot remedy it here within the CSIRO. The only thing that you can do is to log out of 
Windows and re-boot your PC. This will clear the memory and you can start again. 
<P>.
<P>

<B>Q.	<I>Why do</I> <I>I get a</I> <I>Windows General Protection Error when accessing a 
pulldown menu in the Circulation module?</I></B> 
<P>

<B>A.	</B>This problem seems to only appear on particular PC's and once this error occurs on the 
machine it doesn't seem to ever work again. This has been reported as a bug to Ferntree Computing 
who have been able to reproduce the problem and have, in turn, logged it with Endeavor. Voyager 
version 3.1 has made a little bit of a difference but there are still quite a few Voyager users who are 
reporting this problem to us from time to time. We will log each incidence as it arises and will feed 
them back to Ferntree. When contacting the Helpdesk about this problem please advise on which 
menu you receive the Windows General Protection Error (i.e. File, Edit etc.)
<P>.
<P>

<H3>Circulation Suggested Bugs and Enhancements Outstanding</H3>
<UL>
<LI>Once an item record is displayed in CIRC,  clicking on the <B>Edit</B> pulldown menu causes a General Protection Fault error which then throws you out of CIRC. This does not happen on all machines.
<LI>View Circ Only access from OPAC 
<LI>Item type/Temp.item type/Patron type to appear on our overdue notices.
<LI>The so-called sequence number on overdue notices doesn't seem to start from 1 again after an item has been renewed.
<LI>Windows General Protection Error when accessing a pulldown menu in the Circulation module.
</UL>
<P>.
<P>

<H3><A NAME="opac">OPAC</A></H3>
<P>
Q.	<I>I have done a couple of searches for titles beginning with "The", and have been surprised not 
to find them.</I>
<P>

A.	</B>This problem is occuring because of incorrectly coded indicator values of records in GEAC. The 
second indicator value was left as was in the records for the transfer from GEAC to Voyager. 
Unfortunately, it is impossible for one person to amend each occurence of this problem you can 
imagine the volume of checking required. Robert has fixed those with 'a' and 'an', but has not been able 
to do the same for 'the'.
<P>
	The zero non-filing character values for other tags are again coding errors. 
<P>
	It is recommended that anyone finding such errors during their scanning of titles etc. make the 
necessary changes. Please see OPAC FAQ3 on WWW at:
<CENTER><I><A HREF="http://www.cis.csiro.au/usersupp/faqopa03.htm">http://www.cis.csiro.au/usersupp/faqopa03.htm</A></I></CENTER>
<P>.
<P>

<B>Q.	<I>My Basic author search for Lemee brings up 1 hit. A Keyword author search brings up no 
hits.</I></B> 
<P>

<B>A.	</B>You can retrieve author Lemee in Basic and not Keyword because the normalisation tables 
contain codes allowing diacritics to be searched. The code has been entered for Basic but not for 
Keyword. (Also listed as an outstanding bug).
<P>.
<P>

<B>Q.	<I>I have uncharacteristically slow response times in OPAC.</I>
<P>

A.	</B>It seems that the afternoon from 2.30 pm is a very busy time and response times tend to slow 
around then. Our Slow Response Times Test project is completed and results are being analysed at the 
moment. We'll keep you posted.
<P>.
<P>

<B>Q.</B>	<B><I>When doing an ISSN search in OPAC I get the message "General Protection 
Error in module CSHT UBX at 0001.09 CD". When clicking on OK Voyager throws me out.</I>
<P>

A.</B>	Close all software applications running on your computer, then close down Windows and re-start 
your PC. After this the error should not occur again.
<P>.
<P>

<H3>OPAC Suggested Bugs and Enhancement Oustanding</H3>

<UL>
<LI>We can experience some very slow response times in Voyager OPAC<P>
<LI>Can we limit locality to more than one site. EG. Div Hort has four sites and wish to be able to limit search to all of these sites, not just Merbein?<P>
<LI>Is it possible to download records from Voyager Opac into Procite?<P>
<LI>OPAC time out. Even after setting OPAC to the highest time out value, when it times out, it pops up on top of the current working window and interrupts my thought processes. Could we ask for this to be stopped?<P>
<LI>Can we please have an option in the Catalogue module <B>File</B> menu to change the printer setup as OPAC has?<P>
<LI>OPAC - with Keyword searching we should be given an option not to proceed with the search if there are more than a certain number of headings.<P>
<LI>Can we have a facility to append saved displays to existing files over different sessions.<P>
<LI>I would like to be able to limit keyword searches to our own collection.<P>
<LI>The help text that appears in the basic search box says that truncation on the left is implied - when it should be truncation on the right is implied<P>
<LI>Increase of space in Heading List boxes in OPAC (current width is 65 characters -approx).<P>
<LI>My Basic author search for Lemee brings up 1 hit. A Keyword author search brings up no hits. <P>
</UL>
<P>.
<P>

<B><H3><A NAME="misc">MISCELLANEOUS</A></H3>
<P>
Q.	</B>Where do I find the latest version of Voyager?
<P>
<B>A.	</B>You can download the latest Version of Voyager onto your own PCs through CSI on WWW 
at:
<CENTER><I><A HREF="http://www.csiro.au/csi/index.html">http://www.csiro.au/csi/index.html</A></I></CENTER>
<BR>Select <B>Library Management Software </B>under the <B>Library Utilities</B> heading.

 	________________________________________________________________________________ June 96 MAQ 	

30/09/96
</HTML>

</DOC>
<DOC>
<DOCNO>WT22-B27-51</DOCNO>
<DOCOLDNO>IA057-000935-B039-139</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/faqacq01.htm 192.102.250.248 19970208000358 text/html 4591
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:51:20 GMT
Server: NCSA/1.5.2
Last-modified: Wed, 23 Oct 1996 04:44:33 GMT
Content-type: text/html
Content-length: 4408
</DOCHDR>
<HTML>
<!--
Author:	Jackie Buchanan
Date:	July 10, 1996
-->
<Title>Acquisitions FAQ1</Title>
<BODY bgcolor="#ffffff">
<CENTER>
<H2>Acquisitions Frequently Asked Questions 1</H2>
19/07/96
</CENTER>
<HR>
<P>


<P>.<P>
<B>How do you find a Purchase Order by title in Acq?</B>
<P>
<OL>
<LI>Click on the Search icon
<LI>Select Purchase Order as type 
<LI>Select Bibliographic Info as type
<LI>Search by title as type
</OL>


<P>.<P>.<P>
<B>When you delete an order linked to a location in ACQ the holdings record in CAT at that location in is also deleted, even though the holdings record was pre-existing, i.e. not created in ACQ.  We found that the pre-existing CAT holdings record was dele

ted even if we unlinked the order from it (in the
Copies/Fund window) before deleting the order</B>
<P>
The only way to prevent the above from occurring seems to be to go into CIRC
and attach an item record to the holdings record.   This item record need
only be a "shell" record, nothing need be entered into it;  what seems to be
crucial is the link between the item record and the holdings record, which
effectively prevents the holdings record from being deleted without going
back to CIRC and deleting the item record first.
<P>
There is a possibility that this may not be the case in Voyager Version 3.1
(planned for 19 July).  The documentation we have received so far is
ambiguous on this topic so we will test again to see what happens.


<P>.<P>.<P>
<B>How are credit notes treated by the system? Negative amounts seem to be converted to an amount in square brackets, eg [$19.27]. This is ambiguous.</B>
<P>
The description of how Voyager deals with credits is accurate. Voyager uses the statndard automated accounting system notation of square brackets to record negative/credit amounts. Credited amounts in pending invoices are displayed as pending in Fund ledg

ers under Expenditures. When the invoice is approved the Expenditure amount is adjusted accordingly, thus balancing fund figures.


<P>.<P>.<P>
<B>Searching for Purchase Order by Bib details requires you to double click on the selected item to get the Voyager reference number, then click on "Find" to retreive the order line item. Why is this the case and can this extra step be eliminated?</B>
<P>
With all of the searches except for Bib details, you are searching information contained in the Purchase Order header. With Bib details you are actually searching line items on a purchase order. The information contained in the line items are actually kep

t in a different table in the RDBMS than the purchase order header information. The reference number which appears in the search string after conducting a Bib details search is the link between the 2 tables. So it is in reality a two step process to retri

eve the purchase order from the line item level.


<P>.<P>.<P>
<B>What actually happens to an invoice once it is approved and completed?</B>
<P>
Once an invoice is approved the status will change to "approved"; the funds will be altered to reflect the invoice totals as expended; the document is a legal document and changes may not be make to the invoice (with the exception of adding notes which is

 availabe in V#.1); the voucher is automatically queued for printing (V3.1). "Complete" freezes the record and cannot be applied unless all line items are "received complete" and "invoiced".


<P>.<P>.<P>
<B>When creating publication patterns, the "descriptive name" window allows you to enter a least 50 characters. When the pattern is save, the "descriptive name immediately defaults to the first 40 characters, and the remaining characters have disappeared.

 When you search for a pattern for which more than 40 characters have been entered, it appears in the search results window with a name corresponding to the last few characters of the original name, the number of characters, depending on how far over 40 t

he original name was, but not necessarily including all the discarded character. This search can be either a search for all patterns, or a specific search commencing with the first characters of the original title. When you search for the characters which

 appear in the search results window and the resulting descriptive name, no items are found. When used to create a checkin pattern appears to behave as expected.</B>
<P>
This problem has been looked at and is fixed in Version 3.1.
<P>

</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-52</DOCNO>
<DOCOLDNO>IA057-000935-B039-178</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/faqcat01.htm 192.102.250.248 19970208000406 text/html 6929
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:51:30 GMT
Server: NCSA/1.5.2
Last-modified: Wed, 23 Oct 1996 04:45:19 GMT
Content-type: text/html
Content-length: 6746
</DOCHDR>
<HTML>
<!--
Author:	Jackie Buchanan
Date:	July 19, 1996
-->
<Title>Cataloguing FAQ 1</Title>
<BODY bgcolor="#ffffff">
<CENTER>
<H2>Cataloguing Frequently Asked Questions 1</H2>
19/07/96
</CENTER>
<P>
<HR>


<P>.<P>
<H3><I>The following is an ABN FAQ prepared by Robert Ho</I></H3>
<P>.<P>
<B>What is the situation of downloaded ABN records since November?</B>
<P>
All records have been extracted into files on weekly basis.


<P>.<P>.<P>
<B>What is the procedure in transferring records to Voyager?</B>
<P>
Records have to be imported one by one to Voyager using the IMPORT function
in the Cataloguing module.


<P>.<P>.<P>
<B>What is the process when these ABN records are imported to Voyager?</B>
<P>
 When a record is imported, the following processes are performed manually:
 <UL><LI>duplicate checking;
 <LI>existing holdings checking;
 <LI>deletion of unwanted fields (eg NLM call numbers);
 <LI>rearrange of Tag data (eg transfer ABN Immutable number from Tag 019 
to Tag
035);
 <LI>transfer of Tag 984 to existing records
</UL>


<P>.<P>.<P>
<B>What do we have to do once the records are in Voyager?</B>
<P>
 You have to search your records in Cataloguing Module.  Once you have found
the records, your holdings information will be coded as Tag 984 in the
bibliographic record.  If you do not find such a Tag, it normally means that
there is already a Holdings record in the system or your holdings
information has not been downloaded.  Check the Holdings record.
 If you do not have a Holdings record of your library attached to the
bibliographic record, you should use CREATE HOLDING to create a Holdings
record and transfer your Tag 984 data to the Tag 852.
 You have to delete this Tag 984 in the bibliographic record after you have
created the Holdings record.
 Both records have to be sent to database.
 If you have other information for the copy, you should add it in the ITEM
record for this copy in the Circulation module.


<P>.<P>.<P>
<B>Can I add holdings to ABN now?</B>
<P>
 Yes, holdings can be added to ABN anytime.


<P>.<P>.<P>
<B>What will happen to these records after I have added my holdings?</B>
<P>
 These records will be downloaded for import into Voyager.


<P>.<P>.<P>
<B>What is the turnaround time for the ABN records to go into Voyager?</B>
<P>
 It is not possible to say this because the process of importing records is
one record at a time.  There are various additional work (as stated above)
to be done before the records can be used in Voyager.  [On average, it take
at least five minutes to import one record.]


<P>.<P>.<P>
<B>Is there a duplicate checking facility in Voyager to detect such records
from being loaded again?</B>
<P>
Yes, there is a duplicate checking programme in Voyager.  We are still
trying to find out how it works.


<P>.<P>.<P>
<B>Who is doing the transfer of records after the files have been ftped?</B>
<P>
 At the moment, Robert Ho is retrieving the records from ABN via ftp and is
also importing these records to Voyager. In the future, each Divisional 
cataloguer will have to ftp
the weekly file from ABN individually and use the CSIRO ABN-preprocessing 
programme to
extract records with their Customer number/s attached. These records will 
be saved into a file for
import into Voyager. It is hope that we may be able to download records 
on a daily basis once we
have organised the MARC*link with ABN.


<P>.<P>.<P>
<B>Is there a way that I can add holdings to ABN without downloading the 
record?</B>
<P>
Yes, there is the MRM command.  But only when we have MARC*link in operation.


<P>.<P>.<P>
<B>What is MARC*link?</B>
<P>
MARC*link is a batched direct downloading process developed by ABN to
facilitate downloading of records using the ftp function via the 
Internet. Records are extracted
nightly and are available the next day for ftp. These records will be 
stored for a period of ten
days, after that the files will be deleted. In MARC*link, all the ABN 
standard downline record
selection commands (MRM, HNEW, HMOD, HDEL) can be used.


<P>.<P>.<P>
<B>What is the ABN preprocessing programme?</B>
<P>
The ABN preprocessing programme is a programme written specially for CSIRO
to facilitate the extraction of records from the downloaded ABN record files
according to the ABN Customer number of the Library.  During the process of
extraction, some of the processes that can be manipulated by machine (eg
deletion of unwanted tags from the record) will be performed.  These records
are then saved in a file in the Cataloguers PC for import into Voyager.


<P>.<P>.<P>
<B>What happens if there are more than one library holdings in the
downloaded record?</B>
<P>
 There will be multiple 984 Tags in the bibliographic record.
 The first cataloguer who works on the bibliographic record will have to
perform all the necessary work such as creation of authority records,
checking of correctness of data.
 Other cataloguers will only have to create Holdings records for their
respective libraries.  They can of course input additional information to
the bibliographic record.


<P>.<P>.<P>
<B>What do I have to do if I need to use the CIRCULATION module to loan 
out a
book which is waiting for the ABN downloaded record?</B>
<P>
 In this case, you can use the ADD BIB/ITEM function in Circulation  to
create the item record for loan.  In this process, you have to fill in the
bibliographic information relating to the item.  The information is
automatically transferred to the Cataloguing module to create a brief
Bibliographic record and a Holdings record.  This means that the item record
created in Circulation is linked to a Holdings record in Cataloguing.
<P>


<P>.<P>.<P>
<B>What do I have to do when the ABN record for the brief bibliographic
record created via Circulation has been imported?</B>
<P>
 Until the overlay of data from the incoming record to the existing 
record is available, the
suggestion is to delete the existing Item record, then the Holdings 
recordand the Bibliographic
record.  Fianally, create a new Item record with same
circulation information and attach it to the NEW bibliographic record.


<P>.<P>.<P>
<B>Is there a batch-loading programme available (similar to that used in 
GEAC)?</B>

 Batch-loading programme exists in Voyager.  We are waiting for
documentation on how it works.


<P>.<P>.<P>
<B>If there is already a very brief record in Voyager, is there a programme
that can overlay data to the existing record?</B>
<P>
 This is not available at the moment.


<P>.<P>.<P>
<B>Who is responsible when there are missing records from downloading?  </B>
<P>
 Basically you are responsible.   The Union Catalogue Quality Group at 
CCIM will
assist in the communication with the ABN Office in relation to this.

</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-53</DOCNO>
<DOCOLDNO>IA057-000935-B039-114</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/faqopa03.htm 192.102.250.248 19970208000347 text/html 2586
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:51:09 GMT
Server: NCSA/1.5.2
Last-modified: Wed, 23 Oct 1996 04:42:49 GMT
Content-type: text/html
Content-length: 2403
</DOCHDR>
<HTML>
<!--
Author:	Jackie Buchanan
Date:	July 19, 1996
-->
<Title>OPAC FAQ 3</Title>
<BODY bgcolor="#ffffff">
<CENTER>
<H2>OPAC Frequently Asked Questions 2</H2>
19/07/96
</CENTER>
<P>
<HR>


<P>.<P>
<B>Is it possible to change the default display from Description to Holdings?</B>
<P>
Yes, it certainly is.  
<OL>
<LI>Open the c:\voyager\opac.ini file in Notepad 
<LI>Move to the [Record Details] section
<LI>Change Default=1 to Default=0
<LI>Save the file
</OL>


<P>.<P>.<P>
<B>Using ADVANCED subject search for "chromatography", retrieves 66 titles while a BASIC subject search for "chromatography" finds 83 titles. Why are there suddenly 17 more records?</B>
<P>
The ADVANCED and BASIC searches search different indices.  At the moment, we are not sure which field(s)/subfield(s) are included in OPAC SUBJECT and ADVANCED SUBJECT.  The manual and on-line help seem to hold contradictory information, however, we will t

ry and find out the correct details. 


<P>.<P>.<P>
<B>Keyword searching for terms with diacritics or hyphens returns fewer records than a basic search for the same.</B>
<P>
This is a bug in Voyager. Usually you could xpect two normalizations in any library system, one for index setup normalization and one for search terms normalization.  It would seem that the normalization of Keyword search in VOYAGER does not work as it sh

ould.  So the problem is not only for "Diacritical" searches, but also for other characters like "-". 
<P>
This problem is is expected to be fixed in Voyager Version 4.0. 


<P>.<P>.<P>
<B>I have done a couple of searches for titles beginning with "THE", and have been suprised not to find them.</B>
<P>
The non-filing character value in Tag 245, etc.  of 'the' has been noticed as have 'a' and 'an'.  Robert has fixed those with 'a' and 'an', but has not been able to do the same for 'the'.
<P>
This problem is occuring because of incorrectly coded indicator values of records in GEAC. The second indicator value was left as was in the records for the transfer from GEAC to Voyager.  Unfortunately, it almost impossible for one person to ammend each 

occurance of this problem you can imagine the volume of checking recquired.
<P>
The zero non-filing character values for other tag are again coding errors.
<P>
It is recommended that anyone finding such errors during their scanning of titles etc. make the necessary changes.


</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-54</DOCNO>
<DOCOLDNO>IA057-000935-B039-197</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cim/usersupp/faqcir01.htm 192.102.250.248 19970208000418 text/html 5531
HTTP/1.0 200 Document follows
Date: Fri, 07 Feb 1997 23:51:38 GMT
Server: NCSA/1.5.2
Last-modified: Wed, 23 Oct 1996 04:46:34 GMT
Content-type: text/html
Content-length: 5348
</DOCHDR>
<HTML>
<!--
Author:	Jackie Buchanan
Date:	July 19, 1996
-->
<Title>Circulation FAQ1</Title>
<BODY bgcolor="#ffffff">
<CENTER>
<H2>Circulation Frequently Asked Questions 1</H2>
19/07/96
</CENTER>
<P>
<HR>


<P>.<P>
<B>CIRC will successfully search for and display an Item Record, however, when you click on the item or Edit pulldown menu, you receive a general protection fault error message and are forced to close CIRC down. This may happen only only one PC within a g

roup of PCs on the one network.</B>
<P>
This problem has been replicated on one machine at Ferntree. They have reported the bug to Endeavor and are waiting on their response.


<P>.<P>.<P>
<B>I have two patron records for each of my patrons. How do I tidy this up?</B>
<P>
After the loading of Patron records into Voyager from the Human Resources system, some libraries will notice that some patrons may have two records. You must keep the Patron Record where the Institute Id begins with "HR" and delete the other.
<P>
If you have never used CIRC before, that is, <B>there have been no transactions against the Patron</B>, deleting the Old Record (ie the record where the Institute Id does not begin with "HR") is easy;
<P>
<OL>
<LI>Pull up the Patron Record
<LI>From the <B>Patron</B> pulldown menu, select <B>Edit Patron</B>
<LI>Click on <B>Delete</B>
<LI>Click on <B>OK</B> in the Confirmation window</OL>
<P>
If you have <B>previously recorded transactions against the Old Patron Record</B>, you will want to keep that history. Therefore, you must copy the details from the old Patron Record to the new Patron Record. You must also ensure you copy across the Insti

tution Id, so that the one record remaining for the Patron can be easily updated with the details from the Human Resources System periodically.
<P>
<OL>
<LI>Pull up the New Patron Record (ie. where the Institution Id begins with "HR")
<LI><I>Alt-Tab </I>to reactivate the Program Manager window. 
<BR>(While holding the <I>Alt</I> key down on your keyboard, hit the <I>Tab</I> key until you find the Program Manager icon and release both of the keys. This will put the Program Manager window to the front of your screen.)
<LI>Start another CIRC session. You will now have two CIRC sessions running concurrently.
<LI>Pull up the Old Patron Record (ie. where the Institution Id does not begin with "HR")
<LI>From the <B>Patron</B> pulldown menu, select <B>Edit Patron</B>
<LI>Copy and Paste all the details from the New Record to the Old Record by highlight the fields and using <I>Cntrl+C</I> to Copy fields and <I>Cntrl+V</I> to Paste.
<BR>NOTE: the Copy and Paste options in the Edit pulldown menu will not work.
<BR>Use <I>Alt-Tab</I> to move between the two records.
<LI>Click on <B>Save</B> to save the Old recrod with the details of the New Record and with the Institution Id beginning with "HR". You can now end this CIRC session.
<LI>Delete the record no longer required by clicking on <B>Delete</B> in the Edit Patron Window.
<LI>Click on <B>OK</B> in the Confirmation window</OL>
</OL>


<P>.<P>.<P>
<B>Who do I contact for Item and Patron Barcodes?</B>
<P>
Please contact CCIM User Support for Barcodes by email <I>
<A HREF="mailto:helpdesk@cis.csiro.au">helpdesk@cis.csiro.au</A></I> or by phone on PH: 1800 810 729


<P>.<P>.<P>
<B>My Datalogic CCD Barcode Reader places and "a" at the end of each wanted item barcode. How do I get rid of the 'A'?</B>
<P>
Thanks to Norma Penny QS:TL for providing the following instructions to reconfigure your barcode reader:
<OL>
<LI>Wand top left barcode (Enter the configuration mode). Should get four high pitched beeps.
<LI>Go to Page 2.6 and wand the barcode 2nd from top 1 field setting (one beep).
<LI>Go to Appendix Page 5 and wand CODABAR (4th from bottom) (one beep).
<LI>Back to Page 2.6 and wand "with left deletion" (one beep).
<LI>Go to Appendix-1 and wand 1 (2nd from top) (one beep).
<LI>Back to Page 2.6 and wand field setting (same as 2. above) (one beep)
<LI>Go to Appendix Page 5 and want CODABAR (4th from bottom) (one beep).
<LI>Back to Page 2.6 and wand "with right deletion" (one beep)
<LI>Go to Appendix-1 and wand 1 (one beep).
<LI>Go to Appendix-2. Wand "exit and save" (one beep, followed by four beeps).
</OL>
If it doesn't work, restore defaults, and try again. If you get three beeps anwhere along the way, something has gone wrong, so restore defaults and start again.
<P>
To restore defaults:
<OL>
<LI>Appendix-2 and wand "enter configuration".
<LI>Wand "default" (last one)
<LI>Wand "exit and save"
</OL>


<P>.<P>.<P>
<B>I'm still having problems with the system making overdue items "lost". I have tryed renewing the item and then recalling it but the system won't allow me as the item is still "lost" even though it has been renewed. I can see most of our loans becoming 

"lost" which is already proving to be a nuisance as I have to manually write overdue notices.</B>
<P>
Once an item has the status of "lost", it will not be selected for overdue notices or recalls. If the item has been found the "lost" status must be removed to allow the item to be treated as any other item. To remove the "lost " status, do the following;
<OL>
<LI>Call up the item record
<LI>From the <B>Item</B> pull-down menu, select <B>Status</B>
<LI>Double-click on the status "Lost-Library Applied"
<LI>Click<B>OK</B>
</OL>

</body>
</html>
</DOC>
<DOC>
<DOCNO>WT22-B27-55</DOCNO>
<DOCOLDNO>IA057-000945-B040-272</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cis/lib/csix/PubStats.html 192.102.250.248 19970208053430 text/html 1272
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 05:21:30 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 13 Jun 1996 03:55:55 GMT
Content-type: text/html
Content-length: 1089
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CSIRO Index</TITLE>
</HEAD>
<H1>CSIRO Published output (CSIX)</H1></CENTER>
<BODY>

 Papers authored by CSIRO staff (or otherwise sponsored by CSIRO).<P>
<UL><LI><FONT SIZE=5>Publications by Field of Research 1986 to 1994</FONT SIZE>
<UL><LI><a href=http://www.csiro.au/csiro/databook/fig1p7.htm>Graph</a>
<LI><a href=http://www.csiro.au/csiro/databook/tab1p4.htm>Table</a></UL>

<LI><FONT SIZE=5>Publications by Document Type 1985 to 1995</FONT SIZE>
<UL><LI><a href=http://www.csiro.au/csiro/databook/fig1p8.htm>Graph</a>
<LI><a href=http://www.csiro.au/csiro/databook/tab1p5.htm>Table</a></UL></UL>
<HR>

Source: CSIRO Index Database (CSIX), Corporate Information Management,
CSIRO Australia

<HR>
<B>Note:</B> All of the above tables and graphs are published in the <a
href=http://www.csiro.au/csiro/databook/contents.htm >CSIRO Data
Book</a>.<BR>  Printed copies are available from <a
href=http://www.publish.csiro.au/>CSIRO Publishing</a>

<HR>
<A href="/../index.html"><img src="/cis/lib/home.gif"></A><HR>
<B>Last updated:</B> June 14, 1996
</BODY>
</HTML>



</DOC>
<DOC>
<DOCNO>WT22-B27-56</DOCNO>
<DOCOLDNO>IA057-000945-B040-196</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cis/lib/csix/OzSample.html 192.102.250.248 19970208053356 text/html 2097
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 05:21:16 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 13 Jun 1996 04:18:01 GMT
Content-type: text/html
Content-length: 1914
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CSIX SAMPLE : Ozline </TITLE>
</HEAD>
<BODY>
<H2>CSIX: Ozline Sample Record 1</H2>

<I>Formatted Fields</I>
<PRE>
        Document number  DN             = 9305131
       Publication date  DATE           = 1993
          Document type  DOCTYPE        = C
</PRE>

<P>
<I>Paragraphs</I>
<PRE>
              Title  TI           Embryonic stem cells in animal breeding

             Author  AU           Sleigh=MJ; Hannan=GN

 Author location(s)  AULOC        NBE: CSIRO Division of Biomolecular

                                  Engineering, North Ryde, NSW

             Source  SOURCE       In: Beh, K J (ed.). Animal health and

                                  production for the 21st century East

                                  Melbourne, Vic: CSIRO Australia (Ch. 4):

                                  35-40 19 refs, illus. 1993

              Notes  NOTE         Proceedings of a conference held at Sydney,
                                  NSW, November 1989

       Availability  SUPPLY       $60.00 (entire volume: 173p.) paperback
	                          Available from: CSIRO Bookshop, 314 Albert St
		                  EAST MELBOURNE  Vic  3002
		                  Phone: (03) 9418 7217	Fax: (03) 9419 0459
		                  e-mail: bookshop@cis.csiro.au

           Abstract  AB           Not used in this record

  Major descriptors  DE           Genetic engineering (Animals); Cell lines

  Minor descriptors  MINOR        Animal genetics; Recombinant DNA
 
                                  techniques;

                                  Blastocysts; Cell genetics; Cell

                                  differentiation; Cell development
 
                                  (Biology); Gene mapping; Mice

     Classification  CL           BZBG: Animal genetics, Reproduction
              codes

       Shelf number  SHELFLOC     636.08 An
</PRE>
</BODY>
</HTML>


</DOC>
<DOC>
<DOCNO>WT22-B27-57</DOCNO>
<DOCOLDNO>IA057-000945-B040-7</DOCOLDNO>
<DOCHDR>
http://solaris.cis.csiro.au:8001/cis/lib/csix/CSIXpublic.html 192.102.250.248 19970208053217 text/html 2479
HTTP/1.0 200 Document follows
Date: Sat, 08 Feb 1997 05:19:39 GMT
Server: NCSA/1.5.2
Last-modified: Thu, 13 Jun 1996 03:55:31 GMT
Content-type: text/html
Content-length: 2296
</DOCHDR>
<HTML>
<HEAD>
<TITLE>CSIRO Index</TITLE>
</HEAD>
<CENTER><H1>CSIRO Index (CSIX)</H1></CENTER>
<BODY>
<B>CSIRO Index</B> is a comprehensive database of publications by CSIRO
authors or otherwise sponsored by CSIRO in both Australia and overseas.
Coverage is extremely broad and includes topics such as manufacturing,
nature conservation, radioastronomy, sustainable agriculture and
biotechnology. The CSIX database is produced by CSIRO Corporate Information
Management.
CSIX is updated weekly.  It includes publications from 1969 onwards.
<P>
<UL>
<LI><FONT SIZE=5>Public Access:</FONT>  CSIX is available to organisations
and individuals by
subscription to <A
HREF="http://www.nla.gov.au/2/ozline/ozlbro.html">Ozline</A> (hosted by
National Library of Australia).  View <a href="OzSample.html">sample
record</a> (CSIX on Ozline).  CSIX will be accessible on <A
HREF="http://www.nla.gov.au/2/NDIS/">World 1</A> by 1997.
<LI> <FONT SIZE=5>Index to Publications 1994-96:</FONT>   Lists of
<A HREF="http://www.cis.csiro.au:8001/its/csxpubs/divpubs.html">Divisional
Publications</A> sorted by document type (or by year).

<LI><FONT SIZE=5>Published output:</FONT>  Graphs and tables of <A
HREF="PubStats.html">CSIRO Output</A>.

<LI><FONT SIZE=5>Publications from CSIRO:</FONT> Check out <A
HREF="http://www.publish.csiro.au/">CSIRO Publishing</A> for information
about publications for sale.  Books, Journals, Electronic media.  Fun with
CyberScience.
<LI><FONT SIZE=5>Search guidelines:</FONT> for Ozline users (FAQs).
Will include hints & tips.
<UL><LI>Complete list of expansions for
<A HREF="/cis/lib/sim/csixdbg.app.html">Classification (CL) codes</A>
</UL>
<LI><FONT SIZE=5>Document Delivery:</FONT> Contact your
nearest Library regarding delivery of documents from the CSIRO Index
Collection.
<LI><FONT SIZE=5>Information for staff:</FONT> Resources restricted to <A
HREF="/cis/csiroonly/csix/guidelines.html">CSIRO Staff </A> only.
<LI><FONT SIZE=5>Feedback:</FONT> Send e-mail <A
HREF="mailto:index@cis.csiro.au">comments</A> about this page and the CSIX
database.
Contact the Database Manager <A HREF="SteveS.html">Steve Sunter</A>
regarding Policy issues.</UL>
<HR>
<A href="/../index.html"><img src="/cis/lib/home.gif"></A><P>
<B>Last updated:</B> June 30, 1996
</BODY>
</HTML>










</DOC>
<DOC>
<DOCNO>WT22-B27-58</DOCNO>
<DOCOLDNO>IA050-000869-B025-28</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/index.htm 199.92.136.137 19970111134036 text/html 2775
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:42:16 GMT
Last-modified: Wednesday, 11-Dec-96 20:54:36 GMT
Content-length: 2582
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA Home Page</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF" TEXT="#000080" LINK="#0000FF" ALINK="#0000FF">
<CENTER><IMG SRC="dia3.gif"></CENTER>


<HR>
<P>
<CENTER><H2>Welcome to the DIA Home Page.</H2></CENTER>
<P>
The DIA (Drug Information Association) is a non-profit scientific
association with a membership of over 15,000. These members are
primarily from the international pharmaceutical industry, regulatory
agencies and academia.
<UL>
<IMG SRC="bullet2.gif">          <A HREF="dhp2.htm"><STRONG> About DIA</STRONG></A> <BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp3.htm"> <STRONG>Membership</STRONG> </A><BR>
<IMG SRC="bullet2.gif">          <A HREF="search.htm"><B>DIA Membership Directory</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp4.htm"> <STRONG>Upcoming Meetings</STRONG></A> <BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp5b2.htm"><B>Recent Meetings</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="exhibit.htm"> <B>Exhibitor's Corner</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="employ1.htm"><B>Employment Information</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp5b4.htm"><B>Internships in Industry</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp5.htm"> <STRONG>Publications</STRONG></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="pcsoreg.htm"><B> PCSO Register (Pharmaceutical Contract Support Organizations)</B></A><BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp6.htm"> <STRONG>Grants and Awards </STRONG></A><BR>
<IMG SRC="bullet2.gif">          <STRONG><A HREF="dhp7.htm"> Fellowships</A> </STRONG><BR>
<IMG SRC="bullet2.gif">          <STRONG><A HREF="dhp8.htm"> Continuing Education</A></STRONG> <BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp10.htm"> <STRONG>Information Central - Hyperlinks</STRONG> </A><BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp11.htm"> <STRONG>Personal Notes</STRONG></A> <BR>
<IMG SRC="bullet2.gif">          <A HREF="dhp12.htm"> <B>Send a Message to the DIA</B> </A><BR>
</UL>

<P>

<HR>


<CENTER>US <A HREF="mailto:dia@diahome.org">  dia@diahome.org</A><BR>
Basel Switzerland  <A HREF="mailto:diaeurope@stepnet.de">diaeurope@stepnet.de</A></CENTER>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-59</DOCNO>
<DOCOLDNO>IA050-000869-B022-399</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp2.htm 199.92.136.137 19970111133422 text/html 1250
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:35:42 GMT
Last-modified: Thursday, 01-Aug-96 13:11:49 GMT
Content-length: 1058
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>About the DIA</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
ABOUT DIA
<P><HR><UL>
<IMG SRC="bullet2.gif">          <A HREF="dhp2a.htm"> MISSION</A>
</UL>

<P>

<UL>
<IMG SRC="bullet2.gif">         <A HREF="dhp2b.htm">  HISTORY</A>
</UL>

<P>

<UL>
<IMG SRC="bullet2.gif">          <A HREF="dhp2c.htm"> BOARD OF DIRECTORS</A>
</UL>

<P>
<UL>
<IMG SRC="bullet2.gif">         <A HREF="dhp5f10.htm"> PHOTOGRAPHS OF THE BOARD</A>
</UL>
<P>
<UL>
<IMG SRC="bullet2.gif">         <A HREF="dhp2d.htm">  COMMITTEES</A>
</UL>

<P>

<P><BR>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-60</DOCNO>
<DOCOLDNO>IA050-000869-B023-32</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp3.htm 199.92.136.137 19970111133443 text/html 1093
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:36:25 GMT
Last-modified: Tuesday, 23-Jul-96 17:02:45 GMT
Content-length: 903
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Membership </TITLE>


</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

<P>
<CENTER><STRONG>MEMBERSHIP</STRONG></CENTER>
<P><HR><P><UL>
 <IMG SRC="bullet2.gif">          <A HREF="dhp3a.htm"> MEMBERSHIP APPLICATION</A>
<P>
<IMG SRC="bullet2.gif">           <A HREF="dhp3b.htm"> BENEFITS OF MEMBERSHIP</A>
<P>
<IMG SRC="bullet2.gif">           <A HREF="dhp3c.htm"> ABOUT THE MEMBERS</A>
<P></UL><P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-61</DOCNO>
<DOCOLDNO>IA050-000869-B023-65</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/search.htm 199.92.136.137 19970111133507 text/html 2374
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:36:38 GMT
Last-modified: Tuesday, 03-Sep-96 19:28:33 GMT
Content-length: 2183
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Search Engine</TITLE>
</HEAD>


<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF" TEXT="#000000" LINK="#800000" VLINK="#008000" ALINK="#C0C0C0">

<CENTER><font size=6>The Drug Information Association</font><BR><font size=4>Membership Directory Search Engine</font>
</CENTER><P>
<!--------------Search Query ------------------------>

<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome1.cfg">
<CENTER><B>Last Name (A - C)                    </B>     <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query">
</FORM>

<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome2.cfg">
<B>Last Name (D - G)</B>                    <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query">
</FORM>

<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome3.cfg">
<B>Last Name (H - K)  </B>    <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query">
</FORM>


<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome4.cfg">
<B>Last Name (L - O)</B>     <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query">
</FORM>

<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome5.cfg">
<B>Last Name (P - S)</B>     <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query">
</FORM>

<FORM METHOD="POST" ACTION="http://www.diahome.org/cgi-bin/dbsearch.cgi">
<INPUT TYPE="HIDDEN" NAME="CONFFILE" VALUE="/public/htdocs/diahome6.cfg">
<B>Last Name (T - Z)</B>     <INPUT NAME="lastname" SIZE="20">       <INPUT TYPE=SUBMIT VALUE="Submit Query"></CENTER>
</FORM>

<HR>

<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>











</BODY>


</HTML>



</DOC>
<DOC>
<DOCNO>WT22-B27-62</DOCNO>
<DOCOLDNO>IA050-000869-B023-102</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4.htm 199.92.136.137 19970111133525 text/html 1697
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:37:03 GMT
Last-modified: Tuesday, 19-Nov-96 21:58:27 GMT
Content-length: 1506
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Upcoming Meetings</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

<P>
<CENTER><STRONG>UPCOMING MEETINGS</STRONG></CENTER>
<P>
<HR>

<UL>
<IMG SRC="bullet2.gif">   <A HREF="dhp4a.htm"> 1997 ANNUAL MEETING   22-26 June Palais des Congress, Montreal, Canada<BR></A>
1998 7-11 June Hynes Convention Center, Boston, MA, USA<BR>
1999 25 June-1 July Baltimore Convention Center, Baltimo;re, MD, USA<BR>
2000 11-15 June San Diego, CA, USA<BR>
2001 24-28 June Metro Toronto Convention Centre, Toronto, Canada<BR>
2002 23-27 Navy Pier, Chicago, IL, USA
</UL>



<P>

<UL>
<IMG SRC="bullet2.gif">           1997 ANNUAL EUROMEETING</A> "26-28 May Congress Center Dusseldorf, Germany"<BR>
1998 ANNUAL EUROMEETING "29-31 March, - Acropolis, Nice, France"


</UL>

<P>

<UL>
<IMG SRC="bullet2.gif">           <A HREF="dhp4c.htm"> WORKSHOPS/TRAINING PROGRAMS</A>
</UL>

<P>
<UL>
<IMG SRC="bullet2.gif">          <A HREF="dhp4c.htm"> TO REGISTER FOR A MEETING</A>
</UL>

<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-63</DOCNO>
<DOCOLDNO>IA050-000869-B023-139</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2.htm 199.92.136.137 19970111133542 text/html 823
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:37:23 GMT
Last-modified: Thursday, 19-Dec-96 20:14:37 GMT
Content-length: 632
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P><UL>
 DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG><A HREF="dhp5b2a.htm"> RECENT MEETINGS</STRONG></CENTER></A>
<P><HR>
<CENTER>   Note: In several instances, presentations at a meeting may
have <BR>
   been summarized for the Newsletter. When a presentation was
so <BR>
   summarized, the summary is also included.</CENTER>
<P><HR><P>
<UL>

<P>

<P>

</UL>
<HR>
<P>

<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-64</DOCNO>
<DOCOLDNO>IA050-000869-B023-181</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/exhibit.htm 199.92.136.137 19970111133603 text/html 1533
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:37:43 GMT
Last-modified: Friday, 22-Nov-96 19:29:44 GMT
Content-length: 1343
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Exhibitor's Corner</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><FONT SIZE=6>Exhibitor's Corner</FONT></CENTER>
<HR>
Exhibits are scheduled for the following meetings.  Please contact the DIA Exhibit Manager for further information and to reserve space at:
<P>
email,      <A HREF="mailto:eileen@diahome.org"><B>eileen@diahome.org</B></A>      or by fax      215 641-1229 
<P>

<B>Pharmaceutical Document Management East</B><BR>
February 10-12, 1997; Philadelphia, Pennsylvania<BR>
Booths only
<P>
<B>Clinical Data Management: Innovative Technologies and Strategies <BR>
for the Global Management of Clinical Information</B><BR>
March 16-19, 1997; Philadelphia, Pennsylvania<BR>
Booths Only
<P>
<B>Developing the Competitive Edge for Global Supplies Operations:<BR>
Strategies for the 21st Century</B><BR>
April 7-9, 1997; New Orleans, Louisiana<BR>
Booths 1 Day only
<P>
<B>9th Annual Euromeeting<BR>
The 1998 Impact on the Pharmaceutical Industry: Are YOU Prepared?</B><BR>
May 26-28, 1997; Dusseldorf, Germany<BR>
Booths only
<P>
<B>33rd Annual Meeting<BR>
Optimizing Pharmaceutical Development: The Global Experience</B><BR>
June 22-26, 1997; Montreal, Canada<BR>
Booths only
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-65</DOCNO>
<DOCOLDNO>IA050-000869-B023-208</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ1.htm 199.92.136.137 19970111133613 text/html 747
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:37:56 GMT
Last-modified: Thursday, 22-Aug-96 18:55:29 GMT
Content-length: 556
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Employment Information</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<UL>
<A HREF="employ4.htm"> <IMG BORDER=0 SRC="bullet2.gif">     <B>How to post a Position</B></A>
<P>
<A HREF="employ2.htm"> <IMG BORDER=0 SRC="bullet2.gif">     <B>Positions Desired</B></A>
<P>
<A HREF="employ3.htm"> <IMG BORDER=0 SRC="bullet2.gif">     <B>Positions Available</B></A>
</UL>
<P>
<HR>

<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-66</DOCNO>
<DOCOLDNO>IA050-000869-B023-229</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b4.htm 199.92.136.137 19970111133636 text/html 805
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:38:03 GMT
Last-modified: Monday, 30-Dec-96 20:15:45 GMT
Content-length: 616
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Internships in Industry</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>INTERNSHIPS IN INDUSTRY</STRONG></CENTER>
<P><HR><UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp5b4a.htm"> INTERNSHIPS NOW AVAILABLE IN INDUSTRY</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5b4b.htm"> INTERNSHIP REPORT FORM</A><BR>
 (Form Used to Advise the DIA of an Available Internship)</UL>
<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-67</DOCNO>
<DOCOLDNO>IA050-000869-B023-261</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5.htm 199.92.136.137 19970111133651 text/html 1071
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:38:33 GMT
Last-modified: Wednesday, 09-Oct-96 18:14:43 GMT
Content-length: 879
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Publications</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<CENTER><STRONG>PUBLICATIONS</STRONG></CENTER>
<P>
<HR>
<UL>
<IMG SRC="bullet2.gif">    <A HREF="dhp5a.htm"> DRUG INFORMATION JOURNAL</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5b.htm"> DIA NEWSLETTER</A>

<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f.htm"> ANNUAL REPORT</A>
<P>
</UL>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>




</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-68</DOCNO>
<DOCOLDNO>IA050-000869-B023-286</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcsoreg.htm 199.92.136.137 19970111133703 text/html 718
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:38:44 GMT
Last-modified: Wednesday, 09-Oct-96 18:15:50 GMT
Content-length: 526
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><FONT SIZE=6>PCSO Register</FONT><BR>(Pharmaceutical Contract Support Organizations)</CENTER>

<UL>
<A HREF="company.htm"> <IMG BORDER=0 SRC="bullet2.gif">  <B>Companies</B></A><BR>
<P>
<A HREF="service.htm"> <IMG BORDER=0 SRC="bullet2.gif">  <B>Services</B></A>

</UL>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-69</DOCNO>
<DOCOLDNO>IA050-000869-B023-318</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp6.htm 199.92.136.137 19970111133714 text/html 1177
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:38:55 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:55 GMT
Content-length: 987
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Grants and Awards</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
GRANTS AND AWARDS
<P><HR>
 <UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp6a.htm"> RESEARCH GRANTS PROGRAM</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp6b.htm"> DONALD E. FRANCKE AWARD</A><BR>
(Drug Information Journal Article)
<P>
<IMG SRC="bullet2.gif">      <A HREF="dhp6c.htm"> DISTINGUISHED CAREER AWARD</A>
<P>
<IMG SRC="bullet2.gif">      <A HREF="dhp6d.htm"> OUTSTANDING SERVICE AWARD</A>
<P></UL><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

<HR><CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-70</DOCNO>
<DOCOLDNO>IA050-000869-B024-17</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp7.htm 199.92.136.137 19970111133736 text/html 708
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:39:15 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:42 GMT
Content-length: 518
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Fellowships</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<CENTER><H2>Fellowships</H2></CENTER>
<HR>
<UL><P>
<IMG SRC="bullet2.gif">     <A HREF="dhp7a.htm"> CLINICAL PHARMACOLOGY FELLOWSHIPS</A><BR>

<P>
<IMG SRC="bullet2.gif">      <A HREF="dhp7b.htm"> PHARMACOEPIDEMIOLOGY AND DRUG REGULATION FELLOWSHIPS</A><BR>
</UL>
<HR>

<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>



</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-71</DOCNO>
<DOCOLDNO>IA050-000869-B024-41</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp8.htm 199.92.136.137 19970111133746 text/html 2354
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:39:27 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:34 GMT
Content-length: 2163
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Continuing Education</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<CENTER><H2>Continuing Education</H2></CENTER>
<HR>
<P>
The goal of the Drug Information Association's continuing education
program is to provide our members with opportunities to increase
and maintain their professional knowledge and skills. Both medical
and pharmacy continuing education credits are offered by the DIA
at appropriate meetings.<BR>

<P>
<CENTER><B>ACCME</B></CENTER>

<CENTER><FONT SIZE=2>(Accreditation Council for Continuing Medical
Education)<BR>
</FONT></CENTER>
<P>
ACCME has accredited the DIA (in 1994) as a provider of continuing
education credits to physicians for specifically designated activities
in Category 1 of the Physician's Recognition Award of the American
Medical Association. The DIA CME Committee selects programming
to meet the needs of physician attendees in their ongoing licensing
requirements. Many of the DIA meetings are certified for CME credits.
The hours of credits earned for attending appear in the program
material for each workshop or meeting.<BR>

<P>
<CENTER><B>ACPE</B></CENTER>

<CENTER><FONT SIZE=2>(American Council on Pharmaceutical Education)
<BR>
</FONT></CENTER>
<P>
The DIA offers continuing pharmaceutical education credits through
a provider who has been approved as a provider by the ACPE. Participants
attending these selected programs earn credits acceptable by all
boards of pharmacy that recognize ACPE approved providers. The
hours of credits earned appear in the program material for each
workshop or meeting.<BR>

<P>
For all activities offering continuing education credits, clearly
defined learning objectives are presented, allowing physicians
and pharmacists to choose the most appropriate workshop or meeting
for their needs. Information on continuing education as well as
other topics dealing with the programs is available approximately
four months prior to each meeting.<BR>

<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>





</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-72</DOCNO>
<DOCOLDNO>IA050-000869-B024-75</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp10.htm 199.92.136.137 19970111133802 text/html 3057
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:39:40 GMT
Last-modified: Monday, 23-Dec-96 18:48:07 GMT
Content-length: 2867
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Information Central</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif"></HEAD>
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<CENTER><H1>Information Central</H1></CENTER>
<P>
<HR>
<CENTER><H2>Other sites of interest</H2> </CENTER>
<P>
<OL>



<LI><A HREF="http://www.ama-assn.org">   American Medical Association</A>

<P>

<LI><A HREF="http://weber.u.washington.edu/d78/asaccp">   American Society of Anesthesiologists</A>
<P>

<LI><A HREF="http://www.nih.gov">   National Institute of Health</A>
<P>
<LI><A HREF="http://www.nlm.nih.gov">   National Library of Medicine</A>
<P>
<LI><A HREF="http://www.fda.gov">   Food and Drug Administration</A>
<P>
<LI><A HREF="http://www.fundesco.es/ctn139">AEN/CTN 139, Comite'Te'enico de Normalizacio'n de la Asociacio'n Espan~ola de Normalizacio'n y Certificacio'n</A>
<P>
<LI><A HREF="http://www.eudra.org">EudraNet (European Union Drug Regulatory Authorities NETwork)   <BR>European Agency for the Evaluation of Medicinal Products - EMEA</A>

<P>
<LI><A HREF="http://miginfo.rug.ac.be:8001">CEN/TC 251, European Committee for Stadardisation. Technical Committee TC 251: Medical Informatics</A>
<P>
<LI><A HREF="http://www.hwc.ca">The Canada Health Network</A>
<P>

<LI><A HREF="http://www.usp.org">U.S. Pharmacopeia</A>
<P>

<LI><A HREF="http://www.medinfo.org">Medinfo.org</A>
<P>
<LI><A HREF="http://www.mpa.se">Medical Products Agency of Sweden</A>
<P>
<LI><A HREF="http://www.cmr.org">Centre for Medicines Research</A>
<P>
<LI><A HREF="http://hiru.mcmaster.ca/cpg">McMaster University Clinical Practice Guidelines</A>
<P>
<LI><A HREF="http://www.medwork.co.uk/">UK Health Organizations</A>
<P>
<LI><A HREF="http://www.ncemi.org">National Center for Emergency Medicine Informatics</A>
<P>
<LI><A HREF="http://ourworld.compuserve.com/homepages/Tom_Feise">Pharma Companies</A>
<P>
<LI><A HREF="http://druginfo.sunnybrook.on.ca/main.html">Sunnybrook Health Sciences Center Drug Information</A>
<P>
<LI><A HREF="http://www.webmedlit.com">Medical Journals</A>
<P>
<LI><A HREF="http://pharma.mond.org">Pharmaceutical News</A>
<P>
<LI><A HREF="http://www.galter.nwu.edu">Northwestern University Galter Library</A>
<P>
<LI><A HREF="http://www.ahcpr.gov">Agency for Health Care Policy and Research</A>
<P>
<LI><A HREF="http://www.cdc.gov">Centers for Disease Control and Prevention</A>
<P>
<LI><A HREF="http://www.dhhs.gov">Department of Health and Human Services</A>
<P>
<LI><A HREF="http://www.samhsa.gov">Substance Abuse and Mental Health Service Administration</A>
<P>
<LI><A HREF="http://www.hrsa.dhhs.gov">Health Resources and Services Administration</A>
<P>
<LI><A HREF="http://www.centerwatch.com">CenterWatch</A>
<P>
</OL>

<HR>


<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-73</DOCNO>
<DOCOLDNO>IA050-000869-B024-100</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp11.htm 199.92.136.137 19970111133812 text/html 4183
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:39:52 GMT
Last-modified: Monday, 30-Dec-96 20:19:38 GMT
Content-length: 3993
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Changes in Members Location or Title</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PERSONAL NOTES
<P>
<CENTER> <STRONG>RECENT CHANGES IN MEMBERS LOCATION OR TITLE</STRONG></CENTER>
<HR>
<P>
<b>Philip M. Budashewitz</b><br>
to Associate Director<br>
International Affairs<br>
Food and Drug Administration<br>
<b><p>
Elizabeth A. Cundy</b><br>
to Director, Scientific Data Management<br>
Quintiles Pacific, Inc.<br>
<p>
<b>Robert E. Conway</b><br>
to Executive Vice President and General Manager<br>
Pharmaceutical Clinical Trials Division<br>
Hill Top Research, Inc.<br>
<p>
<b>Joyce M. Libera</b><br>
to Medeva Americas, Inc.<br>
<p>
<b>Dennis O'Donnell</b><br>
to Senior Vice President<br>
New Product Marketing<br>
Whitehall-Robins Healthcare<br>
<p>
<b>Professor Gordon D. Murray</b><br>
to Chair of Medical Statistics<br>
University of Edinburgh, UK<br>
<b><p>
Yechiel Golander, PhD</b><br>
to Senior Vice President<br>
Research and Development<br>
Taro Pharmaceutical Industries<br>
<p>
<b>Robert Byrnes</b><br>
to Matria Healthcare, Inc.<br>
<p>
<b>Christine Greifzu</b><br>
to Product Implementation Manager<br>
Clinarium, Inc.<br>
<p>
<b>Roger H. Meacham, Jr.</b><br>
to Vice President, Analytical and Development Services<br>
Tektagen, Inc.<br>
<p>
<b>James T. Ogle</b><br>
to President, Quintiles Americas<br>
Quintiles Transnational Corporation<br>
<p>
<b>Beth M. O'Dell</b><br>
to Associate Director, Data Management<br>
ClinTrials Research, Inc.<br>
<p>
<b>Angelo Sambunaris, MD</b><br>
to Director, Psychiatric Clinical Research<br>
Solvay Pharmaceuticals, Inc.<br>
<p>
<b>Sally Shumaker</b><br>
to Bowman Gray School of Medicine<br>
<p>
<b>Mark S. Robbins, PhD</b><br>
to President<br>
Certus International, Inc.<br>
<b><p>
Ludo J. Reynders</b><br>
to Chief Executive Officer, Quintiles Contract Research Organization Division<br>
Quintiles Transnational Corporation<br>
<p>
<b>Douglas A. Rogers</b><br>
to Executive Vice President, Marketing<br>
Whitehall-Robins Healthcare<br>
<p>
<b>David A. Amato, PhD</b><br>
to Associate Director<br>
Biostatistics and Epidemiology<br>
Abt Associates, Inc.<br>
<p>
<b>Bruce Wentworth</b><br>
to Senior Systems Analyst<br>
PharmaNet, Inc..<br>
<p>
<b>Victor Buford</b><br>
to Vice President, Health Care/ Pharmaceutical Sales<br>
ICT Solution Research<br>
<p>
<b>Timothy A. Anderson</b><br>
to Vice President, Regulatory Affairs<br>
Taro Pharmaceutical Industries<br>
<b><p>
Jack Redmond</b><br>
to Group Product Director<br>
Mental Health Marketing<br>
Solvay Pharmaceuticals, Inc.<br>
<p>
<b>Zola P. Horovitz</b><br>
to Board of Directors<br>
Roberts Pharmaceutical Corporation<br>
<p>
<b>William S. Craig, PhD</b><br>
to Vice President, R&D<br>
Alpha Therapeutic Corporation<br>
<p>
<b>Keith Wypyszynski</b><br>
to Senior Vice President of Sales<br>
Whitehall-Robins Healthcare<br>
<p>
<b>Patricia Young, PhD</b><br>
to Vice President, Regulatory Affairs<br>
Corning Besselaar<br>
<p>
<b>Louis Savastano</b><br>
to Vice President, Preclinical Research and Development<br>
Solvay Pharmaceuticals, Inc.<br>
<p><HR>
<p>
<center><b>AmericanPharmaceuticalAssociation (APhA)<br>Announces Staff Promotions</b></center><br>
<p>
<center><b>Mitchel C. Rothholz</b> to Deputy to the Executive Vice President<br>
<b>Linda G. Faison</b> to Director of Executive Office Operations<br>
<b>James P. Caro</b> to Senior Vice President of Professional Resources<br>
<b>Lucinda L. Maine</b> to Senior Vice President of Professional Affairs<br>
<b>Robert A. Fulcher </b>to Vice President of Membership and Marketing<br>
<b>Roger K. Browning</b> to Vice President of Finance and Administration<br></center><BR>
<P>

<P></CENTER>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>









</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-74</DOCNO>
<DOCOLDNO>IA050-000869-B024-134</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp12.htm 199.92.136.137 19970111133824 text/html 2397
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:40:02 GMT
Last-modified: Monday, 02-Dec-96 17:49:19 GMT
Content-length: 2207
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE> Send a Message to the DIA</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF" TEXT="#000080" LINK="#0000FF" ALINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H3>Send a Message to the DIA.</H3></CENTER>
<CENTER>US <A HREF="mailto:dia@diahome.org">  dia@diahome.org</A><BR>
Basel Switzerland  <A HREF="mailto:diaeurope@stepnet.de">diaeurope@stepnet.de</A></CENTER>
<HR>
<CENTER><H2>USA</H2></CENTER><BR>
<CENTER><A HREF="mailto:dia@diahome.org"><B>Anyone</B></A><BR>
<A HREF="mailto:jenniferA@diahome.org"><B>Andree, Jennifer</B><BR></A>
<A HREF="mailto:bobA@diahome.org"><B>Assenzo, (Bob) J.R.</B><BR></A>
<A HREF="mailto:chrisD@diahome.org"><B>Dunn, Chris</B><BR></A>
<A HREF="mailto:loisG@diahome.org"><B>Gordon, Lois</B><BR></A>
<A HREF="mailto:susanG@diahome.org"><B>Greco, Susan</B><BR></A>
<A HREF="mailto:sheilaH@diahome.org"><B>Heenan, Sheila</B><BR></A>
<A HREF="mailto:nancyK@diahome.org"><B>Keiser, Nancy</B><BR></A>
<A HREF="mailto:carolL@diahome.org"><B>Layer, Carol</B><BR></A>
<A HREF="mailto:taniaM@diahome.org"><B>Moyer, Tania</B><BR></A>
<A HREF="mailto:olgaP@diahome.org"><B>Pomper, Olga</B><BR></A>
<A HREF="mailto:carolP@diahome.org"><B>Pratt, Carol</B><BR></A>
<A HREF="mailto:loriR@diahome.org"><B>Risboskin, Lori</B><BR></A>
<A HREF="mailto:eileenR@diahome.org"><B>Roth, Eileen</B><BR></A>
<A HREF="mailto:joannS@diahome.org"><B>Serrao, JoAnn</B><BR></A>
<A HREF="mailto:marybethS@diahome.org"><B>Spigelmyer, Marybeth</B><BR></A>
<A HREF="mailto:micheleS@diahome.org"><B>Stortz, Michelle</B><BR></A>
<A HREF="mailto:tomT@diahome.org"><B>Teal, Tom</B><BR></A>
<A HREF="mailto:chrisZ@diahome.org"><B>Zelek, Chris</B><BR></A>
</CENTER>
<HR>
<CENTER><H2>EUROPE</H2></CENTER>
<CENTER><A HREF="mailto:alexa-diaeurope@stepnet.de"><B>Alex Anderson</B></A><BR>
<A HREF="mailto:dorisw-diaeurope@stepnet.de"><B>Doris Weber</B></A><BR>
<A HREF="mailto:jakobk-diaeurope@stepnet.de"><B>Jakob Kuendig</B></A><BR>
<A HREF="mailto:elisabethh-diaeurope@stepnet.de"><B>Elisabeth Heinrich</B></A><BR>
</CENTER>
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-75</DOCNO>
<DOCOLDNO>IA050-000869-B024-165</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp2a.htm 199.92.136.137 19970111133834 text/html 760
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:40:15 GMT
Last-modified: Tuesday, 23-Jul-96 17:03:02 GMT
Content-length: 570
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Mission</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">

<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
ABOUT DIA
<P>
<CENTER><STRONG>MISSION</STRONG></CENTER>
<HR><P>
The Drug Information Association provides a worldwide forum for
the exchange and dissemination of information that is intended
to advance the discovery, development, evaluation, and utilization
of medicines and related healthcare technologies.
<P>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-76</DOCNO>
<DOCOLDNO>IA050-000869-B024-205</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp2b.htm 199.92.136.137 19970111133927 text/html 5063
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:40:52 GMT
Last-modified: Tuesday, 23-Jul-96 17:02:59 GMT
Content-length: 4872
Content-type: text/html
</DOCHDR>

<HTML>

<HEAD>

<TITLE>History</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

<P>
ABOUT DIA
<P>
<CENTER><STRONG>HISTORY</STRONG></CENTER>
<P><HR>
The Drug Information Association was founded in 1964, and incorporated
in the state of Maryland, USA, during that year. It has evolved
from a founding group of 30 professionals employed in the US pharmaceutical
industry into an organization of over 14,000 worldwide. During
the early years, 1964 through 1979, the membership grew to 300.
Publications were the Drug Information Bulletin which was the
forerunner of the Drug Information Journal. A quarterly Presidents
message was also published.
<P>
Initially, the DIA President managed the records, meetings and
financial matters. Meetings consisted of an Annual Meeting and
an occasional additional meeting on a specific topic. During the
latter part of the early period 1964-1979, Ms. Claire R. McDonnell
managed the association.
<P>
Mr. Thomas W. Teal was employed as the Executive Director in 1980.
The administrative office was established in Maple Glen, PA. Mr.
Teal's tenure continued through 1991. During this period, the
activities of the DIA increased to include a growth in membership
to 9,000, and around 30 meetings, training courses and symposia
per year. While those meetings were primarily in the US, meetings
were also held in Europe, Canada and Japan during this period.
To promote the development of workshops and meetings, a North
American Steering Committee was established. That committee was
closely followed by the establishment of a Steering Committee
for Europe. The DIA Pharmaceutical Contract Support Organizations
<B>Register</B> was developed to provide recognition for the many
companies supporting the development and management of the new
drug development process. The growth of the DIA during this period
required that sophisticated association management software be
installed on the ever faster, larger computers.
<P>
The DIA European office was opened in Basel, Switzerland during
1991. That office was and continues to be managed by Mr. Alex
Anderson, DIA European Administrator.
<P>
In 1992, Mr. Erich F. Lukas, Jr. was employed as the Executive Director. His tenure continued through 1995. During this period financial management of registration funds was distributed in order to better accommodate members from European and other international locations. The concept of committees organized to address particular topics through meetings and workshops on a recurring basis was expanded and membership grew to over 13,000. The DIA became the publisher of the Drug Information Journal during this period. The DIA world web site "http://www.diahome.org" became operational in April 1996.
<P>
In July, 1996, Joseph R. (Bob) Assenzo, PhD was employed as the new DIA Executive Director. Bob came to the DIA from his position of Vice President and Senior Advisor for Regulatory Affairs and Project Management, Novo Nordisk, in Copenhagen, Denmark. He previously had served the DIA as President, Director, Chair of the DIA Steering Committee for the Americas, member of the Drug Information Journal editorial board and as chair of the Annual Meeting and various workshops.
<P>
Past Presidents of the Drug Information Association are listed below. We take this opportunity to thank these contributors to the success of the DIA and to also thank the many sincere professionals who also contributed as members of the Board of Directors, meeting Chairpersons, committee members and speakers at DIA meetings.

<P>
<HR>
<CENTER><B>Past Presidents of the Drug Information Association</B> </CENTER>

<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=55>

        <TR>
        <TD VALIGN=TOP>
E. W. Martin 1965<BR>
E. A. Conrad 1966<BR>
Oliver Buchanan 1967<BR>
Jean Weston 1968<BR>
Donald Francke 1969<BR>
Winifred Sewell 1970<BR>
Paul De Haen 1971<BR>
J. D. Archer 1972<BR>
Charles Leighton 1973<BR>
Bob West 1974<BR>
John R. Lewis 1975<BR>
Frank J. Liska 1976<BR>
Daniel A. Hussar 1977<BR>
Dwight Tousignaut 1978<BR>
Samuel Rock 1979<BR>
Howard Corey 1980<BR>

      </TD>
      <TD VALIGN=TOP>

Judith K. Jones 1981<BR>

Robert V. Cuddihy 1982<BR>

Stephen J. Frycki 1983<BR>

Peter H. Rheinstein 1984<BR>

Roger W. Croswell 1985<BR>

Elizabeth E. Force 1986<BR>

Joseph R. Assenzo 1987<BR>

Peter H. Rheinstein 1988<BR>

Elizabeth B. D'Angelo 1989<BR>

Karen K. Church 1990<BR>

Roger W. Croswell 1991<BR>

Harry A. Guess 1992<BR>

Patricia E. Stewart 1993<BR>

Louis A. Morris 1994<BR>

David M. Cocchetto 1995<BR>

John J. Donahue 1996<BR>
</TD>
</TABLE>
<P>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-77</DOCNO>
<DOCOLDNO>IA050-000869-B024-247</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp2c.htm 199.92.136.137 19970111133948 text/html 2309
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:41:29 GMT
Last-modified: Monday, 16-Sep-96 13:42:43 GMT
Content-length: 2119
Content-type: text/html
</DOCHDR>

<HTML>

<HEAD>
<TITLE>Board of Directors</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
ABOUT DIA
<P>
<CENTER><B>BOARD OF DIRECTORS 1996-1997</B>
<P><HR>
<B>President</B><BR>
<B>John J. Donahue, PhD</B><BR>
Bristol-Myers Squibb Company, USA</CENTER>
<HR><P>
<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>

        <TR>
        <TD VALIGN=TOP>

<CENTER><I><B>President-Elect</B></I><BR>
<B>Kenneth I. Kaitin, PhD</B><BR>
Tufts University, USA
<P>
<I><B>Immediate Past-President</B></I><BR>
<B>David M. Cocchetto, PhD</B><BR>
Glaxo Wellcome, Inc., USA
<P>
<I><B>Vice President</B></I><BR>
<B>Mary Doug Tyson, MS</B><BR>
Food and Drug Administration, USA
<P>
<I><B>Secretary</B></I><BR>
<B>Win M. Castle, MD, PhD, MFCM</B><BR>
Safety First, USA
<P>
<I><B>Treasurer</B></I><BR>
<B>Dana D. Rife</B><BR>
Johnson &amp; Johnson Services, Inc., USA
<P>

<CENTER><I><B>Directors</B></I><BR>
<B>John C. Alexander, MD, MPH</B><BR>
G.D. Searle and Company, USA<BR>
<P>

<B>Elizabeth B. D'Angelo, PhD</B><BR>
Zeneca Pharmaceuticals, Inc., USA<BR>
<P>
<B>Teresa P. Dowling, PharmD</B><BR>
Dupont Merck Pharmaceutical Company, USA<BR>
<P>

       </TD>
       <TD VALIGN=TOP>



<B>Robert S. Epstein, MD, MS</B><BR>
Merck &amp; Company, USA<BR>

<P>
<B>Rodney C. Hall, PhD</B><BR>
Astra Pharmaceuticals Pty. Ltd., Australia<BR>
<P>
<B>Brenton E. James</B><BR>
Glaxo Research &amp; Development, UK<BR>
<P>
<B>N. Peter Maurice, MB, MO, FFPM</B><BR>
Consultant, ICHRQA, Switzerland<BR>
<P>
<B>L. Bruce Rowsell, BScPhm</B><BR>
Health Protection Branch, Canada<BR>
<P>
<B>Karen E. Woodin, PhD</B><BR>
Pharmacia & Upjohn, Inc., USA<BR>
<P>
<B><I>Executive Director</I></B><BR>
<B>Joseph R. Assenzo, PhD</B>

</CENTER>
</TABLE>
<CENTER><I><B>1997 Annual Meeting </B></I><BR>
<I><B>Program Chairperson</B></I><BR>
<B>Irwin G. Martin, PhD</B><BR>
Parke-Davis, USA</CENTER>
<P>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-78</DOCNO>
<DOCOLDNO>IA050-000869-B024-276</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f10.htm 199.92.136.137 19970111134001 text/html 2249
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:41:42 GMT
Last-modified: Monday, 23-Dec-96 15:19:28 GMT
Content-length: 2059
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Board of Directors (Photographs)</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>ANNUAL REPORT</UL>
<P>
  <CENTER><STRONG>BOARD OF DIRECTORS - PHOTOGRAPHS</STRONG></CENTER>
<P><HR>
<CENTER>
<IMG SRC="donahue.gif"><BR>
<B>PRESIDENT</B><BR>
John J. Donahue, PhD<BR>
Bristol-Myers Squibb Company
<P>
<IMG SRC="ken.gif"><BR>
<B>PRESIDENT - ELECT</B><BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University

<P>
<IMG SRC="presel.gif"><BR>
<B>PAST PRESIDENT</B><BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.

<P>
<IMG SRC="tyson.gif"><BR>
<B>VICE-PRESIDENT</B><BR>
Mary Doug Tyson, MS<BR>
Food and Drug Administration
<P>
<IMG SRC="castle.gif"><BR>
<B>SECRETARY</B><BR>
Win M. Castle, MD, PhD, MFCM<BR>
Safety First
<P>
<IMG SRC="treas.gif"><BR>
<B>TREASURER</B><BR>
Dana D. Rife<BR>
Johnson & Johnson Services, Inc.
<P>
<B>DIRECTORS</B>
<P>
<IMG SRC="alexand.gif"><BR>
<B>John C. Alexander, MD, MPH</B><BR>
G.D. Searle and Company, USA
<P>
<IMG SRC="bass.gif"><BR>
Rolf Bass, MD<BR>
European Medicines Evaluation Agency, UK
<P>
<IMG SRC="direct1.gif"><BR>
Elizabeth B. DAngelo, PhD<BR>
Zeneca Pharmaceuticals, Inc.
<P>
<IMG SRC="dowling.gif"><BR>
Teresa P. Dowling, PharmD<BR>
DuPont Merck Pharmaceutical Company
<P>
<IMG SRC="direct2.gif"><BR>
Robert S. Epstein, MD, MS<BR>
Merck & Company
<P>
<IMG SRC="hall.gif"><BR>
Rodney C. Hall, PhD<BR>
Astra Pharmaceuticals Pty. Ltd., Australia
<P>
<IMG SRC="direct3.gif"><BR>
Brenton E. James<BR>
Glaxo Wellcome Research & Development, UK
<P>
<IMG SRC="maurice.gif"><BR>
N. Peter Maurice, MB, <BR>
MO, FFPM, Consultant, ICHRQA, Switzerland
<P>
<IMG SRC="rowsell.gif"><BR>
L. Bruce Rowsell, BScPhm <BR>
Health Protection Branch, Canada
<P>
<IMG SRC="woodin.gif"><BR>
<B>Karen E. Woodin, PhD</B><BR>
Pharmacia & Upjohn, Inc., USA
</CENTER>
<P>
<HR>

<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-79</DOCNO>
<DOCOLDNO>IA050-000869-B024-335</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp2d.htm 199.92.136.137 19970111134024 text/html 15648
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:41:53 GMT
Last-modified: Thursday, 02-Jan-97 21:39:32 GMT
Content-length: 15455
Content-type: text/html
</DOCHDR>
<HTML>
<head>
<title>Committees</title></head>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>

<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>

        <TR>
        <TD VALIGN=TOP>

<B>
STEERING COMMITTEE<BR> 
FOR THE AMERICAS</B><BR>
<B><I>Chairperson</I></B><BR>
Elizabeth B. DAngelo, PhD<BR>
Zeneca Pharmaceuticals, Inc., USA<BR>
<B><I>Committee</I></B><BR>
Hctor A. Bolaos<BR>
AFAMELA, Mexico<BR>
Robert F. Butz, PhD<BR>
Consultant, USA<BR>
Mary E. Carman<BR>
Drugs Directorate, Canada<BR>
Ann O. Carter, MD<BR>
Canadian Medical Association, Canada<BR>
Win M. Castle, MD, PhD, MFCM<BR>
SmithKline Beecham Pharmaceuticals, USA<BR>
Karen K. Church<BR>
InSite Vision, Inc., USA<BR>
John E. Derry<BR>
Glaxo Wellcome, Canada<BR>
Robert S. Epstein, MD, MS<BR>
Merck-Medco Managed Care, Inc., USA<BR>
Ophelia Espejo<BR>
University of Mexico, Mexico<BR>
Ronald D. Fitzmartin, PhD<BR>
Purdue Pharma L.P., USA<BR>
Professor Jacqueline S. Gardner<BR>
University of Washington, USA<BR>
Cheryl F. Graham, MD<BR>
Biometric Research Institute, USA<BR>
Jerome A. Halperin, MPH<BR>
US Pharmacopeia, USA<BR>
Michael R. Hamrell, PhD<BR>
MORIAH Consultants, USA<BR>
Kiyoshi Hayase, PhD<BR>
Merck Sharp & Dohme, Japan<BR>
Thrse Hlie, PhD<BR>
Sandoz Canada, Inc., Canada<BR>
Raymond L. Herman, MA<BR>
Zeneca Pharmaceuticals, Inc., USA<BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University, USA<BR>
Thomas J. Kirsch<BR>
R. W. Johnson, PRI, USA<BR>
Daryl Krepps<BR>
Drugs Directorate, Canada<BR>
William Leslie<BR>
Canadian Society of Hospital <BR>
Pharmacists, Canada<BR>
Nancy C. MacDonald, PharmD<BR>
McNeil Consumer Products <BR>
Company, Canada<BR>
Iain J. McGilveray, PhD<BR>
Drugs Directorate, Canada<BR>
Elizabeth A. Moench<BR>
MediciGroup<SUP>TM</SUP>, Inc., USA<BR>
Wayne M. Nitchuk, PhD<BR>
Drugs Directorate, Canada<BR>
Rosane Ouellet<BR>
Bristol-Myers Squibb, Canada<BR>
Eleanor M. Perfetto, PhD<BR>
Wyeth-Ayerst Research, USA<BR>
Anita Piergiovanni<BR>
Phoenix International, Canada<BR>
Peter H. Rheinstein, MD, JD<BR>
Food and Drug Administration, USA<BR>
L. Bruce Rowsell, BScPhm<BR>
Drugs Directorate, Canada<BR>
David J. Sabritt, MA<BR>
Immunex Research & Development, USA<BR>
Thomas B. Semler, MBA<BR>
IBRD-ROSTRUM GLOBAL, Inc., USA<BR>
Julie Tam, PharmD<BR>
Canadian Drug Manufacturers Association, Canada<BR>
Anthony R. Temple, MD<BR>
McNeil Consumer Products Company, USA<BR>
Jon R. Wallace<BR>
Genentech, Inc., USA<BR>
Judi Weissinger, PhD<BR>
Weissinger Solutions, Inc., USA<BR>
<P> 
<B>STEERING COMMITTEE 
FOR EUROPE</B><BR>
<B><I>Chairperson</I></B><BR>
Brenton E. James<BR>
Glaxo Wellcome Research & Development, UK<BR>
<B><I>Committee</I></B><BR>
Eric Abadie, PhD<BR>
Agence du Mdicament, France<BR>
Professor Jean-Pierre Bader, PhD<BR>
Agence du Mdicament, France<BR>
Juan Bigorra, PhD<BR>
Sandoz Pharma S.A.E., Spain<BR>
Gerd Bode, PhD<BR>
Roussel Uclaf, France<BR>
Roger G. Bolton, PhD<BR>
Zeneca Pharmaceuticals, Ltd., UK<BR>
Bruce Campbell, PhD<BR>
Servier Research & Development, UK<BR>
Stuart W. Cummings, PhD<BR>
Merck Sharp & Dohme (Europe), Inc., Belgium<BR>
Andrzej Czarnecki, PhD<BR>
Drug Institute, Poland<BR>
Franoise de Crmiers, PhD<BR>
Wyeth-Ayerst EU CR&D, France<BR>
Per P. Helboe, PhD, DSc<BR>
National Board of Health, Denmark<BR>
Professor Jean-Marc Husson, MD, PhD<BR>
Roussel-Uclaf, France<BR>
Ingrid Klingmann, MD, PhD<BR>
Corning Besselaar, Belgium<BR>
Marijke Korteweg, PhD<BR>
Bristol-Myers Squibb International Corporation, Belgium<BR>
N. Peter Maurice, MB, MO, FFPM, PhD<BR>
Intl Consultancies for Human Research Quality Assurance & Harmonisation of Regulatory <BR>QA (ICHRQA), Switzerland<BR>
Noriaki Murao, MS<BR>
Otsuka Pharmaceutical Co. Ltd., Germany<BR>
Per Tomas Salmonson, PhD<BR>
Medical Products Agency, Sweden<BR>
Barbara Sickmller, PhD<BR>
Bundesverband der Pharmazeutischen Industrie e.V., Germany<BR>
Rolf Spang, PhD<BR>
Intercantonal Office for the Control of Medicines (IOCM/IKS), Switzerland<BR>
Willem F. van der Giesen, PhD, PharmD<BR>
Medicines Evaluation Board,<BR>
The Netherlands<BR>
<P>
<B><I>DIA EUROPEAN ADMINISTRATOR</I></B><BR>
Alex Anderson, MRPharm, AUA<BR>
Basel, Switzerland<BR>
<P> 
<B> STEERING COMMITTEE FOR SOUTHWEST ASIAN PACIFIC</B><BR>
<B><I>Chairperson</I></B><BR>
Rodney C. Hall, PhD<BR>
Astra Pharmaceuticals Pty. Ltd., Australia<BR>
<B><I>Committee</I></B><BR>
John Dowden<BR>
Australian Prescriber, Australia<BR>
Laurence Fong, MSc, MHP<BR>
Merck Sharpe & Dohme, Australia<BR>
Susan Hill<BR>
Newcastle Mater Hospital, Australia<BR>
Deborah Monk<BR>
APMA, Australia<BR>
Professor Gillian Shenfield<BR>
Royal North Shore Hospital, Australia<BR>
Anthea Steans<BR>
The Boots Company (Aus) <BR>
Pty. Ltd., Australia<BR>
Chris J. Wicks<BR>
Roche Products Pty. Ltd., Australia<BR>
Andrew Wood<BR>
Therapeutic Goods Administration<BR>
Drug Safety and Evaluation, Australia<BR>
 <P>
<B><I>DIA SOUTH WEST ASIAN PACIFIC ADMINISTRATOR</I></B><BR>
David Addison<BR>
Annandale NSW, Australia<BR>
<P>
<B>STEERING COMMITTEE FOR INTERNATIONAL DEVELOPMENT</B><BR>
<B><I>Chairperson</I></B><BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc., USA<BR>
<B><I>Committee</I></B><BR>
Win M. Castle, MD, PhD, MFCM<BR>
SmithKline Beecham Pharmaceuticals, USA<BR>
Teresa P. Dowling, PharmD<BR>
DuPont Merck Pharmaceuticals, USA<BR>
Brenton E. James<BR>
Glaxo Wellcome Research & Development, UK<BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University, USA<BR>
N. Peter Maurice, MB, MO, FFPM<BR>
ICHRQA, Switzerland<BR>
Mary Doug Tyson, MS<BR>
Food and Drug Administration, USA<BR>
 <P>
<B>CME COMMITTEE</B><BR>
<B><I>Chairperson</I></B><BR>
David A. Shapiro, MB ChB, MRCP<BR>
Scripps Clinic, USA<BR>
<B><I>Committee</I></B><BR>
John C. Alexander, MD, MPH<BR>
G. D. Searle & Company, USA<BR>
Grant P. Bagley, MD<BR>
Health Care Financing Administration, USA<BR>
Lynn A. Bosco, MD, MPH<BR>
AHCPR, USA<BR>
Louis R. Cantilena, MD<BR>
USUHS, USA<BR>
Scott D. Clark, MD<BR>
Longmont Medical Research Network, USA<BR>
Bernard S. Coleman, MD<BR>
Pharmacia & Upjohn, Inc., USA<BR>
Terrance C. Coyne, MD<BR>
Medeva Americas, Inc., USA<BR>
Jan I. Drayer, MD<BR>
Somatix Therapy Corporation, USA<BR>
Roy Fleischmann, MD<BR>
Metroplex Clinical Research Center, USA<BR>
George M. Gill, MD<BR>
Ligand Pharmaceuticals, USA<BR>
George S. Goldstein, MD<BR>
Pharmaceutical Development Corporation, USA<BR>
Daniel B. Goodman, MD<BR>
GDXI, Inc., USA<BR>
Cheryl F. Graham, MD<BR>
Biometric Research Institute, USA<BR>
Harry A. Guess, MD, PhD<BR>
Merck Research Laboratories, USA<BR>
Frederick H. Hausheer, MD<BR>
BioNumerik Pharmaceuticals, USA<BR>
Marc L. Hoffman, MD<BR>
MEDEX, Inc., USA<BR>
Peter K. Honig, MD<BR>
Food and Drug Administration, USA<BR>
Jean-Marc Husson, MD, PhD<BR>
Roussel-Uclaf, France<BR>
Gary G. Ingenito, MD, PhD<BR>
Otsuka America Pharmaceutical, USA<BR>
Louis C. Kirby, MD<BR>
Medici Research, USA<BR>
Sheila N. Linder, MD<BR>
Linder International, Inc., USA<BR>
Robert A. Mathews, MD<BR>
Merck Research Laboratories, USA<BR>
Joyce D. Moscaritola, MD<BR>
Ciba-Geigy, USA<BR>
Thomas J. Newman, MD<BR>
Corning Besselaar, USA<BR>
Peter H. Rheinstein, MD, JD<BR>
Food and Drug Administration, USA<BR>
Robert H. Rubin, MD<BR>
Harvard University/MIT, USA<BR>
Malcolm J. Sperling, MD<BR>
Edinger Medical Group, Inc., USA<BR>
Patricia E. Stewart, MD<BR>
McNeil Consumer Products Company, USA<BR>
Randall R. Stoltz, MD<BR>
GRI Pharmaceutical Services, USA<BR>
Herbert Swarz, MD<BR>
Intl. Pharmaceutical Consulting, Inc., USA<BR>
Wesley Mark Todd, MD<BR>
Pharmacia & Upjohn, Inc., USA<BR>
Edward L. Zimney, MD<BR>
Immunex Corporation, USA<BR>
<P>


       </TD>
		      <TD VALIGN=TOP>



<P>
<B>DRUG INFORMATION JOURNAL</B><BR>
<B><I>Editor-in-Chief</I></B><BR>
Thomas W. Teal<BR>
<B><I>Editorial Board     Term ends 12/31/97</I></B><BR>
Joseph R. Assenzo, PhD<BR>
Drug Information Association<BR>
Christy Chuang-Stein, PhD<BR>
Pharmacia & Upjohn, Inc.<BR>
Wayne A. Colburn, PhD<BR>
Harris Laboratories<BR>
Roger W. Croswell, PhD<BR>
Boehringer-Ingelheim, Ltd.<BR>
Elizabeth B. DAngelo, PhD<BR>
Zeneca Pharmaceuticals, Inc.<BR>
Robert C. de Groof, PhD<BR>
Keystone Regulatory Associates<BR>
Joseph A. DiMasi, PhD<BR>
Tufts University<BR>
Jan I. Drayer, MD<BR>
Somatix Therapy Corporation<BR>
Raymond L. Herman<BR>
Zeneca Pharmaceuticals, Inc.<BR>
Ludwig A. Hothorn, PhD<BR>
University of Hannover, Germany<BR>
Arthur I. Jacknowitz, PharmD<BR>
West Virginia University<BR>
Vaila M. Marshall<BR>
Pfizer Ltd.<BR>
Todd D. McIntyre, PhD<BR>
Janssen Research Foundation<BR>
Joseph A. Meschino, PhD<BR>
National Institutes of Health<BR>
John R. Schultz, PhD<BR>
Consultant<BR>
Gary T. Shearman, PhD<BR>
Rhne-Poulenc Rorer<BR>
Sheila R. Shulman, LLB, MPH<BR>
Tufts University<BR>
Mary Doug Tyson, MS<BR>
Food and Drug Administration<BR>
Daniel E. Worden<BR>
Price Waterhouse L.L.P.<BR>
<P><B><I>Term ends 12/31/98</I></B><BR>
Shein-Chung Chow, PhD<BR>
Bristol-Myers Squibb Company<BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.<BR>
Thomas L. Copmann, PhD<BR>
Eli Lilly and Company<BR>
Charles F. Curran, PhD<BR>
Fujisawa USA, Inc., USA<BR>
Charles C. Depew, PharmD<BR>
SmithKline Beecham <BR>
Elizabeth M. Factor, PhD<BR>
Concorde Clinical Research, Inc.<BR>
Michael R. Hamrell, PhD<BR>
MORIAH Consultants<BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University<BR>
Thomas J. Kirsch<BR>
R. W. Johnson, PRI<BR>
Gary G. Koch, PhD<BR>
University of North Carolina<BR>
Richard T. Layer, PhD<BR>
National Institutes of Health<BR>
Morgan Little, PhD<BR>
OML Associates<BR>
Vincent Mattaliano, Jr.<BR>
Roche Laboratories<BR>
Loren L. Miller, PhD<BR>
Quintiles, Inc.<BR>
Louis A. Morris, PhD<BR>
Food and Drug Administration<BR>
Patricia E. Stewart, MD<BR>
McNeil Consumer Products Company<BR>
Bradley S. Stolshek, PharmD<BR>
Hoffmann-La Roche<BR>
Russell J. Taylor, PhD<BR>
Bayer Corporation<BR>
Madhu C. Trivedi, PhD<BR>
MGI Pharma, Inc.<BR>
Michael J. Umen, PhD<BR>
Michael Umen & Company<BR>
 <P>
<B>FINANCE COMMITTEE</B><BR>
Peggy Gerencser<BR>
Bristol-Myers Squibb, PRI<BR>
Kenneth B. Leahey<BR>
R. W. Johnson, PRI<BR>
John Papa<BR>
Johnson & Johnson Corporate<BR>
Dana D. Rife<BR>
Johnson & Johnson Services<BR>
Tom Zaher, CPA<BR>
Consultant/Advisor<BR>
<P> 
<B>FELLOWSHIP COMMITTEE</B><BR>
William Beaver, PhD<BR>
Georgetown University<BR>
Paula Botstein, MD<BR>
Food and Drug Administration<BR>
Louis A. Morris, PhD<BR>
Food and Drug Administration<BR>
Robert C. Nelson, PhD<BR>
Food and Drug Administration<BR>
Paul Stolley, MD<BR>
University of Maryland<BR>
Raymond Woosley, MD, PhD<BR>
Georgetown University<BR>
<P> 
<B>GRANTS AND AWARDS COMMITTEE</B><BR>
<B><I>Chairperson</I></B><BR>
Louis A. Morris, PhD<BR>
Food and Drug Administration<BR>
Roger G. Bolton, PhD<BR>
Zeneca Pharmaceuticals, Ltd., UK<BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.<BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University<BR>
Susan L. McLaughlin<BR>
R. W. Johnson, PRI<BR>
Thomas W. Teal<BR>
Drug Information Association<BR>
Mary Doug Tyson, MS<BR>
Food and Drug Administration<BR>
Judi Weissinger, PhD<BR>
Weissinger Solutions, Inc.<BR>
<P> 
<B>NOMINATING COMMITTEE</B><BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.<BR>
John J. Donahue, PhD<BR>
Bristol-Myers Squibb Company<BR>
Kenneth I. Kaitin, PhD<BR>
Tufts University<BR>
<P> 
<B>TRAINING COURSE COMMITTEE</B><BR>
<B><I>Chairperson</I></B><BR>
Susan L. McLaughlin<BR>
R. W. Johnson, PRI<BR>
Karen K. Church<BR>
InSite Vision, Inc.<BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.<BR>
Elizabeth B. DAngelo, PhD<BR>
Zeneca Pharmaceuticals, Inc.<BR>
Gerald A. Faich, MD, MPH<BR>
Outcomes Research Corporation<BR>
Brenton E. James<BR>
Glaxo Wellcome Research & Development, UK<BR>
Ronald G. Leonardi, PhD<BR>
R & R Registrations<BR>
Karen E. Woodin, PhD<BR>
Pharmacia & Upjohn, Inc.<BR>
 <P>
<B>COURSE FACULTIES</B><BR>
<P><B><I>Clinical Research Associate</I></B><BR>
Karen K. Church<BR>
InSite Vision, Inc.<BR>
David M. Cocchetto, PhD<BR>
Glaxo Wellcome, Inc.<BR>
Elizabeth B. DAngelo, PhD<BR>
Zeneca Pharmaceuticals, Inc.<BR>
Isabel B. Drzewiecki<BR>
R. W. Johnson, PRI<BR>
Jerry D. Johnson, PhD<BR>
Fujisawa Pharmaceuticals<BR>
Lauren M. Kelley<BR>
Boehringer Mannheim<BR>
Ronald G. Leonardi, PhD<BR>
R & R Registrations<BR>
Ronald G. Montgomery<BR>
Pharmacia & Upjohn, Inc.<BR>
Mary Bernadette Ott<BR>
Consultant<BR>
Alan F. Sewell, PhD<BR>
Consultant<BR>
Mary Jane Silvey, MBA<BR>
Glaxo Wellcome, Inc.<BR>
Bruce M. Wagman, RN, BSN, MBA<BR>
Astra USA<BR>
Kevin Darryl White<BR>
Glaxo Wellcome, Inc.<BR>
Karen E. Woodin, PhD<BR>
Pharmacia & Upjohn, Inc.<BR>

<P><B><I>Advanced Clinical</I></B><BR>
<B><I>Research Associate</I></B><BR>
George H. DAddamio, PhD<BR>
PharmConsult, Inc.<BR>
Nadene K. Hausmann<BR>
Consultant<BR>
James P. McCafferty<BR>
SmithKline Beecham<BR>
R. William Mounce, MEd<BR>
MEDEX<BR>
Axel K. Olsen, PhD<BR>
Wyeth-Ayerst Laboratories<BR>
Patrice H. Pompa<BR>
SmithKline Beecham Pharmaceuticals<BR>
<P> 
<B><I>Drug Safety Surveillance Course</I></B><BR>
Gerald A. Faich, MD, MPH<BR>
Outcomes Research Corporation<BR>
Garth K. Graham, MD<BR>
Consultant<BR>
Linda S. Hostelley<BR>
Merck Research Laboratories<BR>
Annette Stemhagen, DrPH<BR>
Janssen Research Foundation<BR>

<P><B><I>GCP Compliance Auditing Course</I></B><BR>
Marijke Korteweg, PhD<BR>
Bristol-Myers Squibb Company, Belgium<BR>
Sheila N. Linder, MD<BR>
Hoffmann-La Roche AG, Switzerland<BR>
Elisabeth Poy, PhD<BR>
Sanofi Recherche, France<BR>
 
<P><B><I>Investigational Supply Process Course</I></B><BR>
David F. Bernstein, PhD<BR>
Cato Research Ltd.<BR>
Frank J. Tiano, RPh<BR>
McNeil Consumer Products Company<BR>
Martin L. Jeiven, MS<BR>
Martin L. Jeiven & Associates, Inc.<BR>
Klaus Kehne, PhD<BR>
Boehringer Mannheim GmbH<BR>
 
<P><B><I>Regulatory Training <BR>
Course I:</I></B><BR>
<B><I>The Investigational </I></B><BR>
<B><I>New Drug Phase</I></B><BR>
John F. Bedard, MS<BR>
Bristol-Myers Squibb Company<BR>
Elliott T. Berger, PhD<BR>
Astra/Merck Group<BR>
Karen K. Church<BR>
InSite Vision, Inc.<BR>
Isabel B. Drzewiecki<BR>
R. W. Johnson, PRI<BR>
Jerry D. Johnson, PhD<BR>
Fujisawa Pharmaceuticals<BR>
Ronald G. Leonardi, PhD<BR>
R & R Registrations<BR>
Benjamin J. Marafino, Jr., PhD<BR>
Consultant<BR>
Loren L. Miller, PhD<BR>
Quintiles, Inc.<BR>
Ruth Wikberg-Leonardi<BR>
R & R Registrations<BR>
 
<P><B><B><I>Regulatory Training <BR>
Course II:</I></B></B><BR>
<B><I>The New Drug Application Phase</I></B><BR>
John F. Bedard, MS<BR>
Bristol-Myers Squibb Company<BR>
Elliott T. Berger, PhD<BR>
Astra/Merck Group<BR>
Karen K. Church<BR>
InSite Vision, Inc.<BR>
Jerry D. Johnson, PhD<BR>
Fujisawa Pharmaceuticals<BR>
Ronald G. Leonardi, PhD<BR>
R & R Registrations<BR>
Loren L. Miller, PhD<BR>
Quintiles, Inc.<BR>
Michael C. Powanda, PhD<BR>
M/P Biomedical Consultant<BR>

</TABLE>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-80</DOCNO>
<DOCOLDNO>IA050-000869-B025-69</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp3a.htm 199.92.136.137 19970111134049 text/html 9176
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:42:30 GMT
Last-modified: Thursday, 03-Oct-96 14:53:12 GMT
Content-length: 8984
Content-type: text/html
</DOCHDR>
<!doctype HTML SYSTEM "html.dtd">
<HTML>
<HEAD>
<TITLE>Membership Application</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#30lafa" vlink= "551a8b">
<HREF="http://wwwbbnplanet.com">
<CENTER><IMG BORDER=0 SRC="dia.gif"></CENTER>
<HR>
<P>
<CENTER><TABLE>
<TR><TH ALIGN=MIDDLE><FONT SIZE=2>Drug Information Association <BR>321 Norristown Road, Suite 225,<BR>Ambler, PA,
19002-2755</FONT><BR>
<FONT SIZE=2>Tel. +1-215-628-2288, Fax. +1-215-641-1229</FONT><BR><A HREF="mailto:dia@diahome.org">  dia@diahome.org</A></TH><TH><FONT SIZE=2>or, for Europe, DIA, Postfach 4012,<BR>Basel,
Switzerland</FONT><BR>
<FONT SIZE=2>Tel. +41 61 382 90 19, Fax. +41 61 382 90
50<BR></FONT>
<FONT SIZE=2>&copy; Drug Information Association 1996<BR></FONT><A HREF="mailto:diaeurope@stepnet.de">diaeurope@stepnet.de</A></TH></TR>
</TABLE></CENTER>
<P>
<HR>

MEMBERSHIP<BR>

<P>
<CENTER><STRONG> MEMBERSHIP APPLICATION</STRONG></CENTER><BR>

<P><HR>
Individuals wishing to join the Drug Information Association may
use a copy of this page as the application blank. Simply fill
out the form and mail it with the membership fee of $65.00 to:
<P>
<CENTER><B>Drug Information Association<BR>
P.O. Box 7777-W8405,<BR> Philadelphia, PA 19175, USA</B><P></CENTER>
Payment must be made in US dollars. Do not send cash. Checks must be drawn on a US Bank payable to: Drug Information Association. The DIA encourages you to use your credit card to facilitate payment.
<P>
If a credit card is used to pay the membership fee, simply fill out the form on-line and email it to the DIA Office - or, fill it out on-line, print out the form, and fax it to the DIA Office. If a credit card is not used, print out the form and mail the completed form to the DIA office with the membership fee of $65.00 to:<BR>


<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">


<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var1">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var2" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var3" >
       Company:   <input type="text" size="30" maxlength="256"
name="var4" >
       Address:   <input type="text" size="30" maxlength="256"
name="var5" >
          City:   <input type="text" size="30" maxlength="256"
name="var6">
         State:   <input type="text" size="30" maxlength="256"
name="var7">
       Country:   <input type="text" size="30" maxlength="256"
name="var8">
           Zip:   <input type="text" size="30" maxlength="10"
name="var9">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var10">
Internet Address: <input type="text" size="30" maxlength="256"
name="var11">
           FAX:   <input type="text" size="30" maxlength="256"
name="var12">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var13">
</CENTER>
<UL>
<INPUT TYPE="radio" NAME="var14" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var14" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var14" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var15">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var16"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."


<HR>




<CENTER><B><FONT SIZE=2>Primary Professional Interest Areas</FONT></B><BR>
<FONT SIZE=2>(Select up to four and number according  to interest)</CENTER>
<BR>
</FONT>
<P>
<INPUT NAME="var17" TYPE="CHECKBOX" VALUE="Adverse Experience Monitoring" ALIGN=left><FONT SIZE=2> Adverse Experience Monitoring</FONT><BR>

<INPUT NAME="var18" TYPE="CHECKBOX" VALUE="Alternative Medicine" ALIGN=left><FONT SIZE=2> Alternative Medicine</FONT><BR>

<INPUT NAME="var19" TYPE="CHECKBOX" VALUE="Biotechnology" ALIGN=left><FONT SIZE=2> Biotechnology</FONT><BR>

<INPUT NAME="var20" TYPE="CHECKBOX" VALUE="Clinical Data Management" ALIGN=left><FONT SIZE=2> Clinical Data Management  (Clinical
/ CANDA / CAPLA / Validation)</FONT><BR>

<INPUT NAME="var21" TYPE="CHECKBOX" VALUE="Chemistry / Drug Design" ALIGN=left><FONT SIZE=2> Chemistry / Drug Design</FONT><BR>

<INPUT NAME="var22" TYPE="CHECKBOX" VALUE="Clinical Laboratory Data" ALIGN=left><FONT SIZE=2> Clinical Laboratory Data
</FONT><BR>

<INPUT NAME="var23" TYPE="CHECKBOX" VALUE="Clinical Research / GCP" ALIGN=left><FONT SIZE=2> Clinical Research / GCP</FONT><BR>

<INPUT NAME="var24" TYPE="CHECKBOX" VALUE="Dictionaries" ALIGN=left><FONT SIZE=2> Dictionaries</FONT><BR>

<INPUT NAME="var25" TYPE="CHECKBOX" VALUE="Devices" ALIGN=left><FONT SIZE=2> Devices</FONT><BR>

<INPUT NAME="var26" TYPE="CHECKBOX" VALUE="Document Management / Information Technology / Communications" ALIGN=left><FONT SIZE=2> Document Management / Information Technology / Communications</FONT><BR>

<INPUT NAME="var27" TYPE="CHECKBOX" VALUE="GLP (Laboratories)" ALIGN=left><FONT SIZE=2> GLP (Laboratories)
</FONT><BR>

<INPUT NAME="var28" TYPE="CHECKBOX" VALUE="GMP (Manufacturing & Technology)" ALIGN=left><FONT SIZE=2> GMP (Manufacturing & Technology)</FONT><BR>

<INPUT NAME="var29" TYPE="CHECKBOX" VALUE="Health Economics / Outcomes Research" ALIGN=left><FONT SIZE=2> Health Economics / Outcomes Research</FONT><BR>

<INPUT NAME="var30" TYPE="CHECKBOX" VALUE="Information Management" ALIGN=left><FONT SIZE=2> Information Management</FONT><BR>

<INPUT NAME="var31" TYPE="CHECKBOX" VALUE="Legal Affairs / Law" ALIGN=left><FONT SIZE=2> Legal Affairs / Law</FONT><BR>

<INPUT NAME="var32" TYPE="CHECKBOX" VALUE="Medical Communications / Information" ALIGN=left><FONT SIZE=2> Medical Communications / Information</FONT><BR>

<INPUT NAME="var33" TYPE="CHECKBOX" VALUE="Managed Healthcare" ALIGN=left><FONT SIZE=2> Managed Healthcare</FONT><BR>

<INPUT NAME="var34" TYPE="CHECKBOX" VALUE="Manufacturing - Chemical & Pharmaceutical Packaging" ALIGN=left><FONT SIZE=2> Manufacturing - Chemical & Pharmaceutical Packaging</FONT><BR>

<INPUT NAME="var35" TYPE="CHECKBOX" VALUE="Over the Counter" ALIGN=left><FONT SIZE=2> Over the Counter</FONT><BR>

<INPUT NAME="var36" TYPE="CHECKBOX" VALUE="Pharmaceutics / Clinical Supplies" ALIGN=left><FONT SIZE=2> Pharmaceutics / Clinical Supplies
</FONT><BR>

<INPUT NAME="var37" TYPE="CHECKBOX" VALUE="Pharmacoepidemiology" ALIGN=left><FONT SIZE=2> Pharmacoepidemiology</FONT><BR>

<INPUT NAME="var38" TYPE="CHECKBOX" VALUE="Pharmacology" ALIGN=left><FONT SIZE=2> Pharmacology</FONT><BR>

<INPUT NAME="var39" TYPE="CHECKBOX" VALUE="Pharmacokinetics / Metabolism" ALIGN=left><FONT SIZE=2> Pharmacokinetics / Metabolism</FONT><BR>

<INPUT NAME="var40" TYPE="CHECKBOX" VALUE="Project Management / Finance" ALIGN=left><FONT SIZE=2> Project Management / Finance</FONT><BR>

<INPUT NAME="var41" TYPE="CHECKBOX" VALUE="Quality Control / Quality Assurance" ALIGN=left><FONT SIZE=2> Quality Control / Quality Assurance</FONT><BR>

<INPUT NAME="var42" TYPE="CHECKBOX" VALUE="Regulatory Affairs / Drug Approval" ALIGN=left><FONT SIZE=2> Regulatory Affairs / Drug Approval</FONT><BR>

<INPUT NAME="var43" TYPE="CHECKBOX" VALUE="Research & Development" ALIGN=left><FONT SIZE=2> Research & Development</FONT><BR>

<INPUT NAME="var44" TYPE="CHECKBOX" VALUE="Statistics / Biostatistics" ALIGN=left><FONT SIZE=2> Statistics / Biostatistics
Assurance</FONT><BR>

<INPUT NAME="var45" TYPE="CHECKBOX" VALUE="Technology" ALIGN=left><FONT SIZE=2> Technology
</FONT><BR>

<INPUT NAME="var46" TYPE="CHECKBOX" VALUE="Training" ALIGN=left><FONT SIZE=2> Training</FONT><BR>

</FONT>
<P>
<FONT SIZE=2>DIA dues may be deducted as a business expense. Payment
received after July 30, 1997 will be applied to 1998 membership,
unless otherwise requested.
</FONT>
<P>
<FONT SIZE=2>Please add your recommendations for workshops and
training programs. Also, for your recommended programs please
indicate whether you would like to participate as a speaker or
member of a program committee.
</FONT>
<P>
<B><FONT SIZE=2>Program Suggestions Committee Speaker
</FONT></B>
<P>
<FONT SIZE=2>1.</FONT><input name="var47" type="text" size="70" maxlength="70">
<P>
<INPUT NAME="var48" TYPE="radio"  VALUE="Committee">Committee
<INPUT NAME="var48" TYPE="radio" VALUE="Speaker">Speaker
<P>
<FONT SIZE=2>2.</FONT><input name="var49" type="text" size="70" maxlength="70">
<P>
<INPUT NAME="var50" TYPE="radio"  VALUE="Committee">Committee
<INPUT NAME="var50" TYPE="radio" VALUE="Speaker">Speaker
<P>

    <p><input type="submit" value="Submit"> <input type="reset"
    value="Clear Form"></p>

</form>









</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-81</DOCNO>
<DOCOLDNO>IA050-000869-B025-97</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp3b.htm 199.92.136.137 19970111134058 text/html 1121
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:42:38 GMT
Last-modified: Tuesday, 23-Jul-96 17:02:39 GMT
Content-length: 931
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Benefits</TITLE>

</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>

 <UL>MEMBERSHIP</UL>
<P>
  <CENTER><STRONG>BENEFITS OF MEMBERSHIP</STRONG></CENTER>
<P><HR>
<CENTER><B>The Quarterly</B> <I><B>Drug Information Journal</B></I><BR>
($25 of the annual membership fee is for a year's subscription)
<P>
<B>The Quarterly</B> <I><B>DIA Newsletter</B></I><BR>
($20 of the annual membership fee is for a year's subscription)
<P>
<B>The Annual DIA Membership Directory</B><BR>
(a $100.00 value)
<P>
<B>Reduced Rates on Registration at DIA Workshops and Training
Programs</B><BR>
(a $65.00 value per program)
<P>
<B>Pharmaceutical/Biotech Contract Support Organization (PCSO)
Register</B><BR>
(a $75.00 value)</CENTER>
<P>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-82</DOCNO>
<DOCOLDNO>IA050-000869-B025-133</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp3c.htm 199.92.136.137 19970111134218 text/html 1240
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:43:44 GMT
Last-modified: Tuesday, 23-Jul-96 17:02:36 GMT
Content-length: 1049
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>About the Members</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

<P>
MEMBERSHIP
<P>
<CENTER><STRONG>ABOUT THE MEMBERS</STRONG></CENTER>
<P><HR>
<B>Multi-Disciplinary, International Representation</B>
<P>
The Drug Information Association was founded in 1964 as a non-profit
scientific organization. Starting with a small group of 30 professionals,
the DIA has grown to an international organization with over 13,000
members which includes a large North American, European, Scandinavian,
Australian and Japanese membership. Many other countries have
DIA members. This constituency of personnel from health care companies,
academic institutions and government regulatory agencies is involved
in the full range of new drug and application development - discovery,
development, evaluation, regulation, surveillance and marketing.
<P>
<HR>
<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-83</DOCNO>
<DOCOLDNO>IA050-000869-B025-167</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4a.htm 199.92.136.137 19970111134236 text/html 3495
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:44:14 GMT
Last-modified: Tuesday, 19-Nov-96 21:35:15 GMT
Content-length: 3304
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Annual Meetings</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

<P>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> 1997 ANNUAL MEETING</STRONG></CENTER>
<P><HR>
<CENTER><B>33rd ANNUAL MEETING</B><BR>
<I><B>Optimizing Pharmaceutical Development: <BR>
The Global Experience</B></I>
<P>
<B>22-26 June, 1997</B><BR>
<B>Palais des Congrs de Montral, Montral, Quebec, Canada</B>
<P>
<I><B>Program Chairperson: </B></I><BR>
<B>Irwin G. Martin, PhD, </B>
<B>Parke-Davis</B></CENTER>
<P>
<CENTER><I><B>Keynote Presentation: </B></I><BR>
<B>Dann M. Michols, </B>
<B>Director General, Drugs Directorate, Health Canada</B></CENTER>
</CENTER><BR>
<HR>
<B>SCIENTIFIC EXHIBITS</B>
<P>
There will be over 300 exhibit booths at this meeting. The exhibit
area will provide attendees and exhibitors an opportunity
to view material and products that are designed to increase the
effectiveness and efficiency of the Pharmaceutical Development
and Registration process. The exhibit area will also serve as
the site of coffee breaks, luncheons, and social functions.
<P>
<HR>
<B>POSTER AND SCIENTIFIC/ACADEMIC TECHNOLOGY SESSION</B>
<P>
An area has been set aside to provide certain attendees with an
opportunity to exhibit scientific developments associated with
the Pharmaceutical Development and Registration Process. This
&quot;Poster Board&quot; session will take place Tuesday, June
24, in the Exhibit Hall. If you are interested in presenting a
poster, please contact the Poster Session Chairperson, Cheryl
Weinrich, Rh&ocirc;ne-Poulenc Rorer at telephone +1 610 454 8129
or telefax +1 610 454 8107. <STRONG><EM>The poster deadline is April 21, 1997.</EM></STRONG><P>
<HR>
<B>DICTIONARY USERS GROUPS MEETING: COSTART, WHO/ART AND WHO DRUG</B>
<P>
The COSTART, WHO/ART and WHO Drug Dictionary User Groups' meeting will
again be scheduled at this Annual Meeting.
<P>
<HR>
<B>TUTORIALS</B>
<P>
On Sunday, June 22, there will be a variety of tutorials offered
for your interest and training. Detailed information regarding
these tutorials will be included in the preliminary program which
will be mailed to the membership in early March, 1997.
<P>
<HR>
<B>NETWORKING DINNER</B>
<P>
DIA is continuing the tradition of our successful Networking Dinner
which offers attendees the opportunity to meet with peers from
the industry. Dinner, followed by a dessert reception, will take
place on Sunday evening, June 22, 1997.
<P>
<HR>
<CENTER><A HREF="dhp2.htm"><IMG  BORDER=0 SRC="about.gif"></A><A HREF="dhp3.htm"><IMG BORDER=0 SRC="member.gif"></A><A HREF="dhp5b2.htm"><IMG BORDER=0 SRC="recent.gif"><A HREF="dhp4.htm"><IMG BORDER=0 SRC="upcom.gif"></A><A HREF="dhp5.htm"><IMG BORDER=0 SRC="public.gif"></A><A HREF="dhp6.htm"><IMG BORDER=0 SRC="awards.gif"></A><A HREF="dhp7.htm"><IMG BORDER=0 SRC="fellow.gif"><A HREF="dhp8.htm"><BR><IMG BORDER=0 SRC="conted.gif"><A HREF="dhp9.htm"><IMG BORDER=0 SRC="dianews.gif"><A HREF="dhp10.htm"><IMG BORDER=0 SRC="infocen.gif"></A><A HREF="dhp11.htm"><IMG BORDER=0 SRC="personal.gif"></A><A HREF="dhp12.htm"><IMG BORDER=0 SRC="message.gif"></A><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-84</DOCNO>
<DOCOLDNO>IA050-000869-B025-206</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4c.htm 199.92.136.137 19970111134315 text/html 1247
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:44:50 GMT
Last-modified: Monday, 23-Sep-96 14:36:55 GMT
Content-length: 1057
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Workshops & Training Programs</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
UPCOMING MEETINGS
<P>
<CENTER><STRONG>WORKSHOPS/TRAINING PROGRAMS</STRONG></CENTER>
<P>
<HR>
<UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp4c1.htm"> ALL MEETINGS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp4c2.htm"> MEETINGS IN THE AMERICAS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp4c3.htm"> MEETINGS IN EUROPE</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp4c4.htm"> MEETINGS IN JAPAN, SOUTH WEST PACIFIC, ELSEWHERE</A>
<P></UL>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>








<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50<BR>
Drug Information Association 1996</CENTER>




</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-85</DOCNO>
<DOCOLDNO>IA050-000869-B025-237</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a.htm 199.92.136.137 19970111134329 text/html 2570
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:45:09 GMT
Last-modified: Thursday, 19-Dec-96 20:27:28 GMT
Content-length: 2378
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<HR>
<UL>
<A HREF="dhp5b2a1.htm"> <LI>Medical Approach in Diagnosis and Management of Adverse Drug Reactions<BR></A>
<A HREF="dhp5b2a2.htm"> <LI>Clinical Trials and GCP in East Asia<BR></A>
<A HREF="dhp5b2a3.htm"> <LI>3rd Annual Bistatistics Meeting in Tokyo, Japan<BR></A>
<A HREF="dhp5b2a4.htm"> <LI>Monitoring Drug Safety in "Third Party" Joint Projects<BR></A>
<A HREF="dhp5b2a5.htm"> <LI>Regulatory and Practical Issues on New Drug, New Dosage Form and Generic Drug Development<BR></A>
<A HREF="dhp5b2a6.htm"> <LI>Drug Compliance Issues in Clinical Trials and Patient Care<BR></A>
<A HREF="dhp5b2a7.htm"> <LI>Global CMC (Chemistry, Manufacturing & Controls): Challenges for the 21st Century<BR></A>
<A HREF="dhp5b2a8.htm"> <LI>Immunotoxicity of Pharmaceuticals<BR></A>
<A HREF="dhp5b2a9.htm"> <LI>Crisis Management in the Pharmaceutical Industry<BR></A>
<A HREF="dh5b2a10.htm"> <LI>First DIA Meeting on Regulatory Efficiency<BR></A>
<A HREF="dh5b2a11.htm"> <LI>Clinical Interpretation Issues in Laboratory Data and New Technologies<BR></A>
<A HREF="dh5b2a12.htm"> <LI>Current Situation and Perspectives on Non-Prescription Herbal Medicines<BR></A>
<A HREF="dh5b2a13.htm"> <LI>Practical GCP Compliance Auditing of Trials & Systems<BR></A>
<A HREF="dh5b2a14.htm"> <LI>The Notice to Applicants: Latest Revisions<BR></A>
<A HREF="dh5b2a15.htm"> <LI>Real World Studies of Treatment Outcomes<BR></A>
<A HREF="dh5b2a16.htm"> <LI>The First Joint CDER/CBER Pharmaceutical Industry Workshop:<BR>
Proposed Interim Guidance for Electronic Submission of Case Report Forms and Tabulations<BR></A>
<A HREF="dh5b2a17.htm"> <LI>3rd DIA Sponsored Workshop on Case Report Form Design<BR></A>
<A HREF="dh5b2a18.htm"> <LI>Clinical Data Management<BR></A>
<A HREF="dh5b2a19.htm"> <LI>Regulatory Affairs in the European Union & United States: <BR>
An Introduction for Newcomers to Regulatory Affairs and Non-Regulatory Personnel<BR></A>
<A HREF="dh5b2a20.htm"> <LI>Towards a Common Clinical Data Documentation<BR></A>
</UL>

<HR>
<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-86</DOCNO>
<DOCOLDNO>IA050-000869-B025-267</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ4.htm 199.92.136.137 19970111134340 text/html 2297
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:45:22 GMT
Last-modified: Wednesday, 04-Sep-96 12:54:00 GMT
Content-length: 2104
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Employment Information</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H2>How to post a position.</H2></CENTER>
<P>
The DIA is a non-profit scientific association with over 14,000 members, serving the worldwide pharmaceutical industry. We are pleased to inform both applicants and employers of the positions listed under "Employment Information." 
<P>
That section of this home page lists positions desired and positions available. 
<P>
There is no charge for this service. 
<P>
The DIA reserves the right to edit or reject material submitted for posting on these pages.
<P>
Positions desired or available will be assigned a "control number" and a "date of posting" and posted in the appropriate listing. 
<P>
Positions will be posted for about 60 days. The posting will be deleted after the 60 day period. Please give the DIA about 5 working days to post the material.
<P>
<B>To post a position available</B>, send an email message (which identifies the
sender) to jobs@diahome.org. If email is not available, send a fax to Carol
Layer at the DIA, 215 641-1229. Please provide the following information:
Position title, Brief Position Description, Name of company person to
contact, Company name, Address, Telephone number, Fax number, and email
address. The approximate length of the position description should be 50 to
100 words.

<P>
<B>To post a position wanted</B>, send an email message (which identifies the
sender) to jobs@diahome.org. If email is not available, send a fax to Carol
Layer at the DIA, 215 641-1229. Please provide the following information: A
brief description of the position wanted and your experience. (Please include
your Name, Address, Telephone, Fax numbers and your email address. This
personal information will not appear in the listing. It will be used to
forward your name and address to employers contacting the DIA in response to
your ad.)



<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-87</DOCNO>
<DOCOLDNO>IA050-000869-B025-291</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ2.htm 199.92.136.137 19970111134350 text/html 1876
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:45:31 GMT
Last-modified: Friday, 03-Jan-97 19:28:50 GMT
Content-length: 1686
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Employment Information</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H3>Positions Desired</H3></CENTER>
<P>
<UL>
<A HREF="employ/w903.htm"><LI>   W903,   11/11/96   Clinical Research Manager</A>
<A HREF="employ/w904.htm"> <LI>  W904,   11/12/96   Regional Field Monitor/Clinical Trials Manager</A>
<A HREF="employ/w907.htm"> <LI>  W907,   11/5/96     Senior Management Document Safety Reporting</A>
<A HREF="employ/w908.htm"> <LI>  W908,   11/25/96   Clinical Data Manager</A>
<A HREF="employ/w909.htm"> <LI>  W909,   11/25/96   Clinical Pharmacokinetics/Pharmacology Consultant</A>
<A HREF="employ/w910.htm"> <LI>  W910,   11/25/96   Project Director/Consultant</A>
<A HREF="employ/w911.htm"> <LI>   W911,   12/4/96     Project Director/Manager -- Clinical Trials/Epidemiology/Safety</A>
<A HREF="employ/w912.htm"> <LI>   W912,   12/20/96   Oncology Monitors</A>
<A HREF="employ/w913.htm"> <LI>   W913,   12/20/96   Asthma Therapy Area Monitors</A>
<A HREF="employ/w914.htm"> <LI>   W914,   12/20/96   Senior Director, Safety/Medical Affairs</A>
<A HREF="employ/w915.htm"> <LI>   W915,   1/2/97       Pharmaceutical Grad</A>
<A HREF="employ/w916.htm"> <LI>   W916,   1/2/97       Medical Writer</A>
<A HREF="employ/w917.htm"> <LI>   W917,   1/2/97       Independant CRA/Project Consultant</A>
<A HREF="employ/w918.htm"> <LI>   W918,   1/3/97       Research Associate</A>
<A HREF="employ/w919.htm"> <LI>   W919,   1/3/97       Biomedical Editor, Freelance/Permanent</A>

</UL>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-88</DOCNO>
<DOCOLDNO>IA050-000869-B025-326</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ3.htm 199.92.136.137 19970111134423 text/html 13144
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:46:00 GMT
Last-modified: Friday, 03-Jan-97 19:12:28 GMT
Content-length: 12953
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Employment Information</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<B>Positions Available</B>
<P>
<UL>


<A HREF="employ/a094.htm"> <LI>   A094,   11/5/96     Regulatory Safety Associate: New York</A>
<A HREF="employ/a095.htm"> <LI>   A095,   11/5/96     Safety Reporting Associate: New York</A>
<A HREF="employ/a096.htm"> <LI>   A096,   11/5/96     Regulatory Safety Custodian: New York</A>
<A HREF="employ/a097.htm"> <LI>   A097,   11/5/96     Clinical Data Specialists: Northern New Jersey</A>
<A HREF="employ/a098.htm"> <LI>   A098,   11/5/96     Manager, Pharmaceutical Regulatory Education: New York</A>
<A HREF="employ/a099.htm"> <LI>   A099,   11/5/96     Senior Data Associates (2) & Data Associates (2-4)</A>
<A HREF="employ/a100.htm"> <LI>   A100,   11/5/96     Senior Statistical Programmer/Analyst</A>
<A HREF="employ/a101.htm"> <LI>   A101,   11/5/96     Statistical Programmer</A>
<A HREF="employ/a102.htm"> <LI>   A102,   11/5/96     Biostatistician</A>
<A HREF="employ/a103.htm"> <LI>   A103,   11/5/96     Medical Writer/Sr. Medical Writer</A>
<A HREF="employ/a104.htm"> <LI>   A104,   11/5/96     Clinical Scientist/Sr. Clinical Scientist  (Philadelphia Area)</A>
<A HREF="employ/a105.htm"> <LI>   A105,   11/5/96     Clinical Research Associate  (regionally based)</A>
<A HREF="employ/a106.htm"> <LI>   A106,   11/5/96     Data Operations Team Leader  (Philadelphia Area)</A>
<A HREF="employ/a107.htm"> <LI>   A107,   11/5/96     RN, Safety Review Team, CRA</A>
<A HREF="employ/a108.htm"> <LI>   A108,   11/11/96      CRA's</A>
<A HREF="employ/a109.htm"> <LI>   A109,   11/11/96     OTC Clinical Project Manager - North Central NJ</A>
<A HREF="employ/a110.htm"> <LI>   A110,   11/11/96     CRA's</A>
<A HREF="employ/a111.htm"> <LI>   A111,   11/11/96     Clinical Research Managers</A>
<A HREF="employ/a112.htm"> <LI>   A112,   11/11/96     Medical Writers</A>
<A HREF="employ/a113.htm"> <LI>   A113,   11/11/96     SAS Programmers</A>
<A HREF="employ/a114.htm"> <LI>   A114,   11/20/96     Data Manager</A>
<A HREF="employ/a115.htm"> <LI>   A115,   11/20/96     Clinical Research Associate or Senior Clinical Research Associate</A>
<A HREF="employ/a116.htm"> <LI>   A116,   11/20/96     Site Manager</A>
<A HREF="employ/a117.htm"> <LI>   A117,   11/20/96     Contract Administrator</A>
<A HREF="employ/a118.htm"> <LI>   A118,   11/20/96     Associate Medical Director, Clinical Affairs</A>
<A HREF="employ/a119.htm"> <LI>   A119,   11/20/96     Clinical Research Associate, Clinical Development</A>
<A HREF="employ/a120.htm"> <LI>   A120,   11/20/96     Clinical Data Associate</A>
<A HREF="employ/a121.htm"> <LI>   A121,   11/20/96     Manager, Continuing Assessment</A>
<A HREF="employ/a122.htm"> <LI>   A122,   11/20/96     SAS Programmer</A>
<A HREF="employ/a123.htm"> <LI>   A123,   11/20/96     Pharmacokineticist</A>
<A HREF="employ/a124.htm"> <LI>   A124,   11/20/96     Biostatistician</A>
<A HREF="employ/a125.htm"> <LI>   A125,   11/20/96     Medical Writer</A>
<A HREF="employ/a126.htm"> <LI>   A126,   11/20/96     Scientist/Development</A>
<A HREF="employ/a127.htm"> <LI>   A127,   11/20/96     Chemist/Immunoassay</A>
<A HREF="employ/a128.htm"> <LI>   A128,   11/21/96     Senior Clinical Applications Programmer</A>
<A HREF="employ/a129.htm"> <LI>   A129,   11/21/96     Assistant Operations Manager</A>
<A HREF="employ/a130.htm"> <LI>   A130,   11/21/96     Associate Director/Director Infectious Diseases</A>
<A HREF="employ/a131.htm"> <LI>   A131,   11/21/96     Manager, Biostatics</A>
<A HREF="employ/a132.htm"> <LI>   A132,   11/21/96     Manager Formulation Development</A>
<A HREF="employ/a133.htm"> <LI>   A133,   11/21/96     Consulting Statisticians</A>
<A HREF="employ/a134.htm"> <LI>   A134,   11/22/96     Senior Regulatory Affairs Consultant</A>
<A HREF="employ/a135.htm"> <LI>   A135,   11/22/96     Director of Regulatory Affairs</A>
<A HREF="employ/a136.htm"> <LI>   A136,   11/22/96     Clinical Research Associates</A>
<A HREF="employ/a137.htm"> <LI>   A137,   11/22/96     Statistical Programmer Analyst III</A>
<A HREF="employ/a138.htm"> <LI>   A138,   11/22/96     Statistical Programmer</A>
<A HREF="employ/a139.htm"> <LI>   A139,   11/22/96     Medical Director</A>
<A HREF="employ/a140.htm"> <LI>   A140,   11/22/96     Clinical Pharmacologists</A>
<A HREF="employ/a141.htm"> <LI>   A141,   11/22/96     Director Biostatics</A>
<A HREF="employ/a142.htm"> <LI>   A142,   11/22/96     Director Regulatory Affairs</A>
<A HREF="employ/a143.htm"> <LI>   A143,   11/22/96     Business Development</A>
<A HREF="employ/a144.htm"> <LI>   A144,   11/22/96     Quality Assurance Manager</A>
<A HREF="employ/a146.htm"> <LI>   A146,   11/22/96     Medical Writer</A>
<A HREF="employ/a147.htm"> <LI>   A147,   11/22/96     Design Specialist</A>
<A HREF="employ/a148.htm"> <LI>   A148,   11/25/96     Quality Assurance Manager</A>
<A HREF="employ/a149.htm"> <LI>   A149,   11/25/96     Quality Control Manager</A>
<A HREF="employ/a150.htm"> <LI>   A150,   11/25/96     Senior Regulatory Affairs Associate</A>
<A HREF="employ/a151.htm"> <LI>   A151,   11/25/96     Regulatory Affairs Associate/Assistant</A>
<A HREF="employ/a152.htm"> <LI>   A152,   11/25/96     Quality Assurance Auditor</A>
<A HREF="employ/a153.htm"> <LI>   A153,   11/25/96     Medical Affairs Liaison (Oncology)</A>
<A HREF="employ/a154.htm"> <LI>   A154,   11/25/96     Head of Statistics & Data Management</A>
<A HREF="employ/a155.htm"> <LI>   A155,   11/25/96     Associate Director</A>
<A HREF="employ/a156.htm"> <LI>   A156,   11/25/96     Senior Technical/Scientific Editor</A>
<A HREF="employ/a157.htm"> <LI>   A157,   11/25/96     Medical Writer</A>
<A HREF="employ/a158.htm"> <LI>   A158,   11/25/96     Patient Recruitment Specialist</A>
<A HREF="employ/a159.htm"> <LI>   A159,   11/25/96     Clinical Research Associates</A>
<A HREF="employ/a160.htm"> <LI>   A160,   11/25/96     Clinical Research Assistants</A>
<A HREF="employ/a161.htm"> <LI>   A161,   12/2/96       Assoc Med Dir Development</A>
<A HREF="employ/a162.htm"> <LI>   A162,   12/2/96       Clin Data Coordinator I/II</A>
<A HREF="employ/a163.htm"> <LI>   A163,   12/2/96       Assoc Med Dir Development</A>
<A HREF="employ/a164.htm"> <LI>   A164,   12/2/96       Assoc Mgr Clin Affairs/Mgr</A>
<A HREF="employ/a165.htm"> <LI>   A165,   12/2/96       Assoc Mgr Clin Affairs/Mgr</A>
<A HREF="employ/a166.htm"> <LI>   A166,   12/2/96       Assoc Mgr/Mgr Clin Affairs</A>
<A HREF="employ/a167.htm"> <LI>   A167,   12/3/96       Assoc Mgr/Mgr Clin Data</A> 
<A HREF="employ/a168.htm"> <LI>   A168,   12/3/96       Biostatistician II/Sr. Biostat</A>
<A HREF="employ/a169.htm"> <LI>   A169,   12/3/96       Clin Data Assoc II/III</A>
<A HREF="employ/a170.htm"> <LI>   A170,   12/3/96       Clin Data Assoc II/III</A>
<A HREF="employ/a171.htm"> <LI>   A171,   12/3/96       Clin Data Assoc II/III</A>
<A HREF="employ/a172.htm"> <LI>   A172,   12/3/96       Clin Ed & Training Advisor</A>
<A HREF="employ/a173.htm"> <LI>   A173,   12/3/96       Clin Logistics Spec</A>
<A HREF="employ/a174.htm"> <LI>   A174,   12/3/96       Clin Research Assoc I/II</A>
<A HREF="employ/a175.htm"> <LI>   A175,   12/4/96       Clin Research Assoc II/III</A>
<A HREF="employ/a176.htm"> <LI>   A176,   12/4/96       Clin Research Assoc II/III</A>
<A HREF="employ/a177.htm"> <LI>   A177,   12/4/96       Compliance Educ Assoc II/Spec</A>
<A HREF="employ/a178.htm"> <LI>   A178,   12/4/96       Mgr Clin Data</A>
<A HREF="employ/a179.htm"> <LI>   A179,   12/4/96       Mgr Intl Clin Logistics</A>
<A HREF="employ/a180.htm"> <LI>   A180,   12/4/96       Reg Affairs Spec I/II</A>
<A HREF="employ/a181.htm"> <LI>   A181,   12/4/96       Validation Assoc III/Vld Spc I</A>
<A HREF="employ/a182.htm"> <LI>   A182,   12/4/96       Medical Information Coordinator</A>
<A HREF="employ/a183.htm"> <LI>   A183,   12/4/96       Associate Director/Director Internat Clin Research</A>
<A HREF="employ/a184.htm"> <LI>   A184,   12/4/96       Manager, Adverse Experience Reporting</A>
<A HREF="employ/a185.htm"> <LI>   A185,   12/4/96       Clinical SAS Programmer/Analyst</A>
<A HREF="employ/a186.htm"> <LI>   A186,   12/20/96     Clinical Data Coordinator</A>
<A HREF="employ/a187.htm"> <LI>   A187,   12/20/96     Clinical Research Associate</A>
<A HREF="employ/a188.htm"> <LI>   A188,   12/20/96     Clinical Database Administrator</A>
<A HREF="employ/a189.htm"> <LI>   A189,   12/20/96     Manager, Regulatory Affairs</A>
<A HREF="employ/a190.htm"> <LI>   A190,   12/20/96     Director, Clinical Research</A>
<A HREF="employ/a191.htm"> <LI>   A191,   12/20/96     Clinical Research Associate</A>
<A HREF="employ/a192.htm"> <LI>   A192,   12/20/96     Associate Director, Medical Devices, Regulatory Affairs</A>
<A HREF="employ/a193.htm"> <LI>   A193,   12/20/96     Senior Associate, Medical Devices, Regulatory Affairs</A>
<A HREF="employ/a194.htm"> <LI>   A194,   12/20/96     Senior Associate, Drugs & Biologics, Regulatory Affairs</A>
<A HREF="employ/a195.htm"> <LI>   A195,   12/20/96     Safety Monitor</A>
<A HREF="employ/a196.htm"> <LI>   A196,   12/20/96     Clinical Research Associates</A>
<A HREF="employ/a197.htm"> <LI>   A197,   12/20/96     Clinical Research Assistants</A>
<A HREF="employ/a198.htm"> <LI>   A198,   12/20/96     Various Openings</A>
<A HREF="employ/a199.htm"> <LI>   A199,   12/20/96     Manager, Clinical Data Management</A>
<A HREF="employ/a200.htm"> <LI>   A200,   12/20/96     CRAs/Data Managers</A>
<A HREF="employ/a201.htm"> <LI>   A201,   12/20/96     Manager, Pharmaceutical Consulting Services</A>
<A HREF="employ/a202.htm"> <LI>   A202,   12/23/96     Technical Training Specialist</A>
<A HREF="employ/a203.htm"> <LI>   A203,   12/23/96     Technical Consultant</A>
<A HREF="employ/a204.htm"> <LI>   A204,   12/23/96     Clinical Trial Monitor</A>
<A HREF="employ/a205.htm"> <LI>   A205,   12/23/96     Clinical Operations Associate</A>
<A HREF="employ/a206.htm"> <LI>   A206,   12/23/96     Consultants, Clinical Research</A>
<A HREF="employ/a207.htm"> <LI>   A207,   12/23/96     Manager, Regulatory Affairs</A>
<A HREF="employ/a208.htm"> <LI>   A208,   12/30/96     Senior Clinical Research Associate</A>
<A HREF="employ/a209.htm"> <LI>   A209,   12/30/96     Biostatistician</A>
<A HREF="employ/a210.htm"> <LI>   A210,   12/30/96     Sr. CRA/Project Manager</A>
<A HREF="employ/a211.htm"> <LI>   A211,   12/30/96     Director, International Regulatory Affairs</A>
<A HREF="employ/a212.htm"> <LI>   A212,   12/30/96     Executive Director of Biostatics</A>
<A HREF="employ/a213.htm"> <LI>   A213,   12/30/96     Vice President of Operations</A>
<A HREF="employ/a214.htm"> <LI>   A214,   12/30/96     Vice President and Director Business Development</A>
<A HREF="employ/a215.htm"> <LI>   A215,   12/30/96     Clinical Research Associate</A>
<A HREF="employ/a216.htm"> <LI>   A216,   12/30/96     Director of Regulatory Affairs</A>
<A HREF="employ/a217.htm"> <LI>   A217,   1/2/97        Various Opportunities</A>
<A HREF="employ/a218.htm"> <LI>   A218,   1/2/97        Data Management/CRA</A>
<A HREF="employ/a219.htm"> <LI>   A219,   1/2/97        Senior Research Fellow</A>
<A HREF="employ/a220.htm"> <LI>   A220,   1/2/97        CRA/Senior CRA</A>
<A HREF="employ/a221.htm"> <LI>   A221,   1/2/97        Associate Director Regulatory Affairs</A>
<A HREF="employ/a222.htm"> <LI>   A222,   1/2/97        Biostatistician</A>
<A HREF="employ/a223.htm"> <LI>   A223,   1/2/97        Regulatory Affairs Associate</A>
<A HREF="employ/a224.htm"> <LI>   A224,   1/2/97        Senior Clinical Data Associates</A>
<A HREF="employ/a225.htm"> <LI>   A225,   1/3/97        Clinical Data Associates</A>
<A HREF="employ/a226.htm"> <LI>   A226,   1/3/97        Clinical Research Associates</A>
<A HREF="employ/a227.htm"> <LI>   A227,   1/3/97        Regional Clinical Research Associates</A>
<A HREF="employ/a228.htm"> <LI>   A228,   1/3/97        SAS Programmers</A>
<A HREF="employ/a229.htm"> <LI>   A229,   1/3/97        Senior Technical Trainer</A>
<A HREF="employ/a230.htm"> <LI>   A230,   1/3/97        Medical Writers</A>
<A HREF="employ/a231.htm"> <LI>   A231,   1/3/97        ADME/Pharmakokinetics Manager</A>
<A HREF="employ/a232.htm"> <LI>   A232,   1/3/97        Project Manager</A>
<A HREF="employ/a233.htm"> <LI>   A233,   1/3/97        Associate Medical Director</A>
<A HREF="employ/a234.htm"> <LI>   A234,   1/3/97        Research Analyst</A>
<A HREF="employ/a235.htm"> <LI>   A235,   1/3/97        Executive Director</A>
<A HREF="employ/a236.htm"> <LI>   A236,   1/3/97        Marketing Research Manager</A>

</UL>
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-89</DOCNO>
<DOCOLDNO>IA050-000869-B025-358</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b4a.htm 199.92.136.137 19970111134443 text/html 5990
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:46:25 GMT
Last-modified: Monday, 30-Dec-96 20:16:38 GMT
Content-length: 5800
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Internships now Available in Industry</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
  <CENTER><STRONG>INTERNSHIPS NOW AVAILABLE IN INDUSTRY</STRONG></CENTER>
<P><HR>
<CENTER><B>Internships in Industry</B></CENTER>
<P>
The DIA is pleased to advise interested members of currently available
internships. We encourage interested parties to contact the appropriate
person directly.
<P>
<b>1.Huddinge University Hospital</b><br>
Epidemiology / Pharmacoepidemiology - Stipend available to cover living expenses in Stockholm<br>
Duration - 1-2 years<br>
Minimum Qualification - Training in epidemiology with an interest in pharmacoepidemiology, preferably a PhD or MD in epidemiology<br>
Contact - Bengt Winblad, MD, PhD (Sweden)<br>
Phone-+011 46 8 746 361    Fax-+011 46 8 746 3690<br>
Contact - Elizabeth Corder, PhD, MPH (USA)<br>
Phone - +1 919 684 6126    Fax - +1 919 684 3861<br><p>

<b>2.Hoechst-Roussel Canada, Inc.</b><br>
Health Economics<br>
Contact - Drug Regulatory Affairs<br>
Phone- +1 514 333 2900    Fax-+ 1 514 333 3623<br>
<p>
<b>3.Hoffmann-La Roche</b><br>
Internships in Outcomes Management and Payment Planning<br>
Duration - Minimum one semester<br>
Minimum Qualification - Graduate program in pharmacoeconomics / health care / business<br>
Contact - Dr. George P. Sillup<br>
Phone- +1 201 562 2143    Fax- +1 201 562 2445<br>
<p>
<b>4.Janssen Pharmaceutica</b><br>
Janssen Outcomes Research Fellowships in conjunction with Thomas Jefferson University and the University of South Carolina<br>
Duration - 2 years<br>
Minimum Qualification - Advanced degree preferred<br>
Contact - Bryan J. Lawrence, PharmD<br>
Phone-+1 609 730 3493    Fax-+1 609 730 3044<br>
<p>
<b>5.Merck Research Laboratories</b><br>
Opportunity to work with pre-clinical or clinical biostatisticians on new drug discovery or development projects including clinical trials<br>
Duration - 10-12 weeks<br>
Minimum Qualification - Completion of at least one year of graduate study in statistics or biostatistics; letter of intent with resume to Lisa Hayden at Merck & Co., Inc., P.O. Box 4, West Point, PA 19486-0004<br>
Contact - Lisa Hayden<br>
Phone-+1 610 397 7007    Fax-+1 610 397 2572<br>
<p>
<b>6.Pharmacon International, Inc. (NYC)</b><br>
Internship in Pharmacoeconomics<br>
Duration - 8 weeks (Negotiable)<br>
Minimum Qualification - M.S. in Epidemiology or Doctorate in health-related discipline<br>
Contact - Dr. Rene Arnold or Dr. Diana Kaniecki<br>
Phone-+1 212 643 0740    Fax- +1 212 643 1496<br>
<p>
<b>7.Solvay Pharmaceuticals - The Netherlands</b><br>
Internship in Health Economics<br>
Duration - To be discussed<br>
Minimum Qualification - M.S. in Epidemiology or Doctorate in Health Economics or related disciplines<br>
Contact - L. Hadjadjeba<br>
Phone-+011 31 294 479336    Fax-+011 31 294 477139<br>
<p>
<b>8.SmithKline Beecham</b><br>
Post-doctoral Fellowship in Epidemiology and Applied Health Economics<br>
Duration - Negotiable<br>
Minimum Qualification - Doctoral level degree, previous work experience. Sabbatical applicants welcomed.<br>
Contact - Paul E. Stang, PhD<br>
Phone-+1 610 917 5651Fax-+1 610 917 4818<br>
<p>
<b>9.SmithKline Beecham</b><br>
Fellowship in Applied Health Economics<br>
Duration - 2 years<br>
Minimum Qualification - Advanced degree in health-related discipline.<br>
Contact - Marc L. Watrous, PhD<br>
Phone-+1 610 917 5695    Fax-+1 610 917 4818<br>
<p>
<b>10.Statistics Collaborative, Inc.</b><br>
Gain experience in practical problems in clinical trial design and analysis<br>
Duration - Summer or up to 3 months<br>
Minimum Qualification - One year graduate training in biostatistics or epidemiology or strong undergraduate experience in programming<br>
Contact - Janet Wittes, PhD<br>
Phone-+1 202 429 9267    Fax- +1 202 429 9268<br>
<p>
<b>11.University of Michigan (Two Positions)</b><br>
Two Fellowships in Pharmacoeconomics. Includes on-site experience with pharmaceutical industry. Degree granting - stipend for tuition and salary included.<br>
Duration - 1-2 years<br>
Minimum Qualification - M.D.<br>
Contact - A. Mark Fendrick or Susan Wagner<br>
Phone-+1 313 936 4787    Fax - +1 313 936 8944<br>
<p>
<b>12.Wyeth-Ayerst Research</b><br>
Pharmacokinetics in CR&D<br>
Duration - 6 months, maximum<br>
Minimum Qualification - Graduate or post-doctoral students in pharmaceutics or pharmacy<br>
Contact - Kirsten Hyland or Soong T. Chiang<br>
Phone-+1 610 341 2621 or 610 341 5712        Fax- +1 610 989 4574<br>
email-chiangs@war.wyeth.com<br><BR>

<P>
DIA's role does not include sponsorship, underwriting or the validation
of any internships advertised as part of this program. Advertised
internships are initiated by and are the responsibility of the
sponsoring organization.
<P>
<HR>
<CENTER><A HREF="dhp2.htm"><IMG  BORDER=0 SRC="about.gif"></A><A HREF="dhp3.htm"><IMG BORDER=0 SRC="member.gif"></A><A HREF="dhp5b2.htm"><IMG BORDER=0 SRC="recent.gif"><A HREF="dhp4.htm"><IMG BORDER=0 SRC="upcom.gif"></A><A HREF="dhp5.htm"><IMG BORDER=0 SRC="public.gif"></A><A HREF="dhp6.htm"><IMG BORDER=0 SRC="awards.gif"></A><A HREF="dhp7.htm"><IMG BORDER=0 SRC="fellow.gif"><A HREF="dhp8.htm"><BR><IMG BORDER=0 SRC="conted.gif"><A HREF="dhp9.htm"><IMG BORDER=0 SRC="dianews.gif"><A HREF="dhp10.htm"><IMG BORDER=0 SRC="infocen.gif"></A><A HREF="dhp11.htm"><IMG BORDER=0 SRC="personal.gif"></A><A HREF="dhp12.htm"><IMG BORDER=0 SRC="message.gif"></A><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-90</DOCNO>
<DOCOLDNO>IA050-000869-B026-11</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b4b.htm 199.92.136.137 19970111134456 text/html 2278
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:46:37 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:07 GMT
Content-length: 2087
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Internship Report Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>INTERNSHIP REPORT FORM</STRONG><BR>
(Form Used to Advise DIA of an Available Internship)</CENTER>
<P><HR>
<CENTER><B>Internship Report Form</B></CENTER>
<P>
The DIA will coordinate information regarding available internships
in industry for the benefit of our academic members who might
be in a position to recommend appropriate candidates. DIA's role
does not include sponsorship, underwriting or the validation of
any internships advertised as part of this program. Advertised
internships are initiated by and are the responsibility of the
sponsoring organization.
<P>
If an internship is available at your company, please complete
the following contact information and mail or fax the form to
the DIA office at +1 215 641-1229. The information will be disseminated
to DIA members in academia who have expressed an interest in statistics/biostatistics,
pharmacoeconomics and/or health economics. The contact information
will also be included in the DIA Newsletter which is published
quarterly.
<P>
CONTACT NAME:  _______________________________________________________<P>
COMPANY:  _____________________________________________________________<P>
OPPORTUNITY:  _________________________________________________________<P>
DURATION OF INTERNSHIP:  ______________________________________________<P>
MINIMUM QUALIFICATION:  ______________________________________________<P>
PHONE:  _______________________________ <BR>
<P>
FAX:  __________________________________
<P>
Please direct your questions or comments to the DIA Internship
Coordinator at the following address:
<P>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA 19002-2755<BR>
TEL: +1 215 628 2288   
  FAX: +1 215 641 1229</CENTER>



<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>



</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-91</DOCNO>
<DOCOLDNO>IA050-000869-B026-47</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a.htm 199.92.136.137 19970111134515 text/html 1443
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:46:49 GMT
Last-modified: Thursday, 10-Oct-96 17:26:30 GMT
Content-length: 1251
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Drug Information Journal</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<CENTER><STRONG>DRUG INFORMATION JOURNAL</STRONG></CENTER>
<P>
 <HR>
<UL>
 <IMG SRC="bullet2.gif">          <A HREF="dhp5a1.htm"> ABOUT THE JOURNAL</A>
<P>
  <IMG SRC="bullet2.gif">         <A HREF="dhp5a2.htm"> EDITORIAL BOARD</A>
<P>
<IMG SRC="bullet2.gif">           <A HREF="dhp5a3.htm"> INFORMATION FOR AUTHORS</A>
<P>
<IMG SRC="bullet2.gif">          <A HREF="jourrate.htm"> ADVERTISING INFORMATION</A>
<P>
 <IMG SRC="bullet2.gif">          <A HREF="dhp5a4.htm"> INDEX TO VOLUME 29 (1995)<BR>
 <CENTER>ARTICLE INDEX <BR>
(Table of Contents for each Issue)<BR>
 AUTHOR INDEX</CENTER></A>
<P>
<P>
 <IMG SRC="bullet2.gif">          <A HREF="dhp5a5a5.htm"> INDEX TO VOLUME 30 (1996) (AUTHOR INDEX)</A><BR>

<P>
 <IMG SRC="bullet2.gif">     <A HREF="dhp5a5.htm"> TABLE OF CONTENTS<BR>
 <CENTER>VOLUME 30 (1996), ISSUE 1<BR>
 VOLUME 30 (1996), ISSUE 2<BR>VOLUME 30 (1996), ISSUE 3<BR>VOLUME 30 (1996), ISSUE 4</CENTER></A>
<P>
</UL>
<HR>

<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>




</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-92</DOCNO>
<DOCOLDNO>IA050-000869-B026-73</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b.htm 199.92.136.137 19970111134536 text/html 1075
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:47:17 GMT
Last-modified: Thursday, 03-Oct-96 13:45:13 GMT
Content-length: 884
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA Newsletter</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<CENTER><STRONG> DIA NEWSLETTER</STRONG></CENTER>
<P><HR><UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp5b1.htm"> PRESIDENTS MESSAGE</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5b2.htm"> RECENT MEETINGS</A>

<P>
<IMG SRC="bullet2.gif">     <A HREF="newsrate.htm"> ADVERTISING INFORMATION</A>
</UL>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

<CENTER>Drug Information Association<BR>

321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>

Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>

or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>

Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>

Drug Information Association 1996</CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-93</DOCNO>
<DOCOLDNO>IA050-000869-B026-104</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f.htm 199.92.136.137 19970111134552 text/html 1703
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:47:29 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:04 GMT
Content-length: 1512
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Annual Report 1995</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<CENTER><STRONG> ANNUAL REPORT - 1995</STRONG></CENTER>
<P><HR><UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f1.htm"> PRESIDENT'S ANNUAL REPORT MESSAGE</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f2.htm"> EXECUTIVE DIRECTOR'S MESSAGE</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f3.htm"> DIA MEETING STATISTICS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f4.htm"> DIJ, EDITOR-IN-CHIEF'S MESSAGE</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f5.htm"> DIA TRAINING COURSE COMMITTEE REPORT</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f6.htm"> AWARDS AND FELLOWSHIPS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f7.htm"> STEERING COMMITTEE REPORTS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f8.htm"> DIA AWARDS</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f9.htm"> FINANCIAL REPORT</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5f10.htm"> BOARD OF DIRECTORS - PHOTOGRAPHS</A>
<P></UL><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

<CENTER>Drug Information Association<BR>

321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>

Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>

or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>

Tel. +41 61 382 90 19, Fax. +41 61 382 90 50<BR>

Drug Information Association 1996</CENTER>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-94</DOCNO>
<DOCOLDNO>IA050-000869-B026-144</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/company.htm 199.92.136.137 19970111134611 text/html 11338
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:47:51 GMT
Last-modified: Tuesday, 10-Dec-96 20:28:05 GMT
Content-length: 11146
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Directory "Companies"</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H1>PCSO Companies</H1></CENTER>
<HR>
AAI<BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm"> ACER/EXCEL</A><BR>
Advanced BioAnalytical Services, Inc.<BR>
Advanced Biomedical Research, Inc.<BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso7.htm"> Affiliated Research Centers, Inc.</A><BR>
<A HREF="pcso/pcso8.htm"> Alliance Telemanagement, Inc.</A><BR>
Almedica International<BR>
<A HREF="pcso/pcso10.htm"> Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso11.htm"> ANAWA Laboratories AG</A><BR>
<A HREF="pcso/pcso12.htm"> Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
ASTER/CEPHAC<BR>
<A HREF="pcso/pcso16.htm"> BARC (Bio Analytical Research Corporation)</A><BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso18.htm"> Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso19.htm"> Belmont Research, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso21.htm"> BFR Systems, Inc.</A><BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso23.htm"> Biomedical Systems</A><BR>
<A HREF="pcso/pcso24.htm"> Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
<A HREF="pcso/pcso26.htm"> BioResearch Monitors, Inc.</A><BR>
Biotechnical Services Inc.<BR>
BLIS-TECH Corporation<BR>
Boston Biostatistics, Inc.<BR>
Bowen, Sherri and Associates<BR>
BRI International, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm"> Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso34.htm"> CB Technologies, Inc.</A><BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso36.htm"> Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
C.I.T. Centre International de Toxicologie<BR>
ClinAudits<BR>
CLINICA Research Incorporated<BR>
Clinical Investigation Support Ges.mbH. <BR>
& Co., KG<BR>
<A HREF="pcso/pcso41.htm"> Clinical R&D Services Corp.</A><BR>
Clinical Solutions<BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/ctss.htm"> Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso45.htm"> ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso46.htm"> ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso47.htm"> CompleWare Corporation</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
Concepts Meeting & Trade Show <BR>
Management, Inc.<BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso52.htm"> Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm"> Corning Besselaar</A><BR>
<A HREF="pcso/pcso54.htm"> Corning Hazleton</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso56.htm"> Corning Pharmaceutical Services</A><BR>
<A HREF="pcso/pcso57.htm"> Corning SciCor</A><BR>
<A HREF="pcso/pcso58.htm"> Coromed, Inc.</A><BR>
<A HREF="pcso/pcso59.htm"> Covalent Research Alliance Corp.</A><BR>
CRL-MEDINET<BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Data Analysis Systems, Inc. (DAS)<BR>
De Milto, Lori, Writer for Rent<BR>
<A HREF="pcso/pcso64.htm"> DLB Systems, Inc.</A><BR>
Dow Pharmaceutical Sciences<BR>
Drug Research and Analysis Corporation<BR>
Dynacare Clinical Research Inc.<BR>
ECRON<BR>
<A HREF="pcso/pcso69.htm"> Electronic Submission Publishing Systems (ESPS), Inc.</A><BR>
<A HREF="pcso/pcso70.htm"> Elsevier Science, Secondary Publishing Division</A><BR>
EMO Clinical Research<BR>
Endpoint Research Ltd.<BR>
<A HREF="pcso/pcso73.htm"> Epidemiology Resources Inc.</A><BR>
ESA Laboratories, Inc.<BR>
Essex Testing Clinic, Inc.<BR>
<A HREF="pcso/pcso76.htm"> European Regulatory Affairs Group, The</A><BR>
Exima<BR>
4C-SONS<BR>
First Image Data Acquisition Division<BR>
Fraser Williams Pharma Systems<BR>
Frederick Research Center, Southern <BR>
Research Institute<BR>
<A HREF="pcso/pcso82.htm"> Frontier Technology, Inc.</A><BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso84.htm"> GFI Pharmaceutical Services, Inc.</A><BR>
<A HREF="pcso/glenmere.htm"> Glenmere Research</A><BR>
<A HREF="pcso/pcso85.htm"> gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
<A HREF="pcso/pcso86.htm"> Good Clinical Research Practices Limited</A><BR>
Group Syndetic, Inc.<BR>
GTFH Clinical Trial Recruitment<BR>
Guidelines, Incorporated<BR>
<A HREF="pcso/pcso90.htm"> GXP Consulting</A><BR>
GXP International<BR>
Hardardt Group, The<BR>
Harper, Beth D.  Site Performance Specialist<BR>
<A HREF="pcso/pcso94.htm"> Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso97.htm"> HealthQuest Research</A><BR>
Hurd & Associates, Inc.<BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso100.htm"> IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm"> ICON Clinical Research, Inc.</A><BR>
<A HREF="pcso/pcso102.htm"> IDRAC  IMS International</A><BR>
idv Data Analysis and Study Planning<BR>
IFE GmbH<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso106.htm"> IIT Research Institute (IITRI)</A><BR>
ILEX Oncology, Inc.,<BR>
<A HREF="pcso/pcso108.htm"> Imperial Graphics, Inc.</A><BR>
<A HREF="pcso/pcso109.htm"> IMRO bv</A><BR>
Informatics, Inc.<BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso114.htm"> Integrated Research Inc.</A><BR>
INTERLAB  international clinical laboratory and research organisation<BR>
International Research Consultants (IRC)<BR>
Inveresk Research<BR>
IPS International Pharmaceutical Services<BR>
JAPANESE LANGUAGE SERVICES LTD<BR>
Kendle<BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research <BR>
International Inc.<BR>
L.A.B. GmbH & Co.<BR>
Laboratoires ADME Bioanalyses<BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso125.htm"> LOGOS GmbH</A><BR>
Magellan Laboratories Incorporated<BR>
MAPI S.A.<BR>
MARAS AG<BR>
<A HREF="pcso/pcso129.htm"> McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso130.htm"> McKesson BioServices</A><BR>
MDS Clinical Trial Services<BR>
<A HREF="pcso/pcso132.htm"> MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm"> MedFocus, Inc.</A><BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm"> Medical Research Services, Ltd.</A><BR>
Medical & Technical Research <BR>
Associates, Inc. (MTRA)<BR>
MediciGroupTM Inc.<BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso139.htm"> Medilab Clinical Laboratories AB</A><BR>
<A HREF="pcso/pcso140.htm"> Mediscience Planning Inc.</A><BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso142.htm"> MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso143.htm"> MediTech International Co., Ltd.</A><BR>
Mercury Printing, Inc.  (MPI)<BR>
MetaWorks Inc.<BR>
<A HREF="pcso/pcso146.htm"> METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso149.htm"> NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso150.htm"> NetForce Incorporated</A><BR>
<A HREF="pcso/pcso151.htm"> Neuroclinical Trials Center</A><BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso153.htm"> NJC Enterprises, Ltd.</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso155.htm"> NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso156.htm"> Olsten Kimberly QualityCare</A><BR>
<A HREF="pcso/pcso157.htm"> Oneida Research Services, Inc.</A><BR>
Oread<BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso161.htm"> Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/paragon.htm"> Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm"> PAREXEL</A><BR>
PAREXEL/S&FA<BR>
<A HREF="pcso/pcso169.htm"> Partners In Research, Inc.</A><BR>
<A HREF="pcso/pcso170.htm"> PDS Research</A><BR>
Pennsylvania Merchant Group Ltd.<BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
Pharma Bio-Research International B.V.<BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm"> Pharmaceutical Consultants, Inc.</A><BR>
Pharmaceutical Development Group, Inc.<BR>
<A HREF="pcso/prc.htm"> Pharmaceutical Resource Corporation</A><BR>
Pharmaceutical Service Division, <BR>
  University of Iowa<BR>
<A HREF="pcso/pcso178.htm"> Pharmaco International Inc.</A><BR>
Pharmakon Research International<BR>
Pharmakopius International plc<BR>
PharmAlliance, Inc.SM<BR>
<A HREF="pcso/pcso182.htm"> PHARMAPART AG</A><BR>
PharmaSoft AB<BR>
PHARMNET, s.r.o.<BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso186.htm"> Phoenix International Life Sciences Inc.</A><BR>
<A HREF="pcso/pcso187.htm"> Phoenix Regulatory Associates, Ltd.</A><BR>
Premier Research Worldwide<BR>
Princeton Biostatistics Group, Inc.<BR>
Product Investigations, Inc.<BR>
Q2 Marketing Research, Inc.<BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso193.htm"> Quintiles Emerging Companies Institute</A><BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso195.htm"> Research Dynamics Consulting Group, Ltd.</A><BR>
<A HREF="pcso/pcso196.htm"> Research Services, Inc.</A><BR>
<A HREF="pcso/pcso197.htm"> Research Testing Laboratories, Inc.</A><BR>
Rho, Inc.<BR>
<A HREF="pcso/pcso199.htm"> Rohrbaugh Associates, Inc.</A><BR>
Schiff & Company<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm"> SCIREX Corporation</A><BR>
S-Cubed<BR>
SEQ Limited<BR>
<A HREF="pcso/pcso205.htm"> SHARK dm Co.</A><BR>
Simbec Research Limited<BR>
<A HREF="pcso/pcso207.htm"> SIMIREX INC.</A><BR>
<A HREF="pcso/pcso208.htm"> Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso209.htm"> Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso210.htm"> Solutions, Inc. by Fix and Co.</A><BR>
<A HREF="pcso/pcso211.htm"> Spadille ApS</A><BR>
Springborn Laboratories, Inc.<BR>
<A HREF="pcso/pcso213.htm"> SRL Inc.</A><BR>
Stalder, David G.<BR>
STAT, inc.<BR>
Statcon ApS<BR>
<A HREF="pcso/pcso217.htm"> Statistics and Epidemiology Research Corporation</A><BR>
STATPROBE, Inc.<BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<A HREF="pcso/pcso220.htm"> SYNERGOS, Inc.</A><BR>
Target Research Associates, Inc.<BR>
Telerx<BR>
<A HREF="pcso/pcso223.htm"> TKL Research, Inc.</A><BR>
TRAMARKO<BR>
<A HREF="pcso/pcso225.htm"> Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso226.htm"> Trilogy Consulting Corporation</A><BR>
Trilsch, William & Associates (WTA)<BR>
<A HREF="pcso/pcso228.htm"> Turning Point Associates, Inc.</A><BR>
U-Gene Research BV<BR>
<A HREF="pcso/pcso230.htm"> Universal Systems Inc.</A><BR>
Validation Associates, Inc.<BR>
VERUM European Clinical Development<BR>
VUJAKLIJA CRO LTD<BR>
<A HREF="pcso/pcso234.htm"> Waife & Associates, Inc.</A><BR>
<A HREF="pcso/pcso235.htm"> Westat, Inc.</A><BR>
Western Data Safety Monitoring Board<BR>
Western International Review Board<BR>
<A HREF="pcso/pcso238.htm"> WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre</A><BR>
Wiedy Clinical Research<BR>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-95</DOCNO>
<DOCOLDNO>IA050-000869-B026-220</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/service.htm 199.92.136.137 19970111134717 text/html 106001
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:48:16 GMT
Last-modified: Tuesday, 10-Dec-96 20:29:15 GMT
Content-length: 105808
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Services "Services"</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H1>PCSO Services</H1></CENTER>
<HR>

<B>Abstracting</B><BR>
Bowen, Sherri and Associates<BR>
<A HREF="pcso/pcso70.htm">Elsevier Science, Secondary Publishing Division</A></A><BR>
4C-SONS<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A></A><BR>
<P>
<B>Accountability & Destruction/Clinical Supplies</B><BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso207.htm"><A HREF="pcso/pcso207.htm">SIMIREX INC.</A>
<P>
<B>ADE Evaluation/Drug Safety Assessment</B><BR>
<A HREF="pcso/pcso208.htm"><A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A></A><BR>
Adverse Event Software<BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
PharmaSoft AB<BR>
Rho, Inc.<BR>
<A HREF="pcso/pcso230.htm"><A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
WHO Collaborating Centre for International  Drug Monitoring
<P>
<B>Advertising</B><BR>
<A HREF="pcso/pcso8.htm"><A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Clinical Solutions<BR>
NFO Research, Inc.<BR>
STAT, inc.
<P>
<B>Aerosol Delivery Technology</B><BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A>
<P>
<B>AIDS Trials</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
Clinical Solutions<BR>
Corning PACT<BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
Drug Research and Analysis Corporation<BR>
Endpoint Research Ltd.<BR>
Frederick Research Center, Southern Research Institute<BR>
Hardardt Group, The<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
InSite Clinical Trials<BR>
Kern McNeill International<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A>
<P>
<B>Allergy and Asthma Studies</B><BR>
Advanced Research Management<BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
CLINICA Research Incorporated<BR>
Clinical Solutions<BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Drug Research and Analysis Corporation<BR>
Endpoint Research Ltd.<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
NFO Research, Inc.<BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
Simbec Research Limited<BR>
Target Research Associates, Inc.
<P>
<B>Ambulatory Cardiovascular Monitoring</B><BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Healthcare Services International<BR>
Premier Research Worldwide
<P>
<B>Analgesic and/or Anesthetics R&D</B><BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
Swe.doc Pharmaceutical Medicine AB
<P>
<B>Analytical Assay Development and/or Laboratory Service</B><BR>
AAI<BR>
Advanced BioAnalytical Services, Inc.<BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
CRL-MEDINET<BR>
Dow Pharmaceutical Sciences<BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
IBRD Center for Clinical Research (ICCR)<BR>
INTERLAB - international clinical laboratory and research organisation<BR>
IPS International Pharmaceutical Services<BR>
L.A.B. GmbH & Co.<BR>
Laboratoires ADME Bioanalyses<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
MDS Clinical Trial Services<BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A></A><BR>
Oread<BR>
Pharma Bio-Research International B.V.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Simbec Research Limited<BR>
Springborn Laboratories, Inc.
<P>
<B>Bibliographic Services</B><BR>
<A HREF="pcso/pcso70.htm">Elsevier Science, Secondary Publishing Division</A><BR>
IDRAC  IMS International<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
<P>
<B>Bids and Contracts Management</B><BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A>
<P>
<B>Bioanalytical Data Audits/Laboratory & Validation Evaluation</B><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<P>
<B>Biological Specimen Collection and/or Storage</B><BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A>
<P>
<B>Blister Card Design & Packaging</B><BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A>
<P>
<B>CANDAS</B><BR>
ASG, Inc./CORE<BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
BRI International, Inc.<BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
First Image Data Acquisition Division<BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
Group Syndetic, Inc.<BR>
GXP International<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PharmaSoft AB<BR>
Premier Research Worldwide<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A>
<P>
<B>Cardiovascular Drug R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
Drug Research and Analysis Corporation<BR>
ECRON<BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
Harrison Clinical Research GmbH<BR>
Healthcare Services International<BR>
IFE GmbH<BR>
InSite Clinical Trials<BR>
Kendle<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
U-Gene Research BV<BR>
VUJAKLIJA CRO LTD
<P>
<B>Case Report Forms</B><BR>
Abt Associates Inc.<BR>
Bowen, Sherri and Associates<BR>
<A HREF="pcso/pcso33.htm"><A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A></A><BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso47.htm"><A HREF="pcso/pcso47.htm">CompleWare Corporation</A></A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Drug Research and Analysis Corporation<BR>
Dynacare Clinical Research Inc.<BR>
Endpoint Research Ltd.<BR>
First Image Data Acquisition Division<BR>
<A HREF="pcso/glenmere.htm"><A HREF="pcso/glenmere.htm">Glenmere Research</A></A><BR>
<A HREF="pcso/pcso85.htm"><A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A></A><BR>
Group Syndetic, Inc.<BR>
Hardardt Group, The<BR>
idv Data Analysis and Study Planning<BR>
<A HREF="pcso/pcso108.htm"><A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
<A HREF="pcso/pcso109.htm"><A HREF="pcso/pcso109.htm">IMRO bv</A></A><BR>
INNOVUS Inc.<BR>
<A HREF="pcso/pcso114.htm"><A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
<A HREF="pcso/pcso132.htm"><A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso140.htm"><A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
MEDISCRIBE, INC.<BR>
Mercury Printing, Inc.  (MPI)<BR>
<A HREF="pcso/pcso146.htm"><A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A></A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso161.htm"><A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A></A><BR>
<A HREF="pcso/pcso162.htm"><A HREF="pcso/pcso162.htm">PAREXEL</A></A><BR>
PharmAlliance, Inc.<BR>
PHARMNET, s.r.o.<BR>
<A HREF="pcso/pcso196.htm"><A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso211.htm"><A HREF="pcso/pcso211.htm">Spadille ApS</A></A><BR>
<A HREF="pcso/pcso217.htm"><A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A></A><BR>
STATPROBE, Inc.<BR>
<A HREF="pcso/pcso220.htm"><A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
TRAMARKO<BR>
<A HREF="pcso/pcso230.htm"><A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
Wiedy Clinical Research
<P>
<B>Central Laboratory Services</B><BR>
<A HREF="pcso/pcso11.htm"><A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A></A><BR>
ASTER/CEPHAC<BR>
<A HREF="pcso/pcso12.htm"><A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation</A>)</A><BR>
<A HREF="pcso/pcso56.htm"><A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A></A><BR>
<A HREF="pcso/pcso57.htm"><A HREF="pcso/pcso57.htm">Corning SciCor</A></A><BR>
CRL-MEDINET<BR>
Dynacare Clinical Research Inc.<BR>
ESA Laboratories, Inc.<BR>
INTERLAB - international clinical laboratory and research organisation<BR>
Inveresk Research<BR>
MAPI S.A.<BR>
MDS Clinical Trial Services<BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso139.htm"><A HREF="pcso/pcso139.htm">Medilab Clinical Laboratories AB</A></A><BR>
Pharma Bio-Research International B.V.<BR>
Premier Research Worldwide<BR>
Simbec Research Limited
<P>
<B>Change Management/Implementation</B><BR>
<A HREF="pcso/pcso228.htm"><A HREF="pcso/pcso228.htm">Turning Point Associates, Inc.</A>
<P>
<B>Chemistry/Manufacturing/Controls</B><BR>
AAI<BR>
<A HREF="pcso/pcso10.htm"><A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso58.htm"><A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
<A HREF="pcso/pcso76.htm"><A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A></A><BR>
IPS International Pharmaceutical Services<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso153.htm"><A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Pharmaceutical Development Group, Inc.<BR>
<A HREF="pcso/pcso187.htm"><A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso210.htm"><A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
Springborn Laboratories, Inc.<BR>
Trilsch, William & Associates (WTA)
<P>
<B>Claims Support Studies/Safety and Efficiency Studies</B><BR>
Product Investigations, Inc.
<P>
<B>Client/Server Database Development and Migration</B><BR>
Informatics, Inc.
<P>
<B>Clinical Activity and Cost Benchmarking Services</B><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
Coopers & Lybrand<BR>
Harper, Beth D. - Site Performance Specialist<BR>
<A HREF="pcso/pcso162.htm"><A HREF="pcso/pcso162.htm">PAREXEL</A>
<P>
<B>Clinical Drug Study Labels</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso108.htm"><A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR><A HREF="pcso/pcso130.htm"><A HREF="pcso/pcso130.htm">McKesson BioServices</A></A><BR>
Mercury Printing, Inc.  (MPI)<BR>
<A HREF="pcso/pcso207.htm"><A HREF="pcso/pcso207.htm">SIMIREX INC.</A>
<P>
<B>Clinical Laboratory</B><BR>
<A HREF="pcso/pcso11.htm"><A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A></A><BR>
<A HREF="pcso/pcso12.htm"><A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation</A>)</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso57.htm"><A HREF="pcso/pcso57.htm">Corning SciCor</A></A><BR>
CRL-MEDINET<BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/pcso84.htm"><A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
<A HREF="pcso/pcso94.htm"><A HREF="pcso/pcso94.htm">Harris Laboratories</A></A><BR>
<A HREF="pcso/pcso101.htm"><A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
L.A.B. GmbH & Co.<BR>
MDS Clinical Trial Services<BR>
<A HREF="pcso/pcso139.htm"><A HREF="pcso/pcso139.htm">Medilab Clinical Laboratories AB</A></A><BR>
<A HREF="pcso/pcso162.htm"><A HREF="pcso/pcso162.htm">PAREXEL</A></A><BR>
Simbec Research Limited<BR>
<A HREF="pcso/pcso213.htm"><A HREF="pcso/pcso213.htm">SRL Inc.</A>
<P>
<B>Clinical Logistics, Supplies Software</B><BR>
Almedica International<BR>
<A HREF="pcso/pcso82.htm"><A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A>
<P>
<B>Clinical Packaging</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso56.htm"><A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A></A><BR>
Dow Pharmaceutical Sciences<BR>
ECRON
<P>
<B>Clinical Pharmacology</B><BR>
ASTER/CEPHAC<BR>
<A HREF="pcso/pcso36.htm"><A HREF="pcso/pcso36.htm">Chiltern International Limited</A></A><BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/pcso94.htm"><A HREF="pcso/pcso94.htm">Harris Laboratories</A></A><BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso106.htm"><A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
Inveresk Research<BR>
L.A.B. GmbH & Co.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso162.htm"><A HREF="pcso/pcso162.htm">PAREXEL</A></A><BR>
Pharma Bio-Research International B.V.<BR>
Simbec Research Limited<BR>
U-Gene Research BV<BR>
WHO Collaborating Centre for International Drug Monitoring
<P>
<B>Clinical Study Reports</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm"><A HREF="pcso/pcso3.htm">ACER/EXCEL</A> </A><BR>
Advanced Biomedical Research, Inc.<BR>
ASRU Ltd.<BR>
<A HREF="pcso/pcso18.htm"><A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
Biotechnical Services Inc.<BR>
Bowen, Sherri and Associates<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
Drug Research and Analysis Corporation<BR>
Endpoint Research Ltd.<BR>
Exima<BR>
4C-SONS<BR>
Gad Consulting Services<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
Guidelines, Incorporated<BR>
Harrison Clinical Research GmbH<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
idv Data Analysis and Study Planning<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
MARAS AG<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A></A><BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
Rho, Inc.<BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
S-Cubed<BR>
SEQ Limited<BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A></A><BR>
Stalder, David G.<BR>
STATPROBE, Inc.<BR>
Swe.doc Pharmaceutical Medicine AB
<P>
<B>Clinical Supplies</B><BR>
AAI<BR>
Almedica International<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
BLIS-TECH Corporation<BR>
Dow Pharmaceutical Sciences<BR>
Mercury Printing, Inc.  (MPI)<BR>
Pharmaceutical Development Group, Inc.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
TRAMARKO
<P>
<B>Clinical Supplies Distribution</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
Dow Pharmaceutical Sciences<BR>
Drug Research and Analysis Corporation<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A>
<P>
<B>Clinical Trial Design</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASRU Ltd.<BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Boston Biostatistics, Inc.<BR>
BRI International, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
CLINICA Research Incorporated<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Dynacare Clinical Research Inc.<BR>
EMO Clinical Research<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
Exima<BR>
Guidelines, Incorporated<BR>
Hardardt Group, The<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
idv Data Analysis and Study Planning<BR>
IFE GmbH<BR>
ILEX Oncology Inc.<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
INNOVUS Inc.<BR>
Inveresk Research<BR>
Kendle<BR>
MARAS AG<BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A></A><BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Premier Research Worldwide<BR>
Princeton Biostatistics Group, Inc.<BR>
Product Investigations, Inc.<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
S-Cubed<BR>
SEQ Limited<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
Statcon ApS<BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
TKL Research, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
Wiedy Clinical Research
<P>
<B>Clinical Trial Monitoring</B><BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL </A><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
Boston Biostatistics, Inc.<BR>
BRI International, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
Clinical Solutions<BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/ctss.htm"Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A></A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Drug Research and Analysis Corporation<BR>
Dynacare Clinical Research Inc.<BR>
ECRON<BR>
Endpoint Research Ltd.<BR>
Fraser Williams Pharma Systems<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
Guidelines, Incorporated<BR>
Hardardt Group, The<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
IFE GmbH<BR>
IFNS GmbH<BR>
ILEX Oncology Inc.<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
Inveresk Research<BR>
Kendle<BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
MAPI S.A.<BR>
MARAS AG<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakopius International plc<BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
PHARMNET, s.r.o.<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Premier Research Worldwide<BR>
Product Investigations, Inc.<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
Rho, Inc.<BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
Schiff & Company<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
Stalder, David G.<BR>
STATPROBE, Inc.<BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
Target Research Associates, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
U-Gene Research BV<BR>
VERUM European Clinical Development<BR>
VUJAKLIJA CRO LTD<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
Wiedy Clinical Research<BR>
<P>
<B>CNS Drug R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
Clinical Trial Associates, Inc.SM<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
Endpoint Research Ltd.<BR>
Gad Consulting Services<BR>
Healthcare Services International<BR>
IFE GmbH<BR>
InSite Clinical Trials<BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
L.A.B. GmbH & Co.<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
U-Gene Research BV<BR>
VUJAKLIJA CRO LTD<BR>
<P>
<B>Compassionate Use Trials</B><BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
Clinical Trial Management Services, Inc.<BR>
Concepts in Pharmaceutical Research, Inc.<BR>
Corning PACT<BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
MAPI S.A.<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<P>
<B>Comprehensive Drug and Biologic Development</B><BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
<P>
<B>Computer System Validation</B><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
ClinAudits<BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Informatics, Inc.<BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
Rho, Inc.<BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
Validation Associates, Inc.<BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
<P>
<B>Consumer Awareness</B><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Clinical Solutions<BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Q2 Marketing Research, Inc.<BR>
<P>
<B>Consumer Testing</B><BR>
ASTER/CEPHAC<BR>
Essex Testing Clinic, Inc.<BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Product Investigations, Inc.<BR>
Q2 Marketing Research, Inc.<BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
<P>
<B>Contract Auditing</B><BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
<P>
<B>Cosmetic Product R & D</B><BR>
Advanced Research Management<BR>
ASTER/CEPHAC<BR>
Essex Testing Clinic, Inc.<BR>
<P>
<B>CTX Preparation</B><BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
<P>
<B>DAMOS/CAMA Services</B><BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
<P>
<B>Data Management</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
ASTER/CEPHAC<BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Biotechnical Services Inc.<BR>
Boston Biostatistics, Inc.<BR>
BRI International, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
CLINICA Research Incorporated<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
CRL-MEDINET<BR>
Data Analysis Systems, Inc. (DAS)<BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Dynacare Clinical Research Inc.<BR>
ECRON<BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
Endpoint Research Ltd.<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
Exima<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
Group Syndetic, Inc.<BR>
Harrison Clinical Research GmbH<BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
IDRAC  IMS International<BR>
IFE GmbH<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
InSite Clinical Trials<BR>
Kendle<BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
L.A.B. GmbH & Co.<BR>
MAPI S.A.<BR>
MDS Clinical Trial Services<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
Pharma-Consulting<BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakopius International plc<BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Premier Research Worldwide<BR>
Princeton Biostatistics Group, Inc.<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
Regions Limited Incorporated<BR>
Rho, Inc.<BR>
Schiff & Company<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
Statcon ApS<BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
STATPROBE, Inc.<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
Target Research Associates, Inc.<BR>
TKL Research, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
U-Gene Research BV<BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
VERUM European Clinical Development<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
Wiedy Clinical Research<BR>
<P>
<B>Data Safety Monitoring Board Services</B><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASRU Ltd.<BR>
Boston Biostatistics, Inc.<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
Rho, Inc.<BR>
Western Data Safety Monitoring Board<BR>
<P>
<B>Data Validation</B><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
Exima<BR>
Group Syndetic, Inc.<BR>
IFE GmbH<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Kendle<BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
Pharma-Consulting<BR>
Princeton Biostatistics Group, Inc.<BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
TRAMARKO<BR>
<P>
<B>Database Conversions</B><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
Informatics, Inc.<BR>
<P>
<B>Dental Product R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
Essex Testing Clinic, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
TKL Research, Inc.<BR>
<P>
<B>Dermatology R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
Concepts in Pharmaceutical Research, Inc.<BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
Dow Pharmaceutical Sciences<BR>
Essex Testing Clinic, Inc.<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Target Research Associates, Inc.<BR>
TKL Research, Inc.<BR>
VUJAKLIJA CRO LTD<BR>
<P>
<B>Diabetes R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
CLINICA Research Incorporated<BR>
Clinical Trial Associates, Inc.SM<BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
ECRON<BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
Healthcare Services International<BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
VUJAKLIJA CRO LTD<BR>
<P>
<B>Diagnostic Test Evaluation</B><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
idv Data Analysis and Study Planning<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
Premier Research Worldwide<BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
<P>
<B>Disease Management</B><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
IFE GmbH<BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
<P>
<B>Dissolution Testing</B><BR>
AAI<BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
IBRD Center for Clinical Research (ICCR)<BR>
Laboratoires ADME Bioanalyses<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
Oread<BR>
Pharma Bio-Research International B.V.<BR>
Pharmaceutical Development Group, Inc.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Springborn Laboratories, Inc.<BR>
<P>
<B>DNA Diagnostics</B><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
MDS Clinical Trial Services<BR>
<P>
<B>Document Management</B><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
Coopers & Lybrand<BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
Group Syndetic, Inc.<BR>
IDRAC  IMS International<BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PharmaSoft AB<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
<P>
<B>Drug Master File Dossiers</B><BR>
SEQ Limited<BR>
<P>
<B>Drug Storage</B><BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<P>
<B>Editorial Services</B><BR>
Barton & Polansky Associates, Inc.<BR>
Bowen, Sherri and Associates<BR>
De Milto, Lori, Writer for Rent<BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
MEDISCRIBE, INC.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
<P>
<B>Environmental Assessments</B><BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
Springborn Laboratories, Inc.<BR>
<P>
<B>European Marketing Application/MAA Preparation</B><BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
IDRAC  IMS International<BR>
Pharmakopius International plc<BR>
<P>
<B>Expert Reports</B><BR>
ASRU Ltd.<BR>
BIOKINET GmbH<BR>
CERB Centre de Recherches Biologiques<BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
4C-SONS<BR>
International Research Consultants (IRC)<BR>
IPS International Pharmaceutical Services<BR>
Kern McNeill International<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
MARAS AG<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
SEQ Limited<BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<P>
<B>Financial Consulting</B><BR>
Pennsylvania Merchant Group Ltd.<BR>
<P>
<B>Formulation Development</B><BR>
AAI<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Coopers & Lybrand<BR>
Dow Pharmaceutical Sciences<BR>
Oread<BR>
Pharmaceutical Development Group, Inc.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
<P>
<B>Gastrointestinal Drug R & D</B><BR>
Advanced Research Management<BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
ECRON<BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
Harrison Clinical Research GmbH<BR>
IFE GmbH<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
U-Gene Research BV<BR>
VUJAKLIJA CRO LTD<BR>
<P>
<B>GCP Compliance</B><BR>
Barton & Polansky Associates, Inc.<BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
Biotechnical Services Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
ClinAudits<BR>
Concepts in Pharmaceutical Research, Inc.<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
Dynacare Clinical Research Inc.<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
<A HREF="pcso/pcso86.htm">Good Clinical Research Practices Limited</A><BR>
Guidelines, Incorporated<BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Hardardt Group, The<BR>
Hurd & Associates, Inc.<BR>
Medi-Lab A/S<BR>
MOR Research Applications Ltd.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
Pharma-Consulting<BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
Product Investigations, Inc.<BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
Stalder, David G.<BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
<P>
<B>Genetics Research</B><BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
<P>
<B>GLP Compliance</B><BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
Biotechnical Services Inc.<BR>
CERB Centre de Recherches Biologiques<BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
CRL-MEDINET<BR>
ESA Laboratories, Inc.<BR>
Frederick Research Center, Southern Research Institute<BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Hurd & Associates, Inc.<BR>
INTERLAB - international clinical laboratory and research organisation<BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
Pharmakon Research International<BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
Springborn Laboratories, Inc.<BR>
Trilsch, William & Associates (WTA)<BR>
<P>
<B>GMP Compliance</B><BR>
AAI<BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
BRI International, Inc.<BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Hurd & Associates, Inc.<BR>
IPS International Pharmaceutical Services<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharmaceutical Development Group, Inc.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
Schiff & Company<BR>
Trilsch, William & Associates (WTA)<BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
<P>
<B>GMP Manufacturing: Clinical/Commercial Supply</B><BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
ILEX Oncology Inc.<BR>
<P>
<B>Health Economics</B><BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
<P>
<B>Hematology R & D</B><BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
<A HREF="pcso/pcso139.htm">Medilab Clinical Laboratories AB</A><BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<P>
<B>Histopathology/Cytology</B><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
<P>
<B>Home-Based Assessments of and Health Care for Study Participants</B><BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<P>
<B>Home Infusion of Investigational Drugs</B><BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<P>
<B>Immunomodulator R & D</B><BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
U-Gene Research BV<BR>
<P>
<B>IND Preparation</B><BR>
Advanced Biomedical Research, Inc.<BR>
Biotechnical Services Inc.<BR>
Bowen, Sherri and Associates<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
Frederick Research Center, Southern Research Institute<BR>
Guidelines, Incorporated<BR>
Hurd & Associates, Inc.<BR>
ILEX Oncology Inc.<BR>
IPS International Pharmaceutical Services<BR>
Locus Medicus, Inc.<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
Pharmaceutical Development Group, Inc.<BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
Schiff & Company<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
Trilsch, William & Associates (WTA)<BR>
<P>
<B>Indexing</B><BR>
<A HREF="pcso/pcso70.htm">Elsevier Science, Secondary Publishing Division</A><BR>
<P>
<B>Inpatient Facility</B><BR>
CLINICA Research Incorporated<BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
IBRD Center for Clinical Research (ICCR)<BR>
L.A.B. GmbH & Co.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Premier Research Worldwide<BR>
<P>
<B>Institutional Review Board Services</B><BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
Western International Review Board<BR>
<P>
<B>Intra/Internet Development</B><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
De Milto, Lori, Writer for Rent<BR>
<P>
<B>Investigational Site/Network</B><BR>
Drug Research and Analysis Corporation<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
<P>
<B>Investigator Brochures</B><BR>
Advanced Biomedical Research, Inc.<BR>
Biotechnical Services Inc.<BR>
Bowen, Sherri and Associates<BR>
4C-SONS<BR>
Guidelines, Incorporated<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
Locus Medicus, Inc.<BR>
Medical Industries Corp.<BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
<P>
<B>Investigator Recruiting</B><BR>
Barton & Polansky Associates, Inc.<BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
Clinical Solutions<BR>
Clinical Trial Associates, Inc.SM<BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Drug Research and Analysis Corporation<BR>
ECRON<BR>
Endpoint Research Ltd.<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
GTFH Clinical Trial Recruitment<BR>
Harper, Beth D. - Site Performance Specialist<BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
Innovex Ltd.<BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
Inveresk Research<BR>
MAPI S.A.<BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
Oxford Research International Corp.<BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
PHARMNET, s.r.o.<BR>
Premier Research Worldwide<BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
Swe.doc Pharmaceutical Medicine AB<BR>
VERUM European Clinical Development<BR>
VUJAKLIJA CRO LTD<BR>
Wiedy Clinical Research<BR>
<P>
<B>Investigators' Meetings</B><BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
Clinical Solutions<BR>
Concepts in Pharmaceutical Research, Inc.<BR>
Concepts Meeting & Trade Show Management, Inc.<BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
CRL-MEDINET<BR>
Dynacare Clinical Research Inc.<BR>
Harper, Beth D. - Site Performance Specialist<BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
Kern McNeill International<BR>
Medical Industries Corp.<BR>
MediciGroupTM Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PHARMNET, s.r.o.<BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<P>
<B>Leadership Development</B><BR>
<A HREF="pcso/pcso228.htm">Turning Point Associates, Inc.</A><BR>
<P>
<B>Licensing</B><BR>
Locus Medicus, Inc.<BR>
<P>
<B>Managed Care: Clinical, Health Economics, Organizations, Outcomes Research and Consulting</B><BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
<P>
<B>Manuscript Preparation</B><BR>
Advanced Biomedical Research, Inc.<BR>
Biotechnical Services Inc.<BR>
Bowen, Sherri and Associates<BR>
De Milto, Lori, Writer for Rent<BR>
4C-SONS<BR>
Gad Consulting Services<BR>
Hurd & Associates, Inc.<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
<P>
<B>Market Research</B><BR>
MediciGroupTM Inc.<BR>
NFO Research, Inc.<BR>
Pennsylvania Merchant Group Ltd.<BR>
Q2 Marketing Research, Inc.<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
<P>
<B>Mass Spectrometry</B><BR>
Advanced BioAnalytical Services, Inc.<BR>
<P>
<B>Medical Writing</B><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASTER/CEPHAC<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Bowen, Sherri and Associates<BR>
BRI International, Inc.<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
De Milto, Lori, Writer for Rent<BR>
Exima<BR>
4C-SONS<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
Hardardt Group, The<BR>
IFNS GmbH<BR>
ILEX Oncology Inc.<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
MARAS AG<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
MORIAH Consultants<BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
Princeton Biostatistics Group, Inc.<BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
Schiff & Company<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
SEQ Limited<BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
STATPROBE, Inc.<BR>
Target Research Associates, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
Trilsch, William & Associates (WTA)<BR>
VERUM European Clinical Development<BR>
Wiedy Clinical Research<BR>
<P>
<B>Metabolism Studies</B><BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<P>
<B>Microbiology Testing and Services</B><BR>
AAI<BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
<A HREF="pcso/pcso57.htm">Corning SciCor</A><BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
Magellan Laboratories Incorporated<BR>
MDS Clinical Trial Services<BR>
<A HREF="pcso/pcso139.htm">Medilab Clinical Laboratories AB</A><BR>
Oread<BR>
Springborn Laboratories, Inc.<BR>
<P>
<B>NDA Preparation</B><BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Biotechnical Services Inc.<BR>
Bowen, Sherri and Associates<BR>
BRI International, Inc.<BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
Guidelines, Incorporated<BR>
Hurd & Associates, Inc.<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
IDRAC  IMS International<BR>
ILEX Oncology Inc.<BR>
International Research Consultants (IRC)<BR>
Kendle<BR>
Locus Medicus, Inc.<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
Schiff & Company<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
STATPROBE, Inc.<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
Trilsch, William & Associates (WTA)<BR>
<P>
<B>Neuroscience, Urology, Internal Medicine R&D</B><BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
<P>
<B>Non-clinical Pharmacology</B><BR>
CERB Centre de Recherches Biologiques<BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
IPS International Pharmaceutical Services<BR>
Oread<BR>
Pharmakon Research International<BR>
<P>
<B>Nursing Services</B><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<P>
<B>Nutrition Analysis/Assessment Services</B><BR>
CLINICA Research Incorporated<BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<P>
<B>Oncologic Drug R & D</B><BR>
Berger-Boyer & Associates, Inc.<BR>
Cincinnati Clinical Consultants, Inc.<BR>
Clinical Trial Associates, Inc.SM<BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
Endpoint Research Ltd.<BR>
Gad Consulting Services<BR>
ILEX Oncology Inc.<BR>
Kern McNeill International<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
L.A.B. GmbH & Co.<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
VUJAKLIJA CRO LTD<BR>
<P>
<B>Outpatient Facility</B><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
CLINICA Research Incorporated<BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
EMO Clinical Research<BR>
Essex Testing Clinic, Inc.<BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
TKL Research, Inc.<BR>
<P>
<B>Packaging of Clinical Supplies</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
<P>
<B>Patient Compliance</B><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
GTFH Clinical Trial Recruitment<BR>
Harper, Beth D. - Site Performance Specialist<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
MediciGroupTM Inc.<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<P>
<B>Patient Education</B><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Clinical Solutions<BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
GTFH Clinical Trial Recruitment<BR>
Harper, Beth D. - Site Performance Specialist<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
MediciGroupTM Inc.<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<P>
<B>Patient Information Leaflets (PIL), Labelling</B><BR>
SEQ Limited<BR>
<P>
<B>Patient Recruitment</B><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Clinical Solutions<BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
EMO Clinical Research<BR>
Essex Testing Clinic, Inc.<BR>
<A HREF="pcso/pcso84.htm">GFI Pharmaceutical Services, Inc.</A><BR>
GTFH Clinical Trial Recruitment<BR>
Harper, Beth D. - Site Performance Specialist<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
IBRD Center for Clinical Research (ICCR)<BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
InSite Clinical Trials<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
MediciGroupTM Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
STAT, inc.<BR>
Telerx<BR>
TKL Research, Inc.<BR>
<P>
<B>Pharmaceutical Clinical Packaging</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
<P>
<B>Pharmaco EEG Studies</B><BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<P>
<B>Pharmacoeconomic Studies</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Boston Biostatistics, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
Corning PACT<BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Data Analysis Systems, Inc. (DAS)<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
Exima<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
IFE GmbH<BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
Kendle<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
MAPI S.A.<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
MetaWorks Inc.<BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
Phase V Technologies, Inc.<BR>
Regions Limited Incorporated<BR>
Schiff & Company<BR>
STATPROBE, Inc.<BR>
Target Research Associates, Inc.<BR>
TKL Research, Inc.<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
Wiedy Clinical Research<BR>
<P>
<B>Pharmacoepidemiology Studies</B><BR>
Abt Associates Inc.<BR>
Corning PACT<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
<A HREF="pcso/pcso108.htm">Imperial Graphics, Inc.</A><BR>
MAPI S.A.<BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
<P>
<B>Pharmacokinetic / Pharmacodynamic Modeling</B><BR>
ASTER/CEPHAC<BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
Laboratoires ADME Bioanalyses<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Simbec Research Limited<BR>
<P>
<B>Pharmacokinetics</B><BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
ASTER/CEPHAC<BR>
BARC (Bioa Analytical Research Corporation)<BR>
BIOKINET GmbH<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
ECRON<BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
Inveresk Research<BR>
L.A.B. GmbH & Co.<BR>
Laboratoires ADME Bioanalyses<BR>
Locus Medicus, Inc.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
Oread<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma Bio-Research International B.V.<BR>
Pharmakon Research International<BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
Princeton Biostatistics Group, Inc.<BR>
Simbec Research Limited<BR>
Springborn Laboratories, Inc.<BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
U-Gene Research BV<BR>
<P>
<B>Pharmacovigilance</B><BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
Kendle<BR>
Norwich Clinical Research Associates Ltd.<BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
U-Gene Research BV<BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Physician-Patient Communications Training</B><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
De Milto, Lori, Writer for Rent<BR>
GTFH Clinical Trial Recruitment<BR>
MediciGroupTM Inc.<BR>
<P>
<B>PLA Preparation</B><BR>
ASG, Inc./CORE<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
Biotechnical Services Inc.<BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
IDRAC  IMS International<BR>
International Research Consultants (IRC)<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharmaceutical Development Group, Inc.<BR>
Regions Limited Incorporated<BR>
Schiff & Company<BR>
Trilsch, William & Associates (WTA)<BR>
<P>
<B>Preclinical Development Services</B><BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
<P>
<B>Process Validation</B><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
Coopers & Lybrand<BR>
IPS International Pharmaceutical Services<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Oread<BR>
Pharmaceutical Development Group, Inc.<BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
Schiff & Company<BR>
Trilsch, William & Associates (WTA)<BR>
<P>
<B>Programming (Database, SAS, etc)</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
Boston Biostatistics, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Clinical Trial Management Services, Inc.<BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
CRL-MEDINET<BR>
Data Analysis Systems, Inc. (DAS)<BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
Group Syndetic, Inc.<BR>
Informatics, Inc.<BR>
INNOVUS Inc.<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PharmaSoft AB<BR>
Rho, Inc.<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
Statcon ApS<BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
STATPROBE, Inc.<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
Target Research Associates, Inc.<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Project Management</B><BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
<A HREF="pcso/pcso8.htm">Alliance Telemanagement, Inc.</A><BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
Boston Biostatistics, Inc.<BR>
BRI International, Inc.<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
ClinAudits<BR>
CLINICA Research Incorporated<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso56.htm">Corning Pharmaceutical Services</A><BR>
CRL-MEDINET<BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Drug Research and Analysis Corporation<BR>
Dynacare Clinical Research Inc.<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
Hardardt Group, The<BR>
Harrison Clinical Research GmbH<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
IDRAC  IMS International<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
Inveresk Research<BR>
Kendle<BR>Kern McNeill International<BR>
MARAS AG<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Oxford Research International Corp.<BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
PHARMNET, s.r.o.<BR>
Phase V Technologies, Inc.<BR>
Product Investigations, Inc.<BR>
Regions Limited Incorporated<BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
Simbec Research Limited<BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
TKL Research, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
VERUM European Clinical Development<BR>
VUJAKLIJA CRO LTD<BR>
Wiedy Clinical Research<BR>
<P>
<B>Protocol Development</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso7.htm">Affiliated Research Centers, Inc.</A><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
C.I.T. Centre International de Toxicologie<BR>
CLINICA Research Incorporated<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
Continuous Health Improvement Program, Geisinger Health Plans<BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
CRN/Asthma and Allergy Network, Inc.<BR>
Dynacare Clinical Research Inc.<BR>
EMO Clinical Research<BR>
Endpoint Research Ltd.<BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
ESA Laboratories, Inc.<BR>
Essex Testing Clinic, Inc.<BR>
Exima<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
Guidelines, Incorporated<BR>
Hardardt Group, The<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
Harrison Clinical Research GmbH<BR>
Healthcare Services International<BR>
IBRD Center for Clinical Research (ICCR)<BR>
idv Data Analysis and Study Planning<BR>
IFNS GmbH<BR>
ILEX Oncology Inc.<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
INNOVUS Inc.<BR>
<A HREF="pcso/pcso114.htm">Integrated Research Inc.</A><BR>
Inveresk Research<BR>
MARAS AG<BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
MediciGroupTM Inc.<BR>
MEDISCRIBE, INC.<BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/paragon.htm">Paragon Biomedical, Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
PharmAlliance, Inc.<BR>
PHARMNET, s.r.o.<BR>
Phase V Technologies, Inc.<BR>
Princeton Biostatistics Group, Inc.<BR>
Product Investigations, Inc.<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso199.htm">Rohrbaugh Associates, Inc.</A><BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
STATPROBE, Inc.<BR>
Swe.doc Pharmaceutical Medicine AB<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
VERUM European Clinical Development<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
<P>
<B>Protocol Simulation</B><BR>
Harper, Beth D. - Site Performance Specialist<BR>
<P>
<B>Pulmonary Diagnostics</B><BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
<P>
<B>Quality Assurance/Control</B><BR>
ASRU Ltd.<BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
Bowen, Sherri and Associates<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
ClinAudits<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
Concepts in Pharmaceutical Research, Inc.<BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
CRL-MEDINET<BR>
Dynacare Clinical Research Inc.<BR>
ESA Laboratories, Inc.<BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
<A HREF="pcso/pcso86.htm">Good Clinical Research Practices Limited</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Hurd & Associates, Inc.<BR>
Innovex Ltd.<BR>
IPS International Pharmaceutical Services<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
MDS Clinical Trial Services<BR>
Medi-Lab A/S<BR>
<A HREF="pcso/pcso149.htm">NCGS and Associates, Inc.</A><BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
Rho, Inc.<BR>
S-Cubed<BR>
Simbec Research Limited<BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
Stalder, David G.<BR>
TRAMARKO<BR>
Trilsch, William & Associates (WTA)<BR>
Validation Associates, Inc.<BR>
VERUM European Clinical Development<BR>
Wiedy Clinical Research<BR>
<P>
<B>Quality of Life Assessment</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
Boston Biostatistics, Inc.<BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
GTFH Clinical Trial Recruitment<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
INNOVUS Inc.<BR>
MAPI S.A.<BR>
NFO Research, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
<A HREF="pcso/pcso169.htm">Partners In Research, Inc.</A><BR>
PharmAlliance, Inc.<BR>
Phase V Technologies, Inc.<BR>
Princeton Biostatistics Group, Inc.<BR>
Target Research Associates, Inc.<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
<P>
<B>Randomization (Automated, Centralized, Vocal Computer)</B><BR>
4C-SONS<BR>
<P>
<B>Registration Dossiers</B><BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
IDRAC  IMS International<BR>
International Research Consultants (IRC)<BR>
JAPANESE LANGUAGE SERVICES LTD<BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
Magellan Laboratories Incorporated<BR>
MARAS AG<BR>
Medical Industries Corp.<BR>
MEDISCRIBE, INC.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
Pharma-Consulting<BR>
SEQ Limited<BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
Springborn Laboratories, Inc.<BR>
<P>
<B>Regulatory Affairs</B><BR>
AAI<BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
BRI International, Inc.<BR>
CERB Centre de Recherches Biologiques<BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Cincinnati Clinical Consultants, Inc.<BR>
C.I.T. Centre International de Toxicologie<BR>
ClinAudits<BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
<A HREF="pcso/pcso58.htm">Coromed, Inc.</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
<A HREF="pcso/glenmere.htm">Glenmere Research</A><BR>
Guidelines, Incorporated<BR>
Hurd & Associates, Inc.<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
IDRAC  IMS International<BR>
ILEX Oncology Inc.<BR>
Innovex Ltd.<BR>
International Research Consultants (IRC)<BR>
JAPANESE LANGUAGE SERVICES LTD<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
L.A.B. GmbH & Co.<BR>
<A HREF="pcso/pcso125.htm">LOGOS GmbH</A><BR>
Magellan Laboratories Incorporated<BR>
MARAS AG<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
MOR Research Applications Ltd.<BR>
MORIAH Consultants<BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Oread<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
Pharmaceutical Development Group, Inc.<BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakon Research International<BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
PHARMNET, s.r.o.<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
Regions Limited Incorporated<BR>
Schiff & Company<BR>
SEQ Limited<BR>
<A HREF="pcso/pcso205.htm">SHARK dm Co.</A><BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
Stalder, David G.<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
VERUM European Clinical Development<BR>
VUJAKLIJA CRO LTD<BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Remote Data Entry</B><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
Data Analysis Systems, Inc. (DAS)<BR>
Exima<BR>
First Image Data Acquisition Division<BR>
Group Syndetic, Inc.<BR>
GXP International<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
IFNS GmbH<BR>
Informatics, Inc.<BR>
Innovex Ltd.<BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
PharmAlliance, Inc.<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Rx to OTC Switch</B><BR>
Advanced Research Management<BR>
Berger-Boyer & Associates, Inc.<BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
Corning PACT<BR>
<A HREF="pcso/pcso59.htm">Covalent Research Alliance Corp.</A><BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
Essex Testing Clinic, Inc.<BR>
Hardardt Group, The<BR>
International Research Consultants (IRC)<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
Product Investigations, Inc.<BR>
Q2 Marketing Research, Inc.<BR>
<A HREF="pcso/pcso196.htm">Research Services, Inc.</A><BR>
<A HREF="pcso/pcso197.htm">Research Testing Laboratories, Inc.</A><BR>
<A HREF="pcso/pcso208.htm">Slone Epidemiology Unit</A><BR>
Target Research Associates, Inc.<BR>
TKL Research, Inc.<BR>
<P>
<B>Shipments of Clinical Supplies</B><BR>
Almedica International<BR>
BLIS-TECH Corporation<BR>
CRL-MEDINET<BR>
Dow Pharmaceutical Sciences<BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
<P>
<B>Site Performance Metrics</B><BR>
Harper, Beth D. - Site Performance Specialist<BR>
<P>
<B>Software Development & Evaluation</B><BR>
<A HREF="pcso/pcso18.htm">Beardsworth Consulting Group, Inc.</A><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso47.htm">CompleWare Corporation</A><BR>
<A HREF="pcso/pcso64.htm">DLB Systems, Inc.</A><BR>
Electronic Submission Publishing Systems  (ESPS), Inc.<BR>
Exima<BR>
Fraser Williams Pharma Systems<BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
Group Syndetic, Inc.<BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
idv Data Analysis and Study Planning<BR>
Informatics, Inc.<BR>
IPS International Pharmaceutical Services<BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
PharmaSoft AB<BR>
<A HREF="pcso/pcso186.htm">Phoenix International Life Sciences Inc.</A><BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
Validation Associates, Inc.<BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Solid Dosage Bottle Filling/Packaging</B><BR>
Almedica International<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
Pharmaceutical Service Division, University of Iowa<BR>
<A HREF="pcso/pcso207.htm">SIMIREX INC.</A><BR>
<P>
<B>Spirometry/Challenge Testing</B><BR>
<A HREF="pcso/pcso23.htm">Biomedical Systems</A><BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso97.htm">HealthQuest Research</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/pcso170.htm">PDS Research</A><BR>
Simbec Research Limited<BR>
<P>
<B>Stability Studies</B><BR>
AAI<BR>
<A HREF="pcso/pcso10.htm">Analytical Bio-Chemistry Laboratories, Inc.</A><BR>
Dow Pharmaceutical Sciences<BR>
IBRD Center for Clinical Research (ICCR)<BR>
L.A.B. GmbH & Co.<BR>
Laboratoires ADME Bioanalyses<BR>
Magellan Laboratories Incorporated<BR>
<A HREF="pcso/pcso157.htm">Oneida Research Services, Inc.</A><BR>
Oread<BR>
Pharmaceutical Development Group, Inc.<BR>
Pharmaceutical Service Division, University of Iowa<BR>
Springborn Laboratories, Inc.<BR>
<P>
Standard Operating Procedures<BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso26.htm">BioResearch Monitors, Inc.</A><BR>
ClinAudits<BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
<A HREF="pcso/pcso86.htm">Good Clinical Research Practices Limited</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
GXP International<BR>
Hardardt Group, The<BR>
Hurd & Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso187.htm">Phoenix Regulatory Associates, Ltd.</A><BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
<A HREF="pcso/pcso210.htm">Solutions, Inc. by Fix and Co.</A><BR>
Stalder, David G.<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
Validation Associates, Inc.<BR>
<P>
<B>Statistical Services</B><BR>
Abt Associates Inc.<BR>
<A HREF="pcso/pcso3.htm">ACER/EXCEL</A><BR>
Advanced Biomedical Research, Inc.<BR>
<A HREF="pcso/pcso12.htm">Applied Logic Associates, Inc.</A><BR>
ASG, Inc./CORE<BR>
ASRU Ltd.<BR>
ASTER/CEPHAC<BR>
Barton & Polansky Associates, Inc.<BR>
<A HREF="pcso/pcso24.htm">Bio-Pharm Clinical Services</A><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Biotechnical Services Inc.<BR>
Boston Biostatistics, Inc.<BR>
BZT Biometric Centre for Therapeutic Studies<BR>
<A HREF="pcso/pcso33.htm">Canadian HIV Trials Network</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso36.htm">Chiltern International Limited</A><BR>
Clinical Investigation Support Ges.mbH. & Co., KG<BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso46.htm">ClinTrials Research Inc.</A><BR>
<A HREF="pcso/pcso52.htm">Copenhagen Trial Unit</A><BR>
<A HREF="pcso/pcso53.htm">Corning Besselaar</A><BR>
Data Analysis Systems, Inc. (DAS)<BR>
ECRON<BR>
Exima<BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
Guidelines, Incorporated<BR>
<A HREF="pcso/pcso94.htm">Harris Laboratories</A><BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
<A HREF="pcso/pcso101.htm">ICON Clinical Research, Inc.</A><BR>
idv Data Analysis and Study Planning<BR>
IFE GmbH<BR>
IFNS GmbH<BR>
<A HREF="pcso/pcso109.htm">IMRO bv</A><BR>
Innovex Ltd.<BR>
INNOVUS Inc.<BR>
Inveresk Research<BR>
Kendle<BR>
MAPI S.A.<BR>
<A HREF="pcso/pcso132.htm">MEDEX, Inc.</A><BR>
<A HREF="pcso/pcso133.htm">MedFocus, Inc.</A><BR>
<A HREF="pcso/pcso135.htm">Medical Research Services, Ltd.</A><BR>
Medical & Technical Research Associates, Inc. (MTRA)<BR>
<A HREF="pcso/pcso142.htm">MEDISEARCH INT. (MSI)</A><BR>
<A HREF="pcso/pcso143.htm">MediTech International Co., Ltd.</A><BR>
MetaWorks Inc.<BR>
<A HREF="pcso/pcso146.htm">METRONOMIA GmbH</A><BR>
MOR Research Applications Ltd.<BR>
<A HREF="pcso/pcso151.htm">Neuroclinical Trials Center</A><BR>
Norwich Clinical Research Associates Ltd.<BR>
<A HREF="pcso/pcso155.htm">NovaTech Sciences Corporation</A><BR>
Oxford Research International Corp.<BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso161.htm">Padcom Clinical Research GmbH</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pharma-Consulting<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/prc.htm">Pharmaceutical Resource Corporation</A><BR>
<A HREF="pcso/pcso178.htm">Pharmaco International Inc.</A><BR>
Pharmakopius International plc<BR>
PharmAlliance, Inc.<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
PHARMNET, s.r.o.<BR>
Phase V Technologies, Inc.<BR>
Premier Research Worldwide<BR>
Princeton Biostatistics Group, Inc.<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
Rho, Inc.<BR>
SciAn Clinical, Division of SciAn Services Inc.<BR>
<A HREF="pcso/pcso202.htm">SCIREX Corporation</A><BR>
S-Cubed<BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
<A HREF="pcso/pcso213.htm">SRL Inc.</A><BR>
Statcon ApS<BR>
<A HREF="pcso/pcso217.htm">Statistics and Epidemiology Research Corporation</A><BR>
STATPROBE, Inc.<BR>
<A HREF="pcso/pcso220.htm">SYNERGOS, Inc.</A><BR>
Target Research Associates, Inc.<BR>
TKL Research, Inc.<BR>
TRAMARKO<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
U-Gene Research BV<BR>
VERUM European Clinical Development<BR>
<A HREF="pcso/pcso235.htm">Westat, Inc.</A><BR>
Wiedy Clinical Research<BR>
<P>
<B>Strategic Planning and Implementation</B><BR>
Biopharmaceutical Research Consultants, Inc. (BRCI)<BR>
Boston Biostatistics, Inc.<BR>
BRI International, Inc.<BR>
CERB Centre de Recherches Biologiques<BR>
Cincinnati Clinical Consultants, Inc.<BR>
C.I.T. Centre International de Toxicologie<BR>
Coopers & Lybrand<BR>
Data Analysis Systems, Inc. (DAS)<BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso140.htm">Mediscience Planning Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso153.htm">NJC Enterprises, Ltd.</A><BR>
Pacific Research Associates, Inc.<BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
Pennsylvania Merchant Group Ltd.<BR>
<A HREF="pcso/pcso175.htm">Pharmaceutical Consultants, Inc.</A><BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
Q2 Marketing Research, Inc.<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso228.htm">Turning Point Associates, Inc.</A><BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
<P>
<B>Taste Testing</B><BR>
EMO Clinical Research<BR>
<P>
<B>Technology Assessment</B><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso34.htm">CB Technologies, Inc.</A><BR>
<A HREF="pcso/pcso73.htm">Epidemiology Resources Inc.</A><BR>
<A HREF="pcso/pcso76.htm">European Regulatory Affairs Group, The</A><BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
Informatics, Inc.<BR>
Locus Medicus, Inc.<BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A>/S&FA<BR>
Phase V Technologies, Inc.<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
<A HREF="pcso/pcso234.htm">Waife & Associates, Inc.</A><BR>
<P>
<B>Telephone Support</B><BR>
MediciGroupTM Inc.<BR>
<P>
<B>Temporary Services</B><BR>
ASG, Inc./CORE<BR>
<A HREF="pcso/pcso21.htm">BFR Systems, Inc.</A><BR>
<A HREF="pcso/pcso41.htm">Clinical R&D Services Corp.</A><BR>
<A HREF="pcso/ctss.htm">Clinical Trials Support Services, Inc.</A><BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
Group Syndetic, Inc.<BR>
Hurd & Associates, Inc.<BR>
<A HREF="pcso/pcso156.htm">Olsten Kimberly QualityCare</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PHARMNET, s.r.o.<BR>
<A HREF="pcso/pcso211.htm">Spadille ApS</A><BR>
Stalder, David G.<BR>
<A HREF="pcso/pcso226.htm">Trilogy Consulting Corporation</A><BR>
VERUM European Clinical Development<BR>
<P>
<B>Toxicology</B><BR>
CERB Centre de Recherches Biologiques<BR>
C.I.T. Centre International de Toxicologie<BR>
<A HREF="pcso/pcso45.htm">ClinTrials BioResearch Ltd.</A><BR>
<A HREF="pcso/pcso54.htm">Corning Hazleton</A><BR>
Frederick Research Center, Southern Research Institute<BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
ILEX Oncology Inc.<BR>
INTERLAB - international clinical laboratory and research organisation<BR>
Inveresk Research<BR>
IPS International Pharmaceutical Services<BR>
Oread<BR>
Pharmakon Research International<BR>
Pharmakopius International plc<BR>
<A HREF="pcso/pcso193.htm">Quintiles Emerging Companies Institute</A><BR>
Springborn Laboratories, Inc.<BR>
WHO Collaborating Centre for International Drug Monitoring<BR>
<P>
<B>Training</B>
AAI<BR>
ClinAudits<BR>
CLINICA Research Incorporated<BR>
<A HREF="pcso/pcso85.htm">gmi, gesellschaft fuer angewandte mathematik und informatik mbh</A><BR>
<A HREF="pcso/pcso86.htm">Good Clinical Research Practices Limited</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
Harper, Beth D. - Site Performance Specialist<BR>
Healthcare Services International<BR>
<A HREF="pcso/pcso100.htm">IBRD-ROSTRUM GLOBAL, Inc.</A><BR>
Innovex Ltd.<BR>
InSite Clinical Trials<BR>
MARAS AG<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PFC, Pharma Focus Consultants, Ltd.<BR>
<A HREF="pcso/pcso192.htm"> Quality and Compliance Consulting, Inc. (qc2)</A><BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
Rho, Inc.<BR>
S-Cubed<BR>
<A HREF="pcso/pcso209.htm">Software Product Services (SPS) Ltd.</A><BR>
Stalder, David G.<BR>
Trilsch, William & Associates (WTA)<BR>
Validation Associates, Inc.<BR>
<P>
<B>Translations</B><BR>
ASTER/CEPHAC<BR>
4C-SONS<BR>
JAPANESE LANGUAGE SERVICES LTD<BR>
Medical Industries Corp.<BR>
<A HREF="pcso/pcso182.htm">PHARMAPART AG</A><BR>
PHARMNET, s.r.o.<BR>
<P>
Treatment IND Implementation<BR>
Corning PACT<BR>
ECRON<BR>
Kern McNeill International<BR>
<A HREF="pcso/pcso130.htm">McKesson BioServices</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
<P>
Vaccine Development<BR>
Cincinnati Clinical Consultants, Inc.<BR>
<P>
<B>Variation Applications</B><BR>
SEQ Limited<BR>
<P>
Veterinary Clinical Chemistry & Hematology<BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
Gad Consulting Services<BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
Medi-Lab A/S<BR>
<P>
<B>Virology</B>
<A HREF="pcso/pcso11.htm">ANAWA Laboratories AG</A><BR>
<A HREF="pcso/pcso16.htm">BARC (Bio Analytical Research Corporation)</A><BR>
Frederick Research Center, Southern Research Institute<BR>
<A HREF="pcso/pcso106.htm">IIT Research Institute (IITRI)</A><BR>
INTERLAB - international clinical laboratory and research organisation<BR>
L.A.B. Biopharmaceutical Research International Inc.<BR>
<P>
<B>Workflow Assessment/Re-engineering</B><BR>
<A HREF="pcso/pcso19.htm">Belmont Research, Inc.</A><BR>
ClinAudits<BR>
Coopers & Lybrand<BR>
<A HREF="pcso/pcso82.htm">Frontier Technology, Inc.</A><BR>
<A HREF="pcso/pcso90.htm">GXP Consulting</A><BR>
Harper, Beth D. - Site Performance Specialist<BR>
Informatics, Inc.<BR>
<A HREF="pcso/pcso129.htm">McCarthy Consultant Services Inc.</A><BR>
<A HREF="pcso/pcso150.htm">NetForce Incorporated</A><BR>
<A HREF="pcso/pcso162.htm">PAREXEL</A><BR>
PharmaSoft AB<BR>
<A HREF="pcso/pcso195.htm">Research Dynamics Consulting Group, Ltd.</A><BR>
Stalder, David G.<BR>
<A HREF="pcso/pcso225.htm">Trilogy Associates, Inc.</A><BR>
<A HREF="pcso/pcso228.htm">Turning Point Associates, Inc.</A><BR>
<A HREF="pcso/pcso230.htm">Universal Systems Inc.</A><BR>
Waife & Associates, Inc<BR>






</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-96</DOCNO>
<DOCOLDNO>IA050-000869-B026-253</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp6a.htm 199.92.136.137 19970111134733 text/html 5175
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:49:12 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:52 GMT
Content-length: 4984
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><META NAME="GENERATOR" CONTENT="Internet Assistant for Word 1.0Z"><TITLE>Research Grants Program</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
GRANTS AND AWARDS
<P>
<CENTER><STRONG> RESEARCH GRANTS PROGRAM</STRONG></CENTER><BR>
<P>
<HR>
<P>
<I><B>ABOUT THE DIA</B></I><HR>
The DIA is an independent, international association of professionals
from all disciplines associated with research, development, monitoring,
documenting, and regulating pharmacotherapeutic products, in industry,
government, and academia. The mission of the DIA is to provide
a worldwide forum for the exchange and dissemination of information
that is intended to advance the discovery, development, evaluation,
and utilization of medicines and related health care technologies.
<P>
<I><B>DIA RESEARCH GRANT PROGRAM</B></I><HR>
The <I>DIA Research Grant Program</I> has been developed to encourage
and foster research in areas pertaining to pharmaceutical and
biotechnology product development, regulation, marketing, utilization,
and surveillance. One-year grants of up to $25,000 will be awarded
on the basis of the quality of the research and contribution to
the mission of the DIA.
<P>
<I><B>APPLICATION CRITERIA AND PROCEDURES</B></I><HR>

<UL>
<LI>Proposals from DIA members and non-members will be considered.
However, applicants must be affiliated with not-for-profit organizations.
<LI>Research grant proposals may be submitted at any time but
will be reviewed once per year. Proposals submitted after February
1 will be considered in the following funding cycle.
<LI>Proposals should be written in English and be no more than
10 pages in length.
<LI>Proposals must be for studies that can be completed in a 12-month
period.
<LI>Proposals need not follow any specific format. Required elements
are as follows:
<UL>
<OL><LI>Abstract of proposed research.
<LI>Detailed project description - including rationale, objectives,
and methodologies to be used. Should also describe how proposed
research fits in with the goals and objectives of the DIA.
<LI>Key study personnel - qualifications, disciplines, and affiliations.
<LI>Financial and budget information - amount (up to $25,000)
and duration of requested support, line item budget, and additional
sources of funding, if any.
</OL></UL>

<LI>Grants may <I><B>not</B></I> include overhead, may <I><B>not</B></I>
be used to acquire capital equipment, and may <I><B>not</B></I>
cover more than 10% of investigator salaries.
<LI>Proposals should be sent to the DIA to the attention of the
Executive Director at the address below. Applicants will be notified
of receipt of the proposal.
</UL>

<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225<BR>
Ambler, PA 19002-2755, USA</CENTER>
<HR>
<UL>
<LI>The Grants and Awards Committee may, in rare circumstances,
recommend extension of a grant if progress has been satisfactory,
but more time and funds are needed to complete the study. Requests
for grant extensions need to be made in writing with appropriate
documentation and rationale.
<LI>A listing of awardees and a brief description of their funded
research programs will be provided annually in the <I>DIA Newsletter</I>
and in the Association's Annual Report. Additionally, awardees
will be announced at the Annual Meeting.
<LI>The results of funded research may be submitted for publication
in a journal of the investigator's choosing. Presentation of findings
at a DIA meeting and publication in the <I>Drug Information Journal</I>,
however, are highly encouraged.
</UL>

<P>
<I><B>REVIEW OF PROPOSALS</B></I>
<HR>

<UL>
<LI>The <I>DIA Research Grant Program</I> is administered by the
DIA Grants and Awards Committee. Final approval for grants in
excess of $5000 will be by the DIA Board of Directors.
<LI>Proposals will be evaluated by the DIA's Grants and Awards
Committee using the following criteria:

<UL>
<OL><LI>Relevance of subject matter to the goals and interests of
the DIA.
<LI>Quality of proposed research, i.e., the significance and originality
of the research and methodological approaches. In some cases,
the Committee may deem it necessary to appoint technically qualified
persons to review the application.
<LI>Feasibility of the research and adequacy of the experimental
design.
<LI>Qualifications of research personnel, i.e., training, experience,
research competence, and commitment of the investigators.
</OL></UL>

<LI>Ranking of the proposals based on the above criteria will
determine how many projects can be funded in the context of available
funding.
<LI>Applicants will be notified as to the funding status of their
proposals in May.
<LI>Funding of approved proposals will commence in September.
</UL>

<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-97</DOCNO>
<DOCOLDNO>IA050-000869-B027-16</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp6b.htm 199.92.136.137 19970111134750 text/html 1901
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:49:31 GMT
Last-modified: Thursday, 10-Oct-96 21:05:17 GMT
Content-length: 1709
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Donald E. Franke Award</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
<CENTER><STRONG> DONALD E. FRANCKE AWARD </STRONG></CENTER>
<CENTER>(<I><B>DRUG INFORMATION JOURNAL</B></I> ARTICLE)</CENTER>
<P>
Each year the <B>Donald E. Francke Award</B> is presented for
an article published in the <I><B>Drug Information Journal</B></I>
during the previous year. The article must be &quot;an authoritative
publication of excellence in the area of drug information and
must make a significant contribution to that literature.&quot;
<P>
<I><B>1994 Recipients:</B></I><BR>

<B>Richard B. Anderson</B>, EdD, Phase V Technologies, Inc. and
<B>Marcia A. Testa</B>, MPH, PhD, Department of Biostatistics,
Harvard School of Public Health, for their article entitled<B>
&quot;Symptom Distress Checklists as a Component of Quality of
Life Measurement: Comparing Prompted Reports by Patient and Physician
with Concurrent Adverse Event Reports via the Physician&quot;</B>
which was published in Volume 28, Number 1, pages 89-114, 1994.
<P>
<I><B>1995 Recipient:</B></I><BR>

<B>Louis Lasagna, MD</B> Dean of the Sackler School of Graduate
Biomedical Sciences at Tufts University. He also serves as Director
and Chairman of the Board for the Tufts Center for the Study of
Drug Development and Dean for Scientific Affairs, Tufts University
School of Medicine. Dr. Lasagna's article <B>entitled &quot;Improving
the Drug Development Process: Needed Reforms.&quot; </B>The article
was published in Volume 29, Number 2, Page 415.
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-98</DOCNO>
<DOCOLDNO>IA050-000869-B027-55</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp6c.htm 199.92.136.137 19970111134808 text/html 1292
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:49:47 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:47 GMT
Content-length: 1101
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Distinguished Career Award</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<UL>GRANTS & AWARDS</UL>
<P>
<CENTER><H2>Distinguished Career Award</H2></CENTER>
<HR>

<CENTER>The Distinguished Career Award recognizes, annually, an individual(s)
who has established a record for excellence in drug information
science research, and has contributed to the expansion and improvements
of drug information generation, processing or use. <BR>

<P>
The recipients of this award for 1995 were:<BR>

<P>
<B>Professor William H. W. Inman, FRCP</B> (retired)<BR>

University of Southampton, UK<BR>

<P>
<B>Charles S. Kumkumian, PhD</B><BR>

Otsuka America Pharmaceutical, USA<BR>

<P>
The recipients of this award for 1996 were:<BR>

<P>
<B>Louis Lasagna, MD</B><BR>

Tufts University, USA<BR>

<P>
<B>Professor Pierre M. B. Simon</B> (retired)<BR>

Sanofi Recherche, France<BR></CENTER>
<BR>
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>







</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-99</DOCNO>
<DOCOLDNO>IA050-000869-B027-79</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp6d.htm 199.92.136.137 19970111134818 text/html 4529
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:50:00 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:44 GMT
Content-length: 4338
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Outstanding Service Awards</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<UL>GRANTS AND AWARDS</UL>
<P>
<CENTER><H2>Outstanding Service Awards</H2></CENTER>
<HR>
<P>
<CENTER>Each year the DIA presents Outstanding Service Awards to individuals
who have provided outstanding service to the DIA.<BR>

<P>
The recipients of this award for 1995 were :<BR>

<P>
<B><FONT SIZE=2>Bruce Campbell, PhD</FONT></B><BR>
<FONT SIZE=2>Servier Research and Development, UK<BR>
</FONT>
<P>
<B><FONT SIZE=2>Kerstin Ekberg-Eriks&eacute;n, PharmB</FONT></B><BR>

<FONT SIZE=2>Astra AB, Sweden<BR>
</FONT>
<P>
<B><FONT SIZE=2>Arthur C. Fabian, PhD</FONT></B><BR>

<FONT SIZE=2>SST Corporation, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Rodney C. Hall, MSc, MD</FONT></B><BR>

<FONT SIZE=2>Astra Australia<BR>
</FONT>
<P>
<B><FONT SIZE=2>Kiyoshi Hayase, PhD</FONT></B><BR>

<FONT SIZE=2>Merck Sharp &amp; Dohme<BR>
Research Laboratories, Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>Gillian A. Le Du</FONT></B><BR>

<FONT SIZE=2>Glaxo Research &amp; Development, UK<BR>
</FONT>
<P>
<B><FONT SIZE=2>Iain J. McGilveray, PhD, FCIC</FONT></B><BR>

<FONT SIZE=2>Health Canada<BR>
</FONT>
<P>
<B><FONT SIZE=2>Kim W. Nitahara, MBA</FONT></B><BR>

<FONT SIZE=2>META Solutions, Inc., USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Wayne M. Turner, PharmD</FONT></B><BR>

<FONT SIZE=2>Food and Drug Administration, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Joachim Vollmar, MS</FONT></B><BR>

<FONT SIZE=2>Pharmaceutical Research <BR>
Associates GmbH, Germany<BR>
</FONT>
<P>
<B><FONT SIZE=2>Karen E. Woodin, PhD</FONT></B><BR>

<FONT SIZE=2>The Upjohn Company, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Manuel Zahn, PhD</FONT></B><BR>

<FONT SIZE=2>Knoll AG, Germany<BR>
</FONT>
<P>
The recipients of this award for 1996 were :<BR>

<P>
<B><FONT SIZE=2>Agn&egrave;s Artiges, PhD</FONT></B><BR>

<FONT SIZE=2>European Pharmacopeia - Council of Europe, France
<BR>
</FONT>
<P>
<B><FONT SIZE=2>Shein-Chung Chow, PhD</FONT></B><BR>

<FONT SIZE=2>Bristol-Myers Squibb Company, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Charles C. DePew, PharmD</FONT></B><BR>

<FONT SIZE=2>SmithKline Beecham Pharmaceuticals, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Marie C. Donnelly, MBA</FONT></B><BR>

<FONT SIZE=2>European Commission,. Belgium<BR>
</FONT>
<P>
<B><FONT SIZE=2>Th&eacute;r&egrave;se H&eacute;lie</FONT></B><BR>

<FONT SIZE=2>Sandoz Canada, Inc., Canada<BR>
</FONT>
<P>
<B><FONT SIZE=2>Hidehiro Ito</FONT></B><BR>

<FONT SIZE=2>Mitsui Pharmaceuticals, Inc., Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>Arthur I. Jacknowitz, PharmD</FONT></B><BR>

<FONT SIZE=2>West Virginia University, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Eva Lydick, PhD</FONT></B><BR>

<FONT SIZE=2>Merck Research Laboratories, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Hiroshi Maeda</FONT></B><BR>

<FONT SIZE=2>Fujisawa Pharmaceuticals, Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>Vaila M. Marshall</FONT></B><BR>

<FONT SIZE=2>Pfizer Central Research, UK<BR>
</FONT>
<P>
<B><FONT SIZE=2>Susan L. McLaughlin</FONT></B><BR>

<FONT SIZE=2>R. W. Johnson, PRI, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Chikayuki Naito, MD, PhD</FONT></B><BR>

<FONT SIZE=2>Teikyo University, Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>B. Lillian Natorff, MD, MFPM</FONT></B><BR>

<FONT SIZE=2>Pharm-Olam International, UK<BR>
</FONT>
<P>
<B><FONT SIZE=2>Kousei Terasaki</FONT></B><BR>

<FONT SIZE=2>Santen Pharmaceutical Co., Ltd., Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>Tohru Uwoi</FONT></B><BR>

<FONT SIZE=2>Yamanouchi Pharmaceutical, Japan<BR>
</FONT>
<P>
<B><FONT SIZE=2>Willem F. van der Giesen, PhD</FONT></B><BR>

<FONT SIZE=2>Medicines Evaluation Board, The Netherlands<BR>
</FONT>
<P>
<B><FONT SIZE=2>Cheryl Weinrich</FONT></B><BR>

<FONT SIZE=2>Rh&ocirc;ne-Poulenc Rorer, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Roger L. Williams, MD</FONT></B><BR>

<FONT SIZE=2>Food and Drug Administration, USA<BR>
</FONT>
<P>
<B><FONT SIZE=2>Susan M. Wood, MBBS, MD, FFPM</FONT></B><BR>

<FONT SIZE=2>Medicines Control Agency, UK</FONT>
<P></CENTER>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>







</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-100</DOCNO>
<DOCOLDNO>IA050-000869-B027-104</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp7a.htm 199.92.136.137 19970111134827 text/html 1000
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:50:09 GMT
Last-modified: Thursday, 10-Oct-96 21:05:02 GMT
Content-length: 809
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Fellowships</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<UL>FELLOWSHIPS</UL>

<P>
<B> <CENTER>Fellowship in Clinical Pharmacology and the Science of Drug
Regulation</CENTER><BR>
</B><HR>
<P>
Funding for this fellowship has been approved for the years 1995-1996
and 1996-1997. The program is administered by the division of
clinical pharmacology at Georgetown University Medical Center
in Washington, DC, and the FDA. Applications are welcome for this
program. Contact the DIA office for the details.<BR>

<P>
The DIA is currently in the search process for a post-doctoral
candidate for the 1996 Fellowship.<BR>
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-101</DOCNO>
<DOCOLDNO>IA050-000869-B027-146</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp7b.htm 199.92.136.137 19970111134914 text/html 1130
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:50:37 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:37 GMT
Content-length: 940
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Fellowships</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
<UL>FELLOWSHIPS<BR></UL>

<P>
<CENTER><STRONG>Pharmacoepidemiology and Drug Regulatory Science Fellowships</STRONG></CENTER>
<BR>
<HR>
<P>
Funding for this fellowship has been approved for the years 1995-1996
and 1996-1997. The program is administered by the division of
pharmacoepidemiology at the University of Maryland, and the FDA.
Applications are welcome for this program. Contact the DIA office
for the details.<BR>

<P>
The 1995 Pharmacoepidemiology Fellowship was awarded to <B>Ms.
Sheila R. Weiss</B>. <BR>
Ms. Weiss will complete her fellowship in June 1996.<BR>

<P>
The DIA is currently in the search process for a post-doctoral
candidate for the 1996 Fellowship.<BR>
<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-102</DOCNO>
<DOCOLDNO>IA050-000869-B027-173</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp9.htm 199.92.136.137 19970111134928 text/html 452
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:51:09 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:31 GMT
Content-length: 262
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA News</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<CENTER><H2>This page still under construction!</H2></CENTER>
<CENTER><P>We are sorry for the inconvenience</CENTER>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-103</DOCNO>
<DOCOLDNO>IA050-000869-B027-209</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4c1.htm 199.92.136.137 19970111134950 text/html 8609
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:51:27 GMT
Last-modified: Thursday, 19-Dec-96 15:24:30 GMT
Content-length: 8417
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Meetings in Chronological order</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

UPCOMING MEETINGS
<P>
<UL>WORKSHOPS/TRAINING PROGRAMS</UL>
<P>
<CENTER><STRONG>ALL MEETINGS IN CHRONOLOGICAL ORDER</STRONG><BR>
Meetings for which registration information is available appear in blue.</CENTER>

<CENTER>





<A HREF="97012.htm"> <B>13-14 January, 1997</B><BR>
<B>Quality of Life: Constructs and Measures</B><BR>
Radisson Hotel<BR>
Scottsdale, AZ, USA</A>

<HR>

<A HREF="97003.htm"> <B>13-14 January, 1997</B><BR>
<B>Dry Powder Inhalers, Theory into Practice</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</A>
<HR>

<A HREF="97013.htm"> <B>27-28 January, 1997</B><BR>
<B>Third DIA Sponsored Workshop on Botanicals: <BR>Botanical Testing: Developing the Scientific and Clinical Evidence to Support <BR>the Clinical Use of Heterogeneous Botanical Products</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</A>

<HR>
<A HREF="97022.htm"> <B>27-28 January, 1997<BR>
Challenges for the Improvement in the Area of GCP, Independent Audits and Inspections in Europe</B><BR>
Hotel Conrad<BR>
Brussels, Belgium<BR></A>


<HR>
<A HREF="97034.htm"> <B>10 February, 1997</B><BR>
<B>New European Drug Registration Procedures Concerning Spain, The European Union and All Memberstates (Based on the Latest Revisions to the Notice to Applicants)</B><BR>
Hotel Melia Castilla<BR>Madrid, Spain<BR></A>

<HR>

<A HREF="97026.htm"> <B>10-11 February, 1997</B><BR>
<B>Research and Regulatory Advances in Drug Safety</B><BR>
Sheraton Centre<BR>Toronto, Canada</A>

<HR>

<A HREF="97005.htm"> <B>10-12 February, 1997</B><BR>
<B>Pharmaceutical Document
Management East</B> <BR>
Adams Mark Hotel <BR>
Philadelphia, PA, USA</A>

<HR>

<A HREF="97027.htm"> <B>10-11 February, 1997</B><BR>
<B>The Changing Face of Drug Development: <BR>The Role of Project Management and R&D Finance</B><BR>
Marriott Marina<BR>
Fort Lauderdale, FL, USA</A>


<HR>
<A HREF="97028.htm"> <B>20-21 February, 1997<BR>
Clinical Trials in Biotechnology</B><BR>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, California, USA<BR></A>

<HR>
<A HREF="feb25.htm"> <B>24-28 February, 1997</B><BR>
<B>Monitoring Safety Through the Life-Cycle of a Pharmaceutical Product</B><BR>
Hotel Copthorne Tara<BR>
London, UK<BR></A>

<HR>
<A HREF="97031.htm"> <B>27-28 February, 1997</B><BR>
<B>Regulating Drug Marketing in a Global Village</B><BR>
Marriott Marquis Hotel<BR>
New York, NY, USA<BR></A>

<HR>
<A HREF="97016.htm"> <B>10-11 March, 1997</B><BR>
<B>Statistical Issues in the Pharmaceutical Industry: Multiplicity in Clinical Trials</B><BR>
Hyatt Hotel<BR>
Hilton Head, SC, USA</A>

<HR>
<A HREF="97010.htm"> <B>16-19 March, 1997</B><BR>
<B>Clinical Data Management: Innovative Technologies and Strategies for the <BR>Global Management of Clinical Information</B><BR>
Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>18-19 March, 1997</B><BR>
<B>Legal Liability Issues</B><BR>
Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>3-4 April, 1997</B><BR>
<B>Medical/Technical Writing and 
Document Preparation for the Pharmaceutical Industry</B><BR>
Hyatt Baltimore Hotel<BR>
Baltimore, MD, USA
<HR>
<B>7-9 April, 1997</B><BR>
<B>Statistical Methodology in Clinical R&D</B><BR>
Hotel Le Mridien<BR>
Nice, France
<HR>
<A HREF="97006.htm"> <B>6-9 April, 1997</B><BR>
<B>Medical Communications</B><BR>Sheraton Hotel<BR>
New Orleans, LA, USA</A>
<HR>
<B>7-9 April, 1997</B><BR>
<B>Developing the Competitive Edge for Global Clinical Supplies Operations: <BR>Strategies for the 21st Century</B><BR>
Sheraton Hotel<BR>
New Orleans, LA, USA
<HR>
<B>9-11 April, 1997</B><BR>
<A HREF="97029.htm"> <B>Current Aspects of Vaccinology and Molecular Virology</B><BR>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, CA, USA</A>

<HR>
<A HREF="97015.htm"> <B>14-15 April, 1997<BR>
Osteoporosis Education:
Focusing on Behavioral Change</B><BR>
Convention Center Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>21-23 April, 1997</B><BR>
<B>Survival Strategies for Document Life Cycle Management</B><BR>
Hotel Sheraton Grand<BR>
Edinburgh, UK<BR>
<P>
<B><I>Call for Papers !!</I></B><BR>
<HR>
<B>23 April, 1997</B><BR>
<B>In-Vitro Metabolism and Drug Interactions</B><BR>
Hotel Copthorne Tara<BR>
London, UK
<HR>
<B>24-25 April, 1997</B><BR>
<B>New Directions for Pharmacokinetics and Metabolism</B><BR>
Hotel Copthorne Tara<BR>
London, UK
<HR>
<A HREF="97017.htm"> <B>1-2 May, 1997<BR>
The Knowledge Management Puzzle: <BR>Putting the Information and Technology Pieces Together</B><BR>
Marriott Philadelphia Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>5-6 May, 1997</B><BR>
<B>GCP Audits and How to Survive an FDA Inspection</B><BR>
Hilton Hotel<BR>
San Jose, California, USA

<HR>
<B>12-13 May, 1997</B><BR>
<B>Quality of Life Evaluation</B><BR>
Charleston Place Hotel<BR>
Charleston, South Carolina, USA

<HR>
<B>8-10 September, 1997</B><BR>
<B>Clinical Research in Managed Care</B><BR>
Sheraton Society Hill Hotel<BR>
Philadelphia, PA, USA

<HR>
<B>15-17 September, 1997</B><BR>
<B>GCP Workshop</B><BR>
Philadelphia Marriott Hotel<BR>
Philadelphia, PA, USA

<HR>
<B>3-5 November, 1997</B><BR>
<B>Clinical Data Management</B><BR>
Hotel Sofitel Paris Forum Rive Gauche<BR>
Paris, France
<HR>
<B>9-11 November, 1997</B><BR>
<B>Medical Communications</B><BR>
Waterfront Centre Hotel<BR>
Vancouver, Canada

<HR>
<B>26-28 May, 1997<BR>
9th Annual Euromeeting</B><BR>
<B>The 1998 Impact on the Pharmaceutical Industry: Are YOU Prepared?</B><BR>Conference Center<BR>
Dsseldorf "Stadthalle", Germany
<HR>
<B>22-26 June, 1997<BR>
33rd Annual Meeting<BR></B>
<B>Optimizing Pharmaceutical Development: The Global Experience</B><BR>Palais des Congrs de Montral<BR>
Montral, Quebec, Canada
			<HR>
 
<B>TRAINING COURSES</B><BR>

<P><B>United States Training Courses</B><BR>
<P><B> Regulatory I: Investigational New Drug Phase</B><BR>
24-26 February, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA, USA<BR>
12-14 May, 1997<BR>
Swissotel, Chicago, IL.<BR>
4-6 August, 1997<BR>
Sheraton Society Hill, Philadelphia, PA<BR>
15-17 October, 1997<BR>
Hyatt Bethesda, Bethesda, MD

<HR>
<B>Regulatory II: Marketing Application and Post-Approval Phase </B><BR>
2-4 April, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
14-16 July, 1997<BR>
Swissotel, Chicago, IL.<BR>
12-14 November, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA

<HR>
<B> Clinical Research Associate</B><BR>
12-14 February, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
14-16 April, 1997<BR>
Westin Hotel, Seattle, WA<BR>
12-14 May, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
14-16 July, 1997<BR>
Swissotel, Chicago, IL<BR>
13-15 October, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
17-19 November, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA


<HR>
<B> Advanced Clinical Research Associate</B><BR>
27-29 January, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
7-9 April, 1997<BR>
Sheraton Hotel, Chicago, IL, USA<BR>
24-27 August, 1997<BR>
Sheraton Society Hill Hotel, Philadelphia, PA, USA<BR>
<HR>
<B>Drug Safety Surveillance</B><BR>
12-14 March, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
8-10 September, 1997<BR>
Doubletree Hotel, Philadelphia, PA
<HR>
<B>Packaging and Labeling of Clinical Supplies</B><BR>
10-14 February, 1997<BR>
Charleston Place Hotel, Charleston, SC
<HR>
<B>Introduction to Repeated Measures and Other Mixed Model Experiments</B><BR>
11-12 May, 1997<BR>
Doubletree Hotel, Philadelphia, PA

<P><HR>
<P>
<B>European Training Courses</B><BR>
<P>
<B>Auditing for Auditees</B><BR>
11-12 February, 1997<BR>
Hotel Le Mridien, Nice, France<BR>
<P>
<B>Practical GCP Compliance Auditing of Trials and Systems</B><BR>
29-31 January, 1997<BR>
Hotel Conrad, Brussels, Belgium<BR>
10-12 February, 1997<BR>
Hotel Le Mridien, Nice, France
<P>
<B>Understanding the ICH GCP Guideline: The Inside Story</B><BR>
13 February, 1997<BR>
Hotel Le Mridien, Nice, France<BR></CENTER>
<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-104</DOCNO>
<DOCOLDNO>IA050-000869-B027-246</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4c2.htm 199.92.136.137 19970111135008 text/html 6533
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:51:46 GMT
Last-modified: Monday, 16-Dec-96 17:05:57 GMT
Content-length: 6343
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Meetings in the Americas</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>

UPCOMING MEETINGS
<P>
<UL>WORKSHOPS/TRAINING PROGRAMS</UL>
<P>
<CENTER><STRONG>ALL MEETINGS IN THE AMERICAS</STRONG><BR>
Meetings for which registration information is available appear in blue.</CENTER>

<CENTER>


<P><A HREF="97012.htm"> <B>13-14 January, 1997</B><BR>
<B>Quality of Life: Constructs and Measures</B><BR>
Radisson Hotel<BR>
Scottsdale, AZ, USA</A>

<HR>

<A HREF="97003.htm"> <B>13-14 January, 1997</B><BR>
<B>Dry Powder Inhalers, Theory into Practice</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</A>
<HR>

<A HREF="97013.htm"> <B>27-28 January, 1997</B><BR>
<B>Third DIA Sponsored Workshop on Botanicals: <BR>Botanical Testing: Developing the Scientific and Clinical Evidence to Support <BR>the Clinical Use of Heterogeneous Botanical Products</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</A>

<HR>

<A HREF="97026.htm"> <B>10-11 February, 1997</B><BR>
<B>Research and Regulatory Advances in Drug Safety</B><BR>
Sheraton Centre<BR>Toronto, Canada</A>

<HR>

<A HREF="97005.htm"> <B>10-12 February, 1997</B><BR>
<B>Pharmaceutical Document
Management East</B> <BR>
Adams Mark Hotel <BR>
Philadelphia, PA, USA</A>

<HR>

<A HREF="97027.htm"> <B>10-11 February, 1997</B><BR>
<B>The Changing Face of Drug Development: <BR>The Role of Project Management and R&D Finance</B><BR>
Marriott Marina<BR>
Fort Lauderdale, FL, USA</A>


<HR>
<A HREF="97028.htm"> <B>20-21 February, 1997<BR>
Clinical Trials in Biotechnology</B><BR>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, California, USA<BR></A>

<HR>
<A HREF="97031.htm"> <B>27-28 February, 1997</B><BR>
<B>Regulating Drug Marketing in a Global Village</B><BR>
Marriott Marquis Hotel<BR>
New York, NY, USA<BR></A>

<HR>
<A HREF="97016.htm"> <B>10-11 March, 1997</B><BR>
<B>Statistical Issues in the Pharmaceutical Industry: Multiplicity in Clinical Trials</B><BR>
Hyatt Hotel<BR>
Hilton Head, SC, USA</A>

<HR>
<A HREF="97010.htm"> <B>16-19 March, 1997</B><BR>
<B>Clinical Data Management: Innovative Technologies and Strategies for the <BR>Global Management of Clinical Information</B><BR>
Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>18-19 March, 1997</B><BR>
<B>Legal Liability Issues</B><BR>
Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>3-4 April, 1997</B><BR>
<B>Medical/Technical Writing and 
Document Preparation for the Pharmaceutical Industry</B><BR>
Hyatt Baltimore Hotel<BR>
Baltimore, MD, USA
<HR>
<A HREF="97006.htm"> <B>6-9 April, 1997</B><BR>
<B>Medical Communications</B><BR>Sheraton Hotel<BR>
New Orleans, LA, USA</A>
<HR>
<B>7-9 April, 1997</B><BR>
<B>Developing the Competitive Edge for Global Clinical Supplies Operations: <BR>Strategies for the 21st Century</B><BR>
Sheraton Hotel<BR>
New Orleans, LA, USA
<HR>
<B>9-11 April, 1997</B><BR>
<A HREF="97029.htm"> <B>Current Aspects of Vaccinology and Molecular Virology</B><BR>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, CA, USA</A>

<HR>
<A HREF="97015.htm"> <B>14-15 April, 1997<BR>
Osteoporosis Education:
Focusing on Behavioral Change</B><BR>
Convention Center Marriott Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<A HREF="97017.htm"> <B>1-2 May, 1997<BR>
The Knowledge Management Puzzle: <BR>Putting the Information and Technology Pieces Together</B><BR>
Marriott Philadelphia Hotel<BR>
Philadelphia, PA, USA</A>

<HR>
<B>5-6 May, 1997</B><BR>
<B>GCP Audits and How to Survive an FDA Inspection</B><BR>
Hilton Hotel<BR>
San Jose, California, USA

<HR>
<B>12-13 May, 1997</B><BR>
<B>Quality of Life Evaluation</B><BR>
Charleston Place Hotel<BR>
Charleston, South Carolina, USA

<HR>
<B>8-10 September, 1997</B><BR>
<B>Clinical Research in Managed Care</B><BR>
Sheraton Society Hill Hotel<BR>
Philadelphia, PA, USA

<HR>
<B>15-17 September, 1997</B><BR>
<B>GCP Workshop</B><BR>
Philadelphia Marriott Hotel<BR>
Philadelphia, PA, USA
<HR>
<B>9-11 November, 1997</B><BR>
<B>Medical Communications</B><BR>
Waterfront Centre Hotel<BR>
Vancouver, Canada

<HR>
<B>22-26 June, 1997<BR>
33rd Annual Meeting<BR></B>
<B>Optimizing Pharmaceutical Development: The Global Experience</B><BR>Palais des Congrs de Montral<BR>
Montral, Quebec, Canada
<HR>
 
<B>TRAINING COURSES</B><BR>

<P><B>United States Training Courses</B><BR>
<P><B> Regulatory I: Investigational New Drug Phase</B><BR>
24-26 February, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA, USA<BR>
12-14 May, 1997<BR>
Swissotel, Chicago, IL.<BR>
4-6 August, 1997<BR>
Sheraton Society Hill, Philadelphia, PA<BR>
15-17 October, 1997<BR>
Hyatt Bethesda, Bethesda, MD

<HR>
<B>Regulatory II: Marketing Application and Post-Approval Phase </B><BR>
2-4 April, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
14-16 July, 1997<BR>
Swissotel, Chicago, IL.<BR>
12-14 November, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA

<HR>
<B> Clinical Research Associate</B><BR>
12-14 February, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
14-16 April, 1997<BR>
Westin Hotel, Seattle, WA<BR>
12-14 May, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
14-16 July, 1997<BR>
Swissotel, Chicago, IL<BR>
13-15 October, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
17-19 November, 1997<BR>
Marriott Fishermans Wharf, San Francisco, CA


<HR>
<B> Advanced Clinical Research Associate</B><BR>
27-29 January, 1997<BR>
Hyatt Bethesda Hotel, Bethesda, MD, USA<BR>
7-9 April, 1997<BR>
Sheraton Hotel, Chicago, IL, USA<BR>
24-27 August, 1997<BR>
Sheraton Society Hill Hotel, Philadelphia, PA, USA<BR>
<HR>
<B>Drug Safety Surveillance</B><BR>
12-14 March, 1997<BR>
Doubletree Hotel, Philadelphia, PA<BR>
8-10 September, 1997<BR>
Doubletree Hotel, Philadelphia, PA
<HR>
<B>Packaging and Labeling of Clinical Supplies</B><BR>
10-14 February, 1997<BR>
Charleston Place Hotel, Charleston, SC
<HR>
<B>Introduction to Repeated Measures and Other Mixed Model Experiments</B><BR>
11-12 May, 1997<BR>
Doubletree Hotel, Philadelphia, PA
<HR>
</CENTER>
<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-105</DOCNO>
<DOCOLDNO>IA050-000869-B028-23</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4c3.htm 199.92.136.137 19970111135022 text/html 2845
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:52:02 GMT
Last-modified: Thursday, 19-Dec-96 15:24:10 GMT
Content-length: 2653
Content-type: text/html
</DOCHDR>

<HTML>

<HEAD>

<TITLE>European Meetings in Chronological order</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<UL>WORKSHOPS/TRAINING PROGRAMS</UL>
<P>
<CENTER><STRONG>EUROPEAN MEETINGS IN CHRONOLOGICAL ORDER</STRONG><BR>
Meetings for which registration information is available appear in blue.</CENTER>


<CENTER>



<HR>
<A HREF="97022.htm"> <B>27-28 January, 1997<BR>
Challenges for the Improvement in the Area of GCP, Independent Audits and Inspections in Europe</B><BR>
Hotel Conrad<BR>
Brussels, Belgium<BR></A>


<HR>
<A HREF="97034.htm"> <B>10 February, 1997</B><BR>
<B>New European Drug Registration Procedures Concerning Spain, The European Union and All Memberstates (Based on the Latest Revisions to the Notice to Applicants)</B><BR>
Hotel Melia Castilla<BR>Madrid, Spain<BR></A>



<HR>
<A HREF="feb25.htm"> <B>24-28 February, 1997</B><BR>
<B>Monitoring Safety Through the Life-Cycle of a Pharmaceutical Product</B><BR>
Hotel Copthorne Tara<BR>
London, UK<BR></A>

<HR>
<B>7-9 April, 1997</B><BR>
<B>Statistical Methodology in Clinical R&D</B><BR>
Hotel Le Mridien<BR>
Nice, France

<HR>
<B>21-23 April, 1997</B><BR>
<B>Survival Strategies for Document Life Cycle Management</B><BR>
Hotel Sheraton Grand<BR>
Edinburgh, UK<BR>
<P>
<B><I>Call for Papers !!</I></B><BR>
<HR>
<B>23 April, 1997</B><BR>
<B>In-Vitro Metabolism and Drug Interactions</B><BR>
Hotel Copthorne Tara<BR>
London, UK
<HR>
<B>24-25 April, 1997</B><BR>
<B>New Directions for Pharmacokinetics and Metabolism</B><BR>
Hotel Copthorne Tara<BR>
London, UK

<HR>
<B>3-5 November, 1997</B><BR>
<B>Clinical Data Management</B><BR>
Hotel Sofitel Paris Forum Rive Gauche<BR>
Paris, France

<HR>
<B>26-28 May, 1997<BR>
9th Annual Euromeeting</B><BR>
<B>The 1998 Impact on the Pharmaceutical Industry: Are YOU Prepared?</B><BR>Conference Center<BR>
Dsseldorf "Stadthalle", Germany

<HR>
 
<B>TRAINING COURSES</B><BR>

<HR>
<P>
<B>European Training Courses</B><BR>
<P>
<B>Auditing for Auditees</B><BR>
11-12 February, 1997<BR>
Hotel Le Mridien, Nice, France<BR>
<P>
<B>Practical GCP Compliance Auditing of Trials and Systems</B><BR>
29-31 January, 1997<BR>
Hotel Conrad, Brussels, Belgium<BR>
10-12 February, 1997<BR>
Hotel Le Mridien, Nice, France
<P>
<B>Understanding the ICH GCP Guideline: The Inside Story</B><BR>
13 February, 1997<BR>
Hotel Le Mridien, Nice, France<BR></CENTER>
</CENTER>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-106</DOCNO>
<DOCOLDNO>IA050-000869-B028-55</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp4c4.htm 199.92.136.137 19970111135045 text/html 767
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:52:14 GMT
Last-modified: Friday, 13-Dec-96 15:43:59 GMT
Content-length: 578
Content-type: text/html
</DOCHDR>

<HTML>

<HEAD>

<TITLE>Other than the Americas and Europe</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
 <UL> WORKSHOPS/TRAINING PROGRAMS</UL>
<P>
<CENTER><STRONG> MEETINGS IN CHRONOLOGICAL ORDER <BR>OTHER THAN THE AMERICAS AND EUROPE</STRONG><BR>
Meetings for which registration information is available appear in blue.</CENTER>
<CENTER>





<HR>



</CENTER>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-107</DOCNO>
<DOCOLDNO>IA050-000869-B028-106</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a1.htm 199.92.136.137 19970111135133 text/html 2186
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:52:59 GMT
Last-modified: Thursday, 19-Dec-96 19:26:16 GMT
Content-length: 1994
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Medical Approach in Diagnosis and Management</B> <BR>
<B>of Adverse Drug Reactions</B><BR><P></CENTER>
When the first two or three cases of serious adverse reactions occur during clinical trials of a drug, medical knowledge is crucial for the diagnosis and management of the reaction. This educational seminar, held for a second time in Paris, September 30 and October 1, 1996, was chaired by Dr. Christian Bnichou, Synthlabo Research, France, and Dr. Gaby Danan, Roussel-Uclaf, France. The conclusions for the medical approach that they presented were drawn from national and international consensus meetings on adverse drug reactions in the system organs most susceptible to drug toxicity, namely, the skin, liver, blood and kidney.<BR><P>
Professor Jean-Pierre Benhamou, Hpital Beaujon, France; Professor Philippe Camus, Department of Pneumology, CHU Dijon, France; Dr. Eugne Rothschild, International Drug Monitoring Department, Roussel-Uclaf, France; Professor Jean-CIaude Roujeau, Department of Dermatology, Hpital Henri Mondor, France; and Dr. Philippe Solal-Cligny, Victor Hugo Oncoradiotherapy & Hematology Center, France were the participating faculty at the seminar. <BR><P>
Participants were health professionals aware of the increased place in the daily diagnostic process that drug-induced disorders occupy and who wished to improve the voluntary reporting of ADRs, as well as professionals involved in the monitoring and assessment of drug adverse events. The DIA wishes to thank faculty and participants for their input. The next rerun of this seminar will take place in Paris, September 25-26, 1997. 
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-108</DOCNO>
<DOCOLDNO>IA050-000869-B028-141</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a2.htm 199.92.136.137 19970111135148 text/html 1929
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:53:29 GMT
Last-modified: Thursday, 19-Dec-96 19:26:18 GMT
Content-length: 1737
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>CLINICAL TRIALS and GCP in EAST ASIA</B><BR><P></CENTER>
Program Co-Chairpersons for this important meeting were Dr. Kiichiro Tsutani, Tokyo Medical and Dental University, Japan and Dr. Robert Teoh, Quintiles East Asia Pte. Ltd., Singapore.<BR><P>
With the rapid international development of new drugs and the establishment of ICH in 1990 which is mainly concerned with OECD countries, the program committee, in this meeting addressed that need by less developed countries. Clinical trials are being carried out in East Asia for local purposes as well as part of multinational studies for international dossiers.<BR><P>
The meeting also addressed implementation of GCP in East Asia. For example, will informed consent alter the patient-physician relationship from a traditional paternalistic Confucian one to a contract oriented one. Experts from several countries contributed to the discussions. In addition to the program chairs, the experts included: Dr. Keiji Ueda, Tama Metropolitan Geriatric Hospital, Japan; Dr. Toshiyoshi Tominaga, Ministry of H & W, Japan; Dr. Sang-Goo Shin, Seoul National University, Republic of Korea; Dr. Carl Becker, Kyoto University, Japan; Dr. Herng-Der Chern, National Taiwan University, Taiwan; and Dr. Sang Guowei, Zhejiang Academy of Medical Sciences, China.<BR><P>
We thank these experts for their participation and contributions.

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-109</DOCNO>
<DOCOLDNO>IA050-000869-B028-180</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a3.htm 199.92.136.137 19970111135216 text/html 14315
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:53:57 GMT
Last-modified: Thursday, 19-Dec-96 19:26:22 GMT
Content-length: 14122
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>3rd Annual Biostatistics Meeting in Tokyo, Japan<BR><P>
</CENTER></B>
Dr. Akira Sakuma, Tokyo Medical and Dental University was program chairman of this excellent meeting. The program committee were Dr. Chihiro Hirotsu and Dr. Yasuo Ohashi, University of Tokyo; Dr. Hiroe Tsubaki, Keio University; Dr. Isao Yoshimura, Science University of Tokyo; Dr. Yoshinobu Hirayama, Ministry of Health and Welfare, Japan; and, also representing the JPMA, Mr. Tohru Uwoi, Yamanouchi Pharmaceutical; Mr. Hiroshi Maeda, Fujisawa Pharmaceutical; Mr. Hidehiro Ito, Mitsui Pharmaceutical; and Mr. Kousei Terasaki, Santen Pharmaceutical. <BR><P>
The meeting focused on the Statistical Guidelines on Clinical Issues in the US, Europe and Japan. Comparisons of the guidelines were made by Dr. Gary G. Koch, University of North Carolina, Dr. Robert T. ONeill, FDA, and Dr. John A. Lewis, Medicines Control Agency, UK. Also addressed in various presentations were Statistical Issues in Preclinical Studies, Session Chair, Dr. Yoshimura. Presentations in this session were offered by Dr. Ludwig A. Hothorn, University of Hannover, Germany; Dr. Ronald G. Menton, Battelle Columbus Division, USA; Mr. Chikuma Hamada, University of Tokyo; and Dr. Ajit Thakur, Hazleton Research Institute, USA. <BR><P>
The Clinical Evaluation of Osteoporosis session was chaired by Dr. Yasuo Ohashi, University of Tokyo. Presentations on this subject were offered by Drs. Desmond E. Thompson and Arthur Santora II, Merck Research Laboratories; Dr. Yasufumi Hayashi, Bureau of Public Health, Tokyo; Dr. Willard H. Dere, Eli Lilly & Company; and Dr. Akira Itabashi, Professor, Saitama Medical School, Japan. Closing remarks for the meeting were made by Dr. Akira Sakuma, Emeritus Professor, Tokyo Medical and Dental University.<BR><P>
We thank these experts for their contributions to the success of this meeting.<BR><P>
<HR><P>
<B><CENTER>Presentation #1</CENTER></B><BR><P>
<CENTER><B>CPMP Guideline</B><BR>
<B><I>John A. Lewis</I>, PhD</B><BR>
Senior Biostatistician<BR>
Medicines Control Agency, United Kingdom<BR></CENTER>
<P>
In developing the CPMP guideline, statisticians agreed upon the basic principles, according to Dr. Lewis. The sample size, the population, the design techniques to avoid bias, randomization, blinding, etc. created no real problems. The original draft on randomization, however, was written from an academic perspective, and it didnt reflect pharmaceutical industry practice. It did contain detailed information about minimization procedures and dynamic allocation. <BR><P>
The European guidelines really consolidated the principle of blind review. There was intense debate over the analysis population. Intention to treat (ITT) implies that all randomized patients be included in the analyses. Any objective criteria measured before randomization which will be used to exclude patients from analysis should be pre-specified and justified. <BR><P>
Researchers must make sure that there are measurements on all patients who withdraw or are otherwise lost to follow up to include in ITT or overall analyses. Dr. Lewis emphasized that withdrawal from treatment is not the same as withdrawal from the trial. This is a principle which I think needs saying loud and clearly many times. <BR><P>
ITT is generally poorly discussed by applicants, and is often used as a smoke screen to hide what has been done to patients who arent compliant or for whom data are incomplete. Dr. Lewis provided his personal principles for dealing with intention to treat:<BR><P>

<UL TYPE=circle>
<LH></LH>
<LI>Account for all randomized patients in the analysis,<BR>
<LI>Minimize deviations from the protocol,<BR>
<LI>Explore the effect of all protocol deviations and missing data on conclusions, and<BR>
<LI>Gather data as completely as possible on all randomized patients regardless of compliance.<BR>

</UL>

<P>
If those principles are satisfied, then I think you do as well as you can with the problems that occur with missing data and missing patients.I hope this discussion has highlighted issues relevant to ICH. I think its vital to build on the guidelines we already have in the states and Europe and Japan in developing the ICH guidelines. Its vital to build a document which reinforces the skills and contributions of the statisticians and not one which attempts to replace them.

<P>
<HR>
<P><CENTER><B>Presentation #2<BR><P>
Controversies in Evaluating Drugs for Osteoporosis</B><BR>
<B><I>Akira Itabashi</I>, MD</B><BR>
Professor, Clinical Laboratory<BR>
Saitama Medical School, Japan<BR></CENTER><P>
Dr. Itabashi began by defining osteoporosis as a systemic skeletal disease characterized by a low bone mass and deterioration of bone tissue, which results in increased bone fragility and susceptibility to fractures. After menopause bone mass and density decrease rapidly. And low bone mass is a predictor of fractures. We have to intervene in the decline of bone mass, said Dr. Itabashi. The main purpose of treatment is to prevent bone loss and fractures.<BR><P>
Reversing bone mass decline should reduce fracture risk. But studies have shown that improving bone mineral density doesnt always improve bone strength. To improve bone mass isnt enough to show efficacy of a drug, an improved fracture rate must be shown. The proposed osteoporosis guidelines in the United States, Europe, and Japan all stress fracture efficacy studies. <BR><P>
Dr. Itabashi also talked about the external factors that contribute to osteoporotic fractures and must be taken into account when evaluating drugs. External factors include stress to the bone and its impact; the risk of fall, which is affected by neuromuscular function, environmental hazards, and time spent at risk; and the type of fall.<BR><P>
If bone is weak, a mild impact can cause a fracture. Treatment can strengthen bone, but a strong impact can cause a fracture even in a patient under treatment. Fracture efficacy studies have many problems. To combat these problems we need to study more patients for a longer length of time. Its become a burden on drug development. <BR><P>
Dr. Itabashi believes that a precise measurement of bone quality would be a better indicator of treatment efficacy than improved fracture rate, but no good method of measurement exists at present. In the meantime, researchers have recently advocated stressing good pre-clinical and clinical studies, as per FDA guidelines. This includes measuring bone chemical markup, bone density, and bone strength in pre-clinical studies. During the clinical studies, if bone mass increases, bone metabolic markup is favorably changed, and the bone is histologically normal, a fracture efficacy study may not be necessary before registration. <BR><P>
The debate over whether or not fracture efficacy studies are necessary for approval of osteoporosis drugs continues. Dr. Itabashi is waiting for the WHO guidelines, which he claims stress the same format for assessment of drugs for osteoporosis as the United States, Europe, and Japan.<P><HR>
<P><CENTER><B>Presentation #3</B><BR><P><B>Closing Remarks</B><BR>
<B><I>Akira Sakuma</I>, PhD</B><BR>
E. Professor, Information Medicine<BR>
Tokyo Medical and Dental University, Japan<BR></CENTER><P>
I would like to take this opportunity to look back on the discussions of yesterday and today, although it may be little more than listing the titles of the presentations, and summarize all the sessions of the 3rd Annual Biostatistics Meeting.<BR><P>
We were honored to have Dr. Tsuruta (MHW) give an opening address at the beginning of this meeting. He has been very busy with pharmaceutical affairs, and we are very grateful to him for his kind words.<BR><P>
In Session 1, the theme was the comparison of statistical guidelines in the USA, Europe and Japan. Discussion on a theme like this has been planned for quite a long time, and I believe the progress of ICH-E9 (harmonization of biostatistics) has finally shown a certain direction for more concrete discussion. At the beginning of this session, Dr. ONeill (FDA) provided some information about the restructuring of the review division of the FDA and how the FDA was trying to establish a consistent review process in order to cope with the upcoming guideline. It was quite interesting to find that some pieces of new information were quite different from our previous understanding of the FDA.<BR><P>
Dr. Lewis (MCA) introduced the CPMP guideline, one of the biostatistical guidelines in Europe, which is the base for discussion among ICH-E9 specialists, and he showed us the principles of this guideline. Dr. Sato (Institute of Statistical Mathematics) and Dr. Yoshimura (Science University of Tokyo) pointed out some problems with the Japanese statistical guideline, including some issues requiring discussion, and gave some comments on the CPMP guideline. They emphasized, as one of the issues specific to Japan, that Japanese biostatisticians need more training and more Japanese people have to be trained as biostatisticians. Mr. Uwoi (Yamanouchi) compared the CPMP and Japanese guidelines and showed the differences in the way of thinking. As Dr. Sato mentioned, Mr. Uwoi also implied that language difference could be a big obstacle to mutual understanding in this field.<BR><P>
Dr. Koch (University of North Carolina) gave us a detailed and well-organized introduction to statistical issues raised at the conference held at De Montfort University in July 1996. He did such a great job in summarizing the discussions that we are worried that there might be only a few people attending this type of conference next year.<BR><P>
In Session 2, we discussed many different statistical issues of nonclinical studies. Dr. Yoshimura presented some issues about nonclinical  we used to say preclinical, and perhaps both words are still used  nonclinical study, chronic toxicity study, and carcinogenicity study. Furthermore, he explained the possibility of international harmonization of nonclinical studies and issues about the standardization of nonclinical studies.<BR><P>
Dr. Hothorn (University of Hannover) commented on statistical issues about repeated administration in toxicity studies and concrete statistical topics. Dr. Menton (Battelle) commented on the standardization of chronic toxicity data ongoing in Battelle, and mentioned that there is a working group to discuss issues related to the standardization and automatic evaluation, involving statisticians, managers of databases, and toxicologists. I have an impression that it is going to be quite similar to what was held in Japan and will be therefore very informative to us.<BR><P>
Dr. Hamada (University of Tokyo) presented some data obtained from a Japanese toxicity study of repeated administration in rats, and pointed out very interesting discrepancies and similarities between specific judgment of toxicologists and statistical testing, including some estimation. Dr. Thakur (Corning Hazleton) had also commented on carcinogenicity study, which is a slightly different field of toxicology, and presented many different issues and statistical techniques.<BR><P>
In Session 3, osteoporosis was thoroughly introduced by Dr. Ohashi (University of Tokyo). We were able to obtain basic information about the disease before actual discussions began.<BR><P>
Dr. Thompson (Merck) and Dr. Dere (Eli Lilly) reported some clinical trials of osteoporosis with many informative comments from each very large study, or megatrial. I am afraid that after hearing about such a study, Japanese people may not feel like conducting such a study any more in Japan.<BR><P>
Dr. Itabashi (Saitama Medical School) presented some issues about endpoints in actual studies, particularly surrogate endpoints. As pointed out by several attendees, surrogate endpoints appear to be very convenient but have a lot of potential problems. Ethnic difference is another problem which may be raised as to whether or not such a study should be conducted in Japan. However, I thought we should identify this as cultural difference for many reasons.<BR><P>
It was asked why there are so many old men and women in Japan whose back is bent. I think it is because we have a different style of life. Those who sit on a chair bend low and those who sit on the floor (tatami mattress) bend down. This difference was reported by Dr. Nishida, an anatomist of an art school. Slight points like this, or things we hardly notice, sometimes raise big problems when we carry out a study or research on an international base. Dr. Itabashi mentioned that the number of episodes of angina pectoris or heart attack increases due to large-scale earthquake. This is very convincing, but I would be happy if there were anyone in the Kansai area who could conduct a scientific survey on the relationship between the earthquake of last year and the incidence of heart attack. We tend to be narrowly focused on drug efficacy evaluation, but I have realized that there are many other factors that affect outcome.<BR><P>
As Dr. Ohasi already explained, we planned this years meeting based on three pillars. The first one is clinical biostatistics, the second is nonclinical biostatistics, and the third is biostatistics related to a specific disease. As far as we are concerned, we feel this has been a very successful arrangement, and we would like to carry on this meeting within a similar framework next year, though we may have some new topics.<BR><P>
Finally, I would like to conclude by thanking all the speakers and attendees. I also would like to thank the interpreters for this strenuous work and their contribution to this meeting. Thank you very much.
<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-110</DOCNO>
<DOCOLDNO>IA050-000869-B029-35</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a4.htm 199.92.136.137 19970111135233 text/html 2458
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:54:10 GMT
Last-modified: Thursday, 19-Dec-96 19:26:24 GMT
Content-length: 2266
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Monitoring Drug Safety in Third Party Joint Projects</B><BR><P>
</CENTER>Meeting regulatory demands for drug safety monitoring is a challenge that takes on a new dimension when Third Parties are involved. The involvement may be in joint development and/or co-marketing, or for licensed products, or in the use of outsourced resources. Through the sharing of experiences in the handling of the problem areas of such co-operation, this workshop, chaired by Dr. Win Castle, of SmithKline Beecham Pharmaceuticals, USA, attempted to provide participants with ideas and suggestions for easing future challenges. Participants came from backgrounds in drug safety monitoring, regulatory affairs, drug development, licensing, computer systems and data management. <BR><P>
The workshop was held in London, September 26-27, 1996. Faculty members joining Dr. Castle were: Christine Bendall, McKenna & Co., London, UK; Robert Blackie, British Biotech, Oxford, UK; Dr. Elliot Brown, Lilly Industries Ltd., Windlesham, UK; Dr. Gaby Danan, Roussel-Uclaf, Romainville, France; Richard Kingham, Covington & Burling, London, UK; Dr. Martin Pfeiffer, Bayer AG, Wuppertal, Germany; George Phillips, Quintiles, Research Triangle Park, USA; Dr. Monika Pietrek, Pharmaceutical Research Associates GmbH, Mannheim, Germany; Dr. Kenneth J. Rakowski, Corning Besselaar Inc., Princeton, USA; Dr. Judith Sills, Warner-Lambert Company, Morris Plains, USA; Elizabeth J. Swain, Glaxo Wellcome Research & Development, Greenford, UK; Dr. Jan Willem van der Velden, Yamanouchi Europe B.V., Leiderdrop, The Netherlands; Robbert P. van Manen, BBN UK Ltd., West Drayton, UK; and Joachim Vollmar, Pharmaceutical Research Associates GmbH, Mannheim, Germany. <BR><P>
No DIA workshop is complete without an opportunity for faculty and participants to meet informally! On this occasion, a reception was held after the first days sessions. 
<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-111</DOCNO>
<DOCOLDNO>IA050-000869-B029-78</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a5.htm 199.92.136.137 19970111135253 text/html 12223
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:54:29 GMT
Last-modified: Thursday, 19-Dec-96 19:26:28 GMT
Content-length: 12030
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Regulatory and Practical Issues on New Drug, <BR>New Dosage Form and Generic Drug Development</B><BR><P>
</CENTER>This important meeting was held in cooperation with the National Defense Medical Center, the National Science Council of Taiwan, the Department of Health, and the Pharmaceutical Society of Taiwan. Program Chairs were Oliver Yoa-Pu Hu, PhD, Professor and Director, Pharmaceutical Research Institute, National Defense Medical Center, Taiwan; and Shein-Chung Chow, PhD, Bristol-Myers Squibb, USA.<BR><P>
The two day international symposiums objectives were to enhance communication among regulatory agencies, academia, and the pharmaceutical industry; and to provide a comprehensive overview of regulatory and practical issues that may occur during the development of new drugs, new dosage forms and generic drug products. An additional objective was to examine the past experiences, present issues, and future challenges in drug development.<BR><P>
Operating procedures in drug development were addressed in the areas of GLP, GCP, GMP, GRP and GSP. The Taiwan experience in Phase I and II clinical trials and the limitations of such trials were discussed as well as the current practical issues in clinical development.<BR><P>
We thank Drs. Hu and Chow for their efforts in developing this important meeting and bringing it to our members in the Asian region! 

<P><HR>
<P><CENTER><B>Presentation #1<BR><P>
Practical and Regulatory Issues on New Drug, <BR>
New Dosage Form, and Generic Drug Development<BR>
<I>Oliver Yoa-Pu Hu</I>, PhD</B><BR>
Professor and Director, Pharmaceutical Research Institute<BR>
National Defense Medical Center, Taiwan<BR></CENTER>
<CENTER><B><I>Shein-Chung Chow</I>, PhD</B><BR>
Director and Head, Biostatistics and Data Management<BR>
Bristol-Myers Squibb Company, USA<BR><P></CENTER>
The development of a new drug is a lengthy process involving drug discovery, formulation, laboratory development, animal studies, clinical development and regulatory registration. This lengthy process is necessary to ensure the effectiveness and safety of the drug under investigation. For the development and regulatory approval of pharmaceutical products, different countries such as the United States, the European Community, Japan, and Taiwan have similar but slightly different sets of regulatory requirements. These requirements provide certain assurance of drug efficacy, safety, and some good drug characteristics such as the identity, strength, quality, purity, and stability of the drug product. To assist the sponsors in fulfilling these regulatory requirements, many regulatory agencies such as the United States Food and Drug Administration (FDA) and the Department of Health of Taiwan have issued a number of guidelines and guidances at various stages of drug development and approval process. These guidelines and guidances are often considered as standards for good laboratory practice (GLP), good clinical practice (GCP), good manufacturing practice (GMP), good regulatory practice (GRP), and good statistics practice (GSP). However, many practical and/or regulatory issues may still occur at various stages of new drug, new dosage form, and generic drug development due to (i) the unfamiliarity of the regulations, (ii) miscommunications among pharmaceutical scientists, and (iii) inappropriate use of statistical design and analysis.  These practical /regulatory difficulties have become a hurdle for the drug development and regulatory approval process.<BR><P>
The United States regulations for drug development are developed based on the United States federal Food, Drug and Cosmetic Act passed in 1938. In 1962, a significant Kefauver-Harris Drug Amendment to the Act was passed which not only strengthens the safety requirements for new drugs but also establishes efficacy requirements for new drugs for the first time. In 1984, the United States Congress passed the Price Competition and Patent Term Restoration Act which authorizes the FDA to approve generic drugs based on bioavailability and bioequivalence trials on healthy male subjects. The United States regulations are codified in the United States Code of Federal Regulations (CFR). The United States regulations are usually modified as standards for regulatory requirements by many regulatory agencies including the Department of Health of Taiwan. As a result, it is of interest to investigate the commonly encountered practical/regulatory issues under the United States regulations to provide corrective actions for future drug development and regulatory approval process. These practical/regulatory experiences are helpful in establishing criteria and methodology for evaluation of Chinese traditional medicines.<BR><P>
To enhance communications and exchange information regarding practical/regulatory issues on new drug, new dosage form, and generic drug development that are commonly encountered among regulatory agencies, academia, and the pharmaceutical industry in the area of Asia, a committee was formed in April 1995 to put together the First DIA International Taipei Symposium. The Program Committee consisted of Co-chairpersons Drs. Oliver Yoa-Pu Hu (Professor and Director, Pharmaceutical Research Institute, National Defense Medical Center) and Shein-Chung Chow (Director and Head, Biostatistics and Data Management, Bristol-Myers Squibb Company) and members Drs. Kin-Wei A. Chan (Associate Professor, National Taiwan University), Jackie de Silva (Senior Director, Bristol-Myers Squibb Company), Chi-Chow Liao (Director, Charng-Geng General Hospital), Li-Ling Liu (Specialist, Bureau of Pharmaceutical Affairs), Tsi-Tee Suen (Deputy Director, National Laboratories for Foods and Drugs), Yen-Huei Tam (Associate Professor, National Defense Medical Center) and Yi-Hung Tsai (Dean Kaohsiung Medical College). During the preparation of the symposium, much constructive input was received from the Advisory Committee which was chaired by Dr. Hsheng-Kai Lee (President, National Defense Medical Center). The Advisory Committee consisted of distinguished members including Drs. Keith Chan (Formerly Director of Division of Bioequivalence, FDA), Mei-Ling Hsiao (Director, Bureau of Pharmaceutical Affairs), Yen-Yau Hsieh (Professor, National Taiwan University), Weng-Foung Huang (President, Pharmaceutical Society of Republic of China, Kin-Kai Hung (Director, Marion Merrel Dow), Chun-Heng Liao (Director, National Laboratories for Foods and Drugs), Sharlin E. Yeh (Director, Asia-Pacific Regional Operations Center Biotechnology & Pharmaceutical Industries Program Office), and Da-Peng Wang (Dean, National Defense Medical Center).<BR><P>
The symposium, which was held August 29-30, 1996, consisted of two plenary lectures and presentations by 15 invited speakers which covered the following topics: (i) business opportunity in new drug, new dosage form, and generic drug development, (ii) strategies in generic drug development, (iii) toxicology in drug discovery and development, (iv) animal and human pharmacokinetics, (v) strategy for selection of a drug candidate with optimal bioavailability, (vi) metabolic/pharmacokinetics druginteraction, (vii) practical/regulatory issues in clinical development, (viii) current issues in the development of Chinese traditional medicines, (ix) Taiwan experience in phases I-III clinical trials, (x) Good Statistics Practice in drug development, (xi) good standard operating procedures including GLP, GCP, GMP, GRP, and GSP, (xii) pharmaceutical validation and process controls. In addition, a panel discussion covered viewpoints regarding (i) the implementation of GCP and GMP, (ii) practical/regulatory difficulties in drug development, and (iii) future strategies and directions for drug development from the perspectives of clinician, regulatory, industry, and academia.<BR><P>
The symposium was well attended, attracting more than 350 attendees. As a result, the DIA decided to devote a special issue of the Drug Information Journal to the papers presented at the symposium. In addition, several outstanding researchers from the areas of non-clinical, pre-clinical and clinical in the drug development and regulatory approval process who could not attend the symposium were invited to participate in this special issue by submitting their research works. It is hoped that this special issue will not only serve as a reference for the commonly encountered practical /regulatory issues on new drug, new dosage form, and generic drug development, but also serve as a bridge among research scientists from different disciplines and countries especially in the area of Asia.<BR><P><HR><P>
<CENTER><B>Presentation #2<BR><P>
Good Statistics Practice in Drug Development and Regulatory Approval Process<BR>
<I>Shein-Chung Chow</I>, PhD</B><BR>
Director and Head, Biostatistics and Data Management Department<BR>
Bristol-Myers Squibb Company<BR></CENTER><P>
During the development and approval process of a new drug, the concept of good statistics practice (GSP) is necessarily implemented. GSP is a set of principles which assures the validity of the design and analysis of the intended studies conducted at various stages of the process of drug development and regulatory approval. GSP provides a fair assessment of the drug product with accuracy, precision, and reliability desired. In essence, GSP not only concerns the validity of statistical inference regarding drug efficacy and safety, but also provides assurance for the identity, strength, quality, purity, and stability of the drug product. This presentation described regulatory requirements for statistics and the role of statistics in drug development and regulatory process. The concept and importance of GSP are illustrated through some practical and/or regulatory statistical issues that commonly occur during the drug development and regulatory approval process.<BR><P><HR><P>
<CENTER><B>Presentation #3<BR><P>
Evolution of Clinical Trial Requirements in Taiwans Pharmaceutical Registration<BR>
<I>Weng-Foung Huang</I>, PhD</B><BR>
Associate Professor, Institute of Health and Welfare<BR>
National Yang-Ming University, Taiwan ROC<BR>
<B><I>Mei-Ling Hsiao</I>, MS</B><BR>
Director, Bureau of Pharmaceutical Affairs<BR>
Department of Health, Taiwan ROC<BR></CENTER><P>
Taiwan has established a relatively effective regulatory process for pharmaceutical registration since the early 1980s after the implementation of GMP. However, the regulatory process of NDAs in Taiwan relied on foreign-derived documentation, especially the clinical data. The evolution of clinical trial requirements for product registration can be documented into four phases over the past fifteen years. It first started with the initiation of Post-Market Surveillance in the early 1980s to restrict the entry of generic imitations and to provide adequate protection of pharmaceutical innovations. It was followed by a series of legislation or amendments on relevant legal requirements, such as the Patent Law, the Medical Care Act, the Bioavailability and Bioequivalence Guidelines and the Pharmaceutical Affairs Law. The emergence of pipeline protection in the early 1990s resulted in the 1993 Amendment of 1983 PMS that requires domestic clinical data for new drug applications. Taiwans experience in the evolution of clinical trial requirements in NDAs could serve as a good example for other developing countries to adopt. It has merits in the advancement of clinical research, the promotion of generic-based pharmaceutical industry, and the improvement of pharmaceutical innovation protection to international standards as well.<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-112</DOCNO>
<DOCOLDNO>IA050-000869-B029-110</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a6.htm 199.92.136.137 19970111135312 text/html 3565
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:54:45 GMT
Last-modified: Thursday, 19-Dec-96 19:27:24 GMT
Content-length: 3373
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Drug Compliance Issues in Clinical Trials and Patient Care</B><BR><P>
</CENTER>Research findings have shattered two myths concerning patient compliance: poor and partial compliance are far more pervasive that previously thought and the incidence is similar in all fields of ambulatory care, irrespective of drug, disease, prognosis or symptoms. Partial compliers are therefore numerous enough to present market opportunities for products that can deliver good outcomes despite partial compliance. This workshop focused on the significance and impact of partial compliance on the practical strategic aspects of product development, clinical development and marketing  how to use any positive aspects of partial compliance. <BR><P>
The workshop, which was held in Paris, September 30 and October 1 1996, was led by: Professor Jean-Pierre Bader, Agence du Medicament, France; Professor Jean-Marc Husson, Roussel-Uclaf, France; Dr. Jean-Michel Mtry, AARDEX Ltd., Switzerland; and Professor Carl Peck, Georgetown University, USA. They were assisted by faculty members: Professor Albert Bakker, University of Utrecht, The Netherlands; Professor Michel Burnier, University of Lausanne, Switzerland; Dr. Jonathan Cooke, Withington Hospital, Manchester, UK; Dr. Sabina De Geest, University of Leuven, Belgium; Dr. Erik De Klerk, University Hospital, Maastricht, The Netherlands; Dr. Claire Dutrey-Dupagne, Laboratories Roussel, Paris, France; Dr. Els Goetghebeur, University of Limburg, Maastricht, The Netherlands; Dr. Alain Golay, University of Geneva, Switzerland; PD Dr. Joerg Hasford, Ludwig-Maximilians-Universitt, Munich, Germany; Dr. Michael Iskedjian, Innovus Inc., Hamilton, Canada; Professor Bert Leufkens, University of Utrecht, The Netherlands; Dr. Chuan Lim, Sevres, France; Prof. Dr. Dieter Magometschnigg, Gesellschaft fr Klinische Pharmakologie, Vienna, Austria; Dr. Peter Meredith, University of Glasgow, UK; Dr. Dieter Petzinna, Bayer AG, Germany; Dr. Jean-Philippe Reymond, Institut Central des Hpitaux Valaisans, Sion, Switzerland; Professor John Urquhart, Rijksuniversiteit Limburg, Maastricht, The Netherlands; Dr. Wolfgang v. Renteln-Kruse, Albertinen Geriatric Hospital, Hamburg, Germany; Dr. Robert A. Vander Stichele, Heymans Institute of Pharmacology, Gent, Belgium; and Professor Bernard Waeber, Uni-versity of Lausanne, Switzerland. <BR><P>
The four sessions of the workshop dealt with: Compliance and Clinical Trials: Methodology and Regulatory Issues; Compliance and Clinical Trials: Quality Assurance and Registration of Drugs; Compliance, Drug Usage and Patient Education; and Compliance and Health Economy. Participants included clinical research managers, project co-ordinators and marketing managers, clinical trial monitors as well as those responsible for designing and assessing trials with particular reference to pharmacoeconomic parameters. Participants were able to meet informally with the faculty during the Workshop Reception held at the close of the first day. 

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-113</DOCNO>
<DOCOLDNO>IA050-000869-B029-156</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a7.htm 199.92.136.137 19970111135357 text/html 9748
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:55:33 GMT
Last-modified: Thursday, 19-Dec-96 19:27:28 GMT
Content-length: 9556
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<STRONG><P>
<CENTER>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>GLOBAL CMC (Chemistry, Manufacturing & Controls):<BR>Challenges for the 21st Century</B><BR><P>
</CENTER>Peter Karlton, Sanofi Winthrop, Inc. and Albert S. Yehaskel, Purdue Pharma, L.P. were co-chairs of this first of its kind DIA meeting. Internationally recognized leaders in regulatory agencies, industry and academia from Canada and the U.S. participated in the program. The meeting challenged the participants to consider how the rapidly evolving global regulatory environment will affect the development of CMC information over the next decade.<BR><P>
The meeting goal of viewing CMC issues in a new light and from a global perspective was met. Specific issues related to global CMC included MERS (Multi-Agency Electronic Regulatory Submissions), Biotechnology (global registration and stability), Impurities, Pre-approval inspections, Dissolution, QA and QC, Development reports, and Global drug development.<BR><P>
Representatives from regulatory agencies included Per P. Helboe, DSc, National Board of Health, Denmark; Peter C. Jeffs (retired), and Robert A. Kapitany, Health Protection Branch, Canada; and representatives of the FDA.<BR><P>
We thank the experts who participated in the meeting for their contributions to the new and evolving techniques in this important area  Chemistry, Manufacturing and Controls.

<P><HR><P>
<CENTER><B>Presentation #1<BR><P>Thorough Technical Review Is the Key to Effective Technical Transfer<BR>
<I>Robert A. Nash</I>, PhD</B><BR>
Associate Professor<BR>
St. Johns University, USA<BR></CENTER><P>
You cant have technology bow to all kinds of management tools and strategy, said Dr. Nash. You have to respect technology, understand it, and attempt to control it. Thorough technical review  at every stage on an ongoing basis  is the key to technical transfer.<BR><P>
Dr. Nash explained the relationship between validation, qualification, and technical transfer. Validation, which he calls the bridge of communication among all aspects of the operation, applies to the whole process or system. Qualification applies to the elements of the process or system. Technical transfer applies to both the process and the system. The standards we establish at the beginning are not quite the standards we have at the end during that final transfer. Its an ongoing evolving system.<BR><P>
The key steps in product evolution are: product design, characterization, and selection; process design; product optimization; and process characterization, optimization, and qualification. The most difficult thing for technology is to go from the laboratory into the first scale-up. If you do it successfully, the second scale-up will not be a problem. For production size batches, you must re-do process qualification, formal validation, and certify acceptability of the product and process. <BR><P>
The validation team must be comprised of the people with the training and experience to carry out the mission: engineering (qualify plant, facilities, equipment, and support systems), development (qualify specific product and manufacturing process), manufacturing (operates plant, facilities, equipment, support systems, and manufacturing process), QA/QC (audits plant, facilities, equipment and support systems, and manufacturing process and product). Working together, problems can be reduced from 40% to 18%.<BR><P>
During pre-formulation studies, you must know the active drug substance and key excipients (using the solid dosage form as an illustration). In the second stage, the first scale-up to GMP facilities, do product optimization, process characterization, and maintain product stability. Come up with design experiments to identify critical variables. During process scale-up and evaluation, conduct pilot production, full scale batch for possible clinical and future commercial use, evaluate critical process parameters at 100X product and process scale, optimize and qualify process, and maintain product stability. Formal process validation goes from pre-formulation to laboratory pilot to formal validation based on a pre-validation batch; it includes a complete development program and report and preparation of the protocol for prospective process validation. Let the forms fit the substance. Do the work and then do the paperwork. <BR><P>
Dr. Nash also discussed amendments to cGMPs published in the <I>Federal Register</I> (May 3, 1996) for comment. While many elements of the amendments are positive, some wont work. For example, the amendments use the word effective for results. Effective is a dangerous word, because it means clinical trials are needed. Technology is not an effective business. The amendments also call for sampling and testing of in-process material at 1X, but Dr. Nash says that technology cant always do this. They also call for establishing and validating maximum time limits for each unit operation in manufacturing, but Dr. Nash maintains that this is unnecessarily time consuming and having information on how long it takes to manufacture a product should be sufficient. He urged attendees to look at the amendments and send their comments to FDA.<BR>
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>FDA Pre-Approval and International Drug Inspections<BR>
<I>Charles M. Edwards</I></B><BR>
National Drug Expert<BR>
Food and Drug Administration, USA<BR></CENTER><P>
The Chemistry, Manufacturing, and Controls submission for dosage form and bulk drug products is used as the standard for on-site inspections worldwide by FDA. The regulations governing this are found in the Code of Federal Regulations, Title 21, 314, D1. cGMP regulations are used for general guidance in finished dosage forms, and a guide has been issued for inspection of bulk pharmaceuticals. <BR><P>
All manufacturers must follow cGMP, which makes no distinctions between foreign and domestic manufacturers, or bulk and finished drugs. Although FDA has no legal authority outside the U.S., manufacturers which want to export products here allow inspections. Since conducting its first international inspection in 1955, FDA has done more than 3,000 inspections in 62 countries. <BR><P>
We try to do international inspections the same way as those in the U.S. but there are some unavoidable differences based on local laws and practical considerations. Outside of the U.S., FDA doesnt issue written notices of inspection because it has no legal authority. Findings are, of course, discussed with management, with copies of all guidance documents provided. Inspectors tell key staff what will be covered, so they can work together. A written list of observations is issued after every inspection  domestic or foreign.<BR><P>
Pre-approval inspections are generally the final stage in an NDA review. Forty percent of international inspections are team inspections, with an analyst, microbiologist, or computer specialist working with the inspector. <BR><P>
From October 1994 through September 1995, FDA conducted over 1,400 international inspections, including 600 drug inspections. Of these, 88% were pre-approval inspections. <BR><P>
Before pre-approval inspections were implemented in 1990, the focus was compliance with cGMPs, and much was left to the honor system. Field investigators became involved, and there was a relationship between approval of the application in Washington and someone going into the plant to verify that the conditions actually existed.<BR><P>
Manufacturers were no longer allowed to ship samples to FDA for analysis. The FDA police force was formed. Inspectors went into R&D buildings, did sampling, and evaluated batches. FDA chemists audited laboratory controls. <BR><P>
The goal of pre-approval inspections is to verify that information submitted to FDA is authentic. Areas covered include: employee training, qualification and cleaning of equipment, provision for process validation, audit of the batch, the proposed manufacturing process for the commercial batch, laboratory raw data and controls, validation of the analytical method, bulk drug substance evaluation, and a review of data on development aspects. <BR><P>
Inspections were covered for 75% of all applications; the others were probably inspected for the same or a similar commodity recently. FDA has found many questionable practices which resulted in withholding approval, for example, analytical methods that didnt detect related compounds, inadequate re-test procedures, raw data sheets lacking traceability, and problems with equivalence between pilot and commercial batches.<BR><P>
Domestically, inspections have resulted in tremendous improvements in turndown rate, from 60% in 1990 to 18% by 1996. The top reasons for withholding approval are: the plant isnt capable (must have building, equipment, and employees); deviations from cGMPs; problems with the laboratory, process validation, development, stability, or equipment; or fraud.<BR><P>
With foreign inspections, approval was withheld on 42% of inspections in 1995. We want to encourage manufacturers wherever theyre located to send drug products or drug substance into the U.S. but they need to meet the same standards.<BR><P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-114</DOCNO>
<DOCOLDNO>IA050-000869-B029-201</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a8.htm 199.92.136.137 19970111135415 text/html 3639
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:55:54 GMT
Last-modified: Thursday, 19-Dec-96 19:27:31 GMT
Content-length: 3447
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Immunotoxicity of Pharmaceuticals</B><BR><P>
</CENTER>Immunotoxicity testing is an important current topic in the pharmaceutical field. This workshop, held in Montreux, Switzerland, on October 2-4, 1996, followed on a workshop held in 1995 which concluded that more research was necessary concerning clinical correlation of observed animal immunotoxicity. The programme committee was: Dr. Jan Willem van der Laan, Dr. Henk van Loveren, and Dr. Joseph Vos, all of the National Institute for Public Health & The Environment, The Netherlands; Dr. Kenneth Hastings, Food and Drug Administration, USA; and Dr. Jack H. Dean, Sanofi Winthrop, Inc., USA.<BR><P>
The session titles were: Health Impact on Drug-Induced Immunotoxicity; Preclinical Testing of Drugs for Immunotoxicity; Extrapolation and Risk Assessment; and Essential of Immunotoxicity Assessment in Humans. The aim of the workshop was to give participants the opportunity to discuss current animal tests, particularly those likely to be included in guidelines, in relation to clinical correlates; how current test systems can be used in risk assessment; and for which type of clinical finding or observation new preclinical tests have to be developed. Participants had backgrounds in Toxicology and Immunotoxicology or were Clinicians and Epidemiologists interested in the immune effects of Pharmaceuticals.<BR><P>
The faculty who joined the programme committee were: Dr. R. Albers, State University of Utrecht, The Netherlands; Professor Klaus Andersen, Odense University Hospital, Denmark; Dr. Derk P. Bruynzeel, Free University Academic Hospital, Amsterdam, The Netherlands; Dr. Eric J. de Waal, National Institute for Public Health & The Environment, The Netherlands; Dr. Robert House, IIT Research Institute, Chicago, USA; Dr. Eiji Maki, Janssen-Kyowa Co. Ltd., Tokyo, Japan; Dr. Albert Munson, National Institute for Occupational Safety and Health, USA; Dr. Marc Pallardy, Universit Paris XI, Chatenay Malabry, France; Dr. J. Schdelin, Pharmacovigilance Group, Novartis, Switzerland; Dr. Vera Stejskal, Danderyds Hospital, Sweden; Dr. Norman Talal, The University of Texas, USA; Dr. Robert Vogt, Centers for Disease Control, Atlanta, USA; and Dr. K. Whaley, University of Leicester, UK.<BR><P>
Informality always has its place at DIA meetings! Faculty and participants were able to enjoy a traditional fondue together at a local restaurant in the heart of old Montreux.

<P><HR>
<CENTER><A HREF="dhp2.htm"><IMG  BORDER=0 SRC="about.gif"></A><A HREF="dhp3.htm"><IMG BORDER=0 SRC="member.gif"></A><A HREF="dhp5b2.htm"><IMG BORDER=0 SRC="recent.gif"><A HREF="dhp4.htm"><IMG BORDER=0 SRC="upcom.gif"></A><A HREF="dhp5.htm"><IMG BORDER=0 SRC="public.gif"></A><A HREF="dhp6.htm"><IMG BORDER=0 SRC="awards.gif"></A><A HREF="dhp7.htm"><IMG BORDER=0 SRC="fellow.gif"><A HREF="dhp8.htm"><BR><IMG BORDER=0 SRC="conted.gif"><A HREF="dhp9.htm"><IMG BORDER=0 SRC="dianews.gif"><A HREF="dhp10.htm"><IMG BORDER=0 SRC="infocen.gif"></A><A HREF="dhp11.htm"><IMG BORDER=0 SRC="personal.gif"></A><A HREF="dhp12.htm"><IMG BORDER=0 SRC="message.gif"></A><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-115</DOCNO>
<DOCOLDNO>IA050-000869-B029-227</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b2a9.htm 199.92.136.137 19970111135433 text/html 5238
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:56:11 GMT
Last-modified: Thursday, 19-Dec-96 19:27:33 GMT
Content-length: 5046
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>CRISIS MANAGEMENT IN THE PHARMACEUTICAL INDUSTRY</B><BR><P>
</CENTER>Wayne L. Pines, APCO Associates, Inc. and Judi L. Weissinger, PhD, Weissinger Solutions, Inc. were co-chairs of this meeting. The workshop was intended to develop the participants knowledge of the fundamental elements of crises and crisis management in the pharmaceutical industry.<BR><P>
Crisis management, through lectures, panel discussions and participatory exercises, was explored instructing the participants on Crises: types, what to expect, impact on the company, proactive planning, interaction with regulatory agencies, and prevention. The workshop included a crisis simulation exercise to develop hands-on skills in dealing with issues.<BR><P>
Crises for the workshop were chosen from situations which included: Changes in Benefit to Risk ratios; Journal or newspaper reports; Tampering and/or extortion; Consumer group allegation; and changes in corporation structure.<BR><P>
Program speakers included Michael McCaughan, Man-aging Editor, The Pink Sheet; John Schwartz, FDA Correspondent, The Washington Post; Robert P. Brady, Esq., Partner, Hogan & Hartson; Richard M. Cooper, Esq., Partner, Williams & Connolly; and Arthur N. Levine, Esq., Partner, Arnold & Porter. <BR>
<P><HR><P><CENTER><B>Presentation #1<BR><P>Graciously Supplied by <I>Judi Weissinger</I>, PhD</B><BR>
President, Weissinger Solutions, Inc.<BR><P>
</CENTER>Wayne Pines, President, APCO Associates, Inc. and Judi Weissinger, PhD, President, Weissinger Solutions, Inc., teamed up to offer a repeat of a previously successful and oft requested workshop geared to increasing the fundamental knowledge of the elements of a crisis and crisis management, specifically for the pharmaceutical industry.<BR><P>
Mr. Pines presentation, Principles for Managing a Crisis, focused on nine key principles for managing a crisis. He discussed the elements of an internal task force, the importance of honestly and thoroughly assessing the situation, keeping target audiences, the media, and regulatory authorities informed, and controlling the flow of information. He reminded the registrants of the importance of crisis prevention and crisis preparedness, and offered insights for being prepared.<BR><P>
Mary Pendergast, Esq., presented the FDA views on pharmaceutical crises. She reminded everyone that FDA is aware that crises do happen! The FDA has matured in its response to crises by setting aside people whose job it is to concentrate on dealing with crises; to work with companies for mutual success in handling crises. Companies need to interact with FDA quickly and honestly. FDA urges companies to look at their product lines and honestly assess the vulnerabilities of their products to tampering, counterfeiting, repackaging, quality and production line interference, potential health consequences, and outside influences such as water supply, pesticides, union activities, etc. Ms. Pendergast urged companies to act quickly if something appears to threaten a product; get the facts and get the product to the FDA laboratories for analyses as fast as possible. She emphasized that rapid action can avoid the Friday afternoon crisis syndrome.<BR><P>
The first day of the program ended as Dr. Weissinger introduced the simulation exercise and summarized the key elements of a crisis management SOP, the need to be proactive, the importance of focus and clear messages, the need for internal and external communication plans, and post-crisis closure with retrospective analyses. The participants were then assigned to companies, issued T-shirts, assigned corporate roles, and given time during the reception to initiate some advance corporate planning in case a crisis might occur over the next 24 hours.<BR><P>
The second day of the workshop, the crisis simulations started early with select officers of each company receiving a copy of a morning news article that affected their companys product. Corporate officers (assigned for the workshop) were busily trying to respond to their individual crises, the press and publics request for statements, whilst their CEOs and FDA were requesting strategies and answers. All participants found themselves challenged to use the knowledge and skills taught during the first day to meet the simulated crises. After satisfactorily meeting the needs of the press (played by Dr. Judi Weissinger), the public (played by our own Carol Pratt), the FDA (played by Dr. Charles Hoiberg) and the internal corporate Crisis Management Team (played by the registrants), each company presented their challenges and solutions to the group, secure in the knowledge that they had succeeded.<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-116</DOCNO>
<DOCOLDNO>IA050-000869-B030-9</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a10.htm 199.92.136.137 19970111135454 text/html 9360
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:56:32 GMT
Last-modified: Thursday, 19-Dec-96 20:21:54 GMT
Content-length: 9168
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Recent Meetings</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>FIRST DIA MEETING ON REGULATORY EFFICIENCY</B><BR><P>
</CENTER>Julie Tam, MBA, Canadian Drug Manufacturers Association, Canada, and Beth Pieterson, MSc, MHA, Bureau of Biologics, Health Canada were co-chairs for this First DIA meeting of its kind. <BR><P>
The two day meeting, in Toronto, Canada, was divided into three sessions: Best Practices for Regulatory Efficiency, Dann M. Michols, Director General, Drugs Directorate, Health Canada, Chair; Future Trends Towards Improved Regulatory Efficiency, Roger W. Schwede, Vice President, Generic Development, Apothecon, USA, Chair; and International Comparison of Regulatory Efficiency, John Stewart, Executive Vice President and General Manager, Purdue Frederick, Canada, Chair.<BR><P>
Speakers included Nelson M. Sims, President, Eli Lilly Canada, Inc., and Chairman of the Board, Pharmaceutical Manufacturers Association of Canada; Robert Goyer, PhD, Dean, Faculty of Pharmacy, University of Montreal, Canada; Michael Corbeil, BSW, Executive Director, British Columbia, Ministry of Health, Pharmacare, Canada; Neil McAuslane, PhD, Research Manager, Centre for Medicines Research, UK; and Sheila R. Shulman, LLB, MPH, Assistant Director and Senior Research Fellow, Tufts Center for the Study of Drug Development, Tufts University, USA.<BR><P>
We thank these experts for their contributions to this excellent meeting.

<P><HR><P>
<CENTER><B>Presentation #1<BR><P>
A Company Strategy for a Quick and Efficient Review<BR>
<I>Suzanne Cadden</I>, MSc</B><BR>
Director, Drug Regulatory Affairs<BR>
Glaxo Wellcome, Canada<BR><P></CENTER>
Cadden used a 4 x 100 meter Olympic relay race as an analogy for the development of an effective and successful regulatory strategy. Like a relay race, strategic planning is critical to success. It has to start early in the process, and involves individuals from many disciplines in many countries, said Cadden. Planning must provide everyone with an opportunity for early input and clear directions in terms of the objective; it must also be flexible enough to be tailored to different countries, without compromising development time. <BR><P>
Its a race to the finish line, every second in a race and every day in drug development does count, said Cadden, who referred to the data package as the baton, handed off between many groups.Competitors are highly and similarly skilled. Never underestimate your competition.<BR><P>
A successful regulatory strategy depends on the companys attitude toward the regulator. In an optimal situation, the regulator is seen to be very much a part of the regulatory team, facilitating smooth handoffs throughout the drug development process and efficient reviews. In a non-optimal role, the regulator functions clearly outside the process, in a sense as a race judge, disqualifying candidates for false starts.<BR><P>
The team is crucial. It must follow a strict code of conduct which calls for: listening to, evaluating and acting on advice and opinions of stakeholders, both critics, and friends; humbleness; respect among team members, with an environment that permits assumptions to be challenged constructively; and focusing on the necessary evidence rather than getting hung up on formal requirements (i.e., more studies arent necessarily the solution). Mutual trust and respect between company and regulators is essential. The quality of the data that you submit and the companys statements that you make about that data are the foundation for that relationship. Teams must also adopt the regulators perspective.<BR><P>
Team dynamics and processes are also important. Dynamics include familiarity with each other, clear expectations early, and awareness of each others activities. Successful processes include not passing on the baton too early or too late, early interaction with regulatory authorities and informing team members about the results of these interactions, and building and monitoring strategies and tactics to satisfy regulatory requirements. We need to get away from this concept that we are submitters of data, that falls short of what we are trying to do. I think if we adopt an attitude that we are educating the regulator in new therapeutic areas and all aspects of drug use it results in a much more effective and understandable process. If you do get a deficiency notice, dont answer perfunctorily: We know best. Pinpoint the regulators area of concern and answer questions thoroughly.<BR><P>
Cadden concluded by noting that: You land where you look. Focusing excessively on avoiding disclosing and discussing issues, and holding proactive discussions with regulators, will cause companies to look down at perceived obstacles, instead of focusing on the strategies, and looking up towards a successful cross of the race finish line.<BR>
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>
Guidelines: Helping or Hindering Regulatory Efficiency?<BR>
<I>Michael Spino</I>, PharmD</B><BR>
Senior Vice President, Scientific Affairs, Apotex, Inc.<BR>
and Professor, University of Toronto, Canada<BR></CENTER><P>
Guidelines pertaining to generic drugs should benefit both industry and regulators, according to Dr. Spino. He discussed changes that would enable them to do so. Generic drugs, usually marketed 10-15 years after the brand, are essentially a formulation change. In order for a generic to demonstrate safety and efficacy, it would seem reasonable that you compare the two formulations and ensure that the brand versus the generic is delivering the same amount of drug into the body at the same rate. But this assumption required evaluation. Clinical studies arent suitable for the majority of generic versus brand comparisons: theyre too imprecise. The disease state is generally much more variable than two formulations which are designed to be identical. Clinical endpoints are fairly obscure, and they require many patients to demonstrate equivalent efficacy. <BR><P>
The rationale behind bioequivalence testing for generics is that comparative bioavailability of the brand and generic determines whether the formulations provide equivalent drug levels. The advantage of bioavailability is that blood concentrations are precise and can be used for all drugs.<BR><P>
In the mid 1980s, Canadas Health Protection Branch re-established its Expert Advisory Committee on Bioavailability to develop guidelines for comparative bioavailibility studies. In 1990, a report was distributed for comment, with Report A for non-complex drugs and Report B for modified dosage forms of non-complex drugs. Both reports called for generics to demonstrate the same (understood to be plus or minus 20%) amount and rate of drug in the same subjects at different times. The committee recommended that non-complex drugs show bioequivalence with a 90% confidence interval, a relative mean AUC within 80-120%, and a relative mean measured Cmax between 80-120%. Most generics meet these criteria, thus, the guidelines have helped with non-complex drugs. <BR><P>
For highly variable drugs, however, the standards may be too austere. Even when true bioavailability is 100% between two formulations on two different days, the variability due to the disposition of the drug, not the formulation, may suggest they are not equivalent. If, when comparing brand to brand in the same individuals on separate days, the product fails, it suggests to me that the criteria are not appropriate. In such cases its essential to establish new criteria to truly demonstrate bioequivalence. Whether its efficient to conduct several studies or study many subjects to demonstrate bioequivalence is being addressed internationally, but it will be some time before there will be clear criteria.<BR><P>
When Report C of the Canadian bioequivalence guidelines was released by the Health Protection Branch to stakeholders for comment, sponsors had serious reservations that the criteria may be incorrect and the resultant studies and process may be highly inefficient. Report C as a report, should be abandoned, and those elements which need to be developed should be brought forward and addressed one by one. Spino admits that regulators are between a rock and a hard place; but appropriate scientific standards must be applied to the question.<BR><P>
HPB must not let the pendulum swing back too far the other way where every i must be dotted and every t crossed before a decision is made. Spino suggests using the Report A criteria until the elements of Report C that are appropriate are determined. The solution: Based on scientific data and reason, reasonable guidelines which are living documents should be prepared. They should serve as framework to consider new submissions, not as a sieve to exclude submissions.
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-117</DOCNO>
<DOCOLDNO>IA050-000869-B030-48</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a11.htm 199.92.136.137 19970111135512 text/html 3210
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:56:52 GMT
Last-modified: Thursday, 19-Dec-96 20:22:12 GMT
Content-length: 3018
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Clinical Interpretation Issues in Laboratory Data and New Technologies</B><BR>
</CENTER><P>
Dr. Alan Craig, of LCG Bioscience, UK, led this workshop which considered interpretation of the data as the ultimate issue for both safety and efficacy. Of course quality standards and the choice of clinical laboratories are important, but are possible new data handling methods, new test selections and new technologies to be ignored because it is simpler to use the well-tried methods?  <BR><P>
The faculty, who gathered in Noordwijk (Amsterdam) October 21-22, 1996, were: Richard Barrett, Pfizer Central Research, UK; Dr. Paul Beranek, Glaxo Wellcome R&D, UK; Dr. John C. Bloom, Lilly Research Laboratories, USA; Professor Hans Peter Breuel, Pharmacon Research, Berlin, Germany; Dr. Paul C. Collinson, Mayday University Hospital, UK; Dr. Giuseppe Colucci, Roche Diagnostic Systems, Basel, Switzerland; Dr. Robert A. Dean, Clinical Laboratory Medicine, Indianapolis, USA; Marian Desmet, Marian Desmet b.v.b.a., Alken, Belgium; Dr. Richard Fink, West Middlesex University Hospital, UK; Mark Fowler, Glaxo Wellcome R&D, UK; Dr. Francisco Harrison, Harrison Clinical Research GmbH, Munich, Germany; Dr. M.H. Harvey, SmithKline Beecham Laboratories, UK; Dr. Peter R. Heine, Pharmacon Research, Berlin, Germany; Dr. Jeffry B. Lawrence, Eli Lilly & Co., Indianapolis, USA; Dr. Sheila Linder, Linder International Inc., Wayne, USA; Dr. Sam Lindgren, Astra Draco AB, Lund, Sweden; Henrik Rist Nielsen, Leo Pharmaceutical Products, Ballerup, Denmark; Dr. Stuart Oliver, Corning Besselaar, Leeds, UK; Susan Oppert, West Middlesex University Hospital, UK; Sally Osmond, Unilabs Clinical Trials Ltd., London, UK; Gregory T. Stelzer, Cytometry Associates, Brentwood, USA; Dr. Marion van der Heijden, Martini Hospital, Groningen, The Netherlands; and Dr. Alec Vardy, Sanofi Research Division.<BR><P>
Faculty had their input divided into three sessions: lnterpretation of Clinical Laboratory Data in Drug Studies & New Technologies in Clinical Trials; Potential Drug-Associated Toxicities; and Update in New Technologies in Clinical Trials. Delegates came from these areas of the health care sector: Clinical Research Associates and Trial Monitors, Statisticians and Regulators, Clinical Project Managers and Clinical Trial Managers, Report Writers and Scientists.<BR><P>
Both the delegates and the faculty benefited from an exhibition by Pharmaceutical Industry Support Organizations at which materials and services were displayed. Everyone was able to enjoy time informally together at the Workshop Reception which was followed by a dinner where lively discussions took place. 
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-118</DOCNO>
<DOCOLDNO>IA050-000869-B030-82</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a12.htm 199.92.136.137 19970111135531 text/html 10451
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:57:08 GMT
Last-modified: Thursday, 19-Dec-96 20:22:15 GMT
Content-length: 10258
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Current Situation and Perspectives on Non-Prescription Herbal Medicines</B><BR><P>
</CENTER>The program chair for this meeting in Mexico City, Mexico was Hctor A. Bolaos, Executive Director, AFAMELA, Mexico. His program committee was Mary E. Carman, Director, Bureau of Pharmaceutical Assessment, Drugs Directorate, Health Canada; Hubertus Cranz, MS, PharmD, Director, The European Proprietary Medicines Manufacturers Association, Belgium; and Jerome A. Reinstein, PhD, Director General, WFPMM, UK.<BR><P>
Representatives from regulatory agencies, international and regional health organizations discussed their commitment to support the appropriate use of non-prescription herbal medicines. The following topics were addressed: Historical development and current acceptance of non-prescription herbal medicines in industrialized and developing countries; Overview of the regulatory requirements enforced around the world and principles used to assess non-prescription herbal medicines in Europe, Canada, United States and Mexico; Harmonization perspectives and developments leading to assure consistent quality of non-prescription herbal medicines.<BR><P>
Dr. Rafael Camacho-Solis, Deputy Minister, Ministry of Health, Mexico welcomed the attendees with the Keynote Address. Dr. Bernd Eberwein, Director, German Medicines Manufacturers Association, Germany; Dr. Konstantin Keller, Director and Professor, Federal Institute for Drugs and Medical Devices, Germany; Guillermo Bierzwinsky, MD, Director, Drug Control Bureau, Ministry of Health, Mexico; and Floyd E. Leaders, Jr., PhD, The Leaders Group, Inc., USA also participated in the meeting. <BR><P>
We thank these experts for their contributions to the meeting on this important topic.<BR>
<P><HR><P>
<CENTER><B>Presentation #1<BR><P>
Overview of the Regulatory Requirements Used Around the World<BR>
<I>Dr. Bernd Eberwein</I></B><BR>
Director, German Medicines Manufacturers Association (BAH), Germany<BR></CENTER><P>
Dr. Eberwein summarized the results of a recent survey on herbal medicines sent to member countries of the World Federation of Proprietary Medicinal Manufacturers:<BR><P>
<OL TYPE=1, 2, 3, ...>
<LH></LH>
<LI>Herbal products are widespread.<BR>
<LI>They are considered medicinal products in the vast majority of countries, except for Indonesia, New Zealand, Peru, Singapore, the U.S., and Venezuela.<BR>
<LI>When considered medicinal products, they need a pre-marketing license in most countries, except for Hong Kong and India. In most countries, herbal products undergo food and medicinal regulations, said Dr. Eberwein. When food regulations are used, herbal products must meet normal safety and quality standards. In a few countries, positive health claims are allowed for herbal foods and additives. Where medicinal regulations apply, most new herbal medicines must meet international efficacy and safety standards. A few countries have pragmatic national rules and some approve safety and efficacy based on tradition alone.<BR>
<LI>Herbal medicines are more than 10% of the total medicinal market in only a few countries: Germany, Hungary, India, Indonesia, Singapore, and China.<BR>
</OL>
<P>
We have a variety of regulations worldwide, therefore, I think we have in some respect a need for harmonization. The model for that could be the WHO guidelines for the assessment of herbal medicines. The WHO guidelines call for pharmaceutical, safety, and efficacy assessments. Dr. Eberwein compared the WHO criteria to selected countries, offering his personal classification of each.<BR><P>
Traditional Indian medicines contain herbal remedies, which are accepted if the ingredients are officially listed. New herbal medicines require a marketing authorization application with safety and efficacy data. Official pharmacopeias for the three WHO criteria are in preparation. Dr. Eberwein believes that India corresponds with the WHO principles.<BR><P>
In Indonesia, quality of crude herbal drugs must comply with six volumes of material medica Indonesia and labeling with special guidelines, but proof of indication isnt required. Dr. Eberwein believes that India isnt refined with regard to WHO principles.<BR><P>
Herbal medicines, considered medicinal products in China, have no efficacy requirements if the drug is listed in the pharmacopeia. New herbal drugs must meet full requirements. Dr. Eberwein believes that China corresponds with WHO principles.<BR><P>
In Japan, traditional herbal remedies are accepted based on philosophy and empirical evidence. New herbal drugs must meet international efficacy requirements. Dr. Eberwein believes that Japan is not yet clarified regarding WHO guidelines.<BR><P>
In Korea, herbal remedies occur in oriental and western medicine. For medicines based on the 11 classical books on traditional Korean and Chinese medicines, there are no efficacy and safety requirements; others must provide the range of doses. Dr. Eberwein expects Korea to adapt to WHO standards.<BR><P>
In Australia, all medicines, including herbal medicines, need a license. There is an efficacy assessment, but herbal medicines enter at a lower level, if there are no safety concerns or an intent to treat serious medical conditions. Dr. Eberwein believes that Australia corresponds with WHO principles.<BR><P>
In Europe, all pharmaceutical products require pre-marketing approval. Old medicines must be reviewed in light of recent directives. Pragmatic standards exist for the pharmaceutical quality of herbal medicines. For efficacy and safety, documented experience and bibliographical data are generally taken into account. Dr. Eberwein believes that Europe corresponds with WHO principles.<BR><P>
In Canada, herbal medicines are regulated as drugs and need pre-marketing approval. There are guidelines on traditional herbal medicines. Dr. Eberwein believes that Canada corresponds with WHO principles.<BR><P>
Herbal medicines are considered foods or dietary supplements in the U.S., but Dr. Eberwein expects this to change a little in the future. Dr. Eberwein believes that there are differences between U.S. and WHO principles.<BR>
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>
Monographs of WHO and ESCOP, Recent Approaches to Addressing the <BR>
Basic Requirements of Quality, Safety and Efficacy for Herbal Medicines<BR>
<I>Norbert Linnenbrink</I>, PhD</B><BR>
Regulatory Affairs Manager<BR>
Zyma Healthcare, Switzerland<BR></CENTER><P>
Dr. Linnenbrink covered the monographs of WHO, FDA, Germany, EU, and ESCOP, using the European regulatory viewpoint that plant medicines must comply with the same rules and requirements as all medicines for quality, safety, and efficacy. These three criteria are inter-dependent.<BR><P>
Traditional uses of plant medicines in the world are diverse; to be used in the modern world, they must be integrated into modern medicine. This is an enormous task which can only be undertaken by a global organization like WHO, said Dr. Linnenbrink. WHO began its program on traditional remedies in 1967. In 1984, it stated that herbal medicines are necessary for primary health care in developing countries and that demand in developed countries is on the rise. WHO recommended action lines to be followed: evaluate to separate mythology from reality, integrate traditional systems into modern health care systems, and train modern health care professionals in traditional medicine and herbalists in modern health care skills.<BR><P>
WHO monographs, drafted using a Western scientific approach and covering Western plants and traditional Chinese medicine, will be proposed to drug regulatory authorities this year. This is an important step to try to bring this harmonization a bit forward. Only the WHO monographs contain complete information on quality.<BR><P>
FDA started preparing OTC monographs in 1973 which are not yet complete. Published in the <I>Federal Register</I>, they contain statements of pharmacology, pathology, mechanism of action, safety and efficacy evaluation, dosage instructions, definition of active substance, and warnings for labeling. The monographs only cover herbal products supported in the U.S.<BR><P>
Germany has accumulated more than 250 individual monographs on plants since 1983. These contain: definition; therapeutic information with contraindications, side effects, interactions, and special precautions; dosage; and pharmacological effects if available. This is a very important source of information on safety because it provides a systematic overview.<BR><P>
While Europe has exhaustive regulations for pharmaceuticals, it has only addressed quality of herbal medicines. In 1987, the European Parliament asked the European Commission to develop a scientific approach toward herbal medicines incorporating centuries of practical experience and scientific accuracy. In 1989, the European Scientific Cooperative on Phytotherapy (ESCOP) was founded to advance the scientific status of phytomedicines and assist harmonization of regulatory status in Europe. To date, ESCOP has worked on 50 monographs; 20 were published in March 1996 and 30 are in preparation. These monographs follow the general European format for professional drug information  the summary of product characteristics.<BR><P>
Dr. Linnenbrink cites these monographs as providing the best scientific literature available today in the list of references. They really give the basis for evaluating the plant and evaluating the text of the monograph. <BR><P>
Dr. Linnenbrink concluded by stating that monographs provide a platform for assessing herbal medicines, and giving proper instructions for their use. Herbal medicines are medicines as all medicines and all medicines must be used following the right instructions, for the right condition, using adequate doses and following the proper use instructions.<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-119</DOCNO>
<DOCOLDNO>IA050-000869-B030-122</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a13.htm 199.92.136.137 19970111135616 text/html 2075
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:57:47 GMT
Last-modified: Thursday, 19-Dec-96 20:22:46 GMT
Content-length: 1883
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Practical GCP Compliance Auditing of Trials & Systems</B><BR></CENTER><P>
The popularity of this educational seminar only increases! Noordwijk (Amsterdam) was the meeting point in October for the auditors and inspectors attending this rerun and they gave a warm welcome to two new faculty members: Dr. Stephen Kendal, Zeneca Pharmaceuticals, UK, and Dr. Fergus Sweeney, Corning Besselaar, Belgium  <BR><P>
As faculty members, they were joined by Dr. Michel Krumenacker, Sanofi Recherche, France; Dr. Jacques Mascaro, H. Lundbeck A/S, Denmark; Dr. Claire Massiot, Sanofi Recherche, France; Kristel van de Voorde, Bristol-Myers Squibb Europe, Belgium; and the seminar was chaired by Dr. Marijke Korteweg, Bristol-Myers Squibb International Corporation, Belgium.  <BR><P>
Step 5, the implementation of the ICH GCP guideline in the EU, Japan and the USA requires an update in the approach to auditing and inspecting. The contents on the seminar have been changed accordingly but the ultimate objective remains experience sharing and a common professional approach to ultimately benefit patients and health care world-wide. A working dinner on one evening and an informal reception on another evening round out the possibilities for interaction between faculty and participants.  <BR><P>
The DIA constantly aims to meets its members needs: it is therefore delighted to announce that due to popular request two more reruns of this seminar will take place in Brussels, January 29-31, 1997 and in Nice, February 10-12, 1997.

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-120</DOCNO>
<DOCOLDNO>IA050-000869-B030-167</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a14.htm 199.92.136.137 19970111135636 text/html 1614
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:58:14 GMT
Last-modified: Thursday, 19-Dec-96 20:22:48 GMT
Content-length: 1422
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>The Notice to Applicants: Latest Revisions</B></CENTER><BR><P>
Simultaneous translation, English/Italian, was offered to participants of this one-day seminar to enable them to make full benefit of the programme. During the opening session, the changes in the Notice to Applicants Part IIA were highlighted, and in subsequent sessions, major new features were discussed in detail and participants were encouraged to raise practical points and questions for clarification. A key feature of the seminar is its interactive nature. <BR><P>
The seminar took place on October 25, 1996 in Milan, Italy, and the faculty were: Dr. Roger Bolton, Zeneca Pharmaceuticals, UK; Marie Donnelly, EC Commission, Brussels; Brenton E. James, Glaxo Wellcome Research & Development, UK; Thomas Lnngren, Medical Products Agency, Sweden; Professor Vittorio Silano, Ministero Della Sanita, Italy; and Dr. Willem F. van der Giesen, Medicines Evaluation Board, The Netherlands. <BR><P>
The DIA thanks participants and faculty for their contributions to the success of the seminar. 


<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-121</DOCNO>
<DOCOLDNO>IA050-000869-B030-200</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a15.htm 199.92.136.137 19970111135719 text/html 13232
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:58:28 GMT
Last-modified: Thursday, 19-Dec-96 20:22:52 GMT
Content-length: 13039
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Real World Studies of Treatment Outcomes</B></CENTER><BR><P>
Paul Coplan, ScD, and Michael Stek, Jr., MD, MSc, both from Merck & Company, Inc., USA, were program co-chairs and session chairs for this meeting. Louis A. Morris, PhD, FDA, also participated as a session chair. The objectives of the workshop included: Clarifying the design and methodology of real world or effectiveness studies; Assessment of how effectiveness studies differ from efficacy trials; Examination of barriers to more frequent use of effectiveness studies; and Evaluation of how effectiveness studies can be used in marketing communication and promotion of pharmaceutical products.<BR><P>
The three meeting sessions dealt with: From Efficacy to Effectiveness  How Much of a Difference Is It Anyway?; Large Simple Trials  Why Arent We Doing More of Them?; and Marketing Communication and Promotion  Whats Important to Communicate and How Do We Say It? <BR><P>
Nancy C. Santanello, MD, MS, Merck, offered a presentation describing the differences between effectiveness and efficacy studies and introduced the value of effectiveness studies. Robert J. Temple, MD, FDA, presented the Real World Studies and Great Potential, Many Pitfalls discussion of the difference in such studies. It should be possible to assess potential real world outcomes, and differences in outcome for similar drugs, by modifying study designs to allow differences to emerge, while still maintaining design rigor. Susan S. Ellenberg, PhD, FDA, discussed the opportunities for Large, Simple Trials in Drug Development. Gerald A. Faich, MD, MPH, Outcomes Research Corporation, provided a discussion of Large Simple Trials for Safety  Examples, Regulatory Implications and Barriers.<BR><P>
We thank these and the other experts on the program for their contribution to this important topic.

<P><HR><P>
<CENTER><B>Presentation #1<BR><P>
Real World Studies and Great Potential, Many Pitfalls<BR>
<I>Robert J. Temple</I>, MD</B><BR>
Associate Director for Medical Policy, Center for Drug Evaluation and Research<BR>
U.S. Food and Drug Administration<BR></CENTER><P>
Dr. Temple discussed the potential and limitations of real world trials and why their results may differ from other trial designs. The distinction between efficacy and effectiveness is important. Efficacy is the effects of a drug in an idealized, typical drug development setting, whereas effectiveness is what a drug can do in a practice-like setting. Results of efficacy and effectiveness trials are supposed to differ. The whole point of a clinical trial is that its designed to discover differences between treatments, said Dr. Temple. Clinical trials use people who are likely to respond, comply, and accept side effects and who are relatively free of things that make noise such as other medications or diseases. They may not be typical of your average patient. The controlled setting includes a detailed protocol, possible stimulation of compliance, and close monitoring of other therapy.<BR><P>
There are a lot of reasons that all of these selection efforts might not help as much as we think. For example, researchers dont know that old people and people with concomitant diseases will have different results yet theyre routinely excluded from trials. Disease severity probably matters, but how much is unknown. The attempt at rigor in trials is probably not as successful as we want.<BR><P>
The efficacy/effectiveness distinction is theoretically plausible and interesting, but its largely hypothetical. Its very closely related to the traditional question of generalizability. There are a few data that suggest that efficacy results are usually not generalizable and should be discarded. I think we should believe them until we know better.<BR><P>
The differences are important for two reasons: 1. Things might not really work or work well enough to bother with in a real life setting, and 2. Tightly controlled environments may equalize therapies, so that drugs which have an advantage in a real world setting cant be distinguished in the artificial clinical trial setting. <BR><P>
Comparative effects must be scientifically meaningful, rigorous, and fair. That means no databases, and not comparing an adequate dose of one drug with an inadequate dose of another, or a proper dose of one drug with an excessive dose of another.<BR><P>
Dr. Temple offered these suggestions for gaining an edge: look at compliance where it matters most, for example, short half life drugs or drugs with steep dose-response curves; and look at situations where missing doses could have a cumulative effect, toxicity leads to many drop outs, and one drug is difficult to test and the other isnt.<BR><P>
Instances where in-use real life effectiveness is different from trial effectiveness or where two drugs similar in trials are different in real life are of great interest. Such differences could lead to labeling or promotional claims if they are rigorously supported. Were very interested in discussing these kinds of study designs and programs and potential claims. We clearly have trouble with database analyses as a basis for claims, and there are some obvious concerns in comparative trials that need to be looked at rigorously.
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>
Opportunities for Large, Simple Trials in Drug Development<BR>
<I>Susan S. Ellenberg</I>, PhD</B><BR>
Director, Division of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research<BR>
U.S. Food and Drug Administration<BR></CENTER><P>
Dr. Ellenberg defined large simple trials, provided their historical background, and discussed opportunities for conducting them. Large simple trials are generally trials with study enrollments in the thousands, minimally restricted entry criteria, minimal data collection, objective, easily documentable endpoints, and a limited impact on routine practice. Follow-up, diagnostic tests, and outcomes documentation are all similar to that required in normal patient care.<BR><P>
The purpose of large simple trials is to identify differences among potential treatment strategies that are meaningful from a public health perspective but are not likely to be detectable in smaller trials, said Dr. Ellenberg. They are simple for physicians entering patients into them, but not necessarily simple for the coordinating center. <BR><P>
One of the earliest modern randomized clinical trials  the Salk Vaccine Trial conducted in the early 1950s  was a large simple trial. During the next two decades, clinical trials became more sophisticated and conventional wisdom dictated homogeneous populations and a detailed protocol to reduce variability and improve understanding. Researchers realized that a new approach might be needed when multiple beta blocker studies in the 1970s suggested a small but worthwhile reduction in mortality that was far too small to be identified in any one trial. A series of large simple trials  the international studies of infarct survival (ISIS)  were initiated and first reported in 1986. Current opportunities for large simple trials include: prevention studies, safety studies for widely used regimens, and vaccines.<BR><P>
Large simple trials are randomized clinical trials. Theyre not a contrast to randomized controlled trials. Theyre not epidemiologic, observational, or cohort studies. Theyre randomized trials, with all of the benefits that you have from randomization. Theyre simple for the participating clinic, not necessarily for the coordinating center.<BR><P>
There has been a successful history of doing large simple trials. Theres ample proof of concept. There are many opportunities to consider large simple trials in drug development.<BR>
<P><HR><P>
<CENTER><B>Presentation #3<BR><P>
Marketing Communications: External Validity, Product Labeling, and Advertising Substantiation<BR>
<I>Louis A. Morris</I>, PhD</B><BR>
Chief, Marketing Practices and Communications<BR>
U.S. Food and Drug Administration<BR><P>
</CENTER>Dr. Morris discussed the relationship between real world studies and marketing claims, how FDA looks at marketing claims, and applications. My thesis is that external validity is vitally important in substantiating advertising claims, said Dr. Morris.<BR><P>
FDAs labeling and marketing concerns stem from the Act, which contains a prohibition against false and misleading claims. What you say about a pharmaceutical product from a marketing sense is supposed to be consistent with the labeling. It doesnt have to be identical to the labeling, and certainly you can go beyond it, but you should have adequate well-controlled studies to support these new claims. New influences, such as quality of life and patient satisfaction, and new methods have made this an important issue recently.<BR><P>
For quality of life claims, for example, companies typically start out with the concept that their drug improves quality of life. FDA, however, asks what claim is being made, what the study is, and if its measures are valid. FDA often looks at the study in retrospect, and sees that the company didnt prove improved quality of life. Some of the more successful companies come to FDA with an idea for a study. Theyll actually write out the claim they want to make and design the study with that claim in mind. FDA is then able to offer advice prior to the study.<BR><P>
In determining the truthfulness of a claim, FDA weighs the evidence, using data that support the claim. Historically, FDA has relied on adequate, well-controlled studies, but the agency is considering advice that it should be more flexible. <BR><P>
Disclosure is important, but its not a remedy for ensuring that claims arent false. Clearly, the existence of loads of footnotes is not going to make a false claim truthful. Other disclosure issues include: the amount of information an audience can readily perceive, and the emphasis placed on information.<BR><P>
The efficacy/effectiveness debate has resulted in criticism, well founded according to Dr. Morris, that clinical trials lack external validity and dont measure outcomes. Dr. Morris emphasized that effectiveness trials must substantiate claims.<BR><P>
Internal and external validity were defined, based on the work of psychologists. Campbell defined internal validity with the question: Does this complex treatment make a real difference in this unique application to these people at this particular place in time? He defined external validity with the question: Does this cause and effect relationship exist under a number of other circumstances? To this, Dr. Morris added that findings must be generalizable over treatments, measurements, populations, settings, and time. Another group of psychologists asked what the effective stimulus is.<BR><P>
Important elements of external validity include: treatments, measurements, populations, settings, and time. Treatment usually refers to a treatment policy, rather than a simple determination that Drug A improves outcome relative to Drug B. Measurement quality varies, particularly some of the newer outcome measures in quality of life or satisfaction. Populations are about representativeness, not size. The frequent claim that because a sample is large it must be representative isnt true. Definitions of settings need to be worked on, since both efficacy and efficiency studies are clinical trials. The effect must be analyzed over a clinically meaningful time course.<BR><P>
Applications include survey methods for quality of life (QOL), patient satisfaction issues, and OTC switch studies. FDA is concerned about the validity of the scales in disease-specific QOL measures. Scales for patient satisfaction arent as well developed as those for QOL and FDA is concerned with the sampling coverage and the surveys. FDA has been active in stimulating real world studies  all-comer and comprehension  on OTC switches.<BR><P>
External validity is vitally important. FDA has been sensitive to this in a number of ways. The distinction between efficacy and effectiveness studies is being blurred. I think this is good because it says that you really want to answer the questions that youre asking in a way thats going to provide the most confidence in the results.<BR><P>
We have a lot to learn. Theres been a lot of discussion on the methodology side. I think there has to be an equal and important debate on the communications side, including determining how to fairly represent the findings of real world studies, not just in journal articles, but also in marketing and advertising.<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-122</DOCNO>
<DOCOLDNO>IA050-000869-B030-245</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a16.htm 199.92.136.137 19970111135738 text/html 13127
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:59:19 GMT
Last-modified: Thursday, 19-Dec-96 20:22:56 GMT
Content-length: 12934
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>The FIRST Joint CDER/CBER Pharmaceutical Industry Workshop<BR>
Proposed Interim Guidance for Electronic Submission of Case Report Forms and Tabulations</B><BR><P>
</CENTER>Kaye Fendt, MSPH, FDA; Mary Buesing, MD, FDA; and Ronald Fitzmartin, PhD, The Purdue Frederick Company were co-chairs for this first of a kind meeting. They were supported by the Electronic CRF/CRT Submissions Committee from CDER and CBER. Representing CDER were Renata Albrecht, Thomas Laughren, Brad Leissa, Randy Levin, Stephen Wilson and Curtis Wright. Representing CBER were Peter A. Lachenbruch, Frederick W. Miller, Linda Sigg and Jeffrey Smith.<BR><P>
The workshop objectives were: To introduce interim guidances for electronic submission of case report forms and case report tabulations; Discuss present and future directions for electronic data submissions; and Solicit Industry comments and ideas for efficient data submissions. The interim guidances were made available by the FDA at the meeting. As a secondary objective, the workshop enabled attendees to immediately begin preparations for electronic submission of CRF/CRTs for currently planned submissions.<BR><P>
The workshop commenced with presentations by Janet Woodcock, MD, Director, CDER and Kathryn C. Zoon, PhD, Director, CBER. Among the topics specifically addressed by speakers from the FDA and industry were: the Role of CRFs/CRTs in the Review Process; Electronic CRF and Tabulation Submissions and Archiving.<BR><P>
Future directions for these new procedures were discussed by a panel of experts, Stephen Wilson, Jeffrey Smith and Randy Levin.<BR><P>
We thank the many FDA and Industry representatives for their initiatives and contributions to the great success of this meeting.

<P><HR><P>
<CENTER><B>Presentation #1<BR><P>
Overview<BR>
<I>Kaye Fendt</I>, MSPH</B><BR>
Chair, Electronic CRF/CRT Submission Committee <BR>
CDER, U.S. Food and Drug Administration<BR>
<B><I>Janet Woodcock</I>, MD</B><BR>
Director, CDER<BR>
U.S. Food and Drug Administration<BR>
<B><I>Kathryn C. Zoon</I>, PhD </B><BR>
Director, CBER, <BR>
U.S. Food and Drug Administration<BR></CENTER><P>
This workshop introduced two new draft guidance documents being developed by the Electronic CRF/CRT Submission Committee: application archival copies in electronic form and electronic-only submission of case report forms (CRFs) and case report tabulations (CRTs), and offered the opportunity for attendees to give FDA comments. Committees, comprised of members of CDER and CBER, are harmonizing requirements across both centers, and will develop processes to maintain electronically sophisticated submissions, and to progressively substitute electronic for paper in marketing applications.<BR><P>
This is not just another CANDA, said Ms. Fendt. Were building on what weve learned from the CANDA and CAPLA process. Were ready to move forward. <BR><P>
FDA is eager to work with industry to develop a process that provides benefits for everyone. The agency has outlined a five-step implementation process to move from paper to electronic submissions: <BR><P>
<OL TYPE=1, 2, 3, ...>
<LH></LH>
<LI>Electronically imaged CRFs and CRTs,<BR>
<LI>Electronically imaged CRFs and electronically functional CRTs,<BR>
<LI>Electronically functional CRFs and CRTs,<BR>
<LI>Fully electronic clinical/statistical submissions, and<BR>
<LI>Fully electronic submissions.<BR><P>

</OL>
Dr. Zoon provided CBERs perspective. Our center is committed to this program, to working together with the Center for Drugs to harmonize requirements, to putting the resources into moving us forward into the electronic environment.<BR><P>
One of the major goals of CBERs strategic plan, which is geared for 2004, is to develop interactive information systems which are integral to all center activities. CBER has three strategies to achieve this: develop a fully integrated information system to support a seamless regulatory process, support the development and use of interactive databases, and work with others outside FDA to affect an appropriate system. <BR><P>
As we move forward to the next century, I think this is where our opportunities lie. In doing so, we go forward with the concept of not only overlaying information systems on existing processes but we also look at improving our business functions and reengineering them so we maximize the efficiency of our organization with our information systems. <BR><P>
Dr. Woodcock provided CDERs perspective. The long-term goal for us all is electronic only generation and submission of data, processing and review of the application, and response to the submission, as well as external and internal dissemination of that information and archiving of the drug information.<BR><P>
Dr. Woodcock noted, however, that the processes to achieve this goal is only beginning, and that the operating environment must be taken into consideration. External forces include the electronic capabilities of sponsors, academic groups, patient advocacy groups, etc. Internally, FDA must ensure that standards are harmonized across centers and applications. FDA must also comply with government record keeping, legal, and regulatory requirements.<BR><P>
Standardization versus customization is a key issue. The CAPLAS and CANDAS were customized, but FDA cant respond quickly to a large volume of customized submissions. FDA must standardize submissions to ensure an efficient review process.<BR><P>
The infrastructure to support this is being put in place. Dr. Woodcock expected the final rule on electronic records to be published by the end of 1996, and implemented five months later. This rule covers electronic signatures and provides a founda-tion for what is an acceptable electronic submission. FDA still needs to determine how records will be archived. <BR><P>
Ultimately we could see electronic submissions of whole NDAs, whole ANDAs, whole supplements of different kinds of correspondence; working with e-mail, submitting over the wire; these things are all technologically totally within our collective grasp. Theres no reason we cant do any of these things. We have to agree on how were going to do it and then we have to implement it in stages that are not disruptive to the process.<BR>
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>
Role of CRFs/CRTs in the Review Process<BR>
<I>Renata Albrecht</I>, MD</B><BR>
Acting Deputy Director DAIDP, ODE IV<BR>
CDER, U.S. Food and Drug Administration<BR>
<B><I>Karen Weiss</I>, MD</B><BR>
Division Director, DCTDA, OTRR<BR>
CBER, U.S. Food and Drug Administration<BR></CENTER><P>
CRFs and CRTs provide the clinical studies data that reviewers need to check, verify, audit, and analyze the sponsors results, conclusions, and recommendations. There are some differences in the review process between reviewers, for example, the review sequence, the specific data points examined, and the depth of the examination. But all reviewers follow the same process.<BR><P>
All data must be available. Reviewers generally only look at some data, but the data they need to review depend on the questions that arise during the review process. <BR><P>
The reviewers challenge is to try to exercise the art of the review process to get a birds eye view of whats going on in the data, to use the microscopic view very sparingly and only in those cases where they truly need to get a closer look and ultimately to reach a happy balance in understanding the data in the NDA application, said Dr. Albrecht. <BR><P>
Electronic CRFs and CRTs require the same amount of information as paper CRFs and CRTs. Reviewers expect to have the same capabilities, for example, they need an index so they can find the actual CRF or page, and the electronic submission must be legible and in an easy to read font.<BR><P>
In the short-term, electronic-only submissions in a standardized format will give CDER the opportunity to learn how to accept, archive, access, and review these electronically. The centers long-term goal is to provide flexibility and functionality to reviewers in order to ensure efficient reviews. <BR><P>
Dr. Weiss provided CBERs perspective on CRFs, which are always discussed with FDA by the sponsor, sometimes at the end of Phase II or pre-Phase III, sometimes later. The specific CRF that should be submitted depends to a large extent on the nature of the application. In therapeutics within biologics, its common to have very small trials, and to ask for or receive all CRFs. It also depends on the type of product.<BR><P>
The type of CRFs FDA asks to see varies. Safety data are very important, including deaths, drop-outs, and serious adverse events. The manufacturers potential claims are also important. <BR><P>
Reviewers use CRFs to confirm eligibility. For example, in studies where there are no alternative therapies, reviewers can determine if the sponsor really targeted a refractory or relapsed population. In diseases where patients are intolerant to existing therapy, CRFs reveal how they are intolerant to therapy. Theyre also used to confirm efficacy variables for primary and secondary outcomes. <BR><P>
In our experience, CRFs have been a very valuable tool to the review process. Theyve been a very diverse tool; weve used them in many different ways but they have been very important. I think this initiative to start getting these things onto an electronic format to start doing more functionality with them is going to do a lot to enhance our review.<BR>
<P><HR><P>
<CENTER><B>Presentation #3<BR><P>
An Industry Perspective on Electronic Submissions<BR>
<I>Ronald W. Helms</I>, PhD</B><BR>
Professor, Department of Biostatistics, School of Public Health<BR>
University of North Carolina<BR></CENTER><P>
Dr. Helms provided an industry perspective on electronic submissions based on confidential inter-views with research data managers at more than a dozen sponsors and his personal experience. Theres a broad range of where people are with respect to imaging technology, said Dr. Helms. No two sponsors that I interviewed use the same combination of hardware and software for dealing with images. Think what those poor folks at FDA are going to have to deal with. <BR><P>
Dr. Helms maintains that having FDA set standards at this time is undesirable. With standards you freeze things, you say youre going to accept this as it stands at this point. We would be frozen in 1996 technology until FDA is forced to change the standards. Both FDA and sponsors want to be able to take advantage of rapidly changing technologies.<BR><P>
There will be standards for CRFs and CRTs, but there are practical reasons why they cant be specified today, even though the technology exists. Standards will have to permit evolution because technology is making dramatic leaps and bounds.<BR><P>
This conference that youre attending is an historic event. I think many people at FDA now see the initiatives announced in conjunction with this conference and in preparation for it as the dawn of a new era. Weve had other dawns and other eras, but in this room, from this podium, highly placed FDA officials publicly committed the agency to make these initiatives work. Instead of simply publishing guidance documents, FDA has invited the industry to participate in developing the technical content of those documents. <BR><P>
The importance of this conference and the surrounding activities is that forces have been put into motion that will result in the development of sound standards and the dynamic standards for submission of images. Dr. Helms predicts that dynamic standards will be in place in two years.<BR><P>
All of us are trying to surf the wave of rapidly improving technology and we will occasionally fall off the board with consequences of varying severity. Dr. Helms provided short- and mid-term outlooks. In the near term, processes have been put in place for solving problems surrounding the submission of images and progress will be made. We must take little steps. Over the next few years, I think theres almost universal agreement that using computer technology to improve the review process will continue to motivate the standards development process. I think the obstacles will continue to come from the fact that were in an era of rapidly improving technology and we still have people who dont want to learn to use new tools. <BR><P>
The source of my optimism with respect to the whole process is the people, both at the sponsors and at the FDA.<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-123</DOCNO>
<DOCOLDNO>IA050-000869-B031-6</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a17.htm 199.92.136.137 19970111135751 text/html 8918
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:59:30 GMT
Last-modified: Thursday, 19-Dec-96 20:52:20 GMT
Content-length: 8726
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>3rd DIA-Sponsored Workshop on Case Report Form Design</B><BR><P>
</CENTER>Wayne R. Crumpton, Clinical Trial Management Services, Inc., was chair for this workshop. His committee members were: Dorothea E. Gibbs, G. D. Searle & Company; Kenneth Gray,  Wyeth-Ayerst; William S. Johnson, Merck Research Laboratories; Gregg E. Kebler, Pharmacia &  Upjohn, Inc.; Beverly Kelly, Berlex Laboratories; and Frances M. Rink, Wyeth-Ayerst.<BR><P>
Recognizing that data resulting from clinical trials is one of the most valuable assets in the industry, the meeting provided a view of the latest techniques used in CRF design. Both good and poor design issues were addressed as well as methodologies used in CRF design and standardization. Remote data capture and the expected attendant decrease in time to market using that technique, fax and other digital technologies were discussed. <BR><P>
Members of the printing industry were available for discussions of the advances made in this area. <BR><P>
The two day meeting was divided into six sessions: Team Interaction/ Strategy, Standardization QC/QA Issues, Quality of Life Instruments and CRFs, ER (Emergency Room) for CRFs, New Technologies, and Out-Sourcing.<BR><P>
The meeting also provided ample time for the attendees to network, socialize, and to discuss particular design problems with the other experts in the field. We thank the program committee and speakers for their many contributions to this workshop. We look forward to the 4th meeting on this topic!<BR>
<P><HR><P>
<CENTER><B>Presentation #1<BR><P>
CRF Design for Health Outcomes Instruments <BR>
<I>Lisa S. Morris</I>, PhD, RPH</B><BR>
Associate Director, Health Outcomes Assessment<BR>
Wyeth-Ayerst Research, USA</CENTER><BR><P>
Dr. Morris provided an overview of health outcomes assessment, quality of life (QOL), health status, and economic endpoints; and discussed selection of instruments and issues in forms design. Health outcomes is defined as a change in patient health status attributable to care, focusing on the endpoints which are most noticeable to patients. QOL and health status are tools used to collect patient outcomes, generally from the patient. They can be generic or disease specific. Health status differs from QOL in that it asks the patient if he/she experiences an event or can perform an activity, whereas QOL determines whether or not the event disrupts the patients life and how important the activity is.<BR><P>
Every pharmaceutical company today has a pharmacoeconomics department which looks at the cost of drug therapy to the health care system and society; QOL can be part of this. Health economics looks at alternatives other than drugs and uses financial parameters to attach costs to treatment. Its very hard to quantify QOL, according to Dr. Morris. Economic endpoints are usually questions which, when answered by patients, health care providers, payers, and other sources, provide direct and indirect expenditures. These questions can now be seen in some case report forms. All were trying to get here is the economic implications by attaching a dollar figure.<BR><P>
Instruments are selected based on the drug, indication, and study population. A collection of instruments can be used covering QOL, health status, health economics or pharmacoeconomics; any one of these alone; or any combination of these. When selecting specific instruments within these categories, the study design and purpose are important. The instrument must be valid, reliable, responsive to change, and generalizable to other populations. Administrative and translation issues must be considered. Administration can be done via office, home, or phone. The questionnaire length must be acceptable to patients and investigators. Translations must be validated culturally and not just translated into the appropriate language.<BR><P>
When designing forms, considerations include: the structure of the validated instrument (wording, left to right versus up and down, etc.), mapping information, standardization (if the instrument is used more than once, it should always look the same), administration, and instructions (to patients on how to complete the form, and to investigators and site coordinators).<BR><P>
In designing the CRF, the title of the instrument must appear on the CRF page. Important layout considerations include the page appearance and order of questions. Copyright permission must be given and noted on the CRF.<BR><P>
There is no single instrument, no gold standard. Youre probably going to see a myriad of instruments and theyre going to change over time. As more instruments come out, were going to have new instruments. So you cant walk into forms design and say print out a QOL form, and always use the same form. Dr. Morris added that the importance of health outcomes in the pharmaceutical industry will continue to grow. These health outcomes whether they be QOL, health status, or economic endpoints  are really being put in to try to drive the marketability of products.<BR>
<P><HR><P>
<CENTER><B>Presentation #2<BR><P>
CRF and Database  An Integrated Activity<BR>
<I>Patricia V. Stone</I></B><BR>
Head, Central CDM Support<BR>
Sandoz Clinical Development Center, UK<BR><P></CENTER>
Ms. Stone discussed a prototype Data Dictionary to CRF application developed by Sandoz to assist in two study initiation deliverables: the database and the CRF. She covered the business requirements that led to the application, application development, implementation considerations, and the risks and benefits.<BR><P>
All pharmaceutical companies face the same inherent study initiation problems: writing the protocol and designing the CRF while each employee has a personal agenda. Nobody is totally accountable for standards and deliverables dont match requirements. <BR><P>
The database and CRF are inherently linked. Theyre one and the same really. Sandoz wanted to: ensure that standards are maintained and cataloged, ensure control within a specified set of individuals (Central CDM Support), and support new technology (bar coding and OMR recognition for scanning). The application had to: work on the desktop, use a client/server application, communicate with clinical trial databases, generate a CRF page, create CRF books, and catalog the pages.<BR><P>
The application has its own database using MS Access, which has all of the data dictionary aspects of Sandozs clin trial data dictionary and can extract information from there. Word was used for the CRF pages because of its compatibility to MS Access. Excel was used for the visit schedule matrix. <BR><P>
Application considerations include the need for: upper management endorsement of the application, cross training of CRF designers and their oriented into database aspects, acceptance of the objectives and a willingness to change by employees, reengineering of processes, and the protocol author and database designer to work closely together. <BR><P>
Ms. Stone pointed out that there are many risks in implementing this type of application, most of which can be controlled. But they do need to be assessed. These include: major organizational repercussions if the implementation is handled badly, database design becomes a critical study initiation activity, the need for a reliable system with lots of technical support and cross training, and the need to maintain and further develop the system.<BR><P>
Short-term benefits include: creating standards for CRFs and databases to adhere to the data dictionary; catalogs; reusability of all meta data, including CRF pages; minimizing study initiation time; increasing productivity; and professional development for CRF design personnel. Long-term benefits could include: integration with other activities, meta data management tool integration, therapeutic indication catalogs, data classification catalogs, standard validation programs, and standard reporting programs with inherent validation.<BR><P>
I really think this would be a good application and I think its a way forward. I think the business requirements can be met. The implementation has to be managed very carefully. The benefits are worth the risks and the risks would have to be managed with the appropriate IT departments. The sad bit is that the reality may take a few years yet.

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-124</DOCNO>
<DOCOLDNO>IA050-000869-B031-45</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a18.htm 199.92.136.137 19970111135828 text/html 4011
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 13:59:49 GMT
Last-modified: Thursday, 19-Dec-96 20:52:23 GMT
Content-length: 3819
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Clinical Data Management</B><BR></CENTER><P>
This was the sixth annual occasion that this particular workshop has been run and its chairpersons, Sheila A. Varley, Corning Besselaar, UK, and Andy H. MacLeod, Procter & Gamble, UK, enjoyed themselves so much that they immediately volunteered to chair the 7th rerun which will take place in Paris, November 3-5, 1997.  <BR><P>
Frances Bradshaw, SmithKline Beecham Pharmaceuticals, UK; Anne Galer, Sandoz Clinical Development Center, UK; Ruth Lane, Glaxo Wellcome Research & Development, UK; and William W. Woods, Virginia Neurological Institute, USA were the programme committee and they were joined by faculty members: Rupert Booth, KPMG Management Consulting, UK; Alan Bridgman, Bridgman Associates, UK; Rosemary Campbell, Data Analysis & Research (DAR) Ltd., UK; Dr. Jeremy Chadwick, Parexel International Corporation, USA; Graham Cockell, GC Consulting Services Ltd., UK; Dr. Stuart Cummings, Merck Sharp & Dohme (Europe) Inc., Belgium; Simon Day, Leo Pharmaceuticals, UK; Anne Dunleavy, Quintiles Ireland Ltd., Ireland; Maggie Gill, Cyanamid of GB Ltd (Wyeth), UK; Dr. Dirk Handschuh, Dr. Ghring & Partner GmbH, Germany; Greg A. Johnson, Pharmaceutical Research Associates GmbH, Germany; Dr. Richard Kay, S-Cubed Ltd., UK; Dipl.Math. Siegfried Klein, Hoechst Marion Roussel, Germany; Siegbert Kloos, Padcom Clinical Research GmbH, Germany; Dr. Mats Lrstad, AB Astra, Sweden; Jeanne Lyons, Roche Bioscience, USA; Angie MacKenzie, SmithKline Beecham Pharmaceuticals, UK; Steve Martin, EORTC, Belgium; Gene Miluk, Carnegie Mellon University, USA; Professor Mervyn Mitchard, Kings College London, UK; Sally Osmond, UCT Unilabs Clinical Trials, UK; Alexandra Paton, Rhne-Poulenc Rorer, France; Dr. Anna Petroccione, Pharmacia & Upjohn, Italy; Monica Pimazzoni, Glaxo Wellcome S.p.A., Italy; Dr. Andy Richardson, ClinTrials Research, UK; Margarete Rudloff, GMI Gesellschaft fr angewandte Mathematik und Informatik mbh, Germany; Yacine Saidi, INSERM, France; John J. Seman, AVANTEC, USA; Udo Siegmann, Parexel GmbH, Germany; Harshad Sodha, Verum Til Occam, UK; Victor Stambaugh, Integrated Systems Consulting Group, Inc., USA; Sarah Taylor, Glaxo Wellcome Research & Development, UK; Dr. Beatrice Vincenzi, Glaxo Wellcome S.p.A., Italy; Robert Vogel, Onsite Systems, USA; Joseph R. Wager, EDS (Schweiz) AG, Switzerland; and Dr. Martin Wilhelm, Dr. Ghring & Partner GmbH, Germany.  <BR><P>
On the day prior to the workshop, participants were able to attend two information sessions for WHO ART and COSTART USER Groups and for MEDDRA. Marie Lindquist and Liza Storm, both from the WHO Collaborating Centre, Sweden, led the WHO session, and the MEDDRA session was guided by Dr. Elliot Brown, Lilly Industries Ltd., UK and Dr. Louise Wood, Medicines Control Agency, UK.<BR><P>
These were followed by the opening of the pharmaceutical industry support organizations exhibition where materials and services available to the industry were on display. Informality was allowed to creep into the workshop at a Round-Table Dinner where faculty and participants were able to exchange information and carry on discussions on topics perhaps not represented during the sessions.<BR><P>
As ever, the DIA is very appreciative of the time and effort put into this workshop by the faculty to make it such a success. Naturally, it would not be such a success if there were no participants: thank you too for being there! 

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-125</DOCNO>
<DOCOLDNO>IA050-000869-B031-91</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a19.htm 199.92.136.137 19970111135854 text/html 1579
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:00:29 GMT
Last-modified: Thursday, 19-Dec-96 20:52:25 GMT
Content-length: 1387
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Regulatory Affairs in the European Union & United States<BR>
An Introduction for Newcomers to Regulatory Affairs and Non-Regulatory Personnel</B><BR><P></CENTER>
The European Agency for the Evaluation of Medicinal Products (EMEA) hosted this meeting at their London offices, and the DIA were delighted to welcome Fernand Sauer, EMEA Executive Director, who opened this one-day seminar. <BR><P>
A key feature of the day was the interactive panel discussion between representatives of the EMEA and participants. This discussion provided further clarification on the working and mechanics of the drug regulatory processes in the EU, particularly in comparison to the US processes. <BR><P>
Participating faculty were: Professor Rolf Bass, EMEA, London, UK: Dr. Roger G. Bolton, Zeneca Pharmaceuticals, UK; Dr. Karel J. de Neef, EMEA, London, UK; Brenton E. James, Glaxo Wellcome Research & Development, UK; Dr. John Purves, EMEA, London, UK; Dr. David Savello, Glaxo Wellcome Inc., USA; and Nol Wathion, EMEA, London, UK. 


<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-126</DOCNO>
<DOCOLDNO>IA050-000869-B031-133</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dh5b2a20.htm 199.92.136.137 19970111135914 text/html 1994
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:00:53 GMT
Last-modified: Thursday, 19-Dec-96 20:52:27 GMT
Content-length: 1802
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>PUBLICATIONS</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>DIA NEWSLETTER</UL>
<P>
<CENTER><STRONG>RECENT MEETINGS</STRONG></CENTER>
<P><HR>
<CENTER><B>Towards a Common Clinical Data Documentation</B><BR></CENTER><P>
This one-day seminar which took place in London in November 1996 gave an opportunity to participants to discuss the new ICH Guideline on Structure and Content of Clinical Study Reports: how it is being implemented by the pharmaceutical companies; what are their experiences of implementation; and what have they encountered  the positive and the negative. <BR><P>
The workshop was chaired by Dr. Franoise de Crmiers, Wyeth-Ayerst EU CR&D, France, assisted by her programme committee: Professor Jean-Michel Alexandre, EMEA/CPMP, UK; Dr. Anthony Pottage, Astra AB, Sweden; and Dr. Robert Temple, Food and Drug Administration, USA. Dr. Alan F. Ebbutt, Glaxo Wellcome plc, UK; Dr. Yves Juillet, Roussel-Uclaf, France; Dr. Betty Kuhnert, Wyeth-Ayerst Research, USA; Dr. Grard Picot, Bristol-Myers Squibb, Belgium; Dr. Ulrich Taglieber, Merck Research Laboratories, USA; Dr. Barbara van Zwieten-Boot, Committee for the Evaluation of Medicines, The Netherlands; and Dr. Leen Vanherle, Janssen Research Foundation, Belgium, completed the faculty who aimed to answer the key question: Can industry use a common clinical package? <BR><P>
Participants represented Regulatory Affairs, Clinical Research and Development and Medical Writing. The DIA thank the participants and the faculty for their input at the seminar which gave everyone something to go home and think about! 


<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-127</DOCNO>
<DOCOLDNO>IA050-000869-B031-165</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w903.htm 199.92.136.137 19970111135923 text/html 1113
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:01:05 GMT
Last-modified: Wednesday, 20-Nov-96 14:43:54 GMT
Content-length: 921
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Manager</H1></CENTER>
<HR>
W903, <BR>11/11/96
Clinical Research Manager.  
<P>
I am 36 years old, by profession a doctor of medicine, with 5 years of
working experience.
<P>
After finishing medical university in 1986, and one year post-degree
supervised training, I worked for two months as Marketing
Representative with a pharmaceutical company.
<P>
From 1988 to 1991, in almost four years, I worked as Physician at a
Pediatric Department.
<P>
This year I have upgraded my experience and knowledge with a
comprehensive course in Clinical Research Management.
<P>
Currently I am looking for a post within pharmaceutical industry or a CRO,
which would enable me to apply my knowledge and experience, as well
as to gain new skills.




<P>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-128</DOCNO>
<DOCOLDNO>IA050-000869-B031-196</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w904.htm 199.92.136.137 19970111135934 text/html 804
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:01:15 GMT
Last-modified: Wednesday, 20-Nov-96 14:44:55 GMT
Content-length: 612
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regional Field Monitor</H1></CENTER>
<HR>
W904, <BR>11/12/96 Regional Field Monitor/Clinical Trials Manager.
<P>
Former Associate Medical Director: DuPont Pharmaceuticals (through
1986):  Cardiovascular: CNS; Anesthesia/Analgesia/Addiction
PhaseIV Clinical Trials Monitor: DuPont/Merck/Burroughs Wellcome
     (1987-93):  Esmolol; Vasotec; Mivacurium respectively
Phase II & III AIDS Clinical Trials Monitoring SDCRA (1994-96):
     Antiretrovirals.




<P>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-129</DOCNO>
<DOCOLDNO>IA050-000869-B031-243</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w907.htm 199.92.136.137 19970111140009 text/html 1445
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:01:39 GMT
Last-modified: Wednesday, 20-Nov-96 14:45:01 GMT
Content-length: 1252
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Management Document Safety Reporting</H1></CENTER>
<HR>
W907, <BR>11/5/96
Senior Management Document Safety Reporting.
<P>
I am a mature, 9-year industry professional (D.V.M.) seeking a senior
management position in the area of preparation and management of the
content, format and production of NDAs, INDs, advisory meeting
presentations, and related documents.  I have broad industry experience,
from CRA with a large pharmaceutical company to Director of Clinical
Research and Regulatory Affairs with a small start-up biotech.  I have
been very fortunate to have been able to gain experience in a wide
range of areas in drug development, from program planning and
management to running clinical trials to final report preparation and
submission.  However, I prefer the "data" end of the industry, and
consider myself a specialist in the project planning and execution of
major regulatory documents and presentations.  I currently reside in
Southern California, and would be willing to consider relocation for the
right opportunity.  (CV, references furnished upon request.)







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-130</DOCNO>
<DOCOLDNO>IA050-000869-B032-28</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w908.htm 199.92.136.137 19970111140046 text/html 796
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:02:08 GMT
Last-modified: Monday, 25-Nov-96 18:21:53 GMT
Content-length: 607
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Data Manager</H1></CENTER>
<HR>
W908, <BR>11/25/96
Clinical Data Manager
<P>
BSc (Biomedicine).  Swiss citizen with 4 1/2 years experience in CRF review,<BR>
query generation, data validation, monitoring.  Working in coordination center for<BR>
long-term, multicenter trials.  Experience in HIV, infectious diseases and their<BR>
therapies.
<P>
Fluent in English, German, French, Spanish, Portuguese.
<P>
Computer oriented.
<P>
Highly motivated.

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-131</DOCNO>
<DOCOLDNO>IA050-000869-B032-65</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w909.htm 199.92.136.137 19970111140059 text/html 1094
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:02:37 GMT
Last-modified: Monday, 25-Nov-96 18:43:33 GMT
Content-length: 905
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Pharmacokinetics/Pharmacology Consultant</H1></CENTER>
<HR>
W909, <BR>11/25/96
Clinical Pharmacokinetics/Pharmacology Consultant
<P>
Consultant in clinical pharmacokinetics and clinical pharmacology seeking suitable<BR>
consulting jobs from pharmaceutical companies or CROs.  I obtained my<BR>
Ph.D. in Pharmacokinetics in 1978 and have approximately 18 years of clinical<BR>
research and management experience. I have assisted pharmaceutical companies<BR>
in developing protocols for various Phase I research projects.  I can also write<BR>
clinical and pharmacokinetic reports.  I have extensive experience in developing<BR>
protocols designed to determine the effect of hepatic impairment or renal<BR>
impairment on pharmacokinetics of drugs.

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-132</DOCNO>
<DOCOLDNO>IA050-000869-B032-102</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w910.htm 199.92.136.137 19970111140112 text/html 1903
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:02:51 GMT
Last-modified: Monday, 25-Nov-96 19:11:36 GMT
Content-length: 1713
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Project Director/Consultant</H1></CENTER>
<HR>
W910, <BR>11/25/96
Project Director/Consultant - Clinical Trials/Regulatory Affairs/Safety/Information Technology
<P>
Consulting position desired: managing, developing, implementing strategies for<BR>
clinical trials and related areas in research, data management, biostatics,<BR>
pharmacoeconomics/epidemiology.  Industry experienced (10+ years healthcare,<BR>
biotech, pharmaceutical) public health professional (Masters Public Health) with<BR>
emphasis in epidemiology/biostatics and healthcare administration training.<BR>
Also knowledgeable in managed care industry.  Willing to travel.
<P>
Experience with all phases of clinical trials (phase I-IV), safety data, pre-clinical/lab<BR>
systems, CANDA/CAPLA, and enterprise wide data systems.  Evaluated clinical<BR>
data management, LIMS, document management systems.  Experienced in<BR>
development of project management systems.  Speaker for numerous professional<BR>
organizations on a variety of clinical trials system/analysis issues.  Interested in<BR>
increasing the efficiency and cost effectiveness of operations, and reducing time to<BR>
market for drugs.  Consulted to physicians, regulatory affairs, clinical, and information<BR>
system professionals.  Managed and developed teams of technical professionals<BR>
for design, implementation, and management of a variety of systems from PC Lans/<BR>
MACs to VAX/VMS, UNIX, Windows NT systems.  Ability to tie technical and<BR>
clinical development plans to business objectives and vice versa.

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-133</DOCNO>
<DOCOLDNO>IA050-000869-B032-135</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w911.htm 199.92.136.137 19970111140120 text/html 1198
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:03:00 GMT
Last-modified: Wednesday, 04-Dec-96 20:54:43 GMT
Content-length: 1005
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Project Director/Manager</H1></CENTER>
<HR>
W911, <BR>12/4/96
Project Director/Manager -- Clinical Trials/Epidemiology/Safety
<P>
Managerial level position wanted in clinical trials/epidemiology/research for a pharmacist<BR>
with a Masters degree in Public Health.  I have over 9 years experience in the<BR>
health care industry, of which 6 years are in clinical trials.  Currently, I am the Director<BR>
of an 8 year, 18 million dollar contract supporting 40,000 patients at over 600 clinical sites.<BR>
I am experienced in phases II-IV and have managed emergency use and treatment IND<BR>
programs.  I have exceptional organizational and administrative abilities and experience<BR>
in communicating/coordinating/planning clinical trial design and implementation with<BR>
health professionals, government agencies, and pharmaceutical companies.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-134</DOCNO>
<DOCOLDNO>IA050-000869-B032-171</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w912.htm 199.92.136.137 19970111140132 text/html 638
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:03:11 GMT
Last-modified: Friday, 20-Dec-96 19:25:48 GMT
Content-length: 449
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Oncology Monitors</H1></CENTER>
<HR>
W912, <BR>12/20/96
Oncology Monitors -- Target Research
<P>
Highly experienced oncology monitors available for your immediate needs.  Please contact<BR>
Lloyd Baroody at Target Research, telephone 908-322-2402, e-mail address:<BR>
targetresearch@mcimail.com
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-135</DOCNO>
<DOCOLDNO>IA050-000869-B032-213</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w913.htm 199.92.136.137 19970111140142 text/html 662
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:03:23 GMT
Last-modified: Friday, 20-Dec-96 19:29:15 GMT
Content-length: 473
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Asthma Therapy Area Monitors</H1></CENTER>
<HR>
W913, <BR>12/20/96
Asthma Therapy Area Monitors -- Target Research
<P>
Highly experienced asthma/allergy therapy area monitors available for yur immediate needs.<BR>
Lloyd Baroody at Target Research, telephone 908-322-2402, e-mail address:<BR>
targetresearch@mcimail.com
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-136</DOCNO>
<DOCOLDNO>IA050-000869-B032-251</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w914.htm 199.92.136.137 19970111140156 text/html 1226
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:03:33 GMT
Last-modified: Friday, 20-Dec-96 21:16:39 GMT
Content-length: 1036
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Director</H1></CENTER>
<HR>
W914, <BR>12/20/96
Senior Director, Safety/Medical Affairs
<P>
Consultant (4 years), former Associate Director (7 years industry experience).  Supervision<BR>
of Data Management and Regulatory Reporting Units.  Task Force and Project Management of<BR>
Treatment INDs, Registries, and Epidemiology Studies.  Substantial experience with<BR>
Postmarketing Surveillance, Adverse Drug Event Management, and industry dictionaries.<BR>
Medical informatics advisor to international regulatory/industry Working Groups.  Pediatrician<BR>
with M.P.H. and exposure to multiple therapeutic areas while in industry.  Innovative,<BR>
analytical, project-oriented, effective, team player.  Respected industry speaker and author.<BR>
Prefer East Coast company or CRO.  Relocation and moderate travel expected.  Comfortable<BR>
in medical French and Spanish.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-137</DOCNO>
<DOCOLDNO>IA050-000869-B032-287</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w915.htm 199.92.136.137 19970111140211 text/html 1149
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:03:50 GMT
Last-modified: Thursday, 02-Jan-97 17:29:22 GMT
Content-length: 958
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Pharmaceutical Grad</H1></CENTER>
<HR>
W915, <BR>1/2/97
Pharmaceutical Grad -- Portland, Oregon Area
<P>
I am currently a graduate student, working toward my Ph.D degree, which I hope to<BR>
attain by March 1997.  I am looking for a position in the Pharmaceutical industry<BR>
in the Portland, Oregon area.  My academic background is as follows:  B. Sc in<BR>
Pharmacology; M. Sc in Physiology in the cardiovascular field; my Ph. D work focuses<BR>
on the regulation of prostaglandins in the kidney.  I realize I do not have any experience<BR>
in the Pharmaceutical industry, however, I am a highly motivated independant individual,<BR>
and I believe I have excellent interpersonal and leadership skills.  I am open to any type<BR>
of position which promises to be both challenging and educational.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-138</DOCNO>
<DOCOLDNO>IA050-000869-B032-323</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w916.htm 199.92.136.137 19970111140221 text/html 714
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:04:01 GMT
Last-modified: Thursday, 02-Jan-97 17:33:09 GMT
Content-length: 523
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer</H1></CENTER>
<HR>
W916, <BR>1/2/97
Medical Writer
<P>
Freelance medical writer: clinical study summaries, ISE, publications, etc.  Ph.D<BR>
with more than 20 years pharmaceutical industry experience.  Strong background<BR>
and experience in statistics and data analysis.  I prefer to work at home and use<BR>
WordPerfect 6.1 on a Pentium 100 computer.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-139</DOCNO>
<DOCOLDNO>IA050-000869-B032-357</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w917.htm 199.92.136.137 19970111140232 text/html 866
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:04:11 GMT
Last-modified: Thursday, 02-Jan-97 17:44:56 GMT
Content-length: 675
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Independant CRA/Project Consultant</H1></CENTER>
<HR>
W917, <BR>1/2/97
Independant CRA/Project Consultant -- CT
<P>
Independant CRA/Project Consultant:  to work/travel within CT.  RN and MSN from<BR>
Yale University with 6 years experience as monitor/project manager.  Experience<BR>
in CNS Clinical (anxiety, depression, migrane, Alzheimer's, Parkinson's)<BR>
but will work in any therapeutic area.  Have worked extensively with Europe.<BR>
Available on a part-time or full-time basis.  Can travel on a limited basis.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-140</DOCNO>
<DOCOLDNO>IA050-000869-B033-22</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w918.htm 199.92.136.137 19970111140242 text/html 1919
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:04:22 GMT
Last-modified: Friday, 03-Jan-97 19:22:25 GMT
Content-length: 1729
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Research Associate</H1></CENTER>
<HR>
W918, <BR>1/3/97
Research Associate Position
<P>
I am 31 years old, married with two children, and will be graduating from  Oregon<BR>
State University on June 15, 1997 with a BS in Microbiology.  While attending Oregon<BR>
State University, I have been working for the US Environmental Protection Agency<BR>
for the past two years on the NNEMS Fellowship.  With the combination of education<BR>
and experience that I can provide, I feel that I could serve as a worthy contributor to<BR>
the goals of your company.  Following is a list of skills that I have acquired at the USEPA.
<P>
NNEMS Student Fellowship<BR>
US Environmental Protection Agency, Corvallis, Oregon<BR>
(August, 1995-present)<BR>
Hours Per Week:  (20-30 during school year, 40 during summers)<BR>
Work in molecular biology laboratory, performing PCR amplification and restriction<BR>
digests of mycorrhizal DNA associated with coniferous trees.  Have made adjustments<BR>
to genomic DNA extraction methods which have resulted in higher yield of DNA product<BR>
from usually low-yielding single root tip samples.<BR>
Trained visiting Professors from Brazil in DNA extraction process.<BR>
First Author on poster Restriction Mapping of Morphologically Similar Ectomycorrhizal<BR>
Root Tips at the NW Regional American Society for Microbiology meeting (June 21, 1996<BR>
in Newport, Oregon).<BR>
Currently assisting in Nested PCR amplification of mycorrhizal DNA by performing DNA<BR>
extractions and initial (outer) PCR amplification of the ITS region.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-141</DOCNO>
<DOCOLDNO>IA050-000869-B033-70</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/w919.htm 199.92.136.137 19970111140315 text/html 1055
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:04:51 GMT
Last-modified: Friday, 03-Jan-97 19:28:37 GMT
Content-length: 866
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biomedical Editor</H1></CENTER>
<HR>
W919, <BR>1/3/97
Biomedical Editing (Freelance or Permanent)
<P>
Specializing in the Neurosciences, Endocrinology and Molecular Biology.
<P>
Ph.D. in Neurobiology; M.A. in English.<BR>
20+ Years Bench Research and Editing/Consulting Experience.<BR>
38 Peer-Reviewed Publications.<BR>
Experience Writing NIH and NSF Grant Applications.<BR>
Extensive Experience with Foreign Clients.<BR>
Current Government and University Editorial Contracts.<BR>
Microcomputer Expertise (both IBM and Macintosh).<BR>
Mainframe Computer Expertise (both UNIX and VAX/VMS).<BR>
Knowledge of UNIX "shell" and HTML programming.
<P>
References and/or curriculum vitae provided on request.
<P>



</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-142</DOCNO>
<DOCOLDNO>IA050-000869-B033-101</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a094.htm 199.92.136.137 19970111140331 text/html 1556
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:05:09 GMT
Last-modified: Thursday, 07-Nov-96 15:08:09 GMT
Content-length: 1364
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regulatory Safety Associate</H1></CENTER>
<HR>
A094, <BR>11/5/96
Regulatory Safety Associate: New York
<P>
The permanent placement division of PRN, a trial management organization, has 
a client with full-time Regulatory Safety Associate positions available with 
immediate start dates.
<P>
DUTIES include:
review of selected adverse event reports for completeness, accuracy 
and consistency,
participation in the development and implementation of Quality Control 
procedures,
interact with project teams to provide safety reports and guidance in 
quality check of clinical data,
develop and maintain documentation supporting quality control efforts.
<P>
QUALIFICATIONS include a B.S. or equivalent in health sciences (including 
nursing or pharmacy); four years experience in clinical research or related 
discipline.  Demonstrated strength in communication and interpersonal skills. 
Some computer skills required.
<P>
Qualified Candidates should send their resume to:
<P>
Robert Gazzale<BR>
Pharmaceutical Research Network, Inc.<BR>
111-05 Jamaica Avenue<BR>
Richmond Hill, NY  11418<BR>

<P>
fax: 718.849.3007<BR>
e-mail: prn@ios.com<BR>

<P>
PRN is an Equal Opportunity Employer.




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-143</DOCNO>
<DOCOLDNO>IA050-000869-B033-134</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a095.htm 199.92.136.137 19970111140341 text/html 1786
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:05:20 GMT
Last-modified: Thursday, 07-Nov-96 15:09:16 GMT
Content-length: 1594
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Safety Reporting Associate</H1></CENTER>
<HR>
A095, <BR>11/5/96
Safety Reporting Associate: New York
<P>
The permanent placement division of PRN, a trial management organization, has 
a client with full-time Safety Reporting Associate positions available with 
immediate start dates.
<P>
DUTIES include:
<UL>
<LI>coordination of the preparation of safety reports from clinical 
databases as required by the FDA and foreign regulators, including the 
interaction with representatives of various departments to establish schedules 
and priorities,
<LI>perform overall quality control on these reports,
<LI>provide overall direction and manage the development of procedures and 
resources for safety report preparation,
<LI>Develop and maintain SOPs re: preparation, review, approval and 
dissemination of safety reports,
Manage staff.
</UL>
<P>
QUALIFICATIONS include a Bachelor's or Master's degree or equivalent in 
scientific discipline; project management skills.  Knowledge of drug safety 
regulations, experience in preparing drug safety reports, an understanding of 
the systems issues associated with production of drug safety reports.
<P>
Qualified Candidates should send their resume to:
<P>
Robert Gazzale<BR>
Pharmaceutical Research Network, Inc.<BR>
111-05 Jamaica Avenue<BR>
Richmond Hill, NY  11418<BR>

<P>
fax: 718.849.3007<BR>
e-mail: prn@ios.com<BR>

<P>
PRN is an Equal Opportunity Employer.




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-144</DOCNO>
<DOCOLDNO>IA050-000869-B033-173</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a096.htm 199.92.136.137 19970111140409 text/html 1660
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:05:44 GMT
Last-modified: Thursday, 07-Nov-96 15:09:20 GMT
Content-length: 1468
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regulatory Safety Custodian</H1></CENTER>
<HR>
A096, <BR>11/5/96
Regulatory Safety Custodian: New York
<P>
The permanent placement division of PRN, a trial management organization, has 
a client with full-time Regulatory Safety Custodian positions available with 
immediate start dates.
<P>
DUTIES include:<BR>
        review and assessment of adverse events (clinical trial and <BR>
spontaneous),<BR>
        determination of regulatory reporting requirements, <BR>
        coordination of the processing of adverse event reports,<BR>
        processing of expedited reports to FDA,<BR>
        interaction with a variety of other disciplines and departments; <BR>
        assist in development of CRF completion standards/conventions.<BR>

<P>
QUALIFICATIONS include a B.S. or equivalent in health sciences; three years 
experience in drug safety, medical information or clinical trial monitoring. 
 Excellent organizational skills are essential along with strong verbal, 
written, and interpersonal communication skills.
<P>
Qualified Candidates should send their resume to:
<P>
Robert Gazzale<BR>
Pharmaceutical Research Network, Inc.<BR>
111-05 Jamaica Avenue<BR>
Richmond Hill, NY  11418<BR>

<P>
fax: 718.849.3007<BR>
e-mail: prn@ios.com<BR>

<P>
PRN is an Equal Opportunity Employer.


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-145</DOCNO>
<DOCOLDNO>IA050-000869-B033-203</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a097.htm 199.92.136.137 19970111140422 text/html 1408
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:06:01 GMT
Last-modified: Thursday, 07-Nov-96 15:09:27 GMT
Content-length: 1216
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Data Specialists</H1></CENTER>
<HR>
A097, <BR>11/5/96
Clinical Data Specialists: Northern New Jersey
<P>
The contract staffing division of PRN, a trial management organization, has 
full-time, long term contract positions starting immediately.
<P>
DUTIES include:<BR>
        the review and coding of clinical data,<BR>
        query generation and resolution, <BR>
        maintenance audit trails,<BR>
        tracking of  milestones, <BR>
        assisting in the design and development of CRFs; <BR>
        assisting in development of CRF completion standards/conventions.<BR>

<P>
QUALIFICATIONS include clinical research experience, familiarity with PCS 
(specialized training will be provided), ability to work in teams and some 
supervisory experience.
<P>
Qualified Candidates should send their resume to:
<P>
Robert Gazzale<BR>
Pharmaceutical Research Network, Inc.<BR>
111-05 Jamaica Avenue<BR>
Richmond Hill, NY  11418<BR>

<P>
fax: 718.849.3007<BR>
e-mail: prn@ios.com<BR>

<P>
PRN is an Equal Opportunity Employer.




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-146</DOCNO>
<DOCOLDNO>IA050-000869-B033-242</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a098.htm 199.92.136.137 19970111140433 text/html 1737
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:06:11 GMT
Last-modified: Thursday, 07-Nov-96 15:09:33 GMT
Content-length: 1545
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Pharmaceutical Regulatory Education</H1></CENTER>
<HR>
A098, <BR>11/5/96
Manager, Pharmaceutical Regulatory Education: New York
<P>
The permanent placement division of PRN, a trial management organization, has 
a client with full-time Safety Reporting Associate positions available with 
immediate start dates.
<P>
DUTIES include:
<UL>
<LI>assist in the development of program plan and curriculum framework for 

many functional groups,

<LI>monitor program development progress to ensure adherence to time 

frames,

<LI>conduct training needs assessments and identify assessment measures,

<LI>assure quality and consistency of divisional training programs,

<LI>serve as liaison with divisional training staff and external training 

consultants/vendors,

<LI>travel approximately 10-20% (some international).
</UL>
<P>
QUALIFICATIONS include graduate degree in scientific discipline. At least five 
years clinical research or related pharmaceutical industry experience.  
Excellent interpersonal, communication and organizational skill.  Ability to 
interact with senior management. 
Qualified Candidates should send their resume to:
<P>
Robert Gazzale<BR>
Pharmaceutical Research Network, Inc.<BR>
111-05 Jamaica Avenue<BR>
Richmond Hill, NY  11418<BR>

<P>
fax: 718.849.3007<BR>
e-mail: prn@ios.com<BR>

<P>
PRN is an Equal Opportunity Employer.

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-147</DOCNO>
<DOCOLDNO>IA050-000869-B033-280</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a099.htm 199.92.136.137 19970111140448 text/html 1597
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:06:28 GMT
Last-modified: Thursday, 07-Nov-96 15:09:35 GMT
Content-length: 1405
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Data Associates (2)<BR> & Data Associates (2-4)</H1></CENTER>
<HR>
A099, <BR>11/5/96
Senior Data Associates (2) & Data Associates (2-4).
<P>
All positions are for our client who is a major company in the
Pharmaceutical industry, located in NJ.  All positions are full time, with
excellent benefits, including 401K.  
<P>
Write and validate diagnostic spec's and annotate clinical report forms. 
Program diagnostics, maintain database,and create data dictionaries. 
MUST HAVE BS/BA in Life Sciences.  MINIMUM of 3 years exp. in a
Pharm. R&D environment for ASSOCIATE and 5 years MINIMUM Clinical
Data Mgmnt Exp. for SR. ASSOCIATE.  Strong Computer Background
required.
<P>
***DATA ASSOCIATE SALARY - $45-60K Plus up to 10% annual bonus + equity.<BR>
***SR. ASSOCIATE SALARY - $60-70K+ Plus up to a 10% annual bonus<BR>

+ equity.
<P>
Interested and Qualified candidates, please contact:
<P>
Douglas Sokoloff<BR>
Senior Accounts Manager<BR>
Gary S. Bell Associates, Inc.<BR>
55 Harristown Road<BR>
Glen Rock, NJ  07452<BR>
Phone - 201-670-4900<BR>
    Fax - 201-670-4940<BR>
e-mail - dougnj@ix.netcom.com<BR>
(please send e-mail resumes as attachments in Word or WP format only)<BR>





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-148</DOCNO>
<DOCOLDNO>IA050-000869-B034-13</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a100.htm 199.92.136.137 19970111140500 text/html 1392
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:06:37 GMT
Last-modified: Thursday, 07-Nov-96 15:10:19 GMT
Content-length: 1200
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Statistical Programmer/Analyst</H1></CENTER>
<HR>
A100, <BR>11/5/96
Senior Statistical Programmer/Analyst (2).
<P>
Positions are for our client who is a major company in the Pharmaceutical
industry, located in NJ.  All positions are full time, with excellent benefits,
including 401K.  
<P>
Write, modify, validate, and implement project work in SAS.  Heavy SAS
programming skills required.  Must review and interpret report and
analysis plans.  MINIMUM of 5 years SAS programming experience in a
Pharm. R&D environment.  MUST HAVE a BS/BA preferably in Computer
Science.  SALARY - $65-80K Plus up to a 10% annual bonus + equity.
<P>
Interested and qualified candidates, please contact:
<P>
Douglas Sokoloff<BR>
Senior Accounts Manager<BR>
Gary S. Bell Associates, Inc.<BR>
55 Harristown Road<BR>
Glen Rock, NJ  07452<BR>
Phone - 201-670-4900<BR>
    Fax - 201-670-4940<BR>
e-mail - dougnj@ix.netcom.com<BR>
(please send e-mail resumes as attachments in Word or WP format only)<BR>





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-149</DOCNO>
<DOCOLDNO>IA050-000869-B034-53</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a101.htm 199.92.136.137 19970111140527 text/html 1476
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:06:49 GMT
Last-modified: Thursday, 07-Nov-96 15:10:24 GMT
Content-length: 1284
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Statistical Programmer </H1></CENTER>
<HR>
A101, <BR>11/5/96
Statistical Programmer (2-3).
<P>
Positions are for our client who is a major company in the Pharmaceutical
Industry, located in NJ.  All positions are full time, with excellent benefits,
including 401K.
<P>
Deal with all levels of project teams and write, monitor, validate and
implement project work in SAS language.  Heavy/In depth SAS
experience and knowledge required.  Write, maintain, and modify
programs which produce diagnostics for review.  MUST HAVE a BS/BA,
preferrably in Statistics, MS is preferred also.  MINIMUM 1 1/2  - 2 years
experience in SAS programming in a Pharm. R&D environment.
***Salary - $60-70K+  Plus up to a 10% bonus + equity.
<P>
Interested and qualified candidates, please contact:
<P>
Douglas Sokoloff<BR>
Senior Accounts Manager<BR>
Gary S. Bell Associates, Inc.<BR>
55 Harristown Rd.<BR>
Glen Rock, NJ  07452<BR>
Phone - 201-670-4900<BR>
    Fax - 201-670-4940<BR>
e-mail - dougnj@ix.netcom.com<BR>
(please send e-mail resumes as attachments in Word or WP format only)<BR>





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-150</DOCNO>
<DOCOLDNO>IA050-000869-B034-96</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a102.htm 199.92.136.137 19970111140557 text/html 1434
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:07:26 GMT
Last-modified: Thursday, 07-Nov-96 15:10:26 GMT
Content-length: 1242
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biostatistician</H1></CENTER>
<HR>
A102, <BR>11/5/96
Biostatistician.
<P>
The Pharmacokinetics-Biopharmaceutics Laboratory of the School of
Pharmacy at the University of Maryland at Baltimore has an immediate
opening for a Biostatistician.  Primary responsibilities include: 
programming in SAS; analyzing data and interpreting results from
pharmaceutical-related studies; maintaining project databases, and
preparing data table, graphs, and written summaries of results from
computer output using statistical, spreadsheet and word processing
software.
<P>
Qualified candidates will possess a master's degree in Biostatistics or a
related field, with 3 years of experience in performing biostatistical
analyses of multi-disciplinary research porjects.  We offer an attractive
salary and benefits package.
<P>
For consideration, send your resume with salary history to Donna Chan,
UMAB, by mail at 100 Penn Street, Rm. 540, Allied Health Bldg., Baltimore,
MD 21201; or by e-mail at chand@pharmacy.ab.umd.edu; or by fax at
(410)706-6580.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-151</DOCNO>
<DOCOLDNO>IA050-000869-B034-133</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a103.htm 199.92.136.137 19970111140608 text/html 1693
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:07:47 GMT
Last-modified: Thursday, 07-Nov-96 15:10:30 GMT
Content-length: 1501
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer/Sr. Medical Writer</H1></CENTER>
<HR>
A103, <BR>11/5/96
Medical Writer/Sr. Medical Writer.
<P>
Schering-Plough Research Institute offers opportunities within its Medical
Communications department, with major responsibility for the preparation
of clinical documents for worldwide regulatory submissions.  Proficiency
in organizing and analyzing clinical data is essential.  An advanced
degree in the biomedical sciences is required, along with demonstrated
excellence in written and verbal communications.  Candidates for the
Senior position should also have at least 3 years' experience in the area
of Phase II-III clinical writing; proven skills in the preparation of NDAs and
HRDs; and a practical understanding of the activities of the disciplines of
biostatistics, data processing, and clinical research.  Competitive salary
and excellent benefits.  Send resume and writing sample to:  Arthur
Gertel, Director, Medical Communications, Schering-Plough Research
Institute, 2015 Galloping Hill Road, K15-2, 2005, Kenilworth, NJ
07033-0539.
<P>
Art Gertel<BR>
Director, Medical Communications<BR>
Schering-Plough Research Institute <BR>
2015 Galloping Hill Road<BR>
Kenilworth, NJ  07033<BR>

<P>
Phone:  (908)298-7964  FAX:  (908)298-1666
e-Mail:  ARTHUR.GERTEL@SPCORP.COM




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-152</DOCNO>
<DOCOLDNO>IA050-000869-B034-163</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a104.htm 199.92.136.137 19970111140620 text/html 1126
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:08:00 GMT
Last-modified: Thursday, 07-Nov-96 15:10:34 GMT
Content-length: 935
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Scientist/Sr. Clinical Scientist</H1></CENTER>
<HR>
A104, <BR>11/5/96
Clinical Scientist/Sr. Clinical Scientist  (Philadelphia Area).
<P>
SmithKline Beecham R&D has opportunities available for Clinical
Scientists in several therapeutic areas.  Responsibilities include
preparing protocols, designing CRFs, interacting with pharmaceutical
technologies and field staff, defining analysis plan, monitoring
conventions and review guidelines.  A BS with 3-5 years in clinical drug
development experience required.  Please mail or fax your resume to
Cheryl Stable, Sr. Employment Administrator, SmithKline Beecham R&D,
709 Swedeland Road, UW2314, King of Prussia, PA  19406.  FAX: 
610-270-6176.  We are an Equal Opportunity Employer.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-153</DOCNO>
<DOCOLDNO>IA050-000869-B034-196</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a105.htm 199.92.136.137 19970111140631 text/html 1017
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:08:10 GMT
Last-modified: Thursday, 07-Nov-96 15:10:38 GMT
Content-length: 826
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associate</H1></CENTER>
<HR>
A105, <BR>11/5/96
Clinical Research Associate  (regionally based).
<P>
SmithKline Beecham R&D has opportunities available for regionally based
CRAs.  Responsibilities include recruiting investigators, initiating and
monitoring clinical trials and negotiating budgets.  A BS with a minimum 2
years industrial clinical research experience required.  50-75% travel. 
Please mail or fax your resume to Cheryl Stable, Sr. Employment
Administrator, SmithKline Beecham R&D, 709 Swedeland Road, UW2314,
King of Prussia, PA  19406.  FAX:  610-270-6176.  We are an Equal
Opportunity Employer.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-154</DOCNO>
<DOCOLDNO>IA050-000869-B034-236</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a106.htm 199.92.136.137 19970111140646 text/html 1027
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:08:24 GMT
Last-modified: Thursday, 07-Nov-96 15:10:46 GMT
Content-length: 836
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Data Operations Team Leader</H1></CENTER>
<HR>
A106, <BR>11/5/96
Data Operations Team Leader  (Philadelphia Area).
<P>
SmithKline Beecham R&D has an opportunity for a Data Operations Team
Leader.  Managing a team of data operations staff, this person will be
responsible for processing clinical trial data and delivering databases to
internal customers.  A BSN (preferred) with experience in drug
development required.  Please mail or fax your resume to Cheryl Stable,
Sr. Employment Administrator, SmithKline Beechmam R&D, 709
Swedeland Road, UW2314, King of Prussia, PA  19406.  FAX: 
610-270-6176.  We are an Equal Opportunity Employer.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-155</DOCNO>
<DOCOLDNO>IA050-000869-B034-274</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a107.htm 199.92.136.137 19970111140658 text/html 1218
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:08:36 GMT
Last-modified: Thursday, 07-Nov-96 15:10:48 GMT
Content-length: 1026
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>RN, Safety Review Team, CRA</H1></CENTER>
<HR>
A107, <BR>11/5/96
RN, Safety Review Team, CRA.
<P>
Description:  Are you a CRA interested in working in-house?  Our client
is interested in a CRA or RN to perform safety review in a position that
will transition into project management.
<P>
Qualifications:  CRA, RN or several years experience in the clinical
research process.  Work experience in the pharmaceutical industry,
clinical study coordination, research or medical technology.  Knowledge
of FDA and GCP regulations.
<P>
Salary is highly compeititve -- commensurate with experience.
<P>
Contact:       
<P>
John Flowers<BR>
Advanced Clinical Services<BR>
1300 E. Woodfield Rd., Suite 506<BR>
Schaumburg, IL  60173<BR>
e-mail:  jflowers@advancedgroup.com<BR>
Phone: 847-995-9222<BR>
Fax:     847-995-9290 <BR>





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-156</DOCNO>
<DOCOLDNO>IA050-000869-B034-305</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a108.htm 199.92.136.137 19970111140709 text/html 1289
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:08:47 GMT
Last-modified: Thursday, 14-Nov-96 14:38:49 GMT
Content-length: 1097
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>CRA's.</H1></CENTER>
<HR>
A108, <BR>11/11/96 CRA's.
North Central NJ - November & December Only
<P>
Target Research Associates, a rapidly growing CRO based in North
Central New Jersey, is seeking CRA's/MRA's or other professionals 
skilled in performing case report form (CRF's) reviews prior to data 
entry.  Data must be reviewed according to a developed list of checks.  
The ideal candidates will be experienced monitors.
<P>
This work is temporary and is anticipated to last through December.   It
must be performed in North Central New Jersey.  We need candidates 
who can offer 2 to 5 days per week of their time until this project is 
complete.  If you currently have some time, please immediately fax  your
CV and telephone number to Silvia Ursic, Office Manager, Target 
Research Associates, Inc., 1801 East Second Street, Scotch Plains, NJ 
07076 USA.  Fax number is (908) 322-5277.





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-157</DOCNO>
<DOCOLDNO>IA050-000869-B034-340</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a109.htm 199.92.136.137 19970111140723 text/html 1651
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:09:00 GMT
Last-modified: Tuesday, 12-Nov-96 14:04:13 GMT
Content-length: 1460
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>OTC CLINCAL PROJECT MANAGER</H1></CENTER>
<HR>
A109, <BR>11/11/96
OTC CLINCAL PROJECT MANAGER - NORTH CENTRAL NJ
<P>
Target Research Associates, a rapidly growing CRO based in North 
Central New Jersey, is seeking a Project Manager for one of its  clients
with an OTC product portfolio.  The Project Manager will help  to design
studies, prepare protocols and case report forms, identify,  recruit, and
qualify investigators, manage studies and the assigned  monitors during
the clinical phase, and work with Target Biostatistics  (our sister
company) during the data management and CRF clean-up  phase.
<P>
Ideal candidates (1) will have had experience in both monitoring and 
project management for OTC's in particular, (2) have excellent written 
and oral communication skills, including demonstrated skills in having 
written protocols, (3) have a high energy level and strong work ethic, 
(4) have excellent interpersonal skills previously demonstrated by 
successful client relationships, (5) are very bright.  Compensation is 
very competitive.  If you fulfill the job requirements, please send  your CV
by mail to:
--  Lloyd J. Baroody, Managing Director, Target Research Associates,
Inc.,  1801 East Second Street, Scotch Plains, NJ 07076 USA





<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-158</DOCNO>
<DOCOLDNO>IA050-000869-B035-30</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a110.htm 199.92.136.137 19970111140812 text/html 711
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:09:27 GMT
Last-modified: Tuesday, 12-Nov-96 14:04:14 GMT
Content-length: 521
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>CRA's.</H1></CENTER>
<HR>
A110, <BR>11/11/96 CRA's.
<P>
Multiple positions with multiple Pharmaceutical, Biotech and Medical
Device companies.  Looking for at least one year of solid on the road
monitoring.  Compensation is open and flexible for the right people. 
Please contact Jeff Schwartz for more details at (215) 654-5151.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-159</DOCNO>
<DOCOLDNO>IA050-000869-B035-68</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a111.htm 199.92.136.137 19970111140857 text/html 710
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:10:33 GMT
Last-modified: Tuesday, 12-Nov-96 14:04:16 GMT
Content-length: 520
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Managers</H1></CENTER>
<HR>
A111, <BR>11/11/96
Clinical Research Managers.
<P>
Several positions on the east coast, with others on the west coast and a
few in central US.  5 plus years required and some management skills. 
Compensation ranges from 60k to 100k.  Please contact Jeff Schwartz at
(215) 654-5151.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-160</DOCNO>
<DOCOLDNO>IA050-000869-B035-103</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a112.htm 199.92.136.137 19970111140910 text/html 612
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:10:48 GMT
Last-modified: Tuesday, 12-Nov-96 14:04:18 GMT
Content-length: 422
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1> Medical Writers</H1></CENTER>
<HR>
A112, <BR>11/11/96   Medical Writers.
<P>
All levels, east and west coast.  Excellent compensation packages for
the right people.  Please contact Jeff Schwartz for more details at (215)
654-5151.




<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-161</DOCNO>
<DOCOLDNO>IA050-000869-B035-139</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a113.htm 199.92.136.137 19970111140921 text/html 654
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:11:00 GMT
Last-modified: Tuesday, 12-Nov-96 14:04:19 GMT
Content-length: 464
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>SAS Programmers</H1></CENTER>
<HR>
A113, <BR>11/11/96
SAS Programmers.
<P>
Senior level positions available for people with 4 or more years
pharmaceutical industry experience.  East and West coast opportunities.
Please contact Jeff Schwartz for more details at (215) 654-5151.


<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-162</DOCNO>
<DOCOLDNO>IA050-000869-B035-174</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a114.htm 199.92.136.137 19970111140932 text/html 1848
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:11:10 GMT
Last-modified: Wednesday, 20-Nov-96 15:40:05 GMT
Content-length: 1655
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Data Manager</H1></CENTER>
<HR>
A114<BR>11/20/96 Data Manager
<P>
<U>Brief Position Description:</U>
<P>
We are a leading European Clinical Research Organization with opportunities for<BR>
ambitious Clinical Data Managers with between 6 months and 3 years experience.  The<BR>
position will be based in the Biometrics Department and involves all aspects of data<BR>
management including Database Design (SAS & ClinTrial), Data Validation, Query<BR>
Raising and Tracking, and Quality Control.  The responsibilities for this position will also<BR>
include project specific management, interaction with clinical and resource planning.<BR>
<P>
<U>Name of Company:</U><BR>
<CENTER>Chiltern International Limited<BR></CENTER>
<U>Person to Contact:</U><BR>
<CENTER>Alyson Berry, Biometrics Manager<BR></CENTER>
<P>
<U>Company Address:</U><BR>
<CENTER>Chiltern International Limited<BR></CENTER>
<P>
<U>Address:</U>	<BR>
<CENTER>Chiltern Place<BR></CENTER>
<CENTER>Upton Road<BR></CENTER>
<CENTER>Slough<BR></CENTER>
<CENTER>Berkshire<BR></CENTER>
<CENTER>SL1 2AD<BR></CENTER>
<P>
<U>Telephone Number</U><BR>
<CENTER>+44 (0) 1753 512000<BR></CENTER>
<P>
<U>Facsimile:</U><BR>
<CENTER>+44 (0) 1753 511116<BR></CENTER>
<P>
<U>E-mail Address:</U><BR>
<CENTER>Dominic.Matthews@dial.pipex.com<BR></CENTER>
<P>
<P>
<P>
We offer a comprehensive package including a non-contributory pension, ongoing<BR>
training and contracting out opportunities.<BR>
<P>

<P>
An Equal Opportunity Employer
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-163</DOCNO>
<DOCOLDNO>IA050-000869-B035-202</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a115.htm 199.92.136.137 19970111140941 text/html 2127
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:11:22 GMT
Last-modified: Wednesday, 20-Nov-96 16:01:33 GMT
Content-length: 1934
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associate</H1></CENTER>
<HR>
A115<BR>11/20/96 Clinical Research Associate or Senior Clinical Research Associate
<P>
<U>Brief Position Description:</U>
<P>
We are a leading European Clinical Research Organization with opportunities for<BR>
ambitious Clinical Research Associates with between 6 months and 3 years<BR>
experience who are enthusiastic and highly motivated.  The positions will involve<BR>
all aspects of Clinical Research from design of protocal and case report form<BR>
through selection of Investigators, submission of ethics committee and regulatory<BR>
documentation, initiation of sites, monitoring and source data verification of data,<BR>
lifting and processing of data and report writing.  The responsibilities for this<BR>
position will also include the organization of and presentation at Investigator<BR>
meetings and the overseeing of production of clinical drug supplies.<BR>
<P>
<U>Name of Company:</U><BR>
<CENTER>Chiltern International Limited<BR></CENTER>
<U>Person to Contact:</U><BR>
<CENTER>Karen Roy, Clinical Trials Manager<BR></CENTER>
<P>
<U>Company Address:</U><BR>
<CENTER>Chiltern International Limited<BR></CENTER>
<P>
<U>Address:</U>	<BR>
<CENTER>Chiltern Place<BR></CENTER>
<CENTER>Upton Road<BR></CENTER>
<CENTER>Slough<BR></CENTER>
<CENTER>Berkshire<BR></CENTER>
<CENTER>SL1 2AD<BR></CENTER>
<P>
<U>Telephone Number</U><BR>
<CENTER>+44 (0) 1753 512000<BR></CENTER>
<P>
<U>Facsimile:</U><BR>
<CENTER>+44 (0) 1753 511116<BR></CENTER>
<P>
<U>E-mail Address:</U><BR>
<CENTER>Dominic.Matthews@dial.pipex.com<BR></CENTER>
<P>
<P>
<P>
We offer a comprehensive package including a non-contributory pension, ongoing<BR>
ongoing training and company car.<BR>
<P>

<P>
An Equal Opportunity Employer
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-164</DOCNO>
<DOCOLDNO>IA051-000870-B015-50</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a116.htm 199.92.136.137 19970111140952 text/html 1408
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:11:30 GMT
Last-modified: Wednesday, 20-Nov-96 16:34:07 GMT
Content-length: 1215
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Site Manager</H1></CENTER>
<HR>
A116, <BR>11/20/96
Site Manager
<P>
 Site Manager - Van Nuys, CA
<P>
 West Coast Clinical Research - a multi-specialty clinical trial organization - is seeking<BR>
a Site Manager position.  You will be responsible for supervision and management of<BR>
clinical drug studies.  Duties include quality management, team logistics, personnel<BR>
administration, patient recruitment, quality assurance, and cost accounting.  You will<BR>
also coordinate daily office activities and assist in planning for future growth.<BR>
<P>
Qualified candidates will have at least two years of experience as a research<BR>
coordinator and/or monitor at a contract research organization (CRO).<BR>
Management and administrative experience and communication and organization<BR>
skills are required.<BR>
<P>
Please submit your resume to T. Mata, West Coast Clinical Research;<BR>
15243 Vanowen Street, Suite 306; Van Nuys, CA 91405;<BR>
Fax:  (818) 901-7659.  Only selected candidates will be contacted.<BR>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-165</DOCNO>
<DOCOLDNO>IA051-000870-B015-80</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a117.htm 199.92.136.137 19970111141025 text/html 1636
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:11:41 GMT
Last-modified: Wednesday, 20-Nov-96 16:46:41 GMT
Content-length: 1443
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Contract Administrator</H1></CENTER>
<HR>
A117, <BR>11/20/96
Contract Administrator
<P>
Contract Administrator - Gurnee, IL
<P>
Affiliated Research Centers, Inc. (ARC) - an investigator owned, nationwide network - <BR>
is seeking two Contract Administrators; one for Internal Medicine Network and another<BR>
for Clinical Development Services Group.  You will review and prepare budgets/contracts,<BR>
identify negotiating strategies, and participate in individual and/or team negotiations<BR>
while ensuring total customer satisfaction.<BR>
<P>
Qualified candidates will possess a B.S. in a business field and/or medical field;<BR>
five-plus years of experience in the budgeting/contract process, including negotiations<BR>
in either the clinical research, pharmaceutical, and/or CRO industries;<BR>
strong oral and written communication, computer, and multi-tasking skills;<BR>
ability to analyze and interpret data; good judgement; and interpersonal skills.<BR>
<P>
Please submit your resume to Kim Britt, Executive Administrative Assistant;<BR>
Affiliated Research Centers, Inc; 1375 Tri-State Parkway, Suite 210; Gurnee, IL 60031;<BR>
Fax: (847) 855-8787; E-Mail: kbritt@arc-centers.com.<BR>
Only selected candidates will be contacted.<BR>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-166</DOCNO>
<DOCOLDNO>IA051-000870-B015-121</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a118.htm 199.92.136.137 19970111141049 text/html 1500
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:12:24 GMT
Last-modified: Wednesday, 20-Nov-96 20:42:33 GMT
Content-length: 1307
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Medical Director</H1></CENTER>
<HR>
A118, <BR>11/20/96
Associate Medical Director, Clinical Affairs
<P>
<B>Job Description</B><BR>
Utilize your in-depth drug development and clinical trial experience and knowledge of FDA/EC/ICH<BR>
regulations to design and manage clinical trials:  medical and safety monitoring.  Emphasis on<BR>
global harmonization of Renal Clinical Affairs across regions.<BR>
<P>
<B>Job Requirements</B><BR>
MD or Ph.D. with 2-5 years experience in the pharmaceutical industry with direct involvement in<BR>
clinical trials (Phase II-III emphasis) and safety monitoring.  Experience developing scientific and<BR>
creative study designs.  Global experience and background in renal disease desirable.<BR>
Demonstrated leadership skills.<BR>
<P>
<P>
<P>
<B>Contact:</B> <CENTER>Dr. Marsha Wolfson, Medical Director</CENTER>
<B>Company:</B> <CENTER>Baxter International, Renal Division</CENTER>
<B>Phone:</B> <CENTER>(847) 473-6343</CENTER>
<B>Fax:</B> <CENTER>(847) 473-6923</CENTER>
<B>Address:</B> <CENTER>1620 Waukegan Road</CENTER>
<CENTER>McGaw Park, IL 60085</CENTER>
<P>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-167</DOCNO>
<DOCOLDNO>IA051-000870-B015-173</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a119.htm 199.92.136.137 19970111141112 text/html 1582
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:12:50 GMT
Last-modified: Wednesday, 20-Nov-96 19:16:58 GMT
Content-length: 1389
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associate</H1></CENTER>
<HR>
A119, <BR>11/20/96
Clinical Research Associate, Clinical Development
<P>
<B>Job Description</B><BR>
Responsible for conducting clinical studies on renal therapies, prescriptions, and outcomes.<BR>
Interface with Renal business representatives, investigators, and contract vendors.  Prepare and<BR>
implement clinical plan, manage study sites, coordinate data collection & analysis and<BR>
report preparation.
<P>
<B>Job Requirements</B><BR>
1 to 3 years clinical study experience, including investigator and study site management,<BR>
protocol, and case report form preparation, data collection and analysis.<BR>
Strong interpersonal, communication, and organizational skills.  Ability to travel<BR>
up to 50% (domestic and international).  Knowledge of Renal therapy and strong<BR>
business orientation.
<P>
<P>
<P>
<B>Contact:</B> <CENTER>Dianne Parsons, Sr. Program Manager</CENTER>
<B>Company:</B> <CENTER>Baxter International, Renal Division</CENTER>
<B>Phone:</B> <CENTER>(847) 473-6073</CENTER>
<B>Fax:</B> <CENTER>(847) 473-6923</CENTER>
<B>Address:</B> <CENTER>1620 Waukegan Road</CENTER>
<CENTER>McGaw Park, IL 60085</CENTER>
<P>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-168</DOCNO>
<DOCOLDNO>IA051-000870-B015-201</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a120.htm 199.92.136.137 19970111141121 text/html 1465
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:01 GMT
Last-modified: Wednesday, 20-Nov-96 19:59:01 GMT
Content-length: 1272
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Data Associate</H1></CENTER>
<HR>
A120, <BR>11/20/96
Clinical Data Associate
<P>
Hybridon, Inc. is a fast-growing pharmaceutical company developing genetic medicines<BR>
based on antisense technology.  Currently located in Worcester, Massachusetts,<BR>
Hybridon is planning to move to Cambridge by year-end, and will occupy a newly<BR>
renovated building on the Charles River in the heart of "Genetown."
<P>
We have an immediate opening for an experienced Clinical Data Associate in the<BR>
Biostatics and Data Management Department.  The Clinical Data Associate will<BR>
work closely with other Data Management personnel to develop case report forms,<BR>
set up databases, design data entry screens, track and review completed case<BR>
report forms, and enter data from clinical trials.
<P>
Hybridon offers a competitive salary and an excellent benefits package.  Please<BR>
forward your resume in confidence to:  Human Resources Dept., Hybridon, Inc.,<BR>
One Innovation Drive, Worcester, MA 01605; or to E-mail address jobs@hybridon.com
<P>
Principals only. 
<P>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-169</DOCNO>
<DOCOLDNO>IA051-000870-B015-233</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a121.htm 199.92.136.137 19970111141130 text/html 2804
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:10 GMT
Last-modified: Wednesday, 20-Nov-96 20:27:21 GMT
Content-length: 2611
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Continuing Assessment</H1></CENTER>
<HR>
A121, <BR>11/20/96
Manager, Continuing Assessment (Federal) - Ottawa, Ontario, Canada
<P>
<B>Area of Selection:</B> Persons residing in Canada
<P>
Permanent position with Health Canada.
<P>
<B>Duties:</B> To manage a program where the main focus is on the continuous<BR>
safety and effectiveness of drugs in the Canadian market to identify potential risks<BR>
and benefits; to estimate their magnitude; to identify and/or evaluate options,<BR>
recommend timely action to be pursued.  Some elements of the program also<BR>
pertain to the monitoring of adverse drug reactions and the evaluation of the<BR>
appropriate use of psychoactive substance.  The incumbent will be the key<BR>
advisor, information provider, and consultant for topics pertaining to drug safety<BR>
with various stakeholders nationally and internationally (including other<BR>
regulatory authorities).
<P>
<B>Salary:</B> $80,313 to $93,745 (MD-MOF-03), commensurate with experience.
<P>
<B>Requirements of the Position:</B>
<P>
<B>Education:</B><BR>
Graduation with a degree from a recognized school of medicine.
<P>
<B>Occupational Certification:</B><BR>
Eligibility for a licence to practice medicine in a province or territory of Canada.
<P>
<B>Experience:</B><BR>
Experience in the evaluation of pharmacotherapy; recent experience as a clinician<BR>
and in the conduct and evaluation of clinical studies, and experience in the supervision<BR>
of professional and support staff.
<P>
Proficiency in English and in French is essential.  Please note that language training<BR>
may be offered.
<P>
For additional information, you may contact Carole Bouchard at:<BR>
CAROLE_BOUCHARD@ISDTCP3.HWC.CA
<P>
Your resume must demonstrate that you meet all the above-mentioned requirements,<BR>
quote the competition number <B>S72858LD38</B>, and clearly indicate<BR>
your citizenship.
<P>
<B>Closing Date:</B> November 29th, 1996
<P>
Please fax your resume to <B>(613) 996-8048</B>, as electronic applications cannot<BR>
be accepted at this time.
<P>
Preference for appointment will be given to Canadian citizens.<BR>
We thank all those who apply.  Only those selected for further consideration will<BR>
be contacted.
<P>
For additional information on our recruiting programs, please visit our Internet<BR>
site at <B>http://www.psc-cfp.ge.ca/recruit/jobse.htm</B>
<P>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-170</DOCNO>
<DOCOLDNO>IA051-000870-B015-266</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a122.htm 199.92.136.137 19970111141140 text/html 1231
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:18 GMT
Last-modified: Wednesday, 20-Nov-96 20:44:46 GMT
Content-length: 1038
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>SAS Programmer</H1></CENTER>
<HR>
A122, <BR>11/20/96
SAS Programmer - PPD Pharmaco International - Richmond,VA
<P>
Provides programming support for pharmacokinetic studies using SAS.  Use specifications<BR>
provided by the project pharmacokineticist and biostatitician to create tables,<BR>
listings, and graphs for reports for submission to FDA.  Candidates must have at<BR>
least 1 year recent SAS programming experience in a scientific or medical environment.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-171</DOCNO>
<DOCOLDNO>IA051-000870-B015-300</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a123.htm 199.92.136.137 19970111141150 text/html 1360
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:29 GMT
Last-modified: Wednesday, 20-Nov-96 21:05:02 GMT
Content-length: 1167
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Pharmacokineticist</H1></CENTER>
<HR>
A123, <BR>11/20/96
Pharmacokineticist - PPD Pharmaco International - Richmond,VA
<P>
Designs protocols and analyzes data from pharmacokinetic, bioavailability,<BR>
bioequivalence, and pharmacodynamic studies.  Provides analysis and<BR>
interpretation of data and preparation of final reports to sponsors for submission<BR>
to FDA.  M.S. or doctoral level with minimum 2 years of experience in<BR>
pharmacokinetic data analysis.  Excellent communication skills are<BR>
necessary to support frequent contact with clients, managers, and biostatisticians.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-172</DOCNO>
<DOCOLDNO>IA051-000870-B015-327</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a124.htm 199.92.136.137 19970111141159 text/html 1234
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:38 GMT
Last-modified: Wednesday, 20-Nov-96 21:27:27 GMT
Content-length: 1041
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biostatistician</H1></CENTER>
<HR>
A124, <BR>11/20/96
Biostatistician - PPD Pharmaco International - Richmond,VA
<P>
Serve as project statistician.  Work wiht project team to form analysis plan, analyze,<BR>
study, and produce tables and listings for study results.  Present and interpret<BR>
statistical results.  Phase I study background and pharmacokinetics experience<BR>
required.  M.S. or doctoral level with minimum 2 years pharmaceutical Phase I experience.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-173</DOCNO>
<DOCOLDNO>IA051-000870-B016-7</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a125.htm 199.92.136.137 19970111141219 text/html 1163
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:13:51 GMT
Last-modified: Wednesday, 20-Nov-96 21:32:04 GMT
Content-length: 971
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer</H1></CENTER>
<HR>
A125, <BR>11/20/96
Medical Writer - PPD Pharmaco International - Richmond,VA
<P>
Research, writing editing clinical/statistical reports and study protocols and<BR>
summarizing data from clinical studies for submission to the FDA.  Pharmacology<BR>
or pharmacy background required with minimum 2 years experience writing in<BR>
pharmaceutical or CRO environment.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-174</DOCNO>
<DOCOLDNO>IA051-000870-B016-50</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a126.htm 199.92.136.137 19970111141258 text/html 1112
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:14:28 GMT
Last-modified: Wednesday, 20-Nov-96 21:44:41 GMT
Content-length: 920
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Scientist/Development</H1></CENTER>
<HR>
A126, <BR>11/20/96
Scientist/Development - PPD Pharmaco International - Richmond,VA
<P>
Provides technical guidance and support to HPLC development team.  Strong organic<BR>
chemistry background with B.S.; M.S./Ph.D. preferred.  At least 2 years experience,<BR>
preferrably in pharmaceutical bioanalysis.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-175</DOCNO>
<DOCOLDNO>IA051-000870-B016-84</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a127.htm 199.92.136.137 19970111141315 text/html 1219
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:14:56 GMT
Last-modified: Wednesday, 20-Nov-96 21:48:12 GMT
Content-length: 1026
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Chemist/Immunoassay</H1></CENTER>
<HR>
A127, <BR>11/20/96
Chemist/Immunoassay - PPD Pharmaco International - Richmond,VA
<P>
Experience in development, validation, and performance of immunoassays<BR>
in support of pharmaceutical studies.  A thorough understanding of FDA Good<BR>
Laboratory Practices is required.  B.S. required and one year experience with<BR>
immunoassay techniques, preferrably in the measurement of pharmaceutical<BR>
compounds.
<P>
PPD-Pharmaco offers an excellent compensation and benefits program.<BR>
To be considered, please forward or fax C.V. with salary requirements to:<BR>
<P>
<CENTER><B>Human Resources</B></CENTER>
<CENTER><B>PPD-Pharmaco International</B></CENTER>
<CENTER><B>2244 Dabney Road</B></CENTER>
<CENTER><B>Richmond, Virginia 23230</B></CENTER>
<CENTER><B>FAX (804) 359-4468</B></CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-176</DOCNO>
<DOCOLDNO>IA051-000870-B016-118</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a128.htm 199.92.136.137 19970111141325 text/html 1964
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:05 GMT
Last-modified: Thursday, 21-Nov-96 15:36:51 GMT
Content-length: 1772
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Applications Programmer</H1></CENTER>
<HR>
A128, <BR>11/21/96
Senior Clinical Applications Programmer
<P>
LIGAND Pharmaceuticals Inc., is a leader in the discovery and development of<BR>
small molecule drugs.  Our mission is to create products that address major<BR>
unmet patient needs in cancer, women's health and skin diseases as well as<BR>
cardiovascular and inflammatory diseases.  Currently, we seek an outstanding<BR>
individual to join us in our Clinical Research Department.
<P>
This individual will develop, document, and maintain general and project specific<BR>
software to support our ongoing clinical trials.  The position will supervise the<BR>
clinical applications programming staff who are responsible for programming<BR>
statistical analyses which produce tables, graphs, listings, and data sets.<BR>
The position requires solid SAS programming skills including experience with<BR>
SAS Macros, AF and SQL.  The successful candidate will have a BS and<BR>
working knowledge of UNIX and Windows.  A minimum of 5 years' experience<BR>
in the pharmaceutical or health care industry using SAS is quired.  Experience<BR>
with ClinTrial/Oracle and statistical methods is desired.
<P>
LIGAND, located in La Jolla's Golden Triangle of San Diego, offers an attractive<BR>
salary and benefits package, including stock options.  Please fax or mail your<BR>
resume to:  LIGAND Pharmaceuticals, Dept. TM, 9393 Towne Centre Drive,<BR>
San Diego, CA 92121.  FAX: (619) 550-7800.  Alternatively, you may send<BR>
your ASCII formatted resume to dmackensen@ligand.com.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-177</DOCNO>
<DOCOLDNO>IA051-000870-B016-153</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a129.htm 199.92.136.137 19970111141335 text/html 1496
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:14 GMT
Last-modified: Thursday, 21-Nov-96 16:21:04 GMT
Content-length: 1304
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assistant Operations Manager</H1></CENTER>
<HR>
A129, <BR>11/21/96
Assistant Operations Manager -- Gurnee, IL
<P>
Affiliated Research Centers, Inc. (ARC) - an investiagtor-owned, nationwide network - is<BR>
seeking an Assistant Operations Manager position for our Internal Medicine Network.<BR>
You will coordinate and implement multiple, simultaneous clinical trials, including<BR>
input site selection and feasibility, budget development, IRB submission, informed<BR>
consent creation, source document generation/review, and study follow through.
<P>
Qualified candidates will possess a B.S. in the medical field; three to five years<BR>
of medical experience in clinical research and/or healthcare management; strong<BR>
communication, computer, organization, and multi-tasking skills; and the<BR>
ability to analyze and interpret data.
<P>
Please submit your resume to Kim Britt, Executive Administrative Assistant,<BR>
Affiliated Research Centers, Inc., 1375 Tri-State Parkway, Suite 210; Gurnee,<BR>
IL 60031; Fax (847) 855-8787; E-Mail kbritt@arc-centers.com<BR>
Selected candidates will be contacted.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-178</DOCNO>
<DOCOLDNO>IA051-000870-B016-179</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a130.htm 199.92.136.137 19970111141345 text/html 1015
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:26 GMT
Last-modified: Thursday, 21-Nov-96 16:37:05 GMT
Content-length: 824
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Director</H1></CENTER>
<HR>
A130, <BR>11/21/96
Associate Director/Director Infectious Diseases<BR>
Clinical Research
<P>
Successful candidate will have an M.D., trained in Infectious Diseases,<BR>
board-certified with 3-5 years academic or industry experience.  Specific<BR>
experience with antivirals, viral infections in transplant patients a plus.
<P>
Please contact:  Angelo G. Angeledes, MS, CPC, 609-584-8300<BR>
FAX 609-584-0187,  AADE Associates, PO Box 2142, Princeton, NJ 08543<BR>
Company Name:  AADE Associates -- Pharmaceutical Executive Recruiter<BR>
PO Box 2142; Princeton, NJ 08543; e-mail:  agapharm@aol.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-179</DOCNO>
<DOCOLDNO>IA051-000870-B016-212</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a131.htm 199.92.136.137 19970111141358 text/html 1647
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:36 GMT
Last-modified: Monday, 02-Dec-96 14:45:19 GMT
Content-length: 1457
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Biostatics</H1></CENTER>
<HR>
A131, <BR>11/21/96
<P>
An international pharmaceutical company is adding a Manager of Biostatics<BR>
into their Biometrics Department in Central New Jersey.  They had sales of<BR>
$350 million in 1996 from 5 drugs and have a very lucrative pipeline.  Excellent<BR>
compensation and benefits - including relocation.
<P>
Responsibilities include managing statistical support for NDA submissions -<BR>
including supervising contract statisticians and CRO's; participating in protocol<BR>
design and review; writing statistical analysis plans; performing statistical analysis;<BR>
participating in clinical report efficacy analysis writing; preparing NDA sections;<BR>
reviewing clinical reports; presenting to regulatory agencies.
<P>
Requirements include a Ph.D. with 3 years experience or a Master's degree with<BR>
6 years experience in pharmaceutical biostatics; supervisory or project management<BR>
experience; NDA submissions experience; experience presenting to the FDA<BR>
and collaborating with CRO's desired.
<P>
<P>
<P>
Contact:
<P>
Lisa Lowe<BR>
Senior Consultant<BR>
5300 College Blvd<BR>
Overland Park, KS 66211<BR>
voice: (800) 465-4933 ext. 161<BR>
local: (913)451-7666<BR>
fax: (913) 451-2043<BR>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-180</DOCNO>
<DOCOLDNO>IA051-000870-B016-253</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a132.htm 199.92.136.137 19970111141411 text/html 1404
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:47 GMT
Last-modified: Thursday, 21-Nov-96 21:09:02 GMT
Content-length: 1212
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager Formulation Development</H1></CENTER>
<HR>
A132, <BR>11/21/96
Manager Formulation Development - South of France.  Ref. 96140
<P>
Position Description: commission and run up a brand new topical form pilot facility,<BR>
manage the development of new products and manufacture for clinical trials,<BR>
interface with European manufacturing plants and subcontractors, and drive<BR>
projects at both the European and worldwide levels.
<P>
Ideal Candidate:  English-speaking EU citizen, pharmacist, PhD or equivalent,<BR>
GMP/GLP awareness, with practical topical and sterile products experience in<BR>
three or more fields of interest to the Company:  preformulation, formulation,<BR>
production scale-up, clinical trials supplies.
<P>
Contact:  send scannable-quality CV/letter to Roger Stephens/Anita McCarthy<BR>
at Roger Stephens & Associates, Chequers House, 1 Park Street, Old Hatfield,<BR>
Hertfordshire, AL9 5AT United Kingdom.  Tel. 44 (0) 1707 275361<BR>
Fax 44 (0) 1707 271366.  E-mail: RDS@RSA.Telme.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-181</DOCNO>
<DOCOLDNO>IA051-000870-B016-285</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a133.htm 199.92.136.137 19970111141421 text/html 1532
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:15:59 GMT
Last-modified: Thursday, 21-Nov-96 21:26:02 GMT
Content-length: 1340
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Consulting Statisticians</H1></CENTER>
<HR>
A133, <BR>11/21/96
Consulting Statisticians
<P>
Searle, a research-based pharmaceutical innovator, is seeking statisticians to<BR>
collaborate with clinical researchers in the arthritis, cardiovascular, women's<BR>
health and CNS areas.  This includes planning, analysis and reporting of<BR>
significant clinical programs and studies, keeping abreast of current issues<BR>
and practices of pharmaceutical R&D, and managing projects.  The work covers<BR>
clinical trials in Phases I-III and NDA preparation.
<P>
Excellent oral and written communication skills are required as is a Ph.D. or M.S.<BR>
in statistics or related field and 5 (8 with M.S.) or more years of experience<BR>
involving clinical trials.  Experience in the pharmaceutical industry and in<BR>
managing projects is highly desirable.
<P>
Located in suburban Chicago, Searle offers an excellent salary and benefits<BR>
package as well as a highly professional work environment.
<P>
Please mail or fax resume to:
<P>
Searle R&D<BR>
Human Resources, Dept. JAS<BR>
4901 Searle Parkway<BR>
Skokie, IL 60077<BR>
(847) 982-4637 (FAX)
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-182</DOCNO>
<DOCOLDNO>IA051-000870-B016-321</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a134.htm 199.92.136.137 19970111141440 text/html 1188
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:16:16 GMT
Last-modified: Friday, 22-Nov-96 15:39:09 GMT
Content-length: 999
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Regulatory Affairs Consultant</H1></CENTER>
<HR>
A134, <BR>11/22/96
Senior Regulatory Affairs Consultant
<P>
A world leading heathcare company making an important impact in Neurology is<BR>
seeking a Regulatory Affairs expert to work closely with their Neuromuscular<BR>
Project Team.  Candidates who may wish to be based in either the Germany,<BR>
UK, or France will have around 5 years regulatory experience and ideally some<BR>
background in biologicals/biotechnology. He/she will have an excellent opportunity<BR>
to utilize, strengthen and develop strategic and technical expertise in this<BR>
multi-national role at the centre of European submissions.
<P>
Please fax resumes to 44 (0) 1707 271366 or call Catriona Shuba or Alison<BR>
Griffiths first for a brief discussion at 44 (0) 1707 275361.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-183</DOCNO>
<DOCOLDNO>IA051-000870-B017-2</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a135.htm 199.92.136.137 19970111141522 text/html 1857
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:16:32 GMT
Last-modified: Friday, 22-Nov-96 16:10:54 GMT
Content-length: 1667
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director of Regulatory Affairs</H1></CENTER>
<HR>
A135, <BR>11/22/96
Director of Regulatory Affairs
<P>
Manhattan-based biopharmaceutical company seeks the following professional to:
<P>
Oversee Company's regulatory affairs activities.<BR>
Assist in the development and proposal of a regulatory strategy for the<BR>
corporation.<BR>
Participate in meetings with regulatory authorities both in the United<BR>
States and Europe.<BR>
Insure compliance of relevant activities with GMP, GLP, and GCP.<BR>
Serve as a liason with and prepare documentation for agencies such as<BR>
FDA, OSHA, NRC, etc.<BR>
Interact  with pre-clinical and clinical departments to prepare new IND<BR>
submissions, amend/supplement existing IND's and eventually prepare<BR>
PLA's or BLA's for the company.<BR>
Participate in product manufacturing and control issues.  Insure necessary<BR>
compliance with FDA and other Agency standards (e.g. cGMP, etc),<BR>
coordinate, organize, and process data on manufacturing and quality assurance.<BR>
Coordinate adverse events reporting to the FDA.<BR>
Compile and submit annual reports to FDA.<BR>
Maintain records of all regulatory submissions and provide an information<BR>
retrieval system for the corporation.<BR>
Implement and oversee a documentation control system.
<P>
Principals Only.
<P>
Undergraduate degree required. Appropriate Industry Experience.
<P>
Please inquire at E-Mail address P.Jill@worldnet.att.net or call 1-617-592-6473.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-184</DOCNO>
<DOCOLDNO>IA051-000870-B017-38</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a136.htm 199.92.136.137 19970111141531 text/html 1277
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:17:10 GMT
Last-modified: Friday, 22-Nov-96 16:36:46 GMT
Content-length: 1087
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associates</H1></CENTER>
<HR>
A136, <BR>11/22/96
Clinical Research Associates
<P>
Several exciting opportunities are available for CRA's to join one of our Clinical Research Groups.
<P>
The ideal candidate will have 1 to 2 years of experience as a CRA in the<BR>
pharmaceutical industry, a degree in the life sciences and ability to travel<BR>
(approximately 30-50%).  Responsibilities include monitoring clinical studies,<BR>
identifying and qualifying clinical investigators and assisting in development of<BR>
case report forms.
<P>
Also, Senior CRA/Clinical Research Manager positions available.<BR>
3 to 7 years experience.
<P>
Send responses to:
<P>
Rick Giles or Jean Boutin<BR>
Pharmaceutical Search Professionals, Inc.<BR>
1201 Bethlehem Pike, Suite 103<BR>
North Wales, PA 19454
<P>
Phone: (215) 654-5151<BR>
Fax: (215) 654-7402<BR>
Email: boutinj@cynet.net
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-185</DOCNO>
<DOCOLDNO>IA051-000870-B017-72</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a137.htm 199.92.136.137 19970111141544 text/html 2501
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:17:24 GMT
Last-modified: Friday, 22-Nov-96 16:55:52 GMT
Content-length: 2311
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Statistical Programmer Analyst III</H1></CENTER>
<HR>
A137, <BR>11/22/96
Statistical Programmer Analyst III or Senior Statistical Programmer Analyst
<P>
Candidate should have extensive experience in the data management, analysis<BR>
file preparation, and statistical presentation (tables and graphs) with respect to<BR>
the statistical analysis of clinical trial data.  He/she should have experience<BR>
working very closely with biostatisticians as well as information systems,<BR>
clinical, medical, and regulatory personnel.
<P>
The candidate should have the demonstrated ability to independantly research<BR>
current and emerging technologies that can impact and improve the design,<BR>
conduct, analysis, and presentation of clinical trial data.  The candidate should<BR>
be able to critically evaluate, communicate, and recommend suggested<BR>
approaches to achieve the above objectives.  Examples of current technology<BR>
might include remote data entry, computer assisted regulatory filings,<BR>
intranet and internet technology.
<P>
<U><B>Candidate should:</B></U><BR>
* be very hands-on with respect to deliverables<BR>
* be a team player and function well within a team environment<BR>
* have the ability to juggle multiple projects<BR>
* be able to work towards very tight timelines<BR>
* be self-motivated with problem solving skills<BR>
* have the potential or demonstrated project management/leadership skills<BR>
* have good to excellent oral and written communication skills
<P>
<U><B>Candidate should be very experienced in:</B></U><BR>
* SAS Macros<BR>
* SAS Data Nulls<BR>
* SQL<BR>
* SAS Graph<BR>
* Base SAS
<P>
<U><B>Experience:</B></U><BR>
* B.A./B.S. in statistics, applied statistics, biostatistics, mathematics, biology<BR>
or related fields.<BR>
* 5-9 years experience using SAS in a biomedical or other health related field is<BR>
required with 1-3 years of full time SAS programming experience in the<BR>
biotech/biopharmaceutics field.
<P>
<U><B>CONTACT:</B></U><BR>
Anna Floyd<BR>
The Chase Group, Inc.<BR>
(913) 663-3100 Ext. 129<BR>
(913) 663-3131 (FAX)
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-186</DOCNO>
<DOCOLDNO>IA051-000870-B017-103</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a138.htm 199.92.136.137 19970111141606 text/html 1563
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:17:42 GMT
Last-modified: Friday, 22-Nov-96 17:21:15 GMT
Content-length: 1373
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Statistical Programmer</H1></CENTER>
<HR>
A138, <BR>11/22/96
Statistical Programmer
<P>
<U><B>Reporting Relationship:</B></U><BR>
Reports to Director Biostatics and Data Management.
<P>
<U><B>Responsibilities:</B></U><BR>
Opportunity exists in Biostatistics Group to develop, validate, and execute<BR>
computer programs primarily utilizing the SAS programming language, to<BR>
create tables, listings, graphs, and statistical analyses for data from nonclinical<BR>
research studies and clinical trials.  Responsibilities include assisting in<BR>
developing and validating databases and creating interfaces between the<BR>
databases and analysis programs.
<P>
<U><B>Experience:</B></U><BR>
* B.S. in statistics, mathematics, or computer science<BR>
* Minimum of 2 years experience as a SAS programmer in the pharmaceutical<BR>
industry supporting the analysis of clinical trial data
* Excellent working knowledge of SAS procedures, SAS GRAPH and<BR>
relational databases<BR>
* Familiarity with SAS statistical procedures
<P>
<U><B>Contact:</B></U><BR>
Anna Floyd<BR>
The Chase Group, Inc.<BR>
913-663-3100 Ext. 129<BR>
913-663-3131 (Fax)<BR>
e-mail anna@chasegroup.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-187</DOCNO>
<DOCOLDNO>IA051-000870-B017-130</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a139.htm 199.92.136.137 19970111141615 text/html 1677
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:17:55 GMT
Last-modified: Friday, 22-Nov-96 18:25:09 GMT
Content-length: 1487
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Director</H1></CENTER>
<HR>
A139, <BR>11/22/96
Medical Director
<P>
A privately held biopharmaceutical company based in Manhattan seeks a Medical Director.<BR>
Responsibilities include:<BR>
Oversee the corporation's clinical and medical activities.<BR>
Bridge the gap in understanding the needs between basic research and<BR>
therapeutic challenges.<BR>
Research oncology practices and devise strategies for the conduct of clinical<BR>
studies to insure expeditious marketing approval.<BR>
Plan new clinical  studies, write protocols and oversee the preparation of<BR>
case reporting forms.<BR>
Oversee the activities of clinical research associates in monitoring of the<BR>
clinical investigations.<BR>
Review adverse events and assist or coordinate with Regulatory Affairs in<BR>
FDA reporting of significant events.<BR>
Assist in the preparation of annual reports to the FDA.<BR>
Oversee the analysis of clinical data.<BR>
Provide a medical review of reports to be submited for a licensing application.<BR>
Implement a compassionate plea system, if necessary.
<P>
M.D. required with a background in oncology/immunology preferred.  Two years<BR>
industry experience.
<P>
Principals Only.
<P>
Please either e-mail interest to P.Jill@worldnet.att.net or call 1-617-592-6473.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-188</DOCNO>
<DOCOLDNO>IA051-000870-B017-170</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a140.htm 199.92.136.137 19970111141627 text/html 3454
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:18:07 GMT
Last-modified: Friday, 22-Nov-96 18:48:44 GMT
Content-length: 3264
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Pharmacologists</H1></CENTER>
<HR>
A140, <BR>11/22/96
Clinical Pharmacologists
<P>
I am seeking to identify several classically trained clinical pharmacologists<BR>
who have been involved in drug development, drug metabolism, pharmacokinetics,BR>
and or bioavailability studies in cardiovascular, endocrinology, immunology,<BR>
nephrology, oncology, or rheumatology.
<P>
He/She would represent a clinical pharmacology department or support a colleague<BR>
in a research institute.  He/She would be responsible for the timely, scientifically<BR>
sound, business orientated development of the clinical pharmacology components<BR>
of the assigned product development plan.  He/She would contribute to appropriate<BR>
budget manpower planning for the assigned projects.
<P>
He/She would be responsible for the timely preparation and quality of relevant<BR>
product development concept documents, final study reports, new drug application<BR>
summaries or contributions to documents for investigational new drugs or new drug<BR>
applications expert reports.
<P>
He/She would interact with clinical pharmacology operations and or clinical<BR>
operations to expedite study conduct.
<P>
He/She would be responsible for the evaluation of clinical pharmacology data, e.g.<BR>
pharmacokinetics, pharmacodynamics, and drug safety from clinical studies,<BR>
interacting as required with operational staff, data management, biostatistics,<BR>
and other corporate partners.
<P>
The successful candidate will interact with the regulatory authorities with regards<BR>
to clinical pharmacology issues.  The successful candidate will prepare information<BR>
and present relevant issues at the clinical pharmacology project review meetings<BR>
with external consultants.
<P>
The successful candidate would be an M.D. or Ph.D. with equivalent experience in<BR>
the field of pharmacology with a complete understanding of the drug development<BR>
process and five or more years of relevant experience.  These positions require<BR>
classical training in clinical pharmacology with a broad overview of clinical pharmacology<BR>
and relevant biological and medical concepts and the ability to handle the<BR>
pharmacokinetic, pharmacodynamic, and drug safety aspects of a clinical<BR>
pharmacology program.
<P>
We have opportunities for those clinical pharmacologists whose post doc training is in<BR>
cardiovascular, endocrinology, immunology, nephrology, oncology, pulmonary, or<BR>
rheumatology.
<P>
The stipends for these opportunities are commensurate with the expertise the<BR>
candidate brings to the table.  There are considerable executive perks and possible<BR>
bonus and stock options for the more senior opportunities.  Relocation packages<BR>
are available depending upon circumstance.
<P>
Please contact:<BR>
J. Stroll Associates, Inc.<BR>
Consultants to Medical Management<BR>
National Association Building<BR>
980 Post Road East<BR>
Westport, CT 06880-5500<BR>
Phone: 203-227-3688<BR>
Fax: 203-222-0180<BR>
E-mail:  stroll@aol.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-189</DOCNO>
<DOCOLDNO>IA051-000870-B018-7</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a141.htm 199.92.136.137 19970111141655 text/html 641
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:18:33 GMT
Last-modified: Friday, 22-Nov-96 20:31:54 GMT
Content-length: 452
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director Biostatics</H1></CENTER>
<HR>
A141, <BR>11/22/96
Director Biostatics - Mid-Atlantic Region
<P>
Strong biostatics background.  Compensation 80k to 120k, possibly more.<BR>
Strong interpersonal skills required.  Please contact Jeff Schwartz at<BR>
215-654-5151.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-190</DOCNO>
<DOCOLDNO>IA051-000870-B018-26</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a142.htm 199.92.136.137 19970111141703 text/html 693
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:18:43 GMT
Last-modified: Friday, 22-Nov-96 20:34:48 GMT
Content-length: 504
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director Regulatory Affairs</H1></CENTER>
<HR>
A142, <BR>11/22/96
Director Regulatory Affairs - Mid-Atlantic Region
<P>
International experience required.  GMP, GCP, GLP experience also. Compensation<BR>
75k to 120k, possibly more.  Strong interpersonal skills required.<BR>
Please contact Jeff Schwartz at 215-654-5151.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-191</DOCNO>
<DOCOLDNO>IA051-000870-B018-69</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a143.htm 199.92.136.137 19970111141744 text/html 1555
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:19:10 GMT
Last-modified: Friday, 22-Nov-96 20:43:46 GMT
Content-length: 1365
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Business Development</H1></CENTER>
<HR>
A143, <BR>11/22/96
Business Development - Lexington, KY
<P>
Service Health, Inc. is a pharmaceutical consultancy based in Spring House,<BR>
Pennsylvania specializing in clinical, pharmacoeconomic, and quality of life<BR>
studies, along with outcomes research and biostatistical analyses.
<P>
We are opening an office in Lexington, Kentucky and are looking for a business<BR>
development person for this region to help establish new opportunities across a<BR>
variety of therapeutic areas for Phase III and IV studies.
<P>
Responsibilities of this position include presenting the scope of our clinical research<BR>
services to clients in the pharmaceutical industry, generating sales leads,<BR>
and developing and negotiating proposal agreements.
<P>
A BA/BS in a health science or a BBA in marketing/management plus 2 years of<BR>
pharmaceutical industry experience is preferred.
<P>
Qualified candidates are welcome to call 888-224-4658 for further information or fax<BR>
their resumes to 606-224-4658.  Resumes may also be mailed to Service Health,<BR>
Inc., Attn: Human Resources, P.O. Box 822, Spring House, PA 19477-0822.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-192</DOCNO>
<DOCOLDNO>IA051-000870-B018-120</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a144.htm 199.92.136.137 19970111141825 text/html 1367
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:19:44 GMT
Last-modified: Friday, 22-Nov-96 20:56:07 GMT
Content-length: 1177
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Quality Assurance Manager</H1></CENTER>
<HR>
A144, <BR>11/22/96
Quality Assurance Manager
<P>
We are seeking a dynamic individual who has extensive GCP and FDA<BR>
knowledge of clinical trials.  Phases I-IV to be a quality assurance manager.<BR>
This position will involve revising internal SOP's when needed, reviewing and<BR>
conducting QA audits at our clinical locations and working with our sites on<BR>
a daily basis to assure SOP adherance.<BR>
The ideal candidate will have the following qualifications:<BR>
1. BS in a scientific discipline<BR>
2. Minimum of 1-3 years as a study coordinator and/or as a CRA<BR>
3. Minimum of 3 years in a QA/QC position within the pharmaceutical<BR>
industry and/or a CRO<BR>
4. Excellent communication skills<BR>
5. Strong organizational skills and the ability to work as a diplomatic team member<BR>
Please send current CV, references, and salary requirements to:<BR>
Clinical Studies, Ltd.<BR>
2 Charles Street<BR>
Providence, RI 02904
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-193</DOCNO>
<DOCOLDNO>IA051-000870-B018-151</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a146.htm 199.92.136.137 19970111141844 text/html 1280
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:20:24 GMT
Last-modified: Friday, 22-Nov-96 21:14:51 GMT
Content-length: 1090
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer</H1></CENTER>
<HR>
A146, <BR>11/22/96
Medical Writer
<P>
Prepare documents on clinical studies, specifically integrated clinical study reports,<BR>
integrated summaries for NDAs, investigative brochures, annual reports,<BR>
safety updates, occasional manuscripts for peer-reviewed journals and other<BR>
items for the medical community.
<P>
BS. degree, (graduate degree preferred), experience writing materials for FDA<BR>
(IND and NDA) in the pharmaceutical industry.  Knowledge of Microsoft Word,<BR>
WordPerfect 6.1 and scientific graphics packages in a Windows environment helpful.
<P>
Compensation and benefits are highly competitive, including relocation assistance.
<P>
Contact Manager of Staffing<BR>
Otsuka America Pharmaceutical, Inc.<BR>
2440 Research Blvd.<BR>
Rockville, MD 20850<BR>
e-mail: karip@otsuka.oapi.com<BR>
Phone: 301-990-0030<BR>
Fax: 301-212-8647<BR>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-194</DOCNO>
<DOCOLDNO>IA051-000870-B018-180</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a147.htm 199.92.136.137 19970111141852 text/html 1667
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:20:33 GMT
Last-modified: Friday, 22-Nov-96 21:23:39 GMT
Content-length: 1477
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Design Specialist</H1></CENTER>
<HR>
A147, <BR>11/22/96
Design Specialist - Grand Rapids, MI
<P>
Imperial Graphics, Inc. a leading and growing manufacturer of case report forms<BR>
and other printed materials, located in Grand Rapids, MI, is seeking a design<BR>
specialist.  The successful candidate will have prior clinical research associate<BR>
experience.  Case report forms design experience would also be useful.  This<BR>
position is based in our Grand Rapids headquarters.
<P>
The ideal candidate will also possess excellent communication skills (both written<BR>
and oral).  The ability to work in a team environment as well as unsupervised will<BR>
be necessary.  Imperial is committed to the highest standards of quality, service<BR>
and excellence.  This position will require the same commitment.
<P>
This is an excellent opportunity in the ever-growing area of clinical research.  If<BR>
you possess the qualifications listed above and are committed to quality, please<BR>
submit your resume and salary history to:<BR>
<P>
CRF Design Specialist<BR>
Attn: Director, Clinical Research Services<BR>
Imperial Graphics, Inc.<BR>
3100 Walkent Dr., N.W.<BR>
Grand Rapids, MI 49544<BR>
Phone: 616-784-0100<BR>
Fax: 616-784-1218<BR>
E-mail: 103033.3523@compuserve.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-195</DOCNO>
<DOCOLDNO>IA051-000870-B018-211</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a148.htm 199.92.136.137 19970111141902 text/html 2128
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:20:42 GMT
Last-modified: Monday, 25-Nov-96 17:04:40 GMT
Content-length: 1938
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Quality Assurance Manager</H1></CENTER>
<HR>
A148, <BR>11/25/96
Quality Assurance Manager
<P>
Genentech is a pace-setting company, internationally known for discovering,<BR>
developing, manufacturing, and marketing human pharmaceuticals for significant<BR>
unmet medical needs.  Our product pipeline is the richest in the industry and we<BR>
are the only biotech company with five marketed products.
<P>
Manage a product release group with responsibility for product quality assurance of<BR>
clinical and marketed processes at Genentech.  You will assure all operations<BR>
comply with cGMP and Genentech quality standards as well as work with<BR>
manufacturing to continually improve the quality of compliance, systems, and<BR>
product.  Requirements include a BS/MS or equivalent with 7-10+ years' experience<BR>
with quality systems, and a strong knowledge of biotech manufacturing processes,<BR>
batch review and product release.  Previous management experience required.<BR>
Job Code ACSCA
<P>
Join us and enjoy our exciting success and progressive benefit package that<BR>
includes free health club membership, 3 weeks paid vacation, 6 weeks sabbatical<BR>
after every 6 years, fully paid medical/dental/vision coverage, and company stock<BR>
purchase opportunities for full time employees.  Send your resume to Genentech, Inc.,<BR>
Human Resources, Job Code ____, 460 Pt. San Bruno Blvd., South San Francisco,<BR>
CA, 94080.  If possible, please avoid bold, underline, or italic type faces.  You<BR>
may also e-mail your resume with the job code to jobs@gene.com (ASCII files<BR>
only with a maximum line width of 76 characters).  Check out additional job<BR>
opportunities available at Genentech online at http://www.gene.com.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-196</DOCNO>
<DOCOLDNO>IA051-000870-B018-238</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a149.htm 199.92.136.137 19970111141911 text/html 2254
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:20:52 GMT
Last-modified: Monday, 25-Nov-96 17:04:44 GMT
Content-length: 2064
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Quality Control Manager</H1></CENTER>
<HR>
A149, <BR>11/25/96
Quality Control Manager
<P>
Genentech is a pace-setting company, internationally known for discovering,<BR>
developing, manufacturing, and marketing human pharmaceuticals for significant<BR>
unmet medical needs.  Our product pipeline is the richest in the industry and we<BR>
are the only biotech company with five marketed products.
<P>
You will be directly responsible for the day to day operation of a clinical product<BR>
testing lab, including the evaluation and development of suitable analytical methods<BR>
and specifications for certificates of analysis of new and later stage clinical products<BR>
and regulatory submissions.  Assure the validity of tests performed for lot release<BR>
of finished product samples.  Must demonstrate a thorough understanding of<BR>
protein chemistry and the relevant chemical and analytical procedures used in<BR>
the laboratory, be well versed in the interpretation and application of cGMPs, and<BR>
have a strong instrumentation background. A BS with 5+ years of lab experience<BR>
is necessary.  Job Code ACSBN.
<P>
Join us and enjoy our exciting success and progressive benefit package that<BR>
includes free health club membership, 3 weeks paid vacation, 6 weeks sabbatical<BR>
after every 6 years, fully paid medical/dental/vision coverage, and company stock<BR>
purchase opportunities for full time employees.  Send your resume to Genentech, Inc.,<BR>
Human Resources, Job Code ____, 460 Pt. San Bruno Blvd., South San Francisco,<BR>
CA, 94080.  If possible, please avoid bold, underline, or italic type faces.  You<BR>
may also e-mail your resume with the job code to jobs@gene.com (ASCII files<BR>
only with a maximum line width of 76 characters).  Check out additional job<BR>
opportunities available at Genentech online at http://www.gene.com.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-197</DOCNO>
<DOCOLDNO>IA051-000870-B018-274</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a150.htm 199.92.136.137 19970111141923 text/html 2309
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:21:00 GMT
Last-modified: Wednesday, 18-Dec-96 19:18:12 GMT
Content-length: 2116
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Regulatory Affairs Associate</H1></CENTER>
<HR>
A150, <BR>11/25/96
Senior Regulatory Affairs Associate, GCP Compliance
<P>
Genentech is a pace-setting company, internationally known for discovering,<BR>
developing, manufacturing, and marketing human pharmaceuticals for significant<BR>
unmet medical needs.  Our product pipeline is the richest in the industry and we<BR>
are the only biotech company with five marketed products.
<P>
Department:  Regulatory Affairs -- Compliance
<P>
Job Summary:  Responsible for developing, implementing, and conducting clinical<BR>
compliance auditing, education, and communication, assignments, and projects<BR>
to assess/assure the quality and integrity of clinical research data and documentation<BR>
included in Genentech FDA submissions.
<P>
Qualifications:  * Bachelor's in scientific, health care, or related field or equivalent.<BR>
* 3-4 years of experience in clinical research, clinical monitoring, quality assurance/<BR>
regulatory compliance, or related areas.<BR>
* Thorough understanding of the clinical drug development process.<BR>
* Working knowledge of GCP regulations, guidelines, and their interpretation.
<P>
Join us and enjoy our exciting success and progressive benefit package that<BR>
includes free health club membership, 3 weeks paid vacation, 6 weeks sabbatical<BR>
after every 6 years, fully paid medical/dental/vision coverage, and company stock<BR>
purchase opportunities for full time employees.  Send your resume to Genentech, Inc.,<BR>
Human Resources, Job Code SEEO, 460 Pt. San Bruno Blvd., South San Francisco,<BR>
CA, 94080.  If possible, please avoid bold, underline, or italic type faces.  You<BR>
may also e-mail your resume with the job code to jobs@gene.com (ASCII files<BR>
only with a maximum line width of 76 characters).  Check out additional job<BR>
opportunities available at Genentech online at http://www.gene.com.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-198</DOCNO>
<DOCOLDNO>IA051-000870-B019-15</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a151.htm 199.92.136.137 19970111141956 text/html 2469
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:21:29 GMT
Last-modified: Wednesday, 18-Dec-96 19:18:18 GMT
Content-length: 2276
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regulatory Affairs Associate</H1></CENTER>
<HR>
A151, <BR>11/25/96
Regulatory Affairs Associate or Assistant, Computer Validation Compliance
<P>
Genentech is a pace-setting company, internationally known for discovering,<BR>
developing, manufacturing, and marketing human pharmaceuticals for significant<BR>
unmet medical needs.  Our product pipeline is the richest in the industry and we<BR>
are the only biotech company with five marketed products.
<P>
Job Summary:  Under the leadership/supervision of the manager, computer validation<BR>
compliance is responsible for helping assure implementation and maintenance of<BR>
computer validation projects and documentation in the pre-clinical and related areas<BR>
(Regulatory, MIDE, etc.) covered by GLP/GCP regulations.
<P>
Qualification:  Bachelor's degree in scientific, health care, or related field or<BR>
equivalent combination of education/experience.
<P>
2-5 years experience in biotechnology, pharmaceutical or other health care products<BR>
industry with knowledge/understanding of the use of computer systems to collect,<BR>
store/retrieve, analyze, manipulate, and present product development or production<BR>
information.
<P>
Basic understanding of FDA regulations/requirements (i.e. cGMPs, GLPs, GCPs)
<P>
Knowledge of QA/QC and auditing methods is desirable.
<P>
Join us and enjoy our exciting success and progressive benefit package that<BR>
includes free health club membership, 3 weeks paid vacation, 6 weeks sabbatical<BR>
after every 6 years, fully paid medical/dental/vision coverage, and company stock<BR>
purchase opportunities for full time employees.  Send your resume to Genentech, Inc.,<BR>
Human Resources, Job Code DLEO, 460 Pt. San Bruno Blvd., South San Francisco,<BR>
CA, 94080.  If possible, please avoid bold, underline, or italic type faces.  You<BR>
may also e-mail your resume with the job code to jobs@gene.com (ASCII files<BR>
only with a maximum line width of 76 characters).  Check out additional job<BR>
opportunities available at Genentech online at http://www.gene.com.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-199</DOCNO>
<DOCOLDNO>IA051-000870-B019-52</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a152.htm 199.92.136.137 19970111142011 text/html 979
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:21:50 GMT
Last-modified: Monday, 25-Nov-96 17:44:50 GMT
Content-length: 790
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Quality Assurance Auditor</H1></CENTER>
<HR>
A152, <BR>11/25/96
Quality Assurance Auditor - Irvine, CA
<P>
CoCensys, Inc., a progressive and innovative pharmaceutical company is currently<BR>
seeking a self-motivated, detail-oriented QA professional.  The successful<BR>
candidate will possess a minimum of 3 years related QA and 1-2 years of GCP<BR>
auditing experience.
<P>
For consideration, please send/fax resume with salary history/requirements to:<BR>
CoCensys, Inc.; Attn: Human Resources - DIA/QA; 213 Technology Drive; Irvine,<BR>
CA 92618; or fax to (714) 753-6135.  No phone calls, please.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-200</DOCNO>
<DOCOLDNO>IA051-000870-B019-99</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a153.htm 199.92.136.137 19970111142033 text/html 1979
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:22:10 GMT
Last-modified: Monday, 25-Nov-96 17:44:59 GMT
Content-length: 1789
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Affairs Liaison</H1></CENTER>
<HR>
A153, <BR>11/25/96
Medical Affairs Liaison (Oncology)
<P>
Company:  Major biopharmaceutical developing and producing therapeutics for<BR>
oncology, infectious diseases and critical care diseases.
<P>
Location:  Company is headquartered in Northern California.  Positions will be based<BR>
in the northeast, southeast, and midwest regions.
<P>
Function:  Responsible for establishing relationships with oncologists and other<BR>
clinical investigators to promote oncology products for use in clinical studies.<BR>
Manages clinical projects and reports on clinical activity in the field.  Provides<BR>
training to medical professionals, patients, and other personnel.  Provides in<BR>
depth scientific/clinical information on company products to health care professionals.
<P>
Requirements:  Bachelor's degree in a scientific or related area and three to five<BR>
years of clinical experience in oncology, i.e. oncology clinical trials.  Must have<BR>
excellent written and verbal communication skills.  An understanding of the needs<BR>
of health care professionals related to the field of oncology is also required.
<P>
Must be willing to do extensive traveling within the region.<BR>
Approximately 50% of the time.
<P>
Compensation and Benefits:  An excellent starting salary is offered plus bonuses and<BR>
stock options.  Comprehensive employee benefits will also be provided.
<P>
Contact:  Romeo-Hudgins & Assoc., Executive Recruiting, 200 Lake Drive East,<BR>
Suite 206, Cherry Hill, NJ 08002.  Phone:  609-486-0387; Fax: 609-486-0387.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-201</DOCNO>
<DOCOLDNO>IA051-000870-B019-121</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a154.htm 199.92.136.137 19970111142048 text/html 1565
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:22:26 GMT
Last-modified: Monday, 25-Nov-96 18:12:41 GMT
Content-length: 1375
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Head of Statistics & Data Management</H1></CENTER>
<HR>
A154, <BR>11/25/96
Head of Statistics & Data Management
<P>
A career development opportunity which will build on your data management,<BR>
statistics, and human relations skills.  You will join a pan-European R&D division<BR>
of a major multi-national pharmaceutical company.  With overall responsibility for<BR>
the co-ordination of all activities related to statistics and data management.
<P>
You will have<BR>
* first and possibly higher degree in maths, statistics, or computer science<BR>
* a min of 4 years' experience of stats/data management in the pharmaceutical industry<BR>
* an in-depth knowledge of, and experience in, CLINTRIAL/ORACLE and associated<BR>
programming language.
<P>
The position will be based in France.  If you are entitled to work in the EU, and would<BR>
like to develop your career internationally, please send your CV in a scannable format to<BR>
Roger Stephens/Anita McCarthy who are advising at Roger Stephens & Associates,<BR>
Chequers House, 1 Park Street, Old Hatfield, Hertfordshire, AL9 5AT, UK.<BR>
Tel. 00 44 (0) 1707 275361, Fax. 00 44 (0) 1707 271366, e-mail NDStephens@aol.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-202</DOCNO>
<DOCOLDNO>IA051-000870-B019-148</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a155.htm 199.92.136.137 19970111142057 text/html 1080
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:22:36 GMT
Last-modified: Monday, 25-Nov-96 19:30:32 GMT
Content-length: 891
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Director</H1></CENTER>
<HR>
A155, <BR>11/25/96
Associate Director/Director International Clinical Research
<P>
Major pharmaceutical company seeking an experienced clinical research generalist<BR>
with background in ethical to OTC switch and dealings with overseas operations.<BR>
Ability to handle CROs both within US and Europe important.  Excellent growth<BR>
opportunity with Fortune 50 international organization.
<P>
Please Contact:  Angelo G. Angeledes, MS, CPC, 609-584-8300<BR>
Fax 609-584-0187, AADE Associates, PO Box 2142, Princeton, NJ 08543<BR>
e-mail: agapharm@aol.com<BR>
Company Name: AADE Associates - Pharmaceutical Executive Recruiter<BR>
PO Box 2142, Princeton, NJ 08543
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-203</DOCNO>
<DOCOLDNO>IA051-000870-B019-176</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a156.htm 199.92.136.137 19970111142106 text/html 1016
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:22:45 GMT
Last-modified: Monday, 25-Nov-96 19:35:39 GMT
Content-length: 827
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Technical/Scientific Editor</H1></CENTER>
<HR>
A156, <BR>11/25/96
Senior Technical/Scientific Editor
<P>
Sr. Technical/Scientific Editor Bi-lingual (Sp, Gm, Fr) PharmD to manage the writing<BR>
and editing of content for a medical communications firm.  Programs range from<BR>
medical product monographs across a variety of mediums.  Must be able to work<BR>
in a team environment and interface with clients.  Every day is exciting, no selling<BR>
required.  Some domestic and international travel.<BR>
Excellent salary and benefits.  Contact Bill Cebak (Headhunter) @ Entelechy<BR>
Group Ltd., 410-840-0157 or fax c.v. 410-857-1267
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-204</DOCNO>
<DOCOLDNO>IA051-000870-B019-209</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a157.htm 199.92.136.137 19970111142117 text/html 1090
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:22:56 GMT
Last-modified: Monday, 25-Nov-96 19:43:03 GMT
Content-length: 901
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer</H1></CENTER>
<HR>
A157, <BR>11/25/96
Medical Writer
<P>
Masters prepared writer in life sciences familiar with medical education and medical<BR>
communications writing requirements.  Work in an exciting and high growth<BR>
firm with other degreed professional medical writers.  You will write presentations.<BR>
You will get to learn a variety of therapeutic areas and write for a variety of<BR>
mediums.  Prior experience would be helpful.  This company is very stable, a<BR>
fun place to work and offers an excellent salary and benefits package.<BR>
Contact Bill Cebak (Retained Headhunter) @ Entelechy Group Ltd.<BR>
410-840-0157 or fax c.v. at 410-857-1267 or send email to entelechia@aol.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-205</DOCNO>
<DOCOLDNO>IA051-000870-B019-247</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a158.htm 199.92.136.137 19970111142128 text/html 1628
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:23:09 GMT
Last-modified: Monday, 25-Nov-96 19:57:41 GMT
Content-length: 1438
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Patient Recruitment Specialist</H1></CENTER>
<HR>
A158, <BR>11/25/96
Patient Recruitment Specialist -- Gurnee, IL
<P>
Affiliated Research Centers, Inc. (ARC) -- an investigator owned, nationwide network of<BR>
clinical research sites -- is seeking a patient recruitment specialist.  You will work<BR>
with sponsors and clinical sites to facilitate recruitment/enrollment in clinical trials:<BR>
develop recruitment plans, materials and budgets, assist with media buys, public<BR>
relations activities, and site recruitment infrastructure development.  You will<BR>
coordinate multiple projects simultaneously.
<P>
Qualified candidates will possess a BA/BS in a communications and/or medical field;<BR>
two plus years of experience in patient recruitment at clinical research site.<BR>
Excellent oral and written communication, computer, organizational, and<BR>
multi-tasking skills; the ability to analyze and interpret data; good judgement<BR>
and interpersonal skills are required.
<P>
Please submit your resume to Kim Britt.  Executive Assistant, Affiliated Research<BR>
Centers, Inc., 1375 Tri-State Parkway, Suite 210; Gurnee, IL 60031; Fax<BR>
(847) 855-8787; E-mail kbritt@arc-centers.com.  Selected candidates will be<BR>
contacted.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-206</DOCNO>
<DOCOLDNO>IA051-000870-B020-4</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a159.htm 199.92.136.137 19970111142201 text/html 1833
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:23:22 GMT
Last-modified: Monday, 25-Nov-96 20:06:14 GMT
Content-length: 1643
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associates</H1></CENTER>
<HR>
A159, <BR>11/25/96
Clinical Research Associates
<P>
ICON Clinical Research, with divisions in the US, UK, Germany, Ireland, and Japan<BR>
has achieved worldwide recognition within the pharmaceutical industry for<BR>
providing international clinical research management services of exceptional<BR>
quality.  We currently have the following employment opportunity at our<BR>
Suburban Chicago location.
<P>
Applicants should possess a BS degree in the life sciences or nursing and at least<BR>
one year's experience of monioring pharmaceutical clinical trials.  Excellent<BR>
communication and organizational skills are essential.  Responsibilities will<BR>
primarily involve management of assigned investigational study sites including:<BR>
prestudy, initiation, in progress monitoring and study close out site visits.<BR>
Approximately 50% travel can be expected.  In line with ICON's philosophy<BR>
of providing the highest quality to our clients, CRAs are only assigned one<BR>
project at any one time.
<P>
ICON offers a competitive compensation package and the opportunity to advance<BR>
in a growing international organization.  Resume/CV, with salary requirements<BR>
and history in confidence to:
<P>
Human Resource Department, ICON Clinical Research, Inc.  190 W. Germantown<BR>
Pike, Suite 200, Norristown, PA 19401.<BR>
Please quote reference number 96-IL-DIA2<BR>
Fax:  610-239-8119
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-207</DOCNO>
<DOCOLDNO>IA051-000870-B020-39</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a160.htm 199.92.136.137 19970111142224 text/html 1542
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:24:01 GMT
Last-modified: Monday, 25-Nov-96 20:09:29 GMT
Content-length: 1352
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Assistants</H1></CENTER>
<HR>
A160, <BR>11/25/96
Clinical Research Assistants
<P>
ICON Clinical Research, with divisions in the US, UK, Germany, Ireland, and Japan<BR>
has achieved worldwide recognition within the pharmaceutical industry for<BR>
providing international clinical research management services of exceptional<BR>
quality.  We currently have the following employment opportunity at our<BR>
Suburban Chicago location.
<P>
Applicants should have a degree in the life sciences or nursing, an interest in<BR>
clinical research, meticulous attention to detail and a willingness to travel.  This<BR>
position is an entry level position that could lead to a clinical research associate<BR>
position.  Initially, any travel would be minimal.
<P>
ICON offers a competitive compensation package and the opportunity to advance<BR>
in a growing international organization.  Resume/CV, with salary requirements<BR>
and history in confidence to:
<P>
Human Resource Department, ICON Clinical Research, Inc.  190 W. Germantown<BR>
Pike, Suite 200, Norristown, PA 19401.<BR>
Please quote reference number 96-IL-DIA2<BR>
Fax:  610-239-8119
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-208</DOCNO>
<DOCOLDNO>IA051-000870-B020-62</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a161.htm 199.92.136.137 19970111142234 text/html 2558
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:24:15 GMT
Last-modified: Monday, 02-Dec-96 20:09:29 GMT
Content-length: 2368
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Med Dir Development</H1></CENTER>
<HR>
A161, <BR>12/2/96
Assoc Med Dir Development -- Amgen
<P>
Responsible for developing the strategic medical approaches to clinical development<BR>
of Amgen products, development of clinical research programs with the National<BR>
Cancer Institute, the National Oncology Cooperative Groups, Australian and Canadian<BR>
Australian Groups which do trials IND's other than Amgen's.  Provides for the direct<BR>
development, maintenance, and integration of information from the world wide safety<BR>
database for reportable adverse events occurring pre and post marketing with Amgen<BR>
products.  Supervises staff providing performance appraisals, hiring, and handling all<BR>
staff relations issues.  The knowledge and skills necessary to perform the duties of<BR>
this position are typical acquired through the following combination of education and<BR>
experience or the equivalent.  MD degree plus accredited residency in Internal Medicine<BR>
and accredited fellowship in relevant clinical specialty.  Typically 5 years related experience<BR>
in direct patient care practicing the specific subspecialty.  Excellent interpersonal and<BR>
communication skills (both = written and oral).  Ability to work in a team environment.<BR>
Previous supervisory or management experience in a clinical environment.  Experience<BR>
with medical/scientific writing and in the conduct of IND studies.
<P>
The Job Identification Number is IDIAT6789.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-209</DOCNO>
<DOCOLDNO>IA051-000870-B020-94</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a162.htm 199.92.136.137 19970111142250 text/html 2291
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:24:23 GMT
Last-modified: Monday, 02-Dec-96 20:31:38 GMT
Content-length: 2101
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Data Coordinator I/II</H1></CENTER>
<HR>
A162, <BR>12/2/96
Clin Data Coordinator I/II -- Amgen
<P>
This position is responsible for receiving, tracking, and processing clinical data from<BR>
receipt at Amgen through all data management processes.  Responsibilities<BR>
include processing of Case Report Forms, data entry and verification for international<BR>
studies, generate and resolve CRF queries, generate miscellaneous study reports,BR>
and resolve discrepancies.  Requirements include an Associates Degree in a<BR>
health-related or computer science field, with a Bachelor's Degree preferred, and<BR>
typically 0-3 years related experience.  The successful applicant will have good typing<BR>
skills, excellent attention to detail, strong communication skills (written and verbal),<BR>
good interpersonal skills, and good computer skills.  Preferred qualifications for<BR>
this position include familiarity with desktop publishing or forms design and knowledge<BR>
of clinical data entry, clinical data management and/or medical terminology.  Must have<BR>
the ability to handle multiple activities/priorities in a fast-paced and changing environment.
<P>
The Job Identification Number is IDIAB8673.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-210</DOCNO>
<DOCOLDNO>IA051-000870-B020-133</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a163.htm 199.92.136.137 19970111142302 text/html 1841
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:24:42 GMT
Last-modified: Monday, 02-Dec-96 20:55:21 GMT
Content-length: 1651
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Med Dir Development</H1></CENTER>
<HR>
A163, <BR>12/2/96
Assoc Med Dir Development -- Amgen
<P>
The responsibilities for this position include developing the strategic medical approaches<BR>
to clinical development of Amgen products.  A MD degree plus accredited residency in Internal<BR>
Medicine and accredited fellowship in relevant clinical specialty as well as typically 5<BR>
years related experience in direct patient care practicing the specific subspecialty is required.<BR>
The candidate should have excellent interpersonal and communicational skills (both<BR>
written and oral).  The ability to work in a team environment and previous supervisory or<BR>
management experience in a clinical environment.
<P>
The Job Identification Number is IDIAT6787.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-211</DOCNO>
<DOCOLDNO>IA051-000870-B020-168</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a164.htm 199.92.136.137 19970111142358 text/html 1676
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:25:21 GMT
Last-modified: Monday, 02-Dec-96 21:01:38 GMT
Content-length: 1486
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Mgr Clin Affairs/Mgr</H1></CENTER>
<HR>
A164, <BR>12/2/96
Assoc Mgr Clin Affairs/Mgr -- Amgen
<P>
The responsibilities for this position include the implementation and execution of<BR>
clinical programs encompassing a product discipline.  A MS, MPH, or Pharm. Degree<BR>
or equivalent is required as well as 7 years of related experience in life sciences, including<BR>
4 years of clinical development experience and previous supervisory/management<BR>
experience.  Travel is typically required 30% of the time worked and occasionally<BR>
up to 80%.
<P>
The Job Identification Number is IDIAT4033.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-212</DOCNO>
<DOCOLDNO>IA051-000870-B021-23</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a165.htm 199.92.136.137 19970111142450 text/html 1729
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:26:30 GMT
Last-modified: Monday, 02-Dec-96 21:08:12 GMT
Content-length: 1539
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Mgr Clin Affairs/Mgr</H1></CENTER>
<HR>
A165, <BR>12/2/96
Assoc Mgr Clin Affairs/Mgr -- Amgen
<P>
Develop, plement and execute clinical trials; supervise Clinical Research Associates;<BR>
participate in Clinical Study Management Teams; Develop final study reports<BR>
in collaboration with other team members.  MS, MPH, PharmD, PhD in Biological<BR>
Science (Pharmacology, Epidemiology or related fields) plus 4 years of clinical<BR>
development experience, including supervision experience with PLA/NDA preferred.<BR>
Microbiology, HIV and infectious disease experience or education is highly desired.
<P>
The Job Identification Number is IDIAT6881.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-213</DOCNO>
<DOCOLDNO>IA051-000870-B021-62</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a166.htm 199.92.136.137 19970111142508 text/html 3696
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:26:45 GMT
Last-modified: Monday, 02-Dec-96 21:48:40 GMT
Content-length: 3506
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Mgr Clin Affairs</H1></CENTER>
<HR>
A166, <BR>12/2/96
Assoc Mgr/Mgr Clin Affairs -- Amgen
<P>
This position requires implementation and execution of clinical studies encompassing<BR>
a product discipline as well as management of clinical studies and one or more Clinical<BR>
Research Associates, and travel is typically 50%, occasionally 80%.  The<BR>
responsibilities for this position include the following:  represents Clinical Affairs<BR>
on the Clinical Management Studies Team (CSMT) to evaluate strategies for clinical<BR>
development within a specified product; represents Clinical Affairs on other satellite<BR>
teams or task forces; interfaces with other Amgen organizations, such as Research<BR>
and Marketing as appropriate; supervises activities of clinical staff, including recruitment<BR>
and hiring of staff, conducting performance appraisals, and handling staff relations issues;<BR>
trains staff in the management and conduct of ongoing clinical studies and Amgen policies<BR>
and procedures; when required, seeks consultation for input to define parameters of the indication<BR>
under investigation; identifies, evaluates, and recruits clinical investigators and negotiates<BR>
grants and program budgets; conducts investigator and expert meetings relevant to the<BR>
applicable indication; resolves patient eligibility and protocol deviation issues; manages<BR>
protocol specific activities of outside contractors (independents, contract research<BR>
organizations, central laboratories, etc); coordinates interdepartmental activities specific<BR>
to implementation and conduct of protocols; participates in interim and final report preparation<BR>
for regulatory submission or other purposes; attends magor scientific meetings as well as<BR>
product and budget specific meetings.  The knowledge and skills necessary to perform<BR>
the duties of this position are typical acquired through the following combination of<BR>
education and experience or the equivalent.  Education/licenses required are MS, MPH,<BR>
or Pharm D.  Experience is typically seven years related experience in life sciences,<BR>
including four years of clinical development experience and previous supervisory/management<BR>
experience.  The preferred requirements are a doctoral level degree, with five years of<BR>
related experience in life sciences, including three years of clinical development experience,<BR>
and experience in independent preparation of clinical sections of IND, PLA, or NDA.<BR>
Knowledge of international regulatory requirements.
<P>
The Job Identification Number is IDIAT7194.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-214</DOCNO>
<DOCOLDNO>IA051-000870-B021-90</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a167.htm 199.92.136.137 19970111142517 text/html 1702
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:26:58 GMT
Last-modified: Tuesday, 03-Dec-96 18:07:18 GMT
Content-length: 1511
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Assoc Mgr/Mgr Clin Data</H1></CENTER>
<HR>
A167, <BR>12/3/96
Assoc Mgr/Mgr Clin Data -- Amgen
<P>
The minimum qualifications for this position are a BA or BS in the life sciences, computer<BR>
sciences, or nursing.  The applicant must have five years of clinical data management<BR>
experience including review of clinical trial data in the biotechnology or pharmaceutical<BR>
industry, and two years experience with clinical data management.  The applicant must also<BR>
have excellent interpersonal and communication skills, both written and verbal and be<BR>
computer literate.
<P>
The Job Identification Number is IDIA2201x.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-215</DOCNO>
<DOCOLDNO>IA051-000870-B021-123</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a168.htm 199.92.136.137 19970111142524 text/html 2033
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:27:05 GMT
Last-modified: Tuesday, 03-Dec-96 18:33:52 GMT
Content-length: 1842
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biostatistician II/Sr. Biostat</H1></CENTER>
<HR>
A168, <BR>12/3/96
Biostatistician II/Sr. Biostat -- Amgen
<P>
Conducts statistical analysis and prepares statistical reports for clinical trials, reviews<BR>
protocols and provides statistical guidance, prepares staitiscal analysis, plans<BR>
and analyzes data subsets.  Serves as a CSMT member, supports regulatory<BR>
filings, makes hiring recommendations and acts as a biostatitics team leader.<BR>
Creates and modifies programs to review or summarize data and provides input on<BR>
study designs.  Typical years of experience are 3-5+ years.  Excellent written and<BR>
oral communications skills, good organizational and planning skills.  Statistical<BR>
programming skills, basic knowledge of clinical research methodology and FDA<BR>
regulations.  Ability to accomplish tasks with limited supervision.  M.Sc or Ph.D<BR>
in Biostatics or related field.
<P>
The Job Identification Number is IDIAT7137.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-216</DOCNO>
<DOCOLDNO>IA051-000870-B021-161</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a169.htm 199.92.136.137 19970111142541 text/html 2161
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:27:15 GMT
Last-modified: Tuesday, 03-Dec-96 18:52:00 GMT
Content-length: 1970
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Data Assoc II/III</H1></CENTER>
<HR>
A169, <BR>12/3/96
Clin Data Assoc II/III -- Amgen
<P>
The responsibilities and experience required for this position are three to four years<BR>
experience in a related medical or research setting.  Familiarity with FDA regulations<BR>
pertaining to data quality and clinical trials conduct.  Experience performing whole-<BR>
patient data review with responsibility for clinical data deccisions, performing ad hoc<BR>
queries against a clinical trials database, database finalization for interim or final data<BR>
analysis, writing of clinical data management plans, including decision-making<BR>
responsibility for content, interactive experience with site personnel, and contract<BR>
research organizations and/or central laboratories.  Computer literate with personal<BR>
computers, computer databases, and performing database queries.  Education required<BR>
is a bachelor's degree or the equivalent combination of education and experience in a<BR>
biological science or computer science.
<P>
The Job Identification Number is IDIAT5485.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-217</DOCNO>
<DOCOLDNO>IA051-000870-B021-199</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a170.htm 199.92.136.137 19970111142554 text/html 2163
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:27:35 GMT
Last-modified: Tuesday, 03-Dec-96 19:02:50 GMT
Content-length: 1972
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Data Assoc II/III</H1></CENTER>
<HR>
A170, <BR>12/3/96
Clin Data Assoc II/III -- Amgen
<P>
The responsibilities and experience required for this position are three to four years<BR>
experience in a related medical or research setting.  Familiarity with FDA regulations<BR>
pertaining to data quality and clinical trials conduct.  Experience performing whole-<BR>
patient data review with responsibility for clinical data decisions, performing ad hoc<BR>
queries against a clinical trials database, database finalization for interim or final data<BR>
analysis, writing of clinical data management plans, including decision-making<BR>
responsibility for content, interactive experience with site personnel, and contract<BR>
research organizations and/or central laboratories.  Computer literate with personal<BR>
computers, computer databases, and performing database queries.  Education required<BR>
is a bachelor's degree or the equivalent combination of education and experience in a<BR>
biological science or in computer science.
<P>
The Job Identification Number is IDIAT5489.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-218</DOCNO>
<DOCOLDNO>IA051-000870-B021-256</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a171.htm 199.92.136.137 19970111142628 text/html 2089
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:27:54 GMT
Last-modified: Tuesday, 03-Dec-96 20:07:23 GMT
Content-length: 1898
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Data Assoc II/III</H1></CENTER>
<HR>
A171, <BR>12/3/96
Clin Data Assoc II/III -- Amgen
<P>
Typically requires three to four years experience in a related medical or research setting.<BR>
Familiarity with FDA regulations pertaining to data quality and clinical trials conduct.<BR>
Experience performing whole-patient data review with responsibility for clinical data decisions,<BR>
experience performing ad hoc queries against a clinical trials database, performing<BR>
database finalization for interim or final data analysis, authoring clinical data management<BR>
plans, including decision making responsibility for content; interactive experience<BR>
with site personnel, contract research organizations and/or central laboratories.<BR>
Experience with personal computers, computer databases and performing database<BR>
queries.  A bachelor's degree or the equivalent combination of education experience in a<BR>
biological science or in computer science.
<P>
The Job Identification Number is IDIAT7920.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-219</DOCNO>
<DOCOLDNO>IA051-000870-B021-308</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a172.htm 199.92.136.137 19970111142659 text/html 2473
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:28:35 GMT
Last-modified: Tuesday, 03-Dec-96 20:27:39 GMT
Content-length: 2282
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Ed & Training Advisor</H1></CENTER>
<HR>
A172, <BR>12/3/96
Clin Ed & Training Advisor -- Amgen
<P>
The responsibilities of this position are to design course content and presentation<BR>
materials for GCP education and training programs, deliver regular GCP education<BR>
and training programs to newly hired and experienced clinical affairs staff, provide<BR>
competency-based coaching and monitoring for newly hired CA managers and staff without<BR>
previous clinical experience, develop new and revised CA SOPs and clinical guidelines,<BR>
develop appropriate action plans for the elimination of common deficiencies found during<BR>
CQA audits, coordinate continuous improvement task forces within clinical affairs and assists<BR>
in the implementation of recommendations, coordinate the integration of HR training programs,<BR>
supervise the external vendor education and training resources and services, supervise<BR>
administrative functions, identify, recommend and implement new approaches and technologies<BR>
to support CA, contribute to the development and maintenance of CA departmental forms,<BR>
supervise the distribution and acknowledge receipt of CA SOPs and make presentations.<BR>
The requirements of this position are a bachelor's degree with 5-7 years of CRA and related<BR>
experience in the pharmaceutical industry.
<P>
The Job Identification Number is IDIAT4034.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-220</DOCNO>
<DOCOLDNO>IA051-000870-B021-344</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a173.htm 199.92.136.137 19970111142709 text/html 1993
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:28:50 GMT
Last-modified: Tuesday, 03-Dec-96 20:38:01 GMT
Content-length: 1802
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Logistics Spec</H1></CENTER>
<HR>
A173, <BR>12/3/96
Clin Logistics Spec -- Amgen
<P>
Responsibilities for this position will include coordination of domestic and/or international<BR>
clinical trial meterial process.  Maintenance of clinical inventory, work order generation and<BR>
interaction with CRPT's, CSMT's, ODT's, PDT's, study managers, and CRA's.  The typical<BR>
skills and experience required for this position are 2-5 years science based industry<BR>
preferrably biotech with clinical logistics experience.  Experience with clinical development<BR>
and associated processes.  Knowledge of or experence with GCP's and GMP's as well as<BR>
manufacturing QA.  Detail oriented with careful attention to procedure and quality.  Good<BR>
analytical/problem solving skills with excellent communication both orally and written.<BR>
BA/BS in science preferred.
<P>
The Job Identification Number is IDIAT6214.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-221</DOCNO>
<DOCOLDNO>IA051-000870-B022-28</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a174.htm 199.92.136.137 19970111142721 text/html 2487
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:29:00 GMT
Last-modified: Tuesday, 03-Dec-96 20:47:33 GMT
Content-length: 2296
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Research Assoc I/II</H1></CENTER>
<HR>
A174, <BR>12/3/96
Clin Research Assoc I/II -- Amgen
<P>
The responsibilities for this position include the following:  Coordinates activities in the<BR>
initiation and ongoing management of clinical studies.  Assists in the operations of clinical<BR>
trials from initiation to study close, assuring adherence to FDA requirements and Amgen<BR>
policies and procedures.  Travels to clinical sites to monitor, supervise, and coordinate clinical<BR>
studies.  Travel typically 50% and occasionally up to 80%.  The candidate should have familiarity<BR>
with research methodology and data abstraction.  Monitors and collects data generated in the<BR>
conduct of study and documents findings, including correcting incomplete or inaccurate data.<BR>
Classifies and tabulates data, assists in the development of case report forms (CRF's) and<BR>
other study documents and forms.  Maintains contact with clinical investigators and staff.<BR>
Encourages to participate in professional activities.  The experience required for this position<BR>
is typically 3 years of work experience in life sciences or a medically related field, including<BR>
one year of clinical development experience.  The education necessary for this position is<BR>
bachelors degree in biological sciences or a related field, or registered nurse (RN).
<P>
The Job Identification Number is IDIAT7195.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-222</DOCNO>
<DOCOLDNO>IA051-000870-B022-58</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a175.htm 199.92.136.137 19970111142732 text/html 2199
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:29:10 GMT
Last-modified: Wednesday, 04-Dec-96 15:43:02 GMT
Content-length: 2006
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Research Assoc II/III</H1></CENTER>
<HR>
A175, <BR>12/4/96
Clin Research Assoc II/III -- Amgen
<P>
The responsibilities for this position include to implement and execute clinical research<BR>
projects.  Develop off site budgets with guidance, write protocols, design case report forms<BR>
and study documentation.  Monitor and supervise trials; evaluate, tablate, and summarize<BR>
clinical data with guidance.  Ensure compliance with protocol, GCP and maintain contact with<BR>
clinical site, investigators, and staff.  Maintain expertise with professional activities, courses<BR>
and review of literature.  A bachelor's degree in biological sciences or a related field, or a registered<BR>
nurse or equivalent as well as typically 4 ears of related experience in life sciences, including<BR>
4 years of experience as a clinical research associate in industry, demonstrating application<BR>
of research methodology in a clinical setting is required.  The preferred candidate will have<BR>
previous experience neurological disorders and conditions and/or neurology.
<P>
The Job Identification Number is IDIAT6880.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-223</DOCNO>
<DOCOLDNO>IA051-000870-B022-101</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a176.htm 199.92.136.137 19970111142751 text/html 3175
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:29:22 GMT
Last-modified: Wednesday, 04-Dec-96 15:57:55 GMT
Content-length: 2982
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clin Research Assoc II/III</H1></CENTER>
<HR>
A176, <BR>12/4/96
Clin Research Assoc II/III -- Amgen
<P>
This position involves coordinating activities in the initiation and ongoing management<BR>
of Amgen's clinical trials.  The knowledge and skills necessary to perform the duties of<BR>
this position are typically acquired through the following combination of education and<BR>
experience or the equivalent: (CRA II) bachelor's degree in biological sciences or a related<BR>
field, or registered nurse (RN)/(CRA III) master's degree, Pharm D., or doctoral level<BR>
degree (CRA III).  Typically 4 years (CRA II)/6 years (CRA III) of related experience in<BR>
life sciences, includin 3 years (CRA II)/5 years (CRA III) of experience as a clinical research<BR>
associate in industry, demonstrating application of research methodology in a clinical setting.<BR>
Travel is required 50% of time worked and occasionally up to 80%.  Skills necessary for this<BR>
position include:  good organizational and planning skills; strong interpersonal skills;<BR>
ability to work effectively in a team/matrix environment; good communication skills<BR>
(both written and oral); ability to effectively document activities and communications; ability<BR>
to read and interpret written information; familiarity with research methodology and data<BR>
abstraction; computer operation skills; demonstrated ability to complete tasks under minimal<BR>
supervision; has independently visited sites for data collection, source verification, drug<BR>
accountability and maintenance of regulatory files; experience in monitoring of multiple sites;<BR>
good comprehension of FDA regulations and GCP guidelines.  Additional skills for CRA III<BR>
include:  experience in contributing to sections of study reports, PLA, NDA, Investigator's<BR>
Brochure or IND; experience with responding to findings of a CQA or regulatory site or<BR>
sponsor audit; demonstrated ability to lead small teams in clinical development process<BR>
(e.g. protocol or CRF working group).
<P>
The Job Identification Number is IDIAT9373.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-224</DOCNO>
<DOCOLDNO>IA051-000870-B022-143</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a177.htm 199.92.136.137 19970111142801 text/html 2474
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:29:41 GMT
Last-modified: Wednesday, 04-Dec-96 16:06:25 GMT
Content-length: 2281
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Compliance Educ Assoc II/Spec</H1></CENTER>
<HR>
A177, <BR>12/4/96
Compliance Educ Assoc II/Spec -- Amgen
<P>
Responsibilities for this position will be to instruct Amgen staff regarding their responsibilities<BR>
in a regulated environment.  This includes delivering compliance education courses,<BR>
and developing new compliance education courses.  This also includes notifying responsible<BR>
management regarding the training status of departmental staff members.  Provide<BR>
expert support for customers by explaining compliance education policies and practices,<BR>
develop contracts for the procurement of course material, revise existing compliance<BR>
education courses, manage assigned proects, oeprate compliance education databases,<BR>
and other functions that may be assigned.  The knowledge and skills necessary to perform<BR>
the duties of this position are typically acquired through the following combination of<BR>
education and experience or the equivalent.  BS/BA in education, social sciences, or<BR>
related field.  Typically 4+ years experience in GMP manufacturing, QA/QC, logistics,<BR>
facilities functions, systems, and regulatory affairs & product development functions.<BR>
Ability to explain drug and biologics laws and regulations, and Amgen SOPs and<BR>
GMP/GCP/GLP education or training experience a plus.
<P>
The Job Identification Number is IDIAT10019.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-225</DOCNO>
<DOCOLDNO>IA051-000870-B022-180</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a178.htm 199.92.136.137 19970111142812 text/html 1691
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:29:51 GMT
Last-modified: Wednesday, 04-Dec-96 16:58:43 GMT
Content-length: 1498
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Mgr Clin Data</H1></CENTER>
<HR>
A178, <BR>12/4/96
Mgr Clin Data -- Amgen
<P>
The minimum qualifications for this position are a BA or BS in the life sciences,<BR>
computer sciences, or nursing.  The applicant must have five years of clinical data<BR>
management experience including review of clinical trial data in the biotechnology or pharmaceutical<BR>
industry and two years must include experience with clinical data management.  The applicant must also have excellent interpersonal and communication skills, both<BR>
written and verbal and be computer literate.
<P>
The Job Identification Number is IDIAT8612.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-226</DOCNO>
<DOCOLDNO>IA051-000870-B022-226</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a179.htm 199.92.136.137 19970111142836 text/html 2672
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:30:07 GMT
Last-modified: Wednesday, 04-Dec-96 17:07:02 GMT
Content-length: 2479
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Mgr Intl Clin Logistics</H1></CENTER>
<HR>
A179, <BR>12/4/96
Mgr Intl Clin Logistics -- Amgen
<P>
This position is responsible for leading the interdepartmental activities required for the<BR>
definition, development, implementation, and continuous improvement of the international<BR>
clinical trial materials system.  The chosen candidate will manage the clinical supply and<BR>
logistics department's direct activities and assist other departments and selected contractors<BR>
to provide the required support to ensure that there is effective, timely forecasting of<BR>
bulk clinical trial materials; ordering labeling, packing and shipping of finished clinical trial<BR>
materials; internationally integrated inventory of finished clinical trial materials in all<BR>
warehouses and system for assigning and tracking drug utilization at drug sites;<BR>
sufficient inventory of finished clinical trial materials to supply ongoing and planned trials.<BR>
This position will assist the clinical affairs department to develop an internationally consistent<BR>
project, study patient and laboratory sample numbering system as well as clinical trial materials<BR>
pack and label numbering system.  This position is responsible for ensuring that there is an<BR>
efficient system for the ordering, preparation and shipping of non-drug clinical trial supplies.<BR>
This position requires a bachelor's degree in science and at least 5 years experience in<BR>
clinical trial materials and clinical research including 5 years management experience.
<P>
The Job Identification Number is IDIAT6796.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-227</DOCNO>
<DOCOLDNO>IA051-000870-B022-275</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a180.htm 199.92.136.137 19970111142911 text/html 3780
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:30:28 GMT
Last-modified: Wednesday, 04-Dec-96 17:25:50 GMT
Content-length: 3587
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Reg Affairs Spec I/II</H1></CENTER>
<HR>
A180, <BR>12/4/96
Reg Affairs Spec I/II -- Amgen
<P>
The responsibilities for this position are to assist the regulatory affairs department in the<BR>
execution of projects necessary to achieve corporate and departmental goals.  The duties<BR>
include the following:  assists in the drafting, editing, compilation, and internal approval of<BR>
regulatory filings (including routine correspondence, INDs, ELAs, PLAs, NDAs, other<BR>
applications and supplements/amendments thereto); participates in internal and external activities<BR>
to ensure the prompt provision to regulatory authorities of information regarding filings; assists<BR>
in interactions and negotiations with regulatory authorities regarding filings; advises corporate<BR>
personnel regarding regulatory strategy, potential areas of regulatory concern, and new<BR>
government/regulatory developments with direct input from regulatory affairs management;<BR>
serves as regulatory affairs representative on assigned domestic and international teams<BR>
(e.g. CRPT, PDT, CSMT, CT) and interacts with other departments, country offices, and<BR>
personnel from contract facilities and sales/marketing, safety, professional services activities to<BR>
ensure cGMP, CGCP, and CGLP compliance; reviews labeling, advertising, and promotional<BR>
materials; assesses the state of compliance with appropriate regulations and participates<BR>
in the development of actin plans to correct deficiencies as a member of the compliance team;<BR>
interacts with contract organizations in the preparation of regulatory submissions; performs<BR>
tasks as assigned; assists in the timely completion of activities associated with the attainment of<BR>
group, departmental, and corporate goals. The knowledge and skills necessary to perform the<BR>
duties of this potion are typically acquired through the following combination of education and<BR>
experience or the equivalent.  A bachelor's degree is required with typically four years related<BR>
experience as a regulatory affairs associate/specialist (or the equivalent) or in the manufacture<BR>
and testing (QA/QC or clinical) of biological/pharmaceutical produects or medical devices.<BR>
Must have good communication skills.  Basic knowledge of US regulations and practices<BR>
pertaining to the manufacture and testing of pharmaceutical/biological products or medical<BR>
devices is required.  The preferred requirements include a bachelor's degree in life sciences,<BR>
with experience in the regulation of biological products and basic knowledge of foreign<BR>
biologic or drug regulation.
<P>
The Job Identification Number is IDIAT6632.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-228</DOCNO>
<DOCOLDNO>IA051-000870-B022-318</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a181.htm 199.92.136.137 19970111142920 text/html 2441
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:31:01 GMT
Last-modified: Wednesday, 04-Dec-96 18:21:04 GMT
Content-length: 2248
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Validation Assoc III/Vld Spc I</H1></CENTER>
<HR>
A181, <BR>12/4/96
Validation Assoc III/Vld Spc -- Amgen
<P>
Perform the validation duties and responsibilities in support of Amgen's corporate validation<BR>
programs.  Develop, support and maintain corporate validation programs to be carried out<BR>
by all Amgen manufacturing and manufacturing support sites through the development of<BR>
corporate validation procedures, including procedures for filter validation and transport<BR>
validation.  Make proposals for new approaches to validation.  Develop, implement and<BR>
support approved proposals.  Provide training on new approaches.  Provide training to all<BR>
Amgen personnel, including personnel at other Amgen sites, for validation programs, strategies,<BR>
policies and procedures.  Typically 5 or more years of related validation experience in the<BR>
pharmaceutical industry, computer literate, proficient on word processing/spreadsheet software.<BR>
Knowledge of cGMP's, CFR's, pharmaceutical equipment/processing, statistical process control<BR>
and aseptic technique.  Experience in technical writing skills.  Knowledge of microbial<BR>
fermentation cell culture, purification, formulation, fill/finish and packaging<BR> processes/procedures, group presentation skills.  Travel required 20-30%.
<P>
The Job Identification Number is IDIAT4465.
<P>
If you feel you meet the qualifications for this position, we encourage you to e-mail your<BR>
resume to jobs@amgen.com (please be sure to have only the word resume in the subject<BR>
field) or to send your resume to Amgen, P.O.Box 2569, Thousand Oaks, CA 91319-2569.<BR>
We encourage you to indicate the job code identification number by placing it on the bottom<BR>
right hand corner of your resume.  Once your resume is received at Amgen, we will send<BR>
you a response card confirming that we have recceived your resume.  Amgen reserves the<BR>
right to fill vacancies at its discretion: therefore, we cannot ensure that a given position will<BR>
be available when you apply.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-229</DOCNO>
<DOCOLDNO>IA051-000870-B023-17</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a182.htm 199.92.136.137 19970111142932 text/html 2141
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:31:12 GMT
Last-modified: Wednesday, 04-Dec-96 20:08:02 GMT
Content-length: 1948
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Information Coordinator</H1></CENTER>
<HR>
A182, <BR>12/4/96
Medical Information Coordinator
<P>
Genentech is a pace-setting biotechnology company that discovers, manufactures, and<BR>
markets human pharmaceuticals for significant unmet medical needs.  Our product<BR>
pipeline is the richest in the industry and we are the only biotech company with six marketed<BR>
products.  To continue our record of success, we are seeking talented Medical information<BR>
Coordinators to join our Medical Affairs Team.
<P>
As a Medical Information Coordinator you will be the primary resource for Genentech product<BR>
information.  Using your clinical pharmacy or pharmacotherapy background, you will<BR>
conscientiously and efficiently provide timely product information.  Applying your broad<BR>
understanding of Genentech products, you will identify the nature of an inquiry and present an<BR>
accurate response that will educate the requester, either verbally or in writing, adjusting<BR>
the level of detail and complexity to the audience.  You will also utilize your product<BR>
knowledge to provide in-depth education and support to the internal staff.  Your breadth<BR>
and depth of product knowledge will allow you to manage our large response library based<BR>
on an understanding of the medical literature.
<P>
To qualify for our opportunity, you must have an MS or PharmD with 3 to 5 years clinical<BR>
pharmacy experience and a thorough grounding in clinical pharmacy and pharmacotherapy.<BR>
You must also be familiar with drug information concepts and literature evaluation, acute<BR>
care experience desirable.  We seek candidates with general therapeutic experience or<BR>
focused experience in cardiology or oncology therapeutics.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-230</DOCNO>
<DOCOLDNO>IA051-000870-B023-53</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a183.htm 199.92.136.137 19970111142949 text/html 1257
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:31:28 GMT
Last-modified: Wednesday, 04-Dec-96 20:15:22 GMT
Content-length: 1064
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Director/Director International Clinical Research</H1></CENTER>
<HR>
A183, <BR>12/4/96
Associate Director/Director International Clinical Research
<P>
Major pharmaceutical company seeks an experienced clinical research generalist with<BR>
background in ethical to OTC switch and dealings with overseas operations.  Ability<BR>
to handle CROs both within US and Europe important.  Excellent growth opportunity with<BR>
Fortune 50 international organization.  MD with background in IM, GP or Ped and<BR>
international research experience preferred.  Fluency in a foreign language desirable.
<P>
Please contact:  Angelo G. Angeledes, MS, CPC, 609-584-8300<BR>
Fax 609-584-0187, AADE Associates, PO Box 2142, Princeton, NJ 08543<BR>
e-mail: agapharm@aol.com<BR>
Company name:  AADE Associates -- Pharmaceutical Executive Recruiter<BR>
PO Box 2142 Princeton, NJ 08543
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-231</DOCNO>
<DOCOLDNO>IA051-000870-B023-78</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a184.htm 199.92.136.137 19970111142958 text/html 2408
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:31:39 GMT
Last-modified: Wednesday, 04-Dec-96 20:40:45 GMT
Content-length: 2215
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Adverse Experience Reporting</H1></CENTER>
<HR>
A184, <BR>12/4/96
Manager, Adverse Experience Reporting
<P>
A major and well-respected pharmaceutical firm is expanding their Adverse Experience<BR>
Reporting organization in support of its worldwide clinical trials, premarketing<BR>
(IND regulations) and post marketing (NDA regulation).  Located in a pleasant suburban<BR>
research campus in West Point, PA, the selected individual will combine pharmaceutical<BR>
regulatory experience, supervisory skills, and strong administrative capabilities.
<P>
As part of the Worldwide Product Safety & Epidemiology activity this function is the<BR>
central safety repository for pre and post marketing product adverse reporting as well as US<BR>
regulatory reporting.  Frequent professional interface with clinical trial teams, marketing,<BR>
and legal staffs and Medical Director/staff at non US subsidiaries.  Will supervise a staff of<BR>
Coodinators (6-10) in the receipt, preparation and review of adverse experience reports and<BR>
the submission of these reports to FDA.  Also, oversees the distribution of reports to non-US<BR>
subsidiaries to insure compliance with local regulatory reporting requirement as well as<BR>
internal domestic distribution.
<P>
Must have five plus years experience in postmarketing safety surveillance and good<BR>
understanding of FDA regulatory reporting; evidence of well developed leadership and<BR>
supervisory skills; strong interpersonal skills and the ability to function in a team oriented<BR>
environment; an innovative and creative perspective and the desire to participate in the<BR>
administrative activities of the development of administrative procedures that enhance efficiency<BR>
and accuracy; excellent communication skills.  Degreed, relocation, competitive compensation<BR>
with excellent benefit package.
<P>
CONTACT:<BR>
Pamela Siedlecki<BR>
FCI, Inc.<BR>
621 Shewsbury, NJ 07702<BR>
908/576-8522<BR>
908/576-8098-Fax<BR>
fci.jobs@ix.netcom.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-232</DOCNO>
<DOCOLDNO>IA051-000870-B023-112</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a185.htm 199.92.136.137 19970111143010 text/html 879
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:31:49 GMT
Last-modified: Wednesday, 04-Dec-96 20:46:11 GMT
Content-length: 687
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical SAS Programmer/Analyst</H1></CENTER>
<HR>
A185, <BR>12/4/96
Clinical SAS Programmer/Analyst
<P>
Supporting biostatisticians with base SAS programming macros, SAS STAT.  Good<BR>
communication and written skills along with a knowledge of how to manipulate<BR>
clinical trial data are needed for the project.  Contact:  Jason Boledovich,<BR>
Trinity Consulting Corporation, 3600 West Bayshore Rd. Suite 100, Palo Alto,<BR>
CA 94303.  800-515-3502, Fax 415-494-3501, jboledovich@trilogycnslt.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-233</DOCNO>
<DOCOLDNO>IA051-000870-B023-144</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a186.htm 199.92.136.137 19970111143020 text/html 1335
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:32:00 GMT
Last-modified: Friday, 20-Dec-96 15:50:21 GMT
Content-length: 1145
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Data Coordinator</H1></CENTER>
<HR>
A186, <BR>12/20/96
Clinical Data Coordinator -- SEQUUS Pharmaceuticals
<P>
This position is responsible for the coordination of all aspects of clinical research data<BR>
management leading to a verified study database, including the design, development,<BR>
testing, documentation, and maintenance of clinical data management collection and<BR>
reporting systems.  Qualifications:  A BA/BS degree in a scientific or health science,<BR>
statistics, computer programming, or biology preferred.  Experience:  1-6 years in database<BR>
management, programming and/or clinical research; preferrably in the pharmaceutical<BR>
or health care industry.  Knowledge of database design (Oracle/Clintrial) and structure,<BR>
programming, and medical terminology necessary.
<P>
Attention: Dept. CDCDIA 1296.54<BR>
SEQUUS Pharmaceuticals, Inc.<BR>
960 Hamilton Court<BR>
Menlo Park, CA 94025
<P>
Fax:  415-324-3928<BR>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-234</DOCNO>
<DOCOLDNO>IA051-000870-B023-176</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a187.htm 199.92.136.137 19970111143043 text/html 2244
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:32:21 GMT
Last-modified: Friday, 20-Dec-96 16:13:45 GMT
Content-length: 2054
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associate</H1></CENTER>
<HR>
A187, <BR>12/20/96
Clinical Research Associate -- ICOS Corporation
<P>
We are seeking a Clinical Research Associate (CRA) for our Clinical Affairs Department.<BR>
This CRA position requires at least 3 years experience in managing and/or monitoring<BR>
drug clinical.  Experience as a liaison with clinical sites, contract research data<BR>
management groups necessary.
<P>
Minimum qualifications include: BS or higher in Biology, or Health Science.  The successful<BR>
candidate will have a demonstrated ability to function productively in a team setting.<BR>
Strong verbal and written skills and attention to detail are essential.  This position requires<BR>
the ability to travel frequently.
<P>
Job Ref: YU0796C
<P>
Located in the Pacific Northwest, ICOS Corporation is discovering and developing new<BR>
pharmaceuticals by seeking points of intervention in the inflammatory process that may lead<BR>
to more specific and efficacious drugs.  The Company's research and drug development<BR>
programs involve both acute and chronic conditions such as ARDS, cardiovascular disease,<BR>
hemorrhagic shock, ischemic stroke, male erectile disorder, and multiple sclerosis.
<P>
ICOS considers its people the company's most important asset.  We emphasize a<BR>
focused team approach in discovery and development that encourages creativity and innovation.<BR>
We offer a comprehensive salary and benefits package that includes both short and long<BR>
term incentives.
<P>
Qualified candidates are encouraged to submit their CV, referencing the job number to:
<P>
Human Resources<BR>
ICOS Corporation<BR>
22021 - 20th Avenue SE<BR>
Bothell, WA 98021
<P>
Or, e-mail your CV (including job number) to: hr@icos.com<BR>
You may also learn about current openings by calling our jobs line at: (206) 485-1900
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-235</DOCNO>
<DOCOLDNO>IA051-000870-B023-206</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a188.htm 199.92.136.137 19970111143056 text/html 2448
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:32:35 GMT
Last-modified: Friday, 20-Dec-96 16:23:58 GMT
Content-length: 2258
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Database Administrator</H1></CENTER>
<HR>
A188, <BR>12/20/96
Clinical Database Administrator -- ICOS Corporation
<P>
We are seeking a Clinical Database Administrator for our Clinical Affairs Department.<BR>
The individual will oversee the data management function for clinical trials.<BR>
Responsibilities include:  database construction, data entry, data verification, systems<BR>
administration, import/export of clinical database, adverse event encoding into the database,<BR>
software validation, and the implementation of SOPs.
<P>
Minimum qualifications include:  BS degree, (Masters Degree preferrable) in addition to<BR>
2-5 years experience in clinical data management.  The successful candidate will have<BR>
familiarity with ORACLE and BBN/Clintrial software.  Personal attributes include:  good<BR>
organizations skills, strong interpersonal skills, as well as the ability to perform in a<BR>
detail-oriented environment.
<P>
Job Ref: YU01096
<P>
Located in the Pacific Northwest, ICOS Corporation is discovering and developing new<BR>
pharmaceuticals by seeking points of intervention in the inflammatory process that may lead<BR>
to more specific and efficacious drugs.  The Company's research and drug development<BR>
programs involve both acute and chronic conditions such as ARDS, cardiovascular disease,<BR>
hemorrhagic shock, ischemic stroke, male erectile disorder, and multiple sclerosis.
<P>
ICOS considers its people the company's most important asset.  We emphasize a<BR>
focused team approach in discovery and development that encourages creativity and innovation.<BR>
We offer a comprehensive salary and benefits package that includes both short and long<BR>
term incentives.
<P>
Qualified candidates are encouraged to submit their CV, referencing the job number to:
<P>
Human Resources<BR>
ICOS Corporation<BR>
22021 - 20th Avenue SE<BR>
Bothell, WA 98021
<P>
Or, e-mail your CV (including job number) to: hr@icos.com<BR>
You may also learn about current openings by calling our jobs line at: (206) 485-1900
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-236</DOCNO>
<DOCOLDNO>IA051-000870-B023-247</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a189.htm 199.92.136.137 19970111143118 text/html 2603
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:32:54 GMT
Last-modified: Friday, 20-Dec-96 16:30:33 GMT
Content-length: 2413
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Regulatory Affairs</H1></CENTER>
<HR>
A189, <BR>12/20/96
Manager, Regulatory Affairs -- ICOS Corporation
<P>
We are seeking a Manager to join our Regulatory Affairs team.  The successful candidate<BR>
will have primary responsibility for:  preparing submissions (INDs, ELAs, PLAs, NDAs, annual<BR>
reports and supplements), participating in the development and implementation of ICOS<BR>
regulatory policy, advising individuals regarding strategy and governmental developments, and<BR>
serving as a representative to assigned product development team(s).  Responsibilities<BR>
also include managing domestic activities in support of international submissions.  A proven<BR>
ability to problem solve using scientific methodology for regulatory issues is a plus.
<P>
Minimum qualifications include:  BS or MS in scientific discipline and 3 years prior regulatory<BR>
experience, preferrably with biological products.  Candidates must possess strong interpersonal<BR>
skills, excellent oral and written communications skills, and have a strong desire to work<BR>
within a team environment.
<P>
Job Ref:  CZA0196
<P>
Located in the Pacific Northwest, ICOS Corporation is discovering and developing new<BR>
pharmaceuticals by seeking points of intervention in the inflammatory process that may lead<BR>
to more specific and efficacious drugs.  The Company's research and drug development<BR>
programs involve both acute and chronic conditions such as ARDS, cardiovascular disease,<BR>
hemorrhagic shock, ischemic stroke, male erectile disorder, and multiple sclerosis.
<P>
ICOS considers its people the company's most important asset.  We emphasize a<BR>
focused team approach in discovery and development that encourages creativity and innovation.<BR>
We offer a comprehensive salary and benefits package that includes both short and long<BR>
term incentives.
<P>
Qualified candidates are encouraged to submit their CV, referencing the job number to:
<P>
Human Resources<BR>
ICOS Corporation<BR>
22021 - 20th Avenue SE<BR>
Bothell, WA 98021
<P>
Or, e-mail your CV (including job number) to: hr@icos.com<BR>
You may also learn about current openings by calling our jobs line at: (206) 485-1900
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-237</DOCNO>
<DOCOLDNO>IA051-000870-B023-282</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a190.htm 199.92.136.137 19970111143151 text/html 1509
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:33:29 GMT
Last-modified: Friday, 20-Dec-96 16:46:55 GMT
Content-length: 1319
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director, Clinical Research</H1></CENTER>
<HR>
A190, <BR>12/20/96
Director, Clinical Research (Vaccine Development) -- Romeo-Hudgings Associates
<P>
Reports to:  Vice President of Clinical Research<BR>
Location:  Northern CA<BR>
Salary:  $130K range + bonus + stock options
<P>
Function:  Will be responsible for planning, directing, and implementing clinical research<BR>
strategies for assigned vaccine candidates for clinical trials.
<P>
Requirements:  MD degree with completion of an approved residency such as internal medicine<BR>
or pediatrics, resulting in board certification.  Subspeciality training in infectious diseases or<BR>
immunology is highly desirable.  Must have several years of clinical research experience<BR>
with adult or pediatric vaccines in the medical or pharmaceutical industry, i.e. Phase 1-4<BR>
clinical trials.  Must have management experience in directing other physicians and clinical<BR>
research personnel.
<P>
Contact:  Paul Romeo, Romeo-Hudgins Assoc., Exec. Search Consultants, 200 Lake Drive<BR>
East, Suite 206, Cherry Hill, NJ 08002<BR>
Phone:  609-482-7840; Fax:  609-486-0387
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-238</DOCNO>
<DOCOLDNO>IA051-000870-B023-317</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a191.htm 199.92.136.137 19970111143210 text/html 1190
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:33:49 GMT
Last-modified: Friday, 20-Dec-96 17:16:07 GMT
Content-length: 1000
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associates</H1></CENTER>
<HR>
A191, <BR>12/20/96
Clinical Research Associates to 67K  -- ReSearch Incorporated
<P>
<CENTER>Clinical Research Associate Opportunities</CENTER>
<P>
<CENTER>Over 90 current positions</CENTER>
<CENTER>Jr. and Sr. Level</CENTER>
<CENTER>In House and Regional</CENTER>
<CENTER>All geographic areas</CENTER>
<P>
We have the most extensive database of current opportunities than most search firms in North<BR>
America so you can count on ReSearch Inc. to confidentially present you with the best possible<BR>
opportunities available.<BR>
Send an updated CV to:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-239</DOCNO>
<DOCOLDNO>IA051-000870-B023-351</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a192.htm 199.92.136.137 19970111143227 text/html 1195
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:34:06 GMT
Last-modified: Friday, 20-Dec-96 17:41:50 GMT
Content-length: 1005
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Director</H1></CENTER>
<HR>
A192, <BR>12/20/96
Associate Director, Medical Devices, Regulatory Affairs -- Phoenix International
<P>
Responsible for management of projects in the area of medical devices (Investigational<BR>
Device Exemptions, Device Listings, 510(K) submissions, Medical Device Establishment<BR>
Registrations, labelling, etc.).  Supervision of Associates, interaction with clients and FDA/HPB.<BR>
Extensive experience in Regulatory Affairs at Senior Associate or management level.<BR>
Excellent English for communication with US clients and the FDA.
<P>
Please submit your CV by mail or fax to:  Employee Recruiting, Phoenix International,<BR>
2350 Cohen Street, Montreal, Quebec H4R 2N6.<BR>
Fax: (514) 335-8340.  Only selected candidates will be contacted.  No telephone calls, please.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-240</DOCNO>
<DOCOLDNO>IA051-000870-B023-396</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a193.htm 199.92.136.137 19970111143258 text/html 1029
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:34:35 GMT
Last-modified: Friday, 20-Dec-96 19:11:46 GMT
Content-length: 840
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Associate</H1></CENTER>
<HR>
A193, <BR>12/20/96
Senior Associate, Medical Devices, Regulatory Affairs -- Phoenix International
<P>
Responsible for preparation of projects in the area of Medical Devices.  Will report to the<BR>
Associate Director.  Experience in the field of Regulatory Affairs, specifically Medical Devices<BR>
is essential.  Excellent English for communication with US clients and the FDA.
<P>
Please submit your CV by mail or fax to:  Employee Recruiting, Phoenix International,<BR>
2350 Cohen Street, Montreal, Quebec H4R 2N6.<BR>
Fax: (514) 335-8340.  Only selected candidates will be contacted.  No telephone calls, please.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-241</DOCNO>
<DOCOLDNO>IA051-000870-B024-31</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a194.htm 199.92.136.137 19970111143319 text/html 1123
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:34:59 GMT
Last-modified: Friday, 20-Dec-96 19:16:58 GMT
Content-length: 934
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Associate</H1></CENTER>
<HR>
A194, <BR>12/20/96
Senior Associate, Drugs & Biologics, Regulatory Affairs -- Phoenix International
<P>
Responsible for the preparation of submissions for new chemical entities and generic drugs,<BR>
supplementary filings, Product Master Files, Drug Master Files, Investigator's Brochure,<BR>
Product Monographs, and Package Inserts, Conversion of European submissions to<BR>
HPB/FDA format.  Extensive experience in Regulatory Affairs and excellent English are required.
<P>
Please submit your CV by mail or fax to:  Employee Recruiting, Phoenix International,<BR>
2350 Cohen Street, Montreal, Quebec H4R 2N6.<BR>
Fax: (514) 335-8340.  Only selected candidates will be contacted.  No telephone calls, please.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-242</DOCNO>
<DOCOLDNO>IA051-000870-B024-69</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a195.htm 199.92.136.137 19970111143357 text/html 1968
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:35:22 GMT
Last-modified: Friday, 20-Dec-96 20:51:55 GMT
Content-length: 1778
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Safety Monitor</H1></CENTER>
<HR>
A195, <BR>12/20/96
Safety Monitor -- ICON Clinical Research
<P>
ICON Clinical Research, with divisions in the US, UK, Germany, Ireland, and Japan<BR>
has achieved worldwide recognition within the pharmaceutical industry for providing<BR>
international clinical research management services of exceptional quality.<BR>
We currently have the following employment opportunity in our <B>Chicago and Nashville</B><BR>
locations: (both offices are located in suburban areas.)
<P>
The successful candidate should possess a BS degree in nursing and have sound clinical<BR>
knowledge.  Strong computer skills as well as excellent communication and organizational<BR>
skills are essential.  Experience in phase III clinical drug trials would be an advantage.<BR>
Responsibilities will include liasing with clinical investigational sites on safety issues,<BR>
documenting adverse events and reporting of events to pharmaceutical sponsor/FDA,<BR>
maintenance of adverse event database and safety review of patient clinical data including<BR>
safety laboratory reports.  Appropriate training will be provided.
<P>
ICON offers a competitive compensation package and the opportunity to advance in a growing<BR>
international organization.  Applicants should send their resume/CV, with salary requirements/<BR>
history and <B>desired location</B> in confidence to:
<P>
Human Resource Department<BR>
ICON Clinical Research, Inc.<BR>
190 West Germantown Pike, Suite 200<BR>
Norristown, PA 19401<BR>
Refer to reference number 96-DIA-SM1<BR>
Fax: 610-239-8119
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-243</DOCNO>
<DOCOLDNO>IA051-000870-B024-108</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a196.htm 199.92.136.137 19970111143410 text/html 2054
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:35:51 GMT
Last-modified: Friday, 20-Dec-96 21:02:21 GMT
Content-length: 1864
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associates</H1></CENTER>
<HR>
A196, <BR>12/20/96
Clinical Research Associates -- ICON Clinical Research
<P>
ICON Clinical Research, with divisions in the US, UK, Germany, Ireland, and Japan<BR>
has achieved worldwide recognition within the pharmaceutical industry for providing<BR>
international clinical research management services of exceptional quality.<BR>
We currently have the following employment opportunity in our <B>Chicago, Nashville,<BR>
Philadelphia, and San Francisco</B> locations: (all offices are located in suburban areas.)
<P>
Applicants should possess a BS degree in the life sciences or nursing and have at least one<BR>
year's experience of monitoring pharmaceutical clinical trials.  Excellent communication<BR>
and organizational skills are essential.  Responsibilities will primarily involve management<BR>
of assigned investigational study sites including:  prestudy, study initiation, in progress<BR>
monitoring and study close out site visits.  Approximately 50% travel can be expected.<BR>
In line with ICON's philosophy of providing the highest quality to our clients, CRAs are<BR>
only assigned to one project at any one time.  (ICON does not employ regional CRAs.)
<P>
ICON offers a competitive compensation package and the opportunity to advance in a growing<BR>
international organization.  Applicants should send their resume/CV, with salary requirements/<BR>
history and <B>desired location</B> in confidence to:
<P>
Human Resource Department<BR>
ICON Clinical Research, Inc.<BR>
190 West Germantown Pike, Suite 200<BR>
Norristown, PA 19401<BR>
Refer to reference number 96-DIA-CRA3<BR>
Fax: 610-239-8119
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-244</DOCNO>
<DOCOLDNO>IA051-000870-B024-143</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a197.htm 199.92.136.137 19970111143428 text/html 1713
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:36:07 GMT
Last-modified: Friday, 20-Dec-96 21:01:56 GMT
Content-length: 1523
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Assistants</H1></CENTER>
<HR>
A197, <BR>12/20/96
Clinical Research Assistants -- ICON Clinical Research
<P>
ICON Clinical Research, with divisions in the US, UK, Germany, Ireland, and Japan<BR>
has achieved worldwide recognition within the pharmaceutical industry for providing<BR>
international clinical research management services of exceptional quality.<BR>
We currently have the following employment opportunity in our <B>Chicago, Nashville,<BR>
Philadelphia, and San Francisco</B> locations: (all offices are located in suburban areas.)
<P>
Applicants should have a degree in the life sciences or nursing, an interest in clinical research,<BR>
meticulous attention to detail and a willingness to travel.  This position is an entry level<BR>
position that could lead to a Clinical Research Associate position.  Initially, any travel<BR>
would be minimal.
<P>
ICON offers a competitive compensation package and the opportunity to advance in a growing<BR>
international organization.  Applicants should send their resume/CV, with salary requirements/<BR>
history and <B>desired location</B> in confidence to:
<P>
Human Resource Department<BR>
ICON Clinical Research, Inc.<BR>
190 West Germantown Pike, Suite 200<BR>
Norristown, PA 19401<BR>
Refer to reference number 96-DIA-CRA3<BR>
Fax: 610-239-8119
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-245</DOCNO>
<DOCOLDNO>IA051-000870-B024-181</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a198.htm 199.92.136.137 19970111143437 text/html 637
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:36:18 GMT
Last-modified: Friday, 20-Dec-96 21:30:07 GMT
Content-length: 448
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Job Opportunities</H1></CENTER>
<HR>
A198, <BR>12/20/96
Job Opportunities -- Aerotek
<P>
ALS is looking for:
<P>
* Data Managers<BR>
* Oracle Experience<BR>
* Experience with CRPs<BR>
* Adverse events<BR>
* 6 month positions
<P>
Call (800) 916-6210 Ext. 2553
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-246</DOCNO>
<DOCOLDNO>IA051-000870-B024-221</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a199.htm 199.92.136.137 19970111143448 text/html 1610
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:36:26 GMT
Last-modified: Friday, 20-Dec-96 21:41:59 GMT
Content-length: 1420
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Clinical Data Management</H1></CENTER>
<HR>
A199, <BR>12/20/96
Manager, Clinical Data Management -- Otsuka America Pharmaceutical, Inc.
<P>
Responsibilities include management and supervision of Data Management Group;<BR>
includes hiring, training, management, and evaluation of Data Entry Specialists and<BR>
Data Management Associates; manage multi-center international phase I-III clinical<BR>
trials in multiple drug development programs; develop clinical data management plans;<BR>
provide leadership in assessing new technologies and improvement of existing processes;<BR>
oversee as well as do the day-to-day processing, review and clean-up of study data.
<P>
You will be in a position to make significant contributions to the growth and success of this office.
<P>
Minimum requirements:<BR>
BA or BS<BR>
At least 5 years of data management experience<BR>
Experience with SAS as a data management tool highly desirable<BR>
Supervisory/management experience desirable
<P>
Full benefis and relocation provided.
<P>
Please contact Anna Shadman, Director of Biostatistics and Data Management<BR>
1290 Page Mill Road, Suite 200<BR>
Palo Alto, CA 94304<BR>
(415) 843-6524<BR>
Email: ashadman@otsuka.oapi.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-247</DOCNO>
<DOCOLDNO>IA051-000870-B024-256</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a200.htm 199.92.136.137 19970111143457 text/html 859
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:36:37 GMT
Last-modified: Friday, 20-Dec-96 21:48:00 GMT
Content-length: 670
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>CRAs/Data Managers</H1></CENTER>
<HR>
A200, <BR>12/20/96
CRAs/Data Managers -- Aerotek
<P>
Aerotek Lab Support of Rockville, Maryland has 4-6 openings for Clinical Data/Research<BR>
Associates.  We are looking for individuals with at least 2 years of experience doing<BR>
CRF reviews, AE forms, and data cleaning/reviews in a pharmaceutical setting.<BR>
This is a contract position in Rockville, looking to begin at the beginning of 1997.<BR>
Please call Ryan at (800) 916-6210 x2580.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-248</DOCNO>
<DOCOLDNO>IA051-000870-B024-301</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a201.htm 199.92.136.137 19970111143512 text/html 2480
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:36:51 GMT
Last-modified: Friday, 20-Dec-96 22:00:03 GMT
Content-length: 2290
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Pharmaceutical Consulting Services</H1></CENTER>
<HR>
A201, <BR>12/20/96
Manager, Pharmaceutical Consulting Services -- Domain Solutions Corporation
<P>
Job Code: MPCS
<P>
A world leader in developing packaged softawre solutions for technical and pharmaceutical<BR>
data analysis, Domain Solutions Corporation (based in Cambridge, MA, formerly<BR>
BBN Domain) is seeking an outstanding individual to lead and manage its rapidly expanding<BR>
global software consulting practice.  This position requires in-depth pharmaceutical<BR>
business process and domain knowledge as well as technical expertise with Domain's<BR>
clinical data management software: Clintrial, Clintrace, and associated third-party software<BR>
products including Oracle.
<P>
You will grow and manage a technical staff, generate proposals, procure and build new<BR>
business, set and manage budgets, perform project management and provide an<BR>
exceptionally high level of customer satisfaction in the consulting work performed.<BR>
Technical work, performed primarily at customer sites, includes:  software installations and<BR>
version upgrades, software validation services, application implementation and customization<BR>
services.  IS/network assessments, and Clintrial migration services.  An advanced degree<BR>
Ph.D or MS) in computer science, engineering (or equivalent) and excellent communication<BR>
skills are required with 6+ years of hands-on technical management experience.  Past<BR>
experience managing subcontractos and working with business partners is a plus.<BR>
Significant travel is required.
<P>
We offer relocation, a competitive salary and outstanding benefits package which includes 401(k), tuition assistance, EAP, flexible spending accounts, a variety of medical<BR>
and dental plans, and much more.  For confidential consideration, forward your resume<BR>
and salary requirements to:  E-mail: domainjobs@domaincorp.com,<BR>
Fax: (617) 873-4273; Phone: (617) 873-5000; Mail: Human Resources, Domain<BR>
Solutions Corporation, 150 Cambridge Park Drive, Cambridge, MA 02140.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-249</DOCNO>
<DOCOLDNO>IA051-000870-B024-343</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a202.htm 199.92.136.137 19970111143525 text/html 1909
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:37:02 GMT
Last-modified: Monday, 23-Dec-96 16:14:05 GMT
Content-length: 1719
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Technical Training Specialist</H1></CENTER>
<HR>
A202, <BR>12/23/96
Technical Training Specialist, Pharmaceutical Division -- Domain Solutions Corporation
<P>
Job Code: TTSPD
<P>
A world leader in developing packaged software solutions for technical and pharmaceutical<BR>
data analysis, Domain Solutions Corporation (based in Cambridge MA, formerly BBN Domain)<BR>
is seeking two technical training specialists to develop and deliver technical training courses in<BR>
its rapidly growing pharmaceutical training department.
<P>
You will design, develop, and revise couse materials; conduct software training classes for<BR>
groups with varying skill levels; test and troubleshoot computer equipment used in training<BR>
classes.  Three to five years experience in technical training and course development;<BR>
familiarity with UNIX, VAX, and PC environments; and excellent communication skills are<BR>
required.  Pharmaceutical industry background and experience with Clintrial and Clintrace<BR>
are preferred.  Travel is required.
<P>
We offer relocation, a competitive salary and outstanding benefits package which includes 401(k), tuition assistance, EAP, flexible spending accounts, a variety of medical<BR>
and dental plans, and much more.  For confidential consideration, forward your resume<BR>
and salary requirements to:  E-mail: domainjobs@domaincorp.com,<BR>
Fax: (617) 873-4273; Phone: (617) 873-5000; Mail: Human Resources, Domain<BR>
Solutions Corporation, 150 Cambridge Park Drive, Cambridge, MA 02140.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-250</DOCNO>
<DOCOLDNO>IA051-000870-B024-375</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a203.htm 199.92.136.137 19970111143534 text/html 2539
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:37:15 GMT
Last-modified: Monday, 23-Dec-96 16:14:09 GMT
Content-length: 2349
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Technical Consultant</H1></CENTER>
<HR>
A203, <BR>12/23/96
Technical Consultant, Pharmaceutical Division -- Domain Solutions Corporation
<P>
Job Code: TCPD
<P>
A world leader in developing packaged software solutions for technical and pharmaceutical<BR>
data analysis, Domain Solutions Corporation (formerly BBN Domain) has attractive<BR>
opportunities for experienced technical consultants in our rapidly expanding global<BR>
Pharmaceutical Consulting Practice.  This group provides post-sales technical consulting,<BR>
primarily at customer sites, for Domain's clinical data management software; Clintrial,<BR>
Clintrace, and associated third-party software products including Oracle.  Consulting<BR>
activities include:  initial software installations and version upgrades, software validation<BR>
services, application implementation and customization services, IS/networking<BR>
assessmens, and Clintrial version 3 to 4 migration services.
<P>
You must have excellent analytical, technical and communication skills, an ability to<BR>
solve problems under pressure, and a passion to deliver outstanding customer support.<BR>
Skills required include experience with Clintrial or Clintrace, RPL and C programming, and<BR>
Oracle (including installations, database administration, PL/SQL application development,<BR>
SQL/NET).  Experience with project management, network design, implementation, and<BR>
performance assessment, or Powerbuilder application development is a plus.  A MS or BS<BR>
in computer science, engineering or equivalent is required with 3+ years of pharmaceutical<BR>
technical consulting experience.  Significant travel is required.
<P>
We offer relocation, a competitive salary and outstanding benefits package which includes 401(k), tuition assistance, EAP, flexible spending accounts, a variety of medical<BR>
and dental plans, and much more.  For confidential consideration, forward your resume<BR>
and salary requirements to:  E-mail: domainjobs@domaincorp.com,<BR>
Fax: (617) 873-4273; Phone: (617) 873-5000; Mail: Human Resources, Domain<BR>
Solutions Corporation, 150 Cambridge Park Drive, Cambridge, MA 02140.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-251</DOCNO>
<DOCOLDNO>IA051-000870-B025-1</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a204.htm 199.92.136.137 19970111143544 text/html 1174
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:37:25 GMT
Last-modified: Monday, 23-Dec-96 17:45:51 GMT
Content-length: 985
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Trial Monitor</H1></CENTER>
<HR>
A204, <BR>12/23/96
Clinical Trial Monitor -- Winnertech Corporation
<P>
To identify the site, facilitate site contact & budget negotiations, grant preparation &<BR>
approval process/subsequent payments.  Facilitate IRB review & collection of reg.<BR>
documentation.  Train site staff on all reg. procedures, commun. update info to<BR>
Study Mgt. Team, ensure data quality, final monitoring & CRF transmittal, final drug<BR>
accountability/reconciliation.
<P>
Experience (yrs): 2+  Permanent hire as a Winnertech consultant.
<P>
Initial assignment is for 6 months plus possible extentions.
<P>
For immediate consideration please contact:<BR>
Michelle Jones<BR>
Winnertech Corporation<BR>
75 West Front St.<BR>
Red Bank, NJ 07701<BR>
(908) 758-9500
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-252</DOCNO>
<DOCOLDNO>IA051-000870-B025-48</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a205.htm 199.92.136.137 19970111143614 text/html 1185
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:37:34 GMT
Last-modified: Monday, 23-Dec-96 17:52:33 GMT
Content-length: 996
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Operations Associate</H1></CENTER>
<HR>
A205, <BR>12/23/96
Operations Associate -- Winnertech Corporation
<P>
Assist in design & development of CRF, mgt of drug supplies; set up data tracking inhouse,<BR>
prepare site contracts/agreements; assist in mgt of a CRO & contract CRAs; assist<BR>
in preparation of materials for investigators mtgs & of project specific procedures<BR>
manual; assist in review of data for all sites, identify data issues.  May involve up to<BR>
20% site management responsibility.
<P>
Experience (yrs): 2+  Permanent hire as a Winnertech consultant.
<P>
Initial assignment is for 6 months plus possible extentions.
<P>
For immediate consideration please contact:<BR>
Michelle Jones<BR>
Winnertech Corporation<BR>
75 West Front St.<BR>
Red Bank, NJ 07701<BR>
(908) 758-9500
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-253</DOCNO>
<DOCOLDNO>IA051-000870-B025-87</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a206.htm 199.92.136.137 19970111143633 text/html 1155
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:38:11 GMT
Last-modified: Monday, 23-Dec-96 18:12:53 GMT
Content-length: 966
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Consultants, Clinical Research</H1></CENTER>
<HR>
A206, <BR>12/23/96
Consultants, Clinical Research -- MedQuest, LLC
<P>
MedQuest, LLC, a clinical research consulting services company, has opportunities<BR>
available in various regions of the US for professional, experienced consultants with a<BR>
background in pharmaceutical or biotechnology, drug development.  Consultants with<BR>
experience in project management, monitoring, auditing, data management, and<BR>
medical writing are needed.
<P>
Send your resume with references and fee requirements to:
<P>
Nadene Hausmann<BR>
MedQuest, LLC<BR>
147 Lewis Street<BR>
Phillipsburg, NJ 08865
<P>
Fax:  (908) 454-2027
<P>
email:  medquest@enter.net
<P>
No agencies, please.  We will contact only principle candidates.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-254</DOCNO>
<DOCOLDNO>IA051-000870-B025-128</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a207.htm 199.92.136.137 19970111143643 text/html 1441
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:38:21 GMT
Last-modified: Thursday, 02-Jan-97 19:19:32 GMT
Content-length: 1249
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager, Regulatory Affairs</H1></CENTER>
<HR>
A207, <BR>12/23/96
Manager, Regulatory Affairs -- LeukoSite, Inc.
<P>
LeukoSite, Inc. is a privately held company specializing in the development of monoclonal<BR>
antibodies and small drug molecules for inflammatory and autoimmune diseases.
<P>
A well-organized, detail-oriented professional with strong interpersonal skills is<BR>
being sought to assist in establishing a regulatory affairs department by participating in:
<P>
Coordination, preparation and assembly of documentation for domestic and international<BR>
regulatory submissions.<BR>
Management of quality assurance programs for GLP, cGMP, GCP<BR>
Proposal and coordination of domestic and international regulatory strategy.
<P>
Minimum requirements are a BS/BA, 4+ years pharmaceutical experience in the<BR>
area of regulatory affairs, good working knowledge of  FDA/EU regulations, and<BR>
experience in biotechnology.
<P>
Please send your resume to:  Human Resources - Medical, LeukoSite Inc. 215 First<BR>
Street, Cambridge MA, 02142.

<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-255</DOCNO>
<DOCOLDNO>IA051-000870-B025-167</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a208.htm 199.92.136.137 19970111143700 text/html 1377
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:38:40 GMT
Last-modified: Monday, 30-Dec-96 21:02:35 GMT
Content-length: 1187
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Clinical Research Associate</H1></CENTER>
<HR>
A208, <BR>12/30/96
Senior Clinical Research Associate -- LeukoSite, Inc.
<P>
LeukoSite, Inc. is a privately held company specializing in the development of monoclonal<BR>
antibodies and small drug molecules for inflammatory and autoimmune diseases.
<P>
An enthusiastic team player with strong organizational skills is being sought to assist in<BR>
establishing a clinical affairs department by participating in:
<P>
International clinical development activities:<BR>
study conduct/monitoring,<BR>
CRO management,<BR>
clinical documentation preparation.<BR>
<P>
Project management activities including forecasting/tracking of: timelines, budgets, and<BR>
clinical trial material.
<P>
Minimum requirements are a BS in Biological Sciences, 3-4 years pharmaceutical experience<BR>
in the area of clinical development.
<P>
Please send your resume to:  Human Resources - Medical, LeukoSite Inc. 215 First<BR>
Street, Cambridge MA, 02142.

<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-256</DOCNO>
<DOCOLDNO>IA051-000870-B025-199</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a209.htm 199.92.136.137 19970111143710 text/html 1263
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:38:50 GMT
Last-modified: Monday, 30-Dec-96 21:09:49 GMT
Content-length: 1073
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biostatistician</H1></CENTER>
<HR>
A209, <BR>12/30/96
Biostatistician -- University of Texas Health Science Center
<P>
Research Assistant/Associate Professor to join experienced Biostatistics and Data Management<BR>
Team with special interests and expertise in evaluation of new anticancer agents.<BR>
Requires solid foundation in the fundamentals of experimental design and analysis of<BR>
medical and biological data, experience with analysis of censored survival data, database<BR>
management skills, familiarity with standard statistical analysis packages.  Excellent<BR>
verbal and written communication skills and ability to collaborate with individuals at<BR>
many different levels essential.
<P>
Send CV, 3 letters of reference to Gary M. Clark, Ph.D., University of Texas<BR>
Health Science Center, Medicine/Oncology, 7703 Floyd Curl Drive, San Antonio, TX<BR>
78284-7884.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-257</DOCNO>
<DOCOLDNO>IA051-000870-B025-240</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a210.htm 199.92.136.137 19970111143728 text/html 895
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:39:04 GMT
Last-modified: Monday, 30-Dec-96 21:14:04 GMT
Content-length: 706
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Sr. CRA/Project Manager</H1></CENTER>
<HR>
A210, <BR>12/30/96
Sr. CRA/Project Manager
<P>
3 major pharmaceutical firms (1) in the southeast (1) in the mid Atlantic region and (1)<BR>
in the upper midwest are seeking experienced Sr. CRAs or Project Managers.  Sr.<BR>
CRAs must have some management experience.  Compensation ranges are completely<BR>
flexible for the right people.  Perfect fit are of more concern.  Any inquiries should be directed<BR>
to Jeff Schwartz at 215-654-5151.  Fax any resumes to 215-654-7402.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-258</DOCNO>
<DOCOLDNO>IA051-000870-B025-282</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a211.htm 199.92.136.137 19970111143801 text/html 1710
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:39:32 GMT
Last-modified: Monday, 30-Dec-96 21:24:33 GMT
Content-length: 1520
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director, International Reg. Affairs</H1></CENTER>
<HR>
A211, <BR>12/30/96
Director, International Regulatory Affairs -- Baxter International
<P>
<B>Job Description:</B>
<P>
This position is responsible for the following:<BR>
* Development of regulatory strategies for new and existing products for the Renal Division<BR>
in Latin America, Asia, and other regions outside of Europe, Japan, and US<BR>
* Defining and leading strategies and regulatory submissions with local country<BR>
regulatory affairs management in those regions.<BR>
* Driving the coordination of global regulatory strategies with Renal Regulatory Affairs<BR>
personnel from Europe, Japan, and the US.
<P>
<B>Job Requirements:</B>
<P>
Qualified candidates must have 7+ years of pharmaceutical regulatory affairs experience.<BR>
Advanced degree in a scientific discipline or equivalent experience is required.<BR>
Demonstrated excellence in program management, leadership skills, and interpersonal<BR>
skills.  Ability to foster and create an environment that embraces an innovative, creative,<BR>
responsive, proactive, and scientifically sound regulatory millieu.
<P>
Contact:  Jyoti Weber<BR>
Company: Baxter International, Renal Division<BR>
Phone: (847)473-6050<BR>
Fax: (847)473-6711<BR>
Address: 1620 Waukegan Road<BR>
McGaw Park, IL 60085
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-259</DOCNO>
<DOCOLDNO>IA051-000870-B025-313</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a212.htm 199.92.136.137 19970111143813 text/html 1405
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:39:53 GMT
Last-modified: Monday, 30-Dec-96 21:32:18 GMT
Content-length: 1215
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Executive Director of Biostatics</H1></CENTER>
<HR>
A212, <BR>12/30/96
Executive Director of Biostatics
<P>
<CENTER>Major Contract Research Organization</CENTER>
<CENTER><B>Executive Director of Biostatics</B></CENTER>
<CENTER>East Coast and</CENTER>
<CENTER>New England</CENTER>
<P>
<CENTER>To 190K + Bonus and Equity</CENTER>
<P>
Major Contract Research Organization in the tri-state area and Major Biotech company in<BR>
New England seeks "responsible head" positions for their biostatics divisions.<BR>
7-10 years experience and a PhD qualifies.
<P>
Having the most extensive database of current opportunities than most search firms in<BR>
North America, you can count on ReSearch, Inc. to confidentially present you with the<BR>
best possible opportunities available.  Send an updated cv to Lance Converse at:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-260</DOCNO>
<DOCOLDNO>IA051-000870-B025-350</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a213.htm 199.92.136.137 19970111143845 text/html 1636
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:40:13 GMT
Last-modified: Monday, 30-Dec-96 21:46:37 GMT
Content-length: 1446
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Vice President of Operations</H1></CENTER>
<HR>
A213, <BR>12/30/96
Vice President of Operations
<P>
<CENTER>Clinical Data/Biostat/Remote Data Contract Research Organization</CENTER>
<CENTER><B>Vice President of Operations</B></CENTER>
<CENTER>Midwest Location</CENTER>
<P>
<CENTER>To 170K + Bonus and Equity</CENTER>
<P>
Unique opportunity to join exciting five year old 100 person organization slated for huge<BR>
success in 1997.  This position will be responsible for this company's clinical,<BR>
biostatics, programming, clinical data, and project operations.  Candidate will have<BR>
strong technical experience in all facets of related areas as well as an innovative<BR>
mindset, excellent managerial skills, and full understanding of the clinical development<BR>
process.
<P>
Having the most extensive database of current opportunities than most search firms in<BR>
North America, you can count on ReSearch, Inc. to confidentially present you with the<BR>
best possible opportunities available.  Send an updated cv to Lance Converse at:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-261</DOCNO>
<DOCOLDNO>IA051-000870-B025-385</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a214.htm 199.92.136.137 19970111143858 text/html 1461
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:40:38 GMT
Last-modified: Monday, 30-Dec-96 21:55:07 GMT
Content-length: 1271
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>VP and Director Business Development</H1></CENTER>
<HR>
A214, <BR>12/30/96
Vice President and Director Business Development
<P>
<CENTER>Major Contract Research Organization</CENTER>
<CENTER>Tri-State Area</CENTER>
<CENTER>PA/NJ/DE</CENTER>
<P>
<CENTER> Director to 115K + Bonus + Equity</CENTER>
<P>
<CENTER>VP to 140K + Bonus and Equity</CENTER>
<P>
Your 5 to 10 years experience in business development and marketing selling clinical<BR>
research services to pharmaceutical - biotech - and contract research groups qualifies<BR>
for these two ground floor opportunities with this $200mm + organization.
<P>
Having the most extensive database of current opportunities than most search firms in<BR>
North America, you can count on ReSearch, Inc. to confidentially present you with the<BR>
best possible opportunities available.  Send an updated cv to Lance Converse at:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-262</DOCNO>
<DOCOLDNO>IA051-000870-B026-14</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a215.htm 199.92.136.137 19970111143905 text/html 1163
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:40:47 GMT
Last-modified: Monday, 30-Dec-96 21:59:24 GMT
Content-length: 974
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associate</H1></CENTER>
<HR>
A215, <BR>12/30/96
Clinical Research Associate
<P>
<CENTER>Clinical Research Associate Opportunities</CENTER>
<CENTER>Over 70 current positions</CENTER>
<CENTER>Jr. and Sr. Level</CENTER>
<CENTER>In House and Regional</CENTER>
<CENTER>All geographic areas</CENTER>

<P>
Having the most extensive database of current opportunities than most search firms in<BR>
North America, you can count on ReSearch, Inc. to confidentially present you with the<BR>
best possible opportunities available.  Send an updated cv to Lance Converse at:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-263</DOCNO>
<DOCOLDNO>IA051-000870-B026-45</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a216.htm 199.92.136.137 19970111143915 text/html 1450
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:40:54 GMT
Last-modified: Monday, 30-Dec-96 22:03:27 GMT
Content-length: 1260
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Director of Regulatory Affairs</H1></CENTER>
<HR>
A216, <BR>12/30/96
Director of Regulatory Affairs
<P>
<CENTER>Major Contract Research Organization</CENTER>
<CENTER><B>Director of Regulatory Affairs</B></CENTER>
<CENTER>East Coast</CENTER>
<CENTER>New England</CENTER>
<CENTER>SouthEast</CENTER>
<CENTER>SouthWest</CENTER>
<P>
<CENTER>To 125K+ Bonus and Equity</CENTER>
<P>
Major Contract Research Organizations seek experienced regulatory professionals to<BR>
head exciting organizations which are focusing their regulatory functions towards<BR>
consulting roles to help grow their clients.
<P>
Having the most extensive database of current opportunities than most search firms in<BR>
North America, you can count on ReSearch, Inc. to confidentially present you with the<BR>
best possible opportunities available.  Send an updated cv to Lance Converse at:
<P>
<CENTER>ReSearch Incorporated</CENTER>
<CENTER>725 Skippack Pike, Suite 200</CENTER>
<CENTER>Blue Bell, PA 19422</CENTER>
<CENTER>(215) 540-0700 Phone</CENTER>
<CENTER>(215) 540-0770 Fax</CENTER>
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-264</DOCNO>
<DOCOLDNO>IA051-000870-B026-76</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a217.htm 199.92.136.137 19970111143924 text/html 986
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:41:05 GMT
Last-modified: Thursday, 02-Jan-97 17:01:40 GMT
Content-length: 795
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Various Opportunities</H1></CENTER>
<HR>
A217, <BR>1/2/97
Various Opportunities -- Resource One
<P>
<CENTER>National/International Opportunities</CENTER>
<P>
Immediate Positions available:
<P>
Study Coordinators<BR>
Physicians/Investigators<BR>
Clinical Trial Managers<BR>
Clinical Data Managers/Coodinators<BR>
Project Managers<BR>
Regulatory Affairs<BR>
Medical Writers
<P>
<B>Resource One</B>
<P>
For immediate consideration contact Ken Writz at Resource One<BR>
Telephone:  (714) 222-4590
<P>
Mail or FAX your CV to (714) 499-9864<BR>
1133 Camelback Street, Box 9203, Newport Beach, CA 92658
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-265</DOCNO>
<DOCOLDNO>IA051-000870-B026-107</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a218.htm 199.92.136.137 19970111143936 text/html 973
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:41:13 GMT
Last-modified: Thursday, 02-Jan-97 19:53:05 GMT
Content-length: 782
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Data Management/CRA</H1></CENTER>
<HR>
A218, <BR>1/2/97
Data Management/CRA -- Rockville, MD
<P>
Two years of experience doing clinical trials, reviewing CRF's, completing Adverse Event<BR>
forms, doing data cleaning, etc.<BR>
In addition, SAS, ClinTrial, and/or Oracle is a distinct advantage.  We currently have<BR>
four openings.  The position is a six month contract in Rockville, Maryland.<BR>
Inerested persons should call Ryan at 1(800) 916-6210 x2580.  Or fax/send resumes<BR>
to:  Aerotek Lab Support at 15850 Crabbs Branch Way, Rockville, MD 20855.<BR>
Fax number is:  (301) 670-4777.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-266</DOCNO>
<DOCOLDNO>IA051-000870-B026-141</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a219.htm 199.92.136.137 19970111143952 text/html 1558
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:41:31 GMT
Last-modified: Thursday, 02-Jan-97 20:04:40 GMT
Content-length: 1366
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Research Fellow</H1></CENTER>
<HR>
A219, <BR>1/2/97
Senior Research Fellow -- Tufts University, Boston, MA
<P>
Senior Research Fellow needed at the Tufts Center for the Study of Drug Development,<BR>
a multi-disciplinary policy research group studying topics related to the<BR>
pharmaceutical and biopharmaceutical industries and the development and<BR>
regulation of biotech drugs.  Primary responsibilities include independent and<BR>
collaborative work on study design, data collection and analysis, and write-up of<BR>
project results for publication.  This is NOT a lab position.  The successful candidate<BR>
will hold an advanced degree, preferably a Ph.D. in molecular biology or a related<BR>
discipline, must have general interest in pharmaceutical regulation or public<BR>
health policy, and specific interest in biotech product development and the<BR>
biotech industry.  Research and publication experience and excellent communication<BR>
skills are required.
<P>
Please send tw copies of curriculum vitae and ccover letter and salary requirements<BR>
to Virginia Marcotte, Human Resources, Tufts University, 200 Harrison Avenue,<BR>
Boston, MA 02111.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-267</DOCNO>
<DOCOLDNO>IA051-000870-B026-173</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a220.htm 199.92.136.137 19970111144001 text/html 1791
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:41:40 GMT
Last-modified: Thursday, 02-Jan-97 20:22:04 GMT
Content-length: 1599
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>CRA/Senior CRA</H1></CENTER>
<HR>
A220, <BR>1/2/97
CRA/Senior CRA -- Trilex Pharmaceuticals
<P>
Trilex Pharmaceuticals, Inc., a Scottsdale, AZ based company developing therapeutic<BR>
cancer vaccines, seeks an experienced professional with a background in<BR>
clinical research.  You will coordinate and manage clinical trials for an<BR>
investigational vaccine.  Responsibilities include:  Investigator selection/<BR>
qualifications; study site quality assurance; managing CRO activities;<BR>
monitoring study progress and data flow; data evaluation; clinical protocol/<BR>
report writing.
<P>
You must have experience in managing clinical research studies.  Experience<BR>
should include on-site monitoring and knowledge of clinical research methodology,<BR>
GCPs and FDA regulations.  Effective communication and interpersonal skills, along<BR>
with excellent organizational skills are required.  Must be computer literate, able to<BR>
work independently and willing to travel.  BS/MS and minimum 2 to 3 years directly related<BR>
clinical research experience required.
<P>
In return, Trilex offers a competitive salary, benefits package, an attractive working<BR>
and living environment, and an excellent career opportunity for a professional who<BR>
wants to make a difference.
<P>
Please FAX your resume to:  Trilex Pharmaceuticals, Attn: Manager of Clinical<BR>
Development, (602) 368-5184.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-268</DOCNO>
<DOCOLDNO>IA051-000870-B026-203</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a221.htm 199.92.136.137 19970111144012 text/html 1881
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:41:51 GMT
Last-modified: Thursday, 02-Jan-97 21:39:24 GMT
Content-length: 1689
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Director</H1></CENTER>
<HR>
A221, <BR>1/2/97
Associate Director Regulatory Affairs -- MB Inc, New York, NY
<P>
Associate Director Regulatory Affairs - $85-95K, plus bonus.
<P>
Primary Duties and Responsibilities:  Individual must have a thorough and current<BR>
working knowledge of both Domestic and International Government Health regulations<BR>
as they pertain to all requirements for purposes of Clinical Trial applications<BR>
and/or Drug Marketing authorizations.  The Associate Director will manage<BR>
the regulatory aspects of the development, registration, and post-marketing<BR>
support for compounds/products in the US and International registrations.<BR>
The Associate Director will manage the liaison and communications between<BR>
company personnel and the FDA on CMA, pre-clinical, and clinical matters<BR>
relevant to the Dermatology Therapeutic area.  The person will be responsible<BR>
for the preparation of registration plans for compounds and their timely submission<BR>
to upper management, as well as regulatory agencies.  Key behavioral<BR>
characteristics the individual must possess are:  attention to detail, ability to<BR>
communicate, both oral and verbal, sense of urgency and excellent interpersonal skills.
<P>
Special Considerations: A PhD in a scientific discipline or an MD with four years of<BR>
experience in Drug Regulatory Affairs, or a Master's of Pharmacy degree with 7<BR>
years DRA experience in the pharmaceutical industry is needed.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-269</DOCNO>
<DOCOLDNO>IA051-000870-B026-248</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a222.htm 199.92.136.137 19970111144026 text/html 1218
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:42:06 GMT
Last-modified: Thursday, 02-Jan-97 21:51:13 GMT
Content-length: 1026
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Biostatistician</H1></CENTER>
<HR>
A222, <BR>1/2/97
Biostatistician - Covance (Formerly Corning Besselaar)
<P>
Prepare key sections of integrated clinical statistical reports.  Review computer<BR>
generated tables to ensure compliance with RAP specifications.  Interact with<BR>
clinical data coordinators and programmers in the production and review of tables,<BR>
appendicies, and data listings for the CTR.  Participate in ISE and ISS summaries<BR>
for NDAs.  MS in statistics; SAS programming skills. 2+ years statistical analysis<BR>
experience in a pharmaceutical R&D environment.  We offer an excellent benefits<BR>
package including Medical/dental, vision, ESOP, 401(k), Tuition reimbursement, and<BR>
bonus plan.  Send/fax resume to:  Covance, HR Dept. ES, 210 Carnegie Center,<BR>
Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-270</DOCNO>
<DOCOLDNO>IA051-000870-B026-280</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a223.htm 199.92.136.137 19970111144053 text/html 1084
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:42:27 GMT
Last-modified: Thursday, 02-Jan-97 21:54:33 GMT
Content-length: 893
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regulatory Affairs Associate</H1></CENTER>
<HR>
A223, <BR>1/2/97
Regulatory Affairs Associate - Covance (Formerly Corning Besselaar)
<P>
You must be experienced in the assembly, submission, and maintenance of<BR>
documents for regulatory applications (e.g. IND & NDA), and in regulatory review of<BR>
pre-study clinical investigator documentation.  Required are a BA/BS in life sciences<BR>
and 3+ years regulatory experience in the pharmaceutical industry.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-271</DOCNO>
<DOCOLDNO>IA051-000870-B026-311</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a224.htm 199.92.136.137 19970111144104 text/html 1174
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:42:44 GMT
Last-modified: Thursday, 02-Jan-97 21:59:20 GMT
Content-length: 983
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Clinical Data Associates</H1></CENTER>
<HR>
A224, <BR>1/2/97
Senior Clinical Data Associates - Covance (Formerly Corning Besselaar)
<P>
You will be an integral part of a multi-disciplinary project team, responsible for<BR>
maintaining the clinical database, developing time and cost estimates, supervising<BR>
Clinical Data Associates and Data Processors, and managing the clinical data<BR>
cleanup process.  A BA/BS in life science or nursing is required, as is 4+ years of<BR>
increasingly responsible clinical data management positions.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-272</DOCNO>
<DOCOLDNO>IA051-000870-B026-343</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a225.htm 199.92.136.137 19970111144114 text/html 1121
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:42:54 GMT
Last-modified: Friday, 03-Jan-97 16:08:43 GMT
Content-length: 932
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Data Associates</H1></CENTER>
<HR>
A225, <BR>1/3/97
Clinical Data Associates - Covance (Formerly Corning Besselaar)
<P>
You will be responsible for maintaining project databases, programming diagnostics,<BR>
creating data dictionaries, prepare monitoring query conventions, coding CRFs, and<BR>
assisting with site management.  Travel required.  Requirements include:  BA/BA in<BR>
life sciences or nursing RN and 2+ years experience in the Biotech, CRO, or<BR>
pharmaceutical industry.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-273</DOCNO>
<DOCOLDNO>IA051-000870-B026-377</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a226.htm 199.92.136.137 19970111144128 text/html 1153
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:43:07 GMT
Last-modified: Friday, 03-Jan-97 16:15:28 GMT
Content-length: 964
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Clinical Research Associates</H1></CENTER>
<HR>
A226, <BR>1/3/97
Clinical Research Associates - Covance (Formerly Corning Besselaar)
<P>
You will initiate, monitor, and closeout clinical investigative sites (approximately<BR>
30% travel), generate and tack drug shipments and storage, provide in-house site<BR>
management, review CRFs, and report, write narratives and follow up on serious AEs.<BR>
Requirements include a BA/BS in life sciences, pharmacy, or nursing RN along with<BR>
2+ years multi-site monitoring experience.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-274</DOCNO>
<DOCOLDNO>IA051-000870-B027-34</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a227.htm 199.92.136.137 19970111144144 text/html 1200
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:43:21 GMT
Last-modified: Friday, 03-Jan-97 16:23:09 GMT
Content-length: 1010
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Regional Clinical Research Associates</H1></CENTER>
<HR>
A227, <BR>1/3/97
Regional Clinical Research Associates - Covance (Formerly Corning Besselaar)
<P>
Based from your home, you will onitor Phase II and Phase III clinical trials.  Current<BR>
openings:  Chicago, Los Angeles, Boston, and San Francisco.  Qualified candidates<BR>
will possess a minimum of two years extensive field monitoring experience for a<BR>
pharmaceutical company or contract research organization.  A BA/BS in life sciences/<BR>
nursing coupled with two years of monitoring experience is required.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-275</DOCNO>
<DOCOLDNO>IA051-000870-B027-70</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a228.htm 199.92.136.137 19970111144156 text/html 1122
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:43:35 GMT
Last-modified: Friday, 03-Jan-97 16:27:59 GMT
Content-length: 933
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>SAS Programmers</H1></CENTER>
<HR>
A228, <BR>1/3/97
SAS Progammers - Covance (Formerly Corning Besselaar)
<P>
You will provide SAS programming support for the display and analysis of data<BR>
from clinical trials.  Primary responsibilities include: performing statistical analyses,<BR>
processing lab data, producing graphs, and generating summary tables and data<BR>
listings.  A BA/BS in computer science, statistics, or a related area, and 2+ years<BR>
SAS programming experience are required.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-276</DOCNO>
<DOCOLDNO>IA051-000870-B027-110</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a229.htm 199.92.136.137 19970111144208 text/html 1388
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:43:45 GMT
Last-modified: Friday, 03-Jan-97 16:57:41 GMT
Content-length: 1198
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Senior Technical Trainer</H1></CENTER>
<HR>
A229, <BR>1/3/97
Senior Technical Trainer - Covance (Formerly Corning Besselaar)
<P>
We seek dynamic, energetic people to train our next generation of top-notch clinical<BR>
research professionals.  You will be responsible for creating and presenting training<BR>
and educational materials, demonstrate systems and processes, aid in process<BR>
improvement, develop and maintain user documentation, and serve as a technical<BR>
resource.  Requirements include:  BA/BS in life sciences or programming, and 3-5<BR>
years of drug development background (SAS programing, monitoring, data management)<BR>
in a pharmaceutical or CRO environment.  Computer literacy, excellent organizational<BR>
and interpersonal skills.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-277</DOCNO>
<DOCOLDNO>IA051-000870-B027-146</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a230.htm 199.92.136.137 19970111144218 text/html 937
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:43:58 GMT
Last-modified: Friday, 03-Jan-97 17:05:33 GMT
Content-length: 748
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Medical Writer</H1></CENTER>
<HR>
A230, <BR>1/3/97
Medical Writer - Covance (Formerly Corning Besselaar)
<P>
Responsible for writing and editing CTRs, NDA summary reports, and clinical/<BR>
statistical reports for FDA submissions.  BA/BS life sciences and 2+ years<BR>
experience in pharmaceutical or CRO setting.<BR>
We offer an excellent benefits package including Medical/dental, vision, ESOP,<BR> 401(k), Tuition reimbursement, and bonus plan.  Send/fax resume to:  Covance, HR<BR>
Dept. ES, 210 Carnegie Center, Princeton, NJ 08540-6233. Fax (609) 734-0064.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-278</DOCNO>
<DOCOLDNO>IA051-000870-B027-194</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a231.htm 199.92.136.137 19970111144231 text/html 1059
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:44:08 GMT
Last-modified: Friday, 03-Jan-97 17:12:58 GMT
Content-length: 870
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Manager</H1></CENTER>
<HR>
A231, <BR>1/3/97
Manager of ADME/Pharmakokinetics -- ABC Laboratories, Columbia, Missouri
<P>
ABC Laboratories has an immediate opening for a leader/manager of ADME/<BR>
Pharmakokinetics.  The successful candidate will have experience as a study<BR>
director on GLP studies (in-life and analytical phases) and will provide hands-on<BR>
leadership in the promotion of ABC's capabilities, winning and performing contracts<BR>
to a standard that exceeds our clients' expectations.  Applicants should contact Dr.<BR>
Jake Halliday (President & CEO) at 1-800-538-5227 or fax their CV to 573-443-9033.<BR>
For background on ABC Labs, see: http://www.abclabs.com
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-279</DOCNO>
<DOCOLDNO>IA051-000870-B027-241</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a232.htm 199.92.136.137 19970111144305 text/html 845
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:44:22 GMT
Last-modified: Friday, 03-Jan-97 17:22:04 GMT
Content-length: 656
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Project Manager</H1></CENTER>
<HR>
A232, <BR>1/3/97
Project Manager -- Southeast
<P>
Southeastern US pharmaceutical company is looking for several Project Managers.<BR>
Prior management skills preferred.  Minimum of 4 years CRA experience<BR>
with a BS or MS in health sciences.  Compensation depends on experience<BR>
level.  If interested, please contact Jeff Schwartz at 215-654-5151.<BR>
You can also visit our web site at www.cynet.net/pspi.  Email: pspi@cynet.net.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-280</DOCNO>
<DOCOLDNO>IA051-000870-B027-277</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a233.htm 199.92.136.137 19970111144333 text/html 2067
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:45:13 GMT
Last-modified: Friday, 03-Jan-97 17:39:38 GMT
Content-length: 1877
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Associate Medical Director</H1></CENTER>
<HR>
A233, <BR>1/3/97
Associate Medical Director, Clinical Research -- Oncology
<P>
Education:  MD with boards in IM and research experience in Oncology or Ph.D.<BR>
with extensive clinical research experience in Oncology.
<P>
Requirements:  At least 1 year pharmaceutical industry experience for the MD or 2-3<BR>
years pharmaceutical industry experience for the Ph.D.  Clinical trials experience a<BR>
must.  Managerial experience desirable.
<P>
Reponsibilities:  You will plan clinical research programs in accordance with the<BR>
clinical development programs and business requirements of both locally and<BR>
internationally established research organizations.  You will supervise the conduct<BR>
of the clinical studies and the research team to assure the timeliness and quality of<BR>
these studies as well as keeping management appraised of progress.  Responsibilities<BR>
include data interpretation, finalization of study report and regulatory and publications<BR>
submissions.  As a member of the management team, you will contribute to the<BR>
development of product market support plans and clinical studies.  You will have<BR>
authority for budgeting and planning all clinical programs within your area.  Reports<BR>
to the Group Medical Director of Medical Development.  Outstanding salary, bonus and<BR>
stock options for qualified personnel.
<P>
Please contact:  Angelo G. Angeledes, MS, CPC, 609-584-8300<BR>
Fax: 609-584-0187, AADE Associates, PO Box 2142, Princeton, NJ 08543<BR>
Email: agapharm@aol.com<BR>
Company Name: AADE Associates - Pharmaceutical Executive Recruiter<BR>
PO Box 2142, Princeton, NJ 08543
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-281</DOCNO>
<DOCOLDNO>IA051-000870-B027-313</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a234.htm 199.92.136.137 19970111144345 text/html 1573
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:45:23 GMT
Last-modified: Friday, 03-Jan-97 18:34:42 GMT
Content-length: 1383
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Research Analyst</H1></CENTER>
<HR>
A234, <BR>1/3/97
Research Analyst  -- Technology Assessment Group, Boston, MA
<P>
Technology Assessment Group (TAG) is a San Francisco-based international health<BR>
care research and consulting firm with special expertise in the evaluation of the<BR>
economic and quality-of-life impact of new medical technologies and health<BR>
conditions.  We have an opportunity in our Boston office for a Research Analyst.
<P>
We seek an individual with a Masters of Public Health degree or related to perform<BR>
economic analysis, develop analytic models, obtain data, manage projects,<BR>
write proposals and reports, and prepare client presentations.
<P>
A background in health care or clinical practice is preferred.  Our ideal candidate<BR>
has strong analytical skills, excellent written and verbal communication skills, and<BR>
the ability to work with a multi-disciplinary team.
<P>
TAG offers competitive salaries and benefits.  No phone calls, please.
<P>
Please send cover letter, resume, and salary requirement to:
<P>
Technology Assessment Group<BR>
1360 Prudential Tower<BR>
800 Boylston Street<BR>
Boston, MA 02199
<P>
Fax: (617) 536-4265
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-282</DOCNO>
<DOCOLDNO>IA051-000870-B027-363</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a235.htm 199.92.136.137 19970111144405 text/html 1797
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:45:41 GMT
Last-modified: Friday, 03-Jan-97 19:01:47 GMT
Content-length: 1607
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Executive Director</H1></CENTER>
<HR>
A235, <BR>1/3/97
Executive Director -- Urology Center of Florida, Ocala, FL
<P>
Executive Director -- Ocala, FL<BR>
Urology Center of Florida -- a single-specialty clinical trial organization that is an<BR>
affiliate member of Affiliated Research Centers, Inc., is seeking an Executive Director<BR>
position.  The position requires an energetic, entrepreneurial individual who is<BR>
searching for an opportunity of unlimited professional growth.  You will coordinate<BR>
the expansion of a successful single-specialty research site into a multi-specialty<BR>
research organization.  Duties include preparing, implementing, and managing business<BR>
plans, budgets, and standard operating procedures; recruiting, hiring, and training<BR>
staff; and managing staff effectively to maximize productivity and enhance the quality<BR>
of work performed.
<P>
Qualified candidates will possess a degree in a business field and/or medical field;<BR>
five-plus years of experience in the clinical research process; knowledge of the<BR>
pharmaceutical industry; and strong oral and written communication, interpersonal,<BR>
computer, and multi-tasking skills.
<P>
Please submit your resume or CV to Ellen Metivier; Urology Center of Florida;<BR>
3201 Southwest 34th Street; Ocala, FL 34474; Fax 1: (352) 237-5684;<BR>
Fax 2: (352) 237-7286.  Selected candidates will be contacted.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-283</DOCNO>
<DOCOLDNO>IA051-000870-B027-388</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/employ/a236.htm 199.92.136.137 19970111144415 text/html 2223
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:45:53 GMT
Last-modified: Friday, 03-Jan-97 19:12:07 GMT
Content-length: 2033
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><H1>Marketing Research Manager</H1></CENTER>
<HR>
A236, <BR>1/3/97
Marketing Research Manager - Covance (Formerly Corning Besselaar)
<P>
In this vital and highly visible role, you will manage the primary marketing research<BR>
program, including customer research, competitor pricing research, account-<BR>
specific studies and in-depth competitor assessments.  We look to you to develop/<BR>
measure critical account performance data to evaluate our sales efforts, including<BR>
profitability, account share/value, and other measures.  Position involves managing<BR>
client database, performing concept/promotional testing for marketing program<BR>
success, developing marketing plan sections, budgeting, and communicating<BR>
marketplace data to Senior Management.
<P>
To qualify, you must have 4-6 years marketing research experience in the healthcare<BR>
services or general services industry, a solid understanding, both theory and<BR>
application, of quantitative and qualitative market research techniques; and<BR>
proven ability to create new methods to measure markets, company, and<BR>
competitor performance.  You must be interested in setting up a market research<BR>
group for a $400+ million development services company.  Knowledge of the drug<BR>
development pathway a strong plus.
<P>
As a prestigious organization at the forefront of our industry, we offer a competitive<BR>
salary and a benefit package that includes medical, dental, vision, 401(K) plan,<BR>
ESOP, and employee stock purchase plan.  All of our employees operate as owners<BR>
of the company.  Please mail or fax your resume with salary history and<BR>
requirements to:  Human Resources, Dept. GVS, Covance, 210 Carnegie Center,<BR>
Princeton, NJ 08540-6233.  Fax: (609) 452-2099.  Principals only.<BR>
Drug screening is a condition of employment.
<P>
An Equal Opportunity Employer


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-284</DOCNO>
<DOCOLDNO>IA051-000870-B028-18</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a1.htm 199.92.136.137 19970111144427 text/html 5489
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:46:04 GMT
Last-modified: Tuesday, 23-Jul-96 17:06:25 GMT
Content-length: 5298
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>About the Journal</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL</UL>
<P>
 <CENTER> <STRONG>ABOUT THE JOURNAL</STRONG></CENTER>
<P>
<HR>
<CENTER><I><B>DRUG INFORMATION JOURNAL</B></I><BR>
(ISSN 00928615)<BR>
Official Publication of the Drug Information Association<BR></CENTER>
<HR>
<P>
<B>AIMS AND SCOPE</B>
<P>
The <I><B>Drug Information Journal</B></I> is the official publication
of the Drug Information Association (DIA). The journal's purposes
are to:  
<UL>
<LI> Disseminate information on manual and automated drug research,
development, and information systems,<BR>
<LI> Foster communication between educational, research, industrial,
and governmental personnel engaged in drug information activities,
and  <BR>
<LI>  Provide a forum for the development of improved methods of
presenting research data generated from chemical, toxicological,
pharmacological, and clinical studies.<BR>
</UL>

<P>
Manuscripts are accepted for consideration with the understanding
that they have not been published elsewhere and are not concurrently
under review elsewhere. Papers that have been given at scientific
meetings are accepted for consideration.  
<P>
<B>Published Quarterly:</B> Twenty Dollars of the members' annual
membership fee is for a year's subscription. Annual Institutional
Subscription Rate (1996) Volume 30: US $225.00. Two-year Institutional
Rate (1997/98): $425.00. Academic organizations, Not-for-Profit
organizations and Personal Subscription Rate, $65.00. Prices include
postage and are subject to change without notice. Notify the DIA
eight weeks in advance of address change with a copy of the subscription
mailing label. Back issues of all previously published volumes,
in hard copy or on microfilm, are available direct from the DIA.
 
<P>
<B>Publishing, Subscription, and Advertising Offices:</B> <I><B>Drug
Information Journal</B></I>, Drug Information Association (DIA),
321 Norristown Road, Suite 225, Ambler, PA 19002-2755, USA.
<P>
<B>Editorial Office:</B> Editor-in-Chief, <I><B>Drug Information
Journal</B></I>, 321 Norristown Road, Suite 225, Ambler, PA 19002-2755,
USA, Telephone (215) 628-2288, Fax (215) 641-1229.  
<P>
The paper used in this publication meets the minimum requirements
of American National Standard for Information Sciences - Permanence
of Paper for Printed Library Materials, ANSI Z39.48-1984.
<P>
<B>Postmaster:</B> Send address changes to the <I>Drug Information
Journal</I>, 321 Norristown Road, Suite 225, Ambler, PA 19002-2755.
<P>
Second Class Postage Paid at Ambler, Pennsylvania and additional
mailing offices.  
<P>
The <B>Drug Information Association</B> is dedicated to the extension
of modern technology in biomedical information and data processing
as well as encouraging cooperative efforts among education, research,
industrial, and government personnel to disseminate information
of that type. For information concerning membership, please see
<B>Membership Information</B> elsewhere in this issue, or write
to: Drug Information Association, 321 Norristown Road, Suite 225,
Ambler, PA 19002-2755, USA, or DIA European Office, Postfach 4012,
Basel, Switzerland.  
<P>
Copyright &#169; 1996 Drug Information Association Inc.      
                    Printed in the USA
<P>
<B>Copyright Notice:</B> It is a condition of publication that
manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
By submitting a manuscript, the authors agree that the copyright
for their article is transferred to the Publisher (DIA) if and
when the article is accepted for publication. The copyright covers
the exclusive rights to reproduce and distribute the article,
including reprints, photographic reproductions, microform or any
other reproductions of similar nature and translations. Except
as indicated below, no part of this publication may be reproduced,
stored in a retrieval system, or transmitted in any form or by
any means, electronic, electrostatic, magnetic tape, mechanical,
photocopying, recording, or otherwise, without permission in writing
from the copyright holder.  
<P>
<B>Photocopying information for users in the USA:</B> The Drug
Information Association grants permission to libraries and other
users of the <I><B>Drug Information Journal</B></I> to make up
to 10 copies (inclusive) of any article for internal or personal
use. There is no fee required for up to 10 copies. Libraries and
other users of the <I><B>Drug Information Journal</B></I> desiring
to make more than 10 copies of any article should refer to <B>&quot;Permission
for other use&quot;</B> below, for guidance.  
<P>
<B>Permission for other use:</B> The copyright owner's consent
does not extend to copying for general distribution, for promotion,
for creating new works, or for resale. Specific written permission
must be obtained from the publisher for such copying. Please contact
the DIA when requesting permission. 
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>



</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-285</DOCNO>
<DOCOLDNO>IA051-000870-B028-51</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a2.htm 199.92.136.137 19970111144438 text/html 4116
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:46:15 GMT
Last-modified: Wednesday, 02-Oct-96 15:34:10 GMT
Content-length: 3923
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Editorial Board</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL</UL>
<P>
<CENTER> <STRONG> EDITORIAL BOARD</STRONG></CENTER>
<P>
<HR>
<CENTER><I><B>DRUG INFORMATION JOURNAL</B></I><BR>
<I><B>Editor-in-Chief</B></I><BR>
<B>Thomas W. Teal</B></CENTER>

<HR>
<CENTER><I><B>Editorial Board</B></I>   <BR>
<I><B> Term ends 12/31/96</B></I></CENTER>

<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>

        <TR>
        <TD VALIGN=TOP>

<B>Shein-Chung Chow, PhD</B><BR>
<I>Bristol-Myers Squibb Company</I><BR>
<P>
<B>David M. Cocchetto, PhD</B><BR>
<I>Glaxo Wellcome, Inc.</I><BR>
<P>
<B>Thomas L. Copmann, PhD</B><BR>
<I>Eli Lilly andCompany</I><BR>
<P>
<B>Charles C. Depew, PharmD</B><BR>
<I>SmithKline Beecham </I><BR>
<P>
<B>Michael R. Hamrell, PhD</B><BR>
<I>MORIAH Consultants</I><BR>
<P>
<B>Kenneth I. Kaitin, PhD</B><BR>
<I>Tufts University</I><BR>
<P>
<B>Thomas J. Kirsch</B><BR>
<I>R. W. Johnson, PRI</I><BR>
<P>
<B>Gary G. Koch, PhD</B><BR>
<I>University of North Carolina</I><BR>
<P>
<STRONG>Richard T. Layer, PhD</STRONG><BR>
<EM>National Institutes of Health</EM><BR>
            </TD>
            <TD VALIGN=TOP>
<P>
<B>Morgan Little, PhD</B><BR>
<I>OML Associates</I><BR>
<P>
<B>Vincent Mattaliano, Jr.</B><BR>
<I>Roche Laboratories</I><BR>
<P>
<B>Loren L. Miller, PhD</B><BR>
<I>Quintiles, Inc.</I><BR>
<P>
<B>Louis A. Morris, PhD</B><BR>
<I>U.S. Food and Drug Administration</I><BR>
<P>
<B>Patricia E. Stewart, MD</B><BR>
<I>McNeil Consumer Products Company</I><BR>
<P>
<B>Bradley S. Stolshek, PharmD</B><BR>
<I>Hoffmann-La Roche</I><BR>
<P>
<B>Encarnacion C. Suarez, PharmD</B><BR>
<I>Hoffmann-La Roche</I><BR>
<P>
<B>Russell J. Taylor, PhD</B><BR>
<I>Bayer Corporation</I><BR>
<P>
<STRONG> Madhu C. Trivedi, PhD.</STRONG><BR>
<EM>MGI Pharma, Inc</EM>
<P>
<B>Michael J. Umen, PhD</B><BR>
<I>Michael Umen &amp;Company</I><BR>
<P>

            </TD>
            <TD VALIGN=TOP>
</TABLE>
<HR>
<STRONG><CENTER><I>Term Ends 12/31/97</I></CENTER></STRONG>

<P>

<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>
<TR>
<TD>

<B>Joseph R. Assenzo, PhD</B><BR>
<I>Novo Nordisk A/S, Denmark</I><BR>
<P>
<STRONG>Christy Chuang-Stein, PhD</STRONG><BR>
<EM>Pharmacia & Upjohn, Inc</EM><BR>
<P>
<B>Wayne A. Colburn, PhD</B><BR>
<I>Harris Laboratories</I><BR>
<P>
<B>Roger W. Croswell, PhD</B><BR>
<I>Boehringer-Ingelheim, Ltd.</I><BR>
<P>
<B>Elizabeth B. D'Angelo, PhD</B><BR>
<I>Zeneca Pharmaceuticals, Inc.</I><BR>
<P>
<B>Robert C. de Groof, PhD</B><BR>
<I>Keystone Regulatory Associates</I><BR>
<P>
<B>Joseph A. DiMasi, PhD</B><BR>
<I>Tufts University</I><BR>
<P>
<B>Jan I. Drayer, MD</B><BR>
<I>Somatix Therapy Corporation</I><BR>
<P>
<B>Raymond L. Herman</B><BR>
<I>Zeneca Pharmaceuticals, Inc.</I><BR>
<P>
<B>Arthur I. Jacknowitz, PharmD</B><BR>
<I>West Virginia University</I><BR>
<P>
            </TD>
            <TD VALIGN=TOP>

<B>Vaila M. Marshall</B><BR>
<I>Pfizer Ltd.</I><BR>
<P>
<STRONG>Todd D. McIntyre, PhD</STRONG><BR>
<EM>Janssen Research Foundation</EM><BR>
<P>

<B>Joseph A. Meschino, PhD</B><BR>
<I>National Institutes of Health</I><BR>
<P>
<B>John R. Schultz, PhD</B><BR>
<I>Pharmacia &amp; Upjohn, Inc.</I><BR>
<P>
<B>Gary T. Shearman, PhD</B><BR>
<I>Rh&ocirc;ne-Poulenc Rorer</I><BR>
<P>
<B>Sheila R. Shulman, LLB, MPH</B><BR>
<I>Tufts University</I><BR>
<P>
<B>Max W. Talbott, PhD</B><BR>
<I>Eli Lilly and Company</I><BR>
<P>
<B>Mary Doug Tyson, MS</B><BR>
<I>U.S. Food and Drug Administration</I><BR>
<P>
<B>Daniel E. Worden</B><BR>
<I>Price Waterhouse L.L.P.</I><BR>
<P>
</TABLE>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>
<HR>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-286</DOCNO>
<DOCOLDNO>IA051-000870-B028-94</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a3.htm 199.92.136.137 19970111144449 text/html 14228
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:46:26 GMT
Last-modified: Tuesday, 23-Jul-96 17:06:20 GMT
Content-length: 14036
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Information for Authors</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL</UL>
<P>
  <CENTER><STRONG>INFORMATION FOR AUTHORS</STRONG></CENTER>
<P>
<HR>
<CENTER><B>Drug Information Journal</B><BR>
<B>Information for Authors</B></CENTER>

<P>
<B>AIMS AND SCOPE</B>
<P>
The <I>Drug Information Journal</I> is the official publication
of the Drug Information Association (DIA). The journal's purposes
are to:  
<UL>
<LI> Disseminate information on manual and automated drug research,
development, and information systems,  <BR>
<LI> Foster communication between educational, research, industrial,
and governmental personnel engaged in drug information activities,
and <BR> 
<LI> Provide a forum for the development of improved methods of
presenting research data generated from chemical, toxicological,
pharmacological, and clinical studies.  
</UL>

<P>
Manuscripts are accepted for consideration with the understanding
that they have not been published elsewhere and are not concurrently
under review elsewhere. Papers that have been given at scientific
meetings are accepted for consideration.  
<P>
<B>MANUSCRIPT SUBMISSION</B>
<P>
Manuscripts should be sent to:
<P>
<HR>
<CENTER>Thomas W. Teal, <BR>
Editor-in-Chief<BR>
<I><B>Drug Information Journal</B></I><BR>
321 Norristown Road, Suite 225<BR>
Ambler, PA 19002-2755<BR>
USA <BR> </CENTER>
<HR>
<P>
Submit three high-quality double-spaced copies of the manuscript
plus one set of camera-ready figures or photographs (original
artwork or prints) and two sets of photocopies. Include: <I>(a)</I>
a cover letter with the name, address and telephone number of
the corresponding author; <I>(b)</I> copies of any published reports
that may duplicate material in the submitted manuscript; and <I>(c)</I>
written permission of author(s) and publisher(s) to use any previously
published material (figures, tables, or quotations of more than
100 words). Authors should retain one copy of the manuscript and
figures for their own files. Upon acceptance of a manuscript for
publication, a copyright transfer (release form) must be signed
by the author(s).
<P>
<B>Computer Floppy Disks.</B> In order to speed publication and
ensure accuracy, authors are requested to submit computer floppy
disk containing the final version of their paper along with the
final manuscript. Please: 1. specify what software was used, including
which release (eg, WordPerfect 4.0); 2. specify what computer
was used, 3. include both text file and ASCII file on the disk
if possible; 4. single-space and use the wrap-around end-of-line
feature (ie, no returns at the end of each line). All textual
elements should begin flush left, no paragraph indents. Place
two returns after every element, such as title, headings, paragraphs,
figure and table callouts, etc.; 5. keep a backup disk for reference
and safety.  
<P>
<B>STYLE  </B>
<P>
<B>Sources.</B> Manuscripts, including references, are to be prepared
according to the <I>AMA Manual of Style</I> (Williams &amp; Wilkins,
Baltimore). <I>Dorland's Illustrated Medical Dictionary</I> (WB
Saunders, Philadelphia) should be used for spelling of medical
terms, and <I>Webster's Third New International</I> or <I>New
Collegiate dictionaries</I> (G. &amp; C. Merriam Co, Springfield,
MO) for spelling and hyphenation of nonmedical terms. For further
information on general style (grammar, capitalization, and so
on), see <I>The Chicago Manual of Style</I> (The University of
Chicago Press, Chicago).  
<P>
<B>Numbers.</B> Use numerals for all units of measure and time
except days, hours, and minutes, and for all numbers greater than
nine. Spell out the numbers one through nine only for general
usage (e.g., &quot;we considered only two possibilities&quot;)
and for quantities of days, hours, and minutes less than or equal
to nine. Spell out numbers, symbols, and figures beginning a sentence.
 
<P>
<B>Abbreviations.</B> Only standard abbreviations, as listed in
the <I>AMA Manual of Style</I> may be used without definition.
Terms appearing frequently within a paper may be abbreviated,
but should be spelled out at first citation, with the abbreviation
following in parentheses.  
<P>
<B>MANUSCRIPT PREPARATION</B>
<P>
Type the manuscript on white bond paper (8 1/2 x 11) with broad
margins. USE DOUBLE SPACING THROUGHOUT! Organize the manuscript
in the order indicated below, with the page number typed in the
upper right-hand corner of each page.  
<P>
<B>Title Page.</B> Page 1 should include: <I>(a)</I> the title
of the article (80 characters maximum), <I>(b)</I> full name(s)
of the author(s) with degree(s); <I>(c)</I> affiliations (job
title, department, institution, city, and state or country where
the work was done) indicating which authors are associated with
which affiliations; <I>(d)</I> acknowledgments of grant support
and of individuals who were of direct help in the preparation
of the study, <I>(e)</I> name, date, and location of DIA Workshop
at which paper was presented, if appropriate; (<I>f )</I> the
name and address of the author to whom reprint requests are to
be sent; and <I>(g)</I> running title (not more than 60 characters).
 
<P>
<B>Abstract and Key Words.</B> Page 2 should include the title
of the article followed by the abstract which should be about
150 words. The abstract should summarize the main points of the
article, the purpose of the study, basic procedures followed,
main findings, and principal conclusions. Following the abstract,
list five key words for indexing.  
<P>
<B>Text.</B> Papers should be organized in the following format:
Introduction, Materials and Methods (for experimental papers),
Results, and Discussion. Other descriptive headings and subheadings
may be used if appropriate. The methods, apparatus (including
manufacturer's name and address), and procedures should be identified
in sufficient detail to allow other investigators to reproduce
the results. References should be given for all discussions of
previous studies and for all nonstandard methods used. Trade names
may appear in parentheses and should be capitalized. Patients'
identification, names, initials, or hospital numbers should not
be used.  
<P>
<B>References.</B> Type references double-spaced and number them
consecutively in the order in which they are first mentioned in
the text, <I>not alphabetically</I>. The references should conform
to the style recommended in the <I>AMA Manual of Style</I>, except
that references in the text, tables, and legends are identified
by Arabic numerals typed parenthetically. References cited only
in tables or figures should be numbered in accordance with a sequence
established by the first mention in the text of the particular
table or figure. 
<P>
The authors are responsible for the accuracy and completeness
of the references. For journal articles, include: <I>(a)</I> author
name(s) (surnames followed by initials without periods); <I>(b)</I>
title; <I>(c)</I> journal title abbreviated as it appears in the
Index Medicus or spelled out if it is not listed; <I>(d)</I> year
of publication; <I>(e)</I> volume number <I>(f)</I> issue; <I>(g)</I>
inclusive page numbers. For books, list: <I>(a)</I> author name(s)
(surnames followed by initials without periods); <I>(b)</I> title,
including number of editions; <I>(c)</I> chapter title if appropriate;
<I>(d)</I> editor; <I>(e)</I> place of publication, publisher,
and year published; <I>(f)</I> volume number; and <I>(g)</I> page
numbers if appropriate.
<P>
Sample references:
<P>
1. Strauss JH, Strauss KG. Togaviruses. In: Nayak, DP ed. <I>The
Molecular Biology of Animal Viruses</I>, New York, NY: Marcel
Dekker, Inc.; 1977:111166. 
<P>
2. Chaung-Stein C. Summarizing Laboratory Data with Different
Reference Ranges in Multi-Center Clinical Trials. <I>Drug Inf.
J</I>. 1992;26(1):7784. 
<P>
3. Fisch FW Jr, Wasser HC, eds. <I>The Aquatic Ecosystem</I>.
Washington, DC: U.S. Environmental Protection Agency; 1984. 
<P>
4. Barnes JJ, Cohen R. Cardoo EJ. Microcosms in aquatic ecosystem
research. In: Hemingway E, ed. <I>Pollution and Aquatic Ecosystems</I>.
Springfield, VA: National Technical Information Service; 1986:2439
<P>
&quot;Unpublished observations&quot; and &quot;personal communications&quot;
should not appear in the references. These should be inserted
in parentheses in the text, and letters of permission from all
individuals cited in this way should accompany the manuscript.
Information obtained from manuscripts that have been submitted
for publication but not yet accepted should be cited in parentheses
in the text: Include authors and manuscript title followed by
&quot;submitted for publication.&quot; Manuscripts that have been
accepted for publication but have not yet been published may appear
in the references: Include authors, manuscript title, and name
of journal followed by &quot;in press&quot; in parentheses.  
<P>
<B>Tables.</B> Each table should have a brief title. Type each
table double spaced on a separate sheet. If the table must exceed
one page, duplicate all headings on the second sheet. Number tables
in the order in which they are cited in the text. Define all abbreviations
and indicate the units of measurement for all values. Explain
all empty spaces or dashes. If data from any other source, published
or unpublished, are used, obtain a permission letter for their
use and cite the source in the legend.  
<P>
<B>Figures.</B> Figures should be professionally drawn in black
ink and, if possible, submitted as glossy, high contrast black-and-white
photographs between three and six inches in width. Letters, numbers,
and symbols should be clear throughout, and should be large enough
to remain legible when reduced for publication. Be sure that all
spelling is correct, that there are no broken letters or uneven
type, and that abbreviations used are consistent with those in
the text.  
<P>
Use a label on the back of each figure to indicate the figure
number, author, and the top of the figure. Do not write directly
on the back of photographs. Do not trim, mount, clip, or staple
the illustrations. Securely package all artwork in a protective
envelope.  
<P>
Four-color illustrations will be considered for publication. However,
the author(s) will be required to bear the costs of their publication.
The color transparency or negative should be supplied, in addition
to color prints.
<P>
<B>Figure Legends.</B> Legends are brief captions that identify
the figure and permit readers to understand it without reference
to the text. Type all legends double spaced on a separate sheet
with arabic numerals corresponding to the illustrations. When
symbols, arrows, numbers, or letters are used to identify parts
of the illustrations, each should be clearly explained in the
legend. The legends should permit the figures to be understood
without reference to the text. If the figure has been previously
published, a credit line should be included and a letter of permission
obtained from the publisher.  
<P>
<B>Editor's Note:</B> These instructions for manuscript preparation
assume certain resources are available to the author. Although
compliance with these instructions will increase the probability
of publication in the Journal, authors should not be discouraged
in submitting manuscripts that do not completely comply with these
instructions. If an author feels his/her manuscript is worthy
of publication in the Journal, he/she should do as much as possible
to comply, then submit it to the Editor. If the Editor and Editorial
Board agree on its desirability for publication, the Editorial
Office will assist in satisfying the Publisher's manuscript preparation
requirements.  
<P>
<B>REVIEW AND PRODUCTION PROCESS</B>
<P>
Manuscripts are examined by the Editor and in most cases by two
reviewers. Decisions of the Editor are final. All material accepted
for publication is subject to copyediting. Authors will receive
page proofs before publication, and should answer all queries
and carefully check all editorial changes at this point. Authors
are responsible for the scientific content of their articles.
The first author of each article will receive 25 free reprints.
Additional reprints and complete copies of the issue may be ordered
directly from the Publisher, the DIA. A reprint order form will
be sent with the page proofs.  
<P>
Authors are responsible for all statements made in their work,
including changes made by the copy editor and authorized by the
corresponding author. While every effort is made by the Publisher
and Editorial Board to see that no inaccurate or misleading data,
opinion, or statement appears in this journal, they wish to make
it clear that the data and opinions appearing in the articles
and advertisements herein are the sole responsibility of the contributor
or advertiser concerned. Accordingly, the Publisher, the Editorial
Board and Editor and their respective employees, officers and
agents accept no responsibility whatsoever for the consequences
of any such inaccurate or misleading data, opinion, or statement.
 
<P>
<B>Drug and Dosage Selection.</B> The authors have made every
effort to ensure the accuracy of the information herein, particularly
with regard to drug selection and dose. However, appropriate information
sources should be consulted, especially for new or unfamiliar
drugs or procedures. It is the responsibility of every practitioner
to evaluate the appropriateness of a particular opinion in the
context of actual clinical situations and with due consideration
to new developments. 
<P><HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-287</DOCNO>
<DOCOLDNO>IA051-000870-B028-139</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/jourrate.htm 199.92.136.137 19970111144526 text/html 5812
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:46:46 GMT
Last-modified: Wednesday, 25-Sep-96 15:43:56 GMT
Content-length: 5619
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Positions Available</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">

<CENTER><IMG SRC="dia.gif"></CENTER>
<CENTER><H3>ADVERTISING  RATE  CARD</H3></CENTER>
<HR>

<P>

<B>EFFECTIVE:</B> July 15, 1996<BR>
<P>
<B>ISSUANCE:</B><BR>
a.	Frequency:	4 issues per annum<BR>
b.	Issue Date:	February, May, August, November<BR>
c.	Mailing Date:	15th of month
<P>
<B>ESTABLISHED:</B> 1966
<P>
<B>ORGANIZATION AFFILIATION:</B><BR>
Drug Information Association
<P>
<B>SUBSCRIPTION DATA:</B> Contact Publisher (DIA)
<P>
<B>EDITORIAL CONTENT:</B><BR>
The scope of this journal is international and multidisciplinary. Its purpose is to publish information dedicated to the dissemination of accurate information in medicine, biology, pharmacy and allied human and animal health fields. Papers featured will: disseminate information on manual and automated drug information systems; foster communication between education, research, hospital, industrial and governmental personnel engaged in drug information activities; provide a forum for the development of improved methods of collecting, selecting, storing, computing, and evaluating research data generated from chemical toxicological, pharmacological and clinical studies.
<P>


<B>
REQUIREMENTS FOR ACCEPTANCE OF ADVERTISING:</B><BR>
Professional and non-professional products. All advertising subject to editorial approval.
<P>
<B>POLICY ON ADVERTISING PLACEMENT:</B><BR>
Subject to approval by DIA Advertising Manager. Appropriate rates will apply.
<P>
<B>SERVICE TO ADVERTISERS:</B><BR>
a. Availability of mailing lists: Not available.<BR>
b. Availability of reprints: Direct requests to publisher.

<P>
<B>	CIRCULATION</B>
<P>
<B>GUARANTEED CIRCULATION:</B> 13,500
<P>
<B>CIRCULATION VERIFICATION:</B> Sworn Statement
<P>
<B>COVERAGE AND MARKET:</B><BR>
Distributed internationally to personnel in the pharmaceutical industry, research and development professionals, industry information specialists, government regulatory personnel, academic faculty in pharmacy, nursing, medicine, biostatisticians and allied health sciences. Distributed to association members for a reduced fee as part of the benefits of membership.
 
<P>









<B>TERMS:</B><BR>
Net 30 days.
<P>
<B>RATES:</B><BR>
Full Page B/W $700<BR>
Half Page B/W $475<BR>
Color, bleed and position charges to be added.<BR>
There is no agency discount; the invoice amount must be <BR>
paid in full.
<P>
<B>COLOR RATES:</B><BR>
a.	Standard color: $250 plus B/W page rate.<BR>
b.	List of standard colors: PMS colors.<BR>
c.	Four-color rate: $900 plus B/W page rate.<BR>
d.	Bleed charge: $50 per page.
<P>
<B>COVER AND PREFERRED POSITION:</B><BR>
a.	Second Cover:<BR>
	30% premium over page rate.<BR>
b.	Second Cover and Facing Page:<BR>
	35% premium over page rate.<BR>
c.	Third Cover:<BR>
	25% premium over page rate.<BR>
d.	Fourth Cover:<BR>
	50% premium over page rate.<BR>
e.	2nd and 4th Cover:<BR>
	4-color preferred - 2 color accepted<BR>
f.	Information on other preferred positions available <BR>
	on request.<BR>
g.	Covers non-cancelable.
<P>
<B>SPECIAL POSITIONING:</B><BR>
When an advertiser requests a specific position, it must be considered "preferred" and charged at the regular rate plus 10% premium.
<P>
<B>MISCELLANEOUS:</B><BR>
Contracts accepted with the understanding that, in the event of rate adjustment, contracts are protected for six
(6) months beyond the last issue closed prior to the announcement date.
<P>
<B> MECHANICAL DATA</B>
<P>
<B>ADVERTISING PAGE SIZES:</B><BR>
		Inches	Metric<BR>
a.	Trim Size:	6-3/4 x 10	170 x 254mm<BR>
b.	Page:	5-3/4 x 9	145 x 228mm<BR>
c.	1/2 Page Vertical:	2-5/8 x 9	 65 x 228mm<BR>
d.	1/2 Page Horizontal:	5-3/4 x 4-3/8	145 x 110mm<BR>
e.	Bleed Size:	7 x 10-1/4	177 x 260mm
<P>
<B>PRINTING:</B> Web and Sheet fed offset<BR>
<B>BINDING:</B> Perfect Bound<BR>
<B>HALFTONE SCREENS:</B> 120-150 line screens
<P>
<B>REPRODUCTION REQUIREMENTS:</B><BR>
Preferred materials: Film negatives, right reading, emulsion side down; photostats; camera-ready copy.
Proofs (one to publisher).<BR>
a.	2 color - PMS colors and clear indication of color 
	breaks by color proof, printed sample or clearly 
	labeled negatives.<BR>
b.	4 color - Color proof or printed sample required only 
	for critical color matching. Otherwise provide only 
	clearly labeled negatives.
<BR>
<B>CLOSING DATES:</B><BR>
a.	Preferred materials due date (with proofs):<BR>
	February Issue  January 1<BR>
	August Issue  July 1<BR>
	May Issue  April 1<BR>
	November Issue  October 1<BR>
b.	Publication set copy:<BR>
	Seven weeks preceding issue date.<BR>
c.	Closing dates are tentative and can vary depending <BR>
	upon production schedule.
<P>
<B>DISPOSITION OF MATERIALS:</B><BR>
Material furnished for advertising reproduction will be destroyed twelve months subsequent to issue date unless otherwise instructed.
<P>
<B>ADDRESSES:</B><BR>
a.	Contracts, insertion orders, patch instructions, set <BR>
	copy, should be sent to Attention: Advertising Dept., <BR>
	DRUG INFORMATION ASSOCIATION, 321 <BR>
	Norristown Road, Suite 225, Ambler 19002-2755 <BR>
	USA; Tel: 215 628-2288  Fax: 215 641-1229; <BR>
	email: eileen@diahome.org<BR>
b.	Advertising film, including all necessary press and <BR>
	progressive proofs - send to: DRUG <BR>
	INFORMATION ASSOCIATION, 321 Norristown <BR>
	Road, Suite 225, Ambler, PA 19002-2755 USA) <BR>
	Tel: 215 628-2288  Fax: 215 641-1229<BR>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-288</DOCNO>
<DOCOLDNO>IA051-000870-B028-182</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a4.htm 199.92.136.137 19970111144549 text/html 1203
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:47:26 GMT
Last-modified: Tuesday, 23-Jul-96 17:06:16 GMT
Content-length: 1012
Content-type: text/html
</DOCHDR>

<HTML>

<HEAD>

<TITLE>Index to Volume 29</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL  (ISSN 0092-8615)</UL>
<P>
 
<P>
<CENTER><STRONG>INDEX TO VOLUME 29 (1995)</STRONG></CENTER>
<P>
<HR>
<UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp5a4a.htm"> ARTICLE INDEX (Table of Contents)</A>
<P>
   <IMG SRC="bullet2.gif">     <A HREF="dhp5a4b.htm"> AUTHOR INDEX (List of Author's Names and Page Numbers)</A>
</UL>
<HR>

<P>
INDEXED IN BIOSIS (Previews database), Chemical Abstracts, Current
Awareness in Biological Sciences (CABS), Excerpta Medica (EMBASE), Health Planning
and Administration (NLM), Hospital Literature Index, Information Science Abstracts, International
Pharmaceutical Abstracts, Life Sciences Collection, Risk Abstracts and Toxicology Abstracts
<P>
<HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-289</DOCNO>
<DOCOLDNO>IA051-000870-B028-214</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a5a5.htm 199.92.136.137 19970111144608 text/html 5800
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:47:47 GMT
Last-modified: Thursday, 10-Oct-96 17:27:17 GMT
Content-length: 5608
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
PUBLICATIONS<BR>

<UL>	DRUG INFORMATION JOURNAL </UL>

<CENTER>		INDEX TO VOLUME 30 (1996)</CENTER>

<CENTER>			AUTHOR INDEX <BR>
(List of Authors Names and Page Numbers)</CENTER>

<CENTER><B>Author Index to Volume 30 (1996)</B></CENTER>
			<HR>
<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>

        <TR>
        <TD VALIGN=TOP>

 Adornato FA, Jr., 869<BR>
Agner S, 753<BR>
Akaho E, 737, 913<BR>
Anderson RJ, 89<BR>
Appel WC, 655<BR>
Asbjorn DT, 207<BR>
Austrian ML, 365<BR>
<P>
Basa F, 621<BR>
Basara LR, 715<BR>
Bell PJ, 473<BR>
Benson LO, 799<BR>
Beretta A, 891<BR>
Birdwell S, 465<BR>
Bishop SK, 389<BR>
Brightwell D, 693<BR>
Britt AL, 47<BR>
Brown JS, 17, 315<BR>
Bryant PJ, 243<BR>
Buckley J, 593<BR>
Burka M, 769<BR>
Bush J, 709<BR>
Byczkowski JZ, 401<BR>
<P>
Capizzi R, 949<BR>
Carmignoto F, 413<BR>
Castle W, 73<BR>
Chen M, 301<BR>
Chow S-C, 881<BR>
Chowhan ZT, 451<BR>
Chuang-Stein C, 351, 421<BR>
Ciociola AA, 433<BR>
Clark P, 769<BR>
Cobert BL, 965<BR>
Colburn WA, 573<BR>
Coleman JC, 243<BR>
Cossry J-M, 517<BR>
Crawley R, 593<BR>
Currie WJC, 869<BR>
<P>
Davis CS, 339<BR>
Dean J, 269, 313<BR>
de Crmiers F, 675<BR>
DeLap RJ, 359<BR>
Descotes J, 271<BR>
De Waal EJ, 275<BR>
DiMasi JA, 315<BR>
Donovan S, 785<BR>
Drews J, 97<BR>
Drummond MF, 491<BR>
Dupin-Spriet T, 661<BR>
Dutar C, 137<BR>
<P>
Edwards IR, 461<BR>
Ellenberg JH, 535<BR>
Ellenberg SS, 521, 553, 563<BR>
Epstein R, 839<BR>
Evans GO, 815<BR>
Evens RP, 583<BR>
<P>
Fairweather WR, 875<BR>
Farrelly JG, 177<BR>
Feifer S, 601<BR>
Feingold SA, 761<BR>
Fieldstad LM, 965<BR>
Finney DJ, 987<BR>
Fisher MP, 41<BR>
Fleming GA, 359<BR>
Fleming TR, 545<BR>
Flynn GA, 181<BR>
Flynn J, 583<BR>
Fourcroy JL, 359<BR>
Fucik H, 461<BR>
Furst SM, 301<BR>
<P>
Gandolfi AJ, 301<BR>
Gans KR, 769<BR>
Gansky SA, 523<BR>
Genduso LA, 1003<BR>
Germolec DR, 281<BR>
Gittelson PL, 703<BR>
Gittins J, 479<BR>
Goldberg Arnold RJ, 609<BR>
Goldstein DJ, 425<BR>
Good AC, 371<BR>
Goodman DB, 237<BR>
Gore MR, 257<BR>
Gosse ME, 991<BR>
Grady LT, 1063<BR>
Gretz M, 217<BR>
Groenewoud G, 473<BR>
Groover S, 753<BR>
Gumbhir AK, 973<BR>
<P>
Haffner ME, 29<BR>
Halliday RG, 821<BR>
Hammerstrom T, 1105<BR>
Hansen SK, 257<BR>
Harkins RD, 811<BR>
Hastings KL, 177, 309<BR>
<P>
Jenkins AA, 207<BR>
Johnson GP, 119<BR>
Johnson LR, 709<BR>
Jones K, 1<BR>
<P>
Kaitin KI, 17<BR>
Kammller ME, 293<BR>
Kaniecki DJ, 609<BR>
Kare A, 465<BR>
Kearns GL, 1121<BR>
Keller K, 933<BR>
Kimber I, 287<BR>
Kirchdoerfer LJ, 185<BR>
Kirk S, 83<BR>
Koch GG, 523<BR>
Kopp SW, 59<BR>
Kotsanos JG, 1003<BR>
Krol TF, 243<BR>
Kucukarslan S, 465<BR>
Kuelbs E, 799<BR>
Kurland M, 961<BR>
Kurjatkin O, 965<BR>
<P>
<TD VALIGN=TOP>

Lachenbruch PA, 921<BR>
Lachin JM, 1017<BR>
Lair TJ, 679<BR>
Landsman PB, 761<BR>
Larus J, 35<BR>
Lasagna L, 315<BR>
Leeder JS, 1135<BR>
Leslie WD, 206<BR>
Levin EA, 35<BR>
Little OM, 637<BR>
Liu J-P, 881<BR>
Lock C, 799<BR>
Lukas G, 1091<BR>
Lumley CE, 441<BR>
Luscombe F, 839<BR>
Luster MI, 281<BR>
Lydick E, 839, 961<BR>
Lynch CJ, 921<BR>
Lyons, Jr. FW, 9<BR>
<P>
Mackintosh DR, 645<BR>
Magidson J, 143<BR>
Maldano S, 1125<BR>
Manocchia M, 991<BR>
Mapes D, 583<BR>
Marc L, 799<BR>
Marsh R, 113<BR>
Matano AMR, 413<BR>
Mathews RA, 207<BR>
McAuslane N, 17<BR>
McFarland LV, 793<BR>
McGilveray IJ, 1029<BR>
McRorie T, 1173<BR>
McSorley DJ, 433<BR>
Mehta MS, 207<BR>
Michalak RA, 207<BR>
Miller LL, 257, 593<BR>
Miranda GF, 891<BR>
Mitchell AS, 495<BR>
Moyer RW, 181<BR>
Munson AE, 281<BR>
Mutlib AF, 905<BR>
Norwood P, 559<BR>
Noursalehi M, 897, 957<BR>
<P>
Oddone EZ, 761<BR>
Osterhaus JT, 185<BR>
Ostman M, 109, 201<BR>
Otun EO, 137<BR>
<P>
Parkinson C, 441<BR>
Pascucci VL, 41<BR>
Phillips G, 73<BR>
Pines WL, 67<BR>
Polli JE, 1113<BR>
Pollock B, 669<BR>
Portier C, 281<BR>
Potyk RP, 609<BR>
<P>
Qureshi SA, 1055<BR>
<P>
Reed MD, 1129<BR>
Rekhi GS, 1113<BR>
Richards WG, 371<BR>
Roberts R, 1125<BR>
Rogers JL, 897, 957<BR>
Rogers R, 1129<BR>
Roylance PJ, 869<BR>
Ruggeri A, 413<BR>
Rumore JS, 601<BR>
Rumore MM, 601<BR>
Ryser S, 97<BR>
<P>
Samsa GP, 761<BR>
Sathe P, 1105<BR>
Sax MJ, 609<BR>
Schubert F, 503<BR>
Section for Official <BR>
Laboratories and Medicines <BR>
Control Services and the <BR>
Section of Industrial <BR>
Pharmacists, Federation<BR>
International <BR>
Pharmacetique, 1071 <BR>
<P>
Shah VP, 1085, 1105, 1113<BR>
Shiu GK, 1045<BR>
Siegel JP, 567<BR>
Silverman D, 693<BR>
Simel DL, 761<BR>
Simeonova P, 281<BR>
Smith C, 769<BR>
Shngen M, 395<BR>
Shngen W, 395<BR>
Soutre E, 489, 513<BR>
Spielberg SP, 1145<BR>
Spriet A, 661<BR>
Storey DE, 1039<BR>
Stringer S, 745<BR>
Sum DS, 973<BR>
Sylvestri MF, 1163<BR>
<P>
Taglieber U, 869<BR>
Taylor A, 177<BR>
Thomas KE, 17<BR>
Thomas M, 217<BR>
Tinianow D, 737<BR>
Tong DM, 421<BR>
Torrance G, 507<BR>
Trampisch H-J, 195<BR>
Tsong Y, 1105<BR>
<P>
Uchida K, 171<BR>
<P>
van der Laan JW, 269, 313<BR>
Van Loveren H, 275<BR>
van Manen RP, 731<BR>
Vercellesi L, 891<BR>
Vos JG, 275<BR>
<P>
Walker SR, 17<BR>
Webb DD, 433<BR>
Wells TG, 1179<BR>
Weinberger M, 761<BR>
Whalen EY, 35<BR>
Wilson JT, 1149<BR>
Wilson MG, 425<BR>
Windeler J, 195<BR>
Winkler G, 35, 113<BR>
<P>
Yawn B, 961<BR>
Young TL, 185<BR>
<P>
Zepp VJ, 645<BR>
Zhang J, 949<BR>
</TABLE>
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-290</DOCNO>
<DOCOLDNO>IA051-000870-B028-246</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a5.htm 199.92.136.137 19970111144618 text/html 1290
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:47:57 GMT
Last-modified: Thursday, 10-Oct-96 17:26:55 GMT
Content-length: 1098
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Table of Contents Volume 30</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL (ISSN 0092-8615)</UL>
<P>
<CENTER><STRONG>TABLE OF CONTENTS- VOLUME 30 (1996)</STRONG></CENTER>
<HR>
<P>
<UL>
<IMG SRC="bullet2.gif">     <A HREF="dhp5a5a1.htm"> ISSUE 1 (FEBRUARY 15)</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5a5a2.htm"> ISSUE 2 (MAY 15)</A> 
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5a5a3.htm"> ISSUE 3 (AUGUST 15)</A>
<P>
<IMG SRC="bullet2.gif">     <A HREF="dhp5a5a6.htm"> ISSUE 4 (NOVEMBER 15)</A>
</UL>
<P>
<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

<CENTER>Drug Information Association<BR>

321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>

Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>

or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>

Tel. +41 61 382 90 19, Fax. +41 61 382 90 50<BR>

Drug Information Association 1996<BR></CENTER>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-291</DOCNO>
<DOCOLDNO>IA051-000870-B028-293</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5b1.htm 199.92.136.137 19970111144632 text/html 7672
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:48:10 GMT
Last-modified: Friday, 13-Dec-96 21:05:41 GMT
Content-length: 7482
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Presidents Message</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P><UL>
 DIA NEWSLETTER
<P></UL></HR>
<CENTER><STRONG>PRESIDENTS MESSAGE</STRONG></CENTER>
<P><HR>
This, my third message to the DIA membership, provides me with an opportunity to wish you a <I>Healthy and Successful 1997!</I><BR><P>

During the fourth quarter of 1996, the DIA held 15 meetings in addition to several training courses. Thanks to your participation on our program committees and as speakers, we continue to provide our membership with high quality, up-to-date presentations on new drug development and related topics. If you wish to participate in a workshop or meeting as a speaker, contact the DIA offices and let them know which meeting you wish to contribute to. The office will pass your request to the Program Chair for that meeting when his/her name is announced.<BR><P>

Have you visited <B>http://www. diahome.org</B> since my last message? The DIA Home Page is thriving and steadily increasing in value through services offered to the membership. Inaugurated in June of this year, the total unique hits (visits to our page) per month was: June 267, July 556, August 701, September 2,570 and for October 2,790. We have added an Employment Information section. Presently there are about 200 jobs posted there. The Information Central section has been expanded to include hyperlinks to new government and non-profit agencies (21 in all). <BR><P>

You may now communicate directly with our DIA staff in the US and European offices through email  fast, economically and personally.  This home page feature has been upgraded to permit communications with each individual in the offices.<BR><P>

<B>http://www.diahome.org<BR><P>
<I>Visit  Us !!!</I></B><BR><P>

An exciting new feature includes the on-line availability of the <B>Drug Information Journal</B><I></I>. The complete text of each issue of the Journal commencing with the first issue of 1996 is available on-line. The quality of articles printed from the home page is about as good as the original! We will continue to put the Journal issues on the home page as they are published. Eventually, we will install a search engine dedicated to retrieving articles from these files.<BR><P>

A survey conducted during the recent DIA Annual Meeting indicated a high regard for the Journal. The broad range of topics is one of the reasons for its value to you as members. I urge you to consider publishing in the Journal. Information for authors appears in each issue.<BR><P>
The Pharmaceutical Contract Support Organizations Register (<B>PCSO <I>Register</I></B>) is now on-line in the home page. Of the 245 companies who will appear in the 1996 Register, 99 of them have registered for a place on the DIA Home Page! Those 99 companies with their own home page are hyperlinked from the DIA Home Page direct to the companys home page. Where those companies have email capability, their email address is included to facilitate members communications with the companies. Companies in the Register who have recently developed a home page can be added to the on-line version. Check with a DIA office!<BR><P>

The DIA <I>Research Grant Program</I> funds several grants (in amounts not to exceed $25,000 each) to encourage and foster research in pharmaceutical and biotechnology product development, regulation, marketing, utilization, and surveillance among others. Recipients of the grants must be affiliated with not-for-profit organizations. If you are interested in participating in the program, ask one of the DIA offices for more information. <BR><P>

The DIA office has been rewired to full ethernet specifications and Windows 95 NT is under test there. Additional upgrades in equipment and software are taking place. Our staff in both Europe and the US are dedicated as well as efficient. A work flow analysis has indicated the need for the addition of staff. That analysis included consideration of the additional training courses and workshops scheduled for 1997 and beyond.<BR><P>

Make your plans to attend the 1997 DIA Annual Meeting Optimizing Pharmaceutical Development: The Global Experience. The venue is the Palais des Congrs de Montral, Montral, Canada. The date of the meeting is June 22 - 26, 1997. <B>Irwin Martin, PhD</B>, Parke-Davis, is the Program Chair. Make your reservations early. The meeting will be very well attended and accommodations in Montral will sell out quickly! We can count on Irwin and his committee to bring us an outstanding meeting. The 9th Annual Euromeeting The 1998 Impact on the Pharmaceutical Industry - Are YOU Prepared? will be held at the Conference Centre, Dsseldorf Stadthalle, Germany, May 26 - 28, 1997. One of the highlights of this meeting will be a series of presentations on current and future activities of the CPMP working parties responsible for quality, safety, efficacy, biotechnology and pharmacovigilance. Plan on attending and make your reservations early!<BR><P>

We continue to advise interested members of currently available Internships. Note the location of this information in the Table of Contents of this newsletter. Interested parties should contact the appropriate person directly. We have also provided in this issue of the Newsletter a form to be used to advertise an available Internship. If your company has Internships available, let us help you advertise them!<BR><P>

Discussions are underway to evaluate the need for a DIA office in Japan as well as discussions for future workshops in Taiwan, China (Beijing), East Pakistan and South America.<BR><P>

I take this opportunity to welcome our new DIA office which will serve the South West Asian Pacific Region (SWAP) and the administrator of this office, <B>Mr. David Addison</B>. The office is located in Annandale NSW, Australia. The telephone, fax and email address for the SWAP office appear on the cover of this newsletter.<BR><P>

Our last DIA Newsletter issued a Call for Nominations for the Board of Directors of the DIA. Nominees for the 1977 election will have been submitted by the nominating committee (Chair is D<B>r. David M. Cocchetto</B>) for consideration by the board at the board meeting December 14, 1996. Ballots for the election will be mailed near February 1st. If your membership dues are paid for 1997, you will receive a ballot. We urge you to vote for the candidates of your choice in this election. Successful candidates names will be announced at the annual meeting in June, in Montral, Canada.<BR><P>


Sincerely<P>
John J. Donahue, PhD<BR>
President<BR>Drug Information Association
<HR>
<P><CENTER><A HREF="dhp2.htm"><IMG  BORDER=0 SRC="about.gif"></A><A HREF="dhp3.htm"><IMG BORDER=0 SRC="member.gif"></A><A HREF="dhp5b2.htm"><IMG BORDER=0 SRC="recent.gif"><A HREF="dhp4.htm"><IMG BORDER=0 SRC="upcom.gif"></A><A HREF="dhp5.htm"><IMG BORDER=0 SRC="public.gif"></A><A HREF="dhp6.htm"><IMG BORDER=0 SRC="awards.gif"></A><A HREF="dhp7.htm"><IMG BORDER=0 SRC="fellow.gif"><A HREF="dhp8.htm"><BR><IMG BORDER=0 SRC="conted.gif"><A HREF="dhp9.htm"><IMG BORDER=0 SRC="dianews.gif"><A HREF="dhp10.htm"><IMG BORDER=0 SRC="infocen.gif"></A><A HREF="dhp11.htm"><IMG BORDER=0 SRC="personal.gif"></A><A HREF="dhp12.htm"><IMG BORDER=0 SRC="message.gif"></A><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>


</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-292</DOCNO>
<DOCOLDNO>IA051-000870-B028-331</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/newsrate.htm 199.92.136.137 19970111144642 text/html 2824
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:48:23 GMT
Last-modified: Wednesday, 25-Sep-96 15:44:13 GMT
Content-length: 2631
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>News Rate "Advertising Rate Sheet"</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<CENTER><H3>DRUG  INFORMATION  ASSOCIATION  NEWSLETTER </H3></CENTER>
<HR>

<CENTER><B>1997 Advertising Rate Sheet<BR>
Effective: October 15, 1996</B></CENTER>
<P>
<CENTER><TABLE BORDER=2 WIDTH=25 HEIGHT=5 CELLPADDING=5 CELLSPACING=5>
<TR><TH>	SIZE</TH><TH>	TYPE</TH><TH>	DIMENSIONS</TH><TH>	COST</TH></TR>
<TR><TH>	QUARTER PAGE</TH><TH></TH><TH>		3 5/8" X 4 7/8"</TH><TH>	$ 365</TH></TR>
<TR><TH>	HALF PAGE</TH><TH>	Vertical</TH><TH>	3 5/8" X 10"</TH><TH>	$ 475</TH></TR>
<TR><TH>	HALF PAGE</TH><TH>	Horizontal</TH><TH>	7 1/2" X 4 7/8"</TH><TH>	$475</TH></TR>
<TR><TH>	FULL PAGE</TH><TH></TH><TH>		7 1/2" x 10"</TH><TH>	$ 700</TH></TR>
<TR><TH>	INSIDE BACK COVER</TH><TH></TH><TH>		71/2" X 10"</TH><TH>$ 750</TH></TR>
<TR><TH>	BACK COVER</TH><TH></TH><TH>				71/2" X 10"</TH><TH>	$ 825</TH></TR>
</TABLE></CENTER>


<P>
<B> Mechanical Requirements:</B><BR>
Offset negatives (right reading emulsion down 
or positives, black & white only), repro proofs, camera-ready art, or scotch prints.  Any ad requiring typesetting will be charged at cost.  
A charge will be made by invoice for revisions made on standing ads.  The Drug Information Association reserves the right to reject any ad that is not professionally prepared (e.g. typewritten copy, hand drawn art, etc.).
<P>
<B>Closing Dates:</B><BR>
<B><I>September 1, December 1, March 1, and June 1.</I></B>  The Newsletter is published quarterly, on the first of October, January, April, and July.
<P>
<B>Payment:</B><BR>
Payment should be received with advertising (camera ready) copy.  Space reservations 
cannot be made over the telephone.  
<B>THERE IS NO AGENCY DISCOUNT; </B>
the amounts listed above must be paid in full. 
<P>
<B>Circulation Information:</B><BR>
There is a guaranteed circulation of 14,000 copies per issue.  Subscription is included as 
part of the benefits of membership in the DIA. Circulation area includes North America, Europe, Japan, and many other countries.
<P>
 The DIA will make every effort to place your ad where requested, but cannot guarantee location.
All ads must be reviewed by DIA for approval before publication in the Newsletter.
<P>
<B>DIA ADVERTISING AND PUBLICATION OFFICE</B><BR>
321 Norristown Road, Suite 225, Ambler, PA 19002-2755, USA<BR>
Telephone:  (215) 628-2288      Telefax:  (215) 641-1229      email:  nancy@diahome.org<BR>
See the DIA home page at -http://www.diahome.org<BR>
9/15/96







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-293</DOCNO>
<DOCOLDNO>IA051-000870-B028-361</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f1.htm 199.92.136.137 19970111144658 text/html 7197
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:48:32 GMT
Last-modified: Tuesday, 23-Jul-96 17:08:02 GMT
Content-length: 7006
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>President's Annual Report Message</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>PRESIDENT'S ANNUAL REPORT MESSAGE</STRONG></CENTER>
<P><HR>
Thank you for the opportunity to serve the DIA as President for the past year. It has been an honor and a pleasure to work in concert with the Executive Director, Board of Directors, and our dedicated staff.
<P>
I will remain on the Board of Directors for one additional year as the Immediate Past President. In that capacity, I will fully support the new President, Dr. John Donahue (Vice President, Project Planning and Management, Bristol-Myers Squibb Co.) DIA is very fortunate to have an individual with Dr. Donahues experience and skills to assume the presidency.
<P>
In this annual report, I want to address the following seven topics:<BR>
<UL>
<LI>DIAs Mission
<LI>Membership
<LI>Meetings
<LI>Publications
<LI>Continuing Education
<LI>Grants and Awards
<LI>Financial Status
</UL>
<P>
<B>Mission:</B> DIA provides a neutral forum for open exchange of drug information among all sectors of the drug development community. In an era of lobbyists, agenda-driven associations, and commercial training organizations, DIA shines as a non-profit professional association whose neutral forum is open to all points of view. Our ability to sustain this neutral forum, coupled with the dedication of our members, are the keys to DIAs sustained success.
<P>
<B>Membership:</B> I am pleased to report that DIA is sustaining its membership at approximately 13,000 people. This sustained membership is laudable at a time when the industry continues to consolidate, removing over 50,000 jobs in recent years. Clearly, those individuals remaining in positions with traditional companies, as well as individuals working in small companies and consultants, need drug information as much as ever, perhaps even more. Opportunities for networking among DIA members are valuable opportunities for learning new skills and benchmarking your practices against those in other organizations.
<P>
<B>Meetings:</B> DIAs principal activity for its members is to sponsor meetings, workshops, and training courses. Over the last year, DIA sponsored approximately 70 meetings. Importantly, DIA offered 18 training courses with 990 attendees on such topics as clinical trial monitoring, safety surveillance, good clinical practices, and regulatory affairs. The revenues produced by these meetings enable DIA to provide member services in the form of publications, continuing education programs, grants, fellowships, and awards.
<P>
<B>Publications:</B> All members of DIA receivethe DIA Newsletter, the Drug Information Journal, an annual Membership Directory, and the Pharma-ceutical Contract Support Organization (PCSO) Register. In 1995, the Journal published 223 articles with a total of 1,742 pages of information 
on diverse, current topics. Many papers were based on presentations at DIA meetings, while others were original scholarly publications. Authors included individuals from government, academia, and industry, from the United States, Europe, Japan, and many other countries. The Journal is a valuable chronicle of current practices by leading participants in the drug development process. All of this has been accomplished under the watchful eye of our devoted Editor-in-Chief, Mr. Thomas W. Teal. I extend my thanks to Tom for a Journal that continues to serve the members and continues to improve on a strong past performance.
<P>
<B>Continuing Education:</B> DIA offers continuing education (CE) credits to physicians and pharmacists who attend our meetings. Such CE credit is increasingly important in this era when expanding your skill base is so necessary. During 1995, DIA sponsored 25 meetings offering Continuing Medical Education credits to physicians; 419 physicians attended and 120 applied for CME credits. We also issued 1,208 certificates for ACPE-certified Continuing Education credits for pharmacists in 1995. The CE credits for physicians and pharmacists were provided as part of DIAs standard service  no additional fee was added to provide this service to these members.
<P>
<B>Grants and Awards:</B> DIAs Board of Directors awards grants and fellowships to advance the dissemination of drug information, worldwide.In March 1996, DIA awarded Research Grants (up to $25,000 each) to six recipients for research on diverse topics including reshaping the pharmaceutical distribution network, factors that influence the commun-ication of drug information, and identification of an essential list of drugs for an Armenian pharmacopeia. DIA also co-sponsored joint fellowships on drug development and pharmaco-epidemiology with the Food and Drug Administration, Georgetown University and the University of Maryland. These fellowship programs help to assure that well-trained scientists continue to enter the drug information field. Finally, DIAs Steering Committee for International Development has offered smaller grants to foster drug information initiatives in regions beyond the US and Europe.
<P>
<B>Financial Status:</B> I am pleased to report that DIA is in sound financial condition. Our meetings have provided sufficient revenues to continue all of our services to members, as well as initiate new activities. For example, we have initiated an effort to provide certain member services through a DIA Home Page on the Internet. Youll find us at "http://www.diahome.org". This page enables DIA to participate in this burgeoning technology. The home page offers information about DIA, its officers, and committees, as well as information on upcoming meetings and important links to other key sources of drug information.
<P>
It has been a challenging and rewarding year for me. Throughout my term, I have tried to think first of what is best for DIAs members as I have led deliberations on various matters. DIA continues to be a healthy, growing, dynamic association because of the energy and ideas contributed by the multitude of active volunteers/members. I am confident that your elected officers will continue to be guided by the goal of providing the best services to you, the members of DIA.
<P>
Finally, I want to publicly state my thanks to my wife, Linda, and my employer, Glaxo Wellcome. My wife has been encouraging and fully supportive throughout my time on the Board; she has tolerated my absences from home with patience and understanding. My employer has supported my voluntary activities in DIA and has appreciated the importance of DIAs role as one of the few, vital, neutral forums for discussion of contemporary issues in drug information.
Thank you,

<P>

<B>David M. Cochetto, PhD, RPh</B><BR>
President<BR>
Drug Information Association



<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-294</DOCNO>
<DOCOLDNO>IA051-000870-B029-27</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f2.htm 199.92.136.137 19970111144715 text/html 2822
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:48:53 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:54 GMT
Content-length: 2631
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Executive Director's Message</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>

<UL> ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>EXECUTIVE DIRECTOR'S MESSAGE</STRONG></CENTER>
<P><HR>
The year 1995-1996 has been exciting and so very successful.  The DIA has sponsored programs including training courses, seminars and symposia, and our two annual meetings  the Euromeeting held in Paris, France and the Annual Meeting in Orlando, Florida  our largest to date at three thousand attendees.  This years Annual Meeting in San Diego, California, promises equal success with over six hundred speakers, twenty-four subject tracks and an exhibition of over 300 companies offering products and services to the pharmaceutical industry.  
<P>
The DIA published four issues of the <B>DIA Newsletter</B>, four issues of the <B>Drug Information Journal</B>, the Membership Directory and the Pharmaceutical Contract Support Organization  <B>PCSO Register.</B>
These programs are supported by a total of sixteen full-time, part-time and seasonal personnel at the DIA headquarters offices in Ambler, Pennsylvania, USA, our European Administrative offices in Basel, Switzerland and newly enlisted support organizations and contractors in Moscow, Russia, Tokyo, Japan, Sydney, Australia, and Mexico City, Mexico.
<P>
The new Internet location "http://www.diahome.org" will allow members and other interested parties access to information about DIA and about DIA programs including planned and recent meetings. The  listing companies in the <B>PCSO Register</B> may elect to be included in the DIAs home page, where a "search engine" will allow members (and others) to search information pages for character strings. This new home page should be very useful to our membership. 
<P>
Member initiatives have allowed the DIA to establish twenty-three special interest advisory committees which intend to develop continuing programming for their peers in the industry.  The members of these advisory committees as well as other committees are shown on page 1721 of this report.  We are grateful to these members for their interest and on-going support for the DIA.
<P>
If you are a member of DIA, please feel welcome to recommend new or additional educational and informational programs.  If you are not presently a member, please understand that you are invited to attend DIA programs.
<P>

Erich F. Lukas, Jr., MBA<BR>
Executive Director

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-295</DOCNO>
<DOCOLDNO>IA051-000870-B029-68</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f3.htm 199.92.136.137 19970111144745 text/html 2266
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:49:06 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:51 GMT
Content-length: 2075
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA Meeting Statistics</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>DIA MEETING STATISTICS</STRONG></CENTER>
<P><HR>
The mission of the DIA charges us to provide a worldwide forum for the exchange and dissemination of information. That neutral forum in which ideas, information, methodology and opinions is provided and shared among and between the many DIA constituents.
<P>
The DIA sponsors meetings, workshops and training courses, highly responsive to the rapidly evolving, multi-disciplinary needs of its international membership. The content and format of these activities are determined by a pro-active, participatory membership. The activities address a broad range of pharmaceutical, regulatory and drug development topics.
<P>
<UL>
<LI>DIA held over 75 meetings, workshops and training courses in
the US, Europe, Canada, Australia and Japan. These meetings 
were attended by over 12,000 of our members.
<LI>DIA continues to expand meeting topics in response to the ever 
changing technology of new drug development.
<LI>DIA meetings covered trends and provided forums for 
discussion of the many topics of pharmaceutical discovery, 
development, evaluation and regulation.
Examples of the broad spectrum of topics addressed by DIA 
meetings during 1995 were:
</UL>
 Disease Management: Strategies for Improving Clinical 
and Economic Efficiency<BR>
 Pharmaceutical Pricing, Reimbursement and Comparative 
Assessment<BR>
 Patient Recruitment - Clinical Trial Strategies and Issues<BR>
 Quality of Life and Pharmacoeconomic Issues<BR>
 Good Clinical Practices Educational Seminar<BR>
 Document Management and Archiving<BR>
 IRBs: Management and Ethical Issues<BR>
 Adverse Drug Reaction Management <BR>
 Case Report Form Development<BR>
 Clinical Data Management<BR>
 The ICH Process

<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-296</DOCNO>
<DOCOLDNO>IA051-000870-B029-105</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f4.htm 199.92.136.137 19970111144802 text/html 2474
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:49:43 GMT
Last-modified: Thursday, 10-Oct-96 15:43:03 GMT
Content-length: 2282
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Editor-in-Chief's Message</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>DIJ, EDITOR-IN-CHIEF'S MESSAGE</STRONG></CENTER>
<P><HR>


<CENTER><B>Drug Information Journal</B><BR>
<I>Contributing to drug information literature</I></CENTER>
<P>
The Drug Information Journal is the official publication of the Drug Information Association. It is published quarterly by the DIA and has a circulation/distribution of over 14,000. Volume 29 (1995) contains 1,742 pages of articles. The articles deal with various topics concerning drug discovery, development, regulation, statistics, pharmacoeconomics, healthcare and related areas. Most of the articles deal with the tech-nology required to accomplish these disciplines most efficiently and are submitted by experts in the pharmaceutical industry. Many of the articles are developed from presentations by experts at DIA meetings, summaries or abstracts of doctoral dissertations dealing with new drug development and from academia on topics related to drug development and healthcare.
<P>
The Journal is provided to DIA members as one of the benefits of membership. It is managed by Editor-in-Chief, Thomas W. Teal. The editorial board is composed of experts in new drug research, development and regulation. Copies and reprints of material starting with Volume 1 are available from the DIA office. Subscription and advertising information are also available from the DIA office. The Journal is indexed in BIOSIS (Previews database), Chemical Abstracts, Current Awareness in Biological Sciences (CABS), Excerpta Medica (EMBASE), Health Planning and Administration (NLM), Hospital Literature Index, Information Science Abstracts, International Pharmaceutical Abstracts, Life Sciences Collection, Risk Abstracts and Toxicology Abstracts. Application for indexing the Journal by Index Medicus has been made. We expect to be indexed by that service shortly.
<P>
I urge the authors and experts among you to consider publishing in the Journal.
<P>
Thomas W. Teal<BR>
Editor-in-Chief,<BR>
<B>Drug Information Journal</B>

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-297</DOCNO>
<DOCOLDNO>IA051-000870-B029-147</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f5.htm 199.92.136.137 19970111144831 text/html 2808
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:50:07 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:47 GMT
Content-length: 2617
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA Training Course Committee Report</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>DIA TRAINING COURSE COMMITTEE REPORT</STRONG></CENTER>
<P><HR>
DIA began to develop training courses in 1990 as a service to its members. The courses are offered in different states or countries throughout the year to make membership attendance and travel more convenient. In 1995, DIA sponsored twenty-one Training Courses with over 1,000 attendees. Most courses were filled and had waiting lists. The first course, "Entry-Level Clinical Research Associate Training Course" has been offered three to five times each year since its first session in 1991. The "Drug Safety Surveillance Training Course" has been offered one or two times each year since its first session in 1991 and for the first time in Montreal, Canada in June, 1995. "Practical GCP Compliance Auditing" has been successfully presented several times in Europe since it was developed in 1993 as a training course. In 1992, two courses in US regulatory affairs were initiated. Both "Regulatory Affairs Training Course I: IND Phase" and "Regulatory Affairs Training Course II: NDA Phase" have been offered three times each year. Each regulatory affairs course was also presented in Europe. "Monitoring Drug Safety for Effective Drug Development," has been offered in 1994 and 1995 and the most recent training course on "Introduction to and Advanced Pharmacoeconomics" was first offered in June, 1994 and has been offered twice yearly.
The "Advanced Clinical Research Associate" course and "The Application of GCP for Study Site Coordinators and Business Administrators" course were both introduced at the end of 1995. Another very popular course is the one-day "European Regulatory Affairs Workshop," which will be offered on the West Coast in the Fall. 
Beginning in 1997, "Packaging and Labeling of Clinical Supplies" course will be available. A potential course, "Systems Audit," is under development.
<P>
Each course is presented by a dedicated faculty with hands-on expertise in the courses area.  DIAs faculty has expanded over the years to meet the demand for these courses. Over the next few years, we hope to continue to increase the frequency of some of the courses, faculty permitting. All training courses are a vital part of DIAs mission of providing service and an educational forum to its members.

<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-298</DOCNO>
<DOCOLDNO>IA051-000870-B029-182</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f6.htm 199.92.136.137 19970111144844 text/html 2553
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:50:23 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:44 GMT
Content-length: 2362
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Awards and Fellowships</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>AWARDS AND FELLOWSHIPS</STRONG></CENTER>
<P><HR>
DIA supports growth and development of pharmaceutical professionals by sponsoring awards and fellowships.
<P>
The DIA is sponsoring the Joint Fellowship Program in "Pharmacoepidemiology and Drug Regulatory Science" in conjunction with the FDA and the University of Maryland. The current fellow is Ms. Sheila R. Weiss. Ms. Weiss is a PhD candidate at Johns Hopkins University. She holds an MS from Northeastern University and a BS from the University of Maine. The DIA is currently in the search process for a post-doctoral candidate for a second fellowship in "Clinical Pharmacology, The Science of Drug Regulation." The successful candidate will spend a year at Georgetown University Medical School and a year at the FDA under the supervision of the FDA staff college.
<P>
The grants awarded for 1995 were:
<UL>
<LI>GCP Training, combined Baltic States  $12,000 (1995 & 1996)
<LI>GCP Training, Hungary  $12,000 (1995 & 1996)
<LI>Clinical Pharmacology Fellowship  $150,000 (1995);
$200,000 (1996)
<LI>Pharmacoepidemiology  $150,000 (1995); $200,000 (1996)
<LI>University of New South Wales Diploma in Pharmaceutical 
Science  $45,000 (1996)
<LI>Dissertation Summary  $100,000 (1995)
</UL>
Drug Safety Program - Warsaw  $12,000 (1996)
The Research Grant proposals that have been chosen to receive funding in 1996 are:
<UL>
<LI>Emil Gabrielian, Ministry of Health, Republic of Armenia  Armenian Essential Drugs
n Martha Rumore, Long Island University  Subjects Presented at the DIA Annual Meetings and Journal, 1994-1995
<LI>Sheila Shulman, Tufts University  Reshaping the Pharmaceutical Distribution Network
<LI>John Swasy, The American University  The Effect of Drug Benefit Information on Consumer Processing and Risk Choices
<LI>Gary Walsh, University of Limerick  Development and Publication on the Internet of a Post-Graduate Course...
<LI>Michael Wogalter, North Carolina State University  Factors that Influence the Communication of Drug Information
</UL>


<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-299</DOCNO>
<DOCOLDNO>IA051-000870-B029-222</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f7.htm 199.92.136.137 19970111144855 text/html 3639
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:50:35 GMT
Last-modified: Thursday, 10-Oct-96 21:05:38 GMT
Content-length: 3447
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Steering Committee Reports</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>ANNUAL REPORT</UL>
<P>
  <CENTER><STRONG>STEERING COMMITTEE REPORTS</STRONG></CENTER>
<P><HR>
<B>SCASteering Committee of the Americas</B><BR>
The Steering Committee of the Americas (SCA), was formed in 1991 to in-sure that an optimal number of high quality DIA workshops and meetings of significant benefit and interest to our -members are held each year in the Americas. It is the SCAs responsibility to formulate internal proposals for DIA-sponsored workshops and meetings to be held in North, Central and South America, as well as to review and approve such proposals coming directly from the membership. Working closely with the Executive Director and his staff, the SCA has been successful in organizing a full schedule of meetings and workshops in the Americas for the remainder of 1996 and for much of 1997.
<P>
The members of the SCA for 1996-1997 are Elizabeth B. DAngelo, PhD, Zeneca Pharmaceuticals, Inc. (Chairperson); Hector A. Bolanos, AFAMELA, Mexico; Robert F. Butz, PhD; Mary E. Carman; Ann O. Carter, MD; Win M. Castle, MD, PhD, MFCM; David L. Chesney; Karen K. Church; John E. Derry; Robert S. Epstein, MD, MS; Ophelia Espejo; Professor Jacqueline S. Gardner; Cheryl F. Graham, MD; Jerome A. Halperin, MPH; Michael R. Hamrell, PhD; Kiyoshi Hayase, PhD; Therese Helie, PhD; Raymond L. Herman, MA; Kenneth I. Kaitin, PhD; Thomas J. Kirsch; Daryl Krepps; Bill Leslie; Iain J. McGilveray, PhD; Nancy C. MacDonald, PharmD; Elizabeth A. Moench; Wayne M. Nitchuk, PhD; Peggy C. Pence, PhD; Eleanor M. Perfetto, PhD; Anita Piergiovani; Peter H. Rheinstein, MD, JD; L. Bruce Rowsell, BScPhm; David J. Sabritt, MA; Thomas B. Semler, MBA; Neil H. Shear, MD, FRCP, FACP; Julie Tam, PharmD; Anthony R. Temple, MD; Jon R. Wallace; and Judi Weissinger, PhD.
<P>
<B>SCE Steering Committee for Europe</B><BR>
The multi-faceted DIA European activities continue to expand in 1996 under the guidance of the Steering Committee for Europe (SCE), which works closely with the DIA European Administrator, Mr. Alex Anderson, and his staff of the DIA European office. In the period since the last Annual Report, 16 Workshops, and 10 Educational Seminars have been successfully completed. The 1995 and 1996 EuroMeetings have been quite successful and the exhibit program continues to grow. The attendance at these events is a mark of their success. Workshop and Seminar topics have ranged from clinical data management, statistics, new European Union regulations and guidelines, biotechnology, health economics, clinical trial supplies, drug safety monitoring and GCP auditing, to mention but a few. The SCE has also sponsored and funded GCP training courses in the Eastern European region.
<P>
The SCE meets periodically during the year. Members are Brenton E. James, Glaxo Research & Development (Chairperson); Jean-Pierre Bader, PhD; Rolf Bass, MD; Juan Bigorra, PhD; Roger G. Bolton, PhD; Win M. Castle, MD, PhD, MFCM; Stuart Cummings, PhD; Francoise de Cremiers, PhD; Per P. Helboe, PhD, DSc; Jean-Marc Husson, MD, PhD; Vaila M. Marshall; Noriaki Murao, MS; Barbara Sickmueller, FPhD; Kjell Strandberg, MD, PhD; and Willem F. van der Giesen, PhD, PharmD.


<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-300</DOCNO>
<DOCOLDNO>IA051-000870-B029-264</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f8.htm 199.92.136.137 19970111144917 text/html 3050
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:50:57 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:38 GMT
Content-length: 2859
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>DIA Awards</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
<UL> ANNUAL REPORT</UL>
<P>
<CENTER><STRONG>DIA AWARDS</STRONG></CENTER>
<P><HR>
Each year the DIA presents <I><B>Outstanding Service Awards</B></I><B>
</B>to individuals who have provided outstanding service to the
DIA. 
<P>
The recipients of this award for 1995 are:
<P>
<CENTER><B>Agnes Artiges, PhD</B><BR>
European Pharmacopeia - <BR>
Council of Europe, France
<P>
<B>Shein-Chung Chow, PhD</B><BR>
Bristol-Myers Squibb Company, USA
<P>
<B>Charles C. DePew, PharmD</B><BR>
SmithKline Beecham Pharmaceuticals, USA
<P>
<B>Marie C. Donnelly, MBA</B><BR>
European Commission,. Belgium
<P>
<B>Therese Helie</B><BR>
Sandoz Canada, Inc., Canada
<P>
<B>Hidehiro Ito</B><BR>
Mitsui Pharmaceuticals, Inc., Japan
<P>
<B>Arthur I. Jacknowitz, PharmD</B><BR>
West Virginia University, USA
<P>
<B>Eva Lydick, PhD</B><BR>
Merck Research Laboratories, USA
<P>
<B>Hiroshi Maeda</B><BR>
Fujisawa Pharmaceuticals, Japan
<P>
<B>Vaila M. Marshall</B><BR>
Pfizer Central Research, UK
<P>
<B> Susan L. McLaughlin</B><BR>
R. W. Johnson, PRI, USA
<P>
<B>Chikayuki Naito, MD, PhD</B><BR>
Teikyo University, Japan
<P>
<B>B. Lillian Natorff, MD, MFPM</B><BR>
Pharm-Olam International, UK
<P>
<B>Kousei Terasaki</B><BR>
Santen Pharmaceutical Co., Ltd., Japan
<P>
<B>Tohru Uwoi</B><BR>
Yamanouchi Pharmaceutical, Japan
<P>
<B>Willem F. van der Giesen, PhD</B><BR>
Medicines Evaluation Board,<BR>
The Netherlands
<P>
<B>Cheryl Weinrich</B><BR>
Rhone-Poulenc Rorer, USA
<P>
<B>Roger L. Williams, MD</B><BR>
Food and Drug Administration, USA
<P>
<B>Susan M. Wood, MBBS, MD, FFPM</B><BR>
Medicines Control Agency, UK
 <P></CENTER>
The <B>Distinguished Career Award</B> recognizes an individual who has established a record for excellence in drug information science research, and has contributed to the expansion and improvements of drug information generation, processing or use. The recipients of this award for 1996 were:
<P>
The <B>Donald E. Francke Award</B> was established to honor Dr. Francke, President of DIA 1969-1970, who chaired the DIA Publications committee from 1965 to 1971, and edited the <B>Drug Information Bulletin</B> (the forerunner of the <B>Drug Information Journal</B> ). The award is given to the author(s) of an article that makes a significant contribution to the drug information literature and was published in the Journal during the year. The recipient of this award for Volume 29 (1995) is:
<P>
<B>Louis Lasagna, MD</B><BR>
Tufts University, USA<BR>
for his article "Improving the Drug Development Process: Needed Reforms."


<P><HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-301</DOCNO>
<DOCOLDNO>IA051-000870-B029-291</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5f9.htm 199.92.136.137 19970111144935 text/html 1645
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:51:14 GMT
Last-modified: Tuesday, 23-Jul-96 17:07:36 GMT
Content-length: 1454
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Financial Report</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif"><CENTER>
<IMG SRC="dia.gif"></CENTER>
<HR><P>
PUBLICATIONS
<P>
 <UL>ANNUAL REPORT</UL>
<P>
  <CENTER><STRONG>FINANCIAL REPORT</STRONG></CENTER>
<P><HR>
The Drug Information Association is financially independent. Funds from membership fees and the financial surplus accrued from workshops and meetings are the primary source of income. The DIA does not accept contributions of any kind from any source.
<P>
The DIA operates on a cash basis. The fund balance was $7.6 million at the end of 1995. The DIA has committed -approximately $200,000 for sponsorship of two DIA Fellowships for 1996-1997 at the University of Maryland and Georgetown University. Other grants include $12,000 for a GCP Training Course in Hungary and $12,000 Drug Safety Program in Warsaw.
<P>
DIA funds are conservatively invested in a mix of bond and 
equity mutual funds, Prudential Bache collateralized mortgage obligations (GNMAs), and money market funds (the latter for operating expenses). Current investments and long term investment strategies are considered several times each year during board of directors and financial committee meetings. The latter committee is chaired by Mr. Dana D. Rife, DIA Treasurer and 
Director, Accounts Payable for Johnson & Johnson. 



<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-302</DOCNO>
<DOCOLDNO>IA051-000870-B029-324</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso3.htm 199.92.136.137 19970111145003 text/html 2697
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:51:26 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:08 GMT
Content-length: 2504
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>ACER/EXCEL</B><BR>
	6 Commerce Drive<BR>
	Cranford, NJ  07016, USA<BR>
	Telephone:  (908) 272-2444, (908) 272-3377<BR>
	Telefax:  (908) 272-3594, (908) 272-6371<BR>
	email:  <A HREF="mailto:mminor@acerexcel.com">mminor@acerexcel.com</A><BR>
	Contact Person:  Michael Minor, President<BR>

<HR>
We have regional offices located in Seattle, WA, Los Angeles, CA, San Diego, CA, Chicago, IL, Boulder, CO, Nederland, CO, Kansas City, KS, Houston, TX, New London, CT, Arlington, VA, Tampa, FL, and Taipei, Taiwan to support sponsors clinical trials and data management. Our combination of central and regionally-based monitors helps to minimize travel time and expense.
<P>
ACER/EXCEL is a group of goal-oriented professionals offering a broad spectrum of services to clinical research and marketing groups of pharmaceutical and device manufacturers interested in Clinical Trials Management.
<P>
Our basic tenet is to provide quality and cost-effective service that is dependable, quickly implemented and sensitive to the sponsors needs for open communication, timely reports, and clean and complete data.
<P>
ACER/EXCELs clinical department has extensive ethical and OTC pharmaceutical and device industry experience spanning Phases I through IV. Our staff has worked in a variety of therapeutic areas including, but not limited to, allergy, anti-infective, analgesic, dementia, hormonal replacement, prostatic hypertrophy, pulmonary compounds and organ transplants. 
We can assist with protocol development, site identification, case record and patient diary design, on-site training, on-site monitoring, as well as preparation of integrated medical statistical reports or complete FDA submissions.
<P>
Our data management department is noted for rapid turnaround of case records into a well-structured database. All information is reviewed by quality assurance auditors for consistency prior to entry, all data is double keyed by different operators to prevent data-entry errors, and extensive computer-driven logic and range checks are applied to the database before analysis begins. Statistical analyses are performed using SAS.
<P>
We are proud of our dedication and accomplishments and look forward to the opportunity to meet with your group, review your needs, present our capabilities, and develop a mutually rewarding business association.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-303</DOCNO>
<DOCOLDNO>IA051-000870-B029-366</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso7.htm 199.92.136.137 19970111145025 text/html 1502
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:52:05 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:27 GMT
Content-length: 1309
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Affiliated Research Centers, Inc.</B><BR>
	1375 Tri-State Parkway, Suite 210<BR>
	Gurnee, IL  60031, USA<BR>
	Telephone:  (847) 855-9595<BR>
	Telefax:  (847) 855-8787<BR>
	Internet:  <A HREF="http://www.arc-centers.com">http://www.arc-centers.com</A><BR>


<HR>
Affiliated Research Centers, Inc. (ARC), is an investigator-owned, nationwide network in internal medicine, neuroscience, and urology. Our network has more than 300 investigators at over 70 quality sites with fast access to 3 million of their patients for your clinical trials.
<P>
ARC gives you The Power of OneTM for fast, accurate completion of your clinical trials:
<P>
<UL>
<LI> One phone call
<LI> One site selection
<LI> One budget
<LI> One contract
<LI> One fast IRB submission
<LI> One informed consent
<LI> One point of contact
</UL>
<P>
ARC is a customer-driven company dedicated to rapidly completing time-sensitive clinical trials. Our mission is to become the leader in providing clinical investigative services to compress drug development timeliness and procedures by public and private organizations.
<P>
Call ARC to discover the new approach to clinical development.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-304</DOCNO>
<DOCOLDNO>IA051-000870-B029-397</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso8.htm 199.92.136.137 19970111145034 text/html 2281
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:52:14 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:03 GMT
Content-length: 2088
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">

<B> Alliance Telemanagement, Inc.</B><BR>
	350 South Main Street, Suite 119<BR>
	Doylestown, PA  18901, USA<BR>
	Telephone:  (215) 340-0773<BR>
	Telefax:  (215) 340-0392<BR>
	Internet:  <A HREF="http://www.alliancetm.com">http://www.alliancetm.com</A><BR>
	email:  <A HREF="mailto:alliance@alliancetm.com">alliance@alliancetm.com</A><BR>
	Contact Person:  Jack Thorne<BR>
<HR>
<CENTER><B>Clinical Trial Recruiting</B></CENTER>
<P>
Alliance Telemanagement is a pioneer in the use of media advertising and 800 #s to speed up the recruitment of participants in clinical trial studies. Alliance Telemanagement handles the telephone portion of these programs and works with partner advertising agencies and medical education companies to create and place advertising, create and produce compliance materials.
<P>
A typical progam involves running advertising in appropriate mass media (including the Internet) reaching consumers that are targets for the trial. The ads contain both emotional and rational appeals (arrived at through research) plus an 800 # to call if there is interest in participation. When a prospect calls, the communicator manning the phone screens the prospect by asking inclusion/exclusion questions, captures other key data and, if the prospect passes the screening, refers the prospect to the nearest study site. Alliance can also help stimulate compliance by prospects that are accepted for the study  sending them information and motivational packages, making appointment reminder phone calls, making follow up information gathering phone calls, etc.
<P>
Alliance has a proven track record, saving pharmaceutical and clinical trial organizations significant amounts of money and precious time. If you would like to see some very interesting case histories and/or would like to learn more, send us an email or call us.
<P>
Call a Specialist: Alliance Telemanagement at 215-340-0773 or email directly. We deliver!








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-305</DOCNO>
<DOCOLDNO>IA051-000870-B030-25</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso10.htm 199.92.136.137 19970111145055 text/html 2251
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:52:33 GMT
Last-modified: Wednesday, 09-Oct-96 21:42:11 GMT
Content-length: 2058
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Analytical Bio-Chemistry Laboratories, Inc.</B><BR>
	7200 East ABC Lane<BR>
	Columbia, MO  65202, USA<BR>
	Telephone:  (800) 538-5227<BR>
	Telefax:  (573) 443-9033<BR>
	Contact Person:  Jim Chastain, PhD<BR>


<HR>
Analytical Bio-Chemistry (ABC) Laboratories, Inc. is a contract research organization providing research and development services to the pharmaceutical industry worldwide. Located in Columbia, Missouri (headquarters); Madera, California; and Coleraine, Northern Ireland; ABC Laboratories has the professional expertise, experience, and facilities to perform a broad range of contract services for the pharmaceutical industry. Since its founding in 1968, ABC Laboratories has had a proven track record of providing clients defensible scientific data. Capabilities/services include:
<UL>
<LI> Comprehensive Bioanalytical Services
<LI> Method Development and Validation
<LI> Preclinical and Clinical Sample Analysis
</UL>
<P>
<UL>
<LI> Complete Pharmacokinetics and Metabolism Services
<LI> Pharmacokinetics/ADME
<LI> Profiling and Identification of Metabolites
<LI> Preclinical and Clinical Pharmacokinetic Protocol Design, Modeling, 
Data Interpretation, and Consultation
</UL>
<P>
<UL>
<LI> Pharmaceutical Manufacturing Support Services
<LI> Analytical Method Development and Validation
<LI> Drug Substance and Drug Product Analysis
<LI> Impurities Identification and Analysis
<LI> Product Chemistry
<LI> Stability and Dissolution Testing
<LI> Microbiological Testing
<LI> Environmental Assessments
</UL>
<P>
State-of-the-Art Analytical Instrumentation<BR>
HPLC, Sciex LC-MS/MS (API III plus and API 300), GC-MSD, ICP
<P>
All studies are conducted with the oversight of an independent Quality Assurance/Quality Control Program, and in compliance with the Food and Drug Administrations Good Laboratory Practices (GLPs) or Current Good Manufacturing Practices (cGMPs).








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-306</DOCNO>
<DOCOLDNO>IA051-000870-B030-57</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso11.htm 199.92.136.137 19970111145113 text/html 1496
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:52:47 GMT
Last-modified: Friday, 11-Oct-96 17:14:21 GMT
Content-length: 1306
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>ANAWA Laboratories AG</B><BR>
	Unterdorfstrasse 23<BR>
	CH 8602 Wangen/Zrich, Switzerland<BR>
	Telephone:  0041 1 833 05 55<BR>
	Telefax:  0041 1 833 05 75<BR>
	email:  <A HREF="mailto:100136.31@compuserve.com">100136.31@compuserve.com</A><BR>
	Contact Person: Dr. Andreas Wicki<BR>
<HR>

ANAWA Laboratories has over 10 years experience in providing high quality laboratory based services to the pharmaceutical and biotechnology industries using state-of-the-art techniques and equipment.
<P>
Our GLP compliant laboratories in Switzerland and Germany provide a range of services for both pre-clinical and clinical investigations.
<P>
Our pre-clinical testing services offer the following:
<P>
Analytical chemistry, Radiochemistry, Immunochemistry, Molecular biology, Enzyme-immunoassays, in-vitro and in-vivo toxicity testing and Genetic toxicity testing.
<P>
Our clinical central laboratory offers the following:
<P>
Over 1,500 standardized clinical trials testing procedures, study design and planning of clinical studies Phase I-IV, study supplies and logistics and specimen processing.
<P>
Reports are provided using sophisticated data management systems to our clients requirements.


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-307</DOCNO>
<DOCOLDNO>IA051-000870-B030-95</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso12.htm 199.92.136.137 19970111145128 text/html 2591
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:53:05 GMT
Last-modified: Friday, 11-Oct-96 17:14:54 GMT
Content-length: 2401
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Applied Logic Associates, Inc.</B><BR>
	5615 Kirby Drive, Suite 710<BR>
	Houston, TX  77005, USA<BR>
	Telephone:  (713) 529-4747<BR>
	Telefax:  (713) 529-4904<BR>
	Internet:  <A HREF="http://www.alogic.com">http://www.alogic.com</A><BR>
	email:  <A HREF="mailto:jherson@alogic.com">jherson@alogic.com</A><BR>
	Contact Person:  Jay Herson, PhD<BR>
<HR>
Applied Logic Associates, Inc. (ALA) serves as a vital link in the process of bringing new products to market for pharmaceutical, biotechnology and medical device firms by providing a full range of clinical and regulatory services, including:
<UL>
<LI> biostatistics  <LI> 24-hour touch-tone randomization
<LI> clinical trial design, analysis <LI> regulatory affairs consulting
      and management <LI> medical report writing
<LI> clinical data management 	<LI> global strategic planning
<LI> clinical study monitoring 	<LI> health care economics
</UL>
These services are performed by our experienced staff in a cost-effective manner and timely fashion, with a watchful eye on science, regulatory requirements and the bottom line. We support these services with the development of PC network-linked database management systems using object-based Paradox and SAS programming. We effectively communicate our findings to management, the FDA, IRBs and the medical community.
<P>
Our services are also available in Europe, Australia and Asia. We are working on projects jointly with our affiliated companies:
<UL>
<LI> International Institute for Drug Development (ID2) in Brussels and Paris
<LI> International Research Consultants (IRC) in Ely, UK
<LI> Harrison Clinical Research in Munich and Brussels
<LI> Australasian Contract Research (ACR) in Brisbane
</UL>
Through this strategic alliance, ALA is able to efficiently handle projects globally.
<P>
ALA continues to develop new services designed to give clients a competitive edge in the changing regulatory arena and the marketplace. We are proud of our expertise in
<UL>
<LI> pharmacoeconomics
<LI> quality-of-life research
<LI> issues management
<LI> third-party reimbursement (Medicare, private insurance)
</UL>
<P>
Since our founding in 1983, ALA has successfully collaborated with more than 100 companies developing a broad spectrum of therapeutic and diagnostic indications.


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-308</DOCNO>
<DOCOLDNO>IA051-000870-B030-131</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso16.htm 199.92.136.137 19970111145140 text/html 1731
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:53:18 GMT
Last-modified: Friday, 25-Oct-96 16:23:34 GMT
Content-length: 1541
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>BARC (Bio Analytical Research Corporation)</B><BR>
	Industriepark Zwijnaarde 7, Box 3<BR>
	B-9052 Gent, Belgium<BR>
	Telephone:  +32.9.220.49.81<BR>
	Telefax:  +32.9.221.85.17<BR>
E-mail:  <A HREF="mailto:barc.j.jonckheere@skynet.be">barc.j.jonckheere@skynet.be</A><BR>
	Contact Person:  Dr. Joseph Jonckheere<BR>

<HR>
<CENTER>THE CENTRAL LABORATORY FOR CLINICAL TRIALS
<P>

WORLDWIDE
<P>
TRULY INDEPENDENT
<P>
ISO25 & GLP CERTIFIED
<P>
FLEXIBLE & UNIQUE SERVICES
<P>
RESULTS BACK WITHIN 24 H
<P>
10 YEARS EXPERIENCE
<P>
CORRECT PRICING</CENTER>
<P>

<B>Analytical Services provided in:</B><BR>
<UL>
<LI> Clinical Chemistry
<LI> Hematology	    investigator/sponsor/CRO
<LI> Immunology
<LI> Endocrinology	
<LI> Bacteriology
<LI> Virology
<LI> Serology
<LI> Toxicology  Drug Monitoring
<LI> Veterinary Clinical Chemistry &
     Hematology	
<LI> Esoteric Testing
<LI> PCR
<LI> Histopathology
<LI> Drug Assays
</UL>

<B>	Central LAB services:</B><BR>

<UL>
<LI> Reporting within 24 H to the
	<LI> Trial Specific Management Reports
<LI> Multilingual Capabilities
	<LI> Worldwide Logistics
<LI> Training
<LI> IATA Approved Shipping Materials
<LI> Own Courier Service
	<LI> Sample Storage (20C, 80C)
<LI> Archiving
	<LI> Study Monitors assigned to each trial
<LI> Professional Consultation
<LI> Electronic Data Transfer
<LI> RDA (Remote Data Access)
</UL>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-309</DOCNO>
<DOCOLDNO>IA051-000870-B030-168</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso18.htm 199.92.136.137 19970111145159 text/html 2860
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:53:29 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:21 GMT
Content-length: 2667
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Beardsworth Consulting Group, Inc.</B><BR>
	403 Route 202 South<BR>
	Flemington, NJ  08822, USA<BR>
	Telephone:  (908) 788-1729<BR>
	Telefax:  (908) 788-5281<BR>
	email:  <A HREF="mailto:kathrynp@beardsworth.com">kathrynp@beardsworth.com</A><BR>
	Contact Person:  Kathryn M. Pappas<BR>
<HR>

<B>Beardsworth Consulting Group, Inc</B>. is a full-service CRO proudly celebrating its <B>10th anniversary</B> in 1996. Hard work by experienced BCG personnel has built BCGs reputation for managing, monitoring, and summarizing clinical trials and resultant data with precision and accuracy. BCGs work has been audited by FDA, and by client companies QA departments, and the product has been universally praised for thoroughness, attention to detail, and strict adherence to FDA regulations and guidelines.
<P>
Beardsworth Consulting Group, Inc. specializes in the clinical development of drugs, devices, and biologicals and has provided consulting services to the regulatory and clinical research and development divisions of many U.S. and foreign companies. BCGs services include:
<UL>
<LI><B>Study Conduct:</B> Protocol/CRF Design, Investigator Recruitment, GCP Monitoring, and Project Management.
<LI><B>Data Management:</B> Statistical Analysis Planning, Database Design, Retrospective Data Collection, Clinical Data Coordination, Double-Key Data Entry, Production of clean SAS Data Sets, and Data Tabulations, Listings and Analysis.
<LI><B>Medical Writing:</B> Investigators Drug Brochure, NDA/PLA Submissions, including: Integrated Summaries of Effectiveness and Safety, Summary of Risk/Benefits, Draft Package Insert, Overall Clinical Summary, Joint Clinical/Statistical Summaries.
</UL>
<P>
<B>Beardsworth Consulting Group, Inc.</B> has been instrumental in the completion of numerous successful NDA, PLA and PMA submissions; in addition, BCG has contributed to international regulatory dossiers and clinical expert reports. BCG provides expertise in all phases of clinical research and development, with R&D experience in immune response modulators, oncology (hematologic and solid organ), anti-infectives, analgesics, dermatology, hormone replacement therapy, fertility, diabetes, endocrinology, and lung surfactants.
<P>
<B>Since 1986</B>, Beardsworth Consulting Group, Inc. has been providing solutions to the challenges of the evolving pharmaceutical industry. In todays most challenging environment, why not take advantage of that knowledge and experience? BCG can help assure your next success.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-310</DOCNO>
<DOCOLDNO>IA051-000870-B030-219</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso19.htm 199.92.136.137 19970111145228 text/html 3209
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:54:02 GMT
Last-modified: Thursday, 14-Nov-96 13:53:14 GMT
Content-length: 3017
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Belmont Research, Inc.</B><BR>
	84 Sherman Street<BR>
	Cambridge, MA  02140, USA<BR>
	Telephone:  (617) 868-6878<BR>
	Telefax:  (617) 868-2654<BR>
	Internet:  <A HREF="http://www.belmont.com">http://www.belmont.com</A><BR>
	email:  <A HREF="mailto:info@belmont.com">info@belmont.com</A><BR>
	Contact Person:  Chan Russell (chan@belmont.com)<BR>
<HR>
Belmont Research offers software products and services to support drug discovery, clinical development, drug safety surveillance, and CANDA development. We deliver solutions based on industry standard software: the BBN ClintrialTM clinical data management system, BBN ClintraceTM adverse event reporting and tracking system, Oracle and Sybase database management systems, and the CrossGraphsTM data visualization and graphical reporting system.
<P>
<B>Clinical Database Planning, Design, and Implementation</B><BR>
We design and implement clinical databases, using Clintrial and Oracle software, to support streamlined clinical data entry and data management.  Services include database implementation, data standardization, dictionary maintenance, database migration, consistency checking, discrepancy resolution, status tracking, and reconciliation with drug safety databases. We develop custom extensions to Clintrial using industry-standard tools (RPL, SQL, SAS, C).
<P>
<B>Clintrace Adverse Event System Implementation </B><BR>
Our knowledge of BBN Clintrace and global adverse event reporting lets you get started using Clintrace more quickly, assured that the system configuration will meet your immediate and long-term requirements for medical evaluation and regulatory reporting. Services include database configuration, database conversion, implementation of custom fields and reports, reconciliation with clinical databases, and multi-site access and distribution.
<P>
<B>CrossGraphs Graphical Reporting Solutions</B><BR>
We provide graphical reporting solutions based on CrossGraphs software, designed specifically for exploratory analysis and graphical review of complex, clinical data. CrossGraphs uniquely presents data in arrays of graphs, one graph per data subset, to help spot trends, detect anomalies, and discover relationships spanning many variables. CrossGraphs supports high-throughput compound screening, drug safety monitoring, project management, and CANDA development.
<P>
<B>Clinical Data Management Services</B><BR>
We provide clinical data management services to support Phase I to IV clinical trials. Our open and interactive approach provides clients with convenient access to and control of their data. Services include study database design, data coordination, case report form (CRF) tracking, double data entry, data validation, query management, lab data loading, auto-encoding of medical terminology, delivery of analysis datasets, and graphical reporting extensions.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-311</DOCNO>
<DOCOLDNO>IA051-000870-B030-253</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso21.htm 199.92.136.137 19970111145241 text/html 2238
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:54:20 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:55 GMT
Content-length: 2045
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>BFR Systems Inc.</B><BR>
	150 Allen Road, Suite 101<BR>
	Liberty Corner, NJ  07938, USA<BR>
	Telephone:  (908) 604-9200<BR>
	Telefax:  (908) 604-4404<BR>
	Internet:  <A HREF="http://www.bfrsys.com">www.bfrsys.com</A><BR>
	email:  <A HREF="mailto:jcharles@cotl.com">jcharles@cotl.com</A><BR>
	Contact Person:  Joe Charles<BR>
<HR>
BFR Systems, Inc.  Our eyes are on your future, with tomorrows solutions today.
<P>
A full-service company which specializes in software-based systems development, support and staff augmentation for the pharmaceutical and related services industries. BFR Systems has a demonstrated capability in:
<UL>
<LI> Clinical Trial Support & Data Management
<LI> Software Development & Evaluation
<LI> Project Management
<LI> Data Management
<LI> Process Validation
<LI> Data Validation
<LI> Computer System Validation
<LI> Programming & Testing
<LI> Documentation
</UL>

<P>
Our experience includes all aspects of the project life cycle: strategic planning, project management, product development and evaluation, system development, implementation, training and support.
<P>
From large scale mainframe to PCs, BFR has developed and currently supports systems which are deployed worldwide. Some of these have successfully undergone ISO 9000 certification, others have been reviewed by government agencies such as the FCC and FDA.
<P>
BFR maintains business partnerships with leaders in the information systems industry, including: DEC, HP, Lotus, Novell, and Tandem, to name a few. BFR is also a member of the National Association of Computer Consultant Business (NACCB). The Association addresses the legislative and business concerns of computer consulting firms and fosters high ethical standards throughout the industry.
<P>
BFR Systems  dedicated systems professionals who know the technology trends that affect your business and your bottom-line.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-312</DOCNO>
<DOCOLDNO>IA051-000870-B030-310</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso23.htm 199.92.136.137 19970111145259 text/html 3268
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:54:35 GMT
Last-modified: Friday, 11-Oct-96 17:15:47 GMT
Content-length: 3078
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Biomedical Systems</B><BR>
<B>	CORPORATE HEADQUARTERS</B><BR>
	2464 West Port Plaza Drive<BR>
	St. Louis, MO  63146, USA<BR>
	Telephone:  (314) 576-6800<BR>
	Telefax:  (314) 576-9735<BR>
	Contact Person:  Kevin J. Klingler<BR>

<HR>
Established in 1975, Biomedical Systems is an international corporation with strategically located offices across the United States and Europe. The U.S. headquarters in St. Louis, Missouri, and the European headquarters in Brussels, Belgium are where the cardiovascular monitoring and pulmonary data analysis, professional interpretation and data formatting services (SAS, etc.) are provided to Pharmaceutical Companies and Contract Research Organizations around the world.
<P>
The centralized cardiovascular and pulmonary services include Holter monitoring, ambulatory blood pressure monitoring, pulmonary function testing, centralized electrocardiography-(ECG), transtelephonic arrhythmia monitoring, and centralized echocardiography. We offer presentations on these services to sponsors around the world. Sponsors often utilize our expertise in study design when developing protocols incorporating these services.
<P>
Biomedical Systems has earned an impeccable reputation with Pharmaceutical Companies and CROs. This global reputation is well documented by many referrals and repeat contracts.
<P>
<CENTER><B>EUROPEAN OPERATIONS</B></CENTER>
Established in 1981 as Cardio-Scan S.A. in Brussels, Belgium, the European center facilitates international trials through its multilingual (Flemish, French, German, Italian, Portuguese, English) staff, assuring smooth data acquisition and communication between the investigative sites and the pharmaceutical companies. Additionally, Brussels and St. Louis both employ standardized equipment to conduct global trials that generate identical reporting formats.
<P>
<CENTER><B>UPDATE:</B><BR>
<B>CENTRALIZED SPIROMETRY SERVICES</B> </CENTER>
Biomedical Systems pioneered the centralization of pulmonary function testing in clinical trials over the last several years. Prior to Biomedicals involvement, all of the pulmonary function testing results were manually transcribed on Case Report Forms and submitted to the Sponsor for manual entry into databases. Today, with Biomedicals innovative approach, manual processing is eliminated and an automated remote data collection and data transfer process has been implemented.
<P>
Biomedical Systems is currently providing centralized spirometry services in respiratory clinical trials in the U.S., Puerto Rico, Canada, South America, Europe and Australia. We can provide an impressive list of pharmaceutical companies who have found this service extremely cost-effective and beneficial in expediting clinical trials.
<P>
<B>EUROPEAN HEADQUARTERS:</B><BR>
CARDIO-SCAN, S.A.<BR>
AVENUE DE LA BRABANCONNE, 135<BR>
1040 BRUSSELS, BELGIUM<BR>
TELEPHONE:  32-2-735-30-59<BR>
TELEFAX:  32-2-735-23-21<BR>
Contact Person:  Rita Jacobs<BR>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-313</DOCNO>
<DOCOLDNO>IA051-000870-B030-337</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso24.htm 199.92.136.137 19970111145307 text/html 2372
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:54:48 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:28 GMT
Content-length: 2179
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Bio-Pharm Clinical Services</B><BR>
	Four Valley Square, 512 Township Line Road<BR>
	Blue Bell, PA  19422, USA<BR>
	Telephone:  (215) 283-0770<BR>
	Telefax:  (215) 283-0733<BR>
	Internet:  <A HREF="http://www.biopharm.com">http://www.biopharm.com</A><BR>
	email:  <A HREF="mailto:bioinfo@biopharm.com">bioinfo@biopharm.com</A><BR>
	Contact Person:  John H. Dillon, II<BR>
<HR>
Bio-Pharm, Euro Bio-Pharm and Pacific Bio-Pharm comprise IBAH, Inc. (International 
Bio-Pharm Affiliated Holdings). Founded in 1985, the IBAHcompanies provide expertise in a broad range of global development services for the pharmaceutical, biotechnology, diagnostics and medical device industries.
<P>
From preclinical development through Phase IV post-market studies, IBAHstands prepared to assist you. Our global development services include:
<P>
<B>Clinical Research Services:	</B><BR>
<UL>
<LI> Development Plan Creation	
<LI> Preclinical Services
<LI> Clinical Trials Management
<LI> Clinical Data Management	
<LI> Biostatistics
<LI> Clinical Writing
<LI> Health Economics
<LI> Safety Surveillance
<LI> Quality Assurance
<LI> Regulatory Affairs
<LI> Medical Consulting
</UL>
<B>Pharmaceutics Services:</B><BR>
<UL>
<LI> Product Formulation
<LI> Process Development
<LI> Clinical Supplies Manufacturing
<LI> Clinical Supplies Distribution
<LI> Analytical Services
</UL>
<P>
<B>Additional International Locations:</B><BR>
<UL>
<LI> Brussels, Belgium
<LI> Chicago, IL, USA
<LI> Copenhagen, Denmark
<LI> Durham, NC, USA
<LI> Emeryville, CA, USA
<LI> Hamburg, Germany
<LI> Moscow, Russia
<LI> Prague, Czech Republic
<LI> Rheinfelden, Switzerland
<LI> St. Paul, MN, USA
<LI> Sydney, Australia
</UL>



<P>
Bad Soden, Germany<BR>
P: 49-(0)6196/602-0<BR>
F: 49-(0)6196/602-155	l 
<P>
Chippenham, England<BR>
P: 44(1249)-444212<BR>
F: 44(1249)-444189
<P>
Ft. Washington, PA, USA<BR>
P: (215) 646-1226	l<BR> 
F: (215) 646-6509	l <BR>
<P>
Paris, France<BR>
P: 33-1-40-60-87-87<BR>
F: 33-1-40-60-87-88








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-314</DOCNO>
<DOCOLDNO>IA051-000870-B030-369</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso26.htm 199.92.136.137 19970111145318 text/html 3145
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:54:56 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:20 GMT
Content-length: 2952
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>BioResearch Monitors, Inc.</B><BR>
	201 Markham Hollow Road<BR>
	Tully, NY  13159, USA<BR>
	Telephone:  (315) 696-8139<BR>
	Telefax:  (315) 696-8722<BR>
	email:  <A HREF="mailto:qaaudits@aol.com">qaaudits@aol.com</A><BR>
	Contact Person:  Paul L. Gittelson, President<BR><P>

<HR><P>

<B>BioResearch Monitors, Inc.</B> is an independent consulting group providing <B>Quality Assurance</B> and <B>Regulatory Compliance</B> Assessments of Pharmaceutical and Biomedical Research and Development activities. Paul L Gittelson and Gary T. Sniffen, the Managing Directors of <B>BioResearch Monitors, Inc</B>., have been involved in managing, conducting and establishing standards for Worldwide Research Quality Assurance since the inception of FDAs Good Practices Regulations. Dr. Bernard Nunning has over 25 years experience in the management of Worldwide Clinical Supply operations. With centrally based and regional QA Associates, <B>BioResearch Monitors, Inc</B>. provides cost-effective, Quality Auditing and Consulting Services related to FDA, ICH, ISO and related worldwide Quality Standards.<P>

<U><B><CENTER>GOOD CLINICAL PRACTICES</CENTER></B></U><P>

<B>GCP Audits and Evaluations</B> including:<LI>Pre-placement Assessments of Contract Research Organizations and Clinical Study Sites<LI>Independent QA Evaluations of CRO study management and CRO managed studies<LI><B>Interim QA Audits</B> of ongoing Clinical Trials<LI><B>Validation Audits</B> of completed Clinical Trials<LI>Accountability & Reconciliation of Study Supplies<LI>Study File and Regulatory Documentation Reviews<LI>Clinical Laboratory and other Clinical Facilities Inspections<LI>IRB Inspections<LI>Final Report, Database and Regulatory Submission Audits<LI>Clinical Trial "Audit Certificates"<LI>Preparation of Clinical Sites for Regulatory Inspections<LI>Automated Data Systems Validation Audits<LI><B>Training</B> of Q.A. and Clinical Research Personnel<LI>Development and review of <B>Standard Operating Procedures</B><LI><B>Data Verification</B> and adjunct Clinical Trial <B>Monitoring</B> services<P>

<B><U><CENTER>GOOD MANUFACTURING PRACTICES</CENTER></U></B><P>

<B>GMP Clinical Supply Evaluations</B> of Sponsors and Contract facilities including:<LI>Oral and Parenteral Drug Product Manufacturing<LI>Drug Substance processing<LI>Scale-up and Process Validations<LI>GMP required Records and Reports<LI>QA/QC systems evaluations<LI>Product Complaint Investigations<LI>Clinical Supplies Blinding & Randomization<LI>Packaging & Labeling<LI>Storage & Distribution

<U><B><CENTER>GOOD LABORATORY PRACTICES</CENTER></B></U><P>

<B>GLP</B> Sponsor and Contract Laboratory Inspections<LI>SOP development and review<LI>Final Report audits<LI>Computer systems validation audits<LI>Animal Welfare Audits<LI>All required QAU functions

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-315</DOCNO>
<DOCOLDNO>IA051-000870-B031-26</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso33.htm 199.92.136.137 19970111145354 text/html 2816
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:55:26 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:59 GMT
Content-length: 2623
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Canadian HIV Trials Network</B><BR>
	Room 620-1081 Burrard<BR>
	Vancouver, BC V6Z 1V6, Canada<BR>
	Telephone: (604) 631-5327<BR>
	Telefax: (604) 631-5210<BR>
	Internet: <A HREF="http://www.hivnet.ubc.ca/ctn.html">http://www.hivnet.ubc.ca/ctn.html</A><BR>
	email: <A HREF="mailto:don@hivnet.ubc.ca">don@hivnet.ubc.ca</A><BR>
	Contact Person: Dr. Donald P. Zarowny<BR><P>
<HR>

The Canadian HIV Trials Network (CTN), is a non-profit organization formed and funded in 1990 by the Canadian government. Our purpose is to encourage and facilitate the conduct of HIV/AIDS clinical trials in Canada.<P>

More than 30 institutional research sites from Vancouver to Halifax form the nexus of the Canadian HIV Trials Network. Each site is headed by a trained AIDS specialist and staffed by people experienced in the rigors of conducting clinical research. Our staff members also include Canadian regulatory experts who fully understand the expectations of Canadas regulatory bodies. We also have staff experts in the epidemiology of HIV/AIDS in Canada which is critical to forming realistic enrollment expectations. So far, over 5,000 Canadians have participated in CTN-affiliated trials. A total of 45,000 Canadians are believed to be infected with HIV.<P>

<B>Involving the CTN in Your AIDS-related Clinical Trial<P></B>

The services offered to our pharmaceutical industry partners are varied and flexible. We tailor every partnership to the specific needs of each trial and sponsor. The CTN provides these services without charge unless we are asked to contribute beyond our available services. Sponsors may choose between one, several, or all of the CTNs services, depending on their needs. Regardless of what form the partnership takes, infrastructure funding of our satellites can relieve sponsors of certain overhead charges. Trial data and results remain the property of the industrial sponsor and the investigator for all industry or investigator-initiated trials.<P>

<B>Our Services Include:<P></B>

<LI>Protocol Development<BR>
<LI>Preparation of Protocols for Canadian Regulatory Review<BR>
<LI>Review of Protocols and Implementation of Trials<BR>
<LI>Clinical Trial Administration<BR>
<LI>Data Management <BR>
<LI>Communications and Community Liaison<BR>
<LI>Financial Support to Study Sites<BR><P>


Please contact us for a complete package detailing our services and introducing the people that form the backbone of the Canadian HIV Trials Network.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-316</DOCNO>
<DOCOLDNO>IA051-000870-B031-64</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso34.htm 199.92.136.137 19970111145409 text/html 2356
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:55:50 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:57 GMT
Content-length: 2163
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>CB Technologies, Inc.</B><BR>
	266 East Lancaster Avenue, Suite 201<BR>
	Malvern, PA  19355, USA<BR>
	Telephone:  (610) 889-7300<BR>
	Telefax:  (610) 648-9259<BR>
	Internet:  <A HREF="http://www.CBTECH.COM">http://www.CBTECH.COM</A><BR>
	email:  <A HREF="mailto:info@CBTECH.COM">info@CBTECH.COM</A><BR>
	Contact Person:  Matthew Huberty<BR><P>

<HR>
<I><B><CENTER>CUSTOM SOFTWARE DEVELOPMENT</CENTER></B></I><P>

CB Technologies, Inc. is a custom software development and consulting firm providing innovative technology solutions to the pharmaceutical and healthcare industries. CB Technologies has emerged as an industry leader specializing in revising the clinical trials process to fully leverage remote data entry opportunities. CB has specifically designed systems which manage health outcomes, track medical devices and provide worldwide remote clinical trials data management.<P>

<I><B><CENTER>REMOTE DATA ENTRY</CENTER></B></I><P>

Moving from a paper driven, manual case report form system to a fully electronic data capture system involves a major paradigm shift. CBs open architecture allows for customization of the system in order to closely integrate with the way that our clients conduct their clinical trials. Modifications to our system can easily be made to accommodate future studies.<P>

<I><B><CENTER>CB BIOSTAT</CENTER></B></I><P>

CB BIOSTAT is a division of CB Technologies which focuses on the collection, management, reporting and analysis of clinical trials data. CB BIOSTATs services include processing of electronic CRFs, statistical analysis, validation or audit reports and data scrubbing.<P>

<I><B>A MICROSOFT SOLUTION SPECIALIZING IN ...</B></I><P>
<LI>Custom Software Development<BR>
<LI>Intra/Internet Development<BR>
<LI>Clinical Data Management<BR>
<LI>SAS Programming<BR>
<LI>Database Administration<BR><P>



<B><I><CENTER>Utilizing emerging technologies<BR>
to address the challenges of Healthcare<BR>
created by the pace of change</CENTER></I></B>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-317</DOCNO>
<DOCOLDNO>IA051-000870-B031-96</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso36.htm 199.92.136.137 19970111145442 text/html 3212
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:56:06 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:53 GMT
Content-length: 3019
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Chiltern International Limited</B><BR>
	Chiltern Place, Upton Road, Slough<BR>
	Berkshire, SL1 2AD, United Kingdom<BR>
	Telephone:  +44 1753 512000<BR>
	Telefax:  +44 1753 511116<BR>
	Contact Person:  Frank Garnham<BR><P>

<HR>


<B>Introduction:</B><BR>
Chiltern is an independently owned clinical research organisation with extensive experience in conducting Phase I-IVclinical trials. Our range of studies include First Administration in Man, Safety and Efficacy, Drug and Food Interaction, Bioequivalence/Bioavailability, Special Populations (e.g. Renal/Hepatic Impairment, Asthmatics/COPD, Stable Mild Heart Failure), Phase II (Single/Multi-centre), Phase III(Multi-centre; Multinational) and Phase IV  Marketing Support. Established in 1982, we now have offices in France, Germany and Sweden, 2 offices and our Clinical Research Unit (Chiltern House) in the UK, and are active in 7 other European countries. We have an office in Canada and also operate in both Israel and South Africa. Our aim is to provide a range of high quality contract research facilities to the pharmaceutical industry in an efficient, timely fashion and at reasonable cost. We have a large and growing network of active investigators in hospitals and general practice, providing a multinational clinical trials facility capable of achieving FDA or EC.GCP. With more medical staff than any of our rivals, Chiltern provides an abundance of relevant clinical expertise right across the therapeutic range.<P>

<B>Services:</B><BR>
Chiltern provides a comprehensive range of clinical trial functions, each available as a stand-alone service or as part of a complete development programme:<P>

<LI>Study Design and Protocol Preparation	<BR>
<LI>Study Administration and Monitoring<BR>
<LI>Quality Assurance<BR>
<LI>Data Management<BR>
<LI>Case Report Form Design &Printing	<BR>
<LI>Statistical Analysis and Reports<BR>
<LI>Regulatory Affairs<BR>
<LI>Full Medical Reports<BR>
<LI>Clinical Trial Supplies<BR>
<LI>Preparation of Regulatory Submissions<BR>
<LI>Investigational Site Selection<BR>
<LI>Expert Reports<BR><P>


Chiltern has assembled an Expert Reports team of associate authorities in Chemistry, Clinical Pharmacology, Pharmacy and Toxicology, with expertise over a wide range of disciplines.<P>

<B>Facilities:</B><BR>
Chiltern has its own 20 bed Clinical Research Unit, Chiltern House, located approximately 5 miles from Heathrow Airport, with access to 58 hospital beds nearby. There is also an on-site pathology laboratory, with automated data capture and the facilities for on-line, link up to any location. Our experienced biometrics team offer a full service either as part of a clinical study or as an individual facility. Databases can be constructed in both SAS and Clintrial amongst others.<P>

<I><CENTER><B>CHILTERN, THEEUROPEANCHOICE</B></CENTER></I>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-318</DOCNO>
<DOCOLDNO>IA051-000870-B031-129</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso41.htm 199.92.136.137 19970111145505 text/html 2936
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:56:42 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:36 GMT
Content-length: 2743
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Clinical R&D Services Corp.</B><BR>
	31 Monhegan Avenue<BR>
	Wayne, NJ  07470, USA<BR>
	Telephone:  (201) 696-0824<BR>
	Telefax:  (201) 696-8541<BR>
	Contact Person:  Bruce A. Lepp, PharmD, President<BR><P>

<HR>


Clinical R&D Services Corp. was founded in 1977 as a full service contract research organization. We have maintained that status through the years and have been involved in clinical trials and consultation in almost every known medical specialty, on prescription products, non-prescription products, medical devices and personal products, as well as Rx to OTC switches utilizing the most current methodologies and study settings. We have assisted clients from other countries in getting a foothold in the United States, as well as working with foreign and domestic clients in what were, at the time, novel and forward thinking fashions. We are receptive to new ideas and will be able to apply our more than 19 years of experience to your project or problem.<P>

Innovative CRO utilization has been our watch word for many years. We have all of the expected capabilities with the ability and desire to use them in new and innovative ways. Entering a project that has already been started is something that we have done on numerous occasions. Transferring an ongoing project to us for completion, while your staff attends to new and/or other pressing problems is something that we can do and have done most readily. The scope of our interactions with our clients is limited only by our collective imaginations. This refers to the services listed in this publication, as well as many others that are not. The listing included in this publication is, by no means, complete. The scope of our services extends far beyond those listed in the services section.<P>

"State of the Art" knowledge and abilities, in all areas, are brought to bear upon your projects.<P>

Our independent IRB has been functioning since 1982. It was one of the first four of its type in the nation. This service can be used either independently from all other services or as an integral part of a "turn-key" project.<P>

In this segment of the industry, the most powerful statement that we can make is the fact that we have been in continuous operation for over 19 years. Most of our clients have worked with us on more than one project and have repeatedly chosen to interact with us since their initial experiences.<P>

If you have any questions regarding the material contained herein or wish to know more about Clinical R&D Services Corp. and other services we offer, please contact us directly.<P>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-319</DOCNO>
<DOCOLDNO>IA051-000870-B031-165</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/ctss.htm 199.92.136.137 19970111145523 text/html 1949
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:03 GMT
Last-modified: Friday, 11-Oct-96 14:14:30 GMT
Content-length: 1759
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Clinical Trials Support Services, Inc.</B><BR>
	P.O. Box 14289<BR>
	Research Triangle Park, NC  27709, USA<BR>
	Telephone:  (800) 964-2877<BR>
	Telefax:  (919) 941-0071<BR>
	email:  <A HREF="mailto:ctss@netpath.net">ctss@netpath.net</A><BR>
	Contact Person:  Hugh MacGregor or Cheryl Hughes
<HR>

<B>Clinical Trials Support Services, Inc. (CTSS)</B> is a contract personnel provider serving pharmaceutical, biotechnology, CRO, medical device and academic clinical research environments.
<P>
The CTSS mission is to provide experienced clinical research professionals on a contract basis to assist clients in meeting critical project deadlines, without increasing their permanent employee headcount. Contract staff can be provided for short or long term assignments, and can work on-site at a clients facility, or work in the CTSS offices in Research Triangle Park, NC, interfacing through telecommunication lines.
<P>
CTSS can provide personnel in all areas of clinical research including the following:
<UL>
<LI> Project Management
<LI> Clinical Monitoring
<LI> Clinical/Medical Data Management
<LI> SAS Programming
<LI> Biostatistics
<LI> Regulatory Affairs
<LI> Medical Review/Writing
<LI> Training
</UL>
<P>
For clients who "outsource" Data Management and Biostatistics projects, or Clinical Monitoring projects, CTSS has the experience and capability of assembling a team of qualified clinical research professionals to undertake "stand-alone" projects. Cost effectiveness, dedicated resources, and enhanced sponsor communication and control, are assets CTSS provides to our client partners.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-320</DOCNO>
<DOCOLDNO>IA051-000870-B031-190</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso45.htm 199.92.136.137 19970111145534 text/html 2211
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:13 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:27 GMT
Content-length: 2018
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>ClinTrials BioResearch Ltd.</B><BR>
	87 Senneville Road<BR>
	Senneville (Montreal), Quebec<BR>
	Canada  H9X 3R3<BR>
	Telephone:  (514) 630-8200<BR>
	Telefax:  (514) 630-8230<BR>
	Contact Person:  Bruce L. Maloff, PhD, Vice President, Business Development
<HR>

Bio-Research Laboratories Ltd. was founded in 1965, and merged with ClinTrials Research* in 1996 to form ClinTrials BioResearch Ltd.
<P>
Bio-Research Laboratories is a leading preclinical contract research laboratory bringing innovative research techniques to the pharmaceutical, chemical and biotechnology industries, 
as well as to specialized segments of the health care industry. Laboratory facilities are located on a 30-acre site in Senneville, Quebec, approximately 20 minutes from Montreals Dorval airport.
<P>
The company employs a staff of 575 in scientific and business operations, including approximately 25 Ph.D. level scientists, working in a 204,000 square foot "state of the art" AAALAC-accredited facility. Through an exclusive arrangement, the company also has access to BSL 2/3 containment facilities at a new research site.  
<P>
All major forms of toxicity testing are performed. The company has leading technical expertise in key speciality areas which are listed below. Bio-Research also provides innovative insights for product development, strategies and protocol design. More than 10,000 studies have been performed for a client base of 1,500 companies in N.America, Europe and Asia, with submissions to regulatory agencies worldwide.  
<P>
Specialized expertise in:
<UL>
<LI> Cardiovascular pharmacology
<LI> Infusion delivery
<LI> Biomaterials testing
<LI> Neuropathology
<LI> Osteoporosis treatment evaluation
<LI> Anti-infectives evaluation
</UL>
<P>
*A profile of our clinical research services is listed in the DIA Registry under 
ClinTrials Research Inc.









</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-321</DOCNO>
<DOCOLDNO>IA051-000870-B031-219</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso46.htm 199.92.136.137 19970111145544 text/html 2943
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:22 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:25 GMT
Content-length: 2750
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>ClinTrials Research Inc.</B><BR>
	One Burton Hills Boulevard, Suite 210<BR>
	Nashville, TN  37215, USA<BR>
	Telephone:  (919) 460-9005 or 1 (800) 421-1952<BR>
	Telefax:  (919) 460-3861<BR>
	Internet:  <A HREF="http://www.clintrialsresearch.com">http://www.clintrialsresearch.com</A><BR>
	email:  <A HREF="mailto:104740.1422@compuserve.com">104740.1422@compuserve.com</A><BR>
	Contact Person:  Michael F. Ryan, PhD
<HR>
<CENTER><B>On Target,      On Time,      On Budget</B></CENTER>
<P>
<B>PROGRAM MANAGEMENT</B>  Our clients demand the highest quality clinical and preclinical research support. And they get it. ClinTrials Research has become one of the foremost CROs for one reason; we focus on your needs. We know you need highly skilled, professional program managers. The leadership of our professional program managers means control of your program, and that control produces the quality you need, when you need it.  
<P>
<B>FULL SERVICE</B>  ClinTrials Research, with 1600 employees world wide, is the development department for many pharmaceutical and biotech companies. We provide the highest quality of research from preclinical through all phases of clinical development, across multiple therapeutic areas. Most significantly, our Regulatory Affairs Department comprises a staff of professionals with many years of experience both in the industry and in the FDA. Their peers in Europe and Asia serve our clients with the needed services in the international environment.  
<P>
Our Biostatistics group, led by a former FDA statistician, provides the insight and writing skills to optimize the interpretation and presentation of your data.  
<P>
<B>MARKET FOCUS</B>  Our clients depend on us to know the market dynamics. We provide both consultation on pharmacoeconomic and outcomes studies, and full implementation of programs. We are a leader in product registries and safety monitoring.
<P>
<B>TECHNOLOGICAL ADVANTAGES</B>  Our financial strength has allowed us to invest in leading edge technologies that speed your trials with quality and expedite regulatory review: IVR, BBN-based databases, Remote Data Entry and Management, Data Review Tools, CANDAs, ClinTrials Proprietary International Electronic Communication Network.  
<P>
<B>MEGATRIALS</B>  All of the above, plus years of experience in setting up and conducting trials with as many as 40,000 subjects and 1000 sites means we can establish your program more quickly than anyone else. Patient Recruiting is our forte.  
<P>
<B>PRECLINICAL RESEARCH See ClinTrials BioResearch, a Division of ClinTrials Research.</B>









</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-322</DOCNO>
<DOCOLDNO>IA040-000752-B013-121</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso47.htm 199.92.136.137 19970111145557 text/html 3178
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:33 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:23 GMT
Content-length: 2985
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>CompleWare Corporation</B><BR>
	P.O. Box 69<BR>
	Iowa City, IA  52244, USA<BR>
	Telephone:  (319) 338-8888<BR>
	Telefax:  (319) 338-1604<BR>
	Internet:  <A HREF="http://www.compleware.com">http://www.compleware.com</A><BR>
	email:  <A HREF="mailto:info@compleware.com">info@compleware.com</A><BR>
	Contact Person:  Kay Weiler
<HR>
<B>CAPTURE CLINICAL DATA USING INNOVATIVE TECHNIQUES TO IMPROVE SPEED, ACCURACY AND EASE OF THE DATA ENTRY PROCESS</B>
<P>
<I>CompleWare offers the opportunity to scan hundreds of CRFs per day or thousands of diary cards per hour or to capture clinical data on-line!</I>
<P>
CompleWare Corporation has become the leader in the innovative use of computer techniques to capture case report form and subject diary data. CompleWare makes data entry highly efficient, accurate, rapid, and user-friendly. CompleWare customizes the data entry process to meet your needs, to enhance subject compliance and to control costs.
<P>
<B>SymptomScoreCardII</B>TM diary cards are optically scanned into the database, eliminating manual double entry and allowing very rapid evaluation and clarification of subject responses using your algorithms.
<P>
<B>ScanCRF</B>TM provides fast, accurate and user-friendly scanned entry for case report form data.
<P>
<B>SymptomDataCapture</B>TM allow subjects to enter symptom data electronically at home, providing time and date stamps on the data that are entered. Data are then automatically transmitted to the site by telephone.
<P>
<B>crfDataCapture</B>TM captures case report form or source document data directly using a digital pen.
<P>
<B>SymptomPhoneLink</B>TM allows subjects to enter symptom data at home directly into the computer database using the telephone by responding to interactive voice prompts. This assures compliance and accuracy of data entry on the proper date and at the specified time. Try our demonstration version at 1-800-FON-WARE.
<P>
<B>SymptomWorldLink</B>TM allows for rapid, accurate, simple capture of symptom diary data using the World Wide Web with on-the-fly edit checks and audit trails.
<P>
crfWorldLinkTM provides for rapid, accurate, simple capture of CRF data using the World Wide Web with on-the-fly edit checks and audit trails.
<P>
<B>GenuineSourceDoc</B>TM and crfAssistantTM allow for ease of monitoring with rapid direct capture of the source document.
<P>
<B>CompleWare Video Productions</B> creates educational videotapes for training subjects about study procedures.
<P>
CompleWare is ready to meet your specifications for clinical trial design and monitoring as well as project and data management and data validation. CompleWare means state-of-the-art data capture. Experience on-line data capture and monitoring. For more information call today or visit us on the Web at the Virtual Clinical Trial SiteTM.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-323</DOCNO>
<DOCOLDNO>IA040-000752-B013-145</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso52.htm 199.92.136.137 19970111145607 text/html 1958
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:47 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:10 GMT
Content-length: 1765
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Copenhagen Trial Unit</B><BR>
	Institute of Preventive Medicine, Kommunehospitalet<BR>
	1399 Copenhagen K, Denmark<BR>
	Telephone:  +45 3338 3740<BR>
	Telefax:  +45 3332 4410<BR>
	Internet:  <A HREF="http://www.inet.uni-c.dk/~ctucph">http://www.inet.uni-c.dk/~ctucph</A><BR>
	email:  <A HREF="mailto:ctucph@inet.uni-c.dk">ctucph@inet.uni-c.dk</A><BR>
	Contact Person:  Kim Krogsgaard
<HR>
The <B>Copenhagen Trial Unit (CTU)</B> was founded in 1995 and is now a rapidly expanding non-profit center for clinical research. The CTU is financially supported by and affiliated to the Copenhagen University Hospital. The CTU is a non-specialty oriented organization offering flexible collaboration in all stages of clinical research from general advice and support to conduct of specific randomized clinical trials.
<P>
The CTU offers advice and support in the planning of randomized controlled trials (RCTs), development of protocols for RCTs, protocol processing including translation, development and production of Case Record Forms, coordination of RCTs, monitoring of RCTs, data management, statistical analyses, and medical writing. The CTU is performing meta-analyses and systematic reviews and forms a part of the international Cochrane Collaboration. Furthermore, the CTU convenes pre- and postgraduate courses dealing with RCTs and meta-analyses.
<P>
The CTU collaborates with the primary and secondary health care sectors and the drug and device industry  in Denmark and internationally.
<P>
The core staff of the CTU comprises physicians, statisticians, data managers, trial coordinators, and secretaries.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-324</DOCNO>
<DOCOLDNO>IA040-000752-B013-175</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso53.htm 199.92.136.137 19970111145621 text/html 2687
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:57:59 GMT
Last-modified: Friday, 11-Oct-96 17:51:19 GMT
Content-length: 2497
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Corning Besselaar</B><BR>
	210 Carnegie Center<BR>
	Princeton, NJ  08540, USA<BR>
	Telephone:  (800) 724-4089 or (609) 452-8550<BR>
	Telefax:  (609) 452-9861-North America/Global Programs<BR>
	Internet:  <A HREF="http://:cps.bio.com">http//:cps.bio.com</A><BR>
	Contact Person:  Cindy van Dijk, Manager, Marketing North America<BR>
<HR>

<B>EUROPE:</B><BR>
Telephone:  +32.2.773.2911<BR>
Telefax: +32.2.772.2998<BR>
Contact Person: Deborah Brewer, Business Development, Europe

<P>
Corning Besselaar is the worldwide comprehensive clinical development services subsidiary of Corning Pharmaceutical Services. Providing full-service and/or stand-alone biopharmaceutical and medical device development expertise, Corning Besselaar has access to the finest global network of investigators, excellent personal relationships with worldwide regulatory authorities, 16 worldwide locations and over two decades of experience. No other company provides you with a broader range of services or the capabilities to meet the specific requirements of your clinical development program.
<P>
Worldwide, Corning Besselaar provides a complete package of clinical development services including:
<P>
Clinical plan development<BR>
Feasibility studies<BR>
Consulting services<BR>
Global megatrials<BR>
Accelerated clinical trials	<BR>
Information technologies<BR>
Internal quality assurance audits<BR>
INDs, European study permissions<BR>
Benchmarking/Best Practices	<BR>
European submission dossiers<BR>
<P>
	Computerized randomization and patient tracking<BR>
	Phase I Study design and implementation<BR>
	Phase II-III clinical design and monitoring<BR>
Data processing/data management<BR>
Statistical analyses and report writing<BR>
	Integrated clinical report writing<BR>
	GCP, GMP audits<BR>
	NDAs/CANDAs/CAPLAs<BR>
Development of SOPs

<P>
Extensive experience with different sizes and types of studies
Whether your needs are for the execution of small, specialized protocols such as pharmacokinetic or drug interaction studies or for large-scale multinational, global megatrials, Corning Besselaar works with you to provide the expertise and resources necessary to execute your clinical development program from beginning to end.
<P>
When you need excellence in outsourced drug development, partner with the professionals from Corning Besselaar, a Corning Pharmaceutical Services company.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-325</DOCNO>
<DOCOLDNO>IA040-000752-B013-209</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso54.htm 199.92.136.137 19970111145635 text/html 1873
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:58:12 GMT
Last-modified: Friday, 11-Oct-96 17:51:25 GMT
Content-length: 1683
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Corning Hazleton</B><BR>
	3301 Kinsman Boulevard<BR>
	Madison, WI  53707-7545, USA<BR>
	Telephone:  (608) 242-2712<BR>
	Telefax:  (608) 241-7227<BR>
	Internet:  <A HREF="http://:cps.bio.com">http//:cps.bio.com</A><BR>
	Contact Person:  Doreen H. Burton
<HR>

Exhibitor:	Corning Hazleton	<BR>
Address:	P.O. Box 7545<BR>
	Madison, WI 53707-7545	<BR>
Telephone:	(608) 242-2712<BR>
Fax:	(608) 241-7227	
<P>
Exhibitor: Corning Hazleton<BR>
Address: 	9200 Leesburg Pike<BR>
Vienna, VA 22182<BR>
Telephone: 	(703) 893-5400<BR>
Fax:	 (703) 759-6947


<P>
Exhibitor:	Corning Hazleton<BR>
Address:	Kowa No. 35 Building 3F<BR>
	1-14-14, Akasaka, Minato-ku	<BR>
	Tokyo 107 Japan<BR>
Telephone:	81-3-3586-5721	<BR>
Fax:	81-3-3586-0598<BR>
		telex:  85157735
<P>
	Corning Hazleton<BR>
Address: 	Otley Road<BR>
Harrogate, Yorkshire HG3 1PY<BR>
	England<BR>
Telephone: 44-1423-500011<BR>
Fax: 	44-1423-508473



<P>
Corning Hazleton, part of Corning Pharmaceutical Services (CPS), is an international contract research laboratory that serves the pharmaceutical and related industries with a complete range of drug development testing services. Corning Hazleton provides testing and guidance to meet international regulatory requirements. In-depth bioanalytical and biological extend from early drug discovery through non-clinical toxicology, toxicokinetics, ADME, and pharmacokinetic studies. In addition to the standard GC and HPLC technologies, Corning Hazleton has unique capabilities in the application of RIA, molecular/genetic toxicology, LC/MS/MS, GC/MS, and robotics.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-326</DOCNO>
<DOCOLDNO>IA040-000752-B013-254</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso56.htm 199.92.136.137 19970111145716 text/html 3388
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:58:40 GMT
Last-modified: Wednesday, 09-Oct-96 21:34:01 GMT
Content-length: 3195
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Corning Pharmaceutical Services</B><BR>
	210 Carnegie Center<BR>
	Princeton, NJ  08540, USA<BR>
	Telephone:  (800) 773-0011<BR>
	Telefax:  (609) 452-9854<BR>
	Internet:  <A HREF="http://www.corningps.com">http://www.corningps.com</A><BR>
	Contact Person:  Andrew MacKnight, Director of Marketing

<HR>
The connected units of Corning Pharmaceutical Services (CPS) form one of the worlds largest biopharmaceutical and medical device development services organizations. Corning Pharmaceutica1 Services operates in 31 geographical areas thoughout the Americas, Europe, and Asia Pacific. 
<P>
<B>Preclinical</B>  Corning Hazleton offers comprehensive safety testing expertise for global registrations including rapid compound development programs, toxicology, pharmacokinetic, bioanalysis testing and immune assessments. 
<P>
<B>Economics and Health Outcomes</B>  Corning HTA is the leader in innovative health economic strategies for biopharmaceutical/medical device product development. From reimbursement planning to economic support programs for providers and patients to rigorous outcome studies, Corning HTA provides health economic programs to understand potential economic impacts in todays changing healthcare environment. 
<P>
<B>Laboratory and Data Management</B>  Corning SciCor is the worldwide leader in centralized laboratory and data management services. Providing globally combinable data, with the flexibility to meet challenging study designs, Corning SciCor has the systems and staff to maximize the number of submissible data points, provide real-time data access and special reporting features for clients clinical development programs. 
<P>
<B>Contract Manufacturing</B>  Corning Bio is a unique, world-class multisource/multiuser independent cGMP outsource manufacturer staffed with industry leaders and specializing in the manufacture of recombinant protein and peptide products from Phase I through commercialization. 
<P>
<B>Packaging Services</B>  Corning National Packaging specializes in customized, innovative package design solutions for biopharmaceutical products. With personalized account management and flexible scheduling to meet critical deadlines, Corning National Packaging is the recognized leader in clinical trial packaging design for patient and site compliance. 
<P>
<B>Clinical Services</B>  Coming Besselaar provides decision-making tools for global clinical development programs. Featuring innovative trial management, "just-in time" management drug supply solutions and in-depth product development strategies, Corning Besselaar is the most experienced outsourced clinical developmenl services company worldwide. 
<P>
<B>Periapproval Services</B>  Corning PACT specializes in large-scale periapproval clinical development programs. From Phase IIIb-IV clinical trials and regulatory mandated postmarketing surveillance studies to treatment IND programs and OTC switching strategies, Corning PACT has established itself as the leader in periapproval clinical development services. 
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-327</DOCNO>
<DOCOLDNO>IA040-000752-B013-284</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso57.htm 199.92.136.137 19970111145734 text/html 1950
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:59:12 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:59 GMT
Content-length: 1757
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Corning SciCor</B><BR>
	8211 SciCor Drive<BR>
	Indianapolis, IN  46214-2985, USA<BR>
	Telephone:  (317) 271-1200<BR>
	Telefax:  (317) 273-4030<BR>
	Internet:  <A HREF="http://cps.bio.com">http://cps.bio.com</A><BR>
	Contact Person:  Tim Mitchell<BR>

<HR>
Corning SciCor is also located in Geneva, Switzerland:<BR>
Telephone:  41.22.989.1989<BR>
Telefax:  41.22.989.1999<BR>
Contact Person:  Gene Odle
<P>

<H3>Central Laboratory & Data Management Services WorldWide</H3>
<P>
Logistical, laboratory, and data management excellence that assists you to:
<P>
<B>Quickly evaluate data and identify trends early</B>
<UL>
<LI> Proven systems to support worldwide monitoring
<LI> Flexibility vital to meeting todays challenging study designs through customized testing, services, reports and data formats
<LI> Remote Data Access (RDA) allows you to download study data into your 
computer 24 hours a day.
</UL>
<P>
<B>Maximize the number of submissible data points</B>
<UL>
<LI> Well-tested worldwide specimen management system (SMARTTM)
<LI> Single electronic data stream for international studies
</UL>
<B>  Shorten NDA preparation time</B>
<UL>
<LI> Patient and specimen questions resolved during the study
<LI> Uniform data simplifies written descriptions of laboratory and data handling, avoiding long, complex algorithm explanations.
</UL>
<P>
Corning SciCor is part of Corning Pharmaceutical Services, a worldwide network of pharmaceutical industry leaders that includes Corning Hazleton, Corning Besselaar, Corning PACT, Corning Bio, Corning National Packaging, and Corning HTA.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-328</DOCNO>
<DOCOLDNO>IA040-000752-B013-310</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso58.htm 199.92.136.137 19970111145744 text/html 2668
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:59:25 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:57 GMT
Content-length: 2475
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Coromed, Inc.</B><BR>
	Rensselaer Technology Park, 185 Jordan Road<BR>
	Troy, NY  12180-7615, USA<BR>
	Telephone:  (518) 283-4000<BR>
	Telefax:  (518) 283-1807<BR>
	Internet:  <A HREF="http://www.coromed.com">http://www.coromed.com</A><BR>
	email:  <A HREF="mailto:info@coromed.com">info@coromed.com</A><BR>
	Contact Person:  Barbara L. Russell, Senior Manager, Information Resources
<HR>
COROMED, Inc., an international full-service contract research organization, provides both preclinical and clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. Distinctive among medium-sized CROs, COROMED can take a project from initial chemical synthesis and pharmacological testing, through international clinical research and regulatory submission, while maintaining the responsiveness, flexibility, and commitment to our clients that COROMED has been noted for since its establishment in 1989.
<P>
Preclinical Research
<UL>
<LI>  Medicinal and Organic Chemistry
<LI>  Pharmacological/Biological Research
<LI>  Quality Assurance and Compliance (GLP and GMP)
</UL>
<P>
Clinical Development
<UL>
<LI>  Clinical Trials Management and Monitoring (Phases I-IV)
<LI>  Regulatory and Medical Affairs
<LI>  Data Management and Biostatistical Analysis
<LI>  Medical Writing
<LI>  Quality Assurance and Compliance (GCP and GMP)
</UL>
<P>
COROMEDs staff has extensive R&D experience in all major therapeutic areas, and offers particular expertise in cardiovascular, oncologic, HIV/AIDS, and respiratory/pulmonary drug development. With operations in the U.S. (east and west coasts), Canada, Argentina, Brazil, and Belgium, COROMED readily and effectively supports clients international product development programs. With well-established operations in South America, COROMED offers experienced access to qualified investigative sites and large patient populations for clinical trials in multiple therapeutic areas.
<P>
During its seven years in business, COROMED has worked with nearly 150 pharmaceutical and biotechnology companies worldwide, with more than 90% of clients returning to us for additional assistance. COROMED provides special attention to the professional relationship and commitment to quality that many of our clients find unparalleled among CROs.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-329</DOCNO>
<DOCOLDNO>IA040-000752-B014-12</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso59.htm 199.92.136.137 19970111145807 text/html 2947
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:59:36 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:55 GMT
Content-length: 2754
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Covalent Research Alliance Corp.</B><BR>
	One Glenhardie Corporate Center, Suite 201<BR>
	1275 Drummers Lane<BR>
	Wayne, PA  19087, USA<BR>
	Telephone:  (610) 975-9533<BR>
	Telefax:  (610) 975-9556<BR>
	email:  <A HREF="mailto:COVALENT@cracorp.com">COVALENT@cracorp.com</A><BR>
	Contact Person:  Al French, Vice President, Marketing and Sales
<HR>
Covalent Research Alliance Corp. is a unique total research management organization whose strength is in the design, coordination, and monitoring of clinical trials. Covalent offers comprehensive services in Phase II-IV clinical trial management including: Regional Clinical Monitoring, Multi-center Management, Data Management, Biostatistics, Regulatory Affairs Management, Quality Assurance and Compliance, and Medical Writing.
<P>
In addition, Covalent designs and manages pharmacoeconomic and medical outcome studies. Covalent has an extensive Managed Care network to conduct both clinical and outcome studies.
<P>
Covalent has an established record of delivering quality research for over four years and is a publicly traded company (FMTI:NASDAQ small caps). There are several reasons for our success:
<P>
<UL>
<LI> We provide the highest quality of service and responsiveness to customers needs.
<LI> Our experienced personnel have a thorough understanding and expertise in the drug development process. The management team averages over 20 years per person of industry experience and clinical monitors average 8 plus years (with virtually no turnover). We have the ability to identify your challenges early in the process and provide solutions.
<LI> Our broad base of therapeutic expertise includes Asthma and Allergy, Cardiovascular, CNS, Dermatology, Gastroenterology, Infectious Diseases, Mental Health, Ophthalmology, and Womens Health.
<LI> The company specializes in conducting clinical trials and the additional dimension of developing and conducting medical outcomes studies. Covalent has successful experience in conducting these trials in the managed care setting which represents the future model for healthcare providers. Our Managed Health Care programs include:
<P>
	 Managed Care Based Clinical Trials<BR>
	 Drug Utilization Reviews<BR>
	 Outcomes Research<BR>
	 Post-Marketing Studies<BR>
	 Pharmacoeconomic Studies<BR>
	 Wellness Programs<BR>
<P><LI> Covalent is investing in and developing technology to enhance research capabilities and also deliver Health Management programs. For example, we have Interactive Voice Recognition programs for Behavioral Modification, Patient Monitoring and Compliance.
 
</UL>






</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-330</DOCNO>
<DOCOLDNO>IA040-000752-B014-47</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso64.htm 199.92.136.137 19970111145818 text/html 3132
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 14:59:58 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:39 GMT
Content-length: 2939
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>DLB Systems, Inc.</B><BR>
	110 Allen Road<BR>
	Liberty Corner, NJ 07938, USA<BR>
	Telephone: (908) 604-8604<BR>
	Telefax: (908) 604-8515 <BR>
	Internet: <A HREF="http://www.dlbsystems.com">http://www.dlbsystems.com</A><BR>
	email: <A HREF="mailto:robh@dlbsys.com">robh@dlbsys.com</A><BR>
	Contact Person: Robert Haarsgaard
<HR>
<B>DLB Systems</B> specializes in the supply of software and services to the pharmaceutical, biotechnological and devices industries worldwide. Particular areas of expertise cover data handling processes and procedures for clinical development and drug safety. All DLB products utilize GUI client/server technology and are fully Windows compliant. Using ORACLE as the core database, they can run independently or integrated to form a complete clinical research and development enterprise-wide system. DLB offers pre- and post-installation training, comprehensive documentation sets, implementation consulting and active product user groups in both North America and Europe. Validation Readiness Kits are provided for all regulated products.
<P>
<B>ALERT  Adverse Event Monitoring</B><BR>
ALERT assists with all aspects of work within the drug safety unit. This includes logging and tracking adverse event cases, dictionary look-up and code assignment, severity, causality and outcome assessment, and standard report generation suitable for submission to regulatory agencies. ALERT is fully user-configurable, allowing users to match operating procedures, data collection, and workflow requirements at headquarters and remote sites.
<P>
<B>RECORDER  Clinical Data Management</B><BR>
RECORDER unifies and simplifies case report form design, data entry screen design, database definition, and data quality checking. Fields, modules, and codelists, together with validation and consistency checks can be selected from a series of libraries and used to build a complete project or modify an existing one.
<P>
<B>MONITOR  Clinical Trials Management</B>
MONITOR supports the planning and management of local and worldwide drug development programs and associated studies from Phase I through Phase IV. Features include CRA checklists, investigator evaluations and information, study budgets and payments, patient recruitment, study document tracking and high level management reports.
<P>
<B>Field MONITOR  Laptop Investigator Site Monitoring</B><BR>
Field MONITOR assists with all tasks involved in monitoring investigator sites by field-based CRAs. Designed by CRAs, Field MONITOR runs on a laptop PC, with uploading and downloading capabilities to host MONITOR. Field MONITOR interfaces with spreadsheets, graphics, and hypertext for large document review.
<P>
<B>UNITED KINGDOM</B>
Telephone:  +44 (0) 1223 51444<BR>
Telefax:  +44 (0) 1223 566044
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-331</DOCNO>
<DOCOLDNO>IA040-000752-B014-77</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso69.htm 199.92.136.137 19970111145829 text/html 2618
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:00:07 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:29 GMT
Content-length: 2425
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Electronic Submission Publishing Systems (ESPS), Inc.</B><BR>
	1300 Virginia Drive<BR>
	Suite 215<BR>
	Fort Washington, PA  19034, USA<BR>
	Telephone:  (215) 654-9122<BR>
	Telefax:  (215) 654-7724<BR>
	Internet:  <A HREF="http://ESPS.com">ESPS.com</A><BR>
	Contact Person:  Stephen Boccardo, Manager, Business Development
<HR>

<CENTER><I>ESPS</I> and <I>CoreDossier</I>TM: <I>Your Total Submission Management solution</I></CENTER>
<P>
<B>The Company</B>
<P>
Founded in 1994 as a joint venture between Adobe Systems, Inc. and Hambrecht and Quist, Inc., ESPS is an information technology company providing regulatory submission management and software with specific focus on the pharmaceutical industry.
<P>
ESPS is staffed with many senior level professionals with over 100 years combined experience in the pharmaceutical industry in such areas as international and domestic regulatory affairs, research and development, CANDAs, pharmaceutical marketing, systems consulting and software.
<P>
<B>The Product</B>
<P>
CoreDossier exploits advanced technologies to increase development process efficiencies and decrease submission publication time. It is a modular system engineered to address all the steps of producing a submission: planning, creating, managing, assembling, publishing, reviewing and distributing. In addition, it integrates with most commercial software packages commonly used by the pharmaceutical industry and with existing document repositories such as DocumentumTM. This allows each submission contributor to continue using their preferred authoring tools and electronic source software, adding to the systems overall flexibility and ease of implementation.
<P>
The four modules (Assembler, Transformer, Publisher and Viewer) work synergistically to plan, regulate and monitor the submissions progress throughout its compilation and allow for a full or partial publishing in either HTML or paper format at any time throughout the process.
<P>
In addition to flexible, comprehensive, on-site client training, ESPS offers technical support through several available comprehensive maintenance programs. ESPS maintains two office locations: in Fort Washington, PA (USA), and in Crawley, UK to provide true global support to customers worldwide.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-332</DOCNO>
<DOCOLDNO>IA040-000752-B014-117</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso70.htm 199.92.136.137 19970111145842 text/html 3416
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:00:18 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:25 GMT
Content-length: 3223
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Elsevier Science, Secondary Publishing Division</B><BR>
	245 West 17th Street<BR>
	New York, NY  10011, USA<BR>
	Telephone:  (800) 457-3633, (212) 633-3980<BR>
	Telefax:  (212) 633-3975<BR>
	Internet:  <A HREF="http://www.elsevier.com">http://www.elsevier.com</A><BR>
	email:  <A HREF="mailto:t.lemair@elsevier.com">t.lemair@elsevier.com</A><BR>
	Contact Person:  Ton le Mair
<HR>
<B>EMSCOPES Services  The Service Designed with Service in Mind</B>
<P>
EMSCOPES Services is a proven solution for reducing turnaround time and costs associated with archiving, networking and redistributing data stored in your in-house databases  with guaranteed copyright compliance.
<P>
EMSCOPES Services is a valuable resource for:
<UL>
<LI> Drug Monitoring
<LI> Competition Monitoring
<LI> Safety and Compliance Monitoring
<LI> Current Awareness
<LI> Post-Marketing Surveillance
<LI> Medical Department Information Resource
<LI> NDA Preparation
<LI> Medical Communications Program Development
</UL>
<P>
EMSCOPES Services is designed for organizations which maintain an in-house literature database, plan to do so in the future, or are looking for a cost-effective way to regularly update a database. Receive customized EMSCOPES database updates directly from Elsevier Science, Secondary Publishing Div-ision, the producer of EMBASE, the Excerpta Medica database. You select the delivery schedule (as frequently as weekly) and medium and/or format (diskette, DAT, cartridge/tape, paper or Internet FTP).
<P>
EMSCOPES Services allows you to construct a combination of customized EMBASE subsets through a convenient licensing program featuring fixed-fee pricing for single-, multi-site or global usage of data.
<P>
EMSCOPES Services encompasses seven major categories:
<LI> EMBASE SDI Service  customized current awareness service
<LI> Multiple Database Search Service  comprehensive cross-database retrieval and deduplication
<LI> Retrospective Search Service  project-based retrospective information
<LI> Document Request Service linked to EMDOCS Document Delivery Service
<LI> Full EMBASE & EMBASE Alert Network Licenses  license for unlimited simultaneous usage of entire EMBASE database or the current awareness "Alert" file delivered weekly
<LI> Turnkey EMSCOPES  EMSCOPES EMBASE SDI subscription bundled with industry-standard database management software. Currently available with ProCiteTM or Reference ManagerTM
<LI> Database Creation & Updating  Additional Services
Additional customized indexing of EMBASE records  link dosage information, side effects, adverse reactions, etc. to your drugs
Additional processing  creation of an EMBASE record bassed on non-EMBASE articles/publications
Authority files
</UL>
<P>
Packaging with other EMBASE products  online or CD-ROM
Licensing for scanning and electronic archiving of Elsevier journal articles
<P>
International in perspective, EMSCOPES Services is offered through Elsevier Sciences offices in New York, Amsterdam and Tokyo; clients are served by a global network of representatives.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-333</DOCNO>
<DOCOLDNO>IA040-000752-B014-152</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso73.htm 199.92.136.137 19970111145902 text/html 3063
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:00:33 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:18 GMT
Content-length: 2870
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Epidemiology Resources Inc.</B><BR>
	One Newton Executive Park<BR>
	Newton Lower Falls, MA  02162-1450, USA<BR>
	Telephone:  (617) 244-1200<BR>
	Telefax:  (617) 244-9669<BR>
	Internet:  <A HREF="http://epidemiology.com">http://epidemiology.com</A><BR>
	email:  <A HREF="mailto:epidemiol@aol.com">epidemiol@aol.com</A><BR>
	Contact Person:  Dr. Nancy Dreyer
<HR>
Epidemiology Resources Inc. (ERI) focuses on the planning, conduct and interpretation of epidemiologic research including adverse events, outcomes and pharmacoeconomics. Founded in 1980, ERIs core scientific staff is a group of experienced epidemiologists who have worked together on a variety of projects involving all aspects of epidemiologic research, including study design, feasibility evaluation, large-scale data collection, analysis and interpretation.
<P>
ERIs president, Dr. Nancy Dreyer, works closely with the research staff. Drs. Stephan Lanes, Donnie Funch and Linda Dicker have considerable experience in drug safety, including large scale health surveillance, and pharmacoeconomics. Working with the core research staff are two well known and widely respected consultants: Dr. Kenneth Rothman, a co-founder of ERI, is an expert methodologist with a strong record of applied research in many areas; Dr. Alexander Walker is also an outstanding methodologist who has studied a wide range of iatrogenic problems.
<P>
ERI has achieved an international reputation for its research efforts on the safety of drugs and medical devices, and cost-of-illness studies. ERI specializes in analyses of large databases, and has developed analytic programs for person-time calculation and screening algorithms for case definition that promote informative analyses and interpretation. Active post-marketing drug surveillance programs are being conducted in the U.S. and abroad. The companys recent experience includes publications on asthma, arthritis, benign prostatic hyperplasia, pelvic inflammatory disease, gastrointestinal and liver disease.
<P>
ERI takes special pride in the quality of its work and in its outstanding record of adhering to project schedules. Research at ERI adheres to the highest standards of epidemiologic practice. A Quality Assurance Audit program was recently established in compliance with Good Laboratory Practice guidelines. ERI also operates the annual New England Epidemiology Summer training program, now in its 17th year, and publishes textbooks and a peer-reviewed journal, Epidemiology.
<P>
<B>Epidemiology Resources Inc. & the New England Epidemiology Institute</B>
One Newton Executive Park, Newton Lower Falls, MA  02162-1450  USA
Telephone (617) 244-1200    Fax (617) 244-9669    E-Mail:  epidemiol@aol.com
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-334</DOCNO>
<DOCOLDNO>IA040-000752-B014-188</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso76.htm 199.92.136.137 19970111145935 text/html 3088
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:01:09 GMT
Last-modified: Wednesday, 09-Oct-96 21:33:11 GMT
Content-length: 2895
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<STRONG>The European Regulatory Affairs Group</STRONG><BR>
	ERP Consulting (USA) LLC.<BR>
	P.O. Box 5347<BR>
	Charlottesville, VA  22905, USA<BR>
	Telephone:  (804) 972-7791<BR>
	Telefax:  (804) 977-3882<BR>
	Contact Person:  Dr. John N. Gardner<BR><P>

<HR>

<STRONG>THE ERA GROUP OF COMPANIES</STRONG><P>

<STRONG>ERA Consulting GmbH<BR>
Postfach-1249<BR>
D-29652 Walsrode<BR>
Germany<BR>
Phone: (49) 5161 9890 0<BR>
Fax:(49) 5161 9890 18</STRONG><BR><P>


<STRONG>ERA Consulting (UK) Ltd.<BR>
10-16 Tiller Road<BR>
London, E14 8PX<BR>
UK<BR>
(44) 171 510 0600	<BR>
(44) 171 510 0618</STRONG><BR><P>



<STRONG>ERP Consulting (USA) Llc.<BR>
P.O. Box 5327<BR>
Charlottesville, VA 22905<BR>
USA<BR>
(1) 804 972 7791<BR>
(1) 804 984 8304</STRONG><BR><P>



<STRONG>European Regulatory Affairs</STRONG> is the specialty of the <STRONG>ERA </STRONG>consulting group. The group provides:<P>

<LI>Strategic advice and regulatory support in the European Union for initiating clinical trials and obtaining marketing approval using the centralized, decentralized or national procedures.<BR>
<LI> Special expertise in the field of manufacturing, control and pharmaceutical development of biotech products and conventional biologics.<BR>
<LI> Diverse services to meet client needs. These range from feasibility studies of product devel-opment plans to expert reports and complete dossier compilations for submissions in Europe.<BR>
<LI> Strategic planning, organization and coordination of meetings with European agencies, together with the preparation and training needed for successful hearings before European committees.<BR>
<LI> A qualified team that has the experience of working with over 50 biotech and biological products.<BR>
<LI> In-house capabilities for biometrics and statistics, with particular emphasis on the design of bioassays to meet the requirements of the European Union.<BR>
<LI> Offices in Germany (headquarters), the UK (adjacent to the European Agency for Evaluation of Medicinal Products, with conference facilities for clients), and the USA (Charlottesville, Virginia).<BR><P>


The<STRONG> ERA</STRONG> team is distinguished by the practical experience of its members in the development of biotech products (both as line managers in industry and as consultants) and by its experience in dealing with European regulatory agencies. It has a proven track record in devising successful regulatory strategies that take into consideration the politics and regulations of Europe and in compiling dossiers and expert reports that have led to product approvals.<P>

<STRONG>In North America contact: John N. Gardner, D.Phil., (1) 804 972-7791<P>

In Europe contact: Doerthe Peters (49) 5161 9890 0
</STRONG>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-335</DOCNO>
<DOCOLDNO>IA040-000752-B014-225</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso82.htm 199.92.136.137 19970111145957 text/html 2124
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:01:36 GMT
Last-modified: Wednesday, 09-Oct-96 21:32:56 GMT
Content-length: 1931
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Frontier Technology, Inc.</B><BR>
	44790 South Grimmer Boulevard, Suite 201<BR>
	Fremont, CA  94538-6370, USA<BR>
	Telephone:  (510) 683-8557<BR>
	Telefax:  (510) 490-4949<BR>
	Internet:  <A HREF="http://www.finc.com">http://www.finc.com</A><BR>
	email:  <A HREF="mailto:sunile@finc.com">sunile@finc.com</A><BR>
	Contact Person:  Sunil Erraballi
<HR>
Frontier is a professional consulting practice specializing in information systems for the pharmaceutical and bio-tech industry. Frontier is involved in the design, development and implementation of information systems, relational databases, graphical user interfaces, client server solutions to a wide range of Fortune 1000 companies.
<P>
Frontier provides consulting in the areas of business analysis, re-engineering, and turnkey software development projects, and data warehousing solutions. Frontier has expertise both in the back-end development of data warehouses and the front-end decision support applications.
<P>
While Frontier Technology is a young company, we are rated by Dun &Bradstreet as having "strong financials," are debt-free and have access to a generous line of credit to fund our growth. We have established solid long term relationships with our customers; we focus on helping our customers be successful in their business. Some of our customers in the bay area are:Syntex (Roche Bioscience), Incyte Pharmaceuticals Inc., Alza Corporation, Chiron Corporation, Bay Networks, Quantum Corporation ...

<P>
One of the ways we attract and retain highly qualified and seasoned Information System professionals is by offering an unusually generous benefits package, including group health, 
life and disability insurance, AD&D, dependent care, flexible spending account and a company matching 401Kprogram.

 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-336</DOCNO>
<DOCOLDNO>IA040-000752-B014-259</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso84.htm 199.92.136.137 19970111150013 text/html 2004
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:01:45 GMT
Last-modified: Wednesday, 09-Oct-96 21:32:52 GMT
Content-length: 1811
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>GFI Pharmaceutical Services, Inc.</B><BR>
	800 St. Marys Drive<BR>
	Evansville, IN  47714, USA<BR>
	Telephone:  (812) 474-6530<BR>
	Telefax:  (812) 474-6539<BR>
	email:  <A HREF="mailto:adamson@gfi.com">adamson@gfi.com</A><BR>
	Contact Person:  Debra Adamson, MS, Executive Director
<HR>

<B>GFI Pharmaceutical Services</B>
The Premier Site for Accelerated Phase I-IV Clinical Trials
<P>
More than 100 of the nations leading companies in pharmaceutical and biotech research now turn to GFI for the accelerated development of their clinical trials.
<P>
<B>GFIs Research Facilities are Specifically Designed for Closely-Monitored Inpatient and Outpatient Studies </B>...
<UL>
<LI> 100-Bed Unit for Phase I Trials including first-time-in-human
<LI> Outpatient Clinic for the Efficient Conduct of Phase II-IV Trials
<LI> Tightly-Controlled Pharmacokinetic Trial Capabilities
<LI> Radiolabeled Study Capabilities
<LI> On-site CLIA-Certified Clinical Laboratory
<LI> Cardiovascular Center with 8-bed Telemetry Unit
</UL>
<P>
Computerized Database of 20,000+ Patients for Rapid Enrollment
<P>
Fully-staffed Advanced Patient Enrollment Center
<P>
Direct Access to Managed Care Organizations
<P>
Specialized populations<BR>

<UL>
<LI> Asthmatics
	<LI> Healthy Males
<LI> Surgically-sterile Women
<LI> Diabetics
<LI> Renal Patients
	<LI> Postmenopausal Women
<LI> Hypertensives
	<LI> Osteoarthritics
	<LI> Healthy Seniors
</UL>
<P>
Streamlined IRB Review Process
<P>
Outstanding Regulatory Track Record
<P>
Patient Profiles Available
<P>
For a computerized patient profile for your therapeutic area ... call GFI at (812) 474-6530
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-337</DOCNO>
<DOCOLDNO>IA040-000752-B014-291</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/glenmere.htm 199.92.136.137 19970111150025 text/html 2259
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:02:04 GMT
Last-modified: Friday, 11-Oct-96 17:48:01 GMT
Content-length: 2069
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Glenmere Research</B><BR>
	345 Route 17 South<BR>
	Upper Saddle River, NJ  07458, USA<BR>
	Telephone:  (201) 934-4220<BR>
	Telefax:  (201) 934-4146<BR>
	email:  <A HREF="mailto:glenmere2@aol.com">glenmere2@aol.com</A><BR>
	Contact Person:  Kathryn Martin, PharmD
<HR>

<I>Glenmere Research</I> offers regulatory and clinical support, including comprehensive data analysis and editorial services to the pharmaceutical and health care industries. The staff at Glenmere collectively have over 100 years of experience in the pharmaceutical industry with thirteen NDA filings and a history of support of more than 20 marketed products. Therapeutic areas of expertise include hematology, oncology, cardiology, infectious disease, rheumatology, diabetes, and pulmonology.
<P>
<CENTER><U>Clinical and Regulatory Support: complete data analysis and editorial support</U></CENTER>
<P>
NDA/PLA planning	<BR>Overview/strategy document research<BR>
Clinical development plans<BR>	Protocol development and review<BR>
Investigator brochure<BR>	CRF development and review<BR>
QA/QC review of data<BR>	Clinical data analysis<BR>
PK data analysis<BR>	Clinical study report preparation<BR>
PK study report preparation<BR>	Integrated summary report<BR>
Adverse event summaries<BR>	Package label preparation and annotation<BR>
Advisory committee preparation<BR>	Project management<BR>
Literature searching and abstracting<BR>	Publication planning<BR>
Product information report<BR>	Manuscript preparation<BR>
Health professional education<BR>	Sales training materials<BR>
Periodic regulatory reporting<BR>	Regulatory inquiry response<BR>
<P>
<CENTER><U>Managed Care: complete medical and scientific support</U></CENTER>
<P>
Prescribing guideline development<BR>	Drug Utilization Rule development<BR>
DUR operationalization	<BR>Prior authorization guideline development<BR>
Product monograph preparation	<BR>Formulary presentation development<BR>
Literature searching
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-338</DOCNO>
<DOCOLDNO>IA040-000752-B014-317</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso85.htm 199.92.136.137 19970111150042 text/html 2604
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:02:16 GMT
Last-modified: Thursday, 14-Nov-96 13:50:19 GMT
Content-length: 2412
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>gmi, gesellschaft fuer angewandte mathematik und informatik mbh</B><BR>
	Stefan-George-Ring 6<BR>
	D-81929 Munich, Germany<BR>
	Telephone:  +49-89-99 39 13-0<BR>
	Telefax:  +49-89-99 39 13-60<BR>
	email:  <A HREF="mailto:gmi.muc@t-online.de">gmi.muc@t-online.de</A><BR>
	Contact Person:  Inge Neiss, Dr. Dagmar Chase
<HR>

<CENTER><U>gmi, an independent contract research organization</U></CENTER>
<P>
Established in 1983, gmi has expanded rapidly due to consistently achieving its mission: to deliver the highest possible quality to its clients. The position now achieved is the result of internationally recognized scientific procedures and a neutral company policy towards its projects. gmi is also one of the founder members of BVMA e. V., the German association of independent CROs.
<P>
The spectrum of gmis capabilities has widened consistently over the years, so that it is now possible to offer total solutions in the areas of clinical drug research and health/pharmacoeconomics.
<P>
<U>	Health/Pharmacoeconomics</U>
<UL>
<LI> Cost-of-illness studies
<LI> 	Cost-minimization studies
<LI> 	Cost-benefit studies
<LI> Cost-effectiveness studies
<LI> Cost-utility studies
<LI> 	Pricing studies
<LI> 	Quality-of-life studies
<LI> 	Stochastic modeling
</UL>
<U>Clinical Research</U>

<UL>
<LI>Design of clinical trials	
<LI>Monitoring
<LI>Data management
<LI>Statistical analysis	
<LI>Medical writing	
<LI>Quality assurance
<LI>Seminars, in-house training
<LI>Postmarking surveillance
</UL>
<P>
gmi has at its disposal a committed and responsible team comprised of more than 60 employees from the diversified disciplines of medicine, pharmaceutics, biology, chemistry, nutritional science, economics, statistics, mathematics, computer science (informatics) and data management. Additional 25 field monitors complete the team. Close cooperation with partner CRO's in Western and Eastern Europe as well as in the USA allows gmi to conduct multinational studies at a competitive price.
<P>
As a result of its methodological know-how as well as practical experience, and because it fulfills national and international quality requirements, gmi has become a respected partner of the pharmaceutical industry both in Germany and abroad.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-339</DOCNO>
<DOCOLDNO>IA040-000752-B014-355</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso86.htm 199.92.136.137 19970111150103 text/html 3271
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:02:43 GMT
Last-modified: Monday, 21-Oct-96 13:36:46 GMT
Content-length: 3081
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Good Clinical Research Practices Limited</B><BR>
	Round Windows, Grayshott Road<BR>
	Headley Down, Hampshire GU35 8JL, UK<BR>
	Telephone:  +44 (0) 1428-713526<BR>
	Telefax:  +44 (0) 1428-713033<BR>
	email: <A HREF="mailto:104533,21@compuserve.com">104533,21@compuserve.com</A><BR>
	Contact Person:  Dr. Graham J. Ball
<HR>
The consultancy, Good Clinical Research Practices Limited, provides services to assure compliance with the highest standards of GCP. These services include auditing of clinical research, training in GCP and QA of GCP, writing and review of SOPs and consultation in the management of clinical research. Our independence assures an unbiased view of the standard of GCP compliance.
<P>
<B>Auditing: Good Clinical Research Practices Limited</B> has a team of auditors, located in the UK, Canada, and the Netherlands, with a broad range of expertise in clinical research which is applied to the auditing of clinical studies for pharmaceutical companies, contract research organizations and research institutes. We have conducted in excess of 600 audits for over 100 companies in the USA, Canada, Australasia and Europe.
<P>
In addition <B>Good Clinical Research Practices Limited</B> audits Standard Operating Procedures, clinical laboratories, data management systems, databases, study reports, clinical sections of product license application submissions (NDS, NDA, PLA) and the general organization and management of clinical research operations.
<P>
<B>Training:</B> Our previous experience with the international monitoring and management of clinical research, combined with our auditing experience in many parts of the world provide us with a good understanding of the problems encountered in the application of GCP. Against this background we have established courses in GCP and QA which are internationally available and can be tailored for in-house courses for pharmaceutical companies, investigators and study coordinators (e.g., research nurses). We also have experience in training monitors in the assessment of the quality of clinical laboratories, and data managers in data processing.
<P>
<B>Standard Operating Procedures:</B> An adequate set of SOPs is vital to the conduct of clinical research to the appropriate standard of GCP. Good Clinical Research Practices Limited has extensive experience in the preparation of SOPs which reflect the organization and culture of the research department.
<P>
<B>Management Consultation:</B> Audit of clinical studies generally uncovers deficiencies in the systems employed in the management of clinical research such as strategic planning, tracking the progress of projects, organization and training of personnel. Our previous experience in the management and monitoring of international clinical research enables us to advise on ways to improve the management of clinical research. Our independence provides unbiased appraisals and recommendations.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-340</DOCNO>
<DOCOLDNO>IA040-000752-B014-394</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso90.htm 199.92.136.137 19970111150126 text/html 2737
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:03:00 GMT
Last-modified: Monday, 30-Dec-96 21:23:30 GMT
Content-length: 2547
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>GXP Consulting</B><BR>
	Groene Wandeling, 19<BR>
	B-2970 Schilde, Belgium<BR>
	Telephone:  +32/3/383.42.60<BR>
	Telefax:  +32/3/385.41.83<BR>
	email:  <A HREF="mailto:gxpconsulting@club.innet.be">gxpconsulting@club.innet.be</A><BR>
	Contact Person:  Dr. Roland Doclo, Managing Consultant

<HR>
<CENTER><B>"Computer System Validation  A common sense, methodological approach."</B></CENTER>
<P>
Providing evidence of plans and their execution is good practice for the design, development, implementation and deployment of computerized systems. Our methodology is based on the application of established practices for good project management based on de-facto industry standards (IEEE, ISO, ...) and global regulations (EU, OECD, US, Japan). The consistent 
application of this pragmatic approach will significantly reduce the efforts devoted to the 
verification and qualification of your computerized systems and IT applications.
<P>
We have provided validation consulting to Pharmaceutical R&D and Manufacturing Companies,
 CROs, Clinical Laboratories and other Health Care Industry organizations, developing practical 
and realistic ways for proving that the work you do with computerized systems meets critical 
regulatory demands for:
<P>
<UL>
<LI>management control
<LI>credibility of data
<LI> reliability of data handling systems
<LI>a verifiable, quality approach
</UL>
<P>
We have applied this methodology in all regulatory areas: GCP, GLP, and GMP, working all the way down from developing a Corporate Policy and Validation Guidelines up to the individual system level with Validation Plans, Test Plans, Test Specifications, User SOPs, System Management SOPs, and Service Level Agreements.
<P>
Our training offering is customized to individual client needs. It covers Management Awareness Training, Skills and Competence Training and Training of System Specialists and Users. Our training methods use interactive processes such as Workshops and Small Group Working Sessions.
<P>
<B>Policy  Validation Guidelines  Validation Plans  Test Plans  Test Procedures  SOPs</B>
<P>
<B>Validation Practice SOPs  Awareness and Training Programs</B>
<P>
<B>Evaluation of Existing Systems  Action Planning  IT Project Management</B>
<P>
Our goal is to help you to be in-control of the way that your computer applications provide support to your business practices.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-341</DOCNO>
<DOCOLDNO>IA040-000752-B015-16</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso94.htm 199.92.136.137 19970111150208 text/html 3841
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:03:45 GMT
Last-modified: Wednesday, 09-Oct-96 21:32:19 GMT
Content-length: 3648
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Harris Laboratories</B><BR>
	P.O. Box 80837<BR>
	621 Rose Street<BR>
	Lincoln, NE  68501, USA<BR>
	Telephone:  (402) 476-2811<BR>
	Telefax:  (402) 476-7598<BR>
	Contact Person:  Jeff Frack, Vice President, Business Development

<HR>
Harris is an independent, scientific research laboratory, offering a complete range of clinical research (Phase I-IV), and bioanalytical and statistical services. These services are provided from facilities, offices, and more than 1,000 clinical investigative sites in six countries. Staffed by experts and scientists from the pharmaceutical, medical, regulatory, and consumer-product industries, Harris has been trusted to perform critical tests for 95 of the top 100 pharmaceutical manufacturers in the world. Harris is a subsidiary of MDSHealth Group Limited, Canadas largest technology-based health and life-sciences company.
<P>
Harris corporate headquarters are located in Lincoln, Nebraska. Phase I facilities are located in Lincoln and Omaha, Nebraska; Belfast, Northern Ireland; Phoenix, Arizona; and Beijing, China. Harris manages Phase II through Phase IV clinical trials at numerous sites across the U.S., Europe, Australia through study management teams headquartered in London and Phoenix.
<P>
Harris Laboratories is the only contract research organization (CRO) that fully automates clinical study conduct for accurate, on-time performance worldwide. Harris ClinQuickTM is an innovative, fully integrated study management system developed by Harris scientists and computer specialists. Harris ClinQuick ensures that each study is precisely defined and accurately executed. Barcoded participants are computer matched with every conduct event, while over 4,728 computerized checks ensure complete accuracy. The system also makes it possible to receive interim and final reports earlier in the clinical trial process.
<P>
Each Phase I facility is fully equipped with telemetry systems for ECG and vital-sign monitoring and is designed to perform any specialized test. Harris also provides bioanalytical research services including method development and validation and high-volume assay capabilities. Harris analyzes samples using the latest bioanalytical technology including LC/MS/MS. Through its many years of service, Harris has developed extensive participant resources, including the ability to recruit large numbers of qualified participants for specific therapeutic classes. A vast physician base has also been developed, giving Harris the ability to initiate multicenter clinical studies quickly and efficiently.
<P>
Harris associates have extensive expertise in a wide range of therapeutic areas. Their Phase I experience includes accurately conducting over 2,157 clinical studies for healthy and special populations, including elderly, diabetic, cardiovascular, HIV+, obese, cancer, postmenopausal, CNS, and hypertensive patients. Their Phase II-IV experience includes studies for leukemia, lung, breast, head/neck, and liver cancer; pharyngitis, bronchitis, pneumonia, UTI, sinusitis, candidiasis, and otitis; eczema, psoriasis, burns, inflammatory skin disorders, skin sensitivity, and acne; vaccines for hepatitis, influenza, herpes simplex, and HIV; and heart failure, hypertension, arrhythmia, angina, claudication, and ischaemia. Harris associates have also worked on complex clinical studies including immunosuppressant drugs in transplantations; orthopaedic drugs and devices; gastric secretion; and patients in intensive care.
 







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-342</DOCNO>
<DOCOLDNO>IA040-000752-B015-50</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso97.htm 199.92.136.137 19970111150239 text/html 1690
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:04:05 GMT
Last-modified: Wednesday, 09-Oct-96 21:32:13 GMT
Content-length: 1497
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>HealthQuest Research</B><BR>
	3807 Spicewood Springs Road, Suite 250<BR>
	Austin, TX  78759, USA<BR>
	Telephone:  (512) 345-7776<BR>
	Telefax:  (512) 345-8685<BR>
	Contact Person:  Terry L. Foster, PhD, Director of Business Development; Gail W. Findlay, President and CEO
<HR>

<CENTER><B>Clinical Testing of Medications  Phases I through IV 
in Austin, Texas</B></CENTER>
<P>
Phase I and Overnight Facilities
<P>
Our dedicated study coordinators and skilled technical support staff have completed studies in the following areas:
<P>
<UL>
<LI> First time in man
<LI> Bioequivalence/Bioavailability
<LI> Pharmacokinetics/Pharmacodynamics
<LI> Exercise Physiology
<LI> Assessing the HPA axis with Cosyntropin Infusion
<LI>Antigen/Methacholine Challenge
<LI> Repeated IV infusions, including Monoclonal Antibodies
</UL>
<P>
<B>Phases II-IV: Specialized Experience in Allergy and Asthma</B>
<P>
We have completed over 170 studies in the following areas:
<UL>
<LI> Seasonal and Perennial Allergic Rhinitis
<LI> Non-Allergic Rhinitis
<LI> Immunotherapy and Antigen Standardization
<LI> Allergic Conjunctivitis
<LI> Urticaria and other allergic skin diseases
<LI> Mild to severe asthma
</UL>
<P>
Our extensive in-house database of allergic and asthmatic patients and healthy volunteers facilitates rapid enrollment of studies.









</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-343</DOCNO>
<DOCOLDNO>IA040-000752-B015-78</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso100.htm 199.92.136.137 19970111150257 text/html 3832
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:04:36 GMT
Last-modified: Wednesday, 09-Oct-96 21:42:09 GMT
Content-length: 3639
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>IBRD-ROSTRUM GLOBAL, Inc.</B><BR>
	Gwynedd Hall, Suite 100, 1777 Sentry Parkway West<BR>
	Blue Bell, PA  19422, USA<BR>
	Telephone:  (215) 540-8400<BR>
	Telefax:  (215) 540-8433<BR>
	Internet:  <A HREF="http://www.IBRD-ROSTRUM.com">http://www.IBRD-ROSTRUM.com</A><BR>
	email:  <A HREF="mailto:Thornton_Susan@IBRD-ROSTRUM.com">Thornton_Susan@IBRD-ROSTRUM.com</A><BR>
	Contact Person:  Susan Thornton, Executive Vice President (215) 540-8400
<HR>
<B>IBRD-ROSTRUM GLOBAL</B> is a leading, full service contract research organization providing worldwide pharmaceutical and biopharmaceutical product development services, including clinical trial management, regulatory affairs, data management, biostatistics, technical writing, quality assurance, and post-marketing surveillance. The companys clinical pharmacology units offer a wide range of studies including first introduction in man, safety and tolerance, PK/PD, drug interaction, dose ranging, bioavailability and bioequivalence. Analytical services include method development and validation, drug and metabolite analysis, and finished product stability testing. From preclinical development to product approvals throughout the world, IBRD-ROSTRUM GLOBAL has the resources required for comprehensive product development.
<P>
<B>IBRD-ROSTRUM GLOBAL</B> places special emphasis on accurate definition of project specifications as well as careful and comprehensive assessment of time lines, resources, and budgets to ensure successful performance. A project team leader is appointed to every program to coordinate all appropriate resources and to serve as a contact for all information needed during the project. Worldwide clinical trial applications and product approvals are handled by our regulatory experts, while physicians and CRAs work closely together to identify the best investigators and expedite study completion. Monitoring is undertaken by a team of more than 110 strategically based regional CRAs managed from our offices in the U.S., Europe, South Africa and Japan. Full medical monitoring and follow-up of all adverse events, is conducted according to regulatory guidelines and the clients specific requirements. Data management and statistics are centralized in the U.S. or U.K. Skilled personnel, SOPs, and carefully validated programs combine to ensure the highest standards of database development and analysis. The extra confidence expected by clients and demanded by regulators is provided by <B>IBRD-ROSTRUM GLOBALs</B> independent QA Unit. All in-house files, procedures, databases, and reports are audited as are selected investigational sites.
<P>
With an experienced staff of over 400 professionals worldwide, IBRD-ROSTRUM GLOBAL has major offices in the U.S. based in Irvine, California and Philadelphia, Pennsylvania. Our European headquarters is located in London, U.K., with other offices located in France, Italy, Germany, Switzerland, South Africa and Japan. Clinical pharmacology units are located in Neptune, New Jersey in the U.S., and London and Bath in the United Kingdom.
<P>
For additional information in the U.S., please contact Susan Thornton, Ph.D., Executive Vice President, IBRD-ROSTRUM GLOBAL at (215) 540-8400. For information on IBRD-ROSTRUM GLOBAL in Europe, please contact Caroline Potter, Ph.D., Senior Vice President at +44 (0) 1 708 735000; Fax +44 (0) 1 708 725413. For information about IBRD JAPAN, please contact Ms. Junko Tomioka at +81 (03) 3237 3271; Fax +81 (03) 3237 3270.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-344</DOCNO>
<DOCOLDNO>IA040-000752-B015-127</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso101.htm 199.92.136.137 19970111150321 text/html 3076
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:04:57 GMT
Last-modified: Wednesday, 09-Oct-96 21:42:07 GMT
Content-length: 2883
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>ICON Clinical Research, Inc.</B><BR>
	190 West Germantown Pike<BR>
	Norristown, PA  19401, USA<BR>
	Telephone:  (610) 239-8119; (800) 711-ICON (4266)<BR>
	Telefax:  (610) 239-8119<BR>
	email:  <A HREF="mailto:info@iconus.com">info@iconus.com</A><BR>
	Contact Person:  Bill Taaffe, Elizabeth A. Bonomo, PhD
<HR>

<B>Company Profile</B><BR>
By applying policies of prudent financial management, high quality standards and controlled growth, ICON has become one of the worlds leading multinational Clinical Research Organizations. The company is managed by dedicated professionals with extensive experience in the pharmaceutical, biotechnology and CRO industries. ICON provides a comprehensive range of Phase II-IV clinical trials management, data management and biostatistical services worldwide. These include investigator recruitment, study set-up, monitoring and management, comprehensive QA auditing to ensure GCP compliance, database design, data entry, statistical analysis and report writing.
<P>
<B>Financial Stability</B><BR>
As a result of the companys broad client base, stringent cost management and policy of profit retention, ICON has no external borrowings and has extensive cash reserves. The company is among the most financially secure of all the major CROs.
<P>
<B>Areas of Operation</B><BR>
ICON specializes in multicenter, multinational studies, which include global clinical and data handling capabilities. The company is currently managing studies in the US, Canada, South Africa, South America, Central America, the Middle East and fourteen European countries.
<P>
<B>Therapeutic Experience</B><BR>
ICONs clinical research team have proven experience in a broad range of therapeutic areas including CNS, cardiovascular, respiratory, anti-infectives, AIDS, gastroenterology, pain, rheumatology, oncology, dermatology, ophthalmology and blood products. Many of the studies successfully completed have been pivotal studies for both US and European regulatory dossiers, carried out on behalf of major multinational clients (US, European and Japanese).
<P>
<B>Client Guarantees</B><BR>
ICONs policy of dedicating CRAs to one project at a time, combined with strong operational and financial controls, allows the company to provide to its clients unique contractual guarantees on both study timelines and data quality.
<P>
<B>ICON IS THE FIRST CRO TO HAVE BEEN AWARDED THE PRESTIGIOUS 
ISO 9002 INTERNATIONAL QUALITY ACCREDITATION.</B>
<P>
Ireland	<BR>
Dr. Ronan Lambe<BR>
Phone:  011-353-1-2941-500<BR>
Fax:  011-353-1-2941-600
<P>

	United Kingdom<BR>
	Ms. Vanessa Cooke<BR>
	011-44-1962-715-800<BR>
	011-44-1962-715-900
<P>
Japan<BR>
	Dr. Syu Tanaka<BR>
	011-81-3-5684-0851<BR>
	011-81-3-5684-0853
</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-345</DOCNO>
<DOCOLDNO>IA040-000752-B015-157</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso102.htm 199.92.136.137 19970111150336 text/html 2836
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:05:14 GMT
Last-modified: Wednesday, 09-Oct-96 21:41:58 GMT
Content-length: 2643
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>IDRAC  IMSInternational</B><BR>
	345, Avenue Georges Clmenceau<BR>
	TSA 30001<BR>
	92882 Nanterre CTC Cedex 04, France<BR>
	Telephone:  +33 1 41 35 10 67<BR>
	Telefax:  +33 1 41 35 13 44<BR>
	Internet:  <A HREF="http://www.ims-international.com/IDRAC">http://www.ims-international.com/IDRAC</A><BR>
	Contact Person:  Claude Basset
<HR>
IDRAC, the worlds most comprehensive Regulatory Affairs database for Europe and the United States, provides a wealth of information on CD-ROM. With clear, step-by-step information on regulatory requirements, IDRAC provides assistance in navigating the drug application process. The pool of information contained in IDRAC includes legal and administrative affairs, quality, safety and efficacy regulations.
<P>
<B>IDRAC, your European regulatory affairs partner, from strategy to tactics:</B>
<P>
<B>Develop a drug in accordance with EU and national regulation:</B> for each step in drug development, from chemical studies to clinical trials, IDRAC integrates information from the many sources available and organizes it along the structure of the Notice to Applicants.
<B>Construct and compile your European application dossier:</B> IDRAC offers definitions and direction for developing an application file. Individual national compiling requirements are detailed and explained. The software facilitates direct comparisons between the requirements of member states. Templates of official forms can be exported for use on a word processor.
<B>Budget your registration European-wide:</B> check IDRAC for the registration fees in each of the countries you plan to register your product.
<P>
<B>US regulations for the development and registration of drugs at your fingertips:</B>
<P>
Following the success of the IDRAC European module, IMS International has developed the US version of IDRAC. IMS took on the support of well-known industry consultants, Mr. Robert A. Bell, former FDA Director, and Mrs. Mary Collins, to prepare the US module. Like the European version this module goes far beyond a simple collection of official texts related to drug registration: gathered on a daily basis these texts are analyzed, enriched with abstracts, key-words and hyperlinks. But IDRAC also presents practical information compiled and developed by our experts.
<P>
IDRAC is a division of IMS International, the worlds number one partner in market research, business analysis, forecasting and sales management services to the global pharmaceutical industry.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-346</DOCNO>
<DOCOLDNO>IA040-000752-B015-189</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso106.htm 199.92.136.137 19970111150405 text/html 2325
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:05:27 GMT
Last-modified: Wednesday, 09-Oct-96 21:41:50 GMT
Content-length: 2132
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B> IIT Research Institute (IITRI)</B><BR>
	10 West 35th Street<BR>
	Chicago, IL  60616, USA<BR>
	Telephone:  (312) 567-4859<BR>
	Telefax:  (312) 567-4466<BR>
	Internet:  <A HREF="http://mail.hq.iitri.com/lifescience/">http://mail.hq.iitri.com/lifescience/</A><BR>
	email:  <A HREF="mailto:pthomas@iitri.com">pthomas@iitri.com</A><BR>
	Contact Person:  Dr. James Fenters

<HR>
IIT Research Institute (IITRI), located in Chicago and founded in 1936, is one of the oldest and largest independent, not-for-profit contract research and development organizations in the nation. IITRIs Life Sciences Department is a full-service contract toxicology and microbiology/ immunology testing laboratory. In addition, active research programs in the areas of cancer chemoprevention, cell and molecular biology, and immunology complement IITRIs expertise 
in protocol-driven testing. Support for research and testing comes in the form of contracts and grants from clients in North America, Europe and Japan, and from the U.S. government. The departments staff of approximately 100 scientists has conducted testing and research in life sciences for more than 40 years. Approximately 25% of the staff have advanced degrees and 
all senior toxicologists are certified by the American Board of Toxicology. IITRI has both small and large animal facilities for preclinical toxicology studies.
<P>
Services offered include:
<UL>
<LI>Preclinical Toxicology, including inhalation, developmental and reproductive toxicology

<LI>Specialized toxicology, including neuro-, immuno-, and molecular toxicology

<LI>Pharmacokinetics, pharmacodynamics, metabolism, and percutaneous absorption

<LI>Clinical trial laboratory support using immunology and cytokine assessment, custom immunoassays, and bioanalytical assays

<LI> New drug discovery services including cancer chemotherapy, antiviral and antibacterial screens, enzymology, and molecular biology

<LI> GLP and GMP operating procedures
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-347</DOCNO>
<DOCOLDNO>IA040-000752-B015-230</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso108.htm 199.92.136.137 19970111150431 text/html 1502
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:06:10 GMT
Last-modified: Friday, 11-Oct-96 18:00:06 GMT
Content-length: 1312
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Imperial Graphics, Inc.</B><BR>
	3100 Walkent Drive, NW<BR>
	Grand Rapids, MI 49504, USA<BR>
	Telephone:  (800) 777-2591<BR>
	Telefax:  (616) 784-1218<BR>
email: <A HREF="mailto:103033.3523@compuserve.com">103033.3523@compuserve.com</A><BR>
	Contact Person:  Peter L. Mier, Director, Clinical Research Services
<HR>


<B>A BISSELL Graphics Company</B>
<P>
For over 20 years Imperial has specialized in the design and manufacture of Case Report 
Forms  patient screening packages and diaries; and other types of printed products for clinical testing. As a result of this specialization Imperial Graphics has become the leading provider of products for Phase I through IVclinical trials. Our expertise has positively impacted larger pharmaceutical manufacturers, clinical research organizations, as well as small start-up companies.
<P>
We have been successful at developing documentation and support for the simplest Phase Itrials to the most complex Phase IVaftermarket study.
<P>
Our products and services include:
<UL>
<LI>Design services from protocol
<LI>Case report forms
<LI>Patient diary forms and cards
<LI>Specialized kit development and assembly
<LI>World wide distribution
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-348</DOCNO>
<DOCOLDNO>IA040-000752-B015-266</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso109.htm 199.92.136.137 19970111150441 text/html 2227
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:06:22 GMT
Last-modified: Wednesday, 09-Oct-96 21:41:44 GMT
Content-length: 2034
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>IMRO bv</B><BR>
	Burg. van Erpstraat 4, P.O. Box 1<BR>
	5350 AA Berghem, The Netherlands<BR>
	Telephone:  +31 412 403222<BR>
	Telefax:  +31 412 403054<BR>
	Contact Person:  A.M. Bonefaas, E.C. Dawson


<HR>
IMRO is a successful, independent, growing Clinical Research Organization (CRO), based in the Netherlands and operating in Europe. Our company was established back in 1990 and has expanded into an international CRO providing services in several therapeutic areas to the pharmaceutical industry and the medical devices industry.
<P>
Our services cover all stages of Phase II, III, and IV international, multicenter clinical studies as well as Post-Marketing Surveillance.
<P>
We have installed and documented a Quality System that complies with Good Clinical Practice and other relevant Regulations and Guidelines (ICH, US Regulations). In addition, we are currently working towards ISO 9001 certification (1997).
<P>
Audits are performed on a regular basis by a certified (IRCA) auditor of our Clinical QA unit.
<P>
We are committed to be a reliable and dedicated partner in the process of clinical drug and medical devices research. We recognize the high responsibilities towards the other partners in the research process viz., health authorities, investigators, patients and towards the Public Health System.
<P>
We wish to have our clients closely involved with assignments  from start till end; project progress and issues are reported on a monthly basis. Only by doing so can unfortunate surprises be avoided. We believe in synergy as the key to success.
<P>
We provide the following services:
<UL>
<LI> Project Management
<LI> Protocol Development
<LI>  Case Report Forms
<LI> Clinical Trial Monitoring
<LI> Data Management
<LI> Data Validation
<LI> Statistical Services
<LI> Clinical Study Reports
<LI> Medical Writing
<LI> Contract Auditing
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-349</DOCNO>
<DOCOLDNO>IA040-000752-B015-298</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso114.htm 199.92.136.137 19970111150452 text/html 1833
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:06:31 GMT
Last-modified: Friday, 11-Oct-96 17:16:42 GMT
Content-length: 1643
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Integrated Research Inc.</B><BR>
	824 Ste-Croix Boulevard<BR>
	St-Laurent (Montreal), Quebec, H4L 3Y4 Canada<BR>
	Telephone: (800) 780-9135 or (514) 747-6703<BR>
	Telefax: (514) 747-6891<BR>
	Internet: <A HREF="http://iri@cam.org">iri@cam.org</A><BR>
	Contact Person: Janice E. Parente, PhD and Joanne E. Watson, MSc

<HR>
<CENTER><B>A Canadian Clinical Trial Management Group</B></CENTER>
<P>
Committed to the highest levels of quality and integrity, Integrated Research Inc. offers many years of clinical research experience in a wide range of therapeutic disciplines. From our headquarters in Montreal, we can fulfill your study requirements at both English- and French-speaking study centers. To minimize your overall study costs and expenses, our innovative site management approach includes a complement of skilled associates located in strategic geographic regions.
<P>
Integrated Research Inc. offers a complete range of services spanning all phases of drug development. These services include:
<UL>
<LI>  Study Monitoring

<LI>  Bilingual, Regional Clinical Research Associates

<LI>  Patient Recruitment

<LI>  Data Management

<LI>  Protocol and Case Report Form Design

<LI> Medical Writing

<LI> Central Ethics Review Committee
</UL>
<P>
With a focus on versatility, our services are tailored to meet your specific needs and schedule. Through weekly study updates and timely communications, Integrated Research Inc. keeps you current and in complete control.
<P>
<B>Please call us for more information.</B>









</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-350</DOCNO>
<DOCOLDNO>IA040-000752-B015-333</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso125.htm 199.92.136.137 19970111150506 text/html 2067
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:06:44 GMT
Last-modified: Friday, 25-Oct-96 16:26:47 GMT
Content-length: 1877
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>LOGOS GmbH</B><BR>
	Kartuserstrasse 47<BR>
	79102 Freiburg, Germany<BR>
	Telephone:  +49 (0)761 282800<BR>
	Telefax:  +49 (0)761 34086<BR>
	Internet:  <A HREF="http://ourworld.compuserve.com/homepages/Logos_GmbH/">http://ourworld.compuserve.com/homepages/Logos_GmbH/</A><BR>
	email:  <A HREF="mailto:100755.3071@compuserve.com">100755.3071@compuserve.com</A><BR>
	Contact Person:  Dr. Dieter Russmann
<HR>

LOGOS is a company which provides specialist services to the pharmaceutical industry and the relevant authorities.
<P>
Preparation of patient information leaflets, data sheets and expert reports are traditionally well established services we offer. The fields of quality assurance, pharmacovigilance and electronic document management have been more recently added to our range.
<P>
At present, we have a staff of over 25 highly qualified specialists working on our projects. Our employees combine scientific knowledge and linguistic ability to the same extent, and are familiar with the latest computer technologies.
<P>
The following services are provided by LOGOS:
<UL>
<LI> Package inserts
<LI>Patient information leaflets
<LI>Summaries of product characteristics (SPC, SmPC)
<LI> Standard information brochures for hospital pharmacists
<LI> Basis monographs
<LI>Expert reports on quality, safety, efficacy
<LI>Expert opinions on drug safety and efficacy, the rationale for drug combinations, periodic safety update reports and applications for PO-to-OTC-switches
<LI>Quality assurance of clinical trials
<LI>Compiling services for DAMOS/CAMA applications
<LI>Preparation of documents for distribution on electronic media
</UL>
<P>
For further information visit our WWW-homepage or contact us.










</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-351</DOCNO>
<DOCOLDNO>IA040-000752-B015-365</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso129.htm 199.92.136.137 19970111150516 text/html 2029
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:06:55 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:35 GMT
Content-length: 1836
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>McCarthy Consultant Services Inc.</B><BR>
	1151 Gorham Street, Unit #8<BR>
	Newmarket, Ontario, Canada L3Y 7V1<BR>
	Telephone: (905) 836-0033<BR>
	Telefax: (905) 836-0006<BR>
	email: <A HREF="mailto:fmcc@interlog.com">fmcc@interlog.com</A><BR>
	Contact Person: David McCarthy
<HR>

Since 1981, McCarthy Consultant Services Inc. has been a leading company of specialists in Canadian regulatory affairs and quality assurance for the pharmaceutical, medical device, food and biotechnology industries.
<P>
<B>Pharmaceuticals</B>
<P>
New Drug Submissions (NDS), Supplemental New Drug Submissions (S/NDS), Investigational New Drug Submissions (IND), Applications for D.I.N. and G.P. numbers, Preparation of Plant Master Files, Preparation of Drug Master Files (USA), Provincial Formulary Submissions, Labeling and Advertising Reviews, GMP Audits, ISO 9000 Audits, GMP Training, QA Systems Design and Management, Government Liaison and Strategy, Validations
<P>
<B>Medical Devices</B>
<P>
Part V Submissions (Pre-market approval), Device Notifications, Labeling and Advertising Reviews, Government Liaison and Strategy, GMP Audits, GMP Training, ISO 9000 Audits, SOP Preparation, Validations
<P>
<B>Foods</B>
<P>
Medical Food Compliance Issues, Product concept/label design, Review Issues with New Products, Reviewing Ingredient Declarations, Determination of Allowable Claims, Compliance Review of Labels, Bilingual Translations, Advertising Copy review, Approvals of Electronic Advertising Copy, Government Liaison and Strategy, New and Novel Food Submissions, GMP Audits, ISO 9000 Audits, Compliance Issues on Food Supplements/Drugs, Compliance Issues on Medical Foods, Validations








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-352</DOCNO>
<DOCOLDNO>IA040-000752-B016-21</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso130.htm 199.92.136.137 19970111150536 text/html 2516
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:07:12 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:30 GMT
Content-length: 2323
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>McKesson BioServices</B><BR>
	Sales and Marketing, 6 Montgomery Village Avenue, Suite 322<BR>
	Gaithersburg, MD  20879, USA<BR>
	Telephone:  (301) 417-0229; 1 (888) 4MBS-BIO<BR>
	Telefax:  (301) 417-0450<BR>
	Internet:  <A HREF="http://www.mckessonbio.com">http://www.mckessonbio.com</A><BR>
	email:  <A HREF="mailto:richard.zakour@mckesson.com">richard.zakour@mckesson.com</A><BR>
	Contact Person:  Richard Zakour/Anita Dopkosky
<HR>
<B>McKesson:  Redefining optimum drug development for todays managed health care environment</B>
<P>
McKesson BioServices (MBS) is a wholly-owned subsidiary of McKesson Corp., a leading provider of pharmaceutical and health care products and services to pharmacies, hospitals, and health care networks. McKesson Corp., with annual sales of over $13 billion, is a "Fortune 100" Company whose shares are traded on the NYSE. Effective December 19, 1995, McKesson Corp. acquired MBS in its entirety from the Ogden Corporation. MBS along with a sister Company, Healthcare Delivery Systems (HDS), comprise McKessons Pharmaceutical Services Group.
<P>
MBS furnishes:
<UL>
<LI> clinical supplies management,
<LI> biomedical repository operations,
<LI> analytical laboratory services,
<LI> packaging and labeling,
<LI> patient-specific drug delivery services, and
<LI> regulatory support services.
</UL>
Because MBS has been successful in meeting these objectives during the past ten years, the Company has grown steadily each year. Today the Company is a leader in establishing and supporting the Government in biomedical programs of national importance, clinical trials support, drug and biological repository operations, and regulatory support services. McKesson BioServices currently is in the process of obtaining ISO-9001 accreditation.
<P>
From McKessons Pharmaceutical Services Group, HDS specializes in innovative services that help insure a successful product launch and rapid market penetration after NDA approval by providing:
<UL>
<LI> cost recovery programs,
<LI> patient transition programs,
<LI> patient assistance programs,
<LI> treatment IND management programs, and
<LI> reimbursement support hotlines.
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-353</DOCNO>
<DOCOLDNO>IA040-000752-B016-58</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso132.htm 199.92.136.137 19970111150551 text/html 1885
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:07:28 GMT
Last-modified: Wednesday, 16-Oct-96 14:30:35 GMT
Content-length: 1692
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>MEDEX, Inc.</B><BR>
	10 East Athens Avenue, Suite 204<BR>
	Ardmore, PA 19003, USA<BR>
	Telephone:  (610) 896-2340<BR>
	Telefax:  (610) 896-2341<BR>
	email:  <A HREF="mailto:medex1@pond.com">medex1@pond.com</A><BR>
	Contact Person:  Joseph T. McDevitt, President and CEO

<HR>
MEDEX offers a complete line of clinical trial management, data management, and medical writing services. As an extension of your team, our team is ready to provide partial or complete support for your Phase I through Phase IV clinical research activities, pharmacoeconomic studies, quality-of-life trials, and expanded use programs.
<P>
MEDEX is now entering its sixth year as a full-service clinical research organization. Since 1991, we have grown to over 70 full-time employees, and we have successfully completed more than 300 clinical research projects which have included:
<P>
<UL>
<LI> Complete NDA and sNDA turn-keys

<LI> Pivotal anti-infective, CNS, cardiovascular, hormone replacement, endocrinology and ophthalmologic clinical trials

<LI> Targeted Phase IV studies resulting in peer review journal publications

<LI> Prospective and Retrospective managed care programs

<LI> An Expanded Access/compassionate use program designed for over 10,000 AIDS patients
</UL>
<P>
The key to our success has been understanding our clients research needs and guaranteeing to provide the clinical trial services they require on time and within budget.
<P>
For more information on MEDEXs capabilities, experience and fixed price guarantees, please contact us directly at 1-800-487-MEDX (6339).







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-354</DOCNO>
<DOCOLDNO>IA040-000752-B016-92</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso133.htm 199.92.136.137 19970111150601 text/html 1207
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:07:41 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:24 GMT
Content-length: 1014
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>MedFocus, Inc.</B><BR>
	2800 River Road, Suite 380<BR>
	Des Plaines, IL  60018, USA<BR>
	Telephone:  (847) 375-9600 or (800) 256-4625<BR>
	Telefax:  (847) 375-9607<BR>
	Internet:  <A HREF="http://www.medfocus.com">http://www.medfocus.com</A><BR>
	email:  <A HREF="mailto:medfocus@taylormgmt.com">medfocus@taylormgmt.com</A><BR>
	Contact Person:  Carl Kutsmode, Dir., Bus Dev., West; Jane Thomsen, Dir., Bus. Dev., East
<HR>
MedFocus is a full service clinical research consulting firm. Our mission is to assist our clients throughout all phases of the clinical research process. We provide Clinical Data Entry Technicians, Clinical Data Managers, Bio-statisticians, SAS programmers, systems analysts/designers, technical/medical writers and Clinical Research Associates. Our consultants are available as entire project teams or individually to augment existing staff.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-355</DOCNO>
<DOCOLDNO>IA040-000752-B016-128</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso135.htm 199.92.136.137 19970111150638 text/html 2484
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:08:08 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:20 GMT
Content-length: 2291
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Medical Research Services, Ltd.</B><BR>
	2 Tesseneer Drive<BR>
	Highland Heights, KY  41076, USA<BR>
	Telephone:  (606) 781-8899<BR>
	Telefax:  (606) 781-9508<BR>
	email:  <A HREF="mailto:medrs@aol.com">MEDRS@AOL.COM</A><BR>
	Contact Person:  August J. Troendle, MD
<HR>

Medical Research Services, Ltd. (MRS) is a full service Contract Research Organization with experience in all aspects of the drug development process. Many of the leaders in the pharmaceutical industry have depended on MRS to prepare a drug development plan design, manage clinical trials, develop statistical analysis and regulatory and report generation. In partnership with Medical Research Laboratories (MRL in USA, CRL in Europe), MRS can provide the global support you require.
<P>
MRS is led by a full-time staff of physicians with FDA and pharmaceutical backgrounds. 
A MRS medical expert is available 24 hours a day to handle any research need that may arise. Our monitoring, data management and biometrics staff is highly trained with years of experience in the research environment.
<P>
Communication is a top priority at MRS to ensure that the exact needs of the project are met. A dedicated and experienced project manager is assigned to each project to guarantee your project is conducted with the highest quality and accuracy and completed on schedule. Our flexibility and extensive therapeutic knowledge allow us to provide research support that conforms with and meets the standards you require on a first time basis. The services MRS provides are in accordance with the highest standards to meet all GCP and FDA requirements. MRS is a goal oriented CRO offering:
<P>
Preparation of Clinical Development Plan<BR>
Medical and Regulatory Counseling<BR>
Protocol Development<BR>
Case Report Form Design and Preparation<BR>
Customized Remote Data Entry (Clintrak)<BR>
Clinical Monitoring<BR>
Project Management and Reporting<BR>
Data Management<BR>
Statistical Analysis and Report Generation<BR>
Final Report Writing<BR>
NDA/Regulatory Document Preparation
<P>
<B>MEDICAL RESEARCH SERVICES, LTD.  YOUR SOLUTION TO QUALITY AND ACCURACY</B>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-356</DOCNO>
<DOCOLDNO>IA040-000752-B016-170</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso139.htm 199.92.136.137 19970111150659 text/html 2500
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:08:29 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:12 GMT
Content-length: 2307
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Medilab Clinical Laboratories AB</B><BR>
	P.O. Box 1550<BR>
	S-183 15 TBY, Sweden<BR>
	Stockholm, Sweden<BR>
	Telephone:  +468 768 0100<BR>
	Telefax:  +468 792 0311<BR>
	email:  <A HREF="mailto:medilab@medilab.se">medilab@medilab.se</A><BR>
	Contact Person:  Eric Wahlo, Marketing Manager
<HR>
<B>Medilab, Central Laboratory for Clinical Trials</B>
<UL>
<LI>  A complete system of logistics
	<LI> Training and information to relevant personnel

<LI> Laboratory reports designed
<LI> Responsible person at laboratory assigned for
   according to sponsors specifications	   each study

<LI> Archiving of raw data
<LI> Solid experience of clinical trials

<LI> Maximum flexibility	
<LI> Electronic data transfer
</UL>
<B>Laboratory Quality</B><BR>
The laboratory is accredited by the Swedish Board for Accreditation and Conformity (Swedac). We are also subject to routine periodic inspections by the Medical Products Agency and hold the Statement of GLP Compliance (OECD Principles of Good Laboratory Practice). Our laboratories are also subject to audits by international pharmaceutical companies. Medilab is a central laboratory appointed as a Pfizer Approved Laboratory.
<P>
<B>Services covering the Nordic Countries</B><BR>
Our logistics cover the Nordic countries. Usually the postal system is sufficient for "next day" delivery of study samples. If special transport of samples is required we use Courier Freight. We also take part in studies in Europe, America, Australia and the Far East.
<P>
<B>Extensive Laboratory Testing Services</B><BR>
Our laboratory capacity covers Clinical Chemistry, Haematology, Microbiology, Histo-Pathology and Cytology. We have developed specialist expertise in the analysis of hormones and hormone-like substances.
<P>
<B>Well-established Laboratory</B><BR>
Medilab is a well-established laboratory which began operating in the 1970s. The Clinical Trials Department was launched in 1989. The central laboratory is situated in Tby, a northern suburb of Stockholm. There are 150 employees and turnover is USD 20 million. Medilab is a member of the multinational Clinical Trials Network SYMBIO-CLIN.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-357</DOCNO>
<DOCOLDNO>IA040-000752-B016-210</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso140.htm 199.92.136.137 19970111150729 text/html 1604
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:09:06 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:07 GMT
Content-length: 1411
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Mediscience Planning Inc.</B><BR>
	Kodenma Fine Building, 2F<BR>
	14-9 Nihonbashi Kodenma-cho,<BR>
	Chuo-ku, Tokyo 103, Japan<BR>
	Telephone:  03-3663-7575<BR>
	Telefax:  03-3663-7271<BR>
	email:  <A HREF="mailto:QWF02012@niftyserve.or.jp">QWF02012@niftyserve.or.jp</A><BR>
	Contact Person:  Yoshifumi Yanase, PhD
<HR>
<CENTER><B>ADVANTAGES OF MEDISCIENCE PLANNING INC. (MPI)</B></CENTER>
<P>
MPI has accumulated a broad range of experience in pharmaceutical development business 
for more than 14 years since its establishment, and offers excellent services in the field of CRO in Japan.
<P>
<B>CONSULTATIONS IN BUILDING DEVELOPMENT STRATEGIES</B><BR>
	 Consultations to establish comprehensive development plan, include overcoming difficulty which appears throughout pharmaceutical development period, utilizing own outstanding know-how.
<P>
<B>CLINICAL STUDIES</B><BR>
	 Organizing researchers meeting with numerous successful experiences, designing, monitoring and evaluation.<BR>
	 Well-structured QC and QA system, originally developed.
<P>
<B>REGULATORY AFFAIRS</B><BR>
	 Consultations on pharmaceutical regulatory affairs.<BR>
	 Supports on preparation for technical reports and registrational brochures including IND and NDA documents.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-358</DOCNO>
<DOCOLDNO>IA040-000752-B016-236</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso142.htm 199.92.136.137 19970111150743 text/html 1942
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:09:21 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:03 GMT
Content-length: 1749
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>MEDISEARCH INT. (MSI)</B><BR>
	Drie Eikenstraat, 661<BR>
	B-2650 Edegem, Antwerp, Belgium<BR>
	Telephone:  32/3/411.24.26<BR>
	Telefax:  32/3/411.24.27<BR>
	Internet:  <A HREF="http://www.ubca.uia.ac.be/medisearch">www.ubca.uia.ac.be/medisearch</A><BR>
	email:  <A HREF="mailto:Remi.VanDenBroeck@medisearch.uia.ac.be">Remi.VanDenBroeck@medisearch.uia.ac.be</A><BR>
	Contact Person: Evelyne Denys

<HR>
<B>MEDISEARCH INT. (MSI)</B> is a <B>European Independent Contract Research Company, </B>
offering a complete R&D service for pharmaceutical, biotechnology and devices companies.
<P>
<B>CORE Activities of MSI consist of:</B><BR>
Coordination of phase I to IV clinical trials
	All aspects of clinical trial design, conduct and reporting are handled in
  agreement with the sponsor.
	Trials are managed according to GCP/GMP and are FDA/EC auditable.
	Recruitment rates and detailed progress reports are provided monthly.
One project manager is responsible for all aspects of the trial and is the first 
  contact person for the sponsor.
<P>
Data management, biostatistics and medical writing
	SAS and ORACLE database programming.
	Solid pretrial agreements with sponsor.
	Audit trail.
	Complete auditable data entry and data review guidelines.
	Statistical analysis to GSP.
	Medical writing, based on recent ICH guidelines
Exchange of Clinical Research Staff
Training<BR>
Pharmaco-economics<BR>
<P>
MSI strengths:
<UL>
<LI> Quality for an acceptable price
<LI> Problem solving thinking
<LI> Location in the center of Europe
<LI> Personal engagement towards each client
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-359</DOCNO>
<DOCOLDNO>IA040-000752-B016-266</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso143.htm 199.92.136.137 19970111150757 text/html 2050
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:09:33 GMT
Last-modified: Wednesday, 09-Oct-96 21:40:01 GMT
Content-length: 1857
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>MediTech International Co., Ltd.</B><BR>
	2-4-7 Doshomachi<BR>
	Chuo-ku, Osaka 541, Japan<BR>
	Telephone:  +81-6-203-3330<BR>
	Telefax:  +81-6-203-0646<BR>
	Internet: <A HREF="http://www.sphere.ad.jp/meditech"> http://www.sphere.ad.jp/meditech</A><BR>
	email:  <A HREF="mailto:tochi@gol.com">tochi@gol.com</A><BR>
	Contact Person:  Toshinori Ochi, PhD
<HR>
<B>Clinical development and NDA submissions for Japanese registration ...</B>
<P>
MediTech International (MTI) is a full service CRO which focuses on assisting overseas pharmaceutical manufacturers obtain Japanese approval for their ethical products.
<P>
As an organization specifically designed to offer international applicants a comprehensive package of new drug registration services, MTI acts as "In-Country Caretaker" (ICC), an organization unique to Japan, not only representing overseas applicants to Japans Health Authorities, but also performing all key activities required for submission of the NDA and final product approval.
<P>
Under the ICC system non-Japanese manufacturers, even those without a base of operations in Japan, are able to delegate clinical development and NDA submission to an ICC organization based in Japan. Close collaboration continues during the post-NDA review process with the ICC closely collaborating with the applicant and providing the crucial link to all review boards and subcommittees.
<P>
<B>MTI  ...  the only In-Country Caretaker in Japan offering ALL of the necessary CRO services to get your product approved and on the Japanese market</B>
<UL>
<LI>Regulatory Consulting
<LI>Feasibility Studies
<LI>Non-Clinical Data Review
<LI>Phase I - III
<LI>NDA Submissions
<LI>PMS Coordination
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-360</DOCNO>
<DOCOLDNO>IA040-000752-B016-294</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso146.htm 199.92.136.137 19970111150808 text/html 2075
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:09:50 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:52 GMT
Content-length: 1882
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>METRONOMIA GmbH</B><BR>
	Feichthofstr. 136<BR>
	81247 Munich, Germany<BR>
	Telephone:  +49-89-88 79 86<BR>
	Telefax:  +49-89-83 62 16<BR>
	email:  <A HREF="mailto:72314.726@compuserve.com">72314.726@compuserve.com</A><BR>
	Contact Person:  Rudolf Koehne-Volland, Managing Director
<HR>

<B>Me\tro\no\mia; <greek>:  Managing the Measurable</B>
<P>
According to the translation of the company name METRONOMIA performs clinical research projects and pharmacoeconomic studies since 1990. Medical doctors, statisticians, economists, CRAs and data management staff concentrate on two main targets to reach for pharmaceutical companies:
<P>
<B>Quality</B>
<UL>
<LI>Qualified, experienced and highly
   motivated personnel
<LI>Extensive database with experienced	   
   investigators	
<LI>Regular training and education 	   
<LI>Internal and external audits
<LI> ISO 9002 certified quality management 
   system
<LI>High quality hardware and software 
   system equipment
</UL>
<B>	Efficiency</B>
<UL>
	<LI>Efficient organizational structure
	<LI>Facilities to perform large clinical studies and post-marketing surveillance studies
<LI>Intensive use of up-to-date communications techniques
	<LI>Performing studies with remote data entry
</UL>

<P>
METRONOMIAs research services cover:
<UL>
<LI>Clinical trials phase II-IV	<LI>Post-marketing surveillance studies
<LI>Study design	<LI>Protocol development, CRF design
<LI>Project management	<LI>Investigator selection and training
<LI>Monitoring and quality assurance	<LI>Data management and coding
<LI>Statistical planning and analysis<LI>Medical writing
<LI>Pharmacoeconomic study design,<LI>xDATA remote data entry system
   analysis and publications
</UL>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-361</DOCNO>
<DOCOLDNO>IA040-000752-B016-332</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso149.htm 199.92.136.137 19970111150844 text/html 3806
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:10:06 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:45 GMT
Content-length: 3613
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>NCGS and Associates, Inc.</B><BR>
	One Unity Alley, Suite 3000, Charleston, SC  29401, USA<BR>
	Telephone:  (803) 723-9555<BR>
	Telefax:  (803) 723-9933<BR>
	Internet:  <A HREF="http://www.webperfection.com/foyer/ncgs/index.html">http://www.webperfection.com/foyer/ncgs/index.html</A><BR>
	email:  <A HREF="mailto:nsnowden@awod.com">nsnowden@awod.com</A> or jpinkas@awod.com or gboyce@awod.com<BR>
	Contact Person:  Nancy C.G. Snowden, President; Julie H. Pinkas, Manager, Marketing and Communications; Gail G. Boyce, Vice President, Operations
<HR>
In the wild, the cheetah is known for its ability to combine speed, precision, and concentration. Cheetahs are by no means the jungles biggest cats ... but are, by any measure, the swiftest. For over a decade, we at NCGS have become known for our ability to combine these three elements in the pursuit of our clients goals. We understand the importance of ensuring that everything we do be accomplished with speed, precision, and concentration, as the contract research industry is an environment of exacting demands.
<P>
When it comes to medical research, NCGS is full-service in every sense of the word. In fact, we are experienced in virtually all of the clinical trials and analytical processes necessary to expedite FDA submissions for drug, device, biologic, and diagnostic products. We are proud to make a point of our wide range of work experience. Without a cumbersome learning curve involved, we can immediately go to work and customize a plan of action. Our goal? "Decreasing cycle time while maintaining quality."
<P>
<B>At NCGS, we believe</B> the very best results occur in an environment of "seamless teamwork". We integrate our staff within your team, to meet your goals in a cost-efficient and timely manner. In fact, we like to begin the teamwork process immediately, by working closely with you to determine the services needed. We find that this helps establish an atmosphere of trust and confidence, as our clients are quickly exposed to both our level of expertise and our commitment to maximizing research budgets.
<P>
Our disease areas, product types and study types of experience include:
<UL>
<LI> Anticoagulant <LI> AIDS <LI>Anti-viral <LI> Asthma <LI> Biologics <LI> Bone Marrow Transplant <LI>
Cystic Fibrosis <LI> Devices <LI> Diagnostics <LI>ELISA <LI>Epidemiological Studies <LI>Flow Cytometry <LI>Graft vs Host Disease <LI>Growth Factors <LI>Hematology <LI> Hemophilia <LI>Hemostasis 
<LI> Immunology <LI> Infectious Disease <LI> Iontophoresis <LI> ITP <LI>Neurology <LI>Neurosurgery 
<LI>Oncology <LI>Ophthalmology <LI> Pediatrics <LI> Pharmaceuticals <LI>Pharmacokinetic <LI>Phase I, II, III <LI>Pulmonary <LI>Sepsis <LI>STDs <LI>Stem Cell Selection <LI> Transdermal Drug <LI>Transplantation 
<LI> Tumor Markers <LI> Veno-Occlusive Disease <LI> Wound Healing

</UL>
As we have expanded, we added numerous specialized ancillary services ... primarily because we feel our clients need someone with a medical research background to perform the services properly. They include: l in-house printing l layout/design l marketing materials l newsletters to disseminate information and generate a spirit of competition between sites l video production and training aids l training program development.
<P>
We welcome the opportunity to discuss your product development needs and invite you to meet our staff and visit our facilities in historic Charleston, South Carolina.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-362</DOCNO>
<DOCOLDNO>IA040-000752-B017-28</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso150.htm 199.92.136.137 19970111150914 text/html 2869
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:10:47 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:40 GMT
Content-length: 2676
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>NetForce Incorporated</B><BR>
	505 Montgomery Street, 15th Floor<BR>
	San Francisco, CA  94111, USA<BR>
	Telephone:  (415) 954-7000<BR>
	Telefax:  (415) 781-3904<BR>
	Internet:  <A HREF="http://www.netforce.com">http://www.netforce.com</A><BR>
	email:  <A HREF="mailto:bvn@netforce.com">bvn@netforce.com</A><BR>
	Contact Person:  Bill Van Nostrand
<HR>
NetForce provides information technology consulting, system integration, and application development services to the healthcare industry, including:
<P>
<LI> Biotechnology/Pharmaceutical products and services, focusing on clinical data management, regulatory compliance, clinical research, and biotechnology industry support.
<P>
<LI> Quality Assurance, focusing on compliance with FDA standards for validated systems and Good Clinical Practices, as well as ISO 9000 qualification and its applicability to software systems in the healthcare field.
<P>
NetForces Strategic Planning Services provides a methodology which synchronizes your information technology strategy, services, and development with your corporate business objectives. Our Project Services expertise provides comprehensive solutions throughout all phases of computer system life cycle. We have successfully applied our strategic planning, project analysis, implementation, quality assurance, and production services to implement strategic solutions that address our clients unique requirements.
<P>
EventNetTM is NetForces full-featured adverse reporting application. Its real-time distributed database architecture allows installation at multiple sites, or even in multiple countries. Each site can create, update, and report events to meet the specific operational needs of the company. Data can be distributed in its entirety or selectively, as dictated by marketing or development agreements for selected drug compounds. When EventNet is installed at multiple locations, its distributed database architecture allows the data to be automatically integrated and made available across multiple sites. You can specify what data, as well as which responsibilities, are distributed between sites. The controlled access is immediate  anywhere around the world.
<P>
Oracle Corporation and NetForce have formed a strategic alliance to integrate Oracle Clinical, Oracles clinical data management application, with EventNet to provide a seamless solution spanning the clinical trials problem space. The integration will facilitate the reconciliation of adverse event reports and clinical trials data.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-363</DOCNO>
<DOCOLDNO>IA040-000752-B017-67</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso151.htm 199.92.136.137 19970111150956 text/html 2977
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:11:32 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:38 GMT
Content-length: 2784
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Neuroclinical Trials Center</B><BR>
	400 Ray C. Hunt Drive, Suite 200<BR>
	Charlottesville, VA  22903, USA<BR>
	Telephone:  (804) 243-0375<BR>
	Telefax:  (804) 243-0290<BR>
	email:  <A HREF="mailto:csg5E@virginia.edu">csg5E@virginia.edu</A><BR>
	Contact Person:  Carolyn Galbraith, RN, CCRA, Director of Business Development
<HR>

<CENTER><B>Neuroclinical Trials Center</B>
A University Based CRO</CENTER>
<P>
NTCs Clinical Research Units focus on:
<UL>
<LI><B>Time-to-Market, Approval and Protocol Development:</B>  NTC assists clients in developing
approval strategies that complement their marketing plans. If the sponsor already has a plan, NTC has the capability to work within it to develop an overall indication plan or a study protocol, or simply provide feedback on an existing protocol.

<LI><B>Communications, Timelines and Project Management:</B>  NTC designates a Project 
Manager to work collaboratively with clients to establish a shared set of expectations which are documented for the client, along with a timeline and specific project deliverables.

<LI><B>Study Initiation  Adherence to Protocol:</B>  Ensuring that a study is initiated successfully is 
critical. NTC can identify highly productive sites with which it has worked in the past and can provide assessments of the capability of potential new sites to enroll patients and comply with a studys protocol.

<LI><B>Site Management Maintaining Quality and Enrollment Rates:</B>  NTC continually 
monitors and reports on enrollment rates, assures the sites administrative manuals are current, and maintains communication to help sustain commitment to the study throughout the enrollment period of the trial.

<LI> <B>Clinical Data Management:</B>  NTCs process incorporate Clinical, Oracles state-of-the-
practice Clinical Data Management application. Oracle/Clinical supports virtually every phase of the Clinical Data Management life cycle.

<LI><B>Reporting and Analysis:</B>  NTCs Reporting and Analysis process can produce tables that 
adhere to either NTCs or other standard layouts and formats. Tables are prepared by our highly qualified and experienced staff of Statistical Programmers and Biostatisticians.

<LI> <B>Quality and Process:</B>  NTCs design goal for all its processes is to build quality in  not add 
it on after inspection. To achieve this goal, NTC enlisted the aid of the Software Engineering Institute (SEI) at Carnegie Mellon University.
</UL>

<P>
NTCs Extended Family of Services
<P>
Applied Neuroimage Analysis	Consulting Services
Medical Monitoring and Safety Committees	Field Monitoring








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-364</DOCNO>
<DOCOLDNO>IA040-000752-B017-122</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso153.htm 199.92.136.137 19970111151014 text/html 2133
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:11:54 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:34 GMT
Content-length: 1940
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>NJC Enterprises, Ltd.</B><BR>
	P.O. Box 14145, 79 T.W. Alexander Drive, 4201 Building, Suite 207<BR>
	Research Triangle Park, NC  27709-4145, USA<BR>
	Telephone:  (919) 549-4100<BR>
	Telefax:  (919) 549-4663<BR>
	Internet:  <A HREF="http://www.njcenterprises.com">http://www.njcenterprises.com</A><BR>
	email:  <A HREF="mailto:nchew@njcenterprises.com">nchew@njcenterprises.com</A><BR>
	Contact Person:  Nancy J. Chew, MS, RAC, President
<HR>
Incorporated in New York in 1977, NJC Enterprises, Ltd. has grown into a full-service regulatory consultancy. Exclusively committed to Regulatory Affairs, NJC Enterprises, Ltd. develops, interprets, and communicates pharmaceutical and biotechnology information for use with U.S., Canadian, and European regulatory authorities. <B>Reliability, dedication to detail, and professional, personalized service are our hallmarks.</B>
<P>
NJC has prepared study reports, investigational new drug applications, clinical trial certificates, investigators brochures, application and technical summaries for new drug applications, drug master files, abbreviated new drug applications, product license applications, establishment license applications, and other such documentation for the Unites States Food and Drug Administration, Canadian Health Protection Branch, European Ministries of Health, and the European Community. NJCs compliance group has managed design review teams and performed GMP, GLP, and GCP compliance audits.
<P>
For 20 years NJC has served the pharmaceutical, biotechnology and medical device industries. <B>If you are looking for a contract regulatory organization, and if you demand uncompromising reliability and quality, consider the resources of NJC Enterprises, Ltd. NJC is a member of the Pharmakopius International Group.</B>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-365</DOCNO>
<DOCOLDNO>IA040-000752-B017-158</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso155.htm 199.92.136.137 19970111151027 text/html 2440
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:12:06 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:29 GMT
Content-length: 2247
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>NovaTech Sciences Corporation</B><BR>
	2 Centerview Drive<BR>
	Greensboro, NC 27407, USA<BR>
	Telephone:  (910) 852-5200<BR>
	Telefax:  (910) 852-3259<BR>
	Internet:  <A HREF="http://www.novatech-sciences.com">http://www.novatech-sciences.com</A><BR>
	email:  <A HREF="mailto:information@novatech-sciences.com">information@novatech-sciences.com</A><BR>
	Contact Person:  Dave Winstead
<HR>

NovaTech Sciences Corporation, established in 1982, is a premier support company to the pharmaceutical and biotechnical industries, offering innovative solutions and scientific excellence in clinical research and information technologies. From a corporate center in North Carolina, with locations in California, Louisiana, New Jersey, Oklahoma, and South Carolina, three divisions of NovaTech specialists assist clients with clinical research, information sciences, and regulatory strategy.
<P>
<B>Clinical Research Division</B>
<P>
For Phases I through IV, eNovaTech professionals provide services ranging from single-center studies to complex global projects, and from CRF development through post-marketing surveillance, ensuring data integrity from point-of-origin through final analysis, including
<UL>
<LI>Feasibility reports	<LI>SAS programming
<LI>Clinical plan development	<LI>Database construction
<LI>Clinical trial management<LI>Statistical analysis
<LI>Regulatory strategy<LI>Document development
<LI>Data management<LI>CANDA/CAPLA development
</UL>
<P>
<B>Information Sciences Division</B>
<P>
<B>NovaTechs</B> Information Sciences professionals have extensive experience developing software products, using state-of-the-art software tools and techniques, including Oracle, 
MS Access, Powerbuilder, DB2, FoxPro, Novell, and SAS.
<P>
<I>Together this unique partnership of science and technology has developed numerous software innovations for managing pharmaceutical studies.</I>
<P>
<B>Learning Labs</B>
<P>
Supporting the other divisions, eNovaTechs unique Learning Labs specializes in high-level seminars for clinical research and information sciences professionals.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-366</DOCNO>
<DOCOLDNO>IA040-000752-B017-204</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso156.htm 199.92.136.137 19970111151042 text/html 2685
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:12:23 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:27 GMT
Content-length: 2492
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Olsten Kimberly QualityCare</B><BR>
	4341 South Westnedge, Suite 2216<BR>
	Kalamazoo, MI  49008, USA<BR>
	Telephone:  (616) 344-9410<BR>
	Telefax:  (616) 344-9182<BR>
	Internet:  <A HREF="http://www.okqchomehealth.com">http://www.okqchomehealth.com</A><BR>
	Contact Person:  Ralph Woods

<HR>
Olsten Kimberly QualityCare is North Americas largest provider of nurses and other allied health care professionals for home care and temporary staffing. With more than 150,000 professionals in over 600 locations in the U.S. and Canada, Olsten Kimberly QualityCare has the staff and expertise to meet a wide variety of needs.
<P>
The Centrally Coordinated Programs unit of Olsten Kimberly QualityCare is a sophisticated internal project management team, dedicated to using the organizations resources to solve unique business problems. All CCP Programs include a single point of access for all required services, centralized customer service and program management, and a single, consolidated invoice for all services provided, regardless of location.
<P>
<B>Clinical Drug<BR>
Trial Support</B>
<P>
	In compliance with GCPs, state nurse practice acts, and 
	study protocols, we provide qualified staff to:
<UL>
<LI>Monitor clinical drug trial data at study sites
<LI> Review incoming data at customer sites
<LI>Provide home infusions of investigational drugs
<LI>Perform at-home assessments of study participants
<LI>Collect biological specimens
</UL>
<P>
<B>Education and<BR>
Compliance<BR>
Monitoring</B>
<P>
	Training potential users is vital to success when a company 
	launches a new drug or health care product. We provide temporary 	staff to assist you in meeting your goals through:
<UL>
<LI>Clinician to clinician education
<LI>Product education/demonstration in clinical settings
<LI>Product specific patient education and compliance monitoring
</UL>
<P>
<B>Health-Related<BR>
Research<BR>
Support</B><BR>
<P>
	In the fast-changing health care field, the demand for relevant 
	information continues to grow. When new procedures, new ideas, 
	new medicines, or new practices are being evaluated, we can 
	assist by using our staff to:
<UL>
<LI>Interview patients or professionals
<LI>Audit records for outcomes data and compliance
<LI>Administer standardized testing tools at homes or facilities
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-367</DOCNO>
<DOCOLDNO>IA040-000752-B017-241</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso157.htm 199.92.136.137 19970111151112 text/html 2439
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:12:51 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:25 GMT
Content-length: 2246
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Oneida Research Services, Inc.</B><BR>
	One Halsey Road<BR>
	Whitesboro, NY  13492, USA<BR>
	Telephone:  (315) 736-3050<BR>
	Telefax:  (315) 736-2460<BR>
	email:  <A HREF="mailto:samaraio@borg.com">samaraio@borg.com</A><BR>
	Contact Person:  Sharon A. Maraio
<HR>

Oneida Research Services, Inc. (ORS) is a contract facility providing GLP/GMP compliant analytical testing and data analysis services to the pharmaceutical industry. The services offered include:
<UL>
<LI>Bioanalytical method development, validation and specimen analysis
<LI> Pharmacokinetic/pharmacodynamic/statistical data analysis and report writing
<LI>Stability and release testing of dosage forms
<LI>Structural and elemental analysis of pharmaceuticals
</UL>
<P>
The bioanalytical services offered by ORS involve the analysis of drug concentrations in biological specimens derived from pre-clinical and Phase I through Phase IV clinical trials. The techniques employed include liquid and gas chromatography, and state-of-the-art mass spectrometry (GC/MS, LC/MS and MS/MS). Analysis of HIV-positive and hepatitis B-infected specimens, are performed in a specially designed containment facility.
<P>
ORS offers both non-compartmental and compartmental pharmacokinetic data analysis, as well as pharmacokinetic/pharmacodynamic modeling and statistical analysis of data. We will also prepare technical reports and submission-ready manuscripts according to your specified format.
<P>
ORSs stability and release testing services include potency, impurity, dissolution and disintegration testing of oral dosage forms, as well as a full range of analytical services directed toward metered dose inhalers, liquids, creams and ointments. On-site sample storage according to ICH guidelines is available.
<P>
Evaluation of the chemical structure and elemental composition of pharmaceuticals is performed using a variety of techniques including CHNS analysis; x-ray powder diffraction; mass spectrometry; gas, liquid and ion chromatography; x-ray fluorescence; TGA-FTIR; ion selective electrodes; and Karl Fischer titration.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-368</DOCNO>
<DOCOLDNO>IA040-000752-B017-271</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso161.htm 199.92.136.137 19970111151120 text/html 2619
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:13:01 GMT
Last-modified: Wednesday, 09-Oct-96 21:39:14 GMT
Content-length: 2426
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Padcom Clinical Research GmbH</B><BR>
	Am Propsthof 80<BR>
	53121 Bonn, Germany<BR>
	Telephone:  ++49.228.97983-14<BR>
	Telefax:  ++49.228.97983-33<BR>
	Internet:  <A HREF="http://www.padcom.de">http://www.padcom.de</A><BR>
	email:  <A HREF="mailto:Compuserve 100042,2134">Compuserve 100042,2134</A><BR>
	Contact Person:  Business Development
<HR>
<B>State-of-the-art solutions for the management of your clinical trials</B>
<P>
Padcom Clinical Research, founded in Bonn in 1991, teams up with Electronic Data Systems (EDS) and A.T. Kearney, both leaders in their field of business: information services and management consulting. Padcom Clinical Research is the only clinical research services company developing sophisticated software to take care of your clinical data at every stage of a trial. For our experienced staff, serving the pharmaceutical industry means taking the responsibility. For you, it means one-stop-shopping either trusting in our software expertise or in our competence in clinical research.
<P>
<B>OpusTwo</B><BR>
OpusTwo is an integrated Clinical Data Management System for the coordination of clinical trials. Its extensive functionality combines study design, data acquisition, and data review in only one application. OpusTwo is designed to simplify clinical trial implementation and execution, improve data quality and reduce duration as well as overall process cost. Our services include: consulting, pilot projects, systems integration, training, user support and help desk.
<P>
<B>Clinical Research Services</B><BR>
To maintain Padcoms expertise in clinical research as a continuous source of product ideas and enhancements, Padcom conducts its own contract research organization business, providing the full service offerings of a CRO. Our qualified CRAs  all with academic credentials  are dedicated to manage your trials of Phases II to IV in line with GCP and your SOPs from the preparation stage to implementation and execution. Services include database, protocol and CRF design, recruitment and training of the investigators, project management, on-site and/or in-house monitoring, including data entry, (Serious) Adverse Event (SAE) reporting, documentation and logistical support as well as statistical planning and reporting.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-369</DOCNO>
<DOCOLDNO>IA040-000752-B017-310</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/paragon.htm 199.92.136.137 19970111151150 text/html 2765
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:13:19 GMT
Last-modified: Friday, 11-Oct-96 17:17:50 GMT
Content-length: 2575
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Paragon Biomedical, Inc.</B><BR>
	2603 Main Street, Suite 850<BR>
	Irvine, CA  92614, USA<BR>
	Telephone:  (714) 224-2800/(800) 6-PARAGON<BR>
	Telefax:  (714) 442-2811<BR>
	Internet:  <A HREF="http://www.paragonbiomedical.com">http://www.paragonbiomedical.com</A><BR>
	Contact Person:  Gena H. Reed, President
<HR>

Paragon Biomedical is a Contract Research Organization specializing in clinical research services from protocol development to clinical summary. With corporate offices in Irvine, California, and regional offices throughout the United States, Paragon manages one of the leading field organizations in the industry. Paragon has over 80 regionally based and experienced clinical research monitors organized in project specific teams.
<P>
Paragon offers the following services separately or as cost-effective integrated processes:
<P>
<UL>
<LI> Project Management	<LI> Grants Administration
<LI> Protocol Development	<LI>  Programming
<LI> Case Report Form Design<LI> Data Management
<LI> Site Recruitment	<LI> Statistical Services
<LI> Site Qualification	<LI> Clinical Reports
<LI> Monitoring	<LI> Audits
</UL>
<P>
Paragons 8 years of extensive therapeutic experience provides support in the following areas:
<P>
	CENTRAL NERVOUS SYSTEM	ENDOCRINE
<UL>
<LI>Alzheimers Disease	<LI>Benign Prostatic Hyperplasia
<LI>Anesthesia	<LI>Diabetes
<LI>Insomnia	<LI>Endometriosis
<LI>Parkinsons Disease	<LI>Hormone Studies
<LI> Psychiatric Disorders
</UL>
<P>
	CARDIOVASCULAR	INPATIENT INFECTIOUS DISEASE
<UL>
<LI>Angina	<LI>Lower Respiratory Tract Infections in 
<LI>Congestive Heart Failure	  Long-Term Care Facilities
<LI> Hypertension	<LI>Nosocomial Pneumonia
<LI>Peripheral Arterial <LI>Serious Gynecological Infections
	  Thromboembolic Occlusion	<LI> Serious Lower Abdominal Infections
<LI>Thrombolysis in Acute Stroke	<LI>Serious Skin and Soft Tissue
</UL>

<P>

	GASTROINTESTINAL	OUTPATIENT INFECTIOUS DISEASE
<UL>
<LI>Duodenal Ulcer<LI>Acute Sinusitis
<LI>Lower Respiratory Tract Infection
	ANTI-INFLAMMATORY	<LI>Otitis Media With and Without Tympanocentesis (Pediatric)
<LI>Asthma	<LI>Pharyngitis (Pediatric)
<LI>Pneumonia (Pediatric)
	ONCOLOGY	<LI>Skin and Soft Tissue Infection (Pediatric)
<LI>Bladder Cancer<LI>Tonsillitis (Pediatric)
<LI>Lung Cancer
<LI>Malignant Melanoma	INFECTIONS IN SPECIAL HOSTS
<LI>Metastatic Cancer	<LI>AIDS related Opportunistic Infections
<LI>Pancreatic Cancer	<LI>HIV
<LI>Prostate Cancer<LI>Antifungals
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-370</DOCNO>
<DOCOLDNO>IA040-000752-B018-28</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso162.htm 199.92.136.137 19970111151203 text/html 2333
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:13:42 GMT
Last-modified: Friday, 11-Oct-96 17:17:11 GMT
Content-length: 2143
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>PAREXEL</B><BR>
	Corporate Headquarters<BR>
	195 West Street, Waltham, MA  02154, USA<BR>
	Telephone:  (617) 487-9900<BR>
	Telefax:  (617) 487-0525<BR>
	Internet:  <A HREF="http://www.PAREXEL.com">http://www.PAREXEL.com</A><BR>
	email:  <A HREF="mailto:Taylor.Crouch@PAREXEL.com">Taylor.Crouch@PAREXEL.com</A><BR>
	Contact Person:  Taylor Crouch
<HR>
Founded in 1982, PAREXELis a premier Contract Research Organization (CRO)with offices worldwide. PAREXELspecializes in the design and management of domestic and multinational Phase I-IV clinical research programs for pharmaceutical, biotechnology and medical device firms.
<P>
The Knowledge and Experience for Optimal Study Design
Globally integrated clinical programs are increasingly being used to reduce the time and cost to obtain regulatory approvals. With international expertise and experience in all therapeutic categories, PAREXELs Clinical Trials Management staff provides valuable insight in study design and implementation and functions within a structure that fosters communication and attention to detail.
<P>
<B>Clinical Trial Consulting Services</B><BR>
<UL>
<LI> Strategic planning
<LI> Assessment of clinical/scientific data
<LI> Development of clinical operating plans
<LI> Study design
<LI> Protocol/study documentation preparation
<LI> Sample size determination
<LI> Statistical methods/analysis planning
<LI> Review of client technical dossiers and development plans
<LI> Research and interpretation of applicable local regulations
<LI> Determination of regulatory status
<LI> Formulation of global and local registration strategies
<LI> Client representation at regulatory agency meetings
</UL>
<P>
<UL>
<B>Process Improvement Consulting Services</B><BR>
<LI> Clinical Research Performance Report industry benchmarking tool
<LI> Workflow analyses
<LI> Process re-engineering
<LI> Staffing/capacity utilization
<LI> Customized training
<LI> SOPdevelopment
</UL>
<P>
Visit our Website at <A HREF="http://www.PAREXEL.com">http://www.PAREXEL.com</A>








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-371</DOCNO>
<DOCOLDNO>IA040-000752-B018-61</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso169.htm 199.92.136.137 19970111151212 text/html 2515
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:13:53 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:57 GMT
Content-length: 2322
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Partners In Research, Inc.</B><BR>
	607 West Main Street, Suite 401<BR>
	Louisville, KY  40202, USA<BR>
	Telephone:  (502) 581-1212<BR>
	Telefax:  (502) 581-1756<BR>
	email:  <A HREF="mailto:partners@iglou.com">partners@iglou.com</A><BR>
	Contact Person:  W. Edward Miller, President

<HR>
Partners In Research specializes in managed care research. Our research staff includes former employees from Humana Inc., one of the largest health plans in the country, with experience in outcomes and clinical research in the health plan setting. We are experienced at working with Managed Care Organizations while meeting the needs of the Pharmaceutical, Biotech and Device Industry. Research relationships with Partners In Research include various models of managed health care plans, physician providers and hospitals across the United States. Integrating clinical information with longitudinal claims and financial information from the Managed Care Organization is our specialty.
<P>
<B>Research Affiliations and Experience</B><BR>
Partners In Research has research relationships with over 20 health plans, 100 staff model medical centers, 90 hospitals, a national home health company, and a national group purchasing organization.
<P>
Partners In Research offers experience, principally in the primary care setting, in the design and conduct of research studies in the following areas:
<P>
	Health Outcomes<BR>
	Health Economics<BR>
	Health Care Quality of Life<BR>
	Phase IIIB<BR>
	Phase IV<BR>
	Post-marketing Surveillance


<P>
<B>Research and Health Care Advisory Board</B><BR>
This expert panel provides an insiders perspective of the product or research needs of a diverse number of nationally known organizations. Our Advisory Board includes current and former executives of:
<P>
	Humana Inc.<BR>
	Harris Methodist Health Plans<BR>
	Friendly Hills Healthcare Network<BR>
	American Medical Association<BR>
	JCAHO<BR>
	IPA  1,500 Physician Members<BR>
	The Health Care Advisory Board
<P>
With the many combined years of research and managed care experience, our staff members at Partners In Research are The Specialists in Managed Care Research.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-372</DOCNO>
<DOCOLDNO>IA040-000752-B018-99</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso170.htm 199.92.136.137 19970111151226 text/html 2754
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:14:01 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:49 GMT
Content-length: 2561
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>PDS Research</B><BR>
	908 Main Street<BR>
	Louisville, CO  80027, USA<BR>
	Telephone: (800) 574-7374 in U.S., (303) 666-8100<BR>
	Telefax:  (303) 666-9886<BR>
	email:  <A HREF="mailto:75452.1543@compuserve.com">75452.1543@compuserve.com</A><BR>
	Contact Person:  Arlin Lehman
<HR>

IN OUR 20TH YEAR OF PRODUCING RESEARCH QUALITY PULMONARY FUNCTION AND AEROSOL DELIVERY INSTRUMENTS
<P>
PDSI designs, manufactures and distributes pulmonary diagnostic and aerosol delivery instruments for research in clinical, pharmaceutical and regulatory industries worldwide. Our experienced applications support team provides technical support for protocol design, on-site training and monitoring of study results for quality control. Our unique instrumentation provides accurate, reproducible control of the many variables inherent in aerosol delivery and spirometric measurements. Utilizing uniform instrumentation, automated methodology and independent quality review, helps insure the internal consistency of your study data and enables pooling of data from multiple investigational centers. Standardized remote data entry and transfer can be utilized for timely monitoring and rapid identification of sub-optimal patient or investigator performance.
<P>
RESEARCH QUALITY SPIROMETERS for pulmonary parameter measurement and study.
<P>
<UL>
<LI>Easy-to-use      <LI> Quick      <LI>Accurate     <LI>Reliable
<LI>Computer automated for reproducible, standardized measurements
<LI> Software can be customized to protocol specific methodology
<LI>Integrated Dosimeter is available for automated metering of aerosol agents and reproducible phasing of delivery
<LI> Dose response and dose ranging curves are automatically calculated and generated 
by the computer
</UL>



<P>
<B>CONTROLLED AEROSOL DELIVERY DEVICES</B> for variable, metered dosing for aerosols.
<UL>
<LI>ROSENTHAL DOSIMETERS provide precise, reproducible dosing for aerosol challenge agents
<LI>METERED DOSE NEBULIZERS provide targeted, selectable dose delivery of aerosol drugs
<LI>ROSENTHAL FLOW REGULATOR VALVE provides respiratory flow rate control to enhance reproducibility of aerosol administration and deposition
<LI>Computer controlled phasing of aerosol delivery allows targeted delivery of aerosol at any specific lung volume
<LI>Characterized Nebulizers and precise delivery control provides accurate dose response studies
</UL>







</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-373</DOCNO>
<DOCOLDNO>IA040-000752-B018-132</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso175.htm 199.92.136.137 19970111151236 text/html 3302
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:14:17 GMT
Last-modified: Thursday, 14-Nov-96 13:59:29 GMT
Content-length: 3110
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Pharmaceutical Consultants, Inc.</B><BR>
	5033 West 117th Street<BR>
	Leawood, KS  66211, USA<BR>
	Telephone:  (888) 491-9825<BR>
	Telefax:  (888) 491-9829<BR>
	Internet:  <A HREF="http://www.pharmconsult.com">www.pharmconsult.com</A><BR>
	email:  <A HREF="mailto:beth@pharmconsult.com">beth@pharmconsult.com</A><BR>
	Contact Person:  Beth Maggio, PhD
<HR>
<B>Our Mission:</B><BR>
To provide quality consulting services to the pharmaceutical research community. 
To assist companies in the acceleration of drug development and thereby reduce the time to market of valuable products. PCIbelieves that by achieving this goal, our client and ultimately the patient will be rewarded with better health care.
<P>
As a Contract Research Organization, PCI provides services that are pertinent to the investigative and approval process of pharmaceuticals. When pharmaceutical companies require new products to be brought to market, existing products updated, or other consulting services provided, PCI can quickly and cost-effectively deliver them.
<P>
Pharmaceutical Consultants, Inc. has been providing services to the international pharmaceutical industry for over ten years. Dr. Beth Maggio, President, founded PCI in the mid-80s after completing lengthy tenures in research and academia. Dr. Maggio has over twenty-five years of experience in the pharmaceutical industry and has established a solid working relationship with the FDA.
<P>
<B>	Partial Listing of Services </B><BR>

	Clinical Plan Development<BR>
	Investigator Identification/Recruitment<BR>
	Case Report Form Design/Printing<BR>
	Database Design/Development<BR>
	Study Monitoring	<BR>
	Project Management<BR>
	Quality Control Audits<BR>
	FDALiaison	<BR>
	INDPreparation and Annual Reports<BR>
	U.S. Agent for International Companies<BR>
	Medical Report Writing<BR>
	Data Entry, Verification and Statistical Analysis	<BR>
	Computerized Project Tracking/Reporting
<P>
<B>	Areas of Expertise</B><BR>
	Analgesics<BR>
	Antiallergy<BR>
	Antibiotics<BR>
	Antifungals<BR>
Antihypertensives<BR>
	Biomaterials<BR>
	Contraceptives<BR>
HIV/AIDS<BR>
	Hormones<BR>
	Immunology<BR>
	NSAIDs<BR>
Osteoporosis<BR>
	Respiratory


<P>
PCI is experienced in all aspects of product development. As an organization that is not inhibited by vast overhead or limiting infrastructure, we are able to design a solution specifically for your needs. PCIwill approach each of your projects with a fresh perspective and will not generically apply a "cookie-cutter" plan designed for every situation. In short, we have an excellent reputation as an organization that delivers tailored results in a timely and cost-effective fashion.
<P>
PCI believes in developing and maintaining a lasting partnership with our clients through professional integrity, mutual respect, and teamwork. For additional information or to request a complete marketing package please email pciinfo@pharmconsult.com.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-374</DOCNO>
<DOCOLDNO>IA040-000752-B018-165</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/prc.htm 199.92.136.137 19970111151246 text/html 2334
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:14:27 GMT
Last-modified: Thursday, 14-Nov-96 13:50:59 GMT
Content-length: 2142
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Pharmaceutical Resource Corporation</B><BR>
	204 Corporate Drive<BR>
	Langhorne, PA  19047, USA<BR>
	Telephone:  (215) 968-7750<BR>
	Telefax:  (215) 968-7572<BR>
	email:  <A HREF="mailto:pharmrs@voicenet.com">pharmrs@voicenet.com</A><BR>
	Contact Person:  Patricia Monteforte or R. Bruce Simonson
<HR>
Pharmaceutical Resource is a full service CRO with an excellent reputation in the areas of Clinical Research and Clinical Quality Assurance. Pharmaceutical Resource delivers high quality services at a reasonable cost. In fact, over 95% of our business is through repeat business and referrals. 
<P>
<B>Clinical Research:</B><BR>
Pharmaceutical Resource personnel are experienced in full service management of multicenter clinical research trials. Our highly trained staff includes two infectious diseases physicians experienced in the conduct and management of clinical trials. Services include trial design, protocol preparation, CRF design/preparation, investigator recruitment/qualification/selection, investigator meetings, monitoring, data management, statistics and report writing.
<P>
<B>Clinical Quality Assurance:</B><BR>
Pharmaceutical Resource personnel have experience in the conduct of international clinical research and multidisciplinary systems/facilities audits across multiple sites/countries to evaluate compliance with local and international laws and regulations as well as company policies and procedures. 
Additionally, we regularly perform audits of clinical trial reports, databases, study files and investigator sites. 
<P>
<B>Literature Search/Publication Retrieval:	</B><BR>
Pharmaceutical Resource offers complete literature search and publication retrieval service for the pharmaceutical industry. Our physicians and scientists can also prepare summaries of the literature for a given topic.
<P>
Pharmaceutical Resource offers our clients the ability to contract for a single service 
(e.g., CRF design) or for complete management of an entire trial. 








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-375</DOCNO>
<DOCOLDNO>IA040-000752-B018-201</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso178.htm 199.92.136.137 19970111151259 text/html 2800
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:14:37 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:31 GMT
Content-length: 2607
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Pharmaco International Inc.</B><BR>
	4009 Banister Lane<BR>
	Austin, TX  78704, USA<BR>
	Telephone:  (512) 447-2663<BR>
	Telefax:  (512) 440-2973<BR>
	Internet:  <A HREF="http://www.pharmaco.com">http://www.pharmaco.com</A><BR>
	email:  <A HREF="mailto:research@pharmaco.com">research@pharmaco.com</A><BR>
	Contact Person:  Constance K. Wierman, Dir. Intl. Marketing & Client Communications
<HR>
Pharmaco International Inc. is a contract clinical research organization providing services for all phases of product development. These include pre-clinical, clinical and data management and evaluation. Pharmaco also provides regulatory support for product approval for the pharmaceutical, medical device and biotechnology industries worldwide. Pharmaco cornerstones of successful global programs include: truly global project management, global SOPs, global communications, centralized database and one of the most experienced CRO teams in the industry in an environment of continual learning.
<P>
INTEGRATED SERVICE CAPABILITIES WORLDWIDE
Phases I - IV 	<BR>
clinical trials management<BR>
	project management<BR>
	protocol development/CRF development<BR>
	clinical supplies<BR>
	site recruitment/initiation<BR>
	investigator meeting<BR>
	patient enrollment<BR>
	monitoring services	<BR>
	medical monitoring	   <BR>


	data management<BR>
	biostatistics<BR>
	medical writing<BR>
	quality assurance services<BR>
	pharmacoeconomics<BR>
	post marketing surveillance<BR>
	product development planning<BR>
analytical chemistry/methodology development<BR>
		regulatory affairs services<BR>



<P>
THERAPEUTIC CAPABILITIES<BR>
Experience in virtually all therapeutic areas including:<BR>

allergy<BR>
analgesic	<BR>
biologics<BR>
cardiovascular<BR>
central nervous system<BR>
dermatology<BR>
endocrinology<BR>
immune system	<BR>
	gastrointestinal	<BR>
geriatric<BR>
	hematology<BR>
	HIV<BR>
	imaging agents<BR>
	infectious disease<BR>
	musculoskeletal<BR>
connective tissue<BR>
oncology<BR>
	ophthalmology<BR>
	respiratory<BR>
	rheumatology<BR>
	urology<BR>
	vaccines<BR>
	womens health
<P>
WORLDWIDE FACILITIES
In the US: Austin, TX; Columbia, MD; Princeton, NJ; Research Triangle Park, NC; Richmond, VA; San Diego, CA. In the UK: Cambridge; Chelmsford, Essex; Leicester, England. In Europe: Belgium, Czech Republic, France, Germany, Poland, Spain, Sweden. In the Southern Hemisphere: Australia, South Africa.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-376</DOCNO>
<DOCOLDNO>IA040-000752-B018-245</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso182.htm 199.92.136.137 19970111151340 text/html 2172
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:15:13 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:15 GMT
Content-length: 1979
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>PHARMAPART AG</B><BR>
	Seefeldstrasse 9<BR>
	8008 Zrich, Switzerland<BR>
	Telphone:  0041/1/251 50 51<BR>
	Telefax:  0041/1/251 51 14<BR>
	Internet:  <A HREF="http://www.access.ch/swisspharmanet/pharmapart/">http://www.access.ch/swisspharmanet/pharmapart/</A><BR>
	email:  <A HREF="mailto:pharmapart@access.ch">pharmapart@access.ch</A><BR>
	Contact Person:  Stephan Henauer, MD
<HR>
PHARMAPART is an independent Swiss CRO, providing a full range of high-quality medical and regulatory services for clinical development, registration and marketing of pharmaceutical drugs.
<P>
<B>PHARMAPART</B> provides cost-effective services on a timely basis and is your reliable partner for:
<P>
<B>Clinical Development  Phase III + IV</B><BR>
	Strategic planning, planning of individual studies<BR>
	Design and production of study protocol and CRF<BR>
	Recruitment of investigators<BR>
	Clinical study monitoring
<P>
<B>Data Management and Statistics</B><BR>
	Database design, data entry and data listings<BR>
	Statistical analysis<BR>
	Biostatistical and integrated reports
<P>
<B>Regulatory Affairs  Regulatory Support for Switzerland and Europe</B><BR>
	Registration dossiers<BR>
	Clinical summaries, expert reports<BR>
	Data Sheets (Fach-/Patienteninformationen)
<P>
<B>Medical Writing, Editorial Services and Translation</B><BR>
	Clinical trial reports and publication manuscripts<BR>
	Literature reviews<BR>
	Document editing<BR>
	Translation of medical texts
<P>
<B>Medical Consulting for Marketing and Sales</B><BR>
	Reliable medical information and relation to experts<BR>
	Design and development of drug monographs
<P>
<B>Medical Informatics</B><BR>
	Bulletin Board System to facilitate the communication and information transfer between pharmaceutical industry, agencies, physicians and pharmacists.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-377</DOCNO>
<DOCOLDNO>IA040-000752-B018-277</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso186.htm 199.92.136.137 19970111151359 text/html 3367
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:15:36 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:06 GMT
Content-length: 3174
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Phoenix International Life Sciences Inc.</B><BR>
	2350 Cohen Street<BR>
	Montreal, Quebec, Canada H4R 2N6<BR>
	Telephone:  (514) 333-0033<BR>
	Telefax:  (514) 333-8861<BR>
	Internet:  <A HREF="http://www.pils.com">http://www.pils.com</A><BR>
	email: <A HREF="mailto:judyz@pils.com"> judyz@pils.com</A><BR>
	Contact Person:  Judy Zilber, Senior Vice President, Bus. Dev., Marketing & Sci. Comm.
<HR>
<CENTER><B>"North Americas Innovation Leader"</B></CENTER>
<P>
<B>Phoenix International</B> is a multi-service contract research organization (CRO), providing an integrated package of services to the pharmaceutical and biotechnology industries.
<UL>
<LI> Phase I clinical research	<LI> Phase II-IV clinical studies
<LI> Animal Metabolism	<LI> Bioanalytical research
<LI> Clinical Pharmacology	<LI> Regulatory Affairs
<LI> Pharmaceutical Product Analysis	<LI> Scientific Software
</UL>
<P>
<B>Phoenix</B> occupies a leadership position in drug bioanalysis, operating the worlds largest bioanalytical laboratory with upwards of 135 instruments including 22 PE Sciex mass spectrometers. The company is additionally equipped and staffed to provide a variety of specialized ancillary laboratory services (e.g. in vitro testing, organic synthesis, infected sample handling). With over 1,000 highly skilled and dedicated employees, Phoenix is among the largest CROs in North America.
<P>
<B>Phoenix</B> is equally a North American leader in Phase I clinical studies. It currently owns clinics in Montreal (94-bed, 12,000 sq. ft.) and Cincinnati (212-bed, 75,000 sq. ft.)  The Cincinnati clinic is a completely renovated hospital facility which contains seven units, including a first-in-man unit and a barrier wing for viral studies.
<P>
<B>Phoenix</B> licenses its proprietary laboratory information management systems (LIMS). These scientific software programs have been developed by an in-house team of programmers to capture, process and report bioanalytical, metabolism and pharmacokinetic data.
<P>
<B>Phoenixs</B> strategy of developing its Phase II-IV clinical studies group and expanding its current areas of therapeutic expertise is further aided by the recent signing of a strategic alliance with VERUM, a leading European CRO consortium specializing in clinical study management. This agreement provides Phoenix with the opportunity to conduct and monitor multi-national clinical studies. The companys reputation for high quality work is reflected in the results of nine audits by the U.S. Food and Drug Administration over the last six years: four were error-free, and the other five required only minor changes to Phoenixs procedures.
<P>
<I><B>Phoenix Internationals</B> reputation for strong, innovative science in its clinics and laboratories is complemented by the numerous national and regional awards it has won, recognizing its managerial excellence and entrepreneurial strengths.</I>
<P>
For more information, please contact: Judy Zilber l Tel:  (908) 781-9666 l Telefax:  (908) 781-9667








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-378</DOCNO>
<DOCOLDNO>IA040-000752-B018-319</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso187.htm 199.92.136.137 19970111151412 text/html 2312
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:15:49 GMT
Last-modified: Wednesday, 09-Oct-96 21:38:04 GMT
Content-length: 2119
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Phoenix Regulatory Associates, Ltd.</B><BR>
	21525 Ridgetop Circle, Suite 240<BR>
	Sterling, VA  20166, USA<BR>
	Telephone:  (703) 406-0906<BR>
	Telefax:  (703) 406-9513<BR>
	Internet:  <A HREF="http://www.phoenixrising.com">http://www.phoenixrising.com</A><BR>
	email:  <A HREF="mailto:phoenixr@ix.netcom.com">phoenixr@ix.netcom.com</A><BR>
	Contact Person:  Dr. Clyde Takeguchi

<HR>
Celebrating its fifth anniversary, Phoenix Regulatory Associates, Ltd. brings together over 100 FDA and industry experts. The majority of the principals and consultants have well over 20 years of experience in the regulatory field.
<P>
Phoenixs clients range from multi-national companies to start-ups. All have one attribute in common. They appreciate the level of expertise and excellence that the Phoenix team brings to each project.
<P>
Services for the pharmaceutical industry include:
<P>
<UL>
<LI> Conducting GMP/GLP/ISO 9000 audits
<LI> Facilitating PAI readiness and validation activities; mock FDA inspections
<LI> Implementing GMP systems and procedures
<LI> Establishing an ISO 9000 program
<LI> Conducting in-house GMP/GLP/ISO 9000 training
<LI> Advising bulk pharmaceutical chemical manufacturers
<LI> Matching your company with engineers who can design new systems and facilities 
to meet your growth requirements
<LI> Writing or supporting the preparation of CMC sections and DMFs
<LI> Developing regulatory strategies for the preparation of preapproval submissions
<LI> Resolving compliance problems
<LI> Performing due diligence audits
</UL>

<P>
The main Phoenix office is conveniently located in the Washington, DC area near FDA headquarters. The European office is directed by Dr. Peter Simons and located near London, England. Contact Dr. Simons by telephone: (44) 1423-770359; or by fax: (44) 1423-770552.
<P>
Please contact us for more information. You can also visit our home page on the Internet at:
<P>
http://www.phoenixrising.com








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-379</DOCNO>
<DOCOLDNO>IA040-000752-B018-365</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso192.htm 199.92.136.137 19970111151430 text/html 2625
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:16:07 GMT
Last-modified: Tuesday, 10-Dec-96 20:32:57 GMT
Content-length: 2434
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Quality and Compliance Consulting, Inc. (qc2)</B><BR>
	P.O. Box 990047<BR>
	Boston, MA  02199, USA<BR>
	Telephone:  (617) 236-2206<BR>
	Telefax:  (617) 236-1802<BR>
	email:  <A HREF="mailto:YLWA29A@prodigy.com">YLWA29A@prodigy.com</A><BR>
	Contact Person:  M. Joseph Mardesich; Leelo A. Bertram
<HR>
<B>Quality and Compliance Consulting, Inc. (qc2)</B>, provides quality audit and compliance evaluation services for Pharmaceutical, Biotechnology, and Medical Device companies, University and private Medical Research centers, Clinical Investigators, Contract Research Organizations, BioAnalytical and Toxicology laboratories, and Institutional Review Boards.
<P>
Our consultants, each with 25 years of research and development experience, work with clients to provide practical solutions for compliance concerns and issues, and help ensure validity and <B>accuracy</B> of regulatory submissions. Our experience has been with projects and facilities throughout the United States, Canada, Europe, and Japan.
<P>
qc2 staff is able to provide <B>bioanalytical</B> facility and methodology validation assessments in support of nonclinical and clinical studies, as well as QC and analytical research and development laboratory control requirements. Audit for both clinical and analytical aspects of pharmacokinetic studies is a unique specialty.
<P>
qc2 staff is able to provide Investigators, Institutional Review Boards, and Trial Management and Contract Facilities, as well as Sponsor departments, with guidance in Standard Operating Procedure (SOP) preparation, establishment of new or evaluation of current systems, source document formulation and organization, and staff training in GCPs, GLPs and SOPs.
<P>
qc2 staff is able to review and assess computer-related system documentation and validation plans for compliance with FDA and OECD guidelines, and provide assistance in preparation of design, installation, specification, performance, and qualification documents.
<P>
qc2 staff has also supplemented or performed as a clients Quality Assurance staff. All projects are individually defined to meet the clients time and budget goals.
<P>
To bring Quality and Compliance together with your operations, contact us at the numbers above or via email at YLWA29A@prodigy.com.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-380</DOCNO>
<DOCOLDNO>IA040-000752-B019-2</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso193.htm 199.92.136.137 19970111151448 text/html 2869
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:16:26 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:43 GMT
Content-length: 2676
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Quintiles Emerging Companies Institute</B><BR>
	P.O. Box 13979<BR>
	Research Triangle Park, NC  27709, USA<BR>
	Telephone:  (919) 941-2299<BR>
	Telefax:  (919) 941-0035<BR>
	Contact Person:  James C. Mannion, PhD

<HR>

<B>QUINTILES 
EMERGING COMPANIES INSTITUTETM</B>
<P>
<I>Helping our clients make the right decisions ... the first time.</I>
<P>
The Emerging Companies Institute (ECI) is a select group of professionals at Quintiles who have extensive experience in all phases of drug development and extensive knowledge of the specific needs of smaller pharmaceutical and biotechnology companies. ECI was founded to broaden and improve Quintiles service to emerging pharmaceutical and biotechnology firms. Our purpose, simply stated is to move beyond the ordinary client-vendor relationship and become a cost-effective drug development partner to these rising stars.
<P>
Our role in this new relationship goes beyond the provision of specific contract research services and includes advice on the selection of promising development candidates and indications; expert consultation on the therapeutic area under study, prospective local and international markets, local and international regulatory requirements, and all aspects of drug development (practical, technical, and financial); collaboration in the formulation of a stepwise drug development plan and a comprehensive regulatory strategy; participation in planning meetings and negotiations with regulatory authorities (FDA, EMEA, Koseisho); assessment of your R&D requirements and internal capabilities to determine which functions should be outsourced for maximum efficiency; creation of a customized package of integrated services for each stage of development, drawing talent, and resources from throughout the Quintiles organization; service as your representative at Quintiles, monitoring and coordinating activities and ensuring open channels of regular communication; and assistance in valuing your company and products for negotiation with venture capitalists and potential licenses.
<P>
Quintiles Emerging Companies Institute is focused on providing its clients with the following benefits to help them make the right decisions, the first time:
<P>
<UL>
<LI>Cost-conscious drug and biologic development
<LI>Special focus on early-stage drug development
<LI>High-performance teams to drive proof-of-concept studies
<LI>Fast, intelligent completion of pivotal registration trials
<LI>Accelerated development through information technology

</UL>






</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-381</DOCNO>
<DOCOLDNO>IA040-000752-B019-27</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso195.htm 199.92.136.137 19970111151457 text/html 2421
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:16:37 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:38 GMT
Content-length: 2228
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Research Dynamics Consulting Group, Ltd.</B><BR>
	8000 Victor-Pittsford Road, Suite 203<BR>
	Victor, NY  14564, USA<BR>
	Telephone:  (716) 624-2250<BR>
	Telefax:  (716) 624-2274<BR>
email:  <A HREF="mailto:LEResDyn@aol.com">LEResDyn@aol.com</A><BR>
	Contact Person:  Lorraine Ellis
<HR>

<CENTER><B>Pharmaceutical, Biotech Companies, CROs, Investigator Sites</B></CENTER>

<CENTER><B>INCREASE CLINICAL RESEARCH PRODUCTIVITY AND GCP COMPLIANCE</B><BR>
<B>THROUGH PROCESS IMPROVEMENT</B></CENTER>
<P>
Improving your clinical research process can increase cost-effectiveness, efficiency, quality and 
improve GCP compliance. Whether you are improving current research procedures to save time 
and money and increase GCP compliance, or starting clinical research and need procedures (SOPs), 
systems training, or experienced personnel to begin, our skills and experience can help you.
<P>
To increase productivity and improve GCP compliance, we provide the following services and products:
<P>
<U>WORKFLOW ANALYSES:</U> 	Determining the most efficient GCP or office procedures 
	for your organization.
<P>
<U>SOP DESIGN AND WRITING:</U>	Design or review SOPs to ensure consistent compliance and quality.
<P>
<U>GCP TRAINING:</U>	Custom training to your SOPs or standard training for your new staff or to improve the skills of your current staff. Will travel to train your CRAs in the field.
<P>
<U>QA AUDITS:</U>	Conduct GCP QA audits to determine deficiencies in compliance and quality management systems.
<P>
<U>PROCEDURES & SYSTEMS:</U>	Design and implement result management systems (such as project management, budget systems, etc.) and management reports to measure performance against plan and ensure maximum efficiency and quality.
<P>
<U>REFERENCE GUIDES AND STANDARD FORMS:</U>
<P>
For CRAs or CRCs the guides contain activity checklists and reference information for GCP compliance. The forms capture critical GCP required information in standard format (i.e. monitoring, drug accountability, standard document checklists, etc.). Call for a catalog.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-382</DOCNO>
<DOCOLDNO>IA040-000752-B019-63</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso196.htm 199.92.136.137 19970111151523 text/html 3011
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:16:46 GMT
Last-modified: Monday, 30-Dec-96 21:23:33 GMT
Content-length: 2821
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Research Services, Inc.</B><BR>
	246 Blossom Hill Road<BR>
	Los Gatos, CA  95030, USA<BR>
	Telephone:  (408) 399-9858<BR>
	Telefax:  (408) 357-3524<BR>
	email:  <A HREF="mailto:Research@accesscom.com">Research@accesscom.com</A><BR>
	Contact Person:  Steven C. Halladay, PhD
<HR>
<B>Research Services, Inc. (RSI)</B> is an exciting and innovative contract research organization for the pharmaceutical, biotechnological, and medical device industries. 
<P>
The <B>Research Division</B> provides expert and unbeatable service to sponsors. RSI offers: 
<P>
 Preclinical consulting and management of pharmacology and toxicology programs<BR>
 Complete clinical program management<BR>
 Extensive experience in single-site, as well as large multi-site study management<BR>
 Expertise in conducting phase I pharmacokinetic, pharmacodynamic, and bioavailability studies through phase IV market support, and safety studies, including quality-of-life and cost effectiveness evaluations<br>
 Experience in drug packaging and labeling requirements<BR>
 Proven investigators in all therapeutic areas<BR>
 Thorough IRB and regulatory agency interaction and compliance<BR>
 Complete GCP and FDA compliance<BR>
 Comprehensive safety monitoring, adverse event reporting and resolution capabilities<BR>
 Experience in case report form and data quality control<BR>
 Data management (conventional or state-of-the-art DataFax) and biostatistics services; providing ongoing up-to-date enrollment and CRF tracking<br>
 Highest quality report writing and regulatory document preparation available<BR>
 Experience in IND/NDA regulatory requirements and interactions for OTC and Rx products<BR>
<P>
The <B>Resource Division</B> provides expertly trained Monitors, Clinical Research Associates and Study Coordinators to assist the sponsor in conducting and monitoring all types of research programs. Our out-placement service provides professional help to your staff without incurring the overpowering costs associated with employing full-time employees. RSI also offers a full range of training opportunities for your employees, as well as study related personnel. 
<P>
Our proven team has the flexibility, responsiveness, and knowledge to meet the fast paced Over-The-Counter and Rx markets. Our experience in OTC program design and management is extensive. This, combined with our strong research background, allows us to conduct the most sophisticated and difficult Rx and OTC studies utilizing specialized patients. RSI welcomes the opportunity to work with a sponsor to develop innovative strategies that will meet the sponsors clinical development program needs. 








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-383</DOCNO>
<DOCOLDNO>IA040-000752-B019-101</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso197.htm 199.92.136.137 19970111151551 text/html 2642
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:17:32 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:34 GMT
Content-length: 2449
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Research Testing Laboratories, Inc.</B><BR>
	255 Great Neck Road<BR>
	Great Neck, NY 11021, USA<BR>
	Telephone: (516) 773-7788<BR>
	Telefax: (516) 773-7799<BR>
	Internet: <A HREF="http://www.RTLab.com">http://www.RTLab.com</A><BR>
	email: <A HREF="mailto:Rtl@Panix.com">Rtl@Panix.com</A><BR>
	Contact Person: Richard Panico
<HR>

Research Testing Laboratories is a thirty-nine year old clinical research company that enjoys 
an excellent reputation for high quality work in the ethical and OTC pharmaceutical industry. The corporation is privately owned and managed by owner managers. RTL employs approximately 100 people consisting of physicians, D.D.S.s, PhDs, RNs, RDs, CRAs, medical technologists, lab technicians, and administrative support personnel. RTL conducts ON-Site clinical trials in each of our three greater New York area laboratories (Great Neck, NY, Huntington Station, NY, and Hackensack, NY). Our ON-Site studies are Phase II through Phase IV in nature.
<P>
The CMS Group (Clinical Management Services) manages studies Off-Site for clients who undertake a clinical testing program at multicenter locations (private practice physicians, University Hospitals, nursing homes, adult residences and other research centers) across the country. These trials are Phase I through Phase IV in nature and cover all therapeutic areas. RTL can manage studies utilizing up to 40 centers.
<P>
RTL International is headquartered in Sevres, France. Our French facility is a CRO unit which manages multicenter studies throughout Europe. RTL Ireland is located in Cork and is a clinical study site. They conduct OTC and ethical studies in Phases I-IV.
<P>
RTL has served most of the major pharmaceutical companies in the United States and internationally. Our expertise includes Dermatology (three dermatologists on staff), Internal Medicine (three internists on staff), Oral Health care (three dentists on staff), OB/GYN (two gynecologists on staff), Nutritional Studies (two RDs on staff) and general medicine. We have participated in safety, efficacy and claim substantiation clinical trials since 1957, many of which have resulted in multi-million dollar product launches and successful product sales. In addition, RTL has and continues to conduct Rx to OTC switch programs for its clients.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-384</DOCNO>
<DOCOLDNO>IA040-000752-B019-138</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso199.htm 199.92.136.137 19970111151601 text/html 1578
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:17:41 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:30 GMT
Content-length: 1385
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Rohrbaugh Associates, Inc.</B><BR>
	12 Zinnia Drive<BR>
	Newtown, PA  18940, USA<BR>
	Telephone:  (215) 579-5961<BR>
	Telefax:  (215) 579-5971<BR>
	Contact Person:  Thomas M. Rohrbaugh, PharmD, President

<HR>

Thomas Rohrbaugh, Pharm.D., President of Rohrbaugh Associates, Inc., has over thirteen years of industry experience in clinical research and development, with skills in all phases of drug development, including developmental planning, IND preparation, protocol writing, clinical trials monitoring and project management, and final study report preparation.
<P>
We have experience in the following areas:
<P>
<B>Clinical Trials Management</B>
<UL>
<LI>Clinical trial design
<LI>Investigator selection and negotiation of study budgets
<LI>Project management
<LI>Clinical trials monitoring per GCPs
<LI>Data review and clean-up
</UL>
<P>
<B>Medical Writing</B>
<UL>
<LI>Clinical development plans
<LI> INDs
<LI>Investigator brochures
<LI>Protocols
<LI>Case report form completion manuals
<LI>Interim and final study reports, manuscripts
<LI>NDAs
</UL>
<P>
<B>Therapeutic Areas</B>
<UL>
<LI>Oncology
<LI>Hematology
<LI>Infectious Diseases, including HIV infection
<LI>Cardiovascular
<LI>Neurology

</UL>






</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-385</DOCNO>
<DOCOLDNO>IA040-000752-B019-172</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso202.htm 199.92.136.137 19970111151612 text/html 3670
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:17:52 GMT
Last-modified: Thursday, 14-Nov-96 13:59:08 GMT
Content-length: 3478
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>SCIREX Corporation</B><BR>
	587 Skippack Pike, Suite 300<BR>
	Blue Bell, PA  19422, USA<BR>
	Telephone:  (215) 646-4117<BR>
	Telefax:  (215) 646-4673<BR>
	Internet: <A HREF="http://www.scirex.com"> http://www.scirex.com</A><BR>
	email:  <A HREF="mailto:linda cruz@scirex.com">linda cruz@scirex.com</A><BR>
	Contact Person:  Linda Cruz
<HR>
SCIREX Corporation is a "second generation" Contract Research Organization (CRO), integrating CRO and Clinical Site services to provide "SCIentific Research EXcellence" (SCIREX) as the foundation to build outstanding Clinical Trials Management, Clinical Site Services, Data Management and Biostatistics, and Regulatory Affairs/Quality Assurance services. Since 1976, SCIREX has conducted over 650 clinical trials in multicenter and single site settings involving over 40,000 patients in therapeutic areas such as: Analgesia, Allergy, Bioequivalence/ Pharmacokinetics, Cardiology, Central Nervous System/Neurology, Gastroenterology, Infectious Diseases, Metabolic Diseases, Ophthalmology, and Respiratory Diseases. SCIREX has over 20 years experience monitoring and managing Phase I-IV studies, Consumer/Actual Use Studies, RX to OTC Switch programs, and Pharmacoeconomic studies. Our Services include:
<P>
<B>CLINICAL TRIALS MANAGEMENT</B>
<UL>
<LI>Clinical Development Planning
<LI>Study Design and Protocol Development
<LI>Case Report Form (CRF) Design	
<LI>Feasibility Studies
<LI>Investigator Recruitment/Meetings
<LI>Investigator Brochures/Project Manuals	
<LI>Patient Recruitment Support Techniques
<LI>Project Information Status Reporting	
<LI>Adverse Event Reporting
<LI>CRF Correction/Query Resolution

</UL>
<P>
<B>	DATA MANAGEMENT AND BIOSTATISTICS</B>
	<LI>Customized Databases
	<LI>Standardized Data Handling and Correction
<LI> Data Import Capability
	<LI>Preplanned Data Review and Editing
	<LI>Automated Document Management and Error Tracking
<LI>Project Management and Work Flow Metrics
	<LI>Comprehensive Reporting Tools
<LI>Design and Analysis Consultation Services
<LI>Data Analysis and Reporting
	<LI>In-house and Client Access to Data Programming
<LI>Innovative Applications (Including IVRS)
</UL>


<P>
CLINICAL SITE SERVICES	
<UL>
<LI>Single and Multicenter Models
<LI>Recruitment Techniques 
  for Rapid Enrollment
<LI>24-hour Observation Capability
<LI>Two Multi-Therapeutic
  Outpatient Clinics
<LI>Three Dental Research Sites
</UL>
<P>
REGULATORY AFFAIRS/QUALITY ASSURANCE
<UL>
	<LI>GCP Investigator Audits/Training
<LI>Audits of Databases and Final Study Reports
	<LI> Computer Validation Support
<LI>GMP Audits
	<LI>Medical Writing
	<LI>Integrated Clinical/Statistical Study Reports
<LI>Safety Reports
<LI>Clinical Supplies Packaging from Bulk Supplies
<LI>Open-, Single-, or Double-Blind Labeling
<LI>Storage/Shipment of Environmentally Liable Supplies
<LI>Destruction of Clinical Supplies
<LI>Drug Accountability and Reconciliation of Supplies
</UL>



<P>
Visit our Web site at:  http://www.scirex.com
<P>
Our other offices are:<BR>
	3200 Red River, Suite 300<BR>
	Austin TX  78705<BR>
	Phone:  (512) 320-1600<BR>
	Fax:  (512) 320-0313<BR>
	Contact:  Douglas R. Baum<BR>
<P>
	25 Main Street<BR>
	Hartford, CT  06106<BR>
	(860) 724-0091<BR>
	(860) 278-4717<BR>
	Contact:  Nancy Brandenberger<BR>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-386</DOCNO>
<DOCOLDNO>IA040-000752-B019-209</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso205.htm 199.92.136.137 19970111151623 text/html 2960
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:02 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:06 GMT
Content-length: 2767
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>SHARK dm Co.</B><BR>
	Park 80 West, Plaza 2, Suite 200<BR>
	Saddle Brook, NJ 07662, USA<BR>
	Telephone: (800) 742-7536<BR>
	Telefax: (800) 742-7535<BR>
	Contact Persons: Dr. M. Issac

<HR>

<B>Areas of Operation:</B>
<P>
Asia, Canada, Central America, Commonwealth of Independent States (CIS), Europe, Middle East, South America, United States
<P>
SHARK dm Co. is a leader in the clinical research and biostatistical arena. Our experts come from all areas of clinical research  including FDA, industry, and academia. SHARK employs the most economical and quickest route to market, along with the latest technology in data management and biostatistical services, including: OCR based case report form collection systems, pen computing data collection, document imaging/storage subsystems, bar-code clinical data management, real-time remote research and data monitoring. These are tied together as a front end to CANDAs. SHARK is experienced in working with foreign firms in the handling of data submissions to government agencies in the U.S. and worldwide. Expert translation services are provided for our international clients.
<P>
Recently SHARK dm Co. has designed a Mobile Biostatistical & CANDA Preparation All Purpose Vehicle. This being the first of its kind in the industry. We call this our:
<P>
<CENTER><B>"CANDA ON WHEELS"</B></CENTER>
<P>
Weve taken the largest motor home found and equipped it with a state-of-the-art high speed computer network, including optical imaging and scanning equipment, unlimited mass storage capabilities, high speed data communications (dial-up and local). Weve added our most seasoned staff of biostatisticians, programmers and data operators. By going mobile SHARK can offer CANDA, biostatistical, and data management services to clients who dont want to part with their data, or would like to hire on-site contract services but have space as well as equipment limitations. SHARK can bring the entire process to your doorstep where your firm can stay in control, yet rely on our seasoned professionals to get the job done. As we complete the project we leave your firm with the final product be it a Compact Disk containing your complete CANDA or a final analysis of your Phase III trial, etc., yet we take the process overhead away with us; leaving you free to concentrate on your regulatory submissions. SHARK can now offer these services to our pharmaceutical, device and diagnostic clients on a per project basis. Weve successfully tested the operation on several of our international clients who have limited resources at their U.S. representative offices.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-387</DOCNO>
<DOCOLDNO>IA040-000752-B019-237</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso207.htm 199.92.136.137 19970111151632 text/html 2649
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:12 GMT
Last-modified: Wednesday, 09-Oct-96 21:37:01 GMT
Content-length: 2456
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>SIMIREX INC.</B><BR>
	12000 Commerce Parkway<BR>
	Mt. Laurel, NJ  08054, USA<BR>
	Telephone:  (609) 235-2333<BR>
	Telefax:  (609) 727-0924<BR>
	email:  <A HREF="mailto:SIMIREX!CENTRAL!GDICK@simirex.attmail.com">SIMIREX!CENTRAL!GDICK@simirex.attmail.com</A><BR>
	Contact Person:  Peter Bernardo, PhD, President
<HR>

<B>Unequaled in quality, service and timeliness ... SIMIREX INC. is a full-service company with a commitment to excellence.</B>
<P>
<B>CONSULTATION AND PACKAGING SERVICES FOR CLINICAL STUDIES</B>
<UL>
<LI>Package design consistent with patient compliance and protocol specifications.
<LI>Automated solid dosage bottle filling of tablets and capsules.
<LI>Versatile blister packaging capabilities and blister card design.
<LI>Graphic protocol interpretation.
<LI>Clinical study label design and preparation  Customized single and double-blind labels.
<LI>In-house graphics department.
<LI>Client as well as SIMIREX in-house QA approval of all labels.
<LI>SIMIREX randomization of patient numbers or computer transfer of client numbers into the SIMIREX double-blind patient label program.
<LI>Documentation approval before release of supplies for shipment to clinical sites.
<LI>Reconciliation/verification procedures maintained throughout study preparation.
<LI>Study-specific/dedicated refrigerator and freezer units with back-up emergency generator.
<LI>Storage of prepared Clinical Supply Kits and pharmaceutical supplies/components.
<LI>Label Bar Coding Capability
<LI>Computer based inventory and shipment system.
<LI> Security access into and limited access within building  controlled by card key, computer record system. Insures complete confidentiality and protection for our clients.
<LI> Controlled temperature conditions throughout facility.
<LI>GMP compliance and quality assurance; comprehensive and continuous employee training.
<LI>SIMIREX facility is DEA approved for handling of Schedule III, IV and V drugs.
</UL>
<P>
<B>COLLABORATIVE SERVICES</B>
<UL>
<LI>Analytical laboratory services.
<LI>Import/Export and customs release.
<LI>Ongoing shipment of compassionate study drug.
<LI> Accountability and destruction of returned clinical supplies.
</UL>


<P>
Our quality is unparalleled, our people care and our work stands on its own merit.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-388</DOCNO>
<DOCOLDNO>IA040-000752-B019-266</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso208.htm 199.92.136.137 19970111151645 text/html 2550
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:26 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:59 GMT
Content-length: 2357
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Slone Epidemiology Unit</B><BR>
	1371 Beacon Street, 3rd Floor<BR>
	Brookline, MA  02146, USA<BR>
	Telephone:  (617) 734-6006<BR>
	Telefax:  (617) 738-5119<BR>
	Internet:  <A HREF="http://seu.bu.edu">http://seu.bu.edu</A><BR>
	email:  <A HREF="mailto:amitchell@slone.bu.edu">amitchell@slone.bu.edu</A><BR>
	Contact Person:  Allen A. Mitchell, MD
<HR>
The Slone Epidemiology Unit (SEU; formerly, Drug Epidemiology Unit) is a multidisciplinary academic research group within the Boston University School of Public Health that has two decades of experience in the design and conduct of postmarketing studies.
<P>
Of particular value to industry has been the SEUs ability to identify the critical issues, typically related to drug safety, to develop study designs that are both scientifically rigorous and logistically feasible, and to successfully conduct the study.
<P>
The SEU has the professional skills and support resources needed to design and execute appropriate studies. Our staff of approximately 100 includes physicians, epidemiologists, nurses, pharmacists, study coordinators, interviewers, and administrators. The SEU also maintains a dedicated and sophisticated computer center, and has developed a unique drug dictionary which has proven particularly useful in a wide variety of applications.
<P>
Many questions can be resolved by analyses of already-collected data (the SEU has amassed national and international data banks with information on drug exposures in relation to a wide range of adult diseases and birth defects); other questions can be resolved by specifically-mounted case-control or cohort studies; still others may require surveys of drug recipients or even RCTs. The SEU has extensive and successful experience in the design and execution of each of these approaches. Further, study results have been widely disseminated through publication in respected general medical, epidemiologic, and pharmacologic journals.
<P>
Combining an academic perspective with an appreciation and understanding of the needs of industry, the SEU has established a strong reputation as a unique resource for the design, conduct, and presentation of objective and rigorous postmarketing studies.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-389</DOCNO>
<DOCOLDNO>IA040-000752-B019-294</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso209.htm 199.92.136.137 19970111151653 text/html 2198
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:33 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:57 GMT
Content-length: 2005
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Software Product Services (SPS) Ltd.</B><BR>
	Regent House, 19-20 The Broadway<BR>
	Woking, UK<BR>
	Telephone:  +44 (0) 1483 730771<BR>
	Telefax:  +44 (0) 1483 727417<BR>
	Internet: <A HREF="http://www.demon.co.uk/sps/"> http://www.demon.co.uk/sps/</A><BR>
	email:  <A HREF="mailto:lclarke@spsuk.demon.co.uk">lclarke@spsuk.demon.co.uk</A><BR>
	Contact Person:  Linda Clarke
<HR>
Software Product Services (SPS) Ltd. was formed in 1982 and currently has offices in Woking (UK), Antwerp (Belgium) and Johannesburg (South Africa). We are an established 4GL company specializing in the SAS System and the ORACLERDBMS. As these products are used by the majority of pharmaceutical companies, SPS can help you in the following areas:
<UL>
<LI>Consultancy
<LI>Training
<LI>Products
</UL>
<P>
<B>Consultancy</B>  SPS has undertaken a wide range of work at major pharmaceutical companies dealing with all aspects of the clinical trials program:
<UL>
<LI>Database design
<LI>Data entry systems
<LI>End-user menu systems
<LI>Data analysis and reporting
<LI>Statistical programming
</UL>
<P>
All of our offices belong to SAS Institutes Quality Partner Program and SPS were the first members to be named in both the UK and mainland Europe. This confirms our high standards of consultancy and project management.
<P>
<B>Training</B>  as a result of the work we have done we have developed specialist courses aimed at Statisticians and Data Managers, as well as teaching all levels of SAS and ORACLE expertise. These courses are available at your site or publicly in Belgium or the UK.
<P>
By attending our courses you benefit from:
<UL>
<LI>Consultant expertise
<LI>Small classes
<LI>Quality documentation
</UL>
<P>
For any assistance in SAS or ORACLE from a company who understands your business call Bronwyn Schmack on +44 (0) 1483 730771.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-390</DOCNO>
<DOCOLDNO>IA040-000752-B019-330</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso210.htm 199.92.136.137 19970111151705 text/html 2257
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:45 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:53 GMT
Content-length: 2064
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Solutions, Inc. by Fix and Co.</B><BR>
	723 Kindred Lane<BR>
	Richardson, TX  75080, USA<BR>
	Telephone:  (214 or 972) 889-1663<BR>
	Telefax:  (214 or 972) 889-1784<BR>
	email:  <A HREF="mailto:75147.2337@compuserve.com">75147.2337@compuserve.com</A><BR>
	Contact Person:  Lori Fix, PhD

<HR>
Solutions, Inc. by Fix and Co. assists business in the integration of science with regulatory and legal concerns. Solutions, Inc. by Fix and Co. can provide the scientific expertise to support, implement, and manage regulatory concerns in the pharmaceutical, biotech, food, and medical device industries. Managing projects and compliance through services such as:
<P>
<B>Regulatory Affairs (GMP, FDA, EPA)</B>
<UL>
<LI>Good Clinical Practices Compliance
<LI>SOP (Standard Operating Procedures) Composition and Audit
<LI>Medical Supplies Tracking
<LI>Computer System Audit and Validation
</UL>
<P>
<B>Regulatory Dossiers</B>
<UL>
<LI>New Drug Applications (IND, NDA)
</UL>
<UL>
<LI> Chemistry/Manufacturing/Control
<LI>Package Insert Brochures
<LI>Environmental Assessments
</UL>
<UL>
<LI>Food Additive Petitions
</UL>
<P>
<B>Medical/Technical Writing</B>
<UL>
<LI> Informed Consent Forms
<LI> Investigator Brochures
<LI> IRB Study Approval Petitions
<LI>Drug Safety Reports
<LI>Pharmacovigilance
<LI>Subject/Consumer Interactions
<LI> Manuscripts
</UL>
<P>
<UL>
<LI>Risk Communication for Public Relations
<LI>Project Management
<LI>Phase I-IV Clinical Trials: Creative Designs, Concise Protocols, Detailed Execution, Monitoring, Audits, High-Quality Reports, Understandable Presentations
<LI>Post-Marketing Consumer Oriented Studies
<LI>IRB Participation
</UL>
<P>
Solutions, Inc. by Fix and Co. will tailor the services to the unique needs of each client. All will be delivered in a service-oriented, high-touch personal style to facilitate the development of best-case solutions.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-391</DOCNO>
<DOCOLDNO>IA040-000752-B019-369</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso211.htm 199.92.136.137 19970111151716 text/html 3819
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:18:54 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:48 GMT
Content-length: 3626
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Spadille ApS</B><BR>
	Jernbanegade 34 C<BR>
	DK-3480 Fredensborg, Denmark<BR>
	Telephone:  +45 48 48 41 00<BR>
	Telefax:  +45 48 48 42 00<BR>
	Internet:  <A HREF="http://home4.inet.tele.dk/spadille/">http://home4.inet.tele.dk/spadille/</A><BR>
	email:  <A HREF="mailto:Spadille@post4.tele.dk">Spadille@post4.tele.dk</A><BR>
	Contact Person:  Dr. Karsten Schmidt
<HR>
<B>Spadille Aps</B>, founded in 1970, has specialized in providing full-service support for pharmaceutical companies within the following areas:
<P>
<UL>
<LI>Design and statistical analyses of clinical trial in all 4 phases.
<LI>Development of investigator brochures, protocols, CRFs, randomization schedules, clinical study reports and integrated reports.
<LI>Planning, initiating, monitoring and reporting clinical trials.
<LI>Database design, data entry, data management and data validation.
<LI>Audit of study reports and statistical reports, GCP compliance.
<LI>Design and conduct of overviews and meta-analyses of clinical trials.
<LI> Design and statistical analyses of toxicologic, pharmacokinetic (including bioequivalence) and pharmacodynamic studies, epidemiologic studies, post-marketing surveillance.
<LI>Supply of contract staff.
</UL>
<P>
<B>Spadille</B> continuously keeps under review the regulatory standards and rules in force or coming up concerning clinical trials of medicinal products issued by the EU and the FDA.
<P>
<B>Spadilles</B> founder and Chief Executive is Karsten Schmidt, MSc (Industrial Statistics) 1964. Assistant professor, Institute of Management Science 1964-65. Associate professor, deputy head, and head of the Institute of Mathematical Statistics and Operations Research, the Technical University of Denmark 1965-72. Associate professor of statistics, in charge of PhD education, at the Royal Veterinary and Agricultural University 1967-72. Associate professor of applied statistics at the Institute of Mathematical Statistics 1967-72. Associate professor of applied statistics at the Institute of Mathematical Statistics, University of Copenhagen 1973-80. Since 1977 external examiner in statistics at several degree granting institutions.
<P>
Executive Committee member of the Danish Society for Theoretical Statistics 1971-75, of the Danish Operations Research Society 1973-77, as president 1977, of the International Society for Clinical Biostatistics 1991-, Honorary Treasurer 1992-94, President-Elect 1994-96, President 1996-. President of the Danish Society for Biopharmaceutical Statistics 1992-. Council member of the European Federation of Statisticians in the Pharmaceutical Industry 1992, as President 1994-. Member of the International Statistical Institute 1993-.
<P>
<B>Spadilles</B> President of clinical research is Lena Ejbye Schmidt, M.D. 1987. Medical Associate at Spadille 1987-88. Clinical Research Associate, ICI-Pharma AS 1988-90. Clinical Research Physician, Wellcome Danmark AS 1990-94. GCP Officer, Wellcome Danmark AS 1991-94. Medical Director, Peptech (Europe) AS 1994-95. Member of the Executive Committee (secretary) at the Danish Association of Physicians in Private Employment, 1992-present. Faculty Member of Pharmaceutical Physicians of the Royal Colleges of Physicians of the United Kingdom.
<P>
<B>Spadilles</B> clientele comprises more than 30 pharmaceutical companies in Denmark and abroad. Our track record is one of thorough, high-quality, successful projects internationally recognized by professionals.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-392</DOCNO>
<DOCOLDNO>IA040-000752-B020-35</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso213.htm 199.92.136.137 19970111151736 text/html 1269
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:19:15 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:44 GMT
Content-length: 1076
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B> SRL Inc.</B><BR>
	Yasudakasai Tatikawa Building, 2-41-19 Akebono-cho<BR>
	Tachikawa, Tokyo 190, Japan<BR>
	Telephone:  +81-425-26-7125<BR>
	Telefax:  +81-425-26-7187<BR>
	email:  <A HREF="mailto:kya01341@niftyserve.or.jp">kya01341@niftyserve.or.jp</A><BR>
	Contact Person:  Toshihito Furukawa

<HR>
<B>SRL Inc. </B>(Special Reference Laboratories), is Japans leading contract research and clinical reference laboratory. The company provides complete central laboratory service for clinical trial. Our network of 76 business locations ensures complete coverage of Japan.
<P>
Biostatistics department also provides the following services:<B>
</B><P>
<B>Information on Japan</B><BR>
 Regulatory Affairs<BR>
 Company backgrounds
<P>
<B>Biostatistic</B><BR>
 Statistical analyses of Phase I-IV studies<BR>
 Medical research
<P>
<B>Consulting</B><BR>
 Laboratory organization and planning<BR>
 Information on CROs








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-393</DOCNO>
<DOCOLDNO>IA040-000752-B020-67</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso217.htm 199.92.136.137 19970111151803 text/html 2759
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:19:27 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:35 GMT
Content-length: 2566
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Statistics and Epidemiology Research Corporation</B><BR>
	1107 NE 45th Street, Suite 520<BR>
	Seattle, WA  98105, USA<BR>
	Telephone:  (206) 547-2829<BR>
	Telefax:  (206) 547-4671<BR>
	Internet:  <A HREF="http://www.sercnw.com">http://www.sercnw.com</A><BR>
	email:  <A HREF="mailto:janh@sercnw.com">janh@sercnw.com</A><BR>
	Contact Person:  Jan Hess, PhD, Chief Operating Officer
<HR>
The Statistics and Epidemiology Research Corporation (SERC) is a leader in innovative, personalized clinical trial management and design.
<P>
Whether youre new to clinical trials or already an established industry leader, we have the experience and flexibility essential to providing the highest quality, personalized service you need. We offer the latest in cutting-edge technology including touch-tone randomization and unmasking as well as automated data collection, including fax-based systems. SERC has been in the clinical trial business for 17 years and our consultants are recognized leaders in trial design and statistical consulting.
<P>
We are experienced in providing the following high-quality services:
<UL>
<LI>Clinical Trial planning and development including sample size calculation, sequential monitoring plans, clinical coordinating and data management
<LI>Protocol development, patient/physician materials and Manual of Operations
<LI> Database design and consulting, including systems recommendations
<LI>Full service data department providing data entry, independent double data entry checking, data entry screen design and internal quality control documentation
<LI>Statistical analyses, interpretation and reports
</UL>
<P>
Our highly-trained staff continuously produces results consistent with the vision of our original shareholders; that quality service, personalized products and meticulous attention to detail will result in a far-better product than is available through larger corporations and academic institutions.
<P>
At SERC we pride ourselves on our ability to work with our clients to create products appropriate to their needs while meeting the guidelines of Good Clinical Practice and the standards of the FDA.
<P>
We feel you will be pleased and surprised by your experience with the Statistics and Epidemiology Research Corporation. For further information about clinical trials and other services we provide, please call Jan Hess, Chief Operating Officer at (206) 547-2829.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-394</DOCNO>
<DOCOLDNO>IA040-000752-B020-106</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso220.htm 199.92.136.137 19970111151833 text/html 2636
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:20:07 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:16 GMT
Content-length: 2443
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>SYNERGOS, Inc.</B><BR>
	2202 Timberloch Place, Suite 230<BR>
	The Woodlands, TX  77380-1109, USA<BR>
	Telephone:  (713) 367-6655<BR>
	Telefax:  (713) 367-9679<BR>
	Internet:  <A HREF="http://www.synergosinc.com">www.synergosinc.com</A><BR>
	email:  <A HREF="mailto:info@synergosinc.com">info@synergosinc.com</A><BR>
	Contact Person:  Jaye Thompson, PhD, President
<HR>
SYNERGOS, Inc. can work with your staff to create synergistic resu1ts.
<P>
SYNERGOS is a contract research organization located in the greater Houston area. Over the past six years we have provided cost effective services to the pharmaceutical, medical device and biotechnology industries. We have extensive experience in all phases of development, particularly for the small start-up company. 
<P>
SYNERGOS takes pride in its proven ability to build and maintain long-term client relationships. Our experience in the clinical trials program includes designing, monitoring, and managing clinical trials, while also providing clinical data management and biostatistical services. 
<P>
In the future, please consider the benefits of working with a firm such as ours that fosters long-term relationships and has the proven ability of delivering quality and cost effective services. 
<P>
<U>CLINICAL TRIAL MANAGEMENT</U>
<UL>
<LI>Protocol development
<LI>Case report form design	  
<LI>Study monitoring; patient tracking, 
  quality assurance, adverse experience 
  summary, drug accountability	 
<LI>Investigator/Site training
<LI>Assistance with Institutional Review 	  
  Board approval
</UL>
<P>
<U>	BIOSTATISTICS</U>
<UL>
	<LI>Statistical analysis of efficacy and safety, Phase I-Phase IV
<LI>Study design and protocol review
<LI>Prepare statistical portions of drug, biologic and device FDA submissions
<LI>Assist with scientific publications and presentations
	<LI>Statistical analysis programming in SAS
</UL>



<P>
<U>DATA MANAGEMENT</U>
<UL>
<LI>Database management systems
<LI>Data entry system development	
<LI> Entry and validation of data 	  
<LI>Concise listings of data
<LI>Computerized FDA submissions
</UL>
<P>
<U>	REGULATORY AFFAIRS</U>	
<UL>
<LI> Interface wth FDA
<LI>Assistance in preparation of FDA submissions (IND, NDA, PLA, IDE, 510(k), PMA)
<LI>FDA presentations
</UL>


</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-395</DOCNO>
<DOCOLDNO>IA040-000752-B020-148</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso223.htm 199.92.136.137 19970111151847 text/html 2478
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:20:25 GMT
Last-modified: Thursday, 14-Nov-96 13:50:42 GMT
Content-length: 2286
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>TKL Research, Inc.</B><BR>
	4 Forest Avenue<BR>
	Paramus, NJ  07652, USA<BR>
	Telephone:  (201) 587-0500<BR>
	Telefax:  (201) 587-0209<BR>
	email:  <A HREF="mailto:tklrsch@soho.ios.com">tklrsch@soho.ios.com</A><BR>
	Contact Person:  Jon C. Anderson, PhD; Robert C. Reardon, PhD; John A. Frascella, DMD; Richard D. Gilbert, PhD; Thomas W. Ritchey, PhD
<HR>
TKL Research is a professionally-managed, independent clinical research organization. TKL manages multi-center clinical trials and also conducts studies in its own clinical centers. At present, TKL has three solely-owned and operated clinical centers/investigational sites in the New York metropolitan area, staffed by approximately 100 professional and support personnel. Within these centers, TKL conducts Phases II through IV outpatient studies in a variety of medical specialties.
<P>
For multi-center trials as well as for studies conducted in its own facilities, TKL designs clinical trials and prepares all study documentation with the assistance of its Biostatistics and Data Management Department. The Quality Assurance unit oversees the executional aspects of all studies and audits all study documentation for completeness, accuracy and GCP compliance. TKL also provides biostatistical and data management services as a separate service for studies which are not conducted by TKL.
<P>
TKL has an especially strong background in the conduct of OTC drug studies, dental and periodontal product evaluations, dermatological studies and studies which require chronic, stable disease states. Over the years, TKL has developed an extensive database of patients and normal healthy subjects supported by a sophisticated inbound and outbound telerecruiting program which allows for efficient and cost-effective recruitment.
<P>
TKL Research was established over 50 years ago and incorporated in 1974. For the past 20 years it has steadily grown, continuously added therapeutic areas of investigation and has undergone four clinical site expansions. TKL has the expertise and stability you can count on 
to complete your clinical trial program efficiently and cost effectively.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-396</DOCNO>
<DOCOLDNO>IA040-000752-B020-183</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso225.htm 199.92.136.137 19970111151857 text/html 2537
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:20:37 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:06 GMT
Content-length: 2344
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Trilogy Associates, Inc.</B><BR>
15 East Ridge Pike, Suite 425<BR>
Conshohocken, PA 19428, USA<BR>
Telephone: (610) 397-0600<BR>
Telefax: (610) 397-0603<BR>
email: <A HREF="mailto:TrilogyAssoc@MSN.COM">TrilogyAssoc@MSN.COM</A><BR>
Contact Person: Marcia Wasserman
<HR>

<CENTER><B>Rising Above The Competition Takes More Than Technology
Trilogy Associates  Your Personal Consultants For Business Excellence</B></CENTER>
<P>
<B>Strategic Focus:</B> Achieving business objectives by capitalizing on your organizational strengths <BR>
<B>Resource Alignment:</B> Optimizing people, process and information<BR>
<B>Benchmarks:</B> Providing metrics to lower costs, improve productivity and maximize profitability<BR>
<B>Workable Solutions:</B> Matching top down objectives with bottom up business realities<BR>
<B>Client Advocacy:</B> Protecting your interests internally and when interfacing with applications vendors <BR>
<B>Multi-Talented Teams:</B> Bringing together senior level professionals with pharmaceutical, business, financial and technology backgrounds
<P>
Consulting Services  Consistent Resource from Planning through Implementation 
<UL>
<LI>Strategic Planning<LI>System Planning and Architecture
<LI> Workflow Redesign	<LI> Product Selection and Integration
<LI> Change Management	<LI>Data Communications Standards
<LI>Cost/Benefit Analysis	<LI> Information Security
</UL>
<P>
Emerging Technologies  Market Analysis of Pharmaceutical Information Management Products
<UL>
<LI> Document Management<LI>Forms Processing
<LI> Document Imaging<LI>Workflow
<LI>Full Text Retrieval<LI> Groupware
<LI> Case Management<LI> On-line Services
<LI> Foldering<LI> Inter- and Intranet 
</UL>
Trilogy offers a personal approach to this model complementing your resources with our expertise.
<P>
Pharmaceutical Specialties
<UL>
<LI> Clinical Trial Workflow<LI> CANDA Implementation
<LI> Clinical Trial Software<LI> Regulatory Document Compilation
<LI> Document Management and Publishing <LI> Regulatory Review Tools
<LI> Legal Department Case Management<LI> Product Information Automation
</UL>
<P>
Trilogy Focuses On Your Needs Of Today While Planning For Tomorrow








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-397</DOCNO>
<DOCOLDNO>IA040-000752-B020-215</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso226.htm 199.92.136.137 19970111151909 text/html 2260
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:20:49 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:04 GMT
Content-length: 2067
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Trilogy Consulting Corporation</B><BR>
	850 South Greenbay Road<BR>
	Waukegan, IL  60085-7076, USA<BR>
	Telephone:  (847) 244-9520<BR>
	Telefax:  (847) 244-9335<BR>
	Internet: <A HREF="http://www.triologycnslt.com_TCC/Home"> http://www.triologycnslt.com_TCC/Home</A><BR>
	email:  <A HREF="mailto:dladurini@trilogycnslt.com">dladurini@trilogycnslt.com</A><BR>
	Contact Person:  Dan Ladurini
<HR>
Trilogy Consulting Corporation is a nationally based professional services organization providing statistical information and information systems support. Founded in 1982, Trilogy is headquartered in the Chicago area and retains offices in Research Triangle Park, NC; Kalamazoo, MI; Palo Alto, CA; and Princeton, NJ.
<P>
Trilogy provides a wide range of services to support client needs within pharmaceutical, biotechnology and medical device industries to include:
<P>
<B>Statistical Consulting and Analysis</B>  experimental design, econometrics, medical device statistical analysis, product development support, statistical quality control, survey analysis.
<P>
<B>Clinical Research Consulting </B> SAS programming, clinical research support, data entry/data management, document review, study coordination, clinical trial monitoring, medical writing.
<P>
Trilogys experienced professionals possess a thorough understanding of various statistical packages and methods commonly used in the industry. Trilogy is dedicated to providing clients with the best support services available. To achieve this goal, experienced professional consultants are matched with each clients specific need. To supplement on-site consulting projects, Trilogy has a Consultant Resource Center (CRC) located in Michigan. The CRC was developed for projects which require expertise in multiple areas or manpower resources which exceed those available at the client site.
<P>
SAS is a registered trademark of the SAS Institute, Inc.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-398</DOCNO>
<DOCOLDNO>IA040-000752-B020-250</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso228.htm 199.92.136.137 19970111151928 text/html 2162
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:21:02 GMT
Last-modified: Wednesday, 09-Oct-96 21:36:00 GMT
Content-length: 1969
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Turning Point Associates, Inc.</B><BR>
	36 South Pennsylvania Street, Suite 740<BR>
	Indianapolis, IN  46204-3632, USA<BR>
	Telephone:  (317) 633-8747<BR>
	Telefax:  (317) 633-8748<BR>
	email:  <A HREF="mailto:daustrom@iquest.net">daustrom@iquest.net</A><BR>
	Contact Person:  Douglas Austrom, PhD
<HR>

<CENTER><B>"Results-based, integrated solutions for change implementation"</B></CENTER>
<P>
As the competitive environment has become more demanding, pharmaceutical firms have made significant investments in a myriad of change initiatives from total quality management to process reengineering. While impressive results have been achieved in a few cases, all too often the return on investment has been poor. And the common denominator in this sea of unrealized promises has been implementation.
<P>
Turning Point Associates has over ten years of experience helping a variety of pharmaceutical firms in the United States, Canada and Europe to implement significant changes in the ways they organize themselves and do business to achieve dramatic improvements in performance. We adhere to a client ownership model of consulting that emphasizes implementation and results, accountability and client self-sufficiency.
<P>
We work with our clients to ...
<UL>
<LI>Build a compelling case for action based on a balanced set of critical business metrics 
and targets.
<LI> Develop and execute systematic plans for implementation emphasizing sustained 
long-term results.
<LI>Integrate, where appropriate, unfulfilled recommendations from previous change initiatives.
<LI> Develop non-bureaucratic methods for monitoring progress.
<LI> Augment and strengthen in-house implementation resources.
<LI> Integrate change initiatives fully with running the business.

</UL>
<P>
We focus on results, not programs.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-399</DOCNO>
<DOCOLDNO>IA040-000752-B020-284</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso230.htm 199.92.136.137 19970111151949 text/html 1712
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:21:27 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:53 GMT
Content-length: 1519
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Universal Systems Inc.</B><BR>
	14585 Avion Parkway<BR>
	Chantilly, VA 22021, USA<BR>
	Telephone:  (703) 222-2880<BR>
	Telefax:  (703) 222-0543<BR>
	Internet:  <A HREF="http://www.usiva.com">http://www.usiva.com</A><BR>
	email:  <A HREF="mailto:john_malone@usiva.com">john_malone@usiva.com</A><BR>
	Contact Person:  John Malone
<HR>
Universal Systems is a professional services and software company providing solutions to complex business processes utilizing imaging, document management and Workflow automation technologies. USIs Healthcare Practice provides solutions to regulated businesses for Case Report Form Workflow Processing, Global Dossier Management, Customer Services and Event Tracking Workflow Processing, Literature/Library Data Management and Manufacturing Documentation Management.
<P>
USI has worked with numerous pharmaceutical companies and possesses substantial subject matter expertise in the entire NDA process from data collection through publishing. There is significant understanding in applying technology to deliver systems which meet regulatory validation requirements and to support the requirements of GCP, GMP and similar practices. USI has a proven project management methodology which is the basis for delivering successful complex solutions in client/server computing environments using best in class technologies such as Documentum.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-400</DOCNO>
<DOCOLDNO>IA040-000752-B020-305</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso234.htm 199.92.136.137 19970111152000 text/html 2364
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:21:39 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:44 GMT
Content-length: 2171
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Waife & Associates, Inc.</B><BR>
	62 Warren Street<BR>
	Needham, MA  02192, USA<BR>
	Telephone:  (617) 449-7032<BR>
	Telefax:  (617) 444-1763<BR>
	Internet:  <A HREF="http://www.waife.com">http://www.waife.com</A><BR>
	email:  <A HREF="mailto:ronwaife@waife.com">ronwaife@waife.com</A><BR>
	Contact Person:  Ron Waife
<HR>
Waife & Associates, Inc. provides consulting services for the identification, development and marketing of new technology products and services for the pharmaceutical and healthcare industry. It also advises the industry in the selection of these products and vendors, and provides custom solutions in the areas of clinical research, salesforce education and IT infrastructure.
<P>
Our expertise covers four areas: technology planning and vendor evaluation; custom solutions development; strategic planning and process facilitation; and marketing and business development programs for vendors.
<P>
<B>Technology Planning & Vendor Evaluation</B><BR>
Technology planning, RFP preparation and review, vendor analysis, feature evaluation and specification development, pilot design, state-of-the-industry presentations.
<P>
<B>Custom Solution Development</B><BR>
Needs analysis, vendor evaluation, rapid application development (esp. Lotus Notes), project management.
<P>
<B>Strategic Planning & Process Facilitation</B><BR>
Strategic planning and technology planning facilitation, process analysis, quality improvement training, facilitation of concept engineering.
<P>
<B>Marketing & Business Development Programs for Vendors</B><BR>
Message development, corporate and product identity, competitive analysis, message communication in all media (including the Internet), special events, and educational programs production. Also market and vendor analysis, business plan development, business partnership development, intellectual property rights programs, contract negotiation, staffing.
<P>
<B>Technology Specialities:</B> Data collection and management, groupware, project management.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-401</DOCNO>
<DOCOLDNO>IA040-000752-B021-31</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso235.htm 199.92.136.137 19970111152033 text/html 3159
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:22:11 GMT
Last-modified: Thursday, 14-Nov-96 13:53:42 GMT
Content-length: 2967
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>Westat, Inc.</B><BR>
	1650 Research Boulevard<BR>
	Rockville, MD  20850, USA<BR>
	Telephone:  (301) 251-1500<BR>
	Telefax:  (301) 738-8379<BR>
	Internet:  <A HREF="http://www.westat.com/clininfo">http://www.westat.com/clininfo</A><BR>
	email:  <A HREF="mailto:clininfo@westat.com">clininfo@westat.com</A><BR>
	Contact Person:  Suzanne Beckner, PhD, Senior Study Director
<HR>
Westat, Inc. is an employee-owned contract research organization founded in 1961 headquartered in the Washington, DC area. Our staff of 800 designs and conducts research projects of all sizes in many disease areas. Westat provides support for individual components or all aspects of clinical studies. Our staff includes biomedical scientists, biostatisticians, epidemiologists, nurse specialists, computer systems analysts and programmers, in addition to our established network of clinical collaborators.
<P>
<B>Phase I-III Clinical Trials</B>  Westat offers full service clinical trial management by a staff of professionals with expertise in protocol development, statistical design, clinical site management, case report form design, computer database development, site monitoring and the statistical analysis and presentation of clinical data. We prepare FDA regulatory documentation (INDs, Safety Reports, Annual Reports), maintain an IRB and participate in Data Safety Monitoring Boards to ensure compliance with Federal Regulations. Adherence to protocol is ensured by our protocol-specific training sessions, standard operating procedures and proprietary clinical trials management systems (WesTrials).
<P>
<B>Phase IV Postmarketing Studies</B>  Westat provides statistical survey design, development of sampling frames, Adverse Event and medical records review, risk assessment and biostatistical analyses to implement surveillance studies of morbidity and mortality. In-house expertise includes an internationally renowned survey statistics department, a national network of field supervisors and interviewers, state-of-the-art computer-assisted telephone and in-person interviewing capabilities, facility with death record and national health care database utilization and extensive resources to aid in subject tracking.
<P>
<B>Epidemiologic Research</B>  Westat conducts research for a broad range of observational studies to assess risk factors, progression, quality of life, outcomes, and cost of disease. Services include research design, selection of study subjects, subject tracking, interviewing, medical record abstraction, quality control monitoring and data collection, processing, analysis and reporting. Westat serves as the coordinating center for many major cross-sectional and prospective collaborative studies of the etiology, prevention, costs, types of care, and outcomes of a wide range of disease areas.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-402</DOCNO>
<DOCOLDNO>IA040-000752-B021-59</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/pcso/pcso238.htm 199.92.136.137 19970111152045 text/html 2360
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:22:25 GMT
Last-modified: Wednesday, 09-Oct-96 21:35:33 GMT
Content-length: 2167
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>PCSO Register</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<B>WHO Collaborating Centre for International Drug Monitoring
Uppsala Monitoring Centre</B>
	P.O. Box 26, Husargatan 8, S-75103 Uppsala, Sweden<BR>
	Telephone:  +46 18 174850<BR>
	Telefax:  +46 18 548566 or 507840<BR>
	Internet:  <A HREF="http://www.who.pharmasoft.se">http://www.who.pharmasoft.se</A><BR>
	email:  <A HREF="mailto:who.drugs@who.pharmasoft.se">who.drugs@who.pharmasoft.se</A><BR>
	Contact Person:  Liza Storm, Marketing Manager
<HR>
<B>WHO Dictionaries</B>
<P>
The WHO Collaborating Centre for International Drug Monitoring, which collects reports of suspected adverse drug reactions from approximately 47 countries (June 1996) in its database, offers the WHO Drug Dictionary and WHO Adverse Reaction Dictionary for purchase.
<P>
The WHO Drug Dictionary, available as hard copy (WHO Drug Reference List) or diskette/magnetic tape, now contains basic data on approximately 38,000 drug names (June 1996) and is updated quarterly.
<P>
DD Access is a new computerized version of the WHO Drug Reference List offering a user-friendly and efficient search facility.
<P>
The WHO Adverse Reaction Dictionary, available as hard copy or diskette/magnetic tape, is also updated quarterly. The computerized version contains ADRs in English, German, French, Spanish and Portuguese and hard copy is available in English, German, French and Portuguese.
<P>
You may subscribe for the WHO Dictionaries on a regular basis including updates or order just a single copy.
<P>
<B>On-line access to the WHO database</B>
<P>
On-line access to the open part of INTDIS, the WHO database of adverse reaction reports (from 26 countries), is available at a charge for academic and industrial inquiries among others. INTDIS, containing 1.6 million adverse reaction case reports (June 1996), is updated with 150-200,000 reports/year.
<P>
Custom searches by request
<P>
Retrievals in the INTDIS database in relation to specific drug safety issues are performed at a charge by the WHO Collaborating Centre staff on request.








</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-403</DOCNO>
<DOCOLDNO>IA040-000752-B021-89</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97012.htm 199.92.136.137 19970111152056 text/html 4134
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:22:35 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:19 GMT
Content-length: 3941
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Quality of Life: Constructs and Measures</B></CENTER>
<P>
<CENTER><B>I.D. # 97012<BR>
</B></CENTER>
<P>
<CENTER><B><B>13-14 January, 1997</B><BR>
Radisson Hotel<BR>
Scottsdale, AZ, USA</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $595      <BR>

Nonmembers* $660      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-404</DOCNO>
<DOCOLDNO>IA040-000752-B021-126</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97003.htm 199.92.136.137 19970111152133 text/html 4147
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:22:56 GMT
Last-modified: Wednesday, 27-Nov-96 21:41:27 GMT
Content-length: 3954
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Dry Powder Inhalers, Theory into practice<BR></B></CENTER>
<P>
<CENTER><B>I.D. # 97003<BR>
</B></CENTER>
<P>
<CENTER><B>13-14 January, 1997</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $680      <BR>

Nonmembers* $745      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-405</DOCNO>
<DOCOLDNO>IA040-000752-B021-158</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97013.htm 199.92.136.137 19970111152146 text/html 4249
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:23:27 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:24 GMT
Content-length: 4056
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Third DIA Sponsored Workshop on Botanicals: Botanical Testing: Developing the Scientific Evidence to Support the Medical Use of Heterogeneous Botanical Products</B></CENTER>
<P>
<CENTER><B>I.D. # 97013<BR>
</B></CENTER>
<P>
<CENTER><B>27-28 January, 1997</B><BR>
Washington Marriott Hotel<BR>
Washington, DC, USA</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $585      <BR>

Nonmembers* $650      <BR>

Government & Academia (Full-Time) $200<BR>

Government & Academia - Nonmembers $265



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-406</DOCNO>
<DOCOLDNO>IA040-000752-B021-185</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97022.htm 199.92.136.137 19970111152200 text/html 3814
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:23:41 GMT
Last-modified: Thursday, 12-Dec-96 21:42:46 GMT
Content-length: 3622
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Challenges for Improvement in the Area of GCP, Independent Audits and Inspections</B></CENTER>
<P>
<CENTER><B>I.D. # 97022<BR>
</B></CENTER>
<P>
<CENTER><B>27-28 January, 1997<BR>
Hotel CONRAD<BR>
Brussels, Belgium<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $760      <BR>

Nonmembers* $835      <BR>

Government &amp; Academia (Full-Time) $150<BR>

Government &amp; Academia - Nonmembers* $215<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>

<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-407</DOCNO>
<DOCOLDNO>IA040-000752-B021-215</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97034.htm 199.92.136.137 19970111152210 text/html 3902
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:23:51 GMT
Last-modified: Thursday, 12-Dec-96 21:42:52 GMT
Content-length: 3710
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>New European Drug Registration Procedures Concerning <BR>Spain, The European Union and All Member-States <BR>(Based on the Latest Revisions to the Notice to Applicants)</B></CENTER>
<P>
<CENTER><B>I.D. # 97034<BR>
</B></CENTER>
<P>
<CENTER><B>10 February, 1997<BR>
Hotel MELIA CASTILLA<BR>
Madrid, Spain<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $500      <BR>

Nonmembers* $565      <BR>

Government &amp; Academia (Full-Time) $80<BR>

Government &amp; Academia - Nonmembers* $145<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>

<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-408</DOCNO>
<DOCOLDNO>IA040-000752-B021-239</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97026.htm 199.92.136.137 19970111152219 text/html 4157
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:23:59 GMT
Last-modified: Monday, 02-Dec-96 14:41:58 GMT
Content-length: 3967
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Research and Regulatory Advances in Drug Safety</B></CENTER>
<P>
<CENTER><B>I.D. # 97026<BR>
</B></CENTER>
<P>
<CENTER><B>10-11 February, 1997</B><BR>
Sheraton Centre<BR>
Toronto, Ontario, Canada</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $595      <BR>

Nonmembers* $660      <BR>

Government &amp; Academia (Full-Time) $250<BR>

Government &amp; Academia - Nonmembers* $315<BR><BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER><BR>
<P>


</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-409</DOCNO>
<DOCOLDNO>IA040-000752-B021-274</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97005.htm 199.92.136.137 19970111152249 text/html 4136
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:24:10 GMT
Last-modified: Wednesday, 27-Nov-96 21:41:39 GMT
Content-length: 3943
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Pharmaceutical Document Management East</B></CENTER>
<P>
<CENTER><B>I.D. # 97005<BR>
</B></CENTER>
<P>
<CENTER><B>10-12 February, 1997</B><BR>
Adams Mark Hotel <BR>
Philadelphia, PA, USA</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $495      <BR>

Nonmembers* $560      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-410</DOCNO>
<DOCOLDNO>IA040-000752-B021-310</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97027.htm 199.92.136.137 19970111152302 text/html 4135
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:24:41 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:49 GMT
Content-length: 3942
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>The Changing Face of Drug Development</B></CENTER>
<P>
<CENTER><B>I.D. # 97027<BR>
</B></CENTER>
<P>
<CENTER><B>10-11 February, 1997</B><BR>
Marriott Marina<BR>
Fort Lauderdale, FL, USA</CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $510      <BR>

Nonmembers* $575      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-411</DOCNO>
<DOCOLDNO>IA040-000752-B021-347</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97028.htm 199.92.136.137 19970111152320 text/html 4152
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:24:55 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:51 GMT
Content-length: 3959
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Clinical Trials in Biotechnology</B></CENTER>
<P>
<CENTER><B>I.D. # 97028<BR>
</B></CENTER>
<P>
<CENTER><B>20-21 February, 1997<BR>
</B>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, California, USA<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $560      <BR>

Nonmembers* $625      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-412</DOCNO>
<DOCOLDNO>IA040-000752-B022-22</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/feb25.htm 199.92.136.137 19970111152331 text/html 15698
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:25:10 GMT
Last-modified: Thursday, 19-Dec-96 15:23:01 GMT
Content-length: 15505
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>
<TITLE>Program</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><B>P R O G R A M M E</B></CENTER>

<P>
<CENTER>Day 1<BR>
Monday 24 February, 1997<BR></CENTER>
<P>
<CENTER><B>Theme</B><BR>
NON-CLINICAL SAFETY DATA AND COLLECTING DATA FROM CLINICAL TRIALS<BR></CENTER>
<P>
<B>Seminar Objectives</B><BR>
<UL>
<LI>To discuss the phases of early drug development in determining the safety profile of a drug.<BR>
<LI>To acquire knowledge concerning the information the regulators are seeking in assessing the safety of a drug.<BR>
<LI>To benefit from hearing about the different experiences and consider good and not so good practices.<BR>
</UL>
<P>
09:30 
<BLOCKQUOTE>
<U>	SESSION 1</U> - NON-CLINICAL SAFETY DATA<BR>
	Session Chairperson<BR>
	Dr. Bruce Campbell, Servier R&D, UK<BR>
<P>
	A Historic Perspective<BR>
	Dr. Herman Van Cauteren, Janssen Research Foundation, Belgium<BR>
<P>
	Usefulness of Non-Clinical Data in Prediction and Interpretation of Safety<BR>
<P>
	Risk/Benefit and Role of Metabolism & Kinetics<BR>
	Dr. Bruce Campbell, Servier R&D, UK<BR>
<P>
</BLOCKQUOTE>


10:45-11:15	 
<BLOCKQUOTE>
<U>COFFEE BREAK</U><BR>
<P>
	Minimal Data required before going into Humans<BR>
	Dr. Jenny Sims, Medicines Control Agency, UK<BR>
<P>
	What is the Future of Non-Clinical Toxicology?<BR>
	Professor Anthony Dayan, St. Bartholomews Hospital Medical College, UK<BR>
<P>
	Panel Discussion<BR>
<P>
</BLOCKQUOTE>
12:30 
<BLOCKQUOTE>
<U>	LUNCHEON</U><BR>
</BLOCKQUOTE>
<P>
13:30	 
<BLOCKQUOTE>
<U>SESSION 2</U> - SAFETY DATA FROM CLINICAL TRIALS<BR>
	Session Chairperson<BR>
	Dr. Win Castle, SmithKline Beecham, USA<BR>
<P>
	A Regulatory Assessor's View<BR>
	Dr. Brian Davis, Medicines Control Agency, UK<BR>
<P>
	Safety Considerations in the design of an Individual Trial<BR>
	Dr. John Talbot, Astra Charnwood, UK<BR>
<P>
	A Clinical Research Directors View<BR>
	Dr. Michael Tansey, Pharmacia & Upjohn, UK<BR>
<P>
</BLOCKQUOTE>

14:45-15:15
<BLOCKQUOTE>
<U>	COFFEE BREAK</U><BR>
<P>
	Lessons Learned<BR>
	Dr. Win Castle, SmithKline Beecham, USA<BR>
<P>
	Panel Discussion<BR>
<P>
16:15	Close of Day-1 Sessions<BR>
<P>
</BLOCKQUOTE>

16:30-18:30
<BLOCKQUOTE>
<U>	WORKSHOP</U><BR>
	Record From Design: Instructions to Investigators and Computer<BR>
	Dr. Win Castle, SmithKline Beecham, USA<BR>
	Dr. Michael Ibara, Quintiles, USA<BR>
<P>
Workshop Objectives<BR>
<UL>
<LI>To consider the design of a "serious adverse event record form"<BR>
   in relation to its purpose and the potential problems of <BR>
   reconciliation.<BR>
</UL>
<P>
</BLOCKQUOTE>

18:30-19:30
<BLOCKQUOTE>
<U>	Reception</U><BR>
</BLOCKQUOTE>

<HR>
<CENTER><B>P R O G R A M M E</B></CENTER>
<P>

<CENTER>Day 2<BR>
Tuesday 25 February, 1997<BR></CENTER>

<P>

<CENTER><B>Theme</B><BR>
COLLECTING CLINICAL TRIALS SAFETY DATA; ITS MANAGEMENT AND STATISTICAL ANALYSIS<BR></CENTER>

<P>
<B>Seminar Objectives</B><BR>
<UL>
<LI>	To discuss the clinical and regulatory issues in interpreting safety data from pre-marketing clinical trials.
<LI>	To understand the need for balance between quality data handling and its presentation, and the need for pragmatism.
</UL>


<P>
09:30
<BLOCKQUOTE>
<U>		SESSION 1</U> - CLINICAL TRIAL SAFETY DATA<BR>
	Session Chairperson<BR>
	Professor Michael Rawlins, University of Newcastle, UK<BR>

<P>
	Safety & Ethics Committees: Their Purpose & Responsibilities<BR>
	Dr. Frank Wells, UK<BR>

	<P>
	The Role of the Investigator<BR>
	Professor Michael Rawlins, University of Newcastle, UK<BR>

	<P>
	Case Evaluation and Follow-Up<BR>
	Dr. Val Simmons, Glaxo Wellcome R&D, UK<BR>

</BLOCKQUOTE>

10:45-11:15	
<BLOCKQUOTE>
<U>COFFEE BREAK</U>
<P>
	Clinical Descriptions and Follow-Up<BR>
	Dr. Christian Benichou, Synthlabo, France<BR>
<P>
	
	Writing the Safety Section of End of Study Reports<BR>
	Dr. Win Castle, SmithKline Beecham, USA<BR>
<P>


	Panel Discussion<BR>
</BLOCKQUOTE>
<P>

12:30
<BLOCKQUOTE>
<U>	LUNCHEON</U>
</BLOCKQUOTE>
<P>

13:30 
<BLOCKQUOTE>
<U>	SESSION 2</U> - SAFETY DATA MANAGEMENT AND ANALYSIS<BR>
	Session Chairperson<BR>
	Dr. Stuart Cummings, Merck Sharp & Dohme (Europe), Belgium<BR>
<P>
	
	EU Systems for Information Transfer & Dissemination<BR>
	Dr. Karel de Neef, EMEA, UK<BR>
<P>
	
	Commercial Systems - To Build or to Buy?<BR>
	Michael Tydeman, SmithKline Beecham, UK<BR>
<P>
	
	QC and Archiving<BR>
	Dr. Andy Richardson, ClinTrials Research, UK<BR>
</BLOCKQUOTE>
<P>
14:45-15:15

<BLOCKQUOTE>
<U>	COFFEE BREAK</U>
<P>
	Analysis - What does the Assessor need?<BR>
	Dr. John Lewis, Medicines Control Agency, UK<BR>
</BLOCKQUOTE>
<P>

	Panel Discussion
<P>
16:15	 
<BLOCKQUOTE>
Close of Day-2 Sessions
</BLOCKQUOTE>
<P>
16:30-18:30 
<BLOCKQUOTE>
<U>	WORKSHOP</U><BR>
	Clinical Trial Safety Data: Understanding the Statistics (For Non-Statisticians)<BR>
	Joachim Vollmar, Pharmaceutical Research Associates, Germany<BR>
</BLOCKQUOTE>
<P>


Workshop Objectives
<UL>
<LI>To learn of the different statistical evaluation methods which can 
   be used in processing and presenting clinical safety data.
</UL>


18:30-19:30
<BLOCKQUOTE>

	Reception
</BLOCKQUOTE>


<HR>

<CENTER><B>P R O G R A M M E</B></CENTER>

<P>
<CENTER>Day 3<BR>
Wednesday 26 February, 1997<BR></CENTER>

<P>

<CENTER><B>Theme</B><BR>
REGULATORY REQUIREMENTS:
 PRE AND POST MARKETING</CENTER>
<P>
<B>Seminar Objectives</B><BR>
<UL>
<LI>	Expedited case reporting, both pre- and post-marketing is an evolving area which is most important but currently confusing. Harmonization initiatives, including ICH and CIOMS have achieved considerable successes, but  there is still some way to go before appropriate regulatory case reporting becomes a straight forward exercise.
<LI>The objective is to review the current situation and hopefully throw some light on the probable way ahead.
</UL>
<P>
09:30
<BLOCKQUOTE>
<U>	SESSION 1</U> - REQUIREMENTS FOR EXPEDITED CASE 	REPORTING - NOW AND IN THE FUTURE<BR>
	Session Chairperson<BR>
	Dr. Murray Lumpkin, FDA, USA<BR>

	<P>
	The FDA View<BR>
	Dr. Beje Wiholm, Medical Products Agency, Sweden<BR>

<P>
	The German View<BR>
	Dr. Ernst Weidmann, Hoechst AG, Germany<BR>

</BLOCKQUOTE>
	
10:45-11:15	

<BLOCKQUOTE>
<U>COFFEE BREAK</U>
<P>
	The Japanese View<BR>
	Dr. Willem van der Velden, Yamanouchi Europe, The Netherlands<BR>

	<P>
	The UK View<BR>
	Dr. Susan Wood, Medicines Control Agency, UK<BR>

	<P>
	Panel Discussion
</BLOCKQUOTE>

12:30
<BLOCKQUOTE>
<U>	LUNCHEON</U>
</BLOCKQUOTE>


13:30
<BLOCKQUOTE>
<U>	SESSION 2</U> - OBSERVATIONS ON HARMONIZATION INITIATIVES<BR>
	Session Chairperson<BR>
	Dr. Wendy Stephenson, Merck Sharp & Dohme, USA<BR>

	<P>
	France & the EU Exchange of Information<BR>
	Dr. Nicholas Moore, Hpital de Bois Guillaume, France<BR>

	<P>
	ICH Initiatives<BR>
	Dr. Gaby Danan, Roussel-Uclalf, France<BR>

	<P>
	CIOMS Initiatives<BR>
	Dr. Win Castle, SmithKline Beecham, USA
</BLOCKQUOTE>

14:45-15:15
<BLOCKQUOTE>
<U>	COFFEE BREAK</U>
<P>
	EMEA Now and in the Future<BR>
	Professor Rolf Bass, EMEA, UK<BR>

<P>
	Living with the Requirements - An Industry View<BR>
	Dr. Wendy Stephenson, Merck Sharp & Dohme, USA<BR>

<P>
	Panel Discussion
</BLOCKQUOTE>

16:15
<BLOCKQUOTE>
	Close of Day-3 Sessions
</BLOCKQUOTE>


16:30-18:30
<BLOCKQUOTE>
<U>	WORKSHOP</U>
<P>
	MEDDRA in Practice<BR>
	Morrell David, Medicines Control Agency, UK<BR>
	Dr. Elliot Brown, Lilly, UK<BR>

<P>
Workshop Objectives
<UL>
<LI>Harmonization requires the use of standard medical terminology, 
  and this workshop will present the current status of this initiative.
</UL>

</BLOCKQUOTE>


18:30-19:30
<BLOCKQUOTE>
	Reception
</BLOCKQUOTE>
<HR>

<CENTER><B>P R O G R A M M E</B></CENTER>

<P>
<CENTER>Day 4<BR>
Thursday 27 February, 1997<BR></CENTER>

<P>

<CENTER><B>Theme</B><BR>
HANDLING AND ANALYSING POST 
MARKETING CASE REPORTS</CENTER>
<P>

<B>Seminar Objectives</B><BR>
<UL>
<LI>	To discuss the methods available for monitoring the evolving safety profile of a marketed drug with particular consideration of the regulatory, clinical, legal and epidemiological issues.
<LI>	To acquire knowledge about the appropriateness or otherwise of different processes used in identifying signals.
<LI>	To discuss the methods used to investigate a safety hypothesis.
</UL>



09:30	
<BLOCKQUOTE>
<U>	SESSION 1</U> - INDIVIDUAL CASES, POST APPROVAL<BR>
	Session Chairperson<BR>
	Richard Kingham, Covington & Burling, UK<BR>

<P>
	The Legal Implications<BR>
	Richard Kingham, Covington & Burling, UK<BR>

	<P>
	The Medical Significance of Cases<BR>
	Miles Stevens, Fisons, UK<BR>

	<P>
	Lessons Learned in Handling the Process<BR>
	Dr. George Phillips, Quintiles, USA<BR>

</BLOCKQUOTE>

<P>

10:45-11:15

<BLOCKQUOTE>
<U>	COFFEE BREAK</U>
<P>
	The French Approach<BR>
	Dr. Bernard Begaud, Hpital Pellegrin, Bordeaux, <BR>
	France<BR>
<P>
	
	Panel Discussion
</BLOCKQUOTE>



12:30

<BLOCKQUOTE>
<U>	LUNCHEON</U>
</BLOCKQUOTE>


13:30

<BLOCKQUOTE>
<U>	SESSION 2</U> - SIGNALS! THEIR IDENTIFICATION AND INVESTIGATION<BR>
	Session Chairperson<BR>
	Dr. Beje Wiholm, Medical Products Agency, Sweden<BR>

	<P>
	A Historic Perspective<BR>
	Dr. Beje Wiholm, Medical Products Agency, Sweden<BR>

	<P>
	Methods of Investigating<BR>
	Dr. Monika Pietrek, Pharmaceutical Research Associates, Germany<BR>

	<P>
	UK Viewpoint<BR>
	Dr. Ennis Lee, Medicines Control Agency, UK<BR>

</BLOCKQUOTE>



14:45-15:15

<BLOCKQUOTE>
<U>	COFFEE BREAK</U>
<P>
	Use of PEM, VAMP & Other Record Linkage Systems<BR>
	Dr. Ron Mann, Royal Society of Medicine, UK<BR>
<P>

	Lessons Learned in Practice

	<P>
	Panel Discussion
</BLOCKQUOTE>




16:15

<BLOCKQUOTE>
	Close of Day-4 Sessions
</BLOCKQUOTE>



16:30-18:30

<BLOCKQUOTE>
<U>	WORKSHOP</U><BR>
	Periodic Updates in Practice<BR>
	Dr. Wendy Stephenson, Merck Sharp & Dohme, USA<BR>
	Sue Roden, Glaxo Wellcome R&D, UK<BR>

</BLOCKQUOTE>


Workshop Objectives
<UL>
<LI>To learn about the principle issues of generating "Periodic Safety
   Updates" recognising their importance and the need for efficiencies 
   in the preparation of the process.
</UL>

18:30-19:30
<BLOCKQUOTE>
	Reception
</BLOCKQUOTE>

<HR>

<CENTER><B>P R O G R A M M E</B></CENTER>

<P>
<CENTER>Day 5<BR>
Friday 28 February, 1997<BR></CENTER>

<P>

<CENTER><B>Theme</B><BR>
SAFETY INFORMATION AND MANAGING ISSUES<BR></CENTER>
<P>


<B>Seminar Objectives</B><BR>
<UL>
<LI>	To discuss how best to communicate drug safety information to the prescriber and their patients.
<LI>To discuss the appropriate ways of assessing the evidence on safety issues in determining the options available so as to minimize:
</UL>
		1) 	the risk to patients present and future.<BR>
		2)	the risk to damaging the credentials of the 			drug.	and	<BR>
3)	the risk to damaging the reputation of the 			Pharmaceutical Industry.	<BR>
<P>

09:30

<BLOCKQUOTE>
<U>	SESSION 1</U> - SAFETY INFORMATION TO PRESCRIBER 	AND PATIENTS<BR>
	Session Chairperson<BR>
	Dr. Elliot Brown, Lilly, UK<BR>
<P>
	
	CIOMS III, Safety Information and the View of a US Company<BR>
	Dr. Wendy Stephenson, Merck Sharp & Dohme, USA<BR>
<P>

	Safety Information: the View of an EU "Responsible" Person<BR>
	Dr. Elliot Brown, Lilly, UK<BR>
<P>

	The Needs of the Consumer<BR>
	Dr. Patricia Wilkie, Patients Association, UK<BR>
</BLOCKQUOTE>
<P>
	

10:45-11:15	

<BLOCKQUOTE>
<U>COFFEE BREAK</U>
<P>
	The Role of the Medical Journals<BR>
	Dr. David McNamee, Lancet, UK<BR>
<P>
	
	CIOMS IV and Benefit Risk Evaluations<BR>
	Dr. Win Castle, SmithKline Beecham, USA<BR>
<P>

	Panel Discussion
</BLOCKQUOTE>

12:30

<BLOCKQUOTE>
<U>	LUNCHEON</U>
</BLOCKQUOTE>
<P>
13:30

<BLOCKQUOTE>
<U>	SESSION 2</U> - ISSUES MANAGEMENT<BR>
	Session Chairperson<BR>
	Dr. Ola Rnn, Pharmacia & Upjohn, Sweden<BR>
<P>
	
	Pharmacoepidemiology in Real Life<BR>
	Dr. Ola Rnn, Pharmacia & Upjohn, Sweden<BR>
</BLOCKQUOTE>

<P>
	
	
14:45-15:15	

<BLOCKQUOTE>

<U>COFFEE BREAK</U>

</BLOCKQUOTE>





	
15:15-17:15


<BLOCKQUOTE>
<U>	WORKSHOP</U><BR>
	Crisis Management: Decision-Making in a Pressure Cooker<BR>
	Paul Gillions, Fleishman-Hillard, Inc, UK<BR>

</BLOCKQUOTE>

<P>
	
Workshop Profile<BR>
<UL>
<LI>	An interactive workshop, supported by a slide-and-video presentation and management planning tools, to give participants a practical, live-action experience of how crisis unfold, how they can be managed, how they can be pre-empted and how reputations can be maintained and/or re-built.
</UL>


17:30
<BLOCKQUOTE>
	Close of the Seminar Modules
</BLOCKQUOTE>



<U>TRAVEL INFORMATION</U>
<P>
The Seminars Venue, the COPTHORNE TARA Hotel is situated near the Underground Station Kensington High Street, which is served by the Circle and Districts (Wimbledon) lines. These lines both share several transfer stations with the Piccadilly Line from and to the Airport London Heathrow.
<P>

<U>HOTEL INFORMATION</U>
<P>
The DIA has blocked a number of rooms at the COPTHORNE TARA Hotel, Scarsdale Place, Kensington, LONDON W8 5SR, UK, at the special rates:
<P>
		Single Room:	  95.00 GBP<BR>
		Double Room:	110.00 GBP<BR>

<P>
Attendees must make their own hotel reservation by telephone +44 171 937 72 11 or telefax +44 171 937 7100 referring to the DIA Seminar on MONITORING DRUG SAFETY THROUGH THE LIFE-CYCLE OF A PHARMACEUTICAL PRODUCT, Reference N 1947
<P>
A deposit payment for one night must be made to secure the reservation, either by cheque mailed to the respective hotel, or by providing, with signature, the name, number, and expiry date of your credit card.
<P>
IMPORTANT: To be assured of accomodation in the Hotel COPTHORNE TARA, registrants are recommended to complete their hotel reservation, if possible, by
<P>
January 10, 1997
<P>

<U>PAYMENT</U>
<P>
Payment may be made by check in US$, payable to Drug Information Association. You may also arrange payment by Bank Transfer, of appropriate amount, to:
<P>
CITIBANK, N.A., 460 Park Avenue<BR>
NEW YORK, NY 10022, USA<BR>
DIA Account Number: 46820821<BR>
Routing Number: 021000089 * ABA # 210<BR>
<P>

Your name and company name must be included on the transfer document to ensure payment to your account.
<P>
<U>CANCELLATION POLICY</U>
<P>
10 days in advance, 90% refund<BR>
4 to 9 days in advance, 70% refund<BR>
3 days, no refund but registration may be transfered to another person<BR>
<P>
<CENTER><A HREF="97035.htm"> If you would like to register for this meeting please click here!</A></CENTER>
<U>F G F G</U>
<P>
For further information, or more details, please contact your nearest DIA Office:
<P>
DRUG INFORMATION ASSOCIATION<BR>
European Office<BR>
Postfach<BR>
4012 - BASEL, Switzerland<BR>
Tel.: +41 61 382 90 19<BR>
Fax: +41 61 382 90 50<BR>
E-Mail: diaeurope@stepnet.de<BR>
<P>
or
DRUG INFORMATION ASSOCIATION<BR>
321 Norristown Road, Suite 225<BR>
AMBLER, PA 19002-2755, USA<BR>
Tel.: +1 215 628 2288<BR>
Fax: +1 215 641 12 29<BR>
E-Mail: dia@diahome.org<BR>

</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-413</DOCNO>
<DOCOLDNO>IA040-000752-B022-50</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97031.htm 199.92.136.137 19970111152341 text/html 4147
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:25:21 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:56 GMT
Content-length: 3954
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Regulatory Drug Marketing in a Global Village</B></CENTER>
<P>
<CENTER><B>I.D. # 97031<BR>
</B></CENTER>
<P>
<CENTER><B>27-28 February, 1997</B><BR>
Marriott Marquis Hotel<BR>
New York, NY, USA<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $550      <BR>

Nonmembers* $615      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-414</DOCNO>
<DOCOLDNO>IA040-000752-B022-114</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97016.htm 199.92.136.137 19970111152407 text/html 4216
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:25:41 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:35 GMT
Content-length: 4023
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Statistical Issues in the Pharmaceutical Industry: Multiplicity in Clinical Trials</B></CENTER>
<P>
<CENTER><B>I.D. # 97016<BR>
</B></CENTER>
<P>
<CENTER><B>10-11 March, 1997</B><BR>
Hyatt Hotel<BR>
Hilton Head, SC, USA</CENTER>
<P>

Tutorial Fee Sunday, March 9  $120<BR>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $530      <BR>

Nonmembers* $595      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-415</DOCNO>
<DOCOLDNO>IA040-000752-B022-138</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97010.htm 199.92.136.137 19970111152417 text/html 4243
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:25:58 GMT
Last-modified: Monday, 02-Dec-96 14:41:38 GMT
Content-length: 4053
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Clinical Data Management: Innovative Technologies and Strategies for the Global Management of Clinical Information</B></CENTER>
<P>
<CENTER><B>I.D. # 97010<BR>
</B></CENTER>
<P>
<CENTER><B>16-19 March, 1997<BR>
Marriott Hotel<BR>
Philadelphia, PA, USA<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $450      <BR>

Nonmembers* $515      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR><BR>

Tutorial* $162      <BR>


<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER><BR>
<P>


</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-416</DOCNO>
<DOCOLDNO>IA040-000752-B022-172</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97006.htm 199.92.136.137 19970111152430 text/html 4143
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:26:10 GMT
Last-modified: Wednesday, 27-Nov-96 21:41:43 GMT
Content-length: 3950
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Medical Communications</B></CENTER>
<P>
<CENTER><B>I.D. # 97006<BR>
</B></CENTER>
<P>
<CENTER><B> 6-9 April, 1997<BR></B>
Sheraton Hotel<BR>
New Orleans, LA, USA</CENTER>
<P>

<B>Tuition/Registration Fees: </B>
<P>
Member $520      <BR>

Nonmembers* $585      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>

Networking Dinner  $35<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-417</DOCNO>
<DOCOLDNO>IA040-000752-B022-212</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97029.htm 199.92.136.137 19970111152501 text/html 4168
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:26:33 GMT
Last-modified: Thursday, 12-Dec-96 21:42:49 GMT
Content-length: 3976
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Current Aspects of Vaccinology and Molecular Virology</B></CENTER>
<P>
<CENTER><B>I.D. # 97029<BR>
</B></CENTER>
<P>
<CENTER><B>9-11 April, 1997<BR>
</B>
Laguna Cliffs Marriott Hotel<BR>
Dana Point, California, USA<BR></CENTER>
<P>
<B>Tuition/Registration Fees: </B>
<P>
Member $600      <BR>

Nonmembers* $665      <BR>

Government &amp; Academia (Full-Time) $300<BR>

Government &amp; Academia - Nonmembers* $365<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-418</DOCNO>
<DOCOLDNO>IA040-000752-B022-251</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97015.htm 199.92.136.137 19970111152530 text/html 4160
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:27:11 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:30 GMT
Content-length: 3967
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>Osteoporosis Education: Focusing on Behavioral Change</B></CENTER>
<P>
<CENTER><B>I.D. # 97015<BR>
</B></CENTER>
<P>
<CENTER><B>14-15 April, 1997<BR>
Convention Center Marriott Hotel<BR>
Philadelphia, PA, USA</CENTER>
<P>

<B>Tuition/Registration Fees: </B>
<P>
Member $575      <BR>

Nonmembers* $640      <BR>

Government &amp; Academia (Full-Time) $150<BR>

Government &amp; Academia - Nonmembers* $215<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-419</DOCNO>
<DOCOLDNO>IA040-000752-B022-285</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/97017.htm 199.92.136.137 19970111152540 text/html 4198
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:27:19 GMT
Last-modified: Wednesday, 27-Nov-96 21:42:38 GMT
Content-length: 4005
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD><TITLE>Meeting Registration Form</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" BGCOLOR="#FFFFFF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
UPCOMING MEETINGS
<P>
<CENTER><STRONG> MEETING REGISTRATION FORM</STRONG></CENTER>
<HR>
<CENTER><B>PLEASE CONSIDER THIS FORM AN INVOICE<BR></B></CENTER>
<P>
<CENTER><B>The Knowledge Management Puzzle: Putting the Information and Technology Pieces Together</B><BR></B></CENTER>
<P>
<CENTER><B>I.D. # 97017<BR>
</B></CENTER>
<P>
<CENTER><B> 1-2 May, 1997<BR></B>
Marriott Philadelphia Hotel<BR>
Philadelphia, PA, USA</CENTER>
<P>

<B>Tuition/Registration Fees: </B>
<P>
Member $495      <BR>

Nonmembers* $560      <BR>

Government &amp; Academia (Full-Time) $200<BR>

Government &amp; Academia - Nonmembers* $265<BR>



<P>
<form ACTION="/cgi-bin/wa_response.cgi" METHOD="POST">
<input type="hidden" name="savefile" value="NO">



<B>Total Amount of Remittance</B>        <input type="text" size="10"
maxlength="30" name="var1"><BR>

<P>
*Nonmember Registration includes DIA Membership for 1997

<HR>
<CENTER>Early Registration is requested.  Return check may be
drawn on a  US Bank payable to:</CENTER>
<P>
<CENTER>Drug Information Association  <BR>
Mail your payment along with this form to: <BR>
DIA, P.O. Box 7777-W8405, Philadelphia, PA, USA 19175</CENTER>
<HR>




<CENTER>    <pre>          Name:   <input type="text" size="30"
maxlength="256" name="var2">
  Degrees Held:   <input type="text" size="30" maxlength="256"
name="var3" >
Position Title:   <input type="text" size="30" maxlength="256"
name="var4" >
       Company:   <input type="text" size="30" maxlength="256"
name="var5" >
       Address:   <input type="text" size="30" maxlength="256"
name="var6" >
          City:   <input type="text" size="30" maxlength="256"
name="var7">
         State:   <input type="text" size="30" maxlength="256"
name="var8">
       Country:   <input type="text" size="30" maxlength="256"
name="var9">
           Zip:   <input type="text" size="30" maxlength="10"
name="var10">
     Telephone:   <input type="text" size="30" maxlength="256"
name="var11">
Internet Address: <input type="text" size="30" maxlength="256"
name="var12">
           FAX:   <input type="text" size="30" maxlength="256"
name="var13">
        E-mail:   <input type="text" size="30" maxlength="256"
name="var14">
</CENTER>
<CENTER><FONT SIZE=3>*(A Telephone and Fax Number are required for  faxed confirmation.)</FONT></CENTER>
<UL>
<INPUT TYPE="radio" NAME="var15" VALUE="Visa">Visa
<INPUT TYPE="radio" NAME="var15" VALUE="Mastercard">Mastercard
<INPUT TYPE="radio" NAME="var15" VALUE="American Express" CHECKED>Amex.
</UL>
<CENTER>
        Card #: <input type="text" size="30" maxlength="256"
name="var16">
     Exp. Date: <input type="text" size="30" maxlength="256"
name="var17"></pre>
</CENTER>
"Note, the information on this form is <B>NOT ENCRYPTED</B> when forwarded by email. If you are uncomfortable about entering your credit card number and transmitting it by email, then please print out the form, complete the form, and send it by Fax or by the postal service."<BR>
<P>
<CENTER><input type="submit" value="Submit"><input type="reset"
    value="Clear Form"></CENTER>

</form>
<HR>
<CENTER>Participants with disabilities: DIA meeting facilities
and overnight accommodations are <BR>
accessible to persons with disabilities. Services will be made
available to sensory-impaired <BR>
persons attending the meeting if requested at least 15 days prior
to the meeting. <BR>
Contact the DIA office to indicate your needs.<BR>
<P>
<HR>
<CENTER>Drug Information Association<BR>
321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>
Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>
or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>
Tel. +41 61 382 90 19, Fax. +41 61 382 90 50 <BR>
Drug Information Association 1996</CENTER>




</BODY>
</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-420</DOCNO>
<DOCOLDNO>IA040-000752-B022-333</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a4a.htm 199.92.136.137 19970111152603 text/html 30513
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:27:41 GMT
Last-modified: Tuesday, 23-Jul-96 17:06:14 GMT
Content-length: 30321
Content-type: text/html
</DOCHDR>
<HTML>
<HEAD>

<TITLE>Article Index (Table of Contents)</TITLE>
</HEAD>
<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL</UL>
<P>
<CENTER>INDEX TO VOLUME 29 (1995)</CENTER>
<P>
<CENTER><STRONG>ARTICLE INDEX (Table of Contents)</STRONG></CENTER>
<P>
<HR>
<CENTER><B>CONTENTS FOR VOLUME 29, 1995</B></CENTER>
<P>
<CENTER><B>Volume 29, Number 1         ( January-March 1995 )</B></CENTER>
<P>
<HR>
<B>Stuart L. Nightingale</B><BR> 1 Challenges in International Harmonization
<P>
<HR><B>Minna S. Golden</B><BR>
<B>Ann Witt</B> <BR>  11 Reinventing Advisory Committee Management at the Food and Drug Administration
<P>
<HR><B>Mary Jo Veverka</B><BR> 19  FDA 2000-Building for the Future
<P>
<HR><B>Shaw T. Chen</B><BR>  27  Supporting Your Claims: Recent Issues
in Cardiovascular Drugs
<P>
<HR><B>David R. Bristol</B> <BR> 33  Delta: The True Clinically Significant
Difference to be Detected
<P>
<HR><B>Christy Chuang-Stein</B><BR>  37  Points for Consideration in the
Collection and Analysis of Safety Data
<P>
<HR><B>Stan C. Lin</B><BR>  45  Sample Size for Therapeutic Equivalence
Based on Confidence Interval
<P>
<HR><B>Willem K. Amery</B><BR><B>Marianne Van Winkel</B><BR>  51  Patient Package Inserts for Prescription Drugs in an International Pharmaceutical Company
<P>
<HR><B>Charles P. Barranco</B><BR>  61  Clinical Data Acquisition Using
FivePart NCR Case Record Forms and Overnight Delivery
<P>
<HR><B>David I. Hopp</B><BR>  69  The Portable Desktop Revisited: Present
Status and Future Directions
<P>
<HR><B>Genevieve Decoster</B><BR><B>Marc Buyse</B><BR>  79  Phase IV Clinical Trials: Purposes,
Design, and a Limited Place for Good Clinical Practice
<P>
<HR><B>Albin Chaves</B><BR>  87  Drug Monitoring in Latin America
<P>
<HR><B>Pauline A. Bartek</B> <BR> 91  Increasing Subject Comprehension
of the Informed Consent Form
<P>
<HR><B>Joseph Gasperino</B><BR> <B>Richard Lynn</B><BR> 99  Responding to Drug Information Requests
Using RAPID
<P>
<HR><B>Terry L. Gillum</B> <BR><B>Robert H. George</B><BR><B>Jack E. Leitmeyer</B><BR>  107  An Autoencoder for Clinical and Regulatory Data Processing
<P>
<HR><B>Albert J. Giovenella</B><BR>  115  Partnering in Pharmaceutical
Education: A Model to Help Industry Shape Health Care Reform
<P>
<HR><B>Peter K. Honig</B> <BR> 127  Drug Safety: A Clinical Pharmacologist's Perspective
<P>
<HR><B>Claudio Macchetto</B><BR>  131  Intellectual Property Negotiations:
A Managerial Perspective of Basic Intellectual Property Issues for Small Pharmaceutical Companies in Research Contract Negotiations with Contract Research Organizations
<P>
<HR><B>Gary E. Pakes</B> <BR> 139  A Guide to Effective Presentation Skills
for Drug Information Personnel
<P>
<HR><B>Charles A. Ritrovato</B><BR><B>Cynthia Dinella</B> <BR> 147  The Representation of Women
in Clinical Drug Trials
<P>
<HR><B>Bruce A. Ryerson</B><BR>  155  A Model for an EndUser Computer
Validation Control System in a Research Laboratory Environment
<P>
<HR><B>Marianne Gretz</B><BR><B>Martin Thomas</B> <BR> 163  The Inhouse Database-Nicety or Necessity?
<P>
<HR><B>Ranga Velagaleti</B><BR>  171  Technical and Schedule Impacts of
Environmental Assessments on the Drug Development Process
<P>
<HR><B>Marjory S. White</B><BR>  181  Standardizing Data Screening Tools
<P>
<HR><B>Mary Lou Cardie</B> <BR><B>Nancy G. Tucker</B><BR> 187  How to Validate a Computer System
<P>
<HR><B>C. Legrand</B><BR><B>F. Cheix</B><BR><B>H. Dumais</B> <BR><B>V. Laugel</B><BR><B>F. de Cr&eacute;miers</B> <BR><B>Ch. Dupont</B><BR> 201  Clinical Trial Initiation Procedures in
Europe: The Legal Framework and Practical Aspects
<P>
<HR><B>Ansis M. Helmanis</B> <BR> 261  The European Community-Regulatory
Affairs Post1995
<P>
<HR><B>Betty R. Kuhnert</B> <BR> 267  Experience with an International
Approval Process for Clinical Documents
<P><HR><B>Bryan G. Reuben</B><BR><B>Michael L. Burstall</B> <BR> 273  Pricing and Reimbursement Regulation
in Europe: The Industry Perspective
<P>
<HR><B>Robert H. Vander Sffchele</B><BR><B>Marc G. Bogaert</B> <BR> 285  European Legislation and
Research Projects Regarding Patient Education for Medication
<P>
<HR><B>Yves Juillet</B> <BR><B>Gaby Danan</B><BR> 291  Drug Safety: Legal Requirements in Europe
and in the United States-A European Industry View
<P>
<HR><B>Kathleen McCool</B><BR>  297  Vaccine Data Reporting: Standard,
yet Flexible 
<P>
<HR><B>Peter I. Folb</B> <BR> 303  Drug Monitoring in Developing Countries:
A Drug Regulator's Perspective
<P>
<HR><B>Andrzej Czarnecki</B> <BR> 307  Monitoring of Adverse Events and
Reporting
<HR><CENTER><H2><B>Management of Adverse Drug Reactions</B></H2></CENTER>
<P>
<HR><B>Raymond L. Herman</B> <BR> 313  Guest Editor's Note
<P>
<HR><B>Christian B&eacute;nichou</B> <BR> 315  Medical Knowledge: The
Essential of Causality Assessment
<P>
<HR><B>Krista L. Lanct&ocirc;t</B><BR><B>Michael C. O. Kwok</B> <BR><B>Claudio A. Naranjo</B> <BR>319  Computerized Bayesian Evaluation of Adverse Events
<P>
<HR><B>Joseph M. Fallowfield</B> <BR> 327  Adverse Drug Reactions from
Database to Prescriber: The United Kingdom Experience
<P>
<HR><B>Myles D. Stephens</B> <BR> 335  Dechallenge Revisited
<P>
<HR><B>K. K. Jain</B><BR>  339  A Short Practical Method for Triage of
Adverse Drug Reactions
<P>
<HR><B>M. ten Ham</B><BR>  343  Confidentiality of Medical Databases and
Pharmacoepidemiology
<P>
<HR><B>Marc A. Pierredon</B><BR>  351  Confidentiality of Databases: The
View of One Pharmaceutical Company
<P>
<HR><CENTER><B>Volume 29, Number 2          ( April-June 1995 )</B></CENTER>
<P>
<CENTER><STRONG>CONTENTS</STRONG></CENTER>
<P>
<CENTER><B>White Paper on Four Areas of Relevance to New Drug Development
and</B></CENTER><BR>
<B>Review in the United States</B>
<P>
<HR><B>Kenneth 1. Kaitin</B><BR>  355  Guest Editor's Note: White Paper
on Four Areas of Relevance to New Drug Development and Review in the United States 
<P>
<HR><B>Tufts Center for the Study</B><BR><B>of Drug Development</B><BR> 357  Executive Summary: White Paper on Four Areas of Relevance to New Drug Development and Review
in the United States
<P>
<HR><B>Kenneth I. Kaitin</B><BR><B>Jeffrey S. Brown</B><BR>  361  A Drug Lag Update
<P>
<HR><B>Joseph A. DiMasi</B> <BR> 375  Trends in Drug Development Costs,
Times, and Risks
<P>
<HR><B>Sheila R. Shulman</B><BR> <B>Peg Hewitt</B><BR><B>Michael Manocchia</B><BR>385  Studies and Inquiries into the FDA Regulatory Process: An Historical Review
<P>
<HR><B>Louis Lasagna</B> <BR> 415  Improving the Drug Development Process:
Needed Reforms
<P>
<HR><CENTER><H2><B>Health Care Reform Through Innovation</B></H2></CENTER>
<P>
<HR><B>Albert Giovenella</B><BR>  425  Introduction: Health Care Reform
Through Innovation
<P>
<HR><B>Alan L. Hillman</B><BR>  429  The Economic Effects of Reform on
Innovation
<P>
<HR><B>Carl B. Feldbaum</B><BR>  435  The Crushing Effects of Price Controls
on Biotechnology
<P>
<HR><B>William A. Zellmer</B> <BR> 439  Effects of Health Care Reform
on Pharmacists
<P>
<HR><B>Don W. Brock</B><BR><B>Norman Daniels</B> <BR> 445  Ethical Principles and Values of Health
Care Reform
<P>
<HR><B>Michael A. Caso</B><BR>  453  Worldwide Harmony, American Diversity-A
Marketing Paradox? 
<P>
<HR><B>Michael Wilkes</B> <BR> 461  The Changing Role of Medical Education
in the Face of Pressure to Reform Health Care 
<P>
<HR><B>Albert Giovenella</B><BR>  469  Closing Remarks: Health Care Reform
Through Innovation 
<P>
<HR><CENTER><H2><B>A European Concept for Good Statistical Practices in Global Drug Development</B></H2></CENTER>
<P>
<HR><B>Andreas Zipfel</B><BR>  471  Guest Editor's Note: A European Concept
for Good Statistical Practice in Global Drug Development
<P>
<HR><B>Andreas Zipfel</B><BR><B>Annette Robertson</B><BR><B>Marco Girelli</B><BR> <B>Karsten Schmidt</B><BR> 473  Discussion Papers: A European Concept
for Good Statistical Practice in Global Drug Development
<P>
<HR><B>Klas Svensson</B><BR>  475  How Many Populations Must be Analyzed
and How Should They be Defined (Intention-to-Treat, Eligible, Per Protocol Population, Etc. )?
<P>
<HR><B>Andreas Zipfel</B> <BR><B>Paul Grob</B><BR> 479  How Much Detail on Confirmatory Statistics
and Exploratory Statistics Must a Statistical Report Contain?
<P>
<HR><B>Karsten Schmidt</B><BR>  483  Statistical Tests and Estimations
<P>
<HR><B>Mike Collins</B><BR>  493  PlaceboControlled Trials and Alternatives
<P>
<HR><B>Annette Robertson</B><BR><B>Anne Wiles</B> <BR><B>John Alexander</B><BR><B>Peter Clark</B><BR><B>Mick Godley</B> <BR><B>Dennis Lendrem</B><BR>497  Standard Operating Procedures
<P>
<HR><B>Remy von Frenckell </B><BR><B>Jim Copp</B><BR><B>Hans Essers</B><BR><B>Ad Theeuwes</B><BR> 503  Format/Content of Overviews (Integrated
Efficacy and Safety Report)
<P>
<HR><B>Annick Leroy</B><BR><B>M. Buyse</B><BR> <B>M. Harrison</B><BR><B>J. M. Zayas</B> <BR>507  Interim Analyses
<P>
<HR><B>Alec Vardy</B> <BR><B>Stefan Driessen</B><BR><B>Marco Girelli</B> <BR><B>John Lewis</B> <BR> 509  The Issue of Multicenter Trials: Can One Multicenter Trial be an Alternative to
the Concept of &quot;At Least Two Pivotal Studies&quot;?
<P>
<HR><CENTER><H2><B>Dissertation/Thesis Summary Abstracts</B></H2></CENTER>
<P>
<HR><B>Thomas W. Teal</B><BR>  511  Editor's Note: Dissertation/Thesis
Summary Abstracts 
<P>
<HR><B>Abstracts</B> <BR> 513  Dissertation/Thesis Summary Abstracts
<P>
<HR><CENTER><H2><B>Additional Articles of Interest</B></H2></CENTER>
<P>
<HR><B>Brigitta Bienz-Tadmor</B><BR><B>Pheak Son Seo</B><BR><B>Natalie R. Bryant</B><BR>  523  Research and Development, Manufacturing, and Marketing of Biopharmaceuticals: An International Comparison
<P>
<HR><B>Alan Saltzman</B><BR>  531  Cost and Value of Information in American Pharmaceutical Companies
<P>
<HR><B>Theodore L. Ploughman</B><BR>  545  Evolution of the Role of Project
Manager
<P>
<HR><B>Kenneth A. Getz</B><BR><B>Scott F. Fisher</B><BR><B>Sheldon Brookman</B> <BR> 551  Managing Research Centers as a Portfolio of Strategic Resources
<P>
<HR><B>George Bolger</B><BR> <B>Paul Reinstein</B><BR><B>Traci Tate</B><BR> 563  Communicating Drug Quality Observations
<P>
<HR><B>Sylvia M. Wallace</B><BR><B>Linda G. Suveges</B><BR><B>Kathleen F. Gesy</B><BR> 571  Adverse Drug Reaction Reporting
Part I: A Survey of Pharmacists and Physicians in Saskatchewan
<P>
<HR><B>Linda G. Suveges</B><BR><B>Kathleen F. Gesy</B><BR><B>Sylvia M. Wallace</B><BR><B>James L. Blackburn</B><BR><B>W. C. Appel</B> <BR>581  Adverse Drug Reaction Reporting Part II: Evaluation of the Saskatchewan Pilot Project for a Regional Reporting Program in Canada
<P>
<HR><B>Gregory B. Brown</B><BR> 591  The Changing Audience for Clinical
Trials
<P>
<HR><B>M. R. Couper</B><BR> 599  Prescribing-A Global Perspective
<P>
<HR><B>Alan T. Cariski</B><BR> 603  Patient Package Inserts-The American
Regulatory and Industry Perspective
<P>
<HR><B>Urban Rosenqvist</B><BR><B>Aina H&ouml;glund</B><BR><B>J.</B> <B>Lars G. Nilsson </B> <BR> 609  Diabetes Mass Education for Patients, Their Educators, and the General Public by
the Pharmacies of Sweden
<P>
<HR><B>Juan Carlos Prieto</B> <BR>617  Problems with Practical Therapeutics
in Chile
<P>
<HR><B>D. C. Jayasurlya</B><BR> 623  Legislative Measures for Dealing
with Counterfeit Drugs in Developing Countries
<P>
<HR><B>Mohammed Hassar</B><BR> 629  Problems with Practical Therapeutics
in Morocco
<P>
<HR><B>Roger Cuff</B><BR> 633  United Kingdom Guidelines on Counterfeit
Drugs
<P>
<HR><B>G.</B> <B>Groenewoud</B><BR><B>P. J. Bell</B> <BR> 639  The Need for Pretrial Audits
in Clinical Trials-An Investigator's Perspective
<P>
<HR><B>Yasuo Sakurai</B><BR><B>Norio Kugai</B><BR><B>Toshio Kawana</B><BR><B>Tadazumi Fukita</B> <BR><B>Shigeo Fukumoto</B><BR> 645  A Comprehensive Adverse Events Management System for the Pharmaceutical Industry: The Takeda TRAC System
<P>
<HR><B>Steve Jolley</B><BR> 661  Clinical Safety, Administration, and
Data Systems: How Should They be Integrated?<P>
<HR><B>Douglas E. May</B><BR> 665  The Impact of Technology on Everything
Else
<P>
<HR><B>Vinay Bhatt</B><BR> 675  How Validation Pays for Itself
<P>
<HR><B>F. Ferigo</B><BR><B>B. Vincenzi</B> <BR>683  Experience of International Data Management
for Drug Development in a Local Operating Company
<P>
<HR><B>David Elderkin</B><BR> 687  Choosing a Software Development Methodology
for Document Management Systems
<P>
<HR><B>Kellie Souza</B> <BR><B>Robert D. Small</B><BR>695  The Use of Total Quality Management Principles in Placing and Monitoring Clinical Trials
<P>
<HR><B>Nancy L. Geller</B><BR><B>Michael A. Proschan </B><BR><B>Dean A. Follmann</B><BR> 705  Group Sequential Monitoring of MultiArmed Clinical Trials
<P>
<HR><B>Fanny Y. C. Ki</B><BR><B>Shein-Chung Chow </B><BR> 715  Statistical Justification for the Use
of Composite Scores in Quality of Life Assessment
<P>
<HR><B>A. J. Sankoh</B> <BR> 729  Interim Analyses: An FDA Reviewer's
Experience and Perspective
<P>
<HR><B>Abie Ekangaki   </B><BR>739  Assessing the Adequacy of Standard
Clinical Definitions of Important Vaginal Bleeding Disorders 
<P>
<HR><B>Harold E. Glass  </B><BR><B>Joann M. Sullivan </B><BR><B>Joann M. Sullivan </B><BR>  751  Managing Clinical Grant Costs Through the Use of Unaffiliated Investigators
<P>
<HR><B>Kjell Skaug  </B><BR>761  The Changing Focus in the Pharmaceutical
Industry
<P>
<HR><B>Peter J. D. Ryan  </B><BR>767  Integrated Clinical Databases: Developing
an Effective Strategy Toward a CANDA
<P>
<HR><B>Matevz Kmet  </B><BR><B>Mirjam Sopar-Urleb</B><BR> 773  LEK's Approach to CANDAs
<P>
<HR><B>Thomas J. Hill  </B><BR>783  Forecasting Resources for Clinical
Trials: An Art or a Science? 
<P>
<HR><CENTER><B>Volume 29, Number 3         ( July-September 1995 )</B></CENTER>
<P>
<CENTER><STRONG>CONTENTS</STRONG></CENTER>
<P>
<HR><B>Shein-Chung Chow  </B><BR>793  Guest Editor's Note: Bioavailability
and Bioequivalence
<P>
<HR><B>Shein-Chung Chow  </B><BR><B>Jen-Pei Liu</B><BR> 795  Current Issues in Bioequivalence
Trials
<P>
<HR><B>Marvin C. Meyer  </B><BR>805  Current Scientific Issues Regarding
Bioavailability/ Bioequivalence Studies: An Academic View
<P>
<HR><B>Mei-Ling Chen  </B><BR><B>Roger L. Williams </B> <BR>813  Women in Bioavailability/Bioequivalence Trials-A Regulatory Perspective
<P>
<HR><B>Larry F. Lacey  </B><BR><B>Oliver N. Keene</B><BR><B>Alan Bye  </B><BR> 821  Glaxo's Experience of Different Absorption
Rate Metrics of Immediate Release and Extended Release Dosage Forms
<P>
<HR><B>Nancy C. Sambol  </B><BR>841  Analysis of a Bioequivalence Trial
Using Mixed Effects Modeling
<P>
<HR><B>Laszlo Endrenyi  </B><BR>847  A Simple Approach for the Evaluation
of Individual Bioequivalence
<P>
<HR><B>Olivier Guilbaud  </B><BR>857  Exact Comparisons of Means and Within-Subject
Variances in 2 x 2 Crossover Trials
<P>
<HR><B>Jen-Pei Liu   </B><BR><B>Shein-Chung Chow </B><BR>871   Replicated Crossover Designs in Bioavailability and Bioequivalence Trials
<P>
<HR><B>Vinod P. Shah  </B><BR><B>Lawrence J. Lesko   </B><BR> 885  Current Challenges and Future Regulatory Directions in <I>In Vitro </I>Dissolution
<P>
<HR><B>P. G. Welling  </B><BR><B>S. T. Forgue</B><BR><B>J. A. Cook</B><BR><B>T. M. deVries</B><BR>893  <I>In Vitro-In Vivo </I>Correlations-Quo
Vadis
<P>
<HR><B>Lewis J. Leeson  </B><BR>903  <I>In Vitro/In Vivo </I>Correlations
<P>
<HR><B>Wayne A. Colburn  </B><BR>917  Clinical Markers and Endpoints in
Bioequivalence Assessment
<P>
<HR><B>Lynn K. Pershing  </B><BR>923  Assessment of Topical Corticosteroidlnduced
Skin Blanching Response Using the Visual McKenzieStoughton and Colorimetric Methods
<P>
<HR><B>Wallace P. Adams  </B><BR>935  Albuterol MDI <I>In Vivo </I>Bioequivalence:
FDA's Office of Generic Drugs' DoseResponse Studies
<P>
<HR><B>Alison Bowers  </B><BR>941  Regulatory Considerations Associated
with the <I>In Vivo</I> Bioequivalence Assessment of Metered-Dose Inhalers
<P>
<HR><B>Sharon Anderson  </B><BR> 961  Current Issues of Individual Bioequivalence
<P>
<HR><B>Daniel J. Holder  </B><BR><B>Francis Hsuan   </B><BR> 965  A Moment-Based Criterion for Determining Individual Bioequivalence
<P>
<HR><B>Volker W. Steinijans  </B><BR><B>Rita Sauter    </B><BR><B>Dieter Hauschke</B><B>Martina Elze</B><BR> 981  Metrics to Characterize ConcentrationTime
Profiles in Single and MultipleDose Bioequivalence Studies
<P>
<HR><B>Jiuhong Zha  </B><BR><B>Laszlo Tothfalusi   </B><BR><B>Laszlo Endrenyi</B><BR>989  Properties of Metrics Applied for the Evaluation of Bioequivalence
<P>
<HR><B>France Mentr&eacute;  </B><BR><B>Pascale Burtin   </B><BR><B>Yann Merl&eacute;</B><BR><B>Joost Van Bree</B><BR><B>Alain Mallet</B><BR><B>Jean-Louis Steimer</B> <BR>997  SparseSampling Optimal Designs in Pharmacokinetics and Toxicokinetics
<P>
<HR><B>Hsing-Chu Hsu  </B><BR><B>Hai-Lin Lu</B><BR><B>T. Cynthia Chi   </B><BR><B>Keith K. H. Chan</B> <BR>1021  A Comparative Study of Confidence
Interval and Confidence Region Methods in Determination of Bioequivalence Between Two Formulations
<P>
<HR><B>Emmanuel Mohandoss  </B><BR><B>Shein-Chung Chow   </B><BR><B>Fanny Y. C. Ki</B> <BR>1029  Application of Williams' Design for Bioequivalence Trials
<P>
<HR><B>Kevin Gough  </B><BR><B>Michael Hutchison </B><BR><B>Oliver Keene</B><BR><B>Bill Byrom</B><BR><B>Stuart Ellis</B><BR><B>Larry Lacey</B><BR><B>John McKellar</B><BR>1039  Assessment of Dose Proportionality: Report From the Statisticians in the Pharmaceutical Industry/ Pharmacokinetics UK Joint Working Party
<P>
<HR><B>Oliver Yoa-Pu Hu  </B><BR><B>Mei-Ling Hsiao   </B><BR><B>LiLing Liu   </B><BR>1049  The Drug Regulatory Process of the Republic of China-Taiwan's Experiences in Bioavailability and Bioequivalence
<P>
<HR><B>Volker W. Steinijans  </B><BR><B>Dieter Hauschke   </B><BR><B>Robert Schall   </B><BR> 1055  International Harmonization of Regulatory Requirements for Average Bioequivalence and Current Issues in Individual Bioequivalence
<P>
<HR>
<CENTER><H2><B>Letters to the Editor</B></H2></CENTER>
<P>
<HR><B>Jen-Pei Liu  </B><BR>1063  Letter to the Editor on &quot;Sample
Size for Therapeutic Equivalence Based on Confidence Interval,&quot; S. C. Lin, <I>Drug Information</I><I>   Journal, </I>1995 ;29(1)4550
<P>
<HR><B>Carl M. Metzler  </B><BR>1065  Letter to the Editor on &quot;Sample
Size for Therapeutic Equivalence Based on Confidence Interval,&quot; S. C. Lin, <I>Drug Information
</I><I>   Journal, </I>1995 ;29(1)4550
<P>
<HR><B>Stan C. Lin  </B><BR>1067  Reply to Carl M. Metzler's Letter to
the Editor 
<P>
<HR>
<CENTER><B>Volume 29, Number 4          October-December 1995</B></CENTER>
<P>
<CENTER><STRONG>CONTENTS</STRONG></CENTER>
<P>
<HR><B>Thomas W. Teal  </B><BR>1069  Editor's Note
<P>
<HR><B>David Jefferys  </B>1071  Can the Drug Regulatory Process be
Made More Efficient?- A View From the Medicines Control Agency
<P>
<HR><B>Gerald J. Mossinghoff  </B><BR>1077  Health Care Reform and Pharmaceutical
Innovation
<P>
<HR><B>David M. Cocchetto  </B><BR>1091  Can Regulatory Affairs Personnel
Add Value When the Goal is Increasing Speed of Drug Development?
<P>
<HR><B>Larry R. Versteegh  </B><BR>1097  Bringing Information on Evolving
FDA Standards to Bear on Ongoing Drug Development Programs
<P>
<HR><B>Carolyn Blank Morris  </B><BR><B>Kevin Alan Schulman   </B> <BR>1105  The Emerging Role of the Food and Drug Administration in Pharmacoeconomic Evaluation During the Drug Development Process
<P>
<HR><B>Hubertus Cranz  </B><BR>1113  Switching in Europe: Prescription
to Nonprescription Status
<P>
<HR><B>Helene Dumitriu  </B><BR>1121  The Industry View of International
Standardization of Regulatory Dossiers
<P>
<HR><B>Helene Dumitriu  </B><BR>1125  Draft Notice to Applicants III/5445/94:
What is New?
<P>
<HR><B>Kathryn Huntley  </B><BR><B>Mary Jo Veverka</B><BR><B>Minna Golden</B><BR> 1133  The FDA's Medical Dictionary for Drug Regulatory Affairs Alpha Test 
<P>
<HR><B>Frank A. Beebe  </B><BR>1145  Pharmaceutical Marketing in the 1990s: Adjusting to New Market Realities
<P>
<HR><B>Gunther Winkler  </B><BR><B>Rufus Marsh   </B> <BR>1155  An Instrument to Evaluate the Performance of Contract Research Organizations
<P>
<HR><B>Gunther Winkler  </B><BR><B>Nicki S. Kirchof   </B> <BR>1165  Preparing the Sponsor's Project Manager for a CRO-Based Clinical Trial
<P>
<HR><B>Douglas R. Mackintosh  </B><BR><B>Vernette J. Zepp</B> <BR>1175  Getting a Better Deal: Unbundled Contract Research Organization Prices
<P>
<HR><B>Robert H. Jones  </B><BR>1181  The Pharmaceutical Price Regulation
Scheme in the United Kingdom
<P>
<HR><B>E. Paul Larrat  </B><BR>1187  Principles and Approaches to Pharmacoeconomics:
The Perspective of Higher Education
<P>
<HR><B>Michael E. Minshall  </B><BR><B>Alison Dawson   </B><BR> 1191  Integrating a Global Health
Economics Study Within a Phase III Clinical Trial
<P>
<HR><B>Manai Yamamoto  </B><BR><B>Yuna Onaka</B><BR><B>Tomoko Hirai</B> <BR><B>Megumi Kuroko</B><BR><B>Hisako Negi</B><BR><B>Akimoto Yamada</B> <BR><B>Seizaburo Okada</B><BR>1201  Drug Information in the Japanese
Pharmaceutical Industry: Analysis of an Eight-Year Investigation
<P>
<HR><B>Karin Bredal Jensen </B><BR> 1211  Good Manufacturing Practice Inspection
in Europe, in Light of the New Central Agency and Current International Agreements 
<P>
<HR><B>Paul Meng  </B><BR><B>Otmar Ladanyi </B><BR><B>Pamela Walil</B><BR> 1217  Clinical Trials in Eastern Europe 
<P>
<HR><B>Anthony C. Cartwright  </B><BR><B>Manuel Zahn</B><BR> 1225  The Format and Content of
a Global Chemical/ Pharmaceutical Documentation-A Proposal
<P>
<HR><B>Andreas Zipfel  </B><BR>1237  The Industry Perspective Regarding
Compliance With Both European Union and American Good Clinical Practice Guidelines
<P>
<HR><B>J.</B> <B>Lars G. Nilsson  </B><BR><B>Hans Johansson   </B><BR><B>Mats Wennberg   </B> <BR>1243  Large Differences Between Prescribed and Dispensed Medicines Could Indicate Undertreatment
<P>
<HR><B>James Nickas  </B><BR>1247  Adverse Event Data Collection and Reporting:
A Discussion of Two Grey Areas
<P>
<HR><B>Richard A. Wildeman  </B><BR>1253  Pharmacoeconomic Challenges in Canada
<P>
<HR><B>Ruth Fries  </B><BR><B>James Ray</B><BR> 1259  A Computerized Informed Consent Document
<P>
<HR><B>Thomas J. Newman  </B><BR>1263  From Bedside to Package Insert:
Presentation of AEs in Product Labeling
<P>
<HR><B>Yvan Bogaievsky  </B><BR>1269  Fraud and Misconduct in Clinical
Research: Company Dilemmas and Solutions
<P>
<HR><B>G. Tabusso  </B><BR>1275  Quality Education: Regulatory Aspects
in the Pharmaceutical Industry
<P>
<HR><B>Jon M. Rogers  </B><BR><B>Elizabeth J. Alter   </B><BR><B>David J. Carpenter</B><BR> 1285  A Method for Investigator Identification
and Recruitment at Scientific Meetings
<P>
<HR><B>Malcolm L. Schuyl  </B><BR><B>Thim Engel   </B><BR> 1291  A Review of the Source Document
Verification Process in Clinical Trials 
<P>
<HR><B>John F. Kamp  </B><BR>1301  An Advertising Agency Perspective of
Food and Drug Administration Pharmaceutical Regulation 
<P>
<HR><B>llyssa Levins  </B><BR>1307  Good Health Care Public Relations
Mirrors the Practice of Good Medicine
<P>
<HR><B>Patricia M. E. McCormack  </B><BR><B>J.</B> <B>Feely   </B><BR> 1311  Special Populations and
Product Labeling: The Consumer's Perspective
<P>
<HR><B>Sarah L. Labor  </B><BR><B>Jon C. Schommer   </B><BR><B>Dev S. Pathak </B><BR>1317  Information Overload with Written Prescription Drug Information 
<P>
<HR>
<CENTER><H2><B>1st Annual Biostatistics Meeting in Tokyo, Japan</B></H2></CENTER>
<P>
<HR><B>Yayoi Sasaki  </B><BR>1329  Guest Editor's Note: 1st Annual Biostatistics
Meeting: Similarities and Differences in Statistical Drug Evaluation Methodology Among
Japan, the United States, and Europe, Including Current Issues in Biostatistics
<P>
<HR><B>Akira Sakuma  </B><BR>1331  An Overview of Current Statistical
Issues Relevant to International Harmonization
<P>
<HR><B>Uwe J. Ferner  </B><BR><B>Michael R. Clarke   </B> <BR>1337  American, Japanese, and European Regulatory Guidelines with Respect to Biostatistics:
A Personal View
<P>
<HR><B>Thomas J. Cook  </B><BR>1345  Differences in Clinical Drug Development
in Europe, Japan, and the United States: A Biostatistician's Perspective
<P>
<HR><B>Robert T. O'Neill  </B><BR>1357  Recent Methodological Issues in
Drug Evaluation: A Perspective from the United States
<P>
<HR>
<CENTER><H2><B>Measures and Methods in Clinical Trials</B></H2></CENTER>
<P>
<HR><B>Eva Lydick  </B><BR><B>M. Eugene Smith   </B><BR> 1369  Cost-Effectiveness Analysis: Measures
and Methods in Clinical Trials: Introduction
<P>
<HR><B>Eva Lydick  </B><BR><B>M. Eugene Smith   </B><BR>1371  Cost-Effectiveness Analysis: Measures
and Methods in Clinical Trials: Orientation
<P>
<HR><B>Earl P. Steinberg  </B><BR>1375  The Role of Outcomes Research
in a Cost-Conscious Health Care Marketplace
<P>
<HR><B>Jan E. Hansen  </B><BR>1383  Pharmacoeconomics in Clinical Trials:
Why Bother?
<P>
<HR><B>Henry Glick  </B><BR>1391  Strategies for Economic Assessment During the Development of New Drugs
<P>
<HR><B>Kevin A. Schulman  </B><BR><B>K. Robin Yabroff   </B><BR><B>Henry Glick   </B> <BR>1405  A Health Services Approach for
the Evaluation of Innovative Pharmaceutical and Biotechnology Products
<P>
<HR><B>Marc L. Berger  </B><BR>1415  Design of Prospective Cost-Effectiveness
Clinical Trials: The Critical Role of the Comparator Group
<P>
<HR><B>Andrew M. Baker  </B><BR><B>Renee J. Goldberg Arnold   </B><BR><B>Diana J. Kaniecki</B> <BR>1421  Considerations in Measuring Resource Use in Clinical Trials
<P>
<HR><B>Jon Clouse  </B><BR>1429  The Effect of Methodological Advances
in Health Economics on the Marketplace
<P>
<HR><B>Kit N. Simpson  </B><BR>1431  Modeling with Clinical Trial Data:
Moving from the Data Researchers Have to the Data Decision Makers Need
<P>
<HR><B>Henry Glick  </B><BR><B>Bruce Kinosian   </B><BR> 1441  Evaluating the Efficiency of Cholesterol Modification for Coronary Heart Disease with Decision Analytic Models: A Case Study
<P>
<HR><B>Dennis A. Revicki  </B><BR>1459  Measuring Health Outcomes for
Cost-Effectiveness Studies: Are All Quality Adjusted Life Years Created Equal?
<P>
<HR><B>Bryan R. Luce  </B><BR>1469  Policy Implications of Modeling the Cost-Effectiveness of Health Care Technologies
<P>
<HR><B>Peter Vlasses  </B><BR>1477  Conducting and Applying Pharmacoeconomic
Studies in Academic Health Centers
<P>
<HR><B>Barbara Yawn </B> <BR>1487   Point of View of A Clinician
<P>
<HR><B>Kathleen A. Weis</B> <BR> 1491  A Federal Perspective
<P>
<HR><B>Jill Wechsler  </B><BR>1495  The FDA Position on Cost-Effectiveness:
A Reporter's View
<P>
<HR><CENTER>Volume 29 Supplement          October-December 1995</CENTER>
<P>
<CENTER><STRONG>CONTENTS</STRONG></CENTER>
<P>
<CENTER><B>Summaries of Doctoral Dissertations/Theses</B></CENTER>
<P>
<HR><B>Thomas W. Teal  </B><BR>1499S  Editor's Note: Dissertation/Thesis
Summaries
<P>
<HR><B>Ann E. Eakin  </B><BR><B>James H. McKerrow   </B><BR><B>Charles S. Craik</B><BR>1501S  A Cysteine Protease is a Target for
the Enzyme StructureBased Design of Antiparasitic Drugs
<P>
<HR><B>Joseph F. Spillane  </B><BR>1519S  Discovering Cocaine: An Historical
Perspective on Drug Development and Regulation
<P>
<HR><B>Susan F. Law  </B><BR>1529S  Somatostatin Receptor/G Protein Coupling
Directs the Regulation of Effector Systems
<P>
<HR><B>Susan Murray  </B><BR>1543S  Improving Efficiency of Estimation
and Testing for Censored Data Using Auxiliary Covariates
<P>
<HR><B>Sandra J. Lee  </B><BR>1563S  Group Sequential Monitoring of Clinical
Trials with Multivariate Outcomes
<P>
<HR><B>Eric M. Hillson  </B><BR><B>Jaxk H. Reeves   </B><BR>1583S  A Lag Adjusted Model for Postmarketing Surveillance of Adverse Drug Event Reports
<P>
<HR><B>Hyungjin Myra Kim  </B><BR><B>Stephen W. Lagakos   </B><BR>1601S  Estimation of Individual and
Population Noncompliance Using Longitudinal Marker Data, with Application to AIDS 
<P>
<HR><B>Paul Bamborough  </B><BR><B>W.</B> <B>Graham Richards   </B><BR>1615S  Molecular Modeling of Cytokines and Their Receptors
<P>
<HR><B>Kevin J. Yarema  </B><BR>1633S  Comparative Toxicities and Mutagenicities
of Platinum Anticancer Drugs 
<P>
<HR>
<CENTER><H2><B>Abstracts of Summaries of Doctoral Dissertations/Theses</B></H2></CENTER>
<P>
<HR><B>Thomas W. Teal  </B><BR>1645S  Editor's Note: Dissertation/Thesis
Summary Abstracts 
<P>
<HR><B>Abstracts</B> <BR> 1647S  Dissertation/Thesis Summary Abstracts
<P>
<HR><CENTER><H2><B>Additional Articles of Interest</B></H2></CENTER>
<P>
<HR><B>Daniel E. Worden  </B><BR>1663S  The Drive Toward Regulatory Harmonization:
What is Harmonization and How Will it Impact the Global Development of New Drugs? 
<P>
<HR><B>Thomas R. Fleming  </B><BR>1681S  Interpretation of Subgroup Analyses
in Clinical Trials
<P>
<HR><B>Richard B. Anderson  </B><BR><B>Johanna F. Nackley   </B><BR><B>Marcia A. Testa   </B> <BR>1689S  Symptom Distress Check Lists as a Component of Quality of Life Measurement: Comparing Symptom Reports with Responses to Multiple Choice Questionnaires
<P>
<HR><B>Stephen Cutler  </B><BR><B>Cavan Redmond   </B><BR> 1709S  Reducing Drug Development Time-Focus on Patient Recruitment
<P>
<HR><B>Sven A. Eriksson  </B><BR>1719S<B>  </B>Statistical Analysis of
Ulcer Trials with Intermittent Treatment 
<P>
<HR><B>Bill G. Felkey  </B><BR><B>J. Tyrone Gibson   </B><BR><B>Kenneth N. Barker   </B><BR><B>Robert E. Pearson </B><BR>1727S  Development of a Visualized Drug
Information Database for United States Pharmacopeia Dispensing Information 
<P><HR><P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
</BODY>



</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-421</DOCNO>
<DOCOLDNO>IA040-000752-B023-22</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a4b.htm 199.92.136.137 19970111152620 text/html 8084
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:28:00 GMT
Last-modified: Tuesday, 23-Jul-96 17:06:07 GMT
Content-length: 7893
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Author Index</TITLE>
</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL> DRUG INFORMATION JOURNAL </UL>
<P>
<CENTER>  INDEX TO VOLUME 29 (1995)</CENTER>
<P>
   
<P>
<CENTER><STRONG>AUTHOR INDEX </STRONG><BR>
(List of Author's Names and Page Numbers)</CENTER>
<P>
<HR>
<CENTER><STRONG><B>Author Index to Volume 29 (1995)</B></STRONG></CENTER>
<TABLE BORDER=0 ALIGN=CENTER VALIGN=TOP CELLPADDING=45>

        <TR>
        <TD VALIGN=TOP>

Adams WP, 935<BR>

Alexander J, 497<BR>

Alter EJ, 1285<BR>

Amery WK, 51<BR>

Anderson RB, 1689S<BR>

Anderson S, 961<BR>

Appel WC, 581<BR>

Baker A, 1421<BR>

Bamborough P, 1615S<BR>

Barker KN, 1727S<BR>

Barranco CP, 61<BR>

Bartek PA, 91<BR>

Beebe FA, 1145<BR>

Bell PJ, 639<BR>

Benichou C, 315<BR>

Berger ML, 1415<BR>

Bhatt V, 675<BR>

BienzTadmor B, 523<BR>

Blackburn JL, 581<BR>

Blank Morris C, 1105<BR>

Bogaert MG, 285<BR>

Bogaievsky Y, 1269<BR>

Bolger G, 563<BR>

Bowers A, 941<BR>

Bredal Jensen K, 1211<BR>

Bristol DR, 33<BR>

Brock DW, 445<BR>

Brookman S, 551<BR>

Brown GB, 591<BR>

Brown JS, 361<BR>

Bryant N, 523<BR>

Burstall ML, 273<BR>

Burtin P, 997<BR>

Buyse M, 79, 507<BR>

Bye A, 821<BR>

Byrom B, 1039<BR>

Cardie ML, 187<BR>

Cariski AT, 603<BR>

Carpenter DJ, 1285<BR>

Cartwright AC, 1225<BR>

Caso MA, 453<BR>

Chan KKH, 1021<BR>

Chaves A, 87<BR>

Cheix F, 201<BR>

Chen ML, 813<BR>

Chen ST, 27<BR>

Chi TC, 1021<BR>

Chow S-C, 715, 793, 795, 871, 1029<BR>

ChuangStein C, 37<BR>

Clark P, 497<BR>

Clarke MR, 1337<BR>

Clouse J, 1429<BR>

Cocchetto DM, 1091<BR>

Colburn WA, 917<BR>

Collins M, 493<BR>

Cook JA, 893<BR>

Cook TJ, 1345<BR>

Copp J, 503<BR>

Couper MR, 599<BR>

Craik CS, 1501S<BR>

Cranz H, 1113<BR>

Cuff R, 633<BR>

Cutler S, 1709S<BR>

Czarnecki A, 307<BR>

Danan G, 291 <BR>

Daniels N, 445 <BR>

Dawson A, 1191 <BR>

Decoster G, 79 <BR>

de Cr&eacute;miers F, 201 <BR>

de Vries TM, 893 <BR>

Dimasi JA, 375 <BR>

Dinella C, 147 <BR>

Driessen S, 509 <BR>

Dumais H, 201 <BR>

Dumitriu H, 1121, 1125 <BR>

Dupont Ch, 201<BR>

Eakin AE, 1501S<BR>

Ekangaki A,739<BR>

Elderkin D, 687<BR>

Ellis S, 1039<BR>

Elze M, 981<BR>

Endrenyi L, 847, 989<BR>

Engel T, 1291<BR>

Eriksson SA, 1719S<BR>

Essers H, 503<BR>

Fallowfield JM, 327<BR>

Feely J, 1311<BR>

Feldbaum CB, 435<BR>

Felkey BG, 1727S<BR>

Ferigo F, 683<BR>

Ferner UJ, 1337<BR>

Fisher SF, 551<BR>

Fleming TR, 1681S<BR>

Folb PI, 303<BR>

Follmann DA, 705<BR>

Forgue ST, 893<BR>

Fries R, 1259<BR>

Fukita T, 645<BR>

Fukumoto S, 645<BR>

Gasperino J, 99<BR>

Geller NL, 705<BR>

George RH, 107<BR>

Gesy KF, 571, 581<BR>

Getz KA, 551<BR>

Gibson JT, 1727S<BR>

Gillum TL, 107<BR>

Giovenella AJ, 115, 425, 469<BR>

Girelli M, 473, 509<BR>

Glass HE, 751<BR>

Glick H, 1391, 1405, 1441<BR>

Godley M, 497<BR>

Goldberg Arnold RJ, 1421<BR>

Golden MS, 11, 1133<BR>

Gough K, 1039<BR>

Gretz M, 163<BR>

Grob A, 479<BR>

Groenewoud G, 639<BR>

Guilbaud O, 857<BR>

Hansen JE, 1383<BR>

Harrison M, 507<BR>

Hassar M, 629<BR>

Hauschke D, 981, 1055<BR>

Helmanis AM, 261<BR>

Herman RL, 313<BR>

Hewitt P, 385<BR>

Hill TJ, 783<BR>

Hillman AL, 429<BR>

Hillson EM, 1583S<BR>

Hirai T, 1201<BR>

Hoglundand A, 609<BR>

Holder DJ, 965<BR>

Honig PK, 127<BR>

Hopp Dl, 69<BR>

Hsiao ML, 1049<BR>

Hsu HC, 1021<BR>

Hsuan F, 965<BR>

Hu OYP, 1049<BR>

HuntleyK, 1133<BR>

Hutchison M, 1039<BR>

Jain KK, 339<BR>

Jayasuriya DC, 623<BR>

Jefferys D, 1071<BR>

Johansson H' 1243<BR>

Jolley S, 661<BR>

Jones RH, 1181<BR>

Juillet Y, 291<BR>

Kaitin KI, 355, 361<BR>

Kamp JF, 1301<BR>

Kaniecki DJ, 1421<BR>

Kawana T, 645<BR>
Keene ON, 821, 1039<BR>

Ki FYC, 715, 1029<BR>

Kim HM, 1601S<BR>

Kinosian B, 1441<BR>

Kmet M, 773<BR>Kuhnert BR, 267<BR>
<TD VALIGN=TOP>
Kirchof NS, 1165<BR>

Kugai N, 645<BR>

Kuroko M, 1201<BR>

Kwok MCO, 319<BR>

Labor SL, 1317<BR>

Lacey LF, 821, 1039<BR>

Ladanyi O, 1217<BR>

Lagakos SW, 1601S<BR>

Lanctot KL, 319<BR>

LarratEP, 1187<BR>

Lasagna L, 415<BR>

Laugel V, 201<BR>

Law SF, 1529S<BR>

Lee SJ, 1563S<BR>

Leeson LJ, 903<BR>

Legrand C, 201<BR>

Leitmeyer JE, 107<BR>

Lendrem D, 497<BR>

Leroy A, 507<BR>

Lesko LJ, 885<BR>

Levins I, 1307<BR>

Lewis J, 509<BR>

Lin SC, 45<BR>

Liu JP, 795, 871, 1063<BR>

Liu LL, 1049<BR>

Lu HL, 1021<BR>

Luce BR, 1469<BR>

Lydick E, 1369, 1371<BR>

Lynn R, 99<BR>

Macchetto C, 131<BR>

Mackintosh DR, 1175<BR>

Mallet A, 997<BR>

Manocchia M, 385<BR>

Marsh R, 1155<BR>

May DE, 665<BR>

McCool K, 297<BR>

McCormack PME, 1311<BR>

McKellar J, 1039<BR>

McKerrow JH, 1501S<BR>

Meng P, 1217<BR>

Mentre F, 997<BR>

Merle Y, 997<BR>

Metzler CM, 1065<BR>

Meyer MC, 805<BR>

Minshall ME, 1191<BR>

Mohandoss E, 1029<BR>

Mossinghoff GJ, 1077<BR>

Murray S, 1543S<BR>

Nackley JF, 1689S<BR>

Naranjo CA, 319<BR>

Negi H, 1201<BR>

Newman TJ, 1263<BR>

Nickas J, 1247<BR>

Nightingale SL, 1<BR>

Nilsson JLG, 609, 1243<BR>

Okada S, 1201<BR>

Onaka Y, 1201<BR>

O'Neill RT, 1357<BR>

Pakes GE, 139<BR>

Pathak DS, 1317<BR>

Pearson RE, 1727S<BR>

Pershing LK, 923<BR>

Pierredon MA, 351<BR>

Ploughman TL, 545<BR>

Prieto JC, 617<BR>

Proschan MA, 705<BR>

Ray J, 1259<BR>

Reeves JH, 1583S<BR>

Reuben BG, 273<BR>

Redmond C, 1709S<BR>

Reinstein P, 563<BR>

Revicki DA, 1459<BR>

Richards WG, 1615S<BR>

Ritrovato CA, 147<BR>

Robertson A, 473,497<BR>

Rogers JM, 1285<BR>

Rosenqvist U, 609<BR>

Ryan PJD, 767<BR>

Ryerson BA, 155<BR>

Sakuma A, 1331<BR>

Sakurai Y, 645<BR>

Sambol NC, 841<BR>

Saltzman A, 531<BR>

Sankoh AJ,729<BR>

Sasaki Y, 1329<BR>

Sauter R, 981<BR>

Schall R, 1055<BR>

Schmidt K, 473, 483<BR>

Schommer JC, 1317<BR>

SchulmanKA, 1105, 1405<BR>

Schuyl ML, 1291<BR>

Seo PS, 523<BR>

Shah VP, 885<BR>

Shulman SR, 385<BR>

Simpson KN, 1431<BR>

Skaug K, 761<BR>

Small RD, 695<BR>

Smith ME, 1369, 1371<BR>

SoparUrleb M, 773<BR>

Spillane JF; 1519S<BR>

Steimer JL, 997<BR>

Steinberg EP, 1375<BR>

Steinijans VW, 981, 1055<BR>

Stephens MD, 335<BR>

Souza K, 695<BR>

Sullivan JM, 751<BR>

Suveges LG, 571, 581<BR>

Svensson K, 475<BR>

Tabusso G, 1275 <BR>

Tate T, 563 <BR>

Teal TW, 511, 1069, 1499S, 1645S <BR>

ten Ham M, 343 <BR>

Testa MA, 1689S <BR>

Theeuwes A, 503 <BR>

Thomas M, 163 <BR>

Tothfalusi L, 989 <BR>

Tucker NG, 187<BR>

Tufts Center for the Study of Drug Development, 357<BR>

Van Bree J, 997 <BR>

Vander Stichhele RH, 285 <BR>

Van Winkel M, 51 <BR>

Vardy A, 509 <BR>

Velagaleti R, 171 <BR>

Versteegh LR, 1097 <BR>

VeverkaMJ, 19, 1133 <BR>

Vincenzi B, 683 <BR>

Vlasses P, 1477 <BR>

von Frenckell R, 503<BR>

Yabroff KR, 1405<BR>

Yamada A, 1201<BR>

Yamamoto M, 1201<BR>

Yarema KJ, 1633S<BR>

Yawn B, 1487<BR>

Wallace SM, 571, 581<BR>

Waltl P, 1217<BR>

Wechsler J, 1495<BR>

Weis KA, 1491<BR>

Welling PG, ~3<BR>

Wennberg M, 1243<BR>

White MS, 181<BR>

Wildeman RA, 1253<BR>

Wiles A, 497<BR>

Wilkes M, 461<BR>

Williams RL, 813<BR>

WinklerG, 1155, 1165<BR>

Witt A, 11<BR>

Worden DE, 1633S<BR>

Zahn M, 1225<BR>

Zayas JM, 507<BR>

Zellmer WA, 439<BR>

Zepp J, 1175<BR>

ZhaJ, 11<BR>

Zipfel A, 471, 473, 479, 1237<BR>
</TABLE>
<HR>
<P>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>

</BODY>

</HTML>
</DOC>
<DOC>
<DOCNO>WT22-B27-422</DOCNO>
<DOCOLDNO>IA040-000752-B023-60</DOCOLDNO>
<DOCHDR>
http://www.diahome.org:80/dhp5a5a1.htm 199.92.136.137 19970111152638 text/html 7881
HTTP/1.0 200 OK
Server: Netscape-Communications/1.1
Date: Saturday, 11-Jan-97 15:28:18 GMT
Last-modified: Tuesday, 19-Nov-96 18:33:53 GMT
Content-length: 7690
Content-type: text/html
</DOCHDR>
<HTML>

<HEAD>

<TITLE>Table of Contents Volume 30 Issue 1</TITLE>


</HEAD>

<BODY BACKGROUND="paper.gif" LINK="#0000FF">
<CENTER><IMG SRC="dia.gif"></CENTER>
<HR>
<P>
PUBLICATIONS
<P>
<UL>DRUG INFORMATION JOURNAL</UL>
<P>
<CENTER><STRONG>TABLE OF CONTENTS - VOLUME 30 (1996)</STRONG></CENTER>
<P>
<CENTER><STRONG>ISSUE 1 (FEBRUARY 15)</STRONG></CENTER>
<P>
<CENTER><A HREF="http://www.adobe.com"><IMG SRC="acrowin.gif"></A>          <A HREF="http://www.adobe.com"><IMG SRC="acromac.gif"></A>          <A HREF="http://www.adobe.com"><IMG SRC="acrosun.gif"></A></CENTER> To view these abstracts of the Drug Information Journal you must have the appropriate viewer for your operating system, please download the Acrobat Reader for your specific operating system. Then just click on the abstract you wish to read and print it out. 

<HR>
<P>
<CENTER><B>CONTENTS FOR VOLUME 30, 1996</B>
<P>
<B>Volume 30, Number 1           January-March 1996</B></CENTER>
<P>
<HR><B>Keith Jones</B><BR> 1  <A HREF="dj230176.pdf"> Wider Perspectives of European Medicines
Control</A>

<HR><B>Fred W. Lyons, Jr.</B><BR> 9  <A HREF="dj230175.pdf"> The Patient is Waiting</A>

<HR><B>Jeffrey S. Brown</B><BR><B>Kenneth I. Kaitin</B><BR><B>Neil McAuslane </B><BR><B>Kate E. Thomas</B><BR><B>Stuart R. Walker</B><BR> 17  <A HREF="dj230162.pdf"> Population Exposure Required to Assess
Clinical Safety: Report to the International Conference on Harmonization Working Group</A>

<HR><B>Marlene E. Haffner</B><BR> 29  <A HREF="dj230161.pdf"> Orphan Drug Development Update</A>

<HR><B>Gunther Winkler </B> <BR><B>Elizabeth A. Levin</B><BR><B>Evelyn Y. Whalen</B><BR><B>John Larus</B><BR>35 <A HREF="dj230171.pdf"> Overcoming &quot;Trial Fatigue&quot;:
A Strategy for Optimizing Patient Accrual Speed and Resource Utilization</A>

<HR><B>Melvin P. Fisher</B> <BR><B>Virginia L. Pascucci </B><BR>41  <A HREF="dj230157.pdf"> Regulatory Reflections Concerning
the State of Biotechnology Progress</A>

<HR><B>Annie L. Britt</B><BR> 47  <A HREF="dj230168.pdf"> Safety Information Processing at the
FDA</A>

<HR><B>Steven W. Kopp</B><BR> 59  <A HREF="dj230156.pdf"> Direct to Consumer Advertising and Consumer Prescription Prices
</A>
<HR><B>Wayne L. Pines</B><BR> 67  <A HREF="dj230160.pdf"> A Time for Change in Advertising and
Promotion Regulation</A>

<HR><B>Win Castle</B><BR><B>George Phillips </B><BR> 73  <A HREF="dj230167.pdf"> Standardizing &quot;Expectedness&quot;   and&quot;Seriousness&quot; for Adverse Experience Case Reporting</A>

<HR><B>Stephanie Kirk</B><BR> 83  <A HREF="abstract/744.pdf"> The Value of CANDAs in Drug Development</A>

<HR><B>Rebecca J. Anderson</B><BR> 89  <A HREF="abstract/694.pdf"> Reducing and Controlling Overhead
Costs</A>

<HR><B>J&uuml;rgen Drews</B><BR><B>Stefan Ryser</B><BR> 97  <A HREF="abstract/764.pdf"> Innovation Deficit in the Pharmaceutical Industry</A>

<HR><B>Marie Ostman</B><BR> 109  <A HREF="abstract/596.pdf"> Product Specifications Setting and Review
Process for New Drug Entities</A>

<HR><B>Gunther Winkler</B><BR><B>Rufus Marsh</B><BR> 113   <A HREF="abstract/595.pdf"> Creating a Successful CROSponsor
Relationship Through Alignment of Goals and Values</A>

<HR><B>Guy P. Johnson  </B><BR>119  <A HREF="abstract/619.pdf"> A Financial Coming of Age for Clinical
Trial Investigators</A>

<HR><B>C. Dutar  </B><BR><B>E.</B> <B>O. Otun</B><BR>137  <A HREF="abstract/552.pdf"> A Worldwide Strategy for Dictionary Management</A>

<HR><B>Jay Magidson  </B><BR>143  <A HREF="abstract/554.pdf"> Maximum Likelihood Assessment of Clinical
Trials Based on an Ordered Categorical Response</A>

<HR><B>Kosaku Uchida  </B><BR>171  <A HREF="abstract/698.pdf"> Orphan Drugs in Japan </A>

<HR><B>Kenneth L. Hastings</B><BR><B>James G. Farrelly  </B><BR><B>Alan Taylor</B> <BR>177  <A HREF="abstract/682.pdf"> Evaluation of Preclinical Findings for 10-Day IND Safety Reports: FDA Considerations</A>

<HR><B>Gayle A. Flynn</B><BR><B>Robert W. Moyer  </B><BR> 181  <A HREF="abstract/692.pdf"> Processing Strategies for Integrated Safety Updates: The Venlafaxine Experience</A>

<HR><B>Terri L. Young</B><BR><B>Leonard J. Kirchdoerfer  </B><BR><B>Jane T. Osterhaus</B> <BR>185  <A HREF="abstract/611.pdf"> A Development and Validation Process
for a Disease-Specific Quality of Life Instrument</A>

<HR><B>J&uuml;rgen Windeler</B><BR><B>Hans-Joachim Trampisch</B><BR> 195  <A HREF="abstract/768.pdf"> Recommendations Concerning Studies on Therapeutic Equivalence</A>

<HR><B>Marie Ostman</B><BR> 201 <A HREF="abstract/581.pdf"> Standardization of Report Formats for
Chemistry/ Pharmacy Documents</A>

<HR><B>Robert A. Michalak</B><BR><B>Robert A. Mathews </B><BR><B>William D. Leslie</B> <BR><B>Ann A. Jenkins</B><BR><B>Manal S. Mehta</B><BR><B>Diana T. Asbjorn</B> <BR>207  <A HREF="abstract/621.pdf"> The Query Response System-A Database Which Captures Regulatory Questions/Responses</A>

<HR><B>Martin Thomas</B><BR><B>Marianne Gretz </B><BR> 217  <A HREF="abstract/622.pdf"> From Serum Cholesterol in Elephants to Morbidity in Nepal: An Empirical Analysis of 6,729 On-Line Searches at Boehringer Mannheim GmbH</A>

<HR><B>Daniel B. Goodman</B><BR> 237  <A HREF="abstract/684.pdf"> Standards for ECGs in Clinical Trails</A>

<HR><B>Thomas F. Krol  </B><BR><B>James C. Coleman </B><BR><B>Patrick J. Bryant</B><BR>243  <A HREF="abstract/685.pdf"> Scientific Competitive Intelligence
in R&amp;D Decision Making</A>

<HR><B>Mugdha R. Gore  </B><BR><B>Suzanne K. Hansen</B><BR><B>Loren L. Miller</B><BR>257  <A HREF="abstract/691.pdf"> Developing a Regulatory Strategy for
Monoclonal Antibodies</A>


<HR><CENTER><H2>Immunotoxicity and Carcinogenicity of Pharmaceuticals</H2></CENTER>

<HR><B>Jan Willem van der Laan</B><BR><B>Jack Dean</B><BR> 269  <A HREF="abstract/739.pdf"> Immunotoxicity of Pharmaceuticals: An Introduction to the Workshop</A>
<P>
<HR><B>J.</B> <B>Descotes</B><BR> 271  <A HREF="abstract/770.pdf"> Immunotoxicity of Pharmaceuticals:
An Introduction</A>

<HR><B>H. Van Loveren</B><BR><B>J. G. Vos  </B><BR><B>E. J. De Waal</B><BR> 275  <A HREF="abstract/740.pdf"> Testing lmmunotoxicity of Chemicals
as a Guide for Testing Approaches for Pharmaceuticals</A>

<HR><B>Michael I. Luster</B><BR><B>Petia Simeonova </B><BR><B>Dori R. Germolec</B><BR> <B>Christopher Portier</B><BR><B>Albert E. Munson</B><BR> 281  <A HREF="abstract/771.pdf"> Relationships Between Chemical-Induced Immunotoxicity and Carcinogenesis</A>

<HR><B>Ian Kimber</B><BR> 287  <A HREF="abstract/772.pdf"> Assessment of Allergic Potential</A>

<HR><B>Michael E. Kamm&uuml;ller</B><BR> 293  <A HREF="abstract/741.pdf"> Drug Induced Autoimmune Disorders</A>

<HR><B>Sylvia M. Furst</B><BR><B>Mingli Chen </B><BR><B>A. Jay Gandolfi</B><BR> 301  <A HREF="abstract/773.pdf"> Use of Halothane as a Model for Investigating Chemical-Induced Autoimmune Hepatotoxicitv</A>


<HR><B>Kenneth L. Hastings</B><BR> 309  <A HREF="abstract/742.pdf"> Autoimmunity and Allergy: Regulatory
Implications</A>

<HR><B>Jan Willem van der Laan</B><BR><B>Jack Dean</B><BR> 313  <A HREF="abstract/743.pdf"> Immunotoxicity of Pharmaceuticals: Conclusions of the Workshop</A>

<HR>
<CENTER><A HREF="index.htm"><IMG BORDER =0 SRC="home.gif"></A></CENTER><P>
<CENTER>Drug Information Association<BR>

321 Norristown Road, Suite 225, Ambler, PA, 19002-2755<BR>

Tel. +1-215-628-2288, Fax. +1-215-641-1229<BR>

or, for Europe, DIA, Postfach 4012, Basel, Switzerland<BR>

Tel. +41 61 382 90 19, Fax. +41 61 382 90 50<BR>

Drug Information Association 1996<BR></CENTER>
</BODY>

</HTML>
</DOC>
